PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, R; Cheung, NKV; Vider, J; Cheung, IY; Gerald, WL; Tickoo, SK; Holland, EC; Blasberg, RG				Huang, Ruimin; Cheung, Nai-Kong V.; Vider, Jelena; Cheung, Irene Y.; Gerald, William L.; Tickoo, Satish K.; Holland, Eric C.; Blasberg, Ronald G.			MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas	FASEB JOURNAL			English	Article						transcriptional regulation; survival	C-MYC; SELF-RENEWAL; TARGET GENE; N-MYC; TRANSGENIC MICE; BREAST-CANCER; STEM-CELLS; EXPRESSION; SENESCENCE; HETEROGENEITY	The BMI1 gene is overexpressed in similar to 90% of human neuroblastomas. However, little is known about the regulation of BMI1 expression. Using microarray and immunohistochemical analysis, we show that BMI1 expression correlated with MYCN levels in MYCN-amplified human neuroblastomas, and with MYC levels in the MYCN-nonamplified group. We further demonstrated that BMI1 is a direct target gene of MYCN/MYC in 3 neuroblastoma cell lines: BE (2)-C, LAN1, and SH-SY5Y. Overexpression of MYCN or MYC transactivated the BMI1 promoter and up-regulated BMI1 gene expression. shRNA-mediated knockdown of MYCN or MYC decreased BMI1 gene expression. Chromatin immunoprecipitation and point-mutation assays revealed that both MYCN and MYC bind to the E-box within the BMI1 promoter. Overexpression of BMI1, MYCN, and MYC independently increased both cell proliferation and tumor growth. Conversely, specific inhibition of BMI1, MYCN, and MYC decreased tumor cell proliferation and tumor growth. Interestingly, BMI1 suppression in MYCN/MYC-overexpressing cells resulted in significantly greater inhibition compared to that in mock-transduced and parental cells. Our results indicate that MYCN and MYC regulate BMI1 gene expression at the transcriptional level and that dysregulation of the BMI1 gene mediated by MYCN or MYC overexpression, confers increased cell proliferation during neuroblastoma genesis and tumor progression.-Huang, R., Cheung, N.-K. V., Vider, J., Cheung, I. Y., Gerald, W. L., Tickoo, S. K., Holland, E. C., Blasberg, R. G. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. FASEB J. 25, 4138-4149 (2011). www.fasebj.org	[Blasberg, Ronald G.] Mem Sloan Kettering Canc Ctr, Dept Neurol, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Cheung, Nai-Kong V.; Cheung, Irene Y.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Gerald, William L.; Tickoo, Satish K.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Blasberg, Ronald G.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Blasberg, RG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, Mol Pharmacol & Chem Program, Box 52,1275 York Ave, New York, NY 10065 USA.	blasberg@neuro1.mskcc.org	Vider, Jelena/AAW-8577-2020; Vider, Jelena/B-9663-2011	Vider, Jelena/0000-0003-1696-9812	Small Animal Imaging Core; U.S. National Institutes of Health [R01-CA102673, P50-CA086438, P01-CA106450]; NATIONAL CANCER INSTITUTE [R01CA102673, P01CA106450, P50CA086438] Funding Source: NIH RePORTER	Small Animal Imaging Core; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. David Cobrinik for the valuable comments on the manuscript. The authors thank Drs. Michael Cole (Dartmouth Medical School, Lebanon, NH, USA), Jan Jacob Schuringa (University Medical Center Groningen, Groningen, The Netherlands), and Anna Marie Kenney (Vanderbilt University Medical Center, Nashville, TN, USA) for their plasmids. The authors thank Katerina Dyomina, Hong-Fen Guo, Yi Feng, and Jim Finney for technical assistance. The authors thank the Small Animal Imaging Core for their support. This work was supported by U.S. National Institutes of Health grants R01-CA102673 and P50-CA086438 (R.G.B.) and P01-CA106450 (N-K.V.C. and W.L.G.).	Alaminos M, 2005, PEDIATR BLOOD CANCER, V45, P909, DOI 10.1002/pbc.20505; Alaminos M, 2003, CANCER RES, V63, P4538; Castleberry RP, 1997, EUR J CANCER, V33, P1430, DOI 10.1016/S0959-8049(97)00308-0; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; GAZITT Y, 1992, CANCER RES, V52, P2957; Giannini G, 2005, CANCER RES, V65, P8308, DOI 10.1158/0008-5472.CAN-05-0607; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Iyengar RV, 2001, CANCER RES, V61, P3045; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Malynn BA, 2000, GENE DEV, V14, P1390; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Mora J, 2001, BRIT J CANCER, V85, P182, DOI 10.1054/bjoc.2001.1849; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Ross RA, 2004, JNCI-J NATL CANCER I, V96, P1192, DOI 10.1093/jnci/djh262; Sawa M, 2005, INT J HEMATOL, V82, P42, DOI 10.1532/IJH97.05013; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; SLAVC I, 1990, CANCER RES, V50, P1459; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Zhe Xiaoning, 1999, Chinese Medical Sciences Journal, V14, P102	37	60	63	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4138	4149		10.1096/fj.11-185033	http://dx.doi.org/10.1096/fj.11-185033			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21856782	Green Published			2022-12-25	WOS:000298138100008
J	Hibino, K; Shibata, T; Yanagida, T; Sako, Y				Hibino, Kayo; Shibata, Tatsuo; Yanagida, Toshio; Sako, Yasushi			Activation Kinetics of RAF Protein in the Ternary Complex of RAF, RAS-GTP, and Kinase on the Plasma Membrane of Living Cells SINGLE-MOLECULE IMAGING ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-RAF; PHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; H-RAS; DYNAMICS; FEEDBACK; IDENTIFICATION; RECRUITMENT; SURFACE; EGF	RAS is an important cell signaling molecule, regulating the activities of various effector proteins, including the kinase c-RAF (RAF). Despite the critical function of RAS signaling, the activation kinetics have not been analyzed experimentally in living cells for any of the RAS effectors. Here, we analyzed the kinetics of RAF activation on the plasma membrane in living HeLa cells after stimulation with EGF to activate RAS. RAF is recruited by the active form of RAS (RAS-GTP) from the cytoplasm to the plasma membrane through two RAS-binding sites (the RAS-binding domain and the cysteine-rich domain (CRD)) and is activated by its phosphorylation by still undetermined kinases on the plasma membrane. Using single-molecule imaging, we measured the dissociation time courses of GFP-tagged molecules of wild type RAF and fragments or mutants of RAF containing one or two of the three functional domains (the RAS-binding domain, the CRD, and the catalytic domain) to determine their interaction with membrane components. Each molecule showed a unique dissociation time course, indicating that both its interaction with RAS-GTP and its phosphorylation by the kinases are rate-limiting steps in RAF activation. Based on our experimental results, we propose a kinetic model for the activation of RAF. The model suggests the importance of the interaction between RAS-GTP and CRD for the effective activation of RAF, which is triggered by rapid RAS-GTP-induced conformational changes in RAF and the subsequent presentation of RAF to the kinase. The model also suggests necessary properties of the kinases that activate RAF.	[Hibino, Kayo; Sako, Yasushi] RIKEN, Adv Sci Inst, Cellular Informat Lab, Wako, Saitama 3510198, Japan; [Shibata, Tatsuo] RIKEN, Ctr Dev Biol, Phys Biol Lab, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shibata, Tatsuo] JST, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Nano Biosci Labs, Suita, Osaka 5650871, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST); Osaka University	Sako, Y (corresponding author), RIKEN, Adv Sci Inst, Cellular Informat Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sako@riken.jp	Shibata, Tatsuo/A-8119-2012; Sako, Yasushi/B-3253-2015	Shibata, Tatsuo/0000-0002-9294-9998; Sako, Yasushi/0000-0002-5707-5455; Hibino, Kayo/0000-0002-4047-883X	Grants-in-Aid for Scientific Research [21570226] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FORCE T, 1994, P NATL ACAD SCI USA, V91, P1270, DOI 10.1073/pnas.91.4.1270; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Hibino K, 2009, METHODS MOL BIOL, V544, P451, DOI 10.1007/978-1-59745-483-4_30; Hibino K, 2009, BIOPHYS J, V97, P1277, DOI 10.1016/j.bpj.2009.05.048; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mayawala K, 2004, BIOPHYS J, V87, pL1, DOI 10.1529/biophysj.104.051888; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sako Y, 2011, CELL SIGNALING REACTIONS: SINGLE-MOLECULAR KINETIC ANALYSIS, P1, DOI 10.1007/978-90-481-9864-1; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	44	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36460	36468		10.1074/jbc.M111.262675	http://dx.doi.org/10.1074/jbc.M111.262675			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862573	hybrid, Green Published			2022-12-25	WOS:000296538300031
J	Jiang, YL; Zhang, JW; Yu, WL; Cheng, W; Zhang, CC; Frolet, C; Di Guilmi, AM; Vernet, T; Zhou, CZ; Chen, YX				Jiang, Yong-Liang; Zhang, Jun-Wei; Yu, Wei-Li; Cheng, Wang; Zhang, Chen-Chen; Frolet, Cecile; Di Guilmi, Anne-Marie; Vernet, Thierry; Zhou, Cong-Zhao; Chen, Yuxing			Structural and Enzymatic Characterization of the Streptococcal ATP/Diadenosine Polyphosphate and Phosphodiester Hydrolase Spr1479/SapH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIADENOSINE TETRAPHOSPHATE HYDROLASE; CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; PROTEIN PHOSPHATASE; NUDIX HYDROLASES; ADP-RIBOSE; MECHANISM; GENOME; CATABOLISM; REVEALS	Spr1479 from Streptococcus pneumoniae R6 is a 33-kDa hypothetical protein of unknown function. Here, we determined the crystal structures of its apo-form at 1.90 angstrom and complex forms with inorganic phosphate and AMP at 2.30 and 2.20 angstrom, respectively. The core structure of Spr1479 adopts a four-layer alpha beta beta alpha-sandwich fold, with Fe3+ and Mn2+ coordinated at the binuclear center of the active site (similar to metallophosphoesterases). Enzymatic assays showed that, in addition to phosphodiesterase activity for bis(p-nitrophenyl) phosphate, Spr1479 has hydrolase activity for diadenosine polyphosphate (Ap(n)A) and ATP. Residues that coordinate with the two metals are indispensable for both activities. By contrast, the streptococcus-specific residue Trp-67, which binds to phosphate in the two complex structures, is indispensable for the ATP/Ap(n)A hydrolase activity only. Moreover, the AMP-binding pocket is conserved exclusively in all streptococci. Therefore, we named the protein SapH for streptococcal (A) under bar TP/Ap(n)A and phosphodiester hydrolase.	[Jiang, Yong-Liang; Zhang, Jun-Wei; Yu, Wei-Li; Cheng, Wang; Zhang, Chen-Chen; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Jiang, Yong-Liang; Zhang, Jun-Wei; Yu, Wei-Li; Cheng, Wang; Zhang, Chen-Chen; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Frolet, Cecile; Di Guilmi, Anne-Marie; Vernet, Thierry] Inst Biol Struct Jean Pierre Ebel, UMR 5075, Lab Ingn Macromol, F-38027 Grenoble, France	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zcz@ustc.edu.cn; cyxing@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011; Vernet, Thierry/G-1118-2012	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Di Guilmi, Anne Marie/0000-0001-7335-3470; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2009CB918804]; National Natural Science Foundation of China [30870488]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB918804 and National Natural Science Foundation of China Grant 30870488.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Chen SF, 2004, J BIOL CHEM, V279, P31854, DOI 10.1074/jbc.M401059200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guranowski A, 2000, PHARMACOL THERAPEUT, V87, P117, DOI 10.1016/S0163-7258(00)00046-2; GURANOWSKI A, 1983, J BIOL CHEM, V258, P4784; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iwai T, 2004, J BIOL CHEM, V279, P21732, DOI 10.1074/jbc.M312018200; Iwanicki A, 2002, BIOCHEM J, V366, P929, DOI 10.1042/BJ20011591; Jeyakanthan J, 2010, ACTA CRYSTALLOGR D, V66, P116, DOI 10.1107/S0907444909047064; Keppetipola N, 2006, RNA, V12, P73, DOI 10.1261/rna.2196406; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martins A, 2005, RNA, V11, P1271, DOI 10.1261/rna.2690505; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Handley SF, 1998, J BIOL CHEM, V273, P3192, DOI 10.1074/jbc.273.6.3192; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Schenk G, 2005, P NATL ACAD SCI USA, V102, P273, DOI 10.1073/pnas.0407239102; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Swarbrick JD, 2000, J MOL BIOL, V302, P1165, DOI 10.1006/jmbi.2000.4085; Swarbrick JD, 2005, J BIOL CHEM, V280, P8471, DOI 10.1074/jbc.M412318200; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wang QH, 2006, PROTEINS, V65, P1032, DOI 10.1002/prot.21106; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Xu WL, 2002, J BIOL CHEM, V277, P23181, DOI 10.1074/jbc.M203325200	49	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35906	35914		10.1074/jbc.M111.228585	http://dx.doi.org/10.1074/jbc.M111.228585			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865160	Green Published, hybrid			2022-12-25	WOS:000295927100064
J	Sebastian, BM; Roychowdhury, S; Tang, H; Hillian, AD; Feldstein, AE; Stahl, GL; Takahashi, K; Nagy, LE				Sebastian, Becky M.; Roychowdhury, Sanjoy; Tang, Hui; Hillian, Antoinette D.; Feldstein, Ariel E.; Stahl, Gregory L.; Takahashi, Kazue; Nagy, Laura E.			Identification of a Cytochrome P4502E1/Bid/C1q-dependent Axis Mediating Inflammation in Adipose Tissue after Chronic Ethanol Feeding to Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LIVER-INJURY; INDUCED FATTY LIVER; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; HEPATIC STEATOSIS; APOPTOTIC CELLS; DEFICIENT MICE; COMPLEMENT; OBESITY; ADIPONECTIN	Background: Chronic alcohol consumption leads to inflammation in adipose tissue, disrupting normal metabolic activity of adipocytes. Results: Expression of an alcohol metabolizing enzyme, cytochrome P4502E1, initiates inflammation in adipose. Bid-dependent apoptosis and activation of complement then exacerbate this initial response. Conclusion: Adipose inflammation during alcohol feeding develops in response to cytochrome P450 expression. Significance: Preventing adipose inflammation may prevent the pathphysiological effects of ethanol.	[Nagy, Laura E.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Cleveland Clin, Dept Cell Biol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Cleveland Clin, Dept Pediat Gastroenterol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol & Hepatol, Liver Dis Res Ctr, Cleveland, OH 44195 USA; [Feldstein, Ariel E.; Nagy, Laura E.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44190 USA; [Stahl, Gregory L.] Harvard Univ, Sch Med, Dept Anesthesiol Peroperat & Pain Med, Boston, MA 02115 USA; [Takahashi, Kazue] Harvard Univ, Sch Med, Lab Dev Immunol, Boston, MA 02115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nagy, LE (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Liver Dis Res Ctr, NE40,9500 Euclid Ave, Cleveland, OH 44195 USA.	nagyL3@ccf.org		Stahl, Gregory/0000-0002-4805-8119	National Institutes of Health [P20 AA017837, 5R01 AA016399, R37 AA011876, P20 AA17069 (6017), R01 DK076852, R56AI089781, RC1HL099130, R01HL056086, T32DK007319, U01 AI074503]; Case Western Reserve University [CTSA UL1RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099130, R01HL056086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074503, R56AI089781, R01AI089781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076852, T32DK007319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011876, P20AA017837, R01AA016399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 AA017837, 5R01 AA016399, and R37 AA011876 (to L. E. N.), P20 AA17069 (#6017) and R01 DK076852 (to A. E. F.), R56AI089781, RC1HL099130, and R01HL056086 (to G. L. S.), Training grant T32DK007319 (to A. D. H.), and U01 AI074503 (to K. T.). This work was also supported by Case Western Reserve University/Cleveland Clinic Grant CTSA UL1RR024989.	Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Cohen JI, 2011, ANTIOXID REDOX SIGN, V15, P523, DOI 10.1089/ars.2010.3746; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Fischer MB, 1996, J IMMUNOL, V157, P549; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hillemacher T, 2009, DRUG ALCOHOL DEPEN, V99, P333, DOI 10.1016/j.drugalcdep.2008.07.019; Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, P1581, DOI 10.1111/j.1530-0277.2007.00452.x; KORTELAINEN ML, 1991, ALCOHOL, V8, P151, DOI 10.1016/0741-8329(91)91324-U; Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Mevorach D, 2010, APOPTOSIS, V15, P1114, DOI 10.1007/s10495-010-0530-8; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Pravdova E, 2009, Endocr Regul, V43, P117; Pravdova Eliska, 2006, Endocr Regul, V40, P91; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Sebastian Becky M., 2008, V447, P357, DOI 10.1007/978-1-59745-242-7_23; Shannon JG, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-26; Tenner AJ, 2006, ADV EXP MED BIOL, V586, P153; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wu Defeng, 2008, V447, P137, DOI 10.1007/978-1-59745-242-7_11; Wurst FM, 2007, ALCOHOL CLIN EXP RES, V31, P1963, DOI 10.1111/j.1530-0277.2007.00531.x; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshinari K, 2004, J PHARMACOL EXP THER, V311, P147, DOI 10.1124/jpet.104.067066	43	68	68	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35989	35997		10.1074/jbc.M111.254201	http://dx.doi.org/10.1074/jbc.M111.254201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856753	Green Published, hybrid			2022-12-25	WOS:000295927100072
J	Wisskirchen, C; Ludersdorfer, TH; Muller, DA; Moritz, E; Pavlovic, J				Wisskirchen, Christian; Ludersdorfer, Thomas H.; Mueller, Dominik A.; Moritz, Eva; Pavlovic, Jovan			Interferon-induced Antiviral Protein MxA Interacts with the Cellular RNA Helicases UAP56 and URH49	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; MESSENGER-RNA; THOGOTO-VIRUS; BOX PROTEIN; NUCLEAR-LOCALIZATION; GTPASE; OLIGOMERIZATION; EXPRESSION; OVEREXPRESSION; TRANSCRIPTION	Mx proteins are a family of large GTPases that are induced exclusively by interferon-alpha/beta and have a broad antiviral activity against several viruses, including influenza A virus (IAV). Although the antiviral activities of mouse Mx1 and human MxA have been studied extensively, the molecular mechanism of action remains largely unsolved. Because no direct interaction between Mx proteins and IAV proteins or RNA had been demonstrated so far, we addressed the question of whether Mx protein would interact with cellular proteins required for efficient replication of IAV. Immunoprecipitation of MxA revealed its association with two closely related RNA helicases, UAP56 and URH49. UAP56 and its paralog URH49 play an important role in IAV replication and are involved in nuclear export of IAV mRNAs and prevention of dsRNA accumulation in infected cells. In vitro binding assays with purified recombinant proteins revealed that MxA formed a direct complex with the RNA helicases. In addition, recombinant mouse Mx1 was also able to bind to UAP56 or URH49. Furthermore, the complex formation between cytoplasmic MxA and UAP56 or URH49 occurred in the perinuclear region, whereas nuclear Mx1 interacted with UAP56 or URH49 in distinct dots in the nucleus. Taken together, our data reveal that Mx proteins exerting antiviral activity can directly bind to the two cellular DExD/H box RNA helicases UAP56 and URH49. Moreover, the observed subcellular localization of the Mx-RNA helicase complexes coincides with the subcellular localization, where human MxA and mouse Mx1 proteins act antivirally. On the basis of these data, we propose that Mx proteins exert their antiviral activity against IAV by interfering with the function of the RNA helicases UAP56 and URH49.	[Wisskirchen, Christian; Ludersdorfer, Thomas H.; Mueller, Dominik A.; Moritz, Eva; Pavlovic, Jovan] Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland; [Wisskirchen, Christian; Ludersdorfer, Thomas H.] Univ Zurich, PhD Program Microbiol & Immunol, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Pavlovic, J (corresponding author), Univ Zurich, Inst Med Virol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pavlovic.jovan@virology.uzh.ch	Pavlovic, Jovan/G-9669-2015	Pavlovic, Jovan/0000-0003-4428-2487	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This work was supported by a grant from the Swiss National Science Foundation and a Forschungskredit from the University of Zurich.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Engelhardt OG, 2004, J GEN VIROL, V85, P2315, DOI 10.1099/vir.0.79795-0; Engelhardt OG, 2001, EXP CELL RES, V271, P286, DOI 10.1006/excr.2001.5380; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; HUANG T, 1992, J VIROL, V66, P4154, DOI 10.1128/JVI.66.7.4154-4160.1992; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Meignin C, 2008, DEV BIOL, V315, P89, DOI 10.1016/j.ydbio.2007.12.004; Melen K, 1997, J BIOL CHEM, V272, P32353, DOI 10.1074/jbc.272.51.32353; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Pryor A, 2004, NUCLEIC ACIDS RES, V32, P1857, DOI 10.1093/nar/gkh347; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Sahni A, 2010, BIOCHEM BIOPH RES CO, V393, P106, DOI 10.1016/j.bbrc.2010.01.093; Schmidt U, 2009, RNA, V15, P862, DOI 10.1261/rna.1387009; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Shen HH, 2008, GENE DEV, V22, P1796, DOI 10.1101/gad.1657308; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022671; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x; ZURCHER T, 1992, J VIROL, V66, P5059	49	31	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34743	34751		10.1074/jbc.M111.251843	http://dx.doi.org/10.1074/jbc.M111.251843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21859714	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000295406300028
J	Feist, BE; Buhle, ER; Arnold, P; Davis, JW; Scholz, NL				Feist, Blake E.; Buhle, Eric R.; Arnold, Paul; Davis, Jay W.; Scholz, Nathaniel L.			Landscape Ecotoxicology of Coho Salmon Spawner Mortality in Urban Streams	PLOS ONE			English	Article							LAND-USE; PETROLEUM-HYDROCARBONS; PARVICAPSULA-MINIBICORNIS; ONCORHYNCHUS-KISUTCH; SOCKEYE-SALMON; CHINOOK SALMON; STORM WATER; RUNOFF; RIVER; URBANIZATION	In the Pacific Northwest of the United States, adult coho salmon (Oncorhynchus kisutch) returning from the ocean to spawn in urban basins of the Puget Sound region have been prematurely dying at high rates (up to 90% of the total runs) for more than a decade. The current weight of evidence indicates that coho deaths are caused by toxic chemical contaminants in land-based runoff to urban streams during the fall spawning season. Non-point source pollution in urban landscapes typically originates from discrete urban and residential land use activities. In the present study we conducted a series of spatial analyses to identify correlations between land use and land cover (roadways, impervious surfaces, forests, etc.) and the magnitude of coho mortality in six streams with different drainage basin characteristics. We found that spawner mortality was most closely and positively correlated with the relative proportion of local roads, impervious surfaces, and commercial property within a basin. These and other correlated variables were used to identify unmonitored basins in the greater Seattle metropolitan area where recurrent coho spawner die-offs may be likely. This predictive map indicates a substantial geographic area of vulnerability for the Puget Sound coho population segment, a species of concern under the U. S. Endangered Species Act. Our spatial risk representation has numerous applications for urban growth management, coho conservation, and basin restoration (e. g., avoiding the unintentional creation of ecological traps). Moreover, the approach and tools are transferable to areas supporting coho throughout western North America.	[Feist, Blake E.; Buhle, Eric R.; Scholz, Nathaniel L.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Arnold, Paul; Davis, Jay W.] US Fish & Wildlife Serv, Washington Fish & Wildlife Off, Lacey, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service	Feist, BE (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	blake.feist@noaa.gov	Feist, Blake E/H-2669-2012; Scholz, Nathaniel L/L-1642-2013	Feist, Blake E/0000-0001-5215-4878; Scholz, Nathaniel L/0000-0001-6207-0272	National Oceanic and Atmospheric Administration; U.S. Fish and Wildlife Service; City of Seattle (Seattle Public Utilities); U.S. Environmental Protection Agency - Region 10	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); City of Seattle (Seattle Public Utilities); U.S. Environmental Protection Agency - Region 10(United States Environmental Protection Agency)	This work was supported by the National Oceanic and Atmospheric Administration - Coastal Storms Program; U.S. Fish and Wildlife Service - National Contaminants Program; City of Seattle (Seattle Public Utilities); and the U.S. Environmental Protection Agency - Region 10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2004, PHOTOGRAMM ENG REM S, V70, P1043, DOI 10.14358/PERS.70.9.1043; Alberti M, 2007, LANDSCAPE URBAN PLAN, V80, P345, DOI 10.1016/j.landurbplan.2006.08.001; [Anonymous], 2010, R LANG ENV STAT COMP; Bilby RE, 2008, CAN J FISH AQUAT SCI, V65, P2138, DOI 10.1139/F08-113; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; BOURCIER DR, 1979, SCI TOTAL ENVIRON, V12, P205, DOI 10.1016/0048-9697(79)90086-X; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Claireaux G, 2010, AQUAT TOXICOL, V98, P113, DOI 10.1016/j.aquatox.2010.02.006; Conko KM, 2004, ATMOS ENVIRON, V38, P4025, DOI 10.1016/j.atmosenv.2004.03.062; Cuffney TF, 2010, ECOL APPL, V20, P1384, DOI 10.1890/08-1311.1; Davis AP, 2001, CHEMOSPHERE, V44, P997, DOI 10.1016/S0045-6535(00)00561-0; Feist BE, 2010, LANDSCAPE ECOL, V25, P727, DOI 10.1007/s10980-010-9458-1; Gelman A., 2007, DATA ANAL USING REGR; HOFFMAN EJ, 1982, J WATER POLLUT CON F, V54, P1517; Hoffman RS, 2000, ENVIRON TOXICOL CHEM, V19, P2249, DOI [10.1002/etc.5620190915, 10.1897/1551-5028(2000)019&lt;2249:COPIEU&gt;2.3.CO;2]; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; KARR JR, 1991, ECOL APPL, V1, P66, DOI 10.2307/1941848; Katz SL, 2007, RESTOR ECOL, V15, P494, DOI 10.1111/j.1526-100X.2007.00245.x; Keefer ML, 2010, ECOL FRESHW FISH, V19, P361, DOI 10.1111/j.1600-0633.2010.00418.x; Kocan R, 2004, J AQUAT ANIM HEALTH, V16, P58, DOI 10.1577/H03-068.1; McCarthy SG, 2008, AM FISH S S, V64, P7; Morley SA, 2002, CONSERV BIOL, V16, P1498, DOI 10.1046/j.1523-1739.2002.01067.x; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Pess GR, 2002, CAN J FISH AQUAT SCI, V59, P613, DOI 10.1139/F02-035; *PEW OC COMM, 2003, AM LIV OC CHART COUR; PINHEIRO JC, 2001, MIXED EFFECTS MODELS; Raverty S, 2000, CAN VET J, V41, P317; Spromberg JA, 2006, ECOL MODEL, V199, P240, DOI 10.1016/j.ecolmodel.2006.05.007; St-Hilaire S, 2002, J FISH DIS, V25, P107, DOI 10.1046/j.1365-2761.2002.00344.x; Stein ED, 2006, ENVIRON TOXICOL CHEM, V25, P373, DOI 10.1897/05-285R.1; Tiefenthaler LL, 2008, ENVIRON TOXICOL CHEM, V27, P277, DOI 10.1897/07-126R.1; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI; Weinstein MP, 2007, FRONT ECOL ENVIRON, V5, P43, DOI 10.1890/1540-9295(2007)5[43:MCRITS]2.0.CO;2; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; WHIPPLE W, 1979, WATER RESOUR BULL, V15, P1096; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1007/S10980-010-9458-1; [No title captured]; [No title captured], DOI DOI 10.1016/J.AQUATOX.2010.02.006; [No title captured]; [No title captured], DOI DOI 10.1002/IEAM.219	50	31	31	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23424	10.1371/journal.pone.0023424	http://dx.doi.org/10.1371/journal.pone.0023424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858112	Green Published, gold			2022-12-25	WOS:000294121300045
J	Lok, GTM; Chan, DW; Liu, VWS; Hui, WWY; Leung, THY; Yao, KM; Ngan, HYS				Lok, Gabriel T. M.; Chan, David W.; Liu, Vincent W. S.; Hui, Winnie W. Y.; Leung, Thomas H. Y.; Yao, K. M.; Ngan, Hextan Y. S.			Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells	PLOS ONE			English	Article							M1 TRANSCRIPTION FACTOR; INDUCE APOPTOSIS; OVER-EXPRESSION; GLIOMA-CELLS; ERK ACTIVITY; FOXM1; TARGET; REPRESSION; TUMORIGENICITY; PROLIFERATION	Forkhead box M1 (FOXM1) is a proliferation-associated transcription factor essential for cell cycle progression. Numerous studies have documented that FOXM1 has multiple functions in tumorigenesis and its elevated levels are frequently associated with cancer progression. Here, we characterized the role of ERK/FOXM1 signaling in mediating the metastatic potential of ovarian cancer cells. Immunohistochemical (IHC), immunoblotting and semi-quantitative RT-PCR analyses found that both phospho-ERK and FOXM1 were frequently upregulated in ovarian cancers. Intriguingly, the overexpressed phospho-ERK (p<0.001) and FOXM1 (p<0.001) were significantly correlated to high-grade ovarian tumors with aggressive behavior such as metastasized lymph node (5 out of 6). Moreover, the expressions of phospho-ERK and FOXM1 had significantly positive correlation (p<0.001). Functionally, ectopic expression of FOXM1B remarkably enhanced cell migration/invasion, while FOXM1C not only increased cell proliferation but also promoted cell migration/invasion. Conversely, inhibition of FOXM1 expression by either thiostrepton or U0126 could significantly impair FOXM1 mediated oncogenic capacities. However, the down-regulation of FOXM1 by either thiostrepton or U0126 required the presence of p53 in ovarian cancer cells. Collectively, our data suggest that over-expression of FOXM1 might stem from the constitutively active ERK which confers the metastatic capabilities to ovarian cancer cells. The impairment of metastatic potential of cancer cells by FOXM1 inhibitors underscores its therapeutic value in advanced ovarian tumors.	[Lok, Gabriel T. M.; Chan, David W.; Liu, Vincent W. S.; Hui, Winnie W. Y.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Yao, K. M.] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lok, GTM (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hkucc.hku.hk	Chan, David/O-9896-2018	Chan, David/0000-0002-6951-3467; Ngan, Hextan Y S/0000-0003-3945-159X	Wong Cheuk She Charitable Foundation	Wong Cheuk She Charitable Foundation	This study was supported by the Wong Cheuk She Charitable Foundation. This support is from private donations, and no funder's website is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Frau M, 2010, MOL ASPECTS MED, V31, P179, DOI 10.1016/j.mam.2010.02.007; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Liao YC, 2009, J AGR FOOD CHEM, V57, P8933, DOI 10.1021/jf902630w; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Neill GW, 2008, CARCINOGENESIS, V29, P738, DOI 10.1093/carcin/bgn037; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Teh MT, 2002, CANCER RES, V62, P4773; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	38	64	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23790	10.1371/journal.pone.0023790	http://dx.doi.org/10.1371/journal.pone.0023790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858223	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300095
J	Poiroux, G; Pitie, M; Culerrier, R; Lafont, E; Segui, B; Van Damme, EJM; Peumans, WJ; Bernadou, J; Levade, T; Rouge, P; Barre, A; Benoist, H				Poiroux, Guillaume; Pitie, Marguerite; Culerrier, Raphael; Lafont, Elodie; Segui, Bruno; Van Damme, Els J. M.; Peumans, Willy J.; Bernadou, Jean; Levade, Thierry; Rouge, Pierre; Barre, Annick; Benoist, Herve			Targeting of T/Tn Antigens with a Plant Lectin to Kill Human Leukemia Cells by Photochemotherapy	PLOS ONE			English	Article							JACALIN-RELATED LECTINS; GROWTH-FACTOR RECEPTOR; HUMAN-COLON-CANCER; PHOTODYNAMIC THERAPY; OXIDATIVE STRESS; LYMPHOCYTIC-LEUKEMIA; FLUORESCENT-PROBES; ANTIOXIDANT STATUS; INDUCED APOPTOSIS; SIALOSYL-TN	Photochemotherapy is used both for solid tumors and in extracorporeal treatment of various hematologic disorders. Nevertheless, its development in oncology remains limited, because of the low selectivity of photosensitizers (PS) towards human tumor cells. To enhance PS efficiency, we recently covalently linked a porphyrin (TrMPyP) to a plant lectin (Morniga G), known to recognize with high affinity tumor-associated T and Tn antigens. The conjugation allowed a quick uptake of PS by Tn-positive Jurkat leukemia cells and efficient PS-induced phototoxicity. The present study was performed: (i) to evaluate the targeting potential of the conjugate towards tumor and normal cells and its phototoxicity on various leukemia cells, (ii) to investigate the mechanism of conjugate-mediated cell death. The conjugate: (i) strongly increased (x1000) the PS phototoxicity towards leukemic Jurkat T cells through an O-glycan-dependent process; (ii) specifically purged tumor cells from a 1:1 mixture of Jurkat leukemia (Tn-positive) and healthy (Tn-negative) lymphocytes, preserving the activation potential of healthy lymphocytes; (iii) was effective against various leukemic cell lines with distinct phenotypes, as well as fresh human primary acute and chronic lymphoid leukemia cells; (iv) induced mostly a caspase-independent cell death, which might be an advantage as tumor cells often resist caspase-dependent cell death. Altogether, the present observations suggest that conjugation with plant lectins can allow targeting of photosensitizers towards aberrant glycosylation of tumor cells, e. g. to purge leukemia cells from blood and to preserve the normal leukocytes in extracorporeal photochemotherapy.	[Poiroux, Guillaume; Lafont, Elodie; Segui, Bruno; Levade, Thierry; Benoist, Herve] CHU Rangueil, Ctr Rech Cancerol Toulouse, INSERM, UMR 1037,Equipe 4, F-31432 Toulouse, France; [Lafont, Elodie; Segui, Bruno; Bernadou, Jean; Barre, Annick; Benoist, Herve] Univ Toulouse, Fac Pharmaceut Sci, F-31062 Toulouse, France; [Poiroux, Guillaume; Culerrier, Raphael; Rouge, Pierre; Barre, Annick] Univ Toulouse, UMR UPS CNRS 5546, F-31326 Castanet Tolosan, France; [Pitie, Marguerite; Bernadou, Jean] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France; [Van Damme, Els J. M.; Peumans, Willy J.] Univ Ghent, Dept Mol Biotechnol, Lab Biochem & Glycobiol, B-9000 Ghent, Belgium	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Ghent University	Poiroux, G (corresponding author), CHU Rangueil, Ctr Rech Cancerol Toulouse, INSERM, UMR 1037,Equipe 4, BP84225, F-31432 Toulouse, France.	herve.benoist@inserm.fr	Benoist, Hervé/P-2927-2014; Van Damme, Els J/B-4410-2015; Van Damme, Els/U-3904-2019; Lafont, Elodie/L-3288-2019; Lafont, Elodie/GPS-9642-2022; Levade, Thierry/O-8948-2014; Ségui, Bruno/O-8957-2014; Guillaume, Poiroux/M-2854-2015; Rouge, Pierre/T-2059-2019	Van Damme, Els/0000-0001-9848-766X; Lafont, Elodie/0000-0003-1978-7491; Lafont, Elodie/0000-0003-1978-7491; Ségui, Bruno/0000-0002-6119-1889; Guillaume, Poiroux/0000-0002-6769-3716; Barre, annick/0000-0002-1360-8491	Universite Paul Sabatier; Institut National de la Sante et de la Recherche Medicale [U858, I2MR]; Centre National de la Recherhce Scientifique [UMR5546]; Scientific Research Flanders	Universite Paul Sabatier; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherhce Scientifique; Scientific Research Flanders(FWO)	Funding provided by: Universite Paul Sabatier; Institut National de la Sante et de la Recherche Medicale U858, I2MR; Centre National de la Recherhce Scientifique UMR5546; and Scientific Research Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcouffe J, 2004, FASEB J, V18, P122, DOI 10.1096/fj.02-0808fje; Battisti V, 2008, CLIN BIOCHEM, V41, P511, DOI 10.1016/j.clinbiochem.2008.01.027; Benoist H, 2009, J LEUKOCYTE BIOL, V86, P103, DOI [10.1189/JLB.0708434, 10.1189/jlb.0708434]; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Brooks CL, 2010, P NATL ACAD SCI USA, V107, P10056, DOI 10.1073/pnas.0915176107; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Cao Y, 2008, INT J CANCER, V123, P89, DOI 10.1002/ijc.23493; CASAS C, 1993, J ORG CHEM, V58, P2913, DOI 10.1021/jo00062a045; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chen BJ, 2002, BLOOD, V99, P3083, DOI 10.1182/blood.V99.9.3083; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Copley L, 2008, INT J BIOCHEM CELL B, V40, P227, DOI 10.1016/j.biocel.2007.07.014; del Carmen MG, 2005, JNCI-J NATL CANCER I, V97, P1516, DOI 10.1093/jnci/dji314; Del Governatore M, 2000, BRIT J CANCER, V82, P56; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Giusti C, 2009, EXP CELL RES, V315, P26, DOI 10.1016/j.yexcr.2008.09.028; Hamblin MR, 2000, BRIT J CANCER, V83, P1544, DOI 10.1054/bjoc.2000.1486; Heimburg-Molinaro J, 2009, NEOPLASIA, V11, P780, DOI 10.1593/neo.09504; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; ITZKOWITZ SH, 1989, CANCER RES, V49, P197; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; Kessel D, 1999, CELL DEATH DIFFER, V6, P28, DOI 10.1038/sj.cdd.4400446; Korbelik M, 2007, BRIT J CANCER, V97, P1381, DOI 10.1038/sj.bjc.6604059; Lafont E, 2010, CELL DEATH DIFFER, V17, P642, DOI 10.1038/cdd.2009.130; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Marchal S, 2005, BIOCHEM PHARMACOL, V69, P1167, DOI 10.1016/j.bcp.2005.01.021; Mazor D, 2008, PEDIATR BLOOD CANCER, V51, P613, DOI 10.1002/pbc.21665; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; Moran EC, 2002, BRIT J HAEMATOL, V116, P316, DOI 10.1046/j.1365-2141.2002.03280.x; Negre-Salvayre A, 2002, METHOD ENZYMOL, V352, P62; Nyman ES, 2004, J PHOTOCH PHOTOBIO B, V73, P1, DOI 10.1016/j.jphotobiol.2003.10.002; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oliven A, 2001, BLOOD REV, V15, P103, DOI 10.1054/blre.2001.0155; PILLER V, 1990, J BIOL CHEM, V265, P9264; Poiroux G, 2011, PHOTOCHEM PHOTOBIOL, V87, P370, DOI 10.1111/j.1751-1097.2010.00858.x; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Savellano MD, 2005, CANCER RES, V65, P6371, DOI 10.1158/0008-5472.CAN-05-0426; Savellano MD, 2005, CLIN CANCER RES, V11, P1658, DOI 10.1158/1078-0432.CCR-04-1902; Separovic D, 2009, BRIT J CANCER, V100, P626, DOI 10.1038/sj.bjc.6604896; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Shan L, 2004, MOL IMAGING CONTRAST; Shanafelt TD, 2005, BLOOD, V105, P2099, DOI 10.1182/blood-2004-06-2205; Singh T, 2007, MOL IMMUNOL, V44, P451, DOI 10.1016/j.molimm.2006.02.017; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Sze KL, 2011, APPL MICROBIOL BIOT, V89, P45, DOI 10.1007/s00253-010-2892-9; Thurston G, 1998, AM J PATHOL, V153, P1099, DOI 10.1016/S0002-9440(10)65654-4; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Van Damme EJM, 2002, PLANT PHYSIOL, V130, P757, DOI 10.1104/pp.005892; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; Vittar NBR, 2010, INT J BIOCHEM CELL B, V42, P1123, DOI 10.1016/j.biocel.2010.03.019; Wu AM, 2009, GLYCOCONJUGATE J, V26, P899, DOI 10.1007/s10719-008-9119-7; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003	54	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23315	10.1371/journal.pone.0023315	http://dx.doi.org/10.1371/journal.pone.0023315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858067	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300033
J	Saber, T; Veale, DJ; Balogh, E; McCormick, J; NicAnUltaigh, S; Connolly, M; Fearon, U				Saber, Tajvur; Veale, Douglas J.; Balogh, Emese; McCormick, Jennifer; NicAnUltaigh, Sinead; Connolly, Mary; Fearon, Ursula			Toll-Like Receptor 2 Induced Angiogenesis and Invasion Is Mediated through the Tie2 Signalling Pathway in Rheumatoid Arthritis	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; SYNOVIAL TISSUE; GENE-THERAPY; EXPRESSION; ANGIOPOIETIN-1; PATHOGENESIS; INHIBITION; CYTOKINES; CELLS	Background: Angiogenesis is a critical early event in inflammatory arthritis, facilitating leukocyte migration into the synovium resulting in invasion and destruction of articular cartilage and bone. This study investigates the effect of TLR2 on angiogenesis, EC adhesion and invasion using microvascular endothelial cells and RA whole tissue synovial explants ex-vivo. Methods: Microvascular endothelial cells (HMVEC) and RA synovial explants ex vivo were cultured with the TLR2 ligand, Pam3CSK4 (1 mu g/ml). Angiopoietin 2 (Ang2), Tie2 and TLR2 expression in RA synovial tissue was assessed by immunohistology. HMVEC tube formation was assessed using Matrigel matrix assays. Ang2 was measured by ELISA. ICAM-1 cell surface expression was assessed by flow cytometry. Cell migration was assessed by wound repair scratch assays. ECM invasion, MMP-2 and -9 expression were assessed using transwell invasion chambers and zymography. To examine if the angiopoietin/Tie2 signalling pathway mediates TLR2 induced EC tube formation, invasion and migration assays were performed in the presence of a specific neutralising anti-Tie2mAb (10 ug/ml) and matched IgG isotype control Ab (10 ug/ml). Results: Ang2 and Tie2 were localised to RA synovial blood vessels, and TLR2 was localised to RA synovial blood vessels, sub-lining infiltrates and the lining layer. Pam3CSK4 significantly increased angiogenenic tube formation (p<0.05), and upregulated Ang2 production in HMVEC (p<0.05) and RA synovial explants (p<0.05). Pam3CSK4 induced cell surface expression of ICAM-1, from basal level of 149+/-54 (MFI) to 617+/-103 (p<0.01). TLR-2 activation induced an 8.8+/-2.8 fold increase in cell invasion compared to control (p<0.05). Pam3CSK4 also induced HMVEC cell migration and induced MMP-2 and -9 from RA synovial explants. Neutralisation of the Ang2 receptor, Tie2 significantly inhibited Pam3CSK4-induced EC tube formation and invasion (p<0.05). Conclusion: TLR2 activation promotes angiogenesis, cell adhesion and invasion, effects that are in part mediated through the Tie2 signalling pathway, key mechanisms involved in the pathogenesis of RA.	[Saber, Tajvur] Univ Coll Dublin, Dublin Acad Med Ctr, Dept Rheumatol, Dublin 2, Ireland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Saber, T (corresponding author), Univ Coll Dublin, Dublin Acad Med Ctr, Dept Rheumatol, Dublin 2, Ireland.	ursula.fearon@ucd.ie		Fearon, Ursula/0000-0001-8084-0429; Saber, Tajvur/0000-0002-2599-2400; Veale, Douglas/0000-0003-2802-4971	Centrocor Newman fellowship; EU	Centrocor Newman fellowship; EU(European Commission)	This study was sponsored by a Centrocor Newman fellowship and EU FP6 Autocure. The anti-TLR2 antibody was a kind gift from Opsona Therapeutics Ltd, The Trinity Centre for Health Sciences, Institute of Molecular Medicine, St James' Hospital, Dublin, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; BUCALA R, 1991, J EXP MED, V173, P569, DOI 10.1084/jem.173.3.569; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Chen Y, 2005, ARTHRITIS RHEUM-US, V52, P1585, DOI 10.1002/art.21016; Cho ML, 2007, IMMUNOL LETT, V108, P121, DOI 10.1016/j.imlet.2006.11.005; CHU CQ, 1992, BRIT J RHEUMATOL, V31, P653; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; DeBusk LM, 2003, ARTHRITIS RHEUM-US, V48, P2461, DOI 10.1002/art.11213; Donnini S, 2004, LIFE SCI, V74, P2975, DOI 10.1016/j.lfs.2003.09.075; Faveeuw C, 2001, BLOOD, V98, P688, DOI 10.1182/blood.V98.3.688; Fearon U, 2003, J RHEUMATOL, V30, P260; Fearon U, 2006, ARTHRITIS RHEUM-US, V54, P3152, DOI 10.1002/art.22161; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gravallese EM, 2003, ANN RHEUM DIS, V62, P100, DOI 10.1136/ard.62.2.100; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Haas CS, 2007, ARTHRITIS RHEUM-US, V56, P2535, DOI 10.1002/art.22823; Hayashi K, 2009, ARCH VIROL, V154, P219, DOI 10.1007/s00705-008-0303-7; Hitchon CA, 2002, J RHEUMATOL, V29, P107; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Kasama T, 2007, TRANSL RES, V149, P265, DOI 10.1016/j.trsl.2006.12.007; Koch AE, 2003, ANN RHEUM DIS, V62, P60, DOI 10.1136/ard.62.suppl_2.ii60; KOCH AE, 1994, J IMMUNOL, V152, P4149; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; LI Y, 2009, AM J PHYSIOL-REG I; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; Nijhuis MMO, 2007, J VASC RES, V44, P214, DOI 10.1159/000100420; Przybysz M, 2007, RHEUMATOLOGY, V46, P1071, DOI 10.1093/rheumatology/kem067; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Reece RJ, 1999, ARTHRITIS RHEUM, V42, P1481, DOI 10.1002/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Sawa Y, 2008, CELL TISSUE RES, V333, P237, DOI 10.1007/s00441-008-0625-5; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472.CAN-07-1034; Schrijver IA, 2000, ARTHRITIS RHEUM-US, V43, P2160, DOI 10.1002/1529-0131(200010)43:10<2160::AID-ANR3>3.0.CO;2-T; Scott BB, 2002, J RHEUMATOL, V29, P230; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Shahrara S, 2002, ARTHRITIS RES, V4, P201, DOI 10.1186/ar407; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Szekanecz Z, 2004, CURR OPIN PHARMACOL, V4, P423, DOI 10.1016/j.coph.2004.03.013; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Takahara K, 2004, HUM PATHOL, V35, P150, DOI 10.1016/j.humpath.2003.11.010; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Ultaigh SNA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3261; Varoga D, 2006, J PATHOL, V210, P315, DOI 10.1002/path.2059; Yu D, 1997, ARTHRITIS RHEUM-US, V40, P648, DOI 10.1002/art.1780400409; ZHANG J, 2009, FASEB J, P23153	53	51	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23540	10.1371/journal.pone.0023540	http://dx.doi.org/10.1371/journal.pone.0023540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858161	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300059
J	Sutherland, KP; Shaban, S; Joyner, JL; Porter, JW; Lipp, EK				Sutherland, Kathryn Patterson; Shaban, Sameera; Joyner, Jessica L.; Porter, James W.; Lipp, Erin K.			Human Pathogen Shown to Cause Disease in the Threatened Eklhorn Coral Acropora palmata	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; INTENSIVE-CARE-UNIT; CARIBBEAN ELKHORN CORAL; WHITE-BAND DISEASE; SERRATIA-MARCESCENS; FLORIDA-KEYS; HUMAN SEWAGE; OUTBREAK; WATERS; REEFS	Coral reefs are in severe decline. Infections by the human pathogen Serratia marcescens have contributed to precipitous losses in the common Caribbean elkhorn coral, Acropora palmata, culminating in its listing under the United States Endangered Species Act. During a 2003 outbreak of this coral disease, called acroporid serratiosis (APS), a unique strain of the pathogen, Serratia marcescens strain PDR60, was identified from diseased A. palmata, human wastewater, the non-host coral Siderastrea siderea and the corallivorous snail Coralliophila abbreviata. In order to examine humans as a source and other marine invertebrates as vectors and/or reservoirs of the APS pathogen, challenge experiments were conducted with A. palmata maintained in closed aquaria to determine infectivity of strain PDR60 from reef and wastewater sources. Strain PDR60 from wastewater and diseased A. palmata caused disease signs in elkhorn coral in as little as four and five days, respectively, demonstrating that wastewater is a definitive source of APS and identifying human strain PDR60 as a coral pathogen through fulfillment of Koch's postulates. A. palmata inoculated with strain PDR60 from C. abbreviata showed limited virulence, with one of three inoculated fragments developing APS signs within 13 days. Strain PDR60 from non-host coral S. siderea showed a delayed pathogenic effect, with disease signs developing within an average of 20 days. These results suggest that C. abbreviata and non-host corals may function as reservoirs or vectors of the APS pathogen. Our results provide the first example of a marine "reverse zoonosis" involving the transmission of a human pathogen (S. marcescens) to a marine invertebrate (A. palmata). These findings underscore the interaction between public health practices and environmental health indices such as coral reef survival.	[Sutherland, Kathryn Patterson; Shaban, Sameera] Rollins Coll, Dept Biol, Winter Pk, FL 32789 USA; [Joyner, Jessica L.; Porter, James W.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Joyner, Jessica L.; Lipp, Erin K.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	Rollins College; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sutherland, KP (corresponding author), Rollins Coll, Dept Biol, Winter Pk, FL 32789 USA.	kpsutherland@rollins.edu		Patterson Sutherland, Kathryn/0000-0002-8192-1500; Lipp, Erin/0000-0002-8066-0636				Alaidan A, 2009, J MICROBIOL METH, V78, P238, DOI 10.1016/j.mimet.2009.05.007; Alfizah H., 2004, SMJ Singapore Medical Journal, V45, P214; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Bayramoglu G, 2011, J MICROBIOL IMMUNOL, V44, P111, DOI 10.1016/j.jmii.2010.02.002; Bonkosky M, 2009, MAR POLLUT BULL, V58, P45, DOI 10.1016/j.marpolbul.2008.09.008; CABRERA HA, 1969, ARCH INTERN MED, V123, P650, DOI 10.1001/archinte.123.6.650; CH2MHILL, 2000, MONR COUNT SAN WAST; FARMER JJ, 1973, APPL MICROBIOL, V25, P151, DOI 10.1128/AEM.25.1.151-152.1973; Futch JC, 2010, ENVIRON MICROBIOL, V12, P964, DOI 10.1111/j.1462-2920.2010.02141.x; GLADFELTER WB, 1982, B MAR SCI, V32, P639; GRABER CD, 1965, J AMER MED ASSOC, V192, P956, DOI 10.1001/jama.1965.03080240026005; GRASSO GM, 1988, EPIDEMIOL INFECT, V101, P315, DOI 10.1017/S0950268800054248; Griffin DW, 1999, APPL ENVIRON MICROB, V65, P4118; GRIMONT F, 2006, PROKARYOTES, V6, P219; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HAZEN TC, 1988, TOXIC ASSESS, V3, P461, DOI 10.1002/tox.2540030504; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hogarth W.T., 2006, FED REGISTER, V71, P26852; Krediet CJ, 2009, APPL ENVIRON MICROB, V75, P3851, DOI 10.1128/AEM.00457-09; LAPOINTE BE, 1990, BIOGEOCHEMISTRY, V10, P289; Ligozzi M, 2010, J CLIN MICROBIOL, V48, P1690, DOI 10.1128/JCM.01528-09; Looney EE, 2010, ENVIRON MICROBIOL, V12, P2479, DOI 10.1111/j.1462-2920.2010.02221.x; MAGNUSON CW, 1966, ANN INTERN MED, V65, P409, DOI 10.7326/0003-4819-65-3-409; Maragakis LL, 2008, INFECT CONT HOSP EP, V29, P418, DOI 10.1086/587969; Milisavljevic V, 2004, INFECT CONT HOSP EP, V25, P719, DOI 10.1086/502466; Miller MW, 2001, CORAL REEFS, V19, P293, DOI 10.1007/PL00006963; Miranda G, 1996, J CLIN MICROBIOL, V34, P3138, DOI 10.1128/JCM.34.12.3138-3141.1996; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Nobles R., 2000, FLORIDA J ENV HLTH, V169, P15; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Paul JH, 1997, WATER RES, V31, P1448, DOI 10.1016/S0043-1354(96)00374-0; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; RINGROSE RE, 1968, ANN INTERN MED, V69, P719, DOI 10.7326/0003-4819-69-4-719; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez-Martinez RE, 2001, DIS AQUAT ORGAN, V47, P229, DOI 10.3354/dao047229; Shi ZY, 1997, J CLIN MICROBIOL, V35, P325, DOI 10.1128/JCM.35.1.325-327.1997; Steppberger K, 2002, INFECTION, V30, P277, DOI 10.1007/s15010-002-2141-y; Sutherland KP, 2010, ENVIRON MICROBIOL, V12, P1122, DOI 10.1111/j.1462-2920.2010.02152.x; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; TILLOTSON JR, 1969, J INFECT DIS, V119, P597, DOI 10.1093/infdis/119.6.597; van der Vorm ER, 2002, J HOSP INFECT, V52, P263, DOI 10.1053/jhin.2002.1313; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Wilson VL, 1999, J MICROBIOL METH, V39, P59, DOI 10.1016/S0167-7012(99)00098-6; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	44	99	104	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23468	10.1371/journal.pone.0023468	http://dx.doi.org/10.1371/journal.pone.0023468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858132	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300049
J	Sathish, V; Delmotte, PF; Thompson, MA; Pabelick, CM; Sieck, GC; Prakash, YS				Sathish, Venkatachalem; Delmotte, Philippe F.; Thompson, Michael A.; Pabelick, Christina M.; Sieck, Gary C.; Prakash, Y. S.			Sodium-Calcium Exchange in Intracellular Calcium Handling of Human Airway Smooth Muscle	PLOS ONE			English	Article							RETICULUM CA2+ REUPTAKE; NECROSIS-FACTOR-ALPHA; NA+/CA2+ EXCHANGER; SARCOPLASMIC-RETICULUM; NA+-CA2+ EXCHANGE; REVERSE-MODE; VOLATILE ANESTHETICS; CELLS; INFLUX; CHANNELS	Enhanced airway contractility following inflammation by cytokines such as tumor necrosis factor alpha (TNF alpha) or interleukin-13 (IL-13) involves increased intracellular Ca2+ ([Ca2+](i)) levels in airway smooth muscle (ASM). In ASM, plasma membrane Ca2+ fluxes form a key component of [Ca2+](i) regulation. There is now growing evidence that the bidirectional plasma membrane Na+/Ca2+ exchanger (NCX) contributes to ASM [Ca2+](i) regulation. In the present study, we examined NCX expression and function in human ASM cells under normal conditions, and following exposure to TNFa or IL-13. Western blot analysis showed significant expression of the NCX1 isoform, with increased NCX1 levels by both cytokines, effects blunted by inhibitors of nuclear factor NF-kappa B or mitogen-activated protein kinase. Cytokine-mediated increase in NCX1 involved enhanced transcription followed by protein synthesis. NCX2 and NCX3 remained undetectable even in cytokine-stimulated ASM. In fura-2 loaded human ASM cells, NCX-mediated inward Ca2+ exchange as well as outward exchange (measured as rates of change in [Ca2+](i)) was elicited by altering extracellular Na+ and Ca2+ levels. Contribution of NCX was verified by measuring [Na+](i) using the fluorescent Na+ indicator SBFI. NCX-mediated inward exchange was verified by demonstrating prevention of rising [Ca2+](i) or falling [Na+](i) in the presence of the NCX inhibitor KBR7943. Inward exchange-mode NCX was increased by both TNF beta and IL-13 to a greater extent than outward exchange. NCX siRNA transfection substantially blunted outward exchange and inward exchange modes. Finally, inhibition of NCX expression or function blunted peak [Ca2+](i) and rate of fall of [Ca2+](i) following histamine stimulation. These data suggest that NCX-mediated Ca2+ fluxes normally exist in human ASM (potentially contributing to rapid Ca2+ fluxes), and contribute to enhanced [Ca2+](i) regulation in airway inflammation.	[Sathish, Venkatachalem; Delmotte, Philippe F.; Pabelick, Christina M.; Sieck, Gary C.; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sathish, Venkatachalem; Thompson, Michael A.; Pabelick, Christina M.; Sieck, Gary C.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Sathish, V (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	prakash.ys@mayo.edu		sieck, gary/0000-0003-3040-9424; venkatachalem, sathish/0000-0001-9770-8299; Prakash, Y S/0000-0002-2968-224X	NIH [HL74309, HL090595, HL090595-S2, HL088029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090595, R01HL074309, R01HL088029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH grants HL74309 (GCS), HL090595 (CMP), HL090595-S2 (CMP, VS), and HL088029 (YSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICKIN CC, 1994, J PHYSIOL-LONDON, V479, P301, DOI 10.1113/jphysiol.1994.sp020297; Algara-Suarez P, 2007, AM J PHYSIOL-LUNG C, V293, pL191, DOI 10.1152/ajplung.00485.2006; AMRANI Y, 1993, CR ACAD SCI III-VIE, V316, P1489; Ay B, 2006, AM J PHYSIOL-LUNG C, V290, pL278, DOI 10.1152/ajplung.00188.2005; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BEAUVAIS F, 1994, CLIN EXP IMMUNOL, V95, P191; Bers DM, 1996, ANN NY ACAD SCI, V779, P430, DOI 10.1111/j.1749-6632.1996.tb44818.x; Bers DM, 2007, ANN NY ACAD SCI, V1099, P326, DOI 10.1196/annals.1387.060; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bradley E, 2006, J PHYSIOL-LONDON, V574, P651, DOI 10.1113/jphysiol.2006.110932; Chalmers S, 2007, CELL CALCIUM, V42, P447, DOI 10.1016/j.ceca.2007.05.010; Chen H, 2003, J APPL PHYSIOL, V95, P864, DOI 10.1152/japplphysiol.00140.2003; COBURN RF, 1990, AM J PHYSIOL, V258, pL119, DOI 10.1152/ajplung.1990.258.4.L119; Dai JM, 2007, AM J RESP CELL MOL, V36, P600, DOI 10.1165/rcmb.2006-0096OC; Davis KA, 2009, J CELL MOL MED, V13, P1775, DOI 10.1111/j.1582-4934.2008.00480.x; Despa S, 2002, J PHYSIOL-LONDON, V539, P133, DOI 10.1113/jphysiol.2001.012940; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirota S, 2007, EUR RESPIR J, V30, P269, DOI 10.1183/09031936.00008507; Hirota S, 2007, AM J PHYSIOL-LUNG C, V292, pL438, DOI 10.1152/ajplung.00222.2006; Iwamoto T, 2004, MOL CELL BIOCHEM, V259, P157, DOI 10.1023/B:MCBI.0000021367.42752.54; Iwamoto Takahiro, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P188, DOI 10.2174/187152907781745288; Janssen LJ, 1997, AM J PHYSIOL-LUNG C, V273, pL322, DOI 10.1152/ajplung.1997.273.2.L322; Janssen LJ, 1996, J PHARMACOL EXP THER, V279, P813; Jeffs GJ, 2007, J CLIN NEUROSCI, V14, P507, DOI 10.1016/j.jocn.2006.07.013; Kannan MS, 1997, AM J PHYSIOL-LUNG C, V272, pL659, DOI 10.1152/ajplung.1997.272.4.L659; KAWANISHI M, 1984, JPN J PHYSIOL, V34, P127, DOI 10.2170/jjphysiol.34.127; KHOYI MA, 1993, AM J PHYSIOL, V265, pC1325; KNOX AJ, 1995, THORAX, V50, P894, DOI 10.1136/thx.50.8.894; KNOX AJ, 1994, PULM PHARMACOL, V7, P99, DOI 10.1006/pulp.1994.1011; Lamont C, 1998, PFLUG ARCH EUR J PHY, V435, P523, DOI 10.1007/s004240050548; Liu B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-168; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; McCarron JG, 2006, CELL CALCIUM, V40, P461, DOI 10.1016/j.ceca.2006.08.010; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; MURRAY RK, 1991, J PHYSIOL-LONDON, V435, P123, DOI 10.1113/jphysiol.1991.sp018501; Nagano T, 2004, J NEUROCHEM, V90, P784, DOI 10.1111/j.1471-4159.2004.02511.x; Pabelick CM, 2004, ANESTHESIOLOGY, V101, P373, DOI 10.1097/00000542-200408000-00018; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Prakash YS, 2006, ANESTHESIOLOGY, V105, P976, DOI 10.1097/00000542-200611000-00019; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash YS, 2009, AM J PHYSIOL-LUNG C, V297, pL794, DOI 10.1152/ajplung.00237.2009; Prakash YS, 2002, ANN NY ACAD SCI, V976, P530; Prakash YS, 1997, AM J PHYSIOL-CELL PH, V272, pC966, DOI 10.1152/ajpcell.1997.272.3.C966; Raina H, 2008, J PHYSIOL-LONDON, V586, P1669, DOI 10.1113/jphysiol.2007.150268; Rebolledo A, 2006, BIOCHEM BIOPH RES CO, V339, P840, DOI 10.1016/j.bbrc.2005.11.084; Reuter H, 2005, CARDIOVASC RES, V67, P198, DOI 10.1016/j.cardiores.2005.04.031; REUTER H, 1973, PHILOS T R SOC B, V265, P87, DOI 10.1098/rstb.1973.0011; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Sakai Y, 2005, CAN J PHYSIOL PHARM, V83, P791, DOI 10.1139/Y05-079; Sathish V, 2009, AM J PHYSIOL-LUNG C, V297, pL26, DOI 10.1152/ajplung.00026.2009; Sathish V, 2008, AM J PHYSIOL-LUNG C, V294, pL787, DOI 10.1152/ajplung.00461.2007; Schneider JC, 2002, AM J PHYSIOL-HEART C, V283, pH837, DOI 10.1152/ajpheart.00789.2001; Schuster A, 2004, J CARDIOVASC PHARM, V43, P539, DOI 10.1097/00005344-200404000-00009; Shore SA, 2004, CURR OPIN PHARMACOL, V4, P235, DOI 10.1016/j.coph.2004.01.008; Sieck GC, 2008, AM J PHYSIOL-LUNG C, V294, pL378, DOI 10.1152/ajplung.00394.2007; Sieck GC, 1997, CAN J PHYSIOL PHARM, V75, P878, DOI 10.1139/cjpp-75-7-878; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Wang XH, 2000, CHINESE MED J-PEKING, V113, P18; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; WORLEY JF, 1990, AM J PHYSIOL, V259, pL468, DOI 10.1152/ajplung.1990.259.6.L468; Zhang S, 2005, AM J PHYSIOL-CELL PH, V288, pC245, DOI 10.1152/ajpcell.00411.2004	64	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23662	10.1371/journal.pone.0023662	http://dx.doi.org/10.1371/journal.pone.0023662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858195	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700037
J	Liu, J; Zhang, CY				Liu, Jun; Zhang, Chiyu			Phylogeographic Analyses Reveal a Crucial Role of Xinjiang in HIV-1 CRF07_BC and HCV 3a Transmissions in Asia	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INJECTION-DRUG USERS; CIRCULATING RECOMBINANT; GENETIC DIVERSITY; TYPE-1 GENOME; INFECTION; FORMS; EPIDEMIOLOGY; CRF08-BC; DYNAMICS	Background: China faces an increasing prevalence of two HIV-1 circulating recombinant forms (CRFs) 07_BC and 08_BC. Both CRFs_BC were previously demonstrated to originate in Yunnan and spread to Liaoning from Yunnan via injection drug use (IDU) in China. Supposing it is true, we are unable to answer why only CRF07_BC, rather than both CRFs_BC together, was transmitted to Xinjiang. Methodology/Principal Findings: We investigated the phylogeography of CRF07_BC and CRF08_BC using multiple HIV-1 genomic regions with Bayesian phylogeography method. Phylogenetic reconstructions showed that all CRF07_BC sequences were divided into two clades, Yunnan and Xinjiang, and all strains from other regions of mainland China clustered within the Xinjiang clade. Significant geographic diffusion links of Xinjiang with other regions (including Liaoning, Beijing, Jiangsu and Guangdong) were supported by Bayes factor tests. The temporal dynamics analyses showed that CRF07_BC spread from Xinjiang to Liaoning in 1996.10, and to Jiangsu in 2000.9. The analyses of CRF08_BC not only confirmed the previous conclusion on temporal and spatial dynamics of CRF08_BC, but also indicated that the CRF08_BC strains from Guangdong and Shanghai originated from Yunnan. The analyses of HCV 3a showed that it was introduced into Xinjiang in the early 1980s, and spread from Xinjiang to Yunnan in 1990.10 and to Jiangsu in 1999.2, and further from Yunnan to Guangxi in 1995.3. The temporal and spatial dynamics of HCV 3a were similar to some extent to that of HIV-1 CRF07_BC and/or CRF08_BC, suggesting a possible association in migration patterns between HCV and HIV-1 through IDU. In addition, HCV 3a spread from Xinjiang to Pakistan, implying a drug trafficking route linking them. Conclusions/Significance: Xinjiang, as the most important transfer station for drug trafficking from Golden Crescent to other regions of China, plays a very crucial role in the transmission of viruses (e. g., HIV-1 and HCV) through IDU in Asia.	[Liu, Jun; Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Liu, J (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	zhangcy1999@hotmail.com		Zhang, Chiyu/0000-0001-8735-9857	Jiangsu University; National Natural Science Foundation of China [81071391]	Jiangsu University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the "Top-notch personnel" Project of Jiangsu University (to C. Zhang) and the National Natural Science Foundation of China (No. 81071391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Guo HX, 2009, AIDS RES HUM RETROV, V25, P463, DOI 10.1089/aid.2008.0250; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Lam TTY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000130; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lemey Philippe, 2009, PLoS Curr, V1, pRRN1031; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu SY, 2008, ARCH VIROL, V153, P1233, DOI 10.1007/s00705-008-0107-9; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Takebe Y, 2010, VACCINE, V28, pB39, DOI 10.1016/j.vaccine.2009.07.101; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tebit DM, 2007, AIDS REV, V9, P75; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2008, AIDS, V22, P156, DOI 10.1097/QAD.0b013e3282f2d77a; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Xin RL, 2009, J GEN VIROL, V90, P1757, DOI 10.1099/vir.0.009290-0; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016817; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017	46	33	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23347	10.1371/journal.pone.0023347	http://dx.doi.org/10.1371/journal.pone.0023347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858079	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500032
J	Thompson, PA; Brewster, AM; Do, KA; Baladandayuthapani, V; Broom, BM; Edgerton, ME; Hahn, KM; Murray, JL; Sahin, A; Tsavachidis, S; Wang, YK; Zhang, L; Hortobagyi, GN; Mills, GB; Bondy, ML				Thompson, Patricia A.; Brewster, Abenaa M.; Do, Kim-Anh; Baladandayuthapani, Veerabhadran; Broom, Bradley M.; Edgerton, Mary E.; Hahn, Karin M.; Murray, James L.; Sahin, Aysegul; Tsavachidis, Spyros; Wang, Yuker; Zhang, Li; Hortobagyi, Gabriel N.; Mills, Gordon B.; Bondy, Melissa L.			Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; GENE-EXPRESSION SIGNATURES; ALLELIC LOSS; ARRAY-CGH; SURVIVAL; SUBTYPES; PATTERNS; BASAL; RISK; 8P22	A number of studies of copy number imbalances (CNIs) in breast tumors support associations between individual CNIs and patient outcomes. However, no pattern or signature of CNIs has emerged for clinical use. We determined copy number (CN) gains and losses using high-density molecular inversion probe (MIP) arrays for 971 stage I/II breast tumors and applied a boosting strategy to fit hazards models for CN and recurrence, treating chromosomal segments in a dose-specific fashion (-1 [loss], 0 [no change] and +1 [gain]). The concordance index (C-Index) was used to compare prognostic accuracy between a training (n = 728) and test (n = 243) set and across models. Twelve novel prognostic CNIs were identified: losses at 1p12, 12q13.13, 13q12.3, 22q11, and Xp21, and gains at 2p11.1, 3q13.12, 10p11.21, 10q23.1, 11p15, 14q13.2-q13.3, and 17q21.33. In addition, seven CNIs previously implicated as prognostic markers were selected: losses at 8p22 and 16p11.2 and gains at 10p13, 11q13.5, 12p13, 20q13, and Xq28. For all breast cancers combined, the final full model including 19 CNIs, clinical covariates, and tumor marker-approximated subtypes (estrogen receptor [ER], progesterone receptor, ERBB2 amplification, and Ki67) significantly outperformed a model containing only clinical covariates and tumor subtypes (C-Index full model, train[test] = 0.72[0.71] +/- 0.02 vs. C-Index (clinical + subtype model), train[test] = 0.62[0.62] +/- 0.02; p < 10(-6)). In addition, the full model containing 19 CNIs significantly improved prognostication separately for ER-, HER2+, luminal B, and triple negative tumors over clinical variables alone. In summary, we show that a set of 19 CNIs discriminates risk of recurrence among early-stage breast tumors, independent of ER status. Further, our data suggest the presence of specific CNIs that promote and, in some cases, limit tumor spread.	[Thompson, Patricia A.] Univ Arizona, Arizona Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Brewster, Abenaa M.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Do, Kim-Anh; Baladandayuthapani, Veerabhadran; Zhang, Li] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Broom, Bradley M.; Sahin, Aysegul] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Edgerton, Mary E.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hahn, Karin M.; Murray, James L.; Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Tsavachidis, Spyros; Bondy, Melissa L.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wang, Yuker] Affymetrix Inc, Santa Clara, CA USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Arizona Center Cancer Care; University of Arizona; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Affymetrix; University of Texas System; UTMD Anderson Cancer Center	Thompson, PA (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.	PThompson@azcc.arizona.edu		Zhang, Li/0000-0003-0517-7860	National Institute of Health; Cancer Institute; Susan G. Komen for the Cure; National Breast Cancer Foundation; SPORE [P50CA116199]; CCSG [CA023074];  [R01CA089608]; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA023074, R01CA089608, P50CA098258, P50CA116199] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Institute; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Breast Cancer Foundation; SPORE; CCSG; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding sources for the study included the National Institute of Health, Cancer Institute, and Susan G. Komen for the Cure, National Breast Cancer Foundation, SPORE P50CA116199, R01CA089608, and CCSG CA023074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Binder H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-14; Binder H, 2009, BIOINFORMATICS, V25, P890, DOI 10.1093/bioinformatics/btp088; Brewster AM, 2007, J CLIN ONCOL, V25, P4438, DOI 10.1200/JCO.2007.10.6815; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Du J, 2010, J BIOCHEM, V147, P265, DOI 10.1093/jb/mvp161; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heagerty PJ., **DATA OBJECT**; Hirano A, 2001, CLIN CANCER RES, V7, P876; Hirano Akira, 2001, International Journal of Clinical Oncology, V6, P6, DOI 10.1007/PL00012082; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Horlings HM, 2010, CLIN CANCER RES, V16, P651, DOI 10.1158/1078-0432.CCR-09-0709; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Mollerstrom E, 2010, CANCER GENET CYTOGEN, V198, P79, DOI 10.1016/j.cancergencyto.2009.12.012; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Raftery AE, 2011, BMA BAYESIAN MODEL A; Rennstam K, 2003, CANCER RES, V63, P8861; Rodriguez C, 2004, CLIN CANCER RES, V10, P5785, DOI 10.1158/1078-0432.CCR-03-0410; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; SAHIN AA, 1991, CANCER-AM CANCER SOC, V68, P549, DOI 10.1002/1097-0142(19910801)68:3<549::AID-CNCR2820680318>3.0.CO;2-J; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Therneau TM, 2000, MODELING SURVIVAL DA; Tsuneizumi M, 2002, CANCER LETT, V180, P75, DOI 10.1016/S0304-3835(02)00010-1; Utada Y, 2000, CANCER, V88, P1410, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1410::AID-CNCR19>3.3.CO;2-O; van Beers EH, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1510; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Venkatraman ES, 2009, DNACOPY PACKAGE ANAL; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Volinsky CT, 1997, J R STAT SOC C-APPL, V46, P433, DOI 10.1111/1467-9876.00082; Wang Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r246; Wang Y, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-8; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	52	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23543	10.1371/journal.pone.0023543	http://dx.doi.org/10.1371/journal.pone.0023543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858162	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500053
J	Strickland, IT; Richards, L; Holmes, FE; Wynick, D; Uney, JB; Wong, LF				Strickland, Iain T.; Richards, Louise; Holmes, Fiona E.; Wynick, David; Uney, James B.; Wong, Liang-Fong			Axotomy-Induced miR-21 Promotes Axon Growth in Adult Dorsal Root Ganglion Neurons	PLOS ONE			English	Article							NERVE INJURY; GENE-EXPRESSION; SCIATIC-NERVE; SPINAL-CORD; TRANSCRIPTION FACTOR; PERIPHERAL AXOTOMY; LENTIVIRAL VECTOR; NEUROPATHIC PAIN; SENSORY AXONS; C-JUN	Following injury, dorsal root ganglion (DRG) neurons undergo transcriptional changes so as to adopt phenotypic changes that promote cell survival and axonal regeneration. Here we used a microarray approach to profile changes in a population of small noncoding RNAs known as microRNAs ( miRNAs) in the L4 and L5 DRG following sciatic nerve transection. Results showed that 20 miRNA transcripts displayed a significant change in expression levels, with 8 miRNAs transcripts being altered by more than 1.5-fold. Using quantitative reverse transcription PCR, we demonstrated that one of these miRNAs, miR-21, was upregulated by 7-fold in the DRG at 7 days post-axotomy. In dissociated adult rat DRG neurons lentiviral vector-mediated overexpression of miR-21 promoted neurite outgrowth on a reduced laminin substrate. miR-21 directly downregulated expression of Sprouty2 protein, as confirmed by Western blot analysis and 39 untranslated region (UTR) luciferase assays. Our data show that miR-21 is an axotomy-induced miRNA that enhances axon growth, and suggest that miRNAs are important players in regulating growth pathways following peripheral nerve injury.	[Strickland, Iain T.; Richards, Louise; Holmes, Fiona E.; Wynick, David; Uney, James B.; Wong, Liang-Fong] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Holmes, Fiona E.; Wynick, David] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; University of Bristol	Strickland, IT (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	L.Wong@bristol.ac.uk			Medical Research Council [G0700986]; Research Councils UK; Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish; Medical Research Council [G0300028, G1000863] Funding Source: researchfish; MRC [G0700986, G1000863, G0300028] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK(UK Research & Innovation (UKRI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (grant code G0700986) and Research Councils UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alexander M, 2003, ACTA NEUROPATHOL, V105, P420, DOI 10.1007/s00401-002-0658-x; Araki T, 2001, J BIOL CHEM, V276, P34131, DOI 10.1074/jbc.M104271200; BOLIN LM, 1995, J NEUROCHEM, V64, P850; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hausott B, 2009, MOL CELL NEUROSCI, V42, P328, DOI 10.1016/j.mcn.2009.08.005; Izumi B, 2011, NEUROSCI LETT, V492, P114, DOI 10.1016/j.neulet.2011.01.068; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Jimenez CR, 2005, MOL CELL PROTEOMICS, V4, P120, DOI 10.1074/mcp.M400076-MCP200; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Komori N, 2007, PHYSIOL GENOMICS, V29, P215, DOI 10.1152/physiolgenomics.00255.2006; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lee N, 2004, J COMP NEUROL, V474, P535, DOI 10.1002/cne.20140; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Paschen W, 1998, NEUROREPORT, V9, P3147, DOI 10.1097/00001756-199810050-00005; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Rau CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-181; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Stam FJ, 2007, EUR J NEUROSCI, V25, P3629, DOI 10.1111/j.1460-9568.2007.05597.x; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wong LF, 2006, NAT NEUROSCI, V9, P243, DOI 10.1038/nn1622; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yip PK, 2006, HUM MOL GENET, V15, P3107, DOI 10.1093/hmg/ddl251; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010	46	127	133	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23423	10.1371/journal.pone.0023423	http://dx.doi.org/10.1371/journal.pone.0023423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853131	gold, Green Submitted, Green Published			2022-12-25	WOS:000295454200084
J	Yu, R; Dhall, D; Nissen, NN; Zhou, CQ; Ren, SG				Yu, Run; Dhall, Deepti; Nissen, Nicholas N.; Zhou, Cuiqi; Ren, Song-Guang			Pancreatic Neuroendocrine Tumors in Glucagon Receptor-Deficient Mice	PLOS ONE			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; ALPHA-CELL HYPERPLASIA; KNOCKOUT MICE; GLUCOSE-HOMEOSTASIS; PRECURSOR LESIONS; GLYCEMIC CONTROL; TRANSGENIC MICE; T-ANTIGEN; MEN1; GENE	Inhibition of glucagon signaling causes hyperglucagonemia and pancreatic alpha cell hyperplasia in mice. We have recently demonstrated that a patient with an inactivating glucagon receptor mutation (P86S) also exhibits hyperglucagonemia and pancreatic alpha cell hyperplasia but further develops pancreatic neuroendocrine tumors (PNETs). To test the hypothesis that defective glucagon signaling causes PNETs, we studied the pancreata of mice deficient in glucagon receptor (Gcgr(-/-)) from 2 to 12 months, using WT and heterozygous mice as controls. At 2-3 months, Gcgr(-/-) mice exhibited normal islet morphology but the islets were mostly composed of alpha cells. At 5-7 months, dysplastic islets were evident in Gcgr(-/-) mice but absent in WT or heterozygous controls. At 10-12 months, gross PNETs (>= 1 mm) were detected in most Gcgr(-/-) pancreata and micro-PNETs (<1 mm) were found in all (n = 14), whereas the islet morphology remained normal and no PNETs were found in any WT (n = 10) or heterozygous (n = 25) pancreata. Most PNETs in Gcgr(-/-) mice were glucagonomas, but some were non-functioning. No tumors predominantly expressed insulin, pancreatic polypeptide, or somatostatin, although some harbored focal aggregates of tumor cells expressing one of those hormones. The PNETs in Gcgr(-/-) mice were well differentiated and occasionally metastasized to the liver. Menin expression was aberrant in most dysplatic islets and PNETs. Vascular endothelial growth factor (VEGF) was overexpressed in PNET cells and its receptor Flk-1 was found in the abundant blood vessels or blood islands inside the tumors. We conclude that defective glucagon signaling causes PNETs in the Gcgr(-/-) mice, which may be used as a model of human PNETs. Our results further suggest that completely inhibiting glucagon signaling may not be a safe approach to treat diabetes.	[Yu, Run] Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Div Endocrinol, Los Angeles, CA 90048 USA; [Yu, Run] Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Carcinoid & Neuroendocrine Tumor Ctr, Los Angeles, CA 90048 USA; [Dhall, Deepti] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Nissen, Nicholas N.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Nissen, Nicholas N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Zhou, Cuiqi; Ren, Song-Guang] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Yu, R (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Div Endocrinol, Los Angeles, CA 90048 USA.	run.yu@cshs.org			National Institutes of Health [DK071870]; Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: Supported by National Institutes of Health grant DK071870 (R.Y.) and Cedars-Sinai Medical Center. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Anlauf M, 2007, PATHOBIOLOGY, V74, P279, DOI 10.1159/000105810; Antonello D, 2009, PANCREATOLOGY, V9, P25, DOI 10.1159/000178872; Asa SL, 1996, VIRCHOWS ARCH, V427, P595; Authier F, 2008, CELL MOL LIFE SCI, V65, P1880, DOI 10.1007/s00018-008-7479-6; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chesnokova V, 2009, ENDOCRINOLOGY, V150, P2603, DOI 10.1210/en.2008-0972; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Corbo V, 2010, ENDOCR-RELAT CANCER, V17, P771, DOI 10.1677/ERC-10-0028; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gu W, 2009, J PHARMACOL EXP THER, V331, P871, DOI 10.1124/jpet.109.157685; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kedees MH, 2007, DEV DYNAM, V236, P1126, DOI 10.1002/dvdy.21112; KIMURA W, 1991, DIGEST DIS SCI, V36, P933, DOI 10.1007/BF01297144; Kloppel G, 2007, ENDOCR PATHOL, V18, P150, DOI 10.1007/s12022-007-0025-5; LEE YC, 1992, J BIOL CHEM, V267, P10705; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Mang Y, 2004, DIABETES, V53, P410; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Oberg K, 2009, CURR OPIN ENDOCRINOL, V16, P72, DOI 10.1097/MED.0b013e328320d845; Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265; Perren A, 2007, J CLIN ENDOCR METAB, V92, P1118, DOI 10.1210/jc.2006-1944; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; RINDI G, 1991, VIRCHOWS ARCH A, V419, P115, DOI 10.1007/BF01600225; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Sloop KW, 2005, EXPERT OPIN THER TAR, V9, P593, DOI 10.1517/14728222.9.3.593; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sorensen H, 2006, DIABETES, V55, P2843, DOI 10.2337/db06-0222; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Webb GC, 2002, DIABETES, V51, P398, DOI 10.2337/diabetes.51.2.398; Winzell MS, 2007, DIABETOLOGIA, V50, P1453, DOI 10.1007/s00125-007-0675-3; Wu Xinjiang, 2008, Curr Mol Med, V8, P805, DOI 10.2174/156652408786733702; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009; Yu R, 2008, PANCREAS, V36, P428, DOI 10.1097/MPA.0b013e31815ceb23; Yu Run, 2011, Endocrinol Nutr, V58, P258, DOI 10.1016/j.endonu.2011.04.002; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	49	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23397	10.1371/journal.pone.0023397	http://dx.doi.org/10.1371/journal.pone.0023397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853126	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200080
J	Ung, D; Amy, M; Leboucher, G				Ung, Davy; Amy, Mathieu; Leboucher, Gerard			Heaven It's My Wife! Male Canaries Conceal Extra-Pair Courtships but Increase Aggressions When Their Mate Watches	PLOS ONE			English	Article							SIAMESE FIGHTING FISH; SERINUS-CANARIA; JAPANESE-QUAIL; MALE DISPLAYS; AUDIENCE; PREFERENCES; EAVESDROP; CHOICE; BIRDS; INFORMATION	Many animals live in a communication network, an environment where individuals can obtain information about competitors or potential mates by observing interactions between conspecifics. In such an environment, interactants might benefit by changing their signalling behaviour in the presence of an audience. This audience effect seems widespread among species, has been observed during various types of interaction (e. g. intra-sexual vs. inter-sexual interaction) and varies according to the social context (e. g. gender, hierarchical or mating status of the audience). However, the way individuals might adapt their signalling behaviour to a combination of these factors remains poorly understood. To address this question, we studied how the presence of an audience affects the behaviour of male domestic canaries Serinus canaria during two types of interactions: (i) an extra-pair interaction and (ii) a male-male competition for food. Males were observed under three conditions: (a) in the absence of audience, (b) in the presence of their mate or (c) of a familiar female. Our results show that male domestic canaries minutely adapt their courting and agonistic behaviours to a combination of: (i) the type of interaction (extra-pair interaction/male-male competition), (ii) the social context (mate, familiar female or nobody in audience) and (iii) the behaviours of both the audience and the interactant. These results highlight the ability of animals to subtly adapt their behaviour to the social environment. This also raises questions about the cognitive foundations and evolution of these processes especially considering that canaries are known neither for having high cognitive abilities nor for being a typical example for the social intelligence hypothesis.	[Ung, Davy; Amy, Mathieu; Leboucher, Gerard] Univ Paris Ouest Nanterre Def, Lab Ethol & Cognit Comparees, EA 3456, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Universite Paris Nanterre	Ung, D (corresponding author), Univ Paris Ouest Nanterre Def, Lab Ethol & Cognit Comparees, EA 3456, Paris, France.	davyu@free.fr			French Ministry of National Education [20028-2010]	French Ministry of National Education	Dr. Ung is supported by the French Ministry of National Education (no 20028-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy M, 2008, ANIM BEHAV, V76, P971, DOI 10.1016/j.anbehav.2008.03.023; Amy M, 2007, ANIM BEHAV, V74, P57, DOI 10.1016/j.anbehav.2006.07.019; Amy M, 2009, ETHOLOGY, V115, P239, DOI 10.1111/j.1439-0310.2008.01579.x; Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Beguin N, 2006, ACTA ETHOL, V9, P65, DOI 10.1007/s10211-006-0017-3; BIRKHEAD TR, 1981, ANIM BEHAV, V29, P304, DOI 10.1016/S0003-3472(81)80183-2; Brockway B. F., 1964, Behaviour, V23, P294, DOI 10.1163/156853964X00193; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; Daumas F, 1982, REV STAT APPL, V30, P23; Di Bitetti MS, 2005, ANIM BEHAV, V69, P911, DOI 10.1016/j.anbehav.2004.05.021; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; FOLLETT BK, 1973, J ENDOCRINOL, V59, P151, DOI 10.1677/joe.0.0590151; HECTOR ACK, 1989, ANIM BEHAV, V38, P262, DOI 10.1016/S0003-3472(89)80088-0; HOVI M, 1995, BEHAV ECOL SOCIOBIOL, V37, P283; Leboucher G, 2004, ANIM BEHAV, V68, P957, DOI 10.1016/j.anbehav.2003.12.011; LINDSAY DR, 1976, ANIM BEHAV, V24, P818, DOI 10.1016/S0003-3472(76)80012-7; Matessi G, 2005, BEHAVIOUR, V142, P507, DOI 10.1163/1568539054012010; Matos Ricardo J., 2005, P63, DOI 10.1017/CBO9780511610363.006; Matos RJ, 2003, BEHAV PROCESS, V63, P53, DOI 10.1016/S0376-6357(03)00029-9; Matos RJ, 2002, BEHAVIOUR, V139, P1211, DOI 10.1163/15685390260437344; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; McGregor Peter K., 1996, P409; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mulligan J. A., 1969, P165; Naguib M, 1997, ANIM BEHAV, V54, P1535, DOI 10.1006/anbe.1997.9997; Naguib M, 1999, P ROY SOC B-BIOL SCI, V266, P537, DOI 10.1098/rspb.1999.0669; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Ophir AG, 2005, J COMP PSYCHOL, V119, P3, DOI 10.1037/0735-7036.119.1.3; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Peake TM, 2001, P ROY SOC B-BIOL SCI, V268, P1183, DOI 10.1098/rspb.2001.1648; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Price AC, 2006, ETHOLOGY, V112, P22, DOI 10.1111/j.1439-0310.2006.01142.x; Ratikainen II, 2010, BEHAV ECOL, V21, P195, DOI 10.1093/beheco/arp168; Tachon G, 1999, J INSECT BEHAV, V12, P533, DOI 10.1023/A:1020970908541; Townsend Simon, 2009, Communicative & Integrative Biology, V2, P282; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Voigt C., 1998, Boletim do Museu Municipal do Funchal, P117; Voigt C, 2003, J ORNITHOL, V144, P86, DOI 10.1007/BF02465520; WETTON JH, 1991, P ROY SOC B-BIOL SCI, V245, P227, DOI 10.1098/rspb.1991.0114; Zuberbuhler K, 2008, CURR BIOL, V18, pR189, DOI 10.1016/j.cub.2007.12.041	44	19	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22686	10.1371/journal.pone.0022686	http://dx.doi.org/10.1371/journal.pone.0022686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857945	Green Submitted, Green Published, gold			2022-12-25	WOS:000293774300006
J	Bregeon, F; Xeridat, F; Andreotti, N; Lepidi, H; Delpierre, S; Roch, A; Ravailhe, S; Jammes, Y; Steinberg, JG				Bregeon, Fabienne; Xeridat, Francois; Andreotti, Nicolas; Lepidi, Hubert; Delpierre, Stephane; Roch, Antoine; Ravailhe, Sylvie; Jammes, Yves; Steinberg, Jean-Guillaume			Activation of Nicotinic Cholinergic Receptors Prevents Ventilator-Induced Lung Injury in Rats	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; ACETYLCHOLINE-RECEPTORS; ANTIINFLAMMATORY PATHWAY; HUMAN-MONOCYTES; STIMULATION; ALPHA-7; CYTOKINES; METHYLLYCACONITINE; DISCOVERY; AGONISTS	Respiratory distress syndrome is responsible for 40 to 60 percent mortality. An over mortality of about 10 percent could result from additional lung injury and inflammation due to the life-support mechanical ventilation, which stretches the lung. It has been recently demonstrated, in vitro, that pharmacological activation of the alpha 7 nicotinic receptors (alpha 7-nAChR) could down regulate intracellular mediators involved in lung cell inflammatory response to stretch. Our aim was to test in vivo the protective effect of the pharmacological activation of the alpha 7-nAChR against ventilator-induced lung injury (VILI). Anesthetized rats were ventilated for two hours with a high stretch ventilation mode delivering a stroke volume large enough to generate 25-cmH(2)O airway pressure, and randomly assigned to four groups: pretreated with parenteral injection of saline or specific agonist of the alpha 7-nAChR (PNU-282987), or submitted to bilateral vagus nerve electrostimulation while pre-treated or not with the alpha 7-nAChR antagonist methyllycaconitine (MLA). Controls ventilated with a conventional stroke volume of 10 mL/kg gave reference data. Physiological indices (compliance of the respiratory system, lung weight, blood oxygenation, arterial blood pressure) and lung contents of inflammatory mediators (IL-6 measured by ELISA, substance P assessed using HPLC) were severely impaired after two hours of high stretch ventilation (sham group). Vagal stimulation was able to maintain the respiratory parameters close to those obtained in Controls and reduced lung inflammation except when associated to nicotinic receptor blockade (MLA), suggesting the involvement of alpha 7-nAChR in vagally-mediated protection against VILI. Pharmacological pre-treatment with PNU-282987 strongly decreased lung injury and lung IL-6 and substance P contents, and nearly abolished the increase in plasmatic IL-6 levels. Pathological examination of the lungs confirmed the physiological differences observed between the groups. In conclusion, these data suggest that the stimulation of alpha 7-nAChR is able to attenuate VILI in rats.	[Bregeon, Fabienne; Delpierre, Stephane; Ravailhe, Sylvie; Jammes, Yves; Steinberg, Jean-Guillaume] Univ Aix Marseille 2, Fac Med, Inst Federatif Rech Jean Roche, UMR MD2 P2COE, F-13284 Marseille 07, France; [Xeridat, Francois; Roch, Antoine] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Detresses Resp & Infect Severes, Marseille, France; [Xeridat, Francois; Roch, Antoine] Univ Mediterrane & Reanimat Med, Fac Med, Unite Rech Malad Infect & Trop URMITE, Marseille, France; [Andreotti, Nicolas] Univ Aix Marseille 2, ERT 62, Inst Federatif Rech Jean Roche, F-13284 Marseille 07, France; [Lepidi, Hubert] Hop La Timone, Assistance Publ Hop Marseille, Serv Anat Pathol & Neuropathol, Marseille, France; [Lepidi, Hubert] URMITE, CNRS, IRD 198, Unite Rickettsies,UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Bregeon, F (corresponding author), Univ Aix Marseille 2, Fac Med, Inst Federatif Rech Jean Roche, UMR MD2 P2COE, F-13284 Marseille 07, France.	fabienne.bregeon@ap-hm.fr			Universite de la Mediterranee Aix Marseille II institute	Universite de la Mediterranee Aix Marseille II institute	This study was supported by the Universite de la Mediterranee Aix Marseille II institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALELBERMANI WI, 1973, AM J ANAT, V137, P19; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; BARNES PJ, 1986, LANCET, V1, P242; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Bodnar AL, 2005, J MED CHEM, V48, P905, DOI 10.1021/jm049363q; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bregeon F, 2010, J PHYSIOL-LONDON, V588, P1309, DOI 10.1113/jphysiol.2010.187658; Bregeon F, 2008, CRIT CARE MED, V36, P3205, DOI 10.1097/CCM.0b013e31818f0e20; CAMPOS HA, 1969, J PHYSIOL-LONDON, V200, P311, DOI 10.1113/jphysiol.1969.sp008695; Davies ARL, 1999, NEUROPHARMACOLOGY, V38, P679, DOI 10.1016/S0028-3908(98)00221-4; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; DeKoninck P, 1995, J NEUROSCI, V15, P7966; dos Santos CC, 2011, AM J RESP CRIT CARE, V183, P471, DOI 10.1164/rccm.201002-0314OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Grando SA, 2003, LIFE SCI, V72, P2009, DOI 10.1016/S0024-3205(03)00063-8; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Killingsworth CR, 1997, AM J PHYSIOL-LUNG C, V273, pL1073, DOI 10.1152/ajplung.1997.273.5.L1073; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Laffey JG, 2003, CRIT CARE MED, V31, P2634, DOI 10.1097/01.CCM.0000089646.52395.BA; Li HF, 2009, ADV EXP MED BIOL, V648, P421, DOI 10.1007/978-90-481-2259-2_48; Li YF, 2009, NEUROSCI LETT, V462, P20, DOI 10.1016/j.neulet.2009.06.081; LOTVALL J, 1992, ACTA PHYSIOL SCAND, V144, P101, DOI 10.1111/j.1748-1716.1992.tb09272.x; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; LUNDBERG JM, 1987, ANNU REV PHYSIOL, V49, P557; Mioni C, 2005, CRIT CARE MED, V33, P2621, DOI 10.1097/01.CCM.0000186762.05301.13; Oke SL, 2008, J LEUKOCYTE BIOL, V83, P512, DOI 10.1189/jlb.0607363; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Stegelmeier BL, 2003, J ANIM SCI, V81, P1237; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Sykes AP, 2000, INFLAMM RES, V49, P311, DOI 10.1007/s000110050597; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; TUREK JW, 1995, J NEUROSCI METH, V61, P113, DOI 10.1016/0165-0270(95)00032-P; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Wong SS, 2004, AM J PHYSIOL-LUNG C, V287, pL859, DOI 10.1152/ajplung.00388.2003; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Yu J, 2007, RESP PHYSIOL NEUROBI, V156, P116, DOI 10.1016/j.resp.2006.11.005	42	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22386	10.1371/journal.pone.0022386	http://dx.doi.org/10.1371/journal.pone.0022386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857926	Green Published, gold, Green Submitted			2022-12-25	WOS:000293773300004
J	Vilboux, T; Ciccone, C; Blancato, JK; Cox, GF; Deshpande, C; Introne, WJ; Gahl, WA; Smith, ACM; Huizing, M				Vilboux, Thierry; Ciccone, Carla; Blancato, Jan K.; Cox, Gerald F.; Deshpande, Charu; Introne, Wendy J.; Gahl, William A.; Smith, Ann C. M.; Huizing, Marjan			Molecular Analysis of the Retinoic Acid Induced 1 Gene (RAI1) in Patients with Suspected Smith-Magenis Syndrome without the 17p11.2 Deletion	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; SYNDROME DEL 17P11.2; REAL-TIME PCR; INTERSTITIAL DELETION; ALAGILLE-SYNDROME; HUMAN JAGGED1; MUTATIONS; EXPRESSION; PHENOTYPE; DISEASE	Smith-Magenis syndrome (SMS) is a complex neurobehavioral disorder characterized by multiple congenital anomalies. The syndrome is primarily ascribed to a similar to 3.7 Mb de novo deletion on chromosome 17p11.2. Haploinsufficiency of multiple genes likely underlies the complex clinical phenotype. RAI1 (Retinoic Acid Induced 1) is recognized as a major gene involved in the SMS phenotype. Extensive genetic and clinical analyses of 36 patients with SMS-like features, but without the 17p11.2 microdeletion, yielded 10 patients with RAI1 variants, including 4 with de novo deleterious mutations, and 6 with novel missense variants, 5 of which were familial. Haplotype analysis showed two major RAI1 haplotypes in our primarily Caucasian cohort; the novel RAI1 variants did not occur in a preferred haplotype. RNA analysis revealed that RAI1 mRNA expression was significantly decreased in cells of patients with the common 17p11.2 deletion, as well as in those with de novo RAI1 variants. Expression levels varied in patients with familial RAI1 variants and in non-17p11.2 deleted patients without identified RAI1 defects. No correlation between SNP haplotype and RAI1 expression was found. Two clinical features, ocular abnormalities and polyembolokoilomania (object insertion), were significantly correlated with decreased RAI1 expression. While not significantly correlated, the presence of hearing loss, seizures, hoarse voice, childhood onset of obesity and specific behavioral aspects and the absence of immunologic abnormalities and cardiovascular or renal structural anomalies, appeared to be specific for the de novo RAI1 subgroup. Recognition of the combination of these features will assist in referral for RAI1 analysis of patients with SMS-like features without detectable microdeletion of 17p11.2. Moreover, RAI1 expression emerged as a genetic target for development of therapeutic interventions for SMS.	[Vilboux, Thierry; Ciccone, Carla; Gahl, William A.; Huizing, Marjan] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Blancato, Jan K.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Cox, Gerald F.] Harvard Univ, Sch Med, Dept Pediat, Div Genet,Childrens Hosp Boston, Boston, MA 02115 USA; [Deshpande, Charu] Guys Hosp, Dept Genet, London SE1 9RT, England; [Introne, Wendy J.; Gahl, William A.; Smith, Ann C. M.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Cox, Gerald F.] Genzyme Corp, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; Harvard University; Boston Children's Hospital; Harvard Medical School; Guy's & St Thomas' NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Sanofi-Aventis; Genzyme Corporation	Vilboux, T (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	mhuizing@mail.nih.gov	Huizing, Marjan/AAR-8860-2020		National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322, ZIAHG000215] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Burns B, 2010, HUM MOL GENET, V19, P4026, DOI 10.1093/hmg/ddq317; Carmona-Mora P, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-63; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Devriendt Koen, 2004, Human Genomics, V1, P126; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girirajan S, 2009, MAMM GENOME, V20, P247, DOI 10.1007/s00335-009-9180-y; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Griffin AE, 2005, CLIN GENET, V68, P23, DOI 10.1111/j.1399-0004.2005.00461.x; Gropman AL, 2007, CURR OPIN NEUROL, V20, P125, DOI 10.1097/WCO.0b013e3280895dba; Gropman AL, 2006, PEDIATR NEUROL, V34, P337, DOI 10.1016/j.pediatrneurol.2005.08.018; Gualandi G, 2001, MUTAGENESIS, V16, P203, DOI 10.1093/mutage/16.3.203; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Huizing M, 2001, AM J HUM GENET, V69, P1022, DOI 10.1086/324168; IMAI Y, 1995, MOL BRAIN RES, V31, P1, DOI 10.1016/0169-328X(95)00020-S; INTRONE W, 2005, IMMUNOLOGIC ABNORMAL; Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010; Juyal RC, 1996, AM J HUM GENET, V58, P998; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Livak K., 1997, COMP CT METHOD ABI P; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Rachid R, 2006, CURR ALLERGY ASTHM R, V6, P357, DOI 10.1007/s11882-996-0004-9; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; Seranski P, 2001, GENE, V270, P69, DOI 10.1016/S0378-1119(01)00415-2; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; SMITH ACM, 2005, CLIN MANAGEMENT GENE; SMITH ACM, 2004, GROWTH ASSESSMENT SM; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Truong HT, 2008, GENET TEST, V12, P67, DOI 10.1089/gte.2007.0058; Truong HT, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-142; Vlangos CN, 2005, AM J MED GENET A, V132A, P278, DOI 10.1002/ajmg.a.30461; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Williams SR, 2010, J MED GENET, V47, P223, DOI 10.1136/jmg.2009.068072; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	59	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22861	10.1371/journal.pone.0022861	http://dx.doi.org/10.1371/journal.pone.0022861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857958	gold, Green Submitted, Green Published			2022-12-25	WOS:000293773300010
J	Landgraf, T; Rojas, R; Nguyen, H; Kriegel, F; Stettin, K				Landgraf, Tim; Rojas, Raul; Hai Nguyen; Kriegel, Fabian; Stettin, Katja			Analysis of the Waggle Dance Motion of Honeybees for the Design of a Biomimetic Honeybee Robot	PLOS ONE			English	Article							COMMUNICATION; BEES; INFORMATION; COMMON	The honeybee dance "language" is one of the most popular examples of information transfer in the animal world. Today, more than 60 years after its discovery it still remains unknown how follower bees decode the information contained in the dance. In order to build a robotic honeybee that allows a deeper investigation of the communication process we have recorded hundreds of videos of waggle dances. In this paper we analyze the statistics of visually captured high-precision dance trajectories of European honeybees (Apis mellifera carnica). The trajectories were produced using a novel automatic tracking system and represent the most detailed honeybee dance motion information available. Although honeybee dances seem very variable, some properties turned out to be invariant. We use these properties as a minimal set of parameters that enables us to model the honeybee dance motion. We provide a detailed statistical description of various dance properties that have not been characterized before and discuss the role of particular dance components in the commmunication process.	[Landgraf, Tim; Rojas, Raul; Hai Nguyen; Kriegel, Fabian] Free Univ Berlin, Dept Math & Comp Sci, D-1000 Berlin, Germany; [Stettin, Katja] Univ Cambridge, Dept Zool, Cambridge, England	Free University of Berlin; University of Cambridge	Landgraf, T (corresponding author), Free Univ Berlin, Dept Math & Comp Sci, D-1000 Berlin, Germany.	tim.landgraf@fu-berlin.de	Rojas-Gonzalez, Raul/AAF-1871-2020	Rojas-Gonzalez, Raul/0000-0003-1596-7030; Kriegel, Fabian/0000-0003-1536-2840; Landgraf, Tim/0000-0003-4951-5235	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozic J., 1991, J APIC RES; De Marco RJ, 2008, J EXP BIOL, V211, P1635, DOI 10.1242/jeb.013425; DEMARCO R, 2008, LEARNING MEMORY COMM, P1; ESCH H, 1965, SCIENCE, V149, P320, DOI 10.1126/science.149.3681.320; Gil M, 2010, ANIM BEHAV, V80, P887, DOI 10.1016/j.anbehav.2010.08.012; Griffin D., 1994, ANIMAL MINDS; KIRCHNER WH, 1994, SCI AM; LANDGRAF T, 2007, B0177 FB MATH INF; Landgraf T, 2010, IEEE INT C INT ROBOT, P3097, DOI 10.1109/IROS.2010.5650930; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Michelsen A, 2003, J COMP PHYSIOL A, V189, P165, DOI 10.1007/s00359-003-0398-y; Peirce C., 1965, COLLECTED PAPERS CHA, V5; Rohrseitz K, 1999, J COMP PHYSIOL A, V184, P463, DOI 10.1007/s003590050346; SCHWAIER T, 2010, THESIS FREIE U BERLI; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Tautz J, 1996, J EXP BIOL, V199, P1375; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; von Frisch Karl, 1965, TANZSPRACHE ORIENTIE; Weidenmuller A, 1999, BEHAV ECOL SOCIOBIOL, V46, P190, DOI 10.1007/s002650050609	23	26	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21354	10.1371/journal.pone.0021354	http://dx.doi.org/10.1371/journal.pone.0021354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857906	Green Submitted, Green Published, gold			2022-12-25	WOS:000293558900007
J	Soowannayan, C; Cowley, JA; Michalski, WP; Walker, PJ				Soowannayan, Chumporn; Cowley, Jeff A.; Michalski, Wojtek P.; Walker, Peter J.			RNA-Binding Domain in the Nucleocapsid Protein of Gill-Associated Nidovirus of Penaeid Shrimp	PLOS ONE			English	Article							YELLOW-HEAD-VIRUS; INFECTIOUS-BRONCHITIS VIRUS; MONOCLONAL-ANTIBODIES; PACKAGING SIGNAL; CORONAVIRUS; IDENTIFICATION; MONODON; GENES; DIFFERENTIATION; PHOSPHOPROTEIN	Gill-associated virus (GAV) infects Penaeus monodon shrimp and is the type species okavirus in the Roniviridae, the only invertebrate nidoviruses known currently. Electrophoretic mobility shift assays (EMSAs) using His(6)-tagged full-length and truncated proteins were employed to examine the nucleic acid binding properties of the GAV nucleocapsid (N) protein in vitro. The EMSAs showed full-length N protein to bind to all synthetic single-stranded (ss) RNAs tested independent of their sequence. The ssRNAs included (+) and (-) sense regions of the GAV genome as well as a (+) sense region of the M RNA segment of Mourilyan virus, a crustacean bunya-like virus. GAV N protein also bound to double-stranded (ds) RNAs prepared to GAV ORF1b gene regions and to bacteriophage M13 genomic ssDNA. EMSAs using the five N protein constructs with variable-length N-terminal and/or C-terminal truncations localized the RNA binding domain to a 50 amino acid (aa) N-terminal sequence spanning Met(11) to Arg(60). Similarly to other RNA binding proteins, the first 16 aa portion of this sequence was proline/arginine rich. To examine this domain in more detail, the 18 aa peptide (M(11) PVRRPLPPQPPRNARLI(29)) encompassing this sequence was synthesized and found to bind nucleic acids similarly to the full-length N protein in EMSAs. The data indicate a fundamental role for the GAV N protein proline/arginine-rich domain in nucleating genomic ssRNA to form nucleocapsids. Moreover, as the synthetic peptide formed higher-order complexes in the presence of RNA, the domain might also play some role in protein/protein interactions stabilizing the helical structure of GAV nucleocapsids.	[Soowannayan, Chumporn; Cowley, Jeff A.; Walker, Peter J.] Queensland Biosci Precinct, CSIRO Livestock Ind, St Lucia, Qld, Australia; [Michalski, Wojtek P.; Walker, Peter J.] Australian Anim Hlth Lab, CSIRO Livestock Ind, Geelong, Vic, Australia; [Soowannayan, Chumporn] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Patumthani, Thailand; [Soowannayan, Chumporn] Mahidol Univ, Fac Sci, CENTEX SHRIMP, Bangkok 10400, Thailand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Soowannayan, C (corresponding author), Queensland Biosci Precinct, CSIRO Livestock Ind, St Lucia, Qld, Australia.	chumporn@biotec.or.th	Walker, Peter J/H-6059-2013; Cowley, Jeff A/H-7553-2013; Michalski, Wojtek/H-3544-2013	Walker, Peter J/0000-0003-1851-642X; Cowley, Jeff/0000-0003-0454-4825	CSIRO Livestock Industries; Australian Government Department of Education, Employment and Workplace Relations (DEEWR); Thai National Center for Genetic Engineering and Biotechnology	CSIRO Livestock Industries; Australian Government Department of Education, Employment and Workplace Relations (DEEWR)(Australian GovernmentDepartment of Industry, Innovation and Science); Thai National Center for Genetic Engineering and Biotechnology	Research contributing to the PhD degree of CS was supported financially by CSIRO Livestock Industries (JAC and PJW) and by an Australia-Asia Award from the Australian Government Department of Education, Employment and Workplace Relations (DEEWR), formerly the Department of Education Science and Training (DEST) and by the split mode scholarship from the Thai National Center for Genetic Engineering and Biotechnology. The funders had no role in study design, data collection and analysis, or the decision prepare this manuscript for publication.	BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CAREY J, 1991, METHOD ENZYMOL, V208, P103; Cowley JA, 2005, DIS AQUAT ORGAN, V66, P91, DOI 10.3354/dao066091; Cowley JA, 2004, J VIROL, V78, P8935, DOI 10.1128/JVI.78.16.8935-8941.2004; Cowley JA, 2004, J VIROL METHODS, V117, P49, DOI 10.1016/j.jviromet.2003.11.018; COWLEY JA, 2001, GILL ASS VIRUS PENAE, P43; Duckmanton LM, 1998, VIRUS RES, V58, P83, DOI 10.1016/S0168-1702(98)00104-X; FOSMIRE JA, 1992, J VIROL, V66, P3522, DOI 10.1128/JVI.66.6.3522-3530.1992; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Herranz MC, 2004, J GEN VIROL, V85, P761, DOI 10.1099/vir.0.19534-0; Kroneman A, 1998, J VIROL, V72, P3507, DOI 10.1128/JVI.72.5.3507-3511.1998; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Lesley SA, 2002, PROTEIN ENG, V15, P153, DOI 10.1093/protein/15.2.153; Liu PH, 2004, J GEN VIROL, V85, P3725, DOI 10.1099/vir.0.80325-0; MAKINO S, 1990, J VIROL, V64, P6045, DOI 10.1128/JVI.64.12.6045-6053.1990; MASTERS PS, 1990, ADV EXP MED BIOL, V276, P235; MASTERS PS, 1992, ARCH VIROL, V125, P141, DOI 10.1007/BF01309634; Mavrakis M, 2006, VIROLOGY, V349, P422, DOI 10.1016/j.virol.2006.01.030; Nadala ECB, 1997, DIS AQUAT ORGAN, V31, P141, DOI 10.3354/dao031141; Narayanan K, 2001, J VIROL, V75, P9059, DOI 10.1128/JVI.75.19.9059-9067.2001; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244-9258.2003; Sithigorngul P, 2002, DIS AQUAT ORGAN, V49, P71, DOI 10.3354/dao049071; Sittidilokratna N, 2006, VIRUS RES, V116, P21, DOI 10.1016/j.virusres.2005.08.009; SNIJDER EJ, 1989, J GEN VIROL, V70, P3363, DOI 10.1099/0022-1317-70-12-3363; Soowannayan C, 2003, DIS AQUAT ORGAN, V57, P193, DOI 10.3354/dao057193; STOHLMAN SA, 1988, J VIROL, V62, P4288, DOI 10.1128/JVI.62.11.4288-4295.1988; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; Wijegoonawardane PKM, 2008, VIROLOGY, V380, P213, DOI 10.1016/j.virol.2008.07.005; WILLIAMS AK, 1992, VIRUS RES, V25, P213, DOI 10.1016/0168-1702(92)90135-V; Wootton SK, 1998, CLIN DIAGN LAB IMMUN, V5, P773, DOI 10.1128/CDLI.5.6.773-779.1998; YOUN S, 2003, IN VITRO ASSEMBLY IN; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou ML, 1996, VIROLOGY, V217, P191, DOI 10.1006/viro.1996.0106; Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22156	10.1371/journal.pone.0022156	http://dx.doi.org/10.1371/journal.pone.0022156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857914	gold, Green Published, Green Submitted			2022-12-25	WOS:000293558900011
J	Zhang, H; Wong, CCL; Wei, H; Gilkes, DM; Korangath, P; Chaturvedi, P; Schito, L; Chen, J; Krishnamachary, B; Winnard, PT; Raman, V; Zhen, L; Mitzner, WA; Sukumar, S; Semenza, GL				Zhang, H.; Wong, C. C. L.; Wei, H.; Gilkes, D. M.; Korangath, P.; Chaturvedi, P.; Schito, L.; Chen, J.; Krishnamachary, B.; Winnard, P. T., Jr.; Raman, V.; Zhen, L.; Mitzner, W. A.; Sukumar, S.; Semenza, G. L.			HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs	ONCOGENE			English	Article						breast cancer; metastasis; hypoxia	INDUCIBLE FACTOR-I; LYSYL OXIDASE; FACTOR-1-ALPHA; OVEREXPRESSION; PROGNOSIS; PREDICTS; BIOLOGY; SERIES; GENES	Most cases of breast cancer (BrCa) mortality are due to vascular metastasis. BrCa cells must intravasate through endothelial cells (ECs) to enter a blood vessel in the primary tumor and then adhere to ECs and extravasate at the metastatic site. In this study we demonstrate that inhibition of hypoxia-inducible factor (HIF) activity in BrCa cells by RNA interference or digoxin treatment inhibits primary tumor growth and also inhibits the metastasis of BrCa cells to the lungs by blocking the expression of angiopoietin-like 4 (ANGPTL4) and L1 cell adhesion molecule (L1CAM). ANGPTL4 is a secreted factor that inhibits EC-EC interaction, whereas L1CAM increases the adherence of BrCa cells to ECs. Interference with HIF, ANGPTL4 or L1CAM expression inhibits vascular metastasis of BrCa cells to the lungs. Oncogene (2012) 31, 1757-1770; doi: 10.1038/onc.2011.365; published online 22 August 2011	[Zhang, H.; Wong, C. C. L.; Wei, H.; Gilkes, D. M.; Chaturvedi, P.; Schito, L.; Chen, J.; Semenza, G. L.] Johns Hopkins Univ, Vasc Program, Inst Cell Engn, Sch Med, Baltimore, MD 21205 USA; [Zhang, H.; Korangath, P.; Sukumar, S.; Semenza, G. L.] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD 21205 USA; [Wong, C. C. L.; Wei, H.; Gilkes, D. M.; Chaturvedi, P.; Chen, J.; Semenza, G. L.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, Baltimore, MD 21205 USA; [Krishnamachary, B.; Winnard, P. T., Jr.; Raman, V.] Johns Hopkins Univ, Dept Radiol, Sch Med, Baltimore, MD 21205 USA; [Zhang, H.] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Schito, L.] Univ Roma La Sapienza, Rome, Italy; [Zhen, L.; Mitzner, W. A.] Johns Hopkins Univ, Div Physiol, Sch Publ Hlth, Baltimore, MD 21205 USA; [Semenza, G. L.] Johns Hopkins Univ, Dept Pediat, Sch Med, Baltimore, MD 21205 USA; [Semenza, G. L.] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Semenza, G. L.] Johns Hopkins Univ, Dept Radiat Oncol, Sch Med, Baltimore, MD 21205 USA; [Semenza, G. L.] Johns Hopkins Univ, Dept Biol Chem, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sapienza University Rome; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Vasc Program, Inst Cell Engn, Sch Med, 733 N Broadway,Suite 671, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Gilkes, Daniele M/AAI-8133-2020; Zhang, Huafeng/A-7188-2012; Wong, Carmen Chak Lui/C-4660-2009	Gilkes, Daniele M/0000-0003-3984-9338; Korangath, Preethi/0000-0002-6623-493X; Wong, Carmen Chak Lui/0000-0001-5866-4705; Chen, Jasper/0000-0001-6070-5940	Emerald Foundation; National Institutes of Health [U54-CA143868]; Johns Hopkins Institute for Cell Engineering; Postdoctoral Training Program in Nanotechnology for Cancer Medicine [T32-CA130840]; NATIONAL CANCER INSTITUTE [T32CA130840, U54CA143868] Funding Source: NIH RePORTER	Emerald Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Institute for Cell Engineering; Postdoctoral Training Program in Nanotechnology for Cancer Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Karen Padgett of Novus Biologicals for generous gifts of antibodies against HIF-1 alpha, HIF-2 alpha and L1CAM. This work was supported by the Emerald Foundation, the National Institutes of Health (U54-CA143868) and the Johns Hopkins Institute for Cell Engineering. DMG was supported by the Postdoctoral Training Program in Nanotechnology for Cancer Medicine (T32-CA130840). GLS is the C Michael Armstrong Professor at Johns Hopkins University School of Medicine.	Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chintala S, 2010, CANCER CHEMOTH PHARM, V66, P899, DOI 10.1007/s00280-009-1238-8; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P7972, DOI 10.1158/1078-0432.CCR-04-1068; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Issa Y, 2009, J MOL MED, V87, P99, DOI 10.1007/s00109-008-0410-7; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kronblad A, 2006, INT J CANCER, V118, P2609, DOI 10.1002/ijc.21676; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Liotta LA, 2000, CANC MED, P121; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nishi H, 2004, ENDOCRINOLOGY, V145, P4113, DOI 10.1210/en.2003-1639; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Palmieri C, 2010, NAT REV CLIN ONCOL, V7, P561, DOI 10.1038/nrclinonc.2010.122; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Tafani M, 2010, CANCER SCI, V101, P1014, DOI 10.1111/j.1349-7006.2010.01493.x; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	43	243	254	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	14					1757	1770		10.1038/onc.2011.365	http://dx.doi.org/10.1038/onc.2011.365			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21860410	Green Accepted			2022-12-25	WOS:000302785200002
J	Zhang, J; Zhu, F; Li, X; Dong, Z; Xu, Y; Peng, C; Li, S; Cho, YY; Yao, K; Zykova, TA; Bode, AM; Dong, Z				Zhang, J.; Zhu, F.; Li, X.; Dong, Z.; Xu, Y.; Peng, C.; Li, S.; Cho, Y-Y; Yao, K.; Zykova, T. A.; Bode, A. M.; Dong, Z.			Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation	ONCOGENE			English	Article						cell transformation; Rack1; c-Jun; phosphorylation; degradation	UBIQUITIN LIGASE; JNK; RAS; AP-1; RECOGNITION; ACTIVATION; RECEPTOR; TARGETS	The c-Jun transcription factor is a highly unstable oncoprotein. Several ubiquitin ligases mediate c-Jun degradation. However, c-Jun can be stabilized once it is phosphorylated at the N-terminus by c-Jun N-terminal kinases (JNKs) or other protein kinases. This phosphorylation decreases c-Jun ubiquitination and degradation. The underlying mechanism for this phenomenon is still unknown. Here, we show that receptor for activated C-kinase 1 (Rack1) can bind with c-Jun and ubiquitin ligase Fbw7 to form a complex. When c-Jun is phosphorylated at the N-terminus, c-Jun is released from the complex and cannot be ubiquitinated by Fbw7, which leads to increased stabilization and accumulation of c-Jun. These results reveal that Rack1 has a very important role in tumorigenesis by maintaining the stability of c-Jun that has been phosphorylated at its N-terminus by JNKs or other kinases. Oncogene (2012) 31, 1835-1844; doi: 10.1038/onc.2011.369; published online 22 August 2011	[Zhang, J.; Zhu, F.; Li, X.; Xu, Y.; Peng, C.; Li, S.; Cho, Y-Y; Yao, K.; Zykova, T. A.; Bode, A. M.; Dong, Z.] Univ Minnesota, Hormel Inst, Dept Cellular & Mol Biol, 801 16th Ave NE, Austin, MN 55912 USA; [Li, X.; Dong, Z.] Zhengzhou Univ, Basic Med Sch, Zhengzhou, Peoples R China; [Cho, Y-Y] Catholic Univ Korea, Coll Pharm, Gyeonggi Do, South Korea	University of Minnesota System; Zhengzhou University; Catholic University of Korea	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, Dept Cellular & Mol Biol, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; ZHU, Feng/G-3567-2010; ZHU, Feng/C-1303-2010; zhang, jinhui/GXF-6528-2022	Zhu, Feng/0000-0003-1172-0102; Cho, Yong-Yeon/0000-0003-1107-2651	The Hormel Foundation; National Institutes of Health [CA077646, CA111536, CA120388, ES016548, R37 CA081064]; NATIONAL CANCER INSTITUTE [R01CA111536, R37CA081064, R01CA120388, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	The Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Wang Luhai and Dr Ronai Ze'ev for providing the HA-FL-Rack1, HA-WD1-4-Rack1 and HA-WD5-7-Rack1 vectors and Dr Wei Wenyi for providing the Flag-wt-c-Jun, Flag-Delta JNK-c-Jun, Flag-AF-c-Jun and Flag-AF-Delta JNK-c-Jun plasmids. We also thank Dr Bohmann Dirk for providing the c-Jun<SUP>Ala</SUP> and c-Jun<SUP>Asp</SUP> mutant c-Jun plasmids. This study was supported by The Hormel Foundation and National Institutes of Health grants CA077646, CA111536, CA120388, ES016548 and R37 CA081064.	Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; Cao XX, 2010, BREAST CANCER RES TR, V123, P375, DOI 10.1007/s10549-009-0657-x; Cao XX, 2010, INT J CANCER, V127, P1172, DOI 10.1002/ijc.25120; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Dong Z, 1994, EARLY DETECTION CANC, P123; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Egidy G, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-34; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nagashio R, 2010, LUNG CANCER, V69, P54, DOI 10.1016/j.lungcan.2009.09.015; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; PAPAVASSILIOU AG, 1995, EMBO J, V14, P2014, DOI 10.1002/j.1460-2075.1995.tb07193.x; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang WZ, 2008, J BIOL CHEM, V283, P16416, DOI 10.1074/jbc.M802360200	36	18	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	14					1835	1844		10.1038/onc.2011.369	http://dx.doi.org/10.1038/onc.2011.369			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21860413				2022-12-25	WOS:000302785200009
J	Edrington, TC; Kintz, E; Goldberg, JB; Tamm, LK				Edrington, Thomas C.; Kintz, Erica; Goldberg, Joanna B.; Tamm, Lukas K.			Structural Basis for the Interaction of Lipopolysaccharide with Outer Membrane Protein H (OprH) from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; POLYMYXIN-B; PHOP-PHOQ; TRANSMEMBRANE DOMAIN; REGULATED GENES; SOFTWARE SUITE; RESISTANCE; DYNAMICS; SYSTEM; H-1	Pseudomonas aeruginosa is a major nosocomial pathogen that infects cystic fibrosis and immunocompromised patients. The impermeability of the P. aeruginosa outer membrane contributes substantially to the notorious antibiotic resistance of this human pathogen. This impermeability is partially imparted by the outer membrane protein H (OprH). Here we have solved the structure of OprH in a lipid environment by solution NMR. The structure reveals an eight-stranded beta-barrel protein with four extracellular loops of unequal size. Fast time-scale dynamics measurements show that the extracellular loops are disordered and unstructured. It was previously suggested that the function of OprH is to provide increased stability to the outer membranes of P. aeruginosa by directly interacting with lipopolysaccharide (LPS) molecules. Using in vivo and in vitro biochemical assays, we show that OprH indeed interacts with LPS in P. aeruginosa outer membranes. Based upon NMR chemical shift perturbations observed upon the addition of LPS to OprH in lipid micelles, we conclude that the interaction is predominantly electrostatic and localized to charged regions near both rims of the barrel, but also through two conspicuous tyrosines in the middle of the bilayer. These results provide the first molecular structure of OprH and offer evidence for multiple interactions between OprH and LPS that likely contribute to the antibiotic resistance of P. aeruginosa.	[Edrington, Thomas C.; Kintz, Erica; Goldberg, Joanna B.; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Edrington, Thomas C.; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Kintz, Erica; Goldberg, Joanna B.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Tamm, LK (corresponding author), POB 800886, Charlottesville, VA 22908 USA.	lkt2e@virginia.edu			National Institutes of Health [RO1 GM51329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM51329 (to L. K. T.).	Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; BELL A, 1991, J BACTERIOL, V173, P6657, DOI 10.1128/jb.173.21.6657-6664.1991; BELL A, 1989, J BACTERIOL, V171, P3211, DOI 10.1128/jb.171.6.3211-3217.1989; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BROWN MRW, 1969, J GEN MICROBIOL, V59, P263, DOI 10.1099/00221287-59-2-263; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ferguson AD, 2000, STRUCTURE, V8, P585; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HANCOCK REW, 1988, J CLIN MICROBIOL, V26, P2423, DOI 10.1128/JCM.26.11.2423-2424.1988; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Hunter RC, 2005, J BACTERIOL, V187, P7619, DOI 10.1128/JB.187.22.7619-7630.2005; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Liang B, 2010, BBA-BIOMEMBRANES, V1798, P68, DOI 10.1016/j.bbamem.2009.07.022; Liu WM, 1998, J MOL BIOL, V275, P541, DOI 10.1006/jmbi.1997.1501; Macfarlane ELA, 2000, MICROBIOL-SGM, V146, P2543, DOI 10.1099/00221287-146-10-2543; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; NICAS TI, 1980, J BACTERIOL, V143, P872, DOI 10.1128/JB.143.2.872-878.1980; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Rehm BH, 1996, J BACTERIOL, V178, P3346, DOI 10.1128/jb.178.11.3346-3349.1996; Renault M, 2009, J MOL BIOL, V385, P117, DOI 10.1016/j.jmb.2008.10.021; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716	49	47	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39211	39223		10.1074/jbc.M111.280933	http://dx.doi.org/10.1074/jbc.M111.280933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21865172	Green Published, hybrid			2022-12-25	WOS:000296759800040
J	Pfeiffer, M; Kayzer, EB; Yang, XM; Abramson, E; Kenaston, MA; Lago, CU; Lo, HH; Sedensky, MM; Lunceford, A; Clarke, CF; Wu, SJ; McLeod, C; Finkel, T; Morgan, PG; Mills, EM				Pfeiffer, Matthew; Kayzer, Ernst-Bernhard; Yang, Xianmei; Abramson, Ellen; Kenaston, M. Alexander; Lago, Cory U.; Lo, Herng-Hsiang; Sedensky, Margaret M.; Lunceford, Adam; Clarke, Catherine F.; Wu, Sarah J.; McLeod, Chris; Finkel, Toren; Morgan, Philip G.; Mills, Edward M.			Caenorhabditis elegans UCP4 Protein Controls Complex II-mediated Oxidative Phosphorylation through Succinate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING-PROTEIN; BROWN-ADIPOSE-TISSUE; RECEPTOR GPR91; PROTON CONDUCTANCE; CLK-1 MUTANTS; FAT STORAGE; C-ELEGANS; RECONSTITUTION; SUPEROXIDE; METABOLISM	The novel uncoupling proteins (UCP2-5) are implicated in the mitochondrial control of oxidant production, insulin signaling, and aging. Attempts to understand their functions have been complicated by overlapping expression patterns in most organisms. Caenorhabditis elegans nematodes are unique because they express only one UCP ortholog, ceUCP4 (ucp4). Here, we performed detailed metabolic analyzes in genetically modified nematodes to define the function of the ceUCP4. The knock-out mutant ucp4 (ok195) exhibited sharply decreased mitochondrial succinate-driven (complex II) respiration. However, respiratory coupling and electron transport chain function were normal in ucp4 mitochondria. Surprisingly, isolated ucp4 mitochondria showed markedly decreased succinate uptake. Similarly, ceUCP4 inhibition blocked succinate respiration and import in wild type mitochondria. Genetic and pharmacologic inhibition of complex I function was selectively lethal to ucp4 worms, arguing that ceUCP4-regulated succinate transport is required for optimal complex II function in vivo. Additionally, ceUCP4 deficiency prolonged lifespan in the short-lived mev1 mutant that exhibits complex II-generated oxidant production. These results identify a novel function for ceUCP4 in the regulation of complex II-based metabolism through an unexpected mechanism involving succinate transport.	[Kayzer, Ernst-Bernhard; Sedensky, Margaret M.; Morgan, Philip G.] Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA; [Pfeiffer, Matthew; Abramson, Ellen; Kenaston, M. Alexander; Lago, Cory U.; Lo, Herng-Hsiang; Wu, Sarah J.; Mills, Edward M.] Univ Texas Austin, Dept Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; [Abramson, Ellen; Lago, Cory U.; Lo, Herng-Hsiang; Mills, Edward M.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Yang, Xianmei] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Lunceford, Adam; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lago, Cory U.; Finkel, Toren] NHLBI, NIH, Bethesda, MD 20892 USA; [McLeod, Chris] Mayo Clin, Rochester, MN 55905 USA	Seattle Children's Hospital; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Fudan University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic	Morgan, PG (corresponding author), Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA.	philip.morgan@seattlechildrens.org; ted_mills@mail.utexas.edu		Wu, Sarah/0000-0003-1755-6454	National Institutes of Health [DK089224, GM58881, AG026073, GMS 45952, ES007247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK089224 (to E. M. M.), GM58881 and AG026073 (to P. G. M., M. M. S., and E.-B. K.), and GMS 45952 (to C. F. C.), and Training Grant ES007247 (to M. E. P).	Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; CANNON B, 1982, FEBS LETT, V150, P129, DOI 10.1016/0014-5793(82)81319-7; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Falk MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006607; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hakak Y, 2009, J LEUKOCYTE BIOL, V85, P837, DOI 10.1189/jlb.1008618; Hanak P, 2001, FEBS LETT, V495, P137, DOI 10.1016/S0014-5793(01)02338-9; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Ichimiya H, 2002, MITOCHONDRION, V2, P191, DOI 10.1016/S1567-7249(02)00069-7; Iser WB, 2005, MECH AGEING DEV, V126, P1090, DOI 10.1016/j.mad.2005.04.002; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii N, 2006, EXP GERONTOL, V41, P952, DOI 10.1016/j.exger.2006.06.037; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; Jezek P, 2010, FEBS LETT, V584, P2135, DOI 10.1016/j.febslet.2010.02.068; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KAPLAN RS, 1985, J BIOL CHEM, V260, P293; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Klingenberg M, 2001, BIOCHEM SOC T, V29, P806; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lee HJ, 2008, CLIN CHIM ACTA, V398, P27, DOI 10.1016/j.cca.2008.07.029; LIPPITT B, 1972, J BIOL CHEM, V247, P4688; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Nakamichi N, 2009, PLANT SIGNAL BEHAV, V4, P660, DOI [10.4161/psb.4.7.9001, 10.1073/pnas.0900952106]; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867; Parker N, 2008, BIOSCIENCE REP, V28, P83, DOI 10.1042/BSR20080002; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Sokolova IM, 2005, FEBS LETT, V579, P313, DOI 10.1016/j.febslet.2004.11.103; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Szolnoki Z, 2011, ACTA NEUROL SCAND, V123, P352, DOI 10.1111/j.1600-0404.2010.01391.x; Szolnoki Z, 2009, NEUROMOL MED, V11, P101, DOI 10.1007/s12017-009-8071-4; Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Urbankova E, 2003, INT J BIOCHEM CELL B, V35, P212, DOI 10.1016/S1357-2725(02)00131-0; Yasuno K, 2007, AM J MED GENET B, V144B, P250, DOI 10.1002/ajmg.b.30443	52	28	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37712	37720		10.1074/jbc.M111.271452	http://dx.doi.org/10.1074/jbc.M111.271452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21862587	Green Published, hybrid			2022-12-25	WOS:000296542400067
J	Cottingham, C; Chen, YJ; Jiao, K; Wang, Q				Cottingham, Christopher; Chen, Yunjia; Jiao, Kai; Wang, Qin			The Antidepressant Desipramine Is an Arrestin-biased Ligand at the alpha(2A)-Adrenergic Receptor Driving Receptor Down-regulation in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; LONG-TERM TREATMENT; MICE LACKING; SOMATODENDRITIC ALPHA(2)-ADRENOCEPTORS; NORADRENERGIC TRANSMISSION; NORADRENALINE RELEASE; MEMBRANE TRAFFICKING; AGONIST BINDING; SUICIDE VICTIMS; LOCUS-COERULEUS	The neurobiological mechanisms of action underlying antidepressant drugs remain poorly understood. Desipramine (DMI) is an antidepressant classically characterized as an inhibitor of norepinephrine reuptake. Available evidence, however, suggests a mechanism more complex than simple reuptake inhibition. In the present study, we have characterized the direct interaction between DMI and the alpha(2A)-adrenergic receptor (alpha(2A)AR), a key regulator of noradrenergic neurotransmission with altered expression and function in depression. DMI alone was found to be sufficient to drive receptor internalization acutely and a robust down-regulation of alpha(2A)AR expression and signaling following prolonged stimulation in vitro. These effects are achieved through arrestin-biased regulation of the receptor, as DMI selectively induces recruitment of arrestin but not activation of heterotrimeric G proteins. Meanwhile, a physiologically relevant concentration of endogenous agonist (norepinephrine) was unable to sustain a down-regulation response. Prolonged in vivo administration of DMI resulted in significant down-regulation of synaptic alpha(2A)AR expression, a response that was lost in arrestin3-null animals. We contend that direct DMI-driven arrestin-mediated alpha(2A)AR down-regulation accounts for the therapeutically desirable but mechanistically unexplained adaptive alterations in receptor expression associated with this antidepressant. Our results provide novel insight into both the pharmacology of this antidepressant drug and the targeting of the alpha(2A)AR in depression.	[Cottingham, Christopher; Chen, Yunjia; Wang, Qin] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, Q (corresponding author), 986 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	qinwang@uab.edu		jiao, kai/0000-0002-1901-8329; Wang, Qin/0000-0002-1079-5914; Jiao, Kai/0000-0002-5415-9020	National Institutes of Health [T32 NS061788-03]; National Institute of Mental Health [MH081917]; University of Alabama at Birmingham; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Alabama at Birmingham; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 NS061788-03 (to C. C.), Grant MH081917 from the National Institute of Mental Health (to Q. W.), and the University of Alabama at Birmingham Training Program in Neurobiology of Cognition and Cognitive Disorders.	Ahern TH, 2006, NEUROPSYCHOPHARMACOL, V31, P730, DOI 10.1038/sj.npp.1300847; ALEXANDER SP, 2001, TRENDS PHARM SCI N S, V12, P15; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; BALDESSARINI RJ, 1989, J CLIN PSYCHIAT, V50, P117; BARTUREN F, 1992, MOL PHARMACOL, V42, P846; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Callado LF, 1998, J NEUROCHEM, V70, P1114; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHERRY DK, 2008, NATL HLTH STAT REPOR, V6, P1; CHOU TC, 1974, MOL PHARMACOL, V10, P235; DePaermentier F, 1997, BRAIN RES, V757, P60, DOI 10.1016/S0006-8993(97)00138-8; Deupree JD, 2007, EUR J PHARMACOL, V576, P55, DOI 10.1016/j.ejphar.2007.08.017; DEVOS H, 1992, J NEUROCHEM, V58, P1555; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dziedzicka-Wasylewska M, 2006, NEUROPSYCHOPHARMACOL, V31, P2424, DOI 10.1038/sj.npp.1301064; Escriba PV, 2004, NEUROPSYCHOPHARMACOL, V29, P1512, DOI 10.1038/sj.npp.1300459; Esteban S, 1999, N-S ARCH PHARMACOL, V360, P135, DOI 10.1007/s002109900045; Garcia-Sevilla JA, 1999, J NEUROCHEM, V72, P282, DOI 10.1046/j.1471-4159.1999.0720282.x; Gilsbach R, 2006, J NEUROCHEM, V96, P1111, DOI 10.1111/j.1471-4159.2005.03598.x; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; GIRALT MT, 1989, EUR J PHARMACOL, V164, P455; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Gonzalez-Maeso J, 2002, MOL PSYCHIATR, V7, P755, DOI 10.1038/sj.mp.4001067; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knaus AE, 2007, NEUROCHEM INT, V51, P277, DOI 10.1016/j.neuint.2007.06.036; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Limbird LE, 2005, CELL SURFACE RECEPTO; Lu R, 2010, MOL PHARMACOL, V78, P279, DOI 10.1124/mol.110.065300; Lu RJ, 2009, J BIOL CHEM, V284, P13233, DOI 10.1074/jbc.M807535200; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; Mateo Y, 1998, J NEUROCHEM, V71, P790; Mateo Y, 2001, BRIT J PHARMACOL, V133, P1362, DOI 10.1038/sj.bjp.0704196; MEANA JJ, 1992, BIOL PSYCHIAT, V31, P471; MONGEAU R, 1994, NEUROPSYCHOPHARMACOL, V10, P41, DOI 10.1038/npp.1994.6; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Ordway GA, 2003, BIOL PSYCHIAT, V53, P315, DOI 10.1016/S0006-3223(02)01728-6; Ouimet CC, 2004, J COMP NEUROL, V479, P374, DOI 10.1002/cne.20313; Parini S, 2005, NEUROPSYCHOPHARMACOL, V30, P1048, DOI 10.1038/sj.npp.1300661; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; RICHELSON E, 1984, J PHARMACOL EXP THER, V230, P94; Sacchetti G, 2001, N-S ARCH PHARMACOL, V363, P66, DOI 10.1007/s002100000334; SASTRE M, 1994, J NEUROCHEM, V63, P1077; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shields AD, 2009, NEUROSCIENCE, V163, P339, DOI 10.1016/j.neuroscience.2009.06.022; Subhash MN, 2003, NEUROCHEM INT, V43, P603, DOI 10.1016/S0197-0186(03)00097-4; Tan CM, 2002, P NATL ACAD SCI USA, V99, P12471, DOI 10.1073/pnas.122368499; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang Q, 2006, J BIOL CHEM, V281, P25948, DOI 10.1074/jbc.M605415200; Wang R, 1996, NEUROSCIENCE, V74, P199, DOI 10.1016/0306-4522(96)00116-9; WONG DT, 1982, J PHARMACOL EXP THER, V222, P61; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; Yanpallewar SU, 2010, J NEUROSCI, V30, P1096, DOI 10.1523/JNEUROSCI.2309-09.2010	69	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36063	36075		10.1074/jbc.M111.261578	http://dx.doi.org/10.1074/jbc.M111.261578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859713	hybrid, Green Published			2022-12-25	WOS:000295927100079
J	Dahl, JU; Urban, A; Bolte, A; Sriyabhaya, P; Donahue, JL; Nimtz, M; Larson, TJ; Leimkuhler, S				Dahl, Jan-Ulrik; Urban, Alexander; Bolte, Andrea; Sriyabhaya, Promjit; Donahue, Janet L.; Nimtz, Manfred; Larson, Timothy J.; Leimkuehler, Silke			The Identification of a Novel Protein Involved in Molybdenum Cofactor Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SYNTHESIS; FE-S CLUSTER; MOLYBDOPTERIN SYNTHASE; CYSTEINE DESULFURASE; CRYSTAL-STRUCTURE; CONVERTING FACTOR; PRECURSOR-Z; SULFUR; DOMAIN; GENE	Background: In Moco biosynthesis, sulfur is transferred from L-cysteine to MPT synthase, catalyzing the conversion of cPMP to MPT. Results: The rhodanese-like protein YnjE is a novel protein involved in Moco biosynthesis. Conclusion: YnjE enhances the rate of conversion of cPMP to MPT and interacts with MoeB and IscS. S ignificance: To understand the mechanism of sulfur transfer and the role of rhodaneses in the cell.	[Dahl, Jan-Ulrik; Urban, Alexander; Bolte, Andrea; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Sriyabhaya, Promjit; Donahue, Janet L.; Larson, Timothy J.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Nimtz, Manfred] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Potsdam; Virginia Polytechnic Institute & State University; Helmholtz Association; Helmholtz-Center for Infection Research	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	sleim@uni-potsdam.de	Dahl, Jan-Ulrik/J-4970-2017; Dahl, Jan-Ulrik/J-1893-2019	Dahl, Jan-Ulrik/0000-0002-4164-6129; Dahl, Jan-Ulrik/0000-0001-8597-7416; Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/5-3]; Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/5-3 (to S. L.), and by a grant from the Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust (to T. J. L.).	Begley TP, 1999, CURR OPIN CHEM BIOL, V3, P623, DOI 10.1016/S1367-5931(99)00018-6; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Cheng Hui, 2008, Open Microbiol J, V2, P18, DOI 10.2174/1874285800802010018; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; GLASER JH, 1972, MOL GEN GENET, V116, P1, DOI 10.1007/BF00334254; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2009, PROTEIN SCI, V18, P2480, DOI 10.1002/pro.260; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mueller EG, 1999, PROTEIN SCI, V8, P2424; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Nichols BP, 1998, J BACTERIOL, V180, P6408; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; PITTERLE DM, 1989, J BACTERIOL, V171, P3373, DOI 10.1128/jb.171.6.3373-3378.1989; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schmitz J, 2007, BIOCHEMISTRY-US, V46, P909, DOI 10.1021/bi062011w; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Silhavy T. J., 1984, EXPT GENE FUSIONS, P107; Spallarossa A, 2001, STRUCTURE, V9, P1117, DOI 10.1016/S0969-2126(01)00666-9; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Wang CY, 2001, NAT STRUCT BIOL, V8, P47; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	49	37	39	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35801	35812		10.1074/jbc.M111.282368	http://dx.doi.org/10.1074/jbc.M111.282368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856748	Green Published, hybrid			2022-12-25	WOS:000295927100053
J	Forment, JV; Blasius, M; Guerini, I; Jackson, SP				Forment, Josep V.; Blasius, Melanie; Guerini, Ilaria; Jackson, Stephen P.			Structure-Specific DNA Endonuclease Mus81/Eme1 Generates DNA Damage Caused by Chk1 Inactivation	PLOS ONE			English	Article							REPLICATION FORK PROGRESSION; VERTEBRATE S-PHASE; CHECKPOINT FUNCTION; GENOME INTEGRITY; ATR; KINASE; ROLES; CONTRIBUTES; INITIATION; RESTART	The DNA-damage checkpoint kinase Chk1 is essential in higher eukaryotes due to its role in maintaining genome stability in proliferating cells. CHK1 gene deletion is embryonically lethal, and Chk1 inhibition in replicating cells causes cell-cycle defects that eventually lead to perturbed replication and replication-fork collapse, thus generating endogenous DNA damage. What is the cause of replication-fork collapse when Chk1 is inactivated, however, remains poorly understood. Here, we show that generation of DNA double-strand breaks at replication forks when Chk1 activity is compromised relies on the DNA endonuclease complex Mus81/Eme1. Importantly, we show that Mus81/Eme1-dependent DNA damage-rather than a global increase in replication-fork stalling-is the cause of incomplete replication in Chk1-deficient cells. Consequently, Mus81/Eme1 depletion alleviates the S-phase progression defects associated with Chk1 deficiency, thereby increasing cell survival. Chk1-mediated protection of replication forks from Mus81/Eme1 even under otherwise unchallenged conditions is therefore vital to prevent uncontrolled fork collapse and ensure proper S-phase progression in human cells.	[Forment, Josep V.; Blasius, Melanie; Guerini, Ilaria; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Gurdon Inst, Cambridge CB2 1QW, England	University of Cambridge	Forment, JV (corresponding author), Univ Cambridge, Dept Biochem, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QW, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Forment, Josep/J-3678-2015	Jackson, Stephen Philip/0000-0001-9317-7937; Forment, Josep/0000-0002-7797-2583; Blasius, Melanie/0000-0001-5032-2209	Cancer Research UK [C6/A11226]; European Community; Wellcome Trust; University of Cambridge; Swiss National Foundation; Cancer Research UK [11224] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Community(European Commission); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Cancer Research UK(Cancer Research UK)	Research in the Jackson Lab is supported by grants from Cancer Research UK (C6/A11226) and the European Community's Seventh Framework Program (GENICA and DDResponse) and by core infrastructure funding provided by Cancer Research UK and the Wellcome Trust. SPJ receives his salary from the University of Cambridge, supplemented by Cancer Research UK. MB is funded by a Swiss National Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Froget B, 2008, MOL BIOL CELL, V19, P445, DOI 10.1091/mbc.E07-07-0728; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Scorah J, 2009, CELL CYCLE, V8, P1036, DOI 10.4161/cc.8.7.8040; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	29	80	81	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23517	10.1371/journal.pone.0023517	http://dx.doi.org/10.1371/journal.pone.0023517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858151	gold, Green Submitted, Green Published			2022-12-25	WOS:000294121300056
J	Hadjidimitrakis, K; Breveglieri, R; Placenti, G; Bosco, A; Sabatini, SP; Fattori, P				Hadjidimitrakis, Kostas; Breveglieri, Rossella; Placenti, Giacomo; Bosco, Annalisa; Sabatini, Silvio P.; Fattori, Patrizia			Fix Your Eyes in the Space You Could Reach: Neurons in the Macaque Medial Parietal Cortex Prefer Gaze Positions in Peripersonal Space	PLOS ONE			English	Article							VISUAL AREA V6; PARIETOOCCIPITAL CORTEX; DISTANCE PERCEPTION; 3-DIMENSIONAL SPACE; FIXATION-DISTANCE; BRAIN LOCATION; FMRI REVEALS; MONKEY; MOVEMENTS; REPRESENTATION	Interacting in the peripersonal space requires coordinated arm and eye movements to visual targets in depth. In primates, the medial posterior parietal cortex (PPC) represents a crucial node in the process of visual-to-motor signal transformations. The medial PPC area V6A is a key region engaged in the control of these processes because it jointly processes visual information, eye position and arm movement related signals. However, to date, there is no evidence in the medial PPC of spatial encoding in three dimensions. Here, using single neuron recordings in behaving macaques, we studied the neural signals related to binocular eye position in a task that required the monkeys to perform saccades and fixate targets at different locations in peripersonal and extrapersonal space. A significant proportion of neurons were modulated by both gaze direction and depth, i. e., by the location of the foveated target in 3D space. The population activity of these neurons displayed a strong preference for peripersonal space in a time interval around the saccade that preceded fixation and during fixation as well. This preference for targets within reaching distance during both target capturing and fixation suggests that binocular eye position signals are implemented functionally in V6A to support its role in reaching and grasping.	[Hadjidimitrakis, Kostas; Breveglieri, Rossella; Placenti, Giacomo; Bosco, Annalisa; Fattori, Patrizia] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Sabatini, Silvio P.] Univ Genoa, Dept Biophys & Elect Engn, Genoa, Italy	University of Bologna; University of Genoa	Hadjidimitrakis, K (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy.	patrizia.fattori@unibo.it	Sabatini, Silvio P/A-5500-2012; Fattori, Patrizia/Q-8947-2017; breveglieri, rossella/C-2014-2014	Sabatini, Silvio P/0000-0002-0557-7306; Fattori, Patrizia/0000-0002-0079-3755; breveglieri, rossella/0000-0001-5059-1441; BOSCO, ANNALISA/0000-0003-3032-9571	European Union [FP7-ICT-217077-'EYESHOTS']; Italian Ministry of Education; University and Research (MIUR); Fondazione del Monte di Bologna e Ravenna, Italy	European Union(European Commission); Italian Ministry of Education; University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna e Ravenna, Italy(Fondazione del Monte di Bologna e Ravenna)	This work was supported by the European Union (FP7-ICT-217077-'EYESHOTS', www.eyeshots.it), Italian Ministry of Education, University and Research (MIUR,www.miur.it), Fondazione del Monte di Bologna e Ravenna, Italy (www.fondazionedelmonte.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2005, J NEUROPHYSIOL, V93, P2415, DOI 10.1152/jn.01028.2004; Baylis GC, 2001, NEUROPSYCHOLOGIA, V39, P865, DOI 10.1016/S0028-3932(01)00009-4; BHATTACHARYYA R, 2009, J NEUROPHYSIOL; Breveglieri R, 2002, NEUROREPORT, V13, P2113, DOI 10.1097/00001756-200211150-00024; Brozzoli C, 2010, NEUROPSYCHOLOGIA, V48, P796, DOI 10.1016/j.neuropsychologia.2009.10.009; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; CRITCHLEY M, 1953, BRAIN, V76, P19, DOI 10.1093/brain/76.1.19; Culham J. C., 2008, EMBODIMENT EGO SPACE, P247; Danckert J, 2009, EXP BRAIN RES, V195, P183, DOI 10.1007/s00221-009-1766-9; Dounskaia N, 2011, EXP BRAIN RES, V209, P299, DOI 10.1007/s00221-011-2547-9; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Fattori P, 2009, J NEUROSCI, V29, P1928, DOI 10.1523/JNEUROSCI.4998-08.2009; FOLEY JM, 1980, PSYCHOL REV, V87, P411, DOI 10.1037/0033-295X.87.5.411; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; Gamberini M, 2011, J NEUROSCI, V31, P5145, DOI 10.1523/JNEUROSCI.5489-10.2011; Gamberini M, 2009, J COMP NEUROL, V513, P622, DOI 10.1002/cne.21980; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Henriques DYP, 2003, EXP BRAIN RES, V152, P70, DOI 10.1007/s00221-003-1523-4; Karnath HO, 1997, PHILOS T ROY SOC B, V352, P1411, DOI 10.1098/rstb.1997.0127; Kutz DF, 2005, J NEUROPHYSIOL, V93, P3674, DOI 10.1152/jn.01292.2004; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; Mon-Williams M, 1999, EXP BRAIN RES, V128, P578, DOI 10.1007/s002210050885; Moody SL, 1998, J COGNITIVE NEUROSCI, V10, P35, DOI 10.1162/089892998563761; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; PELISSON D, 1986, EXP BRAIN RES, V62, P303; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; POUGET A, 1994, CEREB CORTEX, V4, P314, DOI 10.1093/cercor/4.3.314; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Trotter Y, 1996, J NEUROPHYSIOL, V76, P2872, DOI 10.1152/jn.1996.76.5.2872; Vernet M, 2008, INVEST OPHTH VIS SCI, V49, P230, DOI 10.1167/iovs.07-0854; Viguier A, 2001, PERCEPTION, V30, P115, DOI 10.1068/p3119; Williams AL, 2010, J NEUROPHYSIOL, V104, P2169, DOI 10.1152/jn.00713.2009; YGGE J, 1995, VISION RES, V35, P3169, DOI 10.1016/0042-6989(95)00125-J	54	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23335	10.1371/journal.pone.0023335	http://dx.doi.org/10.1371/journal.pone.0023335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858075	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300036
J	Kakazu, E; Ueno, Y; Kondo, Y; Inoue, J; Ninomiya, M; Kimura, O; Wakui, Y; Fukushima, K; Tamai, K; Shimosegawa, T				Kakazu, Eiji; Ueno, Yoshiyuki; Kondo, Yasuteru; Inoue, Jun; Ninomiya, Masashi; Kimura, Osamu; Wakui, Yuta; Fukushima, Koji; Tamai, Keiichi; Shimosegawa, Tooru			Plasma L-Cystine/L-Glutamate Imbalance Increases Tumor Necrosis Factor-Alpha from CD14+Circulating Monocytes in Patients with Advanced Cirrhosis	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; DENDRITIC CELLS; LIVER-DISEASE; EX-VIVO; INTERLEUKIN-6; EXPRESSION; MATURATION; CYSTEINE	Background and Aims: The innate immune cells can not normally respond to the pathogen in patients with decompensated cirrhosis. Previous studies reported that antigen-presenting cells take up L-Cystine (L-Cys) and secrete substantial amounts of L-Glutamate (L-Glu) via the transport system Xc-(4F2hc+xCT), and that this exchange influences the immune responses. The aim of this study is to investigate the influence of the plasma L-Cys/L-Glu imbalance observed in patients with advanced cirrhosis on the function of circulating monocytes. Methods: We used a serum-free culture medium consistent with the average concentrations of plasma amino acids from patients with advanced cirrhosis (ACM), and examined the function of CD14+ monocytes or THP-1 under ACM that contained 0-300 nmol/mL L-Cys with LPS. In patients with advanced cirrhosis, we actually determined the TNF-alpha and xCT mRNA of monocytes, and evaluated the correlation between the plasma L-Cys/L-Glu ratio and TNF-alpha. Results: The addition of L-Cys significantly increased the production of TNF alpha from monocytes under ACM. Monocytes with LPS and THP-1 expressed xCT and a high level of extracellular L-Cys enhanced L-Cys/L-Glu antiport, and the intracellular GSH/GSSG ratio was decreased. The L-Cys transport was inhibited by excess L-Glu. In patients with advanced cirrhosis (n = 19), the TNF-alpha and xCT mRNA of monocytes were increased according to the Child-Pugh grade. The TNF-alpha mRNA of monocytes was significantly higher in the high L-Cys/L-Glu ratio group than in the low ratio group, and the plasma TNF-alpha was significantly correlated with the L-Cys/L-Glu ratio. Conclusions: A plasma L-Cys/L-Glu imbalance, which appears in patients with advanced cirrhosis, increased the TNF-alpha from circulating monocytes via increasing the intracellular oxidative stress. These results may reflect the immune abnormality that appears in patients with decompensated cirrhosis.	[Kakazu, Eiji; Ueno, Yoshiyuki; Kondo, Yasuteru; Inoue, Jun; Ninomiya, Masashi; Kimura, Osamu; Wakui, Yuta; Fukushima, Koji; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 980, Japan; [Tamai, Keiichi] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan	Tohoku University; Miyagi Cancer Center	Kakazu, E (corresponding author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 980, Japan.	yueno@med.tohoku.ac.jp	Tamai, Keiichi/AAW-8261-2021; Ueno, Yoshiyuki/R-9242-2019; Kondo, Yasuteru/A-6893-2010; Inoue, Jun/S-9282-2019	Ueno, Yoshiyuki/0000-0001-5623-4250; Kondo, Yasuteru/0000-0001-5935-4346; Inoue, Jun/0000-0003-1171-7835; Tamai, Keiichi/0000-0003-0813-5885	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23790762]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to EK (23790762), and by Health and Labour Sciences Research Grants for the Research on Measures for Intractable Diseases (from the Ministry of Health, Labour and Welfare of Japan) to YU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNAI S, 1980, J BIOL CHEM, V255, P2372; BYL B, 1993, GASTROENTEROLOGY, V104, P1492, DOI 10.1016/0016-5085(93)90361-F; D'Angelo JA, 2010, J IMMUNOL, V185, P3217, DOI 10.4049/jimmunol.1001199; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; ECK HP, 1989, BIOL CHEM H-S, V370, P109, DOI 10.1515/bchm3.1989.370.1.109; Galbois A, 2009, HEPATOLOGY, V49, P175, DOI 10.1002/hep.22582; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Gustot T, 2009, HEPATOLOGY, V50, P2022, DOI 10.1002/hep.23264; Iyer SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005017; Kakazu E, 2007, J IMMUNOL, V179, P7137, DOI 10.4049/jimmunol.179.10.7137; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MORGAN MY, 1982, GUT, V23, P362, DOI 10.1136/gut.23.5.362; Navasa M, 1998, HEPATOLOGY, V27, P1227, DOI 10.1002/hep.510270507; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Riordan SM, 2003, HEPATOLOGY, V37, P1154, DOI 10.1053/jhep.2003.50180; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Ubeda M, 2010, HEPATOLOGY, V52, P2086, DOI 10.1002/hep.23961; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; WALSHE JM, 1955, J CLIN INVEST, V34, P302, DOI 10.1172/JCI103083	26	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23402	10.1371/journal.pone.0023402	http://dx.doi.org/10.1371/journal.pone.0023402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858100	Green Submitted, gold, Green Published			2022-12-25	WOS:000294121300043
J	Lee, JY; Lee, YM; Chang, GC; Yu, SL; Hsieh, WY; Chen, JJW; Chen, HW; Yang, PC				Lee, Jen-Yi; Lee, Yee-Ming; Chang, Gee-Chen; Yu, Sung-Liang; Hsieh, Wan-Yu; Chen, Jeremy J. W.; Chen, Huei-Wen; Yang, Pan-Chyr			Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; PREVIOUSLY TREATED PATIENTS; TYROSINE KINASE-ACTIVITY; FACTOR-KAPPA-B; GENE-EXPRESSION; PROSTATE-CANCER; IN-VITRO; MUTATIONS; INHIBITION; RESISTANCE	Background: Non-small cell lung cancer (NSCLC) patients with L858R or exon 19 deletion mutations in epidermal growth factor receptor (EGFR) have good responses to the tyrosine kinase inhibitor (TKI), gefitinib. However, patients with wild-type EGFR and acquired mutation in EGFR T790M are resistant to gefitinib treatment. Here, we showed that curcumin can improve the efficiency of gefitinib in the resistant NSCLC cells both in vitro and in vivo models. Methods/Principal Findings: After screening 598 herbal and natural compounds, we found curcumin could inhibit cell proliferation in different gefitinib-resistant NSCLC cell lines; concentration-dependently down-regulate EGFR phosphorylation through promoting EGFR degradation in NSCLC cell lines with wild-type EGFR or T790M EGFR. In addition, the antitumor activity of gefitinib was potentiated via curcumin through blocking EGFR activation and inducing apoptosis in gefitinib-resistant NSCLC cell lines; also the combined treatment with curcumin and gefitinib exhibited significant inhibition in the CL1-5, A549 and H1975 xenografts tumor growth in SCID mice through reducing EGFR, c-MET, cyclin D1 expression, and inducing apoptosis activation through caspases-8, 9 and PARP. Interestingly, we observed that the combined treatment group represented better survival rate and less intestinal mucosal damage compare to gefitinib-alone therapy. We showed that curcumin attenuated the gefitinib-induced cell proliferation inhibition and apoptosis through altering p38 mitogen-activated protein kinase (MAPK) activation in intestinal epithelia cell. Conclusions/Significance: Curcumin potentiates antitumor activity of gefitinib in cell lines and xenograft mice model of NSCLC through inhibition of proliferation, EGFR phosphorylation, and induction EGFR ubiquitination and apoptosis. In addition, curcumin attenuates gefitinib-induced gastrointestinal adverse effects via altering p38 activation. These findings provide a novel treatment strategy that curcumin as an adjuvant to increase the spectrum of the usage of gefitinib and overcome the gefitinib inefficiency in NSCLC patients.	[Lee, Jen-Yi; Lee, Yee-Ming; Hsieh, Wan-Yu] Natl Yang Ming Univ, Sch Med, Dept Pharmacol, Taipei 112, Taiwan; [Lee, Jen-Yi; Lee, Yee-Ming; Hsieh, Wan-Yu] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Lee, Jen-Yi; Lee, Yee-Ming; Hsieh, Wan-Yu; Chen, Huei-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chang, Gee-Chen; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Coll Life Sci, Inst Biomed Sci, Taichung 40227, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; Taichung Veterans General Hospital; National Chung Hsing University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, JY (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Pharmacol, Taipei 112, Taiwan.	shwchen@ntu.edu.tw		CHEN, HUEI-WEN/0000-0001-5051-9896; YU, SUNG-LIANG/0000-0003-4535-9036; YANG, PAN-CHYR/0000-0001-6330-6048; Chen, Jeremy J.W./0000-0003-1049-3825	National Science Council [NSC95-2314-B-002-340-MY3]; Department of Health, Taiwan [DOH100-TD-B-111-001]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	This work was supported by grants from the National Science Council (NSC95-2314-B-002-340-MY3) and the Department of Health, Taiwan (DOH100-TD-B-111-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Arteaga CL, 2007, NAT MED, V13, P675, DOI 10.1038/nm0607-675; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914; Chen HW, 2004, MOL PHARMACOL, V65, P99, DOI 10.1124/mol.65.1.99; Cheng AL, 2001, ANTICANCER RES, V21, P2895; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Dorai T, 2000, MOL UROL, V4, P1; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Epstein J, 2010, BRIT J NUTR, V103, P824, DOI 10.1017/S0007114509992510; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Giommarelli C, 2010, CELL MOL LIFE SCI, V67, P995, DOI 10.1007/s00018-009-0233-x; Hong RL, 1999, CLIN CANCER RES, V5, P1884; Howells LM, 2007, INT J CANCER, V121, P175, DOI 10.1002/ijc.22645; HUANG MT, 1991, CANCER RES, V51, P813; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Judde JG, 2007, INT J CANCER, V120, P1579, DOI 10.1002/ijc.22364; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Kari C, 2003, CANCER RES, V63, P1; Kim SY, 2005, BIOCHEM BIOPH RES CO, V337, P510, DOI 10.1016/j.bbrc.2005.09.079; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kokubo Y, 2005, BRIT J CANCER, V92, P1711, DOI 10.1038/sj.bjc.6602559; KORUTLA L, 1995, CARCINOGENESIS, V16, P1741, DOI 10.1093/carcin/16.8.1741; KORUTLA L, 1994, BBA-MOL CELL RES, V1224, P597, DOI 10.1016/0167-4889(94)90299-2; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Levitzki A, 2003, LUNG CANCER, V41, pS9, DOI 10.1016/S0169-5002(03)00134-X; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Patel BB, 2008, INT J CANCER, V122, P267, DOI 10.1002/ijc.23097; Perez-Soler R, 2004, ONCOLOGIST, V9, P58, DOI 10.1634/theoncologist.9-1-58; Reck M, 2005, RESP MED, V99, P298, DOI 10.1016/j.rmed.2004.08.009; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; Sheng G, 2007, AM J PHYSIOL-GASTR L, V293, pG599, DOI 10.1152/ajpgi.00182.2007; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Song WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012969; Sung B, 2009, MOL CANCER THER, V8, P959, DOI 10.1158/1535-7163.MCT-08-0905; Thangapazham RL, 2008, INT J ONCOL, V32, P1119; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Vansteenkiste Johan, 2004, Expert Rev Anticancer Ther, V4, P5, DOI 10.1586/14737140.4.1.5; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wu SG, 2008, ONCOLOGIST, V13, P1276, DOI 10.1634/theoncologist.2008-0093	62	75	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23756	10.1371/journal.pone.0023756	http://dx.doi.org/10.1371/journal.pone.0023756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858220	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300093
J	Li, T; Yu, SY; Du, J; Chen, HH; Jiang, HF; Xu, K; Fu, YM; Wang, DX; Zhao, M				Li, Ting; Yu, Shunying; Du, Jiang; Chen, Hanhui; Jiang, Haifeng; Xu, Ke; Fu, Yingmei; Wang, Dongxiang; Zhao, Min			Role of Novelty Seeking Personality Traits as Mediator of the Association between COMT and Onset Age of Drug Use in Chinese Heroin Dependent Patients	PLOS ONE			English	Article							EXON-III POLYMORPHISM; ENVIRONMENTAL RISK-FACTORS; DOPAMINE TRANSPORTER GENE; SUBSTANCE USE; TRIDIMENSIONAL PERSONALITY; VAL158MET POLYMORPHISM; CHARACTER INVENTORY; PROMOTER REGION; ENZYME-ACTIVITY; ALCOHOL-USE	Background: Personality traits such as novelty seeking (NS) are associated with substance dependence but the mechanism underlying this association remains uncertain. Previous studies have focused on the role of the dopamine pathway. Objective: Examine the relationships between allelic variants of the catechol-O-methlytransferase (COMT) gene, NS personality traits, and age of onset of drug use in heroin-dependent subjects in China. Methods: The 478 heroin dependent subjects from four drug rehabilitation centers in Shanghai who were genotyped for eight tagging single nucleotide polymorphisms (SNP) on the COMT gene completed the NS subscale from the Temperament and Character Inventory. Multivaritate analyses were used to assess the potential mediating role of NS personality traits in the association between COMT gene variants and the age of onset of heroin use. Principal Findings and Conclusions: In the univariate analysis the COMT rs737866 gene variants were independently associated with both NS and age of onset of drug use: those with the TT genotype had higher NS subscale scores and an earlier onset age of heroin use than individuals with CT or CC genotypes. In the multivariate analysis the inclusion of the NS subscore variable weakened the relationship between the COMT rs737866 TT genotype and an earlier age of onset of drug use. Our findings that COMT is associated with both NS personality traits and with the age of onset of heroin use helps to clarify the complex relationship between genetic and psychological factors in the development of substance abuse.	[Li, Ting; Yu, Shunying; Du, Jiang; Chen, Hanhui; Jiang, Haifeng; Fu, Yingmei; Wang, Dongxiang; Zhao, Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Xu, Ke] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Shanghai Jiao Tong University; Yale University	Li, T (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	drminzhao@gmail.com	Xu, Ke/V-5941-2019; Fu, Yingmei/AAN-1675-2021	Xu, Ke/0000-0002-6472-7052; Li, Ting/0000-0002-8408-2482	National Nature Science Foundation [30971048]; National Institutes of Health/Fogarty International Center [R01TW007279]; Science and Technology Commission of Shanghai Municipality [09410707000]; FOGARTY INTERNATIONAL CENTER [R01TW007279] Funding Source: NIH RePORTER	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Institutes of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the National Nature Science Foundation (30971048), National Institutes of Health/Fogarty International Center (R01TW007279) and Science and Technology Commission of Shanghai Municipality (09410707000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; Barnow S, 2005, NERVENARZT, V76, P839, DOI 10.1007/s00115-004-1810-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basiaux P, 2001, ALCOHOL ALCOHOLISM, V36, P584, DOI 10.1093/alcalc/36.6.584; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Cao Liping, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P127; CASTROMAN JL, 2009, DRUG ALCOHOL DEPEN, V101, P210; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; CHUAN YC, 2009, ADDICITIVE BEHAV, V34, P319; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 1998, J AFFECT DISORDERS, V51, P21, DOI 10.1016/S0165-0327(98)00153-0; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Conner BT, 2010, J SUBST ABUSE TREAT, V38, P178, DOI 10.1016/j.jsat.2009.07.004; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Golimbet V E, 2007, Neurosci Behav Physiol, V37, P601, DOI 10.1007/s11055-007-0058-8; Gordon HW, 2002, PSYCHONEUROENDOCRINO, V27, P115, DOI 10.1016/S0306-4530(01)00039-7; Gruber SA, 2007, NEUROPSYCHOL REV, V17, P299, DOI 10.1007/s11065-007-9041-y; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Gunnarsdottir ED, 2000, ADDICT BEHAV, V25, P641, DOI 10.1016/S0306-4603(99)00043-X; Han DH, 2008, COMPR PSYCHIAT, V49, P387, DOI 10.1016/j.comppsych.2008.01.008; Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036; Heck A, 2009, GENES BRAIN BEHAV, V8, P464, DOI 10.1111/j.1601-183X.2009.00494.x; Hien D, 2010, CHILD ABUSE NEGLECT, V34, P105, DOI 10.1016/j.chiabu.2009.05.006; Hill SY, 2008, AM J MED GENET B, V147B, P517, DOI 10.1002/ajmg.b.30630; Horowitz R, 2000, AM J MED GENET, V96, P599, DOI 10.1002/1096-8628(20001009)96:5<599::AID-AJMG4>3.3.CO;2-F; Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Ko CH, 2006, CAN J PSYCHIAT, V51, P887, DOI 10.1177/070674370605101404; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Laucht M, 2005, J AM ACAD CHILD PSY, V44, P477, DOI 10.1097/01.chi.0000155980.01792.7f; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Najafabadi MS, 2005, AM J MED GENET B, V134B, P39, DOI 10.1002/ajmg.b.30117; Parker G, 2003, ACTA PSYCHIAT SCAND, V108, P367, DOI 10.1034/j.1600-0447.2003.00192.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; Ronai Z, 2001, MOL PSYCHIATR, V6, P35, DOI 10.1038/sj.mp.4000832; Saxon AJ, 2005, HARVARD REV PSYCHIAT, V13, P218, DOI 10.1080/10673220500243364; Schmid B, 2009, ADDICT BIOL, V14, P489, DOI 10.1111/j.1369-1600.2009.00171.x; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Silberg J, 2003, J CHILD PSYCHOL PSYC, V44, P664, DOI 10.1111/1469-7610.00153; Suzuki G, 2009, HUM MOL GENET, V18, P3914, DOI 10.1093/hmg/ddp334; Tarter RE, 2007, PSYCHOL ADDICT BEHAV, V21, P266, DOI 10.1037/0893-164X.21.2.266; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; Whitty M, 2007, PSYCHIATR BULL, V31, P450, DOI 10.1192/pb.bp.106.011585; Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6	51	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22923	10.1371/journal.pone.0022923	http://dx.doi.org/10.1371/journal.pone.0022923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21857968	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300009
J	Scharadin, TM; Jiang, HB; Jans, R; Rorke, EA; Eckert, RL				Scharadin, Tiffany M.; Jiang, Haibing; Jans, Ralph; Rorke, Ellen A.; Eckert, Richard L.			TIG3 Tumor Suppressor-Dependent Organelle Redistribution and Apoptosis in Skin Cancer Cells	PLOS ONE			English	Article							TRANSGLUTAMINASE CROSS-LINKING; MITOGEN-ACTIVATED-KINASE; KERATINOCYTE TRANSGLUTAMINASE; DOWN-REGULATION; RETINOIC ACID; IN-VIVO; GENE; RIG1; DIFFERENTIATION; EXPRESSION	TIG3 is a tumor suppressor protein that limits keratinocyte survival during normal differentiation. It is also important in cancer, as TIG3 level is reduced in tumors and in skin cancer cell lines, suggesting that loss of expression may be required for cancer cell survival. An important goal is identifying how TIG3 limits cell survival. In the present study we show that TIG3 expression in epidermal squamous cell carcinoma SCC-13 cells reduces cell proliferation and promotes morphological and biochemical apoptosis. To identify the mechanism that drives these changes, we demonstrate that TIG3 localizes near the centrosome and that pericentrosomal accumulation of TIG3 alters microtubule and microfilament organization and organelle distribution. Organelle accumulation at the centrosome is a hallmark of apoptosis and we demonstrate that TIG3 promotes pericentrosomal organelle accumulation. These changes are associated with reduced cyclin D1, cyclin E and cyclin A, and increased p21 level. In addition, Bax level is increased and Bcl-XL level is reduced, and cleavage of procaspase 3, procaspase 9 and PARP is enhanced. We propose that pericentrosomal localization of TIG3 is a key event that results in microtubule and microfilament redistribution and pericentrosomal organelle clustering and that leads to cancer cell apoptosis.	[Scharadin, Tiffany M.; Jiang, Haibing; Jans, Ralph; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Rorke, Ellen A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Jans, Ralph/F-2150-2013		National Institutes of Health [NIH R01 AR094713, NIH R01 AR04694]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants to RE (NIH R01 AR094713 and NIH R01 AR04694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aslan JE, 2009, TRAFFIC, V10, P1390, DOI 10.1111/j.1600-0854.2009.00951.x; BROWN WJ, 1984, CELL, V36, P295, DOI 10.1016/0092-8674(84)90223-X; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; CHAKRAVARTY R, 1989, J BIOL CHEM, V264, P625; Cheong JW, 2010, CANCER LETT, V297, P171, DOI 10.1016/j.canlet.2010.05.009; DEGLI EM, 2008, METHOD ENZYMOL, V442, P421; Degli Esposti M, 2009, MOL BIOL CELL, V20, P600, DOI 10.1091/mbc.E08-09-0925; Deucher A, 2000, INT J ONCOL, V17, P1195; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Duvic M, 2003, J INVEST DERMATOL, V121, P902, DOI 10.1046/j.1523-1747.2003.12488.x; Duvic M, 2000, CLIN CANCER RES, V6, P3249; Duvic M, 1997, J AM ACAD DERMATOL, V37, pS18; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; HAJNAL A, 1994, ONCOGENE, V9, P479; Han BG, 2010, PROTEIN EXPRES PURIF, V71, P103, DOI 10.1016/j.pep.2010.01.018; Higuchi E, 2003, ONCOGENE, V22, P4627, DOI 10.1038/sj.onc.1206235; Huang SL, 2002, ANTICANCER RES, V22, P799; Huang SL, 2000, MOL CELL ENDOCRINOL, V159, P15, DOI 10.1016/S0303-7207(99)00207-5; Husmann K, 1998, ONCOGENE, V17, P1305, DOI 10.1038/sj.onc.1202060; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; Jiang SY, 2005, BIOCHEM BIOPH RES CO, V331, P630, DOI 10.1016/j.bbrc.2005.03.214; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; KIM SY, 1995, J INVEST DERMATOL, V104, P211, DOI 10.1111/1523-1747.ep12612769; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Lim HH, 2009, TRENDS CELL BIOL, V19, P325, DOI 10.1016/j.tcb.2009.03.008; Lotz K, 2005, INT J CANCER, V116, P894, DOI 10.1002/ijc.21127; Matarrese P, 2008, BIOCHEM J, V413, P467, DOI 10.1042/BJ20071704; Nozawa K, 2009, CELL BIOL INT, V33, P148, DOI 10.1016/j.cellbi.2008.10.016; OGAWA H, 1976, J BIOL CHEM, V251, P7281; Ou CC, 2008, CARCINOGENESIS, V29, P299, DOI 10.1093/carcin/bgm263; Ouasti S, 2007, CELL DEATH DIFFER, V14, P453, DOI 10.1038/sj.cdd.4402043; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Rice R H, 1988, Adv Exp Med Biol, V231, P51; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1990, BIOCHEM J, V265, P351, DOI 10.1042/bj2650351; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Sesso A, 1999, TISSUE CELL, V31, P357, DOI 10.1054/tice.1999.0042; Shyu RY, 2005, ANTICANCER RES, V25, P2453; Simmons DP, 2006, CARCINOGENESIS, V27, P693, DOI 10.1093/carcin/bgi235; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Steinert PM, 1999, CELL DEATH DIFFER, V6, P916, DOI 10.1038/sj.cdd.4400568; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; TA BM, 1990, J CELL SCI, V95, P631; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Tsai FM, 2006, CELL SIGNAL, V18, P349, DOI 10.1016/j.cellsig.2005.05.005; Tsai FM, 2007, CELL SIGNAL, V19, P989, DOI 10.1016/j.cellsig.2006.11.005; Tsai FM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-15; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200	55	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23230	10.1371/journal.pone.0023230	http://dx.doi.org/10.1371/journal.pone.0023230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858038	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300021
J	Van Hoeck, V; Sturmey, RG; Bermejo-Alvarez, P; Rizos, D; Gutierrez-Adan, A; Leese, HJ; Bols, PEJ; Leroy, JLMR				Van Hoeck, Veerle; Sturmey, Roger G.; Bermejo-Alvarez, Pablo; Rizos, Dimitrios; Gutierrez-Adan, Alfonso; Leese, Henry J.; Bols, Peter E. J.; Leroy, Jo L. M. R.			Elevated Non-Esterified Fatty Acid Concentrations during Bovine Oocyte Maturation Compromise Early Embryo Physiology	PLOS ONE			English	Article							BODY-MASS INDEX; IN-VITRO; PREIMPLANTATION DEVELOPMENT; GLUCOSE-TRANSPORTER; INDUCE APOPTOSIS; INFERTILE WOMEN; PALMITIC ACID; STEARIC-ACID; METABOLISM; OBESITY	Elevated concentrations of serum non-esterified fatty acids (NEFA), associated with maternal disorders such as obesity and type II diabetes, alter the ovarian follicular micro-environment and have been associated with subfertility arising from reduced oocyte developmental competence. We have asked whether elevated NEFA concentrations during oocyte maturation affect the development and physiology of zygotes formed from such oocytes, using the cow as a model. The zygotes were grown to blastocysts, which were evaluated for their quality in terms of cell number, apoptosis, expression of key genes, amino acid turnover and oxidative metabolism. Oocyte maturation under elevated NEFA concentrations resulted in blastocysts with significantly lower cell number, increased apoptotic cell ratio and altered mRNA abundance of DNMT3A, IGF2R and SLC2A1. In addition, the blastocysts displayed reduced oxygen, pyruvate and glucose consumption, up-regulated lactate consumption and higher amino acid metabolism. These data indicate that exposure of maturing oocytes to elevated NEFA concentrations has a negative impact on fertility not only through a reduction in oocyte developmental capacity but through compromised early embryo quality, viability and metabolism.	[Van Hoeck, Veerle; Bols, Peter E. J.; Leroy, Jo L. M. R.] Univ Antwerp, Lab Vet Physiol & Biochem, Dept Vet Sci, Fac Biomed Pharmaceut & Vet Sci, Antwerp, Belgium; [Sturmey, Roger G.; Leese, Henry J.] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Bermejo-Alvarez, Pablo; Rizos, Dimitrios; Gutierrez-Adan, Alfonso] INIA, Dept Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain	University of Antwerp; University of Hull; University of York - UK	Van Hoeck, V (corresponding author), Univ Antwerp, Lab Vet Physiol & Biochem, Dept Vet Sci, Fac Biomed Pharmaceut & Vet Sci, Antwerp, Belgium.	veerle.vanhoeck@ua.ac.be	Leroy, Jo/AAC-1791-2020; Gutierrez-Adan, Alfonso/A-1485-2014; Rizos, Dimitrios/E-7058-2012	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; Rizos, Dimitrios/0000-0001-6813-3940; Sturmey, Roger/0000-0003-4423-5058; Bermejo-Alvarez, Pablo/0000-0001-9907-2626; Bols, Peter/0000-0003-0432-8719	Flemish Research Fund (FWO) [1106910N]; GEMINI COST ACTION [FA0702]; Spanish Ministry of Science and Innovation (AGA) [AGL2009-11358, AGL2009-11810]; Special Research Fund (BOF-UA: JLMRL); MRC [G0802556] Funding Source: UKRI; Medical Research Council [G0802556] Funding Source: researchfish	Flemish Research Fund (FWO)(FWO); GEMINI COST ACTION; Spanish Ministry of Science and Innovation (AGA)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Special Research Fund (BOF-UA: JLMRL); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded by the Flemish Research Fund (FWO grant 1106910N: VVH), GEMINI COST ACTION FA0702 (short mission scientific stay in HJL's lab), the Spanish Ministry of Science and Innovation (AGA by Grant AGL2009-11358; DR by Grant AGL2009-11810) and the Special Research Fund (BOF-UA: JLMRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDEMA H, 2011, BIOL REPROD IN PRESS; Anderiesz C, 2000, HUM REPROD, V15, P1140, DOI 10.1093/humrep/15.5.1140; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Campbell BK, 2003, REPRODUCTION, P429; Clark AM, 1998, HUM REPROD, V13, P1502, DOI 10.1093/humrep/13.6.1502; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; Fedorcsak P, 2000, ACTA OBSTET GYN SCAN, V79, P43, DOI 10.1034/j.1600-0412.2000.079001043.x; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Harding EA, 1999, PFLUG ARCH EUR J PHY, V438, P397, DOI 10.1007/s004240050927; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Humpherson PG, 2005, THERIOGENOLOGY, V64, P1852, DOI 10.1016/j.theriogenology.2005.04.019; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jorritsma R, 2004, ANIM REPROD SCI, V81, P225, DOI 10.1016/j.anireprosci.2003.10.005; KAKINUMA K, 1978, BIOCHIM BIOPHYS ACTA, V538, P50, DOI 10.1016/0304-4165(78)90251-9; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; Lane M, 2000, BIOL REPROD, V62, P16, DOI 10.1095/biolreprod62.1.16; LASH NM, 2009, FERTIL STERIL, V91, P12; Latham KE, 1998, DEVELOPMENT, V125, P929; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; Leroy JLMR, 2010, HUM REPROD, V25, P768, DOI 10.1093/humrep/dep420; Leroy JLMR, 2005, REPRODUCTION, V130, P485, DOI 10.1530/rep.1.00735; LEVESQUE JT, 1995, MOL REPROD DEV, V42, P114, DOI 10.1002/mrd.1080420115; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lopes AS, 2007, HUM REPROD, V22, P558, DOI 10.1093/humrep/del404; Lopes AS, 2005, REPRODUCTION, V130, P669, DOI 10.1530/rep.1.00703; Lu ZH, 2003, BIOCHEM BIOPH RES CO, V303, P1002, DOI 10.1016/S0006-291X(03)00449-2; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Menezo YJR, 2000, THERIOGENOLOGY, V53, P599, DOI 10.1016/S0093-691X(99)00260-5; Metwally M, 2007, REPROD BIOMED ONLINE, V15, P532, DOI 10.1016/S1472-6483(10)60385-9; Minge CE, 2008, ENDOCRINOLOGY, V149, P2646, DOI 10.1210/en.2007-1570; Mooradian AD, 2008, OBESITY, V16, P1152, DOI 10.1038/oby.2008.202; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; NAVARA CS, 1995, THERIOGENOLOGY, V44, P1099, DOI 10.1016/0093-691X(95)00323-Z; Pantaleon M, 1997, P NATL ACAD SCI USA, V94, P3795, DOI 10.1073/pnas.94.8.3795; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; SIRARD MA, 1989, BIOL REPROD, V40, P1257, DOI 10.1095/biolreprod40.6.1257; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; STOLBA P, 1993, ANN NY ACAD SCI, V683, P373, DOI 10.1111/j.1749-6632.1993.tb35738.x; Sturmey RG, 2010, MOL REPROD DEV, V77, P285, DOI 10.1002/mrd.21145; Sturmey RG, 2009, HUM REPROD, V24, P81, DOI 10.1093/humrep/den346; Sviderskaya EV, 1996, J MEMBRANE BIOL, V149, P133, DOI 10.1007/s002329900014; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.1471-4159.2003.01571.x; van der Steeg JW, 2008, HUM REPROD, V23, P324, DOI 10.1093/humrep/dem371; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; VanBlerkom J, 1995, HUM REPROD UPDATE, V1, P429, DOI 10.1093/humupd/1.5.429; Vandaele L, 2008, ANIM REPROD SCI, V106, P168, DOI 10.1016/j.anireprosci.2007.12.016; Vandaele L, 2006, THERIOGENOLOGY, V65, P1691, DOI 10.1016/j.theriogenology.2005.09.014; Vanholder T, 2005, ANIM REPROD SCI, V87, P33, DOI 10.1016/j.anireprosci.2004.09.006; Watson AJ, 1999, THERIOGENOLOGY, V51, P117, DOI 10.1016/S0093-691X(98)00236-2; WENGER RH, 1999, ENV STRESS GENE REGU, P25; Wilding M, 2009, REPRODUCTION, V137, P619, DOI 10.1530/REP-08-0444; Wittemer C, 2000, J ASSIST REPROD GEN, V17, P547, DOI 10.1023/A:1026477628723; Wrenzycki C, 2007, THERIOGENOLOGY, V68, pS77, DOI 10.1016/j.theriogenology.2007.04.028; Wu DF, 2000, MOL CELL BIOCHEM, V204, P157, DOI 10.1023/A:1007064706101; Wutz A, 2001, DEVELOPMENT, V128, P1881; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	63	183	185	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23183	10.1371/journal.pone.0023183	http://dx.doi.org/10.1371/journal.pone.0023183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858021	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300017
J	McLaren, JR; Turkington, R				McLaren, Jennie R.; Turkington, Roy			Plant Identity Influences Decomposition through More Than One Mechanism	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; LEAF-LITTER DECOMPOSITION; FUNCTIONAL-GROUP IDENTITY; BOREAL FOREST; TERRESTRIAL ECOSYSTEMS; NITROGEN DEPOSITION; NUTRIENT RELEASE; SPECIES IDENTITY; ELEVATED CO2; DIVERSITY	Plant litter decomposition is a critical ecosystem process representing a major pathway for carbon flux, but little is known about how it is affected by changes in plant composition and diversity. Single plant functional groups (graminoids, legumes, non-leguminous forbs) were removed from a grassland in northern Canada to examine the impacts of functional group identity on decomposition. Removals were conducted within two different environmental contexts (fertilization and fungicide application) to examine the context-dependency of these identity effects. We examined two different mechanisms by which the loss of plant functional groups may impact decomposition: effects of the living plant community on the decomposition microenvironment, and changes in the species composition of the decomposing litter, as well as the interaction between these mechanisms. We show that the identity of the plant functional group removed affects decomposition through both mechanisms. Removal of both graminoids and forbs slowed decomposition through changes in the decomposition microenvironment. We found non-additive effects of litter mixing, with both the direction and identity of the functional group responsible depending on year; in 2004 graminoids positively influenced decomposition whereas in 2006 forbs negatively influenced decomposition rate. Although these two mechanisms act independently, their effects may be additive if both mechanisms are considered simultaneously. It is essential to understand the variety of mechanisms through which even a single ecosystem property is affected if we are to predict the future consequences of biodiversity loss.	Univ British Columbia, Dept Bot, Vancouver, BC, Canada; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	McLaren, JR (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	jennie.mclaren@gmail.com	McLaren, Jennie/U-9130-2019	McLaren, Jennie/0000-0003-2004-4783	Natural Science and Engineering Research Council of Canada; Killam Foundation; Northern Scientific Training Program	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Foundation; Northern Scientific Training Program	This research was supported by the Natural Science and Engineering Research Council of Canada (Discovery grant to R. T. and scholarship to J.R.M.), the Killam Foundation (fellowship to J.R.M.), and the Northern Scientific Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Ayres E, 2009, J ECOL, V97, P901, DOI 10.1111/j.1365-2745.2009.01539.x; Bryant DM, 1998, CAN J BOT, V76, P1295, DOI 10.1139/cjb-76-7-1295; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; CHRISTENSEN H, 1993, BIOL FERT SOILS, V15, P253, DOI 10.1007/BF00337209; Cody W. J., 2000, FLORA YUKON TERRITOR; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Duffy J. Emmett, 2009, P60; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hector A, 2000, OIKOS, V90, P357, DOI 10.1034/j.1600-0706.2000.900217.x; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; Hobbie SE, 1999, OIKOS, V84, P417, DOI 10.2307/3546421; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hobbie SE, 2000, ECOSYSTEMS, V3, P484, DOI 10.1007/s100210000042; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; John E, 1997, J ECOL, V85, P419, DOI 10.2307/2960566; JOHNSON NC, 1993, ECOL APPL, V3, P749, DOI 10.2307/1942106; Jonsson M, 2008, OIKOS, V117, P1674, DOI 10.1111/j.1600-0706.2008.16810.x; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; Knops JMH, 2001, OECOLOGIA, V126, P429, DOI 10.1007/s004420000537; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Madritch MD, 2004, OIKOS, V105, P125, DOI 10.1111/j.0030-1299.2004.12760.x; Marshall CB, 2011, SOIL BIOL BIOCHEM, V43, P78, DOI 10.1016/j.soilbio.2010.09.016; McLaren JR, 2011, J VEG SCI, V22, P503, DOI 10.1111/j.1654-1103.2011.01263.x; McLaren JR, 2010, GLOBAL CHANGE BIOL, V16, P3075, DOI 10.1111/j.1365-2486.2009.02151.x; McLaren JR, 2010, J ECOL, V98, P459, DOI 10.1111/j.1365-2745.2009.01630.x; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Moore TN, 2006, OIKOS, V114, P329, DOI 10.1111/j.2006.0030-1299.14576.x; Moorhead DL, 1998, OECOLOGIA, V113, P530, DOI 10.1007/s004420050406; Pfister JA, 2001, J RANGE MANAGE, V54, P447, DOI 10.2307/4003116; Prescott CE, 1999, CAN J FOREST RES, V29, P393, DOI 10.1139/cjfr-29-3-393; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Scherer-Lorenzen M, 2008, FUNCT ECOL, V22, P547, DOI 10.1111/j.1365-2435.2008.01389.x; SEASTEDT TR, 1984, ANNU REV ENTOMOL, V29, P25, DOI 10.1146/annurev.en.29.010184.000325; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Shevtsova A, 1997, OIKOS, V78, P440, DOI 10.2307/3545606; Smith MD, 2000, SOIL BIOL BIOCHEM, V32, P935, DOI 10.1016/S0038-0717(99)00223-0; Smith VC, 2003, OIKOS, V102, P235, DOI 10.1034/j.1600-0706.2003.12503.x; Talley SM, 2002, J CHEM ECOL, V28, P2141, DOI 10.1023/A:1021037029684; Turkington R, 2002, J ECOL, V90, P325, DOI 10.1046/j.1365-2745.2001.00666.x; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Wardle DA, 2008, J ECOL, V96, P1174, DOI 10.1111/j.1365-2745.2008.01437.x; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053	60	25	25	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23702	10.1371/journal.pone.0023702	http://dx.doi.org/10.1371/journal.pone.0023702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858210	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500042
J	Mulcahy, H; Lewenza, S				Mulcahy, Heidi; Lewenza, Shawn			Magnesium Limitation Is an Environmental Trigger of the Pseudomonas aeruginosa Biofilm Lifestyle	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEMS; RECOMBINANT HUMAN DNASE; CYSTIC-FIBROSIS; BACTERIAL BIOFILMS; POLYMYXIN-B; ANTIBIOTIC-RESISTANCE; SIGNAL-TRANSDUCTION; EXTRACELLULAR DNA; GENE-EXPRESSION; SMALL RNAS	Biofilm formation is a conserved strategy for long-term bacterial survival in nature and during infections. Biofilms are multicellular aggregates of cells enmeshed in an extracellular matrix. The RetS, GacS and LadS sensors control the switch from a planktonic to a biofilm mode of growth in Pseudomonas aeruginosa. Here we detail our approach to identify environmental triggers of biofilm formation by investigating environmental conditions that repress expression of the biofilm repressor RetS. Mg2+ limitation repressed the expression of retS leading to increased aggregation, exopolysaccharide (EPS) production and biofilm formation. Repression of retS expression under Mg2+ limitation corresponded with induced expression of the GacA-controlled small regulatory RNAs rsmZ and rsmY and the EPS biosynthesis operons pel and psl. We recently demonstrated that extracellular DNA sequesters Mg2+ cations and activates the cation-sensing PhoPQ two-component system, which leads to increased antimicrobial peptide resistance in biofilms. Here we show that exogenous DNA and EDTA, through their ability to chelate Mg2+, promoted biofilm formation. The repression of retS in low Mg2+ was directly controlled by PhoPQ. PhoP also directly controlled expression of rsmZ but not rsmY suggesting that PhoPQ controls the equilibrium of the small regulatory RNAs and thus fine-tunes the expression of genes in the RetS pathway. In summary, Mg2+ limitation is a biologically relevant environmental condition and the first bonafide environmental signal identified that results in transcriptional repression of retS and promotes P. aeruginosa biofilm formation.	[Mulcahy, Heidi; Lewenza, Shawn] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Calgary	Mulcahy, H (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	slewenza@ucalgary.ca			Westaim Corporation; Alberta Science and Research Authority; Cystic Fibrosis Canada; Canadian Foundation for Innovation	Westaim Corporation; Alberta Science and Research Authority; Cystic Fibrosis Canada; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This research was supported by the Westaim Corporation and the Alberta Science and Research Authority. HM is the recipient of a Cystic Fibrosis Canada fellowship. SL holds the Westaim-Alberta Science and Research Authority Chair in Biofilm Research. This work was supported by an equipment and infrastructure grant from the Canadian Foundation for Innovation and the Alberta Science and Research Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Banin E, 2006, APPL ENVIRON MICROB, V72, P2064, DOI 10.1128/AEM.72.3.2064-2069.2006; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; BRANDT T, 1995, THORAX, V50, P880, DOI 10.1136/thx.50.8.880; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hardalo C, 1997, CRIT REV MICROBIOL, V23, P47, DOI 10.3109/10408419709115130; HOSKINS LC, 1978, J INFECT DIS, V137, P694, DOI 10.1093/infdis/137.5.694; Hyland RM, 2006, J MED MICROBIOL, V55, P669, DOI 10.1099/jmm.0.46344-0; Irie Y, 2010, MOL MICROBIOL; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; Kuchma SL, 2005, J BACTERIOL, V187, P1441, DOI 10.1128/JB.187.4.1441-1454.2005; Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; Lesley JA, 2001, J BIOL CHEM, V276, P30827, DOI 10.1074/jbc.M104262200; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Lewenza S, 2008, J BACTERIOL, V190, P6119, DOI 10.1128/JB.00603-08; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; NICAS TI, 1980, J BACTERIOL, V143, P872, DOI 10.1128/JB.143.2.872-878.1980; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Prost LR, 2008, MOL MICROBIOL, V69, P503, DOI 10.1111/j.1365-2958.2008.06303.x; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Ramsey MM, 2004, MOL MICROBIOL, V53, P1075, DOI 10.1111/j.1365-2958.2004.04181.x; RANASINHA C, 1993, LANCET, V342, P199, DOI 10.1016/0140-6736(93)92297-7; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Shih PC, 2002, J ANTIMICROB CHEMOTH, V49, P309, DOI 10.1093/jac/49.2.309; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Workentine ML, 2010, ENV MICROBIOL; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	67	52	52	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23307	10.1371/journal.pone.0023307	http://dx.doi.org/10.1371/journal.pone.0023307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858064	Green Submitted, gold, Green Published			2022-12-25	WOS:000294125500026
J	Peterson, SE; Westra, JW; Rehen, SK; Young, H; Bushman, DM; Paczkowski, CM; Yung, YC; Lynch, CL; Tran, HT; Nickey, KS; Wang, YC; Laurent, LC; Loring, JF; Carpenter, MK; Chun, J				Peterson, Suzanne E.; Westra, Jurjen W.; Rehen, Stevens K.; Young, Holly; Bushman, Diane M.; Paczkowski, Christine M.; Yung, Yun C.; Lynch, Candace L.; Tran, Ha T.; Nickey, Kyle S.; Wang, Yu-Chieh; Laurent, Louise C.; Loring, Jeanne F.; Carpenter, Melissa K.; Chun, Jerold			Normal Human Pluripotent Stem Cell Lines Exhibit Pervasive Mosaic Aneuploidy	PLOS ONE			English	Article							CHROMOSOMAL-ABNORMALITIES; SEGREGATION DEFECTS; GENE-EXPRESSION; CULTURE; BRAIN; DIFFERENTIATION; HETEROGENEITY; FIBROBLASTS; DERIVATION; SELECTION	Human pluripotent stem cell (hPSC) lines have been considered to be homogeneously euploid. Here we report that normal hPSC - including induced pluripotent - lines are karyotypic mosaics of euploid cells intermixed with many cells showing non-clonal aneuploidies as identified by chromosome counting, spectral karyotyping (SKY) and fluorescent in situ hybridization (FISH) of interphase/non-mitotic cells. This mosaic aneuploidy resembles that observed in progenitor cells of the developing brain and preimplantation embryos, suggesting that it is a normal, rather than pathological, feature of stem cell lines. The karyotypic heterogeneity generated by mosaic aneuploidy may contribute to the reported functional and phenotypic heterogeneity of hPSCs lines, as well as their therapeutic efficacy and safety following transplantation.	[Peterson, Suzanne E.; Westra, Jurjen W.; Bushman, Diane M.; Paczkowski, Christine M.; Yung, Yun C.; Chun, Jerold] Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Peterson, Suzanne E.; Lynch, Candace L.; Tran, Ha T.; Nickey, Kyle S.; Wang, Yu-Chieh; Laurent, Louise C.; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Westra, Jurjen W.; Bushman, Diane M.; Yung, Yun C.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, San Diego, CA 92103 USA; [Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Young, Holly; Carpenter, Melissa K.] Robarts Res Inst, London, ON N6A 5C1, Canada; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92103 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; Universidade Federal do Rio de Janeiro; Western University (University of Western Ontario); University of California System; University of California San Diego	Peterson, SE (corresponding author), Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@scripps.edu	Rehen, Stevens/J-5874-2012; Chun, Jerold/Y-4670-2019; Loring, Jeanne F/A-1620-2011	Rehen, Stevens/0000-0003-4216-9501; Loring, Jeanne F/0000-0001-6226-9767; Yung, Yun/0000-0001-8973-7612; Laurent, Louise/0000-0002-2095-7534	NIMH [R21 MH076145, K02 MH01723]; NIH [T32 AG00216-13]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001723, R21MH076145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIMH R21 MH076145, K02 MH01723 (JC), NIH Training Grant T32 AG00216-13 (SP), and NSF Predoctoral Fellowship (YY). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambartsumyan G, 2008, HUM MOL GENET, V17, pR10, DOI 10.1093/hmg/ddn170; Barch MJ, 1997, AGT CYTOGENETICS LAB; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Dupont C, 2010, FERTIL STERIL, V93, P2545, DOI 10.1016/j.fertnstert.2009.06.040; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Frumkin T, 2008, MOL CELL ENDOCRINOL, V282, P112, DOI 10.1016/j.mce.2007.11.009; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Mack GS, 2011, NAT BIOTECHNOL, V29, P95, DOI 10.1038/nbt0211-95; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Meisner LF, 2008, METHODS, V45, P133, DOI 10.1016/j.ymeth.2008.03.005; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; MUNNE S, 1994, BIOL REPROD, V51, P373, DOI 10.1095/biolreprod51.3.373; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pera MF, 2004, NAT BIOTECHNOL, V22, P42, DOI 10.1038/nbt0104-42; Peterson S, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P71, DOI 10.1016/B978-012370465-8/50011-9; Rajendran RS, 2007, DEV NEUROBIOL, V67, P1334, DOI 10.1002/dneu.20365; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilton L, 2002, PRENATAL DIAG, V22, P512, DOI 10.1002/pd.388; Wisconsin Alumni Research Foundation, 2001, [No title captured], Patent No. [US6200806, 6200806]; Yang AH, 2003, J NEUROSCI, V23, P10454; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	60	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23018	10.1371/journal.pone.0023018	http://dx.doi.org/10.1371/journal.pone.0023018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857983	gold, Green Published, Green Submitted			2022-12-25	WOS:000294125500013
J	Sale, MM; Chen, WM; Weeks, DE; Mychaleckyj, JC; Hou, XL; Marion, M; Segade, F; Casselbrant, ML; Mandel, EM; Ferrell, RE; Rich, SS; Daly, KA				Sale, Michele M.; Chen, Wei-Min; Weeks, Daniel E.; Mychaleckyj, Josyf C.; Hou, Xuanlin; Marion, Miranda; Segade, Fernando; Casselbrant, Margaretha L.; Mandel, Ellen M.; Ferrell, Robert E.; Rich, Stephen S.; Daly, Kathleen A.			Evaluation of 15 Functional Candidate Genes for Association with Chronic Otitis Media with Effusion and/or Recurrent Otitis Media (COME/ROM)	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; SURFACTANT PROTEIN-A; SYNCYTIAL VIRUS-INFECTION; HUMAN MIDDLE-EAR; UP-REGULATION; MUCIN GENE; INFLAMMATORY CYTOKINES; SUSCEPTIBILITY LOCI; UNITED-STATES; EXPRESSION	DNA sequence variants in genes involved in the innate immune response and secondary response to infection may confer susceptibility to chronic otitis media with effusion and/or recurrent otitis media (COME/ROM). We evaluated single nucleotide polymorphisms (SNPs) in 15 functional candidate genes. A total of 99 SNPs were successfully genotyped on the Sequenom platform in 142 families (618 subjects) from the Minnesota COME/ROM Family Study. Data were analyzed for association with COME/ROM using the Generalized Disequilibrium Test (GDT). Sex and age at exam were adjusted as covariates, relatedness was accounted for, and genotype differences from all phenotypically discordant relative pairs were utilized to measure the evidence of association between COME/ROM and each SNP. SNP rs2735733 in the region of the mucin 5, subtypes A/C gene (MUC5AC) exhibited nominal evidence for association with COME/ROM (P = 0.002). Two additional SNPs from this region had P values < 0.05. Other variants exhibiting associations with COME/ROM at P < 0.05 included the SCN1B SNP rs8100085 (P = 0.013), SFTPD SNP rs1051246 (P = 0.039) and TLR4 SNP rs2770146 (P = 0.038). However, none of these associations replicated in an independent sample of COME/ROM families. The candidate gene variants examined do not appear to make a major contribution to COME/ROM susceptibility, despite a priori evidence from functional or animal model studies for a role in COME/ROM pathology.	[Sale, Michele M.; Chen, Wei-Min; Mychaleckyj, Josyf C.; Hou, Xuanlin; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Sale, Michele M.; Rich, Stephen S.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Sale, Michele M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Chen, Wei-Min; Mychaleckyj, Josyf C.; Hou, Xuanlin; Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Weeks, Daniel E.; Casselbrant, Margaretha L.; Ferrell, Robert E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Marion, Miranda] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Segade, Fernando] Univ Penn, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Casselbrant, Margaretha L.; Mandel, Ellen M.] UPMC, Childrens Hosp Pittsburgh, Dept Otolaryngol, Pittsburgh, PA USA; [Daly, Kathleen A.] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest Baptist Medical Center; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities	Sale, MM (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	msale@virginia.edu	Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Rich, Stephen/0000-0003-3872-7793	National Institutes of Health [DC003166, DC003166-S1, R01DC005630, UL1RR024153]; National Institutes of Health General Clinical Research Center [M01RR000084]; Children's Hospital of Pittsburgh of UPMC; University of Pittsburgh; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005630, R01DC003166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Children's Hospital of Pittsburgh of UPMC; University of Pittsburgh(University of Pittsburgh); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants DC003166 and DC003166-S1 (KAD). The replication work was supported primarily by the National Institutes of Health grant R01DC005630 (to MLC), as well as by the National Institutes of Health General Clinical Research Center grant M01RR000084, National Institutes of Health Clinical and Translational Science Award UL1RR024153, Children's Hospital of Pittsburgh of UPMC, and the University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; Daly K A, 1999, Pediatr Rev, V20, P85, DOI 10.1542/pir.20-3-85; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Daly KA, 1996, GENET EPIDEMIOL, V13, P451, DOI 10.1002/(SICI)1098-2272(1996)13:5<451::AID-GEPI2>3.0.CO;2-5; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Elsheikh MN, 2006, LARYNGOSCOPE, V116, P365, DOI 10.1097/01.MLG.0000195290.71090.A1; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Heikkinen T, 2000, VACCINE, V19, pS51, DOI 10.1016/S0264-410X(00)00278-4; Ho V, 2002, LARYNGOSCOPE, V112, P513, DOI 10.1097/00005537-200203000-00020; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; HOTOMI M, 1994, ACTA OTO-LARYNGOL, V114, P406, DOI 10.3109/00016489409126078; Hunter LL, 2007, INT J PEDIATR OTORHI, V71, P1429, DOI 10.1016/j.ijporl.2007.05.020; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kawano H, 2000, LARYNGOSCOPE, V110, P668, DOI 10.1097/00005537-200004000-00024; Kerschner JE, 2004, ARCH OTOLARYNGOL, V130, P1163, DOI 10.1001/archotol.130.10.1163; Kim YT, 2001, ACTA OTO-LARYNGOL, V121, P364; Klein JO, 1997, PEDIATR INFECT DIS J, V16, pS5, DOI 10.1097/00006454-199702001-00002; Kubba H, 2000, CLIN OTOLARYNGOL, V25, P181, DOI 10.1046/j.1365-2273.2000.00350.x; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; KVAERNER KJ, 2004, ADV THERAPY OTITIS M, P106; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lin JZ, 2002, INT J PEDIATR OTORHI, V65, P203, DOI 10.1016/S0165-5876(02)00130-1; Lofgren J, 2002, J INFECT DIS, V185, P283, DOI 10.1086/338473; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Moon SK, 2007, INFECT IMMUN, V75, P3361, DOI 10.1128/IAI.01886-06; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramet M, 2001, J PEDIATR-US, V138, P266, DOI 10.1067/mpd.2001.110133; RASMUSSEN F, 1993, INT J PEDIATR OTORHI, V26, P29, DOI 10.1016/0165-5876(93)90193-7; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Schousboe LP, 2001, ACTA OTO-LARYNGOL, V121, P596, DOI 10.1080/000164801316878881; Segade F, 2006, ARCH OTOLARYNGOL, V132, P729, DOI 10.1001/archotol.132.7.729; Smirnova MG, 2002, EUR CYTOKINE NETW, V13, P161; SPRAY BJ, 2002, P 7 INT S REC ADV OT, P225; Takeuchi K, 2003, INT J PEDIATR OTORHI, V67, P53, DOI 10.1016/S0165-5876(02)00361-0; TAKEUCHI K, 1994, ANN OTO RHINOL LARYN, V103, P404, DOI 10.1177/000348949410300511; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; UBELL ML, 2009, MUCIN GENE POLYMORPH; *US DEP HHS, 2006, VIS HEAR HLTH PEOPL, P28; Wiertsema SP, 2006, CLIN VACCINE IMMUNOL, V13, P892, DOI 10.1128/CVI.00100-06; Wiertsema SP, 2006, J ALLERGY CLIN IMMUN, V117, P1344, DOI 10.1016/j.jaci.2006.01.031; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619	58	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22297	10.1371/journal.pone.0022297	http://dx.doi.org/10.1371/journal.pone.0022297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857919	Green Accepted, Green Published, gold			2022-12-25	WOS:000294125500007
J	Lingappa, JR; Dumitrescu, L; Zimmer, SM; Lynfield, R; McNicholl, JM; Messonnier, NE; Whitney, CG; Crawford, DC				Lingappa, Jairam R.; Dumitrescu, Logan; Zimmer, Shanta M.; Lynfield, Ruth; McNicholl, Janet M.; Messonnier, Nancy E.; Whitney, Cynthia G.; Crawford, Dana C.			Identifying Host Genetic Risk Factors in the Context of Public Health Surveillance for Invasive Pneumococcal Disease	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; C-REACTIVE PROTEIN; PROMOTER POLYMORPHISM; SURFACTANT PROTEINS; PLASMINOGEN-ACTIVATOR-INHIBITOR-1 GENE; ALVEOLAR MACROPHAGES; SEPTIC SHOCK; IN-VIVO; ASSOCIATION; ALPHA	Host genetic factors that modify risk of pneumococcal disease may help target future public health interventions to individuals at highest risk of disease. We linked data from population-based surveillance for invasive pneumococcal disease (IPD) with state-based newborn dried bloodspot repositories to identify biological samples from individuals who developed invasive pneumococcal disease. Genomic DNA was extracted from 366 case and 732 anonymous control samples. TagSNPs were selected in 34 candidate genes thought to be associated with host response to invasive pneumococcal disease, and a total of 326 variants were successfully genotyped. Among 543 European Americans (EA) (182 cases and 361 controls), and 166 African Americans (AA) (53 cases and 113 controls), common variants in surfactant protein D (SFTPD) are consistently underrepresented in IPD. SFTPD variants with the strongest association for IPD are intronic rs17886286 (allelic OR 0.45, 95% confidence interval (CI) [0.25, 0.82], with p = 0.007) in EA and 59 flanking rs12219080 (allelic OR 0.32, 95% CI [0.13, 0.78], with p = 0.009) in AA. Variants in CD46 and IL1R1 are also associated with IPD in both EA and AA, but with effects in different directions; FAS, IL1B, IL4, IL10, IL12B, SFTPA1, SFTPB, and PTAFR variants are associated (p <= 0.05) with IPD in EA or AA. We conclude that variants in SFTPD may protect against IPD in EA and AA and genetic variation in other host response pathways may also contribute to risk of IPD. While our associations are not corrected for multiple comparisons and therefore must be replicated in additional cohorts, this pilot study underscores the feasibility of integrating public health surveillance with existing, prospectively collected, newborn dried blood spot repositories to identify host genetic factors associated with infectious diseases.	[Lingappa, Jairam R.] Univ Washington, Dept Global Hlth, Dept Med, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dumitrescu, Logan; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Zimmer, Shanta M.] Emory Univ, Atlanta, GA 30322 USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [McNicholl, Janet M.; Messonnier, Nancy E.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Atlanta, GA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University; Emory University; Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Dept Med, Seattle, WA 98195 USA.	lingappa@u.washington.edu	Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012; Lingappa, Jairam/N-7760-2017	Crawford, Dana/0000-0002-6437-6248; 	U.S. Federal Government, National Heart, Lung, and Blood Institute [N01-HV-48195]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	U.S. Federal Government, National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Genotyping services were provided by the Johns Hopkins University under U.S. Federal Government contract number N01-HV-48195 from the National Heart, Lung, and Blood Institute. Intramural support was also provided through the Centers for Disease Control and Prevention (CDC) Genetics Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bernard GR, 2003, CRIT CARE MED, V31, pS85, DOI 10.1097/00003246-200301001-00012; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BOUDEWIJNS M, 2005, J LEUKOC BIOL; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; Chen QY, 2006, J IMMUNOL, V177, P6044, DOI 10.4049/jimmunol.177.9.6044; Crawford DC, 2008, EMERG INFECT DIS, V14, P1138, DOI 10.3201/eid1407.071287; Crawford DC, 2005, ANNU REV GENOM HUM G, V6, P287, DOI 10.1146/annurev.genom.6.080604.162309; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dumitrescu L, 2010, GENET MED, V12, P648, DOI 10.1097/GIM.0b013e3181efe2df; Echchannaoui H, 2005, IMMUNOBIOLOGY, V210, P229, DOI 10.1016/j.imbio.2005.05.017; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Falush D, 2003, GENETICS, V164, P1567; Fang XM, 1999, CRIT CARE MED, V27, P1330, DOI 10.1097/00003246-199907000-00024; Forbes LR, 2010, CLIN EXP ALLERGY, V40, P547, DOI 10.1111/j.1365-2222.2010.03483.x; Gallagher PM, 2003, THORAX, V58, P154, DOI 10.1136/thorax.58.2.154; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Geishofer G, 2005, EUR J PEDIATR, V164, P486, DOI 10.1007/s00431-005-1673-4; Gordon SB, 2005, AIDS, V19, P1197, DOI 10.1097/01.aids.0000176220.25614.5e; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; IOM (Institute of Medicine), 2010, CHALL OPP US RES NEW; Jeurissen A, 2004, EUR J IMMUNOL, V34, P850, DOI 10.1002/eji.200324381; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Jounblat R, 2004, INFECT IMMUN, V72, P709, DOI 10.1128/IAI.72.2.709-716.2004; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Letiembre M, 2005, J NEUROIMMUNOL, V168, P21, DOI 10.1016/j.jneuroim.2005.06.016; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x; Ling E, 2003, J INFECT DIS, V188, P1752, DOI 10.1086/379371; Liu CF, 2010, CLIN EXP ALLERGY, V40, P111, DOI [10.1111/j.1365-2222.2009.03367.x, 10.1111/j.1365-2222.2010.03549.x]; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Lynch JM, 2003, INFECT IMMUN, V71, P4780, DOI 10.1128/IAI.71.8.4780-4788.2003; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matute-Bello G, 2005, J INFECT DIS, V191, P596, DOI 10.1086/427261; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Mold C, 2002, J IMMUNOL, V168, P6375, DOI 10.4049/jimmunol.168.12.6375; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; Paterson GK, 2005, J MED MICROBIOL, V54, P323, DOI 10.1099/JMM.0.45873-0; Paul R, 2004, J NEUROIMMUNOL, V152, P78, DOI 10.1016/j.jneuroim.2004.04.004; Pendergrass SA, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-10; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Read RC, 2003, ANN INTERN MED, V138, P534, DOI 10.7326/0003-4819-138-7-200304010-00009; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Schaaf BM, 2003, AM J RESP CRIT CARE, V168, P476, DOI 10.1164/rccm.200210-1164OC; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Seya T, 1999, INT J BIOCHEM CELL B, V31, P1255, DOI 10.1016/S1357-2725(99)00092-8; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Stuber F, 1996, CRIT CARE MED, V24, P381, DOI 10.1097/00003246-199603000-00004; van der Pol WL, 2001, J INFECT DIS, V184, P1548, DOI 10.1086/324662; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Waterer GW, 2005, CLIN CHEST MED, V26, P29, DOI 10.1016/j.ccm.2004.10.002; Westendorp RGJ, 1999, LANCET, V354, P561, DOI 10.1016/S0140-6736(98)09376-3; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yamamoto N, 2004, MICROBES INFECT, V6, P1241, DOI 10.1016/j.micinf.2004.08.007; Yee AMF, 1997, ARTHRITIS RHEUM, V40, P1180, DOI 10.1002/art.1780400626; YOTHER J, 1982, J IMMUNOL, V128, P2374; Zwijnenburg PJG, 2003, J NEUROIMMUNOL, V138, P31, DOI 10.1016/S0165-5728(03)00088-2	77	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23413	10.1371/journal.pone.0023413	http://dx.doi.org/10.1371/journal.pone.0023413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858107	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953700021
J	Ozato-Sakurai, N; Fujita, A; Fujimoto, T				Ozato-Sakurai, Nami; Fujita, Akikazu; Fujimoto, Toyoshi			The Distribution of Phosphatidylinositol 4,5-Bisphosphate in Acinar Cells of Rat Pancreas Revealed with the Freeze-Fracture Replica Labeling Method	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; GOLGI-APPARATUS; PLASMA-MEMBRANE; PHOSPHOINOSITIDES; POLARITY; PTDINS(4,5)P-2; LOCALIZATION; 3-PHOSPHATE; EXOCYTOSIS; ENDOCRINE	Phosphatidylinositol 4,5-bisphosphate [PI(4,5)P-2] is a phospholipid that has been implicated in multiple cellular activities. The distribution of PI(4,5)P-2 has been analyzed extensively using live imaging of the GFP-coupled phospholipase C-delta 1 pleckstrin homology domain in cultured cell lines. However, technical difficulties have prevented the study of PI(4,5)P-2 in cells of in vivo tissues. We recently developed a method to analyze the nanoscale distribution of PI(4,5)P-2 in cultured cells by using the quick-freezing and freeze-fracture replica labeling method. In principle, this method can be applied to any cell because it does not require the expression of artificial probes. In the present study, we modified the method to study cells of in vivo tissues and applied it to pancreatic exocrine acinar cells of the rat. We found that PI(4,5)P-2 in the plasma membrane is distributed in an equivalent density in the apical and basolateral domains, but exists in a significantly higher concentration in the gap junction. The intracellular organelles did not show labeling for PI(4,5)P-2. The results are novel or different from the reported distribution patterns in cell lines and highlight the importance of studying cells differentiated in vivo.	[Ozato-Sakurai, Nami; Fujita, Akikazu; Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan	Nagoya University	Ozato-Sakurai, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan.	afujita@agri.kagoshima-u.ac.jp; tfujimot@med.nagoya-u.ac.jp	Fujimoto, Toyoshi/ABH-9058-2020	Fujimoto, Toyoshi/0000-0002-3601-7977	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [21890095, 50115929, 21390053]	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-Aid for Scientific Research 21890095 to NS, 50115929 to AF, 21390053 to TF (http://www.jsps.go.jp/english/e-grants/grants.html), and the Global COE Program "Integrated Molecular Medicine for Neuronal and Neoplastic Disorders'' from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government to NS, TF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Balla T, 2007, J PHYSIOL-LONDON, V582, P927, DOI 10.1113/jphysiol.2007.132795; CHANDLER DE, 1984, J CELL SCI, V72, P23; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; FUJITA A, 2009, BIOCH BIOPHYS ACTA; Akikazu F, 2007, HISTOCHEM CELL BIOL, V128, P385, DOI 10.1007/s00418-007-0341-3; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujita A, 2010, NAT PROTOC, V5, P661, DOI 10.1038/nprot.2010.20; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; GILKEY JC, 1986, J ELECTRON MICR TECH, V3, P177, DOI 10.1002/jemt.1060030206; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Hofgaard JP, 2008, PFLUG ARCH EUR J PHY, V457, P303, DOI 10.1007/s00424-008-0538-x; ICHIKAWA A, 1965, J CELL BIOL, V24, P369, DOI 10.1083/jcb.24.3.369; Irvine R, 2004, CURR BIOL, V14, pR308, DOI 10.1016/j.cub.2004.03.051; JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; JOST P, 1973, J MOL BIOL, V76, P313, DOI 10.1016/0022-2836(73)90394-X; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MEDA P, 1993, ENDOCRINOLOGY, V133, P2371, DOI 10.1210/en.133.5.2371; MOOR H, 1980, CELL TISSUE RES, V209, P201; SCHEELE GA, 1975, J BIOL CHEM, V250, P2660; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Sweeney DA, 2002, J BIOL CHEM, V277, P3030, DOI 10.1074/jbc.M104639200; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; VANDEURS B, 1979, J ULTRA MOL STRUCT R, V68, P160, DOI 10.1016/S0022-5320(79)90151-5; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657	41	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23567	10.1371/journal.pone.0023567	http://dx.doi.org/10.1371/journal.pone.0023567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858170	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953700034
J	Sun, YW; Dai, MH; Hao, HH; Wang, YL; Huang, LL; Almofti, YA; Liu, ZL; Yuan, ZH				Sun, Yawei; Dai, Menghong; Hao, Haihong; Wang, Yulian; Huang, Lingli; Almofti, Yassir A.; Liu, Zhenli; Yuan, Zonghui			The Role of RamA on the Development of Ciprofloxacin Resistance in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							MUTANT PREVENTION CONCENTRATION; MEDIATED MULTIDRUG-RESISTANCE; EFFLUX SYSTEMS; ACTIVE EFFLUX; QUINOLONE RESISTANCE; EMERGING MECHANISMS; ESCHERICHIA-COLI; SELECTION WINDOW; ACRB; MUTATIONS	Active efflux pump is a primary fluoroquinolone resistant mechanism of clinical isolates of Salmonella enterica serovar Typhimurium. RamA is an essential element in producing multidrug resistant (MDR) S. enterica serovar Typhimurium. The aim of the present study was to elucidate the roles of RamA on the development of ciprofloxacin, the first choice for the treatment of salmonellosis, resistance in S. enterica serovar Typhimurium. Spontaneous mutants were selected via several passages of S. enterica serovar Typhimurium CVCC541 susceptible strain (ST) on M-H agar with increasing concentrations of ciprofloxacin (CIP). Accumulation of ciprofloxacin was tested by the modified fluorometric method. The expression levels of MDR efflux pumps were determined by real time RT-PCR. In ST and its spontaneous mutants, the ramA gene was inactivated by insertion of the kan gene and compensated on a recombinant plasmid pGEX Phi(gst-ramA). The mutant prevention concentration (MPC) and mutant frequencies of ciprofloxacin against ST and a spontaneous mutant in the presence, absence and overexpression of RamA were tested. Four spontaneous mutants (SI1-SI4) were obtained. The SI1 (CIP MICs, 0.1 mg/L) without any target site mutation in its quinolone resistant determining regions (QRDRs) and SI3 (CIP MICs, 16 mg/L) harboring the Ser83 -> Phe mutation in its QRDR of GyrA strains exhibited reduced susceptibility and resistance to multidrugs, respectively. In SI1, RamA was the main factor that controlled the susceptibility to ciprofloxacin by activating MdtK as well as increasing the expression level of acrAB. In SI3, RamA played predominant role in ciprofloxacin resistance via increasing the expression level of acrAB. Likewise, the deficiency of RamA decreased the MPCs and mutant frequencies of ST and SI2 to ciprofloxacin. In conclusion, the expression of RamA promoted the development of ciprofloxacin resistant mutants of S. enterica serovar Typhimurium. The inhibition of RamA could decrease the appearance of the ciprofloxacin resistant mutants.	[Sun, Yawei; Dai, Menghong; Hao, Haihong; Wang, Yulian; Huang, Lingli; Almofti, Yassir A.; Liu, Zhenli; Yuan, Zonghui] Huazhong Agr Univ, MOA Key Lab Food Safety Evaluat, Natl Reference Lab Vet Drug Residues HZAU, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Sun, YW (corresponding author), Huazhong Agr Univ, MOA Key Lab Food Safety Evaluat, Natl Reference Lab Vet Drug Residues HZAU, Wuhan, Hubei, Peoples R China.	yuan5802@mail.hzau.edu.cn	yuan, zonghui/A-1158-2017; DAI, M/GPS-8291-2022; Hao, Haihong/E-2789-2019	Hao, Haihong/0000-0003-0199-5700	China Ministry of Agriculture	China Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This work was financially supported by China Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; Baucheron S, 2004, ANTIMICROB AGENTS CH, V48, P3729, DOI 10.1128/AAC.48.10.3729-3735.2004; Chen Feng-Jui, 2003, Journal of Microbiology Immunology and Infection, V36, P1; Chinni SV, 2010, NUCLEIC ACIDS RES, V38, P5893, DOI 10.1093/nar/gkq281; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Coldham NG, 2010, J ANTIMICROB CHEMOTH, V65, P1655, DOI 10.1093/jac/dkq169; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Cristobal RE, 2006, J ANTIMICROB CHEMOTH, V58, P31, DOI 10.1093/jac/dkl172; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; Escribano I, 2004, INT J ANTIMICROB AG, V24, P428, DOI 10.1016/j.ijantimicag.2004.05.004; Ferrari R, 2011, CURR MICROBIOL, V62, P628, DOI 10.1007/s00284-010-9754-7; Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131, DOI 10.1128/AAC.43.9.2131; Giraud E, 2000, ANTIMICROB AGENTS CH, V44, P1223, DOI 10.1128/AAC.44.5.1223-1228.2000; Giraud E, 2006, MICROBES INFECT, V8, P1937, DOI 10.1016/j.micinf.2005.12.025; Hansen GT, 2006, INT J ANTIMICROB AG, V27, P120, DOI 10.1016/j.ijantimicag.2005.10.005; Hansen GT, 2003, ANTIMICROB AGENTS CH, V47, P440, DOI 10.1128/AAC.47.1.440-441.2003; Hawkey PM, 2003, J ANTIMICROB CHEMOTH, V51, P29, DOI 10.1093/jac/dkg207; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Horiyama T, 2010, J ANTIMICROB CHEMOTH, V65, P1372, DOI 10.1093/jac/dkq160; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V59, P886, DOI 10.1093/jac/dkm072; Kehrenberg C, 2009, J ANTIMICROB CHEMOTH, V64, P1175, DOI 10.1093/jac/dkp347; Koutsolioutsou A, 2001, ANTIMICROB AGENTS CH, V45, P38, DOI 10.1128/AAC.45.1.38-43.2001; Lee A, 2000, J BACTERIOL, V182, P3142, DOI 10.1128/JB.182.11.3142-3150.2000; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Linde HJ, 2004, J ANTIMICROB CHEMOTH, V53, P252, DOI 10.1093/jac/dkh036; Mann PA, 1997, GENETICS, V146, P447; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Randall LP, 2004, J ANTIMICROB CHEMOTH, V54, P688, DOI 10.1093/jac/dkh360; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; Ricci V, 2009, J ANTIMICROB CHEMOTH, V64, P654, DOI 10.1093/jac/dkp234; Rodriguez JC, 2004, J ANTIMICROB CHEMOTH, V53, P441, DOI 10.1093/jac/dkh119; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sulavik MC, 1997, J BACTERIOL, V179, P1857, DOI 10.1128/jb.179.6.1857-1866.1997; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; van der Straaten T, 2004, INFECT IMMUN, V72, P996, DOI 10.1128/IAI.72.2.996-1003.2004; van der Straaten T, 2004, ANTIMICROB AGENTS CH, V48, P2292, DOI 10.1128/AAC.48.6.2292-2294.2004; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Yang S, 2003, J ANTIMICROB CHEMOTH, V51, P545, DOI 10.1093/jac/dkg126; Zheng J, 2009, J ANTIMICROB CHEMOTH, V63, P95, DOI 10.1093/jac/dkn448	50	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23471	10.1371/journal.pone.0023471	http://dx.doi.org/10.1371/journal.pone.0023471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858134	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500045
J	Ugolin, N; Ory, C; Lefevre, E; Benhabiles, N; Hofman, P; Schlumberger, M; Chevillard, S				Ugolin, Nicolas; Ory, Catherine; Lefevre, Emilie; Benhabiles, Nora; Hofman, Paul; Schlumberger, Martin; Chevillard, Sylvie			Strategy to Find Molecular Signatures in a Small Series of Rare Cancers: Validation for Radiation-Induced Breast and Thyroid Tumors	PLOS ONE			English	Article							GENE-EXPRESSION DATA; MICROARRAY DATA; CLASSIFICATION; TRANSCRIPTOMES; PREDICTION; NEOPLASMS; CARCINOMA; PROFILE	Methods of classification using transcriptome analysis for case-by-case tumor diagnosis could be limited by tumor heterogeneity and masked information in the gene expression profiles, especially as the number of tumors is small. We propose a new strategy, EMts_2PCA, based on: 1) The identification of a gene expression signature with a great potential for discriminating subgroups of tumors (EMts stage), which includes: a) a learning step, based on an expectation-maximization (EM) algorithm, to select sets of candidate genes whose expressions discriminate two subgroups, b) a training step to select from the sets of candidate genes those with the highest potential to classify training tumors, c) the compilation of genes selected during the training step, and standardization of their levels of expression to finalize the signature. 2) The predictive classification of independent prospective tumors, according to the two subgroups of interest, by the definition of a validation space based on a two-step principal component analysis (2PCA). The present method was evaluated by classifying three series of tumors and its robustness, in terms of tumor clustering and prediction, was further compared with that of three classification methods (Gene expression bar code, Top-scoring pair(s) and a PCA-based method). Results showed that EMts_2PCA was very efficient in tumor classification and prediction, with scores always better that those obtained by the most common methods of tumor clustering. Specifically, EMts_2PCA permitted identification of highly discriminating molecular signatures to differentiate post-Chernobyl thyroid or post-radiotherapy breast tumors from their sporadic counterparts that were previously unsuccessfully classified or classified with errors.	[Ugolin, Nicolas; Ory, Catherine; Lefevre, Emilie; Benhabiles, Nora; Chevillard, Sylvie] CEA, DSV, IRCM, SREIT,Lab Cancerol Expt, Fontenay Aux Roses, France; [Hofman, Paul] INSERM ERI 21, Nice, France; [Hofman, Paul] Louis Pasteur Hosp, Lab Clin & Expt Pathol, Nice, France; [Hofman, Paul] Louis Pasteur Hosp, CHU CRLCC UNSA Tumour Tissue Bank Nice Area, Nice, France; [Hofman, Paul] Univ Nice Sophia Antipolis, IFR 50, Nice, France; [Schlumberger, Martin] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Gustave Roussy	Ugolin, N (corresponding author), CEA, DSV, IRCM, SREIT,Lab Cancerol Expt, BP6, Fontenay Aux Roses, France.	catherine.ory@cea.fr	Hofman, Paul/P-7654-2018	Hofman, Paul/0000-0003-0431-9353; Chevillard, Sylvie/0000-0001-5889-4041	Electricite de France; European DoReMi framework; European Union	Electricite de France; European DoReMi framework; European Union(European Commission)	This work was supported by Electricite de France, the European DoReMi framework and the European Union 6th Framework GenRiskT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, GENOME INFORM SER, V18, P130; Amundson SA, 2005, ONCOGENE, V24, P4572, DOI 10.1038/sj.onc.1208653; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Chevillard S, 2004, CLIN CANCER RES, V10, P6586, DOI 10.1158/1078-0432.CCR-04-0053; Chiappetta P, 2004, J COMPUT BIOL, V11, P1090, DOI 10.1089/cmb.2004.11.1090; Cuperlovic-Culf M, 2005, DRUG DISCOV TODAY, V10, P429, DOI 10.1016/S1359-6446(05)03393-3; Daino K, 2009, INT J CANC; Detours V, 2007, BRIT J CANCER, V97, P818, DOI 10.1038/sj.bjc.6603938; Detours V, 2005, BRIT J CANCER, V92, P1545, DOI 10.1038/sj.bjc.6602521; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1993, MONOGRAPHS STAT APPL; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Fujarewicz K, 2007, ENDOCR-RELAT CANCER, V14, P809, DOI 10.1677/ERC-06-0048; Geman Donald, 2004, Stat Appl Genet Mol Biol, V3, pArticle19; Ghosh Debashis, 2002, Pac Symp Biocomput, P18; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Hastie T, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-2-RESEARCH0003; Hofman P, 2006, M S-MED SCI, V22, P21; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Kong W, 2008, BIOTECHNIQUES, V45, P501, DOI 10.2144/000112950; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Manly BF., 2006, RANDOMIZATION BOOTST; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Ory C, 2011, ENDOCR-RELAT CANCER, V18, P193, DOI 10.1677/ERC-10-0205; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ressom HW, 2008, FRONT BIOSCI-LANDMRK, V13, P691, DOI 10.2741/2712; Tothill RW, 2005, CANCER RES, V65, P4031, DOI 10.1158/0008-5472.CAN-04-3617; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Vegt B, 2009, CRIT REV ONCOL HEMAT, V70, P1, DOI 10.1016/j.critrevonc.2008.09.001; Yang XMJ, 2006, J UROLOGY, V175, P2302, DOI 10.1016/S0022-5347(06)00255-2; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	36	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23581	10.1371/journal.pone.0023581	http://dx.doi.org/10.1371/journal.pone.0023581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853153	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400053
J	Ahmed, F; Raghava, GPS				Ahmed, Firoz; Raghava, Gajendra P. S.			Designing of Highly Effective Complementary and Mismatch siRNAs for Silencing a Gene	PLOS ONE			English	Article							TARGET RNA; SEQUENCE; PREDICTION; EFFICIENT; DISCRIMINATION; ACCESSIBILITY; SPECIFICITY; TOLERANCE; SELECTION; STRAND	In past, numerous methods have been developed for predicting efficacy of short interfering RNA (siRNA). However these methods have been developed for predicting efficacy of fully complementary siRNA against a gene. Best of author's knowledge no method has been developed for predicting efficacy of mismatch siRNA against a gene. In this study, a systematic attempt has been made to identify highly effective complementary as well as mismatch siRNAs for silencing a gene. Support vector machine (SVM) based models have been developed for predicting efficacy of siRNAs using composition, binary and hybrid pattern siRNAs. We achieved maximum correlation 0.67 between predicted and actual efficacy of siRNAs using hybrid model. All models were trained and tested on a dataset of 2182 siRNAs and performance was evaluated using five-fold cross validation techniques. The performance of our method desiRm is comparable to other well-known methods. In this study, first time attempt has been made to design mutant siRNAs (mismatch siRNAs). In this approach we mutated a given siRNA on all possible sites/positions with all possible nucleotides. Efficacy of each mutated siRNA is predicted using our method desiRm. It is well known from literature that mismatches between siRNA and target affects the silencing efficacy. Thus we have incorporated the rules derived from base mismatches experimental data to find out over all efficacy of mutated or mismatch siRNAs. Finally we developed a webserver, desiRm (http://www.imtech.res.in/raghava/desirm/) for designing highly effective siRNA for silencing a gene. This tool will be helpful to design siRNA to degrade disease isoform of heterozygous single nucleotide polymorphism gene without depleting the wild type protein.	[Ahmed, Firoz; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ahmed, F (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Ahmed, Firoz/AAR-6971-2021; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009	Ahmed, Firoz/0000-0003-4702-5144; Raghava, Gajendra P.S./0000-0002-8902-2876; 	Open Source for Drug Discovery, Council of Scientific and Industrial Research, and Department of Biotechnology, Government of India	Open Source for Drug Discovery, Council of Scientific and Industrial Research, and Department of Biotechnology, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaDepartment of Biotechnology (DBT) India)	This study was supported by Open Source for Drug Discovery, Council of Scientific and Industrial Research, and Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Firoz, 2009, In Silico Biology, V9, P135, DOI 10.3233/ISB-2009-0395; Ahmed F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-105; Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Burchard J, 2009, RNA, V15, P308, DOI 10.1261/rna.1326809; Chalk AM, 2008, BIOINFORMATICS, V24, P1316, DOI 10.1093/bioinformatics/btn121; Chu CY, 2008, RNA, V14, P1714, DOI 10.1261/rna.1161908; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Far RKK, 2003, NUCLEIC ACIDS RES, V31, P4417, DOI 10.1093/nar/gkg649; Geng CM, 2008, ACTA PHARMACOL SIN, V29, P211, DOI 10.1111/j.1745-7254.2008.00740.x; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jia PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-271; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Qiu SB, 2009, IEEE ACM T COMPUT BI, V6, P190, DOI 10.1109/TCBB.2008.139; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Zhou H, 2006, INFORM-J COMPUT INFO, V30, P357	41	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23443	10.1371/journal.pone.0023443	http://dx.doi.org/10.1371/journal.pone.0023443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853133	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200086
J	Cheng, J; Phong, B; Wilson, DC; Hirsch, R; Kane, LP				Cheng, Jing; Phong, Binh; Wilson, David C.; Hirsch, Raphael; Kane, Lawrence P.			Akt Fine-tunes NF-kappa B-dependent Gene Expression during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLISTATIN-LIKE PROTEIN-1; TNF-ALPHA PRODUCTION; IN-VIVO; POSTTRANSCRIPTIONAL REGULATION; TEMPORAL CONTROL; UP-REGULATION; KINASE B/AKT; IFN-GAMMA; BONE LOSS; TRANSCRIPTION	Activation of the NF-kappa B signaling pathway is critical for leukocyte activation and development. Although previous studies suggested a role for the Akt kinase in coupling the T cell antigen receptor and CD28 to NF-kappa B activation in T cells, the nature of the role of Akt in this pathway is still unclear. Using a targeted gene profiling approach, we found that a subset of NF-kappa B-dependent genes required Akt for optimal up-regulation during T cell activation. The selective effects of Akt were manifest at the level of mRNA transcription and p65/RelA binding to upstream promoters and appear to be due to altered formation of the Carma1-Bcl10 complex. The proinflammatory cytokine TNF-alpha was found to be particularly sensitive to Akt inhibition or knockdown, including in primary human blood T cells and a murine model of rheumatoid arthritis. Our findings are consistent with a hierarchy in the expression of NF-kappa B-dependent genes, controlled by the strength and/or duration of NF-kappa B signaling. More broadly, our results suggest that defining the more graded effects of signaling, such as those demonstrated here for Akt and the NF-kappa B pathway, is important to understanding how cells can fine-tune signaling responses for optimal sensitivity and specificity.	[Cheng, Jing; Phong, Binh; Kane, Lawrence P.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA; [Wilson, David C.; Hirsch, Raphael] Childrens Hosp Pittsburgh, Div Rheumatol, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kane, LP (corresponding author), Univ Pittsburgh, Dept Immunol, Sch Med, BST E-1056, Pittsburgh, PA 15261 USA.	lkane@pitt.edu	Cheng, Jing/AGR-7527-2022	Hirsch, Raphael/0000-0002-7273-8536; Kane, Lawrence/0000-0001-5198-516X	NIGMS National Institutes of Health [GM030398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080398] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS National Institutes of Health Grant GM030398 (to L. P. K.).	Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brehm MA, 2007, BLOOD, V109, P819, DOI 10.1182/blood-2006-03-008219; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Clutter SD, 2009, J IMMUNOL, V182, P234, DOI 10.4049/jimmunol.182.1.234; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilot D, 2010, CHEM-BIOL INTERACT, V188, P546, DOI 10.1016/j.cbi.2010.08.011; Gold MR, 2003, TRENDS IMMUNOL, V24, P104, DOI 10.1016/S1471-4906(03)00022-X; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jones RG, 2005, J IMMUNOL, V175, P3790, DOI 10.4049/jimmunol.175.6.3790; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Killestein J, 2001, NEUROLOGY, V57, P1129, DOI 10.1212/WNL.57.6.1129; Latham KA, 2005, J IMMUNOL, V174, P3978, DOI 10.4049/jimmunol.174.7.3978; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Narayan P, 2006, MOL CELL BIOL, V26, P2327, DOI 10.1128/MCB.26.6.2327-2336.2006; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shen Z, 2002, BIOTECHNIQUES, V32, P1168, DOI 10.2144/02325dd07; Shi N, 2009, MULT SCLER J, V15, P120, DOI 10.1177/1352458508096871; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; TREDE NS, 1995, J IMMUNOL, V155, P902; Uddin S, 2004, BIOCHEM BIOPH RES CO, V320, P932, DOI 10.1016/j.bbrc.2004.06.038; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	43	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36076	36085		10.1074/jbc.M111.259549	http://dx.doi.org/10.1074/jbc.M111.259549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862580	Green Published, hybrid			2022-12-25	WOS:000295927100080
J	Maiti, A; Drohat, AC				Maiti, Atanu; Drohat, Alexander C.			Thymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine POTENTIAL IMPLICATIONS FOR ACTIVE DEMETHYLATION OF CpG SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; REPAIR; DEAMINATION; PRODUCT; 5-FORMYL-2'-DEOXYCYTIDINE; 5-HYDROXYMETHYLCYTOSINE; HYDROXYLATION; CONVERSION	Thymine DNA glycosylase (TDG) excises T from G.T mispairs and is thought to initiate base excision repair (BER) of deaminated 5-methylcytosine (mC). Recent studies show that TDG, including its glycosylase activity, is essential for active DNA demethylation and embryonic development. These and other findings suggest that active demethylation could involve mC deamination by a deaminase, giving a G.T mispair followed by TDG-initiated BER. An alternative proposal is that demethylation could involve iterative oxidation of mC to 5-hydroxymethylcytosine (hmC) and then to 5-formylcytosine (fC) and 5-carboxylcytosine (caC), mediated by a Tet (ten eleven translocation) enzyme, with conversion of caC to C by a putative decarboxylase. Our previous studies suggest that TDG could excise fC and caC from DNA, which could provide another potential demethylation mechanism. We show here that TDG rapidly removes fC, with higher activity than for G.T mispairs, and has substantial caC excision activity, yet it cannot remove hmC. TDG excision of fC and caC, oxidation products of mC, is consistent with its strong specificity for excising bases from a CpG context. Our findings reveal a remarkable new aspect of specificity for TDG, inform its catalytic mechanism, and suggest that TDG could protect against fC-induced mutagenesis. The results also suggest a new potential mechanism for active DNA demethylation, involving TDG excision of Tet-produced fC (or caC) and subsequent BER. Such a mechanism obviates the need for a decarboxylase and is consistent with findings that TDG glycosylase activity is essential for active demethylation and embryonic development, as are mechanisms involving TDG excision of deaminated mC or hmC.	[Maiti, Atanu; Drohat, Alexander C.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Drohat, AC (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	adrohat@som.umaryland.edu	Maiti, Atanu/E-9968-2012	Maiti, Atanu/0000-0002-9080-1025; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [R01-GM72711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM72711 (to A.C.D.).	Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Darwanto A, 2009, J BIOL CHEM, V284, P15835, DOI 10.1074/jbc.M807846200; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Karino N, 2001, NUCLEIC ACIDS RES, V29, P2456, DOI 10.1093/nar/29.12.2456; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; La Francois CJ, 2000, CHEM RES TOXICOL, V13, P462, DOI 10.1021/tx990209u; Leatherbarrow R, 1998, GRAFIT 5 0; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; Masaoka A, 2003, BIOCHEMISTRY-US, V42, P5003, DOI 10.1021/bi0273213; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Murata-Kamiya N, 1999, NUCLEIC ACIDS RES, V27, P4385, DOI 10.1093/nar/27.22.4385; Neidigh JW, 2009, CHEM RES TOXICOL, V22, P885, DOI 10.1021/tx8004482; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; SIBGHATULLAH GP, 1996, BIOCHEMISTRY-US, V35, P12926; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Sumino M, 2008, BIOORG MED CHEM LETT, V18, P274, DOI 10.1016/j.bmcl.2007.10.081; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Wu PY, 2003, J BIOL CHEM, V278, P5285, DOI 10.1074/jbc.M210884200; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	47	603	634	4	84	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35334	35338		10.1074/jbc.C111.284620	http://dx.doi.org/10.1074/jbc.C111.284620			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862836	hybrid, Green Published			2022-12-25	WOS:000295927100004
J	Soshilov, A; Denison, MS				Soshilov, Anatoly; Denison, Michael S.			Ligand Displaces Heat Shock Protein 90 from Overlapping Binding Sites within the Aryl Hydrocarbon Receptor Ligand-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-LOOP-HELIX; AH RECEPTOR; DIOXIN RECEPTOR; ALPHA-NAPHTHOFLAVONE; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; BREAST-CANCER; HSP90; KINASE; IDENTIFICATION	Hsp90 (heat shock protein of 90 kDa) is often found associated with functional domains of client proteins, including those for ligand binding, dimerization, DNA binding, and enzymatic activity. Although Hsp90 can maintain the conformation of functionally important domains prior to activation of the client protein, its specific binding site and the mechanism(s) of Hsp90 dissociation during activation are unknown. Here, we have identified and characterized residues involved in Hsp90 binding within the aryl hydrocarbon receptor (AhR) ligand-binding domain and demonstrate that they overlap with those involved in ligand binding. In agreement with this spatial model, ligand binding results in Hsp90 dissociation from the AhR Per-ARNT-Sim B fragment. Interestingly, whereas Hsp90-binding residues within the ligand-binding domain were not involved in Hsp90-dependent AhR protein stability, several of these residues are important for ligand-dependent AhR activation, and their mutation resulted in conversion of two AhR antagonists/partial agonists into full AhR agonists. These studies reveal co-localization of a tentative Hsp90-binding site with that for AhR ligand binding and provide the first molecular mechanism for Hsp90 dissociation in the activation of a client protein.	[Soshilov, Anatoly; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis	Denison, MS (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	msdenison@ucdavis.edu			National Institutes of Health, NIEHS [R01 ES007685, R01 ES012498]; California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, R01ES012498] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES007685 and R01 ES012498 from NIEHS. This work was also supported by the California Agricultural Experiment Station.	ANTONSSON C, 1995, MOL CELL BIOL, V15, P756; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; BROWN DJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P217, DOI 10.1006/abbi.1995.1285; CARVER LA, 1994, J BIOL CHEM, V269, P30109; Chen HS, 1997, ARCH BIOCHEM BIOPHYS, V348, P190, DOI 10.1006/abbi.1997.0398; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Clark RD, 2008, CURR TOP MED CHEM, V8, P813, DOI 10.2174/156802608784535011; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kaul S, 2002, J BIOL CHEM, V277, P36223, DOI 10.1074/jbc.M206748200; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Lees MJ, 1999, MOL CELL BIOL, V19, P5811; LU YF, 1995, ARCH BIOCHEM BIOPHYS, V316, P470, DOI 10.1006/abbi.1995.1062; MERCHANT M, 1990, ARCH BIOCHEM BIOPHYS, V281, P84, DOI 10.1016/0003-9861(90)90416-V; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Phelan DM, 1998, ARCH BIOCHEM BIOPHYS, V353, P47, DOI 10.1006/abbi.1997.0614; POLAND A, 1994, MOL PHARMACOL, V46, P915; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; PROBST MR, 1993, MOL PHARMACOL, V44, P511; Rushing SR, 2002, ARCH BIOCHEM BIOPHYS, V403, P189, DOI 10.1016/S0003-9861(02)00233-3; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scroggins BT, 2003, BIOCHEMISTRY-US, V42, P12550, DOI 10.1021/bi035001t; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Soshilov A, 2008, J BIOL CHEM, V283, P32995, DOI 10.1074/jbc.M802414200; WHITELAW ML, 1995, P NATL ACAD SCI USA, V92, P4437, DOI 10.1073/pnas.92.10.4437; WILHELMSSON A, 1994, J BIOL CHEM, V269, P19028; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Zhou JG, 2003, ARCH BIOCHEM BIOPHYS, V416, P68, DOI 10.1016/S0003-9861(03)00274-1	41	34	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35275	35282		10.1074/jbc.M111.246439	http://dx.doi.org/10.1074/jbc.M111.246439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21856752	Green Published, hybrid			2022-12-25	WOS:000295406300080
J	Benedetti, G; Morais, KLP; Guerreiro, JR; de Oliveira, EF; Hoshida, MS; Oliveira, L; Sass, N; Lebrun, I; Ulrich, H; Lameu, C; de Camargo, ACM				Benedetti, Gabriel; Morais, Katia L. P.; Guerreiro, Juliano R.; de Oliveira, Eduardo Fontana; Hoshida, Mara Sandra; Oliveira, Leandro; Sass, Nelson; Lebrun, Ivo; Ulrich, Henning; Lameu, Claudiana; Martins de Camargo, Antonio Carlos			Bothrops jararaca Peptide with Anti-Hypertensive Action Normalizes Endothelium Dysfunction Involved in Physiopathology of Preeclampsia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; L-ARGININE; CALMODULIN; PREGNANCIES; INHIBITION; SYNTHETASE; MECHANISMS; THERAPY; TISSUES	Preeclampsia, a pregnancy-specific syndrome characterized by hypertension, proteinuria and edema, is a major cause of fetal and maternal morbidity and mortality especially in developing countries. Bj-PRO-10c, a proline-rich peptide isolated from Bothrops jararaca venom, has been attributed with potent anti-hypertensive effects. Recently, we have shown that Bj-PRO-10c-induced anti-hypertensive actions involved NO production in spontaneous hypertensive rats. Using in vitro studies we now show that Bj-PRO-10c was able to increase NO production in human umbilical vein endothelial cells from hypertensive pregnant women (HUVEC-PE) to levels observed in HUVEC of normotensive women. Moreover, in the presence of the peptide, eNOS expression as well as argininosuccinate synthase activity, the key rate-limiting enzyme of the citrulline-NO cycle, were enhanced. In addition, excessive superoxide production due to NO deficiency, one of the major deleterious effects of the disease, was inhibited by Bj-PRO-10c. Bj-PRO-10c induced intracellular calcium fluxes in both, HUVEC-PE and HUVEC, which, however, led to activation of eNOS expression only in HUVEC-PE. Since Bj-PRO-10c promoted biological effects in HUVEC from patients suffering from the disorder and not in normotensive pregnant women, we hypothesize that Bj-PRO-10c induces its anti-hypertensive effect in mothers with preeclampsia. Such properties may initiate the development of novel therapeutics for treating preeclampsia.	[Benedetti, Gabriel; Morais, Katia L. P.; de Oliveira, Eduardo Fontana; Martins de Camargo, Antonio Carlos] Inst Butantan, Ctr Pesquisa Inovacio & Difusao, Ctr Appl Toxinol, Sao Paulo, Brazil; [Benedetti, Gabriel; Morais, Katia L. P.; de Oliveira, Eduardo Fontana] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Guerreiro, Juliano R.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Ciencias Biol, Ctr Biotecnol Agr,Lab Bioquim Prot, Sao Paulo, Brazil; [Hoshida, Mara Sandra] Univ Sao Paulo, Fac Med, Lab Fisiol Obstet, Sao Paulo, Brazil; [Oliveira, Leandro; Sass, Nelson] Hosp Maternidade Vila Nova Cachoeirinha, Sao Paulo, Brazil; [Lebrun, Ivo] Inst Butantan, Lab Bioquim & Biofis, Sao Paulo, Brazil; [Ulrich, Henning; Lameu, Claudiana] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Martins de Camargo, Antonio Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Benedetti, G (corresponding author), Inst Butantan, Ctr Pesquisa Inovacio & Difusao, Ctr Appl Toxinol, Sao Paulo, Brazil.	claulameu@usp.br	Ulrich, Henning/C-5245-2013; Lameu, Claudiana/B-9089-2012; De Oliveira, Leandro/G-3476-2012; Hoshida, Mara S/D-3900-2012; Ulrich, Henning/AAX-8586-2021; Sass, Nelson/AAD-8259-2020; Sass, Nelson/E-3252-2013	Ulrich, Henning/0000-0002-2114-3815; Lameu, Claudiana/0000-0002-6874-5864; De Oliveira, Leandro/0000-0002-8422-9907; Hoshida, Mara S/0000-0003-2232-4631; Ulrich, Henning/0000-0002-2114-3815; Morais, Katia/0000-0001-8877-5887	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Pesquisa, Brazil through the Center for Applied Toxinology-Centros de Pesquisa, Inovacio e Difusao	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa, Brazil through the Center for Applied Toxinology-Centros de Pesquisa, Inovacio e Difusao	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Pesquisa, Brazil through the Center for Applied Toxinology-Centros de Pesquisa, Inovacio e Difusao supported this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Atherton E., 1990, SOLID PHASE PEPTIDE; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Cawley SM, 2007, CELL SIGNAL, V19, P1023, DOI 10.1016/j.cellsig.2006.11.012; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; Duley L, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001449.pub2, 10.1002/14651858.CD001449.pub3]; Escudero C, 2008, PLACENTA, V29, P469, DOI 10.1016/j.placenta.2008.02.008; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Gu Y, 2006, HYPERTENS PREGNANCY, V25, P169, DOI 10.1080/10641950600912950; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Ianzer D, 2007, J PHARMACOL EXP THER, V322, P795, DOI 10.1124/jpet.107.120873; Khalil A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002766; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; LAMEU C, 2010, HYP RES IN PRESS; Lameu C, 2010, CYTOM PART A, V77A, P220, DOI 10.1002/cyto.a.20860; Lindheimer MD, 2010, J AM SOC HYPERTENS, V4, P68, DOI 10.1016/j.jash.2010.03.002; Lopez-Jaramillo Patricio, 2008, Ther Adv Cardiovasc Dis, V2, P261, DOI 10.1177/1753944708092277; LOWE D, 2000, BIOL CHEM, V4, P441; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NEGRAES PD, 2010, CYTOMETRY A IN PRESS; Noris M, 2004, HYPERTENSION, V43, P614, DOI 10.1161/01.HYP.0000116220.39793.c9; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; RUGGENENTI MDP, 2005, L ARGININE PREECLAMP; Rytlewski K, 2005, EUR J CLIN INVEST, V35, P32, DOI 10.1111/j.1365-2362.2005.01445.x; Sachdeva P, 2009, INDIAN J PHARM SCI, V71, P1, DOI 10.4103/0250-474X.51941; Sankaralingam S, 2010, CARDIOVASC RES, V85, P194, DOI 10.1093/cvr/cvp277; Santana LF, 2009, J MOL CELL CARDIOL, V47, P436, DOI 10.1016/j.yjmcc.2009.07.008; SCHMIDT HHHW, 1991, P NATL ACAD SCI USA, V88, P365, DOI 10.1073/pnas.88.2.365; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Thadhani R, 2010, HYPERTENSION, V55, P238, DOI 10.1161/HYPERTENSIONAHA.109.143933; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Zhang G, 2006, AM J PHYSIOL-HEART C, V290, pH1172, DOI 10.1152/ajpheart.00441.2005	39	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23680	10.1371/journal.pone.0023680	http://dx.doi.org/10.1371/journal.pone.0023680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858206	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300082
J	Botti, V; Bianchi, A; Foung, SKH; Merola, M				Botti, Valentina; Bianchi, Alessia; Foung, Steven K. H.; Merola, Marcello			The Hepatitis C Virus E1 Glycoprotein Undergoes Productive Folding but Accelerated Degradation When Expressed as an Individual Subunit in CHO Cells	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; DISULFIDE BOND FORMATION; NEUTRALIZING ANTIBODIES; MISFOLDED GLYCOPROTEINS; PROTEIN; BINDING; DIMERIZATION; RECOGNITION; VACCINATION; SIGNAL	Hepatitis C Virus E1E2 heterodimers are components of the viral spike. Although there is a general agreement on the necessity of the co-expression of both E1 and E2 on a single coding unit for their productive folding and assembly, in a previous study using an in vitro system we obtained strong indications that E1 can achieve folding in absence of E2. Here, we have studied the folding pathway of unescorted E1 from stably expressing CHO cells, compared to the folding observed in presence of the E2 protein. A DTT-resistant conformation is achieved by E1 in both situations, consistent with the presence of an E2-independent oxidative pathway. However, while the E1E2 heterodimer is stable inside cells, E1 expressed alone is degraded within a few hours. On the other hand, the oxidation and stability of individually expressed E2 subunits is dependent on E1 co-expression. These data are consistent with E1 and E2 assisting each other for correct folding via different mechanisms: E2 assists E1 by stabilizing a semi-native conformation meanwhile E1 drives E2 towards a productive folding pathway.	[Botti, Valentina; Bianchi, Alessia; Merola, Marcello] Novartis Vaccines & Diagnost, Siena, Italy; [Foung, Steven K. H.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Merola, Marcello] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy	Novartis; Stanford University; University of Naples Federico II	Botti, V (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	marcello.merola@novartis.com		Foung, Steven/0000-0001-7149-6160	PHS [AI081903]; EU [LSH-CT-2007-037435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081903] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); EU(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by PHS grant AI081903 to SKHF and by the EU FP6 contract LSH-CT-2007-037435 HEPACIVAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI LS, 2009, J VIROL; Andersson H, 1997, J VIROL, V71, P9654, DOI 10.1128/JVI.71.12.9654-9663.1997; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Brazzoli M, 2005, VIROLOGY, V332, P438, DOI 10.1016/j.virol.2004.11.034; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2003, J VIROL, V77, P1604, DOI 10.1128/JVI.77.2.1604-1609.2003; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Lin YL, 2008, J VIROL, V82, P7492, DOI 10.1128/JVI.02743-07; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; Merola M, 2001, J VIROL, V75, P11205, DOI 10.1128/JVI.75.22.11205-11217.2001; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SPAETE RR, 1992, VIROLOGY, V188, P819, DOI 10.1016/0042-6822(92)90537-Y; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Zeisel MB, 2007, WORLD J GASTROENTERO, V13, P4824, DOI 10.3748/wjg.v13.i36.4824	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23838	10.1371/journal.pone.0023838	http://dx.doi.org/10.1371/journal.pone.0023838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858229	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300100
J	Finley, LWS; Haas, W; Desquiret-Dumas, V; Wallace, DC; Procaccio, V; Gygi, SP; Haigis, MC				Finley, Lydia W. S.; Haas, Wilhelm; Desquiret-Dumas, Valerie; Wallace, Douglas C.; Procaccio, Vincent; Gygi, Steven P.; Haigis, Marcia C.			Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LYSINE ACETYLATION; COMPLEX-II; CALORIE RESTRICTION; RESPIRATORY-CHAIN; SIRT3-MEDIATED DEACETYLATION; MITOCHONDRIA; METABOLISM; PROTEOMICS; STRESS	Background: Sirtuins (SIRT1-7) are a family of NAD-dependent deacetylases and/or ADP-ribosyltransferases that are involved in metabolism, stress responses and longevity. SIRT3 is localized to mitochondria, where it deacetylates and activates a number of enzymes involved in fuel oxidation and energy production. Methodology/Principal Findings: In this study, we performed a proteomic screen to identify SIRT3 interacting proteins and identified several subunits of complex II and V of the electron transport chain. Two subunits of complex II (also known as succinate dehydrogenase, or SDH), SDHA and SDHB, interacted specifically with SIRT3. Using mass spectrometry, we identified 13 acetylation sites on SDHA, including six novel acetylated residues. SDHA is hyperacetylated in SIRT3 KO mice and SIRT3 directly deacetylates SDHA in a NAD-dependent manner. Finally, we found that SIRT3 regulates SDH activity both in cells and in murine brown adipose tissue. Conclusions/Significance: Our study identifies SDHA as a binding partner and substrate for SIRT3 deacetylase activity. SIRT3 loss results in decreased SDH enzyme activity, suggesting that SIRT3 may be an important physiological regulator of SDH activity.	[Finley, Lydia W. S.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; [Finley, Lydia W. S.; Haas, Wilhelm; Gygi, Steven P.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Desquiret-Dumas, Valerie; Procaccio, Vincent] Angers Univ Hosp, Sch Med, Dept Biochem & Genet, Angers, France; [Desquiret-Dumas, Valerie; Procaccio, Vincent] U771 CNRS6214, UMR INSERM, Angers, France; [Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Finley, LWS (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu	Desquiret-Dumas, Valérie/K-2695-2015	procaccio, Vincent/0000-0002-1537-4684; Desquiret-Dumas, Valerie/0000-0001-9551-9400	National Science Foundation; National Institutes of Health [AG032375]; Muscular Dystrophy Association; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	LWSF is supported by a National Science Foundation graduate research fellowship. MH is supported in part by National Institutes of Health grant AG032375 and funding from the Muscular Dystrophy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackrell BAC, 2000, FEBS LETT, V466, P1, DOI 10.1016/S0014-5793(99)01749-4; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	249	259	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23295	10.1371/journal.pone.0023295	http://dx.doi.org/10.1371/journal.pone.0023295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858060	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300029
J	Li, J; Hand, LE; Meng, QJ; Loudon, ASI; Bechtold, DA				Li, Jian; Hand, Laura E.; Meng, Qing-Jun; Loudon, Andrew S. I.; Bechtold, David A.			GPR50 Interacts with TIP60 to Modulate Glucocorticoid Receptor Signalling	PLOS ONE			English	Article							MELATONIN-RELATED RECEPTOR; PROTEIN TIP60; IDENTIFICATION; ACTIVATION; BINDING	GPR50 is an orphan G-protein coupled receptor most closely related to the melatonin receptors. The physiological function of GPR50 remains unclear, although our previous studies implicate the receptor in energy homeostasis. Here, we reveal a role for GPR50 as a signalling partner and modulator of the transcriptional co-activator TIP60. This interaction was identified in a yeast-two-hybrid screen, and confirmed by co-immunoprecipitation and co-localisation of TIP60 and GPR50 in HEK293 cells. Co-expression with TIP60 increased perinuclear localisation of full length GPR50, and resulted in nuclear translocation of the cytoplasmic tail of the receptor, suggesting a functional interaction of the two proteins. We further demonstrate that GPR50 can enhance TIP60-coactiavtion of glucocorticoid receptor (GR) signalling. In line with in vitro results, repression of pituitary Pomc expression, and induction of gluconeogenic genes in liver in response to the GR agonist, dexamethasone was attenuated in Gpr50(-/-) mice. These results identify a novel role for GPR50 in glucocorticoid receptor signalling through interaction with TIP60.	[Li, Jian; Hand, Laura E.; Meng, Qing-Jun; Loudon, Andrew S. I.; Bechtold, David A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Li, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	andrew.loudon@manchester.ac.uk; david.bechtold@manchester.ac.uk		Meng, Qing Jun/0000-0002-9426-8336; Loudon, Andrew/0000-0003-3648-445X; Bechtold, David/0000-0001-8676-8704	Biotechnology and Biological Sciences Research Council (BBSRC) [BBE0104901]; MRC [G0900414] Funding Source: UKRI; Medical Research Council [G0900414] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC #BBE0104901, www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Bhattacharyya S, 2006, J LIPID RES, V47, P761, DOI 10.1194/jlr.M500338-JLR200; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Conway S, 2000, J BIOL CHEM, V275, P20602, DOI 10.1074/jbc.M002358200; Dufourny L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-105; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Giles A, 2011, J CELL SCI, V124, P540, DOI 10.1242/jcs.078642; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Ivanova EA, 2008, AM J PHYSIOL-ENDOC M, V294, pE176, DOI 10.1152/ajpendo.00199.2007; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kim MS, 2006, J BIOL CHEM, V281, P15082, DOI 10.1074/jbc.M513593200; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; MacIntyre DJ, 2010, NEUROSCI LETT, V475, P169, DOI 10.1016/j.neulet.2010.03.072; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Ran QT, 2000, GENE, V258, P141, DOI 10.1016/S0378-1119(00)00410-8; Reppert SM, 1996, FEBS LETT, V386, P219, DOI 10.1016/0014-5793(96)00437-1; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sliva D, 1999, BIOCHEM BIOPH RES CO, V263, P149, DOI 10.1006/bbrc.1999.1083; Thomson PA, 2005, MOL PSYCHIATR, V10, P470, DOI 10.1038/sj.mp.4001593; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595	32	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23725	10.1371/journal.pone.0023725	http://dx.doi.org/10.1371/journal.pone.0023725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858214	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300087
J	Mueller, C; Edmiston, KH; Carpenter, C; Gaffney, E; Ryan, C; Ward, R; White, S; Memeo, L; Colarossi, C; Petricoin, EF; Liotta, LA; Espina, V				Mueller, Claudius; Edmiston, Kirsten H.; Carpenter, Calvin; Gaffney, Eoin; Ryan, Ciara; Ward, Ronan; White, Susan; Memeo, Lorenzo; Colarossi, Cristina; Petricoin, Emanuel F., III; Liotta, Lance A.; Espina, Virginia			One-Step Preservation of Phosphoproteins and Tissue Morphology at Room Temperature for Diagnostic and Research Specimens	PLOS ONE			English	Article							PHASE PROTEIN MICROARRAYS; IMMUNOHISTOCHEMICAL DETECTION; WOUND AGE; DECALCIFICATION; RECOMMENDATIONS; EXPRESSION; RECEPTORS; PATHWAYS; FIXATION; VITALITY	Background: There is an urgent need to measure phosphorylated cell signaling proteins in cancer tissue for the individualization of molecular targeted kinase inhibitor therapy. However, phosphoproteins fluctuate rapidly following tissue procurement. Snap-freezing preserves phosphoproteins, but is unavailable in most clinics and compromises diagnostic morphology. Formalin fixation preserves tissue histomorphology, but penetrates tissue slowly, and is unsuitable for stabilizing phosphoproteins. We originated and evaluated a novel one-step biomarker and histology preservative (BHP) chemistry that stabilizes signaling protein phosphorylation and retains formalin-like tissue histomorphology with equivalent immunohistochemistry in a single paraffin block. Results: Total protein yield extracted from BHP-fixed, routine paraffin-embedded mouse liver was 100% compared to snap-frozen tissue. The abundance of 14 phosphorylated proteins was found to be stable over extended fixation times in BHP fixed paraffin embedded human colon mucosa. Compared to matched snap-frozen tissue, 8 phosphoproteins were equally preserved in mouse liver, while AMPK beta 1 Ser108 was slightly elevated after BHP fixation. More than 25 tissues from mouse, cat and human specimens were evaluated for preservation of histomorphology. Selected tissues were evaluated in a multi-site, independent pathology review. Tissue fixed with BHP showed equivalent preservation of cytoplasmic and membrane cytomorphology, with significantly better nuclear chromatin preservation by BHP compared to formalin. Immunohistochemical staining of 13 non-phosphorylated proteins, including estrogen receptor alpha, progesterone receptor, Ki-67 and Her2, was equal to or stronger in BHP compared to formalin. BHP demonstrated significantly improved immunohistochemical detection of phosphorylated proteins ERK Thr202/Tyr204, GSK3-alpha/beta Ser21/Ser9, p38-MAPK Thr180/Tyr182, eIF4G Ser1108 and Acetyl-CoA Carboxylase Ser79. Conclusion: In a single paraffin block BHP preserved the phosphorylation state of several signaling proteins at a level comparable to snap-freezing, while maintaining the full diagnostic immunohistochemical and histomorphologic detail of formalin fixation. This new tissue fixative has the potential to greatly facilitate personalized medicine, biobanking, and phospho-proteomic research.	[Mueller, Claudius; Petricoin, Emanuel F., III; Liotta, Lance A.; Espina, Virginia] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA; [Edmiston, Kirsten H.] Inova Fairfax Hosp, Inova Hlth Syst, Canc Translat Res Ctr, Falls Church, VA USA; [Carpenter, Calvin] George Mason Univ, Ctr Biodefense & Infect Dis, Manassas, VA USA; [Gaffney, Eoin; Ryan, Ciara; Ward, Ronan; White, Susan] St James Hosp, Dublin, Ireland; [Memeo, Lorenzo; Colarossi, Cristina] Mediterranean Inst Oncol, Pathol Unit, Catania, Italy	George Mason University; Inova Fairfax Hospital; Inova Health System; George Mason University; Trinity College Dublin; Mediterranean Institute of Oncology	Mueller, C (corresponding author), George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA.	cmuelle1@gmu.edu	Mueller, Claudius/A-4459-2012	Mueller, Claudius/0000-0003-4499-4724; Memeo, Lorenzo/0000-0003-4251-7203; Espina, Virginia/0000-0001-5080-5972; Colarossi, Cristina/0000-0001-5395-8608	George Mason University; Inova Fairfax Hospital; Istituto Superiore di Sanita, Italy; National Institutes of Health, National Cancer Institute [R21CA125698-01A1]; NATIONAL CANCER INSTITUTE [R33CA157403, R21CA125698] Funding Source: NIH RePORTER	George Mason University; Inova Fairfax Hospital; Istituto Superiore di Sanita, Italy; National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by George Mason University, Inova Fairfax Hospital, the Istituto Superiore di Sanita, Italy, and a National Institutes of Health grant to LAL (R21CA125698-01A1) from the National Cancer Institute program "Innovations in cancer sample preparation". The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funding agencies.	Adegboyega PA, 2003, APPL IMMUNOHISTO M M, V11, P194, DOI 10.1097/00129039-200306000-00019; Alers JC, 1999, J HISTOCHEM CYTOCHEM, V47, P703, DOI 10.1177/002215549904700512; Arber DA, 2002, APPL IMMUNOHISTO M M, V10, P183, DOI 10.1097/00022744-200206000-00015; ATHANASOU NA, 1987, J CLIN PATHOL, V40, P874, DOI 10.1136/jcp.40.8.874; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Bell WC, 2008, BIOTECH HISTOCHEM, V83, P71, DOI 10.1080/10520290802127610; Bignold LP, 2002, BRIT J BIOMED SCI, V59, P105; BIRNER P, 2010, J NEUROONCOL; Boenisch T, 2005, APPL IMMUNOHISTO M M, V13, P283, DOI 10.1097/01.0000146524.74402.a4; Broxterman HJ, 2004, DRUG RESIST UPDATE, V7, P79, DOI 10.1016/j.drup.2004.02.004; Burns JA, 2009, J HISTOCHEM CYTOCHEM, V57, P257, DOI 10.1369/jhc.2008.952911; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; *CLSI, 1999, QUAL ASS IMM APPR GU; Davenport A, 2003, J CLIN PATHOL, V56, P200, DOI 10.1136/jcp.56.3.200; Delfour C, 2006, J MOL DIAGN, V8, P157, DOI 10.2353/jmoldx.2006.050105; ESPINA VA, 2008, MOL CELL PROTEOMICS; Espina V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010240; Espina V, 2009, PROTEOM CLIN APPL, V3, P874, DOI 10.1002/prca.200800001; Feng W, 2008, ANN CLIN LAB SCI, V38, P195; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Goldstein NS, 2007, APPL IMMUNOHISTO M M, V15, P124, DOI 10.1097/PAI.0b013e31804c7283; Grellner W, 2005, FORENSIC SCI INT, V153, P174, DOI 10.1016/j.forsciint.2004.08.021; Grellner W, 2002, FORENSIC SCI INT, V130, P90, DOI 10.1016/S0379-0738(02)00342-0; Grellner W, 2007, FORENSIC SCI INT, V165, P150, DOI 10.1016/j.forsciint.2006.05.029; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; KIERNAN, 2000, MICROSCOPY TODAY, V8, P8; Lee P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002007; LIM MD, 2010, ANAL CHEM; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; MARWITZ S, 2011, J HISTOCHEM CYTOCHEM; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Mueller C, 2010, MOL ONCOL, V4, P461, DOI 10.1016/j.molonc.2010.09.003; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Ostasiewicz P, 2010, J PROTEOME RES, V9, P3688, DOI 10.1021/pr100234w; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Robinson AA, 2009, PROTEOMICS, V9, P4433, DOI 10.1002/pmic.200900287; Rountree CB, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-61; Sarsfield P, 2000, J CLIN PATHOL-MOL PA, V53, P336; START RD, 1992, J CLIN PATHOL, V45, P1120, DOI 10.1136/jcp.45.12.1120; van Essen HF, 2010, J CLIN PATHOL, V63, P1090, DOI 10.1136/jcp.2010.079905; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2	47	60	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23780	10.1371/journal.pone.0023780	http://dx.doi.org/10.1371/journal.pone.0023780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858221	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300094
J	Kondrak, M; Marincs, F; Kalapos, B; Juhasz, Z; Banfalvi, Z				Kondrak, Mihaly; Marincs, Ferenc; Kalapos, Balazs; Juhasz, Zsofia; Banfalvi, Zsofia			Transcriptome Analysis of Potato Leaves Expressing the Trehalose-6-Phosphate Synthase 1 Gene of Yeast	PLOS ONE			English	Article							MADS-BOX GENE; MEDIATED REGULATION; METABOLIC PATHWAYS; TREHALOSE; PLANTS; GROWTH; PHOSPHORYLATION; BIOSYNTHESIS; EVOLUTION; RESPONSES	Transgenic lines of the potato cultivar White Lady expressing the trehalose-6-phosphate synthase (TPS1) gene of yeast exhibit improved drought tolerance, but grow slower and have a lower carbon fixation rate and stomatal density than the wild-type. To understand the molecular basis of this phenomenon, we have compared the transcriptomes of wild-type and TPS1-transgenic plants using the POCI microarray containing 42,034 potato unigene probes. We show that 74 and 25 genes were up-, and down-regulated, respectively, in the mature source leaves of TPS1-transgenic plants when compared with the wild-type. The differentially regulated genes were assigned into 16 functional groups. All of the seven genes, which were assigned into carbon fixation and metabolism group, were up-regulated, while about 42% of the assigned genes are involved in transcriptional and post-transcriptional regulation. Expression of genes encoding a 14-3-3 regulatory protein, and four transcription factors were down-regulated in the TPS1-transgenic leaves. To verify the microarray results, we used RNA gel blot analysis to examine the expression of eight genes and found that the RNA gel blot and microarray data correlated in each case. Using the putative Arabidopsis orthologs of the assigned potato sequences we have identified putative transcription binding sites in the promoter region of the differentially regulated genes, and putative protein-protein interactions involving some of the up-and down-regulated genes. We have also demonstrated that starch content is lower, while malate, inositol and maltose contents are higher in the TPS1-transgenic than in the wild-type leaves. Our results suggest that a complex regulatory network, involving transcription factors and other regulatory proteins, underpins the phenotypic alterations we have observed previously in potato when expressing the TPS1 gene of yeast.	[Kondrak, Mihaly; Marincs, Ferenc; Juhasz, Zsofia; Banfalvi, Zsofia] Agr Biotechnol Ctr, H-2101 Godollo, Hungary; [Kalapos, Balazs] Szent Istvan Univ, Inst Genet & Biotechnol, Godollo, Hungary	Hungarian University of Agriculture & Life Sciences	Kondrak, M (corresponding author), Agr Biotechnol Ctr, H-2101 Godollo, Hungary.	banfalvi@abc.hu	Juhász, Zsófia/D-3740-2012; Bánfalvi, Zsófia/D-3494-2012; Kondrák, Mihály/D-3748-2012; Marincs, Ferenc/A-8562-2011	Marincs, Ferenc/0000-0002-5388-8344; Kalapos, Balazs/0000-0003-2340-4270	Hungarian grant OTKA [F68318]; Janos Bolyai Research Fellowship	Hungarian grant OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was supported by the Hungarian grant OTKA F68318. MK was a recipient of the Janos Bolyai Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; BANFALVI Z, 1994, MOL GEN GENET, V245, P517, DOI 10.1007/BF00302265; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Bulow L, 2009, NUCLEIC ACIDS RES, V37, pD983, DOI 10.1093/nar/gkn709; Carmona MJ, 1998, PLANTA, V207, P181, DOI 10.1007/s004250050471; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Doczi R, 2002, PLANT CELL ENVIRON, V25, P1197, DOI 10.1046/j.1365-3040.2002.00904.x; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; FU HY, 1995, PLANT CELL, V7, P1369, DOI 10.1105/tpc.7.9.1369; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kutter C, 2007, PLANT CELL, V19, P2417, DOI 10.1105/tpc.107.050377; Lozano-Juste J, 2010, PLANT PHYSIOL, V152, P891, DOI 10.1104/pp.109.148023; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Mitra A, 1998, FUNDAMENTALS QUALITY; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Rosin FM, 2003, PLANT PHYSIOL, V131, P1613, DOI 10.1104/pp.102.012500; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Rutschow H, 2008, PLANT PHYSIOL, V148, P156, DOI 10.1104/pp.108.124545; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sawchuk MG, 2008, PLANT PHYSIOL, V148, P1908, DOI 10.1104/pp.108.126946; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spooner DM, 2007, P NATL ACAD SCI USA, V104, P19398, DOI 10.1073/pnas.0709796104; STIEKEMA WJ, 1988, PLANT MOL BIOL, V11, P255, DOI 10.1007/BF00027383; Stiller I, 2008, PLANTA, V227, P299, DOI 10.1007/s00425-007-0617-9; Sun YJ, 2007, J INTEGR PLANT BIOL, V49, P940, DOI 10.1111/j.1744-7909.2007.00498.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Wei W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007209; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	56	24	27	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23466	10.1371/journal.pone.0023466	http://dx.doi.org/10.1371/journal.pone.0023466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858131	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500035
J	Klein, JD; Ossowski, S; Schneeberger, K; Weigel, D; Huson, DH				Klein, Juliane D.; Ossowski, Stephan; Schneeberger, Korbinian; Weigel, Detlef; Huson, Daniel H.			LOCAS - A Low Coverage Assembly Tool for Resequencing Projects	PLOS ONE			English	Article							DE-NOVO; SHORT READS; ARABIDOPSIS-THALIANA; HUMAN GENOME; ALIGNMENT; ALGORITHMS; DISCOVERY; EFFICIENT; ABYSS	Motivation: Next Generation Sequencing (NGS) is a frequently applied approach to detect sequence variations between highly related genomes. Recent large-scale re-sequencing studies as the Human 1000 Genomes Project utilize NGS data of low coverage to afford sequencing of hundreds of individuals. Here, SNPs and micro-indels can be detected by applying an alignment-consensus approach. However, computational methods capable of discovering other variations such as novel insertions or highly diverged sequence from low coverage NGS data are still lacking. Results: We present LOCAS, a new NGS assembler particularly designed for low coverage assembly of eukaryotic genomes using a mismatch sensitive overlap-layout-consensus approach. LOCAS assembles homologous regions in a homology-guided manner while it performs de novo assemblies of insertions and highly polymorphic target regions subsequently to an alignment-consensus approach. LOCAS has been evaluated in homology-guided assembly scenarios with low sequence coverage of Arabidopsis thaliana strains sequenced as part of the Arabidopsis 1001 Genomes Project. While assembling the same amount of long insertions as state-of-the-art NGS assemblers, LOCAS showed best results regarding contig size, error rate and runtime. Conclusion: LOCAS produces excellent results for homology-guided assembly of eukaryotic genomes with short reads and low sequencing depth, and therefore appears to be the assembly tool of choice for the detection of novel sequence variations in this scenario.	[Klein, Juliane D.; Huson, Daniel H.] Univ Tubingen, Chair Algorithms Bioinformat, Tubingen, Germany; [Ossowski, Stephan] Univ Pompeu Fabra, Barcelona, Spain; [Ossowski, Stephan] Ctr Genom Regulat, Genes & Dis Program, Barcelona, Spain; [Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Max Planck Society; Max Planck Society	Klein, JD (corresponding author), Univ Tubingen, Chair Algorithms Bioinformat, Tubingen, Germany.	kleinj@informatik.uni-tuebingen.de	Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Huson, Daniel H./AAC-5494-2019; Weigel, Detlef/GSJ-0799-2022; Schneeberger, Korbinian/U-6329-2019; Ossowski, Stephan/E-2139-2011	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Schneeberger, Korbinian/0000-0002-5512-0443; Ossowski, Stephan/0000-0002-7416-9568	BMBF [German Plant Genome Initiative GABI-GNADE]	BMBF [German Plant Genome Initiative GABI-GNADE]	The study was supported by the BMBF [German Plant Genome Initiative GABI-GNADE]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arslan AN, 2001, BIOINFORMATICS, V17, P327, DOI 10.1093/bioinformatics/17.4.327; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; KECECIOGLU JD, 1995, ALGORITHMICA, V13, P7, DOI 10.1007/BF01188580; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Palmer LE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-33; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Pop M, 2004, GENOME RES, V14, P149; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Rausch T, 2009, BIOINFORMATICS, V25, P1118, DOI 10.1093/bioinformatics/btp131; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wendl MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-485; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	31	15	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23455	10.1371/journal.pone.0023455	http://dx.doi.org/10.1371/journal.pone.0023455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858125	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953700024
J	Wu, MC; Lin, TL; Hsieh, PF; Yang, HC; Wang, JT				Wu, Meng-Chuan; Lin, Tzu-Lung; Hsieh, Pei-Fang; Yang, Hui-Ching; Wang, Jin-Town			Isolation of Genes Involved in Biofilm Formation of a Klebsiella pneumoniae Strain Causing Pyogenic Liver Abscess	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL BIOFILMS; RESISTANCE; DISEASE; MECHANISMS; EXPRESSION; VIRULENCE; SURFACES; TAIWAN; TRACT	Background: Community-acquired pyogenic liver abscess (PLA) complicated with meningitis and endophthalmitis caused by Klebsiella pneumoniae is an emerging infectious disease. To investigate the mechanisms and effects of biofilm formation of K. pneumoniae causing PLA, microtiter plate assays were used to determine the levels of biofilm formed by K. pneumoniae clinical isolates and to screen for biofilm-altered mutants from a transposon mutant library of a K. pneumoniae PLA-associated strain. Methodology/Principal Findings: The biofilm formation of K. pneumoniae was examined by microtiter plate assay. Higher levels of biofilm formation were demonstrated by K. pneumoniae strains associated with PLA. A total of 23 biofilm-decreased mutants and 4 biofilm-increased mutants were identified. Among these mutants, a biofilm-decreased treC mutant displayed less mucoviscosity and produced less capsular polysaccharide (CPS), whereas a biofilm-increased sugE mutant displayed higher mucoviscosity and produced more CPS. The biofilm phenotypes of treC and sugE mutants also were confirmed by glass slide culture. Deletion of treC, which encodes trehalose-6-phosphate hydrolase, impaired bacterial trehalose utilization. Addition of glucose to the culture medium restored the capsule production and biofilm formation in the treC mutant. Transcriptional profile analysis suggested that the increase of CPS production in Delta sugE may reflect elevated cps gene expression (upregulated through rmpA) in combination with increased treC expression. In vivo competition assays demonstrated that the treC mutant strain was attenuated in competitiveness during intragastric infection in mice. Conclusions/Significance: Genes important for biofilm formation by K. pneumoniae PLA strain were identified using an in vitro assay. Among the identified genes, treC and sugE affect biofilm formation by modulating CPS production. The importance of treC in gastrointestinal tract colonization suggests that biofilm formation contributes to the establishment and persistence of K. pneumoniae infection.	[Wu, Meng-Chuan; Lin, Tzu-Lung; Hsieh, Pei-Fang; Yang, Hui-Ching; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wu, MC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	wangjt@ntu.edu.tw			National Science Council; National Taiwan University; Liver Disease Prevention and Treatment Research Foundation in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Liver Disease Prevention and Treatment Research Foundation in Taiwan	The work was supported by National Science Council (http://web1.nsc.gov.tw/), the Excellent Research Projects of National Taiwan University (http://www.ntu.edu.tw), and the Liver Disease Prevention and Treatment Research Foundation in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Boddicker JD, 2006, INFECT IMMUN, V74, P4590, DOI 10.1128/IAI.00129-06; Chang SC, 2000, DIAGN MICR INFEC DIS, V37, P279, DOI 10.1016/S0732-8893(00)00157-7; Chen W, 2008, CRIT CARE MED, V36, P1184, DOI 10.1097/CCM.0b013e31816a0a06; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Chou FF, 1997, WORLD J SURG, V21, P384, DOI 10.1007/PL00012258; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsieh PF, 2010, J INFECT DIS, V202, P52, DOI 10.1086/653079; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; KLEIN W, 1995, J BACTERIOL, V177, P4043, DOI 10.1128/jb.177.14.4043-4052.1995; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Ramphal R, 2006, CLIN INFECT DIS, V42, pS164, DOI 10.1086/500663; RIMMELE M, 1994, J BACTERIOL, V176, P5654, DOI 10.1128/JB.176.18.5654-5664.1994; Rosen DA, 2008, INFECT IMMUN, V76, P3346, DOI 10.1128/IAI.00340-08; Sikora CW, 2005, BIOCHEM BIOPH RES CO, V335, P105, DOI 10.1016/j.bbrc.2005.07.051; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wellman N, 1996, ANTIMICROB AGENTS CH, V40, P2012, DOI 10.1128/AAC.40.9.2012; Yeoh KG, 1997, POSTGRAD MED J, V73, P89, DOI 10.1136/pgmj.73.856.89; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07	43	84	93	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23500	10.1371/journal.pone.0023500	http://dx.doi.org/10.1371/journal.pone.0023500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858144	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953500049
J	Frisvad, JC; Larsen, TO; Thrane, U; Meijer, M; Varga, J; Samson, RA; Nielsen, KF				Frisvad, Jens C.; Larsen, Thomas O.; Thrane, Ulf; Meijer, Martin; Varga, Janos; Samson, Robert A.; Nielsen, Kristian F.			Fumonisin and Ochratoxin Production in Industrial Aspergillus niger Strains	PLOS ONE			English	Article							CITRIC-ACID PRODUCTION; ORGANIC-ACIDS; B-2; METABOLITES; GENOMICS; GRAPES; SAFETY; WASTE; WINE; B2	Aspergillus niger is perhaps the most important fungus used in biotechnology, and is also one of the most commonly encountered fungi contaminating foods and feedstuffs, and occurring in soil and indoor environments. Many of its industrial applications have been given GRAS status (generally regarded as safe). However, A. niger has the potential to produce two groups of potentially carcinogenic mycotoxins: fumonisins and ochratoxins. In this study all available industrial and many non-industrial strains of A. niger (180 strains) as well as 228 strains from 17 related black Aspergillus species were examined for mycotoxin production. None of the related 17 species of black Aspergilli produced fumonisins. Fumonisins (B-2, B-4, and B-6) were detected in 81% of A. niger, and ochratoxin A in 17%, while 10% of the strains produced both mycotoxins. Among the industrial strains the same ratios were 83%, 33% and 26% respectively. Some of the most frequently used strains in industry NRRL 337, 3112 and 3122 produced both toxins and several strains used for citric acid production were among the best producers of fumonisins in pure agar culture. Most strains used for other biotechnological processes also produced fumonisins. Strains optimized through random mutagenesis usually maintained their mycotoxin production capability. Toxigenic strains were also able to produce the toxins on media suggested for citric acid production with most of the toxins found in the biomass, thereby questioning the use of the remaining biomass as animal feed. In conclusion it is recommended to use strains of A. niger with inactive or inactivated gene clusters for fumonisins and ochratoxins, or to choose isolates for biotechnological uses in related non-toxigenic species such as A. tubingensis, A. brasiliensis, A vadensis or A. acidus, which neither produce fumonisins nor ochratoxins.	[Frisvad, Jens C.; Larsen, Thomas O.; Thrane, Ulf; Nielsen, Kristian F.] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Meijer, Martin; Varga, Janos; Samson, Robert A.] CBS Fungal Biodivers Ctr, Utrecht, Netherlands; [Varga, Janos] Univ Szeged, Dept Microbiol, Fac Sci & Informat, Szeged, Hungary	Technical University of Denmark; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Szeged University	Frisvad, JC (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	jcf@bio.dtu.dk	Thrane, Ulf/G-2978-2016; Samson, Robert/ABE-6704-2020; Frisvad, Jens C/K-2818-2017; Nielsen, Kristian Fog/C-7233-2011	Thrane, Ulf/0000-0002-6040-4141; Frisvad, Jens C/0000-0002-0573-4340; Nielsen, Kristian Fog/0000-0002-5848-0911; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Samson, Robert A./0000-0002-2979-3097	The Danish Research Council for Production and Technology Sciences [26-04-0050]; Danish Food Industry Agency [3304-FVFP-07-730-01]	The Danish Research Council for Production and Technology Sciences; Danish Food Industry Agency	The authors were supported by The Danish Research Council for Production and Technology Sciences (26-04-0050) and Danish Food Industry Agency for financial support (3304-FVFP-07-730-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca ML, 2004, ANTON LEEUW INT J G, V86, P33, DOI 10.1023/B:ANTO.0000024907.85688.05; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; ARCHER DB, 1990, BIO-TECHNOL, V8, P741, DOI 10.1038/nbt0890-741; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; BLOCH F, 1973, AM POTATO J, V50, P357, DOI 10.1007/BF02851891; Blumenthal CZ, 2004, REGUL TOXICOL PHARM, V39, P214, DOI 10.1016/j.yrtph.2003.09.002; Brown DW, 2005, FUNGAL GENET BIOL, V42, P848, DOI 10.1016/j.fgb.2005.06.001; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; CHRISTIAS C, 1975, APPL MICROBIOL, V29, P250, DOI 10.1111/1741-5705.00031; Coulibaly L, 2002, WATER RES, V36, P3941, DOI 10.1016/S0043-1354(02)00117-3; Frisvad JC, 2004, STUD MYCOL, P1; Frisvad JC, 2007, J AGR FOOD CHEM, V55, P9727, DOI 10.1021/jf0718906; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Goldberg I, 2006, J CHEM TECHNOL BIOT, V81, P1601, DOI 10.1002/jctb.1590; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; HANG YD, 1976, PROG WATER TECHNOL, V8, P325; Hofmann G, 2009, METAB ENG, V11, P8, DOI 10.1016/j.ymben.2008.07.002; JERNEJC K, 1982, EUR J APPL MICROBIOL, V14, P29, DOI 10.1007/BF00508000; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; Kirimura K, 1999, BIOSCI BIOTECH BIOCH, V63, P226, DOI 10.1271/bbb.63.226; Knudsen PB, 2011, J AGR FOOD CHEM, V59, P772, DOI 10.1021/jf103855x; Logrieco A, 2010, FOOD ADDIT CONTAM A, V27, P1136, DOI 10.1080/19440041003716547; Lubertozzi D, 2009, BIOTECHNOL ADV, V27, P53, DOI 10.1016/j.biotechadv.2008.09.001; Magnoli C, 2003, LETT APPL MICROBIOL, V37, P179, DOI 10.1046/j.1472-765X.2003.01376.x; Mansson M, 2010, J AGR FOOD CHEM, V58, P949, DOI 10.1021/jf902834g; Mogensen JM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-281; Mogensen JM, 2010, J AGR FOOD CHEM, V58, P954, DOI 10.1021/jf903116q; Mogensen JM, 2010, J AGR FOOD CHEM, V58, P4853, DOI 10.1021/jf904520t; MOYER AJ, 1953, APPL MICROBIOL, V1, P1; Myung K, 2008, APPL MICROBIOL BIOT, V78, P343, DOI 10.1007/s00253-007-1314-0; Navaratnam P, 1998, WORLD J MICROB BIOT, V14, P559, DOI 10.1023/A:1008856603769; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Noonim P, 2009, FOOD ADDIT CONTAM A, V26, P94, DOI 10.1080/02652030802366090; Oboh G, 2002, J FOOD COMPOS ANAL, V15, P617, DOI [10.1016/S0889-1575(02)91065-3, 10.1006/jfca.2002.1065]; Ousmanova D, 2007, WATER AIR SOIL POLL, V179, P365, DOI 10.1007/s11270-006-9241-8; Pariza MW, 2010, REGUL TOXICOL PHARM, V56, P332, DOI 10.1016/j.yrtph.2009.10.005; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Romero SM, 2005, INT J FOOD MICROBIOL, V104, P43, DOI 10.1016/j.ijfoodmicro.2005.04.001; Samson RA, 2007, STUD MYCOL, P129, DOI 10.3114/sim.2007.59.13; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6; Soccol CR, 2006, FOOD TECHNOL BIOTECH, V44, P141; Sorensen LM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-255; Sun JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r182; Susca A, 2010, J AGR FOOD CHEM, V58, P9266, DOI 10.1021/jf101591x; Varga J, 2010, INT J FOOD MICROBIOL, V143, P143, DOI 10.1016/j.ijfoodmicro.2010.08.008; Wang JL, 1998, PROCESS BIOCHEM, V33, P313, DOI 10.1016/S0032-9592(97)87513-9	51	128	133	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23496	10.1371/journal.pone.0023496	http://dx.doi.org/10.1371/journal.pone.0023496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853139	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400048
J	Roe, B; Kensicki, E; Mohney, R; Hall, WW				Roe, Barbara; Kensicki, Elizabeth; Mohney, Robert; Hall, William W.			Metabolomic Profile of Hepatitis C Virus-Infected Hepatocytes	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; OXIDATIVE STRESS; LIPID-METABOLISM; RNA REPLICATION; RAT HEPATOCYTES; IN-VITRO; CELLS; LIVER; METHYLTHIOADENOSINE; APOPTOSIS	Hepatitis C virus (HCV) is capable of disrupting different facets of lipid metabolism and lipids have been shown to play a crucial role in the viral life cycle. The aim of this study was to examine the effect HCV infection has on the hepatocyte metabolome. Huh-7.5 cells were infected using virus produced by the HCV J6/JFH1 cell culture system and cells were harvested 24, 48, and 72-hours following infection. Metabolic profiling was performed using a non-targeted multiple platform methodology combining ultrahigh performance liquid chromatography/tandem mass spectrometry (UHPLC/MS/MS(2)) and gas chromatography/mass spectrometry (GC/MS). There was a significant increase in a number of metabolites involved in nucleotide synthesis and RNA replication during early HCV infection. NAD levels were also significantly increased along with several amino acids. A number of lipid metabolic pathways were disrupted by HCV infection, resulting in an increase in cholesterol and sphingolipid levels, altered phospholipid metabolism and a possible disruption in mitochondrial fatty acid transport. Fluctuations in 5'-methylthioadenosine levels were also noted, along with alterations in the glutathione synthesis pathway. These results highlight a number of previously unreported metabolic interactions and give a more in depth insight into the effect HCV has on host cell biochemical processes.	[Roe, Barbara; Hall, William W.] Univ Coll Dublin, Ctr Res Infect Dis, Sch Med & Med Sci, Dublin 2, Ireland; [Kensicki, Elizabeth; Mohney, Robert] Metabolon Inc, Durham, NC USA	University College Dublin; Metabolon	Roe, B (corresponding author), Univ Coll Dublin, Ctr Res Infect Dis, Sch Med & Med Sci, Dublin 2, Ireland.	barbara.roe@ucd.ie			National Virus Reference Laboratory; Centre for Research in Infectious Diseases, University College Dublin, Ireland [8090]	National Virus Reference Laboratory; Centre for Research in Infectious Diseases, University College Dublin, Ireland	This study was funded by the National Virus Reference Laboratory and the Centre for Research in Infectious Diseases, University College Dublin, Ireland (Grant No. 8090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Ahn EH, 2010, ANTICANCER RES, V30, P2881; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; D'Arrigo P, 2010, MOLECULES, V15, P1354, DOI 10.3390/molecules15031354; Dabrowska MM, 2009, WORLD J GASTROENTERO, V15, P2184, DOI 10.3748/wjg.15.2184; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; Nakano T, 2009, BBA-BIOMEMBRANES, V1788, P2222, DOI 10.1016/j.bbamem.2009.07.015; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmeding M, 2007, LIVER TRANSPLANT, V13, P687, DOI 10.1002/lt.21138; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; SOGA T, 2011, J HEPATOL; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Stuyver LJ, 2003, J VIROL, V77, P10689, DOI 10.1128/JVI.77.19.10689-10694.2003; Tan KC, 2009, MOL PLANT PATHOL, V10, P703, DOI [10.1111/J.1364-3703.2009.00565.X, 10.1111/j.1364-3703.2009.00565.x]; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	48	71	76	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23641	10.1371/journal.pone.0023641	http://dx.doi.org/10.1371/journal.pone.0023641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853158	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400054
J	Ribeiro, AC; Ceccarini, G; Dupre, C; Friedman, JM; Pfaff, DW; Mark, AL				Ribeiro, Ana C.; Ceccarini, Giovanni; Dupre, Christophe; Friedman, Jeffrey M.; Pfaff, Donald W.; Mark, Allyn L.			Contrasting Effects of Leptin on Food Anticipatory and Total Locomotor Activity	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSE; GENE-EXPRESSION; BODY-WEIGHT; OBESE GENE; DEFICIENCY; REPLACEMENT; DYSFUNCTION; RESISTANCE; BEHAVIOR	Obese, leptin deficient obob mice have profoundly decreased activity and increased food seeking behavior. The decreased activity has been attributed to obesity. In mice, we tested the hypothesis that leptin increases total locomotor activity but inhibits food anticipatory activity. We also sought to determine if leptin induced increases in total locomotor activity are independent of changes in body weight and obesity. We studied obob mice and also created a novel transgenic mouse where leptin is over-expressed in a tetracycline-off system and can be abruptly and non-invasively suppressed by doxycycline within few hours. The studies were performed using two independent behavioral assays: home cage activity (HCA) and running wheel activity (RWA). Systemic administration of leptin (150 ng/hr) to obob mice produced a 122% +/- 30% (mean +/- SEM) increase (p <= 0.01) in locomotor activity within 2 days In addition, cerebroventricular administration of leptin (5 ng/hr) also produced an early and progressive increase in total locomotor activity beginning on the 1st day (+28 +/- 8%; p <= 0.05) and increasing to +69 +/- 23% on day 3 without a decrease in body weight during this time. The increase in activity was restricted to the dark phase. Conversely, in a tet-off transgenic obob mouse line, acute leptin suppression reduced spontaneous locomotor activity. To further define activities that are leptin regulated, we assayed food anticipatory activity (FAA) and found that it was markedly augmented in obob mice compared to wild type mice (+38 +/- 6.7 in obob vs +20 +/- 6.3% in wild type at peak; mean +/- SEM; p <= 0.001) and abolished by leptin. Although melanocortin-3 receptors (MC3R) reportedly mediate FAA, we found augmented FAA and preserved inhibitory effects of leptin on FAA in MC3R-/-obob mice. In summary, this study demonstrates that total activity and FAA are regulated independently by leptin. Leptin, acting in the central nervous system and at physiologic levels, produces early increases in locomotor activity before substantial weight loss. In contrast, leptin suppresses augmented food anticipatory activity in obob mice.	[Ribeiro, Ana C.; Dupre, Christophe; Pfaff, Donald W.] Rockefeller Univ, Neurobiol & Behav Lab, New York, NY 10021 USA; [Ribeiro, Ana C.] Coll Mt St Vincent, Div Nat Sci, New York, NY USA; [Ceccarini, Giovanni; Friedman, Jeffrey M.; Mark, Allyn L.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA; [Mark, Allyn L.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Ceccarini, Giovanni] Univ Hosp Pisa, Dept Endocrinol, Pisa, Italy	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Iowa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Ribeiro, AC (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA.	friedj@rockefeller.edu; pfaff@rockefeller.edu; amark@rockefeller.edu	CECCARINI, GIOVANNI/S-3871-2019	CECCARINI, GIOVANNI/0000-0003-0701-642X; Dupre, Christophe/0000-0002-5929-8492	Howard Hughes Medical Institute; National Institutes of Health [NIH HD-05751, NIH HL-086018, NIH PO1-HL84207]; Roy J. Carver Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD005751] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207, F32HL086018] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds from the Howard Hughes Medical Institute (Jeffrey M. Friedman; www.hhmi.org); National Institutes of Health (www.nih.gov) NIH HD-05751 (Donald W. Pfaff), NIH HL-086018 (Ana C. Ribeiro); NIH PO1-HL84207 (Allyn L Mark) and the Roy J. Carver Trust (Allyn L. Mark; carvertrust.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gossen Manfred, 1994, Current Opinion in Biotechnology, V5, P516, DOI 10.1016/0958-1669(94)90067-1; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Ioffe E, 1998, P NATL ACAD SCI USA, V95, P11852, DOI 10.1073/pnas.95.20.11852; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Mesaros A, 2008, CELL METAB, V7, P236, DOI 10.1016/j.cmet.2008.01.007; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Montez JM, 2005, P NATL ACAD SCI USA, V102, P2537, DOI 10.1073/pnas.0409530102; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348; Rico L, 2005, ENDOCRINOLOGY, V146, P4167, DOI 10.1210/en.2005-0156; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Surwit RS, 2000, DIABETES, V49, P1203, DOI 10.2337/diabetes.49.7.1203; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; VASSELLI JR, 1980, PHYSIOL BEHAV, V25, P565, DOI 10.1016/0031-9384(80)90123-7; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	34	67	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23364	10.1371/journal.pone.0023364	http://dx.doi.org/10.1371/journal.pone.0023364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853117	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200074
J	Wlodarski, T; Kutner, J; Towpik, J; Knizewski, L; Rychlewski, L; Kudlicki, A; Rowicka, M; Dziembowski, A; Ginalski, K				Wlodarski, Tomasz; Kutner, Jan; Towpik, Joanna; Knizewski, Lukasz; Rychlewski, Leszek; Kudlicki, Andrzej; Rowicka, Maga; Dziembowski, Andrzej; Ginalski, Krzysztof			Comprehensive Structural and Substrate Specificity Classification of the Saccharomyces cerevisiae Methyltransferome	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; MESSENGER-RNA; TRANSMEMBRANE TOPOLOGY; LOCALIZATION PREDICTOR; CONSENSUS PREDICTION; RIBOSOMAL-RNA; YEAST; METHYLATION; DATABASE; IDENTIFICATION	Methylation is one of the most common chemical modifications of biologically active molecules and it occurs in all life forms. Its functional role is very diverse and involves many essential cellular processes, such as signal transduction, transcriptional control, biosynthesis, and metabolism. Here, we provide further insight into the enzymatic methylation in S. cerevisiae by conducting a comprehensive structural and functional survey of all the methyltransferases encoded in its genome. Using distant homology detection and fold recognition, we found that the S. cerevisiae methyltransferome comprises 86 MTases (53 well-known and 33 putative with unknown substrate specificity). Structural classification of their catalytic domains shows that these enzymes may adopt nine different folds, the most common being the Rossmann-like. We also analyzed the domain architecture of these proteins and identified several new domain contexts. Interestingly, we found that the majority of MTase genes are periodically expressed during yeast metabolic cycle. This finding, together with calculated isoelectric point, fold assignment and cellular localization, was used to develop a novel approach for predicting substrate specificity. Using this approach, we predicted the general substrates for 24 of 33 putative MTases and confirmed these predictions experimentally in both cases tested. Finally, we show that, in S. cerevisiae, methylation is carried out by 34 RNA MTases, 32 protein MTases, eight small molecule MTases, three lipid MTases, and nine MTases with still unknown substrate specificity.	[Wlodarski, Tomasz; Kutner, Jan; Towpik, Joanna; Knizewski, Lukasz; Ginalski, Krzysztof] Univ Warsaw, Lab Bioinformat & Syst Biol, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Rychlewski, Leszek] BioInfoBank Inst, Poznan, Poland; [Kudlicki, Andrzej; Rowicka, Maga] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Rowicka, Maga] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA; [Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Wlodarski, T (corresponding author), Univ Warsaw, Lab Bioinformat & Syst Biol, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland.	kginal@icm.edu.pl	Włodarski, Tomasz/G-3343-2013; Kudlicki, Andrzej/AAG-8537-2019; Rowicka, Maga/E-2496-2012; Kudlicki, Andrzej/C-7612-2012; Kutner, Jan/R-6653-2016	Kudlicki, Andrzej/0000-0001-8158-9600; Rowicka, Maga/0000-0002-4011-071X; Wlodarski, Tomasz/0000-0001-6498-334X; Kutner, Jan/0000-0002-3647-5556; Knizewski, Lukasz/0000-0003-1882-4051; Dziembowski, Andrzej/0000-0001-8492-7572	European Molecular Biology Organization; Foundation for Polish Science; Ministry of Science and Higher Education; Innovative Economy 2007-2013 Programme; European Social Fund; March of Dimes [5-FY10-136]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Innovative Economy 2007-2013 Programme; European Social Fund(European Social Fund (ESF)); March of Dimes(March of Dimes)	This work was supported by the European Molecular Biology Organization, the Foundation for Polish Science, the Ministry of Science and Higher Education, the Innovative Economy 2007-2013 Programme, the European Social Fund and March of Dimes grant 5-FY10-136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Cheng X, 1999, S ADENOSYLMETHIONINE; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franke J, 2008, J CELL SCI, V121, P3553, DOI 10.1242/jcs.033308; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Ginalski K, 2004, NUCLEIC ACIDS RES, V32, pW576, DOI 10.1093/nar/gkh370; Ginalski K, 2003, NUCLEIC ACIDS RES, V31, P3291, DOI 10.1093/nar/gkg503; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hansen J, 1997, FEBS LETT, V401, P20, DOI 10.1016/S0014-5793(96)01423-8; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MCCAMMON MT, 1984, J BACTERIOL, V157, P475, DOI 10.1128/JB.157.2.475-483.1984; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; ROSE MD, 1999, METHODS YEAST GENETI; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 1998, NAT STRUCT BIOL, V5, P585, DOI 10.1038/846; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SUBBARAMAIAH K, 1992, J BIOL CHEM, V267, P8636; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wade CH, 2006, YEAST, V23, P293, DOI 10.1002/yea.1353; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Yang CK, 2006, MOL ENDOCRINOL, V20, P3251, DOI 10.1210/me.2006-0200	65	41	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23168	10.1371/journal.pone.0023168	http://dx.doi.org/10.1371/journal.pone.0023168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858014	gold, Green Published			2022-12-25	WOS:000293774300024
J	Quaranta, MG; Vincentini, O; Felli, C; Spadaro, F; Silano, M; Moricoli, D; Giordani, L; Viora, M				Quaranta, Maria Giovanna; Vincentini, Olimpia; Felli, Cristina; Spadaro, Francesca; Silano, Marco; Moricoli, Diego; Giordani, Luciana; Viora, Marina			Exogenous HIV-1 Nef Upsets the IFN-gamma-Induced Impairment of Human Intestinal Epithelial Integrity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-DIFFERENTIATION; BARRIER FUNCTION; T-CELLS; POSSIBLE MECHANISM; DENDRITIC CELLS; LYMPHOID-TISSUE; CACO-2 CELLS; TAT PROTEIN; INFECTION	Background: The mucosal tissues play a central role in the transmission of HIV-1 infection as well as in the pathogenesis of AIDS. Despite several clinical studies reported intestinal dysfunction during HIV infection, the mechanisms underlying HIV-induced impairments of mucosal epithelial barrier are still unclear. It has been postulated that HIV-1 alters enterocytic function and HIV-1 proteins have been detected in several cell types of the intestinal mucosa. In the present study, we analyzed the effect of the accessory HIV-1 Nef protein on human epithelial cell line. Methodology/Principal Findings: We used unstimulated or IFN-gamma-stimulated Caco-2 cells, as a model for homeostatic and inflamed gastrointestinal tracts, respectively. We investigated the effect of exogenous recombinant Nef on monolayer integrity analyzing its uptake, transepithelial electrical resistance, permeability to FITC-dextran and the expression of tight junction proteins. Moreover, we measured the induction of proinflammatory mediators. Exogenous Nef was taken up by Caco-2 cells, increased intestinal epithelial permeability and upset the IFN-gamma-induced reduction of transepitelial resistance, interfering with tight junction protein expression. Moreover, Nef inhibited IFN-gamma-induced apoptosis and up-regulated TNF-alpha, IL-6 and MIP-3 alpha production by Caco-2 cells while down-regulated IL-10 production. The simultaneous exposure of Caco-2 cells to Nef and IFN-gamma did not affect cytokine secretion respect to untreated cells. Finally, we found that Nef counteracted the IFN-gamma induced arachidonic acid cascade. Conclusion/Significance: Our findings suggest that exogenous Nef, perturbing the IFN-gamma-induced impairment of intestinal epithelial cells, could prolong cell survival, thus allowing for accumulation of viral particles. Our results may improve the understanding of AIDS pathogenesis, supporting the discovery of new therapeutic interventions.	[Quaranta, Maria Giovanna; Felli, Cristina; Giordani, Luciana; Viora, Marina] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Vincentini, Olimpia; Silano, Marco] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Spadaro, Francesca] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Moricoli, Diego] Diatheva Srl, Fano, PU, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Quaranta, MG (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	mariagiovanna.quaranta@iss.it	vincentini, olimpia/N-3332-2019; VINCENTINI, OLIMPIA/B-3837-2015; Silano, Marco/AAC-9792-2022; Felli, Cristina/I-9795-2014; Silano, Marco/B-3835-2015; Spadaro, Francesca/M-7512-2017	vincentini, olimpia/0000-0002-4137-4135; VINCENTINI, OLIMPIA/0000-0002-4137-4135; Felli, Cristina/0000-0002-5253-0367; Silano, Marco/0000-0002-7051-3405; Spadaro, Francesca/0000-0002-6610-350X; Quaranta, Maria Giovanna/0000-0002-1077-1488	National Research Project on AIDS	National Research Project on AIDS	This work was funded by a grant to M. Viora from the National Research Project on AIDS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Diatheva s.r.l. had a role in the study as employer of author D. Moricoli who contributed to the recombinant HIV-1 Nef protein manufacturing process and analysis tools for this manuscript.	Alessandrini L, 2000, J GEN VIROL, V81, P2905, DOI 10.1099/0022-1317-81-12-2905; Belyakov IM, 2004, IMMUNITY, V20, P247, DOI 10.1016/S1074-7613(04)00053-6; BISWAS P, 1992, J EXP MED, V176, P739, DOI 10.1084/jem.176.3.739; Boirivant M, 1998, J CLIN IMMUNOL, V18, P39, DOI 10.1023/A:1023235803948; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Campbell TD, 2008, ETHN DIS, V18; Canani RB, 2006, AIDS, V20, P5, DOI 10.1097/01.aids.0000198088.85572.68; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; De Angelis I, 1998, TOXICOL APPL PHARM, V152, P119, DOI 10.1006/taap.1998.8445; Delezay O, 1997, VIROLOGY, V238, P231, DOI 10.1006/viro.1997.8829; Dhawan S, 1995, J LEUKOCYTE BIOL, V58, P713, DOI 10.1002/jlb.58.6.713; Fackler OT, 2001, J VIROL, V75, P6601, DOI 10.1128/JVI.75.14.6601-6608.2001; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Giordani L, 2000, CLIN EXP IMMUNOL, V122, P358, DOI 10.1046/j.1365-2249.2000.01388.x; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Hariharan D, 1999, BLOOD, V93, P1137, DOI 10.1182/blood.V93.4.1137.404a35_1137_1144; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Husain M, 2005, AIDS, V19, P1975, DOI 10.1097/01.aids.0000191918.42110.27; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Janoff EN, 2001, GASTROENTEROLOGY, V120, P607, DOI 10.1053/gast.2001.22427; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kaiserlian D, 2005, J LEUKOCYTE BIOL, V78, P311, DOI 10.1189/jlb.0105053; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; Kuster H, 2000, AM J PATHOL, V156, P1973, DOI 10.1016/S0002-9440(10)65070-5; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Martin-Venegas R, 2006, J LIPID RES, V47, P1416, DOI 10.1194/jlr.M500564-JLR200; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Ndolo T, 2005, VIROLOGY, V343, P1, DOI 10.1016/j.virol.2005.08.013; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Olivetta E, 2000, J VIROL, V74, P483, DOI 10.1128/JVI.74.1.483-492.2000; Paiardini M, 2008, AIDS REV, V10, P36; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Peretti S, 2005, MOL THER, V12, P1185, DOI 10.1016/j.ymthe.2005.06.474; POLI G, 1992, AIDS RES HUM RETROV, V8, P191, DOI 10.1089/aid.1992.8.191; Quaranta MG, 2007, FASEB J, V21, P2323, DOI 10.1096/fj.06-7883com; Quaranta MG, 2011, VIRAL IMMUNOL, V24, P245, DOI 10.1089/vim.2010.0112; Quaranta MG, 2009, BIOFACTORS, V35, P169, DOI 10.1002/biof.28; Quaranta MG, 1999, EXP CELL RES, V250, P112, DOI 10.1006/excr.1999.4494; Quaranta MG, 2004, FASEB J, V18, P1459, DOI 10.1096/fj.04-1633fje; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Quaranta MG, 2002, EXP CELL RES, V275, P243, DOI 10.1006/excr.2002.5497; ROSENBERG ZF, 1990, IMMUNOL TODAY, V11, P176, DOI 10.1016/0167-5699(90)90070-P; Sharpstone D, 1996, LANCET, V348, P379, DOI 10.1016/S0140-6736(96)01034-3; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Sunamoto M, 2003, KIDNEY INT, V64, P1695, DOI 10.1046/j.1523-1755.2003.00283.x; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08	54	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23442	10.1371/journal.pone.0023442	http://dx.doi.org/10.1371/journal.pone.0023442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858117	gold, Green Published, Green Submitted			2022-12-25	WOS:000293773300029
J	Chen, JC; Dai, FP; Balakrishnan-Renuka, A; Leese, F; Schempp, W; Schaller, F; Hoffmann, MM; Morosan-Puopolo, G; Yusuf, F; Bisschoff, IJ; Chankiewitz, V; Xue, JL; Chen, JZ; Ying, K; Brand-Saberi, B				Chen, Jingchen; Dai, Fangping; Balakrishnan-Renuka, Ajeesh; Leese, Florian; Schempp, Werner; Schaller, Felix; Hoffmann, Michael M.; Morosan-Puopolo, Gabriela; Yusuf, Faisal; Bisschoff, Izak Johannes; Chankiewitz, Verena; Xue, Jinglun; Chen, Jingzhong; Ying, Kang; Brand-Saberi, Beate			Diversification and Molecular Evolution of ATOH8, a Gene Encoding a bHLH Transcription Factor	PLOS ONE			English	Article							PRONEURAL GENE; GENOME; EXPRESSION; PROMOTER; ORIGIN; FAMILY; MATH6; IDENTIFICATION; PHYLOGENIES; COMPONENT	ATOH8 is a bHLH domain transcription factor implicated in the development of the nervous system, kidney, pancreas, retina and muscle. In the present study, we collected sequence of ATOH8 orthologues from 18 vertebrate species and 24 invertebrate species. The reconstruction of ATOH8 phylogeny and sequence analysis showed that this gene underwent notable divergences during evolution. For those vertebrate species investigated, we analyzed the gene structure and regulatory elements of ATOH8. We found that the bHLH domain of vertebrate ATOH8 was highly conserved. Mammals retained some specific amino acids in contrast to the non-mammalian orthologues. Mammals also developed another potential isoform, verified by a human expressed sequence tag (EST). Comparative genomic analyses of the regulatory elements revealed a replacement of the ancestral TATA box by CpG-islands in the eutherian mammals and an evolutionary tendency for TATA box reduction in vertebrates in general. We furthermore identified the region of the effective promoter of human ATOH8 which could drive the expression of EGFP reporter in the chicken embryo. In the opossum, both the coding region and regulatory elements of ATOH8 have some special features, such as the unique extended C-terminus encoded by the third exon and absence of both CpG islands and TATA elements in the regulatory region. Our gene mapping data showed that in human, ATOH8 was hosted in one chromosome which is a fusion product of two orthologous chromosomes in non-human primates. This unique chromosomal environment of human ATOH8 probably subjects its expression to the regulation at chromosomal level. We deduce that the great interspecific differences found in both ATOH8 gene sequence and its regulatory elements might be significant for the fine regulation of its spatiotemporal expression and roles of ATOH8, thus orchestrating its function in different tissues and organisms.	[Chen, Jingchen; Balakrishnan-Renuka, Ajeesh; Morosan-Puopolo, Gabriela; Yusuf, Faisal; Chankiewitz, Verena; Brand-Saberi, Beate] Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany; [Leese, Florian] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Hoffmann, Michael M.] Univ Freiburg, Dept Med, D-7800 Freiburg, Germany; [Balakrishnan-Renuka, Ajeesh] Univ Freiburg, Fac Biol, D-7800 Freiburg, Germany; [Dai, Fangping; Brand-Saberi, Beate] Univ Freiburg, Dept Mol Embryol, D-7800 Freiburg, Germany; [Schempp, Werner; Schaller, Felix; Bisschoff, Izak Johannes] Univ Freiburg, Inst Human Genet, D-7800 Freiburg, Germany; [Xue, Jinglun; Chen, Jingzhong; Ying, Kang] Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China	Ruhr University Bochum; Ruhr University Bochum; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Fudan University	Chen, JC (corresponding author), Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany.	Beate.Brand-Saberi@rub.de	Hoffmann, Michael M/D-4074-2015; Brand-Saberi, Beate/GVT-9451-2022; Leese, Florian/D-4277-2012	Hoffmann, Michael M/0000-0001-8459-6080; Leese, Florian/0000-0002-5465-913X	EU [511978]; DFG [GRK 1104]; DAAD [D/08/01771]	EU(European Commission); DFG(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	The project was supported by an EU's Sixth Framework Program grant to Prof. Dr. B. Brand-Saberi (MYORES, 511978), by the DFG (GRK 1104) and the DAAD D/08/01771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Brentrup D, 2000, DEVELOPMENT, V127, P4729; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; DRUMMOND AJ, 2009, GENEIOUS V4 7; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Freire P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004076; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kubo F, 2010, DEV DYNAM, V239, P2492, DOI 10.1002/dvdy.22381; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; LEDENT V, 2002, GENOME BIOL, V3; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Sambrook J, 2001, MOL CLONING LAB MANU; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Schmidt J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005288; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Spicuglia S, 2006, CURR OPIN IMMUNOL, V18, P158, DOI 10.1016/j.coi.2006.01.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Thomas N, 2005, CELL CYCLE, V4, P191, DOI 10.4161/cc.4.1.1405; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang Y, 2009, J MOL EVOL, V68, P629, DOI 10.1007/s00239-009-9232-7; Watanabe Hidemi, 2006, Tanpakushitsu Kakusan Koso, V51, P178; Yao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010945; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; 1991, P NATL ACAD SCI US, V88, P9051	48	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23005	10.1371/journal.pone.0023005	http://dx.doi.org/10.1371/journal.pone.0023005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21857980	gold, Green Submitted, Green Published			2022-12-25	WOS:000293561200041
J	Mihlan, M; Blom, AM; Kupreishvili, K; Lauer, N; Stelzner, K; Bergstrom, F; Niessen, HWM; Zipfel, PF				Mihlan, Michael; Blom, Anna M.; Kupreishvili, Koba; Lauer, Nadine; Stelzner, Kristin; Bergstrom, Frida; Niessen, Hans W. M.; Zipfel, Peter F.			Monomeric C-reactive protein modulates classic complement activation on necrotic cells	FASEB JOURNAL			English	Article						cell death; C1q; C4b-binding protein; myocardial infarction	HEMOLYTIC-UREMIC SYNDROME; FACTOR-H; C4B-BINDING PROTEIN; APOPTOTIC CELLS; ENDOTHELIAL-CELLS; MYOCARDIAL-INFARCTION; HUMAN-DISEASES; 2 PARTS; PATHWAY; PHAGOCYTOSIS	The acute-phase protein C-reactive protein (CRP) recruits C1q to the surface of damaged cells and thereby initiates complement activation. However, CRP also recruits complement inhibitors, such as C4b-binding protein (C4bp) and factor H, which both block complement progression at the level of C3 and inhibits inflammation. To define how CRP modulates the classic complement pathway, we studied the interaction of CRP with the classic pathway inhibitor C4bp. Monomeric CRP (mCRP), but not pentameric CRP (pCRP), binds C4bp and enhances degradation of C4b and C3b. Both C1q, the initiator, and C4bp, the inhibitor of the classic pathway, compete for mCRP binding, and this competition adjusts the local balance of activation and inhibition. After attachment of pCRP to the surface of necrotic rat myocytes, generation of mCRP was demonstrated over a period of 18 h. Similarly, a biological role for mCRP, C1q, and C4bp in the disease setting of acute myocardial infarction was revealed. In this inflamed tissue, mCRP, pCRP, C4bp, C1q, and C4d were detected in acetone-fixed and in unfixed tissue. Protein levels were enhanced 6 h to 5 d after infarction. Thus, mCRP bound to damaged cardiomyocytes recruits C1q to activate and also C4bp to control the classic complement pathway.-Mihlan, M., Blom, A. M., Kupreishvili, K., Lauer, N., Stelzner, K., Bergstro " m, F., Niessen, H. W. M., Zipfel, P. F. Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J. 25, 4198-4210 (2011). www.fasebj.org	[Mihlan, Michael; Lauer, Nadine; Stelzner, Kristin; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Blom, Anna M.; Bergstrom, Frida] Lund Univ, Dept Lab Med, Malmo, Sweden; [Kupreishvili, Koba; Niessen, Hans W. M.] Vrije Univ Med Ctr Amsterdam, Dept Pathol, Amsterdam, Netherlands; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Lund University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Beutenbergstr 11A, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Mihlan, Michael/0000-0002-3946-6583; Niessen, Hans/0000-0001-9404-9822	Deutsche Forschungsgemeinschaft [Zi432-9/1]; Swedish Research Council [K2009-68X-14928-06-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors thank Steffi Halbich for expert assistance with surface plasmon resonance. The work was supported by the Deutsche Forschungsgemeinschaft (Zi432-9/1) and Swedish Research Council (K2009-68X-14928-06-3).	BARNUM SR, 1990, COMPLEMENT INFLAMMAT, V7, P71, DOI 10.1159/000463131; BERMAN S, 1986, J IMMUNOL, V136, P1354; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Blom AM, 2004, ARCH IMMUNOL THER EX, V52, P83; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; DAHLBACK B, 1983, P NATL ACAD SCI-BIOL, V80, P3461, DOI 10.1073/pnas.80.11.3461; Eisenhardt SU, 2009, TRENDS CARDIOVAS MED, V19, P232, DOI 10.1016/j.tcm.2010.02.002; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Heinen S, 2007, J AM SOC NEPHROL, V18, P506, DOI 10.1681/ASN.2006091069; Hellwage J, 1997, IMMUNOPHARMACOLOGY, V38, P149, DOI 10.1016/S0162-3109(97)00075-1; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Lagrand WK, 1997, CIRCULATION, V95, P97, DOI 10.1161/01.CIR.95.1.97; Luo SS, 2011, J BIOL CHEM, V286, P8021, DOI 10.1074/jbc.M110.130138; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Mevorach D, 2010, APOPTOSIS, V15, P1114, DOI 10.1007/s10495-010-0530-8; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Mihlan M, 2009, MOL IMMUNOL, V46, P335, DOI 10.1016/j.molimm.2008.10.029; Mold C, 2001, J IMMUNOL, V166, P1200, DOI 10.4049/jimmunol.166.2.1200; MOLD C, 1984, J IMMUNOL, V133, P882; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schwedler SB, 2006, AM J KIDNEY DIS, V47, P212, DOI 10.1053/j.ajkd.2005.10.028; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Slevin M, 2010, BRAIN PATHOL, V20, P151, DOI 10.1111/j.1750-3639.2008.00256.x; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Trouw LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002886; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	51	79	83	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4198	4210		10.1096/fj.11-186460	http://dx.doi.org/10.1096/fj.11-186460			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21856781				2022-12-25	WOS:000298138100013
J	Kumaraswami, M; Avanigadda, L; Rai, R; Park, HW; Howe, MM				Kumaraswami, Muthiah; Avanigadda, Lakshmi; Rai, Rajendra; Park, Hee-Won; Howe, Martha M.			Genetic Analysis of Phage Mu Mor Protein Amino Acids Involved in DNA Minor Groove Binding and Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATOR COMPLEX REVEALS; BACTERIOPHAGE-MU; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENOME SEQUENCE; TRANSCRIPTION ACTIVATION; POSITIVE REGULATOR; TERMINAL DOMAIN; RNA-POLYMERASE; P-M	Background: The phage Mu Mor activator protein structure led to predictions of key amino acids needed for DNA binding. Results: Mutational analysis identified specific Mor amino acids needed for DNA binding and transcription activation. Conclusion: The properties of the mutants support the predictions from the structure. Significance: The Mor protein family is unique among regulatory proteins.	[Kumaraswami, Muthiah; Avanigadda, Lakshmi; Rai, Rajendra; Howe, Martha M.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Tennessee System; University of Tennessee Health Science Center; University of Toronto; Structural Genomics Consortium	Howe, MM (corresponding author), 858 Madison Ave, Memphis, TN 38163 USA.	mhowe@uthsc.edu			National Institutes of Health [GM-35642]; Harriett S. Van Vleet Chair of Excellence in Virology; Harriett S. Van Vleet Chair of Excellence in Microbiology and Immunology; College of Medicine at the University of Tennessee Health Science Center; National Science Foundation [MCB-0318108, MCB-0418108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriett S. Van Vleet Chair of Excellence in Virology; Harriett S. Van Vleet Chair of Excellence in Microbiology and Immunology; College of Medicine at the University of Tennessee Health Science Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642, the Harriett S. Van Vleet Chair of Excellence in Virology, Harriett S. Van Vleet Chair of Excellence in Microbiology and Immunology, the College of Medicine at the University of Tennessee Health Science Center, and National Science Foundation Grants MCB-0318108 and MCB-0418108.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Artsimovitch I, 1996, J BIOL CHEM, V271, P32343, DOI 10.1074/jbc.271.50.32343; Artsimovitch I, 1996, P NATL ACAD SCI USA, V93, P9408, DOI 10.1073/pnas.93.18.9408; Artsimovitch I, 1996, NUCLEIC ACIDS RES, V24, P450, DOI 10.1093/nar/24.3.450; Bell CE, 2001, J MOL BIOL, V312, P921, DOI 10.1006/jmbi.2001.5024; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FOX KR, 1985, NUCLEIC ACIDS RES, V13, P8695, DOI 10.1093/nar/13.24.8695; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fuhrmann J, 2009, SCIENCE, V324, P1323, DOI 10.1126/science.1170088; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Hamelberg D, 2005, J AM CHEM SOC, V127, P13778, DOI 10.1021/ja054338a; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; HOWE MM, 1979, VIROLOGY, V93, P303, DOI 10.1016/0042-6822(79)90235-6; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KahmeyerGabbe M, 1996, J BACTERIOL, V178, P1585, DOI 10.1128/jb.178.6.1585-1592.1996; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KRAUSE HM, 1986, J BIOL CHEM, V261, P3744; Kumaraswami M, 2004, J BIOL CHEM, V279, P16581, DOI 10.1074/jbc.M313555200; Kurkcuoglu O, 2010, BIOPHYS J, V99, P1212, DOI 10.1016/j.bpj.2010.06.006; LAHM A, 1991, J MOL BIOL, V222, P645, DOI 10.1016/0022-2836(91)90502-W; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Luscombe NM, 2000, GENOME BIOL, V1; Ma J, 2004, J BACTERIOL, V186, P7858, DOI 10.1128/JB.186.23.7858-7864.2004; MARGOLIN W, 1986, NUCLEIC ACIDS RES, V14, P4881, DOI 10.1093/nar/14.12.4881; MARGOLIN W, 1990, J BACTERIOL, V172, P1424, DOI 10.1128/jb.172.3.1424-1429.1990; MARGOLIN W, 1989, J BACTERIOL, V171, P2003, DOI 10.1128/jb.171.4.2003-2018.1989; MARRS CF, 1990, VIROLOGY, V174, P192, DOI 10.1016/0042-6822(90)90068-3; MATHEE K, 1990, J BACTERIOL, V172, P6641, DOI 10.1128/jb.172.12.6641-6650.1990; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Paolozzi L, 2006, BACTERIOPHAGES, P469; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Ramesh V, 1996, J MOL BIOL, V260, P22, DOI 10.1006/jmbi.1996.0379; REIDHAAROLSON JF, 1991, METHOD ENZYMOL, V208, P564; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; ROBERTS MS, 1988, J VIROL, V62, P4307, DOI 10.1128/JVI.62.11.4307-4320.1988; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Schumacher MA, 1997, J BIOL CHEM, V272, P22648, DOI 10.1074/jbc.272.36.22648; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; STODDARD SF, 1989, J BACTERIOL, V171, P3440, DOI 10.1128/jb.171.6.3440-3448.1989; Suzuki M, 1996, J MOL BIOL, V255, P677, DOI 10.1006/jmbi.1996.0055; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Vila R, 2002, PROTEIN SCI, V11, P214, DOI 10.1110/ps.29602; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Waheed I, 1998, VIROLOGY, V252, P235, DOI 10.1006/viro.1998.9448; WELCH JJ, 1994, J BIOL CHEM, V269, P31051; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Wyrwicz LS, 2007, ACTA BIOCHIM POL, V54, P551, DOI 10.18388/abp.2007_3228; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084	69	1	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35852	35862		10.1074/jbc.M111.269860	http://dx.doi.org/10.1074/jbc.M111.269860			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859715	Green Published, hybrid			2022-12-25	WOS:000295927100058
J	Murayama, T; Kurebayashi, N; Oba, T; Oyamada, H; Oguchi, K; Sakurai, T; Ogawa, Y				Murayama, Takashi; Kurebayashi, Nagomi; Oba, Toshiharu; Oyamada, Hideto; Oguchi, Katsuji; Sakurai, Takashi; Ogawa, Yasuo			Role of Amino-terminal Half of the S4-S5 Linker in Type 1 Ryanodine Receptor (RyR1) Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; CONTINUUM SECONDARY STRUCTURE; CA2+-INDUCED CA2+ RELEASE; CENTRAL CORE DISEASE; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; CALCIUM-RELEASE; POSTULATED ROLE; VOLTAGE SENSOR; CONTRACTION	The type 1 ryanodine receptor (RyR1) is a Ca2+ release channel found in the sarcoplasmic reticulum of skeletal muscle and plays a pivotal role in excitation-contraction coupling. The RyR1 channel is activated by a conformational change of the dihydropyridine receptor upon depolarization of the transverse tubule, or by Ca2+ itself, i.e. Ca2+-induced Ca2+ release (CICR). The molecular events transmitting such signals to the ion gate of the channel are unknown. The S4-S5 linker, a cytosolic loop connecting the S4 and S5 transmembrane segments in six-transmembrane type channels, forms an alpha-helical structure and mediates signal transmission in a wide variety of channels. To address the role of the S4-S5 linker in RyR1 channel gating, we performed alanine substitution scan of N-terminal half of the putative S4-S5 linker (Thr(4825)-Ser(4829)) that exhibits high helix probability. The mutant RyR1 was expressed in HEK cells, and CICR activity was investigated by caffeine-induced Ca2(+) release, single-channel current recordings, and [H-3] ryanodine binding. Four mutants (T4825A, I4826A, S4828A, and S4829A) had reduced CICR activity without changing Ca2+ sensitivity, whereas the L4827A mutant formed a constitutive active channel. T4825I, a disease-associated mutation for malignant hyperthermia, exhibited enhanced CICR activity. An alpha-helical wheel representation of the N-terminal S4-S5 linker provides a rational explanation to the observed activities of the mutants. These results suggest that N-terminal half of the S4-S5 linker may form an alpha-helical structure and play an important role in RyR1 channel gating.	[Murayama, Takashi] Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Oba, Toshiharu] Nagoya City Univ, Dept Cell Physiol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Oyamada, Hideto; Oguchi, Katsuji] Showa Univ, Sch Med, Dept Pharmacol, Tokyo 1428555, Japan	Juntendo University; Nagoya City University; Showa University	Murayama, T (corresponding author), Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	takashim@juntendo.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency; Vehicle Racing Commemorative Foundation; Sportology Center, Juntendo University Graduate School of Medicine	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Vehicle Racing Commemorative Foundation; Sportology Center, Juntendo University Graduate School of Medicine	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, the Japan Science and Technology Agency (to T. M.), the Vehicle Racing Commemorative Foundation (to N. K.), and the Sportology Center, Juntendo University Graduate School of Medicine (to N. K. and T. S.).	Boden M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-68; Boden M, 2006, BIOINFORMATICS, V22, P1809, DOI 10.1093/bioinformatics/btl198; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Brown RL, 2000, HUM MOL GENET, V9, P1515, DOI 10.1093/hmg/9.10.1515; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Hamada T, 2007, BIOCHEMISTRY-US, V46, P4272, DOI 10.1021/bi061557f; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kusch J, 2010, BIOPHYS J, V99, P2488, DOI 10.1016/j.bpj.2010.07.041; Lee EH, 2007, EXP MOL MED, V39, P594, DOI 10.1038/emm.2007.65; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Murayama T, 2005, AM J PHYSIOL-CELL PH, V288, pC1222, DOI 10.1152/ajpcell.00415.2004; Murayama T, 2000, BIOPHYS J, V78, P1810, DOI 10.1016/S0006-3495(00)76731-2; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Murayama T, 2011, PROG BIOPHYS MOL BIO, V105, P134, DOI 10.1016/j.pbiomolbio.2010.10.003; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; Oba T, 2004, AM J PHYSIOL-CELL PH, V286, pC1188, DOI 10.1152/ajpcell.00388.2003; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Sei Y, 2004, ANESTHESIOLOGY, V101, P824, DOI 10.1097/00000542-200410000-00005; Shepherd S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014274; Song DW, 2011, PROG BIOPHYS MOL BIO, V105, P145, DOI 10.1016/j.pbiomolbio.2010.09.021; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	36	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35571	35577		10.1074/jbc.M111.255240	http://dx.doi.org/10.1074/jbc.M111.255240			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862589	Green Published, hybrid			2022-12-25	WOS:000295927100029
J	Zheng, H; Qian, J; Baker, DP; Fuchs, SY				Zheng, Hui; Qian, Juan; Baker, Darren P.; Fuchs, Serge Y.			Tyrosine Phosphorylation of Protein Kinase D2 Mediates Ligand-inducible Elimination of the Type 1 Interferon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP SER(744); PLECKSTRIN HOMOLOGY DOMAIN; DELTA PKC-DELTA; NF-KAPPA-B; ALPHA RECEPTOR; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; LEUKEMIA-CELLS; C-THETA; TYK2	Type 1 interferons (including IFN alpha/beta) activate their cell surface receptor to induce the intracellular signal transduction pathways that play an important role in host defenses against infectious agents and tumors. The extent of cellular responses to IFN alpha is limited by several important mechanisms including the ligand-stimulated and specific serine phosphorylation-dependent degradation of the IFNAR1 chain of Type 1 IFN receptor. Previous studies revealed that acceleration of IFNAR1 degradation upon IFN stimulation requires activities of tyrosine kinase TYK2 and serine/threonine protein kinase D2 (PKD2), whose recruitment to IFNAR1 is also induced by the ligand. Here we report that activation of PKD2 by IFN alpha (but not its recruitment to the receptor) depends on TYK2 catalytic activity. PKD2 undergoes IFN alpha-inducible tyrosine phosphorylation on specific phospho-acceptor site (Tyr-438) within the plekstrin homology domain. Activated TYK2 is capable of facilitating this phosphorylation in vitro. Tyrosine phosphorylation of PKD2 is required for IFN alpha-stimulated activation of this kinase as well as for efficient serine phosphorylation and degradation of IFNAR1 and ensuing restriction of the extent of cellular responses to IFN alpha.	[Zheng, Hui; Qian, Juan; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Zheng, Hui; Qian, Juan; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA	University of Pennsylvania; University of Pennsylvania; Biogen	Fuchs, SY (corresponding author), 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Zheng, Hui/ABD-6141-2021		National Institutes of Health [CA92900, CA142425]; NATIONAL CANCER INSTITUTE [R01CA142425, R01CA092900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92900 and CA142425 (to S. Y. F.). All authors involved in this studies have no conflict of interest to declare except Dr. Darren P. Baker, who is a Biogen Idec employee and owns a company stock.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Agrawal M, 2011, CANCER-AM CANCER SOC, V117, P662, DOI 10.1002/cncr.25672; Arun SN, 2011, ONCOGENE, V30, P1586, DOI 10.1038/onc.2010.540; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Coccia EM, 2006, CELL MOL BIOL, V52, P77, DOI 10.1170/T701; COLAMONICI OR, 1991, PHARMACOL THERAPEUT, V52, P227, DOI 10.1016/0163-7258(91)90010-J; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fuchs SY, 2005, CANCER METAST REV, V24, P329, DOI 10.1007/s10555-005-1581-0; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Good LM, 2011, J AM ACAD DERMATOL, V64, P413, DOI 10.1016/j.jaad.2009.12.013; Huangfu Wei-Chun, 2010, Genes Cancer, V1, P725, DOI 10.1177/1947601910382901; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; KESSLER DS, 1991, J BIOL CHEM, V266, P23471; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; PFEFFER LM, 1991, PHARMACOL THERAPEUT, V52, P149, DOI 10.1016/0163-7258(91)90005-7; PFEFFER LM, 1991, P NATL ACAD SCI USA, V88, P7988, DOI 10.1073/pnas.88.18.7988; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rani MRS, 1999, J BIOL CHEM, V274, P1891, DOI 10.1074/jbc.274.4.1891; REICH NC, 1990, P NATL ACAD SCI USA, V87, P8761, DOI 10.1073/pnas.87.22.8761; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Soldatenkov VA, 1999, CANCER RES, V59, P5085; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yan H, 1996, MOL CELL BIOL, V16, P2074; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	58	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35733	35741		10.1074/jbc.M111.263608	http://dx.doi.org/10.1074/jbc.M111.263608			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865166	Green Published, hybrid			2022-12-25	WOS:000295927100046
J	Barrett, S; Mohr, PG; Schmidt, PM; McKimm-Breschkin, JL				Barrett, Susan; Mohr, Peter G.; Schmidt, Peter M.; McKimm-Breschkin, Jennifer L.			Real Time Enzyme Inhibition Assays Provide Insights into Differences in Binding of Neuraminidase Inhibitors to Wild Type and Mutant Influenza Viruses	PLOS ONE			English	Article							SLOW-BINDING; ACTIVE-SITE; B VIRUSES; OSELTAMIVIR; SENSITIVITY; RESISTANCE; PERAMIVIR; SIALIDASE; SUSCEPTIBILITY; MUTATIONS	The influenza neuraminidase (NA) inhibitors zanamivir, oseltamivir and peramivir were all designed based on the knowledge that the transition state analogue of the cleaved sialic acid, 2-deoxy, 2,3-dehydro N-acetyl neuraminic acid (DANA) was a weak inhibitor of NA. While DANA bound rapidly to the NA, modifications leading to the improved potency of these new inhibitors also conferred a time dependent or slow binding phenotype. Many mutations in the NA leading to decreased susceptibility result in loss of slow binding, hence this is a phenotypic marker of many but not all resistant NAs. We present here a simplified approach to determine whether an inhibitor is fast or slow binding by extending the endpoint fluorescent enzyme inhibition assay to a real time assay and monitoring the changes in IC(50)s with time. We carried out two reactions, one with a 30 min preincubation with inhibitor and the second without. The enzymatic reaction was started via addition of substrate and IC(50)s were calculated after each 10 min interval up to 60 min. Results showed that without preincubation IC(50)s for the wild type viruses started high and although they decreased continuously over the 60 min reaction time the final IC(50)s remained higher than for pre-incubated samples. These results indicate a slow equilibrium of association and dissociation and are consistent with slow binding of the inhibitors. In contrast, for viruses with decreased susceptibility, preincubation had minimal effect on the IC(50)s, consistent with fast binding. Therefore this modified assay provides additional phenotypic information about the rate of inhibitor binding in addition to the IC(50), and critically demonstrates the differential effect of incubation times on the IC(50) and K(i) values of wild type and mutant viruses for each of the inhibitors.	[Barrett, Susan; Schmidt, Peter M.; McKimm-Breschkin, Jennifer L.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia; [Mohr, Peter G.] CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Barrett, S (corresponding author), CSIRO Mat Sci & Engn, Parkville, Vic, Australia.	mck245@csiro.au	McKimm-Breschkin, Jennifer L/D-1880-2013; Schmidt, Peter/V-3882-2019	Schmidt, Peter/0000-0003-1340-9086; McKimm-Breschkin, Jennifer/0000-0002-2345-6786; Barrett, Susan/0000-0003-1132-5268	NIAID [RO1A1062721]; NHMRC Australia [595625]; MRC UK [77869]; Medical Research Council [G0600514] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062721] Funding Source: NIH RePORTER; MRC [G0600514] Funding Source: UKRI	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Parts of this work were supported by Grant RO1A1062721 from the NIAID http://www.niaid.nih.gov/Pages/default.aspx, a Pandemic influenza grant 595625 from the NHMRC Australia http://www.nhmrc.gov.au/and Grant ID 77869 from the MRC UK http://www.mrc.ac.uk/index. htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantia S, 2006, ANTIVIR RES, V69, P39, DOI 10.1016/j.antiviral.2005.10.002; BANTIA S, 2011, ANTIVIRAL RES; Baum EZ, 2003, ANTIVIR RES, V59, P13, DOI 10.1016/S0166-3542(03)00011-1; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Blick TJ, 1995, VIROLOGY, V214, P475, DOI 10.1006/viro.1995.0058; Buxton RC, 2000, ANAL BIOCHEM, V280, P291, DOI 10.1006/abio.2000.4517; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Hurt AC, 2006, ANTIMICROB AGENTS CH, V50, P1872, DOI 10.1128/AAC.50.5.1872-1874.2006; Kati WM, 1998, BIOCHEM BIOPH RES CO, V244, P408, DOI 10.1006/bbrc.1998.8282; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000786; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; PEGG MS, 1994, BIOCHEM MOL BIOL INT, V32, P851; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Tashiro M, 2009, ANTIVIR THER, V14, P751, DOI 10.3851/IMP1194; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003	28	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23627	10.1371/journal.pone.0023627	http://dx.doi.org/10.1371/journal.pone.0023627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858186	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300071
J	Bedard, JEJ; Haaning, AM; Ware, SM				Bedard, James E. J.; Haaning, Allison M.; Ware, Stephanie M.			Identification of a Novel ZIC3 Isoform and Mutation Screening in Patients with Heterotaxy and Congenital Heart Disease	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; ZINC-FINGER PROTEIN; GLI PROTEINS; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; GREAT-ARTERIES; SUPPRESSOR; DEFECTS; TRANSPOSITION; ABNORMALITIES	Patients with heterotaxy have characteristic cardiovascular malformations, abnormal arrangement of their visceral organs, and midline patterning defects that result from abnormal left-right patterning during embryogenesis. Loss of function of the transcription factor ZIC3 causes X-linked heterotaxy and isolated congenital heart malformations and represents one of the few known monogenic causes of congenital heart disease. The birth incidence of heterotaxy-spectrum malformations is significantly higher in males, but our previous work indicated that mutations within ZIC3 did not account for the male over-representation. Therefore, cross species comparative sequence alignment was used to identify a putative novel fourth exon, and the existence of a novel alternatively spliced transcript was confirmed by amplification from murine embryonic RNA and subsequent sequencing. This transcript, termed Zic3-B, encompasses exons 1, 2, and 4 whereas Zic3-A encompasses exons 1, 2, and 3. The resulting protein isoforms are 466 and 456 amino acid residues respectively, sharing the first 407 residues. Importantly, the last two amino acids in the fifth zinc finger DNA binding domain are altered in the Zic3-B isoform, indicating a potential functional difference that was further evaluated by expression, subcellular localization, and transactivation analyses. The temporo-spatial expression pattern of Zic3-B overlaps with Zic3-A in vivo, and both isoforms are localized to the nucleus in vitro. Both isoforms can transcriptionally activate a Gli binding site reporter, but only ZIC3-A synergistically activates upon co-transfection with Gli3, suggesting that the isoforms are functionally distinct. Screening 109 familial and sporadic male heterotaxy cases did not identify pathogenic mutations in the newly identified fourth exon and larger studies are necessary to establish the importance of the novel isoform in human disease.	Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati	Bedard, JEJ (corresponding author), Adams State Coll, Alamosa, CO 81102 USA.	stephanie.ware@cchmc.org	Ware, Stephanie M./AAF-5577-2020		NIH [HL088639]; American Heart Association [0725539B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (HL088639) to SMW and an American Heart Association Postdoctoral Fellowship Research Award, Great Rivers Affiliate (0725539B) to JEJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUGA J, 1994, J NEUROCHEM, V63, P1880; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Bedard JEJ, 2007, HUM MOL GENET, V16, P187, DOI 10.1093/hmg/ddl461; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; Czosek RJ, 2010, PEDIATR RES, V68, P275, DOI 10.1203/00006450-201011001-00539; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; De Luca A, 2010, HEART, V96, P673, DOI 10.1136/hrt.2009.181685; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kitaguchi T, 2000, DEVELOPMENT, V127, P4787; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Kuiper RP, 2004, NUCLEIC ACIDS RES, V32, P2315, DOI 10.1093/nar/gkh571; Lim LS, 2010, STEM CELLS, V28, P1961, DOI 10.1002/stem.527; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Megarbane A, 2000, EUR J HUM GENET, V8, P704, DOI 10.1038/sj.ejhg.5200526; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nakata K, 1997, P NATL ACAD SCI USA, V94, P11980, DOI 10.1073/pnas.94.22.11980; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Purandare SM, 2002, DEVELOPMENT, V129, P2293; Sakai-Kato K, 2008, BBA-PROTEINS PROTEOM, V1784, P1011, DOI 10.1016/j.bbapap.2008.01.013; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Stone DM, 1999, J CELL SCI, V112, P4437; Tzschach A, 2006, EUR J HUM GENET, V14, P1317, DOI 10.1038/sj.ejhg.5201707; Ware SM, 2006, DEV DYNAM, V235, P776, DOI 10.1002/dvdy.20668; Ware SM, 2004, AM J HUM GENET, V74, P93, DOI 10.1086/380998; Ware SM, 2006, DEV DYNAM, V235, P1631, DOI 10.1002/dvdy.20719; ZHU L, 2007, HUM MUTAT, P1; Zhu L, 2007, HUM MOL GENET, V16, P1649, DOI 10.1093/hmg/ddm106	37	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23755	10.1371/journal.pone.0023755	http://dx.doi.org/10.1371/journal.pone.0023755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858219	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300092
J	Everaert, BR; Boulet, GA; Timmermans, JP; Vrints, CJ				Everaert, Bert R.; Boulet, Gaelle A.; Timmermans, Jean-Pierre; Vrints, Christiaan J.			Importance of Suitable Reference Gene Selection for Quantitative Real-Time PCR: Special Reference to Mouse Myocardial Infarction Studies	PLOS ONE			English	Article							EXPRESSION	Background: Quantitative real-time PCR (qPCR) is a widely used technique for gene expression analysis. Its reliability is highly dependent upon selection of the appropriate reference genes for accurate gene expression normalization. In this study, we investigated the expression stability of 10 commonly used reference genes in a mouse myocardial infarction model. Methods & Results: The expression stability of the 10 reference genes (Actb, B2m, Eef1a1, Gapdh, Hprt, Polr2a, Ppia, Rpl13a, Tbp, Tpt1) was analyzed using the geNorm software. Overall, the combination of Hprt, Rpl13a and Tpt1 was the most stable reference gene set in our experiments. Gapdh, Polr2a and Actb consistently showed the highest gene expression variability and the expression levels of Gapdh, Polr2a, Actb, B2m and Eef1a1 were found to be selectively up-or downregulated after myocardial infarction. We normalized the expression of Nppb and Vcam1, using different reference gene strategies and demonstrated that their induction after myocardial infarction was most clearly revealed with the optimal reference gene combination. However, the use of suboptimal reference gene combinations resulted in detrimental effects on gene expression levels and variability with a gradual loss of the expression differences and a significant reduction in statistical power. Conclusions: Hprt, Rpl13a and Tpt1 are a set of stably expressed reference genes for accurate gene expression normalization in myocardial infarction studies in mice. We found that Gapdh, Polr2a and Actb display high expression variability in mouse myocardial infarction tissues and that loss of statistical power and increase in sample size are the evident consequences of choosing suboptimal combinations of reference genes. We furthermore caution against the use of Gapdh, Polr2a, Actb, B2m and Eef1a1 for gene expression normalization in myocardial infarction studies because of selective up-or downregulation after myocardial infarction, which could potentially lead to biased study outcomes.	[Everaert, Bert R.; Boulet, Gaelle A.; Timmermans, Jean-Pierre] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium; [Everaert, Bert R.; Vrints, Christiaan J.] Univ Antwerp Hosp, Lab Cellular & Mol Cardiol, Antwerp, Belgium	University of Antwerp; University of Antwerp	Everaert, BR (corresponding author), Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium.	bert.everaert@ua.ac.be		Timmermans, Jean-Pierre/0000-0003-2506-6252	Research Foundation - Flanders (FWO) [G014906]	Research Foundation - Flanders (FWO)(FWO)	This work was supported by the Research Foundation - Flanders (FWO), grant No. G014906. B. Everaert is supported by a Ph.D. fellowship of the Reseach Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bommer UA, 2010, ONCOGENE, V29, P763, DOI 10.1038/onc.2009.380; Brattelid T, 2007, BASIC RES CARDIOL, V102, P198, DOI 10.1007/s00395-007-0648-1; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Lenth RV, JAVA APPLETS POWER S; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Perez S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-114; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Thiele H, 2000, EUR J BIOCHEM, V267, P5473, DOI 10.1046/j.1432-1327.2000.01609.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	21	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23793	10.1371/journal.pone.0023793	http://dx.doi.org/10.1371/journal.pone.0023793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858224	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300096
J	Friberg, U; Stewart, AD; Rice, WR				Friberg, Urban; Stewart, Andrew D.; Rice, William R.			Empirical Evidence for Son-Killing X Chromosomes and the Operation of SA-Zygotic Drive	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; Y-CHROMOSOME; CONFLICT; SIMULANS; SYSTEM; GENES	Background: Diploid organisms have two copies of all genes, but only one is carried by each haploid gamete and diploid offspring. This causes a fundamental genetic conflict over transmission rate between alternative alleles. Single genes, or gene clusters, only rarely code for the complex phenotypes needed to give them a transmission advantage (drive phenotype). However, all genes on a male's X and Y chromosomes co-segregate, allowing different sex-linked genes to code for different parts of the drive phenotype. Correspondingly, the well-characterized phenomenon of male gametic drive, occurring during haploid gametogenesis, is especially common on sex chromosomes. The new theory of sexually antagonistic zygotic drive of the sex chromosomes (SA-zygotic drive) extends the logic of gametic drive into the diploid phase of the lifecycle, whenever there is competition among siblings or harmful sib-sib mating. The X and Y are predicted to gain a transmission advantage by harming offspring of the sex that does not carry them. Results: Here we analyzed a mutant X-chromosome in Drosophila simulans that produced an excess of daughters when transmitted from males. We developed a series of tests to differentiate between gametic and SA-zygotic drive, and provide multiple lines of evidence that SA-zygotic drive is responsible for the sex ratio bias. Driving sires produce about 50% more surviving daughters than sons. Conclusion: Sex-ratio distortion due to genetic conflict has evolved via gametic drive and maternally transmitted endosymbionts. Our data indicate that sex chromosomes can also drive by harming the non-carrier sex of offspring.	[Friberg, Urban; Stewart, Andrew D.; Rice, William R.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Friberg, Urban] Uppsala Univ, Dept Evolutionary Biol, Uppsala, Sweden	University of California System; University of California Santa Barbara; Uppsala University	Friberg, U (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	Urban.Friberg@ebc.uu.se	Friberg, Urban/C-9412-2015; Friberg, Urban/H-4569-2011	Friberg, Urban/0000-0001-6112-9586; 	National Science Foundation [DEB-0128780, DEB-0111613]; National Institutes of Health [1R01HD057974-01]; Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057974] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Science Foundation (DEB-0128780 and DEB-0111613), the National Institutes of Health (1R01HD057974-01), and the Wenner-Gren Foundations (http://www.swgc.org/index.aspx?languageID = 5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Burt A, 2006, GENES CONFLICT BIOL; Dawkins R, 1976, SELFISH GENE; Fox M, 2010, P ROY SOC B-BIOL SCI, V277, P567, DOI 10.1098/rspb.2009.1660; Golic KG, 1998, CURR BIOL, V8, P1273, DOI 10.1016/S0960-9822(07)00537-4; HOFFMANN AA, 1985, AM NAT, V125, P421, DOI 10.1086/284351; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; HURST LD, 1992, P ROY SOC B-BIOL SCI, V248, P135, DOI 10.1098/rspb.1992.0053; Jaenike J, 2003, EVOL ECOL RES, V5, P1023; Koerich LB, 2008, NATURE, V456, P949, DOI 10.1038/nature07463; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lloyd V, 2000, GENETICA, V109, P35, DOI 10.1023/A:1026592318341; Maggert KA, 2002, GENETICS, V162, P1245; Menon DU, 2009, GENETICS, V183, P811, DOI 10.1534/genetics.109.107219; Miller PM, 2006, SCIENCE, V312, P73, DOI 10.1126/science.1123727; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; NEELEY JC, 1971, J HERED, V62, P334, DOI 10.1093/oxfordjournals.jhered.a108187; NOOR MAF, 1995, RES NOTE DROSOPHILA, V76, P151; Rice WR, 2010, P ROY SOC B-BIOL SCI, V277, P2727, DOI 10.1098/rspb.2010.0409; Rice WR, 2009, BIOL LETTERS, V5, P686, DOI 10.1098/rsbl.2009.0061; Rice WR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000313; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Tao Y, 2007, PLOS BIOL, V5, P2560, DOI 10.1371/journal.pbio.0050292; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; Williamson DL., 1979, MYCOPLASMAS, P175, DOI [10.1016/B978-0-12-078403-5.50012-8, DOI 10.1016/B978-0-12-078403-5.50012-8]	27	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23508	10.1371/journal.pone.0023508	http://dx.doi.org/10.1371/journal.pone.0023508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858149	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300054
J	Nagoor, NH; Muttiah, NSJ; Lim, CS; In, LLA; Mohammad, K; Awang, K				Nagoor, Noor Hasima; Muttiah, Norliza Shah Jehan; Lim, Chong Soon; In, Lionel L. A.; Mohammad, Khalit; Awang, Khalijah			Regulation of Apoptotic Effects by Erythrocarpine E, a Cytotoxic Limonoid from Chisocheton erythrocarpus in HSC-4 Human Oral Cancer Cells	PLOS ONE			English	Article							PRODUCTS; BAX	The aim of this study was to determine the cytotoxic and apoptotic effects of erythrocarpine E (CEB4), a limonoid extracted from Chisocheton erythrocarpus on human oral squamous cell carcinoma. Based on preliminary dimethyl-2-thiazolyl-2,5-diphenyl-2H-tetrazolium bromide (MTT) assays, CEB4 treated HSC-4 cells demonstrated a cytotoxic effect and inhibited cell proliferation in a time and dose dependent manner with an IC50 value of 4.0+/-1.9 mu M within 24 h of treatment. CEB4 was also found to have minimal cytotoxic effects on the normal cell line, NHBE with cell viability levels maintained above 80% upon treatment. Annexin V-fluorescein isothiocyanate (FITC), poly-ADP ribose polymerase (PARP) cleavage and DNA fragmentation assay results showed that CEB4 induces apoptosis mediated cell death. Western blotting results demonstrated that the induction of apoptosis by CEB4 appeared to be mediated through regulation of the p53 signalling pathway as there was an increase in p53 phosphorylation levels. CEB4 was also found to up-regulate the pro-apoptotic protein, Bax, while down-regulating the anti-apoptotic protein, Bcl-2, suggesting the involvement of the intrinsic mitochondrial pathway. Reduced levels of initiator procaspase-9 and executioner caspase-3 zymogen were also observed following CEB4 exposure, hence indicating the involvement of cytochrome c mediated apoptosis. These results demonstrate the cytotoxic and apoptotic ability of erythrocarpine E, and suggest its potential development as a cancer chemopreventive agent.	[Nagoor, Noor Hasima; Muttiah, Norliza Shah Jehan; In, Lionel L. A.] Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia; [Lim, Chong Soon; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Ctr Nat Prod Res & Drug Discovery CENAR, Kuala Lumpur 59100, Malaysia; [Mohammad, Khalit] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Nagoor, NH (corresponding author), Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia.	hasima@um.edu.my; lionelin@um.edu.my	IN, LIONEL/AAI-9847-2020; In, Lionel/D-1338-2013; PITCHAI, NOOR HASIMA A K NAGOOR/B-9270-2010; AWANG, KHALIJAH/B-8781-2010	IN, LIONEL/0000-0001-7182-112X; In, Lionel/0000-0001-7182-112X; AWANG, KHALIJAH/0000-0001-5971-6570	University of Malaya [PS166-2008B, RG0008/09BIO]; Ministry of Science, Technology and Innovation (MOSTI) [12-02-03-2022]; Centre for Natural Product Research and Drug Discovery (CENAR) [4911274]	University of Malaya(Universiti Malaya); Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Centre for Natural Product Research and Drug Discovery (CENAR)	This study was supported by the University of Malaya Postgraduate Research Grant (PPP) (PS166-2008B), the Ministry of Science, Technology and Innovation (MOSTI) eScience Fund (12-02-03-2022), the University of Malaya Research Grant (UMRG) (RG0008/09BIO), and the Centre for Natural Product Research and Drug Discovery (CENAR) Grant (4911274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awang K, 2007, BIOORGAN MED CHEM, V15, P5997, DOI 10.1016/j.bmc.2007.05.049; Bursztajn S, 2000, MOL BRAIN RES, V76, P363; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Gewies A, 2003, APOREVIEW, V1002, P1; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Guthrie N., 2000, CITRUS LIMONOIDS FUN, V758, P164, DOI DOI 10.1021/BK-2000-0758.CH012; Hasima N, 2010, PHYTOMEDICINE, V17, P935, DOI 10.1016/j.phymed.2010.03.011; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; JESSIE L, 1999, AAPS PHARMSCI, V1, P1; Kumar S, 2006, J ETHNOPHARMACOL, V105, P246, DOI 10.1016/j.jep.2005.11.006; LAM LKT, 1994, FOOD TECHNOL-CHICAGO, V48, P104; Matsumoto H, 2004, JPN J CLIN ONCOL, V34, P124, DOI 10.1093/jjco/hyh026; OZAKI Y, 1995, J FOOD SCI, V60, P186, DOI 10.1111/j.1365-2621.1995.tb05634.x; Patil JR, 2010, MICROCHEM J, V94, P108, DOI 10.1016/j.microc.2009.09.008; Patil JR, 2009, FOOD CHEM, V114, P1351, DOI 10.1016/j.foodchem.2008.11.033; Tanaka T., 2000, CITRUS LIMONOIDS FUN, P145, DOI DOI 10.1021/BK-2000-0758.CH011; Tolis C, 1999, EUR J CANCER, V35, P796, DOI 10.1016/S0959-8049(98)00425-0; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Zhao JF, 2009, MICROB PATHOGENESIS, V46, P194, DOI 10.1016/j.micpath.2008.12.005	22	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23661	10.1371/journal.pone.0023661	http://dx.doi.org/10.1371/journal.pone.0023661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858194	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300075
J	Scott, D; Shields, A; Straker, M; Dalrymple, H; Dhillon, PK; Harbinder, S				Scott, David; Shields, Alicia; Straker, Michaela; Dalrymple, Heidi; Dhillon, Priya K.; Harbinder, Singh			Variation in the Male Pheromones and Mating Success of Wild Caught Drosophila melanogaster	PLOS ONE			English	Article							CIS-VACCENYL ACETATE; CUTICULAR HYDROCARBONS; INCIPIENT SPECIATION; BEHAVIORAL-RESPONSES; GENETIC-ANALYSIS; MALE COURTSHIP; SEX-PHEROMONE; FEMALES; SONG; ATTRACTIVENESS	Drosophila melanogaster males express two primary cuticular hydrocarbons (male-predominant hydrocarbons). These act as sex pheromones by influencing female receptivity to mating. The relative quantities of these hydrocarbons vary widely among natural populations and can contribute to variation in mating success. We tested four isofemale lines collected from a wild population to assess the effect of intrapopulation variation in male-predominant hydrocarbons on mating success. The receptivity of laboratory females to males of the four wild-caught lines varied significantly, but not consistently in the direction predicted by variation in male-predominant hydrocarbons. Receptivity of the wild-caught females to laboratory males also varied significantly, but females from lines with male-predominant hydrocarbon profiles closer to a more cosmopolitan one did not show a correspondingly strong mating bias toward a cosmopolitan male. Among wild-caught lines, the male-specific ejaculatory bulb lipid, cis-vaccenyl acetate, varied more than two-fold, but was not associated with variation in male mating success. We observed a strong inverse relationship between the receptivity of wild-caught females and the mating success of males from their own lines, when tested with laboratory flies of the opposite sex.	[Scott, David; Straker, Michaela] S Carolina State Univ, Dept Biol & Phys Sci, Orangeburg, SC 29117 USA; [Shields, Alicia] Stanford Univ, Beckman Ctr, Sch Med, Stanford, CA 94305 USA; [Dalrymple, Heidi] St Georges Univ Grenagde, Univ Ctr, Sch Med, St Georges, Grenada; [Dhillon, Priya K.; Harbinder, Singh] Delaware State Univ, Dept Biol, Dover, DE USA	South Carolina State University; Stanford University; Delaware State University	Scott, D (corresponding author), S Carolina State Univ, Dept Biol & Phys Sci, Orangeburg, SC 29117 USA.	dscott@physics.scsu.edu	Dhillon, Harbinder Singh/J-1981-2019	Dhillon, Harbinder Singh/0000-0002-9760-6724; Shields, Alicia/0000-0002-0280-7188	United States Department of Agriculture, Cooperative State Research Service [CRS SCX-420-18-04]	United States Department of Agriculture, Cooperative State Research Service(United States Department of Agriculture (USDA))	This research was funded by the United States Department of Agriculture, Cooperative State Research Service, Grant # CRS SCX-420-18-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Blows MW, 1999, P ROY SOC B-BIOL SCI, V266, P2169, DOI 10.1098/rspb.1999.0904; Box GE., 1978, STAT EXPT; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Carson HL, 2002, GENETICA, V116, P383, DOI 10.1023/A:1021280325474; Casares P, 2007, BEHAV GENET, V37, P498, DOI 10.1007/s10519-006-9141-0; Coyne JA, 1999, GENET RES, V73, P189, DOI 10.1017/S0016672398003723; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Etges WJ, 2008, J EVOLUTION BIOL, V21, P1641, DOI 10.1111/j.1420-9101.2008.01601.x; Etges WJ, 2007, EVOLUTION, V61, P1106, DOI 10.1111/j.1558-5646.2007.00104.x; Etges WJ, 2010, EVOLUTION, V64, P3549, DOI 10.1111/j.1558-5646.2010.01096.x; Etges WJ, 2009, EVOLUTION, V63, P1712, DOI 10.1111/j.1558-5646.2009.00661.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 1996, GENET RES, V67, P211, DOI 10.1017/S0016672300033693; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Ferveur JF, 1996, GENETICA, V97, P73, DOI 10.1007/BF00132583; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Hoikkala A, 2005, CURR TOP DEV BIOL, V67, P225, DOI 10.1016/S0070-2153(05)67007-X; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; MARKOW TA, 1981, P NATL ACAD SCI-BIOL, V78, P430, DOI 10.1073/pnas.78.1.430; Petfield D, 2005, P NATL ACAD SCI USA, V102, P6045, DOI 10.1073/pnas.0409378102; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; SCOTT D, 1986, P NATL ACAD SCI USA, V83, P8429, DOI 10.1073/pnas.83.21.8429; SCOTT D, 1987, J INSECT PHYSIOL, V33, P363, DOI 10.1016/0022-1910(87)90125-9; SCOTT D, 1988, GENETICS, V119, P639; SCOTT D, 1988, J INSECT PHYSIOL, V34, P863, DOI 10.1016/0022-1910(88)90120-5; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; SCOTT D, 1994, EVOLUTION, V48, P112, DOI [10.2307/2410007, 10.1111/j.1558-5646.1994.tb01298.x]; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P383; Svetec N, 2005, GENET RES, V85, P183, DOI 10.1017/S0016672305007536; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; VANDENBERG MJ, 1984, BEHAV GENET, V14, P45, DOI 10.1007/BF01066068; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x; Yew JY, 2008, P NATL ACAD SCI USA, V105, P7135, DOI 10.1073/pnas.0802692105; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	41	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23645	10.1371/journal.pone.0023645	http://dx.doi.org/10.1371/journal.pone.0023645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858189	gold, Green Submitted, Green Published			2022-12-25	WOS:000294121300073
J	Baugh, EH; Lyskov, S; Weitzner, BD; Gray, JJ				Baugh, Evan H.; Lyskov, Sergey; Weitzner, Brian D.; Gray, Jeffrey J.			Real-Time PyMOL Visualization for Rosetta and PyRosetta	PLOS ONE			English	Article							SWISS-MODEL; PROTEIN	Computational structure prediction and design of proteins and protein-protein complexes have long been inaccessible to those not directly involved in the field. A key missing component has been the ability to visualize the progress of calculations to better understand them. Rosetta is one simulation suite that would benefit from a robust real-time visualization solution. Several tools exist for the sole purpose of visualizing biomolecules; one of the most popular tools, PyMOL (Schrodinger), is a powerful, highly extensible, user friendly, and attractive package. Integrating Rosetta and PyMOL directly has many technical and logistical obstacles inhibiting usage. To circumvent these issues, we developed a novel solution based on transmitting biomolecular structure and energy information via UDP sockets. Rosetta and PyMOL run as separate processes, thereby avoiding many technical obstacles while visualizing information on-demand in real-time. When Rosetta detects changes in the structure of a protein, new coordinates are sent over a UDP network socket to a PyMOL instance running a UDP socket listener. PyMOL then interprets and displays the molecule. This implementation also allows remote execution of Rosetta. When combined with PyRosetta, this visualization solution provides an interactive environment for protein structure prediction and design.	[Baugh, Evan H.; Lyskov, Sergey; Weitzner, Brian D.; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Baugh, EH (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	pyrosetta@graylab.jhu.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Weitzner, Brian/0000-0002-1909-0961	National Institutes of Health [R01-GM073151]; National Science Foundation [CBET 0846324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grant R01-GM073151 and a National Science Foundation CAREER grant to JJG (CBET 0846324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; FRIGERIO F, 1992, J MOL BIOL, V225, P107, DOI 10.1016/0022-2836(92)91029-O; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson GT, 2011, STRUCTURE, V19, P293, DOI 10.1016/j.str.2010.12.023; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; O'Donoghue SI, 2010, NAT METHODS, V7, pS42, DOI [10.1038/NMETH.1427, 10.1038/nmeth.1427]; RICHARDSON DC, 1992, PROTEIN SCI, V1, P3; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Wang Yi, 2011, Comput Sci Discov, V4, DOI 10.1088/1749-4699/4/1/015002	17	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e21931	10.1371/journal.pone.0021931	http://dx.doi.org/10.1371/journal.pone.0021931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857909	gold, Green Published, Green Submitted			2022-12-25	WOS:000294125500005
J	Igari, S; Ohtaki, A; Yamanaka, Y; Sato, Y; Yohda, M; Odaka, M; Noguchi, K; Yamada, K				Igari, Sayaka; Ohtaki, Akashi; Yamanaka, Yasuaki; Sato, Yuichi; Yohda, Masafumi; Odaka, Masafumi; Noguchi, Keiichi; Yamada, Kazuhiro			Properties and Crystal Structure of Methylenetetrahydrofolate Reductase from Thermus thermophilus HB8	PLOS ONE			English	Article							DEPENDENT 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; ESCHERICHIA-COLI; VASCULAR-DISEASE; RISK-FACTOR; PURIFICATION; ASPARTATE-120; CATALYSIS; BINDING; ROLES	Background: Methylenetetrahydrofolate reductase ( MTHFR) is one of the enzymes involved in homocysteine metabolism. Despite considerable genetic and clinical attention, the reaction mechanism and regulation of this enzyme are not fully understood because of difficult production and poor stability. While recombinant enzymes from thermophilic organisms are often stable and easy to prepare, properties of thermostable MTHFRs have not yet been reported. Methodology/Principal Findings: MTHFR from Thermus thermophilus HB8, a homologue of Escherichia coli MetF, has been expressed in E. coli and purified. The purified MTHFR was chiefly obtained as a heterodimer of apo- and holo-subunits, that is, one flavin adenine dinucleotide ( FAD) prosthetic group bound per dimer. The crystal structure of the holo-subunit was quite similar to the beta(8)alpha(8) barrel of E. coli MTHFR, while that of the apo-subunit was a previously unobserved closed form. In addition, the intersubunit interface of the dimer in the crystals was different from any of the subunit interfaces of the tetramer of E. coli MTHFR. Free FAD could be incorporated into the apo-subunit of the purified Thermus enzyme after purification, forming a homodimer of holo-subunits. Comparison of the crystal structures of the heterodimer and the homodimer revealed different intersubunit interfaces, indicating a large conformational change upon FAD binding. Most of the biochemical properties of the heterodimer and the homodimer were the same, except that the homodimer showed approximate to 50% activity per FAD-bound subunit in folate-dependent reactions. Conclusions/Significance: The different intersubunit interfaces and rearrangement of subunits of Thermus MTHFR may be related to human enzyme properties, such as the allosteric regulation by S-adenosylmethionine and the enhanced instability of the Ala222Val mutant upon loss of FAD. Whereas E. coli MTHFR was the only structural model for human MTHFR to date, our findings suggest that Thermus MTHFR will be another useful model for this important enzyme.	[Igari, Sayaka; Ohtaki, Akashi; Yamanaka, Yasuaki; Sato, Yuichi; Yohda, Masafumi; Odaka, Masafumi; Noguchi, Keiichi; Yamada, Kazuhiro] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan	Tokyo University of Agriculture & Technology	Igari, S (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan.	yamadak@cc.tuat.ac.jp	Yohda, Masafumi/A-5149-2013; Noguchi, Keiichi/B-9978-2013; Odaka, Masafumi/C-2378-2013	Yohda, Masafumi/0000-0001-8307-9671; Noguchi, Keiichi/0000-0003-0833-0808; 	Ministry of Education, Culture, Sports, Science and Technology through the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21570132] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology through the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology through the Japan Science and Technology Agency (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLARK JE, 1984, J BIOL CHEM, V259, P845; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DRUMMOND JT, 1995, ANAL BIOCHEM, V228, P323, DOI 10.1006/abio.1995.1358; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MN, 2009, BIOCHEMISTRY-US, V48, P7673, DOI 10.1021/bi9007325; MATTHEWS RG, 1984, J BIOL CHEM, V259, P1647; MATTHEWS RG, 1986, METHOD ENZYMOL, V122, P372; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2006, BIOCHEMISTRY-US, V45, P4808, DOI 10.1021/bi052294c; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Roje S, 1999, J BIOL CHEM, V274, P36089, DOI 10.1074/jbc.274.51.36089; Segel I.H., 1975, ENZYME KINETICS; Sheppard CA, 1999, J BACTERIOL, V181, P718, DOI 10.1128/JB.181.3.718-725.1999; Trimmer EE, 2005, BIOCHEMISTRY-US, V44, P6809, DOI 10.1021/bi0477236; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6205, DOI 10.1021/bi002789w; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6216, DOI 10.1021/bi002790v; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Williams C H Jr, 1979, Methods Enzymol, V62, P185; WOHLFARTH G, 1990, EUR J BIOCHEM, V192, P411, DOI 10.1111/j.1432-1033.1990.tb19242.x; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	29	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23716	10.1371/journal.pone.0023716	http://dx.doi.org/10.1371/journal.pone.0023716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858212	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700040
J	Singh, NP; Singh, UP; Singh, B; Price, RL; Nagarkatti, M; Nagarkatti, PS				Singh, Narendra P.; Singh, Udai P.; Singh, Balwan; Price, Robert L.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.			Activation of Aryl Hydrocarbon Receptor (AhR) Leads to Reciprocal Epigenetic Regulation of FoxP3 and IL-17 Expression and Amelioration of Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HELPER-CELL DIFFERENTIATION; NF-KAPPA-B; T-CELLS; FAS LIGAND; IN-VIVO; CHEMOKINE RECEPTORS; ULCERATIVE-COLITIS; DNA METHYLATION; IL-10(-/-) MICE	Background: Aryl hydrocarbon receptor (AhR), a transcription factor of the bHLH/PAS family, is well characterized to regulate the biochemical and toxic effects of environmental chemicals. More recently, AhR activation has been shown to regulate the differentiation of Foxp3(+) Tregs as well as Th17 cells. However, the precise mechanisms are unclear. In the current study, we investigated the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent AhR ligand, on epigenetic regulation leading to altered Treg/Th17 differentiation, and consequent suppression of colitis. Methodology/Principal Findings: Dextran sodium sulphate (DSS) administration induced acute colitis in C57BL/6 mice, as shown by significant weight loss, shortening of colon, mucosal ulceration, and increased presence of CXCR3(+) T cells as well as inflammatory cytokines. Interestingly, a single dose of TCDD (25 mg/kg body weight) was able to attenuate all of the clinical and inflammatory markers of colitis. Analysis of T cells in the lamina propria (LP) and mesenteric lymph nodes (MLN), during colitis, revealed decreased presence of Tregs and increased induction of Th17 cells, which was reversed following TCDD treatment. Activation of T cells from AhR(+/+) but not AhR(-/-) mice, in the presence of TCDD, promoted increased differentiation of Tregs while inhibiting Th17 cells. Analysis of MLN or LP cells during colitis revealed increased methylation of CpG islands of Foxp3 and demethylation of IL-17 promoters, which was reversed following TCDD treatment. Conclusions/Significance: These studies demonstrate for the first time that AhR activation promotes epigenetic regulation thereby influencing reciprocal differentiation of Tregs and Th17 cells, and amelioration of inflammation.	[Singh, Narendra P.; Singh, Udai P.; Price, Robert L.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Singh, Balwan] Emory Univ, Primate Res Ctr, Atlanta, GA 30322 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Emory University	Singh, NP (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	pnagark@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Singh, Udai/0000-0002-7048-4325	National Institutes of Health [R01-DA016545, R01-ES09098, P01-AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was funded by National Institutes of Health (R01-DA016545, R01-ES09098, and P01-AT003961 to MN and PSN). The funding agency had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Beedanagari SR, 2010, MOL PHARMACOL, V78, P608, DOI 10.1124/mol.110.064899; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Camacho IA, 2005, J IMMUNOL, V175, P90, DOI 10.4049/jimmunol.175.1.90; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; CLARK DA, 1981, P SOC EXP BIOL MED, V168, P290; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Desaulniers D, 2005, TOXICOL SCI, V86, P175, DOI 10.1093/toxsci/kfi178; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Kamath AB, 1999, TOXICOL APPL PHARM, V160, P141, DOI 10.1006/taap.1999.8753; Kamath AB, 1997, TOXICOL APPL PHARM, V142, P367, DOI 10.1006/taap.1996.8049; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon JH, 2005, AM J PHYSIOL-GASTR L, V289, pG1075, DOI 10.1152/ajpgi.00073.2005; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Luster MI, 2010, METHODS MOL BIOL, V598, P3, DOI 10.1007/978-1-60761-401-2_1; Marshall NB, 2010, ANN NY ACAD SCI, V1183, P25, DOI 10.1111/j.1749-6632.2009.05125.x; Mir A, 2002, AM J GASTROENTEROL, V97, P1452, DOI 10.1016/S0002-9270(02)04043-1; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NAGARKATTI PS, 1984, TOXICOL APPL PHARM, V72, P169, DOI 10.1016/0041-008X(84)90261-8; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Scheerens H, 2001, EUR J IMMUNOL, V31, P1465, DOI 10.1002/1521-4141(200105)31:5<1465::AID-IMMU1465>3.0.CO;2-E; Singh NP, 2008, MOL PHARMACOL, V73, P1722, DOI 10.1124/mol.107.043406; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Singh NP, 2007, MOL PHARMACOL, V71, P145, DOI 10.1124/mol.106.028365; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Singh UP, 2003, J IMMUNOL, V171, P1401, DOI 10.4049/jimmunol.171.3.1401; Singh UP, 2003, J INTERFERON CYTOKIN, V23, P2000; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; TAKAMURA T, 2010, IMMUNOL CELL BIOL; Tian YA, 2009, BIOCHEM PHARMACOL, V77, P670, DOI 10.1016/j.bcp.2008.10.023; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	58	189	204	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23522	10.1371/journal.pone.0023522	http://dx.doi.org/10.1371/journal.pone.0023522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858153	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700028
J	Aburto-Oropeza, O; Erisman, B; Galland, GR; Mascarenas-Osorio, I; Sala, E; Ezcurra, E				Aburto-Oropeza, Octavio; Erisman, Brad; Galland, Grantly R.; Mascarenas-Osorio, Ismael; Sala, Enric; Ezcurra, Exequiel			Large Recovery of Fish Biomass in a No-Take Marine Reserve	PLOS ONE			English	Article							CORAL-REEFS; PROTECTION; COMMUNITIES; ASSEMBLAGES; FISHERIES; ISLANDS; TRENDS; RATES; SIZE	No-take marine reserves are effective management tools used to restore fish biomass and community structure in areas depleted by overfishing. Cabo Pulmo National Park (CPNP) was created in 1995 and is the only well enforced no-take area in the Gulf of California, Mexico, mostly because of widespread support from the local community. In 1999, four years after the establishment of the reserve, there were no significant differences in fish biomass between CPNP (0.75 t ha(-1) on average) and other marine protected areas or open access areas in the Gulf of California. By 2009, total fish biomass at CPNP had increased to 4.24 t ha(-1) (absolute biomass increase of 3.49 t ha(-1), or 463%), and the biomass of top predators and carnivores increased by 11 and 4 times, respectively. However, fish biomass did not change significantly in other marine protected areas or open access areas over the same time period. The absolute increase in fish biomass at CPNP within a decade is the largest measured in a marine reserve worldwide, and it is likely due to a combination of social (strong community leadership, social cohesion, effective enforcement) and ecological factors. The recovery of fish biomass inside CPNP has resulted in significant economic benefits, indicating that community-managed marine reserves are a viable solution to unsustainable coastal development and fisheries collapse in the Gulf of California and elsewhere.	[Aburto-Oropeza, Octavio; Erisman, Brad; Galland, Grantly R.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Mascarenas-Osorio, Ismael] Ctr Biodiversidad Marina & Conservac, La Paz, Bcs, Mexico; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Sala, Enric] Ctr Estudis Avancats Blanes CSIC, Blanes, Spain; [Ezcurra, Exequiel] Univ Calif Riverside, UC MEXUS, Riverside, CA 92521 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Riverside	Aburto-Oropeza, O (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	maburto@ucsd.edu	Erisman, Brad/R-8827-2019; Erisman, Brad/P-1640-2019	Erisman, Brad/0000-0002-9336-7957; Erisman, Brad/0000-0002-9336-7957; Aburto-Oropeza, Octavio/0000-0002-8173-1432	Kathryn Fuller Fellowship - WWF Scientific Program; David and Lucile Packard Foundation; Tinker Foundation; Robins Family Foundation; Pew Fellowship Program on Marine Conservation; Walton Family Foundation	Kathryn Fuller Fellowship - WWF Scientific Program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Tinker Foundation; Robins Family Foundation; Pew Fellowship Program on Marine Conservation; Walton Family Foundation	OA-O was supported by a Kathryn Fuller Fellowship - WWF Scientific Program. Additional funding for this research was provided by the David and Lucile Packard Foundation, The Tinker Foundation, the Robins Family Foundation, the Pew Fellowship Program on Marine Conservation, and the Walton Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O., 2006, RED RESERVAS MARINAS; Aburto-Oropeza O, 2007, ECOLOGY, V88, P2220, DOI 10.1890/06-0857.1; Aburto-Oropeza O, 2009, MAR BIOL, V156, P2461, DOI 10.1007/s00227-009-1271-5; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bonilla HR, 1997, CONSERV BIOL, V11, P838; Cudney-Bueno R, 2009, OCEAN COAST MANAGE, V52, P207, DOI 10.1016/j.ocecoaman.2008.12.005; DELATORRE JAM, 2008, TURISMO SUSTENTABILI, P133; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2005, MAR ECOL PROG SER, V297, P259, DOI 10.3354/meps297259; Erisman BE, 2011, ICES J MAR SCI, V68, P564, DOI 10.1093/icesjms/fsq179; Ezcurra E., 2009, ECOSYSTEM BASED MANA, P227; FRAGA J, 2008, COASTAL MARINE PROTE, P16976; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Froese R., 2011, FISHBASE WORLD WIDE; Gamez A. E., 2008, TURISMO SUSTENTABILI; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harmelin-Vivien Mireille L., 2002, P265, DOI 10.1016/B978-012615185-5/50016-5; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Leisher C., 2007, NATURES INVESTMENT B; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; LOPEZSAGASTEGUI C, 2005, MARINE BIODIVERSITY, P16976; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Montes HML, 2008, FRONT ECOL ENVIRON, V6, P75, DOI 10.1890/070056; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; PESENTI C, 2003, SUSTAINABLE COASTAL, P16976; Roberts CM, 1997, CORAL REEFS, V16, P150, DOI 10.1007/BF03257480; ROBERTS CM, 1995, CONSERV BIOL, V9, P815, DOI 10.1046/j.1523-1739.1995.09040815.x; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 1999, CORAL REEFS, V18, P307, DOI 10.1007/s003380050203; SAENZARROYO A, 2005, DESIGN EVALUATION MA, P16976; Sagarin AD, 2008, FRONT ECOL ENVIRON, V6, P374, DOI 10.1890/070067; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Sala E, 2003, B MAR SCI, V72, P103; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; SQUIRES DONALD F., 1959, BULL AMER MUS NAT HIST, V118, P367; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	54	147	153	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23601	10.1371/journal.pone.0023601	http://dx.doi.org/10.1371/journal.pone.0023601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858183	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500058
J	Le Lay, S; Rodriguez, M; Jessup, W; Rentero, C; Li, Q; Cartland, S; Grewal, T; Gaus, K				Le Lay, Soazig; Rodriguez, Macarena; Jessup, Wendy; Rentero, Carles; Li, Qiong; Cartland, Sian; Grewal, Thomas; Gaus, Katharina			Caveolin-1-Mediated Apolipoprotein A-I Membrane Binding Sites Are Not Required for Cholesterol Efflux	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR-BI; AORTIC ENDOTHELIAL-CELLS; CASSETTE TRANSPORTER A1; MACROPHAGE FOAM CELLS; CELLULAR CHOLESTEROL; PLASMA-MEMBRANE; SR-BI; LIPID RAFTS; APOA-I	Caveolin-1 (Cav1), a structural protein required for the formation of invaginated membrane domains known as caveolae, has been implicated in cholesterol trafficking and homeostasis. Here we investigated the contribution of Cav1 to apolipoprotein A-I (apoA-I) cell surface binding and intracellular processing using mouse embryonic fibroblasts (MEFs) derived from wild type (WT) or Cav1-deficient (Cav1(-/-)) animals. We found that cells expressing Cav1 have 2.6-fold more apoA-I binding sites than Cav1(-/-) cells although these additional binding sites are not associated with detergent-free lipid rafts. Further, Cav1-mediated binding targets apoA-I for internalization and degradation and these processes are not correlated to cholesterol efflux. Despite lower apoA-I binding, cholesterol efflux from Cav1(-/-) MEFs is 1.7-fold higher than from WT MEFs. Stimulation of ABCA1 expression with an LXR agonist enhances cholesterol efflux from both WT and Cav1(-/-) cells without increasing apoA-I surface binding or affecting apoA-I processing. Our results indicate that there are at least two independent lipid binding sites for apoA-I; Cav1-mediated apoA-I surface binding and uptake is not linked to cholesterol efflux, indicating that membrane domains other than caveolae regulate ABCA1-mediated cholesterol efflux.	[Le Lay, Soazig] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Rodriguez, Macarena; Jessup, Wendy; Rentero, Carles; Li, Qiong; Cartland, Sian; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of New South Wales Sydney; University of Sydney	Le Lay, S (corresponding author), Ctr Rech Cordeliers, INSERM, U872, Paris, France.	k.gaus@unsw.edu.au	Le Lay, Soazig/AAI-2442-2021; Le Lay, Soazig/N-6862-2018; Rentero Alfonso, Carles/L-4430-2017	Le Lay, Soazig/0000-0003-2456-2422; Rentero Alfonso, Carles/0000-0003-4684-0278; Gaus, Katharina/0000-0002-8009-9658; Grewal, Thomas/0000-0002-7937-8887; Cartland, Sian/0000-0003-1723-2679	Australian Research Council; National Heart Foundation of Australia; National Health and Medical Research Council [455301, 510293, 510294]; University of Sydney [2010-02681]; Beatriu de Pinos fellowship	Australian Research Council(Australian Research Council); National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Beatriu de Pinos fellowship	KG would like to acknowledge funding from the Australian Research Council and the National Heart Foundation of Australia. KG and WJ are recipients of funding by the National Health and Medical Research Council (Project Grant 455301). TG is supported by the NHMRC (510293, 510294) and the University of Sydney (2010-02681). CR holds a Beatriu de Pinos fellowship (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa R, 2000, J LIPID RES, V41, P1952; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Boucrot E, 2011, J CELL SCI, V124, P1965, DOI 10.1242/jcs.076570; Bultel S, 2008, ARTERIOSCL THROM VAS, V28, P2288, DOI 10.1161/ATVBAHA.108.175042; Cao H, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-3; Cavelier C, 2006, CIRC RES, V99, P1060, DOI 10.1161/01.RES.0000250567.17569.b3; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Denis M, 2008, J BIOL CHEM; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; Faulkner LE, 2008, J LIPID RES, V49, P1322, DOI 10.1194/jlr.M800048-JLR200; Fielding CJ, 1999, BIOCHEMISTRY-US, V38, P2506, DOI 10.1021/bi981012o; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Frank PG, 2001, AM J PHYSIOL-CELL PH, V280, pC1204, DOI 10.1152/ajpcell.2001.280.5.C1204; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Gargalovic P, 2001, J BIOL CHEM, V276, P26164, DOI 10.1074/jbc.M011291200; Gaus K, 2005, J LIPID RES, V46, P1526, DOI 10.1194/jlr.M500103-JLR200; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gaus K, 2001, BIOCHEMISTRY-US, V40, P9363, DOI 10.1021/bi010323n; Gaus K, 2001, BIOCHEMISTRY-US, V40, P13002, DOI 10.1021/bi010833h; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gelissen IC, 1999, J LIPID RES, V40, P1636; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ikonen E, 2000, TRAFFIC, V1, P212, DOI 10.1034/j.1600-0854.2000.010303.x; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lin GR, 2000, ATHEROSCLEROSIS, V149, P359, DOI 10.1016/S0021-9150(99)00503-1; Lin YC, 2007, CARDIOVASC RES, V75, P575, DOI 10.1016/j.cardiores.2007.04.012; Lin YC, 2009, BIOCHEM BIOPH RES CO, V382, P189, DOI 10.1016/j.bbrc.2009.03.005; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Matveev S, 1999, J LIPID RES, V40, P1647; Matveev S, 2001, EUR J BIOCHEM, V268, P5609, DOI 10.1046/j.1432-1033.2001.02496.x; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Razani B, 2001, J BIOL CHEM, V276, P38121; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Skretting G, 1999, J CELL SCI, V112, P3899; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Sviridov D, 2001, BIOCHEM J, V358, P79, DOI 10.1042/0264-6021:3580079; Takahashi Y, 1999, P NATL ACAD SCI USA, V96, P11358, DOI 10.1073/pnas.96.20.11358; Truong TQ, 2006, BBA-MOL CELL BIOL L, V1761, P24, DOI 10.1016/j.bbalip.2005.12.004; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200	74	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23353	10.1371/journal.pone.0023353	http://dx.doi.org/10.1371/journal.pone.0023353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858084	Green Published, gold			2022-12-25	WOS:000293953500033
J	Li, H; Wang, HW; Wang, F; Gu, Q; Xu, X				Li, Hui; Wang, Hongwei; Wang, Fang; Gu, Qing; Xu, Xun			Snail Involves in the Transforming Growth Factor beta 1-Mediated Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; PROLIFERATIVE VITREORETINOPATHY; GENE-EXPRESSION; TUMOR-GROWTH; FIBROSIS; ACTIVATION; REPRESSOR	Background: The proliferation of retinal pigment epithelium (RPE) cells resulting from an epithelial-mesenchymal transition (EMT) plays a key role in proliferative vitreoretinopathy (PVR), which leads to complex retinal detachment and the loss of vision. Genes of Snail family encode the zinc finger transcription factors that have been reported to be essential in EMT during embryonic development and cancer metastasis. However, the function of Snail in RPE cells undergoing EMT is largely unknown. Principal Findings: Transforming growth factor beta(TGF-beta)-1 resulted in EMT in human RPE cells (ARPE-19), which was characterized by the expected decrease in E-cadherin and Zona occludin-1(ZO-1) expression, and the increase in fibronectin and a-smooth muscle actin (alpha-SMA) expression, as well as the associated increase of Snail expression at both mRNA and protein levels. Furthermore, TGF-beta 1 treatment caused a significant change in ARPE-19 cells morphology, with transition from a typical epithelial morphology to mesenchymal spindle-shaped. More interestingly, Snail silencing significantly attenuated TGF-beta 1-induced EMT in ARPE-19 cells by decreasing the mesenchymal markers fibronectin and a-SMA and increasing the epithelial marker E-cadherin and ZO-1. Snail knockdown could effectively suppress ARPE-19 cell migration. Finally, Snail was activated in epiretinal membranes from PVR patients. Taken together, Snail plays very important roles in TGF-beta-1-induced EMT in human RPE cells and may contribute to the development of PVR. Significance: Snail transcription factor plays a critical role in TGF-beta 1-induced EMT in human RPE cells, which provides deep insight into the pathogenesis of human PVR disease. The specific inhibition of Snail may provide a new approach to treat and prevent PVR.	[Li, Hui; Gu, Qing; Xu, Xun] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Wang, Hongwei] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Wang, Fang] Tongji Univ, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; University of Chicago; Tongji University	Li, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China.	milwang_122@msn.com			National Natural Science Funding of China [30870558]	National Natural Science Funding of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Funding of China (30870558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2008, BRIT J OPHTHALMOL, V92, P699, DOI 10.1136/bjo.2007.134346; Abu El-Asrar AM, 2011, ACTA OPHTHALMOL, V89, pE115, DOI 10.1111/j.1755-3768.2010.01916.x; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Ceglia L, 2010, J MOL HISTOL, V41, P137, DOI 10.1007/s10735-010-9270-x; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Franz M, 2009, HISTOCHEM CELL BIOL, V131, P651, DOI 10.1007/s00418-009-0559-3; Garcia S, 2008, J CELL BIOCHEM, V104, P377, DOI 10.1002/jcb.21633; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kokudo T, 2008, J CELL SCI, V121, P3317, DOI 10.1242/jcs.028282; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee J, 2008, J CELL PHYSIOL, V216, P520, DOI 10.1002/jcp.21424; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Palma-Nicolas JP, 2010, J CELL BIOCHEM, V110, P948, DOI 10.1002/jcb.22608; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Saika S, 2007, ARCH OPHTHALMOL-CHIC, V125, P647, DOI 10.1001/archopht.125.5.647; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/S0968-0004(96)80182-4; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146; Yu J, 2008, PROTEOMICS, V8, P3667, DOI 10.1002/pmic.200700824; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	40	33	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23322	10.1371/journal.pone.0023322	http://dx.doi.org/10.1371/journal.pone.0023322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853110	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200069
J	Parhar, RK; Mooers, AO				Parhar, Rakesh K.; Mooers, Arne O.			Phylogenetically Clustered Extinction Risks Do Not Substantially Prune the Tree of Life	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; BIODIVERSITY CONSERVATION; MOLECULAR PHYLOGENIES; NONRANDOM EXTINCTION; MAMMALIAN DIVERSITY; PATTERNS; DIVERSIFICATION; SPECIATION; MODELS; SIGNAL	Anthropogenic activities have increased the rate of biological extinction many-fold. Recent empirical studies suggest that projected extinction may lead to extensive loss to the Tree of Life, much more than if extinction were random. One suggested cause is that extinction risk is heritable (phylogenetically patterned), such that entire higher groups will be lost. We show here with simulation that phylogenetically clustered extinction risks are necessary but not sufficient for the extensive loss of phylogenetic diversity (PD) compared to random extinction. We simulated Yule trees and evolved extinction risks at various levels of heritability (measured using Pagel's lambda). At most levels of heritability (l in range of 0 to 10), mean values of extinction risk (range 0.25 to 0.75), tree sizes (64 to 128 tips), tree balance and temporal heterogeneity of diversification rates (Yule and coalescent trees), extinction risks do not substantially increase the loss of PD in these trees when compared to random extinction. The maximum loss of PD (20% above random) was only associated with the combination of extremely excessive values of phylogenetic signal, high mean species' extinction probabilities, and extreme (coalescent) tree shapes. Interestingly, we also observed a decline in the rate of increase in the loss of PD at high phylogenetic clustering (l? 10) of extinction risks. Our results suggest that the interplay between various aspects of tree shape and a predisposition of higher extinction risks in species-poor clades is required to explain the substantial pruning of the Tree of Life.	[Parhar, Rakesh K.; Mooers, Arne O.] Simon Fraser Univ, IRMACS, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Parhar, RK (corresponding author), Simon Fraser Univ, IRMACS, Burnaby, BC V5A 1S6, Canada.	rakesh_parhar@yahoo.ca			NSERC Canada	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	RKP and AOM each acknowledge NSERC Canada for funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; BROWN JKM, 1994, SYST BIOL, V43, P78, DOI 10.2307/2413582; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Ceballos G, 1998, ECOL APPL, V8, P8, DOI 10.1890/1051-0761(1998)008[0008:ACPIMM]2.0.CO;2; Corey SJ, 2008, DIVERS DISTRIB, V14, P614, DOI 10.1111/j.1472-4642.2007.00448.x; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faller B, 2008, J THEOR BIOL, V251, P286, DOI 10.1016/j.jtbi.2007.11.034; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hartmann K, 2010, SYST BIOL IN PRESS; Hartmann K, 2006, SYST BIOL, V55, P644, DOI 10.1080/10635150600873876; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; HEY J, 1992, EVOLUTION, V46, P627, DOI [10.2307/2409633, 10.1111/j.1558-5646.1992.tb02071.x]; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Mooers A.O., 2007, RECONSTRUCTING EVOLU, P149; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Mooers AO, 2003, ANIM CONSERV, V6, P183, DOI 10.1017/S1367943003003226; Mooers Arne O., 2009, P263; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; O'Meara BC, 2006, EVOLUTION, V60, P922; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2005, EVOLUTION, V59, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Velasco JD, 2008, BIOL PHILOS, V23, P455, DOI 10.1007/s10539-007-9105-7; von Euler F, 2001, P ROY SOC B-BIOL SCI, V268, P127, DOI 10.1098/rspb.2000.1340; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	55	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23528	10.1371/journal.pone.0023528	http://dx.doi.org/10.1371/journal.pone.0023528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853147	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200095
J	Valdes, AM; Styrkarsdottir, U; Doherty, M; Morris, DL; Mangino, M; Tamm, A; Doherty, SA; Kisand, K; Kerna, I; Tamm, A; Wheeler, M; Maciewicz, RA; Zhang, WY; Muir, KR; Dennison, EM; Hart, DJ; Metrustry, S; Jonsdottir, I; Jonsson, GF; Jonsson, H; Ingvarsson, T; Cooper, C; Vyse, TJ; Spector, TD; Stefansson, K; Arden, NK				Valdes, Ana M.; Styrkarsdottir, Unnur; Doherty, Michael; Morris, David L.; Mangino, Massimo; Tamm, Agu; Doherty, Sally A.; Kisand, Kalle; Kerna, Irina; Tamm, Ann; Wheeler, Margaret; Maciewicz, Rose A.; Zhang, Weiya; Muir, Kenneth R.; Dennison, Elaine M.; Hart, Deborah J.; Metrustry, Sarah; Jonsdottir, Ingileif; Jonsson, Gudbjorn F.; Jonsson, Helgi; Ingvarsson, Thorvaldur; Cooper, Cyrus; Vyse, Timothy J.; Spector, Tim D.; Stefansson, Kari; Arden, Nigel K.			Large Scale Replication Study of the Association between HLA Class II/BTNL2 Variants and Osteoarthritis of the Knee in European-Descent Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS II/III REGION; EXTENDED HUMAN MHC; RISK-FACTORS; T-CELLS; GENOTYPES; DISEASE; ATLAS; GENE; MAP	Osteoarthritis (OA) is the most common form of arthritis and a major cause of disability. This study evaluates the association in Caucasian populations of two single nucleotide polymorphisms (SNPs) mapping to the Human Leukocyte Antigen (HLA) region and deriving from a genome wide association scan (GWAS) of knee OA in Japanese populations. The frequencies for rs10947262 were compared in 36,408 controls and 5,749 knee OA cases from European-descent populations. rs7775228 was tested in 32,823 controls and 1,837 knee OA cases of European descent. The risk (major) allele at rs10947262 in Caucasian samples was not significantly associated with an odds ratio (OR) = 1.07 (95% CI 0.94 -1.21; p = 0.28). For rs7775228 the meta-analysis resulted in OR = 0.94 (95% CI 0.81-1.09; p = 0.42) for the allele associated with risk in the Japanese GWAS. In Japanese individuals these two SNPs are in strong linkage disequilibrium (LD) (r(2) = 0.86) with the HLA class II haplotype DRB1*1502 DQA1*0103 DQB1*0601 (frequency 8%). In Caucasian and Chinese samples, using imputed data, these SNPs appear not to be in LD with that haplotype (r(2)<0.07). The rs10947262 and rs7775228 variants are not associated with risk of knee OA in European descent populations and they do not appear tag the same HLA class II haplotype as they do in Japanese individuals.	[Valdes, Ana M.; Mangino, Massimo; Hart, Deborah J.; Metrustry, Sarah; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Styrkarsdottir, Unnur; Jonsdottir, Ingileif; Jonsson, Gudbjorn F.; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Doherty, Michael; Doherty, Sally A.; Wheeler, Margaret; Zhang, Weiya] Univ Nottingham, Nottingham NG7 2RD, England; [Morris, David L.; Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Morris, David L.; Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Tamm, Agu; Kisand, Kalle; Kerna, Irina; Tamm, Ann] Univ Tartu, Dept Internal Med, EE-50090 Tartu, Estonia; [Tamm, Ann] Univ Tartu, Dept Sports Med & Rehabil, EE-50090 Tartu, Estonia; [Maciewicz, Rose A.] AstraZeneca, Resp & Inflammat Res Area, Loughborough, Leics, England; [Muir, Kenneth R.] Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Dennison, Elaine M.; Cooper, Cyrus; Arden, Nigel K.] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England; [Jonsdottir, Ingileif; Jonsson, Helgi; Ingvarsson, Thorvaldur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonsson, Helgi] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Univ Hosp, Inst Hlth Sci, Akureyri, Iceland; [Cooper, Cyrus; Arden, Nigel K.] Univ Oxford, Musculoskeletal Biomed Res Unit, Oxford, England	University of London; King's College London; University of Nottingham; University of London; King's College London; University of London; King's College London; University of Tartu; University of Tartu; AstraZeneca; University of Warwick; University of Southampton; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; University of Akureyri; University of Oxford	Valdes, AM (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	ana.valdes@kcl.ac.uk	Kisand, Kalle/S-5958-2016; Zhang, Weiya/X-9481-2019; Stefansson, Kari/AAE-7187-2019; Mangino, Massimo/F-5134-2011; Kisand, Kalle/AAZ-2563-2020	Kisand, Kalle/0000-0002-7789-5565; Zhang, Weiya/0000-0003-1142-1460; Mangino, Massimo/0000-0002-2167-7470; Kisand, Kalle/0000-0002-7789-5565; Doherty, Michael/0000-0002-5763-8326; Dennison, Elaine/0000-0002-3048-4961; Morris, David/0000-0002-1754-8932; Valdes, Ana M./0000-0003-1141-4471; Cooper, Cyrus/0000-0003-3510-0709; Styrkarsdottir, Unnur/0000-0001-8146-8278; Jonsson, Helgi/0000-0003-0187-8985	European Commission [200800]; Wellcome Trust UK; Medical Research Council (UK); Oxford NIHR Musculoskeletal Biomedical Research Unit; Estonian Science Foundation [5308]; Estonian Ministry of Social Affairs [9.6-4/2035, 12.1-5/597]; Arthritis Research Campaign UK; Medical Research Council [U1475000001, MC_UP_A620_1014] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust UK(Wellcome Trust); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford NIHR Musculoskeletal Biomedical Research Unit; Estonian Science Foundation; Estonian Ministry of Social Affairs; Arthritis Research Campaign UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This project was funded by European Commission Framework 7 programme grant 200800 TREAT-OA and the Wellcome Trust UK. Individual cohort data collection was funded by the Medical Research Council (UK), the Oxford NIHR Musculoskeletal Biomedical Research Unit, the Estonian Science Foundation grant No 5308, the Estonian Ministry of Social Affairs grants No 9.6-4/2035 and 12.1-5/597, the Arthritis Research Campaign UK, and the Wellcome Trust UK. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The GOAL study was funded by AstraZeneca, Macclesfield UK, and a BBSRC for CASE studentship funding. AstraZeneca had a role in the GOAL study design. deCODE genetics had a role in study design of the deCODE case controls, data collection of the same study and analysis, decision to publish, and preparation of the manuscript.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; HART DJ, 1993, ANN RHEUM DIS, V52, P93, DOI 10.1136/ard.52.2.93; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mack SJ, 2000, TISSUE ANTIGENS, V55, P383, DOI 10.1034/j.1399-0039.2000.550501.x; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nagaosa Y, 2000, ANN RHEUM DIS, V59, P587, DOI 10.1136/ard.59.8.587; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Nakamura H, 2006, RHEUMATOL INT, V26, P984, DOI 10.1007/s00296-006-0116-5; Neame RL, 2004, ANN RHEUM DIS, V63, P1022, DOI 10.1136/ard.2003.014498; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Samuels J, 2008, BULL HOSP JT DIS, V66, P244; Shi D, 2010, OSTEOARTHR CARTILAGE, V18, P1454, DOI 10.1016/j.joca.2010.07.009; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Tamm A, 2008, J RHEUMATOL, V35, P543; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2688, DOI 10.1002/art.27574; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; Zhang W, 2008, ARTHRITIS RHEUM, V58, P137, DOI 10.1002/art.23237	28	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23371	10.1371/journal.pone.0023371	http://dx.doi.org/10.1371/journal.pone.0023371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853121	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000295454200078
J	Garcia-Serrano, L; Gomez-Ferreria, MA; Contreras-Jurado, C; Segrelles, C; Paramio, JM; Aranda, A				Garcia-Serrano, Laura; Ana Gomez-Ferreria, Maria; Contreras-Jurado, Constanza; Segrelles, Carmen; Paramio, Jesus M.; Aranda, Ana			The Thyroid Hormone Receptors Modulate the Skin Response to Retinoids	PLOS ONE			English	Article							KERATIN GENE-EXPRESSION; UNION-OF-PHARMACOLOGY; NUCLEAR RECEPTORS; EPIDERMAL TRANSGLUTAMINASE; TERMINAL DIFFERENTIATION; ACID TREATMENT; MICE; PROLIFERATION; TRANSCRIPTION; LORICRIN	Background: Retinoids play an important role in skin homeostasis and when administered topically cause skin hyperplasia, abnormal epidermal differentiation and inflammation. Thyroidal status in humans also influences skin morphology and function and we have recently shown that the thyroid hormone receptors (TRs) are required for a normal proliferative response to 12-O-tetradecanolyphorbol-13-acetate (TPA) in mice. Methodology/Principal findings: We have compared the epidermal response of mice lacking the thyroid hormone receptor binding isoforms TR alpha 1 and TR beta to retinoids and TPA. Reduced hyperplasia and a decreased number of proliferating cells in the basal layer in response to 9-cis-RA and TPA were found in the epidermis of TR-deficient mice. Nuclear levels of proteins important for cell proliferation were altered, and expression of keratins 5 and 6 was also reduced, concomitantly with the decreased number of epidermal cell layers. In control mice the retinoid (but not TPA) induced parakeratosis and diminished expression of keratin 10 and loricrin, markers of early and terminal epidermal differentiation, respectively. This reduction was more accentuated in the TR deficient animals, whereas they did not present parakeratosis. Therefore, TRs modulate both the proliferative response to retinoids and their inhibitory effects on skin differentiation. Reduced proliferation, which was reversed upon thyroxine treatment, was also found in hypothyroid mice, demonstrating that thyroid hormone binding to TRs is required for the normal response to retinoids. In addition, the mRNA levels of the pro-inflammatory cytokines TNF alpha and IL-6 and the chemotactic proteins S1008A and S1008B were significantly elevated in the skin of TR knock-out mice after TPA or 9-cis-RA treatment and immune cell infiltration was also enhanced. Conclusions/significance: Since retinoids are commonly used for the treatment of skin disorders, these results demonstrating that TRs regulate skin proliferation, differentiation and inflammation in response to these compounds could have not only physiological but also therapeutic implications.	[Garcia-Serrano, Laura; Ana Gomez-Ferreria, Maria; Contreras-Jurado, Constanza; Aranda, Ana] CSIC, Inst Invest Biomed, Madrid, Spain; [Garcia-Serrano, Laura; Ana Gomez-Ferreria, Maria; Contreras-Jurado, Constanza; Aranda, Ana] Univ Autonoma Madrid, Madrid, Spain; [Segrelles, Carmen; Paramio, Jesus M.] Ctr Invest Energt Medioambientales & Tecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Garcia-Serrano, L (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	aaranda@iib.uam.es	Paramio, Jesus M/M-8482-2014; Aranda, Ana/ABG-8820-2020; Segrelles, Carmen/E-3655-2016; Contreras-Jurado, Constanza/K-9028-2014	Paramio, Jesus M/0000-0001-7520-3177; Aranda, Ana/0000-0002-8338-9589; Segrelles, Carmen/0000-0001-9340-2102; Contreras-Jurado, Constanza/0000-0002-4578-801X	Ministerio de Ciencia e Innovacion [BFU2007-62402, SAF2008-00121]; Fondo de Investigaciones Sanitarias [RD06/0020/0036, RD06/0020/0029]; European Grant CRESCENDO [FP-018652]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); European Grant CRESCENDO	This work was supported by grants BFU2007-62402 and SAF2008-00121 from Ministerio de Ciencia e Innovacion, RD06/0020/0036 and RD06/0020/0029 from the Fondo de Investigaciones Sanitarias and by the European Grant CRESCENDO (FP-018652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan Mohammad Kamrul, 1998, Journal of Medical Investigation, V44, P179; ANESKIEVICH BJ, 1992, MOL CELL BIOL, V12, P4862, DOI 10.1128/MCB.12.11.4862; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ASSELINEAU D, 1989, DEV BIOL, V133, P322, DOI 10.1016/0012-1606(89)90037-7; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; BLUMENBERG M, 1992, J INVEST DERMATOL, V98, pS42, DOI 10.1111/1523-1747.ep12462194; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Contreras-Jurado C, 2011, J BIOL CHEM, V286, P24079, DOI 10.1074/jbc.M111.218487; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Ghyselinck NB, 2002, ANN DERMATOL VENER, V129, P793; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Goyette P, 2000, J BIOL CHEM, V275, P16497, DOI 10.1074/jbc.M909382199; GRIFFITHS CEM, 1992, J INVEST DERMATOL, V99, P283, DOI 10.1111/1523-1747.ep12616626; GRIFFITHS RJ, 1988, AGENTS ACTIONS, V25, P344, DOI 10.1007/BF01965041; GSCHWENDT M, 1984, CANCER LETT, V25, P177, DOI 10.1016/S0304-3835(84)80043-9; HOHL D, 1991, J INVEST DERMATOL, V96, P414, DOI 10.1111/1523-1747.ep12469779; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; Jho SH, 2005, J INVEST DERMATOL, V124, P1034, DOI 10.1111/j.0022-202X.2005.23691.x; Jho SH, 2001, J BIOL CHEM, V276, P45914, DOI 10.1074/jbc.M103144200; Lee DD, 2009, J CELL PHYSIOL, V220, P427, DOI 10.1002/jcp.21784; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; MAGNALDO T, 1992, DIFFERENTIATION, V49, P39, DOI 10.1111/j.1432-0436.1992.tb00767.x; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Martinez-Iglesias O, 2009, CANCER RES, V69, P501, DOI 10.1158/0008-5472.CAN-08-2198; MOLLOY CJ, 1987, CANCER RES, V47, P4674; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; O'Shea PJ, 2002, J ENDOCRINOL, V175, P553, DOI 10.1677/joe.0.1750553; PARAMIO JM, 1994, EXP CELL RES, V215, P319, DOI 10.1006/excr.1994.1348; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Paus R, 2010, J INVEST DERMATOL, V130, P7, DOI 10.1038/jid.2009.359; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Radoja N, 2004, MOL CELL BIOL, V24, P3168, DOI 10.1128/MCB.24.8.3168-3179.2004; Radoja N, 1997, J INVEST DERMATOL, V109, P566, DOI 10.1111/1523-1747.ep12337483; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; RAO TS, 1993, INFLAMMATION, V17, P723, DOI 10.1007/BF00920477; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; ROOP DR, 1987, DIFFERENTIATION, V35, P143, DOI 10.1111/j.1432-0436.1987.tb00162.x; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; ROSENTHAL DS, 1992, J INVEST DERMATOL, V98, P343, DOI 10.1111/1523-1747.ep12499802; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Safer JD, 2004, ENDOCRINOLOGY, V145, P2357, DOI 10.1210/en.2003-1696; Safer JD, 2001, THYROID, V11, P717, DOI 10.1089/10507250152484547; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; THIBOUTOT DM, 1995, J CLIN ENDOCR METAB, V80, P3082, DOI 10.1210/jc.80.10.3082; TOMIC M, 1990, CELL REGUL, V1, P965, DOI 10.1091/mbc.1.12.965; TomicCanic M, 1996, J BIOL CHEM, V271, P1416, DOI 10.1074/jbc.271.3.1416; Varani J, 2003, ARCH DERMATOL RES, V295, P255, DOI 10.1007/s00403-003-0416-5; Varani J, 2008, ARCH DERMATOL RES, V300, P27, DOI 10.1007/s00403-007-0797-y; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011	63	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23825	10.1371/journal.pone.0023825	http://dx.doi.org/10.1371/journal.pone.0023825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858227	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300098
J	Lee, TS; Kantarjian, H; Ma, WL; Yeh, CH; Giles, F; Albitar, M				Lee, Tai-Sung; Kantarjian, Hagop; Ma, Wanlong; Yeh, Chen-Hsiung; Giles, Francis; Albitar, Maher			Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; RECEPTOR TYROSINE KINASES; MOLECULAR-DYNAMICS; THROMBOPOIETIN RECEPTOR; ERYTHROPOIETIN RECEPTOR; ACTIVE CONFORMATION; LIPID-MEMBRANES; ACTIVATION; JUXTAMEMBRANE; JAK2	Background: Mutations in the thrombopoietin receptor (MPL) may activate relevant pathways and lead to chronic myeloproliferative neoplasms (MPNs). The mechanisms of MPL activation remain elusive because of a lack of experimental structures. Modern computational biology techniques were utilized to explore the mechanisms of MPL protein activation due to various mutations. Results: Transmembrane (TM) domain predictions, homology modeling, ab initio protein structure prediction, and molecular dynamics (MD) simulations were used to build structural dynamic models of wild-type and four clinically observed mutants of MPL. The simulation results suggest that S505 and W515 are important in keeping the TM domain in its correct position within the membrane. Mutations at either of these two positions cause movement of the TM domain, altering the conformation of the nearby intracellular domain in unexpected ways, and may cause the unwanted constitutive activation of MPL's kinase partner, JAK2. Conclusions: Our findings represent the first full-scale molecular dynamics simulations of the wild-type and clinically observed mutants of the MPL protein, a critical element of the MPL-JAK2-STAT signaling pathway. In contrast to usual explanations for the activation mechanism that are based on the relative translational movement between rigid domains of MPL, our results suggest that mutations within the TM region could result in conformational changes including tilt and rotation (azimuthal) angles along the membrane axis. Such changes may significantly alter the conformation of the adjacent and intrinsically flexible intracellular domain. Hence, caution should be exercised when interpreting experimental evidence based on rigid models of cytokine receptors or similar systems.	[Lee, Tai-Sung] Rutgers State Univ, Dept Chem & Chem Biol, BioMaPS Inst, Piscataway, NJ 08854 USA; [Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ma, Wanlong; Yeh, Chen-Hsiung; Albitar, Maher] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA; [Giles, Francis] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA; [Giles, Francis] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Rutgers State University New Brunswick; University of Texas System; UTMD Anderson Cancer Center; Nichols Institute; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Lee, TS (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, BioMaPS Inst, Piscataway, NJ 08854 USA.	cancersimulation@gmail.com	Lee, Tai-Sung/HCH-7775-2022	Lee, Tai-Sung/0000-0003-2110-2279	National Science Foundation (NSF) through Ranger and the Kraken systems [TG-MCB100054]	National Science Foundation (NSF) through Ranger and the Kraken systems(National Science Foundation (NSF))	This research was supported by the National Science Foundation (NSF) through TeraGrid resources (the Ranger and the Kraken systems) under grant number TG-MCB100054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett M, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-41; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chaligne R, 2008, LEUKEMIA, V22, P1557, DOI 10.1038/leu.2008.137; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; DING J, 2009, BLOOD; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Drexler HG, 1996, LEUKEMIA, V10, P1405; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grotzinger J, 2002, BBA-MOL CELL RES, V1592, P215, DOI 10.1016/S0167-4889(02)00316-6; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Hubbard SR, 2009, CELL, V137, P1181, DOI 10.1016/j.cell.2009.06.008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kilpivaara O, 2008, LEUKEMIA, V22, P1813, DOI 10.1038/leu.2008.229; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018103; Lee TS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-58; Lee TS, 2009, J MOL BIOL, V388, P195, DOI 10.1016/j.jmb.2009.02.054; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Norman KE, 2006, BIOPHYS J, V91, P2046, DOI 10.1529/biophysj.105.080275; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pezet A, 1997, MOL CELL ENDOCRINOL, V129, P199, DOI 10.1016/S0303-7207(97)00063-4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schnittger S, 2009, HAEMATOL-HEMATOL J, V94, P141, DOI 10.3324/haematol.13224; Sebald W, 2010, FEBS J, V277, P106, DOI 10.1111/j.1742-4658.2009.07480.x; Shi L, 2009, BIOPHYS J, V96, P3648, DOI 10.1016/j.bpj.2009.02.025; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Tefferi A, 2008, LEUKEMIA LYMPHOMA, V49, P388, DOI 10.1080/10428190801895360; Tong W, 2007, EXP HEMATOL, V35, P1447, DOI 10.1016/j.exphem.2007.05.010; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ulmschneider MB, 2006, BIOPHYS J, V90, P1650, DOI 10.1529/biophysj.105.065367; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; Wendling F, 1998, EUR CYTOKINE NETW, V9, P221; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018	41	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23396	10.1371/journal.pone.0023396	http://dx.doi.org/10.1371/journal.pone.0023396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858098	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300042
J	Pierer, M; Wagner, U; Rossol, M; Ibrahim, S				Pierer, Matthias; Wagner, Ulf; Rossol, Manuela; Ibrahim, Saleh			Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced Arthritis in DBA1J Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; TLR4; RESPONSES; DISEASE; PATHOGENESIS; PROTEINS; DECTIN-1; CELLS	In rheumatoid arthritis, a significant proportion of cytokine and chemokine synthesis is attributed to innate immune mechanisms. TLR4 is a prominent innate receptor since several endogenous ligands known to activate the innate immune system bind to it and may thereby promote joint inflammation. We generated TLR4 deficient DBA1J mice by backcrossing the TLR4 mutation present in C3H/HeJ strain onto the DBA1J strain and investigated the course of collagen-induced arthritis in TLR4 deficient mice in comparison to wild type littermates. The incidence of collagen-induced arthritis was significantly lower in TLR4 deficient compared to wild type mice (59 percent vs. 100 percent). The severity of arthritis was reduced in the TLR4 deficient mice compared to wild type littermates (mean maximum score 2,54 vs. 6,25). Mice deficient for TLR4 were virtually protected from cartilage destruction, and infiltration of inflammatory cells was reduced compared to wt mice. In parallel to the decreased clinical severity, lower anti-CCP antibody concentrations and lower IL-17 concentrations were found in the TLR4 deficient mice. The study further supports the role of TLR4 in the propagation of joint inflammation and destruction. Moreover, since deficiency in TLR4 led to decreased IL-17 and anti-CCP antibody production, the results indicate a link between TLR4 stimulation and the adaptive autoimmune response. This mechanism might be relevant in human rheumatoid arthritis, possibly in response to activating endogenous ligands in the affected joints.	[Pierer, Matthias; Wagner, Ulf; Rossol, Manuela] Univ Leipzig, Dept Med 2, Rheumatol Sect, Leipzig, Germany; [Ibrahim, Saleh] Univ Lubeck, Dept Dermatol, Lubeck, Germany	Leipzig University; University of Lubeck	Pierer, M (corresponding author), Univ Leipzig, Dept Med 2, Rheumatol Sect, Leipzig, Germany.	matthias.pierer@medizin.uni-leipzig.de	Wagner, Ulf/F-4351-2016; Ibrahim, Saleh/AAO-9541-2020	Ibrahim, Saleh/0000-0001-7827-2290	Deutsche Forschungsgemeinschaft [Pi 624/1-2, IB 24/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft, grant number Pi 624/1-2 and IB 24/5-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Choe JY, 2003, J EXP MED, V197, P537, DOI 10.1084/jem.20021850; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; van de Veerdonk FLV, 2010, J LEUKOCYTE BIOL, V88, P227, DOI 10.1189/jlb.0809550; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	20	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23539	10.1371/journal.pone.0023539	http://dx.doi.org/10.1371/journal.pone.0023539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858160	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300058
J	Chaves, I; Nijman, RM; Biernat, MA; Bajek, MI; Brand, K; da Silva, AC; Saito, S; Yagita, K; Eker, APM; van der Horst, GTJ				Chaves, Ines; Nijman, Romana M.; Biernat, Magdalena A.; Bajek, Monika I.; Brand, Karl; da Silva, Antonio Carvalho; Saito, Shoko; Yagita, Kazuhiro; Eker, Andre P. M.; van der Horst, Gijsbertus T. J.			The Potorous CPD Photolyase Rescues a Cryptochrome-Deficient Mammalian Circadian Clock	PLOS ONE			English	Article							GENE-EXPRESSION; DNA PHOTOLYASE; TRANSCRIPTION; EVOLUTION; FAMILY; REPAIR; OSCILLATIONS; MECHANISMS; SIMILARITY; COMPONENTS	Despite the sequence and structural conservation between cryptochromes and photolyases, members of the cryptochrome/photolyase (flavo) protein family, their functions are divergent. Whereas photolyases are DNA repair enzymes that use visible light to lesion-specifically remove UV-induced DNA damage, cryptochromes act as photoreceptors and circadian clock proteins. To address the functional diversity of cryptochromes and photolyases, we investigated the effect of ectopically expressed Arabidopsis thaliana (6-4) PP photolyase and Potorous tridactylus CPD-photolyase (close and distant relatives of mammalian cryptochromes, respectively), on the performance of the mammalian cryptochromes in the mammalian circadian clock. Using photolyase transgenic mice, we show that Potorous CPD-photolyase affects the clock by shortening the period of behavioral rhythms. Furthermore, constitutively expressed CPD-photolyase is shown to reduce the amplitude of circadian oscillations in cultured cells and to inhibit CLOCK/BMAL1 driven transcription by interacting with CLOCK. Importantly, we show that Potorous CPD-photolyase can restore the molecular oscillator in the liver of (clock-deficient) Cry1/Cry2 double knockout mice. These data demonstrate that a photolyase can act as a true cryptochrome. These findings shed new light on the importance of the core structure of mammalian cryptochromes in relation to its function in the circadian clock and contribute to our further understanding of the evolution of the cryptochrome/photolyase protein family.	[Chaves, Ines; Nijman, Romana M.; Bajek, Monika I.; Brand, Karl; da Silva, Antonio Carvalho; Saito, Shoko; Eker, Andre P. M.; van der Horst, Gijsbertus T. J.] Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands; [Biernat, Magdalena A.] Wageningen Univ, Virol Lab, Wageningen, Netherlands; [Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Neurosci & Cell Biol, Kyoto, Japan	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Kyoto Prefectural University of Medicine	Chaves, I (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands.	i.chaves@erasmusmc.nl; g.vanderhorst@erasmusmc.nl	Chaves, Ines/L-3074-2015; van der Horst, Gijsbertus TJ/E-3661-2015	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Carvalho da Silva, Antonio Manuel/0000-0002-8017-104X	Netherlands Organization for Scientific Research [ZonMW Vici 918.36.619, NWO-CW 700.51.304, NWO-CW ECHO 700.57.012]; SenterNovem [Neuro-Bsik BSIK03053]; European Community [EUCLOCK LSHG-CT-2006-018741]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); SenterNovem; European Community(European Commission)	This work was supported in part by grants from the Netherlands Organization for Scientific Research (ZonMW Vici 918.36.619, NWO-CW 700.51.304, NWO-CW ECHO 700.57.012), SenterNovem (Neuro-Bsik BSIK03053) and the European Community (EUCLOCK LSHG-CT-2006-018741) to GTJvdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Eker APM, 2009, CELL MOL LIFE SCI, V66, P968, DOI 10.1007/s00018-009-8735-0; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; HOGAN B, 1994, MANIPULATING MOUSE E, P217; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jans J, 2006, MOL CELL BIOL, V26, P8515, DOI 10.1128/MCB.00807-06; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; RUSAK B, 1989, BRAIN RES, V493, P283, DOI 10.1016/0006-8993(89)91163-3; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schul W, 2002, EMBO J, V21, P4719, DOI 10.1093/emboj/cdf456; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Schalie EA, 2007, MOL CELL BIOL, V27, P2120, DOI 10.1128/MCB.01638-06; vanderSpek PJ, 1996, GENOMICS, V37, P177, DOI 10.1006/geno.1996.0539; Vanselow K, 2007, COLD SPRING HARB SYM, V72, P167, DOI 10.1101/sqb.2007.72.036; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	42	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23447	10.1371/journal.pone.0023447	http://dx.doi.org/10.1371/journal.pone.0023447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858120	gold, Green Published			2022-12-25	WOS:000294125500034
J	Tavares, FN; Campos, RD; Burlandy, FM; Fontella, R; de Melo, MMM; da Costa, EV; da Silva, EE				Tavares, Fernando Neto; Campos, Renata de Mendonca; Burlandy, Fernanda Marcicano; Fontella, Rachel; Monte de Melo, Maria Mabel; da Costa, Eliane Veiga; da Silva, Edson Elias			Molecular Characterization and Phylogenetic Study of Coxsackievirus A24v Causing Outbreaks of Acute Hemorrhagic Conjunctivitis (AHC) in Brazil	PLOS ONE			English	Article							VARIANT; EPIDEMIC	Background: Coxsackievirus A24 variant (CA24v) is the most prevalent viral pathogen associated with acute hemorrhagic conjunctivitis (AHC) outbreaks. Sixteen years after its first outbreak in Brazil, this agent reemerged in 2003 in Brazil, spread to nearly all states and caused outbreaks until 2005. In 2009, a new outbreak occurred in the northeast region of the country. In this study, we performed a viral isolation in cell culture and characterized clinical samples collected from patients presenting symptoms during the outbreak of 2005 in Vitoria, Espirito Santo State (ES) and the outbreak of 2009 in Recife, Pernambuco State (PE). We also performed a phylogenetic analysis of worldwide strains and all meaningful Brazilian isolates since 2003. Methods and Findings: Sterile cotton swabs were used to collect eye discharges, and all 210 clinical samples were used to inoculate cell cultures. Cytopathic effects in HEp-2 cells were seen in 58 of 180 (32%) samples from Vitoria and 3 of 30 (10%) samples from Recife. Phylogenetic analysis based on a fragment of the VP1 and 3C gene revealed that the CA24v causing outbreaks in Brazil during the years 2003, 2004 and 2005 evolved from Asian isolates that had caused the South Korean outbreak of AHC during the summer of 2002. However, the 2009 outbreak of AHC in Pernambuco was originated from the reintroduction of a new CA24v strain that was circulating during 2007 in Asia, where CA24v outbreaks has been continuously reported since 1970. Conclusions: This study is the first phylogenetic analysis of AHC outbreaks caused by CA24v in Brazil. The results showed that Asian strains of CA24v were responsible for the outbreaks since 1987 and were independently introduced to Brazil in 2003 and 2009. Phylogenetic analysis of complete VP1 gene is a useful tool for studying the epidemiology of enteroviruses associated with outbreaks.	[Tavares, Fernando Neto; Campos, Renata de Mendonca; Burlandy, Fernanda Marcicano; da Costa, Eliane Veiga; da Silva, Edson Elias] Fiocruz MS, Inst Oswaldo Cruz, Lab Enterovirus, BR-21045900 Rio De Janeiro, Brazil; [Fontella, Rachel] Univ Fed Rio de Janeiro, Dept Genet, Lab Biol Evolut Teor & Aplicada, Rio De Janeiro, Brazil; [Monte de Melo, Maria Mabel] Lab Cent Saude Publ LACEN, Virol Lab, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Tavares, FN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Enterovirus, BR-21045900 Rio De Janeiro, Brazil.	edson@ioc.fiocruz.br	Azevedo, Renata/V-3130-2019		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministry of Health of Brazil (CGLAB/SVS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health of Brazil (CGLAB/SVS)	This work was partially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Ministry of Health of Brazil (CGLAB/SVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BRANDFUL JAM, 1990, E AFR MED J, V67, P878; Cabrerizo M, 2008, J CLIN VIROL, V43, P323, DOI 10.1016/j.jcv.2008.07.017; *CDCP, 1987, MMWR-MORBID MORTAL W, V36, P245; *CDCP, 1989, MMWR-MORBID MORTAL W, V38, P327; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P632; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P899; Dussart P, 2005, J MED VIROL, V75, P559, DOI 10.1002/jmv.20304; Finger C, 2003, LANCET, V361, P1714, DOI 10.1016/S0140-6736(03)13391-0; GHENDON Y, 1989, ACUTE HEMORRHAGIC CO, P3; Gopalkrishna V, 2007, J MED VIROL, V79, P748, DOI 10.1002/jmv.20886; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Ishiguru K., 1989, Annual Report of the Society of Plant Protection of North Japan, P11; Khan A, 2008, VIRUS RES, V137, P150, DOI 10.1016/j.virusres.2008.06.011; Kurokawa Manabu, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P904; Leveque N, 2007, EUR J CLIN MICROBIOL, V26, P199, DOI 10.1007/s10096-007-0265-9; LINHARES AC, 1989, ACUTE HEMORRHAGIC CO, P201; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; MIRKOVIC RR, 1974, INTERVIROLOGY, V4, P119, DOI 10.1159/000149850; Moura FEA, 2006, BRIT J OPHTHALMOL, V90, P1091, DOI 10.1136/bjo.2006.098822; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oh MD, 2003, EMERG INFECT DIS, V9, P1010; SANTOS ED, 1989, REV I MED TROP, V31, P183; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares FN, 2006, EMERG INFECT DIS, V12, P495, DOI 10.3201/eid1203.051173; Wu D, 2008, J MED VIROL, V80, P1762, DOI 10.1002/jmv.21288	27	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23206	10.1371/journal.pone.0023206	http://dx.doi.org/10.1371/journal.pone.0023206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858030	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500021
J	Johnell, K; Fischer, H				Johnell, Kristina; Fischer, Hakan			Dopaminergic and Serotonergic Drug Use: A Nationwide Register-Based Study of Over 1 300 000 Older People	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; AGE-DEPENDENT DECLINE; HUMAN BRAIN; F-18 SETOPERONE; RECEPTORS; ANTIDEPRESSANTS; DISEASE; PET; ACTIVATION; MANAGEMENT	Objective: To investigate the use of dopaminergic and serotonergic drugs in elderly people. Methods: We analyzed data on age, sex and dispensed drugs for individuals aged >= 65 years registered in the Swedish Prescribed Drug Register from July to September 2008 (n = 1 347 564; 81% of the total population aged >= 65 years in Sweden). Main outcome measures were dopaminergic (enhancing and/or lowering) and serotonergic (enhancing and/or lowering) drugs and combinations of these. Results: Dopaminergic and serotonergic drugs were used by 5.6% and 13.2% the participants, respectively. Female gender was related to use of both dopaminergic and, particularly, serotonergic drugs. Higher age was associated with use of dopamine lowering drugs and serotonergic drugs, whereas the association with use of dopamine enhancing drugs declined in the oldest old. The occurrence of combinations of dopaminergic and serotonergic drugs was generally low, with dopamine lowering + serotonin lowering drug the most common combination (1.6%). Female gender was associated with all of the combinations of dopaminergic and serotonergic drugs, whereas age showed a mixed pattern. Conclusion: Approximately one out of ten older patients uses serotonergic drugs and one out of twenty dopaminergic drugs. The frequent use of dopaminergic and serotonergic drugs in the elderly patients is a potential problem due to the fact that aging is associated with a down-regulation of both these monoaminergic systems. Future studies are needed for evaluation of the impact of these drugs on different cognitive and emotional functions in old age.	[Johnell, Kristina; Fischer, Hakan] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Fischer, Hakan] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Johnell, K (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	kristina.johnell@ki.se		Fischer, Hakan/0000-0001-6710-1744	Swedish Research Council [dnr 2007-5870]; Konung Gustav V:s och Drottning Victorias Frimurarstiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Konung Gustav V:s och Drottning Victorias Frimurarstiftelse	This study was supported financially by a grant from the Swedish Research Council (dnr 2007-5870) and from Konung Gustav V:s och Drottning Victorias Frimurarstiftelse (HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI A, 1993, ARCH NEUROL-CHICAGO, V50, P474, DOI 10.1001/archneur.1993.00540050026010; Arbouw MEL, 2011, OSTEOPOROSIS INT, V22, P2197, DOI 10.1007/s00198-010-1455-3; ARBOUW ME, 2010, OSTEOPOROS INT; Backman L, 1997, BRAIN, V120, P2207, DOI 10.1093/brain/120.12.2207; Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; Bannon MJ, 1997, NEUROLOGY, V48, P969, DOI 10.1212/WNL.48.4.969; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; BLIN J, 1993, BRAIN, V116, P497, DOI 10.1093/brain/116.3.497; Chan DKY, 2008, GERIATRICS-US, V63, P22; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; DESPLENTER F, INT PSYCHOG IN PRESS; Fischer H, 2010, BIOL PSYCHIAT, V67, P575, DOI 10.1016/j.biopsych.2009.12.013; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Ginzburg R, 2009, ANN PHARMACOTHER, V43, P98, DOI 10.1345/aph.1L264; Giron MST, 2005, INT J GERIATR PSYCH, V20, P201, DOI 10.1002/gps.1273; Glickstein SB, 2005, CEREB CORTEX, V15, P1016, DOI 10.1093/cercor/bhh202; Haider SI, 2008, CLIN THER, V30, P419, DOI 10.1016/j.clinthera.2008.02.010; Hasnain M, 2009, AM J MED, V122, P614, DOI 10.1016/j.amjmed.2009.01.025; Haukka J, 2007, EUR J CLIN PHARMACOL, V63, P1069, DOI 10.1007/s00228-007-0349-6; Hovstadius Bo, 2009, BMC Clin Pharmacol, V9, P11, DOI 10.1186/1472-6904-9-11; JEDENIUS E, SCAND J PRI IN PRESS; JOHNELL K, EUR J CLIN IN PRESS; Johnell K, 2007, ANN PHARMACOTHER, V41, P1243, DOI 10.1345/aph.1K154; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Lotrich FE, 2005, J CLIN PHARMACOL, V45, P1106, DOI 10.1177/0091270005280297; Lovheim H, 2008, PHARMACOEPIDEM DR S, V17, P912, DOI 10.1002/pds.1600; Luciana M, 1998, CEREB CORTEX, V8, P218, DOI 10.1093/cercor/8.3.218; Meltzer HY, 2011, PSYCHOPHARMACOLOGY, V213, P289, DOI 10.1007/s00213-010-2137-8; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Mozley LH, 2001, AM J PSYCHIAT, V158, P1492, DOI 10.1176/appi.ajp.158.9.1492; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; PARABIAGHI A, EUR J CLIN IN PRESS; Rajji TK, 2008, DRUG AGING, V25, P841, DOI 10.2165/00002512-200825100-00003; RINNE JO, 1990, BRAIN RES, V508, P349, DOI 10.1016/0006-8993(90)90423-9; Stein M, 2010, CURR TOP BEHAV NEURO, V2, P469, DOI 10.1007/7854_2009_35; Treit D, 2010, CURR TOP BEHAV NEURO, V2, P121, DOI 10.1007/7854_2009_17; Verdel BM, 2011, CLIN PHARMACOL THER, V89, P89, DOI 10.1038/clpt.2010.240; Verhoeff NPLG, 2000, PSYCHIAT RES-NEUROIM, V99, P123, DOI 10.1016/S0165-1781(00)00198-0; Wang Y, 1998, SYNAPSE, V30, P56, DOI 10.1002/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23750	10.1371/journal.pone.0023750	http://dx.doi.org/10.1371/journal.pone.0023750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858217	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700041
J	Miron, RJ; Hedbom, E; Ruggiero, S; Bosshardt, DD; Zhang, YF; Mauth, C; Gemperli, AC; Iizuka, T; Buser, D; Sculean, A				Miron, Richard J.; Hedbom, Erik; Ruggiero, Sabrina; Bosshardt, Dieter D.; Zhang, Yufeng; Mauth, Corinna; Gemperli, Anja C.; Iizuka, Tateyuki; Buser, Daniel; Sculean, Anton			Premature Osteoblast Clustering by Enamel Matrix Proteins Induces Osteoblast Differentiation through Up-Regulation of Connexin 43 and N-Cadherin	PLOS ONE			English	Article							GAP-JUNCTIONAL COMMUNICATION; INTRABONY PERIODONTAL DEFECTS; TO-CELL COMMUNICATION; GENE-EXPRESSION; INCREASES PROLIFERATION; SIGNAL-TRANSDUCTION; PARATHYROID-HORMONE; BONE; AMELOGENIN; EMDOGAIN	In recent years, enamel matrix derivative (EMD) has garnered much interest in the dental field for its apparent bioactivity that stimulates regeneration of periodontal tissues including periodontal ligament, cementum and alveolar bone. Despite its widespread use, the underlying cellular mechanisms remain unclear and an understanding of its biological interactions could identify new strategies for tissue engineering. Previous in vitro research has demonstrated that EMD promotes premature osteoblast clustering at early time points. The aim of the present study was to evaluate the influence of cell clustering on vital osteoblast cell-cell communication and adhesion molecules, connexin 43 (cx43) and N-cadherin (N-cad) as assessed by immunofluorescence imaging, real-time PCR and Western blot analysis. In addition, differentiation markers of osteoblasts were quantified using alkaline phosphatase, osteocalcin and von Kossa staining. EMD significantly increased the expression of connexin 43 and N-cadherin at early time points ranging from 2 to 5 days. Protein expression was localized to cell membranes when compared to control groups. Alkaline phosphatase activity was also significantly increased on EMD-coated samples at 3, 5 and 7 days post seeding. Interestingly, higher activity was localized to cell cluster regions. There was a 3 fold increase in osteocalcin and bone sialoprotein mRNA levels for osteoblasts cultured on EMD-coated culture dishes. Moreover, EMD significantly increased extracellular mineral deposition in cell clusters as assessed through von Kossa staining at 5, 7, 10 and 14 days post seeding. We conclude that EMD up-regulates the expression of vital osteoblast cell-cell communication and adhesion molecules, which enhances the differentiation and mineralization activity of osteoblasts. These findings provide further support for the clinical evidence that EMD increases the speed and quality of new bone formation in vivo.	[Miron, Richard J.; Ruggiero, Sabrina; Bosshardt, Dieter D.; Sculean, Anton] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Miron, Richard J.; Hedbom, Erik; Ruggiero, Sabrina; Bosshardt, Dieter D.; Zhang, Yufeng; Buser, Daniel] Univ Bern, Sch Dent Med, Dept Oral Surg & Stomatol, Bern, Switzerland; [Hedbom, Erik; Iizuka, Tateyuki] Univ Hosp Bern, Inselspital, Dept Craniomaxillofacial Surg, CH-3010 Bern, Switzerland; [Mauth, Corinna; Gemperli, Anja C.] Inst Straumann AG, Basel, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern; Institut Straumann AG	Miron, RJ (corresponding author), Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland.	richard.miron@zmk.unibe.ch	Miron, Richard/J-4995-2012; Zhang, Yufeng/GZL-1973-2022; Buser, Daniel/D-3971-2011; Bosshardt, Dieter D/C-9442-2012		Institute Straumann	Institute Straumann	This study was funded by Institute Straumann (www.straumann.com). Corinna Mauth and Anja Graf are employed by Straumann's research department and assisted in the study design, data collection and analysis of the data.	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Bartold PM, 2010, PERIODONTOL 2000, V53, P55, DOI 10.1111/j.1600-0757.2010.00347.x; Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; Carinci F, 2006, ORAL DIS, V12, P329, DOI 10.1111/j.1601-0825.2005.01204.x; Cho SW, 2009, BONE, V44, P1069, DOI 10.1016/j.bone.2009.02.012; CHRIST GJ, 1993, J PHARMACOL EXP THER, V266, P1054; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; Du C, 2005, J DENT RES, V84, P1070, DOI 10.1177/154405910508401120; Esposito M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub3; Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P678, DOI 10.1111/j.1600-051X.1997.tb00249.x; Gramsch B, 2001, EXP CELL RES, V264, P397, DOI 10.1006/excr.2000.5145; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hagewald S, 2004, ORAL SURG ORAL MED O, V98, P243, DOI 10.1016/j.tripleo.2004.02.063; HAYASHI M, 2011, DENT MAT J; He JN, 2004, ORAL SURG ORAL MED O, V97, P239, DOI 10.1016/j.tripleo.2003.10.005; Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713; Huang YC, 2010, CELL TISSUE RES, V342, P205, DOI 10.1007/s00441-010-1064-7; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jepsen S, 2004, J PERIODONTOL, V75, P1150, DOI 10.1902/jop.2004.75.8.1150; Jiang J, 2001, ORAL SURG ORAL MED O, V91, P95, DOI 10.1067/moe.2001.111304; Johnson DL, 2009, J PERIODONTOL, V80, P648, DOI 10.1902/jop.2009.070420; Kawana F, 2001, ANAT RECORD, V264, P438, DOI 10.1002/ar.10016; Kawase T, 2002, J PERIODONTAL RES, V37, P255, DOI 10.1034/j.1600-0765.2002.01615.x; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Laird DW, 2008, J BIOL CHEM, V283, P2997, DOI 10.1074/jbc.R700041200; Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li ZY, 2006, AM J PHYSIOL-CELL PH, V290, pC1248, DOI 10.1152/ajpcell.00428.2005; Lin WL, 1999, J PERIODONTOL, V70, P1039, DOI 10.1902/jop.1999.70.9.1039; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; Matsuzawa M, 2009, J PERIODONTAL RES, V44, P289, DOI 10.1111/j.1600-0765.2008.01091.x; Megson E, 2010, INT J EVID-BASED HEA, V8, P129, DOI 10.1111/j.1744-1609.2010.00171.x; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; Mumulidu A, 2007, J CHROMATOGR B, V857, P210, DOI 10.1016/j.jchromb.2007.07.017; MUNARISILEM Y, 1995, J CLIN INVEST, V95, P1429, DOI 10.1172/JCI117813; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Olkku A, 2010, BONE, V47, P320, DOI 10.1016/j.bone.2010.04.604; PALUMBO C, 1990, BONE, V11, P401, DOI 10.1016/8756-3282(90)90134-K; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Reseland JE, 2006, EUR J ORAL SCI, V114, P205, DOI 10.1111/j.1600-0722.2006.00333.x; SAEZ JC, 1993, ADV SEC MESS PHOSPH, V27, P163; Saito K, 2008, BONE, V43, P371, DOI 10.1016/j.bone.2008.03.029; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0; Schwartz Z, 2000, J PERIODONTOL, V71, P1287, DOI 10.1902/jop.2000.71.8.1287; Schwarz Frank, 2004, Clin Oral Investig, V8, P165; Sculean A, 1999, INT J PERIODONT REST, V19, P157; Sculean A, 2008, J CLIN PERIODONTOL, V35, P817, DOI 10.1111/j.1600-051X.2008.01295.x; Sculean A, 2007, INT J PERIODONT REST, V27, P221; Sculean A, 2007, MED PRIN PRACT, V16, P167, DOI 10.1159/000100386; Shimizu E, 2005, J PERIODONTOL, V76, P1482, DOI 10.1902/jop.2005.76.9.1482; Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012; Statuto M, 1997, J BIOL CHEM, V272, P24710, DOI 10.1074/jbc.272.39.24710; Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605; Takayama T, 2005, J PERIODONTOL, V76, P244, DOI 10.1902/jop.2005.76.2.244; Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007; van Haasteren G, 1999, J RECEPT SIGNAL TR R, V19, P481, DOI 10.3109/10799899909036666; Weishaupt P, 2008, ORAL SURG ORAL MED O, V106, P304, DOI 10.1016/j.tripleo.2008.02.033; Wu Chun-lan, 2002, Shanghai Kou Qiang Yi Xue, V11, P135; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Yang RJ, 1996, J BIOL CHEM, V271, P29839, DOI 10.1074/jbc.271.47.29839; Yoneda Satoshi, 2002, Kokubyo Gakkai Zasshi, V69, P207; Zeichner-David M, 2006, EUR J ORAL SCI, V114, P244, DOI 10.1111/j.1600-0722.2006.00322.x; Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218	74	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23375	10.1371/journal.pone.0023375	http://dx.doi.org/10.1371/journal.pone.0023375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858092	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700019
J	Quinlan, AMT; Sierad, LN; Capulli, AK; Firstenberg, LE; Billiar, KL				Quinlan, Angela M. Throm; Sierad, Leslie N.; Capulli, Andrew K.; Firstenberg, Laura E.; Billiar, Kristen L.			Combining Dynamic Stretch and Tunable Stiffness to Probe Cell Mechanobiology In Vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMOOTH MUSCLE ACTIN; SUBSTRATE STIFFNESS; ENDOTHELIAL-CELLS; SILICONE-RUBBER; EXPRESSION; LOCOMOTION; STRESSES; STRAIN; GROWTH	Cells have the ability to actively sense their mechanical environment and respond to both substrate stiffness and stretch by altering their adhesion, proliferation, locomotion, morphology, and synthetic profile. In order to elucidate the interrelated effects of different mechanical stimuli on cell phenotype in vitro, we have developed a method for culturing mammalian cells in a two-dimensional environment at a wide range of combined levels of substrate stiffness and dynamic stretch. Polyacrylamide gels were covalently bonded to flexible silicone culture plates and coated with monomeric collagen for cell adhesion. Substrate stiffness was adjusted from relatively soft (G' = 0.3 kPa) to stiff (G' = 50 kPa) by altering the ratio of acrylamide to bis-acrylamide, and the silicone membranes were stretched over circular loading posts by applying vacuum pressure to impart near-uniform stretch, as confirmed by strain field analysis. As a demonstration of the system, porcine aortic valve interstitial cells (VIC) and human mesenchymal stem cells (hMSC) were plated on soft and stiff substrates either statically cultured or exposed to 10% equibiaxial or pure uniaxial stretch at 1Hz for 6 hours. In all cases, cell attachment and cell viability were high. On soft substrates, VICs cultured statically exhibit a small rounded morphology, significantly smaller than on stiff substrates (p < 0.05). Following equibiaxial cyclic stretch, VICs spread to the extent of cells cultured on stiff substrates, but did not reorient in response to uniaxial stretch to the extent of cells stretched on stiff substrates. hMSCs exhibited a less pronounced response than VICs, likely due to a lower stiffness threshold for spreading on static gels. These preliminary data demonstrate that inhibition of spreading due to a lack of matrix stiffness surrounding a cell may be overcome by externally applied stretch suggesting similar mechanotransduction mechanisms for sensing stiffness and stretch.	[Quinlan, Angela M. Throm; Sierad, Leslie N.; Capulli, Andrew K.; Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Quinlan, Angela M. Throm] UMass Med Sch, Grad Sch Biomed Sci, Worcester, MA USA; [Firstenberg, Laura E.] Franklin W Olin Coll Engn, Needham, MA USA; [Billiar, Kristen L.] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA	Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Worcester; Franklin W. Olin College of Engineering; University of Massachusetts System; University of Massachusetts Worcester	Quinlan, AMT (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.	kbilliar@wpi.edu			American Heart Association [SDG 0535265N]	American Heart Association(American Heart Association)	This project was supported by the American Heart Association (www.heart.org) to KLB (SDG 0535265N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; BALESTRINI JL, 2005, J BIOMECH, V28, P28; Banes AJ, 1995, BIOCHEM CELL BIOL, V73, P349, DOI 10.1139/o95-043; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Chen YJ, 2008, CONNECT TISSUE RES, V49, P7, DOI 10.1080/03008200701818561; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Humphrey JD, 2003, BIOMECH MODEL MECHAN, V2, P109, DOI [10.1007/s10237-003-0033-4, 10.1007/S10237-003-0033-4]; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kelly DJ, 2007, MED ENG PHYS, V29, P154, DOI 10.1016/j.medengphy.2006.01.001; KLOXIN AM, IN SITU ELASTICITY M; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; LEUNG DYM, 1976, SCIENCE, V191, P475; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331; Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Wang D, 2010, INTEGR BIOL-UK, V2, P288, DOI 10.1039/b920644b; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang JHC, 2000, J THEOR BIOL, V202, P33, DOI 10.1006/jtbi.1999.1035; Wang JHC, 2000, ANN BIOMED ENG, V28, P1165, DOI 10.1114/1.1317528; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046	50	73	75	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23272	10.1371/journal.pone.0023272	http://dx.doi.org/10.1371/journal.pone.0023272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858051	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953700013
J	Cuadros, DF; Branscum, AJ; Garcia-Ramos, G				Cuadros, Diego F.; Branscum, Adam J.; Garcia-Ramos, Gisela			No Evidence of Association between HIV-1 and Malaria in Populations with Low HIV-1 Prevalence	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM MALARIA; CLINICAL EPISODES; RISK-FACTORS; 4 CITIES; INFECTION; TRANSMISSION; ADULTS; EPIDEMICS; SPREAD	Background: The geographic overlap between HIV-1 and malaria has generated much interest in their potential interactions. A variety of studies have evidenced a complex HIV-malaria interaction within individuals and populations that may have dramatic effects, but the causes and implications of this co-infection at the population level are still unclear. In a previous publication, we showed that the prevalence of malaria caused by the parasite Plasmodium falciparum is associated with HIV infection in eastern sub-Saharan Africa. To complement our knowledge of the HIV-malaria co-infection, the objective of this work was to assess the relationship between malaria and HIV prevalence in the western region of sub-Saharan Africa. Methodology/Principal Findings: Population-based cross-sectional data were obtained from the HIV/AIDS Demographic and Health Surveys conducted in Burkina Faso, Ghana, Guinea, Mali, Liberia and Cameroon, and the malaria atlas project. Using generalized linear mixed models, we assessed the relationship between HIV-1 and Plasmodium falciparum parasite rate (PfPR) adjusting for important socio-economic and biological cofactors. We found no evidence that individuals living in areas with stable malaria transmission (PfPR>0.46) have higher odds of being HIV-positive than individuals who live in areas with PfPR <= 0.46 in western sub-Saharan Africa (estimated odds ratio 1.14, 95% confidence interval 0.86-1.50). In contrast, the results suggested that PfPR was associated with being infected with HIV in Cameroon (estimated odds ratio 1.56, 95% confidence interval 1.23-2.00). Conclusion/Significance: Contrary to our previous research on eastern sub-Saharan Africa, this study did not identify an association between PfPR and infection with HIV in western sub-Saharan Africa, which suggests that malaria might not play an important role in the spread of HIV in populations where the HIV prevalence is low. Our work highlights the importance of understanding the epidemiologic effect of co-infection and the relevant factors involved in this relationship for the implementation of effective control strategies.	[Cuadros, Diego F.; Garcia-Ramos, Gisela] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Branscum, Adam J.] Oregon State Univ, Dept Publ Hlth, Corvallis, OR 97331 USA	University of Kentucky; Oregon State University	Cuadros, DF (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	dfcuad2@uky.edu						Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; [Anonymous], 2010, R LANG ENV STAT COMP; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Herrero MD, 2007, AIDS REV, V9, P88; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Idemyor V, 2007, HIV CLIN TRIALS, V8, P246, DOI 10.1310/hct0804-246; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2006, J INFECT DIS, V193, P1, DOI 10.1086/498581; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Renia L, 2006, PARASITE IMMUNOL, V28, P589, DOI 10.1111/j.1365-3024.2006.00903.x; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1093/IJE/DYQ1256; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23458	10.1371/journal.pone.0023458	http://dx.doi.org/10.1371/journal.pone.0023458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858127	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953500042
J	Dezzutti, CS; Hendrix, CW; Marrazzo, JM; Pan, ZY; Wang, L; Louissaint, N; Kalyoussef, S; Torres, NM; Hladik, F; Parikh, U; Mellors, J; Hillier, SL; Herold, BC				Dezzutti, Charlene S.; Hendrix, Craig W.; Marrazzo, Jeanne M.; Pan, Zhenyu; Wang, Lei; Louissaint, Nicolette; Kalyoussef, Sabah; Torres, N. Merna; Hladik, Florian; Parikh, Urvi; Mellors, John; Hillier, Sharon L.; Herold, Betsy C.			Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; BACTERIAL VAGINOSIS; DOUBLE-BLIND; REPRODUCTIVE-TRACT; EPITHELIAL-CELLS; HIV-1 INFECTION; CHLAMYDIA-TRACHOMATIS; IMMUNE MEDIATORS; TRIAL; ACQUISITION	Background: Measurement of immune mediators and antimicrobial activity in female genital tract secretions may provide biomarkers predictive of risk for HIV-1 acquisition and surrogate markers of microbicide safety. However, optimal methods for sample collection do not exist. This study compared collection methods. Methods: Secretions were collected from 48 women (24 with bacterial vaginosis [BV]) using vaginal and endocervical Dacron and flocked swabs. Cervicovaginal lavage (CVL) was collected with 10 mL of Normosol-R (n = 20), saline (n = 14), or water (n = 14). The concentration of gluconate in Normosol-R CVL was determined to estimate the dilution factor. Cytokine and antimicrobial mediators were measured by Luminex or ELISA and corrected for protein content. Endogenous anti-HIV-1 and anti-E. coli activity were measured by TZM-bl assay or E. coli growth. Results: Higher concentrations of protein were recovered by CVL, despite a 10-fold dilution of secretions, as compared to swab eluents. After protein correction, endocervical swabs recovered the highest mediator levels regardless of BV status. Endocervical and vaginal flocked swabs recovered significantly higher levels of anti-HIV-1 and anti-E. coli activity than Dacron swabs (P < 0.001). BV had a significant effect on CVL mediator recovery. Normosol-R tended to recover higher levels of most mediators among women with BV, whereas saline or water tended to recover higher levels among women without BV. Saline recovered the highest levels of anti-HIV-1 activity regardless of BV status. Conclusions: Endocervical swabs and CVL collected with saline provide the best recovery of most mediators and would be the optimal sampling method(s) for clinical trials.	[Dezzutti, Charlene S.; Hillier, Sharon L.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Parikh, Urvi; Mellors, John] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Hendrix, Craig W.; Louissaint, Nicolette] Johns Hopkins Univ, Dept Clin Pharmacol, Baltimore, MD USA; [Marrazzo, Jeanne M.] Univ Washington, Dept Med, Seattle, WA USA; [Hladik, Florian] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Pan, Zhenyu; Wang, Lei] SCHARP Stat Ctr, Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Kalyoussef, Sabah; Torres, N. Merna; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Dezzutti, CS (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	cdezzutti@mwri.magee.edu	Hendrix, Craig W/G-4182-2014; Hladik, Florian/G-1041-2012; Hladik, Florian/AAR-8852-2021	Hendrix, Craig W/0000-0002-5696-8665; Hladik, Florian/0000-0002-0375-2764; Hladik, Florian/0000-0002-0375-2764; Herold, Betsy/0000-0001-9974-0786; Dezzutti, Charlene/0000-0001-5902-5841; Marrazzo, Jeanne/0000-0002-9277-7364	National Institute of Allergy and Infectious Diseases [U01 AI068633]; National Institute of Child Health and Development; National Center for Research Resources [UL1 RR 025005]; National Institute of Mental Health; United States National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was performed by the Microbicide Trials Network's Biomedical Sciences Working Group, which is funded by the National Institute of Allergy and Infectious Diseases (U01 AI068633), the National Institute of Child Health and Development, the National Center for Research Resources (UL1 RR 025005), and the National Institute of Mental Health, all of the United States National Institutes of Health (NIH). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance for Microbicide Development, 2006, MICR DEV STRAT; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Berneman A, 1998, INFECT IMMUN, V66, P4163; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; Chomont N, 2001, AIDS, V15, P801, DOI 10.1097/00002030-200104130-00018; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Draper DL, 2000, AM J OBSTET GYNECOL, V183, P1243, DOI 10.1067/mob.2000.107383; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Ghanem KG, 2005, J CLIN MICROBIOL, V43, P5295, DOI 10.1128/JCM.43.10.5295-5297.2005; Ghanem Khalil G, 2006, J Pediatr Adolesc Gynecol, V19, P23, DOI 10.1016/j.jpag.2005.11.002; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Jespers V, 2010, EXPERT REV VACCINES, V9, P381, DOI [10.1586/erv.10.21, 10.1586/ERV.10.21]; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Krech T, 2009, J VIROL METHODS, V162, P291, DOI 10.1016/j.jviromet.2009.08.011; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Mitchell C, 2011, AIDS RES HUM RETROV, V27, P35, DOI 10.1089/aid.2010.0129; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Shust GF, 2010, AM J REPROD IMMUNOL, V63, P110, DOI 10.1111/j.1600-0897.2009.00768.x; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; *UNAIDS WHO, 2010, REP GLOB AIDS EP; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yudin MH, 2003, OBSTET GYNECOL, V102, P527, DOI 10.1016/S0029-7844(03)00566-0	46	67	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23136	10.1371/journal.pone.0023136	http://dx.doi.org/10.1371/journal.pone.0023136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858008	Green Published, gold			2022-12-25	WOS:000293953500022
J	Lecours, PB; Duchaine, C; Taillefer, M; Tremblay, C; Veillette, M; Cormier, Y; Marsolais, D				Lecours, Pascale Blais; Duchaine, Caroline; Taillefer, Michel; Tremblay, Claudine; Veillette, Marc; Cormier, Yvon; Marsolais, David			Immunogenic Properties of Archaeal Species Found in Bioaerosols	PLOS ONE			English	Article							HYPERSENSITIVITY PNEUMONITIS; DENDRITIC CELLS; CONVENTIONAL LIPOSOMES; METHANOGENIC ARCHAEA; RESPIRATORY VIRUSES; IN-VIVO; INFLAMMATION; RESPONSES; ADJUVANT; ACTIVATION	The etiology of bioaerosol-related pulmonary diseases remains poorly understood. Recently, archaea emerged as prominent airborne components of agricultural environments, but the consequences of airway exposure to archaea remain unknown. Since subcomponents of archaea can be immunogenic, we used a murine model to study the pulmonary immune responses to two archaeal species found in agricultural facilities: Methanobrevibacter smithii (MBS) and Methanosphaera stadtmanae (MSS). Mice were administered intranasally with 6.25, 25 or 100 mu g of MBS or MSS, once daily, 3 days a week, for 3 weeks. MSS induced more severe histopathological alterations than MBS with perivascular accumulation of granulocytes, pronounced thickening of the alveolar septa, alveolar macrophages accumulation and increased perivascular mononucleated cell accumulation. Analyses of bronchoalveolar lavage fluids revealed up to 3 times greater leukocyte accumulation with MSS compared to MBS. Instillation of 100 mu g of MBS or MSS caused predominant accumulation of monocyte/macrophages (4.5 x 10(5) and 4.8 x 10(5) cells/ml respectively) followed by CD4(+) T cells (1.38 x 10(5) and 1.94 x 10(5) cells/ml respectively), B cells (0.73 x 10(5) and 1.28 x 10(5) cells/ml respectively), and CD8(+) T cells (0.20 x 10(5) and 0.31 x 10(5) cells/ml respectively) in the airways. Both archaeal species induced similar titers of antigen-specific IgGs in plasma. MSS but not MBS caused an accumulation of eosinophils and neutrophils in the lungs, which surprisingly, correlated inversely with the size of the inoculum. Stronger immunogenicity of MSS was confirmed by a 3 fold higher accumulation of myeloid dendritic cells in the airways, compared to MBS. Thus, the dose and species of archaea determine the magnitude and nature of the pulmonary immune response. This is the first report of an immunomodulatory role of archaeal species found in bioaerosols.	[Lecours, Pascale Blais; Duchaine, Caroline; Taillefer, Michel; Veillette, Marc; Cormier, Yvon; Marsolais, David] Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Duchaine, Caroline] Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Tremblay, Claudine] Serv Preclin, Labs Charles River, Montreal, PQ, Canada; [Cormier, Yvon; Marsolais, David] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Lecours, PB (corresponding author), Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	David.Marsolais@criucpq.ulaval.ca			Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST)/Canadian Centre for Health and Safety in Agriculture (CCHSA) [099-8640]; Respiratory Health Network of the Fonds de Recherche en Sante du Quebec; La chaire de pneumologie de la Fondation J-D Begin de l'Universite Laval; la Fondation de l'IUCPQ; department de medicine at Laval University	Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST)/Canadian Centre for Health and Safety in Agriculture (CCHSA); Respiratory Health Network of the Fonds de Recherche en Sante du Quebec; La chaire de pneumologie de la Fondation J-D Begin de l'Universite Laval; la Fondation de l'IUCPQ; department de medicine at Laval University	This study was funded by the Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST)/Canadian Centre for Health and Safety in Agriculture (CCHSA) (099-8640; www.irsst.qc.ca; www.cchsa-ccssma.usask.ca) (CD); Respiratory Health Network of the Fonds de Recherche en Sante du Quebec (http://rsr.chus.qc.ca) (DM, CD); and by La chaire de pneumologie de la Fondation J-D Begin de l'Universite Laval and la Fondation de l'IUCPQ (DM). PBL is a Canadian Institutes of Health Research Strategic Training Fellow in Public Health and the Agricultural Rural Ecosystem Training program (PHARE), and received research internship grant from Respiratory Health Network of the Fonds de Recherche en Sante du Quebec. MT has a scholarship from the department de medicine at Laval University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; *ATS, 1998, RESP HLTH HAZ AGR AM, pS1; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cayer MP, 2007, CAN J MICROBIOL, V53, P92, DOI 10.1139/W06-105; CHEN W, 2010, HUM VACCIN, V6; Cormier Y, 2000, EUR RESPIR J, V15, P560, DOI 10.1034/j.1399-3003.2000.15.22.x; Cormier Y, 2000, ARCH ENVIRON HEALTH, V55, P424, DOI 10.1080/00039890009604041; Dakhama A, 1999, AM J RESP CRIT CARE, V159, P1316, DOI 10.1164/ajrccm.159.4.9807085; *DEP HLTH HUM SERV, 2007, PUBL DHHS; DONHAM KJ, 1995, AM J IND MED, V27, P405, DOI 10.1002/ajim.4700270309; Dutil S, 2009, J OCCUP ENVIRON HYG, V6, P121, DOI 10.1080/15459620802633957; Gilbert Y, 2010, J OCCUP ENVIRON HYG, V7, P280, DOI 10.1080/15459621003680227; Girard M, 2009, ALLERGY, V64, P322, DOI 10.1111/j.1398-9995.2009.01949.x; Girard M, 2010, CURR OPIN ALLERGY CL, V10, P99, DOI 10.1097/ACI.0b013e3283373bb8; Gudmundsson G, 1997, J CLIN INVEST, V99, P2386, DOI 10.1172/JCI119420; HUET J, 1983, EMBO J, V2, P1291, DOI 10.1002/j.1460-2075.1983.tb01583.x; Israel-Assayag E, 1999, J IMMUNOL, V163, P6794; Kates M, 1992, Biochem Soc Symp, V58, P51; Krishnan L, 2000, INFECT IMMUN, V68, P54, DOI 10.1128/IAI.68.1.54-63.2000; Krishnan L, 2001, J IMMUNOL, V166, P1885, DOI 10.4049/jimmunol.166.3.1885; Krishnan L, 2008, VACCINE, V26, P2043, DOI 10.1016/j.vaccine.2008.02.026; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2000, J IMMUNOL, V164, P2937, DOI 10.4049/jimmunol.164.6.2937; LECOURS R, 1986, THORAX, V41, P924, DOI 10.1136/thx.41.12.924; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Nance S, 2004, EUR J IMMUNOL, V34, P677, DOI 10.1002/eji.200324634; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Patel GB, 2007, VACCINE, V25, P8622, DOI 10.1016/j.vaccine.2007.09.042; Patel GB, 2010, EXPERT REV VACCINES, V9, P431, DOI 10.1586/ERV.10.34; Poole JA, 2007, J ALLERGY CLIN IMMUN, V120, P366, DOI 10.1016/j.jaci.2007.04.033; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Sprott GD, 2003, METHOD ENZYMOL, V373, P155; Sprott GD, 1999, BBA-MOL CELL BIOL L, V1440, P275, DOI 10.1016/S1388-1981(99)00130-4; Tolson Douglas L., 1996, Journal of Liposome Research, V6, P755, DOI 10.3109/08982109609039925; Wang ZP, 1996, AM J RESP CRIT CARE, V154, P1261, DOI 10.1164/ajrccm.154.5.8912733; Whitehead TR, 1999, FEMS MICROBIOL LETT, V179, P223, DOI 10.1111/j.1574-6968.1999.tb08731.x; Wiley JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007142; Yamabe K, 2010, MOL ORAL MICROBIOL, V25, P112, DOI 10.1111/j.2041-1014.2009.00548.x; Yamabe K, 2008, FEMS MICROBIOL LETT, V287, P69, DOI 10.1111/j.1574-6968.2008.01304.x	42	39	39	9	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23326	10.1371/journal.pone.0023326	http://dx.doi.org/10.1371/journal.pone.0023326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858070	gold, Green Published			2022-12-25	WOS:000293953500030
J	Lim, CH; Hamazaki, T; Braun, EL; Wade, J; Terada, N				Lim, Chae Ho; Hamazaki, Takashi; Braun, Edward L.; Wade, Juli; Terada, Naohiro			Evolutionary Genomics Implies a Specific Function of Ant4 in Mammalian and Anole Lizard Male Germ Cells	PLOS ONE			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; MITOCHONDRIAL ADP/ATP CARRIER; ADP ATP TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; TISSUE DISTRIBUTION; MAXIMUM-LIKELIHOOD; DNA METHYLATION; GENE; SPERM; EXPRESSION	Most vertebrates have three paralogous genes with identical intron-exon structures and a high degree of sequence identity that encode mitochondrial adenine nucleotide translocase (Ant) proteins, Ant1 (Slc25a4), Ant2 (Slc25a5) and Ant3 (Slc25a6). Recently, we and others identified a fourth mammalian Ant paralog, Ant4 (Slc25a31), with a distinct intron-exon structure and a lower degree of sequence identity. Ant4 was expressed selectively in testis and sperm in adult mammals and was indeed essential for mouse spermatogenesis, but it was absent in birds, fish and frogs. Since Ant2 is X-linked in mammalian genomes, we hypothesized that the autosomal Ant4 gene may compensate for the loss of Ant2 gene expression during male meiosis in mammals. Here we report that the Ant4 ortholog is conserved in green anole lizard (Anolis carolinensis) and demonstrate that it is expressed in the anole testis. Further, a degenerate DNA fragment of putative Ant4 gene was identified in syntenic regions of avian genomes, indicating that Ant4 was present in the common amniote ancestor. Phylogenetic analyses suggest an even more ancient origin of the Ant4 gene. Although anole lizards are presumed male (XY) heterogametic, like mammals, copy numbers of the Ant2 as well as its neighboring gene were similar between male and female anole genomes, indicating that the anole Ant2 gene is either autosomal or located in the pseudoautosomal region of the sex chromosomes, in contrast to the case to mammals. These results imply the conservation of Ant4 is not likely simply driven by the sex chromosomal localization of the Ant2 gene and its subsequent inactivation during male meiosis. Taken together with the fact that Ant4 protein has a uniquely conserved structure when compared to other somatic Ant1, 2 and 3, there may be a specific advantage for mammals and lizards to express Ant4 in their male germ cells.	[Lim, Chae Ho; Hamazaki, Takashi; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32611 USA; [Braun, Edward L.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA; [Wade, Juli] Michigan State Univ, Neurosci Program, Dept Psychol, Dept Zool, E Lansing, MI 48824 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Michigan State University	Lim, CH (corresponding author), Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32611 USA.	terada@pathology.ufl.edu	wade, juli/F-4993-2012	Braun, Edward/0000-0003-1643-5212	University of Florida; NIH [HD060474]; NSF [IOS0742833]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060474] Funding Source: NIH RePORTER	University of Florida(University of Florida); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	C.H.L. is a recipient of University of Florida Alumni Fellowship. This work was supported in part by NIH grants HD060474 to N.T. and NSF grant IOS0742833 to J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, INFORM THEORY EXTENS, P267; Amiri H, 2003, J MOL EVOL, V56, P137, DOI 10.1007/s00239-002-2387-0; Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; Braun Edward L, 2003, Appl Bioinformatics, V2, P13; Braun EL, 2001, MOL BIOL EVOL, V18, P1401, DOI 10.1093/oxfordjournals.molbev.a003924; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; Brower JV, 2009, BBA-GENE REGUL MECH, V1789, P198, DOI 10.1016/j.bbagrm.2008.12.005; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cai XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003569; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; CECI JD, 1994, MAMM GENOME, V5, pS124; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Cueto MA, 2011, B MATH BIOL, V73, P1202, DOI 10.1007/s11538-010-9556-x; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Ellison JW, 1996, GENOMICS, V36, P369, DOI 10.1006/geno.1996.0478; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gorman G.C., 1973, P349; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Holland BR, 2003, SYST BIOL, V52, P229, DOI 10.1080/10635150390192771; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katsu Y, 2009, CYTOGENET GENOME RES, V127, P79, DOI 10.1159/000297715; KIERSZENBAUM AL, 2002, SPERMATOGENESIS HIST, P541; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Kimura MA, 1985, NEUTRAL THEORY MOL E; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lin YH, 2002, MOL BIOL EVOL, V19, P2060, DOI 10.1093/oxfordjournals.molbev.a004031; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; LUNARDI J, 1992, J BIOL CHEM, V267, P15267; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MEISEL RP, 2011, MOL BIOL EV IN PRESS; Mentel M, 2005, MOL GENET GENOMICS, V273, P84, DOI 10.1007/s00438-005-1107-z; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Miura I, 1998, MOL BIOL EVOL, V15, P1612, DOI 10.1093/oxfordjournals.molbev.a025889; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rodic N, 2005, STEM CELLS, V23, P1314, DOI 10.1634/stemcells.2005-0119; Rolland AD, 2011, BIOL REPROD, V84, P790, DOI 10.1095/biolreprod.110.088443; SABOVA L, 1993, EUR J BIOCHEM, V213, P547, DOI 10.1111/j.1432-1033.1993.tb17793.x; Sassi SO, 2007, MOL BIOL EVOL, V24, P1012, DOI 10.1093/molbev/msm020; Smith CP, 2008, GENETICS, V179, P1285, DOI 10.1534/genetics.108.087700; Spinks PQ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-56; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suarez SS, 2003, CELL MOL BIOL, V49, P351; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Varriale A, 2006, GENE, V385, P122, DOI 10.1016/j.gene.2006.05.034; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	68	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23122	10.1371/journal.pone.0023122	http://dx.doi.org/10.1371/journal.pone.0023122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858006	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500021
J	Van den Hove, D; Jakob, SB; Schraut, KG; Kenis, G; Schmitt, AG; Kneitz, S; Scholz, CJ; Wiescholleck, V; Ortega, G; Prickaerts, J; Steinbusch, H; Lesch, KP				Van den Hove, Daniel; Jakob, Sissi Brigitte; Schraut, Karla-Gerlinde; Kenis, Gunter; Schmitt, Angelika Gertrud; Kneitz, Susanne; Scholz, Claus-Juergen; Wiescholleck, Valentina; Ortega, Gabriela; Prickaerts, Jos; Steinbusch, Harry; Lesch, Klaus-Peter			Differential Effects of Prenatal Stress in 5-Htt Deficient Mice: Towards Molecular Mechanisms of Gene x Environment Interactions	PLOS ONE			English	Article							SEROTONIN TRANSPORTER POLYMORPHISM; ACUTE TRYPTOPHAN DEPLETION; ANXIETY-LIKE BEHAVIOR; LONG-TERM DEPRESSION; KNOCK-OUT MICE; MAJOR DEPRESSION; INTERFERON-ALPHA; PHYSIOLOGICAL FUNCTIONS; RESTRAINT STRESS; BIPOLAR DISORDER	Prenatal stress (PS) has been shown to influence the development of the fetal brain and to increase the risk for the development of psychiatric disorders in later life. Furthermore, the variation of human serotonin transporter (5-HTT, SLC6A4) gene was suggested to exert a modulating effect on the association between early life stress and the risk for depression. In the present study, we used a 5-HttxPS paradigm to investigate whether the effects of PS are dependent on the 5-Htt genotype. For this purpose, the effects of PS on cognition, anxiety-and depression-related behavior were examined using a maternal restraint stress paradigm of PS in C57BL6 wild-type (WT) and heterozygous 5-Htt deficient (5-Htt +/-) mice. Additionally, in female offspring, a genome-wide hippocampal gene expression profiling was performed using the Affymetrix GeneChip (R) Mouse Genome 430 2.0 Array. 5-Htt +/- offspring showed enhanced memory performance and signs of reduced anxiety as compared to WT offspring. In contrast, exposure of 5-Htt +/- mice to PS was associated with increased depressive-like behavior, an effect that tended to be more pronounced in female offspring. Further, 5-Htt genotype, PS and their interaction differentially affected the expression of numerous genes and related pathways within the female hippocampus. Specifically, MAPK and neurotrophin signaling were regulated by both the 5-Htt +/- genotype and PS exposure, whereas cytokine and Wnt signaling were affected in a 5-Htt genotypexPS manner, indicating a genexenvironment interaction at the molecular level. In conclusion, our data suggest that although the 5-Htt +/- genotype shows clear adaptive capacity, 5-Htt +/- mice -particularly females-at the same time appear to be more vulnerable to developmental stress exposure when compared to WT offspring. Moreover, hippocampal gene expression profiles suggest that distinct molecular mechanisms mediate the behavioral effects of the 5-Htt genotype, PS exposure, and their interaction.	[Van den Hove, Daniel; Jakob, Sissi Brigitte; Schraut, Karla-Gerlinde; Ortega, Gabriela; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Inst Mol Psychiat, Wurzburg, Germany; [Van den Hove, Daniel; Kenis, Gunter; Prickaerts, Jos; Steinbusch, Harry; Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Maastricht, Netherlands; [Kneitz, Susanne; Scholz, Claus-Juergen] Univ Wurzburg, Interdisciplinary Ctr Clin Res, Lab Microarray Applicat, Wurzburg, Germany; [Wiescholleck, Valentina] Ruhr Univ Bochum, Dept Neurophysiol, Bochum, Germany	University of Wurzburg; Maastricht University; University of Wurzburg; Ruhr University Bochum	Van den Hove, D (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Inst Mol Psychiat, Wurzburg, Germany.	d.vandenhove@maastrichtuniversity.nl	Steinbusch, Heinrich/L-6950-2017; Scholz, Claus Jürgen/H-3202-2019; Lesch, Klaus-Peter/J-4906-2013	Scholz, Claus Jürgen/0000-0002-6406-7859; Lesch, Klaus-Peter/0000-0001-8348-153X; van den Hove, Daniel/0000-0003-4047-3198	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich Transregio (SFB TRR)58 Sonderforschungsbereich (SFB) 581, Klinische Forschergruppe (KFO) 125]; Interdisziplinaeres Zentrum fuer Klinische Forschung [(IZKF)-Z6]; European Commission (EC) [NEWMOOD LSHM-CT-2003-503474]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisziplinaeres Zentrum fuer Klinische Forschung; European Commission (EC)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereich Transregio (SFB TRR) 58, Sonderforschungsbereich (SFB) 581, Klinische Forschergruppe (KFO) 125 to KPL, Interdisziplinaeres Zentrum fuer Klinische Forschung (IZKF)-Z6 to SK and the European Commission (EC) (NEWMOOD LSHM-CT-2003-503474 to HWMS, KPL, GK, JP and DLAVDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Asaoka Y, 2010, J BIOCHEM, V148, P393, DOI 10.1093/jb/mvq098; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Behan AT, 2011, EUR NEUROPSYCHOPHARM, V21, P71, DOI 10.1016/j.euroneuro.2010.07.004; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Capuron L, 2000, J CLIN ONCOL, V18, P2143, DOI 10.1200/JCO.2000.18.10.2143; Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9; Capuron L, 2008, BIOL PSYCHIAT, V64, P896, DOI 10.1016/j.biopsych.2008.05.019; Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CASPI A, 2010, AM J PSYCHIAT; CHAPMAN RH, 1979, DEV PSYCHOBIOL, V12, P255, DOI 10.1002/dev.420120309; Chen Qi, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005008; Cizza G, 2008, BIOL PSYCHIAT, V64, P907, DOI 10.1016/j.biopsych.2008.05.035; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duman RS, 2000, BIOL PSYCHIAT, V48, P732, DOI 10.1016/S0006-3223(00)00935-5; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fredericks CA, 2010, BRAIN BEHAV IMMUN, V24, P350, DOI 10.1016/j.bbi.2009.10.014; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Gould TD, 2004, J CLIN PSYCHIAT, V65, P10; Gould TD, 2008, BEHAV BRAIN RES, V189, P117, DOI 10.1016/j.bbr.2007.12.028; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2002, BIOINFORMATICS, V18, pS96; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033; Jones KL, 2010, INT J DEV NEUROSCI, V28, P529, DOI 10.1016/j.ijdevneu.2010.05.002; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; KENIS G, 2010, INT J NEUROPSYCHOPH, V29, P1; Leonard BE, 2009, HUM PSYCHOPHARM CLIN, V24, P165, DOI 10.1002/hup.1011; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li HH, 2009, BEHAV BRAIN RES, V205, P32, DOI 10.1016/j.bbr.2009.06.036; Liu YF, 2004, J NEUROCHEM, V89, P1034, DOI 10.1111/j.1471-4159.2004.02391.x; Lotrich FE, 2009, BIOL PSYCHIAT, V65, P344, DOI 10.1016/j.biopsych.2008.08.009; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Martins-de-Souza D, 2010, J PSYCHIAT RES; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Olivier JDA, 2008, PSYCHOPHARMACOLOGY, V200, P243, DOI 10.1007/s00213-008-1201-0; Pallares ME, 2007, PHYSIOL BEHAV, V92, P951, DOI 10.1016/j.physbeh.2007.06.021; Patin V, 2002, DEV BRAIN RES, V139, P1, DOI 10.1016/S0165-3806(02)00491-1; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Persico AM, 2003, NEUROREPORT, V14, P341, DOI 10.1097/01.wnr.0000058244.21747.83; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Ravary A, 2001, EUR J NEUROSCI, V13, P1349, DOI 10.1046/j.0953-816x.2001.1511.x; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Robinson CM, 2005, J INTERF CYTOK RES, V25, P20, DOI 10.1089/jir.2005.25.20; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Tsao CW, 2006, PROG NEURO-PSYCHOPH, V30, P899, DOI 10.1016/j.pnpbp.2006.01.029; Turner CA, 2006, BIOL PSYCHIAT, V59, P1128, DOI 10.1016/j.biopsych.2006.02.026; van den Hove Daniel L A, 2010, Front Biosci (Elite Ed), V2, P43; Van Den Hove DLA, 2006, NEUROSCIENCE, V137, P145, DOI 10.1016/j.neuroscience.2005.08.060; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANMIERLO T, 2009, NEUROBIOL AGING; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Wu XJ, 2011, PSYCHONEUROENDOCRINO, V36, P266, DOI 10.1016/j.psyneuen.2010.07.017; Wu XJ, 2010, BRAIN BEHAV IMMUN, V24, P1340, DOI 10.1016/j.bbi.2010.06.012; Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Zeng H, 2007, MOL ENDOCRINOL, V21, P2795, DOI 10.1210/me.2007-0048; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170	91	64	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22715	10.1371/journal.pone.0022715	http://dx.doi.org/10.1371/journal.pone.0022715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857948	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500006
J	Moens, LN; De Rijk, P; Reumers, J; Van den Bossche, MJA; Glassee, W; De Zutter, S; Lenaerts, AS; Nordin, A; Nilsson, LG; Castello, IM; Norrback, KF; Goossens, D; Van Steen, K; Adolfsson, R; Del-Favero, J				Moens, Lotte N.; De Rijk, Peter; Reumers, Joke; Van den Bossche, Maarten J. A.; Glassee, Wim; De Zutter, Sonia; Lenaerts, An-Sofie; Nordin, Annelie; Nilsson, Lars-Goran; Castello, Ignacio Medina; Norrback, Karl-Fredrik; Goossens, Dirk; Van Steen, Kristel; Adolfsson, Rolf; Del-Favero, Jurgen			Sequencing of DISC1 Pathway Genes Reveals Increased Burden of Rare Missense Variants in Schizophrenia Patients from a Northern Swedish Population	PLOS ONE			English	Article							CHILDHOOD-ONSET SCHIZOPHRENIA; INTRINSICALLY DISORDERED PROTEINS; CASE-CONTROL ASSOCIATION; MAJOR MENTAL-ILLNESS; BIPOLAR DISORDER; CANDIDATE GENES; GRAY-MATTER; SUSCEPTIBILITY LOCUS; INTERACTION NETWORKS; STRUCTURAL VARIANTS	In recent years, DISC1 has emerged as one of the most credible and best supported candidate genes for schizophrenia and related neuropsychiatric disorders. Furthermore, increasing evidence - both genetic and functional - indicates that many of its protein interaction partners are also involved in the development of these diseases. In this study, we applied a pooled sample 454 sequencing strategy, to explore the contribution of genetic variation in DISC1 and 10 of its interaction partners (ATF5, Grb2, FEZ1, LIS-1, PDE4B, NDE1, NDEL1, TRAF3IP1, YWHAE, and ZNF365) to schizophrenia susceptibility in an isolated northern Swedish population. Mutation burden analysis of the identified variants in a population of 486 SZ patients and 514 control individuals, revealed that non-synonymous rare variants with a MAF<0.01 were significantly more present in patients compared to controls (8.64% versus 4.7%, P = 0.018), providing further evidence for the involvement of DISC1 and some of its interaction partners in psychiatric disorders. This increased burden of rare missense variants was even more striking in a subgroup of early onset patients (12.9% versus 4.7%, P = 0.0004), highlighting the importance of studying subgroups of patients and identifying endophenotypes. Upon investigation of the potential functional effects associated with the identified missense variants, we found that similar to 90% of these variants reside in intrinsically disordered protein regions. The observed increase in mutation burden in patients provides further support for the role of the DISC1 pathway in schizophrenia. Furthermore, this study presents the first evidence supporting the involvement of mutations within intrinsically disordered protein regions in the pathogenesis of psychiatric disorders. As many important biological functions depend directly on the disordered state, alteration of this disorder in key pathways may represent an intriguing new disease mechanism for schizophrenia and related neuropsychiatric diseases. Further research into this unexplored domain will be required to elucidate the role of the identified variants in schizophrenia etiology.	[Moens, Lotte N.; De Rijk, Peter; Van den Bossche, Maarten J. A.; Glassee, Wim; De Zutter, Sonia; Lenaerts, An-Sofie; Goossens, Dirk; Del-Favero, Jurgen] Flanders Inst Biotechnol VIB, Appl Mol Genom Grp, Dept Mol Genet, Flanders, Belgium; [Moens, Lotte N.; De Rijk, Peter; Van den Bossche, Maarten J. A.; Glassee, Wim; De Zutter, Sonia; Lenaerts, An-Sofie; Goossens, Dirk; Del-Favero, Jurgen] Univ Antwerp, B-2020 Antwerp, Belgium; [Reumers, Joke] Flanders Inst Biotechnol VIB, SWITCH Lab, Flanders, Belgium; [Reumers, Joke] Vrije Univ Brussel, Brussels, Belgium; [Nordin, Annelie; Norrback, Karl-Fredrik; Adolfsson, Rolf] Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden; [Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Castello, Ignacio Medina] Prince Felipe Res Ctr CIPF, Funct Genom Unit, Bioinformat & Genom Dept, Valencia, Spain; [Van Steen, Kristel] Univ Liege, Syst & Modeling Unit, Montefiore Inst GIGA, Liege, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Umea University; Stockholm University; Prince Felipe Research Center; University of Liege	Moens, LN (corresponding author), Flanders Inst Biotechnol VIB, Appl Mol Genom Grp, Dept Mol Genet, Flanders, Belgium.	jurgen.delfavero@molgen.vib-ua.be	De Rijk, Peter/GXH-9837-2022	De Rijk, Peter/0000-0001-8558-9288; Del Favero, jurgen/0000-0002-7427-7489; Van Den Bossche, Maarten/0000-0002-2989-6600; Adolfsson, Rolf/0000-0001-9785-8473; /0000-0002-8114-7615; Goossens, Dirk/0000-0002-2080-7464; Van Steen, Kristel/0000-0001-9868-5033; Reumers, Joke/0000-0001-5434-6515	University of Antwerp; Fund for Scientific Research Flanders (FWO-F); Institute for Science and Technology-Flanders (IWT-F); Swedish Research Council [2006-4472, 2009-5269]; Medical Faculty, Umea University; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	University of Antwerp; Fund for Scientific Research Flanders (FWO-F)(FWO); Institute for Science and Technology-Flanders (IWT-F)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Umea University; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	This research was supported by the Special Research Fund of the University of Antwerp, the Fund for Scientific Research Flanders (FWO-F), the Institute for Science and Technology-Flanders (IWT-F), the Swedish Research Council (grants 2006-4472 and 2009-5269), the Medical Faculty, Umea University and the County Councils of Vasterbotten and Norrbotten, Sweden. LNM was supported by a postdoctoral fellowship from IWT-F, and MVDB holds a PhD fellowship of the IWT-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2007, MOL PSYCHIATR, V12, P195, DOI 10.1038/sj.mp.4001906; Addington AM, 2004, BIOL PSYCHIAT, V55, P976, DOI 10.1016/j.biopsych.2004.01.024; Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Burdick KE, 2005, NEUROREPORT, V16, P1399, DOI 10.1097/01.wnr.0000175248.25535.f6; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Chen QY, 2007, J PSYCHIATR RES, V41, P428, DOI 10.1016/j.jpsychires.2006.01.001; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; CHILDS B, 1986, PERSPECT BIOL MED, V29, P437; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Di Giorgio A, 2008, EUR J NEUROSCI, V28, P2129, DOI 10.1111/j.1460-9568.2008.06482.x; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eastwood SL, 2009, MOL PSYCHIATR, V14, P556, DOI 10.1038/mp.2009.13; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Ekelund J, 2004, MOL PSYCHIATR, V9, P1037, DOI 10.1038/sj.mp.4001536; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; Hamshere ML, 2005, ARCH GEN PSYCHIAT, V62, P1081, DOI 10.1001/archpsyc.62.10.1081; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hennah W, 2005, MOL PSYCHIATR, V10, P1097, DOI 10.1038/sj.mp.4001731; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hennah W, 2006, SCHIZOPHRENIA BULL, V32, P409, DOI 10.1093/schbul/sbj079; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Macgregor S, 2004, MOL PSYCHIATR, V9, P1083, DOI 10.1038/sj.mp.4001544; Maeda K, 2006, BIOL PSYCHIAT, V60, P929, DOI 10.1016/j.biopsych.2006.03.032; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Mohan A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000497; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakata K, 2009, P NATL ACAD SCI USA, V106, P15873, DOI 10.1073/pnas.0903413106; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Ogawa F, 2005, BIOCHEM BIOPH RES CO, V338, P771, DOI 10.1016/j.bbrc.2005.10.013; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Palo OM, 2007, HUM MOL GENET, V16, P2517, DOI 10.1093/hmg/ddm207; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P53, DOI 10.1001/archgenpsychiatry.2007.15; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu M, 2007, AM J MED GENET B, V144B, P266, DOI 10.1002/ajmg.b.30322; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Saetre P, 2008, SCHIZOPHR RES, V106, P237, DOI 10.1016/j.schres.2008.08.024; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schaefer C, 2010, BIOINFORMATICS, V26, P625, DOI 10.1093/bioinformatics/btq012; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shih RA, 2004, INT REV PSYCHIATR, V16, P260, DOI 10.1080/09540260400014401; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Thomson PA, 2005, NEUROSCI LETT, V389, P41, DOI 10.1016/j.neulet.2005.07.004; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Vyas NS, 2011, EARLY INTERV PSYCHIA, V5, P3, DOI 10.1111/j.1751-7893.2010.00253.x; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Williams HJ, 2009, J HUM GENET, V54, P9, DOI 10.1038/jhg.2008.7	92	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23450	10.1371/journal.pone.0023450	http://dx.doi.org/10.1371/journal.pone.0023450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853134	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953400045
J	Cooper, MT; Kennison, JA				Cooper, Monica T.; Kennison, James A.			Molecular Genetic Analyses of Polytene Chromosome Region 72A-D in Drosophila melanogaster Reveal a Gene Desert in 72D	PLOS ONE			English	Article							INDUCED MUTATIONS; GENOME; IDENTIFICATION; SEQUENCE; EXPRESSION; PROJECT; PROTEIN; BRAHMA; SCREEN; BLAT	We have investigated a region of similar to 310 kb of genomic DNA within polytene chromosome subdivisions 72A to 72D of Drosophila melanogaster. This region includes 57 predicted protein-coding genes. Seventeen of these genes are in six clusters that appear to have arisen by tandem duplication. Within this region we found 23 complementation groups that are essential for zygotic viability, and we have identified the transcription units for 18 of the 23. We also found a 55 kb region in 72D that is nonessential. Flies deficient for this region are viable and fertile. Within this nonessential region are 48 DNA sequences of 12 to 33 base pairs that are completely conserved among 12 distantly related Drosophila species. These sequences do not have the evolutionary signature of conserved protein-coding DNA sequences, nor do they appear to encode microRNAs, however, the strong selection suggests functions in wild populations that are not apparent in laboratory cultures. This region resembles dispensable gene deserts previously characterized in the mouse genome.	[Cooper, Monica T.; Kennison, James A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Cooper, MT (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	Jim_Kennison@nih.gov			National Institutes of Health, NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001005] Funding Source: NIH RePORTER	National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the National Institutes of Health, NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 1999, GENETICS, V153, P179; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Blumenstiel JP, 2009, GENETICS, V182, P25, DOI 10.1534/genetics.109.101998; BRIZUELA BJ, 1994, GENETICS, V137, P803; Brumby A, 2004, GENETICS, V168, P227, DOI 10.1534/genetics.104.026617; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; Cooper JL, 2008, GENETICS, V180, P661, DOI 10.1534/genetics.108.092437; Cooper MT, 2010, GENETICS, V185, P811, DOI 10.1534/genetics.110.115121; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Huang AM, 2000, DROSOPHILA PROTOCOLS, P429; KENNISON JA, 1983, GENETICS, V103, P219; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; LEFEVRE G, 1986, GENETICS, V113, P869; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MELENDEZ A, 1995, GENETICS, V141, P1507; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Mizuno T, 2002, DEVELOPMENT, V129, P1215; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; STOWERS RS, 2007, DROSOPHILA HUNTINGTI; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23509	10.1371/journal.pone.0023509	http://dx.doi.org/10.1371/journal.pone.0023509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853143	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200091
J	Pachikian, BD; Essaghir, A; Demoulin, JB; Neyrinck, AM; Catry, E; De Backer, FC; Dejeans, N; Dewulf, EM; Sohet, FM; Portois, L; Deldicque, L; Molendi-Coste, O; Leclercq, IA; Francaux, M; Carpentier, YA; Foufelle, F; Muccioli, GG; Cani, PD; Delzenne, NM				Pachikian, Barbara D.; Essaghir, Ahmed; Demoulin, Jean-Baptiste; Neyrinck, Audrey M.; Catry, Emilie; De Backer, Fabienne C.; Dejeans, Nicolas; Dewulf, Evelyne M.; Sohet, Florence M.; Portois, Laurence; Deldicque, Louise; Molendi-Coste, Olivier; Leclercq, Isabelle A.; Francaux, Marc; Carpentier, Yvon A.; Foufelle, Fabienne; Muccioli, Giulio G.; Cani, Patrice D.; Delzenne, Nathalie M.			Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets	PLOS ONE			English	Article							LIVER-X-RECEPTOR; LONG-CHAIN; FISH-OIL; SREBP-1C TRANSCRIPTION; CB1 RECEPTORS; GENE; ACTIVATION; BINDING; GLUCOSE; ALPHA	Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsaturated fatty acid (PUFA) ratio in hepatic phospholipids. The metabolic consequences of n-3 PUFA depletion in the liver are poorly understood. We have reproduced a drastic drop in n-3 PUFA among hepatic phospholipids by feeding C57Bl/6J mice for 3 months with an n-3 PUFA depleted diet (DEF) versus a control diet (CT), which only differed in the PUFA content. DEF mice exhibited hepatic insulin resistance (assessed by euglycemic-hyperinsulinemic clamp) and steatosis that was associated with a decrease in fatty acid oxidation and occurred despite a higher capacity for triglyceride secretion. Microarray and qPCR analysis of the liver tissue revealed higher expression of all the enzymes involved in lipogenesis in DEF mice compared to CT mice, as well as increased expression and activation of sterol regulatory element binding protein-1c (SREBP-1c). Our data suggest that the activation of the liver X receptor pathway is involved in the overexpression of SREBP-1c, and this phenomenon cannot be attributed to insulin or to endoplasmic reticulum stress responses. In conclusion, n-3 PUFA depletion in liver phospholipids leads to activation of SREBP-1c and lipogenesis, which contributes to hepatic steatosis.	[Pachikian, Barbara D.; Neyrinck, Audrey M.; Catry, Emilie; De Backer, Fabienne C.; Dewulf, Evelyne M.; Sohet, Florence M.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium; [Dejeans, Nicolas] Catholic Univ Louvain, Louvain Drug Res Inst, Toxicol & Canc Biol Res Grp, B-1200 Brussels, Belgium; [Portois, Laurence; Carpentier, Yvon A.] Univ Libre Bruxelles, Expt Surg Lab, Brussels, Belgium; [Deldicque, Louise] Katholieke Univ Leuven, Dept Biomed Kinesiol, Res Ctr Exercise & Hlth, Louvain, Belgium; [Molendi-Coste, Olivier; Leclercq, Isabelle A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Hepatogastroenterol, B-1200 Brussels, Belgium; [Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, Res Grp Muscle & Exercise Physiol, B-1348 Louvain, Belgium; [Foufelle, Fabienne] Ctr Rech Cordeliers, INSERM, UMR S 872, Paris, France; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, CHAM7230, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Libre de Bruxelles; KU Leuven; Universite Catholique Louvain; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Catholique Louvain	Pachikian, BD (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016; Neyrinck, Audrey/AAE-7929-2019	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Neyrinck, Audrey/0000-0002-9435-3338; Demoulin, Jean-Baptiste/0000-0002-8016-6689; Molendi-Coste, Olivier/0000-0002-0498-9456; FOUFELLE, Fabienne/0000-0002-0752-622X; Deldicque, Louise/0000-0003-3393-5278; Muccioli, Giulio/0000-0002-1600-9259; Francaux, Marc/0000-0001-8182-1588	FRS-FNRS (Fonds de la recherche scientifique) [FRSM 3.4574.07, FRFC 2.4555.08]; Region Wallonne [Walnut 20]	FRS-FNRS (Fonds de la recherche scientifique)(Fonds de la Recherche Scientifique - FNRS); Region Wallonne	This work was supported by the FRS-FNRS (Fonds de la recherche scientifique) (convention FRSM 3.4574.07 and FRFC 2.4555.08) and by the Region Wallonne (Walnut 20). P. D. C. and I. L. are research associates from the FRS-FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL LJ, 1993, ARCH INTERN MED, V153, P1429, DOI 10.1001/archinte.153.12.1429; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Clarke SD, 2001, AM J PHYSIOL-GASTR L, V281, pG865, DOI 10.1152/ajpgi.2001.281.4.G865; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Delarue J, 2006, BRIT J NUTR, V95, P267, DOI 10.1079/BJN20051631; Dentin R, 2006, J NUTR, V136, P1145, DOI 10.1093/jn/136.5.1145; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Elizondo A, 2007, OBESITY, V15, P24, DOI 10.1038/oby.2007.518; Esfandiari F, 2005, AM J PHYSIOL-GASTR L, V289, pG54, DOI 10.1152/ajpgi.00542.2004; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Howell III G, 2009, BIOCH BIOPHYS ACTA; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kammoun HL, 2009, CURR OPIN CLIN NUTR, V12, P575, DOI 10.1097/MCO.0b013e32833189db; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Louchami K, 2006, INT J MOL MED, V18, P1047; Malaisse WJ, 2009, INT J MOL MED, V24, P111, DOI 10.3892/ijmm_00000214; Malhi H, 2010, J HEPATOL; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nakatani T, 2005, BBA-MOL CELL BIOL L, V1736, P77, DOI 10.1016/j.bbalip.2005.07.003; Neyrinck A, 1999, LIFE SCI, V65, P2851, DOI 10.1016/S0024-3205(99)00554-8; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pachikian B. D., 2008, BMC Physiology, V8, P21, DOI 10.1186/1472-6793-8-21; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; RICHELLE M, 1994, BIOCHEMISTRY-US, V33, P4872, DOI 10.1021/bi00182a015; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Shapiro H, 2011, CLIN NUTR, V30, P6, DOI 10.1016/j.clnu.2010.06.001; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Xu J, 2002, J NUTR, V132, P3333, DOI 10.1093/jn/132.11.3333; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020	63	71	72	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23365	10.1371/journal.pone.0023365	http://dx.doi.org/10.1371/journal.pone.0023365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853118	gold, Green Published, Green Submitted			2022-12-25	WOS:000295454200075
J	Bridle, A; Nosworthy, E; Polinski, M; Nowak, B				Bridle, Andrew; Nosworthy, Elizabeth; Polinski, Mark; Nowak, Barbara			Evidence of an Antimicrobial-Immunomodulatory Role of Atlantic Salmon Cathelicidins during Infection with Yersinia ruckeri	PLOS ONE			English	Article							RAINBOW-TROUT; ANTIBACTERIAL PEPTIDES; KERATINOCYTE MIGRATION; GENE-EXPRESSION; SKIN; IDENTIFICATION; LL-37; RECEPTOR; FAMILY; LIPOPOLYSACCHARIDE	Cathelicidins are a family of antimicrobial peptides that act as effector molecules of the innate immune system with broad-spectrum antimicrobial properties. These evolutionary conserved cationic host-defence peptides are integral components of the immune response of fish, which are generally believed to rely heavily on innate immune defences to invading pathogens. In this study we showed that Atlantic salmon cathelicidin 1 and 2 (asCATH1 and asCATH2) stimulated peripheral blood leukocytes increasing the transcription of the chemokine interleukin-8. Further, functional differences were identified between the two cathelicidins. In the presence of serum, asCATH1 displayed greatly diminished host haemolytic activity, while the constitutively expressed asCATH2 had no haemolytic activity with or without serum. These findings support our hypothesis that fish cathelicidins exert their primary antimicrobial action at the site of pathogen invasion such as epithelial surfaces. Further, we hypothesise that like their mammalian counterparts in the presence of serum they act as mediators of the innate and adaptive immune response via the release of cytokines thus indirectly protecting against a variety of pathogens. We highlight the importance of this immunomodulatory role from the involvement of asCATHs during an infection with the fish pathogen Yersinia ruckeri. While we were able to demonstrate in vitro that asCATH1 and 2, possessed direct microbicidal activity against the fish pathogen, Vibrio anguillarum, and a common gram negative bacterium, Escherichia coli, little or no bactericidal activity was found against Y. ruckeri. The contribution of either asCATH in the immune response or as a potential virulence factor during yersiniosis is highlighted from the increased expression of asCATH1 and 2 mRNA during an in vivo challenge with Y. ruckeri. We propose that Atlantic salmon cathelicidins participate in the interplay between the innate and adaptive immune systems via the release of cytokines enabling a more effective response to invading pathogens.	[Bridle, Andrew; Nosworthy, Elizabeth; Polinski, Mark; Nowak, Barbara] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Hobart, Tas 7001, Australia	University of Tasmania	Bridle, A (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Hobart, Tas 7001, Australia.	Andrew.Bridle@utas.edu.au	Bridle, Andrew/B-4117-2013; Nowak, Barbara/J-7261-2014	Nowak, Barbara/0000-0002-0347-643X; Polinski, Mark/0000-0001-7237-3808; Bridle, Andrew/0000-0002-5788-1297	Australian Research Council [LP0883880]	Australian Research Council(Australian Research Council)	This research was supported under Australian Research Council's Linkage Projects funding scheme (project number LP0883880). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 1999, J CLIN INVEST, V103, P1113, DOI 10.1172/JCI6570; Basanez G, 2002, FEBS LETT, V532, P115, DOI 10.1016/S0014-5793(02)03651-7; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bowdish DME, 2004, J IMMUNOL, V172, P3758, DOI 10.4049/jimmunol.172.6.3758; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Caipang CMA, 2010, COMP BIOCHEM PHYS B, V156, P319, DOI 10.1016/j.cbpb.2010.04.009; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Carson J., 2009, YERSINIOSIS FISH, P1; Casadei E, 2009, MOL IMMUNOL, V46, P3358, DOI 10.1016/j.molimm.2009.07.018; Castaneda-Delgado J, 2010, CLIN EXP IMMUNOL, V161, P542, DOI 10.1111/j.1365-2249.2010.04199.x; Chang CI, 2006, ANTIMICROB AGENTS CH, V50, P185, DOI 10.1128/AAC.50.1.185-195.2006; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Dawson RM, 2009, DRUG DEVELOP RES, V70, P481, DOI 10.1002/ddr.20329; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Feng CY, 2009, PHYSIOL GENOMICS, V37, P149, DOI 10.1152/physiolgenomics.90373.2008; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Maier VH, 2008, MOL IMMUNOL, V45, P2352, DOI 10.1016/j.molimm.2007.11.008; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; OTVOS L, 2007, BROTH MICRODILUTION, P309; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Rajanbabu V, 2011, PEPTIDES, V32, P415, DOI 10.1016/j.peptides.2010.11.005; Ramanathan B, 2002, MICROBES INFECT, V4, P361, DOI 10.1016/S1286-4579(02)01549-6; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Ruckner R. R., 1966, Bulletin Office International des Epizooties, V65, P825; Scocchi M, 2009, COMP BIOCHEM PHYS B, V152, P376, DOI 10.1016/j.cbpb.2009.01.003; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2009, DIS AQUAT ORGAN, V84, P219, DOI 10.3354/dao02057; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wu H, 2000, INFECT IMMUN, V68, P5552, DOI 10.1128/IAI.68.10.5552-5558.2000; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yahata Y, 2006, J BIOL CHEM, V281, P13209, DOI 10.1074/jbc.M509771200; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yu K, 2002, J PEPT RES, V60, P1, DOI 10.1034/j.1399-3011.2002.01968.x; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; ZANETTI M, 1993, J BIOL CHEM, V268, P522; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008	61	68	72	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23417	10.1371/journal.pone.0023417	http://dx.doi.org/10.1371/journal.pone.0023417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858109	Green Submitted, Green Published, gold			2022-12-25	WOS:000293774300035
J	Wang, LL; Li, CZ; Guo, H; Kern, TS; Huang, K; Zheng, L				Wang, Leilei; Li, Chuanzhou; Guo, Hao; Kern, Timothy S.; Huang, Kun; Zheng, Ling			Curcumin Inhibits Neuronal and Vascular Degeneration in Retina after Ischemia and Reperfusion Injury	PLOS ONE			English	Article							NF-KAPPA-B; DIABETIC-RETINOPATHY; GANGLION-CELLS; EXPRESSION; STAT3; REGENERATION; INFLAMMATION; DAMAGE	Background: Neuron loss, glial activation and vascular degeneration are common sequelae of ischemia-reperfusion (I/R) injury in ocular diseases. The present study was conducted to explore the ability of curcumin to inhibit retinal I/R injury, and to investigate underlying mechanisms of the drug effects. Methodology/Principal Findings: Different dosages of curcumin were administered. I/R injury was induced by elevating the intraocular pressure for 60 min followed by reperfusion. Cell bodies, brn3a stained cells and TUNEL positive apoptotic cells in the ganglion cell layer (GCL) were quantitated, and the number of degenerate capillaries was assessed. The activation of glial cells was measured by the expression level of GFAP. Signaling pathways including IKK-IkB alpha, JAK-STAT1/3, ERK/MAPK and the expression levels of beta-tubulin III and MCP-1 were measured by western blot analysis. Pre-treatment using 0.01%-0.25% curcumin in diets significantly inhibited I/R-induced cell loss in GCL. 0.05% curcumin pre-treatment inhibited I/R-induced degeneration of retinal capillaries, TUNEL-positive apoptotic cell death in the GCL, brn3a stained cell loss, the I/R-induced up-regulation of MCP-1, IKK alpha, p-IkB alpha and p-STAT3 (Tyr), and down-regulation of beta-tubulin III. This dose showed no effect on injury-induced GFAP overexpression. Moreover, 0.05% curcumin administered 2 days after the injury also showed a vaso-protective effect. Conclusions/Significance: Curcumin protects retinal neurons and microvessels against I/R injury. The beneficial effects of curcumin on neurovascular degeneration may occur through its inhibitory effects on injury-induced activation of NF-kappa B and STAT3, and on over-expression of MCP-1. Curcumin may therefore serve as a promising candidate for retinal ischemic diseases.	[Wang, Leilei; Li, Chuanzhou; Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Guo, Hao; Huang, Kun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH USA	Wuhan University; Huazhong University of Science & Technology; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Wang, LL (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	kunhuang2008@hotmail.com; lzheng217@hotmail.com	Huang, Kun/H-4427-2012	Zheng, Ling/0000-0002-6545-4180; Li, Chuanzhou/0000-0003-0174-4215	Natural Science Foundation of China [30801445, 30970607, 30870949]; National Basic Research Program of China [2009CB918304]; Program for New Century Excellent Talents in University [NECT-10-0623]; Chinese Ministry of Education [109103]; Important National Science and Technology Specific Projects [2009ZX09301-014]; NATIONAL EYE INSTITUTE [R01EY000300] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Ministry of Education(Ministry of Education, China); Important National Science and Technology Specific Projects; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Natural Science Foundation of China (Nos. 30801445, 30970607 and 30870949; www.nsfc.gov.cn), the National Basic Research Program of China (2009CB918304; http://www.973.gov.cn/AreaAppl.aspx), the Program for New Century Excellent Talents in University (NECT-10-0623; www.dost.moe.gov.cn), the Key Project of Chinese Ministry of Education (No. 109103; www.dost.moe.gov.cn), and the Important National Science and Technology Specific Projects (2009ZX09301-014; www.cncbd.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Broadbelt NV, 2009, AM J PHYSIOL-RENAL, V297, pF114, DOI 10.1152/ajprenal.90752.2008; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Ghoneim AI, 2002, PHARMACOL RES, V46, P273, DOI 10.1016/S1043-6618(02)00123-8; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Jo N, 2003, INVEST OPHTH VIS SCI, V44, P4054, DOI 10.1167/iovs.02-1308; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; LIN MS, 2009, J SURG RES; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; MIDDELDORP J, 2011, PROG NEUROBIOL; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pari Leelavinothan, 2008, Archives of Physiology and Biochemistry, V114, P127, DOI [10.1080/13813450802033958, 10.1080/13813450802033958 ]; Pimentel B, 2000, J NEUROSCI, V20, P3254, DOI 10.1523/JNEUROSCI.20-09-03254.2000; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Ramudo L, 2009, J CELL MOL MED, V13, P1314, DOI 10.1111/j.1582-4934.2008.00529.x; Rathore P, 2008, NEUROCHEM RES, V33, P1672, DOI 10.1007/s11064-007-9515-6; Raymond ID, 2008, MOL VIS, V14, P1559; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yin YQ, 2003, J NEUROSCI, V23, P2284; YU S, 2011, REJUV RES, V13, P55; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2004, DIABETES, V53, P2960, DOI 10.2337/diabetes.53.11.2960; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, PROTEOMICS, V9, P1869, DOI 10.1002/pmic.200701071	41	73	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23194	10.1371/journal.pone.0023194	http://dx.doi.org/10.1371/journal.pone.0023194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858029	Green Submitted, Green Published, gold			2022-12-25	WOS:000293774300026
J	Boteva, L; Wu, YL; Cortes-Hernandez, J; Martin, J; Vyse, TJ; Fernando, MMA				Boteva, Lora; Wu, Yee Ling; Cortes-Hernandez, Josefina; Martin, Javier; Vyse, Timothy J.; Fernando, Michelle M. A.		IMAGEN	Determination of the Loss of Function Complement C4 Exon 29 CT Insertion Using a Novel Paralog-Specific Assay in Healthy UK and Spanish Populations	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DETERMINING DISEASE SUSCEPTIBILITY; COPY-NUMBER; MOLECULAR-BASIS; GENE; DEFICIENCY; ASSOCIATION; RISK; NULL; SLE	Genetic variants resulting in non-expression of complement C4A and C4B genes are common in healthy European populations and have shown association with a number of diseases, most notably the autoimmune disease, systemic lupus erythematosus. The most frequent cause of a C4 "null" allele, following that of C4 gene copy number variation (CNV), is a non-sense mutation arising from a 2 bp CT insertion into codon 1232 of exon 29. Previous attempts to accurately genotype this polymorphism have not been amenable to high-throughput typing, and have been confounded by failure to account for CNV at this locus, as well as by inability to distinguish between paralogs. We have developed a novel, high-throughput, paralog-specific assay to detect the presence and copy number of this polymorphism. We have genotyped healthy cohorts from the United Kingdom (UK) and Spain. Overall, 30/719 (4.17%) individuals from the UK cohort and 8/449 (1.78%) individuals from the Spanish cohort harboured the CT insertion in a C4A gene. A single Spanish individual possessed a C4B CT insertion. There is weak correlation between the C4 CT insertion and flanking MHC polymorphism. Therefore it is important to note that, as with C4 gene CNV, disease-association due to this variant will be missed by current SNP-based genome-wide association strategies.	[Boteva, Lora; Vyse, Timothy J.; Fernando, Michelle M. A.] Kings Coll London, Guys Hosp, Div Mol Med & Genet, London WC2R 2LS, England; [Boteva, Lora; Vyse, Timothy J.; Fernando, Michelle M. A.] Kings Coll London, Guys Hosp, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Wu, Yee Ling] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Cortes-Hernandez, Josefina] Univ Autonoma Barcelona, Vall dHebron Univ Hosp Res Inst, Autoimmune Dis Res Unit, E-08193 Barcelona, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Boteva, L (corresponding author), Kings Coll London, Guys Hosp, Div Mol Med & Genet, London WC2R 2LS, England.	michelle.fernando@kcl.ac.uk	Centeno, Norberto Ortego/C-4793-2019; Fernando, Michelle/F-5554-2012; Martín, Javier/AAV-5209-2021; de Bakker, Paul IW/B-8730-2009; Martín, María/HDL-9512-2022; Martin, Javier/B-8141-2008	Centeno, Norberto Ortego/0000-0003-2325-0937; de Bakker, Paul IW/0000-0001-7735-7858; Martin, Javier/0000-0002-2202-0622; Lopez Nevot, Miguel Angel/0000-0002-3465-6062; Klareskog, Lars/0000-0001-9601-6186; Alfredsson, Lars/0000-0003-1688-6697	Arthritis Research UK [18239]; National Institutes of Allergy and Infectious Diseases [AI067152]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MF and LB are supported by a Clinician Scientist Fellowship from Arthritis Research UK (Grant 18239). The IMAGEN consortium is supported by Grant AI067152 from the National Institutes of Allergy and Infectious Diseases. We acknowledge the use of DNA from the 1958 British Birth Cohort (D. Strachan, S. Ring, W. McArdle and M. Pembrey) funded by the Medical Research Council Grant G0000934 and Wellcome Trust Grant 068545/Z/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBA G, 1993, J CLIN INVEST, V91, P1681, DOI 10.1172/JCI116377; CHRISTIANSEN FT, 1983, AUST NZ J MED, V13, P483, DOI 10.1111/j.1445-5994.1983.tb02699.x; Dragon-Durey MA, 2001, CLIN EXP IMMUNOL, V123, P133, DOI 10.1046/j.1365-2249.2001.01438.x; Fernando MMA, 2010, HUM MUTAT, V31, P866, DOI 10.1002/humu.21259; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; Fredrikson GN, 1998, HUM IMMUNOL, V59, P713, DOI 10.1016/S0198-8859(98)00068-8; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Ittiprasert W, 2005, J AUTOIMMUN, V25, P77, DOI 10.1016/j.jaut.2005.04.004; Lokki ML, 1999, J IMMUNOL, V162, P3687; Man XY, 2003, ANN RHEUM DIS, V62, P71, DOI 10.1136/ard.62.1.71; Naves M, 1998, EUR J IMMUNOGENET, V25, P317, DOI 10.1046/j.1365-2370.1998.00110.x; Pickering MC, 2000, RHEUMATOLOGY, V39, P133, DOI 10.1093/rheumatology/39.2.133; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rupert KL, 2002, J IMMUNOL, V169, P1570, DOI 10.4049/jimmunol.169.3.1570; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wu YL, 2009, GENES IMMUN, V10, P433, DOI 10.1038/gene.2009.10; Wu YL, 2008, CYTOGENET GENOME RES, V123, P131, DOI 10.1159/000184700; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1991, J IMMUNOL, V146, P1057	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22128	10.1371/journal.pone.0022128	http://dx.doi.org/10.1371/journal.pone.0022128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857912	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900010
J	McCowan, B; Beisner, BA; Capitanio, JP; Jackson, ME; Cameron, AN; Seil, S; Atwill, ER; Fushing, H				McCowan, Brenda; Beisner, Brianne A.; Capitanio, John P.; Jackson, Megan E.; Cameron, Ashley N.; Seil, Shannon; Atwill, Edward R.; Fushing, Hsieh			Network Stability Is a Balancing Act of Personality, Power, and Conflict Dynamics in Rhesus Macaque Societies	PLOS ONE			English	Article							PRIMATES; BEHAVIOR	Stability in biological systems requires evolved mechanisms that promote robustness. Cohesive primate social groups represent one example of a stable biological system, which persist in spite of frequent conflict. Multiple sources of stability likely exist for any biological system and such robustness, or lack thereof, should be reflected and thus detectable in the group's network structure, and likely at multiple levels. Here we show how network structure and group stability are linked to the fundamental characteristics of the individual agents in groups and to the environmental and social contexts in which these individuals interact. Both internal factors (e.g., personality, sex) and external factors (e.g., rank dynamics, sex ratio) were considered from the level of the individual to that of the group to examine the effects of network structure on group stability in a nonhuman primate species. The results yielded three main findings. First, successful third-party intervention behavior is a mechanism of group stability in rhesus macaques in that successful interventions resulted in less wounding in social groups. Second, personality is the primary factor that determines which individuals perform the role of key intervener, via its effect on social power and dominance discrepancy. Finally, individuals with high social power are not only key interveners but also key players in grooming networks and receive reconciliations from a higher diversity of individuals. The results from this study provide sound evidence that individual and group characteristics such as personality and sex ratio influence network structures such as patterns of reconciliation, grooming and conflict intervention that are indicators of network robustness and consequent health and well-being in rhesus macaque societies. Utilizing this network approach has provided greater insight into how behavioral and social processes influence social stability in nonhuman primate groups.	[McCowan, Brenda; Beisner, Brianne A.; Capitanio, John P.; Jackson, Megan E.; Cameron, Ashley N.; Seil, Shannon] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [McCowan, Brenda; Atwill, Edward R.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Beisner, Brianne A.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Capitanio, John P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Fushing, Hsieh] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis; University of California System; University of California Davis	McCowan, B (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	bjmccowan@ucdavis.edu			National Institutes of Health [R24 RR024396, PR51 RR000169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169, R24RR024396] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by National Institutes of Health grants #R24 RR024396 and #PR51 RR000169, and conducted under Institutional Animal Care and Use Committee protocol #11843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Beisner BA, APPL ANIMAL IN PRESS; Beisner BA, 2010, AM J PRIMATOLOGY; Beisner BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016365; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; DAZEY J, 1977, AM J PHYS ANTHROPOL, V46, P73, DOI 10.1002/ajpa.1330460110; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Flack JC, 2006, AM NAT, V168, pE87, DOI 10.1086/506526; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NATURALIST, V165, pE000; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Hogg RV, 1995, MATH STAT, P251; *INS CORP, 2001, S PLUS; Isbell LA, 2002, BEHAVIOUR, V139, P177, DOI 10.1163/156853902760102645; Krakauer David C., 2006, P183; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Sprague DS, 1998, AM J PHYS ANTHROPOL, V105, P511, DOI 10.1002/(SICI)1096-8644(199804)105:4<511::AID-AJPA8>3.3.CO;2-Z; Stata, 2009, STAT STAT SOFTW REL, V2; STEVENSONHINDE, 1978, PRIMATES, V19, P473; Thierry B., 2007, PRIMATES PERSPECTIVE, P224; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Wasserman S., 1995, SOCIAL NETWORK ANAL; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	28	49	49	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22350	10.1371/journal.pone.0022350	http://dx.doi.org/10.1371/journal.pone.0022350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857922	Green Published, gold, Green Submitted			2022-12-25	WOS:000293558900015
J	Kersse, K; Lamkanfi, M; Bertrand, MJM; Vanden Berghe, T; Vandenabeele, P				Kersse, Kristof; Lamkanfi, Mohamed; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Vandenabeele, Peter			Interaction Patches of Procaspase-1 Caspase Recruitment Domains (CARDs) Are Differently Involved in Procaspase-1 Activation and Receptor-interacting Protein 2 (RIP2)-dependent Nuclear Factor kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; DEATH DOMAIN; NMR STRUCTURE; CELL-DEATH; CRYSTAL-STRUCTURE; MICE DEFICIENT; FORCE-FIELD; INFLAMMATION; GENERATION; APOPTOSIS	Background: The CARD of procaspase-1 regulates activation of procaspase-1 and NF-kappa B. Results: We show that the CARD procaspase-1 interacts with ASC through a type I interaction, whereas RIP2-mediated NF-kappa B activation involves a type III interaction. Conclusion: These findings indicate that the CARD of procaspase-1 is differently involved in inflammasome formation and NF-kappa B activation. Significance: These findings may allow development of therapeutics that specifically target a procaspase-1 function.	[Kersse, Kristof; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Vandenabeele, Peter] VIB, Dept Mol Biomed Res, B-9052 Ghent, Zwijnaarde, Belgium; [Kersse, Kristof; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Zwijnaarde, Belgium; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), Technol Pk 927, B-9052 Zwijnaarde, Belgium.	peter.vandenabeele@dmbr.vib-ugent.be	Vanden Berghe, Tom/C-4916-2009; Bertrand, Mathieu JM/AAD-2653-2019; Bertrand, Mathieu J/P-6465-2016; Berghe, Tom Vanden/N-2902-2019; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Vanden Berghe, Tom/0000-0002-1633-0974; Bertrand, Mathieu JM/0000-0001-9000-0626; Bertrand, Mathieu J/0000-0001-9000-0626; Berghe, Tom Vanden/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; 	EC [MRTN-CT-035624, FP7-200767]; Euregional PACT II; Belgian Grants Interuniversity Attraction Poles; IAP [6/18]; Flemish Grants Fonds Wetenschappelijk Onderzoek Vlaanderen [FWO G.0875.11, FWO G.0973.11]; Ghent University [BOF-GOA 12.0505.02, BOF-GOA 01.GC02.05]; Flanders Institute for Biotechnology; Stichting tegen Kanker; Fonds voor Wetenschappelijk Onderzoek; Flemish Government [BOF09/01M00709]	EC(European CommissionEuropean Commission Joint Research Centre); Euregional PACT II; Belgian Grants Interuniversity Attraction Poles(Belgian Federal Science Policy Office); IAP; Flemish Grants Fonds Wetenschappelijk Onderzoek Vlaanderen; Ghent University(Ghent University); Flanders Institute for Biotechnology; Stichting tegen Kanker; Fonds voor Wetenschappelijk Onderzoek(FWO); Flemish Government(European Commission)	This work was supported by European Grants FP6 ApopTrain MRTN-CT-035624 and FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767, Euregional PACT II, Belgian Grants Interuniversity Attraction Poles, IAP 6/18, Flemish Grants Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO G.0875.11 and FWO G.0973.11, Ghent University grants MRP, GROUP-ID, and grants from Flanders Institute for Biotechnology (to VIB).; Supported by Ghent University Grants BOF-GOA 12.0505.02 and BOF-GOA 01.GC02.05, "Stichting Emmanuel van der Schueren" and the "Stichting tegen Kanker."; Supported by a grant from the "Fonds voor Wetenschappelijk Onderzoek."; Supported by Methusalem Grant BOF09/01M00709 from the Flemish Government. To whom correspondence should be addressed: Technologiepark 927, B-9052 Zwijnaarde, Belgium. Tel.: 32-9-3313763; Fax: 32-9-3313609; E-mail: peter.vandenabeele@dmbr.vib-ugent.be.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; da Cunha JPC, 2008, J MOL EVOL, V66, P591, DOI 10.1007/s00239-008-9110-8; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kersse K, 2007, BIOCHEM SOC T, V35, P1508, DOI 10.1042/BST0351508; Kersse K., 2011, TRENDS BIOC IN PRESS; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Mace PD, 2010, CURR OPIN CELL BIOL, V22, P828, DOI 10.1016/j.ceb.2010.08.004; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Naik E, 2010, J CLIN IMMUNOL, V30, P485, DOI 10.1007/s10875-010-9383-8; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Yu JR, 2011, CURR ALLERGY ASTHM R, V11, P12, DOI 10.1007/s11882-010-0160-9	50	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35874	35882		10.1074/jbc.M111.242321	http://dx.doi.org/10.1074/jbc.M111.242321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862576	Green Published, hybrid			2022-12-25	WOS:000295927100060
J	Shakor, ABA; Taniguchi, M; Kitatani, K; Hashimoto, M; Asano, S; Hayashi, A; Nomura, K; Bielawski, J; Bielawska, A; Watanabe, K; Kobayashi, T; Igarashi, Y; Umehara, H; Takeya, H; Okazaki, T				Shakor, Abo Bakr Abdel; Taniguchi, Makoto; Kitatani, Kazuyuki; Hashimoto, Mayumi; Asano, Satoshi; Hayashi, Akira; Nomura, Kenichi; Bielawski, Jacek; Bielawska, Alicja; Watanabe, Ken; Kobayashi, Toshihide; Igarashi, Yasuyuki; Umehara, Hisanori; Takeya, Hiroyuki; Okazaki, Toshiro			Sphingomyelin Synthase 1-generated Sphingomyelin Plays an Important Role in Transferrin Trafficking and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; GLUCOSYLCERAMIDE SYNTHASE; RAB11-POSITIVE ENDOSOMES; INDEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; RECEPTOR; CERAMIDE; SPHINGOLIPIDS; GROWTH; MECHANISMS	Transferrin (Tf) endocytosis and recycling are essential for iron uptake and the regulation of cell proliferation. Tf and Tf receptor (TfR) complexes are internalized via clathrin-coated pits composed of a variety of proteins and lipids and pass through early endosomes to recycling endosomes. We investigated the role of sphingomyelin (SM) synthases (SMS1 and SMS2) in clathrin-dependent trafficking of Tf and cell proliferation. We employed SM-deficient lymphoma cells that lacked SMSs and that failed to proliferate in response to Tf. Transfection of SMS1, but not SMS2, enabled these cells to incorporate SM into the plasma membrane, restoring Tf-mediated proliferation. SM-deficient cells showed a significant reduction in clathrin-dependent Tf uptake compared with the parental SM-producing cells. Both SMS1 gene transfection and exogenous short-chain SM treatment increased clathrin-dependent Tf uptake in SM-deficient cells, with the Tf being subsequently sorted to Rab11-positive recycling endosomes. We observed trafficking of the internalized Tf to late/endolysosomal compartments, and this was not dependent on the clathrin pathway in SM-deficient cells. Thus, SMS1-mediated SM synthesis directs Tf-TfR to undergo clathrin-dependent endocytosis and recycling, promoting the proliferation of lymphoma cells.	[Umehara, Hisanori; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Kanazawa, Ishikawa 9020293, Japan; [Shakor, Abo Bakr Abdel; Taniguchi, Makoto; Kitatani, Kazuyuki; Hashimoto, Mayumi; Asano, Satoshi; Hayashi, Akira; Nomura, Kenichi; Okazaki, Toshiro] Tottori Univ, Fac Med, Div Clin Lab Med & Hematol Oncol, Yonago, Tottori 6838503, Japan; [Takeya, Hiroyuki] Tottori Univ, Fac Med, Dept Biomed Sci, Div Pathol Biochem, Yonago, Tottori 6838503, Japan; [Bielawski, Jacek; Bielawska, Alicja] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Aichi 4748511, Japan; [Kobayashi, Toshihide] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Kanazawa Medical University; Tottori University; Tottori University; Medical University of South Carolina; National Center for Geriatrics & Gerontology; RIKEN; Hokkaido University	Okazaki, T (corresponding author), Kanazawa Med Univ, Dept Hematol & Immunol, 1-1 Daigaku Uchinada, Kanazawa, Ishikawa 9020293, Japan.	toshiroo@kanazawa-med.ac.jp	Asano, Satoshi/AAQ-3817-2020; Abdel shakor, Abo bakr/R-7133-2016; Kobayashi, Toshihide/B-6298-2015; Watanabe, Ken/I-3960-2013; Kitatani, Kazuyuki/H-7100-2019; KOBAYASHI, TOSHIHIDE/S-8313-2019; Taniguchi, Makoto/L-5757-2019	Abdel shakor, Abo bakr/0000-0003-2792-9066; Kobayashi, Toshihide/0000-0002-4811-7270; Watanabe, Ken/0000-0003-0664-3915; Kitatani, Kazuyuki/0000-0002-8516-6135; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Taniguchi, Makoto/0000-0001-5920-8285; Asano, Satoshi/0000-0003-1537-4307	Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology (Japan); Japan Society for the Promotion of Science [21890144, 23790366]; Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science, and Technology [22249041, 21113530, 22390018]; RIKEN; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	Sapporo Biocluster "Bio-S"; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology (Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	This study was supported in part by the Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science, and Technology (Japan), Japan Society for the Promotion of Science Grants-in-aid for Young Scientists 21890144 and 23790366 (to K. K.), the Sumitomo Foundation (to K. K.), Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 22249041 (to H. U.) and 21113530 and 22390018 (to T. K.), Lipid Dynamics Program of RIKEN (to T. K.), the Uehara Memorial Foundation (to H. U.), the Vehicle Racing Commemorative Foundation (to H. U.), and the Kanazawa Medical University Research Foundation (to H. U.).	Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourteele S, 1998, J BIOL CHEM, V273, P31245, DOI 10.1074/jbc.273.47.31245; CANO E, 1990, EUR J IMMUNOL, V20, P765, DOI 10.1002/eji.1830200409; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Ding T, 2008, J LIPID RES, V49, P376, DOI 10.1194/jlr.M700401-JLR200; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; HANADA K, 1992, J BIOL CHEM, V267, P23527; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Hughes WE, 2001, BIOCHEM J, V356, P727, DOI 10.1042/0264-6021:3560727; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Itoh M, 2003, CLIN CANCER RES, V9, P415; JEFFERIES WA, 1985, IMMUNOLOGY, V54, P333; Kaksonen M, 2008, J CELL BIOL, V180, P1059, DOI 10.1083/jcb.200802174; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; KOVAL M, 1990, J CELL BIOL, V111, P429, DOI 10.1083/jcb.111.2.429; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Liebl D, 2006, J VIROL, V80, P4610, DOI 10.1128/JVI.80.9.4610-4622.2006; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MANGER B, 1986, J IMMUNOL, V136, P532; MATSUI T, 2011, TRAFFIC IN PRESS; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MIROOBRADORS MJ, 1993, CARCINOGENESIS, V14, P941, DOI 10.1093/carcin/14.5.941; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; PANACCIO M, 1987, IMMUNOL CELL BIOL, V65, P461, DOI 10.1038/icb.1987.55; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Riboni L, 2001, J BIOL CHEM, V276, P12797, DOI 10.1074/jbc.M011570200; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; SUBTIL A, 1994, J CELL SCI, V107, P3461; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Taguchi Y, 2004, BLOOD, V104, P3285, DOI 10.1182/blood-2004-03-0900; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Trischler M, 1999, J CELL SCI, V112, P4773; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Watanabe M, 2004, CANCER RES, V64, P1000, DOI 10.1158/0008-5472.CAN-03-1383; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	59	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36053	36062		10.1074/jbc.M111.228593	http://dx.doi.org/10.1074/jbc.M111.228593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856749	hybrid, Green Published			2022-12-25	WOS:000295927100078
J	Wu, R; Wu, H				Wu, Ren; Wu, Hui			A Molecular Chaperone Mediates a Two-protein Enzyme Complex and Glycosylation of Serine-rich Streptococcal Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIMBRIAE-ASSOCIATED ADHESIN; GROUP-B STREPTOCOCCUS; BIOFILM FORMATION; PROTEIN GLYCOSYLATION; PILIN GLYCOSYLATION; PARASANGUIS FW213; ESCHERICHIA-COLI; SURFACE PROTEIN; FAP1; GLYCOPROTEIN	Serine-rich repeat glycoproteins identified from streptococci and staphylococci are important for bacterial adhesion and biofilm formation. Two putative glycosyltransferases, Gtf1 and Gtf2, from Streptococcus parasanguinis form a two-protein enzyme complex that is required for glycosylation of a serinerich repeat adhesin, Fap1. Gtf1 is a glycosyltransferase; however, the function of Gtf2 is unknown. Here, we demonstrate that Gtf2 enhances the enzymatic activity of Gtf1 by its chaperone-like property. Gtf2 interacted with Gtf1, mediated the subcellular localization of Gtf1, and stabilized Gtf1. Deletion of invariable amino acid residues in a conserved domain of unknown function (DUF1975) at the N terminus of Gtf2 had a greater impact on Fap1 glycosylation than deletion of the C-terminal non-DUF1975 residues. The DUF1975 deletions concurrently reduced the interaction between Gtf1 and Gtf2, altered the subcellular localization of Gtf1, and destabilized Gtf1, suggesting that DUF1975 is crucial for the chaperone activity of Gtf2. Homologous GtfA and GtfB from Streptococcus agalactiae rescued the glycosylation defect in the gtf1gtf2 mutant; like Gtf2, GtfB also possesses chaperone-like activity. Taken together, our studies suggest that Gtf2 and its homologs possess the conserved molecular chaperone activity that mediates protein glycosylation of bacterial adhesins.	[Wu, Hui] Univ Alabama, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Sch Dent, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Birmingham, AL 35294 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Wu, H (corresponding author), Univ Alabama, Sch Dent, Dept Pediat Dent, SDB 802, Birmingham, AL 35294 USA.	hwu@uab.edu			National Institutes of Health from NIDCR [R01DE017954]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE017954 from NIDCR (to H. W.).	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Brockhausen I, 2008, J BACTERIOL, V190, P4922, DOI 10.1128/JB.00160-08; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Chen Q, 2007, J BACTERIOL, V189, P7610, DOI 10.1128/JB.00748-07; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Deng LYL, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/395758; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Levesque C, 2001, J BACTERIOL, V183, P2724, DOI 10.1128/JB.183.9.2724-2732.2001; Li J, 1997, P NATL ACAD SCI USA, V94, P13251, DOI 10.1073/pnas.94.24.13251; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McNab Roderick, 1998, Methods in Cell Science, V20, P209, DOI 10.1023/A:1009763626485; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Ramboarina S, 2010, J BIOL CHEM, V285, P32446, DOI 10.1074/jbc.M110.128165; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0; Zurawski DV, 2004, MICROBIOL-SGM, V150, P2055, DOI 10.1099/mic.0.26997-0	49	34	41	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34923	34931		10.1074/jbc.M111.239350	http://dx.doi.org/10.1074/jbc.M111.239350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862581	Green Published, hybrid			2022-12-25	WOS:000295406300046
J	Cui, WC; Ma, JF; Wang, YL; Biswal, S				Cui, Wanchang; Ma, Jinfang; Wang, Yulei; Biswal, Shyam			Plasma miRNA as Biomarkers for Assessment of Total-Body Radiation Exposure Dosimetry	PLOS ONE			English	Article							CIRCULATING MICRORNAS; IONIZING-RADIATION; QUANTITATIVE DETECTION; SYSTEMIC RNAI; BLOOD; CANCER; MOUSE; DNA; EXPRESSION; VESICLES	The risk of radiation exposure, due to accidental or malicious release of ionizing radiation, is a major public health concern. Biomarkers that can rapidly identify severely-irradiated individuals requiring prompt medical treatment in mass-casualty incidents are urgently needed. Stable blood or plasma-based biomarkers are attractive because of the ease for sample collection. We tested the hypothesis that plasma miRNA expression profiles can accurately reflect prior radiation exposure. We demonstrated using a murine model that plasma miRNA expression signatures could distinguish mice that received total body irradiation doses of 0.5 Gy, 2 Gy, and 10 Gy (at 6 h or 24 h post radiation) with accuracy, sensitivity, and specificity of above 90%. Taken together, these data demonstrate that plasma miRNA profiles can be highly predictive of different levels of radiation exposure. Thus, plasma-based biomarkers can be used to assess radiation exposure after mass-casualty incidents, and it may provide a valuable tool in developing and implementing effective countermeasures.	[Cui, Wanchang; Ma, Jinfang; Biswal, Shyam] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Wang, Yulei] Life Technol, Genom Assays R&D, Foster City, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Thermo Fisher Scientific	Cui, WC (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	sbiswal@jhsph.edu		Cui, Wanchang/0000-0001-6408-8601; Wang, Yulei/0000-0002-9057-9786	National Institutes of Health [R33 AI080541, ES03819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI080541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health Grants R33 AI080541 and ES03819. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2010, DNA CELL BIOL, V29, P553, DOI 10.1089/dna.2009.0978; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Coleman CN, 2004, SCIENCE, V304, P693, DOI 10.1126/science.1095956; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cowan Matthew L, 2008, Expert Rev Proteomics, V5, P21, DOI 10.1586/14789450.5.1.21; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Ebert MPA, 2006, J PROTEOME RES, V5, P19, DOI 10.1021/pr050271e; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Gougelet RM, 2010, HEALTH PHYS, V98, P118, DOI 10.1097/HP.0b013e3181a6de7d; GREENBERG ML, 1968, RADIAT RES, V35, P147, DOI 10.2307/3572441; HALL EJ, 2000, RADIOBIOLOGY RADIOLO, pR11; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muriithi EV, 2000, PLATELETS, V11, P33; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang L, 2010, BRIT J RADIOL, V83, P694, DOI 10.1259/bjr/49886569; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	51	63	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22988	10.1371/journal.pone.0022988	http://dx.doi.org/10.1371/journal.pone.0022988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857976	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300010
J	Graziano, F; Elia, C; Laudanna, C; Poli, G; Alfano, M				Graziano, Francesca; Elia, Chiara; Laudanna, Carlo; Poli, Guido; Alfano, Massimo			Urokinase Plasminogen Activator Inhibits HIV Virion Release from Macrophage-Differentiated Chronically Infected Cells via Activation of RhoA and PKC epsilon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-KINASE-C; PHORBOL-MYRISTATE ACETATE; GTP-BINDING PROTEIN; CYTOCHALASIN-D; ANTIRETROVIRAL THERAPY; PROMONOCYTIC CELLS; ACTIN CYTOSKELETON; INDUCED MIGRATION; LFA-1 ACTIVATION	Background: HIV replication in mononuclear phagocytes is a multi-step process regulated by viral and cellular proteins with the peculiar feature of virion budding and accumulation in intra-cytoplasmic vesicles. Interaction of urokinase-type plasminogen activator (uPA) with its cell surface receptor (uPAR) has been shown to favor virion accumulation in such subcellular compartment in primary monocyte-derived macrophages and chronically infected promonocytic U1 cells differentiated into macrophage-like cells by stimulation with phorbol myristate acetate (PMA). By adopting this latter model system, we have here investigated which intracellular signaling pathways were triggered by uPA/uPAR interaction leading the redirection of virion accumulation in intra-cytoplasmic vesicles. Results: uPA induced activation of RhoA, PKC delta and PKC epsilon in PMA-differentiated U1 cells. In the same conditions, RhoA, PKC delta and PKC epsilon modulated uPA-induced cell adhesion and polarization, whereas only RhoA and PKC epsilon were also responsible for the redirection of virions in intracellular vesicles. Distribution of G and F actin revealed that uPA reorganized the cytoskeleton in both adherent and polarized cells. The role of G and F actin isoforms was unveiled by the use of cytochalasin D, a cell-permeable fungal toxin that prevents F actin polymerization. Receptor-independent cytoskeleton remodeling by Cytochalasin D resulted in cell adhesion, polarization and intracellular accumulation of HIV virions similar to the effects gained with uPA. Conclusions: These findings illustrate the potential contribution of the uPA/uPAR system in the generation and/or maintenance of intra-cytoplasmic vesicles that actively accumulate virions, thus sustaining the presence of HIV reservoirs of macrophage origin. In addition, our observations also provide evidences that pathways controlling cytoskeleton remodeling and activation of PKC epsilon bear relevance for the design of new antiviral strategies aimed at interfering with the partitioning of virion budding between intra-cytoplasmic vesicles and plasma membrane in infected human macrophages.	[Graziano, Francesca; Elia, Chiara; Poli, Guido; Alfano, Massimo] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunophatogenesis Unit, I-20132 Milan, Italy; [Poli, Guido] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy; [Laudanna, Carlo] Fac Med & Surg, Dept Pathol & Diagnost, Verona, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Graziano, F (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunophatogenesis Unit, I-20132 Milan, Italy.	massimo.alfano@hsr.it	ALESSANDRIA, CARLO/AAH-1448-2019; Alfano, Massimo/AAC-1950-2019	Alfano, Massimo/0000-0002-6904-9158; Poli, Guido/0000-0001-7241-4526; Graziano, Francesca/0000-0001-5294-8459	VI National Program of Research against HIV/AIDS of the ISS; Italian Minister of Health [40H11]; NIH [1R21 MH075670-01A1]; Fondation Dormeur; Italian Association for Cancer Research (AIRC); MIUR; Fondazione Cariverona, Verona, Italy; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH075670] Funding Source: NIH RePORTER	VI National Program of Research against HIV/AIDS of the ISS; Italian Minister of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Dormeur; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by grants of the VI National Program of Research against HIV/AIDS of the ISS (to MA and GP), by grant of Italian Minister of Health (#40H11 to MA), by the NIH grant n. 1R21 MH075670-01A1 to MA and GP, the Fondation Dormeur to GP, and the Italian Association for Cancer Research (AIRC) 2009-2011, MIUR and Fondazione Cariverona, Verona, Italy, to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aepfelbacher M, 1996, J IMMUNOL, V157, P5070; Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; Alfano M, 2002, P NATL ACAD SCI USA, V99, P8862, DOI 10.1073/pnas.142078099; ALFANO M, 2007, HIV MACROPHAGE, P89; Alfano M, 2006, LETT DRUG DES DISCOV, V3, P598, DOI 10.2174/157018006778341183; Alfano M, 2009, BLOOD, V113, P1699, DOI 10.1182/blood-2008-02-138412; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Audoly G, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-48; Azab AK, 2009, BLOOD, V114, P619, DOI 10.1182/blood-2009-01-199281; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; BISWAS P, 1992, J EXP MED, V176, P739, DOI 10.1084/jem.176.3.739; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blasi F, 1997, IMMUNOL TODAY, V18, P415, DOI 10.1016/S0167-5699(97)01121-3; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; CAVNAR PJ, J CELL BIOL, V193, P465; Cinque P, 2004, ANN NEUROL, V55, P687, DOI 10.1002/ana.20076; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Elia C, 2007, J LEUKOCYTE BIOL, V82, P1212, DOI 10.1189/jlb.0407251; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; FANTUZZI L, 2003, BLOOD; FERNIE BF, 1991, J VIROL, V65, P3968, DOI 10.1128/JVI.65.7.3968-3971.1991; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Kamiya K, 2007, J SURG RES, V141, P91, DOI 10.1016/j.jss.2007.02.025; Karczewski MK, 1996, J VIROL, V70, P494, DOI 10.1128/JVI.70.1.494-507.1996; Kiian I, 2003, THROMB HAEMOSTASIS, V89, P904; Kindzelskii AL, 1996, J IMMUNOL, V156, P297; KINTER AL, 1990, J VIROL, V64, P4306, DOI 10.1128/JVI.64.9.4306-4312.1990; Konecny G, 2001, CLIN CANCER RES, V7, P1743; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LAURENCE J, 1990, BIOCHEM BIOPH RES CO, V166, P349, DOI 10.1016/0006-291X(90)91952-O; LUCKENBILLEDDS L, 1990, CELL TISSUE RES, V260, P485, DOI 10.1007/BF00297228; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Madsen CD, 2008, EUR J CELL BIOL, V87, P617, DOI 10.1016/j.ejcb.2008.02.003; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; MULLOY JC, BLOOD, V115, P936; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Ostrowski SR, 2006, SCAND J IMMUNOL, V63, P478, DOI 10.1111/j.1365-3083.2006.001768.x; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Petzinger J, 2007, CELL COMMUN ADHES, V14, P137, DOI 10.1080/15419060701557487; PICONE R, 1989, J CELL BIOL, V108, P693, DOI 10.1083/jcb.108.2.693; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Rabbi MF, 1998, VIROLOGY, V245, P257, DOI 10.1006/viro.1998.9158; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Shoeman RL, 2001, MOL BIOL CELL, V12, P143, DOI 10.1091/mbc.12.1.143; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Sidenius N, 2004, J NEUROIMMUNOL, V157, P133, DOI 10.1016/j.jneuroim.2004.08.038; Sidenius N, 2000, BLOOD, V96, P4091; Sidenius N, 2002, J BIOL CHEM, V277, P27982, DOI 10.1074/jbc.M111736200; Sier CFM, 2004, THROMB HAEMOSTASIS, V91, P403, DOI 10.1160/TH03-06-0351; Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Sporer B, 2005, J NEUROIMMUNOL, V163, P190, DOI 10.1016/j.jneuroim.2005.02.013; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Surin B, 2002, INT J MOL MED, V10, P25; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wada M, 2001, BIOCHEM BIOPH RES CO, V284, P346, DOI 10.1006/bbrc.2001.4965; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang LP, 2000, J IMMUNOL, V164, P5369, DOI 10.4049/jimmunol.164.10.5369; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015	77	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23674	10.1371/journal.pone.0023674	http://dx.doi.org/10.1371/journal.pone.0023674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858203	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300079
J	Kok, J; Thomas, LC; Olma, T; Chen, SCA; Iredell, JR				Kok, Jen; Thomas, Lee C.; Olma, Thomas; Chen, Sharon C. A.; Iredell, Jonathan R.			Identification of Bacteria in Blood Culture Broths Using Matrix-Assisted Laser Desorption-Ionization Sepsityper (TM) and Time of Flight Mass Spectrometry	PLOS ONE			English	Article							STREAM INFECTIONS; PSEUDOMONAS; MICROORGANISMS; PHYLOGENY; DIAGNOSIS; BOTTLES	Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) is a novel method for the direct identification of bacteria from blood culture broths. We evaluate for the first time, the performance of the MALDI Sepsityper (TM) Kit and MS for the identification of bacteria compared to standard phenotypic methods using the manufacturer's specified bacterial identification criteria (spectral scores >= 1.700-1.999 and >= 2.000 indicated identification to genus and species level, respectively). Five hundred and seven positive blood culture broths were prospectively examined, of which 379 (74.8%; 358 monomicrobial, 21 polymicrobial) were identified by MALDI-TOF MS; 195 (100%) and 132 (67.7%) of 195 gram-positive; and 163 (100%) and 149 (91.4%) of 163 gram-negative organisms from monomicrobial blood cultures were correctly identified to genus and species level, respectively. Spectral scores <1.700 (no identification) were obtained in 128/507 (25.2%) positive blood culture broths, including 31.6% and 32.3% of gram-positive and polymicrobial blood cultures, respectively. Significantly more gram-negative organisms were identified compared to gram-positive organisms at species level (p < 0.0001). Five blood cultures were misidentified, but at species level only; including four monomicrobial blood cultures with Streptococcus oralis/mitis that were misidentified as Streptococcus pneumoniae. Positive predictive values for the direct identification of both gram-positive and gram-negative bacteria from monomicrobial blood culture broths to genus level were 100%. A diagnostic algorithm for positive blood culture broths that incorporates gram staining and MALDI-TOF MS should identify the majority of pathogens, particularly to genus level.	[Kok, Jen; Thomas, Lee C.; Olma, Thomas; Chen, Sharon C. A.; Iredell, Jonathan R.] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis, Westmead, NSW 2145, Australia; [Kok, Jen; Thomas, Lee C.; Olma, Thomas; Chen, Sharon C. A.; Iredell, Jonathan R.] Westmead Hosp, Inst Clin Pathol & Med Res, Microbiol Lab Serv, Westmead, NSW 2145, Australia; [Kok, Jen; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Res Excellence Crit & Emerging Infect Dis, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney	Kok, J (corresponding author), Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis, Westmead, NSW 2145, Australia.	jen.kok@swahs.health.nsw.gov.au						Almuzara MN, 2010, J CLIN MICROBIOL, V48, P660, DOI 10.1128/JCM.01849-09; Arise Committee AAM, 2007, CRIT CARE RESUSC, V9, P8; Beekmann SE, 2003, J CLIN MICROBIOL, V41, P3119, DOI 10.1128/JCM.41.7.3119-3125.2003; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Kochanek KD, 2011, NATL VITAL STAT REPO; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Mehta MS, 2009, J CLIN MICROBIOL, V47, P1082, DOI 10.1128/JCM.01850-08; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Petti CA, 2005, J CLIN MICROBIOL, V43, P2510, DOI 10.1128/JCM.43.5.2510-2512.2005; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Romero-Gomez MP, 2011, J INFECTION, V62, P251, DOI 10.1016/j.jinf.2010.12.008; Saavedra MJ, 2006, INT J SYST EVOL MICR, V56, P2481, DOI 10.1099/ijs.0.64351-0; Seok Y, 2010, J CLIN MICROBIOL, V48, P2656, DOI 10.1128/JCM.01609-09; Stender H, 2003, EXPERT REV MOL DIAGN, V3, P649, DOI 10.1586/14737159.3.5.649; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Szabados F, 2011, CLIN MICROBIOL INFEC, V17, P192, DOI 10.1111/j.1469-0691.2010.03229.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	23	119	131	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23285	10.1371/journal.pone.0023285	http://dx.doi.org/10.1371/journal.pone.0023285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858058	Green Submitted, Green Published, gold			2022-12-25	WOS:000294125500025
J	Matsumoto, M; Kurihara, S; Kibe, R; Ashida, H; Benno, Y				Matsumoto, Mitsuharu; Kurihara, Shin; Kibe, Ryoko; Ashida, Hisashi; Benno, Yoshimi			Longevity in Mice Is Promoted by Probiotic-Induced Suppression of Colonic Senescence Dependent on Upregulation of Gut Bacterial Polyamine Production	PLOS ONE			English	Article							INTESTINAL ENVIRONMENT; LKM512 YOGURT; LIFE-SPAN; MICROBIOTA; CONSUMPTION; AUTOPHAGY; CYTOKINE; SURVIVAL; IMPROVES; HEALTH	Background: Chronic low-grade inflammation is recognized as an important factor contributing to senescence and age-related diseases. In mammals, levels of polyamines (PAs) decrease during the ageing process; PAs are known to decrease systemic inflammation by inhibiting inflammatory cytokine synthesis in macrophages. Reductions in intestinal luminal PAs levels have been associated with intestinal barrier dysfunction. The probiotic strain Bifidobacterium animalis subsp. lactis LKM512 is known to increase intestinal luminal PA concentrations. Methodology/Principal Findings: We supplemented the diet of 10-month-old Crj:CD-1 female mice with LKM512 for 11 months, while the controls received no supplementation. Survival rates were compared using Kaplan-Meier survival curves. LKM512-treated mice survived significantly longer than controls (P<0.001); moreover, skin ulcers and tumors were more common in the control mice. We then analyzed inflammatory and intestinal conditions by measuring several markers using HPLC, ELISA, reverse transcription-quantitative PCR, and histological slices. LKM512 mice showed altered 16S rRNA gene expression of several predominant intestinal bacterial groups. The fecal concentrations of PAs, but not of short-chain fatty acids, were significantly higher in LKM512-treated mice (P<0.05). Colonic mucosal function was also better in LKM512 mice, with increased mucus secretion and better maintenance of tight junctions. Changes in gene expression levels were evaluated using the NimbleGen mouse DNA microarray. LKM512 administration also downregulated the expression of ageing-associated and inflammation-associated genes and gene expression levels in 21-month-old LKM512-treated mice resembled those in 10-month-old untreated (younger) mice. Conclusion/Significance: Our study demonstrated increased longevity in mice following probiotic treatment with LKM512, possibly due to the suppression of chronic low-grade inflammation in the colon induced by higher PA levels. This indicates that ingestion of specific probiotics may be an easy approach for improving intestinal health and increasing lifespan. Further studies are required to clarify its effectiveness in humans.	[Matsumoto, Mitsuharu] Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan; [Matsumoto, Mitsuharu; Kibe, Ryoko; Benno, Yoshimi] RIKEN, Innovat Ctr, Benno Lab, Wako, Saitama, Japan; [Kurihara, Shin] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Appl Biol, Kyoto 606, Japan; [Kurihara, Shin; Ashida, Hisashi] Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Kyoto, Japan	RIKEN; Kyoto Institute of Technology; Kyoto University	Matsumoto, M (corresponding author), Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan.	m-matumoto@meito.co.jp	Ashida, Hisashi/HCI-0293-2022; Matsumoto, Mitsuharu/AHB-4023-2022	Ashida, Hisashi/0000-0001-5844-4075; Matsumoto, Mitsuharu/0000-0002-0378-3077	Bio-oriented Technology Research Advancement Institution (BRAIN), Japan; Kyodo Milk Industry Co. Ltd	Bio-oriented Technology Research Advancement Institution (BRAIN), Japan; Kyodo Milk Industry Co. Ltd	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also funded by Kyodo Milk Industry Co. Ltd. M. Matsumoto is an employee of Kyodo Milk Industry Co. Ltd. and had a role in study design, data analysis, preparation of the manuscript, and the decision to publish the manuscript.	Anderson Rozalyn M., 2007, V35, P18; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Cipolla BG, 2007, AMINO ACIDS, V33, P203, DOI 10.1007/s00726-007-0524-1; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Deloyer P, 2001, EUR J GASTROEN HEPAT, V13, P1027, DOI 10.1097/00042737-200109000-00005; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GORDON HA, 1966, J GERONTOL, V21, P380, DOI 10.1093/geronj/21.3.380; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; KATNIK I, 1990, J IMMUNOASSAY, V11, P503; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koltun WA, 1996, GUT, V39, P291, DOI 10.1136/gut.39.2.291; Lee HM, 2001, MECH AGEING DEV, V122, P355, DOI 10.1016/S0047-6374(00)00254-2; Li L, 2001, AM J PHYSIOL-GASTR L, V280, pG992, DOI 10.1152/ajpgi.2001.280.5.G992; Loft S, 1998, FREE RADICAL RES, V29, P525, DOI 10.1080/10715769800300571; LUK GD, 1980, SCIENCE, V210, P195, DOI 10.1126/science.6774420; MA TY, 1992, EXP GERONTOL, V27, P321, DOI 10.1016/0531-5565(92)90059-9; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsumoto M, 2007, CLIN EXP ALLERGY, V37, P358, DOI 10.1111/j.1365-2222.2007.02642.x; Matsumoto M, 2001, FEMS IMMUNOL MED MIC, V31, P181, DOI 10.1111/j.1574-695X.2001.tb00518.x; Matsumoto M, 2011, MED HYPOTHE IN PRESS; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; Matsumoto M, 2007, FEMS IMMUNOL MED MIC, V49, P387, DOI 10.1111/j.1574-695X.2007.00215.x; Matsumoto M, 2006, BIOSCI BIOTECH BIOCH, V70, P1287, DOI 10.1271/bbb.50464; Matsumoto M, 2009, MICROBIOL IMMUNOL, V53, P421, DOI 10.1111/j.1348-0421.2009.00140.x; Matsuzaki T, 2007, J NUTR, V137, p798S, DOI 10.1093/jn/137.3.798S; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Metchnikoff E., 1907, PROLONGATION LIFE OP; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Noack J, 1998, J NUTR, V128, P1385, DOI 10.1093/jn/128.8.1385; ODA Y, 1985, MUTAT RES, V147, P219, DOI 10.1016/0165-1161(85)90062-7; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pillai SP, 1997, MUTAT RES-FUND MOL M, V377, P217, DOI 10.1016/S0027-5107(97)00075-4; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; RUSSELL DH, 1971, CANCER RES, V31, P1555; SARHAN S, 1992, ANTICANCER RES, V12, P457; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Sreekumar O, 1998, J DAIRY SCI, V81, P1508, DOI 10.3168/jds.S0022-0302(98)75716-9; Takahashi T, 2010, ANN BOT-LONDON, V105, P1, DOI 10.1093/aob/mcp259; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tosato M, 2007, CLIN INTERV AGING, V2, P401; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Weindruch R., 1988, RETARDATION AGING DI; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759	58	153	156	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23652	10.1371/journal.pone.0023652	http://dx.doi.org/10.1371/journal.pone.0023652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858192	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500039
J	Steinacker, P; Fang, LB; Kuhle, J; Petzold, A; Tumani, H; Ludolph, AC; Otto, M; Brettschneider, J				Steinacker, Petra; Fang, Lubin; Kuhle, Jens; Petzold, Axel; Tumani, Hayrettin; Ludolph, Albert C.; Otto, Markus; Brettschneider, Johannes			Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MARKERS; DEGENERATION; BIOMARKERS; DIAGNOSIS; CRITERIA; CLEAVAGE	Background: Biomarkers of disease progression in amyotrophic lateral sclerosis (ALS) could support the identification of beneficial drugs in clinical trials. We aimed to test whether soluble fragments of beta-amyloid precursor protein (sAPPa and sAPP beta) correlated with clinical subtypes of ALS and were of prognostic value. Methodology/Principal Findings: In a cross-sectional study including patients with ALS (N = 68) with clinical follow-up data over 6 months, Parkinson's disease (PD, N = 20), and age-matched controls (N = 40), cerebrospinal fluid (CSF) levels of sAPP alpha a, sAPP beta and neurofilaments (NfH(SMI35)) were measured by multiplex assay, Progranulin by ELISA. CSF sAPP alpha and sAPP beta levels were lower in ALS with a rapidly-progressive disease course (p = 0.03, and p = 0.02) and with longer disease duration (p = 0.01 and p = 0.01, respectively). CSF NfH(SMI35) was elevated in ALS compared to PD and controls, with highest concentrations found in patients with rapid disease progression (p, 0.01). High CSF NfH(SMI35) was linked to low CSF sAPP alpha and sAPP beta (p = 0.001, and p = 0.007, respectively). The ratios CSF NfH(SMI35)/CSF sAPP alpha,-beta were elevated in patients with fast progression of disease (p = 0.002 each). CSF Progranulin decreased with ongoing disease (p = 0.04). Conclusions: This study provides new CSF candidate markers associated with progression of disease in ALS. The data suggest that a deficiency of cellular neuroprotective mechanisms (decrease of sAPP) is linked to progressive neuro-axonal damage (increase of NfH(SMI35)) and to progression of disease.	[Steinacker, Petra; Fang, Lubin; Tumani, Hayrettin; Ludolph, Albert C.; Otto, Markus; Brettschneider, Johannes] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Kuhle, Jens] Univ Basel, Dept Neurol, Basel, Switzerland; [Petzold, Axel] Natl Hosp Neurol & Neurosurg, Dept Neuroimmunol, UCL Inst Neurol, London WC1N 3BG, England	Ulm University; University of Basel; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Steinacker, P (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	Johannes.brettschneider@uni-ulm.de	Kuhle, Jens/AGE-3474-2022; Petzold, Axel/C-1090-2009; Otto, Markus/F-4304-2015	Petzold, Axel/0000-0002-0344-9749; Otto, Markus/0000-0003-4273-4267				[Anonymous], 1996, Arch Neurol, V53, P141; Beghi E, 2006, BBA-MOL BASIS DIS, V1762, P1150, DOI 10.1016/j.bbadis.2006.09.008; Bodansky A, 2010, AMYOTROPH LATERAL SC, V11, P321, DOI 10.3109/17482961003602363; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Ehehalt R, 2002, BIOCHEM BIOPH RES CO, V293, P30, DOI 10.1016/S0006-291X(02)00169-9; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Kogel D, 2003, J NEUROCHEM, V87, P248, DOI 10.1046/j.1471-4159.2003.02000.x; Kuhle J, 2010, J NEUROIMMUNOL, V220, P114, DOI 10.1016/j.jneuroim.2010.01.004; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; Steinacker P, 2009, J NEURAL TRANSM, V116, P1169, DOI 10.1007/s00702-009-0271-4; Strong M, 2003, AMYOTROPH LATERAL SC, V4, P136, DOI 10.1080/14660820310011250; Sussmuth SD, 2010, NEUROLOGY, V74, P982, DOI 10.1212/WNL.0b013e3181d5dc3b; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Tumani H, 2008, EXPERT REV MOL DIAGN, V8, P479, DOI 10.1586/14737159.8.4.479; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Winhammar JMC, 2005, LANCET NEUROL, V4, P229, DOI 10.1016/S1474-4422(05)70042-9; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	32	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23600	10.1371/journal.pone.0023600	http://dx.doi.org/10.1371/journal.pone.0023600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858182	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953700036
J	Ahrens, I; Domeij, H; Topcic, D; Haviv, I; Merivirta, RM; Agrotis, A; Leitner, E; Jowett, JB; Bode, C; Lappas, M; Peter, K				Ahrens, Ingo; Domeij, Helena; Topcic, Denijal; Haviv, Izhak; Merivirta, Ruusu-Maaria; Agrotis, Alexander; Leitner, Ephraem; Jowett, Jeremy B.; Bode, Christoph; Lappas, Martha; Peter, Karlheinz			Successful In Vitro Expansion and Differentiation of Cord Blood Derived CD34+Cells into Early Endothelial Progenitor Cells Reveals Highly Differential Gene Expression	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; BONE-MARROW; NEOVASCULARIZATION; TRANSPLANTATION; FACTOR-15; MOBILIZATION; RECRUITMENT; ACTIVATION; GALECTIN-3	Endothelial progenitor cells (EPCs) can be purified from peripheral blood, bone marrow or cord blood and are typically defined by a limited number of cell surface markers and a few functional tests. A detailed in vitro characterization is often restricted by the low cell numbers of circulating EPCs. Therefore in vitro culturing and expansion methods are applied, which allow at least distinguishing two different types of EPCs, early and late EPCs. Herein, we describe an in vitro culture technique with the aim to generate high numbers of phenotypically, functionally and genetically defined early EPCs from human cord blood. Characterization of EPCs was done by flow cytometry, immunofluorescence microscopy, colony forming unit (CFU) assay and endothelial tube formation assay. There was an average 48-fold increase in EPC numbers. EPCs expressed VEGFR-2, CD144, CD18, and CD61, and were positive for acetylated LDL uptake and ulex lectin binding. The cells stimulated endothelial tube formation only in co-cultures with mature endothelial cells and formed CFUs. Microarray analysis revealed highly up-regulated genes, including LL-37 (CAMP), PDK4, and alpha-2-macroglobulin. In addition, genes known to be associated with cardioprotective (GDF15) or pro-angiogenic (galectin-3) properties were also significantly up-regulated after a 72 h differentiation period on fibronectin. We present a novel method that allows to generate high numbers of phenotypically, functionally and genetically characterized early EPCs. Furthermore, we identified several genes newly linked to EPC differentiation, among them LL-37 (CAMP) was the most up-regulated gene.	[Ahrens, Ingo; Bode, Christoph] Univ Hosp Med Ctr, Dept Cardiol & Angiol, Freiburg, Germany; [Haviv, Izhak; Jowett, Jeremy B.] Baker IDI Heart & Diabet Inst, Blood & DNA Profiling Facil, Melbourne, Vic, Australia; [Agrotis, Alexander] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Lappas, Martha] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Melbourne, Vic, Australia	University of Freiburg; Baker Heart and Diabetes Institute; Monash University; University of Melbourne	Ahrens, I (corresponding author), Univ Hosp Med Ctr, Dept Cardiol & Angiol, Freiburg, Germany.	ingo.ahrens@uniklinik-freiburg.de	/S-2765-2019; Peter, Karlheinz/E-8772-2010; Haviv, Izhak/E-3782-2015	/0000-0002-8040-2258; Peter, Karlheinz/0000-0002-8040-2258; Haviv, Izhak/0000-0002-0837-5005	National Health and Medical Research Council (NHMRC) of Australia; German Research Foundation [185/1-1]; Australian Research Council; Henning and Johan Throne-Holst's foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Research Foundation(German Research Foundation (DFG)); Australian Research Council(Australian Research Council); Henning and Johan Throne-Holst's foundation	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, the German Research Foundation (AH 185/1-1, Ahrens I), the Australian Research Council (Peter K), and the Henning and Johan Throne-Holst's foundation (Domeij H). Dr. Martha Lappas is a recipient of a NHMRC RD Wright Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bowman Teresa V., 2007, V134, P1; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Eggers KM, 2008, EUR HEART J, V29, P2327, DOI 10.1093/eurheartj/ehn339; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erbs S, 2005, CIRC RES, V97, P756, DOI 10.1161/01.RES.0000185811.71306.8b; Eunju O, 2011, FASEB J, V25, P159, DOI 10.1096/fj.10-162040; Furuhata S, 2007, MOL CELL BIOCHEM, V298, P125, DOI 10.1007/s11010-006-9359-4; Hahne F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-3; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2009, J THROMB HAEMOST, V7, P31, DOI 10.1111/j.1538-7836.2009.03406.x; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Iacobini C, 2009, ARTERIOSCL THROM VAS, V29, P831, DOI 10.1161/ATVBAHA.109.186791; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Leone AM, 2009, EUR HEART J, V30, P890, DOI 10.1093/eurheartj/ehp078; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Neidhart M, 2005, ANN RHEUM DIS, V64, P419, DOI 10.1136/ard.2004.023135; Ott HC, 2005, NEW ENGL J MED, V353, P2614; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pfosser A, 2010, STEM CELLS, V28, P376, DOI 10.1002/stem.280; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Raponi M, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-56; Redondo S, 2008, J IMMUNOL METHODS, V335, P21, DOI 10.1016/j.jim.2008.02.011; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Renault MA, 2007, MICROVASC RES, V74, P159, DOI 10.1016/j.mvr.2007.08.005; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Taddei S, 2010, EUR HEART J, V31, P1168, DOI 10.1093/eurheartj/ehq077; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Umemoto T, 2008, BIOCHEM BIOPH RES CO, V365, P176, DOI 10.1016/j.bbrc.2007.10.168; Wang XG, 2007, J AM COLL CARDIOL, V49, P1566, DOI 10.1016/j.jacc.2006.12.037; Wu YJ, 2006, CIRC RES, V99, P315, DOI 10.1161/01.RES.0000235986.35957.a3; Yamagishi SI, 2009, CURR PHARM DESIGN, V15, P1027, DOI 10.2174/138161209787581940; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Zhang Y, 2006, J BIOL CHEM, V281, P39096, DOI 10.1074/jbc.M601362200; Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985	51	38	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23210	10.1371/journal.pone.0023210	http://dx.doi.org/10.1371/journal.pone.0023210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858032	Green Published, gold			2022-12-25	WOS:000293953500025
J	Zhang, YJ; Klein, K; Sugathan, A; Nassery, N; Dombkowski, A; Zanger, UM; Waxman, DJ				Zhang, Yijing; Klein, Kathrin; Sugathan, Aarathi; Nassery, Najlla; Dombkowski, Alan; Zanger, Ulrich M.; Waxman, David J.			Transcriptional Profiling of Human Liver Identifies Sex-Biased Genes Associated with Polygenic Dyslipidemia and Coronary Artery Disease	PLOS ONE			English	Article							SEXUALLY DIMORPHIC GENE; LIPID-LEVELS; EPIGENETIC REGULATION; DOSAGE COMPENSATION; GENDER-DIFFERENCES; NUCLEAR RECEPTORS; IMPRINTED GENE; HEART-DISEASE; PPAR-ALPHA; EXPRESSION	Sex-differences in human liver gene expression were characterized on a genome-wide scale using a large liver sample collection, allowing for detection of small expression differences with high statistical power. 1,249 sex-biased genes were identified, 70% showing higher expression in females. Chromosomal bias was apparent, with female-biased genes enriched on chrX and male-biased genes enriched on chrY and chr19, where 11 male-biased zinc-finger KRAB-repressor domain genes are distributed in six clusters. Top biological functions and diseases significantly enriched in sex-biased genes include transcription, chromatin organization and modification, sexual reproduction, lipid metabolism and cardiovascular disease. Notably, sex-biased genes are enriched at loci associated with polygenic dyslipidemia and coronary artery disease in genome-wide association studies. Moreover, of the 8 sex-biased genes at these loci, 4 have been directly linked to monogenic disorders of lipid metabolism and show an expression profile in females (elevated expression of ABCA1, APOA5 and LDLR; reduced expression of LIPC) that is consistent with the lower female risk of coronary artery disease. Female-biased expression was also observed for CYP7A1, which is activated by drugs used to treat hypercholesterolemia. Several sex-biased drug-metabolizing enzyme genes were identified, including members of the CYP, UGT, GPX and ALDH families. Half of 879 mouse orthologs, including many genes of lipid metabolism and homeostasis, show growth hormone-regulated sex-biased expression in mouse liver, suggesting growth hormone might play a similar regulatory role in human liver. Finally, the evolutionary rate of protein coding regions for human-mouse orthologs, revealed by dN/dS ratio, is significantly higher for genes showing the same sex-bias in both species than for non-sex-biased genes. These findings establish that human hepatic sex differences are widespread and affect diverse cell metabolic processes, and may help explain sex differences in lipid profiles associated with sex differential risk of coronary artery disease.	[Zhang, Yijing; Sugathan, Aarathi; Nassery, Najlla; Waxman, David J.] Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA; [Klein, Kathrin; Zanger, Ulrich M.] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Dombkowski, Alan] Wayne State Univ, Dept Pediat, Div Clin Pharmacol & Toxicol, Detroit, MI 48202 USA	Boston University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Wayne State University	Zhang, YJ (corresponding author), Boston Univ, Dept Biol, Div Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA.	djw@bu.edu	Zanger, Ulrich M./A-9364-2012	Zanger, Ulrich M./0000-0002-5276-2002; Waxman, David/0000-0001-7982-9206; Zhang, Yijing/0000-0001-9568-9389; Dombkowski, Alan/0000-0002-0312-8750	National Institutes of Health [DK33765]; German Federal Ministry of Education and Research [0315755]; Robert Bosch Foundation, Stuttgart, Germany; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Bosch Foundation, Stuttgart, Germany; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by National Institutes of Health grant DK33765 (to D.J.W.), the German Federal Ministry of Education and Research grant "Virtual Liver" 0315755 and the Robert Bosch Foundation, Stuttgart, Germany (to U.M.Z.). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Arnold AP, 2009, TRENDS ENDOCRIN MET, V20, P471, DOI 10.1016/j.tem.2009.06.007; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Balci H, 2005, MATURITAS, V50, P289, DOI 10.1016/j.maturitas.2004.07.002; Bittner V, 2006, CURR OPIN CARDIOL, V21, P602, DOI 10.1097/01.hco.0000245739.47712.0a; Blum A, 2009, GENDER MED, V6, P410, DOI 10.1016/j.genm.2009.09.005; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cheung C, 2006, J PHARMACOL EXP THER, V316, P1328, DOI 10.1124/jpet.105.094367; Chu MC, 2003, HUM REPROD, V18, P1570, DOI 10.1093/humrep/deg330; Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Delongchamp RR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S13; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030; Hayes FJ, 1999, METABOLISM, V48, P308, DOI 10.1016/S0026-0495(99)90077-X; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Hemelaar M, 2003, MENOPAUSE, V10, P550, DOI 10.1097/01.GME.0000064866.58809.E5; Hofmann MH, 2008, J PHARMACOL EXP THER, V325, P284, DOI 10.1124/jpet.107.133306; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Hovingh GK, 2005, CURR OPIN LIPIDOL, V16, P139, DOI 10.1097/01.mol.0000162318.47172.ef; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaffe CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE1008, DOI 10.1152/ajpendo.00513.2001; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Johansson A. G., 1999, Journal of Endocrinological Investigation, V22, P58; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Klein K, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00129; Kurian JR, 2010, ENDOCRINOLOGY, V151, P2297, DOI 10.1210/en.2009-0649; Lamba V, 2010, J PHARMACOL EXP THER, V332, P1088, DOI 10.1124/jpet.109.160804; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Lofgren S, 2008, DRUG METAB DISPOS, V36, P955, DOI 10.1124/dmd.107.019349; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; Mosammaparast N, 2010, ANN REV BIOCH; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oliva CP, 2005, ARTERIOSCL THROM VAS, V25, P411, DOI 10.1161/01.ATV.0000153087.36428.dd; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; Paquette A, 2008, MENOPAUSE, V15, P1169, DOI 10.1097/gme.0b013e31817b8159; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Reinius B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000100; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scandlyn MJ, 2008, EXPERT OPIN DRUG MET, V4, P413, DOI 10.1517/17425255.4.4.413; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010; Staels B, 2009, POSTGRAD MED, V121, P25, DOI 10.3810/pgm.2009.05.suppl53.290; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Tsai HW, 2009, EPIGENETICS-US, V4, P47, DOI 10.4161/epi.4.1.7288; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Wauthier V, 2008, MOL ENDOCRINOL, V22, P1962, DOI 10.1210/me.2007-0549; Wauthier Valerie, 2010, Mol Endocrinol, V24, P667, DOI 10.1210/me.2009-0454; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Westberry JM, 2010, ENDOCRINOLOGY, V151, P731, DOI 10.1210/en.2009-0955; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Williams CM, 2004, P NUTR SOC, V63, P153, DOI 10.1079/PNS2003314; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Wranicz JK, 2005, INT J CARDIOL, V101, P105, DOI 10.1016/j.ijcard.2004.07.010; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhang Z, 2004, MOL BIOL EVOL, V21, P2130, DOI 10.1093/molbev/msh223; Zhao SP, 2007, CLIN CHIM ACTA, V376, P68, DOI 10.1016/j.cca.2006.07.014	93	105	107	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23506	10.1371/journal.pone.0023506	http://dx.doi.org/10.1371/journal.pone.0023506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858147	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953500051
J	Ren, P; Nicholls, MER; Ma, YY; Chen, L				Ren, Ping; Nicholls, Michael E. R.; Ma, Yuan-ye; Chen, Lin			Size Matters: Non-Numerical Magnitude affects the Spatial Coding of Response	PLOS ONE			English	Article							MENTAL NUMBER LINE; PARIETAL CORTEX; SPACE; TIME; REPRESENTATION; PERFORMANCE; PERCEPTION; MODULATION; LUMINANCE; QUANTITY	It is known that small and large numbers facilitate left/right respectively (the SNAR effect). Recently, it has been proposed that numerical magnitude is just one example of a range of quantitites, which have a common cognitive/neural representation. To investigate this proposition, response congruency effects were explored for stimuli which differed accoding to their: (a) numerical size, (b) physical size, (c) luminance, (d) conceptual size and (e) auditory eintensity. In a series of experiments, groups of undergraduate participants made two-alternative forced choice discriminiations with their left or right hands. There were clear interactions between magnitude and responding hand whereby rught hand responcses were faster for stimuli with (a) large numbers, (b) large physical size, (c) low luminance, and (d) a refernce to large objeects. There was no congruency effect for the auditory stimuli. The data demonstrate that the response congruency effect observed for numbers also occurs for a variety of other of non-numerical visual quntities. These results support model of general magnitude representation and suggest that the association between magnitude and the left/right sides of space may not be related to culture and/or directional reading habits.	[Ren, Ping; Ma, Yuan-ye] Chinese Acad Sci, State Key Lab Brain & Cognit, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Ren, Ping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Nicholls, Michael E. R.] Flinders Univ S Australia, Sch Psychol, Adelaide, SA, Australia; [Ma, Yuan-ye; Chen, Lin] Chinese Acad Sci, State Key Lab Brain & Cognit, Inst Biophys, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Flinders University South Australia; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ren, P (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	yuanma0716@vip.sina.com	Ren, Ping/AFE-3916-2022; Ren, Ping/AAE-9560-2022	Nicholls, Mike/0000-0002-7072-3744	Ministry of Science and Technology of China [2005CB522800]; National Nature Science Foundation of China [30870825, 30770700, 30921064]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by 973 grant from the National Strategic Basic Research Program of the Ministry of Science and Technology of China (2005CB522800) and National Nature Science Foundation of China grants (30870825, 30770700, 30921064). The funders had no role in study design, data collection and analysis, decision ot publish, or preparation of the manuscript.	Belin P, 1998, J NEUROSCI, V18, P6388; Bryden PJ, 2007, LATERALITY, V12, P364, DOI 10.1080/13576500701356244; Cappelletti M, 2007, EXP BRAIN RES, V179, P631, DOI 10.1007/s00221-006-0820-0; Cappelletti M, 2009, NEUROIMAGE, V46, P522, DOI 10.1016/j.neuroimage.2009.02.016; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Di Luca S, 2006, Q J EXP PSYCHOL, V59, P1648, DOI 10.1080/17470210500256839; Fias W, 2001, COGNITIVE BRAIN RES, V12, P415, DOI 10.1016/S0926-6410(01)00078-7; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Gevers W, 2005, PSYCHOL SCI, V47, P10; Gevers Wim, 2004, Cortex, V40, P171, DOI 10.1016/S0010-9452(08)70938-9; Ito Y, 2004, MEM COGNITION, V32, P662, DOI 10.3758/BF03195857; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Kadosh RC, 2007, CURR BIOL, V17, P689, DOI 10.1016/j.cub.2007.02.056; Knops A, 2006, NEUROPSYCHOLOGIA, V44, P2270, DOI 10.1016/j.neuropsychologia.2006.05.011; McMillan CT, 2006, BRAIN COGNITION, V62, P250, DOI 10.1016/j.bandc.2006.06.005; Nicholls MER, 2008, PSYCHON B REV, V15, P413, DOI 10.3758/PBR.15.2.413; Nuerk HC, 2005, EXP PSYCHOL, V52, P187, DOI 10.1027/1618-3169.52.3.187; Oliveri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007933; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Sato M, 2007, J COGNITIVE NEUROSCI, V19, P684, DOI 10.1162/jocn.2007.19.4.684; Schwarz W, 2006, EXP PSYCHOL, V53, P4, DOI 10.1027/1618-3169.53.1.4; Schwarz W, 2004, CELL, V66, P651; Schwarz W, 2009, J EXP PSYCHOL HUMAN, V35, P989, DOI 10.1037/a0013703; Vallesi A, 2011, CORTEX, V47, P148, DOI 10.1016/j.cortex.2009.09.005; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; WELCH RB, 1986, PERCEPT PSYCHOPHYS, V39, P294, DOI 10.3758/BF03204939; Wood G, 2008, CORTEX, V44, P353, DOI 10.1016/j.cortex.2008.01.002; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; Zebian S, 2005, J COGN CULT, V5, P165, DOI 10.1163/1568537054068660; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	36	77	77	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23553	10.1371/journal.pone.0023553	http://dx.doi.org/10.1371/journal.pone.0023553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853151	gold, Green Published			2022-12-25	WOS:000293953400052
J	Ge, XY; Rameix-Welti, MA; Gault, E; Chase, G; Afonso, ED; Picard, D; Schwemmle, M; Naffakh, N				Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Chase, Geoffrey; Afonso, Emmanuel dos Santos; Picard, Didier; Schwemmle, Martin; Naffakh, Nadia			Influenza Virus Infection Induces the Nuclear Relocalization of the Hsp90 Co-Chaperone p23 and Inhibits the Glucocorticoid Receptor Response	PLOS ONE			English	Article							A VIRUS; RNA-POLYMERASE; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; PROTEIN; IMPORT; ENDONUCLEASE; SUBUNIT; PB2; NUCLEOPROTEIN	The genomic RNAs of influenza A viruses are associated with the viral polymerase subunits (PB1, PB2, PA) and nucleoprotein (NP), forming ribonucleoprotein complexes (RNPs). Transcription/replication of the viral genome occurs in the nucleus of infected cells. A role for Hsp90 in nuclear import and assembly of newly synthetized RNA-polymerase subunits has been proposed. Here we report that the p23 cochaperone of Hsp90, which plays a major role in glucocorticoid receptor folding and function, associates with influenza virus polymerase. We show that p23 is not essential for viral multiplication in cultured cells but relocalizes to the nucleus in influenza virus-infected cells, which may alter some functions of p23 and Hsp90. Moreover, we show that influenza virus infection inhibits glucocorticoid receptor-mediated gene transactivation, and that this negative effect can occur through a p23-independent pathway. Viral-induced inhibition of the glucocorticoid receptor response might be of significant importance regarding the physiopathology of influenza infections in vivo.	[Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Afonso, Emmanuel dos Santos; Naffakh, Nadia] Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, Paris, France; [Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Afonso, Emmanuel dos Santos; Naffakh, Nadia] CNRS, URA3015, Paris, France; [Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Afonso, Emmanuel dos Santos; Naffakh, Nadia] Univ Paris Diderot, Unite Genet Mol Virus ARN, Paris, France; [Rameix-Welti, Marie-Anne; Gault, Elyanne] Univ Versailles St Quentin En Yvelines, Guyancourt, France; [Chase, Geoffrey; Schwemmle, Martin] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, D-7800 Freiburg, Germany; [Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; University of Geneva	Ge, XY (corresponding author), Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, Paris, France.	nadia.naffakh@pasteur.fr	Rameix-Welti, Marie-Anne/H-7526-2019	Naffakh, Nadia/0000-0002-0424-0277; Rameix-Welti, Marie-Anne/0000-0002-5901-3856	EU [FLUINNATE SP5B-CT-2006-044161]	EU(European Commission)	Funding: Institut Pasteur (http://www.pasteur.fr), FLUINNATE SP5B-CT-2006-044161 EU program (http://www.fluinnate.org/), and FLUPHARM FP7-INFLUENZA-2010-259751 (http://flupharm.eu). X.G. was supported by a fellowship from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso EDS, 2005, VIROLOGY, V341, P34, DOI 10.1016/j.virol.2005.06.040; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Crescenzo-Chaigne B, 1999, VIROLOGY, V265, P342, DOI 10.1006/viro.1999.0059; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Ghoshal K, 2001, MOL CELL BIOL, V21, P8301, DOI 10.1128/MCB.21.24.8301-8317.2001; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hinzey A, 2010, ENDOCRINOLOGY; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Robb NC, 2011, J VIROL, V85, P5228, DOI 10.1128/JVI.02562-10; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schneider J, 2009, VACCINE, V27, P6312, DOI 10.1016/j.vaccine.2009.01.015; Shih SR, 1996, EMBO J, V15, P5415, DOI 10.1002/j.1460-2075.1996.tb00925.x; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Vignuzzi M, 2001, J GEN VIROL, V82, P1737, DOI 10.1099/0022-1317-82-7-1737; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	42	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23368	10.1371/journal.pone.0023368	http://dx.doi.org/10.1371/journal.pone.0023368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853119	gold, Green Published, Green Submitted			2022-12-25	WOS:000295454200076
J	Hahm, ER; Moura, MB; Kelley, EE; Van Houten, B; Shiva, S; Singh, SV				Hahm, Eun-Ryeong; Moura, Michelle B.; Kelley, Eric E.; Van Houten, Bennett; Shiva, Sruti; Singh, Shivendra V.			Withaferin A-Induced Apoptosis in Human Breast Cancer Cells Is Mediated by Reactive Oxygen Species	PLOS ONE			English	Article							WITHANIA-SOMNIFERA ASHWAGANDHA; ATP-CONSUMING PROCESSES; COMPOUND WITHAFERIN; DEPENDENT APOPTOSIS; BAX ACTIVATION; IN-VIVO; MITOCHONDRIAL; PREVENTION; DEATH; INFLAMMATION	Withaferin A (WA), a promising anticancer constituent of Ayurvedic medicinal plant Withania somnifera, inhibits growth of MDA-MB-231 and MCF-7 human breast cancer cells in culture and MDA-MB-231 xenografts in vivo in association with apoptosis induction, but the mechanism of cell death is not fully understood. We now demonstrate, for the first time, that WA-induced apoptosis is mediated by reactive oxygen species (ROS) production due to inhibition of mitochondrial respiration. WA treatment caused ROS production in MDA-MB-231 and MCF-7 cells, but not in a normal human mammary epithelial cell line (HMEC). The HMEC was also resistant to WA-induced apoptosis. WA-mediated ROS production as well as apoptotic histone-associated DNA fragment release into the cytosol was significantly attenuated by ectopic expression of Cu, Zn-superoxide dismutase in both MDA-MB-231 and MCF-7 cells. ROS production resulting from WA exposure was accompanied by inhibition of oxidative phosphorylation and inhibition of complex III activity. Mitochondrial DNA-deficient Rho-0 variants of MDA-MB-231 and MCF-7 cells were resistant to WA-induced ROS production, collapse of mitochondrial membrane potential, and apoptosis compared with respective wild-type cells. WA treatment resulted in activation of Bax and Bak in MDA-MB-231 and MCF-7 cells, and SV40 immortalized embryonic fibroblasts derived from Bax and Bak double knockout mouse were significantly more resistant to WA-induced apoptosis compared with fibroblasts derived from wildtype mouse. In conclusion, the present study provides novel insight into the molecular circuitry of WA-induced apoptosis involving ROS production and activation of Bax/Bak.	[Hahm, Eun-Ryeong; Moura, Michelle B.; Van Houten, Bennett; Shiva, Sruti; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Hahm, Eun-Ryeong; Moura, Michelle B.; Van Houten, Bennett; Singh, Shivendra V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Kelley, Eric E.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Shiva, Sruti] Univ Pittsburgh, Sch Med, Vasc Biol Inst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hahm, ER (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	singhs@upmc.edu	Van Houten, Bennett/K-2284-2019		National Cancer Institute [RO1 CA142604]; NATIONAL CANCER INSTITUTE [R01CA142604] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by the National Cancer Institute grant RO1 CA142604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1999, J ETHNOPHARMACOL, V67, P27, DOI 10.1016/S0378-8741(99)00065-3; Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antosiewicz J, 2008, PLANTA MED, V74, P1570, DOI 10.1055/s-2008-1081307; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Choi S, 2005, CANCER RES, V65, P2035, DOI 10.1158/0008-5472.CAN-04-3616; DEVI P U, 1992, Indian Journal of Experimental Biology, V30, P169; Devi P. Uma, 2000, Indian Journal of Experimental Biology, V38, P432; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gupta SK, 2004, MOL CELL BIOCHEM, V260, P39; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Owais M, 2005, PHYTOMEDICINE, V12, P229, DOI 10.1016/j.phymed.2003.07.012; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rasool M, 2006, VASC PHARMACOL, V44, P406, DOI 10.1016/j.vph.2006.01.015; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Wieser W, 2001, BIOCHEM J, V355, P389, DOI 10.1042/0264-6021:3550389; Winters M, 2006, ALTERN MED REV, V11, P269; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	43	147	149	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23354	10.1371/journal.pone.0023354	http://dx.doi.org/10.1371/journal.pone.0023354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853114	Green Published, gold, Green Accepted			2022-12-25	WOS:000295454200071
J	Liu, HJ; Tan, YR; Li, ML; Liu, C; Xiang, Y; Qin, XQ				Liu, Hui Jun; Tan, Yu Rong; Li, Meng Lan; Liu, Chi; Xiang, Yang; Qin, Xiao Qun			Cloning of a Novel Protein Interacting with BRS-3 and Its Effects in Wound Repair of Bronchial Epithelial Cells	PLOS ONE			English	Article							LUNG; EXPRESSION; RECEPTORS	Bombesin receptor subtype 3 (BRS-3), the orphan bombesin receptor, may play a role in the regulation of stress responses in lung and airway epithelia. Bombesin receptor activated protein (BRAP) is a novel protein we found in our previous study which interacts with BRS-3. This study was designed to observe the subcellular location and wound repair function of BRAP in human bronchial epithelial cells (HBECs). BRAP ORF was amplified by RT-PCR and ligated to pEGFP-C1 vector, and then the recombinant plasmid pEGFP-C1-BRAP was transfected into Hela cells. The location of BRAP protein was observed by laser confocal microscope, and the expression of it was analyzed by Western-blot. At the same time, we built the recombinant plasmid pcDNA3.1(+)-BRAP, transfected it into HBECs and observed its impact on cell cycle and wound repair of HBECs. The results showed that BRAP locates in membrane and cytoplasm and increases significantly in transfected cells. Flow cytometry results demonstrated that the recombinant plasmid increases S phase plus G2 phase of cell cycle by 25%. Microscopic video analysis system showed that the repair index of wounded HBECs increases by 20% through stable expression of BRAP. The present study demonstrated that BRAP locates in the membrane and cytoplasm, suggesting that this protein is a cytoplasm protein, which promotes cell cycle and wound repair of HBECs.	[Liu, Hui Jun; Tan, Yu Rong; Li, Meng Lan; Liu, Chi; Xiang, Yang; Qin, Xiao Qun] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha 410083, Peoples R China	Central South University	Liu, HJ (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha 410083, Peoples R China.	xiaoqun1988@xysm.net			National Natural Science Foundation of China [30870917]; hunan college innovation platform [10K079]; construct program of the key discipline in Hunan province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); hunan college innovation platform; construct program of the key discipline in Hunan province	This work was supported by grant #30870917 from National Natural Science Foundation of China, grant #10K079 from the open fund of hunan college innovation platform and the construct program of the key discipline in Hunan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Fathi Z, 1996, J CELL BIOCHEM, P237; Gomperts BN, 2007, AM J RESP CELL MOL, V37, P48, DOI 10.1165/rcmb.2006-0384OC; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; KIM JS, 1995, AM J PHYSIOL-LUNG C, V269, pL119, DOI 10.1152/ajplung.1995.269.1.L119; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; Liu Hui-jun, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P178; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Renz H, 2004, PROG BRAIN RES, V146, P325; Shan L, 2004, AM J PHYSIOL-LUNG C, V286, pL165, DOI 10.1152/ajplung.00436.2002; SPINDEL ER, 1993, RECENT PROG HORM RES, V48, P365; TAN Y, 2006, PEPTIDES, V387, P283; Tesfaigzi Y, 2003, ARCH IMMUNOL THER EX, V51, P283; TOISCOTT M, 1996, LUNG CANCER, V17, P111; Wada K, 2006, BIOCHEM BIOPH RES CO, V340, P872, DOI 10.1016/j.bbrc.2005.12.084	15	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23072	10.1371/journal.pone.0023072	http://dx.doi.org/10.1371/journal.pone.0023072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857995	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300019
J	Machado, MCR; Octacilio-Silva, S; Costa, MSA; Ramos, RGP				Rosa Machado, Maiaro Cabral; Octacilio-Silva, Shirlei; Costa, Mara Silvia A.; Ramos, Ricardo Guelerman P.			rst Transcriptional Activity Influences kirre mRNA Concentration in the Drosophila Pupal Retina during the Final Steps of Ommatidial Patterning	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; CHIASM-C-ROUGHEST; MYOBLAST FUSION; CELL-DEATH; AXONAL PROJECTIONS; EYE DEVELOPMENT; SLIT DIAPHRAGM; ADHESION; NEPHRIN; GENE	Background: Drosophila retinal architecture is laid down between 24-48 hours after puparium formation, when some of the still uncommitted interommatidial cells (IOCs) are recruited to become secondary and tertiary pigment cells while the remaining ones undergo apoptosis. This choice between survival and death requires the product of the roughest (rst) gene, an immunoglobulin superfamily transmembrane glycoprotein involved in a wide range of developmental processes. Both temporal misexpression of Rst and truncation of the protein intracytoplasmic domain, lead to severe defects in which IOCs either remain mostly undifferentiated and die late and erratically or, instead, differentiate into extra pigment cells. Intriguingly, mutants not expressing wild type protein often have normal or very mild rough eyes. Methodology/Principal Findings: By using quantitative real time PCR to examine rst transcriptional dynamics in the pupal retina, both in wild type and mutant alleles we showed that tightly regulated temporal changes in rst transcriptional rate underlie its proper function during the final steps of eye patterning. Furthermore we demonstrated that the unexpected wild type eye phenotype of mutants with low or no rst expression correlates with an upregulation in the mRNA levels of the rst paralogue kin-of-irre (kirre), which seems able to substitute for rst function in this process, similarly to their role in myoblast fusion. This compensatory upregulation of kirre mRNA levels could be directly induced in wild type pupa upon RNAi-mediated silencing of rst, indicating that expression of both genes is also coordinately regulated in physiological conditions. Conclusions/Significance: These findings suggest a general mechanism by which rst and kirre expression could be fine tuned to optimize their redundant roles during development and provide a clearer picture of how the specification of survival and apoptotic fates by differential cell adhesion during the final steps of retinal morphogenesis in insects are controlled at the transcriptional level.	[Rosa Machado, Maiaro Cabral; Octacilio-Silva, Shirlei; Costa, Mara Silvia A.; Ramos, Ricardo Guelerman P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Sao Paulo, Brazil	Universidade de Sao Paulo	Machado, MCR (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Sao Paulo, Brazil.	rgpramos@fmrp.usp.br	Ramos, Ricardo/F-7979-2015; Octacilio-Silva, Shirlei/AAV-6661-2020	Octacilio-Silva, Shirlei/0000-0001-5196-5484	Sao Paulo State Agency for Research Support FAPESP [2007/55984-4]; Brazilian Capes (Coordenadoria de aperfeicoamento de Pessoal de Ensino Superior)	Sao Paulo State Agency for Research Support FAPESP; Brazilian Capes (Coordenadoria de aperfeicoamento de Pessoal de Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Sao Paulo State Agency for Research Support FAPESP, grant # 2007/55984-4. MCRM was recipient of a MSc fellowship from the Brazilian Capes (Coordenadoria de aperfeicoamento de Pessoal de Ensino Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apitz H, 2004, DEV GENES EVOL, V214, P453, DOI 10.1007/s00427-004-0423-3; Araujo H, 2003, MECH DEVELOP, V120, P537, DOI 10.1016/S0925-4773(03)00040-6; Artero RD, 2001, DEVELOPMENT, V128, P4251; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BOSCHERT U, 1990, J NEUROGENET, V6, P153, DOI 10.3109/01677069009107107; Bour BA, 2000, GENE DEV, V14, P1498; Bulchand S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009374; Carthew RW, 2005, CURR OPIN GENET DEV, V15, P358, DOI 10.1016/j.gde.2005.06.002; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Duband JL, 2006, ADV EXP MED BIOL, V589, P45; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Grzeschik NA, 2005, DEVELOPMENT, V132, P2035, DOI 10.1242/dev.01800; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Lee HG, 2010, J CELL SCI, V123, P277, DOI 10.1242/jcs.056853; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Ramos RGP, 2010, METHODS MOL BIOL, V588, P165, DOI 10.1007/978-1-59745-324-0_19; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Reddy GV, 1999, DEV GENES EVOL, V209, P581, DOI 10.1007/s004270050292; Reiter C, 1996, DEVELOPMENT, V122, P1931; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Simon CR, 2009, GENESIS, V47, P492, DOI 10.1002/dvg.20527; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; WOLFF T, 1991, DEVELOPMENT, V113, P825; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22536	10.1371/journal.pone.0022536	http://dx.doi.org/10.1371/journal.pone.0022536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857931	Green Submitted, Green Published, gold			2022-12-25	WOS:000293773300006
J	Sasikumar, R; Rejitha, JR; Binumon, PK; Manoj, M				Sasikumar, Roschen; Rejitha, John Raji; Binumon, Ponthananiyil Kumaran; Manoj, Muraleedharan			Role of Heterozygous APC Mutation in Niche Succession and Initiation of Colorectal Cancer - A Computational Study	PLOS ONE			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; STEM-CELLS; SMALL-INTESTINE; CRYPT DYNAMICS; HUMAN COLON; ORIENTATION; TISSUE; MODEL; ORGANIZATION	Mutations in the adenomatous polyposis coli (APC) gene are found in most colorectal cancers. They cause constitutive activation of proliferative pathways when both alleles of the gene are mutated. However studies on individuals with familial adenomatous polyposis (FAP) have shown that a single mutated APC allele can also create changes in the precancerous colon crypt, like increased number of stem cells, increased crypt fission, greater variability of DNA methylation patterns, and higher somatic mutation rates. In this paper, using a computational model of colon crypt dynamics, we evolve and investigate a hypothesis on the effect of heterozygous APC mutation that explains these different observations. Based on previous reports and the results from the computational model we propose the hypothesis that heterozygous APC mutation has the effect of increasing the chances for a stem cell to divide symmetrically, producing two stem cell daughters. We incorporate this hypothesis into the model and perform simulation experiments to investigate the consequences of the hypothesis. Simulations show that this hypothesis links together the changes in FAP crypts observed in previous studies. The simulations also show that an APC(+/-) stem cell gets selective advantages for dominating the crypt and progressing to cancer. This explains why most colon cancers are initiated by APC mutation. The results could have implications for preventing or retarding the onset of colon cancer in people with inherited or acquired mutation of one APC allele. Experimental validation of the hypothesis as well as investigation into the molecular mechanisms of this effect may therefore be worth undertaking.	[Sasikumar, Roschen; Rejitha, John Raji; Binumon, Ponthananiyil Kumaran; Manoj, Muraleedharan] Natl Inst Interdisciplinary Sci & Technol CSIR, Computat Modeling & Simulat Grp, Trivandrum, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Sasikumar, R (corresponding author), Natl Inst Interdisciplinary Sci & Technol CSIR, Computat Modeling & Simulat Grp, Trivandrum, Kerala, India.	roschen.csir@gmail.com			Council of Scientific and Industrial Research - Inter Agency [IAP 0001]	Council of Scientific and Industrial Research - Inter Agency	Council of Scientific and Industrial Research - Inter Agency Project IAP 0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boman BM, 2008, CANCER RES, V68, P3304, DOI 10.1158/0008-5472.CAN-07-2061; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; Campbell F, 1998, HUM PATHOL, V29, P1531, DOI 10.1016/S0046-8177(98)90026-0; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Graham TA, 2010, BIOESSAYS, V32, P468, DOI 10.1002/bies.201000032; Hisamuddin IM, 2006, CURR COLORECT CANC R, V2, P53, DOI 10.1007/s11888-006-0002-2; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; JOHNSON RO, 1971, NAT C CANC COL RECT, P208; Kim KM, 2004, AM J PATHOL, V164, P1369, DOI 10.1016/S0002-9440(10)63223-3; Kim KM, 2002, ONCOGENE, V21, P5441, DOI 10.1038/sj.onc.1205604; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pepper JW, 2007, PLOS COMPUT BIOL, V3, P2532, DOI 10.1371/journal.pcbi.0030250; POTTEN CS, 1987, J THEOR BIOL, V127, P381, DOI 10.1016/S0022-5193(87)80136-4; Potten CS, 2003, CELL PROLIFERAT, V36, P115, DOI 10.1046/j.1365-2184.2003.00264.x; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Thorne BC, 2007, BRIEF BIOINFORM, V8, P245, DOI 10.1093/bib/bbm024; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22720	10.1371/journal.pone.0022720	http://dx.doi.org/10.1371/journal.pone.0022720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21857949	Green Published, Green Submitted, gold			2022-12-25	WOS:000293563300018
J	Marrero, E; Rossi, SG; Darr, A; Tsoulfas, P; Rotundo, RL				Marrero, Emilio; Rossi, Susana G.; Darr, Andrew; Tsoulfas, Pantelis; Rotundo, Richard L.			Translational Regulation of Acetylcholinesterase by the RNA-binding Protein Pumilio-2 at the Neuromuscular Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B1 MESSENGER-RNA; GERMLINE DEVELOPMENT; MOLECULAR-CLONING; XENOPUS PUMILIO; HOMOLOGY DOMAIN; PUM2 GENES; EXPRESSION; MUSCLE; NANOS; JUNCTION	Acetylcholinesterase (AChE) is highly expressed at sites of nerve-muscle contact where it is regulated at both the transcriptional and post-transcriptional levels. Our understanding of the molecular mechanisms underlying its regulation is incomplete, but they appear to involve both translational and post-translational events as well. Here, we show that Pumilio-2 (PUM2), an RNA binding translational repressor, is highly localized at the neuromuscular junction where AChE mRNA concentrates. Immunoprecipitation of muscle cell extracts with a PUM2 specific antibody precipitated AChE mRNA, suggesting that PUM2 binds to the AChE transcripts in a complex. Gel shift assays using a bacterially expressed PUM2 RNA binding domain showed specific binding using wild type AChE 3'-UTR RNA segment that was abrogated by mutation of the consensus recognition site. Transfecting skeletal muscle cells with shRNAs specific for PUM2 up-regulated AChE expression, whereas overexpression of PUM2 decreased AChE activity. We conclude that PUM2 binds to AChE mRNA and regulates AChE expression translationally at the neuromuscular synapse. Finally, we found that PUM2 is regulated by the motor nerve suggesting a trans-synaptic mechanism for locally regulating translation of specific proteins involved in modulating synaptic transmission, analogous to CNS synapses.	[Marrero, Emilio; Rossi, Susana G.; Tsoulfas, Pantelis; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Darr, Andrew; Tsoulfas, Pantelis; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Tsoulfas, Pantelis] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Tsoulfas, Pantelis] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Rotundo, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, 1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu	Tsoulfas, Pantelis/GNH-1922-2022	Tsoulfas, Pantelis/0000-0003-1974-6366	National Institutes of Health [AG005917, T32 NS07044]; U.S. Army Research Office [ARO 49497-LS-HIS]; Miami Project; Buoniconti fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Research Office; Miami Project; Buoniconti fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AG005917 (to R.L.R.).; Supported in part by U.S. Army Research Office Training Grant ARO 49497-LS-HIS (to R.L.R.) and National Institutes of Health Training Grant T32 NS07044.; Supported by the Miami Project and the Buoniconti fund.	Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BALDWIN TJ, 1988, DEVELOPMENT, V104, P557; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Belanger G, 2003, J NEUROCHEM, V86, P669, DOI 10.1046/j.1471-4159.2003.01883.x; BURDEN S, 1977, DEV BIOL, V57, P317, DOI 10.1016/0012-1606(77)90218-4; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Couteaux R, 1938, NATURE, V142, P481, DOI 10.1038/142481a0; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; JASMIN BJ, 1995, FEBS LETT, V374, P393, DOI 10.1016/0014-5793(95)01131-W; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; LEGAY C, 1993, FEBS LETT, V315, P163, DOI 10.1016/0014-5793(93)81155-S; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LI Y, 1991, J BIOL CHEM, V266, P23083; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Parisi M, 1999, GENETICS, V153, P235; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; ROSSI SG, 1992, J CELL BIOL, V119, P1657, DOI 10.1083/jcb.119.6.1657; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1990, J CELL BIOL, V110, P715, DOI 10.1083/jcb.110.3.715; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; Savas JN, 2010, J BIOL CHEM, V285, P13142, DOI 10.1074/jbc.M110.114561; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; Tubing F, 2010, J NEUROSCI, V30, P4160, DOI 10.1523/JNEUROSCI.3537-09.2010; Vessey J. P., 2010, P NATL ACAD SCI US; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; White EK, 2001, RNA, V7, P1855; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	46	13	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36492	36499		10.1074/jbc.M111.285510	http://dx.doi.org/10.1074/jbc.M111.285510			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21865157	hybrid, Green Published			2022-12-25	WOS:000296538300034
J	Maheswaranathan, M; Gole, HKA; Fernandez, I; Lassegue, B; Griendling, KK; San Martin, A				Maheswaranathan, Mithunan; Gole, Hope K. A.; Fernandez, Isabel; Lassegue, Bernard; Griendling, Kathy K.; San Martin, Alejandra			Platelet-derived Growth Factor (PDGF) Regulates Slingshot Phosphatase Activity via Nox1-dependent Auto-dephosphorylation of Serine 834 in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASES; 14-3-3 PROTEINS; NADPH OXIDASE; LIM KINASE; COFILIN; PHOSPHORYLATION; ACTIVATION; MIGRATION; EXPRESSION; MOTILITY	Migration of vascular smooth muscle cells (VSMCs) contributes to vascular pathology. PDGF induces VSMC migration by a Nox1-based NADPH oxidase mediated mechanism. We have previously shown that PDGF-induced migration in VSMCs requires Slingshot-1L (SSH1L) phosphatase activity. In the present work, the mechanism of SSH1L activation by PDGF is further investigated. We identified a 14-3-3 consensus binding motif encompassing Ser-834 in SSH1L that is constitutively phosphorylated. PDGF induces SSH1L auto-dephosphorylation at Ser-834 in wild type (wt), but not in Nox1(-/y) cells. A SSH1L-S834A phospho-deficient mutant has significantly lower binding capacity for 14-3-3 when compared with the phospho-mimetic SSH1L-S834D mutant, and acts as a constitutively active phosphatase, lacking of PDGF-mediated regulation. Given that Nox1 produces reactive oxygen species, we evaluated their participation in this SSH1L activation mechanism. We found that H2O2 activates SSH1L and this is accompanied by SSH1L/14-3-3 complex disruption and 14-3-3 oxidation in wt, but not in Nox1(-/y) cells. Together, these data demonstrate that PDGF activates SSH1L in VSMC by a mechanism that involves Nox1-mediated oxidation of 14-3-3 and Ser-834 SSH1L auto-dephosphorylation.	[Maheswaranathan, Mithunan; Gole, Hope K. A.; Fernandez, Isabel; Lassegue, Bernard; Griendling, Kathy K.; San Martin, Alejandra] Emory Univ, Div Cardiol, Dept Med, Atlanta, GA 30322 USA	Emory University	San Martin, A (corresponding author), Emory Univ, Div Cardiol, Dept Med, 319 WMB,1639 Pierce Dr, Atlanta, GA 30322 USA.	asanmartin@emory.edu	Gole, Hope/B-9196-2015; San Martin, Alejandra/HDN-0012-2022	Gole, Hope/0000-0001-8550-0853; Lassegue, Bernard/0000-0003-4924-6506; San Martin, Alejandra/0000-0002-4620-1591; Maheswaranathan, Mithu/0000-0003-0866-0022; Griendling, Kathy/0000-0002-9456-8582	National Institutes of Health Heart, Lung, and Blood Institute [HL93115, HL058863, HL007745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL093115, R00HL093115, R01HL058863, T32HL007745] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Heart, Lung, and Blood Institute Grants HL93115, HL058863, and HL007745.	Autieri MV, 1999, DNA CELL BIOL, V18, P555, DOI 10.1089/104454999315105; Autieri MV, 1996, CELL GROWTH DIFFER, V7, P1453; Brandes RP, 2001, THROMB HAEMOSTASIS, V85, P1104; Clark KL, 2004, J BIOL CHEM, V279, P19401, DOI 10.1074/jbc.M312626200; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Deshpande NN, 2002, ANTIOXID REDOX SIGN, V4, P845, DOI 10.1089/152308602760599007; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ellis JJ, 2003, MOL CELL BIOCHEM, V242, P153, DOI 10.1023/A:1021158216582; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; GRUPPUSO PA, 1992, BIOCHEM BIOPH RES CO, V189, P1457, DOI 10.1016/0006-291X(92)90238-G; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Kligys K, 2009, BIOCHEM BIOPH RES CO, V383, P450, DOI 10.1016/j.bbrc.2009.04.031; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Ohmi K, 1997, BIOCHEM BIOPH RES CO, V238, P154, DOI 10.1006/bbrc.1997.7218; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	34	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35430	35437		10.1074/jbc.M111.268284	http://dx.doi.org/10.1074/jbc.M111.268284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21857021	Green Published, hybrid			2022-12-25	WOS:000295927100014
J	Korge, P; Yang, L; Yang, JH; Wang, YB; Qu, ZL; Weiss, JN				Korge, Paavo; Yang, Ling; Yang, Jun-Hai; Wang, Yibin; Qu, Zhilin; Weiss, James N.			Protective Role of Transient Pore Openings in Calcium Handling by Cardiac Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; MEMBRANE; CA2+; ISCHEMIA; CHANNELS; RELEASE	Long-lasting mitochondrial permeability transition pore (mPTP) openings damage mitochondria, but transient mPTP openings protect against chronic cardiac stress. To probe the mechanism, we subjected isolated cardiac mitochondria to gradual Ca2+ loading, which, in the absence of BSA, induced long-lasting mPTP opening, causing matrix depolarization. However, with BSA present to mimic cytoplasmic fatty acid-binding proteins, the mitochondrial population remained polarized and functional, even after matrix Ca2+ release caused an extramitochondrial free [Ca2+] increase to >10 mu M, unless mPTP openings were inhibited. These findings could be explained by asynchronous transient mPTP openings allowing individual mitochondria to depolarize long enough to flush accumulated matrix Ca2+ and then to repolarize rapidly after pore closure. Because subsequent matrix Ca2+ reuptake via the Ca2+ uniporter is estimated to be > 100-fold slower than matrix Ca2+ release via mPTP, only a tiny fraction of mitochondria (<1%) are depolarized at any given time. Our results show that transient mPTP openings allow cardiac mitochondria to defend themselves collectively against elevated cytoplasmic Ca2+ levels as long as respiratory chain activity is able to balance proton influx with proton pumping. We found that transient mPTP openings also stimulated reactive oxygen species production, which may engage reactive oxygen species-dependent cardioprotective signaling.	[Weiss, James N.] Univ Calif Los Angeles, Div Cardiol, David Geffen Sch Med, Cardiovasc Res Lab,Dept Med Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Weiss, JN (corresponding author), Univ Calif Los Angeles, Div Cardiol, David Geffen Sch Med, Cardiovasc Res Lab,Dept Med Cardiol, 3641 MRL Bldg, Los Angeles, CA 90095 USA.	jweiss@mednet.ucla.edu	Yang, Ling/D-2368-2011	Wang, Yibin/0000-0003-0852-0767	National Institutes of Health from NHLBI [P01 HL080111, R01 HL071870, R01 HL095663]; Laubisch Endowment; Kawata Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071870, R01HL095663, P01HL080111] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Laubisch Endowment; Kawata Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL080111, R01 HL071870, and R01 HL095663 from NHLBI. This work was also supported by the Laubisch and Kawata Endowments.	Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; DATORRE SD, 1991, J MOL CELL CARDIOL, V23, P11, DOI 10.1016/0022-2828(91)90019-I; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Jacobson J, 2002, J CELL SCI, V115, P1175; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Korge P, 2001, AM J PHYSIOL-CELL PH, V280, pC517, DOI 10.1152/ajpcell.2001.280.3.C517; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Liobikas J, 2001, BBA-BIOENERGETICS, V1505, P220, DOI 10.1016/S0005-2728(01)00170-0; Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Skulachev VP, 1999, J BIOENERG BIOMEMBR, V31, P431, DOI 10.1023/A:1005492205984; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	34	58	59	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34851	34857		10.1074/jbc.M111.239921	http://dx.doi.org/10.1074/jbc.M111.239921			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21859717	Green Published, hybrid			2022-12-25	WOS:000295406300039
J	Goldfeder, RL; Parker, SCJ; Ajay, SS; Abaan, HO; Margulies, EH				Goldfeder, Rachel L.; Parker, Stephen C. J.; Ajay, Subramanian S.; Abaan, Hatice Ozel; Margulies, Elliott H.			A Bioinformatics Approach for Determining Sample Identity from Different Lanes of High-Throughput Sequencing Data	PLOS ONE			English	Article							MAP	The ability to generate whole genome data is rapidly becoming commoditized. For example, a mammalian sized genome (similar to 3Gb) can now be sequenced using approximately ten lanes on an Illumina HiSeq 2000. Since lanes from different runs are often combined, verifying that each lane in a genome's build is from the same sample is an important quality control. We sought to address this issue in a post hoc bioinformatic manner, instead of using upstream sample or "barcode" modifications. We rely on the inherent small differences between any two individuals to show that genotype concordance rates can be effectively used to test if any two lanes of HiSeq 2000 data are from the same sample. As proof of principle, we use recent data from three different human samples generated on this platform. We show that the distributions of concordance rates are non-overlapping when comparing lanes from the same sample versus lanes from different samples. Our method proves to be robust even when different numbers of reads are analyzed. Finally, we provide a straightforward method for determining the gender of any given sample. Our results suggest that examining the concordance of detected genotypes from lanes purported to be from the same sample is a relatively simple approach for confirming that combined lanes of data are of the same identity and quality.	[Goldfeder, Rachel L.; Parker, Stephen C. J.; Ajay, Subramanian S.; Abaan, Hatice Ozel; Margulies, Elliott H.] NHGRI, Genome Informat Sect, Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Goldfeder, RL (corresponding author), NHGRI, Genome Informat Sect, Technol Branch, NIH, Bethesda, MD 20892 USA.	emargulies@illumina.com	Parker, Stephen/ABF-1063-2021		National Human Genome Research Institute at the National Institutes of Health, USA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200341] Funding Source: NIH RePORTER	National Human Genome Research Institute at the National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the intramural research program of the National Human Genome Research Institute at the National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAY SS, 2011, GENOME RES IN PRESS; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; LANDER E S, 1988, Genomics, V2, P231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; 2001, NATURE, V409, P928, DOI DOI 10.1038/35057149	11	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23683	10.1371/journal.pone.0023683	http://dx.doi.org/10.1371/journal.pone.0023683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858207	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300083
J	Du Pasquier, D; Dupre, A; Jessus, C				Du Pasquier, David; Dupre, Aude; Jessus, Catherine			Unfertilized Xenopus Eggs Die by Bad-Dependent Apoptosis under the Control of Cdk1 and JNK	PLOS ONE			English	Article							BCL-X-L; CELL-DEATH; OOCYTE APOPTOSIS; PROTEIN PHOSPHATASE-1; MEIOTIC MATURATION; SIGNALING PATHWAY; STARFISH EGGS; MOUSE OOCYTES; OKADAIC ACID; PHOSPHORYLATION	Ovulated eggs possess maternal apoptotic execution machinery that is inhibited for a limited time. The fertilized eggs switch off this time bomb whereas aged unfertilized eggs and parthenogenetically activated eggs fail to stop the timer and die. To investigate the nature of the molecular clock that triggers the egg decision of committing suicide, we introduce here Xenopus eggs as an in vivo system for studying the death of unfertilized eggs. We report that after ovulation, a number of eggs remains in the female body where they die by apoptosis. Similarly, ovulated unfertilized eggs recovered in the external medium die within 72 h. We showed that the death process depends on both cytochrome c release and caspase activation. The apoptotic machinery is turned on during meiotic maturation, before fertilization. The death pathway is independent of ERK but relies on activating Bad phosphorylation through the control of both kinases Cdk1 and JNK. In conclusion, the default fate of an unfertilized Xenopus egg is to die by a mitochondrial dependent apoptosis activated during meiotic maturation.	[Du Pasquier, David; Dupre, Aude; Jessus, Catherine] CNRS, UMR Biol Dev 7622, Paris, France; [Du Pasquier, David; Dupre, Aude; Jessus, Catherine] Univ Paris 06, UMR Biol Dev 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Du Pasquier, D (corresponding author), WatchFrog, Evry, France.	catherine.jessus@upmc.fr		Du Pasquier, David/0000-0002-1890-4564	CNRS (Centre National de la Recherche Scientifique); UPMC (Universite Pierre et Marie Curie); ARC (Association pour la Recherche contre le Cancer) [3969]; ANR (Agence Nationale pour la Recherche) [BLAN07-3_185404]	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); UPMC (Universite Pierre et Marie Curie); ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR))	This work was supported by grants from CNRS (Centre National de la Recherche Scientifique), UPMC (Universite Pierre et Marie Curie), ARC (Association pour la Recherche contre le Cancer, N<SUP>o</SUP>3969 to C.J.) and ANR (Agence Nationale pour la Recherche, BLAN07-3_185404 to C.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Austin C R, 1970, J Reprod Fertil Suppl, V12, P39; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhakar AL, 2003, J NEUROSCI, V23, P11373; BRUN G, 1981, EUR J BIOCHEM, V118, P407; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Coen L, 2001, P NATL ACAD SCI USA, V98, P7869, DOI 10.1073/pnas.141226798; De Smedt V, 2002, J BIOL CHEM, V277, P28592, DOI 10.1074/jbc.M202742200; Deming Paula, 2006, V322, P379; Domingos PM, 2007, CURR OPIN GENET DEV, V17, P294, DOI 10.1016/j.gde.2007.05.009; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frank-Vaillant M, 1999, MOL BIOL CELL, V10, P3279, DOI 10.1091/mbc.10.10.3279; Fujino Y, 1996, HUM REPROD, V11, P1480; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; GORIS J, 1989, FEBS LETT, V245, P91, DOI 10.1016/0014-5793(89)80198-X; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Haccard O, 2006, CELL CYCLE, V5, P1152, DOI 10.4161/cc.5.11.2800; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Huchon D, 1981, NATURE, V294, P358, DOI 10.1038/294358a0; JESSUS C, 1991, DEVELOPMENT, V111, P813; Jessus C, 2007, NATURE, V449, P297, DOI 10.1038/449297a; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Klumpp S, 2003, NEUROCHEM INT, V42, P555, DOI 10.1016/S0197-0186(02)00174-2; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane JD, 2001, J CELL BIOL, V153, P1415, DOI 10.1083/jcb.153.7.1415; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Mood K, 2004, CELL SIGNAL, V16, P631, DOI 10.1016/j.cellsig.2003.10.005; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Perez GI, 1997, HUM REPROD, V12, P2781, DOI 10.1093/humrep/12.12.2781; Perez GI, 2000, NATURE, V403, P500, DOI 10.1038/35000651; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rowe I, 2005, DEV DYNAM, V233, P76, DOI 10.1002/dvdy.20312; Sadler KC, 2004, MOL REPROD DEV, V67, P366, DOI 10.1002/mrd.20023; Saitoh T, 2009, BIOCHEM BIOPH RES CO, V384, P491, DOI 10.1016/j.bbrc.2009.05.004; Sasaki K, 2001, DEV BIOL, V237, P18, DOI 10.1006/dbio.2001.0337; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; Tsuchiya Y, 2005, FEBS J, V272, P2237, DOI 10.1111/j.1742-4658.2005.04648.x; Tsuchiya Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175927; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; WALKER DH, 1992, MOL BIOL CELL, V3, P687, DOI 10.1091/mbc.3.6.687; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Yuce O, 2001, DEV BIOL, V237, P29, DOI 10.1006/dbio.2001.0361; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576; Zhou Y, 2009, MOL CELL BIOL, V29, P1786, DOI 10.1128/MCB.01815-08	67	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23672	10.1371/journal.pone.0023672	http://dx.doi.org/10.1371/journal.pone.0023672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858202	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500040
J	Griffin, M; Iqbal, SA; Sebastian, A; Colthurst, J; Bayat, A				Griffin, Michelle; Iqbal, Syed Amir; Sebastian, Anil; Colthurst, James; Bayat, Ardeshir			Degenerate Wave and Capacitive Coupling Increase Human MSC Invasion and Proliferation While Reducing Cytotoxicity in an In Vitro Wound Healing Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PULSED ELECTROMAGNETIC-FIELD; BONE-MARROW; ELECTRICAL-STIMULATION; MYOCARDIAL-INFARCTION; CLINICAL-IMPLICATIONS; TISSUE INHIBITOR; COLLAGEN I; MIGRATION; REPAIR	Non-unions pose complications in fracture management that can be treated using electrical stimulation (ES). Bone marrow mesenchymal stem cells (BMMSCs) are essential in fracture healing; however, the effect of different clinical ES waveforms on BMMSCs cellular activities remains unknown. We compared the effects of direct current (DC), capacitive coupling (CC), pulsed electromagnetic field (PEMF) and degenerate wave (DW) on cellular activities including cytotoxicity, proliferation, cell-kinetics and apoptosis by stimulating human-BMMSCs 3 hours a day, up to 5 days. In addition, migration and invasion were assessed using fluorescence microscopy and by quantifying gene and protein expression. We found that DW had the greatest proliferative and least apoptotic and cytotoxic effects compared to other waveforms. DC, DW and CC stimulations resulted in a higher number of cells in S phase and G(2)/M phase as shown by cell cycle analysis. CC and DW caused more cells to invade collagen and showed increased MMP-2 and MT1-MMP expression. DC increased cellular migration in a scratch-wound assay and all ES waveforms enhanced expression of migratory genes with DC having the greatest effect. All ES treated cells showed similar progenitor potential as determined by MSC differentiation assay. All above findings were shown to be statistically significant (p<0.05). We conclude that ES can influence BMMSCs activities, especially DW and CC, which show greater invasion and higher cell proliferation compared to other types of ES. Application of DW or CC to the fracture site may help in the recruitment of BMMSCs to the wound that may enhance rate of bone healing at the fracture site.	[Griffin, Michelle; Iqbal, Syed Amir; Sebastian, Anil; Bayat, Ardeshir] Univ Manchester, Sch Translat Med, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Colthurst, James] Fenzian Ltd, Hungerford, Berks, England; [Bayat, Ardeshir] S Manchester Univ Hosp Fdn Trust, Wythenshawe Hosp, Dept Plast & Reconstruct Surg, Manchester, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Manchester Acad Hlth Sci Ctr, S Manchester Univ Hosp Fdn Trust, Wythenshawe Hosp, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Griffin, M (corresponding author), Univ Manchester, Sch Translat Med, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	ardeshir.bayat@manchester.ac.uk		BAYAT, ARDESHIR/0000-0002-4116-6491	National Institute of Health and Research (NIHR), United Kingdom; GATT Family Foundation (USA); Fenzian Ltd	National Institute of Health and Research (NIHR), United Kingdom(National Institute for Health Research (NIHR)); GATT Family Foundation (USA); Fenzian Ltd	Senior author (AB) would like to acknowledge personal funding from National Institute of Health and Research (NIHR), United Kingdom, GATT Family Foundation (USA), and partial funding from Fenzian Ltd for their work in bone repair and regeneration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; BRASHEAR HR, 1965, J BONE JOINT SURG AM, VA 47, P174, DOI 10.2106/00004623-196547010-00015; Callaghan MJ, 2008, PLAST RECONSTR SURG, V121, P130, DOI 10.1097/01.prs.0000293761.27219.84; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Cho MR, 2000, ANN BIOMED ENG, V28, P234, DOI 10.1114/1.263; Chung R, 2009, BONE, V44, P878, DOI 10.1016/j.bone.2009.01.377; Cypher T J, 1996, J Foot Ankle Surg, V35, P413; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; Dezawa M, 2005, EXPERT OPIN BIOL TH, V5, P427, DOI 10.1517/14712598.5.4.427; EBERHARDT A, 1986, Acta Physiologica Polonica, V37, P41; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Fiedler J, 2006, BIOCHEM BIOPH RES CO, V345, P1177, DOI 10.1016/j.bbrc.2006.05.034; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; FITZSIMMONS RJ, 1992, J CELL PHYSIOL, V150, P84, DOI 10.1002/jcp.1041500112; Fujii H, 1999, HISTOCHEM CELL BIOL, V112, P131, DOI 10.1007/s004180050399; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Hartig M, 2000, EUR BIOPHYS J BIOPHY, V29, P499, DOI 10.1007/s002490000100; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Iqbal SA, 2010, BR J DERMATOL; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Kim HK, 2010, JPN J OPHTHALMOL, V54, P221, DOI 10.1007/s10384-009-0793-1; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Li XF, 2002, J VASC RES, V39, P391, DOI 10.1159/000064517; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; MACKLIS RM, 1993, ANN INTERN MED, V118, P376, DOI 10.7326/0003-4819-118-5-199303010-00009; Neuss S, 2010, CELLS TISSUES ORGANS, V191, P36, DOI 10.1159/000215579; NIEDZWIEDZKI T, 1993, BIOMATERIALS, V14, P115, DOI 10.1016/0142-9612(93)90221-M; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Sato T, 2008, JPN J OPHTHALMOL, V52, P217, DOI 10.1007/s10384-008-0533-y; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Sebastian A, EXP DERMATOL; Sebastian A, 2011, EXP DERMATOL, V20, P64, DOI 10.1111/j.1600-0625.2010.01150.x; Shumakov VI, 2003, B EXP BIOL MED+, V136, P192, DOI 10.1023/A:1026387411627; Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tsai MT, 2009, J ORTHOP RES, V27, P1169, DOI 10.1002/jor.20862; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Zhang XJ, 2007, ELECTROMAGN BIOL MED, V26, P167, DOI 10.1080/15368370701580756	50	36	37	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23404	10.1371/journal.pone.0023404	http://dx.doi.org/10.1371/journal.pone.0023404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858102	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500031
J	Janzen, DH; Hallwachs, W				Janzen, Daniel H.; Hallwachs, Winnie			Joining Inventory by Parataxonomists with DNA Barcoding of a Large Complex Tropical Conserved Wildland in Northwestern Costa Rica	PLOS ONE			English	Review							PARASITOID FLIES DIPTERA; BIODIVERSITY; GARDENIFICATION; LEPIDOPTERA; INTEGRATION; GENUS	Background: The many components of conservation through biodiversity development of a large complex tropical wildland, Area de Conservacion Guanacaste (ACG), thrive on knowing what is its biodiversity and natural history. For 32 years a growing team of Costa Rican parataxonomists has conducted biodiversity inventory of ACG caterpillars, their food plants, and their parasitoids. In 2003, DNA barcoding was added to the inventory process. Methodology/Principal Findings: We describe some of the salient consequences for the parataxonomists of barcoding becoming part of a field biodiversity inventory process that has centuries of tradition. From the barcoding results, the parataxonomists, as well as other downstream users, gain a more fine-scale and greater understanding of the specimens they find, rear, photograph, database and deliver. The parataxonomists also need to adjust to collecting more specimens of what appear to be the "same species" - cryptic species that cannot be distinguished by eye or even food plant alone while having to work with the name changes and taxonomic uncertainty that comes with discovering that what looked like one species may be many. Conclusions/Significance: These career parataxonomists, despite their lack of formal higher education, have proven very capable of absorbing and working around the additional complexity and requirements for accuracy and detail that are generated by adding barcoding to the field base of the ACG inventory. In the process, they have also gained a greater understanding of the fine details of phylogeny, relatedness, evolution, and species-packing in their own tropical complex ecosytems. There is no reason to view DNA barcoding as incompatible in any way with tropical biodiversity inventory as conducted by parataxonomists. Their year-round on-site inventory effort lends itself well to the sampling patterns and sample sizes needed to build a thorough barcode library. Furthermore, the biological understanding that comes with barcoding increases the scientific penetrance of biodiversity information, DNA understanding, evolution, and ecology into the communities in which the parataxonomists and their families are resident.	[Janzen, Daniel H.; Hallwachs, Winnie] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Janzen, DH (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	djanzen@sas.upenn.edu			United States National Science Foundation [BSR 9024770, DEB 9306296, 9400829, 9705072, 0072730, 0515699]; Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania	United States National Science Foundation(National Science Foundation (NSF)); Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania	This research was supported by United States National Science Foundation grants BSR 9024770 and DEB 9306296, 9400829, 9705072, 0072730, and 0515699, and grants from the Wege Foundation, International Conservation Fund of Canada, Jessie B. Cox Charitable Trust, Blue Moon Fund, Guanacaste Dry Forest Conservation Fund, Area de Conservacion Guanacaste, and University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Gomez L.D., 1983, P1; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hulcr J, 2007, MOL ECOL NOTES, V7, P549, DOI 10.1111/j.1471-8286.2007.01786.x; Janzen D, 1999, P NATL ACAD SCI USA, V96, P5987, DOI 10.1073/pnas.96.11.5987; Janzen D, 1998, SCIENCE, V279, P1312, DOI 10.1126/science.279.5355.1312; Janzen D. H., 1993, Biodiversity prospecting: using genetic resources for sustainable development., P223; Janzen D. H., 2000, Biodiversity, V1, P7; JANZEN D H, 1991, American Entomologist, V37, P159; Janzen Daniel H., 1993, P100; Janzen Daniel H., 2002, P559; Janzen DH, 2010, BIOTROPICA, V42, P540, DOI 10.1111/j.1744-7429.2010.00667.x; Janzen DH, 2010, P NATL ACAD SCI USA, V107, P11659, DOI 10.1073/pnas.0912122107; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Janzen DH, 2008, RESTAURACION BOSQUES, P181; Janzen DH, 2011, PLOS ONE IN PRESS; Janzen DH, 1992, MEXICO ANTE RETOS BI, P243; Janzen DH, 1999, CIENCIAS AMBIENTALES, V16, P8; Janzen DH, 1988, REHABILITATING DAMAG, VII, P143; Miller JC, 2006, 100 CATERPILLARS; MILLER JC, 2007, 100 BUTTERFLIES MOTH; Pfeiffer Jeanine, 2003, Telopea, V10, P61; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stoeckle MY, 2008, SCI AM, V299, P82	36	91	93	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e18123	10.1371/journal.pone.0018123	http://dx.doi.org/10.1371/journal.pone.0018123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857894	Green Published, gold			2022-12-25	WOS:000294125500001
J	Kim, HS; Choi, HC; Cho, B; Lee, JY; Kwon, MJ				Kim, Hyun Su; Choi, Ho Chun; Cho, Belong; Lee, Joon Yong; Kwon, Min Jeong			Effect of the H1N1 Influenza Pandemic on the Incidence of Epidemic Keratoconjunctivitis and on Hygiene Behavior: A Cross-Sectional Study	PLOS ONE			English	Article							RESPONSES; OUTBREAK	Background: EKC is transmitted chiefly by direct hand contact. It is suspected that the 2009/2010 influenza pandemic influenced hand washing. This study aims to examine the relationship between the 2009/2010 H1N1 influenza pandemic and hygiene behavior. Methods: We compared the EKC prevalence trends before, during and after the 2009/2010 influenza pandemic by using a t-test comparison of EKC sentinel surveillance. Results: During the pre-pandemic period, the incidence of EKC increased from the 21st to the 44th week each year. However, during the pandemic period in 2009, there was no epidemic peak. In the post-pandemic period, the epidemic curve was similar to that in the pre-pandemic period. Compared to the pre-pandemic period, the total number of EKC patients during the pandemic period showed a decrease of 44.9% (t value = -7.23, p = 0.002). Comparing the pre-pandemic and pandemic periods by age group, we found there to be a significant decrease in the number of EKC patients for all age groups (-4.12 <= t value <=-27.23, all P<0.05). This finding was most evident in the teenage group (62%) compared to the other age groups (decreases of 29 to 44%). Conclusions: A continuing effort should be made to educate the public on basic infection prevention behaviors in the aftermath of the pandemic, particularly to teenagers.	[Kim, Hyun Su; Choi, Ho Chun; Cho, Belong] Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea; [Lee, Joon Yong] Korea Univ, Guro Hosp, Dept Family Med, Seoul, South Korea; [Kwon, Min Jeong] Korea Ctr Dis Control & Prevent, Div Infect Dis Surveillance, Chungcheongbuk Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control	Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea.	Belong@snu.ac.kr	Cho, Belong/GLU-3443-2022	Cho, Belong/0000-0001-9558-689X; Lee, Junyong/0000-0001-9467-9277				Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413; Aoki Koki, 2002, International Ophthalmology Clinics, V42, P49; Azar MJ, 1996, AM J OPHTHALMOL, V121, P711, DOI 10.1016/S0002-9394(14)70640-3; Chaberny IF, 2003, INFECT CONT HOSP EP, V24, P514, DOI 10.1086/502247; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Gottsch J D, 1999, Ophthalmic Epidemiol, V6, P29; Jung SH, 2010, PERSONAL HYGIENE BEH; Kang S, 2010, J CLIN MICROBIOL, V48, P2177, DOI 10.1128/JCM.00209-10; Kim JH, 2010, J KOREAN MED SCI, V25, P709; Korea Centers for Disease Control and Prevention, 2010, PAND AL STAT DOWNGR; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lee Dong Han, 2010, J Prev Med Public Health, V43, P99, DOI 10.3961/jpmph.2010.43.2.99; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; Manning S, 2010, EURO SURVEILL; Park JO, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-14; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Schmidt WP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-390; Stefkovicova M., 2005, Central European Journal of Public Health, V13, P29; WHO, 2010, H1N1 POSTP PER; Wong LP, 2010, PREV MED, V51, P92, DOI 10.1016/j.ypmed.2010.04.010; Yuan J, 2009, EPIDEMIOL INFECT, V137, P988, DOI 10.1017/S0950268809002726	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23444	10.1371/journal.pone.0023444	http://dx.doi.org/10.1371/journal.pone.0023444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858118	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500033
J	Shen, SK; Yang, WJ; Wang, ZG; Lei, X; Xu, LQ; Wang, Y; Wang, LZ; Huang, L; Yu, ZW; Zhang, XH; Li, J; Chen, Y; Zhao, XP; Yin, XL; Zhang, CP				Shen, Shukun; Yang, Wenjun; Wang, Zhugang; Lei, Xia; Xu, Liqun; Wang, Yang; Wang, Lizhen; Huang, Lei; Yu, Zhiwei; Zhang, Xinhong; Li, Jiang; Chen, Yan; Zhao, Xiaoping; Yin, Xuelai; Zhang, Chenping			Tumor-Initiating Cells Are Enriched in CD44(hi) Population in Murine Salivary Gland Tumor	PLOS ONE			English	Article							CANCER STEM-CELL; PLEOMORPHIC ADENOMAS; IDENTIFICATION; SUBPOPULATION; INDUCTION; CARCINOMA; PLAG1; MICE	Tumor-initiating cells (T-ICs) discovered in various tumors have been widely reported. However, T-IC populations in salivary gland tumors have yet to be elucidated. Using the established Pleomorphic Adenoma Gene-1 (Plag1) transgenic mouse model of a salivary gland tumor, we identified CD44(high) (CD44(hi)) tumor cells, characterized by high levels of CD44 cell surface expression, as the T-ICs for pleomorphic adenomas. These CD44(hi) tumor cells incorporated 5-bromo-2-deoxyuridine (BrdU), at a lower rate than their CD44(negative) (CD44(neg)) counterparts, and also retained BrdU for a long period of time. Cell surface maker analysis revealed that 25% of the CD44(hi) tumor cells co-express other cancer stem cell markers such as CD133 and CD117. As few as 500 CD44(hi) tumor cells were sufficient to initiate pleomorphic adenomas in one third of the wildtype mice, whereas more than 1 x 10(4) CD44(neg) cells were needed for the same purpose. In NIH 3T3 cells, Plag1 was capable of activating the gene transcription of Egr1, a known upregulator for CD44. Furthermore, deletion of sequence 81-96 in the Egr1 promoter region abolished the effect of Plag1 on Egr1 upregulation. Our results establish the existence of T-ICs in murine salivary gland tumors, and suggest a potential molecular mechanism for CD44 upregulation.	[Shen, Shukun; Yang, Wenjun; Xu, Liqun; Wang, Yang; Yu, Zhiwei; Yin, Xuelai; Zhang, Chenping] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Dept Oral & Maxillofacial Surg,Sch Med, Shanghai 200030, Peoples R China; [Shen, Shukun; Yang, Wenjun; Xu, Liqun; Wang, Yang; Yu, Zhiwei; Yin, Xuelai; Zhang, Chenping] Shanghai Key Lab Stomatol, Lab Oral Tumor & Oral Biol, Shanghai, Peoples R China; [Shen, Shukun; Yang, Wenjun; Xu, Liqun; Wang, Yang; Yu, Zhiwei; Yin, Xuelai; Zhang, Chenping] Shanghai Res Inst Stomatol, Shanghai, Peoples R China; [Wang, Zhugang; Lei, Xia; Huang, Lei; Zhang, Xinhong; Chen, Yan; Zhao, Xiaoping] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Model Organism Div, Shanghai 200030, Peoples R China; [Wang, Lizhen; Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Dept Oral Pathol,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, WJ (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Dept Oral & Maxillofacial Surg,Sch Med, Shanghai 200030, Peoples R China.	wenjun_yang2009@163.com; chenping_zhang2009@163.com		Chen, Yan/0000-0001-5325-1151	National Natural Science Foundation of China [30772432, 30772430]; Ministry of Education of China [20070248062]; Shanghai Jiao Tong University School of Medicine; Shanghai Municipal Education Commission; Science and Technology Commission of Shanghai Municipality [10dz1951300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Shanghai Jiao Tong University School of Medicine; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China 30772432 and 30772430, as well as the Doctoral Fund from the Ministry of Education of China 20070248062 and Doctoral Construction Fund of Shanghai Jiao Tong University School of Medicine. It was also partially supported by the Program for Innovative Research Team of Shanghai Municipal Education Commission and by the Research Grants (10dz1951300) from the Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Declercq J, 2005, CANCER RES, V65, P4544, DOI 10.1158/0008-5472.CAN-04-4041; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; GILLIS AJ, 2011, INT J ANDRO IN PRESS; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Laskawi R, 1998, BRIT J ORAL MAX SURG, V36, P48, DOI 10.1016/S0266-4356(98)90748-3; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sabesan T, 2007, BRIT J ORAL MAX SURG, V45, P65, DOI 10.1016/j.bjoms.2005.04.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith BH, 2011, CANCER RES, V71, P716, DOI 10.1158/0008-5472.CAN-10-2254; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XD, 2006, INT J CANCER, V118, P643, DOI 10.1002/ijc.21400; Zhao Xu-dong, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P390; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	38	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23282	10.1371/journal.pone.0023282	http://dx.doi.org/10.1371/journal.pone.0023282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858056	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500024
J	Accetto, T; Avgustin, G				Accetto, Tomaz; Avgustin, Gorazd			Inability of Prevotella bryantii to Form a Functional Shine-Dalgarno Interaction Reflects Unique Evolution of Ribosome Binding Sites in Bacteroidetes	PLOS ONE			English	Article							EXTENSIVE DNA INVERSIONS; ESCHERICHIA-COLI; MICROBIAL GENOMES; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNAS; XYLANASE GENE; TRANSLATION; INITIATION; SEQUENCE	The Shine-Dalgarno (SD) sequence is a key element directing the translation to initiate at the authentic start codons and also enabling translation initiation to proceed in 5' untranslated mRNA regions (5'-UTRs) containing moderately strong secondary structures. Bioinformatic analysis of almost forty genomes from the major bacterial phylum Bacteroidetes revealed, however, a general absence of SD sequence, drop in GC content and consequently reduced tendency to form secondary structures in 5'-UTRs. The experiments using the Prevotella bryantii TC1-1 expression system were in agreement with these findings: neither addition nor omission of SD sequence in the unstructured 5'-UTR affected the level of the reporter protein, non-specific nuclease NucB. Further, NucB level in P. bryantii TC1-1, contrary to hMGFP level in Escherichia coli, was five times lower when SD sequence formed part of the secondary structure with a folding energy -5,2 kcal/mol. Also, the extended SD sequences did not affect protein levels as in E. coli. It seems therefore that a functional SD interaction does not take place during the translation initiation in P. bryanttii TC1-1 and possibly other members of phylum Bacteroidetes although the anti SD sequence is present in 16S rRNA genes of their genomes. We thus propose that in the absence of the SD sequence interaction, the selection of genuine start codons in Bacteroidetes is accomplished by binding of ribosomal protein S1 to unstructured 5'-UTR as opposed to coding region which is inaccessible due to mRNA secondary structure. Additionally, we found that sequence logos of region preceding the start codons may be used as taxonomical markers. Depending on whether complete sequence logo or only part of it, such as information content and base proportion at specific positions, is used, bacterial genera or families and in some cases even bacterial phyla can be distinguished.	[Accetto, Tomaz; Avgustin, Gorazd] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia	University of Ljubljana	Accetto, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	tomaz.accetto@bf.uni-lj.si			Slovenian Research Agency [P4-0097]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency, research project P4-0097 (http://www.arrs.gov.si/en/dobrodoslica.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2007, MICROBIOL-SGM, V153, P2281, DOI 10.1099/mic.0.2007/005850-0; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; Chen S, 2007, APPL ENVIRON MICROB, V73, P1089, DOI 10.1128/AEM.01577-06; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DANIEL AS, 1995, J APPL BACTERIOL, V79, P417, DOI 10.1111/j.1365-2672.1995.tb03156.x; DESMIT MH, 1994, J MOL BIOL, V244, P144, DOI 10.1006/jmbi.1994.1714; DESMIT MH, 1994, J MOL BIOL, V235, P173, DOI 10.1016/S0022-2836(05)80024-5; Fargo DC, 1998, MOL GEN GENET, V257, P271; Gupta RS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-71; Hobson PN, 1969, METHODS MICROBIOLOGY, V3, P133, DOI DOI 10.1016/S0580-9517(08)70504-X; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Nakamoto T, 2007, GENE, V403, P1, DOI 10.1016/j.gene.2007.08.006; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakamoto M, 2006, INT J SYST EVOL MICR, V56, P1599, DOI 10.1099/ijs.0.64192-0; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; VANGYLSWYK NO, 1990, FEMS MICROBIOL ECOL, V73, P243, DOI 10.1016/0378-1097(90)90737-B; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; Vingadassalom D, 2005, MOL MICROBIOL, V56, P888, DOI 10.1111/j.1365-2958.2005.04590.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zhu HQ, 2004, BIOINFORMATICS, V20, P3308, DOI 10.1093/bioinformatics/bth390; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22914	10.1371/journal.pone.0022914	http://dx.doi.org/10.1371/journal.pone.0022914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857964	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953500009
J	Amunugama, R; Fishel, R				Amunugama, Ravindra; Fishel, Richard			Subunit Interface Residues F129 and H294 of Human RAD51 Are Essential for Recombinase Function	PLOS ONE			English	Article							DNA STRAND-EXCHANGE; REPLICATION PROTEIN-A; COLI RECA PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; METHANOCOCCUS-VOLTAE; ATP BINDING; HYDROLYSIS; OVEREXPRESSION; FILAMENT	RAD51 mediated homologous recombinational repair (HRR) of DNA double-strand breaks (DSBs) is essential to maintain genomic integrity. RAD51 forms a nucleoprotein filament (NPF) that catalyzes the fundamental homologous pairing and strand exchange reaction (recombinase) required for HRR. Based on structural and functional homology with archaeal and yeast RAD51, we have identified the human RAD51 (HsRAD51) subunit interface residues HsRad51(F129) in the Walker A box and HsRad51(H294) in the L2 ssDNA binding region as potentially important participants in salt-induced conformational transitions essential for recombinase activity. We demonstrate that the HsRad51(F129V) and HsRad51(H294V) substitution mutations reduce DNA dependent ATPase activity and are largely defective in the formation of a functional NPF, which ultimately eliminates recombinase catalytic functions. Our data are consistent with the conclusion that the HsRAD51(F129) and HsRAD51(H294) residues are important participants in the cation-induced allosteric activation of HsRAD51.	[Amunugama, Ravindra] Ohio State Univ, Med Ctr, Biophys Grad Program, Columbus, OH 43210 USA; [Amunugama, Ravindra; Fishel, Richard] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Amunugama, Ravindra; Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Amunugama, R (corresponding author), Ohio State Univ, Med Ctr, Biophys Grad Program, Columbus, OH 43210 USA.	rfishel@osu.edu			National Institutes of Health [GM080176]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant GM080176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Grigorescu AA, 2009, NUCLEIC ACIDS RES, V37, P557, DOI 10.1093/nar/gkn973; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu YL, 2004, J MOL BIOL, V337, P817, DOI 10.1016/j.jmb.2004.02.022; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renodon-Corniere A, 2008, J MOL BIOL, V383, P575, DOI 10.1016/j.jmb.2008.08.030; Reymer A, 2009, P NATL ACAD SCI USA, V106, P13248, DOI 10.1073/pnas.0902723106; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Schild D, 2010, NUCLEIC ACIDS RES, V38, P1061, DOI 10.1093/nar/gkp1063; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shim KS, 2006, DNA REPAIR, V5, P718, DOI 10.1016/j.dnarep.2006.03.006; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8845; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8829; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	43	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23071	10.1371/journal.pone.0023071	http://dx.doi.org/10.1371/journal.pone.0023071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857994	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953500017
J	Kikkawa, Y; Miwa, T; Tohara, Y; Hamakubo, T; Nomizu, M				Kikkawa, Yamato; Miwa, Takahiro; Tohara, Yukiko; Hamakubo, Takayuki; Nomizu, Motoyoshi			An Antibody to the Lutheran Glycoprotein (Lu) Recognizing the LU4 Blood Type Variant Inhibits Cell Adhesion to Laminin alpha 5	PLOS ONE			English	Article							BINDING-SITES; IMMUNOGLOBULIN SUPERFAMILY; MOLECULE GLYCOPROTEIN; DYSTROGLYCAN-BINDING; IN-VIVO; RECEPTOR; EXPRESSION; INTEGRINS; PROTEIN; CAM	Background: The Lutheran blood group glycoprotein (Lu), an Ig superfamily (IgSF) transmembrane receptor, is also known as basal cell adhesion molecule (B-CAM). Lu/B-CAM is a specific receptor for laminin alpha 5, a major component of basement membranes in various tissues. Previous reports have shown that Lu/B-CAM binding to laminin alpha 5 contributes to sickle cell vaso-occlusion. However, as there are no useful tools such as function-blocking antibodies or drugs, it is unclear how epithelial and sickled red blood cells adhere to laminin alpha 5 via Lu/B-CAM. Methodology/Principal Findings: In this study, we discovered a function-blocking antibody that inhibits Lu binding to laminin alpha 5 using a unique binding assay on tissue sections. To characterize the function-blocking antibody, we identified the site on Lu/B-CAM recognized by this antibody. The extracellular domain of Lu/B-CAM contains five IgSF domains, D1-D2-D3-D4-D5. The antibody epitope was localized to D2, but not to the D3 domain containing the major part of the laminin alpha 5 binding site. Furthermore, mutagenesis studies showed that Arg(175), the LU4 blood group antigenic site, was crucial for forming the epitope and the antibody bound sufficiently close to sterically hinder the interaction with alpha 5. Cell adhesion assay using the antibody also showed that Lu/B-CAM serves as a secondary receptor for the adhesion of carcinoma cells to laminin alpha 5. Conclusion/Significance: This function-blocking antibody against Lu/B-CAM should be useful for not only investigating cell adhesion to laminin alpha 5 but also for developing drugs to inhibit sickle cell vaso-occlusion.	[Kikkawa, Yamato; Miwa, Takahiro; Tohara, Yukiko; Hamakubo, Takayuki; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Kikkawa, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Tokyo, Japan.	kikkawa@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010		Ministry of Education, Sciences, Sports and Culture, Japan	Ministry of Education, Sciences, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the Ministry of Education, Sciences, Sports and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2008, BLOOD, V112, P5212, DOI 10.1182/blood-2008-03-146068; Bartolucci P, 2010, BLOOD, V116, P2152, DOI 10.1182/blood-2009-12-257444; Burton NM, 2008, BLOOD CELL MOL DIS, V40, P446, DOI 10.1016/j.bcmd.2008.01.004; CAMPBELL IG, 1994, CANCER RES, V54, P5761; El Nemer W, 1998, J BIOL CHEM, V273, P16686; El Nemer W, 2001, J BIOL CHEM, V276, P23757, DOI 10.1074/jbc.M102978200; El Nemer W, 1999, J BIOL CHEM, V274, P31903, DOI 10.1074/jbc.274.45.31903; Eyler CE, 2006, TRANSFUSION, V46, P668, DOI 10.1111/j.1537-2995.2006.00779.x; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; Hebbel RP, 1997, J CLIN INVEST, V99, P2561, DOI 10.1172/JCI119442; Hines PC, 2003, BLOOD, V101, P3281, DOI 10.1182/blood-2001-12-0289; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kroviarski Y, 2004, BRIT J HAEMATOL, V126, P255, DOI 10.1111/j.1365-2141.2004.05010.x; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Moulson CL, 2001, DEV DYNAM, V222, P101, DOI 10.1002/dvdy.1169; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Murphy MM, 2005, BLOOD, V105, P3322, DOI 10.1182/blood-2004-07-2881; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Parsons SF, 2001, BLOOD, V97, P312, DOI 10.1182/blood.V97.1.312; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Wick T M, 1996, Curr Opin Hematol, V3, P118; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500; Zen Q, 1999, J BIOL CHEM, V274, P728, DOI 10.1074/jbc.274.2.728; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23329	10.1371/journal.pone.0023329	http://dx.doi.org/10.1371/journal.pone.0023329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858073	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953500031
J	Souza, RT; Lima, FM; Barros, RM; Cortez, DR; Santos, MF; Cordero, EM; Ruiz, JC; Goldenberg, S; Teixeira, MMG; da Silveira, JF				Souza, Renata T.; Lima, Fabio M.; Barros, Roberto Moraes; Cortez, Danielle R.; Santos, Michele F.; Cordero, Esteban M.; Ruiz, Jeronimo Conceicao; Goldenberg, Samuel; Teixeira, Marta M. G.; da Silveira, Jose Franco			Genome Size, Karyotype Polymorphism and Chromosomal Evolution in Trypanosoma cruzi	PLOS ONE			English	Article							CLONE CL-BRENER; FLOW CYTOMETRIC ANALYSIS; CHAGAS-DISEASE; MOLECULAR KARYOTYPE; PARASITIC PROTOZOA; GENETIC EXCHANGE; UNITED-STATES; LINEAGE-I; TOTAL DNA; SEQUENCE	Background: The Trypanosoma cruzi genome was sequenced from a hybrid strain (CL Brener). However, high allelic variation and the repetitive nature of the genome have prevented the complete linear sequence of chromosomes being determined. Determining the full complement of chromosomes and establishing syntenic groups will be important in defining the structure of T. cruzi chromosomes. A large amount of information is now available for T. cruzi and Trypanosoma brucei, providing the opportunity to compare and describe the overall patterns of chromosomal evolution in these parasites. Methodology/Principal Findings: The genome sizes, repetitive DNA contents, and the numbers and sizes of chromosomes of nine strains of T. cruzi from four lineages (TcI, TcII, TcV and TcVI) were determined. The genome of the TcI group was statistically smaller than other lineages, with the exception of the TcI isolate Tc1161 (Jose-IMT). Satellite DNA content was correlated with genome size for all isolates, but this was not accompanied by simultaneous amplification of retrotransposons. Regardless of chromosomal polymorphism, large syntenic groups are conserved among T. cruzi lineages. Duplicated chromosome-sized regions were identified and could be retained as paralogous loci, increasing the dosage of several genes. By comparing T. cruzi and T. brucei chromosomes, homologous chromosomal regions in T. brucei were identified. Chromosomes Tb9 and Tb11 of T. brucei share regions of syntenic homology with three and six T. cruzi chromosomal bands, respectively. Conclusions: Despite genome size variation and karyotype polymorphism, T. cruzi lineages exhibit conservation of chromosome structure. Several syntenic groups are conserved among all isolates analyzed in this study. The syntenic regions are larger than expected if rearrangements occur randomly, suggesting that they are conserved owing to positive selection. Mapping of the syntenic regions on T. cruzi chromosomal bands provides evidence for the occurrence of fusion and split events involving T. brucei and T. cruzi chromosomes.	[Souza, Renata T.; Lima, Fabio M.; Barros, Roberto Moraes; Cortez, Danielle R.; Santos, Michele F.; Cordero, Esteban M.; da Silveira, Jose Franco] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Ruiz, Jeronimo Conceicao] Ctr Pesquisas Rene Rachou Fiocruz, Fiocruz, MG, Brazil; [Goldenberg, Samuel] Inst Carlos Chagas, Curitiba, Parana, Brazil; [Teixeira, Marta M. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Souza, RT (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	jose.franco@unifesp.br	Teixeira, Marta M G/B-1115-2009; Cordero, Esteban M/F-2511-2012; Lima, Fabio Mitsuo/GQH-9488-2022; Ruiz, Jeronimo/D-2511-2011; Lima, Fabio M/C-9018-2013; GOLDENBERG, SAMUEL/B-4116-2009; Goldenberg, Samuel/ABD-8908-2022; de Moraes Barros, Roberto Rudge/F-4973-2018; P, CM/B-1358-2013; Lima, Fabio Mitsuo/AHD-6582-2022; Cordero, Esteban M./Q-6513-2019; Publica, Inct Saude/J-9544-2013; da Silveira, Jose Franco/F-5390-2012	Cordero, Esteban M/0000-0002-6099-5113; Lima, Fabio Mitsuo/0000-0002-1953-2950; Lima, Fabio M/0000-0002-1953-2950; GOLDENBERG, SAMUEL/0000-0002-4892-163X; de Moraes Barros, Roberto Rudge/0000-0002-0155-8431; Lima, Fabio Mitsuo/0000-0002-1953-2950; Cordero, Esteban M./0000-0002-6099-5113; /0000-0002-1361-9721	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (Brazil); FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP (www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (www.cnpq.br) (Brazil) to JFS. RTS and DRC were awarded postdoctoral and master fellowships by FAPESP, respectively. FML and RMB were awarded doctoral fellowships by FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araya J, 1997, PARASITOLOGY, V115, P563, DOI 10.1017/S0031182097001674; Barnabe C, 2001, EXP PARASITOL, V99, P73, DOI 10.1006/expr.2001.4651; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Branche C, 2006, MOL BIOCHEM PARASIT, V147, P30, DOI 10.1016/j.molbiopara.2006.01.005; Briones MRS, 1999, MOL BIOCHEM PARASIT, V104, P219, DOI 10.1016/S0166-6851(99)00155-3; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; Carolina M, 2002, EUKARYOT CELL, V1, P944, DOI 10.1128/EC.1.6.944-953.2002; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CASTRO C, 1981, MOL BIOCHEM PARASIT, V4, P273, DOI 10.1016/0166-6851(81)90060-8; Cornillot E, 2002, GENE, V293, P87, DOI 10.1016/S0378-1119(02)00604-2; Cura CI, 2010, INT J PARASITOL, V40, P1599, DOI 10.1016/j.ijpara.2010.06.006; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4; DVORAK JA, 1982, J PROTOZOOL, V29, P430, DOI 10.1111/j.1550-7408.1982.tb05427.x; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Ghedin E, 2004, MOL BIOCHEM PARASIT, V134, P183, DOI 10.1016/j.molbiopara.2003.11.012; GIBSON WC, 1986, EMBO J, V5, P1299, DOI 10.1002/j.1460-2075.1986.tb04359.x; HENRIKSSON J, 1990, MOL BIOCHEM PARASIT, V42, P213, DOI 10.1016/0166-6851(90)90164-H; HENRIKSSON J, 1995, MOL BIOCHEM PARASIT, V73, P63, DOI 10.1016/0166-6851(95)00096-J; Henriksson J, 1996, PARASITOL TODAY, V12, P108, DOI 10.1016/0169-4758(96)80670-3; Henriksson J, 2002, PARASITOLOGY, V124, P277, DOI 10.1017/S0031182001001093; HENRIKSSON J, 1993, EXP PARASITOL, V77, P334, DOI 10.1006/expr.1993.1091; KOOY RF, 1989, MOL BIOCHEM PARASIT, V36, P73, DOI 10.1016/0166-6851(89)90202-8; LANAR DE, 1981, MOL BIOCHEM PARASIT, V3, P327, DOI 10.1016/0166-6851(81)90006-2; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Martins C, 2008, MOL BIOCHEM PARASIT, V160, P60, DOI 10.1016/j.molbiopara.2008.03.004; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; NOZAKI T, 1991, J PROTOZOOL, V38, P234, DOI 10.1111/j.1550-7408.1991.tb04435.x; Ocana-Mayorga S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000915; PEARSON WR, 1992, METHOD ENZYMOL, V210, P575; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pedroso A, 2003, MOL BIOCHEM PARASIT, V129, P79, DOI 10.1016/S0166-6851(03)00096-3; Porcile PE, 2003, GENE, V308, P53, DOI 10.1016/S0378-1119(03)00489-X; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Santos MRM, 1999, GENOME RES, V9, P1268, DOI 10.1101/gr.9.12.1268; Santos MRM, 1997, MEM I OSWALDO CRUZ, V92, P821, DOI 10.1590/S0074-02761997000600018; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Souza RT, 2007, EUKARYOT CELL, V6, P1228, DOI 10.1128/EC.00036-07; Sterkers Y, 2011, CELL MICROBIOL, V13, P274, DOI 10.1111/j.1462-5822.2010.01534.x; Teixeira MMG, 2006, TROP MED INT HEALTH, V11, P294, DOI 10.1111/j.1365-3156.2006.01575.x; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; THOMPSON CT, 1989, ANAL BIOCHEM, V177, P353, DOI 10.1016/0003-2697(89)90065-1; Tibayrenc M, 1998, INT J PARASITOL, V28, P85, DOI 10.1016/S0020-7519(97)00180-X; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; Tibayrenc Michel, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-12; Tomazi L, 2009, GENET MOL RES, V8, P458, DOI 10.4238/vol8-2gmr591; Vargas N, 2004, MOL BIOCHEM PARASIT, V138, P131, DOI 10.1016/j.molbiopara.2004.08.005; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; Westenberger SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-60; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	61	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23042	10.1371/journal.pone.0023042	http://dx.doi.org/10.1371/journal.pone.0023042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857989	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500015
J	Zemlin, AE; Matsha, TE; Hassan, MS; Erasmus, RT				Zemlin, Annalise E.; Matsha, Tandi E.; Hassan, Mogamat S.; Erasmus, Rajiv T.			HbA1c of 6.5% to Diagnose Diabetes Mellitus - Does It Work for Us? - The Bellville South Africa Study	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; DISEASE; SENSITIVITY; COMMUNITY; GLUCOSE; A(1C); RISK; A1C	Background: HbA1c has been the gold standard for glycaemic control follow-up for decades. In 2009, a level of 6.5% (48 mmol/mol) was proposed as diagnostic for diabetes. We test this cut-off in our community. Methods: Participants (946) from a community-based study were screened for diabetes using either a fasting blood glucose or oral glucose tolerance test (OFTT). The HbA1c cut-off of 6.5% was tested for each group. A receiver operator characteristic (ROC) curve for both groups was generated to establish an optimal cut-off. Results: Our study included 224 (23.7%) males and 722 (76.3%) females. Using fasting blood glucose alone, 117 (14%) were diagnosed with diabetes -250% had an HbA1c value of >= 6.5% (48 mmol/mol). Using an OGTT, 147 (18%) were diagnosed with diabetes -246% had an HbA1c value of >= 6.5% (48 mmol/mol). ROC curves found a level of 6.1% (43 mmol/mol) to be optimal in both groups (AUC 0.85 and 0.82 respectively). The sensitivities were 80% and 75% and the specificities 77% and 78% respectively. Conclusions: A cut off of 6.5% (48 mmol/mol) is a good diagnostic tool with its high specificity; however the low sensitivity limits its use. We found a level of 6.1% (43 mmol/mol) to be optimal. This emphasizes the need for evidenced based values to be established in various population groups.	[Zemlin, Annalise E.; Erasmus, Rajiv T.] Natl Hlth Lab Serv, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa; [Zemlin, Annalise E.; Erasmus, Rajiv T.] Univ Stellenbosch, Cape Town, South Africa; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, Cape Town, South Africa; [Hassan, Mogamat S.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Nursing & Radiog, Cape Town, South Africa	Stellenbosch University; Cape Peninsula University of Technology; Cape Peninsula University of Technology	Zemlin, AE (corresponding author), Natl Hlth Lab Serv, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa.	rte@sun.ac.za		Matsha, Tandi/0000-0001-5251-030X	Cape Peninsula University of Technology, South Africa; National Health Laboratory Services South Africa [94122]	Cape Peninsula University of Technology, South Africa; National Health Laboratory Services South Africa	This research was supported by grants from the University Research Fund of the Cape Peninsula University of Technology, South Africa and the National Health Laboratory Services South Africa (grant number 94122). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, DIABETES CARE S1, V33, pS62; American Diabetes Association: Diagnosis and classification of diabetes mellitus, 2005, DIABETES CARE S1, V28, P537; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P700; Charlton K E, 1997, S Afr Med J, V87, P364; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Goodall Ian, 2005, Clin Biochem Rev, V26, P5; Kumar PR, 2010, J CLIN ENDOCR METAB, V95, P2832, DOI 10.1210/jc.2009-2433; Levitt NS, 1999, DIABETIC MED, V16, P946, DOI 10.1046/j.1464-5491.1999.00185.x; Melchionda N, 2002, INT J OBESITY, V26, P90, DOI 10.1038/sj.ijo.0801847; MOLLEUTZE WF, 2006, CHRONIC DIS LIFESTYL, P190; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Rowley KG, 2005, DIABETIC MED, V22, P833, DOI 10.1111/j.1464-5491.2005.01447.x; Sacks DB, 2009, CLIN CHEM, V55, P1612, DOI 10.1373/clinchem.2009.132704; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Young IS, 2010, CLIN CHEM, V56, P547, DOI 10.1373/clinchem.2009.138677	19	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22558	10.1371/journal.pone.0022558	http://dx.doi.org/10.1371/journal.pone.0022558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857932	Green Published, gold			2022-12-25	WOS:000293953500004
J	Chelouah, S; Monod-Wissler, C; Bailly, C; Barret, JM; Guilbaud, N; Vispe, S; Kas, E				Chelouah, Sonia; Monod-Wissler, Caroline; Bailly, Christian; Barret, Jean-Marc; Guilbaud, Nicolas; Vispe, Stephane; Kaes, Emmanuel			An Integrated Drosophila Model System Reveals Unique Properties for F14512, a Novel Polyamine-Containing Anticancer Drug That Targets Topoisomerase II	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; ORNITHINE-DECARBOXYLASE; CHROMATIN-STRUCTURE; DNA TOPOISOMERASES; GENE-EXPRESSION; ANTITUMOR DRUGS; EYE DEVELOPMENT; CELL-DEATH; IN-VIVO; MELANOGASTER	F14512 is a novel anti-tumor molecule based on an epipodophyllotoxin core coupled to a cancer-cell vectoring spermine moiety. This polyamine linkage is assumed to ensure the preferential uptake of F14512 by cancer cells, strong interaction with DNA and potent inhibition of topoisomerase II (Topo II). The antitumor activity of F14512 in human tumor models is significantly higher than that of other epipodophyllotoxins in spite of a lower induction of DNA breakage. Hence, the demonstrated superiority of F14512 over other Topo II poisons might not result solely from its preferential uptake by cancer cells, but could also be due to unique effects on Topo II interactions with DNA. To further dissect the mechanism of action of F14512, we used Drosophila melanogaster mutants whose genetic background leads to an easily scored phenotype that is sensitive to changes in Topo II activity and/or localization. F14512 has antiproliferative properties in Drosophila cells and stabilizes ternary Topo II/DNA cleavable complexes at unique sites located in moderately repeated sequences, suggesting that the drug specifically targets a select and limited subset of genomic sequences. Feeding F14512 to developing mutant Drosophila larvae led to the recovery of flies expressing a striking phenotype, "Eye wide shut," where one eye is replaced by a first thoracic segment. Other recovered F14512-induced gain- and loss-of-function phenotypes similarly correspond to precise genetic dysfunctions. These complex in vivo results obtained in a whole developing organism can be reconciled with known genetic anomalies and constitute a remarkable instance of specific alterations of gene expression by ingestion of a drug. " Drosophila-based anticancer pharmacology" hence reveals unique properties for F14512, demonstrating the usefulness of an assay system that provides a low-cost, rapid and effective complement to mammalian models and permits the elucidation of fundamental mechanisms of action of candidate drugs of therapeutic interest in humans.	[Chelouah, Sonia; Monod-Wissler, Caroline; Kaes, Emmanuel] Univ Toulouse 3, Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France; [Chelouah, Sonia; Monod-Wissler, Caroline; Kaes, Emmanuel] CNRS, UMR5099, Lab Biol Mol Eucaryote, Toulouse, France; [Bailly, Christian; Barret, Jean-Marc; Guilbaud, Nicolas; Vispe, Stephane] Inst Rech Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chelouah, S (corresponding author), CNRS, Inst Cancerol Gustave Roussy, UMR 8126, Villejuif, France.	stephane.vispe@pierre-fabre.com; kas@ibcg.biotoul.fr	BAILLY, Christian/AAK-2799-2021; Barret, Jean-Marc/AAN-6038-2020	BAILLY, Christian/0000-0002-2973-9357; CHELOUAH, SONIA/0000-0001-5137-9370	Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer (ARC) [4897, ANR-06-BLAN-0419 CSD 8]; Ligue Nationale Contre le Cancer (LNCC); IRPF	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); IRPF	EK was funded by the Centre National de la Recherche Scientifique (CNRS, http://www.cnrs.fr/), the Association pour la Recherche sur le Cancer (ARC, http://www.arc-cancer.net/, grant No. 4897), the Ligue Nationale Contre le Cancer (LNCC, http://www.ligue-cancer.net/) and the Agence Nationale de la Recherche (ANR, http://www.agence-nationale-recherche.fr/, grant DNAMOTORS No. ANR-06-BLAN-0419 CSD 8). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Commercial funding to EK was provided in part by the Institut de Recherche Pierre Fabre, which played a role in study design, part of data collection and analysis, decision to publish and contributed to preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Christian Bailly, Jean-Marc Barret, Nicolas Guilbaud and Stephane Vispe are fulltime employees of Institut de Recherche Pierre Fabre (IRPF), which developed F14512, a patented drug, and conducts its ongoing phase I clinical trials; Research in Emmanuel Kas's lab was funded in part by IRPF, of which EK is neither an employee nor a consultant and is not involved in patents, products in development or marketed products. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; Barret JM, 2008, CANCER RES, V68, P9845, DOI 10.1158/0008-5472.CAN-08-2748; Blattes R, 2006, EMBO J, V25, P2397, DOI 10.1038/sj.emboj.7601125; Borgnetto ME, 1996, CANCER RES, V56, P1855; Borgnetto ME, 1999, J MOL BIOL, V285, P545, DOI 10.1006/jmbi.1998.2330; Byl JAW, 2001, BIOCHEMISTRY-US, V40, P712, DOI 10.1021/bi0021838; Casero RA, 2009, J MED CHEM, V52, P4551, DOI 10.1021/jm900187v; CHARCOSSET JY, 1993, B CANCER, V80, P923; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Chern JJ, 2002, DEVELOPMENT, V129, P4005; El-Awady RA, 2008, SAUDI MED J, V29, P558; FANTI L, 1994, MOL GEN GENET, V244, P588, DOI 10.1007/BF00282748; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; FESEN M, 1989, J BIOL CHEM, V264, P11354; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Gentry AC, 2011, BIOCHEMISTRY-US, V50, P3240, DOI 10.1021/bi200094z; GINDHART JG, 1995, GENETICS, V139, P797; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hasinoff BB, 2002, ANTI-CANCER DRUG, V13, P255, DOI 10.1097/00001813-200203000-00007; Hasinoff BB, 2001, MOL PHARMACOL, V59, P453, DOI 10.1124/mol.59.3.453; Heisig P, 2009, MUTAGENESIS, V24, P465, DOI 10.1093/mutage/gep035; Hu HY, 2005, WORLD J GASTROENTERO, V11, P2244, DOI 10.3748/wjg.v11.i15.2244; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; IMBERT T, 2005, POLY AMINOACETAMIDE; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; JUDD BH, 1995, GENETICS, V141, P245; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; KAS E, 1993, EMBO J, V12, P115, DOI 10.1002/j.1460-2075.1993.tb05637.x; Kluza J, 2006, ANTI-CANCER DRUG, V17, P155, DOI 10.1097/00001813-200602000-00006; KRUCZYNSKI A, 2009, INVEST NEW DRUGS; Laemmli UK, 1992, CURR OPIN GENET DEV, V2, P275, DOI 10.1016/S0959-437X(05)80285-0; Larsen AK, 1998, BBA-GENE STRUCT EXPR, V1400, P257, DOI 10.1016/S0167-4781(98)00140-7; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Larsen Annette K, 2003, Prog Cell Cycle Res, V5, P295; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Mafune K, 1999, CLIN CANCER RES, V5, P4073; Marchion DC, 2005, MOL CANCER THER, V4, P1993, DOI 10.1158/1535-7163.MCT-05-0194; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; MOTTUS R, 1980, MOL GEN GENET, V178, P465; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Osman D, 2009, P NATL ACAD SCI USA, V106, P12043, DOI 10.1073/pnas.0902449106; Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802; POLJAK L, 1995, TRENDS CELL BIOL, V5, P348, DOI 10.1016/S0962-8924(00)89068-6; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; REUTER G, 1982, MOL GEN GENET, V188, P480, DOI 10.1007/BF00330052; Reymann S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-324; Schultz J, 1936, P NATL ACAD SCI USA, V22, P27, DOI 10.1073/pnas.22.1.27; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; SOLARY E, 1994, LEUKEMIA LYMPHOMA, V15, P21, DOI 10.3109/10428199409051674; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Susbielle Guillaume, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P409, DOI 10.2174/1568011054222355; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tian H, 2006, ACTA BIOCH BIOPH SIN, V38, P639, DOI 10.1111/j.1745-7270.2006.00204.x; Tsen C, 2008, J MED CHEM, V51, P324, DOI 10.1021/jm701198s; UDVARDY A, 1991, MOL CELL BIOL, V11, P4973, DOI 10.1128/MCB.11.10.4973; Utsugi T, 1996, CANCER RES, V56, P2809; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WYCKOFF E, 1989, J MOL BIOL, V205, P1, DOI 10.1016/0022-2836(89)90361-6; Yan TD, 2009, MOL CANCER THER, V8, P1075, DOI 10.1158/1535-7163.MCT-09-0139; Young L, 2006, J HISTOCHEM CYTOCHEM, V54, P223, DOI 10.1369/jhc.5A6672.2005	74	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23597	10.1371/journal.pone.0023597	http://dx.doi.org/10.1371/journal.pone.0023597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853156	gold, Green Submitted, Green Published			2022-12-25	WOS:000295454200100
J	Rodriguez-Cruz, TG; Liu, SJ; Khalili, JS; Whittington, M; Zhang, MY; Overwijk, W; Lizee, G				Rodriguez-Cruz, Tania G.; Liu, Shujuan; Khalili, Jahan S.; Whittington, Mayra; Zhang, Minying; Overwijk, Willem; Lizee, Gregory			Natural Splice Variant of MHC Class I Cytoplasmic Tail Enhances Dendritic Cell-Induced CD8(+) T-Cell Responses and Boosts Anti-Tumor Immunity	PLOS ONE			English	Article							COMPLEX CLASS-I; CROSS-PRESENTATION; CANCER-IMMUNOTHERAPY; ANTIGEN PRESENTATION; PHOSPHORYLATION; MOLECULES; DOMAIN; VACCINATION; VACCINES; PEPTIDE	Dendritic cell (DC)-mediated presentation of MHC class I (MHC-I)/peptide complexes is a crucial first step in the priming of CTL responses, and the cytoplasmic tail of MHC-I plays an important role in modulating this process. Several species express a splice variant of the MHC-I tail that deletes exon 7-encoding amino acids (Delta 7), including a conserved serine phosphorylation site. Previously, it has been shown that Delta 7 MHC-I molecules demonstrate extended DC surface half-lives, and that mice expressing Delta 7-K-b generate significantly augmented CTL responses to viral challenge. Herein, we show that Delta 7-D-b-expressing DCs stimulated significantly more proliferation and much higher cytokine secretion by melanoma antigen-specific (Pmel-1) T cells. Moreover, in combination with adoptive Pmel-1 T-cell transfer, Delta 7-D-b DCs were superior to WT-D-b DCs at stimulating anti-tumor responses against established B16 melanoma tumors, significantly extending mouse survival. Human DCs engineered to express Delta 7-HLA-A*0201 showed similarly enhanced CTL stimulatory capacity. Further studies demonstrated impaired lateral membrane movement and clustering of human Delta 7-MHC-I/peptide complexes, resulting in significantly increased bioavailability of MHC-I/peptide complexes for specific CD8(+) T cells. Collectively, these data suggest that targeting exon 7-encoded MHC-I cytoplasmic determinants in DC vaccines has the potential to increase CD8(+) T-cell stimulatory capacity and substantially improve their clinical efficacy.	[Rodriguez-Cruz, Tania G.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Rodriguez-Cruz, TG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.	glizee@mdanderson.org		Lizee, Gregory/0000-0003-4449-7461	National Institutes of Health (NIH) [R01-AI85371, R01-CA111999-S1]; NATIONAL CANCER INSTITUTE [R01CA111999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085371] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (NIH), R01-AI85371. In addition, TR-C was supported by a NIH minority supplement, R01-CA111999-S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Andrews DM, 2008, IMMUNOL REV, V222, P242, DOI 10.1111/j.1600-065X.2008.00612.x; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Capps GG, 2000, MOL IMMUNOL, V37, P59, DOI 10.1016/S0161-5890(00)00019-5; CAPPS GG, 1989, J CELL BIOL, V108, P1317, DOI 10.1083/jcb.108.4.1317; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dalgaard TS, 2005, SCAND J IMMUNOL, V62, P259, DOI 10.1111/j.1365-3083.2005.01652.x; ELLIS SA, 1992, IMMUNOGENETICS, V37, P49, DOI 10.1007/BF00223544; Engell-Noerregaard L, 2009, CANCER IMMUNOL IMMUN, V58, P1, DOI 10.1007/s00262-008-0568-4; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; GUILD BC, 1984, J BIOL CHEM, V259, P9235; Ide F, 2006, J MED VIROL, V78, P711, DOI 10.1002/jmv.20612; Lizee G, 2005, TRENDS IMMUNOL, V26, P141, DOI 10.1016/j.it.2005.01.005; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lou YY, 2004, CANCER RES, V64, P6783, DOI 10.1158/0008-5472.CAN-04-1621; Luo J, 2010, VACCINE, V28, P2497, DOI 10.1016/j.vaccine.2010.01.038; MCCLUSKEY J, 1986, EMBO J, V5, P2477, DOI 10.1002/j.1460-2075.1986.tb04524.x; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; MOTAL UMA, 1995, EUR J IMMUNOL, V25, P1121, DOI 10.1002/eji.1830250441; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Palucka K, 2009, ANN NY ACAD SCI, V1174, P88, DOI 10.1111/j.1749-6632.2009.05000.x; POBER JS, 1978, P NATL ACAD SCI USA, V75, P6002, DOI 10.1073/pnas.75.12.6002; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688	30	15	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22939	10.1371/journal.pone.0022939	http://dx.doi.org/10.1371/journal.pone.0022939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860662	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200027
J	Dykes, J; Lenshof, A; Astrand-Grundstrom, IB; Laurell, T; Scheding, S				Dykes, Josefina; Lenshof, Andreas; Astrand-Grundstrom, Ing-Britt; Laurell, Thomas; Scheding, Stefan			Efficient Removal of Platelets from Peripheral Blood Progenitor Cell Products Using a Novel Micro-Chip Based Acoustophoretic Platform	PLOS ONE			English	Article							P-SELECTIN; FLOW-CYTOMETRY; TRANSPLANTATION; COLLECTION; ACTIVATION; PARTICLE; MOBILIZATION; EXPRESSION; SEPARATION; ULTRASOUND	Background: Excessive collection of platelets is an unwanted side effect in current centrifugation-based peripheral blood progenitor cell (PBPC) apheresis. We investigated a novel microchip-based acoustophoresis technique, utilizing ultrasonic standing wave forces for the removal of platelets from PBPC products. By applying an acoustic standing wave field onto a continuously flowing cell suspension in a micro channel, cells can be separated from the surrounding media depending on their physical properties. Study Design and Methods: PBPC samples were obtained from patients (n = 15) and healthy donors (n = 6) and sorted on an acoustophoresis-chip. The acoustic force was set to separate leukocytes from platelets into a target fraction and a waste fraction, respectively. The PBPC samples, the target and the waste fractions were analysed for cell recovery, purity and functionality. Results: The median separation efficiency of leukocytes to the target fraction was 98% whereas platelets were effectively depleted by 89%. PBPC samples and corresponding target fractions were similar in the percentage of CD34+ hematopoetic progenitor/stem cells as well as leukocyte/lymphocyte subset distributions. Median viability was 98%, 98% and 97% in the PBPC samples, the target and the waste fractions, respectively. Results from hematopoietic progenitor cell assays indicated a preserved colony-forming ability post-sorting. Evaluation of platelet activation by P-selectin (CD62P) expression revealed a significant increase of CD62P+ platelets in the target (19%) and waste fractions (20%), respectively, compared to the PBPC input samples (9%). However, activation was lower when compared to stored blood bank platelet concentrates (48%). Conclusion: Acoustophoresis can be utilized to efficiently deplete PBPC samples of platelets, whilst preserving the target stem/progenitor cell and leukocyte cell populations, cell viability and progenitor cell colony-forming ability. Acoustophoresis is, thus, an interesting technology to improve current cell processing methods.	[Dykes, Josefina] Univ Labs, Lund, Sweden; [Dykes, Josefina; Astrand-Grundstrom, Ing-Britt; Scheding, Stefan] Lund Univ, Inst Lab Med, Stem Cell Ctr, Lund, Sweden; [Scheding, Stefan] Univ Hosp Skane, Dept Hematol, Lund, Sweden; [Laurell, Thomas] Dongguk Univ, Seoul, South Korea	Lund University; Dongguk University	Dykes, J (corresponding author), Univ Labs, Lund, Sweden.	josefina.dykes@med.lu.se	; Lenshof, Andreas/D-8566-2013	Scheding, Stefan/0000-0002-8005-9568; Lenshof, Andreas/0000-0003-2887-6365; Laurell, Thomas/0000-0002-2486-3607	Vinnova (Swedish Innovation Agency)	Vinnova (Swedish Innovation Agency)(Vinnova)	This work was supported by funds from Vinnova (Swedish Innovation Agency) under the program Innovations for Future Health - CellCARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JD, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3467259; Arslan O, 2007, TRANSFUS APHER SCI, V37, P179, DOI 10.1016/j.transci.2007.08.002; Augustsson P, 2009, LAB CHIP, V9, P810, DOI 10.1039/b811027a; *COUNC EUR PUBL, 2006, GUID PREP US QUAL AS; Cutler C, 2001, STEM CELLS, V19, P108, DOI 10.1634/stemcells.19-2-108; DAILEY JF, 1998, BLOOD; Del Fante C, 2005, STEM CELLS DEV, V14, P734; Dykes JH, 2007, TRANSFUSION, V47, P2134, DOI 10.1111/j.1537-2995.2007.01438.x; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; Goodall Alison H, 2004, Methods Mol Biol, V272, P225; Gutensohn K, 1997, J HEMATOTHER, V6, P315, DOI 10.1089/scd.1.1997.6.315; Hagberg IA, 2000, PLATELETS, V11, P137; Hagberg IA, 2000, TRANSFUSION, V40, P182, DOI 10.1046/j.1537-2995.2000.40020182.x; Hawkes JJ, 2004, LAB CHIP, V4, P446, DOI 10.1039/b408045a; HILL L, 2008, J CLIN APHERESIS, V23, P25; Holme S, 1997, TRANSFUSION, V37, P12, DOI 10.1046/j.1537-2995.1997.37197176945.x; Ikeda K, 2003, TRANSFUSION, V43, P814, DOI 10.1046/j.1537-2995.2003.00422.x; Jonsson H, 2004, ANN THORAC SURG, V78, P1572, DOI 10.1016/j.athoracsur.2004.04.071; KIM S, 2011, TRANSFUSION; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Krailadsiri P, 2000, VOX SANG, V78, P171, DOI 10.1046/j.1423-0410.2000.7830171.x; Kronenwett R, 2000, STEM CELLS, V18, P320, DOI 10.1634/stemcells.18-5-320; Laurell T, 2007, CHEM SOC REV, V36, P492, DOI 10.1039/b601326k; Lenshof A, 2010, CHEM SOC REV, V39, P1203, DOI 10.1039/b915999c; MCLEOD BC, 2003, APHERESIS PRINCIPLES; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Metcalfe P, 1997, BRIT J HAEMATOL, V98, P86, DOI 10.1046/j.1365-2141.1997.1572983.x; Michelson AD, 1996, BLOOD, V87, P4925, DOI 10.1182/blood.V87.12.4925.bloodjournal87124925; Nilsson A, 2004, LAB CHIP, V4, P131, DOI 10.1039/b313493h; Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017; Petersson F, 2005, ANAL CHEM, V77, P1216, DOI 10.1021/ac048394q; Petersson F, 2004, ANALYST, V129, P938, DOI 10.1039/b409139f; Petersson F, 2007, ANAL CHEM, V79, P5117, DOI 10.1021/ac070444e; Ravagnani F, 1999, TRANSFUSION, V39, P48, DOI 10.1046/j.1537-2995.1999.39199116894.x; Reddy RL, 2005, TRANSFUS APHER SCI, V32, P63, DOI 10.1016/j.transci.2004.10.007; Reiser M, 2000, TRANSFUSION, V40, P178, DOI 10.1046/j.1537-2995.2000.40020178.x; Scheding S, 1999, TEXTBOOK OF MALIGNANT HAEMATOLOGY, P383; Scheding S, 1999, CYTOKINES IN THE TREATMENT OF HEMATOPOIETIC FAILURE, P51; Skripchenko A, 2008, TRANSFUSION, V48, P1469, DOI 10.1111/j.1537-2995.2008.01733.x; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; *SYSM CORP, 2004, OP MAN SYSM KX 21N; Tassi C, 2005, BONE MARROW TRANSPL, V36, P289, DOI 10.1038/sj.bmt.1705066; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; Zinno F, 2010, CYTOTHERAPY, V12, P60, DOI 10.3109/14653240903348301	44	83	88	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23074	10.1371/journal.pone.0023074	http://dx.doi.org/10.1371/journal.pone.0023074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857996	Green Published, gold, Green Submitted			2022-12-25	WOS:000293774300020
J	Leonhardt, SD; Schmitt, T; Bluthgen, N				Leonhardt, Sara D.; Schmitt, Thomas; Bluethgen, Nico			Tree Resin Composition, Collection Behavior and Selective Filters Shape Chemical Profiles of Tropical Bees (Apidae: Meliponini)	PLOS ONE			English	Article							CUTICULAR HYDROCARBON PROFILES; STINGLESS BEE; POLLINATION; RECOGNITION; ECOLOGY; CUES; HYMENOPTERA; ATTRACTION; EVOLUTION; INSECT	The diversity of species is striking, but can be far exceeded by the chemical diversity of compounds collected, produced or used by them. Here, we relate the specificity of plant-consumer interactions to chemical diversity applying a comparative network analysis to both levels. Chemical diversity was explored for interactions between tropical stingless bees and plant resins, which bees collect for nest construction and to deter predators and microbes. Resins also function as an environmental source for terpenes that serve as appeasement allomones and protection against predators when accumulated on the bees' body surfaces. To unravel the origin of the bees' complex chemical profiles, we investigated resin collection and the processing of resin-derived terpenes. We therefore analyzed chemical networks of tree resins, foraging networks of resin collecting bees, and their acquired chemical networks. We revealed that 113 terpenes in nests of six bee species and 83 on their body surfaces comprised a subset of the 1,117 compounds found in resins from seven tree species. Sesquiterpenes were the most variable class of terpenes. Albeit widely present in tree resins, they were only found on the body surface of some species, but entirely lacking in others. Moreover, whereas the nest profile of Tetragonula melanocephala contained sesquiterpenes, its surface profile did not. Stingless bees showed a generalized collecting behavior among resin sources, and only a hitherto undescribed species-specific "filtering" of resin-derived terpenes can explain the variation in chemical profiles of nests and body surfaces from different species. The tight relationship between bees and tree resins of a large variety of species elucidates why the bees' surfaces contain a much higher chemodiversity than other hymenopterans.	[Leonhardt, Sara D.; Bluethgen, Nico] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Schmitt, Thomas] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, Freiburg, Germany	University of Wurzburg; University of Freiburg	Leonhardt, SD (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany.	bluethgen@bio.tu-darmstadt.de	Leonhardt, Sara/AAI-6901-2020; Schmitt, Thomas/H-3033-2013; Blüthgen, Nico/F-5983-2010	Leonhardt, Sara/0000-0002-8154-9569; 	Deutsche Forschungsgemeinschaft (DFG): Sonderforschungsbereich SFB [554]; German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg; DFG; University of Wurzburg	Deutsche Forschungsgemeinschaft (DFG): Sonderforschungsbereich SFB(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg; DFG(German Research Foundation (DFG)); University of Wurzburg	The study was funded by the following: Deutsche Forschungsgemeinschaft (DFG): Sonderforschungsbereich SFB 554 (Mechanisms and Evolution of Arthropod Behaviour), www.dfg.de; German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg, http://www.graduateschools.uniwuerzburg.de/life_sciences/home/. Publication fees were kindly funded in the programme Open Access Publishing by the DFG and the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; BLUM MS, 1972, AM ZOOL, V12, P553; BREED MD, 1988, BEHAV GENET, V18, P439, DOI 10.1007/BF01065513; Bruschini C, 2008, J EXP BIOL, V211, P2442, DOI 10.1242/jeb.017749; Buchwald R, 2005, ANIM BEHAV, V70, P1331, DOI 10.1016/j.anbehav.2005.03.017; Chen C, 2009, FUNCT ECOL, V23, P941, DOI 10.1111/j.1365-2435.2009.01622.x; Corlett RT, 2004, BIOL REV, V79, P497, DOI 10.1017/S1464793103006341; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dotterl S, 2006, NEW PHYTOL, V169, P707, DOI 10.1111/j.1469-8137.2005.01509.x; Downs SG, 2000, APIDOLOGIE, V31, P357, DOI 10.1051/apido:2000127; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Dudareva N, 2006, BIOL FLORAL SCENT; EDGAR JA, 1974, NATURE, V248, P614, DOI 10.1038/248614a0; EISNER T, 1974, SCIENCE, V184, P996, DOI 10.1126/science.184.4140.996; Eltz T, 2005, BEHAV ECOL SOCIOBIOL, V59, P149, DOI 10.1007/s00265-005-0021-z; Eltz T, 2004, J TROP ECOL, V20, P317, DOI 10.1017/S0266467403001196; Fox J.E.D., 1973, HDB KABILI SEPILOK F; Gleason JM, 2009, HEREDITY, V103, P416, DOI 10.1038/hdy.2009.79; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Gotelli N. J., 2009, ECOSIM NULL MODELS S; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; HOWARD RW, 1982, J CHEM ECOL, V8, P1227, DOI 10.1007/BF00990755; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kainulainen P, 1998, J AGR FOOD CHEM, V46, P3780, DOI 10.1021/jf980108m; Langenheim J.H., 2003, PLANT RESINS CHEM EV; LANGENHEIM JH, 1978, BIOCHEM SYST ECOL, V6, P299, DOI 10.1016/0305-1978(78)90050-9; Legendre A, 2008, INSECT BIOCHEM MOLEC, V38, P244, DOI 10.1016/j.ibmb.2007.11.005; Lehmberg L, 2008, J APICULT RES, V47, P17, DOI 10.1080/00218839.2008.11101418; Leonhardt SD, 2009, INSECT SOC, V56, P157, DOI 10.1007/s00040-009-0007-3; Leonhardt SD, 2010, BEHAV ECOL SOCIOBIOL, V64, P1415, DOI 10.1007/s00265-010-0956-6; Leonhardt SD, 2009, BIOTROPICA, V41, P730, DOI 10.1111/j.1744-7429.2009.00535.x; LEONHARDT SD, 2010, J CHEM ECOL IN PRESS; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Menzel F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-16; MESSER AC, 1985, BIOTROPICA, V17, P175, DOI 10.2307/2388512; MICHENER C D, 1974, P404; Moure J. S., 1961, Studia Entomologica Petropolis (NS), V4, P181; Nielsen J, 1999, INSECT SOC, V46, P58, DOI 10.1007/s000400050113; Nunes TM, 2009, J CHEM ECOL, V35, P1172, DOI 10.1007/s10886-009-9691-8; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Roubik D.W., 1989, ECOLOGY NATURAL HIST, DOI DOI 10.1126/SCIENCE.248.4958.1026; Roubik DW, 2006, APIDOLOGIE, V37, P124, DOI 10.1051/apido:2006026; ROUBIK DW, 1983, J KANSAS ENTOMOL SOC, V56, P327; Said I, 2005, J INSECT PHYSIOL, V51, P995, DOI 10.1016/j.jinsphys.2005.04.017; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; Soepadmo E, 2004, TREE FLORA SABAH SAR; Terzo M, 2005, APIDOLOGIE, V36, P85, DOI 10.1051/apido:2004072; Thomas ML, 2008, J EVOLUTION BIOL, V21, P801, DOI 10.1111/j.1420-9101.2008.01514.x; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; VOGEL S, 1966, OSTERR BOT Z, V113, P302, DOI DOI 10.1007/BF01373435; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	59	30	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23445	10.1371/journal.pone.0023445	http://dx.doi.org/10.1371/journal.pone.0023445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858119	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300030
J	Hauser, S; Ulrich, T; Wurster, S; Schmitt, K; Reichert, N; Gaubatz, S				Hauser, S.; Ulrich, T.; Wurster, S.; Schmitt, K.; Reichert, N.; Gaubatz, S.			Loss of LIN9, a member of the DREAM complex, cooperates with SV40 large T antigen to induce genomic instability and anchorage-independent growth	ONCOGENE			English	Article						DREAM complex; senescence; genomic instability; mitosis	SPINDLE-ASSEMBLY CHECKPOINT; PRB-RELATED PROTEINS; B-MYB; MEDIATED TRANSFORMATION; G(2)/M GENES; IN-VIVO; SIMIAN-VIRUS-40; EXPRESSION; ANEUPLOIDY; P107	The DREAM complex is an important regulator of mitotic gene expression during the cell cycle. Here we report that inactivation of LIN9, a subunit of DREAM, results in premature senescence, which can be overcome by the SV40 large T (LT) antigen. Together with the observation that p16(INK4a) and p21(Waf1) are upregulated upon loss of LIN9, these results indicate that senescence is triggered by the pRB and p53 tumor suppressor pathways. We also find that LIN9-null cells that escape senescence are chromosomally instable because of compromised mitotic fidelity. SV40 LT-expressing cells that adapt to the loss of LIN9 can grow anchorage-independently in soft agar, a hallmark of oncogenic transformation. Taken together, these results suggest an important role of mitotic gene regulation in the maintenance of genomic stability and tumor suppression. Oncogene (2012) 31, 1859-1868; doi: 10.1038/onc.2011.364; published online 22 August 2011	[Hauser, S.; Ulrich, T.; Wurster, S.; Schmitt, K.; Reichert, N.; Gaubatz, S.] Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Bavaria, Germany	University of Wurzburg	Gaubatz, S (corresponding author), Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Bavaria, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de		Wurster, Sebastian/0000-0002-7784-7256; Gaubatz, Stefan/0000-0001-8751-4191	DFG [575/6-1, TR17-B1]	DFG(German Research Foundation (DFG))	We thank all members of the laboratory for their suggestions and critical reading of the manuscript. We also thank Michael Schmid and Claus Steinlein for their advice and help with karyotype analysis. This work was supported by grants from the DFG (575/6-1 and TR17-B1) to SG.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Chao HHA, 2000, MOL CELL BIOL, V20, P7624, DOI 10.1128/MCB.20.20.7624-7633.2000; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cotsiki M, 2004, P NATL ACAD SCI USA, V101, P947, DOI 10.1073/pnas.0308006100; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gagrica S, 2004, EMBO J, V23, P4627, DOI 10.1038/sj.emboj.7600470; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; KIERSTEAD TD, 1993, J VIROL, V67, P1817, DOI 10.1128/JVI.67.4.1817-1829.1993; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Serrano M, 1997, EXP CELL RES, V237, P7, DOI 10.1006/excr.1997.3824; Song J, 2010, ONCOGENE, V29, P1976, DOI 10.1038/onc.2009.485; Stubdal H, 1996, J VIROL, V70, P2781, DOI 10.1128/JVI.70.5.2781-2788.1996; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800	28	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	14					1859	1868		10.1038/onc.2011.364	http://dx.doi.org/10.1038/onc.2011.364			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21860417				2022-12-25	WOS:000302785200011
J	Bosmann, M; Patel, VR; Russkamp, NF; Pache, F; Zetoune, FS; Sarma, JV; Ward, PA				Bosmann, Markus; Patel, Vinay R.; Russkamp, Norman F.; Pache, Florence; Zetoune, Firas S.; Sarma, J. Vidya; Ward, Peter A.			MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway	FASEB JOURNAL			English	Article						macrophages; endotoxemia; endotoxic shock; cecal ligation and puncture; polymicrobial sepsis	COMPLEMENT FRAGMENTS; DENDRITIC CELLS; RECEPTOR; EXPRESSION; ACTIVATION; CYTOKINE; DIFFERENTIATION; GRANULOCYTE; MACROPHAGES; NEUTROPHILS	The interleukin-17 (IL-17) family of cytokines plays important roles in innate immune defenses against bacterial and fungal pathogens. While much is known about IL-17A, much less information is available about the IL-17F isoform. Here, we investigated gene expression and release of IL-17F and its regulation by the complement system. IL-17F was produced in mouse peritoneal elicited macrophages after TLR4 activation by LPS, peaking after 12 h. This effect was completely dependent on the presence of the adaptor protein MyD88. The copresence of the complement activation product, C5a (EC50 = 10 nM), amplified IL-17F production via the receptor C5aR. In vitro signaling studies indicated that LPS or C5a, or the combination, caused phosphorylation of Akt occurring at threonine 308 but not at serine 473. Treatment of macrophages with pharmacologic inhibitors of PI3K-Akt greatly reduced production of IL-17F as well as mRNA for IL-17F. In endotoxemia, C5a levels peaked at 6 h, while IL-17F levels peaked between 6-12 h. Full in vivo production of IL-17F during endotoxemia required C5a. A similar result was found in the cecal ligation and puncture sepsis model. These data suggest that maximal production of IL-17F requires complement activation and presence of C5a.-Bosmann, M., Patel, V. R., Russkamp, N. F., Pache, F., Zetoune, F. S., Sarma, J. V., Ward, P. A. MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway. FASEB J. 25, 4222-4232 (2011). www.fasebj.org	[Bosmann, Markus; Patel, Vinay R.; Russkamp, Norman F.; Pache, Florence; Zetoune, Firas S.; Sarma, J. Vidya; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.	pward@umich.edu		Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health [GM-29507, GM-61656]; Deutsche Forschungsgemeinschaft [571701, BO 3482/1-1]; Boehringer Ingelheim Fonds; Studienstiftung des deutschen Volkes; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Studienstiftung des deutschen Volkes; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health (grants GM-29507 and GM-61656 to P.A.W.), along with the Deutsche Forschungsgemeinschaft (project 571701, BO 3482/1-1, to M.B.), the Boehringer Ingelheim Fonds (to N.F.R.), and the Studienstiftung des deutschen Volkes (to F.P.). The authors cordially thank Rachel Voight, Mike Haggadone, and Fabien Meta for technical assistance, as well as Beverly Schumann, Sue Scott, and Robin Kunkel for assistance in the preparation of the manuscript.	Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236; Bosmann M., 2011, SHOCK; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Fujishima S, 2010, ARCH DERMATOL RES, V302, P499, DOI 10.1007/s00403-010-1033-8; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guo RF, 2006, J LEUKOCYTE BIOL, V80, P1575, DOI 10.1189/jlb.0106065; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Nataf S, 1999, J IMMUNOL, V162, P4018; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Nonaka M, 2004, MOL IMMUNOL, V40, P897, DOI 10.1016/j.molimm.2003.10.009; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Reiman R, 2002, EUR J IMMUNOL, V32, P1157, DOI 10.1002/1521-4141(200204)32:4<1157::AID-IMMU1157>3.3.CO;2-D; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; STRIETER RM, 1992, AM J PATHOL, V141, P397; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Ward PA, 2010, THESCIENTIFICWORLDJO, V10, P2395, DOI 10.1100/tsw.2010.216; Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; WEBSTER RO, 1982, J CLIN INVEST, V70, P1177, DOI 10.1172/JCI110716; Wittmann M, 1999, J IMMUNOL, V162, P6763; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	54	25	26	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4222	4232		10.1096/fj.11-191205	http://dx.doi.org/10.1096/fj.11-191205			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21859896	Green Submitted, Green Published			2022-12-25	WOS:000298138100015
J	Liao, WL; Wang, WC; Chang, WC; Tseng, JT				Liao, Wan-Lin; Wang, Wei-Chiao; Chang, Wen-Chang; Tseng, Joseph T.			The RNA-binding Protein HuR Stabilizes Cytosolic Phospholipase A(2)alpha mRNA under Interleukin-1 beta Treatment in Non-small Cell Lung Cancer A549 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; ARACHIDONIC-ACID; A(2); INFLAMMATION; PHOSPHORYLATION; CYCLOOXYGENASE-2; TRISTETRAPROLIN; TRANSLATION	The activation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) plays an important role in initiating the inflammatory response. The regulation of cPLA(2)alpha mRNA turnover has been proposed to control cPLA(2)alpha gene expression under cytokine and growth factor stimulation. However, the detailed mechanism is still unknown. In this report, we have demonstrated that the cPLA(2)alpha mRNA stability was increased under IL-1 beta treatment in A549 cells. By using EMSAs, HuR was identified as binding with the cPLA(2)alpha mRNA 3'-UTR, and the binding region was located at nucleotides 2716-2807, a fragment containing AUUUA flanked by U-rich sequences. IL-1 beta treatment enhanced the association of cPLA(2)alpha mRNA with cytosolic HuR. The reduction of HuR expression by RNA interference technology inhibited IL-1 beta-induced cPLA2 alpha mRNA and protein expression. Furthermore, blocking the p38 MAPK signaling pathway with SB203580 abolished the effect of IL-1 beta-induced cPLA(2)alpha gene expression. Phosphorylation at residue Thr-118 of HuR is crucial in regulating the interaction between HuR and its target mRNAs. Mutation of HuR Thr-118 reduced the association between HuR and cPLA(2)alpha mRNA under IL-1 beta treatment. This inhibitory effect was also observed in binding with COX-2 mRNA. This result indicated that p38 MAPK-mediated Thr-118 phosphorylation may play a key role in regulating the interaction of HuR with its target mRNAs in inflammation.	[Liao, Wan-Lin; Tseng, Joseph T.] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Wang, Wei-Chiao; Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan; [Chang, Wen-Chang; Tseng, Joseph T.] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Tseng, JT (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan.	tctseng@mail.ncku.edu.tw	Tseng, Joseph Ta-Chien/I-2850-2018	Tseng, Joseph Ta-Chien/0000-0002-3304-6086	National Science Council (Taiwan) [NSC 97-2320-B-006-026-MY3, NSC 99-2923-B-006-002-MY3]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council (Taiwan) Grants NSC 97-2320-B-006-026-MY3 and NSC 99-2923-B-006-002-MY3.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cowan MJ, 2004, BBA-GENE STRUCT EXPR, V1680, P145, DOI 10.1016/j.bbaexp.2004.09.006; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dronadula N, 2005, J BIOL CHEM, V280, P3112, DOI 10.1074/jbc.M409739200; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Huang WL, 2009, J NEUROTRAUM, V26, P1429, DOI [10.1089/neu.2008.0835, 10.1089/neu.2008-0835]; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Leslie CC, 2004, PROSTAG LEUKOTR ESS, V70, P373, DOI 10.1016/j.plefa.2003.12.012; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Linkous A, 2010, CELL MICROBIOL, V12, P1369, DOI 10.1111/j.1462-5822.2010.01505.x; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; Myou S, 2001, NAT IMMUNOL, V2, P145, DOI 10.1038/84244; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; TAY A, 1994, BIOCHEM J, V304, P417, DOI 10.1042/bj3040417; van Hoof A, 2002, CURR BIOL, V12, pR285, DOI 10.1016/S0960-9822(02)00802-3; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Yeh CH, 2008, MOL BIOL CELL, V19, P3812, DOI 10.1091/mbc.E07-09-0962	49	27	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35499	35508		10.1074/jbc.M111.263582	http://dx.doi.org/10.1074/jbc.M111.263582			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862584	Green Published, hybrid			2022-12-25	WOS:000295927100022
J	Duncan, WC; Shaw, JLV; Burgess, S; McDonald, SE; Critchley, HOD; Horne, AW				Duncan, W. Colin; Shaw, Julie L. V.; Burgess, Stewart; McDonald, Sarah E.; Critchley, Hilary O. D.; Horne, Andrew W.			Ectopic Pregnancy as a Model to Identify Endometrial Genes and Signaling Pathways Important in Decidualization and Regulated by Local Trophoblast	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-4; RICH SECRETORY PROTEIN-3; STROMAL CELLS; DIFFERENTIAL EXPRESSION; CHORIONIC-GONADOTROPIN; IMPLANTATION; INVASION; DECIDUA; IDENTIFICATION; PROGESTERONE	The endometrium in early pregnancy undergoes decidualization and functional changes induced by local trophoblast, which are not fully understood. We hypothesized that endometrium from tubal ectopic pregnancy (EP) could be interrogated to identify novel genes and pathways involved in these processes. Gestation-matched endometrium was collected from women with EP (n = 11) and intrauterine pregnancies (IUP) (n = 13). RNA was extracted from the tissue. In addition, tissues were prepared for histological analysis for degree of decidualization. We compared a) the samples from EP that were decidualized (n = 6) with non-decidualized samples (n = 5), and b) the decidualized EP (n = 6) with decidualization-matched IUP (n = 6) samples using an Affymetrix gene array platform, with Ingenuity Pathway Analysis, combined with quantitative RT-PCR. Expression of PRL and IGFBP1 was used to confirm the degree of decidualization in each group. There were no differences in PRL or IGFBP1 expression in the decidualization-matched samples but a marked reduction (P<0.001) in the non-decidualized samples. Decidualization was associated with increased expression of 428 genes including SCARA5 (181-fold), DKK1 (71-fold) and PROK1 (32-fold), and decreased expression of 230 genes including MMP-7 (35-fold) and SFRP4 (21-fold). The top canonical pathways associated with these differentially expressed genes were Natural Killer Cell and Wnt/beta-Catenin signaling. Local trophoblast was associated with much less alteration of endometrial gene expression with an increase in 56 genes, including CSH1 (8-fold), and a reduction in 29 genes including CRISP3 (8-fold). The top associated canonical pathway was Antigen Presentation. The study of endometrium from tubal EP may promote novel insights into genes involved in decidualization and those influenced by factors from neighboring trophoblast. This has afforded unique information not highlighted by previous studies and adds to our understanding of the endometrium in early pregnancy.	[Duncan, W. Colin; Shaw, Julie L. V.; McDonald, Sarah E.; Critchley, Hilary O. D.; Horne, Andrew W.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Burgess, Stewart] Moredun Res Inst, Penicuik, Midlothian, Scotland	University of Edinburgh; Moredun Research Institute	Duncan, WC (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk	CRITCHLEY, HILARY OD/C-7575-2013	Horne, Andrew/0000-0002-9656-493X; McDonald, Sarah/0000-0003-2776-7415; CRITCHLEY, HILARY/0000-0003-1913-4044; burgess, stewart/0000-0002-9268-7641	Wellbeing of Women Project Grant [R40608]; Cunningham Trust; Medical Research Council; Scottish Senior Clinical Fellowship; MRC [G0600048, G1002033, G0802808] Funding Source: UKRI; Medical Research Council [G0802808, G0600048, G1002033] Funding Source: researchfish; Chief Scientist Office [SCD/02] Funding Source: researchfish	Wellbeing of Women Project Grant(Wellbeing of Women (WoW)); Cunningham Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Senior Clinical Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by a Wellbeing of Women Project Grant (R40608) to AWH and HODC and a grant from The Cunningham Trust to WCD. AWH is supported by a Clinician Scientist Fellowship from the Medical Research Council. WCD is a supported by a Scottish Senior Clinical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; Battersby S, 2004, J CLIN ENDOCR METAB, V89, P2463, DOI 10.1210/jc.2003-032012; Bulmer JN, 2010, INT J DEV BIOL, V54, P281, DOI 10.1387/ijdb.082763jb; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chao C, 2010, CURR OPIN ENDOCRINOL, V17, P33, DOI 10.1097/MED.0b013e328333faf8; Chen HW, 2002, MOL HUM REPROD, V8, P475, DOI 10.1093/molehr/8.5.475; Corpa JM, 2006, REPRODUCTION, V131, P631, DOI 10.1530/rep.1.00606; EARL U, 1987, J CLIN PATHOL, V40, P901, DOI 10.1136/jcp.40.8.901; Evans J, 2008, ENDOCRINOLOGY, V149, P2877, DOI 10.1210/en.2007-1633; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; Finn CA, 1996, EUR J OBSTET GYN R B, V70, P3, DOI 10.1016/S0301-2115(96)02565-1; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Fujita M, 2002, J MOL ENDOCRINOL, V28, P213, DOI 10.1677/jme.0.0280213; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; GRAHAM CH, 1992, BIOCHEM CELL BIOL, V70, P867, DOI 10.1139/o92-135; Guzeloglu-Kayisli O, 2007, REPROD BIOMED ONLINE, V15, P728, DOI 10.1016/S1472-6483(10)60541-X; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; Hombach-Klonisch S, 2005, J MOL ENDOCRINOL, V34, P517, DOI 10.1677/jme.1.01550; Horne AW, 2008, J CLIN ENDOCR METAB, V93, P2375, DOI 10.1210/jc.2008-0136; Horne AW, 2009, MOL HUM REPROD, V15, P287, DOI 10.1093/molehr/gap019; Hrzenjak A, 2004, J PATHOL, V204, P19, DOI 10.1002/path.1616; Huang J, 2010, J CLIN INVEST, V120, P223, DOI 10.1172/JCI38012; Ibiza S, 2009, AM J PHYSIOL-CELL PH, V297, pC1588, DOI 10.1152/ajpcell.00082.2009; Jiang Y, 2006, J BIOL CHEM, V281, P9058, DOI 10.1074/jbc.M507874200; Kalma Y, 2009, FERTIL STERIL, V91, P1042, DOI 10.1016/j.fertnstert.2008.01.043; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; KING A, 1990, AM J OBSTET GYNECOL, V162, P308, DOI 10.1016/0002-9378(90)90375-H; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Knoeller S, 2003, AM J REPROD IMMUNOL, V50, P41, DOI 10.1034/j.1600-0897.2003.00046.x; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Liu YA, 2010, HUM REPROD, V25, P479, DOI 10.1093/humrep/dep429; Loke YW, 1995, HUM REPROD, V10, P14, DOI 10.1093/humrep/10.suppl_2.14; Mannik J, 2010, J CLIN ENDOCR METAB, V95, P2433, DOI 10.1210/jc.2010-0023; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Marx L, 1999, AM J REPROD IMMUNOL, V41, P34; MENZIES FM, 2010, HUM REPROD UPDATE; PAIDAS MJ, 2010, AM J OBSTET GYNECOL, V459, pE1; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sarno J, 2009, MOL HUM REPROD, V15, P451, DOI 10.1093/molehr/gap030; Savaris RF, 2008, REPROD SCI, V15, P797, DOI 10.1177/1933719108317585; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sherwin JRA, 2007, ENDOCRINOLOGY, V148, P618, DOI 10.1210/en.2006-0832; SMITH NL, 2010, BLOOD; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; SONG C, 2011, REPROD DOMEST ANIM; STRICKLAND S, 1992, CELL, V71, P355, DOI 10.1016/0092-8674(92)90503-5; Troadec MB, 2009, DEV CELL, V16, P3, DOI 10.1016/j.devcel.2008.12.013; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; von Rango U, 2001, FERTIL STERIL, V76, P116, DOI 10.1016/S0015-0282(01)01859-3	53	30	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23595	10.1371/journal.pone.0023595	http://dx.doi.org/10.1371/journal.pone.0023595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858178	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300067
J	Hoffmann, LS; Schmidt, PM; Keim, Y; Hoffmann, C; Schmidt, HHHW; Stasch, JP				Hoffmann, Linda S.; Schmidt, Peter M.; Keim, Yvonne; Hoffmann, Carsten; Schmidt, Harald H. H. W.; Stasch, Johannes-Peter			Fluorescence Dequenching Makes Haem-Free Soluble Guanylate Cyclase Detectable in Living Cells	PLOS ONE			English	Article							NITRIC-OXIDE; DOWN-REGULATION; PROTEIN; NO; ACTIVATION; IDENTIFICATION; CGMP; STABILIZATION; STIMULATORS; DYSFUNCTION	In cardiovascular disease, the protective NO/sGC/cGMP signalling-pathway is impaired due to a decreased pool of NO-sensitive haem-containing sGC accompanied by a reciprocal increase in NO-insensitive haem-free sGC. However, no direct method to detect cellular haem-free sGC other than its activation by the new therapeutic class of haem mimetics, such as BAY 58-2667, is available. Here we show that fluorescence dequenching, based on the interaction of the optical active prosthetic haem group and the attached biarsenical fluorophor FlAsH can be used to detect changes in cellular sGC haem status. The partly overlap of the emission spectrum of haem and FlAsH allows energy transfer from the fluorophore to the haem which reduces the intensity of FlAsH fluorescence. Loss of the prosthetic group, e. g. by oxidative stress or by replacement with the haem mimetic BAY 58-2667, prevented the energy transfer resulting in increased fluorescence. Haem loss was corroborated by an observed decrease in NO-induced sGC activity, reduced sGC protein levels, and an increased effect of BAY 58-2667. The use of a haem-free sGC mutant and a biarsenical dye that was not quenched by haem as controls further validated that the increase in fluorescence was due to the loss of the prosthetic haem group. The present approach is based on the cellular expression of an engineered sGC variant limiting is applicability to recombinant expression systems. Nevertheless, it allows to monitor sGC's redox regulation in living cells and future enhancements might be able to extend this approach to in vivo conditions.	[Hoffmann, Linda S.; Keim, Yvonne; Stasch, Johannes-Peter] Bayer HealthCare, Pharma Res Ctr, Wuppertal, Germany; [Schmidt, Peter M.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia; [Hoffmann, Carsten] Univ Wurzburg, Sch Pharmacol & Toxicol, Wurzburg, Germany; [Schmidt, Harald H. H. W.] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Sch Pharm, Halle, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Wurzburg; Maastricht University; Martin Luther University Halle Wittenberg	Hoffmann, LS (corresponding author), Univ Sydney, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia.	johannes-peter.stasch@bayer.com	Schmidt, Harald HHW/B-1549-2008; Schmidt, Peter/V-3882-2019	Schmidt, Harald HHW/0000-0003-0419-5549; Schmidt, Peter/0000-0003-1340-9086				Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; Chirkov YY, 2007, PHARMACOL THERAPEUT, V116, P287, DOI 10.1016/j.pharmthera.2007.06.012; Davydov DR, 2008, BIOCHEMISTRY-US, V47, P11348, DOI 10.1021/bi8011803; Estevez JM, 2006, BIOTECHNIQUES, V41, P569, DOI 10.2144/000112264; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; FRITZ BG, 2011, BIOCHEMISTRY; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HOBBS AJ, 2009, NITRIC OXIDE BIOL PA, P301; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Kagota S, 2001, BRIT J PHARMACOL, V134, P737, DOI 10.1038/sj.bjp.0704300; Kosarikov DN, 2001, J INORG BIOCHEM, V87, P267, DOI 10.1016/S0162-0134(01)00387-7; Kuznetsova S, 2006, ANAL BIOCHEM, V350, P52, DOI 10.1016/j.ab.2005.11.036; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu RC, 2006, J AM CHEM SOC, V128, P10034, DOI 10.1021/ja057005m; Lucas KA, 2000, PHARMACOL REV, V52, P375; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Nikolaev Viacheslav O., 2009, V191, P229, DOI 10.1007/978-3-540-68964-5_11; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Straub A, 2002, BIOORGAN MED CHEM, V10, P1711, DOI 10.1016/S0968-0896(02)00034-2; Takeda S, 2001, BIOCHEM BIOPH RES CO, V289, P299, DOI 10.1006/bbrc.2001.5966; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Wunder F, 2005, ANAL BIOCHEM, V339, P104, DOI 10.1016/j.ab.2004.12.025; Yantsevich AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P77, DOI 10.1134/S0006297907010099; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	48	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23596	10.1371/journal.pone.0023596	http://dx.doi.org/10.1371/journal.pone.0023596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858179	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300068
J	Krobath, H; Rozycki, B; Lipowsky, R; Weikl, TR				Krobath, Heinrich; Rozycki, Bartosz; Lipowsky, Reinhard; Weikl, Thomas R.			Line Tension and Stability of Domains in Cell-Adhesion Zones Mediated by Long and Short Receptor-Ligand Complexes	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; PATTERN-FORMATION; TCR-CD28 MICROCLUSTERS; MEMBRANE ADHESION; HYBRID LIPIDS; T-CELLS; ACTIVATION; COSTIMULATION; TRANSLOCATION; RECOGNITION	Submicron scale domains of membrane-anchored receptors play an important role in cell signaling. Central questions concern the stability of these microdomains, and the mechanisms leading to the domain formation. In immune-cell adhesion zones, microdomains of short receptor-ligand complexes form next to domains of significantly longer receptor-ligand complexes. The length mismatch between the receptor-ligand complexes leads to membrane deformations and has been suggested as a possible cause of the domain formation. The domain formation is a nucleation and growth process that depends on the line tension and free energy of the domains. Using a combination of analytical calculations and Monte Carlo simulations, we derive here general expressions for the line tension between domains of long and short receptor-ligand complexes and for the adhesion free energy of the domains. We argue that the length mismatch of receptor-ligand complexes alone is sufficient to drive the domain formation, and obtain submicron-scale minimum sizes for stable domains that are consistent with the domain sizes observed during immune-cell adhesion.	[Krobath, Heinrich; Rozycki, Bartosz; Lipowsky, Reinhard; Weikl, Thomas R.] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society	Krobath, H (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	thomas.weikl@mpikg.mpg.de	Weikl, Thomas/G-8572-2016; Rozycki, Bartosz/B-7005-2009	Weikl, Thomas/0000-0002-0911-5328; Rozycki, Bartosz/0000-0001-5938-7308; Lipowsky, Reinhard/0000-0001-8417-8567; Krobath, Heinrich/0000-0001-6473-8109	interdisciplinary network of excellence "Synthetic Bioactive Surfaces" of the Fraunhofer Society; Max Planck Society	interdisciplinary network of excellence "Synthetic Bioactive Surfaces" of the Fraunhofer Society; Max Planck Society(Max Planck Society)	This work was supported by the interdisciplinary network of excellence "Synthetic Bioactive Surfaces" of the Fraunhofer Society and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann A, 1996, J PHYS II, V6, P255, DOI 10.1051/jp2:1996108; Asfaw M, 2006, EUROPHYS LETT, V76, P703, DOI 10.1209/epl/i2006-10317-0; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Binder K, 2002, MONTE CARLO SIMULATI; Brewster R, 2009, BIOPHYS J, V97, P1087, DOI 10.1016/j.bpj.2009.05.051; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Choudhuri K, 2010, FEBS LETT, V584, P4823, DOI 10.1016/j.febslet.2010.10.015; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Figge MT, 2006, PLOS COMPUT BIOL, V2, P1377, DOI 10.1371/journal.pcbi.0020171; Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gutlederer E, 2009, SOFT MATTER, V5, P3303, DOI 10.1039/b902388g; Heinrich MC, 2008, J PHYS CHEM B, V112, P8063, DOI 10.1021/jp7116246; Hu JL, 2011, SOFT MATTER, V7, P6092, DOI 10.1039/c0sm01500h; JULICHER L, 1993, PHYS REV LETT, V70, P2964; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Krobath H, 2009, SOFT MATTER, V5, P3354, DOI 10.1039/b902036e; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; LIPOWSKY R, 1992, J PHYS II, V2, P1825, DOI 10.1051/jp2:1992238; Lipowsky R, 1996, PHYS REV LETT, V77, P1652, DOI 10.1103/PhysRevLett.77.1652; LIPOWSKY R, 1994, J PHYS II, V4, P1755, DOI 10.1051/jp2:1994230; Milstein O, 2008, J BIOL CHEM, V283, P34414, DOI 10.1074/jbc.M804756200; Molnar E, 2010, FEBS LETT, V584, P4832, DOI 10.1016/j.febslet.2010.09.004; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Raychaudhuri S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208101; Rozycki B, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/095003; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Semrau S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.088101; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Weikl TR, 2006, ADV PLANAR LIP BILAY, V5, P63, DOI 10.1016/S1554-4516(06)05004-6; Weikl TR, 2009, SOFT MATTER, V5, P3213, DOI 10.1039/b902017a; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Weikl TR, 2002, EUROPHYS LETT, V59, P916, DOI 10.1209/epl/i2002-00130-3; Weikl TR, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011903; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yamamoto T, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/28002; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x	51	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23284	10.1371/journal.pone.0023284	http://dx.doi.org/10.1371/journal.pone.0023284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858057	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300028
J	Little, DP				Little, Damon P.			DNA Barcode Sequence Identification Incorporating Taxonomic Hierarchy and within Taxon Variability	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; PLASTID MATK; SENSU-LATO; LAND PLANTS; RBCL; NUCLEAR; EVOLUTION; CHLOROPLAST; GENUS; BIOGEOGRAPHY	For DNA barcoding to succeed as a scientific endeavor an accurate and expeditious query sequence identification method is needed. Although a global multiple-sequence alignment can be generated for some barcoding markers (e. g. COI, rbcL), not all barcoding markers are as structurally conserved (e. g. matK). Thus, algorithms that depend on global multiple-sequence alignments are not universally applicable. Some sequence identification methods that use local pairwise alignments (e. g. BLAST) are unable to accurately differentiate between highly similar sequences and are not designed to cope with hierarchic phylogenetic relationships or within taxon variability. Here, I present a novel alignment-free sequence identification algorithm-BRONX-that accounts for observed within taxon variability and hierarchic relationships among taxa. BRONX identifies short variable segments and corresponding invariant flanking regions in reference sequences. These flanking regions are used to score variable regions in the query sequence without the production of a global multiple-sequence alignment. By incorporating observed within taxon variability into the scoring procedure, misidentifications arising from shared alleles/haplotypes are minimized. An explicit treatment of more inclusive terminals allows for separate identifications to be made for each taxonomic level and/or for user-defined terminals. BRONX performs better than all other methods when there is imperfect overlap between query and reference sequences (e. g. mini-barcode queries against a full-length barcode database). BRONX consistently produced better identifications at the genus-level for all query types.	New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA	New York Botanical Garden	Little, DP (corresponding author), New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA.	dlittle@nybg.org			Consortium for the Barcode of Life; Alfred P. Sloan Foundation; DIMACS	Consortium for the Barcode of Life(Smithsonian InstitutionSmithsonian National Museum of Natural History); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); DIMACS	The author received support from the Consortium for the Barcode of Life (travel grants; http://www.barcodeoflife.org/), Alfred P. Sloan Foundation (http://www.sloan.org/), and DIMACS (travel grants; http://dimacs.rutgers.edu/). There are no relevant grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson L, 2005, TAXON, V54, P17, DOI 10.2307/25065299; Andersson L, 2006, TAXON, V55, P270, DOI 10.2307/25065577; [Anonymous], 2007, NCBI BLAST COMPUTER; [Anonymous], 2009, MYSQL COMPUTER PROGR; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; BARTLETT SE, 1992, BIOTECHNIQUES, V12, P408; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Cabrera LI, 2008, AM J BOT, V95, P1153, DOI 10.3732/ajb.0800073; Cameron KM, 2001, AM J BOT, V88, P1847, DOI 10.2307/3558361; Chandler GT, 2004, BOT J LINN SOC, V144, P123, DOI 10.1111/j.1095-8339.2003.00247.x; CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037/0033-2909.88.2.322; Crisp Michael D., 1996, Telopea, V6, P813; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; Dasgupta Bhaskar, 2005, Int J Bioinform Res Appl, V1, P145, DOI 10.1504/IJBRA.2005.007574; Der JP, 2008, SYST BOT, V33, P107, DOI 10.1600/036364408783887438; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Drabkova L, 2007, TAXON, V56, P95, DOI 10.2307/25065739; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson DL, 2008, TAXON, V57, P1304, DOI 10.1002/tax.574020; Farris J.S., 1983, Advances in Cladistics, V2, P7; FARRIS JS, 1979, SYST ZOOL, V28, P483, DOI 10.2307/2412562; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Gamer M, 2010, IRR PACKAGE VERSION; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gish W, 2006, WU BLAST COMPUTER PR; Goldblatt P, 2008, SYST BOT, V33, P495, DOI 10.1600/036364408785679806; Goldman DH, 2001, SYST BOT, V26, P670; Goloboff PA, 1996, CLADISTICS, V12, P199, DOI 10.1111/j.1096-0031.1996.tb00009.x; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Hao DC, 2008, PLANT SYST EVOL, V276, P89, DOI 10.1007/s00606-008-0069-0; Harrell Jr. FE, 2010, HMISC PACKAGE VERSIO; Harrington MG, 2005, SYST BOT, V30, P366, DOI 10.1600/0363644054223549; Hayashi K, 1998, PLANT SPEC BIOL, V13, P129; Hayashi Kazuhiko, 2001, Plant Species Biology, V16, P119, DOI 10.1046/j.1442-1984.2001.00057.x; Hayashi Kazuhiko, 2000, Plant Species Biology, V15, P73, DOI 10.1046/j.1442-1984.2000.00025.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Kato M, 2003, AUST SYST BOT, V16, P177, DOI 10.1071/SB02020; Kita Y, 2004, J BIOGEOGR, V31, P1605, DOI 10.1111/j.1365-2699.2004.01047.x; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kocyan A, 2007, MOL PHYLOGENET EVOL, V44, P553, DOI 10.1016/j.ympev.2006.12.022; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Les DH, 2002, SYST BOT, V27, P221; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Little DP, 2006, SYST BOT, V31, P461, DOI 10.1600/036364406778388638; Lopez GG, 2002, INT J PLANT SCI, V163, P737, DOI 10.1086/342213; Malecot V, 2008, SYST BOT, V33, P97, DOI 10.1600/036364408783887384; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; McNeal JR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-55; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Muellner AN, 2003, AM J BOT, V90, P471, DOI 10.3732/ajb.90.3.471; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nakazawa M, 1997, J PLANT RES, V110, P265, DOI 10.1007/BF02509315; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nyffeler R, 2005, ORG DIVERS EVOL, V5, P109, DOI 10.1016/j.ode.2004.08.001; Ohi-Toma T, 2006, SYST BOT, V31, P481, DOI 10.1600/036364406778388656; Osaloo Shahrokh Kazempour, 1999, Plant Species Biology, V14, P75, DOI 10.1046/j.1442-1984.1999.00009.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Petersen G, 2002, AUST SYST BOT, V15, P181, DOI 10.1071/SB01007; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; Plunkett GM, 1997, AM J BOT, V84, P565, DOI 10.2307/2446032; R Development Core Team, 2007, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Renner SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-58; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salazar GA, 2003, AM J BOT, V90, P777, DOI 10.3732/ajb.90.5.777; Sanchez A, 2008, SYST BOT, V33, P87, DOI 10.1600/036364408783887456; Sarkar IN, 2002, J BIOMED INFORM, V35, P111, DOI 10.1016/S1532-0464(02)00504-X; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; SAVIR D, 1975, IBM SYST J, V14, P16, DOI 10.1147/sj.141.0016; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sogo A, 2001, J PLANT RES, V114, P459, DOI 10.1007/PL00014011; Soltis DE, 2001, ANN MO BOT GARD, V88, P669, DOI 10.2307/3298639; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Su YCF, 2008, MOL PHYLOGENET EVOL, V48, P188, DOI 10.1016/j.ympev.2008.03.028; Tamura MN, 2004, J PLANT RES, V117, P109, DOI 10.1007/s10265-003-0133-3; Tanaka N, 1997, J PLANT RES, V110, P329, DOI 10.1007/BF02524931; Tippery NP, 2008, SYST BOT, V33, P598, DOI 10.1600/036364408785679851; Tokuoka T, 2008, J PLANT RES, V121, P253, DOI 10.1007/s10265-008-0153-0; Treutlein J, 2003, TAXON, V52, P193, DOI 10.2307/3647389; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Vidal-Russell R, 2008, MOL PHYLOGENET EVOL, V47, P523, DOI 10.1016/j.ympev.2008.01.016; Wagstaff SJ, 2004, J BIOGEOGR, V31, P1569, DOI 10.1111/j.1365-2699.2004.01066.x; Walter KS, 1998, 1997 IUCN RED LIST T; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; Wilkin P, 2005, SYST BOT, V30, P736, DOI 10.1600/036364405775097879; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Yokoyama J, 2000, MOL PHYLOGENET EVOL, V14, P11, DOI 10.1006/mpev.1999.0672; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang LB, 2006, MOL PHYLOGENET EVOL, V39, P305, DOI 10.1016/j.ympev.2005.10.002; Zhang LB, 2006, SYST BOT, V31, P122, DOI 10.1600/036364406775971778	115	48	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e20552	10.1371/journal.pone.0020552	http://dx.doi.org/10.1371/journal.pone.0020552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857897	gold, Green Published, Green Submitted			2022-12-25	WOS:000294125500003
J	Hirakawa, Y; Howe, A; James, ER; Keeling, PJ				Hirakawa, Yoshihisa; Howe, Alexis; James, Erick R.; Keeling, Patrick J.			Morphological Diversity between Culture Strains of a Chlorarachniophyte, Lotharella globosa	PLOS ONE			English	Article							SP-NOV CHLORARACHNIOPHYTA; NUCLEOMORPH; GEN.; CHLOROPLAST	Chlorarachniophytes are marine unicellular algae that possess secondary plastids of green algal origin. Although chlorarachniophytes are a small group (the phylum of Chlorarachniophyta contains 14 species in 8 genera), they have variable and complex life cycles that include amoeboid, coccoid, and/or flagellate cells. The majority of chlorarachniophytes possess two or more cell types in their life cycles, and which cell types are found is one of the principle morphological criteria used for species descriptions. Here we describe an unidentified chlorarachniophyte that was isolated from an artificial coral reef that calls this criterion into question. The life cycle of the new strain includes all three major cell types, but DNA barcoding based on the established nucleomorph ITS sequences showed it to share 100% sequence identity with Lotharella globosa. The type strain of L. globosa was also isolated from a coral reef, but is defined as completely lacking an amoeboid stage throughout its life cycle. We conclude that L. globosa possesses morphological diversity between culture strains, and that the new strain is a variety of L. globosa, which we describe as Lotharella globosa var. fortis var. nov. to include the amoeboid stage in the formal description of L. globosa. This intraspecies variation suggest that gross morphological stages maybe lost rather rapidly, and specifically that the type strain of L. globosa has lost the ability to form the amoeboid stage, perhaps recently. This in turn suggests that even major morphological characters used for taxonomy of this group may be variable in natural populations, and therefore misleading.	[Hirakawa, Yoshihisa] Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada; Univ British Columbia, Dept Bot, Vancouver, BC, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of British Columbia	Hirakawa, Y (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC, Canada.	pkeeling@mail.ubc.ca	Hirakawa, Yoshihisa/A-6119-2012; James, Erick R/D-4725-2012	Hirakawa, Yoshihisa/0000-0002-3780-354X; Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council of Canada [227301]; Tula Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tula Foundation	This work was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (227301), and by a grant to the Centre for Microbial Diversity and Evolution from the Tula Foundation. PJK is a Fellow of the Canadian Institute for Advanced Research and a Senior Scholar of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dietz C, 2003, PHYCOLOGIA, V42, P582, DOI 10.2216/i0031-8884-42-6-582.1; Gile GH, 2010, J PHYCOL, V46, P743, DOI 10.1111/j.1529-8817.2010.00851.x; Gilson PR, 2006, P NATL ACAD SCI USA, V103, P9566, DOI 10.1073/pnas.0600707103; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; Ishida K, 1999, MOL BIOL EVOL, V16, P321, DOI 10.1093/oxfordjournals.molbev.a026113; ISHIDA K, 1994, PHYCOLOGIA, V33, P351, DOI 10.2216/i0031-8884-33-5-351.1; Ishida K, 2011, PHYCOL RES, V59, P52, DOI 10.1111/j.1440-1835.2010.00597.x; Ishida Ken-Ichiro, 1996, Phycological Research, V44, P37, DOI 10.1111/j.1440-1835.1996.tb00036.x; Ishida Ken-ichiro, 2000, Phycological Research, V48, P221, DOI 10.1111/j.1440-1835.2000.tb00218.x; Kasai K, 2009, JPN J PHYCOL SOSUI, V57, P220; MCFADDEN GI, 1994, P NATL ACAD SCI USA, V91, P3690, DOI 10.1073/pnas.91.9.3690; Ota S, 2005, PHYCOL RES, V53, P275, DOI 10.1111/j.1440-183.2005.00395.x; OTA S, 2011, PROTIST IN PRESS; Ota S, 2007, J PLANT RES, V120, P661, DOI 10.1007/s10265-007-0115-y; Ota S, 2007, J PHYCOL, V43, P333, DOI 10.1111/j.1529-8817.2007.00316.x; Ota S, 2009, PHYCOLOGIA, V48, P315, DOI 10.2216/09-02.1; Ota S, 2009, PROTIST, V160, P137, DOI 10.1016/j.protis.2008.09.003; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129	18	5	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23193	10.1371/journal.pone.0023193	http://dx.doi.org/10.1371/journal.pone.0023193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858028	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953700007
J	Fahim, AT; Bowne, SJ; Sullivan, LS; Webb, KD; Williams, JT; Wheaton, DK; Birch, DG; Daiger, SP				Fahim, Abigail T.; Bowne, Sara J.; Sullivan, Lori S.; Webb, Kaylie D.; Williams, Jessica T.; Wheaton, Dianna K.; Birch, David G.; Daiger, Stephen P.			Allelic Heterogeneity and Genetic Modifier Loci Contribute to Clinical Variation in Males with X-Linked Retinitis Pigmentosa Due to RPGR Mutations	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; LEBER CONGENITAL AMAUROSIS; JOUBERT-SYNDROME; CENTROSOMAL PROTEIN; RETINAL DEGENERATION; MISSENSE MUTATION; VISUAL FUNCTION; MECKEL-SYNDROME; EXON ORF15; FAMILIES	Mutations in RPGR account for over 70% of X-linked retinitis pigmentosa (XlRP), characterized by retinal degeneration and eventual blindness. The clinical consequences of RPGR mutations are highly varied, even among individuals with the same mutation: males demonstrate a wide range of clinical severity, and female carriers may or may not be affected. This study describes the phenotypic diversity in a cohort of 98 affected males from 56 families with RPGR mutations, and demonstrates the contribution of genetic factors (i.e., allelic heterogeneity and genetic modifiers) to this diversity. Patients were categorized as grade 1 (mild), 2 (moderate) or 3 (severe) according to specific clinical criteria. Patient DNAs were genotyped for coding SNPs in 4 candidate modifier genes with products known to interact with RPGR protein: RPGRIP1, RPGRIP1L, CEP290, and IQCB1. Family-based association testing was performed using PLINK. A wide range of clinical severity was observed both between and within families. Patients with mutations in exons 1-14 were more severely affected than those with ORF15 mutations, and patients with predicted null alleles were more severely affected than those predicted to make RPGR protein. Two SNPs showed association with severe disease: the minor allele (N) of I393N in IQCB1 (p = 0.044) and the common allele (R) of R744Q in RPGRIP1L (p = 0.049). These data demonstrate that allelic heterogeneity contributes to phenotypic diversity in XlRP and suggest that this may depend on the presence or absence of RPGR protein. In addition, common variants in 2 proteins known to interact with RPGR are associated with severe disease in this cohort.	[Fahim, Abigail T.; Bowne, Sara J.; Sullivan, Lori S.; Williams, Jessica T.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Webb, Kaylie D.; Wheaton, Dianna K.; Birch, David G.] Retina Fdn SW, Dallas, TX USA; [Wheaton, Dianna K.; Birch, David G.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Retina Foundation of the Southwest; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fahim, AT (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA.	stephen.p.daiger@uth.tmc.edu		Fahim, Abigail/0000-0001-9737-054X; Jones, Kaylie/0000-0003-2818-5097; Birch, David/0000-0002-6594-2897	Foundation Fighting Blindness; Nuclear Energy Institute/National Institutes of Health [EY007142]; NATIONAL EYE INSTITUTE [R01EY007142] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); Nuclear Energy Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the Foundation Fighting Blindness (www.blindness.org) and grant EY007142 from the Nuclear Energy Institute/National Institutes of Health (www.nei.org) to SPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Bader I, 2003, INVEST OPHTH VIS SCI, V44, P1458, DOI 10.1167/iovs.02-0605; Banin E, 2007, AM J MED GENET A, V143A, P1150, DOI 10.1002/ajmg.a.31642; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Berson EL, 2007, EXP EYE RES, V85, P7, DOI 10.1016/j.exer.2007.03.001; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; Brancati F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Demirci FYK, 2004, AM J OPHTHALMOL, V138, P504, DOI 10.1016/j.ajo.2004.04.019; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Ebenezer ND, 2005, INVEST OPHTH VIS SCI, V46, P1891, DOI 10.1167/iovs.04-1482; Ferreira PA, 2005, HUM MOL GENET, V14, pR259, DOI 10.1093/hmg/ddi272; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Grover S, 2000, OPHTHALMOLOGY, V107, P386, DOI 10.1016/S0161-6420(99)00045-7; Guevara-Fujita M, 2001, Hum Mutat, V17, P151, DOI 10.1002/1098-1004(200102)17:2<151::AID-HUMU7>3.3.CO;2-N; Guo DC, 2003, BIOTECHNOL LETT, V25, P2079, DOI 10.1023/B:BILE.0000007075.24434.5e; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; He S, 2008, VISION RES, V48, P366, DOI 10.1016/j.visres.2007.08.005; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2004, INVEST OPHTH VIS SCI, V45, P36, DOI 10.1167/iovs.03-0787; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; KEITH CG, 1991, OPHTHALMIC PAED GEN, V12, P91, DOI 10.3109/13816819109023680; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kirschner R, 1999, HUM MOL GENET, V8, P1571, DOI 10.1093/hmg/8.8.1571; Koenekoop RK, 2003, AM J OPHTHALMOL, V136, P678, DOI 10.1016/S0002-9394(03)00331-3; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Mavlyutov TA, 2002, HUM MOL GENET, V11, P1899, DOI 10.1093/hmg/11.16.1899; Neidhardt J, 2007, HUM MUTAT, V28, P797, DOI 10.1002/humu.20521; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schmid F, 2010, INVEST OPHTH VIS SCI, V51, P1628, DOI 10.1167/iovs.09-4031; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Shimmin LC, 2007, DNA SEQUENCE, V18, P432, DOI 10.1080/10425170701388719; Souied E, 1997, J MED GENET, V34, P793, DOI 10.1136/jmg.34.10.793; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Walia S, 2008, ARCH OPHTHALMOL-CHIC, V126, P379, DOI 10.1001/archophthalmol.2007.72; Wheaton DK, 2007, INVEST OPHTHALMOL VI, V48; Yang ZL, 2002, HUM MOL GENET, V11, P605, DOI 10.1093/hmg/11.5.605; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zito I, 1999, HUM GENET, V105, P57, DOI 10.1007/s004390051064	59	69	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23021	10.1371/journal.pone.0023021	http://dx.doi.org/10.1371/journal.pone.0023021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857984	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500014
J	Groleau, J; Dussault, S; Turgeon, J; Haddad, P; Rivard, A				Groleau, Jessika; Dussault, Sylvie; Turgeon, Julie; Haddad, Paola; Rivard, Alain			Accelerated Vascular Aging in CuZnSOD-Deficient Mice: Impact on EPC Function and Reparative Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CIGARETTE-SMOKE EXPOSURE; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; SOD1-DEFICIENT MICE; SKELETAL-MUSCLE; ANGIOGENESIS; DYSFUNCTION; VASCULOGENESIS; IMPAIRMENT	Objective: Aging is associated with increased oxidative stress levels and impaired neovascularization following ischemia. CuZnSOD has an important role to limit oxidative stress in the vasculature. Here we investigated the role of CuZnSOD for the modulation of ischemia-induced neovascularisation during aging. Methods and Results: Hindlimb ischemia was surgically induced in young (2-month-old) or older (8-month-old) wild type (WT) and CuZnSOD-/- mice. We found that blood flow recovery after ischemia and vascular density in ischemic muscles were significantly reduced in older compared to young WT mice. Both in young and older mice, CuZnSOD deficiency led to a further reduction of neovascularization. Accordingly, the resulting neovascularisation potential in a young CuZnSOD-/- mouse was similar to that of an older WT mouse. Oxidative stress levels were also increased to similar levels in the ischemic muscles of young CuZnSOD-/- and older WT mice. To identify potential mechanisms involved, we investigated the effect of aging and CuZnSOD deficiency on the number and the function of endothelial progenitor cells (EPCs). Both aging and CuZnSOD deficiency were associated with reduced number of bone marrow and peripheral EPCs. The effect of moderate aging alone on specific functional activities of EPCs (migration, integration into tubules) was modest. However, CuZnSOD deficiency was associated with severe age-dependent defects in EPC functional activities. Conclusions: CuZnSOD deficiency is associated with accelerated vascular aging and impaired ischemia-induced neovascularization. Our results suggest that in the context of aging, CuZnSOD has an essential role to protect against excessive oxidative stress in ischemic tissues and preserve the function of EPCs.	[Groleau, Jessika; Dussault, Sylvie; Turgeon, Julie; Haddad, Paola; Rivard, Alain] Ctr Hosp Univ Montreal, Dept Cardiovasc Res, Montreal, PQ, Canada	Universite de Montreal	Groleau, J (corresponding author), Ctr Hosp Univ Montreal, Dept Cardiovasc Res, Montreal, PQ, Canada.	rivardal@total.net			Canadian Institute of Health Research (CIHR) [74687]; Heart and Stroke Foundation of Canada	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was supported by grants from the Canadian Institute of Health Research (CIHR#74687) and The Heart and Stroke Foundation of Canada to Alain Rivard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AR is a scholar from the Fonds de Recherche en Sante du Quebec (FRSQ). JG is a doctoral research awardee from the CIHR. PH is a doctoral research awardee from the Heart and Stroke Foundation of Canada. JT is a doctoral research awardee from the FRSQ.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asimakis GK, 2002, CIRCULATION, V105, P981, DOI 10.1161/hc0802.104502; Colak E, 2005, ANN MED, V37, P613, DOI 10.1080/07853890500330193; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Didion SP, 2006, HYPERTENSION, V48, P1072, DOI 10.1161/01.HYP.0000247302.20559.3a; Didion SP, 2002, CIRC RES, V91, P938, DOI 10.1161/01.RES.0000043280.65241.04; Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Edelberg JM, 2002, CIRCULATION, V105, P608, DOI 10.1161/hc0502.103672; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Groleau J, 2010, ARTERIOSCL THROM VAS, V30, P2173, DOI 10.1161/ATVBAHA.110.212530; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hodgkinson AD, 2003, DIABETES, V52, P846, DOI 10.2337/diabetes.52.3.846; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; McFadden SL, 1999, J COMP NEUROL, V413, P101; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Michaud SE, 2006, J MOL CELL CARDIOL, V41, P275, DOI 10.1016/j.yjmcc.2006.05.004; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023	32	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23308	10.1371/journal.pone.0023308	http://dx.doi.org/10.1371/journal.pone.0023308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858065	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500029
J	Kong, XD; Stephens, J; Ball, AR; Heale, JT; Newkirk, DA; Berns, MW; Yokomori, K				Kong, Xiangduo; Stephens, Jared; Ball, Alexander R., Jr.; Heale, Jason T.; Newkirk, Daniel A.; Berns, Michael W.; Yokomori, Kyoko			Condensin I Recruitment to Base Damage-Enriched DNA Lesions Is Modulated by PARP1	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; STRAND BREAK REPAIR; MAMMALIAN-CELLS; CHROMOSOME CONDENSATION; VERTEBRATE CELLS; COMPLEX; ACTIVATION; RESPONSES; SITES	Condensin I is important for chromosome organization and segregation in mitosis. We previously showed that condensin I also interacts with PARP1 in response to DNA damage and plays a role in single-strand break repair. However, whether condensin I physically associates with DNA damage sites and how PARP1 may contribute to this process were unclear. We found that condensin I is preferentially recruited to DNA damage sites enriched for base damage. This process is dictated by PARP1 through its interaction with the chromosome-targeting domain of the hCAP-D2 subunit of condensin I.	[Kong, Xiangduo; Ball, Alexander R., Jr.; Heale, Jason T.; Newkirk, Daniel A.; Yokomori, Kyoko] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92717 USA; [Stephens, Jared; Berns, Michael W.] Univ Calif Irvine, Dept Dev & Cell Biol, Beckman Laser Inst, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Kong, XD (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92717 USA.	kyokomor@uci.edu		Berns, Michael/0000-0002-9640-2885	NIH [RR01192, ES013511]; Air Force Office of Scientific Research [FA9550-04-1-0101]; Beckman Laser Institute Inc. Foundation; CA100710; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203, R01CA100710] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013511] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Beckman Laser Institute Inc. Foundation; CA100710; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the NIH Laser Microbeam and Medical Program (RR01192), the Air Force Office of Scientific Research (FA9550-04-1-0101) and Beckman Laser Institute Inc. Foundation to M.W.B., and NIH ES013511 and CA100710 to K.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ball AR, 2011, CURR OPIN CELL BIOL, V23, P277, DOI 10.1016/j.ceb.2011.03.012; Ball AR, 2002, MOL CELL BIOL, V22, P5769, DOI 10.1128/MCB.22.16.5769-5781.2002; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009	26	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23548	10.1371/journal.pone.0023548	http://dx.doi.org/10.1371/journal.pone.0023548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858164	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953500054
J	Taymans, JM; Vancraenenbroeck, R; Ollikainen, P; Beilina, A; Lobbestael, E; De Maeyer, M; Baekelandt, V; Cookson, MR				Taymans, Jean-Marc; Vancraenenbroeck, Renee; Ollikainen, Petri; Beilina, Alexandra; Lobbestael, Evy; De Maeyer, Marc; Baekelandt, Veerle; Cookson, Mark R.			LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; DOMINANT PARKINSONISM; ROC DOMAIN; PHOSPHORYLATES; PROTEIN; LEUCINE-RICH-REPEAT-KINASE-2; INHIBITION; DIMER; GENE	Leucine rich repeat kinase 2 (LRRK2) is a Parkinson's disease (PD) gene that encodes a large multidomain protein including both a GTPase and a kinase domain. GTPases often regulate kinases within signal transduction cascades, where GTPases act as molecular switches cycling between a GTP bound "on'' state and a GDP bound "off'' state. It has been proposed that LRRK2 kinase activity may be increased upon GTP binding at the LRRK2 Ras of complex proteins (ROC) GTPase domain. Here we extensively test this hypothesis by measuring LRRK2 phosphorylation activity under influence of GDP, GTP or nonhydrolyzable GTP analogues GTP gamma S or GMPPCP. We show that autophosphorylation and lrrktide phosphorylation activity of recombinant LRRK2 protein is unaltered by guanine nucleotides, when co-incubated with LRRK2 during phosphorylation reactions. Also phosphorylation activity of LRRK2 is unchanged when the LRRK2 guanine nucleotide binding pocket is previously saturated with various nucleotides, in contrast to the greatly reduced activity measured for the guanine nucleotide binding site mutant T1348N. Interestingly, when nucleotides were incubated with cell lysates prior to purification of LRRK2, kinase activity was slightly enhanced by GTP gamma S or GMPPCP compared to GDP, pointing to an upstream guanine nucleotide binding protein that may activate LRRK2 in a GTP-dependent manner. Using metabolic labeling, we also found that cellular phosphorylation of LRRK2 was not significantly modulated by nucleotides, although labeling is significantly reduced by guanine nucleotide binding site mutants. We conclude that while kinase activity of LRRK2 requires an intact ROC-GTPase domain, it is independent of GDP or GTP binding to ROC.	[Taymans, Jean-Marc; Ollikainen, Petri; Lobbestael, Evy; Baekelandt, Veerle] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Louvain, Belgium; [Vancraenenbroeck, Renee; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modeling, B-3001 Heverlee, Belgium; [Beilina, Alexandra; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	KU Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Taymans, JM (corresponding author), Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Louvain, Belgium.	Jean-Marc.Taymans@med.kuleuven.be	Lobbestael, Evy/H-7537-2018; Baekelandt, Veerle/ABB-9736-2020; Taymans, Jean-Marc/M-9175-2018; Cookson, Mark/AAW-2516-2021	Lobbestael, Evy/0000-0002-6417-4670; Baekelandt, Veerle/0000-0001-8966-2921; Taymans, Jean-Marc/0000-0001-5503-5524; Cookson, Mark/0000-0002-1058-3831; Vancraenenbroeck, Renee/0000-0003-2685-2749	NIH, National Institute on Aging; Research Foundation-Flanders (FWO) [G.0406.06, G.0666.09]; agency for Innovation by Science and Technology [SBO 80020]; K.U.Leuven [OT/08/052A, IOF-KP/07/001]; Michael J. Fox Foundation; NATIONAL INSTITUTE ON AGING [ZIAAG000937, ZIAAG000948] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Foundation-Flanders (FWO)(FWO); agency for Innovation by Science and Technology; K.U.Leuven(KU Leuven); Michael J. Fox Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. This work was supported by the Research Foundation-Flanders (FWO Vlaanderen projects G.0406.06, G.0666.09, postdoctoral fellowship to J-MT and doctoral fellowships to RV and EL), the agency for Innovation by Science and Technology (IWT project SBO 80020), the K.U.Leuven OT/08/052A and IOF-KP/07/001 and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Asensio CJA, 2003, ANAL BIOCHEM, V319, P21, DOI 10.1016/S0003-2697(03)00282-3; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Daniels V, 2011, NEUROSIGNALS, V19, P1, DOI 10.1159/000324488; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	37	76	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23207	10.1371/journal.pone.0023207	http://dx.doi.org/10.1371/journal.pone.0023207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858031	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500024
J	Toufeer, M; Bonnefont, CMD; Foulon, E; Caubet, C; Tasca, C; Aurel, MR; Robert-Granie, C; Rupp, R; Foucras, G				Toufeer, Mehdi; Bonnefont, Cecile M. D.; Foulon, Eliane; Caubet, Cecile; Tasca, Christian; Aurel, Marie-Rose; Robert-Granie, Christele; Rupp, Rachel; Foucras, Gilles			Gene Expression Profiling of Dendritic Cells Reveals Important Mechanisms Associated with Predisposition to Staphylococcus Infections	PLOS ONE			English	Article							AUREUS INFECTION; ACTIVATION; DIFFERENTIATION; IMMUNITY; MICE; COMPLEMENT; RESISTANCE; RECEPTORS; MODEL; SUSCEPTIBILITY	Background: Staphylococcus aureus is a major pathogen of humans and animals and emerging antibiotic-resistant strains have further increased the concern of this health issue. Host genetics influence susceptibility to S. aureus infections, and the genes determining the outcome of infections should be identified to find alternative therapies to treatment with antibiotics. Here, we used outbred animals from a divergent selection based on susceptibility towards Staphylococcus infection to explore host immunogenetics. Methodology/Principal Findings: We investigated how dendritic cells respond to heat-inactivated S. aureus and whether dendritic cells from animals showing different degrees of susceptibility had distinct gene expression profiles. We measured gene expression levels of in vitro S. aureus-stimulated bone marrow-derived dendritic cells at three different time points (0, 3 and 8 hrs) by using 15 k ovine Agilent microarrays. Furthermore, differential expression of a selected number of genes was confirmed by RT-qPCR. Gene signatures of stimulated DCs were obtained and showed that genes involved in the inflammatory process and T helper cell polarization were highly up-regulated upon stimulation. Moreover, a set of 204 genes were statistically differentially expressed between susceptible and resistant animals, and grouped them according to their predisposition to staphylococcal infection. Interestingly, over-expression of the C1q and Ido1 genes was observed in the resistant line and suggested a role of classical pathway of complement and early regulation of inflammation pathways, respectively. On the contrary, over expression of genes involved in the IL1R pathway was observed in susceptible animals. Furthermore, the leucocyte extravasation pathway was also found to be dominant in the susceptible line. Conclusion/Significance: We successfully obtained Staphylococcus aureus associated gene expression of ovine BM-DC in an 8-hour kinetics experiment. The distinct transcriptional profiles of dendritic cells obtained from resistant and susceptible animals may explain susceptibility towards S. aureus infections in a broader context.	[Toufeer, Mehdi; Bonnefont, Cecile M. D.; Foulon, Eliane; Caubet, Cecile; Tasca, Christian; Foucras, Gilles] Univ Toulouse, ENVT, INP, IHAP,UMR 1225, Toulouse, France; [Toufeer, Mehdi; Bonnefont, Cecile M. D.; Foulon, Eliane; Caubet, Cecile; Tasca, Christian; Foucras, Gilles] INRA, IHAP, UMR1225, F-31931 Toulouse, France; [Bonnefont, Cecile M. D.; Robert-Granie, Christele; Rupp, Rachel] INRA, SAGA, UR631, F-31326 Castanet Tolosan, France; [Aurel, Marie-Rose] INRA, UE321, Roquefort, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; INRAE; INRAE	Toufeer, M (corresponding author), Univ Toulouse, ENVT, INP, IHAP,UMR 1225, Toulouse, France.	g.foucras@envt.fr	FOUCRAS, Gilles/A-3061-2014	FOUCRAS, Gilles/0000-0002-0363-0337; Rupp, Rachel/0000-0003-3375-5816	Action Concertee Incitative (ACI); ANR; APIS-GENE; European Network of Excellence(EADGENE); Higher Education Commission, Pakistan	Action Concertee Incitative (ACI); ANR(French National Research Agency (ANR)); APIS-GENE; European Network of Excellence(EADGENE); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	Studies were supported by Action Concertee Incitative (ACI) Microbiologie 2003, ANR Genanimal 2005 Genoma II, APIS-GENE, and European Network of Excellence(EADGENE). MT was supported by Higher Education Commission, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Balboa L, 2010, IMMUNOL CELL BIOL, V88, P716, DOI 10.1038/icb.2010.22; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Ben Zakour NL, 2008, J BACTERIOL, V190, P6302, DOI 10.1128/JB.01984-07; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bogaerts A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-11; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Catry B, 2010, EPIDEMIOL INFECT, V138, P626, DOI 10.1017/S0950268810000014; Cherfils-Vicini J, 2008, IMMUNOLOGY, V124, P562, DOI 10.1111/j.1365-2567.2008.02810.x; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cohn LA, 2010, J VET EMERG CRIT CAR, V20, P31, DOI 10.1111/j.1476-4431.2009.00497.x; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Foulon E, 2008, J IMMUNOL METHODS, V339, P1, DOI 10.1016/j.jim.2008.07.012; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hope JC, 2000, SCAND J IMMUNOL, V51, P60; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Inaba Kayo, 2009, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0307s86; Jakob T, 1998, J IMMUNOL, V161, P3042; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; Jin P, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-4; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; Kusuhara Koichi, 2010, Journal of UOEH, V32, P177; Langelaar MFM, 2005, VET IMMUNOL IMMUNOP, V107, P153, DOI 10.1016/j.vetimm.2005.04.009; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Nanda SK, 2009, VIROLOGY, V395, P223, DOI 10.1016/j.virol.2009.09.031; Nimura F, 2006, EXP BIOL MED, V231, P431, DOI 10.1177/153537020623100409; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Reis ES, 2007, IMMUNOBIOLOGY, V212, P151, DOI 10.1016/j.imbio.2006.11.010; Rescigno M, 2000, J CLIN IMMUNOL, V20, P161, DOI 10.1023/A:1006629328178; Ribeiro OG, 2003, J LEUKOCYTE BIOL, V74, P497, DOI 10.1189/jlb.0103039; Rozen S, 2000, Methods Mol Biol, V132, P365; Rupp R, 2009, J DAIRY SCI, V92, P1203, DOI 10.3168/jds.2008-1435; Sasaki S, 2000, INFECT IMMUN, V68, P2424, DOI 10.1128/IAI.68.5.2424-2430.2000; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Torri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009404; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; von Stebut E, 2003, J EXP MED, V198, P191, DOI 10.1084/jem.20030159; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010844; Wu K, 2010, CLIN MICROBIOL INFEC, V16, P245, DOI 10.1111/j.1469-0691.2009.02765.x; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x; Zhang L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-87	64	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22147	10.1371/journal.pone.0022147	http://dx.doi.org/10.1371/journal.pone.0022147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857913	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500003
J	Balseiro, P; Falco, A; Romero, A; Dios, S; Martinez-Lopez, A; Figueras, A; Estepa, A; Novoa, B				Balseiro, Pablo; Falco, Alberto; Romero, Alejandro; Dios, Sonia; Martinez-Lopez, Alicia; Figueras, Antonio; Estepa, Amparo; Novoa, Beatriz			Mytilus galloprovincialis Myticin C: A Chemotactic Molecule with Antiviral Activity and Immunoregulatory Properties	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; 2 ANTIMICROBIAL PEPTIDES; TIME RT-PCR; RAINBOW-TROUT; C1Q-DOMAIN-CONTAINING PROTEIN; HUMAN ALPHA-DEFENSIN-1; CRASSOSTREA-VIRGINICA; ESCHERICHIA-COLI; RHABDOVIRUS VHSV; IMMUNE-RESPONSE	Previous research has shown that an antimicrobial peptide (AMP) of the myticin class C (Myt C) is the most abundantly expressed gene in cDNA and suppressive subtractive hybridization (SSH) libraries after immune stimulation of mussel Mytilus galloprovincialis. However, to date, the expression pattern, the antimicrobial activities and the immunomodulatory properties of the Myt C peptide have not been determined. In contrast, it is known that Myt C mRNA presents an unusual and high level of polymorphism of unidentified biological significance. Therefore, to provide a better understanding of the features of this interesting molecule, we have investigated its function using four different cloned and expressed variants of Myt C cDNA and polyclonal anti-Myt C sera. The in vivo results suggest that this AMP, mainly present in hemocytes, could be acting as an immune system modulator molecule because its overexpression was able to alter the expression of mussel immune-related genes (as the antimicrobial peptides Myticin B and Mytilin B, the C1q domain-containing protein MgC1q, and lysozyme). Moreover, the in vitro results indicate that Myt C peptides have antimicrobial and chemotactic properties. Their recombinant expression in a fish cell line conferred protection against two different fish viruses (enveloped and non-enveloped). Cell extracts from Myt C expressing fish cells were also able to attract hemocytes. All together, these results suggest that Myt C should be considered not only as an AMP but also as the first chemokine/cytokine-like molecule identified in bivalves and one of the few examples in all of the invertebrates.	[Balseiro, Pablo; Romero, Alejandro; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz] CSIC, IIM, Vigo, Spain; [Falco, Alberto; Martinez-Lopez, Alicia; Estepa, Amparo] Miguel Hernandez Univ, IBMC, Elche, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Universidad Miguel Hernandez de Elche	Balseiro, P (corresponding author), CSIC, IIM, Vigo, Spain.	virus@iim.csic.es	Falco, Alberto/A-3250-2012; Dios, Sonia/M-4201-2018; Romero, Alejandro/R-4565-2019; Figueras, Antonio/B-5133-2015; Figueras, Antonio/AAB-8921-2019; Novoa, Beatriz/K-3785-2014; Balseiro, Pablo/I-7406-2013	Falco, Alberto/0000-0001-7726-6577; Dios, Sonia/0000-0002-2126-991X; Romero, Alejandro/0000-0002-9343-3352; Figueras, Antonio/0000-0002-0617-0030; Figueras, Antonio/0000-0002-0617-0030; Martinez Lopez, Alicia/0000-0003-3347-0394; Novoa, Beatriz/0000-0003-4888-8419; Balseiro, Pablo/0000-0002-9365-6775	Spanish Ministerio de Ciencia e Innovation [AGL2008-05111/ACU]; Ministerio de Asuntos Exteriores y de Cooperacion [A/026000/09]	Spanish Ministerio de Ciencia e Innovation(Spanish Government); Ministerio de Asuntos Exteriores y de Cooperacion	This work was funded by the project AGL2008-05111/ACU from the Spanish Ministerio de Ciencia e Innovation and project A/026000/09 from the Ministerio de Asuntos Exteriores y de Cooperacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battison AL, 2008, FISH SHELLFISH IMMUN, V25, P181, DOI 10.1016/j.fsi.2008.04.005; BIRKBECK TH, 1982, MAR BIOL, V72, P7, DOI 10.1007/BF00393942; Brocal I, 2006, APPL MICROBIOL BIOT, V72, P1217, DOI 10.1007/s00253-006-0393-7; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chen Y, 2007, FISH SHELLFISH IMMUN, V23, P589, DOI 10.1016/j.fsi.2007.01.006; Chico V, 2006, J VIROL METHODS, V132, P154, DOI 10.1016/j.jviromet.2005.10.005; Chico V, 2009, VACCINE, V27, P1938, DOI 10.1016/j.vaccine.2009.01.103; CHU FLE, 1989, J INVERTEBR PATHOL, V54, P224, DOI 10.1016/0022-2011(89)90032-3; COLL J, 1989, MED VET, V6, P425; Costa MM, 2009, DEV COMP IMMUNOL, V33, P162, DOI 10.1016/j.dci.2008.08.005; DEKINKELIN P, 1977, CR ACAD SCI D NAT, V284, P101; Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256; Falco A, 2008, FISH SHELLFISH IMMUN, V24, P102, DOI 10.1016/j.fsi.2007.09.007; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Falco A, 2007, ANTIVIR RES, V76, P111, DOI 10.1016/j.antiviral.2007.06.006; Falco A, 2009, MINI-REV MED CHEM, V9, P1159, DOI 10.2174/138955709789055171; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Govorin I., 2000, RUSS J MAR BIOL, V26, P81; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hong XT, 2006, FISH SHELLFISH IMMUN, V21, P357, DOI 10.1016/j.fsi.2005.12.013; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; KUMAZAWA NH, 1991, J VET MED SCI, V53, P883; Li H, 2010, FISH SHELLFISH IMMUN, V28, P640, DOI 10.1016/j.fsi.2009.12.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Cortes L, 1999, FISH SHELLFISH IMMUN, V9, P543, DOI 10.1006/fsim.1999.0211; Lorenzo G, 1996, J VIROL METHODS, V58, P1, DOI 10.1016/0166-0934(95)01972-3; Marroqui L, 2008, ANTIVIR RES, V80, P332, DOI 10.1016/j.antiviral.2008.07.007; Mas V, 2002, J GEN VIROL, V83, P2671, DOI 10.1099/0022-1317-83-11-2671; MCDADE JE, 1967, J INVERTEBR PATHOL, V9, P531, DOI 10.1016/0022-2011(67)90134-6; Mitta G, 2000, J BIOL CHEM, V275, P12954, DOI 10.1074/jbc.275.17.12954; Mitta G, 2000, J CELL SCI, V113, P2759; Mitta G, 1999, J CELL SCI, V112, P4233; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Murray HM, 2003, J FISH BIOL, V62, P816, DOI 10.1046/j.1095-8649.2003.00067.x; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; Ottaviani E, 2001, COMP BIOCHEM PHYS C, V129, P295, DOI 10.1016/S1532-0456(01)00211-3; Padhi A, 2008, PEPTIDES, V29, P1094, DOI 10.1016/j.peptides.2008.03.007; Pallavicini A, 2008, DEV COMP IMMUNOL, V32, P213, DOI 10.1016/j.dci.2007.05.008; Patrzykat A, 2005, PROTEIN PEPTIDE LETT, V12, P19, DOI 10.2174/0929866053406057; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roch P, 2008, DEV COMP IMMUNOL, V32, P227, DOI 10.1016/j.dci.2007.05.006; Roch P, 2004, EVID-BASED COMPL ALT, V1, P167, DOI 10.1093/ecam/neh033; Saint-Jean SR, 2006, VET IMMUNOL IMMUNOP, V110, P1, DOI 10.1016/j.vetimm.2005.08.023; STEFANO GB, 1989, P NATL ACAD SCI USA, V86, P626, DOI 10.1073/pnas.86.2.626; Tafalla C, 2007, FISH SHELLFISH IMMUN, V23, P210, DOI 10.1016/j.fsi.2006.10.009; Ulvatne H, 2002, J ANTIMICROB CHEMOTH, V50, P461, DOI 10.1093/jac/dkf156; VALERIO PF, 1992, J EXP BIOL, V164, P135; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003	56	60	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23140	10.1371/journal.pone.0023140	http://dx.doi.org/10.1371/journal.pone.0023140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858010	gold, Green Published, Green Submitted			2022-12-25	WOS:000293773300022
J	Hu, XB; Whaley, MA; Stein, MM; Mitchell, BE; O'Tousa, JE				Hu, Xiaobang; Whaley, Michelle A.; Stein, Michelle M.; Mitchell, Bronwen E.; O'Tousa, Joseph E.			Coexpression of Spectrally Distinct Rhodopsins in Aedes aegypti R7 Photoreceptors	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; DROSOPHILA; GENE; EYE; BEHAVIOR; OPSINS; CELLS	The retina of the mosquito Aedes aegypti can be divided into four regions based on the non-overlapping expression of a UV sensitive Aaop8 rhodopsin and a long wavelength sensitive Aaop2 type rhodopsin in the R7 photoreceptors. We show here that another rhodopsin, Aaop9, is expressed in all R7 photoreceptors and a subset of R8 photoreceptors. In the dorsal region, Aaop9 is expressed in both the cell body and rhabdomere of R7 and R8 cells. In other retinal regions Aaop9 is expressed only in R7 cells, being localized to the R7 rhabdomere in the central and ventral regions and in both the cell body and rhabdomere within the ventral stripe. Within the dorsal-central transition area ommatidia do not show a strict pairing of R7-R8 cell types. Thus, Aaop9 is coexpressed in the two classes of R7 photoreceptors previously distinguished by the non-overlapping expression of Aaop8 and Aaop2 rhodopsins. Electroretinogram analysis of transgenic Drosophila shows that Aaop9 is a short wavelength rhodopsin with an optimal response to 400-450 nm light. The coexpressed Aaop2 rhodopsin has dual wavelength sensitivity of 500-550 nm and near 350 nm in the UV region. As predicted by the spectral properties of each rhodopsin, Drosophila photoreceptors expressing both Aaop9 and Aaop2 rhodopsins exhibit a uniform sensitivity across the broad 350-550 nm light range. We propose that rhodopsin coexpression is an adaptation within the R7 cells to improve visual function in the low-light environments in which Ae. aegypti is active.	[Hu, Xiaobang; Whaley, Michelle A.; Stein, Michelle M.; Mitchell, Bronwen E.; O'Tousa, Joseph E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Hu, XB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	jotousa@nd.edu		Hu, Xiaobang/0000-0001-9964-1067; O'Tousa, Joseph/0000-0001-9754-6816; Stein, Michelle/0000-0002-7680-9012	National Institutes of Health [EY06808]; NATIONAL EYE INSTITUTE [R01EY006808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded by National Institutes of Health grant EY06808 awarded to J. O'Tousa. The web site is http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ST, 2006, INVEST OPHTH VIS SCI, V47, P3722, DOI 10.1167/iovs.06-0281; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Arikawa K, 2003, J NEUROSCI, V23, P4527; Bell ML, 2007, J COMP NEUROL, V502, P75, DOI 10.1002/cne.21298; Blackiston D, 2011, J EXP BIOL, V214, P509, DOI 10.1242/jeb.048728; BRAMMER JD, 1970, J EXP ZOOL, V175, P181, DOI 10.1002/jez.1401750207; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dabdoub A, 2003, VISUAL NEUROSCI, V20, P241, DOI 10.1017/S0952523803203035; Day JF, 2005, J AM MOSQUITO CONTR, V21, P17, DOI 10.2987/8756-971X(2005)21[17:HSOMDV]2.0.CO;2; DESPLAN C, 2003, COLOR POLARIZED LIGH; Earl JB, 2006, GENE EXPR PATTERNS, V6, P687, DOI 10.1016/j.modgep.2006.01.003; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; Greenspan R.J., 2004, FLY PUSHING THEORY P; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Hu XB, 2009, J COMP NEUROL, V516, P334, DOI 10.1002/cne.22114; Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2; Knox BE, 2003, J BIOL CHEM, V278, P40493, DOI 10.1074/jbc.M304567200; Land MF, 1999, J COMP PHYSIOL A, V185, P91, DOI 10.1007/s003590050369; Mazzoni EO, 2004, DEV NEUROSCI-BASEL, V26, P388, DOI 10.1159/000082281; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Morante J, 2007, CURR OPIN GENET DEV, V17, P314, DOI 10.1016/j.gde.2007.05.003; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Spaethe J, 2004, MOL BIOL EVOL, V21, P1583, DOI 10.1093/molbev/msh162; Stavenga DG, 2008, PLOS BIOL, V6, P675, DOI 10.1371/journal.pbio.0060115; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Townson SM, 1998, J NEUROSCI, V18, P2412; VOGT K, 1983, BIOPHYS STRUCT MECH, V9, P319, DOI 10.1007/BF00535667; WASHBURN T, 1992, GENETICS, V130, P585	29	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23121	10.1371/journal.pone.0023121	http://dx.doi.org/10.1371/journal.pone.0023121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858005	gold, Green Published, Green Submitted			2022-12-25	WOS:000293773300021
J	de Barros, FSM; Honorio, NA; Arruda, ME				Monteiro de Barros, Fabio Saito; Honorio, Nildimar Alves; Arruda, Mercia Eliane			Survivorship of Anopheles darlingi (Diptera: Culicidae) in Relation with Malaria Incidence in the Brazilian Amazon	PLOS ONE			English	Article							FIELD OBSERVATIONS; GONOTROPHIC CYCLE; ROOT DIPTERA; TRANSMISSION; VECTOR; MOSQUITOS; BIONOMICS; PATTERNS; RONDONIA; VILLAGES	We performed a longitudinal study of adult survival of Anopheles darlingi, the most important vector in the Amazon, in a malarigenous frontier zone of Brazil. Survival rates were determined from both parous rates and multiparous dissections. Anopheles darlingi human biting rates, daily survival rates and expectation of life where higher in the dry season, as compared to the rainy season, and were correlated with malaria incidence. The biting density of mosquitoes that had survived long enough for completing at least one sporogonic cycle was related with the number of malaria cases by linear regression. Survival rates were the limiting factor explaining longitudinal variations in Plasmodium vivax malaria incidence and the association between adult mosquito survival and malaria was statistically significant by logistic regression (P<0.05). Survival rates were better correlated with malaria incidence than adult mosquito biting density. Mathematical modeling showed that P. falciparum and P. malariae were more vulnerable to changes in mosquito survival rates because of longer sporogonic cycle duration, as compared to P. vivax, which could account for the low prevalence of the former parasites observed in the study area. Population modeling also showed that the observed decreases in human biting rates in the wet season could be entirely explained by decreases in survival rates, suggesting that decreased breeding did not occur in the wet season, at the sites where adult mosquitoes were collected. For the first time in the literature, multivariate methods detected a statistically significant inverse relation (P<0.05) between the number of rainy days per month and daily survival rates, suggesting that rainfall may cause adult mortality.	[Monteiro de Barros, Fabio Saito] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil; [Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunoepidemiol, Recife, PE, Brazil; [Arruda, Mercia Eliane] Fiocruz MS, Inst Oswaldo Cruz, Dept Entomol, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	de Barros, FSM (corresponding author), Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil.	fsaito1@yahoo.com.br			Interamerican Institute for Global Change Research [048]	Interamerican Institute for Global Change Research	The Interamerican Institute for Global Change Research, grant CRN no. 048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, MANUAL PRACTICAL ENT; [Anonymous], 1993, MOSQUITO ECOLOGY FIE; Barros FSM, 2010, NEOTROP ENTOMOL, V39, P1039, DOI 10.1590/S1519-566X2010000600029; BARROS FSM, 2011, B ENTOMOL RES; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Bliss CI, 1967, STAT BIOL; BURKOT TR, 1990, AM J TROP MED HYG, V43, P321, DOI 10.4269/ajtmh.1990.43.321; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CHARLWOOD JD, 1980, B ENTOMOL RES, V70, P685, DOI 10.1017/S0007485300007975; CHARLWOOD JD, 1979, B ENTOMOL RES, V69, P337, DOI 10.1017/S0007485300017818; CHARLWOOD JD, 1986, J MED ENTOMOL, V23, P361, DOI 10.1093/jmedent/23.4.361; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; CHARLWOOD JD, 1989, ANN TROP MED PARASIT, V83, P569, DOI 10.1080/00034983.1989.11812389; Chaves Sandra S., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P269, DOI 10.1590/S0036-46652000000500006; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6, DOI 10.4269/ajtmh.1990.43.1.TM0430010006; Detinova T. S., 1945, MEDITSINSKA PARAZITOLOG[IMAGE] I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V14, P45; Dos Santos RL, 2002, J MED ENTOMOL, V39, P926, DOI 10.1603/0022-2585-39.6.926; Fouque F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-80; FOX AS, 1994, PARASITOL TODAY, V10, P19, DOI 10.1016/0169-4758(94)90349-2; FURLEY PA, OREST FRONTIER; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; GEHAN EA, 1973, J AM STAT ASSOC, V68, P848, DOI 10.2307/2284511; Gil LHS, 2003, J MED ENTOMOL, V40, P636, DOI 10.1603/0022-2585-40.5.636; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389; HOC TQ, 1995, MED VET ENTOMOL, V9, P16, DOI 10.1111/j.1365-2915.1995.tb00112.x; HOC TQ, 1990, MED VET ENTOMOL, V4, P227, DOI 10.1111/j.1365-2915.1990.tb00281.x; HOLM S, 1979, SCAND J STAT, V6, P65; HUGO RL, 2008, J MED ENTOMOL, V453, P353; Kakitani I, 2000, REV SAUDE PUBL, V34, P33, DOI 10.1590/S0034-89102000000100007; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KENNEDY A D, 1971, Computer Programs in Biomedicine, V1, P235, DOI 10.1016/0010-468X(71)90014-6; KLEIN TA, 1990, J AM MOSQUITO CONTR, V6, P700; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Lounibos LP, 1998, J VECTOR ECOL, V23, P195; Macdonald G., 1957, EPIDEMIOLOGY CONTROL, P201; Magris M, 2007, MEM I OSWALDO CRUZ, V102, P303, DOI 10.1590/S0074-02762007005000049; Molineaux L., 1988, P999; de Barros FSM, 2007, J VECTOR ECOL, V32, P54, DOI 10.3376/1081-1710(2007)32[54:PAACFA]2.0.CO;2; de Barros FSM, 2007, MEM I OSWALDO CRUZ, V102, P299, DOI 10.1590/S0074-02762007005000024; de Barros FSM, 2011, J VECTOR ECOL, V36, P159, DOI 10.1111/j.1948-7134.2011.00153.x; MOOR PPD, 1970, T ROY SOC TROP MED H, V64, P927; Moshkovsky S.D., 1951, EPIDEMIOLOGY MED PAR; ONORI E, 1980, B WORLD HEALTH ORGAN, V58, P91; PAAIJMANS KP, 2007, PLOS ONE, V11, P1; Pampana E. J., 1963, TXB MALARIA ERADICAT; Galardo AKR, 2007, AM J TROP MED HYG, V76, P461, DOI 10.4269/ajtmh.2007.76.461; ROBERTS DR, 1983, J MED ENTOMOL, V20, P189, DOI 10.1093/jmedent/20.2.189; Rosa-Freitas MG, 2007, MEM I OSWALDO CRUZ, V102, P349, DOI 10.1590/S0074-02762007005000052; Sawyer DR, 1988, FRONTIER MALARIA AMA; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Souza-Santos Reinaldo, 2002, Cad. Saúde Pública, V18, P1813, DOI 10.1590/S0102-311X2002000600039; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; *WHO, 1997, WHO WEEKLY EPIDEMIOL, V22, P161; Zar JH, 1999, BIOSTATISTICAL ANAL	58	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22388	10.1371/journal.pone.0022388	http://dx.doi.org/10.1371/journal.pone.0022388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857927	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300005
J	Ncaca, LN; Kranzer, K; Orrell, C				Ncaca, Lisa-Noelle; Kranzer, Katharina; Orrell, Catherine			Treatment Interruption and Variation in Tablet Taking Behaviour Result in Viral Failure: A Case-Control Study from Cape Town, South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; HIV-INFECTION; ADHERENCE; DISCONTINUATION; RESISTANCE; COHORT; SUPPRESSION; OUTCOMES; IMPACT	Background: Understanding of the impact of non-structured treatment interruption (TI) and variation in tablet-taking on failure of first-line antiretroviral therapy (ART) is limited in a resource-poor setting. Methods: A retrospective matched case-control analysis. Individuals failing ART were matched by time on ART with 4 controls. Viral load (VL) and CD4 count were completed 4-monthly. Adherence percentages, from tablet returns, were calculated 4-monthly (interval) and from ART start (cumulative). Variation between intervals and TI (>27 days off ART) were recorded. Conditional multivariate logistic regression analysis was performed to estimate the effect of cumulative adherence <90%, at least one episode of adherence variation >10% and TI on virological failure. Age, gender, baseline log VL and CD4 were included as possible confounders in the multivariate model. Results: 244 patients (44 cases, 200 controls) were included. Median age was 32 years (IQR28-37), baseline CD4 108 cells/mm3 (IQR56-151), VL 4.82 log (IQR4.48-5.23). 94% (96% controls, 86% failures) had cumulative adherence >90%. The odds of failure increased 3 times (aOR 3.01, 95% CI 0.81-11.21) in individuals with cumulative adherence <90%, 2.2 times (aOR 2.20, 95% CI 1.04-4.64) in individuals with at least one episode of fluctuating adherence of >10% and 4.01 times (aOR 4.01, 95% CI 1.45-11.10) in individuals with TIs. For individuals with TI and cumulative adherence >95%, the odds of failing were 5.65 (CI 1.40-22.85). Conclusion: It is well known that poor cumulative adherence increases risk of virological failure, but less well understood that TI and variations in tablet-taking also play a key role, despite otherwise excellent adherence.	[Ncaca, Lisa-Noelle; Kranzer, Katharina; Orrell, Catherine] Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Ncaca, LN (corresponding author), Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa.	catherine.orrell@hiv-reseaarch.org.za	Kranzer, Katharina/O-8845-2014; Orrell, Catherine/AAF-3405-2019	Kranzer, Katharina/0000-0001-5691-7270; Orrell, Catherine/0000-0003-1134-7475	USAID; Welltrust Trust	USAID(United States Agency for International Development (USAID)); Welltrust Trust	Lisa-Noelle Ncaca and Catherine Orrell receive funding through the USAID funded Anova Program. Katharina Kranzer receives funding through the Welltrust Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2008, AIDS, V22, P349, DOI 10.1097/QAD.0b013e3282f4709a; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Bisson GP, 2008, JAIDS-J ACQ IMM DEF, V49, P107, DOI 10.1097/QAI.0b013e3181820141; DARMINIO MA, 2005, J ACQ IMMUN DEF SYND, V38, P407; Datay MI, 2010, JAIDS-J ACQ IMM DEF, V54, P489, DOI 10.1097/QAI.0b013e3181d91788; *DEP HLTH, 2010, STAT SO AFR MID POP; Hirschel B, 2009, AIDS, V23, P757, DOI 10.1097/QAD.0b013e328321b791; Kiguba R, 2007, JAIDS-J ACQ IMM DEF, V45, P218, DOI 10.1097/QAI.0b013e31805d8ae3; Knobel H, 2009, HIV MED, V10, P364, DOI 10.1111/j.1468-1293.2009.00696.x; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; National Department of Health, 2004, S AFR NAT ANT TREAT; Olsen CH, 2007, HIV MED, V8, P96, DOI 10.1111/j.1468-1293.2007.00436.x; Orrell C, 2007, ANTIVIR THER, V12, P83; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pogany K, 2007, JAIDS-J ACQ IMM DEF, V44, P395, DOI 10.1097/QAI.0b013e31802f83bc; Taffe P, 2002, AIDS, V16, P747, DOI 10.1097/00002030-200203290-00010; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760	26	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23088	10.1371/journal.pone.0023088	http://dx.doi.org/10.1371/journal.pone.0023088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858001	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300019
J	Lee, HS; Lee, SY; Lee, H; Hwang, YS; Cha, SW; Park, S; Lee, JY; Park, JB; Kim, S; Park, MJ; Kim, J				Lee, Hyun-Shik; Lee, Sung-Young; Lee, Hyosang; Hwang, Yoo-Seok; Cha, Sang-Wook; Park, Soochul; Lee, Jae-Yong; Park, Jae-Bong; Kim, SungChan; Park, Mae Ja; Kim, Jaebong			Direct Response Elements of BMP within the PV.1A Promoter Are Essential for Its Transcriptional Regulation during Early Xenopus Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; HOMEOBOX GENE; XVENT-2; MESODERM; INDUCTION; BINDING; EXPRESSION; EMBRYOS; FAMILY; XOM	Xvent homeobox genes encode transcription factors that repress organizer genes and are essential for dorsoventral specification during early embryogenesis in Xenopus. In contrast to the Xvent-2 gene subfamily, Xvent-1 subfamily members, including PV.1A, have been proposed as indirect targets of Bone Morphogenetic Protein-4 (BMP-4) signaling. Because PV.1A is a critical downstream mediator of, and tightly regulated by, BMP-4 signaling, we hypothesized that its promoter contains a direct BMP-4 response element to effect this transcriptional regulation. We demonstrate that direct regulation by BMP-4 is necessary for transcription of PV.1A: its proximal promoter contains cis-acting binding elements for Smads and Oaz crucial to induction in response to BMP-4 signaling. In addition to these direct cis-acting BMP-4 responsive elements, an indirect Xvent-2 response element and several repressive elements exist in the PV.1A promoter to regulate its transcription. In summary, PV.1A undergoes combinatorial regulation during early Xenopus development as both the direct target of BMP-4 signaling and as the direct and indirect target of positive and negative regulatory factors.	[Lee, Hyun-Shik; Lee, Sung-Young; Lee, Jae-Yong; Park, Jae-Bong; Kim, SungChan; Kim, Jaebong] Hallym Univ, Coll Med, Dept Biochem, Chunchon, Kangwon Do, South Korea; [Lee, Hyosang; Hwang, Yoo-Seok; Cha, Sang-Wook; Park, Mae Ja] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea; [Park, Soochul] Sookmyung Womens Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea; [Lee, Hyun-Shik] Kyungpook Natl Univ, Sch Life Sci, Coll Nat Sci, Taegu, South Korea	Hallym University; Kyungpook National University; Sookmyung Women's University; Kyungpook National University	Lee, HS (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon, Kangwon Do, South Korea.	jbkim@hallym.ac.kr	Kim, Jaebong/AAV-1986-2021; Lee, Hyun-Shik/G-3555-2011; Cha, Sang-Wook/D-3523-2016	Kim, Jaebong/0000-0003-1609-338X; , Hyosang/0000-0002-3200-8678	Ministry of Education, Science and Technology [KRF-2005-C00115, KRF-2005-015-C00390, 2010-0029642]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Basic Science Research Program (KRF-2005-C00115 and KRF-2005-015-C00390) and by the Priority Research Centers Program (2010-0029642) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault KT, 1996, P NATL ACAD SCI USA, V93, P6415, DOI 10.1073/pnas.93.13.6415; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Friedle H, 2002, J BIOL CHEM, V277, P23872, DOI 10.1074/jbc.M201831200; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; HARLAND RM, 1994, P NATL ACAD SCI USA, V91, P10243, DOI 10.1073/pnas.91.22.10243; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; HemmatiBrivanlou A, 1997, ANNU REV NEUROSCI, V20, P43, DOI 10.1146/annurev.neuro.20.1.43; Henningfeld KA, 2002, J BIOL CHEM, V277, P2097, DOI 10.1074/jbc.M108524200; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Ladher R, 1996, DEVELOPMENT, V122, P2385; Lee HS, 2002, BIOCHEM BIOPH RES CO, V298, P815, DOI 10.1016/S0006-291X(02)02570-6; Maeda R, 1997, DEVELOPMENT, V124, P2553; Melby AE, 1999, DEV BIOL, V211, P293, DOI 10.1006/dbio.1999.9296; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Papalopulu N, 1996, DEV BIOL, V174, P104, DOI 10.1006/dbio.1996.0055; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rastegar S, 1999, MECH DEVELOP, V81, P139, DOI 10.1016/S0925-4773(98)00239-1; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Schuler-Metz A, 2000, J BIOL CHEM, V275, P34365, DOI 10.1074/jbc.M003915200; Trindade M, 1999, DEV BIOL, V216, P442, DOI 10.1006/dbio.1999.9507; Zhu CQC, 1999, CELL MOL BIOL, V45, P617; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	25	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22621	10.1371/journal.pone.0022621	http://dx.doi.org/10.1371/journal.pone.0022621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857938	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900022
J	Nagare, T; Sakaue, H; Matsumoto, M; Cao, YH; Inagaki, K; Sakai, M; Takashima, Y; Nakamura, K; Mori, T; Okada, Y; Matsuki, Y; Watanabe, E; Ikeda, K; Taguchi, R; Kamimura, N; Ohta, S; Hiramatsu, R; Kasuga, M				Nagare, Tomoki; Sakaue, Hiroshi; Matsumoto, Michihiro; Cao, Yongheng; Inagaki, Kenjiro; Sakai, Mashito; Takashima, Yasuhiro; Nakamura, Kyoko; Mori, Toshiyuki; Okada, Yuko; Matsuki, Yasushi; Watanabe, Eijiro; Ikeda, Kazutaka; Taguchi, Ryo; Kamimura, Naomi; Ohta, Shigeo; Hiramatsu, Ryuji; Kasuga, Masato			Overexpression of KLF15 Transcription Factor in Adipocytes of Mice Results in Down-regulation of SCD1 Protein Expression in Adipocytes and Consequent Enhancement of Glucose-induced Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; KRUPPEL-LIKE FACTOR; PANCREATIC BETA-CELLS; GENE-EXPRESSION; OXIDATIVE STRESS; ENERGY-BALANCE; OBESITY; CONTRIBUTES; GLUCONEOGENESIS; ANTIOXIDANTS	Kruppel-like factor 15 (KLF15), a member of the Kruppel-like factor family of transcription factors, has been found to play diverse roles in adipocytes in vitro. However, little is known of the function of KLF15 in adipocytes in vivo. We have now found that the expression of KLF15 in adipose tissue is down-regulated in obese mice, and we therefore generated adipose tissue-specific KLF15 transgenic (aP2-KLF15Tg) mice to investigate the possible contribution of KLF15 to various pathological conditions associated with obesity in vivo. The aP2-KLF15 Tg mice manifest insulin resistance and are resistant to the development of obesity induced by maintenance on a high fat diet. However, they also exhibit improved glucose tolerance as a result of enhanced insulin secretion. Furthermore, this enhancement of insulin secretion was shown to result from down-regulation of the expression of stearoyl-CoA desaturase 1 (SCD1) in white adipose tissue and a consequent reduced level of oxidative stress. This is supported by the findings that restoration of SCD1 expression in white adipose tissue of aP2-KLF15 Tg mice exhibited increased oxidative stress in white adipose tissue and reduced insulin secretion with hyperglycemia. Our data thus provide an example of cross-talk between white adipose tissue and pancreatic beta cells mediated through modulation of oxidative stress.	[Kasuga, Masato] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Nagare, Tomoki; Matsumoto, Michihiro; Cao, Yongheng; Inagaki, Kenjiro; Sakai, Mashito] Natl Ctr Global Hlth & Med, Dept Mol Metab Regulat, Tokyo 1628655, Japan; [Nagare, Tomoki; Sakaue, Hiroshi; Takashima, Yasuhiro; Nakamura, Kyoko; Mori, Toshiyuki; Okada, Yuko; Kasuga, Masato] Kobe Univ, Grad Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med, Kobe, Hyogo 6500017, Japan; [Sakaue, Hiroshi] Univ Tokushima, Grad Sch, Dept Nutr & Metab, Inst Hlth Biosci, Tokushima 7708503, Japan; [Matsuki, Yasushi; Watanabe, Eijiro; Hiramatsu, Ryuji] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Takarazuka, Hyogo 6650051, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Kawaguchi, Saitama 3320012, Japan; [Taguchi, Ryo] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Aichi 4878501, Japan; [Kamimura, Naomi; Ohta, Shigeo] Nippon Med Sch, Dept Biochem & Cell Biol, Inst Dev & Aging Sci, Grad Sch Med, Kawasaki, Kanagawa 2118533, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Kobe University; Tokushima University; Dainippon Sumitomo Pharmaceutical Company; Keio University; University of Tokyo; Japan Science & Technology Agency (JST); Chubu University; Nippon Medical School	Kasuga, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Res Inst, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	kasuga@ri.ncgm.go.jp	Sakaue, Hiroshi/ABE-2337-2021	Sakaue, Hiroshi/0000-0002-2468-2363; Takashima, Yasuhiro/0000-0003-0126-7260; Sakai, Mashito/0000-0002-4908-2727	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Center for Global Health and Medicine [21S116]; Takeda Science Foundation; Takeda Medical Science Foundation; Grants-in-Aid for Scientific Research [21591151] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Takeda Medical Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for creative scientific research (to M. K. and M. M.), a grant-in-aid for scientific research (c) (to H. S. and M. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant from the National Center for Global Health and Medicine 21S116 (to M. M.), a grant from Takeda Science Foundation (to H. S. and M. M.), and a grant from Takeda Medical Science Foundation (to H. S.).	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Diehl AM, 1999, J BIOENERG BIOMEMBR, V31, P493, DOI 10.1023/A:1005452624640; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Ikeda K, 2011, CANCER SCI, V102, P79, DOI 10.1111/j.1349-7006.2010.01754.x; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Laurent G, 2008, CELL METAB, V7, P113, DOI 10.1016/j.cmet.2007.12.010; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Liu XQ, 2010, ARTERIOSCL THROM VAS, V30, P31, DOI 10.1161/ATVBAHA.109.195636; Matsushita N, 2004, J NEUROSCI RES, V78, P7, DOI 10.1002/jnr.20229; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagare T, 2009, BIOCHEM BIOPH RES CO, V379, P98, DOI 10.1016/j.bbrc.2008.12.020; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ntambi JM, 1999, J LIPID RES, V40, P1549; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Pagel-Langenickel I, 2007, AM J PHYSIOL-HEART C, V293, pH2659, DOI 10.1152/ajpheart.00782.2007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Teshigawara K, 2005, BIOCHEM BIOPH RES CO, V327, P920, DOI 10.1016/j.bbrc.2004.12.096; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200	37	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37458	37469		10.1074/jbc.M111.242651	http://dx.doi.org/10.1074/jbc.M111.242651			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21862590	Green Published, hybrid			2022-12-25	WOS:000296542400045
J	Meng, XW; Peterson, KL; Dai, HM; Schneider, P; Lee, SH; Zhang, JS; Koenig, A; Bronk, S; Billadeau, DD; Gores, GJ; Kaufmann, SH				Meng, Xue Wei; Peterson, Kevin L.; Dai, Haiming; Schneider, Paula; Lee, Sun-Hee; Zhang, Jin-San; Koenig, Alexander; Bronk, Steve; Billadeau, Daniel D.; Gores, Gregory J.; Kaufmann, Scott H.			High Cell Surface Death Receptor Expression Determines Type I Versus Type II Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; TRAIL-INDUCED APOPTOSIS; WILD-TYPE; FAS EXPRESSION; CANCER-CELLS; DNA-DAMAGE; C-JUN; INHIBITOR; ACTIVATION; PROTEIN	Previous studies have suggested that there are two signaling pathways leading from ligation of the Fas receptor to induction of apoptosis. Type I signaling involves Fas ligand-induced recruitment of large amounts of FADD (FAS-associated death domain protein) and procaspase 8, leading to direct activation of caspase 3, whereas type II signaling involves Bid-mediated mitochondrial perturbation to amplify a more modest death receptor-initiated signal. The biochemical basis for this dichotomy has previously been unclear. Here we show that type I cells have a longer half-life for Fas message and express higher amounts of cell surface Fas, explaining the increased recruitment of FADD and subsequent signaling. Moreover, we demonstrate that cells with type II Fas signaling (Jurkat or HCT-15) can signal through a type I pathway upon forced receptor overexpression and that shRNA-mediated Fas down-regulation converts cells with type I signaling (A498) to type II signaling. Importantly, the same cells can exhibit type I signaling for Fas and type II signaling for TRAIL (TNF-alpha-related apoptosis-inducing ligand), indicating that the choice of signaling pathway is related to the specific receptor, not some other cellular feature. Additional experiments revealed that up-regulation of cell surface death receptor 5 levels by treatment with 7-ethyl-10-hydroxy-camptothecin converted TRAIL signaling in HCT116 cells from type II to type I. Collectively, these results suggest that the type I/type II dichotomy reflects differences in cell surface death receptor expression.	[Meng, Xue Wei; Peterson, Kevin L.; Dai, Haiming; Schneider, Paula; Lee, Sun-Hee; Zhang, Jin-San; Koenig, Alexander; Billadeau, Daniel D.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Dept Oncol, Rochester, MN 55905 USA; [Meng, Xue Wei; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55905 USA; [Bronk, Steve; Gores, Gregory J.] Mayo Clin, Div Gastroenterol, Dept Med, Rochester, MN 55905 USA; [Billadeau, Daniel D.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Meng, XW (corresponding author), Mayo Clin, Div Oncol Res, Dept Oncol, 200 1st St SW, Rochester, MN 55905 USA.	Meng.Xue@Mayo.edu; Kaufmann.Scott@Mayo.edu		Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407	National Institutes of Health [R01 CA69008, P50 CA102701, R01 DK63947]; German Cancer Society; NATIONAL CANCER INSTITUTE [R01CA069008, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA69008 (to S. H. K.), P50 CA102701 (to D. D. B.), and R01 DK63947 (to G. J. G.).; Supported by a Mildred Scheel Fellowship of the German Cancer Society.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Algeciras-Schimnich A, 2003, FEBS LETT, V546, P185, DOI 10.1016/S0014-5793(03)00558-1; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chan H, 1999, MOL CELL BIOL, V19, P2098, DOI 10.1128/mcb.19.3.2098; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Conticello C, 2007, J CLIN ENDOCR METAB, V92, P1938, DOI 10.1210/jc.2006-2157; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hallett WHD, 2008, J IMMUNOL, V180, P163, DOI 10.4049/jimmunol.180.1.163; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Ivanov VN, 2002, J BIOL CHEM, V277, P4932, DOI 10.1074/jbc.M108233200; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Karp JE, 2009, BLOOD, V113, P4841, DOI 10.1182/blood-2008-08-172726; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Knight MJ, 2001, ONCOGENE, V20, P5789, DOI 10.1038/sj.onc.1204810; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lundqvist A, 2006, CANCER RES, V66, P7317, DOI 10.1158/0008-5472.CAN-06-0680; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Masuoka HC, 2009, J BIOL CHEM, V284, P30039, DOI 10.1074/jbc.M109.039545; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Naka T, 2002, CANCER RES, V62, P5800; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nimmanapalli R, 2001, CANCER RES, V61, P759; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Peacock JW, 2009, MOL CELL BIOL, V29, P1222, DOI 10.1128/MCB.01660-08; Qiu YZ, 2007, CANCER RES, V67, P4973, DOI 10.1158/0008-5472.CAN-06-4044; Ravi R, 2002, CANCER RES, V62, P1583; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Thorburn A, 2007, J THORAC ONCOL, V2, P461, DOI 10.1097/JTO.0b013e31805fea64; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wajant H, 2006, CANC TREAT, V130, P141; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wen JH, 2000, BLOOD, V96, P3900, DOI 10.1182/blood.V96.12.3900.h8003900_3900_3906; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhang JS, 2011, ONCOGENE, V30, P3705, DOI 10.1038/onc.2011.90; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	75	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35823	35833		10.1074/jbc.M111.240432	http://dx.doi.org/10.1074/jbc.M111.240432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865165	Green Published, hybrid			2022-12-25	WOS:000295927100055
J	Schnepf, N; Resche-Rigon, M; Chaillon, A; Scemla, A; Gras, G; Semoun, O; Taboulet, P; Molina, JM; Simon, F; Goudeau, A; LeGoff, J				Schnepf, Nathalie; Resche-Rigon, Matthieu; Chaillon, Antoine; Scemla, Anne; Gras, Guillaume; Semoun, Oren; Taboulet, Pierre; Molina, Jean-Michel; Simon, Francois; Goudeau, Alain; LeGoff, Jerome			High Burden of Non-Influenza Viruses in Influenza-Like Illness in the Early Weeks of H1N1v Epidemic in France	PLOS ONE			English	Article							RESPIRATORY VIRUSES; VIRAL-INFECTIONS; SURVEILLANCE; PCR; DIAGNOSIS	Background: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observations are of little help to recognise myxovirus infection and implement appropriate prevention measures. The limited use of molecular tools underestimates the role of other common pathogens. Objectives: During the early weeks of the 2009-2010 flu pandemic, a clinical and virological survey was conducted in adult and paediatric patients with ILI referred to two French University hospitals in Paris and Tours. Aims were to investigate the different pathogens involved in ILI and describe the associated symptoms. Methods: H1N1v pandemic influenza diagnosis was performed with real time RT-PCR assay. Other viral aetiologies were investigated by the molecular multiplex assay RespiFinder19 (R). Clinical data were collected prospectively by physicians using a standard questionnaire. Results: From week 35 to 44, endonasal swabs were collected in 413 patients. Overall, 68 samples (16.5%) were positive for H1N1v. In 13 of them, other respiratory pathogens were also detected. Among H1N1v negative samples, 213 (61.9%) were positive for various respiratory agents, 190 in single infections and 23 in mixed infections. The most prevalent viruses in H1N1v negative single infections were rhinovirus (62.6%), followed by parainfluenza viruses (24.2%) and adenovirus (5.3%). 70.6% of H1N1v cases were identified in patients under 40 years and none after 65 years. There was no difference between clinical symptoms observed in patients infected with H1N1v or with other pathogens. Conclusion: Our results highlight the high frequency of non-influenza viruses involved in ILI during the pre-epidemic period of a flu alert and the lack of specific clinical signs associated with influenza infections. Rapid diagnostic screening of a large panel of respiratory pathogens may be critical to define and survey the epidemic situation and to provide critical information for patient management.	[Schnepf, Nathalie; Simon, Francois; LeGoff, Jerome] Univ Paris Diderot, St Louis Hosp, APHP, Dept Microbiol, Paris, France; [Schnepf, Nathalie; Chaillon, Antoine; Goudeau, Alain] Univ Tours, CHRU Tours, Bretonneau Hosp, Dept Microbiol, F-37041 Tours, France; [Resche-Rigon, Matthieu; Semoun, Oren] Univ Paris Diderot, St Louis Hosp, APHP, Dept Biostat, Paris, France; [Scemla, Anne; Molina, Jean-Michel] Univ Paris Diderot, St Louis Hosp, APHP, Dept Infect Dis, Paris, France; [Gras, Guillaume] CHRU Tours, Bretonneau Hosp, Internal Med & Infect Dis Dept, Tours, France; [Taboulet, Pierre] St Louis Hosp, APHP, Emergency Dept, Paris, France; [Simon, Francois; LeGoff, Jerome] Inst Univ Hematol, INSERM, U941, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Schnepf, N (corresponding author), Univ Paris Diderot, St Louis Hosp, APHP, Dept Microbiol, Paris, France.	jerome.le-goff@sls.aphp.fr	Resche-Rigon, Matthieu/ABA-5374-2021; LeGoff, jerome/AAP-7880-2021; chaillon, antoine/GNH-1623-2022; le goff, jerome/B-3447-2016; Chaillon, Antoine/GNH-6121-2022	le goff, jerome/0000-0001-7111-1865; resche-rigon, matthieu/0000-0003-2220-5085				Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beck ET, 2010, FUTURE MICROBIOL, V5, P901, DOI [10.2217/fmb.10.48, 10.2217/FMB.10.48]; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Brittain-Long R, 2010, J CLIN VIROL, V47, P263, DOI 10.1016/j.jcv.2009.12.010; Butler D, 2010, NATURE, V464, P1112, DOI 10.1038/4641112a; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Casalegno JS, 2010, EURO SURVEILL, V15; CASALEGNO JS, 2009, EUR SURVEILL, V14; Dumoulin A, 2009, TRANSPL INFECT DIS, V11, P287, DOI 10.1111/j.1399-3062.2009.00425.x; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Follin P, 2009, EUROSURVEILLANCE, V14; FUHRMAN C, 2010, EUR SURVEILL, V15; *GROUP REG OBS GRI, 2009, SURV GRIPP FRANC B H; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; Heddini A, 2009, EUROSURVEILLANCE, V14; *I VEILL SAN, 2009, B EP GRIPP A H1N1; *I VEILL SAN, 2009, SURV GRIPP FRANC; *I VEILL SAN, 2009, SIT EP BRONCH; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; LEVYBRUHL D, 2009, EUR SURVEILL, V14; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; Nisii C, 2010, J CLIN MICROBIOL, V48, P3383, DOI 10.1128/JCM.01179-10; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Reijans M, 2008, J CLIN MICROBIOL, V46, P1232, DOI 10.1128/JCM.02294-07; Renois F, 2010, J CLIN MICROBIOL, V48, P3836, DOI 10.1128/JCM.00733-10; *RES SENT, 2009, B HEBD; *RES SENT, 2010, RAPP ANN 2009 UPMC; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; World Health Organization, 2009, CDC PROT REAL TIM RT	34	47	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23514	10.1371/journal.pone.0023514	http://dx.doi.org/10.1371/journal.pone.0023514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858150	gold, Green Submitted, Green Published			2022-12-25	WOS:000294121300055
J	Swali, A; McMullen, S; Hayes, H; Gambling, L; McArdle, HJ; Langley-Evans, SC				Swali, Angelina; McMullen, Sarah; Hayes, Helen; Gambling, Lorraine; McArdle, Harry J.; Langley-Evans, Simon C.			Cell Cycle Regulation and Cytoskeletal Remodelling Are Critical Processes in the Nutritional Programming of Embryonic Development	PLOS ONE			English	Article							LOW-PROTEIN DIETS; SYSTOLIC BLOOD-PRESSURE; GENE-EXPRESSION; MATERNAL UNDERNUTRITION; EPIGENETIC MODIFICATION; FETAL EXPOSURE; WEANLING RATS; LATER LIFE; HYPERTENSION; PREGNANCY	Many mechanisms purport to explain how nutritional signals during early development are manifested as disease in the adult offspring. While these describe processes leading from nutritional insult to development of the actual pathology, the initial underlying cause of the programming effect remains elusive. To establish the primary drivers of programming, this study aimed to capture embryonic gene and protein changes in the whole embryo at the time of nutritional insult rather than downstream phenotypic effects. By using a cross-over design of two well established models of maternal protein and iron restriction we aimed to identify putative common "gatekeepers'' which may drive nutritional programming. Both protein and iron deficiency in utero reduced the nephron complement in adult male Wistar and Rowett Hooded Lister rats (P < 0.05). This occurred in the absence of damage to the glomerular ultrastructure. Microarray, proteomic and pathway analyses identified diet-specific and strain-specific gatekeeper genes, proteins and processes which shared a common association with the regulation of the cell cycle, especially the G1/S and G2/M checkpoints, and cytoskeletal remodelling. A cell cycle-specific PCR array confirmed the down-regulation of cyclins with protein restriction and the up-regulation of apoptotic genes with iron deficiency. The timing and experimental design of this study have been carefully controlled to isolate the common molecular mechanisms which may initiate the sequelae of events involved in nutritional programming of embryonic development. We propose that despite differences in the individual genes and proteins affected in each strain and with each diet, the general response to nutrient deficiency in utero is perturbation of the cell cycle, at the level of interaction with the cytoskeleton and the mitotic checkpoints, thereby diminishing control over the integrity of DNA which is allowed to replicate. These findings offer novel insight into the primary causes and mechanisms leading to the pathologies which have been identified by previous programming studies.	[Swali, Angelina; McMullen, Sarah; Langley-Evans, Simon C.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Hayes, Helen; Gambling, Lorraine; McArdle, Harry J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Nottingham; University of Aberdeen	Swali, A (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	angelina.swali@nottingham.ac.uk	Langley-Evans, Simon/AAR-4181-2020; Langley-Evans, Simon C/F-3564-2012; McMullen, Sarah/H-8652-2012	Langley-Evans, Simon C/0000-0002-1969-8416; Swali, Angelina/0000-0002-6428-6373; Hayes, Helen/0000-0001-5186-2696	Biotechnology and Biological Sciences Research Council; Scottish Government (RERAD); European Union (Nutrigenomics Organisation NoE); BBSRC [BB/F005245/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005245/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government (RERAD); European Union (Nutrigenomics Organisation NoE)(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for the study was provided by a Biotechnology and Biological Sciences Research Council project grant to SLE and SM. HH, HJM and LG were supported by the Scottish Government (RERAD) and the European Union (Nutrigenomics Organisation NoE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Barker DJP, 1997, BRIT MED BULL, V53, P96; Bennis-Taleb N, 1999, J NUTR, V129, P1613, DOI 10.1093/jn/129.8.1613; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Chechi Kanta, 2006, Exp Clin Cardiol, V11, P129; CROWE C, 1995, J PHYSIOL-LONDON, V488, P515, DOI 10.1113/jphysiol.1995.sp020986; Dwyer CM, 1995, REPROD FERT DEVELOP, V7, P1285, DOI 10.1071/RD9951285; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Gaj S, 2008, GENES NUTR, V3, P153, DOI 10.1007/s12263-008-0094-1; Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; LAI AC, 1984, J NUTR SCI VITAMINOL, V30, P285, DOI 10.3177/jnsv.30.285; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans S. C., 2004, FETAL NUTR ADULT DIS; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; LANGLEYEVANS SC, 1994, CLIN NUTR, V13, P319, DOI 10.1016/0261-5614(94)90056-6; LangleyEvans SC, 1996, J REPROD FERTIL, V106, P307, DOI 10.1530/jrf.0.1060307; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Marin ECS, 2008, RENAL FAILURE, V30, P547, DOI 10.1080/08860220802060448; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Watanabe D, 2009, HYPERTENS RES, V32, P807, DOI 10.1038/hr.2009.106; Welham SJM, 2005, PHYSIOL GENOMICS, V22, P48, DOI 10.1152/physiolgenomics.00167.2004; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x; Woodall SM, 1996, PEDIATR RES, V40, P438, DOI 10.1203/00006450-199609000-00012; Woods L. L., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P235, DOI 10.1079/9780851998213.0235; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595	34	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23189	10.1371/journal.pone.0023189	http://dx.doi.org/10.1371/journal.pone.0023189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858025	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300019
J	Arsnoe, DM; Ip, HS; Owen, JC				Arsnoe, Dustin M.; Ip, Hon S.; Owen, Jennifer C.			Influence of Body Condition on Influenza A Virus Infection in Mallard Ducks: Experimental Infection Data	PLOS ONE			English	Article							IMMUNE FUNCTION; SUSCEPTIBILITY; ASSAY; HOST; REPRODUCTION; ANTIBODIES; INCREASES; IMPAIRS	Migrating waterfowl are implicated in the global spread of influenza A viruses (IAVs), and mallards (Anas platyrhynchos) are considered a particularly important IAV reservoir. Prevalence of IAV infection in waterfowl peaks during autumn pre-migration staging and then declines as birds reach wintering areas. Migration is energetically costly and birds often experience declines in body condition that may suppress immune function. We assessed how body condition affects susceptibility to infection, viral shedding and antibody production in wild-caught and captive-bred juvenile mallards challenged with low pathogenic avian influenza virus (LPAIV) H5N9. Wild mallards (n = 30) were separated into three experimental groups; each manipulated through food availability to a different condition level (-20%, -10%, and normal +/- 5% original body condition), and captive-bred mallards (n = 10) were maintained at normal condition. We found that wild mallards in normal condition were more susceptible to LPAIV infection, shed higher peak viral loads and shed viral RNA more frequently compared to birds in poor condition. Antibody production did not differ according to condition. We found that wild mallards did not differ from captive-bred mallards in viral intensity and duration of infection, but they did exhibit lower antibody titers and greater variation in viral load. Our findings suggest that reduced body condition negatively influences waterfowl host competence to LPAIV infection. This observation is contradictory to the recently proposed condition-dependent hypothesis, according to which birds in reduced condition would be more susceptible to IAV infection. The mechanisms responsible for reducing host competency among birds in poor condition remain unknown. Our research indicates body condition may influence the maintenance and spread of LPAIV by migrating waterfowl.	[Arsnoe, Dustin M.; Owen, Jennifer C.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Ip, Hon S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Owen, Jennifer C.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Michigan State University; United States Department of the Interior; United States Geological Survey; Michigan State University	Arsnoe, DM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	arsnoed@gmail.com		Owen, Jennifer/0000-0003-1383-4816; Ip, Hon/0000-0003-4844-7533	Department of Fisheries and Wildlife at Michigan State University; American Museum of Natural History	Department of Fisheries and Wildlife at Michigan State University; American Museum of Natural History	This study was funded by the Department of Fisheries and Wildlife at Michigan State University and the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MA, 2001, J AM COLL NUTR, V20, p384S, DOI 10.1080/07315724.2001.10719172; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Buehler DM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P561, DOI 10.1086/603635; Carney S.M., 1992, SPECIES AGE SEX IDEN; COOLEY AJ, 1989, VET PATHOL, V26, P1, DOI 10.1177/030098588902600101; Devries JH, 2008, AUK, V125, P618, DOI 10.1525/auk.2008.07055; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Flint PL, 2009, P ROY SOC B-BIOL SCI, V276, P2345, DOI 10.1098/rspb.2008.1962; Gregory NG, 1998, NEW ZEAL J AGR RES, V41, P555, DOI 10.1080/00288233.1998.9513338; Hangalapura BN, 2005, POULTRY SCI, V84, P1520, DOI 10.1093/ps/84.10.1520; Hanson BA, 2005, J WILDLIFE DIS, V41, P624, DOI 10.7589/0090-3558-41.3.624; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; HOMME PJ, 1970, AVIAN DIS, V14, P285, DOI 10.2307/1588473; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Klasing KC, 2004, POULTRY SCI, V83, P444; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P2347, DOI 10.1098/rspb.2009.0275; Li W, 2006, J NUTR, V136, P2611, DOI 10.1093/jn/136.10.2611; Louria DB, 2007, CLIN INFECT DIS, V45, P470, DOI 10.1086/520026; MAUSER DM, 1992, WILDLIFE SOC B, V20, P299; Moon JA, 2007, J WILDLIFE MANAGE, V71, P218, DOI 10.2193/2005-596; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen JC, 2008, CAN J ZOOL, V86, P638, DOI 10.1139/Z08-038; PAWLINA IM, 1993, CAN J ZOOL, V71, P2275, DOI 10.1139/z93-319; Pedersen Janice C., 2008, V436, P53, DOI 10.1007/978-1-59745-279-3_8; POLLETT M, 1979, AUST J EXP BIOL MED, V57, P151, DOI 10.1038/icb.1979.16; Ritz BW, 2008, J NUTR, V138, P2269, DOI 10.3945/jn.108.093633; Robb JR, 2001, J WILDLIFE MANAGE, V65, P755, DOI 10.2307/3803026; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; SHERMAN P, 1985, AM J PHYSIOL, V248, pG418, DOI 10.1152/ajpgi.1985.248.4.G418; Simpson JW, 2005, CONDOR, V107, P898, DOI 10.1650/7739.1; Smirnov A, 2004, J NUTR, V134, P736, DOI 10.1093/jn/134.4.736; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SPRUNT DH, 1956, J EXP MED, V104, P687, DOI 10.1084/jem.104.5.687; Sprunt DH, 1942, J EXP MED, V75, P297, DOI 10.1084/jem.75.3.297; STEPHENSEN CB, 1993, J NUTR, V123, P823, DOI 10.1093/jn/123.5.823; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Wu R, 2007, VET RES COMMUN, V31, P631, DOI 10.1007/s11259-007-3510-x	49	35	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22633	10.1371/journal.pone.0022633	http://dx.doi.org/10.1371/journal.pone.0022633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857940	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500010
J	Lezin, G; Kosaka, Y; Yost, HJ; Kuehn, MR; Brunelli, L				Lezin, George; Kosaka, Yasuhiro; Yost, H. Joseph; Kuehn, Michael R.; Brunelli, Luca			A One-Step Miniprep for the Isolation of Plasmid DNA and Lambda Phage Particles	PLOS ONE			English	Article							ESCHERICHIA-COLI; RAPID PREPARATION; LYSIS; DETERGENTS	Plasmid DNA minipreps are fundamental techniques in molecular biology. Current plasmid DNA minipreps use alkali and the anionic detergent SDS in a three-solution format. In addition, alkali minipreps usually require additional column-based purification steps and cannot isolate other extra-chromosomal elements, such as bacteriophages. Non-ionic detergents (NIDs) have been used occasionally as components of multiple-solution plasmid DNA minipreps, but a one-step approach has not been developed. Here, we have established a one-tube, one-solution NID plasmid DNA miniprep, and we show that this approach also isolates bacteriophage lambda particles. NID minipreps are more time-efficient than alkali minipreps, and NID plasmid DNA performs better than alkali DNA in many downstream applications. In fact, NID crude lysate DNA is sufficiently pure to be used in digestion and sequencing reactions. Microscopic analysis showed that the NID procedure fragments E. coli cells into small protoplast-like components, which may, at least in part, explain the effectiveness of this approach. This work demonstrates that one-step NID minipreps are a robust method to generate high quality plasmid DNA, and NID approaches can also isolate bacteriophage lambda particles, outperforming current standard alkali-based minipreps.	[Lezin, George; Kosaka, Yasuhiro; Brunelli, Luca] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA; [Yost, H. Joseph] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Kuehn, Michael R.] NCI, Lab Prot Dynam & Signaling, NIH, Frederick, MD 21701 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lezin, G (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT 84112 USA.	mkuehn@mail.nih.gov; luca.brunelli@genetics.utah.edu	Kuehn, Michael R/A-4573-2014	Kuehn, Michael R/0000-0002-7703-9160	Division of Neonatology, the Children's Health Research Center; Primary Children's Medical Center Foundation; Department of Pediatrics, The University of Utah School of Medicine; American Heart Association; Western States Affiliate [09BGIA2251076]; National Institutes of Health, National Cancer Institute, and Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010256] Funding Source: NIH RePORTER	Division of Neonatology, the Children's Health Research Center; Primary Children's Medical Center Foundation; Department of Pediatrics, The University of Utah School of Medicine; American Heart Association(American Heart Association); Western States Affiliate; National Institutes of Health, National Cancer Institute, and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds to L.B. from the Division of Neonatology, the Children's Health Research Center, and the Primary Children's Medical Center Foundation Innovative Grant, Department of Pediatrics, The University of Utah School of Medicine, and the American Heart Association, Beginning Grant-In-Aid, Western States Affiliate (09BGIA2251076); and by funds to M.R.K. from the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services and nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHULER M, 1994, BIOTECHNIQUES, V17, P434; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Cheng L, 2004, J BIOCHEM MOL BIOL, V37, P351; Chowdhury EH, 2005, J BIOTECHNOL, V119, P343, DOI 10.1016/j.jbiotec.2005.05.013; CHOWDHURY K, 1991, NUCLEIC ACIDS RES, V19, P2792, DOI 10.1093/nar/19.10.2792; CLEWELL DB, 1970, BIOCHEMISTRY-US, V9, P4428; CURRIER TC, 1976, ANAL BIOCHEM, V76, P431, DOI 10.1016/0003-2697(76)90338-9; Ferrus M A, 1999, Int Microbiol, V2, P115; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; GODSON GN, 1967, BIOCHIM BIOPHYS ACTA, V149, P476, DOI 10.1016/0005-2787(67)90175-X; GRIFFIN WC, 1954, J SOC COSMET CHEM, V5, P259; GUERRY P, 1973, J BACTERIOL, V116, P1064, DOI 10.1128/JB.116.2.1064-1066.1973; HE M, 1990, NUCLEIC ACIDS RES, V18, P1660, DOI 10.1093/nar/18.6.1660; HELINSKI DR, 1971, ANNU REV BIOCHEM, V40, P899, DOI 10.1146/annurev.bi.40.070171.004343; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KLEIN RD, 1980, PLASMID, V3, P88, DOI 10.1016/S0147-619X(80)90037-2; KOVALENKO SA, 1994, NUCLEIC ACIDS RES, V22, P5771, DOI 10.1093/nar/22.25.5771; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; LEZIN G, 2011, BIOTECHNOL IN PRESS; Marra MA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e37; MORIYON I, 1982, J BACTERIOL, V152, P822; NEUGEBAUER JM, 1990, METHOD ENZYMOL, V182, P239; Paul B, 2008, ANAL BIOCHEM, V377, P218, DOI 10.1016/j.ab.2008.03.005; READER RW, 1971, VIROLOGY, V43, P607, DOI 10.1016/0042-6822(71)90286-8; Reshes G, 2008, BIOPHYS J, V94, P251, DOI 10.1529/biophysj.107.104398; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sayers JR, 1996, ANAL BIOCHEM, V241, P186, DOI 10.1006/abio.1996.0397; SERGHINI MA, 1989, NUCLEIC ACIDS RES, V17, P3604, DOI 10.1093/nar/17.9.3604; Song J, 1999, ANAL BIOCHEM, V271, P89, DOI 10.1006/abio.1999.4106; SUMMERTON J, 1983, ANAL BIOCHEM, V133, P79, DOI 10.1016/0003-2697(83)90224-5; WEISS RL, 1976, J BACTERIOL, V128, P668, DOI 10.1128/JB.128.2.668-670.1976; WOODFORD K, 1991, NUCLEIC ACIDS RES, V19, P6652, DOI 10.1093/nar/19.23.6652; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	36	11	12	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23457	10.1371/journal.pone.0023457	http://dx.doi.org/10.1371/journal.pone.0023457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858126	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700025
J	Wanner, N; Noutsou, F; Baumeister, R; Walz, G; Huber, TB; Neumann-Haefelin, E				Wanner, Nicola; Noutsou, Foteini; Baumeister, Ralf; Walz, Gerd; Huber, Tobias B.; Neumann-Haefelin, Elke			Functional and Spatial Analysis of C. elegans SYG-1 and SYG-2, Orthologs of the Neph/Nephrin Cell Adhesion Module Directing Selective Synaptogenesis	PLOS ONE			English	Article							GLOMERULAR PODOCYTE; NEPHRIN; PROTEIN; GENE; DROSOPHILA; REGULATORS; MYOBLASTS; SYNAPSES; POLARITY; KINASE	The assembly of specific synaptic connections represents a prime example of cellular recognition. Members of the Ig superfamily are among the most ancient proteins represented in the genomes of both mammalian and invertebrate organisms, where they constitute a trans-synaptic adhesion system. The correct connectivity patterns of the highly conserved immunoglobulin superfamily proteins nephrin and Neph1 are crucial for the assembly of functional neuronal circuits and the formation of the kidney slit diaphragm, a synapse-like structure forming the filtration barrier. Here, we utilize the nematode C. elegans model for studying the requirements of synaptic specificity mediated by nephrin-Neph proteins. In C. elegans, the nephrin/Neph1 orthologs SYG-2 and SYG-1 form intercellular contacts strictly in trans between epithelial guidepost cells and neurons specifying the localization of synapses. We demonstrate a functional conservation between mammalian nephrin and SYG-2. Expression of nephrin effectively compensated loss of syg-2 function in C. elegans and restored defective synaptic connectivity further establishing the C. elegans system as a valuable model for slit diaphragm proteins. Next, we investigated the effect of SYG-1 and SYG-2 trans homodimerization respectively. Strikingly, synapse assembly could be induced by homophilic SYG-1 but not SYG-2 binding indicating a critical role of SYG-1 intracellular signalling for morphogenetic events and pointing toward the dynamic and stochastic nature of extra-and intracellular nephrin-Neph interactions to generate reproducible patterns of synaptic connectivity.	[Wanner, Nicola; Noutsou, Foteini; Walz, Gerd; Huber, Tobias B.; Neumann-Haefelin, Elke] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Bioinformat & Mol Genet Fac Biol, Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ Ctr Biochem & Mol Med, Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, FRIAS Sch Life Sci LIFENET, Freiburg, Germany; [Baumeister, Ralf; Walz, Gerd; Huber, Tobias B.] Univ Freiburg, Ctr Biol Signalling Studies Bioss, Freiburg, Germany; [Wanner, Nicola; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Wanner, N (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de; elke.neumann-haefelin@uniklinik-freiburg.de	Neumann-Haefelin, Elke/ABC-3089-2021	Huber, Tobias B./0000-0001-7175-5062	DFG (German Research Foundation) [KFO 201, HU 1016/5-1, SFB 592]; Excellence Initiative of the German Federal and State Governments [EXC 294]	DFG (German Research Foundation)(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This study was supported by DFG (German Research Foundation) grants to ENH (KFO 201) and TBH (HU 1016/5-1, Else-Kroner-Stiftung, SFB 592 and KFO 201) and by the Excellence Initiative of the German Federal and State Governments (EXC 294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Chao DL, 2008, MOL CELL NEUROSCI, V39, P248, DOI 10.1016/j.mcn.2008.07.001; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; LI M, J PATHOL; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; NEUMANNHAEFELIN E, 2010, HUM MOL GENET; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Simons M, 2009, CURR OPIN NEPHROL HY, V18, P324, DOI 10.1097/MNH.0b013e32832e316d; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229	31	18	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23598	10.1371/journal.pone.0023598	http://dx.doi.org/10.1371/journal.pone.0023598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858180	gold, Green Submitted, Green Published			2022-12-25	WOS:000293953700035
J	Krabberod, AK; Brate, J; Dolven, JK; Ose, RF; Klaveness, D; Kristensen, T; Bjorklund, KR; Shalchian-Tabrizi, K				Krabberod, Anders K.; Brate, Jon; Dolven, Jane K.; Ose, Randi F.; Klaveness, Dag; Kristensen, Tom; Bjorklund, Kjell R.; Shalchian-Tabrizi, Kamran			Radiolaria Divided into Polycystina and Spasmaria in Combined 18S and 28S rDNA Phylogeny	PLOS ONE			English	Article							STRONTIUM SULFATE CRYSTALS; STICHOLONCHE-ZANCLEA; EUKARYOTIC DIVERSITY; ACANTHARIA PROTOZOA; HAECKELS RADIOLARIA; SMALL-SUBUNIT; MIXED MODELS; CLASSIFICATION; CERCOZOA; SEQUENCES	Radiolarians are marine planktonic protists that belong to the eukaryote supergroup Rhizaria together with Foraminifera and Cercozoa. Radiolaria has traditionally been divided into four main groups based on morphological characters; i.e. Polycystina, Acantharia, Nassellaria and Phaeodaria. But recent 18S rDNA phylogenies have shown that Phaeodaria belongs within Cerocozoa, and that the previously heliozoan group Taxopodida should be included in Radiolaria. 18S rDNA phylogenies have not yet resolved the sister relationship between the main Radiolaria groups, but nevertheless suggests that Spumellaria, and thereby also Polycystina, are polyphyletic. Very few sequences other than 18S rDNA have so far been generated from radiolarian cells, mostly due to the fact that Radiolaria has been impossible to cultivate and single cell PCR has been hampered by low success rate. Here we have therefore investigated the mutual evolutionary relationship of the main radiolarian groups by using the novel approach of combining single cell whole genome amplification with targeted PCR amplification of the 18S and 28S rDNA genes. Combined 18S and 28S phylogeny of sequences obtained from single cells shows that Radiolaria is divided into two main lineages: Polycystina (Spumellaria+Nassellaria) and Spasmaria (Acantharia+Taxopodida). Further we show with high support that Foraminifera groups within Radiolaria supporting the Retaria hypothesis.	[Krabberod, Anders K.; Brate, Jon; Klaveness, Dag; Kristensen, Tom; Bjorklund, Kjell R.; Shalchian-Tabrizi, Kamran] Univ Oslo, Dept Biol, MERG, Oslo, Norway; [Bjorklund, Kjell R.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Ose, Randi F.; Kristensen, Tom] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Dolven, Jane K.] Univ Oslo, Dept Geosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Krabberod, AK (corresponding author), Univ Oslo, Dept Biol, MERG, Oslo, Norway.	Kamran@bio.uio.no	Bråte, Jon/P-3939-2014; Kristensen, Tom/C-5873-2019	Bråte, Jon/0000-0003-0490-1175; Kristensen, Tom/0000-0002-2131-4469; Krabberod, Anders Kristian/0000-0001-9481-8396	Norwegian Research Council; UiO	Norwegian Research Council(Research Council of NorwayEuropean Commission); UiO	This work has been founded by grants from the Norwegian Research Council to KRB and UiO grants to KS-T and JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON OR, 1990, PHILOS T ROY SOC B, V329, P81, DOI 10.1098/rstb.1990.0152; Anderson R.O., 1983, RADIOLARIA; Bass D, 2005, PROTIST, V156, P149, DOI 10.1016/j.protis.2005.03.001; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; BURKI F, 2010, BMC EVOLUTIONARY BIO; CACHON J, 1977, J CELL BIOL, V72, P314, DOI 10.1083/jcb.72.2.314; CACHON J, 1978, ARCH PROTISTENKD, V120, P148, DOI 10.1016/S0003-9365(78)80019-0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Chantangsi C, 2010, MOL PHYLOGENET EVOL, V57, P518, DOI 10.1016/j.ympev.2010.07.007; De Wever P., 2001, RADIOLARIANS SEDIMEN; Dolven JK, 2007, PROTIST, V158, P65, DOI 10.1016/j.protis.2006.07.004; FEBVRE J, 1989, BIOL CELL, V67, P251, DOI 10.1016/0248-4900(89)90062-2; FEBVRE J, 1981, BIOSYSTEMS, V14, P327, DOI 10.1016/0303-2647(81)90039-3; Gilg IC, 2010, PROTIST, V161, P197, DOI 10.1016/j.protis.2009.09.002; Guillard RRL, 1973, HDB PHYCOLOGICAL MET, P69; HAECKEL E, 1887, REPORT SCI RESULTS V, P1; HUGHES NP, 1989, PROC R SOC SER B-BIO, V238, P223, DOI 10.1098/rspb.1989.0078; Keeling PJ, 2001, MOL BIOL EVOL, V18, P1551, DOI 10.1093/oxfordjournals.molbev.a003941; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; KUNITOMO Y, 2006, EUROPEAN J PROTISTOL, V42; LEVINE ND, 1980, J PROTOZOOL, V27, P37, DOI 10.1111/j.1550-7408.1980.tb04228.x; Longet D, 2003, INT J SYST EVOL MICR, V53, P1735, DOI 10.1099/ijs.0.02597-0; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Maddison WP, 2017, MESQUITE MODULAR SYS; Marande W, 2009, ENVIRON MICROBIOL, V11, P3179, DOI 10.1111/j.1462-2920.2009.02023.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Spiess AN, 2004, CLIN CHEM, V50, P1256, DOI 10.1373/clinchem.2004.031336; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takahashi Osamu, 2004, Revue de Micropaleontologie, V47, P111, DOI 10.1016/j.revmic.2004.06.002; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Yuasa T, 2006, MAR MICROPALEONTOL, V59, P104, DOI 10.1016/j.marmicro.2006.01.003; Yuasa T, 2005, EUR J PROTISTOL, V41, P287, DOI 10.1016/j.ejop.2005.06.001; Yuasa T., 2004, JAP J PROTOZOOL, V37, P133; Yuasa T, 2009, MAR MICROPALEONTOL, V73, P129, DOI 10.1016/j.marmicro.2009.08.001; Zettler LA, 1997, P NATL ACAD SCI USA, V94, P11411, DOI 10.1073/pnas.94.21.11411; Zettler LAA, 1999, MAR MICROPALEONTOL, V36, P67, DOI 10.1016/S0377-8398(98)00028-0; [No title captured]	49	36	39	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23526	10.1371/journal.pone.0023526	http://dx.doi.org/10.1371/journal.pone.0023526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853146	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200094
J	Kumar, S; Bose, D; Suryawanshi, H; Sabharwal, H; Mapa, K; Maiti, S				Kumar, Santosh; Bose, Debojit; Suryawanshi, Hemant; Sabharwal, Harshana; Mapa, Koyeli; Maiti, Souvik			Specificity of RSG-1.2 Peptide Binding to RRE-IIB RNA Element of HIV-1 over Rev Peptide Is Mainly Enthalpic in Origin	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR EXPORT SIGNAL; DRUG-DNA INTERACTIONS; RESPONSE ELEMENT; GENE-EXPRESSION; MESSENGER-RNAS; RIBOSOMAL-RNA; STRUCTURAL-ANALYSIS; COMPLEX-FORMATION; ALPHA-HELIX	Rev is an essential HIV-1 regulatory protein which binds to the Rev responsive element (RRE) present within the env gene of HIV-1 RNA genome. This binding facilitates the transport of the RNA to the cytoplasm, which in turn triggers the switch between viral latency and active viral replication. Essential components of this complex have been localized to a minimal arginine rich Rev peptide and stem IIB region of RRE. A synthetic peptide known as RSG-1.2 binds with high binding affinity and specificity to the RRE-IIB than the Rev peptide, however the thermodynamic basis of this specificity has not yet been addressed. The present study aims to probe the thermodynamic origin of this specificity of RSG-1.2 over Rev Peptide for RRE-IIB. The temperature dependent melting studies show that RSG-1.2 binding stabilizes the RRE structure significantly (Delta T(m) = 4.3 degrees C), in contrast to Rev binding. Interestingly the thermodynamic signatures of the binding have also been found to be different for both the peptides. At pH 7.5, RSG-1.2 binds RRE-IIB with a K(a) = 16.2 +/- 0.6x10(-7) M(-1) where enthalpic change Delta H = -13.9 +/- 0.1 kcal/mol is the main driving force with limited unfavorable contribution from entropic change T Delta S = -2.8 +/- 0.1 kcal/mol. A large part of Delta H may be due to specific stacking between U72 and Arg15. In contrast binding of Rev (K(a) = 3.1 +/- 0.4x10(-7) M(-1)) is driven mainly by entropy (Delta H = 0 kcal/mol and T Delta S = 10.2 +/- 0.2 kcal/mol) which arises from major conformational changes in the RNA upon binding.	[Kumar, Santosh; Bose, Debojit; Suryawanshi, Hemant; Sabharwal, Harshana; Mapa, Koyeli; Maiti, Souvik] Inst Genom & Integrat Biol, CSIR, Prote & Struct Biol Unit, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Kumar, S (corresponding author), Inst Genom & Integrat Biol, CSIR, Prote & Struct Biol Unit, Delhi, India.	souvik@igib.res.in	Bose, Debojit/GRS-0554-2022; Kumar, Santosh/ABF-3590-2021; Bose, Debojit/H-9375-2019	Bose, Debojit/0000-0002-6862-3007; Kumar, Santosh/0000-0002-3594-4795; , Hemant/0000-0002-8102-9678	Council for Scientific and Industrial Research (CSIR) [NWP 0036]	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	SM acknowledges Council for Scientific and Industrial Research (CSIR, Project Title: NWP 0036). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO SJ, 1990, J VIROL, V64, P4585, DOI 10.1128/JVI.64.9.4585-4588.1990; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Barbieri CM, 2007, TETRAHEDRON, V63, P3567, DOI 10.1016/j.tet.2006.08.107; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; DELLING U, 1991, P NATL ACAD SCI USA, V88, P6234, DOI 10.1073/pnas.88.14.6234; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; Fischer U, 1999, NUCLEIC ACIDS RES, V27, P4128, DOI 10.1093/nar/27.21.4128; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; GAIT MJ, 1993, TRENDS BIOCHEM SCI, V18, P255, DOI 10.1016/0968-0004(93)90176-N; Gosser Y, 2001, NAT STRUCT BIOL, V8, P146, DOI 10.1038/84138; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; Haq I, 1997, J MOL BIOL, V271, P244, DOI 10.1006/jmbi.1997.1170; Haq I, 2000, METHOD ENZYMOL, V323, P373; Harada K, 1997, P NATL ACAD SCI USA, V94, P11887, DOI 10.1073/pnas.94.22.11887; HEAPHY S, 1991, P NATL ACAD SCI USA, V88, P7366, DOI 10.1073/pnas.88.16.7366; HOPE T, 1995, CURR TOP MICROBIOL, V193, P91; Indyk L, 1998, METHOD ENZYMOL, V295, P350; IWAI S, 1992, NUCLEIC ACIDS RES, V20, P6465, DOI 10.1093/nar/20.24.6465; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Luque I, 2002, PROTEINS, V49, P181, DOI 10.1002/prot.10208; MALIM MH, 1993, MOL CELL BIOL, V13, P6180, DOI 10.1128/MCB.13.10.6180; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; MARKY LA, 1983, BIOPOLYMERS, V22, P1247, DOI 10.1002/bip.360220416; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mazur S, 2000, J MOL BIOL, V300, P321, DOI 10.1006/jmbi.2000.3869; Michael LA, 2009, J MOL BIOL, V392, P774, DOI 10.1016/j.jmb.2009.07.047; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SHARP KA, 2000, THERMODYNAMICS BIOL, P113; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Suryawanshi H, 2010, J PHYS CHEM B, V114, P11155, DOI 10.1021/jp1000545; TAN RY, 1994, BIOCHEMISTRY-US, V33, P14579, DOI 10.1021/bi00252a025; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Yedavalli VSRK, 2011, RNA BIOL, V8, P195, DOI 10.4161/rna.8.2.14803; Zhang Q, 2001, CHEM BIOL, V8, P511, DOI 10.1016/S1074-5521(01)00027-8	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23300	10.1371/journal.pone.0023300	http://dx.doi.org/10.1371/journal.pone.0023300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853108	Green Submitted, gold, Green Published			2022-12-25	WOS:000295454200068
J	Sher, RB; Cox, GA; Mills, KD; Sundberg, JP				Sher, Roger B.; Cox, Gregory A.; Mills, Kevin D.; Sundberg, John P.			Rhabdomyosarcomas in Aging A/J Mice	PLOS ONE			English	Article							ALVEOLAR RHABDOMYOSARCOMA; MYOGENIC DIFFERENTIATION; MOLECULAR PATHOGENESIS; SATELLITE CELLS; MUTANT MICE; DEFICIENCY; GENE; INACTIVATION; CHILDHOOD; PAX3	Rhabdomyosarcomas (RSCs) are skeletal muscle neoplasms found in humans and domestic mammals. The A/J inbred strain developed a high frequency (between 70-80%) of adult pleomorphic type (APT) RSC at.20 months of age while BALB/cByJ also develop RSC but less frequently. These neoplasms invaded skeletal muscle surrounding either the axial or proximal appendicular skeleton and were characterized by pleomorphic cells with abundant eosinophilic cytoplasm, multiple nuclei, and cross striations. The diagnosis was confirmed by detection of alpha-sarcomeric actin and myogenin in the neoplastic cells using immunocytochemistry. The A/J strain, but not the related BALB/c substrains, is also characterised by a progressive muscular dystrophy homologous to limb-girdle muscular dystrophy type 2B. The association between the development of RSC in similar muscle groups to those most severely affected by the progressive muscular dystrophy suggested that these neoplasms developed from abnormal regeneration of the skeletal muscle exacerbated by the dysferlin mutation. Transcriptome analyses of RSCs revealed marked downregulation of genes in muscular development and function signaling networks. Non-synonymous coding SNPs were found in Myl1, Abra, Sgca, Ttn, and Kcnj12 suggesting these may be important in the pathogenesis of RSC. These studies suggest that A strains of mice can be useful models for dissecting the molecular genetic basis for development, progression, and ultimately for testing novel anticancer therapeutic agents dealing with rhabdomyosarcoma.	[Sher, Roger B.; Cox, Gregory A.; Mills, Kevin D.; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Sher, RB (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org			NCI NIH HHS [CA089713, R01 CA089713, P30 CA034196, CA34196] Funding Source: Medline; NIA NIH HHS [AG25707, P30 AG038070, P30 AG025707] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196, R01CA089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038070, P30AG025707] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Asakura A, 2003, CANCER CELL, V4, P421, DOI 10.1016/S1535-6108(03)00313-1; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; BOOTH C, 1996, PATHOBIOLOGY AGING M, P51; Brodie SG, 2001, ONCOGENE, V20, P1445, DOI 10.1038/sj.onc.1204222; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; De Bortoli M, 2007, EUR J CANCER, V43, P1308, DOI 10.1016/j.ejca.2007.02.008; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; Fernandez K, 2010, AM J PATHOL, V176, P416, DOI 10.2353/ajpath.2010.090405; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hawkins WG, 2001, CANCER-AM CANCER SOC, V91, P794, DOI 10.1002/1097-0142(20010215)91:4<794::AID-CNCR1066>3.0.CO;2-Q; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huh Michael S., 2005, Birth Defects Research, V75, P180, DOI 10.1002/bdrc.20045; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Jahnke VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008637; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; KRAMER S, 1983, J NATL CANCER I, V70, P49; Kumar S, 2000, MODERN PATHOL, V13, P988, DOI 10.1038/modpathol.3880179; Li HG, 2007, CANCER LETT, V253, P215, DOI 10.1016/j.canlet.2007.01.020; Maas SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-132; Mercado GE, 2007, CURR MOL MED, V7, P47, DOI 10.2174/156652407779940440; Nanni P, 2003, CANCER RES, V63, P2728; Nanni P, 2009, MOL CANCER THER, V8, P754, DOI 10.1158/1535-7163.MCT-08-0678; Ognjanovic S, 2009, CANCER-AM CANCER SOC, V115, P4218, DOI 10.1002/cncr.24465; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Sabbioni S, 1997, CANCER RES, V57, P4493; SEYMOUR R, 2004, NECROPSY METHODS, P495; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; STEWART HL, 1959, PATHOLOGYAFIO, P83; Sundberg J. P., 2005, HDB GENETICALLY ENG, P223; Sundberg JP, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7179; SUNDBERG JP, 1991, VET PATHOL, V28, P200, DOI 10.1177/030098589102800303; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Tiffin N, 2003, BRIT J CANCER, V89, P327, DOI 10.1038/sj.bjc.6601040; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; WANEBO HJ, 1966, SCIENCE, V154, P901, DOI 10.1126/science.154.3751.901; Wang ZQ, 2007, EXP MOL PATHOL, V82, P58, DOI 10.1016/j.yexmp.2006.09.004; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068	47	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23498	10.1371/journal.pone.0023498	http://dx.doi.org/10.1371/journal.pone.0023498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853140	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200089
J	Coll-Llado, M; Acinas, SG; Pujades, C; Pedros-Alio, C				Coll-Llado, Montserrat; Acinas, Silvia G.; Pujades, Cristina; Pedros-Alio, Carlos			Transcriptome Fingerprinting Analysis: An Approach to Explore Gene Expression Patterns in Marine Microbial Communities	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; INTERGENIC SPACER ANALYSIS; DIFFERENTIAL DISPLAY; MESSENGER-RNA; DIVERSITY; BACTERIOPLANKTON; OCEAN; ASSEMBLAGES; TARGET; DGGE	Microbial transcriptomics are providing new insights into the functional processes of microbial communities. However, analysis of each sample is still expensive and time consuming. A rapid and low cost method that would allow the identification of the most interesting samples for posterior in-depth metatranscriptomics analysis would be extremely useful. Here we present Transcriptome Fingerprinting Analysis (TFA) as an approach to fulfill this objective in microbial ecology studies. We have adapted the differential display technique for mRNA fingerprinting based on the PCR amplification of expressed transcripts to interrogate natural microbial eukaryotic communities. Unlike other techniques, TFA does not require prior knowledge of the mRNA sequences to be detected. We have used a set of arbitrary primers coupled with a fluorescence labeled primer targeting the poly(A) tail of the eukaryotic mRNA, with further detection of the resulting labeled cDNA products in an automated genetic analyzer. The output represented by electropherogram peak patterns allowed the comparison of a set of genes expressed at the time of sampling. TFA has been optimized by testing the sensitivity of the method for different initial RNA amounts, and the repeatability of the gene expression patterns with increasing time after sampling both with cultures and environmental samples. Results show that TFA is a promising approach to explore the dynamics of gene expression patterns in microbial communities.	[Coll-Llado, Montserrat; Acinas, Silvia G.; Pedros-Alio, Carlos] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain; [Pujades, Cristina] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Pompeu Fabra University	Coll-Llado, M (corresponding author), CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain.	cpedros@icm.csic.es	Pedrós-Alió, Carlos/H-1222-2011; Acinas, Silvia/F-7462-2016; Pujades, Cristina/F-7908-2014	Pedrós-Alió, Carlos/0000-0003-1009-4277; Acinas, Silvia/0000-0002-3439-0428; Pujades, Cristina/0000-0001-6423-7451; Coll-Llado, Montserrat/0000-0003-0169-4107	Spanish Ministry of Science and Innovation [CTM2007-63753-C02-01/MAR]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MC-L was the recipient of an FPI fellowship from the Spanish Ministry of Science and Innovation. This work was funded by grant GEMMA (CTM2007-63753-C02-01/MAR) from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 1997, FEMS MICROBIOL ECOL, V24, P27, DOI 10.1111/j.1574-6941.1997.tb00420.x; BROOKS EM, 1995, BIOTECHNIQUES, V19, P806; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Diez B, 2004, LIMNOL OCEANOGR, V49, P1022; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hewson I, 2010, ENVIRON MICROBIOL, V12, P1940, DOI 10.1111/j.1462-2920.2010.02198.x; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lo PK, 1999, ONCOGENE, V18, P7765, DOI 10.1038/sj.onc.1203167; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Olson R.J., 2018, HDB METHODS AQUATIC, P175, DOI DOI 10.1201/9780203752746; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; PORETSKY RS, 2009, JOVE-J VIS EXP, DOI DOI 10.3791/1086; Riemann L, 1999, DEEP-SEA RES PT II, V46, P1791, DOI 10.1016/S0967-0645(99)00044-2; Schauer M, 2000, FEMS MICROBIOL ECOL, V33, P51, DOI 10.1111/j.1574-6941.2000.tb00726.x; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tan S S, 1992, PCR Methods Appl, V2, P137; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van Hannen EJ, 1998, J PHYCOL, V34, P206, DOI 10.1046/j.1529-8817.1998.340206.x	33	3	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22950	10.1371/journal.pone.0022950	http://dx.doi.org/10.1371/journal.pone.0022950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857972	Green Published, gold			2022-12-25	WOS:000293774300013
J	Sannasiddappa, TH; Costabile, A; Gibson, GR; Clarke, SR				Sannasiddappa, Thippeswamy H.; Costabile, Adele; Gibson, Glenn R.; Clarke, Simon R.			The Influence of Staphylococcus aureus on Gut Microbial Ecology in an In Vitro Continuous Culture Human Colonic Model System	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INTESTINAL MICROBIOTA; SITU HYBRIDIZATION; NASAL CARRIAGE; MOUSE MODEL; BACTERIA; BUTYRATE; GROWTH; BIFIDOBACTERIA; COLONIZATION	An anaerobic three-stage continuous culture model of the human colon (gut model), which represent different anatomical areas of the large intestine, was used to study the effect of S. aureus infection of the gut on the resident faecal microbiota. Studies on the development of the microbiota in the three vessels were performed and bacteria identified by culture independent fluorescence in situ hybridization (FISH). Furtheremore, short chain fatty acids (SCFA), as principal end products of gut bacterial metabolism, were measured along with a quantitative assessment of the predominant microbiota. During steady state conditions, numbers of S. aureus cells stabilised until they were washed out, but populations of indigenous bacteria were transiently altered; thus S. aureus was able to compromise colonisation resistance by the colonic microbiota. Furthermore, the concentration of butyric acid in the vessel representing the proximal colon was significantly decreased by infection. Thus infection by S. aureus appears to be able to alter the overall structure of the human colonic microbiota and the microbial metabolic profiles. This work provides an initial in vitro model to analyse interactions with pathogens.	[Sannasiddappa, Thippeswamy H.; Clarke, Simon R.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Costabile, Adele; Gibson, Glenn R.] Univ Reading, Sch Food & Nutr Sci, Food Microbial Sci Uni, Reading, Berks, England	University of Reading; University of Reading	Sannasiddappa, TH (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	s.r.clarke@reading.ac.uk	Gibson, Glenn R/A-9595-2009	Costabile, Adele/0000-0003-3185-030X				Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Bhalla A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-105; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Faden H, 2010, PEDIATRICS, V125, pE618, DOI 10.1542/peds.2009-1523; FONS M, 2000, MICROB ECOL HEALTH D, V2, P240; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Froberg MK, 2004, CLIN INFECT DIS, V39, P747, DOI 10.1086/423273; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; GIBSON GR, 1988, APPL ENVIRON MICROB, V54, P2750, DOI 10.1128/AEM.54.11.2750-2755.1988; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hess DJ, 2005, SHOCK, V24, P376, DOI 10.1097/01.shk.0000180615.75822.fe; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lemmens N, 2011, MICROB PATHOGENESIS, V50, P192, DOI 10.1016/j.micpath.2010.12.006; Lindberg E, 2004, J CLIN MICROBIOL, V42, P530, DOI 10.1128/JCM.42.2.530-534.2004; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Lundell AC, 2007, CLIN EXP ALLERGY, V37, P62, DOI 10.1111/j.1365-2222.2006.02625.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; Masaki H, 2003, INTERNAL MED, V42, P281, DOI 10.2169/internalmedicine.42.281; Nakamura Y, 2001, J SURG RES, V96, P35, DOI 10.1006/jsre.2000.6043; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Ochoa-Zarzosa A, 2009, MICROB PATHOGENESIS, V47, P1, DOI 10.1016/j.micpath.2009.04.006; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Ray AJ, 2003, CLIN INFECT DIS, V37, P875, DOI 10.1086/377451; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Rosignoli P, 2001, CARCINOGENESIS, V22, P1675, DOI 10.1093/carcin/22.10.1675; SAKATA T, 1983, COMP BIOCHEM PHYS A, V74, P459, DOI 10.1016/0300-9629(83)90631-X; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Siavoshian S, 1997, CELL BIOL INT, V21, P281, DOI 10.1006/cbir.1997.0153; Squier C, 2002, INFECT CONT HOSP EP, V23, P495, DOI 10.1086/502095; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; VONEIFF C, 2001, NEW ENGL J MED, V344, P505; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	49	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23227	10.1371/journal.pone.0023227	http://dx.doi.org/10.1371/journal.pone.0023227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858036	Green Submitted, Green Published, gold			2022-12-25	WOS:000293774300028
J	Kong, MYF; Li, Y; Oster, R; Gaggar, A; Clancy, JP				Kong, Michele Y. F.; Li, Yao; Oster, Robert; Gaggar, Amit; Clancy, J. P.			Early Elevation of Matrix Metalloproteinase-8 and-9 in Pediatric ARDS Is Associated with an Increased Risk of Prolonged Mechanical Ventilation	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; NEUTROPHIL MIGRATION; PREVENTS; INHIBITION; OUTCOMES	Background: Matrix metalloproteinases (MMP) -8 and -9 may play key roles in the modulation of neutrophilic lung inflammation seen in pediatric Acute Respiratory Distress Syndrome (ARDS). We aimed to perform a comprehensive analysis of MMP-8 and MMP-9 activity in tracheal aspirates of pediatric ARDS patients compared with non-ARDS controls, testing whether increased MMP-8 and -9 activities were associated with clinical outcomes. Methods: Tracheal aspirates were collected from 33 pediatric ARDS patients and 21 non-ARDS controls at 48 hours of intubation, and serially for those who remained intubated greater than five days. MMPs, tissue inhibitor of metalloproteinases (TIMPs), human neutrophil elastase (HNE) and myeloperoxidase (MPO) activity were measured by ELISA, and correlated with clinical indicators of disease severity such as PRISM (Pediatric Risk of Mortality) scores, oxygen index (OI), multi-organ system failure (MOSF) and clinical outcome measures including length of intubation, ventilator-free days (VFDs) and mortality in the Pediatric Intensive Care Unit (PICU). Results: Active MMP-9 was elevated early in pediatric ARDS subjects compared to non-ARDS controls. Higher MMP-8 and active MMP-9 levels at 48 hours correlated with a longer course of mechanical ventilation (r = 0.41, p = 0.018 and r = 0.75, p<0.001; respectively) and fewer number of VFDs (r = -0.43, p = 0.013 and r = -0.76, p<0.001; respectively), independent of age, gender and severity of illness. Patients with the highest number of ventilator days had the highest levels of active MMP-9. MMP-9 and to a lesser extent MMP-8 activities in tracheal aspirates from ARDS subjects were sensitive to blockade by small molecule inhibitors. Conclusions: Higher MMP-8 and active MMP-9 levels at 48 hours of disease onset are associated with a longer duration of mechanical ventilation and fewer ventilator-free days among pediatric patients with ARDS. Together, these results identify early biomarkers predictive of disease course and potential therapeutic targets for this life threatening disease.	[Kong, Michele Y. F.; Li, Yao] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Oster, Robert; Gaggar, Amit] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Clancy, J. P.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cincinnati Children's Hospital Medical Center	Kong, MYF (corresponding author), Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA.	mkong@peds.uab.edu		Oster, Robert/0000-0002-2247-8596	Kaul Pediatric Research Institute	Kaul Pediatric Research Institute	This study is funded by the Kaul Pediatric Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaiceta GM, 2008, AM J PHYSIOL-LUNG C, V294, pL535, DOI 10.1152/ajplung.00334.2007; Bendeck MP, 2002, AM J PATHOL, V160, P1089, DOI 10.1016/S0002-9440(10)64929-2; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Carney DE, 1999, CIRCULATION, V100, P400, DOI 10.1161/01.CIR.100.4.400; Carney DE, 2001, J SURG RES, V99, P245, DOI 10.1006/jsre.2001.6180; Cederqvist K, 2006, PEDIATR RES, V60, P395, DOI 10.1203/01.pdr.0000238342.16081.f9; Dahlem P, 2007, PAEDIATR RESPIR REV, V8, P348, DOI 10.1016/j.prrv.2007.03.001; Delclaux C, 1996, AM J RESP CELL MOL, V14, P288, DOI 10.1165/ajrcmb.14.3.8845180; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; Flori HR, 2007, PEDIATR CRIT CARE ME, V8, P96, DOI 10.1097/01.PCC.0000257097.42640.6F; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Golub L M, 1998, Adv Dent Res, V12, P12; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348; Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005; Kim JH, 2004, AM J PHYSIOL-LUNG C, V287, pL127, DOI 10.1152/ajplung.00047.2003; Kong MYF, 2009, INT J MED SCI, V6, P9; Lanchou J, 2003, CRIT CARE MED, V31, P536, DOI 10.1097/01.CCM.0000048626.02184.F8; Lukkarinen H, 2009, AM J RESP CELL MOL, V41, P59, DOI 10.1165/rcmb.2008-0179OC; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Reel B, 2009, PEDIATR PULM, V44, P1118, DOI 10.1002/ppul.21111; Ricou B, 1996, AM J RESP CRIT CARE, V154, P346, DOI 10.1164/ajrccm.154.2.8756805; Sapru A, 2010, INTENS CARE MED, V36, P157, DOI 10.1007/s00134-009-1690-2; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Steinberg J, 2005, SHOCK, V24, P348, DOI 10.1097/01.shk.0000180619.06317.2c; Torii K, 1997, AM J RESP CRIT CARE, V155, P43, DOI 10.1164/ajrccm.155.1.9001287; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1	29	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22596	10.1371/journal.pone.0022596	http://dx.doi.org/10.1371/journal.pone.0022596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857935	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900019
J	Wang, J; Anderson, PD; Luo, W; Gius, D; Roh, M; Abdulkadir, SA				Wang, J.; Anderson, P. D.; Luo, W.; Gius, D.; Roh, M.; Abdulkadir, S. A.			Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells	ONCOGENE			English	Article						Pim1 kinase; MYC; gene expression; Erk; tumorigenicity	C-MYC; TUMOR-GROWTH; MICE; PHOSPHORYLATION; INHIBITION; CARCINOMA; APOPTOSIS; PROTEIN	PIM1 kinase and MYC are commonly co-expressed in human prostate cancer and synergize to induce rapidly progressing prostate cancer in mouse models. Deficiency of the Pim kinase genes is well tolerated in vivo, suggesting that PIM1 inhibition might offer an attractive therapeutic modality for prostate cancer, particularly for MYC-expressing tumors. Here we examine the molecular consequences of Pim1 and MYC overexpression in the prostate as well as the effects of depleting Pim1 in prostate carcinoma cells with high levels of MYC. Overexpression of Pim1 in the mouse prostate induces several pro-tumorigenic genetic programs including cell cycle genes and Myc regulated genes before the induction of any discernible pathology. Pim1 depletion by RNA interference in mouse and human prostate cancer cells decreased cellular proliferation, survival, Erk signaling and tumorigenicity even when MYC levels were not significantly altered. These results indicate that PIM1 may be necessary to maintain tumorigenicity, and further support efforts aimed at developing PIM1 inhibitors for prostate cancer therapy. Oncogene (2012) 31, 1794-1803; doi: 10.1038/onc.2011.371; published online 22 August 2011	[Anderson, P. D.; Roh, M.; Abdulkadir, S. A.] Vanderbilt Univ, Dept Pathol, Med Ctr, Nashville, TN 37232 USA; [Wang, J.; Gius, D.; Abdulkadir, S. A.] Vanderbilt Univ, Dept Canc Biol, Med Ctr, Nashville, TN 37232 USA; [Luo, W.] Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN 37232 USA; [Gius, D.] Vanderbilt Univ, Dept Pediat, Med Ctr, Nashville, TN 37232 USA; [Gius, D.] Vanderbilt Univ, Dept Radiat Oncol, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Abdulkadir, SA (corresponding author), Vanderbilt Univ, Dept Pathol, Med Ctr, B33321A MCN, Nashville, TN 37232 USA.	sarki.abdulkadir@vanderbilt.edu			NCI [RO1CA123484, R01CA152601]; DOD [BC093803]; NATIONAL CANCER INSTITUTE [R01CA123484, R01CA152601] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Robert Matusik, Simon Hayward, Vito Quaranta, Xiuping Yu and Fritz Parl for helpful discussions. Micrographs were taken from Cell Imaging Core at Vanderbilt University Medical Center. This work was supported by Grant RO1CA123484 from the NCI to SAA. while DG is supported by R01CA152601 from the NCI and BC093803 from the DOD.	Abdulkadir SA, 2000, HUM PATHOL, V31, P443, DOI 10.1053/hp.2000.6547; Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Berns A, 1999, CANCER RES, V59, p1773S; Burton GR, 2004, GENE, V329, P167, DOI 10.1016/j.gene.2003.12.012; Chen J, 2009, AM J PATHOL, V175, P400, DOI 10.2353/ajpath.2009.080972; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Gu JJ, 2009, ONCOGENE, V28, P4261, DOI 10.1038/onc.2009.276; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Kim J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-248; LAIRD PW, 1993, NUCLEIC ACIDS RES, V21, P4750, DOI 10.1093/nar/21.20.4750; Leiblich A, 2007, PROSTATE, V67, P1761, DOI 10.1002/pros.20654; Magnuson NS, 2010, FUTURE ONCOL, V6, P1461, DOI 10.2217/FON.10.106; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Roh M, 2003, CANCER RES, V63, P8079; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	31	54	58	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	14					1794	1803		10.1038/onc.2011.371	http://dx.doi.org/10.1038/onc.2011.371			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21860423	Green Accepted			2022-12-25	WOS:000302785200005
J	Furuya, Y; Mori, K; Ninomiya, T; Tomimori, Y; Tanaka, S; Takahashi, N; Udagawa, N; Uchida, K; Yasuda, H				Furuya, Yuriko; Mori, Kaoru; Ninomiya, Tadashi; Tomimori, Yoshiya; Tanaka, Sakae; Takahashi, Naoyuki; Udagawa, Nobuyuki; Uchida, Kohji; Yasuda, Hisataka			Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-kappa B Ligand-neutralizing Antibody EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLASTOGENESIS-INHIBITORY FACTOR; HUMAN MONOCLONAL-ANTIBODY; DIFFERENTIATION FACTOR; POSTMENOPAUSAL WOMEN; OSTEOPROTEGERIN OPG; CELL FUNCTION; RANK LIGAND; RECEPTOR; RESORPTION; DENOSUMAB	Receptor activator of nuclear factor-kappa B ligand (RANKL) is a pivotal osteoclast differentiation factor. To investigate the effect of RANKL inhibition in normal mice, we prepared an anti-mouse RANKL-neutralizing monoclonal antibody (Mab, clone OYC1) and established a new mouse model with high bone mass induced by administration of OYC1. A single subcutaneous injection of 5 mg/kg OYC1 in normal mice significantly augmented the bone mineral density in the distal femoral metaphysis from day 2 to day 28. The OYC1 treatment markedly reduced the serum level of tartrate-resistant acid phosphatase-5b (TRAP-5b, a marker for osteoclasts) on day 1, and this level was undetectable from day 3 to day 28. The serum level of alkaline phosphatase (a marker for osteoblasts) declined significantly following the reduction of TRAP-5b. Histological analysis revealed few osteoclasts in femurs of the treated mice on day 4, and both osteoclasts and osteoblasts were markedly diminished on day 14. Daily injection of parathyroid hormone for 2 weeks increased the bone mineral density in trabecular and cortical bone by stimulating bone formation in the OYC1-treated mice. These results suggest that parathyroid hormone exerted its bone anabolic activity in mice with few osteoclasts. The mouse anti-RANKL neutralizing antibody OYC1 may be a useful tool to investigate unknown functions of RANKL in vivo.	[Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan; [Furuya, Yuriko; Mori, Kaoru; Tomimori, Yoshiya; Uchida, Kohji] Oriental Yeast Co Ltd, Nagahama Branch, Nagahama Inst Biochem Sci, Shiga 5260804, Japan; [Ninomiya, Tadashi; Takahashi, Naoyuki; Udagawa, Nobuyuki] Matsumoto Dent Univ, Inst Oral Sci, Nagano 3990781, Japan; [Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Nagano 3990781, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan	Oriental Yeast Co., Ltd.; Oriental Yeast Co., Ltd.; Matsumoto Dental University; Matsumoto Dental University; University of Tokyo	Yasuda, H (corresponding author), Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, 3-610 Azusawa, Tokyo 1748505, Japan.	hyasuda@oyc.co.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414				Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Capparelli C, 2003, J BONE MINER RES, V18, P852, DOI 10.1359/jbmr.2003.18.5.852; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Hofbauer LC, 2009, ARTHRITIS RHEUM, V60, P1427, DOI 10.1002/art.24445; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kamijo S, 2006, BIOCHEM BIOPH RES CO, V347, P124, DOI 10.1016/j.bbrc.2006.06.098; Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kostenuik PJ, 2001, ENDOCRINOLOGY, V142, P4295, DOI 10.1210/en.142.10.4295; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Ominsky MS, 2007, OSTEOPOROSIS INT, V18, P1073, DOI 10.1007/s00198-007-0363-7; Oyajobi BO, 2001, CANCER RES, V61, P2572; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pierroz DD, 2010, J BIOL CHEM, V285, P28164, DOI 10.1074/jbc.M110.101964; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	32	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					37023	37031		10.1074/jbc.M111.246280	http://dx.doi.org/10.1074/jbc.M111.246280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862583	hybrid, Green Published			2022-12-25	WOS:000296538300080
J	Sun, JL; Pan, HH; Lei, CW; Yuan, B; Nair, SJ; April, C; Parameswaran, B; Klotzle, B; Fan, JB; Ruan, JH; Li, R				Sun, Jianlong; Pan, Haihui; Lei, Chengwei; Yuan, Bin; Nair, Sreejith J.; April, Craig; Parameswaran, Balaji; Klotzle, Brandy; Fan, Jian-Bing; Ruan, Jianhua; Li, Rong			Genetic and Genomic Analyses of RNA Polymerase II-pausing Factor in Regulation of Mammalian Transcription and Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE ELONGATION-FACTOR; IMMUNODEFICIENCY-VIRUS TRANSCRIPTION; P-TEFB; POL-II; ACTIVE PROMOTERS; FACTOR NELF; DROSOPHILA; COMPLEX; DSIF; EXPRESSION	Many mammalian genes are occupied by paused RNA polymerase II (pol II) in the promoter-proximal region on both sides of the transcription start site. However, the impact of pol II pausing on gene expression and cell biology is not fully understood. In this study, we used a Cre-Lox system to conditionally knock out the b subunit of mouse negative elongation factor (Nelf-b), a key pol II-pausing factor, in mouse embryonic fibroblasts. We found that Nelf-b was associated with the promoter-proximal region of the majority of expressed genes, yet genetic ablation of Nelf-b only affected the steady-state mRNA levels of a small percentage of the Nelf-b-associated genes. Interestingly, Nelf-b deletion also increased levels of transcription start site upstream transcripts at multiple negative elongation factor-associated genes. The direct target genes of Nelf-b were highly enriched with those involved in the control of cell growth and cell death. Correspondingly, Nelf-b knock-out mouse embryonic fibroblasts exhibited slower progression from quiescence to proliferation, as well as in a cycling cell population. Furthermore, Nelf-b deletion also resulted in increased apoptosis. Thus, the genetic and genomic studies provide new physiological and molecular insight into Nelf-mediated pol II pausing.	[Lei, Chengwei; Ruan, Jianhua] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX 78249 USA; [Sun, Jianlong; Pan, Haihui; Yuan, Bin; Nair, Sreejith J.; Parameswaran, Balaji; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78245 USA; [April, Craig; Klotzle, Brandy; Fan, Jian-Bing] Illumina Inc, San Diego, CA 92121 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Illumina	Ruan, JH (corresponding author), Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX 78249 USA.	jruan@cs.utsa.edu; lir3@uthscsa.edu	Yuan, Bin/AAT-1286-2021; Ruan, Jianhua/I-2529-2012	Parameswaran, Balaji/0000-0002-1665-4872; Nair, Sreejith Janardhanan/0000-0001-6295-1133; Ruan, Jianhua/0000-0002-5622-3137	Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, a National Institutes of Health NCI-designated Cancer Center; National Institutes of Health [SC3GM086305]; Voelcker scholar award; Department of Defense [W81XWH-09-1-0014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM086305] Funding Source: NIH RePORTER	Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, a National Institutes of Health NCI-designated Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker scholar award; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Kay-Uwe Wagner for plasmids and Drs. Paul Labhart, Vassili Alexiadis, and Wei Li for technical support and advice. We gratefully acknowledge the support of the Cancer Therapy and Research Center, University of Texas Health Science Center San Antonio, a National Institutes of Health NCI-designated Cancer Center.; This work was supported, in whole or in part, by National Institutes of Health Grant SC3GM086305 (to J. R.). This work was also supported by a Voelcker scholar award (to R. L.) and Department of Defense Breast Cancer Predoctoral Fellowship W81XWH-09-1-0014 (to S. J. N.).	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Fujita T, 2008, MOL CELL BIOL, V28, P1630, DOI 10.1128/MCB.01767-07; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200	50	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36248	36257		10.1074/jbc.M111.269167	http://dx.doi.org/10.1074/jbc.M111.269167			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21865163	Green Published, hybrid			2022-12-25	WOS:000296538300009
J	Kopil, CM; Vais, H; Cheung, KH; Siebert, AP; Mak, DOD; Foskett, JK; Neumar, RW				Kopil, Catherine M.; Vais, Horia; Cheung, King-Ho; Siebert, Adam P.; Mak, Don-On Daniel; Foskett, J. Kevin; Neumar, Robert W.			Calpain-cleaved Type 1 Inositol 1,4,5-Trisphosphate Receptor (InsP(3)R1) Has InsP(3)-independent Gating and Disrupts Intracellular Ca2+ Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT GLOBAL-ISCHEMIA; ASPHYXIAL CARDIAC-ARREST; TRISPHOSPHATE RECEPTOR; RAT-BRAIN; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; CA1 REGION; CELL-DEATH; SHORT-TERM; APOPTOSIS	The type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1) is a ubiquitous intracellular Ca2+ release channel that is vital to intracellular Ca2+ signaling. InsP(3)R1 is a proteolytic target of calpain, which cleaves the channel to form a 95-kDa carboxyl-terminal fragment that includes the transmembrane domains, which contain the ion pore. However, the functional consequences of calpain proteolysis on channel behavior and Ca2+ homeostasis are unknown. In the present study we have identified a unique calpain cleavage site in InsP(3)R1 and utilized a recombinant truncated form of the channel (capn-InsP(3)R1) corresponding to the stable, carboxyl-terminal fragment to examine the functional consequences of channel proteolysis. Single-channel recordings of capn-InsP3R1 revealed InsP(3)-independent gating and high open probability (P-o) under optimal cytoplasmic Ca2+ concentration ([Ca2+](i)) conditions. However, some [Ca2+](i) regulation of the cleaved channel remained, with a lower P-o in suboptimal and inhibitory [Ca2+](i). Expression of capn-InsP(3)R1 in N2a cells reduced the Ca2+ content of ionomycin-releasable intracellular stores and decreased endoplasmic reticulum Ca2+ loading compared with control cells expressing full-length InsP(3)R1. Using a cleavage-specific antibody, we identified calpain-cleaved InsP(3)R1 in selectively vulnerable cerebellar Purkinje neurons after in vivo cardiac arrest. These findings indicate that calpain proteolysis of InsP(3)R1 generates a dys-regulated channel that disrupts cellular Ca2+ homeostasis. Furthermore, our results demonstrate that calpain cleaves InsP(3)R1 in a clinically relevant injury model, suggesting that Ca2+ leak through the proteolyzed channel may act as a feed-forward mechanism to enhance cell death.	[Kopil, Catherine M.; Neumar, Robert W.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Vais, Horia; Cheung, King-Ho; Siebert, Adam P.; Mak, Don-On Daniel; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Cheung, King-Ho] Univ Hong Kong, Dept Physiol, Pok Fu Lam, Hong Kong, Peoples R China	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Hong Kong	Neumar, RW (corresponding author), 3400 Spruce St,Ground Floor Ravdin Bldg, Philadelphia, PA 19104 USA.	neumarr@uphs.upenn.edu	Foskett, Kevin/R-2549-2019; /B-3424-2011	/0000-0001-8683-1654; Foskett, J. Kevin/0000-0002-8854-0268	National Institutes of Health [NS039481, NS069951, NS071828, MH059937, GM065830]; American Heart Association [0815440D]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R01GM065830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS071828, R21NS069951, R01NS039481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants NS039481 (to R. W. N.), NS069951 (to R. W. N.), NS071828 (to C. M. K.), MH059937 (to J. K. F.), and GM065830 (D.-O. D. M. and J. K. F.). This work was also supported by American Heart Association Grant 0815440D (to C. M. K.).	Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Beresewicz M, 2006, NEUROCHEM INT, V48, P568, DOI 10.1016/j.neuint.2005.11.020; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Che DF, 2011, CRIT CARE MED, V39, P1423, DOI 10.1097/CCM.0b013e318212020a; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Colbourne F, 1996, J NEUROSCI METH, V67, P185, DOI 10.1016/0165-0270(96)00047-7; Dahl C, 2000, NEUROCHEM INT, V36, P379, DOI 10.1016/S0197-0186(99)00129-1; Davis RJ, 1999, BIOCHEM J, V341, P813, DOI 10.1042/0264-6021:3410813; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; ERECINSKA M, 1992, CAN J PHYSIOL PHARM, V70, pS190, DOI 10.1139/y92-262; FISCHER GA, 1994, J BIOL CHEM, V269, P19216; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Foskett JK, 2010, CURR TOP MEMBR, V66, P235, DOI 10.1016/S1063-5823(10)66011-5; Galvan DL, 1999, J BIOL CHEM, V274, P29483, DOI 10.1074/jbc.274.41.29483; Hang LS, 2000, J NEUROCHEM, V75, P1852; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Igwe OJ, 1997, MOL BRAIN RES, V46, P39, DOI 10.1016/S0169-328X(96)00269-0; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kohno K, 1997, NEUROSCI LETT, V224, P17, DOI 10.1016/S0304-3940(97)13459-0; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Mackrill JJ, 1996, BIOCHEM J, V318, P871, DOI 10.1042/bj3180871; MAGNUSSON A, 1993, FEBS LETT, V323, P229, DOI 10.1016/0014-5793(93)81345-Z; NAGASAWA H, 1991, NEUROSCI LETT, V133, P129, DOI 10.1016/0304-3940(91)90074-4; Nagata E, 1999, NEUROSCIENCE, V93, P995, DOI 10.1016/S0306-4522(99)00198-0; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Neumar RW, 2000, ANN EMERG MED, V36, P483, DOI 10.1067/mem.2000.110995; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Sayers LG, 1997, BIOCHEM J, V323, P273, DOI 10.1042/bj3230273; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Verbert L, 2008, BIOL CELL, V100, P39, DOI 10.1042/BC20070086; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wojcikiewicz RJH, 1996, J BIOL CHEM, V271, P16652, DOI 10.1074/jbc.271.28.16652; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; ZAIDAN E, 1994, J NEUROCHEM, V63, P1812	47	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35998	36010		10.1074/jbc.M111.254177	http://dx.doi.org/10.1074/jbc.M111.254177			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859719	Green Published, hybrid			2022-12-25	WOS:000295927100073
J	Meslin, B; Beavogui, AH; Fasel, N; Picot, S				Meslin, Benoit; Beavogui, Abdoul H.; Fasel, Nicolas; Picot, Stephane			Plasmodium falciparum Metacaspase PfMCA-1 Triggers a z-VAD-fmk Inhibitable Protease to Promote Cell Death	PLOS ONE			English	Article							INTRACELLULAR LEISHMANIA-DONOVANI; BCL-X-L; TRYPANOSOMA-BRUCEI; ARABIDOPSIS-THALIANA; YEAST METACASPASE; MAJOR METACASPASE; PUTATIVE ROLE; APOPTOSIS; PROTOZOAN; MALARIA	Activation of proteolytic cell death pathways may circumvent drug resistance in deadly protozoan parasites such as Plasmodium falciparum and Leishmania. To this end, it is important to define the cell death pathway(s) in parasites and thus characterize proteases such as metacaspases (MCA), which have been reported to induce cell death in plants and Leishmania parasites. We, therefore, investigated whether the cell death function of MCA is conserved in different protozoan parasite species such as Plasmodium falciparum and Leishmania major, focusing on the substrate specificity and functional role in cell survival as compared to Saccharomyces cerevisae. Our results show that, similarly to Leishmania, Plasmodium MCA exhibits a calcium-dependent, arginine-specific protease activity and its expression in yeast induced growth inhibition as well as an 82% increase in cell death under oxidative stress, a situation encountered by parasites during the host or when exposed to drugs such as artemisins. Furthermore, we show that MCA cell death pathways in both Plasmodium and Leishmania, involve a z-VAD-fmk inhibitable protease. Our data provide evidence that MCA from both Leishmania and Plasmodium falciparum is able to induce cell death in stress conditions, where it specifically activates a downstream enzyme as part of a cell death pathway. This enzymatic activity is also induced by the antimalarial drug chloroquine in erythrocytic stages of Plasmodium falciparum. Interestingly, we found that blocking parasite cell death influences their drug sensitivity, a result which could be used to create therapeutic strategies that by-pass drug resistance mechanisms by acting directly on the innate pathways of protozoan cell death.	[Meslin, Benoit; Beavogui, Abdoul H.; Picot, Stephane] ICBMS UMR 5246 CNRS UCBL1 INSA, Malaria Res Unit, Lyon, France; [Fasel, Nicolas] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University of Lausanne	Meslin, B (corresponding author), ICBMS UMR 5246 CNRS UCBL1 INSA, Malaria Res Unit, Lyon, France.	Nicolas.Fasel@unil.ch	Fasel, Nicolas/O-4253-2016; picot, stephane/F-5973-2014	Fasel, Nicolas/0000-0003-0136-7245; picot, stephane/0000-0002-5735-6759	FNRS [3100A0-116665/1]; Novartis Foundation; Dr Rub Foundation; Swiss Secretariat for Education and Research	FNRS(Fonds de la Recherche Scientifique - FNRS); Novartis Foundation(Novartis); Dr Rub Foundation; Swiss Secretariat for Education and Research	This work was conducted in part with support from the FNRS No 3100A0-116665/1, the Novartis Foundation, the Dr Rub Foundation, and the Swiss Secretariat for Education and Research to NF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; Alzate JF, 2006, APOPTOSIS, V11, P161, DOI 10.1007/s10495-006-4570-z; Alzate JF, 2008, ANTIMICROB AGENTS CH, V52, P3779, DOI 10.1128/AAC.01665-07; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Arambage SC, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-32; Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Gonzalez IJ, 2007, INT J PARASITOL, V37, P161, DOI 10.1016/j.ijpara.2006.10.004; Guaragnella N, 2010, FEBS LETT, V584, P224, DOI 10.1016/j.febslet.2009.11.072; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Jiang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-198; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; Kosec G, 2006, BIOCELL, V30, P479; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lee REC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002956; Liang QL, 2008, BBA-MOL CELL RES, V1783, P1311, DOI 10.1016/j.bbamcr.2008.02.018; Lim HW, 2007, CAN J MICROBIOL, V53, P1016, DOI 10.1139/W07-067; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Madeo F, 2002, CURR GENET, V41, P208, DOI 10.1007/s00294-002-0310-2; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mazzoni C, 2008, BBA-MOL CELL RES, V1783, P1320, DOI 10.1016/j.bbamcr.2008.02.015; Meslin B, 2007, J INFECT DIS, V195, P1852, DOI 10.1086/518253; Meslin B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-26; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1981, J EXP MED, V153, P1690, DOI 10.1084/jem.153.6.1690; MURRAY HW, 1983, J CLIN INVEST, V72, P32, DOI 10.1172/JCI110972; Nedelcu AM, 2009, J MOL EVOL, V68, P256, DOI 10.1007/s00239-009-9201-1; Nogueira F, 2010, ACTA TROP, V114, P109, DOI 10.1016/j.actatropica.2010.01.013; Ojha M, 2010, GENE, V457, P25, DOI 10.1016/j.gene.2010.02.014; Olie RA, 1998, CURR BIOL, V8, P955, DOI 10.1016/S0960-9822(98)70395-1; PEARSON RD, 1983, J IMMUNOL, V131, P1994; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-169; Pino P, 2004, CELL MICROBIOL, V6, P839, DOI 10.1111/j.1462-5822.2004.00406.x; Rico E, 2009, MOL BIOCHEM PARASIT, V163, P28, DOI 10.1016/j.molbiopara.2008.09.007; Totino PRR, 2008, EXP PARASITOL, V118, P478, DOI 10.1016/j.exppara.2007.10.017; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Watanabe N, 2011, J BIOL CHEM, V286, P10027, DOI 10.1074/jbc.M110.194340; Withers-Martinez C, 1999, PROTEIN ENG, V12, P1113, DOI 10.1093/protein/12.12.1113; Woltering EJ, 2010, TRENDS PLANT SCI, V15, P185, DOI 10.1016/j.tplants.2010.02.001; Zalila H, 2011, MOL MICROBIOL, V79, P222, DOI 10.1111/j.1365-2958.2010.07443.x	62	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23867	10.1371/journal.pone.0023867	http://dx.doi.org/10.1371/journal.pone.0023867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858231	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300102
J	Puk, O; Moller, G; Geerlof, A; Krowiorz, K; Ahmad, N; Wagner, S; Adamski, J; de Angelis, MH; Graw, J				Puk, Oliver; Moeller, Gabriele; Geerlof, Arie; Krowiorz, Kathrin; Ahmad, Nafees; Wagner, Sibylle; Adamski, Jerzy; de Angelis, Martin Hrabe; Graw, Jochen			The Pathologic Effect of a Novel Neomorphic Fgf9(Y162C) Allele Is Restricted to Decreased Vision and Retarded Lens Growth	PLOS ONE			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; TRANSGENIC MICE; PTS2 RECEPTOR; FIBER DIFFERENTIATION; EXTRACELLULAR-MATRIX; MISSENSE MUTATION; MUTANT MICE; HUMAN PEX7; GENE; PROTEIN	Fibroblast growth factor (Fgf) signalling plays a crucial role in many developmental processes. Among the Fgf pathway ligands, Fgf9 (UniProt: P54130) has been demonstrated to participate in maturation of various organs and tissues including skeleton, testes, lung, heart, and eye. Here we establish a novel Fgf9 allele, discovered in a dominant N-ethyl-N-nitrosourea (ENU) screen for eye-size abnormalities using the optical low coherence interferometry technique. The underlying mouse mutant line Aca12 was originally identified because of its significantly reduced lens thickness. Linkage studies located Aca12 to chromosome 14 within a 3.6 Mb spanning interval containing the positional candidate genes Fgf9 (MGI: 104723), Gja3 (MGI: 95714), and Ift88 (MGI: 98715). While no sequence differences were found in Gja3 and Ift88, we identified an A -> G missense mutation at cDNA position 770 of the Fgf9 gene leading to an Y162C amino acid exchange. In contrast to previously described Fgf9 mutants, Fgf9(Y162C) carriers were fully viable and did not reveal reduced body-size, male-to-female sexual reversal or skeletal malformations. The histological analysis of the retina as well as its basic functional characterization by electroretinography (ERG) did not show any abnormality. However, the analysis of head-tracking response of the Fgf9(Y162C) mutants in a virtual drum indicated a gene-dosage dependent vision loss of almost 50%. The smaller lenses in Fgf9(Y162C) suggested a role of Fgf9 during lens development. Histological investigations showed that lens growth retardation starts during embryogenesis and continues after birth. Young Fgf9(Y162C) lenses remained transparent but developed age-related cataracts. Taken together, Fgf9(Y162C) is a novel neomorphic allele that initiates microphakia and reduced vision without effects on organs and tissues outside the eye. Our data point to a role of Fgf9 signalling in primary and secondary lens fiber cell growth. The results underline the importance of allelic series to fully understand multiple functions of a gene.	[Puk, Oliver; Krowiorz, Kathrin; Ahmad, Nafees; Graw, Jochen] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany; [Moeller, Gabriele; Wagner, Sibylle; Adamski, Jerzy; de Angelis, Martin Hrabe] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Expt Genet, Neuherberg, Germany; [Geerlof, Arie] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Biol Struct, Neuherberg, Germany; [Adamski, Jerzy; de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci, Inst Expt Genet, D-8050 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Puk, O (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany.	oliver.puk@helmholtz-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012; Graw, Jochen/D-9336-2013; Puk, Oliver/E-1443-2013	de Angelis, Martin Hrabe/0000-0002-7898-2353; Graw, Jochen/0000-0003-0298-9660; Ahmad, Nafees/0000-0002-7436-7644; Adamski, Jerzy/0000-0001-9259-0199; Moller, Gabriele/0000-0002-2730-1351	European Community (European Mouse Disease Clinic); National Genome Network (National Genome Research Network, National Genome Research Network plus) [LSHG-2006-037188, BMBF 01KW9923, BMBF 01GS0850]	European Community (European Mouse Disease Clinic)(European Commission); National Genome Network (National Genome Research Network, National Genome Research Network plus)	This work has been supported by the European Community (European Mouse Disease Clinic) and by National Genome Network Grants (National Genome Research Network, National Genome Research Network plus). Grant Identifications: LSHG-2006-037188, BMBF 01KW9923, and BMBF 01GS0850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Bates PA, 2001, PROTEINS, P39; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CHAMBERLAIN CG, 1987, CURR EYE RES, V6, P1165, DOI 10.3109/02713688709034890; Chamberlain CG, 1989, GROWTH FACTORS, V1, P125, DOI 10.3109/08977198909029122; Cinaroglu A, 2005, J NEUROSCI RES, V79, P329, DOI 10.1002/jnr.20363; Colvin JS, 1999, DEV DYNAM, V216, P72; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Cotton LM, 2008, ENDOCR REV, V29, P193, DOI 10.1210/er.2007-0028; Dalke C, 2004, INVEST OPHTH VIS SCI, V45, P601, DOI 10.1167/iovs.03-0561; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dunia I, 2006, EUR J CELL BIOL, V85, P729, DOI 10.1016/j.ejcb.2006.03.006; EHLING UH, 1985, MUTAT RES, V150, P393, DOI 10.1016/0027-5107(85)90136-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gao Y, 1998, INVEST OPHTH VIS SCI, V39, P1198; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; Koyama N, 2001, BIOTECHNOL APPL BIOC, V33, P117, DOI 10.1042/BA20000075; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Lovicu FJ, 1998, DEVELOPMENT, V125, P3365; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; Menez B, 1981, Med Trop (Mars), V41, P569; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Murakami H, 2002, MAMM GENOME, V13, P341, DOI 10.1007/s00335-001-2143-6; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puk O, 2008, INVEST OPHTH VIS SCI, V49, P1525, DOI 10.1167/iovs.07-1033; Puk O, 2006, MAMM GENOME, V17, P851, DOI 10.1007/s00335-006-0019-5; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; ROBINSON ML, 1995, DEVELOPMENT, V121, P505; Robinson ML, 1998, DEV BIOL, V198, P13, DOI 10.1016/S0012-1606(98)80026-2; Rong P, 2002, DEVELOPMENT, V129, P167; Sanchez E, 1997, KLIN MONATSBL AUGENH, V210, P329, DOI 10.1055/s-2008-1035067; Schmucker C, 2004, VISION RES, V44, P2445, DOI 10.1016/j.visres.2004.05.018; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu XL, 2009, AM J HUM GENET, V85, P53, DOI 10.1016/j.ajhg.2009.06.007; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028; Zhao SL, 2001, DEVELOPMENT, V128, P5051	48	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23678	10.1371/journal.pone.0023678	http://dx.doi.org/10.1371/journal.pone.0023678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858205	Green Submitted, gold, Green Published			2022-12-25	WOS:000294121300081
J	Tong, YG; Zhao, WJ; Zhou, CQ; Wawrowsky, K; Melmed, S				Tong, Yunguang; Zhao, Weijiang; Zhou, Cuiqi; Wawrowsky, Kolja; Melmed, Shlomo			PTTG1 Attenuates Drug-Induced Cellular Senescence	PLOS ONE			English	Article							TUMOR-TRANSFORMING GENE; BREAST-CANCER; DNA-DAMAGE; HISTONE DEACETYLATION; PITUITARY HYPOPLASIA; PROGNOSTIC MARKER; POOR-PROGNOSIS; EXPRESSION; SECURIN; CELLS	As PTTG1 (pituitary tumor transforming gene) abundance correlates with adverse outcomes in cancer treatment, we determined mechanisms underlying this observation by assessing the role of PTTG1 in regulating cell response to antineoplastic drugs. HCT116 cells devoid of PTTG1 (PTTG1(-/-)) exhibited enhanced drug sensitivity as assessed by measuring BrdU incorporation in vitro. Apoptosis, mitosis catastrophe or DNA damage were not detected, but features of senescence were observed using low doses of doxorubicin and TSA. The number of drug-induced PTTG1(-/-) senescent cells increased similar to 4 fold as compared to WT PTTG1-replete cells (p<0.001). p21, an important regulator of cell senescence, was induced similar to 3 fold in HCT116 PTTG1(-/-) cells upon doxorubicin or Trichostatin A treatment. Binding of Sp1, p53 and p300 to the p21 promoter was enhanced in PTTG1(-/-) cells after treatment, suggesting transcriptional regulation of p21. p21 knock down abrogated the observed senescent effects of these drugs, indicating that PTTG1 likely suppresses p21 to regulate drug-induced senescence. PTTG1 also regulated SW620 colon cancer cells response to doxorubicin and TSA mediated by p21. Subcutaneously xenografted PTTG1(-/-) HCT116 cells developed smaller tumors and exhibited enhanced responses to doxorubicin. PTTG1(-/-) tumor tissue derived from excised tumors exhibited increased doxorubicin-induced senescence. As senescence is a determinant of cell responses to anti-neoplastic treatments, these findings suggest PTTG1 as a tumor cell marker to predict anti-neoplastic treatment outcomes.	[Tong, Yunguang; Zhao, Weijiang; Zhou, Cuiqi; Wawrowsky, Kolja; Melmed, Shlomo] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Tong, YG (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	Melmed@csmc.edu		Zhao, Wei-jiang/0000-0002-6556-2827	NIH [CA 75979, K99CA138914]; Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE [K99CA138914, R01CA075979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The manuscript is supported by NIH Grant CA 75979 (SM), K99CA138914 (YT), and The Doris Factor Molecular Endocrinology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbud RA, 2005, MOL ENDOCRINOL, V19, P1383, DOI 10.1210/me.2004-0403; Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; Fujii T, 2006, HEPATOLOGY, V43, P1267, DOI 10.1002/hep.21181; Genkai N, 2006, ONCOL REP, V15, P1569; Ghayad SE, 2009, J MOL ENDOCRINOL, V42, P87, DOI 10.1677/JME-08-0076; GUNVEN P, 1986, CANCER CHEMOTH PHARM, V17, P153, DOI 10.1007/BF00306745; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hlubek F, 2006, BRIT J CANCER, V94, P1672, DOI 10.1038/sj.bjc.6603155; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kim DS, 2007, CARCINOGENESIS, V28, P749, DOI 10.1093/carcin/bgl202; Lehmann BD, 2007, CELL CYCLE, V6, P595, DOI 10.4161/cc.6.5.3901; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Ogbagabriel S, 2005, MODERN PATHOL, V18, P985, DOI 10.1038/modpathol.3800382; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Place RF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-37; Rebbaa A, 2006, CELL DEATH DIFFER, V13, P1960, DOI 10.1038/sj.cdd.4401895; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Saez C, 2006, J CLIN ENDOCR METAB, V91, P1404, DOI 10.1210/jc.2005-2532; Sanchez-Puig N, 2005, PROTEIN SCI, V14, P1410, DOI 10.1110/ps.051368005; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shibata Y, 2002, JPN J CLIN ONCOL, V32, P233, DOI 10.1093/jjco/hyf058; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Solbach C, 2004, BREAST, V13, P80, DOI 10.1016/j.breast.2003.09.008; Solbach C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-242; Thompson AD, 2005, FEBS LETT, V579, P3195, DOI 10.1016/j.febslet.2005.05.008; Tong Y, 2008, ONCOGENE, V27, P6385, DOI 10.1038/onc.2008.234; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; TRAIL PA, 1992, CANCER RES, V52, P5693; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Yu R, 2000, J BIOL CHEM, V275, P36502, DOI 10.1074/jbc.C000546200; Yu R, 2000, MOL ENDOCRINOL, V14, P1137, DOI 10.1210/me.14.8.1137; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	47	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23754	10.1371/journal.pone.0023754	http://dx.doi.org/10.1371/journal.pone.0023754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858218	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300091
J	Tung, JY; Do, CB; Hinds, DA; Kiefer, AK; Macpherson, JM; Chowdry, AB; Francke, U; Naughton, BT; Mountain, JL; Wojcicki, A; Eriksson, N				Tung, Joyce Y.; Do, Chuong B.; Hinds, David A.; Kiefer, Amy K.; Macpherson, J. Michael; Chowdry, Arnab B.; Francke, Uta; Naughton, Brian T.; Mountain, Joanna L.; Wojcicki, Anne; Eriksson, Nicholas			Efficient Replication of over 180 Genetic Associations with Self-Reported Medical Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; VALIDATION; DISEASE; QUESTIONNAIRE; LOCI; PREVALENCE; VARIANTS; STROKE; ONSET	While the cost and speed of generating genomic data have come down dramatically in recent years, the slow pace of collecting medical data for large cohorts continues to hamper genetic research. Here we evaluate a novel online framework for obtaining large amounts of medical information from a recontactable cohort by assessing our ability to replicate genetic associations using these data. Using web-based questionnaires, we gathered self-reported data on 50 medical phenotypes from a generally unselected cohort of over 20,000 genotyped individuals. Of a list of genetic associations curated by NHGRI, we successfully replicated about 75% of the associations that we expected to (based on the number of cases in our cohort and reported odds ratios, and excluding a set of associations with contradictory published evidence). Altogether we replicated over 180 previously reported associations, including many for type 2 diabetes, prostate cancer, cholesterol levels, and multiple sclerosis. We found significant variation across categories of conditions in the percentage of expected associations that we were able to replicate, which may reflect systematic inflation of the effects in some initial reports, or differences across diseases in the likelihood of misdiagnosis or misreport. We also demonstrated that we could improve replication success by taking advantage of our recontactable cohort, offering more in-depth questions to refine self-reported diagnoses. Our data suggest that online collection of self-reported data from a recontactable cohort may be a viable method for both broad and deep phenotyping in large populations.	[Tung, Joyce Y.; Do, Chuong B.; Hinds, David A.; Kiefer, Amy K.; Macpherson, J. Michael; Chowdry, Arnab B.; Francke, Uta; Naughton, Brian T.; Mountain, Joanna L.; Wojcicki, Anne; Eriksson, Nicholas] 23andMe Inc, Mountain View, CA 94043 USA; [Francke, Uta] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Tung, JY (corresponding author), 23andMe Inc, Mountain View, CA 94043 USA.	joyce@23andme.com		Hinds, David/0000-0002-4911-803X				Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; BURGESS AM, 1971, J CHRON DIS, V24, P45, DOI 10.1016/0021-9681(71)90058-0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; DO CB, 2011, PLOS GENETI IN PRESS; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Feldman DE, 2007, ARTHRIT RHEUM-ARTHR, V57, P1419, DOI 10.1002/art.23086; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Gasperini C, 2001, NEUROL SCI, V22, pS93, DOI 10.1007/s100720100043; *GEN, CAT PUBL GEN WID ASS; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; *INT PARK DIS GEN, 2011, PLOS GENETI IN PRESS; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kronz JD, 1999, CANCER, V86, P2426, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3; Latiano A, 2008, WORLD J GASTROENTERO, V14, P4643, DOI 10.3748/wjg.14.4643; Lee K, 2010, TRENDS GENET, V26, P241, DOI 10.1016/j.tig.2010.03.003; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; OMAHONY PG, 1995, STROKE, V26, P1334, DOI 10.1161/01.STR.26.8.1334; Patel BD, 2010, AM J RESP CRIT CARE, V181; Patsopoulos NA, 2010, ANN RHEUM DIS, V69, P561, DOI 10.1136/ard.2009.109447; Pelchat ML, 2011, CHEM SENSES, V36, P9, DOI 10.1093/chemse/bjq081; Perdigones N, 2009, RHEUMATOLOGY, V48, P618, DOI 10.1093/rheumatology/kep053; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Pinto Sanchez Maria Ines, 2009, Acta Gastroenterol Latinoam, V39, P250; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith B, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-37; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; van Durme YMTA, 2010, EUR RESPIR J, V36, P89, DOI 10.1183/09031936.00129509; Walker MK, 1998, AM J EPIDEMIOL, V148, P355; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398	47	91	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23473	10.1371/journal.pone.0023473	http://dx.doi.org/10.1371/journal.pone.0023473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858135	Green Submitted, gold, Green Published			2022-12-25	WOS:000294121300051
J	Woelke, AL; von Eichborn, J; Murgueitio, MS; Worth, CL; Castiglione, F; Preissner, R				Woelke, Anna Lena; von Eichborn, Joachim; Murgueitio, Manuela S.; Worth, Catherine L.; Castiglione, Filippo; Preissner, Robert			Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm	PLOS ONE			English	Article							CANCER VACCINES; MODEL; PREDICTION; BINDING; VIRUS; TOOLS	personalized treatment are difficult to access experimentally. In this respect, in silico models can help to narrow down the parameter space or to explain certain phenomena at a systems level. Herein, we develop two empirical interaction potentials specific to B-cell and T-cell receptor complexes and validate their applicability in comparison to a more general potential. The interaction potentials are applied to the model VaccImm which simulates the immune response against solid tumors under peptide vaccination therapy. This multi-agent system is derived from another immune system simulator (C-ImmSim) and now includes a module that enables the amino acid sequence of immune receptors and their ligands to be taken into account. The multi-agent approach is combined with approved methods for prediction of major histocompatibility complex (MHC)-binding peptides and the newly developed interaction potentials. In the analysis, we critically assess the impact of the different modules on the simulation with VaccImm and how they influence each other. In addition, we explore the reasons for failures in inducing an immune response by examining the activation states of the immune cell populations in detail. In summary, the present work introduces immune-specific interaction potentials and their application to the agent-based model VaccImm which simulates peptide vaccination in cancer therapy.	[Woelke, Anna Lena; von Eichborn, Joachim; Murgueitio, Manuela S.; Worth, Catherine L.; Preissner, Robert] Charite, Inst Physiol, D-13353 Berlin, Germany; [Castiglione, Filippo] Natl Res Council Italy, Inst Comp Applicat, Rome, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Consiglio Nazionale delle Ricerche (CNR)	Woelke, AL (corresponding author), Charite, Inst Physiol, D-13353 Berlin, Germany.	anna-lena.woelke@charite.de	Castiglione, Filippo/B-1366-2010	Castiglione, Filippo/0000-0002-1442-3552; preissner, robert/0000-0002-2407-1087; Worth, Catherine/0000-0002-1796-9606	Deutsche Forschungsgemeinschaft (DFG) [SFB 449]; European Union (EU); Deutsche Krebshilfe; Federal Ministry of Education and Research (BMBF) [0315450]; graduate school "Computational Systems Biology'' of DFG [GRK1772/1]; International Research Training Group "Genomics and Systems Biology of Molecular Networks'' of DFG [GRK1360]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union (EU)(CGIAREuropean Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); graduate school "Computational Systems Biology'' of DFG(German Research Foundation (DFG)); International Research Training Group "Genomics and Systems Biology of Molecular Networks'' of DFG(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) (SFB 449), the European Union (EU) project SynSys, the Deutsche Krebshilfe, and the Federal Ministry of Education and Research (BMBF) project MedSys (0315450). AW was funded by the graduate school "Computational Systems Biology'' (GRK1772/1 of the DFG). JvE was funded by the International Research Training Group "Genomics and Systems Biology of Molecular Networks'' (GRK1360 of the DFG). The open access charge was funded by DFG, BMBF and EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appella E, 1995, EXS, V73, P105; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Castiglione F, 2005, J THEOR BIOL, V237, P390, DOI 10.1016/j.jtbi.2005.04.024; Castiglione F, 2007, BIOINFORMATICS, V23, P1371, DOI 10.1093/bioinformatics/btm044; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; FARMER JD, 1986, PHYSICA D, V22, P187, DOI 10.1016/0167-2789(86)90240-X; Folcik VA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-1; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kalita J K, 2006, Int J Bioinform Res Appl, V2, P63; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Lollini PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-352; Mallet DG, 2006, J THEOR BIOL, V239, P334, DOI 10.1016/j.jtbi.2005.08.002; MEIERSCHELLERSH.M, 1999, SIMMUNE TOOL SIMULAT; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Miller AM, 2007, CANCER IMMUNOL IMMUN, V56, P81, DOI 10.1007/s00262-005-0110-x; Miyazawa S, 1999, PROTEINS, V36, P357, DOI 10.1002/(SICI)1097-0134(19990815)36:3<357::AID-PROT10>3.3.CO;2-L; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Pennisi M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S13; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Pichichero ME, 2008, HUM VACCINES, V4, P262, DOI 10.4161/hv.4.4.5742; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Santoni D, 2008, BIOINFORMATICS, V24, P1374, DOI 10.1093/bioinformatics/btn135; Siebert JC, 2010, IMMUNOTHERAPY-UK, V2, P799, DOI [10.2217/imt.10.76, 10.2217/IMT.10.76]; Tolar P, 2009, IMMUNOL REV, V232, P34, DOI 10.1111/j.1600-065X.2009.00833.x; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; von Eichborn Joachim, 2010, V22, P1; Woelke AL, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/271794	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23257	10.1371/journal.pone.0023257	http://dx.doi.org/10.1371/journal.pone.0023257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858048	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000294121300025
J	Reis, DG; Scopinho, AA; Guimaraes, FS; Correa, FMA; Resstel, LBM				Reis, Daniel G.; Scopinho, America A.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.			Behavioral and Autonomic Responses to Acute Restraint Stress Are Segregated within the Lateral Septal Area of Rats	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; MEDIAL PREFRONTAL CORTEX; MODULATES CARDIOVASCULAR-RESPONSES; DIFFERENTIAL NEURONAL ACTIVATION; ANXIETY-LIKE BEHAVIOR; UNANESTHETIZED RATS; STRIA TERMINALIS; CONDITIONED FEAR; BED NUCLEUS; C-FOS	Background: The Lateral Septal Area (LSA) is involved with autonomic and behavior responses associated to stress. In rats, acute restraint (RS) is an unavoidable stress situation that causes autonomic (body temperature, mean arterial pressure (MAP) and heart rate (HR) increases) and behavioral (increased anxiety-like behavior) changes in rats. The LSA is one of several brain regions that have been involved in stress responses. The aim of the present study was to investigate if the neurotransmission blockade in the LSA would interfere in the autonomic and behavioral changes induced by RS. Methodology/Principal Findings: Male Wistar rats with bilateral cannulae aimed at the LSA, an intra-abdominal datalogger (for recording internal body temperature), and an implanted catheter into the femoral artery (for recording and cardiovascular parameters) were used. They received bilateral microinjections of the non-selective synapse blocker cobalt chloride (CoCl2, 1 mM/ 100 nL) or vehicle 10 min before RS session. The tail temperature was measured by an infrared thermal imager during the session. Twenty-four h after the RS session the rats were tested in the elevated plus maze (EPM). Conclusions/Significance: Inhibition of LSA neurotransmission reduced the MAP and HR increases observed during RS. However, no changes were observed in the decrease in skin temperature and increase in internal body temperature observed during this period. Also, LSA inhibition did not change the anxiogenic effect induced by RS observed 24 h later in the EPM. The present results suggest that LSA neurotransmission is involved in the cardiovascular but not the temperature and behavioral changes induced by restraint stress.	[Reis, Daniel G.; Scopinho, America A.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo	Reis, DG (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil.	leoresstel@yahoo.com.br	Correa, Fernando/D-1614-2012; Guimaraes, Francisco Silveira/C-1059-2012; Resstel, Leonardo/C-6100-2012	Correa, Fernando/0000-0003-4067-9524; Guimaraes, Francisco Silveira/0000-0003-4092-7778; 	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brazil [PNPD0176087]; FAPESP [2009/03187-9]; CNPq [470042/2009-5, 305996/2008-8]; FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia)	D.G.R. is a FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) PhD fellow (2008/04069-7) and A.A.S. is a recipient of financial support from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brazil (PNPD0176087). Research was also supported by a grant from FAPESP (2009/03187-9), CNPq (470042/2009-5 and 305996/2008-8) and FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FHF, 2010, BRAIN RES, V1333, P57, DOI 10.1016/j.brainres.2010.03.077; BECK CHM, 1995, J NEUROSCI, V15, P709; Beig MI, 2009, NEUROSCIENCE, V159, P1185, DOI 10.1016/j.neuroscience.2009.01.038; Blessing WW, 2003, NEUROSCIENCE, V117, P939, DOI 10.1016/S0306-4522(02)00810-2; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Brown DR, 1999, AM J PHYSIOL-REG I, V277, pR650, DOI 10.1152/ajpregu.1999.277.3.R650; CALARESU FR, 1976, J PHYSIOL-LONDON, V260, P515, DOI 10.1113/jphysiol.1976.sp011529; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Chen HC, 2004, CHINESE J PHYSIOL, V47, P49; CORREA FMA, 1975, J PHARMACOL EXP THER, V192, P670; COVIAN MR, 1966, ACTA PHYSIOL LAT AM, VS 16, P119; Crestani CC, 2009, STRESS, V12, P268, DOI 10.1080/10253890802331477; Crestani CC, 2008, NEUROSCI LETT, V448, P189, DOI 10.1016/j.neulet.2008.10.055; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; DEAGUIARCORREA FM, 1978, ACTA PHYSIOL LAT AM, V28, P69; DeBeck LD, 2010, AM J PHYSIOL-REG I, V299, pR80, DOI 10.1152/ajpregu.00246.2009; Degroot A, 2001, PHARMACOL BIOCHEM BE, V69, P391, DOI 10.1016/S0091-3057(01)00541-X; DUNCAN GE, 1993, J NEUROSCI, V13, P3932; FELDON J, 1982, BEHAV NEURAL BIOL, V35, P121, DOI 10.1016/S0163-1047(82)91143-8; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; Fortaleza EAT, 2009, NEUROSCIENCE, V159, P717, DOI 10.1016/j.neuroscience.2009.01.003; GELSEMA AJ, 1987, AM J PHYSIOL, V252, pR760, DOI 10.1152/ajpregu.1987.252.4.R760; GUIMARAES FS, 1993, BEHAV BRAIN RES, V58, P133, DOI 10.1016/0166-4328(93)90098-B; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; Hsu HR, 2007, EUR J PHARMACOL, V566, P124, DOI 10.1016/j.ejphar.2007.03.040; KENNETT GA, 1985, EUR J PHARMACOL, V119, P143, DOI 10.1016/0014-2999(85)90290-0; KENNETT GA, 1987, EUR J PHARMACOL, V134, P265, DOI 10.1016/0014-2999(87)90357-8; Kenney MJ, 1999, J APPL PHYSIOL, V87, P732, DOI 10.1152/jappl.1999.87.2.732; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Kubo T, 2002, NEUROSCI LETT, V318, P25, DOI 10.1016/S0304-3940(01)02463-6; LACHUER J, 1994, BRAIN RES, V638, P196, DOI 10.1016/0006-8993(94)90650-5; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Li HY, 1998, J COMP NEUROL, V393, P244; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Martin J, 2010, AM J PHYSIOL-REG I, V298, pR1383, DOI 10.1152/ajpregu.00371.2009; Menard J, 1996, PHYSIOL BEHAV, V60, P845; Menard J, 2000, BEHAV PHARMACOL, V11, P99, DOI 10.1097/00008877-200004000-00001; Resstel LBM, 2008, CEREB CORTEX, V18, P2027, DOI 10.1093/cercor/bhm232; Morrison SF, 2001, ANN NY ACAD SCI, V940, P286; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Padovan CM, 2000, BRAZ J MED BIOL RES, V33, P79, DOI 10.1590/S0100-879X2000000100011; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Pelosi GG, 2007, AUTON NEUROSCI-BASIC, V131, P70, DOI 10.1016/j.autneu.2006.07.002; PERESPOLON VL, 1992, BRAZ J MED BIOL RES, V25, P257; PERESPOLON VL, 1994, NEUROPHARMACOLOGY, V33, P1537, DOI 10.1016/0028-3908(94)90127-9; Pesold C, 1996, BRAIN RES, V710, P161, DOI 10.1016/0006-8993(95)01359-8; PEZZONE MA, 1992, BRAIN RES, V597, P41, DOI 10.1016/0006-8993(92)91503-7; PIROLA CJ, 1987, NEUROPHARMACOLOGY, V26, P561, DOI 10.1016/0028-3908(87)90148-1; Reis DG, 2010, LEARN MEMORY, V17, P134, DOI 10.1101/lm.1534710; Resstel LBM, 2008, NEUROSCIENCE, V154, P869, DOI 10.1016/j.neuroscience.2008.04.007; Resstel LBM, 2006, EUR J NEUROSCI, V23, P481, DOI 10.1111/j.1460-9568.2005.04566.x; Resstel LBM, 2009, BRIT J PHARMACOL, V156, P181, DOI 10.1111/j.1476-5381.2008.00046.x; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; Scopinho AA, 2006, BRAIN RES, V1122, P126, DOI 10.1016/j.brainres.2006.09.002; Scopinho AA, 2007, AUTON NEUROSCI-BASIC, V137, P77, DOI 10.1016/j.autneu.2007.08.003; Sevgi S, 2006, METHOD FIND EXP CLIN, V28, P95, DOI 10.1358/mf.2006.28.2.977840; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Stornetta RL, 2009, J CHEM NEUROANAT, V38, P222, DOI 10.1016/j.jchemneu.2009.07.005; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; Tavares RF, 2009, J NEUROSCI RES, V87, P2601, DOI 10.1002/jnr.22070; Tavares RF, 2009, J NEUROSCI RES; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vianna DML, 2005, EUR J NEUROSCI, V21, P2505, DOI 10.1111/j.1460-9568.2005.04073.x; VOLZ HP, 1990, ANAT EMBRYOL, V181, P177; Whitehead MC, 2000, J COMP NEUROL, V422, P429; Xia Y, 2003, NEUROSCIENCE, V121, P219, DOI 10.1016/S0306-4522(03)00290-2; Xia Y, 2001, MOL BRAIN RES, V89, P71, DOI 10.1016/S0169-328X(01)00065-1	69	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23171	10.1371/journal.pone.0023171	http://dx.doi.org/10.1371/journal.pone.0023171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858017	gold, Green Submitted, Green Published			2022-12-25	WOS:000294125500016
J	Lamy, JB; Bouffier, L; Burlett, R; Plomion, C; Cochard, H; Delzon, S				Lamy, Jean-Baptiste; Bouffier, Laurent; Burlett, Regis; Plomion, Christophe; Cochard, Herve; Delzon, Sylvain			Uniform Selection as a Primary Force Reducing Population Genetic Differentiation of Cavitation Resistance across a Species Range	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; PINUS-PINASTER POPULATIONS; QUANTITATIVE TRAIT LOCI; SPACE-TIME CLIMATE; MARITIME-PINE; HYDRAULIC ARCHITECTURE; PHYSIOLOGICAL TRAITS; XYLEM VULNERABILITY; HEIGHT GROWTH	Background: Cavitation resistance to water stress-induced embolism determines plant survival during drought. This adaptive trait has been described as highly variable in a wide range of tree species, but little is known about the extent of genetic and phenotypic variability within species. This information is essential to our understanding of the evolutionary forces that have shaped this trait, and for evaluation of its inclusion in breeding programs. Methodology: We assessed cavitation resistance (P-50), growth and carbon isotope composition in six Pinus pinaster populations in a provenance and progeny trial. We estimated the heritability of cavitation resistance and compared the distribution of neutral markers (F-ST) and quantitative genetic differentiation (Q(ST)), for retrospective identification of the evolutionary forces acting on these traits. Results/Discussion: In contrast to growth and carbon isotope composition, no population differentiation was found for cavitation resistance. Heritability was higher than for the other traits, with a low additive genetic variance (h(ns)(2) = 0.43+/-0.18, CVA = 4.4%). Q(ST) was significantly lower than F-ST, indicating uniform selection for P-50, rather than genetic drift. Putative mechanisms underlying Q(ST)<F-ST are discussed.	[Lamy, Jean-Baptiste; Bouffier, Laurent; Burlett, Regis; Plomion, Christophe; Delzon, Sylvain] INRA, UMR BIOGECO 1202, F-33610 Cestas, France; [Lamy, Jean-Baptiste; Burlett, Regis; Plomion, Christophe; Delzon, Sylvain] Univ Bordeaux, UMR BIOGECO 1202, F-33610 Cestas, France; [Lamy, Jean-Baptiste; Cochard, Herve] Univ Blaise Pascal, INRA, UMR PIAF 547, F-63100 Clermont Ferrand, France; [Bouffier, Laurent] FCBA, Stn Sud Ouest, Domaine Sivaillan, F-33480 Moulis En Medoc, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA)	Lamy, JB (corresponding author), INRA, UMR BIOGECO 1202, F-33610 Cestas, France.	sylvain.delzon@u-bordeaux1.fr	Delzon, Sylvain/R-9538-2018; plomion, christophe/F-7578-2013; Cochard, Hervé/P-7406-2015	Delzon, Sylvain/0000-0003-3442-1711; Cochard, Hervé/0000-0002-2727-7072; plomion, christophe/0000-0002-3176-2767; Lamy, Jean-Baptiste/0000-0002-6078-0905	INRA; European Union [TREESNIP-QLK3-CT2002-01973]; NOVELTREE project [FP7-211868]; Auvergne Region	INRA; European Union(European Commission); NOVELTREE project; Auvergne Region(Region Auvergne-Rhone-Alpes)	This research was supported by grants from INRA (innovative project 2010) and the European Union: i) the provenance trial was set up in 2003 by the experimental unit at INRA Pierroton, as part of the TREESNIP-QLK3-CT2002-01973 project. ii) measurements of carbon isotope discrimination and cavitation resistance were funded by the NOVELTREE project (FP7-211868). J-BL was supported by a doctoral fellowship from INRA and the Auvergne Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia R, 1997, CAN J FOREST RES, V27, P1548, DOI 10.1139/cjfr-27-10-1548; Baltunis BS, 2008, TREE GENET GENOMES, V4, P797, DOI 10.1007/s11295-008-0152-2; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Boos DD, 2003, STAT SCI, V18, P168, DOI 10.1214/ss/1063994971; Bouffier L, 2008, HEREDITY, V101, P156, DOI 10.1038/hdy.2008.41; Bouffier L, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2007078; Brendel O, 2002, PLANT CELL ENVIRON, V25, P945, DOI 10.1046/j.1365-3040.2002.00872.x; Brendel O, 2008, TREE GENET GENOMES, V4, P263, DOI 10.1007/s11295-007-0107-z; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Brodribb TJ, 2010, NEW PHYTOL, V188, P533, DOI 10.1111/j.1469-8137.2010.03393.x; Brodribb TJ, 2009, PLANT PHYSIOL, V149, P575, DOI 10.1104/pp.108.129783; Bucci G, 2007, MOL ECOL, V16, P2137, DOI 10.1111/j.1365-294X.2007.03275.x; Burban C, 2003, MOL ECOL, V12, P1487, DOI 10.1046/j.1365-294X.2003.01817.x; Burt DB, 2001, BIOL J LINN SOC, V72, P509, DOI 10.1006/bijl.2000.0512; Cai J, 2010, PHYSIOL PLANTARUM, V140, P311, DOI 10.1111/j.1399-3054.2010.01402.x; Caruso CM, 2006, EVOLUTION, V60, P980, DOI 10.1554/06-050.1; Caruso CM, 2005, EVOLUTION, V59, P826; Caruso CM, 2004, EVOLUTION, V58, P732, DOI 10.1111/j.0014-3820.2004.tb00406.x; Chagne D, 2004, THEOR APPL GENET, V109, P1204, DOI 10.1007/s00122-004-1683-z; Cochard H, 2005, PHYSIOL PLANTARUM, V124, P410, DOI 10.1111/j.1399-3054.2005.00526.x; Cochard H, 2002, PLANT CELL ENVIRON, V25, P815, DOI 10.1046/j.1365-3040.2002.00863.x; Cochard H, 2008, J PLANT PHYSIOL, V165, P976, DOI 10.1016/j.jplph.2007.07.020; Cochard H, 2010, PLANT CELL ENVIRON, V33, P1543, DOI 10.1111/j.1365-3040.2010.02163.x; Correia I, 2008, TREE PHYSIOL, V28, P1545, DOI 10.1093/treephys/28.10.1545; Delzon S, 2004, PLANT CELL ENVIRON, V27, P1077, DOI 10.1111/j.1365-3040.2004.01213.x; Delzon S, 2010, PLANT CELL IN PRESS; Ducrey M, 2008, TREE PHYSIOL, V28, P689, DOI 10.1093/treephys/28.5.689; Eveno E, 2008, THESIS U BORDEAUX 1, V1, P399; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Fichot R, 2010, PLANT CELL ENVIRON, V33, P1553, DOI 10.1111/j.1365-3040.2010.02164.x; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Field CA, 2008, CAN J STAT, V36, P521, DOI 10.1002/cjs.5550360403; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gonzalez-Martinez SC, 2002, HEREDITY, V89, P199, DOI 10.1038/sj.hdy.6800114; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Guehl J. M., 1993, Agricoltura Ricerca, V15, P31; GUEHL JM, 1995, NEW PHYTOL, V131, P149, DOI 10.1111/j.1469-8137.1995.tb05716.x; Guevara MA, 2005, MOL ECOL NOTES, V5, P57, DOI 10.1111/j.1471-8286.2004.00830.x; GUYON JP, 1982, CAN J FOREST RES, V12, P936, DOI 10.1139/x82-136; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Hansen TF, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P130; Hansen TF, 2006, EVOLUTION, V60, P1523; Herbette S, 2010, TREE PHYSL; Houle D, 1996, GENETICS, V143, P1467; HOULE D, 1992, GENETICS, V130, P195; Jacobsen AL, 2005, PLANT PHYSIOL, V139, P546, DOI 10.1104/pp.104.058404; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Johnsen KH, 1999, CAN J FOREST RES, V29, P1727, DOI 10.1139/cjfr-29-11-1727; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kosorok MR, 1999, BIOMETRIKA, V86, P909, DOI 10.1093/biomet/86.4.909; Kremer A., 1979, Comptes-rendus du 104eme Congres National des Societes Savantes., P340; Kruuk LEB, 2001, AM NAT, V158, P557, DOI 10.1086/323585; Le Corre V, 2003, GENETICS, V164, P1205; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lynch M., 1998, GENETICS ANAL QUANTI; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Maherali H, 2009, NEW PHYTOL, V184, P721, DOI 10.1111/j.1469-8137.2009.02997.x; Mariette S, 2001, HEREDITY, V86, P469, DOI 10.1046/j.1365-2540.2001.00852.x; Mariette S, 2001, ANN FOR SCI, V58, P203, DOI 10.1051/forest:2001119; Martin G, 2008, GENETICS, V180, P2135, DOI 10.1534/genetics.107.080820; Martinez-Meier A, 2008, FOREST ECOL MANAG, V256, P837, DOI 10.1016/j.foreco.2008.05.041; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; Matzner SL, 2001, J EXP BOT, V52, P783, DOI 10.1093/jexbot/52.357.783; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Michalakis Y, 1996, GENETICS, V142, P1061; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; Ogle K, 2009, NEW PHYTOL, V182, P541, DOI 10.1111/j.1469-8137.2008.02760.x; Pammenter NW, 1998, TREE PHYSIOL, V18, P589, DOI 10.1093/treephys/18.8-9.589; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pittermann J, 2010, PLANT PHYSIOL, V153, P1919, DOI 10.1104/pp.110.158824; Pot D, 2002, ANN FOREST SCI, V59, P563, DOI 10.1051/forest:2002042; Ramirez-Valiente JA, 2009, MOL ECOL, V18, P3803, DOI 10.1111/j.1365-294X.2009.04317.x; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Ribeiro MM, 2002, ANN FOR SCI, V59, P53, DOI [10.1051/forest:2001005, 10.1051/forest:2002100]; Richardson D. M., 1998, ECOLOGY BIOGEOGRAPHY; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rweyongeza DM, 2005, SILVAE GENET, V54, P228, DOI 10.1515/sg-2005-0033; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SPITZE K, 1993, GENETICS, V135, P367; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tyree MT, 2003, NATURE, V423, P923, DOI 10.1038/423923a; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Waldmann P, 2005, HEREDITY, V94, P623, DOI 10.1038/sj.hdy.6800672; Wang TL, 2003, TREES-STRUCT FUNCT, V17, P269, DOI 10.1007/s00468-002-0236-9; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Willson CJ, 2008, AM J BOT, V95, P299, DOI 10.3732/ajb.95.3.299; Wilson AJ, 2008, J EVOLUTION BIOL, V21, P647, DOI 10.1111/j.1420-9101.2008.01500.x	101	105	107	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23476	10.1371/journal.pone.0023476	http://dx.doi.org/10.1371/journal.pone.0023476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858137	Green Published, gold			2022-12-25	WOS:000293953500047
J	Imanishi, H; Hattori, K; Wada, R; Ishikawa, K; Fukuda, S; Takenaga, K; Nakada, K; Hayashi, JI				Imanishi, Hirotake; Hattori, Keisuke; Wada, Reiko; Ishikawa, Kaori; Fukuda, Sayaka; Takenaga, Keizo; Nakada, Kazuto; Hayashi, Jun-Ichi			Mitochondrial DNA Mutations Regulate Metastasis of Human Breast Cancer Cells	PLOS ONE			English	Article							GENOME INVOLVEMENT; NUCLEAR-DNA; TUMORIGENICITY; TUMORS; MOUSE; PARAGANGLIOMA; EXPRESSION	Mutations in mitochondrial DNA (mtDNA) might contribute to expression of the tumor phenotypes, such as metastatic potential, as well as to aging phenotypes and to clinical phenotypes of mitochondrial diseases by induction of mitochondrial respiration defects and the resultant overproduction of reactive oxygen species (ROS). To test whether mtDNA mutations mediate metastatic pathways in highly metastatic human tumor cells, we used human breast carcinoma MDA-MB-231 cells, which simultaneously expressed a highly metastatic potential, mitochondrial respiration defects, and ROS overproduction. Since mitochondrial respiratory function is controlled by both mtDNA and nuclear DNA, it is possible that nuclear DNA mutations contribute to the mitochondrial respiration defects and the highly metastatic potential found in MDA-MB-231 cells. To examine this possibility, we carried out mtDNA replacement of MDA-MB-231 cells by normal human mtDNA. For the complete mtDNA replacement, first we isolated mtDNA-less (rho(0)) MDA-MB-231 cells, and then introduced normal human mtDNA into the rho(0) MDA-MB-231 cells, and isolated trans-mitochondrial cells (cybrids) carrying nuclear DNA from MDA-MB-231 cells and mtDNA from a normal subject. The normal mtDNA transfer simultaneously induced restoration of mitochondrial respiratory function and suppression of the highly metastatic potential expressed in MDA-MB-231 cells, but did not suppress ROS overproduction. These observations suggest that mitochondrial respiration defects observed in MDA-MB-231 cells are caused by mutations in mtDNA but not in nuclear DNA, and are responsible for expression of the high metastatic potential without using ROS-mediated pathways. Thus, human tumor cells possess an mtDNA-mediated metastatic pathway that is required for expression of the highly metastatic potential in the absence of ROS production.	[Imanishi, Hirotake; Hattori, Keisuke; Wada, Reiko; Ishikawa, Kaori; Fukuda, Sayaka; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Takenaga, Keizo] Shimane Univ, Fac Med, Izumo, Shimane, Japan	University of Tsukuba; Shimane University	Imanishi, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp		ISHIKAWA, Kaori/0000-0001-9895-5996	Japan Society for Promotion of Science (JSPS) [19100007]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Scientific Research (S) from the Japan Society for Promotion of Science (JSPS http://www.jsps.go.jp/) grant number 19100007 to J.-I.H. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2005, BIOCHEM BIOPH RES CO, V327, P1028, DOI 10.1016/j.bbrc.2004.12.105; ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0; BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; HAYASHI JI, 1986, CANCER RES, V46, P4001; HAYASHI JI, 1989, CANCER RES, V49, P4715; HAYASHI JI, 1994, J BIOL CHEM, V269, P6878; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kirschmann DA, 2000, CANCER RES, V60, P3359; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; MIYABAYASHI S, 1989, J INHERIT METAB DIS, V12, P373, DOI 10.1007/BF01799245; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	23	79	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23401	10.1371/journal.pone.0023401	http://dx.doi.org/10.1371/journal.pone.0023401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853128	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953400044
J	Peng, CH; Liao, CT; Peng, SC; Chen, YJ; Cheng, AJ; Juang, JL; Tsai, CY; Chen, TC; Chuang, YJ; Tang, CY; Hsieh, WP; Yen, TC				Peng, Chien-Hua; Liao, Chun-Ta; Peng, Shih-Chi; Chen, Yin-Ju; Cheng, Ann-Joy; Juang, Jyh-Lyh; Tsai, Chi-Ying; Chen, Tse-Ching; Chuang, Yung-Jen; Tang, Chuan-Yi; Hsieh, Wen-Ping; Yen, Tzu-Chen			A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; C-MYC; RISK-FACTORS; EMBRYONIC STEM; BREAST-CANCER; CAVITY CANCER; COPY NUMBER; EXPRESSION; TRANSCRIPTION; PROGRESSION	Molecular methods for predicting prognosis in patients with oral cavity squamous cell carcinoma (OSCC) are urgently needed, considering its high recurrence rate and tendency for metastasis. The present study investigated the genetic basis of variations in gene expression associated with poor prognosis in OSCC using Affymetrix SNP 6.0 and Affymetrix GeneChip Human Gene 1.0 ST arrays. We identified recurrent DNA amplifications scattered from 8q22.2 to 8q24.3 in 112 OSCC specimens. These amplicons demonstrated significant associations with increased incidence of extracapsular spread, development of second primary malignancies, and poor survival. Fluorescence in situ hybridization, in a validation panel consisting of 295 cases, confirmed these associations. Assessment of the effects of copy number variations (CNVs) on genome-wide variations in gene expression identified a total of 85 CNV-associated transcripts enriched in the MYC-centered regulatory network. Twenty-four transcripts associated with increased risk of second primary malignancies, tumor relapse, and poor survival. Besides MYC itself, a novel dysregulated MYC module plays a key role in OSCC carcinogenesis. This study identified a candidate molecular signature associated with poor prognosis in OSCC patients, which may ultimately facilitate patient-tailored selection of therapeutic strategies.	[Peng, Chien-Hua] Chang Gung Mem Hosp, Resource Ctr Clin Res, Tao Yuan, Taiwan; [Peng, Chien-Hua; Liao, Chun-Ta; Peng, Shih-Chi; Chen, Yin-Ju; Cheng, Ann-Joy; Tsai, Chi-Ying; Chen, Tse-Ching; Yen, Tzu-Chen] Chang Gung Univ, Tao Yuan, Taiwan; [Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Tao Yuan, Taiwan; [Peng, Shih-Chi; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan; [Peng, Shih-Chi; Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan; [Chen, Yin-Ju; Cheng, Ann-Joy] Chang Gung Mem Hosp, Dept Med Biotechnol, Tao Yuan, Taiwan; [Tsai, Chi-Ying] Chang Gung Mem Hosp, Dept Oral Maxillofacial Surg, Tao Yuan, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Chuang, Yung-Jen] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Juang, Jyh-Lyh] Natl Hlth Res Inst, Div Mol, Miaoli, Taiwan; [Juang, Jyh-Lyh] Natl Hlth Res Inst, Div Genom Med, Miaoli, Taiwan; [Tang, Chuan-Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Providence University - Taiwan	Peng, CH (corresponding author), Chang Gung Mem Hosp, Resource Ctr Clin Res, Tao Yuan, Taiwan.	wphsieh@stat.nthu.edu.tw; yen1110@adm.cgmh.org.tw	Chuang, Yung-Jen/D-2362-2013; Cheng, Ann-Joy/AAI-4374-2020; Juang, Jyh-Lyh/E-3944-2010; Chun-Ta, Liao/B-9589-2011	Chuang, Yung-Jen/0000-0002-6022-0107; Cheng, Ann-Joy/0000-0002-1317-0725	National Council of Science [NSC 99-2118-M-007-006]	National Council of Science	This work was partly supported by the National Council of Science [NSC 99-2118-M-007-006](http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Broet P, 2009, CANCER RES, V69, P1055, DOI 10.1158/0008-5472.CAN-08-1116; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Cancela MD, 2009, COMMUNITY DENT ORAL, V37, P342, DOI 10.1111/j.1600-0528.2009.00475.x; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Garnis C, 2004, ORAL ONCOL, V40, P511, DOI 10.1016/j.oraloncology.2003.10.006; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iwanami A, 2009, GENE DEV, V23, P1699, DOI 10.1101/gad.1832909; Kane SV, 2006, EJSO-EUR J SURG ONC, V32, P795, DOI 10.1016/j.ejso.2006.05.004; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liao CT, 2008, ANN SURG ONCOL, V15, P915, DOI 10.1245/s10434-007-9761-5; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Liao CT, 2009, ANN SURG ONCOL, V16, P159, DOI 10.1245/s10434-008-0196-4; Liu CJ, 2004, J ORAL PATHOL MED, V33, P327, DOI 10.1111/j.1600-0714.2004.00092.x; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shah NG, 2007, INT J BIOL MARKER, V22, P132, DOI 10.1177/172460080702200207; Sparano A, 2006, LARYNGOSCOPE, V116, P735, DOI 10.1097/01.mlg.0000205141.54471.7f; Subapriya R, 2007, EUR J CANCER PREV, V16, P251, DOI 10.1097/01.cej.0000228402.53106.9e; Veiga LCD, 2003, CANCER GENET CYTOGEN, V146, P110, DOI 10.1016/S0165-4608(03)00132-8; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; YEN TC, 2010, ANN SURG ONCOL; Zhao L, 2003, MOL CANCER RES, V1, P195	43	126	127	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23452	10.1371/journal.pone.0023452	http://dx.doi.org/10.1371/journal.pone.0023452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853135	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400046
J	Bhattacharyya, D; Ramachandran, S; Sharma, S; Pathmasiri, W; King, CL; Baskerville-Abraham, I; Boysen, G; Swenberg, JA; Campbell, SL; Dokholyan, NV; Chaney, SG				Bhattacharyya, Debadeep; Ramachandran, Srinivas; Sharma, Shantanu; Pathmasiri, Wimal; King, Candice L.; Baskerville-Abraham, Irene; Boysen, Gunnar; Swenberg, James A.; Campbell, Sharon L.; Dokholyan, Nikolay V.; Chaney, Stephen G.			Flanking Bases Influence the Nature of DNA Distortion by Platinum 1,2-Intrastrand (GG) Cross-Links	PLOS ONE			English	Article							DOMAIN PROTEIN RECOGNITION; MISMATCH REPAIR-PROFICIENT; ANTICANCER DRUG CISPLATIN; NMR SOLUTION STRUCTURE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; DODECAMER DUPLEX; CARRIER LIGAND; SEX REVERSAL; OXALIPLATIN	The differences in efficacy and molecular mechanisms of platinum anti-cancer drugs cisplatin (CP) and oxaliplatin (OX) are thought to be partially due to the differences in the DNA conformations of the CP and OX adducts that form on adjacent guanines on DNA, which in turn influence the binding of damage-recognition proteins that control downstream effects of the adducts. Here we report a comprehensive comparison of the structural distortion of DNA caused by CP and OX adducts in the TGGT sequence context using nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics (MD) simulations. When compared to our previous studies in other sequence contexts, these structural studies help us understand the effect of the sequence context on the conformation of Pt-GG DNA adducts. We find that both the sequence context and the type of Pt-GG DNA adduct (CP vs. OX) play an important role in the conformation and the conformational dynamics of Pt-DNA adducts, possibly explaining their influence on the ability of many damage-recognition proteins to bind to Pt-DNA adducts.	[Bhattacharyya, Debadeep; Ramachandran, Srinivas; Sharma, Shantanu; Pathmasiri, Wimal; King, Candice L.; Campbell, Sharon L.; Dokholyan, Nikolay V.; Chaney, Stephen G.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Ramachandran, Srinivas] Univ N Carolina, Program Cellular & Mol Biophys, Chapel Hill, NC USA; [Baskerville-Abraham, Irene; Boysen, Gunnar; Swenberg, James A.] Univ N Carolina, Sch Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Swenberg, James A.; Campbell, Sharon L.; Dokholyan, Nikolay V.; Chaney, Stephen G.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bhattacharyya, D (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	campbesl@med.unc.edu; dokh@med.unc.edu; stephen_chaney@med.unc.edu	Boysen, Gunnar/U-3272-2019; Dokholyan, Nikolay/D-8081-2018	Boysen, Gunnar/0000-0001-8364-9881; Dokholyan, Nikolay/0000-0002-8225-4025; Sharma, Shantanu/0000-0002-4992-7291; Baskerville-Abraham, Irene/0000-0002-7458-5422; Pathmasiri, Wimal/0000-0002-5199-5744; Ramachandran, Srinivas/0000-0003-2929-1377; campbell, sharon/0000-0003-0311-409X	National Institutes of Health [CA84480]; National Institute of Environmental Health Sciences [P30ES10126]; NATIONAL CANCER INSTITUTE [R01CA084480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, P42ES005948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was originally supported by National Institutes of Health grant CA84480 and National Institute of Environmental Health Sciences grant P30ES10126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 1996, CANCER RES, V56, P3087; Anthoney DA, 1996, CANCER RES, V56, P1374; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Chaney SG, 1999, J INORG BIOCHEM, V77, P71, DOI 10.1016/S0162-0134(99)00149-X; Churchill MEA, 2010, J MOL BIOL, V403, P88, DOI 10.1016/j.jmb.2010.08.031; Chvalova K, 2008, J INORG BIOCHEM, V102, P242, DOI 10.1016/j.jinorgbio.2007.08.006; Cohen SM, 2000, BIOCHEMISTRY-US, V39, P11771, DOI 10.1021/bi001352l; Cohen SM, 2000, BIOCHEMISTRY-US, V39, P8259, DOI 10.1021/bi0004495; Drotschmann K, 2004, DNA REPAIR, V3, P729, DOI 10.1016/j.dnarep.2004.02.011; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Dunham SU, 1997, BIOCHEMISTRY-US, V36, P11428, DOI 10.1021/bi9709452; EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912, DOI 10.1021/bi00361a026; Fink D, 1996, CANCER RES, V56, P4881; Fink D, 1997, CANCER RES, V57, P1841; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; Gruschus JM, 1998, J MAGN RESON, V135, P87, DOI 10.1006/jmre.1998.1532; He Q, 2000, BIOCHEMISTRY-US, V39, P14426, DOI 10.1021/bi001700j; HERMAN F, 1990, EUR J BIOCHEM, V194, P119, DOI 10.1111/j.1432-1033.1990.tb19435.x; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; JENNERWEIN MM, 1989, CHEM-BIOL INTERACT, V70, P39, DOI 10.1016/0009-2797(89)90061-6; Jung YW, 2003, BIOCHEMISTRY-US, V42, P2664, DOI 10.1021/bi026972w; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lavery R, 1996, CURVES 5 1 HELICAL A; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Malina J, 2007, BIOPHYS J, V93, P3950, DOI 10.1529/biophysj.107.116996; Marzilli LG, 2001, J AM CHEM SOC, V123, P2764, DOI 10.1021/ja0007915; McANulty MM, 1996, MUTAT RES-DNA REPAIR, V362, P75, DOI 10.1016/0921-8777(95)00037-2; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; PAGE JD, 1990, BIOCHEMISTRY-US, V29, P1016, DOI 10.1021/bi00456a026; Press W. H., 1992, ART SCI COMPUTING; Ramachandran S, 2009, NUCLEIC ACIDS RES, V37, P2434, DOI 10.1093/nar/gkp029; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Sharma S, 2007, J MOL BIOL, V373, P1123, DOI 10.1016/j.jmb.2007.07.079; Sixma TK, 2001, CURR OPIN STRUC BIOL, V11, P47, DOI 10.1016/S0959-440X(00)00169-X; Spingler B, 2001, INORG CHEM, V40, P5596, DOI 10.1021/ic010790t; Takahara PM, 1996, J AM CHEM SOC, V118, P12309, DOI 10.1021/ja9625079; Teletchea S, 2009, CHEM-EUR J, V15, P12320, DOI 10.1002/chem.200901158; Todd RC, 2010, J INORG BIOCHEM, V104, P902, DOI 10.1016/j.jinorgbio.2010.04.005; Travers A, 2000, CURR OPIN STRUC BIOL, V10, P102, DOI 10.1016/S0959-440X(99)00056-1; TREIBER DK, 1994, P NATL ACAD SCI USA, V91, P5672, DOI 10.1073/pnas.91.12.5672; Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187; Vaisman A, 1998, CANCER RES, V58, P3579; Voland C, 2006, MOL CANCER THER, V5, P2149, DOI 10.1158/1535-7163.MCT-05-0212; Wei M, 2001, J BIOL CHEM, V276, P38774, DOI 10.1074/jbc.M106374200; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; Woynarowski J. M., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P311; Wu YB, 2004, J MOL BIOL, V341, P1251, DOI 10.1016/j.jmb.2004.06.066; Wu YB, 2007, BIOCHEMISTRY-US, V46, P6477, DOI 10.1021/bi062291f; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YANG DZ, 1995, BIOCHEMISTRY-US, V34, P12912, DOI 10.1021/bi00039a054; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zdraveski ZZ, 2002, J BIOL CHEM, V277, P1255, DOI 10.1074/jbc.M105382200; Zhai XQ, 1998, BIOCHEMISTRY-US, V37, P16307, DOI 10.1021/bi981708h	61	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23582	10.1371/journal.pone.0023582	http://dx.doi.org/10.1371/journal.pone.0023582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853154	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200098
J	Dejean, T; Valentini, A; Duparc, A; Pellier-Cuit, S; Pompanon, F; Taberlet, P; Miaud, C				Dejean, Tony; Valentini, Alice; Duparc, Antoine; Pellier-Cuit, Stephanie; Pompanon, Francois; Taberlet, Pierre; Miaud, Claude			Persistence of Environmental DNA in Freshwater Ecosystems	PLOS ONE			English	Article							PLASMID DNA; PLANT DNA; ANCIENT; TRANSFORMATION; INFERENCES; STABILITY	The precise knowledge of species distribution is a key step in conservation biology. However, species detection can be extremely difficult in many environments, specific life stages and in populations at very low density. The aim of this study was to improve the knowledge on DNA persistence in water in order to confirm the presence of the focus species in freshwater ecosystems. Aquatic vertebrates (fish: Siberian sturgeon and amphibian: Bullfrog tadpoles) were used as target species. In control conditions (tanks) and in the field (ponds), the DNA detectability decreases with time after the removal of the species source of DNA. DNA was detectable for less than one month in both conditions. The density of individuals also influences the dynamics of DNA detectability in water samples. The dynamics of detectability reflects the persistence of DNA fragments in freshwater ecosystems. The short time persistence of detectable amounts of DNA opens perspectives in conservation biology, by allowing access to the presence or absence of species e. g. rare, secretive, potentially invasive, or at low density. This knowledge of DNA persistence will greatly influence planning of biodiversity inventories and biosecurity surveys.	[Dejean, Tony; Valentini, Alice] SPYGEN, Savoie Technolac, Le Bourget Du Lac, France; [Dejean, Tony] Parc Nat Reg Perigord Limousin, La Coquille, France; [Dejean, Tony; Valentini, Alice; Duparc, Antoine; Miaud, Claude] Univ Savoie, UMR CNRS 5553, Lab Ecol Alpine, Le Bourget Du Lac, France; [Pellier-Cuit, Stephanie; Pompanon, Francois; Taberlet, Pierre] Univ Grenoble 1, UMR CNRS 5553, Lab Ecol Alpine, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Dejean, T (corresponding author), SPYGEN, Savoie Technolac, BP 274, Le Bourget Du Lac, France.	claude.miaud@univ-savoie.fr	valentini, alice/S-2040-2019; Pompanon, François/D-3459-2009; Valentini, Alice/AFS-1389-2022; Taberlet, Pierre/D-1178-2010	Pompanon, François/0000-0003-4600-0172; Valentini, Alice/0000-0001-5829-5479; Taberlet, Pierre/0000-0002-3554-5954	Ministry of Research [966/2007]; European Community [1018]	Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); European Community(European Commission)	Tony Dejean was given a grant by the Ministry of Research (Grant CIFRE Number 966/2007), and Claude Miaud by the European Community (Marie Curie OIF grant Number 1018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AJ, 1996, ENVIRON TOXIC WATER, V11, P129, DOI 10.1002/(SICI)1098-2256(1996)11:2<129::AID-TOX8>3.0.CO;2-B; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Cooper A, 2000, SCIENCE, V289, P1139; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; DETAINT M, 2001, INVASION GRENOUILLE; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MARGURRAN AE, 2004, MEASURING BIOL DIVER; Matsui K, 2001, AQUAT MICROB ECOL, V26, P95, DOI 10.3354/ame026095; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Nichols JD, 2009, ENVIRON ECOL STAT SE, V3, P201, DOI 10.1007/978-0-387-78151-8_9; Pote J, 2009, ECOTOX ENVIRON SAFE, V72, P1378, DOI 10.1016/j.ecoenv.2009.04.010; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; ROMANOWSKI G, 1992, APPL ENVIRON MICROB, V58, P3012, DOI 10.1128/AEM.58.9.3012-3019.1992; Shapiro B, 2008, TRENDS BIOTECHNOL, V26, P285, DOI 10.1016/j.tibtech.2008.03.005; Smith DR, 2006, J N AM BENTHOL SOC, V25, P701, DOI 10.1899/0887-3593(2006)25[701:SDFDRF]2.0.CO;2; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Team RDC, 2010, R LANG ENV STAT COMP; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Valiere N, 2000, MOL ECOL, V9, P2150, DOI 10.1046/j.1365-294X.2000.11142.x; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Zhu B, 2006, WATER RES, V40, P3231, DOI 10.1016/j.watres.2006.06.040	31	340	373	17	315	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23398	10.1371/journal.pone.0023398	http://dx.doi.org/10.1371/journal.pone.0023398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858099	Green Published, gold			2022-12-25	WOS:000293773300026
J	Roberti, MJ; Jovin, TM; Jares-Erijman, E				Julia Roberti, M.; Jovin, Thomas M.; Jares-Erijman, Elizabeth			Confocal Fluorescence Anisotropy and FRAP Imaging of alpha-Synuclein Amyloid Aggregates in Living Cells	PLOS ONE			English	Article							MEMBRANE-INTERACTIONS; PROTEIN AGGREGATION; BINDING; MECHANISM; DYNAMICS; RFLIM; PHASE	We assessed the intracellular association states of the Parkinson's disease related protein alpha-synuclein (AS) in living cells by transfection with a functional recombinant mutant protein (AS-C4) bearing a tetracysteine tag binding the fluorogenic biarsenical ligands FlAsH and ReAsH, The aggregation states of AS-C4 were assessed by in situ microscopy of molecular translational mobility with FRAP (fluorescence recovery after photobleaching) and of local molecular density with confocal fluorescence anisotropy (CFA). FRAP recovery was quantitative and rapid in regions of free protein, whereas AS in larger aggregates was >80% immobile. A small 16% recovery characterized by an apparent diffusion constant of 0.03-0.04 mu m(2)/s was attributed to the dynamics of smaller, associated forms of AS-C4 and the exchange of mobile species with the larger immobile aggregates. By CFA, the larger aggregates exhibited high brightness and very low anisotropy, consistent with homoFRET between closely packed AS, for which a Forster distance (R-o) of 5.3 nm was calculated. Other bright regions had high anisotropy values, close to that of monomeric AS, and indicative of membrane-associated protein with both low mobility and low degree of association. The anisotropy-fluorescence intensity correlations also revealed regions of free protein or of small aggregates, undetectable by conventional fluorescence imaging alone. The combined strategy (FRAP+CFA) provides a highly sensitive means for elucidating both the dynamics and structural features of protein aggregates and other intracellular complexes in living cells, and can be extended to other amyloid systems and to drug screening protocols.	[Julia Roberti, M.; Jares-Erijman, Elizabeth] Max Planck Inst Biophys Chem, Lab Cellular Dynam, Gottingen, Germany; [Julia Roberti, M.; Jovin, Thomas M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR,CONICET, RA-1428 Buenos Aires, DF, Argentina	Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Roberti, MJ (corresponding author), Max Planck Inst Biophys Chem, Lab Cellular Dynam, Gottingen, Germany.	eli@qo.fcen.uba.ar			Max Planck Society; ANPCyT; CONICET; UBACyT; DFG Center for Molecular Physiology of the Brain (DFG CMPB); CMPB, in Gottingen, Germany	Max Planck Society(Max Planck SocietyFoundation CELLEX); ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT; DFG Center for Molecular Physiology of the Brain (DFG CMPB)(German Research Foundation (DFG)); CMPB, in Gottingen, Germany	E.A.J.-E. is funded by the Max Planck Society (Partner Group grant), ANPCyT, CONICET and UBACyT. This work was supported by the DFG Center for Molecular Physiology of the Brain (DFG CMPB), Cluster of Excellence 171 (Nanometer Microscopy) of the CMPB, in Gottingen, Germany, and the Max Planck Society (Toxic Protein Conformations project). M.J.R. received fellowship support from the DFG CMPB and CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Allsop D, 2001, BIOCHEM BIOPH RES CO, V285, P58, DOI 10.1006/bbrc.2001.5123; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bertoncini CW, 2011, CURR PROTEIN PEPT SC, V12, P206; Celej MS, 2008, BIOPHYS J, V94, P4867, DOI 10.1529/biophysj.107.125211; Daughdrill GW, 2005, PROTEIN FOLDING HANDBOOK; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Gerard M, 2006, FASEB J, V20, P524, DOI 10.1096/fj.05-5126fje; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Jovin TM, 2004, PROC SPIE, V5323, P1, DOI 10.1117/12.528469; Roberti MJ, 2011, CHEMPHYSCHEM, V12, P563, DOI 10.1002/cphc.201000925; Roberti MJ, 2009, J AM CHEM SOC, V131, P8102, DOI 10.1021/ja900225w; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Koo BW, 2005, PROTEIN SCI, V14, P231, DOI 10.1110/ps.041051205; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Luk KC, 2007, BIOCHEMISTRY-US, V46, P12522, DOI 10.1021/bi701128c; Madine J, 2009, DRUG FUTURE, V34, P655, DOI 10.1358/dof.2009.034.08.1391472; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Outeiro TF, 2009, CURR PHARM DESIGN, V15, P3968, DOI 10.2174/138161209789649321; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Roberti MJ, 2007, NAT METHODS, V4, P345, DOI 10.1038/NMETH1026; ROSS RA, 1983, J NATL CANCER I, V71, P741; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Valeur B, 2001, MOL FLUORESCENCE PRI, V2nd; van Ham TJ, 2010, J MOL BIOL, V395, P627, DOI 10.1016/j.jmb.2009.10.066	33	47	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23338	10.1371/journal.pone.0023338	http://dx.doi.org/10.1371/journal.pone.0023338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858077	Green Submitted, Green Published, gold			2022-12-25	WOS:000293773300023
J	Las, G; Serada, SB; Wikstrom, JD; Twig, G; Shirihai, OS				Las, Guy; Serada, Sam B.; Wikstrom, Jakob D.; Twig, Gilad; Shirihai, Orian S.			Fatty Acids Suppress Autophagic Turnover in beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LIVING MAMMALIAN-CELLS; PANCREATIC-ISLETS; OXIDATIVE STRESS; MONITORING AUTOPHAGY; PUNCTA-FORMATION; PROTON PUMP; FUSION; EXPOSURE; GLUCOSE	Recent studies have shown that autophagy is essential for proper beta-cell function and survival. However, it is yet unclear under what pathogenic conditions autophagy is inhibited in beta-cells. Here, we report that long term exposure to fatty acids and glucose block autophagic flux in beta-cells, contributing to their toxic effect. INS1 cells expressing GFP-LC3 (an autophagosome marker) were treated with 0.4 mM palmitate, 0.4 mM oleate, and various concentrations of glucose for 22 h. Kinetics of the effect of fatty acids on autophagy showed a biphasic response. During the second phase of autophagy, the size of autophagosomes and the content of autophagosome substrates (GFP-LC3, p62) and endogenous LC3 was increased. During the same phase, fatty acids suppressed autophagic degradation of long lived protein in both INS1 cells and islets. In INS1 cells, palmitate induced a 3-fold decrease in the number and the acidity of Acidic Vesicular Organelles. This decrease was associated with a suppression of hydrolase activity, suppression of endocytosis, and suppression of oxidative phosphorylation. The combination of fatty acids with glucose synergistically suppressed autophagic turnover, concomitantly suppressing insulin secretion. Rapamycin treatment resulted in partial reversal of the inhibition of autophagic flux, the inhibition of insulin secretion, and the increase in cell death. Our results indicate that excess nutrient could impair autophagy in the long term, hence contributing to nutrient-induced beta-cell dysfunction. This may provide a novel mechanism that connects diet-induced obesity and diabetes.	[Las, Guy; Serada, Sam B.; Wikstrom, Jakob D.; Twig, Gilad; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University	Shirihai, OS (corresponding author), EBRC 650 Albany St,Rm 804, Boston, MA 02118 USA.	Shirihai@bu.edu	Twig, Gilad/C-4373-2018	Twig, Gilad/0000-0003-2829-3645; Shirihai, Orian/0000-0002-9502-2661; Wikstrom, Jakob/0000-0002-4287-1774	Evans Center; Mitochondria-Affinity Research Collaborative (mtARC); National Institutes of Health [R01 HL071629-03, R01 DK074778, DK035914]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, R56DK035914, R01DK074778, R37DK035914] Funding Source: NIH RePORTER	Evans Center; Mitochondria-Affinity Research Collaborative (mtARC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Evans Center and the Mitochondria-Affinity Research Collaborative (mtARC) and by National Institutes of Health Grants R01 HL071629-03 and R01 DK074778 and DK035914 (to O. S. S. and B. C. Corkey).	Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YAMASHIRO DJ, 1983, J CELL BIOL, V97, P929, DOI 10.1083/jcb.97.3.929; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	40	149	154	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42534	42544		10.1074/jbc.M111.242412	http://dx.doi.org/10.1074/jbc.M111.242412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21859708	Green Published, hybrid			2022-12-25	WOS:000298180900061
J	De Rienzo, G; Bishop, JA; Mao, YW; Pan, LY; Ma, TP; Moens, CB; Tsai, LH; Sive, H				De Rienzo, Gianluca; Bishop, Joshua A.; Mao, Yingwei; Pan, Luyuan; Ma, Taylur P.; Moens, Cecilia B.; Tsai, Li-Huei; Sive, Hazel			Disc1 regulates both beta-catenin-mediated and noncanonical Wnt signaling during vertebrate embryogenesis	FASEB JOURNAL			English	Article						Disc1; zebrafish; brain; neurons; GSK3 beta; pcp; mutant	SCHIZOPHRENIA 1; CELL POLARITY; ZEBRAFISH; EXPRESSION; MECHANISM; BRAIN; DISRUPTED-IN-SCHIZOPHRENIA-1; XENOPUS; ABNORMALITIES; GASTRULATION	Disc1 is a schizophrenia risk gene that engages multiple signaling pathways during neurogenesis and brain development. Using the zebrafish as a tool, we analyze the function of zebrafish Disc1 (zDisc1) at the earliest stages of brain and body development. We define a "tool" as a biological system that gives insight into mechanisms underlying a human disorder, although the system does not phenocopy the disorder. A zDisc1 peptide binds to GSK3 beta, and zDisc1 directs early brain development and neurogenesis, by promoting beta-catenin-mediated Wnt signaling and inhibiting GSK3 beta activity. zDisc1 loss-of-function embryos additionally display a convergence and extension phenotype, demonstrated by abnormal movement of dorsolateral cells during gastrulation, through changes in gene expression, and later through formation of abnormal, U-shaped muscle segments, and a truncated tail. These phenotypes are caused by alterations in the noncanonical Wnt pathway, via Daam and Rho signaling. The convergence and extension phenotype can be rescued by a dominant negative GSK3 beta construct, suggesting that zDisc1 inhibits GSK3 beta activity during noncanonical Wnt signaling. This is the first demonstration that Disc1 modulates the noncanonical Wnt pathway and suggests a previously unconsidered mechanism by which Disc1 may contribute to the etiology of neuropsychiatric disorders.-De Rienzo, G., Bishop, J. A., Mao, Y., Pan, L., Ma, T. P., Moens, C. B., Tsai, L. H., Sive, H. Disc1 regulates both beta-catenin-mediated and noncanonical Wnt signaling during vertebrate embryogenesis. FASEB J. 25, 4184 -4197 (2011). www.fasebj.org	[De Rienzo, Gianluca; Sive, Hazel] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bishop, Joshua A.; Tsai, Li-Huei] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Bishop, Joshua A.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Mao, Yingwei] Penn State Univ, Dept Biol, State Coll, PA USA; [Pan, Luyuan; Ma, Taylur P.; Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98104 USA; [Tsai, Li-Huei] Howard Hughes Med Inst, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA USA; [Sive, Hazel] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Northwell Health; Massachusetts Institute of Technology (MIT)	Sive, H (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sive@wi.mit.edu	Moens, Cecilia/AAN-1536-2020	Sive, Hazel/0000-0002-4890-424X; Moens, Cecilia/0000-0002-1099-0728	Stanley Medical Research Institute; U.S. National Institutes of Health (NIH) [R01 HG002995]; NIH [RO1 MH091115]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076585] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091115] Funding Source: NIH RePORTER	Stanley Medical Research Institute; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the members of the H.S. laboratory for discussion, and Olivier Paugois for expert fish husbandry. The authors are grateful to Ed Scolnick, Stephen Haggarty, Pamela Sklar, and other members of the Stanley Center for input. The authors thank the following colleagues for generous gifts of reagents, as noted in Materials and Methods: Anand Chandrasekhar (University of Missouri, Columbia, MO, USA), Jeremy Green (Dana-Farber Cancer Institute, Boston, MA, USA), Raymond Habas (Temple University, Philadelphia, PA, USA), Stephen Haggarty (Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA), Xi He (Harvard Medical School, Cambridge, MA, USA), David Kimelman (University of Washington, Seattle, WA, USA), Jim Smith (Gurdon Institute, Cambridge, UK), Randall Moon (University of Washington School of Medicine, Seattle, WA, USA), Steven Wilson (University College London, London, UK), Rudi Winklbauer (University of Toronto, Toronto, ON, Canada), and Karen Symes (Boston University, Boston, MA, USA). This work was supported by the Stanley Medical Research Institute, via a grant to the Stanley Center for Psychiatric Research at the Broad Institute. The Disc1<SUP>fh291</SUP> and Disc1<SUP>fh292</SUP> mutants were identified with the support of U.S. National Institutes of Health (NIH) grant R01 HG002995 to C.B.M. This work was partially supported by NIH grant RO1 MH091115 to L.-H.T.	Bingham SM, 2010, DEV NEUROBIOL, V70, P87, DOI 10.1002/dneu.20761; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Cotter D, 1998, NEUROREPORT, V9, P1379, DOI 10.1097/00001756-199805110-00024; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Drerup CM, 2009, DEVELOPMENT, V136, P2623, DOI 10.1242/dev.030577; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Ftouh S, 2005, J NEUROCHEM, V94, P520, DOI 10.1111/j.1471-4159.2005.03239.x; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gutzman Jennifer H, 2009, J Vis Exp, DOI 10.3791/1218; Gutzman JH, 2010, DEVELOPMENT, V137, P795, DOI 10.1242/dev.042705; Harvey SA, 2010, DEVELOPMENT, V137, P1127, DOI 10.1242/dev.046318; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KOLM PJ, 1995, DEV BIOL, V171, P267, DOI 10.1006/dbio.1995.1279; Korth C, 2009, REV NEUROSCIENCE, V20, P321; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108; Liu W., 2007, P NATL ACAD SCI USA, V105, P210; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marley A., 2010, PLOS ONE, V28, P5; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Millar JK, 2007, J PHYSIOL-LONDON, V584, P401, DOI 10.1113/jphysiol.2007.140210; Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Sive H, 2011, DIS MODEL MECH, V4, P137, DOI 10.1242/dmm.007666; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; van de Water S, 2001, DEVELOPMENT, V128, P3877; Vivancos V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-7; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wiellette EL, 2003, DEVELOPMENT, V130, P3821, DOI 10.1242/dev.00572; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	51	31	31	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4184	4197		10.1096/fj.11-186239	http://dx.doi.org/10.1096/fj.11-186239			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21859895	Green Published			2022-12-25	WOS:000298138100012
J	Guan, YJ; Yang, X; Wei, L; Chen, Q				Guan, Ying-Jie; Yang, Xu; Wei, Lei; Chen, Qian			MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4	FASEB JOURNAL			English	Article						mechanotransduction; HDAC4; Indian hedgehog	CARTILAGE MATRIX PROTEIN; INDIAN-HEDGEHOG; CELL-ADHESION; GROWTH-PLATE; EXPRESSION; PROLIFERATION; MECHANOTRANSDUCTION; HYPERTROPHY; MATURATION; BONE	Mechanical stress plays an essential role in tissue development and remodeling. In this study, we determined the role of microRNA in chondrocyte mechanotransduction. Using microarray, we identified miR-365 as a mechanoresponsive microRNA in parallel to mechanical induction of Indian hedgehog (Ihh) in primary chicken chondrocytes cultured in 3-dimensional collagen scaffoldings under cyclic loading (1 Hz, 5% elongation). Interestingly, expression of miR-365 is elevated in the prehypertrophic zone of the growth plate, coinciding with the Ihh expression region in vivo. MiR-365 significantly stimulates chondrocyte proliferation and differentiation. MiR-365 increases expression of Ihh and the hypertrophic marker type X collagen, whereas anti-miR-365 inhibits the expression of these genes. We identified histone deacetylase 4 (HDAC4), an inhibitor of chondrocyte hypertrophy, as a target of miR-365. MiR-365 inhibits both endogenous HDAC4 protein levels as well as the activity of a reporter gene bearing the 3'-untranslated region of HDAC4 mRNA. Conversely, inhibition of endogenous miR-365 relieves the repression of HDAC4. Mutation of the miR-365 binding site in HDAC4 mRNA abolishes miR-365-mediated repression of the reporter gene activity. Overexpression of HDAC4 reverses miR-365 stimulation of chondrocyte differentiation markers including Ihh, Col X, and Runx2. Moreover, inhibition of miR-365 abolishes mechanical stimulation of chondrocyte differentiation. Taken together, miR-365 is the first identified mechanically responsive microRNA that regulates chondrocyte differentiation via directly targeting HDAC4.-Guan, Y.-J., Yang, X., Wei, L., Chen, Q. MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J. 25, 4457-4466 (2011). www.fasebj.org	[Guan, Ying-Jie; Yang, Xu; Wei, Lei; Chen, Qian] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Cell & Mol Biol Lab,Dept Orthopaed, Providence, RI 02903 USA; [Yang, Xu] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Orthopaed, Qingdao 266071, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Qingdao University	Chen, Q (corresponding author), Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Cell & Mol Biol Lab,Dept Orthopaed, 1 Hoppin St,Ste 402, Providence, RI 02903 USA.	qian_chen@brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618	U.S. National Institutes of Health [AG 017021, AG 014399, AR 059142, RR024484]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014399, R29AG014399, R01AG017021] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Gary Stein (University of Massachusetts Medical School, Worcester, MA, USA) and Dr. Da-Zhi Wang (Children's Hospital Boston and Harvard Medical School, Boston, MA, USA) for providing plasmid constructs, and Paul Shultz for critical reading of the manuscript. This study is supported by U.S. National Institutes of Health grants AG 017021, AG 014399, AR 059142 and RR024484.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chan Shih-Peng, 2006, RNA Biol, V3, P97; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; COHEN B, 1992, J ORTHOPAED RES, V10, P263, DOI 10.1002/jor.1100100214; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Guo L, 2009, PHOTOCHEM PHOTOBIOL, V85, P765, DOI 10.1111/j.1751-1097.2008.00482.x; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hug BA, 2004, CELL, V119, P448, DOI 10.1016/j.cell.2004.10.023; Kanbe K, 2007, J BONE MINER RES, V22, P318, DOI 10.1359/JBMR.061104; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; LIU M, 1992, AM J PHYSIOL, V263, pL376; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Makihira S, 1999, J BIOL CHEM, V274, P11417, DOI 10.1074/jbc.274.16.11417; Miyaki S., GENES DEV, V24, P1173; Mohamed J. S., J BIOL CHEM, V285, P29336; Qin B, 2011, BIOCHEM BIOPH RES CO, V410, P127, DOI 10.1016/j.bbrc.2011.05.118; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Tang GH, 2004, J DENT RES, V83, P434, DOI 10.1177/154405910408300516; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang KC, P NATL ACAD SCI US, V107, P3234; Wang X. Y., MOL CELL BIOCH, V345, P283; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200	37	116	122	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4457	4466		10.1096/fj.11-185132	http://dx.doi.org/10.1096/fj.11-185132			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21856783	Green Published			2022-12-25	WOS:000298138100036
J	Fu, LC; Balasubramanian, M; Shan, JX; Dudenhausen, EE; Kilberg, MS				Fu, Lingchen; Balasubramanian, Mukundh; Shan, Jixiu; Dudenhausen, Elizabeth E.; Kilberg, Michael S.			Auto-activation of c-JUN Gene by Amino Acid Deprivation of Hepatocellular Carcinoma Cells Reveals a Novel c-JUN-mediated Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE SYNTHETASE GENE; HUMAN HEPATOMA-CELLS; DIETARY-PROTEIN RESTRICTION; TRANSCRIPTION FACTORS; NUTRITIONAL CONTROL; RESPONSE ELEMENTS; HISTONE ACETYLATION; POSITIVE REGULATOR; MAMMALIAN-CELLS; ATF4 EXPRESSION	Mammalian cells respond to protein or amino acid (AA) limitation by activating a number of signaling pathways, collectively referred to as the AA response (AAR), that modulate a range of cellular functions, including transcriptional induction of target genes. This study demonstrates that in hepatocellular carcinoma cells, expression of c-JUN, JUN-B, c-FOS, and FOS-B was induced by the AAR, whereas JUN-D, FRA-1, and FRA-2 were not. Of the four activated FOS/JUN members, c-JUN made the largest contribution to the induction of several known AAR target genes. For several human liver, prostate, and ovarian cell lines, the AAR-induced increase in c-JUN expression was greater in transformed cells compared with nontransformed counterparts, an effect independent of cell growth rate. Thus far, the best characterized AA-responsive genes are all transcriptionally activated by ATF4, but the AAR-dependent induction of c-JUN transcription was ATF4-independent. The increased expression of c-JUN was dependent on ATF2 and on activation of the MEK-ERK and JNK arms of the MAPK signaling pathways. Formation of c-JUN-ATF2-activated heterodimers was increased after AA limitation, and c-JUN or ATF2 knockdown suppressed the induction of c-JUN and other AAR target genes. AA deprivation triggers a feed-forward process that involves phosphorylation of existing c-JUN protein by JNK and subsequent auto-activation of the c-JUN gene by recruitment of c-JUN and ATF2 to two AP-1 sites within the proximal promoter. The results document the novel observation that AP-1 sequences within the c-JUN gene can function as transcriptional amino acid-response elements.	[Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu			National Institutes of Health [DK-092062]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092062, R01DK094729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-092062 (to M. S. K.).	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Aslanian AM, 2001, BIOCHEM J, V357, P321, DOI 10.1042/0264-6021:3570321; Aubel C, 2001, CELL SIGNAL, V13, P417, DOI 10.1016/S0898-6568(01)00159-0; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hutson RG, 1996, CLIN NUTR, V15, P327, DOI 10.1016/S0261-5614(96)80009-4; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Li J, 2011, AM J PHYSIOL-CELL PH, V301, pC213, DOI 10.1152/ajpcell.00067.2011; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lim PLK, 2007, TOXICOL IN VITRO, V21, P1390, DOI 10.1016/j.tiv.2007.05.003; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; Morley JE, 2009, CURR OPIN CLIN NUTR, V12, P607, DOI 10.1097/MCO.0b013e328331e9ce; MOROOKA H, 1995, J BIOL CHEM, V270, P30084; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Pedrini MT, 1996, ANN INTERN MED, V124, P627, DOI 10.7326/0003-4819-124-7-199604010-00002; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; POHJANPELTO P, 1990, MOL CELL BIOL, V10, P5814, DOI 10.1128/MCB.10.11.5814; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shan JX, 2009, J BIOL CHEM, V284, P21241, DOI 10.1074/jbc.M109.011338; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Singh J, 2002, ONCOGENE, V21, P1812, DOI 10.1038/sj.onc.1205252; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Su N, 2009, HEPATOLOGY, V50, P282, DOI 10.1002/hep.22971; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wei P, 1998, MOL ENDOCRINOL, V12, P1322, DOI 10.1210/me.12.9.1322; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yogev O, 2010, CANCER RES, V70, P2318, DOI 10.1158/0008-5472.CAN-09-3408; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	68	26	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36724	36738		10.1074/jbc.M111.277673	http://dx.doi.org/10.1074/jbc.M111.277673			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862593	hybrid, Green Published			2022-12-25	WOS:000296538300055
J	Schnepple, DJ; Shepard, B; Bren, GD; Cummins, NW; Natesampillai, S; Trushin, S; Algeciras-Schimnich, A; Meng, XW; Sainski, AM; Rizza, SA; Kaufmann, SH; Badley, AD				Schnepple, David J.; Shepard, Brett; Bren, Gary D.; Cummins, Nathan W.; Natesampillai, Sekar; Trushin, Sergey; Algeciras-Schimnich, Alicia; Meng, Xue W.; Sainski, Amy M.; Rizza, Stacey A.; Kaufmann, Scott H.; Badley, Andrew D.			Isolation of a TRAIL Antagonist from the Serum of HIV-infected Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING LIGAND; CD4(+) T-CELLS; NF-KAPPA-B; ANTIRETROVIRAL THERAPY; MEDIATED APOPTOSIS; HUMAN-MELANOMA; UP-REGULATION; TUMOR-GROWTH; FAS LIGAND; VIRUS	Virus-host interactions are characterized by the selection of adaptive mechanisms by which to evade pathogenic and defense mechanisms, respectively. In primary T cells infected with HIV, HIV infection up-regulates TNF-related apoptosis inducing ligand (TRAIL) and death-inducing TRAIL receptors, but blockade of TRAIL: TRAIL receptor interaction does not alter HIV-induced cell death. Instead, HIV infection results in a novel splice variant that we call TRAIL-short (TRAIL-s), which antagonizes TRAIL-R2. In HIV patients, plasma TRAIL-s concentration increases with increasing viral load and renders cells resistant to TRAIL-induced death. Knockdown of TRAIL-s abrogates this resistance. We propose that TRAIL-s is a novel adaptive mechanism of apoptosis resistance acquired by HIV-infected cells to avoid their elimination by TRAIL-dependent effector mechanism.	[Schnepple, David J.; Shepard, Brett; Bren, Gary D.; Cummins, Nathan W.; Natesampillai, Sekar; Trushin, Sergey; Algeciras-Schimnich, Alicia; Sainski, Amy M.; Rizza, Stacey A.; Badley, Andrew D.] Mayo Clin, Coll Med, Div Infect Dis, Rochester, MN 55905 USA; [Schnepple, David J.] Mayo Clin, Coll Med, Program Mol Neurosci, Rochester, MN 55905 USA; [Meng, Xue W.; Kaufmann, Scott H.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; [Sainski, Amy M.; Kaufmann, Scott H.] Mayo Clin, Coll Med, Dept Mol Pharmacol, Rochester, MN 55905 USA; [Cummins, Nathan W.; Badley, Andrew D.] Mayo Clin, Coll Med, Program Translat Immunovirol & Biodef, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Badley, AD (corresponding author), Mayo Clin, Coll Med, Div Infect Dis, 200 1st St SW, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	Serei, Virian D/B-4616-2015; badley, andrew d/O-9022-2014	Kaufmann, Scott/0000-0002-4900-7145; Badley, Andrew/0000-0001-7796-7680	National Institutes of Health [R01 AI62261]; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI62261 (to A. D. B.).	Badley AD, 1998, J CLIN INVEST, V102, P79, DOI 10.1172/JCI2691; BADLEY AD, 2006, CELL DEATH HIV INFEC; Baetu TM, 2002, CYTOKINE GROWTH F R, V13, P199, DOI 10.1016/S1359-6101(02)00006-0; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Bren GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002112; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fryer HR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001196; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Griffith TS, 1998, J IMMUNOL, V161, P2833; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; HAMILTON TC, 1984, SEMIN ONCOL, V11, P285; Hansjee N, 2004, JAIDS-J ACQ IMM DEF, V36, P671, DOI 10.1097/00126334-200406010-00003; Held J, 2001, DRUG RESIST UPDATE, V4, P243, DOI 10.1054/drup.2001.0208; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Holen I, 2002, CANCER RES, V62, P1619; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Johansson P, 2009, J VIROL, V83, P1393, DOI 10.1128/JVI.01637-08; KANZLER S, 2005, EUR J CANCER, V3, P17; Lassen KG, 2010, J BIOL CHEM, V285, P29326, DOI 10.1074/jbc.M110.154054; Lichtner M, 2004, AIDS RES HUM RETROV, V20, P175, DOI 10.1089/088922204773004897; Lum JJ, 2005, AIDS, V19, P1125, DOI 10.1097/01.aids.0000176212.16205.23; Lum JJ, 2004, J VIROL, V78, P6033, DOI 10.1128/JVI.78.11.6033-6042.2004; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; Munshi A, 2001, ONCOGENE, V20, P3757, DOI 10.1038/sj.onc.1204504; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Richard J, 2010, CELL HOST MICROBE, V8, P389, DOI 10.1016/j.chom.2010.11.001; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shankar S, 2004, INT J ONCOL, V24, P1133; Shepard BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003096; Shiozaki T, 2011, J GEN VIROL, V92, P315, DOI 10.1099/vir.0.028316-0; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tazi J, 2010, FEBS J, V277, P867, DOI 10.1111/j.1742-4658.2009.07522.x; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wu XF, 2001, MOL THER, V3, P368, DOI 10.1006/mthe.2001.0280; Yang YD, 2003, J VIROL, V77, P6700, DOI 10.1128/JVI.77.12.6700-6708.2003; Yoo J, 2006, J GENE MED, V8, P163, DOI 10.1002/jgm.832; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045; Zhang XD, 2001, CANCER RES, V61, P7339	58	11	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35742	35754		10.1074/jbc.M111.274639	http://dx.doi.org/10.1074/jbc.M111.274639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859711	Green Published, hybrid			2022-12-25	WOS:000295927100047
J	Etienne-Mesmin, L; Chassaing, B; Sauvanet, P; Denizot, J; Blanquet-Diot, S; Darfeuille-Michaud, A; Pradel, N; Livrelli, V				Etienne-Mesmin, Lucie; Chassaing, Benoit; Sauvanet, Pierre; Denizot, Jeremy; Blanquet-Diot, Stephanie; Darfeuille-Michaud, Arlette; Pradel, Nathalie; Livrelli, Valerie			Interactions with M Cells and Macrophages as Key Steps in the Pathogenesis of Enterohemorragic Escherichia coli Infections	PLOS ONE			English	Article							LONG POLAR FIMBRIAE; PEYERS PATCH; SALMONELLA-TYPHIMURIUM; TISSUE TROPISM; O157-H7; EXPRESSION; STRAINS; TRANSLOCATION; COLONIZATION; ADHESION	Enterohemorrhagic Escherichia coli (EHEC) are food-borne pathogens that can cause serious infections ranging from diarrhea to hemorrhagic colitis (HC) and hemolytic-uremic syndrome (HUS). Translocation of Shiga-toxins (Stx) from the gut lumen to underlying tissues is a decisive step in the development of the infection, but the mechanisms involved remain unclear. Many bacterial pathogens target the follicle-associated epithelium, which overlies Peyer's patches (PPs), cross the intestinal barrier through M cells and are captured by mucosal macrophages. Here, translocation across M cells, as well as survival and proliferation of EHEC strains within THP-1 macrophages were investigated using EHEC O157:H7 reference strains, isogenic mutants, and 15 EHEC strains isolated from HC/HUS patients. We showed for the first time that E. coli O157:H7 strains are able to interact in vivo with murine PPs, to translocate ex vivo through murine ileal mucosa with PPs and across an in vitro human M cell model. EHEC strains are also able to survive and to produce Stx in macrophages, which induce cell apoptosis and Stx release. In conclusion, our results suggest that the uptake of EHEC by M cells and underlying macrophages in the PP may be a critical step in Stx translocation and release in vivo. A new model for EHEC infection in humans is proposed that could help in a fuller understanding of EHEC-associated diseases.	[Etienne-Mesmin, Lucie; Chassaing, Benoit; Sauvanet, Pierre; Denizot, Jeremy; Darfeuille-Michaud, Arlette; Pradel, Nathalie; Livrelli, Valerie] Univ Auvergne, Clermont Univ, Ctr Rech Nutr Humaine Auvergne, JE Evolut Bacteries Pathogenes & Susceptibil Gene, Clermont Ferrand, France; [Etienne-Mesmin, Lucie; Chassaing, Benoit; Sauvanet, Pierre; Denizot, Jeremy; Darfeuille-Michaud, Arlette; Pradel, Nathalie; Livrelli, Valerie] INRA, Unite Contrat USC 2018, Clermont Ferrand, France; [Etienne-Mesmin, Lucie; Blanquet-Diot, Stephanie] Univ Auvergne, Clermont Univ, Ctr Rech Nutr Humaine Auvergne, ERT 18, Clermont Ferrand, France; [Etienne-Mesmin, Lucie; Blanquet-Diot, Stephanie; Livrelli, Valerie] Univ Auvergne, Clermont Univ, UFR Pharm, Clermont Ferrand, France; [Livrelli, Valerie] CHU Clermont Ferrand, Serv Bacteriol Mycol Parasitol, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); INRAE; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Etienne-Mesmin, L (corresponding author), Univ Auvergne, Clermont Univ, Ctr Rech Nutr Humaine Auvergne, JE Evolut Bacteries Pathogenes & Susceptibil Gene, Clermont Ferrand, France.	valerie.livrelli@u-clermont1.fr	Etienne-Mesmin, Lucie/AAD-3754-2019; Blanquet-Diot, Stéphanie/AAD-3759-2019; Chassaing, Benoit/R-3819-2017	Etienne-Mesmin, Lucie/0000-0001-6104-6043; Chassaing, Benoit/0000-0002-4285-769X; Denizot, Jeremy/0000-0003-0078-8996	Ministere de l'Enseignement Superieur et de la Recherche [JE2526]; Institut National de Recherche Agronomique [USC-2018]	Ministere de l'Enseignement Superieur et de la Recherche; Institut National de Recherche Agronomique	This study was supported by grants from the Ministere de l'Enseignement Superieur et de la Recherche (JE2526) (http://www.enseignementsuprecherche.gouv.fr/) and by the Institut National de Recherche Agronomique (USC-2018) (http://www.inra.fr/). There are no grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumler AJ, 1996, P NATL ACAD SCI USA, V93, P279, DOI 10.1073/pnas.93.1.279; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Beutin L, 2006, J VET MED B, V53, P299, DOI 10.1111/j.1439-0450.2006.00968.x; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Chong YW, 2007, MICROBIOL-SGM, V153, P794, DOI 10.1099/mic.0.2006/003178-0; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; DeVinney R, 2001, MOL MICROBIOL, V41, P1445, DOI 10.1046/j.1365-2958.2001.02617.x; Doughty S, 2002, INFECT IMMUN, V70, P6761, DOI 10.1128/IAI.70.12.6761-6769.2002; Etienne-Mesmin L, 2011, APPL ENVIRON MICROB, V77, P1127, DOI 10.1128/AEM.02130-10; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Fitzhenry R, 2006, MICROBES INFECT, V8, P1741, DOI 10.1016/j.micinf.2006.02.012; Frank C, 2011, N ENGL J ME IN PRESS; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Hamzaoui N, 2004, CELL MICROBIOL, V6, P817, DOI 10.1111/j.1462-5822.2004.00391.x; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; HITOTSUBASHI S, 1992, INFECT IMMUN, V60, P4468, DOI 10.1128/IAI.60.11.4468-4474.1992; Hurley BP, 2001, INFECT IMMUN, V69, P6148, DOI 10.1128/IAI.69.10.6148-6155.2001; INMAN LR, 1983, J CLIN INVEST, V71, P1, DOI 10.1172/JCI110737; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Lee SH, 2008, BIOMED MICRODEVICES, V10, P1, DOI 10.1007/s10544-007-9104-0; Lee SY, 2007, INFECT IMMUN, V75, P1291, DOI 10.1128/IAI.01700-06; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; Martinez-Argudo I, 2007, CELL MICROBIOL, V9, P1538, DOI 10.1111/j.1462-5822.2007.00891.x; Martinez-Argudo I, 2008, MICROBIOL-SGM, V154, P3887, DOI 10.1099/mic.0.2008/021162-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Phillips AD, 2000, GUT, V47, P377, DOI 10.1136/gut.47.3.377; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Pradel N, 2000, J CLIN MICROBIOL, V38, P1023, DOI 10.1128/JCM.38.3.1023-1031.2000; Pradel N, 2002, APPL ENVIRON MICROB, V68, P2316, DOI 10.1128/AEM.68.5.2316-2325.2002; Pradel N, 2008, APPL ENVIRON MICROB, V74, P2118, DOI 10.1128/AEM.02688-07; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Roberts CL, 2010, GUT, V59, P1331, DOI 10.1136/gut.2009.195370; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Struelens MJ, 2011, EURO SURVEILL, V16; TARR PI, 1989, J INFECT DIS, V159, P344, DOI 10.1093/infdis/159.2.344; Torres AG, 2008, INFECT IMMUN, V76, P5062, DOI 10.1128/IAI.00654-08; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7	46	40	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23594	10.1371/journal.pone.0023594	http://dx.doi.org/10.1371/journal.pone.0023594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858177	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300066
J	Goldstein, JR				Goldstein, Joshua R.			A Secular Trend toward Earlier Male Sexual Maturity: Evidence from Shifting Ages of Male Young Adult Mortality	PLOS ONE			English	Article							REPRODUCTIVE MATURATION; NETHERLANDS; POPULATION; MENARCHE; GROWTH; BOYS	This paper shows new evidence of a steady long-term decline in age of male sexual maturity since at least the mid-eighteenth century. A method for measuring the timing of male maturity is developed based on the age at which male young adult mortality accelerates. The method is applied to mortality data from Sweden, Denmark, Norway, the United Kingdom, and Italy. The secular trend toward earlier male sexual maturity parallels the trend toward earlier menarche for females, suggesting that common environmental cues influence the speed of both males' and females' sexual maturation.	Max Planck Inst Demog Res, Rostock, Germany	Max Planck Society	Goldstein, JR (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	goldstein@demogr.mpg.de			University of California, Berkeley, Center for Economics and Demography of Aging NIH [P30 AG01283]	University of California, Berkeley, Center for Economics and Demography of Aging NIH(University of California System)	Research was supported by a subaward from University of California, Berkeley, Center for Economics and Demography of Aging NIH P30 AG01283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2003, AM J HUM BIOL, V15, P401, DOI 10.1002/ajhb.10157; Bodzsar Eva B., 2000, Acta Biologica Szegediensis, V44, P155; Bribiescas RG, 2001, YEARB PHYS ANTHROPOL, V44, P148, DOI 10.1002/ajpa.10025; Campbell B, 2006, ANN HUM BIOL, V33, P17, DOI 10.1080/03014460500424068; Campbell BC, 2004, ANN HUM BIOL, V31, P213, DOI 10.1080/03014460310001656604; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; DAW SF, 1970, HUM BIOL, V42, P87; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Fedigan LM, 1997, AM J PHYS ANTHROPOL, V102, P161, DOI 10.1002/(SICI)1096-8644(199702)102:2<161::AID-AJPA2>3.0.CO;2-1; Fogel R., 2004, ESCAPE HUNGER PREMAT, DOI [10.1017/CBO9780511817649, DOI 10.1017/CBO9780511817649]; Frisch RE, 2006, SCIENCE, V311, P337; FRISCH RE, 1978, SCIENCE, V199, P22, DOI 10.1126/science.199.4324.22; Furstenberg F., 2004, CONTEXTS, V3, P33, DOI [10.1525/ctx.2004.3.3.33, DOI 10.1525/CTX.2004.3.3.33]; Gage TB, 1998, ANNU REV ANTHROPOL, V27, P197, DOI 10.1146/annurev.anthro.27.1.197; Heligman L., 1980, J I ACTUARIES, V107, P49, DOI DOI 10.1017/S0020268100040257; Helm P, 1998, ACTA OBSTET GYN SCAN, V77, P198, DOI 10.1034/j.1600-0412.1998.770213.x; Khadilkar VV, 2006, INDIAN PEDIATR, V43, P475; LEE R, 2003, POPULATION DEV REV, V29; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; LUDER HU, 1993, AM J PRIMATOL, V30, P139, DOI 10.1002/ajp.1350300206; Mul D, 2001, PEDIATR RES, V50, P479, DOI 10.1203/00006450-200110000-00010; PARKES AS, 1976, PATTERNS SEXUALITY R; Preston SH, 1976, MORTALITY PATTERNS N; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Statistics Norway, 2005, STAT YB NORW 2005; Stearns S.C., 1992, pi; Steckel RichardH., 1997, HLTH WELFARE IND; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; University of California Berkeley Max Planck Institute for Demographic Research Germany, HUM MORT DAT; Wachter K. W., 1990, CAMBRIDGE STUDIES PO; Wymelenberg S, 1990, SCI BABIES PRIVATE D	31	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e14826	10.1371/journal.pone.0014826	http://dx.doi.org/10.1371/journal.pone.0014826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21857893	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300001
J	Nyuyki, KD; Waldherr, M; Baeuml, S; Neumann, ID				Nyuyki, Kewir D.; Waldherr, Martin; Baeuml, Sandra; Neumann, Inga D.			Yes, I Am Ready Now: Differential Effects of Paced versus Unpaced Mating on Anxiety and Central Oxytocin Release in Female Rats	PLOS ONE			English	Article							PENILE-VAGINAL INTERCOURSE; RECEPTOR MESSENGER-RNA; SEXUAL-BEHAVIOR; PARAVENTRICULAR NUCLEUS; ESTROUS-CYCLE; STRESS; DOPAMINE; BRAIN; HYPOTHALAMUS; VASOPRESSIN	Sexual activity and partner intimacy results in several positive consequences in the context of stress-coping, both in males and females, such as reduced state anxiety in male rats after successful mating. However, in female rats, mating is a rewarding experience only when the estrous female is able to control sexual interactions, i.e., under paced-mating conditions. Here, we demonstrate that sex-steroid priming required for female mating is anxiolytic; subsequent sexual activity under paced mating conditions did not disrupt this anxiolytic priming effect, whereas mating under unpaced conditions increased anxiety-related behavior. In primed females, the release of the neuropeptide oxytocin (OT) within the hypothalamic paraventricular nucleus was found to be elevated and to further increase during paced, but not unpaced mating. Central administration of an OT receptor antagonist partly prevented priming/mating-induced anxiolysis indicating the involvement of brain OT in the anxiolysis triggered by priming and/or sexual activity. These findings reveal that the positive consequences of mating in females are dependent on her ability to control sexual interactions, and that brain OT release is at least in part the underlying neurobiological correlate.	[Nyuyki, Kewir D.; Waldherr, Martin; Baeuml, Sandra; Neumann, Inga D.] Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Bavaria, Germany	University of Regensburg	Nyuyki, KD (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Bavaria, Germany.	inga.neumann@biologie.uni-regensburg.de			Bayerische Forschungsstiftung (BFS); Federal Ministry of Education and Research (BMBF); German Research Foundation (DFG)	Bayerische Forschungsstiftung (BFS); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support from the Bayerische Forschungsstiftung (BFS) (KN), Federal Ministry of Education and Research (BMBF) (IDN) and German Research Foundation (DFG) (IDN) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiolas A, 2004, PHYSIOL BEHAV, V83, P309, DOI 10.1016/j.physbeh.2004.08.019; BALE TL, 1995, J NEUROSCI, V15, P5058; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; BEACH FA, 1976, HORM BEHAV, V7, P105, DOI 10.1016/0018-506X(76)90008-8; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Brody S, 2006, BIOL PSYCHOL, V71, P214, DOI 10.1016/j.biopsycho.2005.03.005; Brody S, 2008, MED HYPOTHESES, V71, P812, DOI 10.1016/j.mehy.2008.06.009; CALDWELL JD, 1986, NEUROPEPTIDES, V7, P175, DOI 10.1016/0143-4179(86)90093-4; CARMICHAEL MS, 1987, J CLIN ENDOCR METAB, V64, P27, DOI 10.1210/jcem-64-1-27; Costa RM, 2007, J SEX MARITAL THER, V33, P319, DOI 10.1080/00926230701385548; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Ditzen B, 2008, PSYCHOSOM MED, V70, P883, DOI 10.1097/PSY.0b013e318185c4fc; FLANAGAN LM, 1993, NEUROENDOCRINOLOGY, V58, P352, DOI 10.1159/000126562; Frye CA, 2008, BEHAV BRAIN RES, V187, P88, DOI 10.1016/j.bbr.2007.08.031; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gonzalez-Flores O, 2004, HORM BEHAV, V46, P151, DOI 10.1016/j.yhbeh.2004.02.006; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hirata H, 2007, PEPTIDES, V28, P1998, DOI 10.1016/j.peptides.2007.07.024; Kelley AE, 2002, J NEUROSCI, V22, P3306; LANDGRAF R, 1995, EUR J NEUROSCI, V7, P592, DOI 10.1111/j.1460-9568.1995.tb00663.x; Liberzon I, 1997, NEUROPSYCHOPHARMACOL, V17, P353, DOI 10.1016/S0893-133X(97)00070-5; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Martinez I, 2001, HORM BEHAV, V40, P510, DOI 10.1006/hbeh.2001.1712; MCCLINTOCK MK, 1978, BEHAVIOUR, V67, P67, DOI 10.1163/156853978X00260; McGregor IS, 2008, BRIT J PHARMACOL, V154, P358, DOI 10.1038/bjp.2008.132; Melis MR, 2007, EUR J NEUROSCI, V26, P1026, DOI 10.1111/j.1460-9568.2007.05721.x; MENDELSON SD, 1987, PHYSIOL BEHAV, V39, P67, DOI 10.1016/0031-9384(87)90345-3; Mora S, 1996, PSYCHONEUROENDOCRINO, V21, P609, DOI 10.1016/S0306-4530(96)00015-7; NEUMANN I, 1993, NEUROSCIENCE, V53, P65, DOI 10.1016/0306-4522(93)90285-N; Neumann I D, 2001, Prog Brain Res, V133, P143; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Neumann ID, 1998, J PHYSIOL-LONDON, V508, P289, DOI 10.1111/j.1469-7793.1998.289br.x; Neumann ID, 2009, FRONT NEUROENDOCRIN, V30, P483, DOI 10.1016/j.yfrne.2009.04.012; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Paredes RG, 1997, BEHAV NEUROSCI, V111, P123, DOI 10.1037/0735-7044.111.1.123; Paredes RG, 2001, BEHAV NEUROSCI, V115, P1363, DOI 10.1037//0735-7044.115.6.1363; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfaff D W, 1999, Results Probl Cell Differ, V26, P91; Pfaus JG, 1999, HORM BEHAV, V35, P224, DOI 10.1006/hbeh.1999.1516; Polston EK, 1998, ENDOCRINOLOGY, V139, P4849, DOI 10.1210/en.139.12.4849; Randall-Thompson JF, 2010, PSYCHOPHARMACOLOGY, V212, P585, DOI 10.1007/s00213-010-1980-y; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Sansone GR, 2002, NEUROENDOCRINOLOGY, V75, P306, DOI 10.1159/000057340; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Young LJ, 1997, J NEUROENDOCRINOL, V9, P859, DOI 10.1046/j.1365-2826.1997.00654.x	49	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23599	10.1371/journal.pone.0023599	http://dx.doi.org/10.1371/journal.pone.0023599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858181	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500037
J	Sauder, LA; Engel, K; Stearns, JC; Masella, AP; Pawliszyn, R; Neufeld, JD				Sauder, Laura A.; Engel, Katja; Stearns, Jennifer C.; Masella, Andre P.; Pawliszyn, Richard; Neufeld, Josh D.			Aquarium Nitrification Revisited: Thaumarchaeota Are the Dominant Ammonia Oxidizers in Freshwater Aquarium Biofilters	PLOS ONE			English	Article							MESOPHILIC CRENARCHAEOTA; NITRIFYING ARCHAEA; BACTERIA; MARINE; OXIDATION; DIVERSITY; COMMUNITY; ABUNDANCE; PROKARYOTES; GENES	Ammonia-oxidizing archaea (AOA) outnumber ammonia-oxidizing bacteria (AOB) in many terrestrial and aquatic environments. Although nitrification is the primary function of aquarium biofilters, very few studies have investigated the microorganisms responsible for this process in aquaria. This study used quantitative real-time PCR (qPCR) to quantify the ammonia monooxygenase (amoA) and 16S rRNA genes of Bacteria and Thaumarchaeota in freshwater aquarium biofilters, in addition to assessing the diversity of AOA amoA genes by denaturing gradient gel electrophoresis (DGGE) and clone libraries. AOA were numerically dominant in 23 of 27 freshwater biofilters, and in 12 of these biofilters AOA contributed all detectable amoA genes. Eight saltwater aquaria and two commercial aquarium nitrifier supplements were included for comparison. Both thaumarchaeal and bacterial amoA genes were detected in all saltwater samples, with AOA genes outnumbering AOB genes in five of eight biofilters. Bacterial amoA genes were abundant in both supplements, but thaumarchaeal amoA and 16S rRNA genes could not be detected. For freshwater aquaria, the proportion of amoA genes from AOA relative to AOB was inversely correlated with ammonium concentration. DGGE of AOA amoA genes revealed variable diversity across samples, with nonmetric multidimensional scaling (NMDS) indicating separation of freshwater and saltwater fingerprints. Composite clone libraries of AOA amoA genes revealed distinct freshwater and saltwater clusters, as well as mixed clusters containing both freshwater and saltwater amoA gene sequences. These results reveal insight into commonplace residential biofilters and suggest that aquarium biofilters may represent valuable biofilm microcosms for future studies of AOA ecology.	[Sauder, Laura A.; Engel, Katja; Stearns, Jennifer C.; Masella, Andre P.; Pawliszyn, Richard; Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Sauder, LA (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	jneufeld@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Andrews C., 1988, MANUAL FISH HLTH; Bartram AK, 2009, BIOTECHNIQUES, V47, P1016, DOI 10.2144/000113276; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Burrell PC, 2001, APPL ENVIRON MICROB, V67, P5791, DOI 10.1128/AEM.67.12.5791-5800.2001; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5; Foesel BU, 2008, FEMS MICROBIOL ECOL, V63, P192, DOI 10.1111/j.1574-6941.2007.00418.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Herrmann M, 2011, APPL ENVIRON MICROB, V77, P1896, DOI 10.1128/AEM.02879-10; Herrmann M, 2009, APPL ENVIRON MICROB, V75, P3127, DOI 10.1128/AEM.02806-08; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Hovanec TA, 1996, APPL ENVIRON MICROB, V62, P2888, DOI 10.1128/AEM.62.8.2888-2896.1996; Hovanec TA, 1998, APPL ENVIRON MICROB, V64, P258; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Limpiyakorn T, 2011, BIORESOURCE TECHNOL, V102, P3694, DOI 10.1016/j.biortech.2010.11.085; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neufeld JD, 2006, ENVIRON MICROBIOL, V8, P126, DOI 10.1111/j.1462-2920.2005.00875.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Parker R, 2002, AQUACULTURE SCI; Reigstad LJ, 2008, FEMS MICROBIOL ECOL, V64, P167, DOI 10.1111/j.1574-6941.2008.00466.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Taylor AE, 2010, APPL ENVIRON MICROB, V76, P7691, DOI 10.1128/AEM.01324-10; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	47	43	44	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23281	10.1371/journal.pone.0023281	http://dx.doi.org/10.1371/journal.pone.0023281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858055	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500023
J	Ando, Y; Tomaru, Y; Morinaga, A; Burroughs, AM; Kawaji, H; Kubosaki, A; Kimura, R; Tagata, M; Ino, Y; Hirano, H; Chiba, J; Suzuki, H; Carninci, P; Hayashizaki, Y				Ando, Yoshinari; Tomaru, Yasuhiro; Morinaga, Ayako; Burroughs, Alexander Maxwell; Kawaji, Hideya; Kubosaki, Atsutaka; Kimura, Ryuichiro; Tagata, Maiko; Ino, Yoko; Hirano, Hisashi; Chiba, Joe; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide			Nuclear Pore Complex Protein Mediated Nuclear Localization of Dicer Protein in Human Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RNA-BINDING; TRANSPORT; IMPORT; TRBP; INTERFERENCE; ORGANIZATION; EXPRESSION; INTERACTS; TURNOVER	Human DICER1 protein cleaves double-stranded RNA into small sizes, a crucial step in production of single-stranded RNAs which are mediating factors of cytoplasmic RNA interference. Here, we clearly demonstrate that human DICER1 protein localizes not only to the cytoplasm but also to the nucleoplasm. We also find that human DICER1 protein associates with the NUP153 protein, one component of the nuclear pore complex. This association is detected predominantly in the cytoplasm but is also clearly distinguishable at the nuclear periphery. Additional characterization of the NUP153-DICER1 association suggests NUP153 plays a crucial role in the nuclear localization of the DICER1 protein.	[Ando, Yoshinari; Tomaru, Yasuhiro; Morinaga, Ayako; Burroughs, Alexander Maxwell; Kawaji, Hideya; Kubosaki, Atsutaka; Suzuki, Harukazu; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Kimura, Ryuichiro; Tagata, Maiko; Chiba, Joe] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Ino, Yoko; Hirano, Hisashi] Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 232, Japan	RIKEN; Tokyo University of Science; Yokohama City University	Ando, Y (corresponding author), RIKEN Omics Sci Ctr, Yokohama, Kanagawa, Japan.	rgscerg@gsc.riken.jp	Carninci, Piero/K-1568-2014; Ando, Yoshinari/AAK-5668-2020; Suzuki, Harukazu/N-9553-2015; Kawaji, Hideya/N-5116-2015; Hayashizaki, Yoshihide/N-6590-2015	Carninci, Piero/0000-0001-7202-7243; Ando, Yoshinari/0000-0002-8128-6201; Suzuki, Harukazu/0000-0002-8087-0836; Kawaji, Hideya/0000-0002-0575-0308; Burroughs, A. Max/0000-0002-2229-8771	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research Grant for RIKEN Omics Science Center from Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan to YH, Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT to YH, and grant for the Genome Network Project from MEXT to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ando Y, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-6; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Carninci P, 2002, BIOTECHNIQUES, V33, P306, DOI 10.2144/02332st01; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Intoh A, 2009, PROTEOMICS, V9, P126, DOI 10.1002/pmic.200800496; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leibovich Limor, 2010, Silence, V1, P17, DOI 10.1186/1758-907X-1-17; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Moser JJ, 2007, J NEUROSCI RES, V85, P3619, DOI 10.1002/jnr.21439; Muljo SA, 2010, WIRES SYST BIOL MED, V2, P148, DOI 10.1002/wsbm.53; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Takahashi N, 2008, BIOCHEM BIOPH RES CO, V374, P424, DOI 10.1016/j.bbrc.2008.06.128; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tomaru Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r121; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	59	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23385	10.1371/journal.pone.0023385	http://dx.doi.org/10.1371/journal.pone.0023385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858095	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700020
J	van der Heijden, M; Amerongen, GPV; van Bezu, J; Paul, MA; Groeneveld, ABJ; van Hinsbergh, VWM				van der Heijden, Melanie; Amerongen, Geerten P. van Nieuw; van Bezu, Jan; Paul, Marinus A.; Groeneveld, A. B. Johan; van Hinsbergh, Victor W. M.			Opposing Effects of the Angiopoietins on the Thrombin-Induced Permeability of Human Pulmonary Microvascular Endothelial Cells	PLOS ONE			English	Article							ACUTE LUNG INJURY; VASCULAR-PERMEABILITY; INDUCED INCREASE; BARRIER FUNCTION; GENE-THERAPY; VE-CADHERIN; IN-VIVO; TIE2; JUNCTIONS; KINASE	Background: Angiopoietin-2 (Ang-2) is associated with lung injury in ALI/ARDS. As endothelial activation by thrombin plays a role in the permeability of acute lung injury and Ang-2 may modulate the kinetics of thrombin-induced permeability by impairing the organization of vascular endothelial (VE-) cadherin, and affecting small Rho GTPases in human pulmonary microvascular endothelial cells (HPMVECs), we hypothesized that Ang-2 acts as a sensitizer of thrombin-induced hyperpermeability of HPMVECs, opposed by Ang-1. Methodology/Principal Findings: Permeability was assessed by measuring macromolecule passage and transendothelial electrical resistance (TEER). Angiopoietins did not affect basal permeability. Nevertheless, they had opposing effects on the thrombin-induced permeability, in particular in the initial phase. Ang-2 enhanced the initial permeability increase (passage, P = 0.010; TEER, P = 0.021) in parallel with impairment of VE-cadherin organization without affecting VE-cadherin Tyr685 phosphorylation or increasing RhoA activity. Ang-2 also increased intercellular gap formation. Ang-1 preincubation increased Rac1 activity, enforced the VE-cadherin organization, reduced the initial thrombin-induced permeability (TEER, P = 0.027), while Rac1 activity simultaneously normalized, and reduced RhoA activity at 15 min thrombin exposure (P = 0.039), but not at earlier time points. The simultaneous presence of Ang-2 largely prevented the effect of Ang-1 on TEER and macromolecule passage. Conclusions/Significance: Ang-1 attenuated thrombin-induced permeability, which involved initial Rac1 activation-enforced cell-cell junctions, and later RhoA inhibition. In addition to antagonizing Ang-1, Ang-2 had also a direct effect itself. Ang-2 sensitized the initial thrombin-induced permeability accompanied by destabilization of VE-cadherin junctions and increased gap formation, in the absence of increased RhoA activity.	[van der Heijden, Melanie; Groeneveld, A. B. Johan] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Inst Cardiovasc Res, Amsterdam, Netherlands; [van der Heijden, Melanie; Amerongen, Geerten P. van Nieuw; van Bezu, Jan; van Hinsbergh, Victor W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands; [Paul, Marinus A.] Vrije Univ Amsterdam, Med Ctr, Dept Cardiothorac Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van der Heijden, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Inst Cardiovasc Res, Amsterdam, Netherlands.	nieuwamerongen@vumc.nl			Netherlands Heart Foundation [2003T032]; European Society of Intensive Care Medicine	Netherlands Heart Foundation(Netherlands Heart Foundation); European Society of Intensive Care Medicine	GPvNA was supported by The Netherlands Heart Foundation (The Hague, grant 2003T032). MvdH was supported by the European Society of Intensive Care Medicine (ECCRN Levi Montalcini Biomedical Sciences Award 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Amerongen GPV, 2000, CIRCULATION, V102, P2803; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Beck GC, 1999, CLIN EXP IMMUNOL, V118, P298; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; Cascone I, 2003, BLOOD, V102, P2482, DOI 10.1182/blood-2003-03-0670; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2010, YAKUGAKU ZASSHI, V130, P1413, DOI 10.1248/yakushi.130.1413; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; Hoang MV, 2011, BLOOD, V117, P1751, DOI 10.1182/blood-2010-05-286831; Huang YQ, 2008, CRIT CARE MED, V36, P262, DOI 10.1097/01.CCM.0000297955.02633.A4; Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Kim SR, 2008, EXP MOL MED, V40, P320, DOI 10.3858/emm.2008.40.3.320; Kinney CM, 2008, AM J PHYSIOL-CELL PH, V294, pC241, DOI 10.1152/ajpcell.00187.2007; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; LANGELER EG, 1988, THROMB HAEMOSTASIS, V60, P240; LEEMREIS JR, 2006, CYTOM PART A, V69, P873; Li XC, 2004, BLOOD, V104, P1716, DOI 10.1182/blood-2003-11-3744; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Marcus BC, 1998, ANN VASC SURG, V12, P384, DOI 10.1007/s100169900173; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Peters S, 2007, CYTOKINE, V40, P144, DOI 10.1016/j.cyto.2007.09.001; Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Schubert SY, 2011, ARTERIOSCL THROM VAS, V31, P870, DOI 10.1161/ATVBAHA.110.218255; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; van der Heijden M, 2008, APOPTOSIS, V13, P404, DOI 10.1007/s10495-007-0173-6; van der Heijden M, 2009, INTENS CARE MED, V35, P1567, DOI 10.1007/s00134-009-1560-y; Wang YH, 2004, J CELL PHYSIOL, V198, P53, DOI 10.1002/jcp.10386; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	58	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23448	10.1371/journal.pone.0023448	http://dx.doi.org/10.1371/journal.pone.0023448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858121	gold, Green Published			2022-12-25	WOS:000293953700023
J	Liu, NN; Li, T; Reid, WR; Yang, T; Zhang, L				Liu, Nannan; Li, Ting; Reid, William R.; Yang, Ting; Zhang, Lee			Multiple Cytochrome P450 Genes: Their Constitutive Overexpression and Permethrin Induction in Insecticide Resistant Mosquitoes, Culex quinquefasciatus	PLOS ONE			English	Article							PYRETHROID-RESISTANT; EXPRESSION; CYP6D1; SUPERFAMILY; STRAINS; ENZYMES; FLORIDA; P450	Four cytochrome P450 cDNAs, CYP6AA7, CYP9J40, CYP9J34, and CYP9M10, were isolated from mosquitoes, Culex quinquefasciatus. The P450 gene expression and induction by permethrin were compared for three different mosquito populations bearing different resistance phenotypes, ranging from susceptible (S-Lab), through intermediate (HAmCq(G0), the field parental population) to highly resistant (HAmCq(G8), the 8(th) generation of permethrin selected offspring of HAmCq(G0)). A strong correlation was found for P450 gene expression with the levels of resistance and following permethrin selection at the larval stage of mosquitoes, with the highest expression levels identified in HAmCq(G8), suggesting the importance of CYP6AA7, CYP9J40, CYP9J34, and CYP9M10 in the permethrin resistance of larva mosquitoes. Only CYP6AA7 showed a significant overexpression in HAmCq(G8) adult mosquitoes. Other P450 genes had similar expression levels among the mosquito populations tested, suggesting different P450 genes may be involved in the response to insecticide pressure in different developmental stages. The expression of CYP6AA7, CYP9J34, and CYP9M10 was further induced by permethrin in resistant mosquitoes. Taken together, these results indicate that multiple P450 genes are up-regulated in insecticide resistant mosquitoes through both constitutive overexpression and induction mechanisms, thus increasing the overall expression levels of P450 genes.	[Liu, Nannan; Li, Ting; Reid, William R.; Yang, Ting] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Zhang, Lee] Auburn Univ, Genom & Sequencing Lab, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Liu, NN (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	liunann@auburn.edu	Li, Ting/L-2400-2016; Li, Ting/D-5181-2015; Li, Ting/ABG-2699-2021	Li, Ting/0000-0002-6004-4617; 	National Institute of Allergy and Infectious Diseases [R21AI076893]; AAES Hatch/Multistate Grants [ALA08-045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076893] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AAES Hatch/Multistate Grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R21AI076893 to N.L. from the National Institute of Allergy and Infectious Diseases and AAES Hatch/Multistate Grants ALA08-045 to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Berenbaum M.R., 1991, P221; CARINO F, 1992, ACS SYM SER, V505, P31; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Feyereisen R., 2005, P1; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Hardstone MC, 2010, INSECT MOL BIOL, V19, P717, DOI 10.1111/j.1365-2583.2010.01030.x; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Korytko PJ, 1998, ARCH INSECT BIOCHEM, V37, P57, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;57::AID-ARCH7&gt;3.0.CO;2-S; Li T, 2010, J MED ENTOMOL, V47, P1127, DOI 10.1603/ME10142; Li XC, 2002, INSECT BIOCHEM MOLEC, V32, P311, DOI 10.1016/S0965-1748(01)00092-3; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu N, 1997, INSECT MOL BIOL, V6, P77, DOI 10.1046/j.1365-2583.1997.00160.x; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Liu NN, 2004, GENE, V327, P81, DOI 10.1016/j.gene.2003.11.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nayar JK, 1999, J MED ENTOMOL, V36, P441, DOI 10.1093/jmedent/36.4.441; OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Terriere L. C., 1983, Pest resistance to pesticides, P265; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Zhu F, 2008, ARCH INSECT BIOCH PH, V34, P147; Zhu F., 2008, INSECT MOL BIOL, V20, P1365, DOI DOI 10.1186/1472-6793-8-18; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	37	85	90	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23403	10.1371/journal.pone.0023403	http://dx.doi.org/10.1371/journal.pone.0023403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858101	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953500037
J	Kasevich, RS; LaBerge, D				Kasevich, Ray S.; LaBerge, David			Theory of Electric Resonance in the Neocortical Apical Dendrite	PLOS ONE			English	Article							NEURONS; OSCILLATIONS; FREQUENCY; INFORMATION; PLASTICITY; LOCATION; CHANNEL; MODELS; NOISE; CAT	Pyramidal neurons of the neocortex display a wide range of synchronous EEG rhythms, which arise from electric activity along the apical dendrites of neocortical pyramidal neurons. Here we present a theoretical description of oscillation frequency profiles along apical dendrites which exhibit resonance frequencies in the range of 10 to 100 Hz. The apical dendrite is modeled as a leaky coaxial cable coated with a dielectric, in which a series of compartments act as coupled electric circuits that gradually narrow the resonance profile. The tuning of the peak frequency is assumed to be controlled by the average amplitude of voltage-gated outward currents, which in turn are regulated by the subthreshold noise in the thousands of synaptic spines that are continuously bombarded by local circuits. The results of simulations confirmed the ability of the model both to tune the peak frequency in the 10-100 Hz range and to gradually narrow the resonance profile. Considerable additional narrowing of the resonance profile is provided by repeated looping through the apical dendrite via the corticothalamocortical circuit, which reduced the width of each resonance curve (at half-maximum) to approximately 1 Hz. Synaptic noise in the neural circuit is discussed in relation to the ways it can influence the narrowing process.	[Kasevich, Ray S.] Stanley Lab Elect Phys, Great Barrington, MA 01230 USA; [LaBerge, David] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Kasevich, RS (corresponding author), Stanley Lab Elect Phys, Great Barrington, MA 01230 USA.	dlaberge@earthlink.net						Angelo E., 1964, POLE ZERO PATTERNS A; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Barlow H. M., 1962, RADIO SURFACE WAVES; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Collins RE, 1960, FIELD THEORY GUIDED, p[528, 529]; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Delogne P., 1982, LEAKY FEEDERS SUBSUR; Destexhe A, 2001, NEUROCOMPUTING, V38, P167, DOI 10.1016/S0925-2312(01)00428-3; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Heaviside Oliver, 1892, ELECT PAPERS; Higgs MH, 2009, J NEUROSCI, V29, P1285, DOI 10.1523/JNEUROSCI.3728-08.2009; HILLE B, 2003, ION CHANNELS EXCITAB; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jones E.G., 2012, THALAMUS; JONES EG, 1970, PHILOS T ROY SOC B, V257, P1, DOI 10.1098/rstb.1970.0003; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Keren N, 2005, J NEUROPHYSIOL, V94, P3730, DOI 10.1152/jn.00408.2005; Keren N, 2009, J PHYSIOL-LONDON, V587, P1413, DOI 10.1113/jphysiol.2008.167130; Koch Christof, 1999, P1; LABERGE D, 1992, NEURAL COMPUT, V4, P318, DOI 10.1162/neco.1992.4.3.318; LaBerge D, 2005, BRAIN RES REV, V50, P86, DOI 10.1016/j.brainresrev.2005.04.004; Larmor J., 1902, SCI WRITINGS LATE GF; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; London M, 1999, J NEUROSCI, V19, P8219; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Mountcastle V. B., 1998, CEREBRAL CORTEX; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Nunnaly J, 1978, PSYCHOMETRIC METHODS; Paik SB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000927; PETERS A, 1991, J COMP NEUROL, V306, P1, DOI 10.1002/cne.903060102; Pike FG, 2000, J PHYSIOL-LONDON, P205; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Segev C, 1989, METHODS NEURONAL MOD, P9; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; van Elburg RAJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000781; Volman V, 2009, J NEUROPHYSIOL, V102, P3234, DOI 10.1152/jn.00260.2009; Volman V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060903; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23412	10.1371/journal.pone.0023412	http://dx.doi.org/10.1371/journal.pone.0023412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853129	gold, Green Published			2022-12-25	WOS:000295454200082
J	Oliveira, SDS; Quintas, LEM; Amaral, LS; Noel, F; Farsky, SH; Silva, CLM				Oliveira, Suellen D. S.; Quintas, Luis E. M.; Amaral, Luciana S.; Noel, Francois; Farsky, Sandra H.; Silva, Claudia L. M.			Increased Endothelial Cell-Leukocyte Interaction in Murine Schistosomiasis: Possible Priming of Endothelial Cells by the Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INFLAMMATORY-BOWEL-DISEASE; ADHESION MOLECULES; MANSONI INFECTION; EXPRESSION; MECHANISMS; MICE; ANGIOGENESIS; RECRUITMENT; INHIBITION	Background and Aims: Schistosomiasis is an intravascular parasitic disease associated with inflammation. Endothelial cells control leukocyte transmigration and vascular permeability being modulated by pro-inflammatory mediators. Recent data have shown that endothelial cells primed in vivo in the course of a disease keep the information in culture. Herein, we evaluated the impact of schistosomiasis on endothelial cell-regulated events in vivo and in vitro. Methodology and Principal Findings: The experimental groups consisted of Schistosoma mansoni-infected and age-matched control mice. In vivo infection caused a marked influx of leukocytes and an increased protein leakage in the peritoneal cavity, characterizing an inflamed vascular and cellular profile. In vitro leukocyte-mesenteric endothelial cell adhesion was higher in cultured cells from infected mice as compared to controls, either in the basal condition or after treatment with the pro-inflammatory cytokine tumor necrosis factor (TNF). Nitric oxide (NO) donation reduced leukocyte adhesion to endothelial cells from control and infected groups; however, in the later group the effect was more pronounced, probably due to a reduced NO production. Inhibition of control endothelial NO synthase (eNOS) increased leukocyte adhesion to a level similar to the one observed in the infected group. Besides, the adhesion of control leukocytes to endothelial cells from infected animals is similar to the result of infected animals, confirming that schistosomiasis alters endothelial cells function. Furthermore, NO production as well as the expression of eNOS were reduced in cultured endothelial cells from infected animals. On the other hand, the expression of its repressor protein, namely caveolin-1, was similar in both control and infected groups. Conclusion/Significance: Schistosomiasis increases vascular permeability and endothelial cell-leukocyte interaction in vivo and in vitro. These effects are partially explained by a reduced eNOS expression. In addition, our data show that the disease primes endothelial cells in vivo, which keep the acquired phenotype in culture.	[Oliveira, Suellen D. S.; Quintas, Luis E. M.; Amaral, Luciana S.; Noel, Francois; Silva, Claudia L. M.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Mol & Biochem Pharmacol, Rio De Janeiro, Brazil; [Farsky, Sandra H.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Oliveira, SDS (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Mol & Biochem Pharmacol, Rio De Janeiro, Brazil.	cmartins@farmaco.ufrj.br	Quintas, Luis Eduardo M/C-3308-2009; Silva, Claudia L. Martins/C-3168-2009; Noël, François/C-3402-2009; Oliveira, Suellen D'Arc/F-6276-2014; Farsky, Sandra HP/C-4044-2012	Quintas, Luis Eduardo M/0000-0002-0767-1240; Silva, Claudia L. Martins/0000-0001-9227-6036; Noël, François/0000-0001-6813-1347; Oliveira, Suellen D'Arc/0000-0002-7654-1909; 	CNPq, Brazil [472474/2010-3, 305460/2009-9]; FAPERJ, Brazil	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The study was supported by the following: CNPq, Brazil (www.cnpq.br) financial support (472474/2010-3) and fellowship (305460/2009-9); FAPERJ, Brazil (www.faperj.br): financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Angeli W, 2001, EUR J IMMUNOL, V31, P2751, DOI 10.1002/1521-4141(200109)31:9&lt;2751::AID-IMMU2751&gt;3.0.CO;2-4; Balcerczyk A, 2005, FREE RADICAL BIO MED, V39, P327, DOI 10.1016/j.freeradbiomed.2005.03.017; Binion DG, 1997, GASTROENTEROLOGY, V112, P1895, DOI 10.1053/gast.1997.v112.pm9178682; Binion DG, 1998, LANCET, V352, P1742, DOI 10.1016/S0140-6736(98)05050-8; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Carreau A, 2011, EXP CELL RES, V317, P29, DOI 10.1016/j.yexcr.2010.08.011; Cavalcanti DMH, 2007, BRIT J PHARMACOL, V152, P1291, DOI 10.1038/sj.bjp.0707512; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Dessy C, 2010, PFLUG ARCH EUR J PHY, V459, P817, DOI 10.1007/s00424-010-0815-3; Esterre P, 1998, PARASITE IMMUNOL, V20, P369, DOI 10.1046/j.1365-3024.1998.00168.x; Fish JE, 2006, CELL MOL LIFE SCI, V63, P144, DOI 10.1007/s00018-005-5421-8; Frid Maria G, 2004, Paediatr Respir Rev, V5 Suppl A, pS253, DOI 10.1016/S1526-0542(04)90048-6; Hickey MJ, 1997, EXP PHYSIOL, V82, P339, DOI 10.1113/expphysiol.1997.sp004029; Jacobs W, 1997, PARASITOL RES, V83, P405, DOI 10.1007/s004360050273; Kimura C, 2004, J PHYSIOL-LONDON, V554, P721, DOI 10.1113/jphysiol.2003.057059; Kubes P, 1997, AM J PHYSIOL-GASTR L, V273, pG628, DOI 10.1152/ajpgi.1997.273.3.G628; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUBES P, 1993, FASEB J, V7, P1293, DOI 10.1096/fasebj.7.13.8405815; KUROSE I, 1993, CIRC RES, V73, P164, DOI 10.1161/01.RES.73.1.164; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Leite ACRM, 2009, BRIT J PHARMACOL, V156, P818, DOI 10.1111/j.1476-5381.2008.00094.x; Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034; Loeffler DA, 2002, J INFECT DIS, V185, P1650, DOI 10.1086/340416; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; PARAENSE W L, 1981, Memorias do Instituto Oswaldo Cruz, V76, P287, DOI 10.1590/S0074-02761981000300006; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Quintas LEM, 2010, J MOL CELL CARDIOL, V49, P525, DOI 10.1016/j.yjmcc.2010.04.015; Rabelink TJ, 2006, ARTERIOSCL THROM VAS, V26, P2585, DOI 10.1161/01.ATV.0000250932.24151.50; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Silva CLM, 2007, BRIT J PHARMACOL, V151, P195, DOI 10.1038/sj.bjp.0707225; Silva CLM, 1998, COMP BIOCHEM PHYS A, V120, P417, DOI 10.1016/S1095-6433(98)10041-7; Stevens Troy, 2001, American Journal of Physiology, V281, pC1422; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x	41	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23547	10.1371/journal.pone.0023547	http://dx.doi.org/10.1371/journal.pone.0023547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853150	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200096
J	Schimpl, M; Moore, C; Lederer, C; Neuhaus, A; Sambrook, J; Danesh, J; Ouwehand, W; Daumer, M				Schimpl, Michaela; Moore, Carmel; Lederer, Christian; Neuhaus, Anneke; Sambrook, Jennifer; Danesh, John; Ouwehand, Willem; Daumer, Martin			Association between Walking Speed and Age in Healthy, Free-Living Individuals Using Mobile Accelerometry-A Cross-Sectional Study	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; GAIT SPEED; CLINICAL-TRIALS; WHITEHALL II; OLDER-ADULTS; DISABILITY; DISTANCE; MS	Context: Walking speed is a fundamental parameter of human motion and is increasingly considered as an important indicator of individuals' health status. Objective: To evaluate the relationship of gait parameters, and demographic and physical characteristics in healthy men and women. Design, Setting, and Participants: Recruitment of a subsample (n = 358) of male and female blood donors taking part in the Cambridge CardioResource study. Collection of demographic data, measurement of physical characteristics (height, weight and blood pressure) and assessment of 7-day, free-living activity parameters using accelerometry and a novel algorithm to measure walking speed. Participants were a median (interquartile range[IQR]) age of 49 (16) years; 45% women; and had a median (IQR) BMI of 26 (5.4). Main Outcome Measure: Walking speed. Results: In this study, the hypothesis that walking speed declines with age was generated using an initial 'open' dataset. This was subsequently validated in a separate 'closed' dataset that showed a decrease of walking speed of -0.0037 m/s per year. This is equivalent to a difference of 1.2 minutes, when walking a distance of 1 km aged 20 compared to 60 years. Associations between walking speed and other participant characteristics (i.e. gender, BMI and blood pressure) were nonsignificant. BMI was negatively correlated with the number of walking and running steps and longest non-stop distance. Conclusion: This is the first study using accelerometry which shows an association between walking speed and age in free-living, healthy individuals. Absolute values of gait speed are comparable to published normal ranges in clinical settings. This study highlights the potential use of mobile accelerometry to assess gait parameters which may be indicative of future health outcomes in healthy individuals.	[Schimpl, Michaela; Lederer, Christian; Neuhaus, Anneke; Daumer, Martin] Human Mot Inst, Sylvia Lawry Ctr Multiple Sclerosis Res eV, Munich, Germany; [Schimpl, Michaela; Daumer, Martin] Trium Anal Online GmbH, Munich, Germany; [Moore, Carmel; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Sambrook, Jennifer; Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge, England; [Sambrook, Jennifer; Ouwehand, Willem] NHS Blood & Transplant, Cambridge, England	University of Cambridge; University of Cambridge	Schimpl, M (corresponding author), Human Mot Inst, Sylvia Lawry Ctr Multiple Sclerosis Res eV, Munich, Germany.	daumer@slcmsr.org		Ouwehand, Willem/0000-0002-7744-1790	German Ministry for Education and Research (BMBF) [01GI0920]; EU [215820-2, FP7-223865, 215820, 223865, LSHM-CT-2006-03759, LSHM-CT-2004-503485]; UK Medical Research Council/Wellcome Trust; Federal Ministry of Education and Research [01GI0920, 01GI0904]; Mayo Clinic Rochester; Federal Ministry of Economics and Technology [KF0564001KF7]; University of Oxford; Technical University of Munich; Hertie Foundation [1.01.1/07/015]; Bavarian Research Foundation; National Multiple Sclerosis Society (NMSS); Porticus Foundation [900.50578]; University of Rochester; GlaxoSmithKline; Merck; Novartis; Pfizer; MRC [MC_qA137933] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/09/012/28096] Funding Source: researchfish; Medical Research Council [MC_qA137933] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); UK Medical Research Council/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Mayo Clinic Rochester; Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); University of Oxford; Technical University of Munich; Hertie Foundation; Bavarian Research Foundation; National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Porticus Foundation; University of Rochester; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was partly supported by grants from the German Ministry for Education and Research (BMBF, "German Competence Network Multiple Sclerosis" (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). The Cambridge CardioResource study was funded by the UK Medical Research Council/Wellcome Trust. Additional support was provided by NHS Blood and Transplant, National Institute for Health Research and British Heart Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michaela Schimpl and Martin Daumer are employees of Trium Analysis Online GmbH and contributed to all aspects of the study. No additional external funding was received for this study.; Martin Daumer, Scientific Director of the Sylvia Lawry Centre for Multiple Sclerosis Research e. V. (SLC) and one of the two Managing Directors of Trium Analysis Online GmbH, serves on the Editorial Board of MedNous and holds Patent 10 2007 044 705.3-35, German patent and trademark office 307 19 449.3/09. The Sylvia Lawry Centre received honoraria for interviews of Dr. Daumer with Propagate Pharma Limited and Deerfield Research LLC; is Medical Advisor of the German Multiple Sclerosis Society; received honoraria for consultancy, statistical analysis and use of actibelt (R) technology from the following entities: Bayer Schering, Biopartners, Biogen Idec, Biogenerix, Bohringer-Ingelheim, EISAI Limited, Heron Evidence Development Ltd, Hoffmann-La Roche, Johnson & Johnson Pharmaceutical Research & Development LLC, Sanofi-Aventis U.S. INC., Novartis Pharma GmbH, University of Oxford, Imperial College London, University of Southampton, Charite Berlin, University of Vienna, Greencoat Ltd, University Medical Center Hamburg-Eppendorf; serves on the advisory board for EPOSA study and received research grants from the following governmental entities: Federal Ministry of Education and Research Grant No 01GI0904, 01GI0920, Mayo Clinic Rochester, European Union (for SLC and Trium) Grant No 215820, European Union (for SLC) Grant No 223865, Federal Ministry of Economics and Technology Grant No KF0564001KF7, University of Oxford, Technical University of Munich, Hertie Foundation Grant No 1.01.1/07/015, Bavarian Research Foundation, National Multiple Sclerosis Society (NMSS), Porticus Foundation Grant No 900.50578, European Union Grant No LSHM-CT-2006-03759, University of Rochester, European Union Grant No LSHM-CT-2004-503485. Michaela Schimpl is an employee of Trium Analysis Online GmbH. Anneke Neuhaus and Christian Lederer are employees of the Sylvia Lawry Centre for Multiple Sclerosis Research. John Danesh is a board member of Merck Sharp & Dohme UK Atherosclerosis Advisory Board and Novartis Cardiovascular & Metabolic Advisory Board. John Danesh has received payment for lectures including service on speakers bureaus as well as travel/accomodation/meeting expenses (unrelated to the activities listed) from GlaxoSmithKline, Merck, Novartis, Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; [Anonymous], GUIDANCE IND PATIENT; BALKE B, 1954, J APPL PHYSIOL, V7, P231, DOI 10.1152/jappl.1954.7.3.231; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brunner E, 2009, J GERONTOL A-BIOL, V64, P1082, DOI 10.1093/gerona/glp078; Chalmers I, 2008, SEM JOINTL ORG J LIN; Daumer M, 2009, NEUROLOGY, V72, P705, DOI 10.1212/01.wnl.0000336916.38629.43; Daumer M, 2008, INT C AMB MON PHYS A; Daumer M, 2007, BIOMED TECH, V52, P149, DOI 10.1515/BMT.2007.028; Daumer M, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-18; Dean CM, 2001, CLIN REHABIL, V15, P415, DOI 10.1191/026921501678310216; Department for Transport GMH, 2011, NAT TRAV SURV 2010 T; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Hamer M, 2010, HEART, V96, P380, DOI 10.1136/hrt.2009.183350; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Levine JA, 2008, DIABETES, V57, P548, DOI 10.2337/db07-0815; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Palombaro KM, 2006, PHYS THER, V86, P809, DOI 10.1093/ptj/86.6.809; Purser JL, 2005, J REHABIL RES DEV, V42, P535, DOI 10.1682/JRRD.2004.07.0087; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Scheermesser M, 2008, 2 INT C PERV COMP HE; Schimpl M, 2011, PLOS ONE IN PRESS; Schlesinger S, 2011, KLIN NEUROPHYSIOL, V42, P17, DOI 10.1055/s-0031-1271750; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Studenski S, 2009, J NUTR HEALTH AGING, V13, P878, DOI 10.1007/s12603-009-0245-0; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Vaney C, 1996, CLIN REHABIL, V10, P216, DOI DOI 10.1177/026921559601000306; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	36	75	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23299	10.1371/journal.pone.0023299	http://dx.doi.org/10.1371/journal.pone.0023299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853107	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200067
J	Ash, MR; Maher, MJ; Guss, JM; Jormakka, M				Ash, Miriam-Rose; Maher, Megan J.; Guss, J. Mitchell; Jormakka, Mika			The Initiation of GTP Hydrolysis by the G-Domain of FeoB: Insights from a Transition-State Complex Structure	PLOS ONE			English	Article							FERROUS IRON UPTAKE; CATALYTIC GLUTAMINE; ACTIVATING PROTEIN; ESCHERICHIA-COLI; BINDING PROTEIN; MAJOR ROLE; GTPASES; ACQUISITION; SWITCH; EVOLUTION	The polytopic membrane protein FeoB is a ferrous iron transporter in prokaryotes. The protein contains a potassium-activated GTPase domain that is essential in regulating the import of iron and conferring virulence to many disease-causing bacteria. However, the mechanism by which the G-domain of FeoB hydrolyzes GTP is not well understood. In particular, it is not yet known how the pivotal step in GTP hydrolysis is achieved: alignment of a catalytic water molecule. In the current study, the crystal structure of the soluble domains from Streptococcus thermophilus FeoB (NFeoB(St)) in complex with the activating potassium ion and a transition-state analogue, GDP center dot AlF4-, reveals a novel mode of water alignment involving contacts with the protein backbone only. In parallel to the structural studies, a series of seven mutant proteins were constructed that targeted conserved residues at the active site of NFeoB(St), and the nucleotide binding and hydrolysis properties of these were measured and compared to the wild-type protein. The results show that mutations in Thr35 abolish GTPase activity of the protein, while other conserved residues (Tyr58, Ser64, Glu66 and Glu67) are not required for water alignment by NFeoB(St). Together with the crystal structure, the findings suggest a new mechanism for hydrolysis initiation in small G-proteins, in which the attacking water molecule is aligned by contacts with the protein backbone only.	[Ash, Miriam-Rose; Guss, J. Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Maher, Megan J.; Jormakka, Mika] Centenary Inst, Struct Biol Program, Sydney, NSW, Australia	University of Sydney; University of Sydney; Centenary Institute	Ash, MR (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	m.jormakka@centenary.org.au	Maher, Megan/B-2239-2012; Guss, Jules Mitchell/N-1387-2019	Guss, Jules Mitchell/0000-0003-4259-6079; Ash, Miriam-Rose/0000-0002-0573-9854; Maher, Megan/0000-0003-0848-9640	National Health and Medical Research Council [570784, 632703]; Australian Postgraduate Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This study was supported by the National Health and Medical Research Council (no. 570784 and 632703; http://www.nhmrc.gov.au). MJM is a Cancer Institute of NSW Career Development Fellow. MRA is a recipient of an Australian Postgraduate Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Birnbaumer L, 2010, J RECEPT SIG TRANSD, V30, P372, DOI 10.3109/10799893.2010.508165; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chakrabarti PP, 2007, J MOL BIOL, V367, P983, DOI 10.1016/j.jmb.2006.11.022; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eng ET, 2008, J MOL BIOL, V375, P1086, DOI 10.1016/j.jmb.2007.11.027; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; Guilfoyle A, 2009, EMBO J, V28, P2677, DOI 10.1038/emboj.2009.208; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hattori M, 2009, STRUCTURE, V17, P1345, DOI 10.1016/j.str.2009.08.007; Huang B, 2010, J BIOCHEM, V148, P103, DOI 10.1093/jb/mvq039; Hung KW, 2010, J STRUCT BIOL, V170, P501, DOI 10.1016/j.jsb.2010.01.017; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; JOHN J, 1993, J BIOL CHEM, V268, P923; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Koster S, 2009, J MOL BIOL, V392, P405, DOI 10.1016/j.jmb.2009.07.020; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Martin RB, 1996, COORDIN CHEM REV, V149, P23, DOI 10.1016/0010-8545(95)01170-6; MARTIN RB, 1988, BIOCHEM BIOPH RES CO, V155, P1194; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Robinson VL, 2002, STRUCTURE, V10, P1649, DOI 10.1016/S0969-2126(02)00905-X; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; TOMAR SK, 2011, BIOCH BIOPHYS RES CO; Tu C, 2009, P NATL ACAD SCI USA, V106, P14843, DOI 10.1073/pnas.0904032106; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yamanaka K, 2000, J BACTERIOL, V182, P7078, DOI 10.1128/JB.182.24.7078-7082.2000; Zurita A, 2010, P NATL ACAD SCI USA, V107, P9596, DOI 10.1073/pnas.1004803107	50	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23355	10.1371/journal.pone.0023355	http://dx.doi.org/10.1371/journal.pone.0023355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858085	Green Published, gold			2022-12-25	WOS:000293774300032
J	Hoare, DJ; Humble, J; Jin, D; Gilding, N; Petersen, R; Cobb, M; McCrohan, C				Hoare, Derek J.; Humble, James; Jin, Ding; Gilding, Niall; Petersen, Rasmus; Cobb, Matthew; McCrohan, Catherine			Modeling Peripheral Olfactory Coding in Drosophila Larvae	PLOS ONE			English	Article							GAIN-CONTROL; NEURONS; PERCEPTION; MECHANISM	The Drosophila larva possesses just 21 unique and identifiable pairs of olfactory sensory neurons (OSNs), enabling investigation of the contribution of individual OSN classes to the peripheral olfactory code. We combined electrophysiological and computational modeling to explore the nature of the peripheral olfactory code in situ. We recorded firing responses of 19/21 OSNs to a panel of 19 odors. This was achieved by creating larvae expressing just one functioning class of odorant receptor, and hence OSN. Odor response profiles of each OSN class were highly specific and unique. However many OSN-odor pairs yielded variable responses, some of which were statistically indistinguishable from background activity. We used these electrophysiological data, incorporating both responses and spontaneous firing activity, to develop a Bayesian decoding model of olfactory processing. The model was able to accurately predict odor identity from raw OSN responses; prediction accuracy ranged from 12%-77% (mean for all odors 45.2%) but was always significantly above chance (5.6%). However, there was no correlation between prediction accuracy for a given odor and the strength of responses of wild-type larvae to the same odor in a behavioral assay. We also used the model to predict the ability of the code to discriminate between pairs of odors. Some of these predictions were supported in a behavioral discrimination (masking) assay but others were not. We conclude that our model of the peripheral code represents basic features of odor detection and discrimination, yielding insights into the information available to higher processing structures in the brain.	[Hoare, Derek J.; Humble, James; Jin, Ding; Gilding, Niall; Petersen, Rasmus; Cobb, Matthew; McCrohan, Catherine] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Hoare, DJ (corresponding author), Univ Nottingham, NIHR Natl Biomed Res Unit Hearing, Nottingham NG7 2RD, England.	Cathy.McCrohan@manchester.ac.uk	Humble, James/M-2145-2014	Humble, James/0000-0003-0695-8343; Cobb, Matthew/0000-0002-8258-4913; Hoare, Derek/0000-0002-8768-1392; McCrohan, Catherine/0000-0002-8855-1194; Gilding, Niall/0000-0002-3540-0712	Biotechnology and Biological Sciences Research Council; Medical Research Council; The Royal Society; Biotechnology and Biological Sciences Research Council [BB/H009914/]; Code analysis, repository, and modelling for e-Neuroscience; Engineering and Physical Sciences Research Council [EP/E002331/1; RP]; BBSRC [BB/H009914/1, BB/G020094/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G020094/1, BB/H009914/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Code analysis, repository, and modelling for e-Neuroscience; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by a Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) studentship (DJH); a Medical Research Council (http://www.mrc.ac.uk) studentship (JH); The Royal Society (http://royalsociety.org) (CM and MC); Biotechnology and Biological Sciences Research Council grant BB/H009914/1 (CM and MC); and the CARMEN e-science project (Code analysis, repository, and modelling for e-Neuroscience; Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk) grant EP/E002331/1; RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Chaudhury D, 2009, J NEUROSCI, V29, P52, DOI 10.1523/JNEUROSCI.4036-08.2009; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; Grosmaitre X, 2006, P NATL ACAD SCI USA, V103, P1970, DOI 10.1073/pnas.0508491103; Guo S, 2010, PROTEINS, V78, P381, DOI 10.1002/prot.22556; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hoare DJ, 2008, J NEUROSCI, V28, P9710, DOI 10.1523/JNEUROSCI.1955-08.2008; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022	23	11	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22996	10.1371/journal.pone.0022996	http://dx.doi.org/10.1371/journal.pone.0022996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857978	Green Published, gold, Green Submitted			2022-12-25	WOS:000293774300015
J	Moltzer, E; Riet, LT; Swagemakers, SMA; van Heijningen, PM; Vermeij, M; van Veghel, R; Bouhuizen, AM; van Esch, JHM; Lankhorst, S; Ramnath, NWM; de Waard, MC; Duncker, DJ; van der Spek, PJ; Rouwet, EV; Danser, AHJ; Essers, J				Moltzer, Els; Riet, Luuk Te; Swagemakers, Sigrid M. A.; van Heijningen, Paula M.; Vermeij, Marcel; van Veghel, Richard; Bouhuizen, Angelique M.; van Esch, Joep H. M.; Lankhorst, Stephanie; Ramnath, Natasja W. M.; de Waard, Monique C.; Duncker, Dirk J.; van der Spek, Peter J.; Rouwet, Ellen V.; Danser, A. H. Jan; Essers, Jeroen			Impaired Vascular Contractility and Aortic Wall Degeneration in Fibulin-4 Deficient Mice: Effect of Angiotensin II Type 1 (AT(1)) Receptor Blockade	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; MARFAN-SYNDROME; MOUSE MODEL; MEDIAL DEGENERATION; EXPRESSION; ARTERIAL; RENIN; PATHOGENESIS; MECHANISMS	Medial degeneration is a key feature of aneurysm disease and aortic dissection. In a murine aneurysm model we investigated the structural and functional characteristics of aortic wall degeneration in adult fibulin-4 deficient mice and the potential therapeutic role of the angiotensin (Ang) II type 1 (AT(1)) receptor antagonist losartan in preventing aortic media degeneration. Adult mice with 2-fold (heterozygous Fibulin-4(+/R)) and 4-fold (homozygous Fibulin-4(R/R)) reduced expression of fibulin-4 displayed the histological features of cystic media degeneration as found in patients with aneurysm or dissection, including elastin fiber fragmentation, loss of smooth muscle cells, and deposition of ground substance in the extracellular matrix of the aortic media. The aortic contractile capacity, determined by isometric force measurements, was diminished, and was associated with dysregulation of contractile genes as shown by aortic transcriptome analysis. These structural and functional alterations were accompanied by upregulation of TGF-beta signaling in aortas from fibulin-4 deficient mice, as identified by genome-scaled network analysis as well as by immunohistochemical staining for phosphorylated Smad2, an intracellular mediator of TGF-beta. Tissue levels of Ang II, a regulator of TGF-beta signaling, were increased. Prenatal treatment with the AT(1) receptor antagonist losartan, which blunts TGF-beta signaling, prevented elastic fiber fragmentation in the aortic media of newborn Fibulin-4(R/R) mice. Postnatal losartan treatment reduced haemodynamic stress and improved lifespan of homozygous knockdown fibulin-4 animals, but did not affect aortic vessel wall structure. In conclusion, the AT(1) receptor blocker losartan can prevent aortic media degeneration in a non-Marfan syndrome aneurysm mouse model. In established aortic aneurysms, losartan does not affect aortic architecture, but does improve survival. These findings may extend the potential therapeutic application of inhibitors of the renin-angiotensin system to the preventive treatment of aneurysm disease.	[Moltzer, Els; Riet, Luuk Te; van Veghel, Richard; Bouhuizen, Angelique M.; van Esch, Joep H. M.; Lankhorst, Stephanie; Danser, A. H. Jan] Erasmus MC, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van Heijningen, Paula M.; Ramnath, Natasja W. M.; de Waard, Monique C.; Essers, Jeroen] Erasmus MC, Canc Genom Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Swagemakers, Sigrid M. A.; van der Spek, Peter J.] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Vermeij, Marcel] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Riet, Luuk Te; Lankhorst, Stephanie; Ramnath, Natasja W. M.; Rouwet, Ellen V.; Essers, Jeroen] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [de Waard, Monique C.; Duncker, Dirk J.] Erasmus MC, Thoraxctr, Div Expt Cardiol, Dept Cardiol, Rotterdam, Netherlands; [Essers, Jeroen] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Moltzer, E (corresponding author), Erasmus MC, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands.	j.essers@erasmusmc.nl	Danser, Jan/GLR-1479-2022		Netherlands Genomics Initiative (NGI)/NOW; Lijf en Leven	Netherlands Genomics Initiative (NGI)/NOW; Lijf en Leven	This work was supported by the Netherlands Genomics Initiative (NGI)/NOW (to SS and PvdS) and by the 'Lijf en Leven' grant (2008): 'Early Detection and Diagnosis of Aneurysms and Heart Valve Abnormalities' (to JE and PvH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Batenburg WW, 2008, ARTERIOSCL THROM VAS, V28, P1151, DOI 10.1161/ATVBAHA.108.164210; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Chew DKW, 2004, J VASC SURG, V40, P1001, DOI 10.1016/j.jvs.2004.08.035; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; DANSER AHJ, 1994, HYPERTENSION, V24, P37, DOI 10.1161/01.HYP.24.1.37; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X; Ford CM, 1999, ARTERIOSCL THROM VAS, V19, P1843, DOI 10.1161/01.ATV.19.8.1843; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HALME T, 1985, EXP MOL PATHOL, V43, P1, DOI 10.1016/0014-4800(85)90050-4; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hawinkels LJAC, 2009, CANCER SCI, V100, P663, DOI 10.1111/j.1349-7006.2009.01100.x; Henriques T, 2008, ARTERIOSCL THROM VAS, V28, P1251, DOI 10.1161/ATVBAHA.107.160382; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; JEREMY RW, 1994, AM J CARDIOL, V74, P369, DOI 10.1016/0002-9149(94)90405-7; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kaijzel EL, 2010, CIRC-CARDIOVASC IMAG, V3, P567, DOI 10.1161/CIRCIMAGING.109.933093; KAWASAKI T, 1987, CARDIOVASC RES, V21, P678, DOI 10.1093/cvr/21.9.678; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezCandales A, 1997, AM J PATHOL, V150, P993; Lu H, 2008, CURR HYPERTENS REP, V10, P99, DOI 10.1007/s11906-008-0020-3; Marque V, 2001, ARTERIOSCL THROM VAS, V21, P1184, DOI 10.1161/hq0701.092136; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Moltzer E, 2011, PHARMACOL THERAPEUT, V131, P50, DOI 10.1016/j.pharmthera.2011.04.002; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nagashima H, 2001, CIRCULATION, V104, pI282; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Sun YO, 1998, J MOL CELL CARDIOL, V30, P1559, DOI 10.1006/jmcc.1998.0721; van den Bos EJ, 2005, AM J PHYSIOL-HEART C, V289, pH1291, DOI 10.1152/ajpheart.00111.2005; van Esch JHM, 2010, CARDIOVASC RES, V86, P401, DOI 10.1093/cvr/cvq004; van Kats JP, 2001, KIDNEY INT, V60, P2311, DOI 10.1046/j.1523-1755.2001.00049.x; Vitarelli A, 2006, AM J CARDIOL, V97, P571, DOI 10.1016/j.amjcard.2005.09.089; WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400; Yang HHC, 2009, BRIT J PHARMACOL, V158, P1503, DOI 10.1111/j.1476-5381.2009.00443.x; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	51	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23411	10.1371/journal.pone.0023411	http://dx.doi.org/10.1371/journal.pone.0023411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858106	Green Published, gold			2022-12-25	WOS:000293774300034
J	Obama, T; Nagaoka, S; Akagi, K; Kato, R; Horiuchi, N; Horai, Y; Aiuchi, T; Arata, S; Yamaguchi, T; Watanabe, M; Itabe, H				Obama, Takashi; Nagaoka, Sayaka; Akagi, Kazuki; Kato, Rina; Horiuchi, Naomi; Horai, Yasushi; Aiuchi, Toshihiro; Arata, Satoru; Yamaguchi, Tomohiro; Watanabe, Mitsuhiro; Itabe, Hiroyuki			Dietary Cholesterol Reduces Plasma Triacylglycerol in Apolipoprotein E-Null Mice: Suppression of Lipin-1 and-2 in the Glycerol-3-Phosphate Pathway	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID SYNTHESIS; GENE-EXPRESSION; BILE-ACIDS; ADIPOSE-TISSUE; KNOCKOUT MICE; LIVER; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; GLUCOCORTICOIDS	Background: Cholesterol metabolism is tightly regulated by both cholesterol and its metabolites in the mammalian liver, but the regulatory mechanism of triacylglycerol (TG) synthesis remains to be elucidated. Lipin, which catalyzes the conversion of phosphatidate to diacylglycerol, is a key enzyme involved in de novo TG synthesis in the liver via the glycerol-3-phosphate (G3P) pathway. However, the regulatory mechanisms for the expression of lipin in the liver are not well understood. Methodology/Principal Findings: Apolipoprotein E-knock out (apoE-KO) mice were fed a chow supplemented with 1.25% cholesterol (high-Chol diet). Cholesterol and bile acids were highly increased in the liver within a week. However, the amount of TG in very low-density lipoprotein (VLDL), but not in the liver, was reduced by 78%. The epididymal adipose tissue was almost eradicated in the long term. DNA microarray and real-time RT-PCR analyses revealed that the mRNA expression of all the genes in the G3P pathway in the liver was suppressed in the high-Chol diet apoE-KO mice. In particular, the mRNA and protein expression of lipin-1 and lipin-2 was markedly decreased, and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), which up-regulates the transcription of lipin-1, was also suppressed. In vitro analysis using HepG2 cells revealed that the protein expression of lipin-2 was suppressed by treatment with taurocholic acid. Conclusions/Significance: These data using apoE-KO mice indicate that cholesterol and its metabolites are involved in regulating TG metabolism through a suppression of lipin-1 and lipin-2 in the liver. This research provides evidence for the mechanism of lipin expression in the liver.	[Obama, Takashi; Nagaoka, Sayaka; Akagi, Kazuki; Kato, Rina; Horiuchi, Naomi; Aiuchi, Toshihiro; Yamaguchi, Tomohiro; Itabe, Hiroyuki] Showa Univ, Sch Pharm, Dept Biol Chem, Shinagawa Ku, Tokyo, Japan; [Horai, Yasushi; Watanabe, Mitsuhiro] Keio Univ, Sch Med, Div Mol Metab & Syst Med, Shinjuku Ku, Tokyo, Japan; [Arata, Satoru] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo, Japan	Showa University; Keio University; Showa University	Obama, T (corresponding author), Showa Univ, Sch Pharm, Dept Biol Chem, Shinagawa Ku, Tokyo, Japan.	h-itabe@pharm.showa-u.ac.jp	板部板部, 洋之/ABC-7746-2020		Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT) [19590076, 20580103, 21590073, 21790092]; Japan Health Sciences Foundation; Showa University; Grants-in-Aid for Scientific Research [23790098, 22500390] Funding Source: KAKEN	Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; Showa University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT) (No. 19590076, No. 20580103, No. 21590073 and No. 21790092), grants for the Private University High Technology Research Center Project from the MEXT, Research on Publicly Essential Drugs and Medical Devices from Japan Health Sciences Foundation, and Showa University Research Grant for Young Researchers. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fukumoto Y, 2004, CIRCULATION, V110, P1953, DOI 10.1161/01.CIR.0000143174.41810.10; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Kato R, 2009, ARTERIOSCL THROM VAS, V29, P33, DOI 10.1161/ATVBAHA.108.164723; Khalil MB, 2010, BBA-MOL CELL BIOL L, V1801, P1249, DOI 10.1016/j.bbalip.2010.07.008; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rehnmark S, 1998, J LIPID RES, V39, P2209; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; Sinal CJ, 2001, J BIOL CHEM, V276, P47154, DOI 10.1074/jbc.M107000200; Stein S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013539; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	29	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22917	10.1371/journal.pone.0022917	http://dx.doi.org/10.1371/journal.pone.0022917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857965	Green Submitted, gold, Green Published			2022-12-25	WOS:000293774300011
J	Scharf, C; Krasniqi, N; Hellermann, J; Rahn, M; Sutsch, G; Brunckhorst, C; Duru, F				Scharf, Christoph; Krasniqi, Nazmi; Hellermann, Jens; Rahn, Mariette; Suetsch, Gabor; Brunckhorst, Corinna; Duru, Firat			Electrical Activation in the Coronary Sinus Branches as a Guide to Cardiac Resynchronisation Therapy: Rationale for a Coordinate System	PLOS ONE			English	Article							RESYNCHRONIZATION THERAPY; HEART-FAILURE; VENTRICULAR ACTIVATION; BLOCK; CONDUCTION; DELAY; NOMENCLATURE; CARDIOLOGY; STATEMENT; ANATOMY	Background: For successful cardiac resynchronisation therapy (CRT) a spatial and electrical separation of right and left ventricular electrodes is essential. The spatial distribution of electrical delays within the coronary sinus (CS) tributaries has not yet been identified. Objective: Electrical delays within the CS are described during sinus rhythm (SR) and right ventricular pacing (RVP). A coordinate system grading the mitral ring from 0 degrees to 360 degrees and three vertical segments is proposed to define the lead positions irrespective of individual CS branch orientation. Methods: In 13 patients undergoing implantation of a CRT device 6 +/- 2.5, (median 5) lead positions within the CS were mapped during SR and RVP. The delay to the onset and the peak of the local signal was measured from the earliest QRS activation or the pacing spike. Fluoroscopic positions were compared to localizations on a nonfluoroscopic electrode imaging system. Results: During SR, electrical delays in the CS were inhomogenous in patients with or without left bundle branch block (LBBB). During RVP, the delays increased by 44 +/- 32 ms (signal onset from 36 +/- 33 ms to 95 +/- 30 ms; p<0.001, signal peak from 105 +/- 44 ms to 156 +/- 30 ms; p<0.001). The activation pattern during RVP was homogeneous and predictable by taking the grading on the CS ring into account: (% QRS) = 78-0.002 (grade-162)(2), p<0.0001. This indicates that 78% of the QRS duration can be expected as a maximum peak delay at 162 degrees on the CS ring. Conclusion: Electrical delays within the CS vary during SR, but prolong and become predictable during RVP. A coordinate system helps predicting the local delays and facilitates interindividual comparison of lead positions irrespective of CS branch anatomy.	[Scharf, Christoph; Krasniqi, Nazmi; Hellermann, Jens; Rahn, Mariette; Suetsch, Gabor; Brunckhorst, Corinna; Duru, Firat] Univ Zurich Hosp, Ctr Cardiovasc, Clin Cardiol, Div Pacing & Electrophysiol, CH-8091 Zurich, Switzerland; [Scharf, Christoph] Clin Pk, Zurich, Switzerland; [Duru, Firat] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharf, C (corresponding author), Univ Zurich Hosp, Ctr Cardiovasc, Clin Cardiol, Div Pacing & Electrophysiol, CH-8091 Zurich, Switzerland.	christoph.scharf@gmail.com	Hellermann, Jens/ABB-2889-2020; Duru, Firat/F-7161-2011	Duru, Firat/0000-0002-4748-0158				Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; CANNOM DS, 1980, CIRCULATION, V62, P621, DOI 10.1161/01.CIR.62.3.621; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Cosio FG, 1999, CIRCULATION, V100, pE31, DOI 10.1161/01.CIR.100.5.e31; Lambiase PD, 2004, HEART, V90, P44, DOI 10.1136/heart.90.1.44; Merchant FM, 2010, PACE, V33, P575, DOI 10.1111/j.1540-8159.2009.02624.x; Peichl P, 2004, PACE, V27, P1105, DOI 10.1111/j.1540-8159.2004.00592.x; Rodriguez LM, 2003, J CARDIOVASC ELECTR, V14, P135, DOI 10.1046/j.1540-8167.2003.02421.x; Sassone B, 2010, EUROPACE, V12, P78, DOI 10.1093/europace/eup347; Singh JP, 2005, J AM COLL CARDIOL, V46, P68, DOI 10.1016/j.jacc.2005.04.017; Tse HF, 2005, J CARDIOVASC ELECTR, V16, P690, DOI 10.1046/j.1540-8167.2005.40568.x; Turner MS, 2004, CIRCULATION, V109, P2544, DOI 10.1161/01.CIR.0000131184.40893.40; VASSALLO JA, 1984, CIRCULATION, V69, P914, DOI 10.1161/01.CIR.69.5.914; Wittkampf FHM, 1999, CIRCULATION, V99, P1312, DOI 10.1161/01.CIR.99.10.1312	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e19914	10.1371/journal.pone.0019914	http://dx.doi.org/10.1371/journal.pone.0019914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857896	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000293773300001
J	Zheng, LH; Michelson, Y; Freger, V; Avraham, Z; Venken, KJT; Bellen, HJ; Justice, MJ; Wides, R				Zheng, Lihua; Michelson, Yehudit; Freger, Vita; Avraham, Ziva; Venken, Koen J. T.; Bellen, Hugo J.; Justice, Monica J.; Wides, Ron			Drosophila Ten-m and Filamin Affect Motor Neuron Growth Cone Guidance	PLOS ONE			English	Article							PAIR-RULE GENE; PERIVENTRICULAR NODULAR HETEROTOPIA; ELEMENT INSERTION ALLELES; AXON GUIDANCE; P-ELEMENT; 3RD CHROMOSOME; MONOCLONAL-ANTIBODIES; COMMISSURAL AXONS; NETRIN-RECEPTOR; CEREBRAL-CORTEX	The Drosophila Ten-m (also called Tenascin-major, or odd Oz (odz)) gene has been associated with a pair-rule phenotype. We identified and characterized new alleles of Drosophila Ten-m to establish that this gene is not responsible for segmentation defects but rather causes defects in motor neuron axon routing. In Ten-m mutants the inter-segmental nerve (ISN) often crosses segment boundaries and fasciculates with the ISN in the adjacent segment. Ten-m is expressed in the central nervous system and epidermal stripes during the stages when the growth cones of the neurons that form the ISN navigate to their targets. Over-expression of Ten-m in epidermal cells also leads to ISN misrouting. We also found that Filamin, an actin binding protein, physically interacts with the Ten-m protein. Mutations in cheerio, which encodes Filamin, cause defects in motor neuron axon routing like those of Ten-m. During embryonic development, the expression of Filamin and Ten-m partially overlap in ectodermal cells. These results suggest that Ten-m and Filamin in epidermal cells might together influence growth cone progression.	[Zheng, Lihua; Venken, Koen J. T.; Bellen, Hugo J.; Justice, Monica J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Michelson, Yehudit; Freger, Vita; Avraham, Ziva; Wides, Ron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Program Dev Biol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Bar Ilan University; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zheng, LH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	mjustice@bcm.edu; ronwides@yahoo.com	Venken, Koen/B-9909-2013	Venken, Koen/0000-0003-0741-4698; Bellen, Hugo/0000-0001-5992-5989	NIH [U01 HD39372, P01 ES11253]; Israel Science Foundation [749_04]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD039372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA115503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants U01 HD39372 and P01 ES11253 to MJJ.www.nih.gov/. This work was supported by Israel Science Foundation Grant 749_04 to RW. www.isf.org.il/english/. HJB is an investigator of the HHMI. www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following for invaluable technical support and help: Karen L. Schuzle, June Cao, Yuchun He, Hongling Pan, Amir Fayyazuddin, Rong Grace Zhai, Yael Kinel-Tahan, and Anna Levine. We thank Stefan Baumgartner, Allan Spradling, Lynn Cooley, Juan Pablo Labrador, Josh Dubnau, Tim Tully and the Bloomington Drosophila Stock Center for kindly providing reagents. Antibodies obtained from the Developmental Studies Hybridoma Bank (DSHB) were developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences.	Araujo SJ, 2003, NAT REV NEUROSCI, V4, P910, DOI 10.1038/nrn1243; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Deak P, 1997, GENETICS, V147, P1697; Dgany O, 2002, BIOCHEM J, V363, P633, DOI 10.1042/0264-6021:3630633; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; KARPEN GH, 1992, GENETICS, V132, P737; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Kinel-Tahan Y, 2007, DEV DYNAM, V236, P2541, DOI 10.1002/dvdy.21284; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Levine A, 1997, GENE, V200, P59, DOI 10.1016/S0378-1119(97)00375-2; Lossie AC, 2005, GENETICS, V169, P285, DOI 10.1534/genetics.104.034967; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Otaki JM, 1999, DEV BIOL, V212, P165, DOI 10.1006/dbio.1999.9310; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Robinson DN, 1997, GENETICS, V145, P1063; ROSEMAN RR, 1995, GENETICS, V141, P1061; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Salzberg A, 1997, GENETICS, V147, P1723; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Schmid A, 1999, DEVELOPMENT, V126, P4653; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; Sink H, 2001, CELL, V105, P57, DOI 10.1016/S0092-8674(01)00296-3; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Sokol NS, 1999, CURR BIOL, V9, P1221, DOI 10.1016/S0960-9822(99)80502-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	68	40	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22956	10.1371/journal.pone.0022956	http://dx.doi.org/10.1371/journal.pone.0022956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857973	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300015
J	Yuan, YY; Cao, PX; Smith, MA; Kramp, K; Huang, Y; Hisamoto, N; Matsumoto, K; Hatzoglou, M; Jin, H; Feng, ZY				Yuan, Yiyuan; Cao, Pengxiu; Smith, Mark A.; Kramp, Kristopher; Huang, Ying; Hisamoto, Naoki; Matsumoto, Kunihiro; Hatzoglou, Maria; Jin, Hui; Feng, Zhaoyang			Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegans	PLOS ONE			English	Article							REPEAT KINASE 2; AUTOSOMAL-DOMINANT PARKINSONISM; UNFOLDED PROTEIN RESPONSE; ALPHA-SYNUCLEIN; CAENORHABDITIS-ELEGANS; CELL-DEATH; DROSOPHILA MODEL; UP-REGULATION; DISEASE; PHOSPHORYLATION	Mutation of leucine-rich repeat kinase 2 (LRRK2) is the leading genetic cause of Parkinson's Disease (PD), manifested as age-dependent dopaminergic neurodegeneration, but the underlying molecular mechanisms remain unclear. Multiple roles of LRRK2 may contribute to dopaminergic neurodegeneration. Endoplasmic reticulum (ER) stress has also been linked to PD pathogenesis, but its interactive mechanism with PD genetic factors is largely unknown. Here, we used C. elegans, human neuroblastoma cells and murine cortical neurons to determine the role of LRRK2 in maintaining dopaminergic neuron viability. We found that LRRK2 acts to protect neuroblastoma cells and C. elegans dopaminergic neurons from the toxicity of 6-hydroxydopamine and/or human alpha-synuclein, possibly through the p38 pathway, by supporting upregulation of GRP78, a key cell survival molecule during ER stress. A pathogenic LRRK2 mutant (G2019S), however, caused chronic p38 activation that led to death of murine neurons and age-related dopaminergic-specific neurodegeneration in nematodes. These observations establish a critical functional link between LRRK2 and ER stress.	[Yuan, Yiyuan; Cao, Pengxiu; Kramp, Kristopher; Huang, Ying; Jin, Hui; Feng, Zhaoyang] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Smith, Mark A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH USA; [Hisamoto, Naoki; Matsumoto, Kunihiro] Japan Sci & Technology Corp, Nagoya Solut Oriented Res Sci & Technol, Dept Mol Biol, Inst Adv Res,Grad Sch Sci,Chikusa Ku, Nagoya, Aichi, Japan; [Feng, Zhaoyang] Xi An Jiao Tong Univ, Dept Physiol, Coll Med, Xian 710049, Shaanxi, Peoples R China	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Japan Science & Technology Agency (JST); Xi'an Jiaotong University	Yuan, YY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	john.feng@case.edu	Cao, Pengxiu/I-5378-2012	Kramp, Kristopher/0000-0003-2121-9274; CAO, PENGXIU/0000-0002-5900-5645	Mt. Sinai Foundation; National Institutes of Health; Grants-in-Aid for Scientific Research [22020016] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596, R01DK053307] Funding Source: NIH RePORTER	Mt. Sinai Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Mt. Sinai Foundation and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao PX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009312; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2010, MOVEMENT DISORD, V25, pS40, DOI 10.1002/mds.22717; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Heo HY, 2009, EXP CELL RES; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kanao T, 2010, HUM MOL GENET; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kong ANT, 2000, ARCH PHARM RES, V23, P1, DOI 10.1007/BF02976458; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Krysov SV, 2007, MOL CANCER THER, V6, P703, DOI 10.1158/1535-7163.MCT-06-0544; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; LEAVITT R, 1977, J VIROL, V21, P375, DOI 10.1128/JVI.21.1.375-385.1977; Lee BD, 2010, NAT MED; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Lee YM, 2003, NEUROSCI LETT, V352, P17, DOI 10.1016/j.neulet.2003.08.018; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Melrose H, 2006, NEUROSCIENCE, V139, P791, DOI 10.1016/j.neuroscience.2006.01.017; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2009, HUM MUTAT, V30, P1153, DOI 10.1002/humu.21038; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Simon-Sanchez J, 2006, EUR J NEUROSCI, V23, P659, DOI 10.1111/j.1460-9568.2006.04616.x; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Varghese J, 2001, J IMMUNOL, V166, P6570, DOI 10.4049/jimmunol.166.11.6570; Vitte J, 2010, J NEUROPATH EXP NEUR, V69, P959, DOI 10.1097/NEN.0b013e3181efc01c; Wang DL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-3; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; White LR, 2007, J NEUROSCI RES, V85, P1288, DOI 10.1002/jnr.21240; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yabe T, 2005, DEVELOPMENT, V132, P3197, DOI 10.1242/dev.01909; Yamamuro A, 2006, NEUROCHEM RES, V31, P657, DOI 10.1007/s11064-006-9062-6; Yao C, 2010, NEUROBIOL DIS, V40, P73, DOI 10.1016/j.nbd.2010.04.002; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	78	59	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22354	10.1371/journal.pone.0022354	http://dx.doi.org/10.1371/journal.pone.0022354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857923	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900016
J	Coleman, JL; Barclay, RMR				Coleman, Joanna L.; Barclay, Robert M. R.			Influence of Urbanization on Demography of Little Brown Bats (Myotis lucifugus) in the Prairies of North America	PLOS ONE			English	Article							INSECTIVOROUS BAT; REPRODUCTIVE SUCCESS; POSTNATAL-GROWTH; BREEDING ECOLOGY; URBAN; POPULATION; SURVIVAL; HABITAT; CONSERVATION; PIPISTRELLUS	Background: We address three key gaps in research on urban wildlife ecology: insufficient attention to (1) grassland biomes, (2) individual-and population-level effects, and (3) vertebrates other than birds. We hypothesized that urbanization in the North American Prairies, by increasing habitat complexity (via the proliferation of vertical structures such as trees and buildings), thereby enhancing the availability of day-roosts, tree cover, and insects, would benefit synanthropic bats, resulting in increased fitness among urban individuals. Methodology/Principal Findings: Over three years, we captured more than 1,600 little brown bats (Myotis lucifugus) in urban and non-urban riparian sites in and around Calgary, Alberta, Canada. This species dominated bat assemblages throughout our study area, but nowhere more so than in the city. Our data did not support most of our specific predictions. Increased numbers of urban bats did not reflect urbanization-related benefits such as enhanced body condition, reproductive rates, or successful production of juveniles. Instead, bats did best in the transition zone situated between strictly urban and rural areas. Conclusions/Significance: We reject our hypothesis and explore various explanations. One possibility is that urban and rural M. lucifugus exhibit increased use of anthropogenic roosts, as opposed to natural ones, leading to larger maternity colonies and higher population densities and, in turn, increased competition for insect prey. Other possibilities include increased stress, disease transmission and/or impacts of noise on urban bats. Whatever the proximate cause, the combination of greater bat population density with decreased body condition and production of juveniles indicates that Calgary does not represent a population source for Prairie bats. We studied a highly synanthropic species in a system where it could reasonably be expected to respond positively to urbanization, but failed to observe any apparent benefits at the individual level, leading us to propose that urban development may be universally detrimental to bats.	[Coleman, Joanna L.; Barclay, Robert M. R.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Coleman, JL (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jcoleman@ucalgary.ca	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Coleman, Joanna/D-1787-2016; Barclay, Robert/D-5514-2012		Natural Sciences and Engineering Research Council of Canada [69-0424]; Killam Trusts; Bat Conservation International; University of Calgary; Canadian Tire	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Killam Trusts; Bat Conservation International; University of Calgary; Canadian Tire	Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant #69-0424, www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp), Killam Trusts (www.killamtrusts.ca), Bat Conservation International (www.batcon.org/index.php/what-we-do/grants/student-research-scholarships), University of Calgary (www.ucalgary.ca), and Canadian Tire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Lowell W., 2005, Urban Ecosystems, V8, P139, DOI 10.1007/s11252-005-4377-7; ADAMS R, 2010, ECOLOGY IN PRESS; Adams RA, 1997, J MAMMAL, V78, P239, DOI 10.2307/1382657; [Anonymous], 1998, RURAL DEV PERSPECTIV; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; BARCLAY RMR, 1991, J ANIM ECOL, V60, P165, DOI 10.2307/5452; Barclay RMR, 2004, CAN J ZOOL, V82, P688, DOI 10.1139/Z04-057; BARCLAY RMR, 1985, J MAMMAL, V66, P782, DOI 10.2307/1380808; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; BARROWCLOUGH GF, 1993, AM NAT, V141, P281, DOI 10.1086/285473; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Boal CW, 1999, J WILDLIFE MANAGE, V63, P77, DOI 10.2307/3802488; Brunet-Rossinni Anja K., 2009, P315; BUCHLER ER, 1975, J MAMMAL, V56, P252, DOI 10.2307/1379630; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; COLEMAN J, 2010, EFFECTS URBANIZATION; Coleman JL, 2002, WILSON BULL, V114, P467, DOI 10.1676/0043-5643(2002)114[0467:HUAPOS]2.0.CO;2; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DeStefano Stephen, 2005, P206; DICKMAN CR, 1989, J ANIM ECOL, V58, P119, DOI 10.2307/4989; Dobson FS, 2007, ECOSCIENCE, V14, P292, DOI 10.2980/1195-6860(2007)14[292:FASLHO]2.0.CO;2; DONCASTER CP, 1994, OIKOS, V69, P182, DOI 10.2307/3546136; Donovan TM, 2001, ECOL APPL, V11, P871; *EC STRAT WORK GRO, 1995, TERR EC EC EC CAN PR; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Garden J, 2006, AUSTRAL ECOL, V31, P126, DOI 10.1111/j.1442-9993.2006.01578.x; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gehrt SD, 2005, J MAMMAL, V86, P1164, DOI 10.1644/04-MAMM-A-173R2.1; GRAFEN A, 1982, NATURE, V298, P425, DOI 10.1038/298425a0; GRINDAL SD, 1992, AM MIDL NAT, V128, P339, DOI 10.2307/2426468; Harveson PM, 2007, BIOL CONSERV, V134, P321, DOI 10.1016/j.biocon.2006.07.022; Holloway GL, 2000, ECOSCIENCE, V7, P115, DOI 10.1080/11956860.2000.11682579; Hoying KM, 1998, J ZOOL, V245, P15, DOI 10.1111/j.1469-7998.1998.tb00067.x; HUMPHREY SR, 1975, J MAMMAL, V56, P321, DOI 10.2307/1379364; Humphries M. M., 2006, FUNCTIONAL EVOLUTION, P23; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; KEEN R, 1980, J MAMMAL, V61, P1, DOI 10.2307/1379951; Kittredge Vanessa C., 2006, Proceedings of the Oklahoma Academy of Science, V86, P33; Koehler CE, 2000, J MAMMAL, V81, P234, DOI 10.1644/1545-1542(2000)081<0234:PNGABB>2.0.CO;2; Kunz TH, 2003, BAT ECOLOGY, P3; KUNZ TH, 1974, ECOLOGY, V55, P693, DOI 10.2307/1934408; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; KURTA A, 1987, S ZOOL SOC LOND, V57, P79; Lausen CL, 2006, CAN J ZOOL, V84, P1079, DOI 10.1139/Z06-093; Lesinski G, 2009, ITAL J ZOOL, V76, P415, DOI 10.1080/11250000802589535; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Marzluff JM, 2001, RESTOR ECOL, V9, P280, DOI 10.1046/j.1526-100x.2001.009003280.x; Marzluff JM., 2001, AVIAN CONSERV ECOL, P1, DOI [DOI 10.1007/978-1-4615-1531-9, 10.1007/978-1-4615-1531-9_1]; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; McCleery RA, 2008, J WILDLIFE MANAGE, V72, P133, DOI 10.2193/2007-138; MCGOWAN KJ, 2001, VIAN ECOLOGY CONSER, P365; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Millsap BA, 2000, J WILDLIFE MANAGE, V64, P33, DOI 10.2307/3802972; MINOR WF, 1993, J FIELD ORNITHOL, V64, P433; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Potere D, 2009, INT J REMOTE SENS, V30, P6531, DOI 10.1080/01431160903121134; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Racey P.A., 1988, P31; Racey PA, 2003, BAT ECOLOGY, P680; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Ransome RD, 1995, PHILOS T ROY SOC B, V350, P153, DOI 10.1098/rstb.1995.0149; Riskin DK, 1998, CAN J ZOOL, V76, P767, DOI 10.1139/cjz-76-4-767; RYDELL J, 1989, OECOLOGIA, V80, P562, DOI 10.1007/BF00380082; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sano Akira, 2000, Mammal Study, V25, P1, DOI 10.3106/mammalstudy.25.1; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; SODHI NS, 1992, CAN J ZOOL, V70, P1477, DOI 10.1139/z92-204; THOMAS DW, 1988, J WILDLIFE MANAGE, V52, P619, DOI 10.2307/3800920; TUTTLE MD, 1976, ECOLOGY, V57, P587, DOI 10.2307/1936443; United Nations. Department of Economic and Social Affairs, 2008, WORLD URB PROSP 2007, DOI 10.1007/BF03343625; van der Ree R, 2005, ANIM CONSERV, V8, P309, DOI 10.1017/S1367943005002258; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Verboom B, 1999, CAN J ZOOL, V77, P1393, DOI 10.1139/cjz-77-9-1393; Verboom B, 1997, LANDSCAPE ECOL, V12, P117, DOI 10.1007/BF02698211; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Willis C., 2006, FUNCTIONAL EVOLUTION, P38; Zahn A, 1999, J ZOOL, V247, P275, DOI 10.1111/j.1469-7998.1999.tb00991.x	83	21	24	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20483	10.1371/journal.pone.0020483	http://dx.doi.org/10.1371/journal.pone.0020483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21857890	Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500065
J	Zawacka-Pankau, J; Grinkevich, VV; Huenten, S; Nikulenkov, F; Gluch, A; Li, H; Enge, M; Kel, A; Selivanova, G				Zawacka-Pankau, Joanna; Grinkevich, Vera V.; Huenten, Sabine; Nikulenkov, Fedor; Gluch, Angela; Li, Hai; Enge, Martin; Kel, Alexander; Selivanova, Galina			Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53 TARGETING WARBURG EFFECT TO FIGHT CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; ENDOTHELIAL GROWTH-FACTOR; SMALL-MOLECULE RITA; CELLULAR LIFE-SPAN; C-MYC; GENE-EXPRESSION; FACTOR 1-ALPHA; FACTOR-I; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION	Unique sensitivity of tumor cells to the inhibition of glycolysis is a good target for anticancer therapy. Here, we demonstrate that the pharmacologically activated tumor suppressor p53 mediates the inhibition of glycolytic enzymes in cancer cells in vitro and in vivo. We showed that p53 binds to the promoters of metabolic genes and represses their expression, including glucose transporters SLC2A12 (GLUT12) and SLC2A1 (GLUT 1). Furthermore, p53-mediated repression of transcription factors c-Myc and HIF1 alpha, key drivers of ATP-generating pathways in tumors, contributed to ATP production block. Inhibition of c-Myc by p53 mediated the ablation of several glycolytic genes in normoxia, whereas in hypoxia down-regulation of HIFla contributed to this effect. We identified Spl as a transcription cofactor cooperating with p53 in the ablation of metabolic genes. Using different approaches, we demonstrated that glycolysis block contributes to the robust induction of apoptosis by p53 in cancer cells. Taken together, our data suggest that tumor-specific reinstatement of p53 function targets the "Achilles heel" of cancer cells (i.e. their dependence on glycolysis), which could contribute to the tumor-selective killing of cancer cells by pharmacologically activated p53.	[Zawacka-Pankau, Joanna] Univ Gdansk, Intercollegiate Fac Biotechnol, Div Mol Diagnost, Dept Biotechnol, PL-80822 Gdansk, Poland; [Zawacka-Pankau, Joanna] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Enge, Martin; Selivanova, Galina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Gluch, Angela] Biobase GmbH, D-38304 Wolfenbuettel, Germany; [Kel, Alexander] GeneXplain GmbH, D-38302 Wolfenbuettel, Germany	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Karolinska Institutet	Zawacka-Pankau, J (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Div Mol Diagnost, Dept Biotechnol, Kladki 24, PL-80822 Gdansk, Poland.	jzawacka@biotech.ug.gda.pl; Galina.Selivanova@ki.se	Enge, Martin/GYQ-5073-2022; Kel, Alexander E/I-7284-2013; Zawacka-Pankau, Joanna/AAE-4600-2019; Nikulenkov, Fedor/AAJ-2304-2021	Zawacka-Pankau, Joanna/0000-0002-7415-2942; Selivanova, Galina/0000-0002-8698-4332; Enge, Martin/0000-0001-8748-8931	Swedish Cancer Society; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; EC FP6 project "Mutant p53"; EC FP6 project "Active p53"; EC FP6 project "Net2Drug"	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; EC FP6 project "Mutant p53"; EC FP6 project "Active p53"; EC FP6 project "Net2Drug"	This study was supported by grants from the Swedish Cancer Society, the Swedish Research Council, and the Torsten and Ragnar Soderberg Foundation (to G. S.). This work was also supported by EC FP6 projects "Mutant p53," "Active p53," and "Net2Drug."	Ahmed A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.42; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ardyanto TD, 2006, INT J ONCOL, V29, P549; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Ceriotti L, 2007, ANAL BIOCHEM, V371, P92, DOI 10.1016/j.ab.2007.07.014; Choi C, 2004, COMP FUNCT GENOM, V5, P163, DOI 10.1002/cfg.386; Choi J, 2010, BIOCHEM BIOPH RES CO, V401, P327, DOI 10.1016/j.bbrc.2010.09.014; Czernin J, 2002, ANNU REV MED, V53, P89, DOI 10.1146/annurev.med.53.082901.104028; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Hainaut P, 2000, ADV CANCER RES, V77, P81; HAWKINS RA, 1988, CANCER METAST REV, V7, P119, DOI 10.1007/BF00046482; Hedstrom E, 2009, CELL CYCLE, V8, P3584, DOI 10.4161/cc.8.21.9977; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jackson P, 1998, ONCOGENE, V16, P283, DOI 10.1038/sj.onc.1201491; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kel A, 2008, SAR QSAR ENVIRON RES, V19, P481, DOI 10.1080/10629360802083806; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kondoh H, 2005, CANCER RES, V65, P177; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Lou JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010522; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Ravi R, 2000, GENE DEV, V14, P34; REMPEL A, 1994, BBA-GENE STRUCT EXPR, V1219, P660, DOI 10.1016/0167-4781(94)90225-9; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Selivanova G, 2010, SEMIN CANCER BIOL, V20, P46, DOI 10.1016/j.semcancer.2010.02.006; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Smith TAD, 2006, J NUCL MED, V47, P1525; Spinnler C., 2011, CELL DEATH IN PRESS; Stegmaier P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017738; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Williams KJ, 2005, RADIOTHER ONCOL, V75, P89, DOI 10.1016/j.radonc.2005.01.009; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Younes M, 1996, CANCER RES, V56, P1164; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zhao RB, 2000, GENE DEV, V14, P981; Zhao YH, 2011, FRONT BIOSCI-LANDMRK, V16, P1844, DOI 10.2741/3826; Zhong H, 1999, CANCER RES, V59, P5830	73	87	87	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41600	41615		10.1074/jbc.M111.240812	http://dx.doi.org/10.1074/jbc.M111.240812			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21862591	Green Published, hybrid			2022-12-25	WOS:000298057500045
J	Takahashi, K; Sugi, Y; Nakano, K; Tsuda, M; Kurihara, K; Hosono, A; Kaminogawa, S				Takahashi, Kyoko; Sugi, Yutaka; Nakano, Kou; Tsuda, Masato; Kurihara, Kenta; Hosono, Akira; Kaminogawa, Shuichi			Epigenetic Control of the Host Gene by Commensal Bacteria in Large Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; SEGMENTED FILAMENTOUS BACTERIA; GUT MICROBIOTA; IMMUNE-SYSTEM; EXPRESSION; DISEASE; LIPOPOLYSACCHARIDE; RECOGNITION; RESPONSES; ALLERGY	Intestinal epithelial cells (IECs) are continuously exposed to large numbers of commensal bacteria but are relatively insensitive to them, thereby averting an excessive inflammatory reaction. We have previously reported that the hyporesponsiveness of a human IEC line to LPS was primarily the result of a down-regulation of TLR4 gene transcription through epigenetic mechanisms. In the present study we show that DNA methylation in the 5' region of the TLR4 gene is significantly higher in IECs than in splenic cells in vivo. The methylation was shown to be dependent on the differentiation state of the IECs, as the differentiated IEC population that expressed higher levels of intestinal alkaline phosphatase (IAP) also displayed greater methylation and lower expression of the TLR4 gene than the undifferentiated population. The IAP(high), differentiated population also showed less abundant expression of CDX2, the transcription factor required for the development of the intestine, than the IAP(low), undifferentiated population. Overexpression of CDX2 in an IEC line decreased the methylation level of the TLR4 gene, increased transcriptional promoter activity of the gene, and increased responsiveness to the TLR4 ligand. Furthermore, the methylation level of the TLR4 gene was significantly lower in IECs of the large intestine of germ-free mice than in those of conventional mice, whereas the level in IECs of the small intestine was almost equal between these mice, indicating that commensal bacteria contribute to the maintenance of intestinal symbiosis by controlling epigenetic modification of the host gene in the large intestine.	[Takahashi, Kyoko; Sugi, Yutaka; Nakano, Kou; Tsuda, Masato; Kurihara, Kenta; Hosono, Akira; Kaminogawa, Shuichi] Nihon Univ, Food & Physiol Funct Lab, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Takahashi, K (corresponding author), Nihon Univ, Food & Physiol Funct Lab, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	ktaka@brs.nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21580158, 23380073] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a grant-in-aid for Scientific Research from Japan Society for the Promotion of Science.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; McCall CE, 2010, J INNATE IMMUN, V2, P395, DOI 10.1159/000314077; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wolfs TGAM, 2010, INFLAMM BOWEL DIS, V16, P68, DOI 10.1002/ibd.20995; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	33	115	117	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35755	35762		10.1074/jbc.M111.271007	http://dx.doi.org/10.1074/jbc.M111.271007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862578	Green Published, hybrid			2022-12-25	WOS:000295927100048
J	Trikha, S; Jeremic, AM				Trikha, Saurabh; Jeremic, Aleksandar M.			Clustering and Internalization of Toxic Amylin Oligomers in Pancreatic Cells Require Plasma Membrane Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET AMYLOID POLYPEPTIDE; II DIABETES-MELLITUS; BETA-CELLS; ALZHEIMERS-DISEASE; LIPID RAFTS; NMR-SPECTROSCOPY; APOLIPOPROTEIN-E; TRANSGENIC MICE; MOUSE MODEL; TYPE-2	Self-assembly of the human pancreatic hormone amylin into toxic oligomers and aggregates is linked to dysfunction of islet beta-cells and pathogenesis of type 2 diabetes mellitus. Recent evidence suggests that cholesterol, an essential component of eukaryotic cells membranes, controls amylin aggregation on model membranes. However, the pathophysiological consequence of cholesterol-regulated amylin polymerization on membranes and biochemical mechanisms that protect beta-cells from amylin toxicity are poorly understood. Here, we report that plasma membrane (PM) cholesterol plays a key role in molecular recognition, sorting, and internalization of toxic amylin oligomers but not monomers in pancreatic rat insulinoma and human islet cells. Depletion of PM cholesterol or the disruption of the cytoskeleton network inhibits internalization of amylin oligomers, which in turn enhances extracellular oligomer accumulation and potentiates amylin toxicity. Confocal microscopy reveals an increased nucleation of amylin oligomers across the plasma membrane in cholesterol-depleted cells, with a 2-fold increase in cell surface coverage and a 3-fold increase in their number on the PM. Biochemical studies confirm accumulation of amylin oligomers in the medium after depletion of PM cholesterol. Replenishment of PM cholesterol from intracellular cholesterol stores or by the addition of water-soluble cholesterol restores amylin oligomer clustering at the PM and internalization, which consequently diminishes cell surface coverage and toxicity of amylin oligomers. In contrast to oligomers, amylin monomers followed clathrin-dependent endocytosis, which is not sensitive to cholesterol depletion. Our studies identify an actin-mediated and cholesterol-dependent mechanism for selective uptake and clearance of amylin oligomers, impairment of which greatly potentiates amylin toxicity.	[Trikha, Saurabh; Jeremic, Aleksandar M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	George Washington University	Jeremic, AM (corresponding author), George Washington Univ, Dept Biol Sci, 2023 G St NW, Washington, DC 20052 USA.	jerema@gwu.edu			George Washington University Columbian College; Islet Cell Resource Center	George Washington University Columbian College; Islet Cell Resource Center	This work was supported by a George Washington University Columbian College Facilitating Fund grant and the Islet Cell Resource Center Basic Science Islet Distribution Program (to A. J.).	Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Cho WJ, 2009, J MOL BIOL, V393, P765, DOI 10.1016/j.jmb.2009.08.055; Cho WJ, 2008, METHOD CELL BIOL, V90, P267, DOI 10.1016/S0091-679X(08)00813-3; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Clark A, 2004, DIABETOLOGIA, V47, P157, DOI 10.1007/s00125-003-1304-4; CLARK A, 1987, LANCET, V2, P231; DEKONING EJP, 1994, DIABETES, V43, P640, DOI 10.2337/diabetes.43.5.640; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Durrbach A, 1996, J CELL SCI, V109, P457; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hailstones D, 1998, J LIPID RES, V39, P369; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Janciauskiene S, 2000, BIOCHEM BIOPH RES CO, V267, P619, DOI 10.1006/bbrc.1999.1989; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kawahara M, 2001, CELL MOL NEUROBIOL, V21, P1, DOI 10.1023/A:1007168910582; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Marchetti P, 2009, DIABETES CARE, V32, pS178, DOI 10.2337/dc09-S306; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; NARITA R, 1992, DIABETES RES CLIN PR, V15, P3, DOI 10.1016/0168-8227(92)90060-5; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Ooi EMM, 2009, DIABETES RES CLIN PR, V85, P310, DOI 10.1016/j.diabres.2009.06.003; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pensalfini A, 2011, NEUROBIOL AGING, V32, P210, DOI 10.1016/j.neurobiolaging.2009.02.010; Potter KJ, 2009, BBA-GEN SUBJECTS, V1790, P566, DOI 10.1016/j.bbagen.2009.02.013; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Radovan D, 2009, FEBS LETT, V583, P1439, DOI 10.1016/j.febslet.2009.03.059; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Sponne I, 2004, FASEB J, V18, P836, DOI 10.1096/fj.03-0372fje; Stirling L, 2009, MOL BIOL CELL, V20, P2991, DOI 10.1091/mbc.E08-10-1074; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; Wakabayashi M, 2007, J MOL BIOL, V371, P924, DOI 10.1016/j.jmb.2007.06.008; Wakabayashi M, 2009, FEBS LETT, V583, P2854, DOI 10.1016/j.febslet.2009.07.044; Weise K, 2010, CHEMBIOCHEM, V11, P1280, DOI 10.1002/cbic.201000039; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhang SP, 2003, J BIOL CHEM, V278, P52810, DOI 10.1074/jbc.M308244200; Zhang SP, 2002, J MOL BIOL, V324, P271, DOI 10.1016/S0022-2836(02)01044-6; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2007, DIABETES, V56, P304, DOI 10.2337/db06-0430	74	66	67	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36086	36097		10.1074/jbc.M111.240762	http://dx.doi.org/10.1074/jbc.M111.240762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865171	Green Published, hybrid			2022-12-25	WOS:000295927100081
J	Mahali, S; Raviprakash, N; Raghavendra, PB; Manna, SK				Mahali, Sidharth; Raviprakash, Nune; Raghavendra, Pongali B.; Manna, Sunil K.			Advanced Glycation End Products (AGEs) Induce Apoptosis via a Novel Pathway INVOLVEMENT OF CA(2+) MEDIATED BY INTERLEUKIN-8 PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CELL-CYCLE ARREST; AUTOPHAGIC VACUOLES; ENDOTHELIAL-CELLS; DIABETIC-PATIENTS; NUCLEAR-FACTOR; ACTIVATION; TRANSCRIPTION; CALCINEURIN; DEATH	Advanced glycation end products (AGEs) accumulate in diabetic patients due to high blood glucose levels and cause multiple deleterious effects. In this study, we provide evidence that the AGE increased cell death, one such deleterious effect. Methyl glyoxal-coupled human serum albumin (AGE-HSA) induced transcription factors such as NF-kappa B, NF-AT, and AP-1. AGE acts through its cell surface receptor, RAGE, and degranulates vesicular contents including interleukin-8 (IL-8). The number of RAGEs, as well as the amount of NF-kappa B activation, is low, but the cell death is higher in neuronal cells upon AGE treatment. Degranulated IL-8 acts through its receptors, IL-8Rs, and induces sequential events in cells: increase in intracellular Ca2+, activation of calcineurin, dephosphorylation of cytoplasmic NF-AT, nuclear translocation of NF-AT, and expression of FasL. Expressed FasL increases activity of caspases and induces cell death. Although AGE increases the amount of reactive oxygen intermediate, accompanying cell death is not dependent upon reactive oxygen intermediate. AGE induces autophagy, which partially protects cells from cell death. A novel mechanism of AGE-mediated cell death in different cell types, especially in neuronal cells where it is an early event, is provided here. Thus, this study may be important in several age-related neuronal diseases where AGE-induced apoptosis is observed because of high amounts of AGE.	[Mahali, Sidharth; Raviprakash, Nune; Raghavendra, Pongali B.; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in	Mahali, Sidhartha/GLT-8791-2022; Mahali, Sidhartha/AAD-8309-2021	Mahali, Sidhartha/0000-0001-5750-7118; 	Defense Research and Development Organization (DRDO), Government of India; Centre for DNA Fingerprinting and Diagnostics (CDFD); Indian Council for Medical Research (ICMR), Government of India; Council for Scientific and Industrial Research (CSIR), Government of India	Defense Research and Development Organization (DRDO), Government of India(Defence Research & Development Organisation (DRDO)); Centre for DNA Fingerprinting and Diagnostics (CDFD); Indian Council for Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Defense Research and Development Organization (DRDO), Government of India and a core grant from the Centre for DNA Fingerprinting and Diagnostics (CDFD), a fellowship from the Indian Council for Medical Research (ICMR), Government of India (to N. R.), and a fellowship from the Council for Scientific and Industrial Research (CSIR), Government of India (to S. M).	Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Bose JS, 2009, J MED CHEM, V52, P3184, DOI 10.1021/jm8015766; Bose JS, 2009, J CELL PHYSIOL, V218, P653, DOI 10.1002/jcp.21640; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gangadharan C, 2010, BREAST CANCER RES TR, V120, P671, DOI 10.1007/s10549-009-0493-z; Jeitner TM, 2005, BIOCHEM PHARMACOL, V69, P961, DOI 10.1016/j.bcp.2004.12.011; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Khuhawar MY, 2006, ANAL LETT, V39, P2205, DOI 10.1080/00032710600754093; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lesort M, 2003, J BIOL CHEM, V278, P3825, DOI 10.1074/jbc.M205812200; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Manna SK, 1999, J IMMUNOL, V162, P1510; Manna SK, 2010, J BIOL CHEM, V285, P22318, DOI 10.1074/jbc.M110.131797; Manna SX, 2006, EUR J IMMUNOL, V36, P754, DOI 10.1002/eji.200535209; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Patschan S, 2008, AUTOPHAGY, V4, P521, DOI 10.4161/auto.5904; Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486; Srivastava RK, 1999, J EXP MED, V190, P253, DOI 10.1084/jem.190.2.253; Wang EX, 2001, J CELL SCI, V114, P3309; Yamagishi Sho-ichi, 2006, Curr Drug Discov Technol, V3, P83, DOI 10.2174/157016306776637555; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yeh YC, 2007, BIOCHEM PHARMACOL, V74, P969, DOI 10.1016/j.bcp.2007.06.031; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	43	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34903	34913		10.1074/jbc.M111.279190	http://dx.doi.org/10.1074/jbc.M111.279190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862577	Green Published, hybrid			2022-12-25	WOS:000295406300044
J	Schneider, RR; Hauer, G; Farr, D; Adamowicz, WL; Boutin, S				Schneider, Richard R.; Hauer, Grant; Farr, Dan; Adamowicz, W. L.; Boutin, Stan			Achieving Conservation when Opportunity Costs Are High: Optimizing Reserve Design in Alberta's Oil Sands Region	PLOS ONE			English	Article							LARGE DISTURBANCES; MAXIMIZING RETURN; REAL-WORLD; BIODIVERSITY; SCALE; CONNECTIVITY; PATTERN; TARGETS; INVESTMENT; LANDSCAPE	Recent studies have shown that conservation gains can be achieved when the spatial distributions of biological benefits and economic costs are incorporated in the conservation planning process. Using Alberta, Canada, as a case study we apply these techniques in the context of coarse-filter reserve design. Because targets for ecosystem representation and other coarse-filter design elements are difficult to define objectively we use a trade-off analysis to systematically explore the relationship between conservation targets and economic opportunity costs. We use the Marxan conservation planning software to generate reserve designs at each level of conservation target to ensure that our quantification of conservation and economic outcomes represents the optimal allocation of resources in each case. Opportunity cost is most affected by the ecological representation target and this relationship is nonlinear. Although petroleum resources are present throughout most of Alberta, and include highly valuable oil sands deposits, our analysis indicates that over 30% of public lands could be protected while maintaining access to more than 97% of the value of the region's resources. Our case study demonstrates that optimal resource allocation can be usefully employed to support strategic decision making in the context of land-use planning, even when conservation targets are not well defined.	[Schneider, Richard R.; Farr, Dan; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hauer, Grant; Adamowicz, W. L.] Univ Alberta, Dept Rural Econ, Edmonton, AB, Canada	University of Alberta; University of Alberta	Schneider, RR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ministik99@telus.net	Boutin, Stan A/A-2619-2014	Boutin, Stan A/0000-0001-6317-038X; Adamowicz, Wiktor/0000-0002-7634-2985	Natural Sciences and Engineering Research Council of Canada; Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta Land-use Secretariat; Sustainable Forest Management Network; Social Science and Humanities Research Council of Canada; Forest Resource Improvement Association of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta Land-use Secretariat; Sustainable Forest Management Network; Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Forest Resource Improvement Association of Alberta	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada, Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta, Alberta Land-use Secretariat, Sustainable Forest Management Network, Social Science and Humanities Research Council of Canada, and the Forest Resource Improvement Association of Alberta. The Alberta Land-use Secretariat provided feedback regarding study design, but did not have a role in data collection and analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2010, BIOL CONSERV, V143, P439, DOI 10.1016/j.biocon.2009.11.011; *ALB DEP EN, 2007, ALB OIL SANDS FISC S; *ALB DEP EN, 2010, EN ANN REP 2009 2010; *ALB DEP EN, 2007, ALB CONV OIL GAS IND; Alberta Department of Energy, 2007, PREL FISC EV ALB OIL; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; BAKER WL, 1992, LANDSCAPE ECOL, V7, P181, DOI 10.1007/BF00133309; Bonn A, 2005, BIODIVERS CONSERV, V14, P1083, DOI 10.1007/s10531-004-8410-6; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Briers RA, 2002, BIOL CONSERV, V103, P77, DOI 10.1016/S0006-3207(01)00123-9; *CAN W FDN, GIBB D BLACK REP YEA; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Desmet P, 2004, ECOL SOC, V9; Energy Alberta, 2007, EUB SER PUBL; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; GAME ET, MARXAN USER MANUAL F; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; GLJ Petroleum Consultants, 2009, CRUD OIL NAT GAS LIQ; GLJ Petroleum Consultants, 2009, NAT GAS SULPH PRIC F; *GOV ALB, 2009, TERM REF DEV LOW ATH; Government of Alberta, 2008, LAND US FRAM; Gurd DB, 2001, CONSERV BIOL, V15, P1355, DOI 10.1046/j.1523-1739.2001.00188.x; Haight RG, 2002, CONSERV BIOL, V16, P1386, DOI 10.1046/j.1523-1739.2002.99510.x; HAUER G, NET PRESENT VALUE MO; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Horskins K, 2006, LANDSCAPE ECOL, V21, P641, DOI 10.1007/s10980-005-5203-6; Huber PR, 2010, LANDSCAPE ECOL, V25, P683, DOI 10.1007/s10980-010-9447-4; Hunter ML, 2005, CONSERV BIOL, V19, P1025, DOI 10.1111/j.1523-1739.2005.00172.x; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; KENNETT SA, NEXT STEPS CUMULATIV; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Leroux SJ, 2007, BIOL CONSERV, V138, P464, DOI 10.1016/j.biocon.2007.05.012; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDonald-Madden E, 2008, CONSERV BIOL, V22, P656, DOI 10.1111/j.1523-1739.2008.00918.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Natural Regions Committee, 2006, NAT REG SUBR ALB; Perhans K, 2008, CONSERV BIOL, V22, P1331, DOI 10.1111/j.1523-1739.2008.00976.x; *PETR SERV ASS CAN, 2008, WELL COST STUD; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Robinson JG, 2006, CONSERV BIOL, V20, P658, DOI 10.1111/j.1523-1739.2006.00469.x; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Schneider RR, 2003, CONSERV ECOL, V7; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Vazquez LB, 2008, BIODIVERS CONSERV, V17, P1367, DOI 10.1007/s10531-008-9320-9; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Young JE, 2006, FOREST ECOL MANAG, V230, P151, DOI 10.1016/j.foreco.2006.04.031	55	18	19	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23254	10.1371/journal.pone.0023254	http://dx.doi.org/10.1371/journal.pone.0023254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858046	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300024
J	Tumban, E; Peabody, J; Peabody, DS; Chackerian, B				Tumban, Ebenezer; Peabody, Julianne; Peabody, David S.; Chackerian, Bryce			A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; HUMAN-PAPILLOMAVIRUS TYPE-16; COTTONTAIL RABBIT PAPILLOMAVIRUS; AGED 16-26 YEARS; MOUSE MODEL; ANTIGEN L2; L1; INFECTION; PSEUDOVIRIONS; PROTECTION	Background: Current human papillomavirus (HPV) vaccines that are based on virus-like particles (VLPs) of the major capsid protein L1 largely elicit HPV type-specific antibody responses. In contrast, immunization with the HPV minor capsid protein L2 elicits antibodies that are broadly cross-neutralizing, suggesting that a vaccine targeting L2 could provide more comprehensive protection against infection by diverse HPV types. However, L2-based immunogens typically elicit much lower neutralizing antibody titers than L1 VLPs. We previously showed that a conserved broadly neutralizing epitope near the N-terminus of L2 is highly immunogenic when displayed on the surface of VLPs derived from the bacteriophage PP7. Here, we report the development of a panel of PP7 VLP-based vaccines targeting L2 that protect mice from infection with carcinogenic and non-carcinogenic HPV types that infect the genital tract and skin. Methodology/Principal Findings: L2 peptides from eight different HPV types were displayed on the surface of PP7 bacteriophage VLPs. These recombinant L2 VLPs, both individually and in combination, elicited high-titer anti-L2 IgG serum antibodies. Immunized mice were protected from high dose infection with HPV pseudovirus (PsV) encapsidating a luciferase reporter. Mice immunized with 16L2 PP7 VLPs or 18L2 PP7 VLPs were nearly completely protected from both PsV16 and PsV18 challenge. Mice immunized with the mixture of eight L2 VLPs were strongly protected from genital challenge with PsVs representing eight diverse HPV types and cutaneous challenge with HPV5 PsV. Conclusion/Significance: VLP-display of a cross-neutralizing HPV L2 epitope is an effective approach for inducing high-titer protective neutralizing antibodies and is capable of offering protection from a spectrum of HPVs associated with cervical cancer as well as genital and cutaneous warts.	[Tumban, Ebenezer; Peabody, Julianne; Peabody, David S.; Chackerian, Bryce] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico	Tumban, E (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	bchackerian@salud.unm.edu			United States National Institutes of Health (National Institute of Allergy and Infectious Diseases) [U19 AI084081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084081] Funding Source: NIH RePORTER	United States National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the United States National Institutes of Health (National Institute of Allergy and Infectious Diseases; U19 AI084081 to B.C.) establishing the University of New Mexico Interdisciplinary HPV Prevention Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Campo MS, 2010, J VIROL, V84, P1214, DOI 10.1128/JVI.01927-09; CAMPO MS, 1993, J GEN VIROL; Chackerian B, 2008, J IMMUNOL, V180, P5816, DOI 10.4049/jimmunol.180.9.5816; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; CHRISTENSEN ND, 1991, VIROLOGY, V181, P572, DOI 10.1016/0042-6822(91)90890-N; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DOORBAR J, 1987, J VIROL, V61, P2793, DOI 10.1128/JVI.61.9.2793-2799.1987; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Karanam B, 2009, IMMUNOL CELL BIOL, V87, P287, DOI 10.1038/icb.2009.13; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawana K, 1998, J VIROL, V72, P10298, DOI 10.1128/JVI.72.12.10298-10300.1998; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; LIN YL, 1992, VIROLOGY, V187, P612, DOI 10.1016/0042-6822(92)90463-Y; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	40	85	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23310	10.1371/journal.pone.0023310	http://dx.doi.org/10.1371/journal.pone.0023310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858066	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300032
J	Fryer, HR; McLean, AR				Fryer, Helen R.; McLean, Angela R.			There Is No Safe Dose of Prions	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE AGENT; LYMPHORETICULAR-SYSTEM; STRAIN DIFFERENCES; BRITISH SHEEP; DISEASE; PATHOGENESIS; PROTEIN; RISK; MOUSE	Understanding the circumstances under which exposure to transmissible spongiform encephalopathies (TSEs) leads to infection is important for managing risks to public health. Based upon ideas in toxicology and radiology, it is plausible that exposure to harmful agents, including TSEs, is completely safe if the dose is low enough. However, the existence of a threshold, below which infection probability is zero has never been demonstrated experimentally. Here we explore this question by combining data and mathematical models that describe scrapie infections in mice following experimental challenge over a broad range of doses. We analyse data from 4338 mice inoculated at doses ranging over ten orders of magnitude. These data are compared to results from a within-host model in which prions accumulate according to a stochastic birth-death process. Crucially, this model assumes no threshold on the dose required for infection. Our data reveal that infection is possible at the very low dose of a 1000 fold dilution of the dose that infects half the challenged animals (ID50). Furthermore, the dose response curve closely matches that predicted by the model. These findings imply that there is no safe dose of prions and that assessments of the risk from low dose exposure are right to assume a linear relationship between dose and probability of infection. We also refine two common perceptions about TSE incubation periods: that their mean values decrease linearly with logarithmic decreases in dose and that they are highly reproducible between hosts. The model and data both show that the linear decrease in incubation period holds only for doses above the ID50. Furthermore, variability in incubation periods is greater than predicted by the model, not smaller. This result poses new questions about the sources of variability in prion incubation periods. It also provides insight into the limitations of the incubation period assay.	[Fryer, Helen R.; McLean, Angela R.] Univ Oxford, Dept Zool, Inst Emerging Infect, Oxford Martin Sch, Oxford OX1 3PS, England	University of Oxford	Fryer, HR (corresponding author), Univ Oxford, Dept Zool, Inst Emerging Infect, Oxford Martin Sch, S Parks Rd, Oxford OX1 3PS, England.	angela.mclean@zoo.ox.ac.uk			Oxford Martin School; Foods Standards Agency [M03027]	Oxford Martin School; Foods Standards Agency	This research was supported by the Oxford Martin School (www.oxfordmartin.ox.ac.uk) and the Foods Standards Agency (www.food.gov.uk), grant number M03027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Boden LA, 2010, J GEN VIROL, V91, P2642, DOI 10.1099/vir.0.022566-0; BOLTON DC, 1991, J GEN VIROL, V72, P2905, DOI 10.1099/0022-1317-72-12-2905; Bolus N E, 2001, J Nucl Med Technol, V29, P67; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Cohen J.T., 2003, EVALUATION POTENTIAL; Comer PJ, 2003, STAT METHODS MED RES, V12, P279, DOI 10.1191/0962280203sm333ra; de Koeijer A, 2004, J MATH BIOL, V48, P1, DOI 10.1007/s00285-003-0206-x; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; DICKINSON AG, 1972, NATURE-NEW BIOL, V237, P244, DOI 10.1038/newbio237244a0; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Ferguson NM, 2003, P ROY SOC B-BIOL SCI, V270, P1579, DOI 10.1098/rspb.2003.2484; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Fryer HR, 2007, P R SOC B, V274, P1497, DOI 10.1098/rspb.2007.0353; GRIMMETT G, 1986, PROBABILITY INTRO; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JEFFREY M, 1995, MICRON, V26, P277, DOI 10.1016/0968-4328(95)00004-N; JENDROSKA K, 1991, NEUROLOGY, V41, P1482, DOI 10.1212/WNL.41.9.1482; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; KIMBERLIN RH, 1988, J GEN VIROL, V69, P2953, DOI 10.1099/0022-1317-69-12-2953; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Laurent M, 1998, BIOPHYS CHEM, V72, P211, DOI 10.1016/S0301-4622(98)00135-5; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1980, BIOCHEMISTRY-US, V19, P4883, DOI 10.1021/bi00562a028; Ross S. M., 1997, INTRO PROBABILITY MO; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392	35	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23664	10.1371/journal.pone.0023664	http://dx.doi.org/10.1371/journal.pone.0023664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858197	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700039
J	Liu, Q; Majdi, M; Cankar, K; Goedbloed, M; Charnikhova, T; Verstappen, FWA; de Vos, RCH; Beekwilder, J; van der Krol, S; Bouwmeester, HJ				Liu, Qing; Majdi, Mohammad; Cankar, Katarina; Goedbloed, Miriam; Charnikhova, Tatsiana; Verstappen, Francel W. A.; de Vos, Ric C. H.; Beekwilder, Jules; van der Krol, Sander; Bouwmeester, Harro J.			Reconstitution of the Costunolide Biosynthetic Pathway in Yeast and Nicotiana benthamiana	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; GERMACRENE-A SYNTHASE; NF-KAPPA-B; SESQUITERPENE LACTONES; ANTIMALARIAL-DRUG; EXPRESSION; CLONING; TRANSFORMATION; METABOLOMICS; PARTHENOLIDE	The sesquiterpene costunolide has a broad range of biological activities and is the parent compound for many other biologically active sesquiterpenes such as parthenolide. Two enzymes of the pathway leading to costunolide have been previously characterized: germacrene A synthase (GAS) and germacrene A oxidase (GAO), which together catalyse the biosynthesis of germacra-1(10), 4,11(13)-trien-12-oic acid. However, the gene responsible for the last step toward costunolide has not been characterized until now. Here we show that chicory costunolide synthase (CiCOS), CYP71BL3, can catalyse the oxidation of germacra-1(10), 4,11(13)-trien-12-oic acid to yield costunolide. Co-expression of feverfew GAS (TpGAS), chicory GAO (CiGAO), and chicory COS (CiCOS) in yeast resulted in the biosynthesis of costunolide. The catalytic activity of TpGAS, CiGAO and CiCOS was also verified in planta by transient expression in Nicotiana benthamiana. Mitochondrial targeting of TpGAS resulted in a significant increase in the production of germacrene A compared with the native cytosolic targeting. When the N. benthamiana leaves were co-infiltrated with TpGAS and CiGAO, germacrene A almost completely disappeared as a result of the presence of CiGAO. Transient expression of TpGAS, CiGAO and CiCOS in N. benthamiana leaves resulted in costunolide production of up to 60 ng.g(-1) FW. In addition, two new compounds were formed that were identified as costunolide-glutathione and costunolide-cysteine conjugates.	[Liu, Qing; Cankar, Katarina; Goedbloed, Miriam; Charnikhova, Tatsiana; Verstappen, Francel W. A.; Beekwilder, Jules; van der Krol, Sander; Bouwmeester, Harro J.] Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands; [Majdi, Mohammad] Univ Kurdistan, Fac Agr, Agron & Plant Breeding Dept, Sanandaj, Iran; [Cankar, Katarina; de Vos, Ric C. H.; Beekwilder, Jules] Plant Res Int, Wageningen, Netherlands; [de Vos, Ric C. H.] Ctr BioSyst Genom, Wageningen, Netherlands; [de Vos, Ric C. H.] Netherlands Metabol Ctr, Leiden, Netherlands	Wageningen University & Research; University of Kurdistan; Centre for BioSystems Genomics	Liu, Q (corresponding author), Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands.	harro.bouwmeester@wur.nl	van der Krol, Alexander/C-5720-2015; Liu, Qing/F-6756-2014; De Vos, Ric/F-5012-2017; Majdi, Mohammad/AAK-9122-2021; Beekwilder, Jules/A-6802-2011; Bouwmeester, Harro J/C-1414-2008	van der Krol, Alexander/0000-0001-6585-7572; Liu, Qing/0000-0002-0257-0694; Majdi, Mohammad/0000-0001-6959-4845; Beekwilder, Jules/0000-0003-3238-4427; Bouwmeester, Harro/0000-0003-0907-2732; Cankar, Katarina/0000-0001-5149-4192	EU [227448]	EU(European Commission)	This project is funded by the EU (Project acronym: TERPMED, grant agreement no.: 227448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero AF, 2000, FITOTERAPIA, V71, P60, DOI 10.1016/S0367-326X(99)00122-7; Bedoya LM, 2008, CURR SIGNAL TRANSD T, V3, P82, DOI 10.2174/157436208784223134; Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; Cankar K, 2011, FEBS LETT, V585, P178, DOI 10.1016/j.febslet.2010.11.040; CHEN HC, 1995, ANTIVIR RES, V27, P99, DOI 10.1016/0166-3542(94)00083-K; Choi JH, 2002, JPN J CANCER RES, V93, P1327, DOI 10.1111/j.1349-7006.2002.tb01241.x; de Kraker JW, 2002, PLANT PHYSIOL, V129, P257, DOI 10.1104/pp.010957; de Kraker JW, 2001, PHYTOCHEMISTRY, V58, P481, DOI 10.1016/S0031-9422(01)00291-6; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; DEKRAKER JW, 1998, TEST, V117, P1381; DEKRAKER JW, 2001, TEST, V125, P1930; Fischer N.H., 1990, BIOCH MEVALONIC ACID; HABIG WH, 1974, J BIOL CHEM, V249, P7130; IKEZAWA N, 2011, J BIOL CHEM; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Klein M, 2002, FEBS LETT, V520, P63, DOI 10.1016/S0014-5793(02)02767-9; KOHLEN W, 2010, PLANT PHYSL; Koo TH, 2001, PLANTA MED, V67, P103, DOI 10.1055/s-2001-11503; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Ma XC, 2007, ENZYME MICROB TECH, V40, P1013, DOI 10.1016/j.enzmictec.2006.07.043; MAJDI M, 2011, PHYTOCHEMIS IN PRESS, DOI DOI 10.1016/J.PHYTOCHEM.2011.1004.1021; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; MORI H, 1994, CANCER LETT, V83, P171, DOI 10.1016/0304-3835(94)90315-8; Nelson David R., 2009, Human Genomics, V4, P59; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Ohkama-Ohtsu N, 2007, PLANT J, V49, P878, DOI 10.1111/j.1365-313X.2006.03005.x; Outchkourov NS, 2003, PLANTA, V216, P1003, DOI 10.1007/s00425-002-0953-8; Park HeeJuhn, 2006, Natural Product Sciences, V12, P175; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; REA PA, 1999, TEST, V50, P895; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; SETO M, 1988, CHEM PHARM BULL, V36, P2423, DOI 10.1248/cpb.36.2423; SHIMIZU H, 1991, BIOTECHNOL BIOENG, V38, P196, DOI 10.1002/bit.260380212; Srivastava SK, 2006, BIOORG MED CHEM LETT, V16, P4195, DOI 10.1016/j.bmcl.2006.05.083; TANIGUCHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P2064, DOI 10.1271/bbb.59.2064; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Turner GW, 2004, PLANT PHYSIOL, V136, P4215, DOI 10.1104/pp.104.050229; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; van Herpen TWJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014222; VANBEEK TA, 1990, J AGR FOOD CHEM, V38, P1035, DOI 10.1021/jf00094a026; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Wedge DE, 2000, PHYTOCHEMISTRY, V53, P747, DOI 10.1016/S0031-9422(00)00008-X; YANG T, 2011, METABOLIC ENG; Zhang DL, 2009, MOL CANCER RES, V7, P1139, DOI 10.1158/1541-7786.MCR-08-0410; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976	53	64	68	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23255	10.1371/journal.pone.0023255	http://dx.doi.org/10.1371/journal.pone.0023255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858047	Green Published, gold			2022-12-25	WOS:000293953700011
J	Sarmady, M; Dampier, W; Tozeren, A				Sarmady, Mahdi; Dampier, William; Tozeren, Aydin			HIV Protein Sequence Hotspots for Crosstalk with Host Hub Proteins	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SHORT LINEAR MOTIFS; VIRAL-INFECTION; SH3 DOMAINS; TAT; NEF; BINDING; KINASE; PHOSPHORYLATION; REPLICATION	HIV proteins target host hub proteins for transient binding interactions. The presence of viral proteins in the infected cell results in out-competition of host proteins in their interaction with hub proteins, drastically affecting cell physiology. Functional genomics and interactome datasets can be used to quantify the sequence hotspots on the HIV proteome mediating interactions with host hub proteins. In this study, we used the HIV and human interactome databases to identify HIV targeted host hub proteins and their host binding partners (H2). We developed a high throughput computational procedure utilizing motif discovery algorithms on sets of protein sequences, including sequences of HIV and H2 proteins. We identified as HIV sequence hotspots those linear motifs that are highly conserved on HIV sequences and at the same time have a statistically enriched presence on the sequences of H2 proteins. The HIV protein motifs discovered in this study are expressed by subsets of H2 host proteins potentially outcompeted by HIV proteins. A large subset of these motifs is involved in cleavage, nuclear localization, phosphorylation, and transcription factor binding events. Many such motifs are clustered on an HIV sequence in the form of hotspots. The sequential positions of these hotspots are consistent with the curated literature on phenotype altering residue mutations, as well as with existing binding site data. The hotspot map produced in this study is the first global portrayal of HIV motifs involved in altering the host protein network at highly connected hub nodes.	[Sarmady, Mahdi; Dampier, William; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA	Drexel University	Sarmady, M (corresponding author), Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA.	at62@drexel.edu	Sarmady/M-9859-2019	Sarmady/0000-0001-6069-804X	Calhoun endowment funds; National Institutes of Health (NIH) [232240]	Calhoun endowment funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Calhoun endowment funds to Drexel University and by the National Institutes of Health (NIH) grant #232240. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada P, 2005, J VIROL, V79, P3627, DOI 10.1128/JVI.79.6.3627-3638.2005; Ackerson B, 1998, J VIROL, V72, P303, DOI 10.1128/JVI.72.1.303-308.1998; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Baier-Bitterlich G, 1998, BIOMED PHARMACOTHER, V52, P421, DOI 10.1016/S0753-3322(99)80019-5; Balakrishnan Sivaraman, 2009, BMC Genomics, V10 Suppl 3, pS30, DOI 10.1186/1471-2164-10-S3-S30; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Chen SSL, 2009, J VIROL, V83, P870, DOI 10.1128/JVI.01088-08; Craig HM, 1999, VIROLOGY, V262, P55, DOI 10.1006/viro.1999.9897; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Dickerson JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-80; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Evans P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008942; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; FRIBORG J, 1995, J ACQ IMMUN DEF SYND, V8, P10; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Haffar O, 2005, J VIROL, V79, P13028, DOI 10.1128/JVI.79.20.13028-13036.2005; HARADA K, 2009, ARTIFICIAL LIFE ROBO, V14, P4; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Henschel A, 2006, BIOINFORMATICS, V22, P550, DOI 10.1093/bioinformatics/bti782; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Jian H, 2003, J BIOL CHEM, V278, P44326, DOI 10.1074/jbc.C300378200; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Li HQ, 2006, BIOINFORMATICS, V22, P989, DOI 10.1093/bioinformatics/btl020; Liu YC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-349; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Meggio F, 2001, MOL CELL BIOCHEM, V227, P145, DOI 10.1023/A:1013177326481; Meggio F, 1996, BIOCHEM BIOPH RES CO, V226, P547, DOI 10.1006/bbrc.1996.1392; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Nie ZL, 1998, J VIROL, V72, P4104, DOI 10.1128/JVI.72.5.4104-4115.1998; Perez MAS, 2010, J PHYS CHEM B, V114, P2525, DOI 10.1021/jp910958u; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRASAD KVS, 1993, MOL CELL BIOL, V13, P7708, DOI 10.1128/MCB.13.12.7708; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schindler M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-1; Sei S, 2000, J VIROL, V74, P4621, DOI 10.1128/JVI.74.10.4621-4633.2000; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tan SH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-502; Tastan O, 2009, BIOPHYS J, V96, P2299, DOI 10.1016/j.bpj.2008.12.3894; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Vendel AC, 2003, BIOCHEMISTRY-US, V42, P910, DOI 10.1021/bi0270034; Wang Hui, 2010, Zhonghua Yi Xue Za Zhi, V90, P584; Yang X, 1996, J BIOL CHEM, V271, P10121, DOI 10.1074/jbc.271.17.10121; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879	67	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23293	10.1371/journal.pone.0023293	http://dx.doi.org/10.1371/journal.pone.0023293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858059	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700015
J	Gafuik, C; Steller, H				Gafuik, Christopher; Steller, Hermann			A Gain-of-Function Germline Mutation in Drosophila ras1 Affects Apoptosis and Cell Fate during Development	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ACTIVATED PROTEIN-KINASE; DNA-BINDING PROTEIN; SIGNALING PATHWAY; KRAS MUTATIONS; STRUCTURAL BASIS; RAS ONCOGENES; GROWTH-FACTOR; RHO GTPASE; DEATH	The RAS/MAPK signal transduction pathway is an intracellular signaling cascade that transmits environmental signals from activated receptor tyrosine kinases (RTKs) on the cell surface and other endomembranes to transcription factors in the nucleus, thereby linking extracellular stimuli to changes in gene expression. Largely as a consequence of its role in oncogenesis, RAS signaling has been the subject of intense research efforts for many years. More recently, it has been shown that milder perturbations in Ras signaling during embryogenesis also contribute to the etiology of a group of human diseases. Here we report the identification and characterization of the first gain-of-function germline mutation in Drosophila ras1 (ras85D), the Drosophila homolog of human K-ras, N-ras and H-ras. A single amino acid substitution (R68Q) in the highly conserved switch II region of Ras causes a defective protein with reduced intrinsic GTPase activity, but with normal sensitivity to GAP stimulation. The ras1(R68Q) mutant is homozygous viable but causes various developmental defects associated with elevated Ras signaling, including cell fate changes and ectopic survival of cells in the nervous system. These biochemical and functional properties are reminiscent of germline Ras mutants found in patients afflicted with Noonan, Costello or cardio-facio-cutaneous syndromes. Finally, we used ras1(R68Q) to identify novel genes that interact with Ras and suppress cell death.	[Gafuik, Christopher; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Gafuik, C (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	steller@rockefeller.edu			National Institutes of Health [R01GM60124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01GM60124 to HS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Asha H, 2003, GENETICS, V163, P203; Bader M, 2009, CURR OPIN CELL BIOL, V21, P878, DOI 10.1016/j.ceb.2009.09.005; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Bergmann A, 1998, ONCOGENE, V17, P3215, DOI 10.1038/sj.onc.1202586; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bilak A, 2009, APOPTOSIS, V14, P943, DOI 10.1007/s10495-009-0374-2; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOS JL, 1989, CANCER RES, V49, P4682; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brose MS, 2002, CANCER RES, V62, P6997; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Cagan RL, 2003, CURR BIOL, V13, pR600, DOI 10.1016/S0960-9822(03)00525-6; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; ELLIS MC, 1993, DEVELOPMENT, V119, P855; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Halfar K, 2001, DEVELOPMENT, V128, P1687; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kaplan Y, 2010, DEV CELL, V19, P160, DOI 10.1016/j.devcel.2010.06.009; Karim FD, 1998, DEVELOPMENT, V125, P1; Karim FD, 1996, GENETICS, V143, P315; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lee SH, 2003, ONCOGENE, V22, P6942, DOI 10.1038/sj.onc.1206749; Lisi S, 2000, GENETICS, V154, P669; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Morante J, 2007, CURR OPIN GENET DEV, V17, P314, DOI 10.1016/j.gde.2007.05.003; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Parrizas M, 1997, J BIOL CHEM, V272, P154; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Peverali FA, 1996, EMBO J, V15, P3943, DOI 10.1002/j.1460-2075.1996.tb00768.x; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rebay I, 2000, GENETICS, V154, P695; Rebay I, 2002, DEV BIOL, V251, P1, DOI 10.1006/dbio.2002.0806; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Sandu C, 2010, J CELL BIOL, V190, P1039, DOI 10.1083/jcb.201004086; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; SONNENFELD MJ, 1995, DEVELOPMENT, V121, P569; STELLER H, 1994, NEURON, V13, P1269, DOI 10.1016/0896-6273(94)90413-8; Steller H, 2008, NAT CELL BIOL, V10, P1387, DOI 10.1038/ncb1208-1387; Stemerdink C, 1997, DEVELOPMENT, V124, P3787; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yang LH, 2001, DEVELOPMENT, V128, P1183; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zachariou A, 2003, EMBO J, V22, P6642, DOI 10.1093/emboj/cdg617; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	101	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23535	10.1371/journal.pone.0023535	http://dx.doi.org/10.1371/journal.pone.0023535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858158	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500052
J	Heldens, L; Hensen, SMM; Onnekink, C; van Genesen, ST; Dirks, RP; Lubsen, NH				Heldens, Lonneke; Hensen, Sanne M. M.; Onnekink, Carla; van Genesen, Siebe T.; Dirks, Ron P.; Lubsen, Nicolette H.			An Atypical Unfolded Protein Response in Heat Shocked Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED GENE-EXPRESSION; ER STRESS; MESSENGER-RNA; TRANSCRIPTION FACTOR; TRANSLATIONAL CONTROL; MOLECULAR CHAPERONES; OXIDATIVE STRESS; MAMMALIAN-CELLS; NF-Y	Background: The heat shock response (HSR) and the unfolded protein response (UPR) are both activated by proteotoxic stress, although in different compartments, and share cellular resources. How these resources are allocated when both responses are active is not known. Insight in possible crosstalk will help understanding the consequences of failure of these systems in (age-related) disease. Results: In heat stressed HEK293 cells synthesis of the canonical UPR transcription factors XBP1s and ATF4 was detected as well as HSF1 independent activation of the promoters of the ER resident chaperones HSPA5 (BiP) and DNAJB9 (ERdj4). However, the heat stress activation of the DNAJB9 promoter, a XBP1s target, was not blocked in cells expressing a dominant negative IRE1a mutant, and thus did not require XBP1s. Furthermore, the DNA element required for heat stress activation of the DNAJB9 promoter is distinct from the ATF4 and ATF6 target elements; even though inhibition of eIF2a phosphorylation resulted in a decreased activation of the DNAJB9 promoter upon heat stress, suggesting a role for an eIF2a phosphorylation dependent product. Conclusions: The initial step in the UPR, synthesis of transcription factors, is activated by heat stress but the second step, transcriptional transactivation by these factors, is blocked and these pathways of the UPR are thus not productive. Expression of canonical ER chaperones is part of the response of heat stressed cells but another set of transcription factors has been recruited to regulate expression of these ER chaperones.	[Heldens, Lonneke; Hensen, Sanne M. M.; Onnekink, Carla; van Genesen, Siebe T.; Dirks, Ron P.; Lubsen, Nicolette H.] Radboud Univ Nijmegen, Dept Biomol Chem, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Heldens, L (corresponding author), Radboud Univ Nijmegen, Dept Biomol Chem, NL-6525 ED Nijmegen, Netherlands.	N.Lubsen@science.ru.nl			IOP Genomics [IGE03018, IGE07004]	IOP Genomics	This work was financially supported by IOP Genomics (project number IGE03018 and IGE07004, www.agentschapnl.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, PLOS ONE, V4, pA57, DOI 10.1371/journal.pone.0007719; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Dirks RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010158; Doerwald L, 2006, CELL MOL LIFE SCI, V63, P735, DOI 10.1007/s00018-005-5582-5; Doerwald L, 2003, J BIOL CHEM, V278, P49743, DOI 10.1074/jbc.M302914200; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Heldens L, 2010, CELL MOL LIFE SCI, V67, P4035, DOI 10.1007/s00018-010-0430-7; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Matsumoto R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-141; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheper GC, 1998, BIOCHEM J, V334, P463, DOI 10.1042/bj3340463; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shang J, 2004, BIOCHEM BIOPH RES CO, V317, P390, DOI 10.1016/j.bbrc.2004.03.058; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Vries RGJ, 1997, J BIOL CHEM, V272, P32779, DOI 10.1074/jbc.272.52.32779; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	61	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23512	10.1371/journal.pone.0023512	http://dx.doi.org/10.1371/journal.pone.0023512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853144	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200092
J	Rae, J; Fontaine, F; Salim, AA; Lo, HP; Capon, RJ; Parton, RG; Martin, S				Rae, James; Fontaine, Frank; Salim, Angela A.; Lo, Harriet P.; Capon, Robert J.; Parton, Robert G.; Martin, Sally			High-Throughput Screening of Australian Marine Organism Extracts for Bioactive Molecules Affecting the Cellular Storage of Neutral Lipids	PLOS ONE			English	Article							CULTURED RAT HEPATOCYTES; DROPLET ACCUMULATION; DIACYLGLYCEROL ACYLTRANSFERASE; MOUSE MACROPHAGES; ADIPOSE-TISSUE; PROTEIN; INHIBITION; REVEALS; CHOLESTEROL; EXPRESSION	Mammalian cells store excess fatty acids as neutral lipids in specialised organelles called lipid droplets (LDs). Using a simple cell-based assay and open-source software we established a high throughput screen for LD formation in A431 cells in order to identify small bioactive molecules affecting lipid storage. Screening an n-butanol extract library from Australian marine organisms we identified 114 extracts that produced either an increase or a decrease in LD formation in fatty acid-treated A431 cells with varying degrees of cytotoxicity. We selected for further analysis a non-cytotoxic extract derived from the genus Spongia (Heterofibria). Solvent partitioning, HPLC fractionation and spectroscopic analysis (NMR, MS) identified a family of related molecules within this extract with unique structural features, a subset of which reduced LD formation. We selected one of these molecules, heterofibrin A1, for more detailed cellular analysis. Inhibition of LD biogenesis by heterofibrin A1 was observed in both A431 cells and AML12 hepatocytes. The activity of heterofibrin A1 was dose dependent with 20 mu M inhibiting LD formation and triglyceride accumulation by similar to 50% in the presence of 50 mM oleic acid. Using a fluorescent fatty acid analogue we found that heterofibrin A1 significantly reduces the intracellular accumulation of fatty acids and results in the formation of distinct fatty acid metabolites in both cultured cells and in embryos of the zebrafish Danio rerio. In summary we have shown using readily accessible software and a relatively simple assay system that we can identify and isolate bioactive molecules from marine extracts, which affect the formation of LDs and the metabolism of fatty acids both in vitro and in vivo.	[Rae, James; Lo, Harriet P.; Parton, Robert G.; Martin, Sally] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia; [Fontaine, Frank; Salim, Angela A.; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Rae, J (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia.	s.martin@uq.edu.au	Capon, Robert/G-9238-2012; Parton, Robert G/C-5673-2009; Salim, Angela/J-4884-2014; Lo, Harriet P/D-2052-2017; Martin, Sally/A-7150-2010	Capon, Robert/0000-0002-8341-7754; Parton, Robert G/0000-0002-7494-5248; Salim, Angela/0000-0002-8177-5689; Lo, Harriet P/0000-0002-3998-6132; Martin, Sally/0000-0001-9294-5404; Fontaine, Frank/0000-0002-3133-8093	National Health and Medical Research Council of Australia [455865]; Diabetes Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia; Australian Research Council(Australian Research Council)	The authors would like to acknowledge the Australian Research Council, National Health and Medical Research Council of Australia, The University of Queensland, The Australian Zebrafish Phenomics Facility and the Queensland State Government for investment in key instrumentation and infrastructure. The BD Pathway 855 high-content screening platform was purchased under the Australian Research Council "Linkage, Infrastructure, Equipment and Facilities" funding scheme. The Institute for Molecular Bioscience is a Special Research Centre of the Australian Research Council. This work was supported by grants from the National Health and Medical Research Council of Australia (RGP and SM. Grant ID 455865, http://www.nhmrc.gov.au) and from Diabetes Australia (SM, http://www.diabetesaustralia.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Andre M, 2000, INT J DEV BIOL, V44, P249; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHAM BE, 1976, J LIPID RES, V17, P176; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Grimard V, 2008, J LIPID RES, V49, P2427, DOI 10.1194/jlr.M800168-JLR200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hasegawa N, 2001, PHYTOTHER RES, V15, P172, DOI 10.1002/ptr.689; HATT HH, 1967, AUST J CHEM, V20, P2285, DOI 10.1071/CH9672285; Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007; Jones G P, 1999, Asia Pac J Clin Nutr, V8, P211, DOI 10.1046/j.1440-6047.1999.00112.x; Kim MS, 2003, J ALTERN COMPLEM MED, V9, P499, DOI 10.1089/107555303322284785; Koyama N, 2005, J ANTIBIOT, V58, P338, DOI 10.1038/ja.2005.42; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Liu YD, 1997, LIPIDS, V32, P965, DOI 10.1007/s11745-997-0125-x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MAYOREK N, 1989, EUR J BIOCHEM, V182, P395, DOI 10.1111/j.1432-1033.1989.tb14844.x; MAYOREK N, 1985, J BIOL CHEM, V260, P6528; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; MORAND O, 1982, BIOCHIM BIOPHYS ACTA, V711, P539, DOI 10.1016/0005-2760(82)90070-4; Morral N, 2003, TRENDS ENDOCRIN MET, V14, P169, DOI 10.1016/S1043-2760(03)00031-6; Namatame I, 2004, P NATL ACAD SCI USA, V101, P737, DOI 10.1073/pnas.0307757100; Namatame I, 1999, J BIOCHEM-TOKYO, V125, P319, DOI 10.1093/oxfordjournals.jbchem.a022289; Obata R, 2005, BIOORG MED CHEM LETT, V15, P4189, DOI 10.1016/j.bmcl.2005.06.070; Ohshiro T, 2005, BIOL PHARM BULL, V28, P1925, DOI 10.1248/bpb.28.1925; Salim AA, 2010, ORG BIOMOL CHEM, V8, P3188, DOI 10.1039/c003840g; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; Uchida R, 2006, J ANTIBIOT, V59, P93, DOI 10.1038/ja.2006.13; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yamazaki H, 2009, J ANTIBIOT, V62, P195, DOI 10.1038/ja.2009.18; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	41	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22868	10.1371/journal.pone.0022868	http://dx.doi.org/10.1371/journal.pone.0022868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857959	gold, Green Submitted, Green Published			2022-12-25	WOS:000293773300011
J	Xiao, XS; Shi, DB; Liu, LQ; Wang, JS; Xie, XM; Kang, TB; Deng, WG				Xiao, Xiangsheng; Shi, Dingbo; Liu, Liqun; Wang, Jingshu; Xie, Xiaoming; Kang, Tiebang; Deng, Wuguo			Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling	PLOS ONE			English	Article							CANCER CELL-GROWTH; BREAST-CANCER; PROMOTER ACTIVATION; COLORECTAL-CANCER; CYCLE ARREST; C/EBP-BETA; APOPTOSIS; INHIBITION; PATHWAY; BINDING	Quercetin, a polyphenolic bioflavonoid, possesses multiple pharmacological actions including anti-inflammatory and antitumor properties. However, the precise action mechanisms of quercetin remain unclear. Here, we reported the regulatory actions of quercetin on cyclooxygenase-2 (COX-2), an important mediator in inflammation and tumor promotion, and revealed the underlying mechanisms. Quercetin significantly suppressed COX-2 mRNA and protein expression and prostaglandin (PG) E(2) production, as well as COX-2 promoter activation in breast cancer cells. Quercetin also significantly inhibited COX-2-mediated angiogenesis in human endothelial cells in a dose-dependent manner. The in vitro streptavidin-agarose pulldown assay and in vivo chromatin immunoprecipitation assay showed that quercetin considerably inhibited the binding of the transactivators CREB2, C-Jun, C/EBP beta and NF-kappa B and blocked the recruitment of the coactivator p300 to COX-2 promoter. Moreover, quercetin effectively inhibited p300 histone acetyltransferase (HAT) activity, thereby attenuating the p300-mediated acetylation of NF-kappa B. Treatment of cells with p300 HAT inhibitor roscovitine was as effective as quercetin at inhibiting p300 HAT activity. Addition of quercetin to roscovitine-treated cells did not change the roscovitine-induced inhibition of p300 HAT activity. Conversely, gene delivery of constitutively active p300 significantly reversed the quercetin-mediated inhibition of endogenous HAT activity. These results indicate that quercetin suppresses COX-2 expression by inhibiting the p300 signaling and blocking the binding of multiple transactivators to COX-2 promoter. Our findings therefore reveal a novel mechanism of action of quercetin and suggest a potential use for quercetin in the treatment of COX-2-mediated diseases such as breast cancers.	[Xiao, Xiangsheng; Shi, Dingbo; Wang, Jingshu; Xie, Xiaoming; Kang, Tiebang; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Liqun] Sun Yat Sen Univ, Affiliated Hosp 1, Huangpu Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xiao, XS (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	dengwg@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81071687]; State Key Laboratory of Oncology in Southern China; Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oncology in Southern China; Sun Yat-Sen University	This work was supported partially by the funds from the National Natural Science Foundation of China (No. 81071687), the State Key Laboratory of Oncology in Southern China, and the "985 Project" of Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Boots AW, 2008, NUTRITION, V24, P703, DOI 10.1016/j.nut.2008.03.023; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen WS, 2007, CARCINOGENESIS, V28, P2114, DOI 10.1093/carcin/bgm133; Chiu WT, 2010, NEUROBIOL DIS, V37, P118, DOI 10.1016/j.nbd.2009.09.015; Choi EJ, 2008, ARCH PHARM RES, V31, P1281, DOI 10.1007/s12272-001-2107-0; Chou CC, 2010, ARCH PHARM RES, V33, P1181, DOI 10.1007/s12272-010-0808-y; de Groot DJA, 2007, CRIT REV ONCOL HEMAT, V61, P52, DOI 10.1016/j.critrevonc.2006.07.001; DEME DNA, 2007, INT J CANCER, V121, P929; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2002, FASEB J, V16, P1286, DOI 10.1096/fj.01-0844fje; Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; DU G, 2009, CANC CHEMOTHER PHARM; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Fu SL, 2004, WORLD J GASTROENTERO, V10, P1971; Gulati N, 2006, ANTICANCER RES, V26, P1177; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Jung YH, 2010, LIFE SCI, V86, P351, DOI 10.1016/j.lfs.2010.01.008; Kajita S, 2005, MODERN PATHOL, V18, P221, DOI 10.1038/modpathol.3800285; Kang CH, 2008, UROLOGY, V72, P153, DOI 10.1016/j.urology.2007.12.029; Kim WK, 2005, J NUTR BIOCHEM, V16, P155, DOI 10.1016/j.jnutbio.2004.10.010; Lee KM, 2010, J AGR FOOD CHEM, V58, P5815, DOI 10.1021/jf903698s; Lee YK, 2010, ONCOL REP, V24, P1493, DOI 10.3892/or_00001010; Lee YK, 2009, EXP MOL MED, V41, P201, DOI 10.3858/emm.2009.41.3.023; Linsalata M, 2010, ANTICANCER RES, V30, P3501; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Onguru O, 2005, ENDOCR PATHOL, V16, P253, DOI 10.1385/EP:16:4:253; Persichini T, 2010, NEUROSCI LETT, V484, P133, DOI 10.1016/j.neulet.2010.08.034; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Russo M, 2010, BRIT J CANCER, V103, P642, DOI 10.1038/sj.bjc.6605794; Sanborn R, 2005, SEMIN ONCOL, V32, P69, DOI 10.1053/j.seminoncol.2004.09.035; Senthilkumar K, 2010, MOL CELL BIOCHEM, V344, P173, DOI 10.1007/s11010-010-0540-4; Singh B, 2002, J SURG RES, V108, P173, DOI 10.1006/jsre.2002.6532; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; Stachowska E, 2009, J PHYSIOL PHARMACOL, V60, P77; Thangasamy T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-282; Turner ND, 2009, ACTA HORTIC, V841, P237; Vijayababu MR, 2006, MOL CELL BIOCHEM, V287, P109, DOI 10.1007/s11010-005-9085-3; Vijayababu Marati R, 2006, J Carcinog, V5, P10, DOI 10.1186/1477-3163-5-10; Wang DZ, 2004, SEMIN ONCOL, V31, P64, DOI 10.1053/j.seminoncol.2004.01.008; Wu KK, 2003, THROMB RES, V110, P273, DOI 10.1016/S0049-3848(03)00412-2; Yang JH, 2006, DRUG METAB DISPOS, V34, P296, DOI 10.1124/dmd.105.005280; Yuan LW, 2001, BBA-MOL CELL RES, V1541, P161, DOI 10.1016/S0167-4889(01)00141-0	46	133	143	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22934	10.1371/journal.pone.0022934	http://dx.doi.org/10.1371/journal.pone.0022934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857970	gold, Green Submitted, Green Published			2022-12-25	WOS:000293773300013
J	Stossi, F; Madak-Erdogan, Z; Katzenellenbogen, BS				Stossi, F.; Madak-Erdogan, Z.; Katzenellenbogen, B. S.			Macrophage-elicited loss of estrogen receptor-alpha in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus	ONCOGENE			English	Article						estrogen receptor; macrophages; MAPK; breast cancer; jun	TUMOR-ASSOCIATED MACROPHAGES; TARGET GENES; DNA-BINDING; IN-VITRO; PROGRESSION; POLARIZATION; RESISTANCE; EXPRESSION; PHENOTYPE; DISTINCT	Estrogen receptor-alpha (ER alpha, ESR1) is a pivotal transcriptional regulator of breast cancer physiology and is targeted by endocrine therapies. Loss of ER alpha activity or expression is an indication of endocrine resistance and is associated with increased risk of tumor recurrence and worse prognosis. In this study, we sought to investigate whether elements of the tumor microenvironment, namely macrophages, would impact on ER alpha and we found that macrophage-derived factors caused loss of ER alpha expression in breast cancer cells. Conditioned media from macrophages caused activation of several intracellular pathways in breast cancer cells of which c-Src, protein kinase c and mitogen-activated protein kinase (MAPK) were essential for loss of ER alpha expression. Moreover, a prolonged hyperactivation of MAPK was observed. The activation of this kinase cascade resulted in recruitment of extracellular signal regulated kinase 2 (ERK2) directly to chromatin at the ESR1 gene locus in a process that was dependent upon activation and recruitment of the c-Jun transcription factor. Thus, we identify a novel mechanism for loss of ER alpha expression in breast cancer cells via macrophage activation of kinase cascades in the cancer cells causing transcriptional repression of the ESR1 gene by a direct chromatin action of a c-Jun/ERK2 complex. The findings in this study support an alternative mechanism, not intrinsic to the tumor cell but derived from the crosstalk with the tumor microenvironment, that could lead to endocrine resistance and might be targeted therapeutically to prevent loss of ER alpha expression in breast tumors. Oncogene (2012) 31, 1825-1834; doi: 10.1038/onc.2011.370; published online 22 August 2011	[Stossi, F.; Madak-Erdogan, Z.; Katzenellenbogen, B. S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Katzenellenbogen, BS (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	katzenel@illinois.edu		Madak-Erdogan, Zeynep/0000-0003-2607-1643	Breast Cancer Research Foundation; ODS, NIH [P50 AT006268]; NCCAM; NCI; National Center for Complementary & Integrative Health [P50AT006268] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; ODS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the Breast Cancer Research Foundation and NIH P50 AT006268 from ODS, NCCAM, and NCI (to BSK).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Brinkman JA, 2009, J MAMMARY GLAND BIOL, V14, P67, DOI 10.1007/s10911-009-9113-0; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Cheung KL, 1997, BREAST CANCER RES TR, V45, P219, DOI 10.1023/A:1005828731462; Chu I, 2007, J CLIN INVEST, V117, P2205, DOI 10.1172/JCI21739; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dumont JA, 1996, CELL GROWTH DIFFER, V7, P351; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnston SRD, 1997, ANTI-CANCER DRUG, V8, P911, DOI 10.1097/00001813-199711000-00002; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Lawrence MC, 2009, P NATL ACAD SCI USA, V106, P22181, DOI 10.1073/pnas.0912596106; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Pupa SM, 1996, J CLIN ONCOL, V14, P85, DOI 10.1200/JCO.1996.14.1.85; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Redente EF, 2010, AM J PATHOL, V176, P2972, DOI 10.2353/ajpath.2010.090879; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Sharma M, 2010, BREAST CANCER RES TR, V123, P397, DOI 10.1007/s10549-009-0654-0; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Yuan A, 2008, ADV CLIN CHEM, V45, P199, DOI 10.1016/S0065-2423(07)00008-X; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	49	38	39	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	14					1825	1834		10.1038/onc.2011.370	http://dx.doi.org/10.1038/onc.2011.370			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21860415	Green Accepted			2022-12-25	WOS:000302785200008
J	Hourcade, DE; Mitchell, LM				Hourcade, Dennis E.; Mitchell, Lynne M.			Access to the Complement Factor B Scissile Bond Is Facilitated by Association of Factor B with C3b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; ALTERNATIVE PATHWAY CONVERTASE; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; REGULATORY PROTEIN; PROVIDES INSIGHTS; INNATE IMMUNITY; A-DOMAIN; ACTIVATION; SYSTEM	Factor B is a zymogen that carries the catalytic site of the complement alternative pathway C3 convertase. During convertase assembly, factor B associates with C3b and Mg2+ forming a pro-convertase C3bB(Mg2+) that is cleaved at a single factor B site by factor D. In free factor B, a pair of salt bridges binds the Arg(234) side chain to Glu(446) and to Glu(207), forming a double latch structure that sequesters the scissile bond (between Arg(234) and Lys(235)) and minimizes its unproductive cleavage. It is unknown how the double latch is released in the pro-convertase. Here, we introduce single amino acid substitutions into factor B that preclude one or both of the Arg(234) salt bridges, and we examine their impact on several different pro-convertase complexes. Our results indicate that loss of the Arg(234)-Glu(446) salt bridge partially stabilizes C3bB(Mg2+). Loss of the Arg(234)-Glu(207) salt bridge has lesser effects. We propose that when factor B first associates with C3b, it bears two intact Arg(234) salt bridges. The complex rapidly dissociates unless the Arg(234)-Glu(446) salt bridge is released whereupon conformational changes occur that activate the metal ion-dependent adhesion site and partially stabilize the complex. The remaining salt bridge is then released, exposing the scissile bond and permitting factor D cleavage.	[Hourcade, Dennis E.; Mitchell, Lynne M.] Washington Univ, Dept Med, Div Rheumatol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Hourcade, DE (corresponding author), 660 S Euclid Ave,Campus Box 8045, St Louis, MO 63110 USA.	dhourcad@dom.wustl.edu			National Institutes of Health [R01 AI051436]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI051436 (to D. E. H.).	Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; FISHELSON Z, 1983, J BIOL CHEM, V258, P7411; Flierl MA, 2006, J INVEST SURG, V19, P255, DOI 10.1080/08941930600778263; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Goodship THJ, 2004, TRENDS MOL MED, V10, P226, DOI 10.1016/j.molmed.2004.03.006; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Hauptmann G, 1988, Immunodefic Rev, V1, P3; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hourcade DE, 1999, J IMMUNOL, V162, P2906; HOURCADE DE, 1995, J BIOL CHEM, V270, P19716, DOI 10.1074/jbc.270.34.19716; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kavanagh D, 2006, BRIT MED BULL, V77-78, P5, DOI 10.1093/bmb/ldl004; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Liszewski M.K., 1998, HUMAN COMPLEMENT SYS, P149; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MEDICUS RG, 1976, J EXP MED, V144, P1076, DOI 10.1084/jem.144.4.1076; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MOLE JE, 1984, J BIOL CHEM, V259, P3407; Pagano MB, 2009, CIRCULATION, V119, P1805, DOI 10.1161/CIRCULATIONAHA.108.832972; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Richards A, 2007, ADV IMMUNOL, V96, P141, DOI 10.1016/S0065-2776(07)96004-6; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Taylor FR, 1999, BIOCHEMISTRY-US, V38, P2849, DOI 10.1021/bi982140f; Torreira E, 2009, J IMMUNOL, V183, P7347, DOI 10.4049/jimmunol.0902310; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; VOGEL CW, 1982, J BIOL CHEM, V257, P8292; Volanakis JE, 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x; Zipfel PF, 2001, INT IMMUNOPHARMACOL, V1, P461, DOI 10.1016/S1567-5769(00)00047-3	42	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35725	35732		10.1074/jbc.M111.263418	http://dx.doi.org/10.1074/jbc.M111.263418			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862585	Green Published, hybrid			2022-12-25	WOS:000295927100045
J	Srikanth, S; Yee, MKW; Gwack, Y; Ribalet, B				Srikanth, Sonal; Yee, Ma-Khin Win; Gwack, Yousang; Ribalet, Bernard			The Third Transmembrane Segment of Orai1 Protein Modulates Ca2+ Release-activated Ca2+ (CRAC) Channel Gating and Permeation Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-CHANNEL; 2-AMINOETHYLDIPHENYL BORATE; INWARD RECTIFICATION; POTASSIUM CHANNELS; FAST INACTIVATION; ION PERMEATION; PORE; STIM1; LYMPHOCYTES; SELECTIVITY	Orai1, the pore subunit of Ca2+ release-activated Ca2+ channels, has four transmembrane segments (TMs). The first segment, TMI, lines the pore and plays an important role in channel activation and ion permeation. TMIII, on the other hand, does not line the pore but still regulates channel gating and permeation properties. To understand the role of TMIII, we have mutated and characterized several residues in this domain. Mutation of Trp-176 to Cys (W176C) and Gly-183 to Ala (G183A) had dramatic effects. Unlike wild-type channels, which exhibit little outward current and are activated by STIM1, W176C mutant channels exhibited a large outward current at positive potentials and were constitutively active in the absence of STIM1. G183A mutant channels also exhibited substantial outward currents but were active only in the presence of 2-aminoethoxydiphenyl borate (2-APB), irrespective of STIM1. With W176C mutant channels inward, monovalent currents were blocked by Ca2+ with a high affinity similar to the wild type, but the Ca2+-dependent blocking of outward currents differed in the two cases. Although a 50% block of the WT outward current required 250 mu M Ca2+, more than 6 mM was necessary to have the same effect on W176C mutant channels. In the presence of extracellular Ca2+, W176C and G183A outward currents developed slowly in a voltage-dependent manner, whereas they developed almost instantaneously in the absence of Ca2+. These changes in permeation and gating properties mimic the changes induced by mutations of Glu-190 in TMIII and Asp-110/Asp-112 in the TMI/TMII loop. On the basis of these data, we propose that TMIII maintains negatively charged residues at or near the selectivity filter in a conformation that facilitates Ca2+ inward currents and prevents outward currents of monovalent cations. In addition, to controlling selectivity, TMIII may also stabilize channel gating in a closed state in the absence of STIM1 in a Trp-176-dependent manner.	[Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gwack, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 53-266 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ygwack@mednet.ucla.edu; bribalet@mednet.ucla.edu			National Institute of Health [AI-083432, AI-088393]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088393, R01AI083432] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institute of Health Grants AI-083432 and AI-088393 (to Y. G.). This work was also supported by a fellowship from the American Heart Association (to S. S.).	Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Eghbali M, 2002, J MEMBRANE BIOL, V188, P73, DOI 10.1007/s00232-001-0173-3; Gwack Y., 2008, MOL CELL BIOL, V19, P2802; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Lear JD, 1997, J AM CHEM SOC, V119, P3212, DOI 10.1021/ja9629672; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Prakriya M, 2009, IMMUNOL REV, V231, P88, DOI 10.1111/j.1600-065X.2009.00820.x; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	35	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35318	35328		10.1074/jbc.M111.265884	http://dx.doi.org/10.1074/jbc.M111.265884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21865174	Green Published, hybrid			2022-12-25	WOS:000295406300085
J	Aydin, I; Saijo-Hamano, Y; Namba, K; Thomas, C; Roujeinikova, A				Aydin, Inci; Saijo-Hamano, Yumiko; Namba, Keiichi; Thomas, Connor; Roujeinikova, Anna			Structural Analysis of the Essential Resuscitation Promoting Factor YeaZ Suggests a Mechanism of Nucleotide Regulation through Dimer Reorganization	PLOS ONE			English	Article							CRYSTALLOGRAPHIC ANALYSIS; NONCULTURABLE STATE; ESCHERICHIA-COLI; PROTEIN; KINASE; ACTIN; COMPLEX	Background: The yeaZ gene product forms part of the conserved network YjeE/YeaZ/YgjD essential for the survival of many Gram-negative eubacteria. Among other as yet unidentified roles, YeaZ functions as a resuscitation promoting factor required for survival and resuscitation of cells in a viable but non-culturable (VBNC) state. Methodology/Principal Findings: In order to investigate in detail the structure/function relationship of this family of proteins we have performed X-ray crystallographic studies of Vibrio parahaemolyticus YeaZ. The YeaZ structure showed that it has a classic actin-like nucleotide-binding fold. Comparisons of this crystal structure to that of available homologues from E. coli, T. maritima and S. typhimurium revealed two distinctly different modes of dimer formation. In one form, prevalent in the absence of nucleotide, the putative nucleotide-binding site is incomplete, lacking a binding pocket for a nucleotide base. In the second form, residues from the second subunit complete the nucleotide-binding site. This suggests that the two dimer architectures observed in the crystal structures correspond to a free and a nucleotide-bound form of YeaZ. A multiple sequence alignment of YeaZ proteins from different bacteria allowed us to identify a large conserved hydrophobic patch on the protein surface that becomes exposed upon nucleotide-driven dimer re-arrangement. We hypothesize that the transition between two dimer architectures represents the transition between the 'on' and 'off' states of YeaZ. The effect of this transition is to alternately expose and bury a docking site for the partner protein YgjD. Conclusions/Significance: This paper provides the first structural insight into the putative mechanism of nucleotide regulation of YeaZ through dimer reorganization. Our analysis suggests that nucleotide binding to YeaZ may act as a regulator or switch that changes YeaZ shape, allowing it to switch partners between YjeE and YgjD.	[Aydin, Inci; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Aydin, Inci; Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; [Saijo-Hamano, Yumiko; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Thomas, Connor] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Monash University; Monash University; Osaka University; University of Adelaide	Aydin, I (corresponding author), Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany.	anna.roujeinikova@monash.edu	Namba, Keiichi/A-9406-2016	Roujeinikova, Anna/0000-0001-8478-4751	Australian Research Council [DP1094619]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Research Fellowship to AR, DP1094619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin I, 2011, ACTA CRYSTALLOGR F, V67, P604, DOI 10.1107/S1744309111010219; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Buss KA, 2001, J BACTERIOL, V183, P680, DOI 10.1128/JB.183.2.680-686.2001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Hecker A, 2009, BIOCHEM SOC T, V37, P29, DOI 10.1042/BST0370029; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Jeudy S, 2005, ACTA CRYSTALLOGR F, V61, P848, DOI 10.1107/S1744309105025856; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Msadek T, 2009, J BACTERIOL, V191, P4701, DOI 10.1128/JB.00572-09; Nichols CE, 2006, PROTEINS, V64, P111, DOI 10.1002/prot.20982; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; Panutdaporn N, 2006, INT J FOOD MICROBIOL, V106, P241, DOI 10.1016/j.ijfoodmicro.2005.06.022; SRINIVASAN M, 2010, EMBO J, V29, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1230, DOI 10.1107/S1744309109022192; YACOUBI BE, 2011, EMBO J, V30, P882	30	18	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23245	10.1371/journal.pone.0023245	http://dx.doi.org/10.1371/journal.pone.0023245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858042	gold, Green Submitted, Green Published			2022-12-25	WOS:000294121300022
J	McCutcheon, S; Blanco, ARA; Houston, EF; de Wolf, C; Tan, BC; Smith, A; Groschup, MH; Hunter, N; Hornsey, VS; MacGregor, IR; Prowse, CV; Turner, M; Manson, JC				McCutcheon, Sandra; Blanco, Anthony Richard Alejo; Houston, E. Fiona; de Wolf, Christopher; Tan, Boon Chin; Smith, Antony; Groschup, Martin H.; Hunter, Nora; Hornsey, Valerie S.; MacGregor, Ian R.; Prowse, Christopher V.; Turner, Marc; Manson, Jean C.			All Clinically-Relevant Blood Components Transmit Prion Disease following a Single Blood Transfusion: A Sheep Model of vCJD	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; VARIANT CJD; INFECTIOUS PRIONS; SCRAPIE; PROTEIN; BSE; PATHOGENESIS; AGENT	Variant CJD (vCJD) is an incurable, infectious human disease, likely arising from the consumption of BSE-contaminated meat products. Whilst the epidemic appears to be waning, there is much concern that vCJD infection may be perpetuated in humans by the transfusion of contaminated blood products. Since 2004, several cases of transfusion-associated vCJD transmission have been reported and linked to blood collected from pre-clinically affected donors. Using an animal model in which the disease manifested resembles that of humans affected with vCJD, we examined which blood components used in human medicine are likely to pose the greatest risk of transmitting vCJD via transfusion. We collected two full units of blood from BSE-infected donor animals during the pre-clinical phase of infection. Using methods employed by transfusion services we prepared red cell concentrates, plasma and platelets units (including leucoreduced equivalents). Following transfusion, we showed that all components contain sufficient levels of infectivity to cause disease following only a single transfusion and also that leucoreduction did not prevent disease transmission. These data suggest that all blood components are vectors for prion disease transmission, and highlight the importance of multiple control measures to minimise the risk of human to human transmission of vCJD by blood transfusion.	[McCutcheon, Sandra; Blanco, Anthony Richard Alejo; de Wolf, Christopher; Tan, Boon Chin; Hunter, Nora; Manson, Jean C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [McCutcheon, Sandra; Blanco, Anthony Richard Alejo; de Wolf, Christopher; Tan, Boon Chin; Hunter, Nora; Manson, Jean C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Houston, E. Fiona] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Smith, Antony] Inst Anim Hlth, Compton, Berks, England; [Groschup, Martin H.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Riems Isl, Germany; [Hornsey, Valerie S.; MacGregor, Ian R.; Prowse, Christopher V.] SNBTS, Natl Sci Lab, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Friedrich Loeffler Institute	McCutcheon, S (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	jean.manson@roslin.ed.ac.uk		Tan, Kyle BC/0000-0001-5901-2418; manson, jean/0000-0002-0175-9890	Department of Health, UK [007/0162]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001161, BBS/E/D/05241339, BBS/E/D/05241340] Funding Source: researchfish; BBSRC [BBS/E/D/05241340, BBS/E/D/05241339] Funding Source: UKRI	Department of Health, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health, UK (007/0162). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Banks WA, 2004, BIOCHEM BIOPH RES CO, V318, P125, DOI 10.1016/j.bbrc.2004.04.009; Beekes M, 1998, J GEN VIROL, V79, P601, DOI 10.1099/0022-1317-79-3-601; Bishop MT, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-146; Bons N, 2002, TRANSFUSION, V42, P513, DOI 10.1046/j.1537-2995.2002.00098.x; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; *COMM JUNPA, 2010, POS STAT CREUTZF JAC; EDGEWORTH JA, 2011, LANCET; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, TRANSFUSION, V46, P1152, DOI 10.1111/j.1537-2995.2006.00865.x; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Krailadsiri P, 2006, TRANSFUSION, V46, P407, DOI 10.1111/j.1537-2995.2006.00737.x; Laegreid WW, 2008, J VIROL, V82, P10318, DOI 10.1128/JVI.00710-08; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Martin S, 2005, J GEN VIROL, V86, P839, DOI 10.1099/vir.0.80364-0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Mattei V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005057; McCutcheon S, 2005, J IMMUNOL METHODS, V298, P119, DOI 10.1016/j.jim.2005.01.012; Miekka SI, 2003, VOX SANG, V84, P36, DOI 10.1046/j.1423-0410.2003.00256.x; *NAT BLOOD SERV U, 2005, GUID BLOOD TRANSF SE; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Peden Alexander H, 2004, Folia Neuropathol, V42 Suppl A, P85; Prowse CV, 1999, BRIT J HAEMATOL, V106, P240; Saunders GC, 2009, J GEN VIROL, V90, P2569, DOI 10.1099/vir.0.012724-0; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Siso S, 2006, BLOOD, V108, P745, DOI 10.1182/blood-2005-12-5156; *UK NCJDSU, TRANSF MED EP REV TM; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	54	66	68	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23169	10.1371/journal.pone.0023169	http://dx.doi.org/10.1371/journal.pone.0023169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858015	Green Accepted, Green Published, gold			2022-12-25	WOS:000294121300015
J	Siegler, JC; Rehman, S; Bhumireddy, GP; Abdula, R; Klem, I; Brener, SJ; Lee, L; Dunbar, CC; Saul, B; Sacchi, TJ; Heitner, JF				Siegler, Jason C.; Rehman, Shafiq; Bhumireddy, Geetha P.; Abdula, Raushan; Klem, Igor; Brener, Sorin J.; Lee, Leonard; Dunbar, Christopher C.; Saul, Barry; Sacchi, Terrence J.; Heitner, John F.			The Accuracy of the Electrocardiogram during Exercise Stress Test Based on Heart Size	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; INCREMENTAL PROGNOSTIC VALUE; MYOCARDIAL-PERFUSION SPECT; CORONARY-ARTERY-DISEASE; GATED SPECT; DIAGNOSTIC-ACCURACY; WOMEN; VOLUME; MEN	Background: Multiple studies have shown that the exercise electrocardiogram (ECG) is less accurate for predicting ischemia, especially in women, and there is additional evidence to suggest that heart size may affect its diagnostic accuracy. Hypothesis: The purpose of this investigation was to assess the diagnostic accuracy of the exercise ECG based on heart size. Methods: We evaluated 1,011 consecutive patients who were referred for an exercise nuclear stress test. Patients were divided into two groups: small heart size defined as left ventricular end diastolic volume (LVEDV) < 65 mL (Group A) and normal heart size defined as LVEDV >= 65 mL (Group B) and associations between ECG outcome (false positive vs. no false positive) and heart size (small vs. normal) were analyzed using the Chi square test for independence, with a Yates continuity correction. LVEDV calculations were performed via a computer-processing algorithm. SPECT myocardial perfusion imaging was used as the gold standard for the presence of coronary artery disease (CAD). Results: Small heart size was found in 142 patients, 123 female and 19 male patients. There was a significant association between ECG outcome and heart size (chi(2) = 4.7, p = 0.03), where smaller hearts were associated with a significantly greater number of false positives. Conclusions: This study suggests a possible explanation for the poor diagnostic accuracy of exercise stress testing, especially in women, as the overwhelming majority of patients with small heart size were women.	[Siegler, Jason C.] Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Rehman, Shafiq; Bhumireddy, Geetha P.; Abdula, Raushan; Brener, Sorin J.; Dunbar, Christopher C.; Saul, Barry; Sacchi, Terrence J.; Heitner, John F.] New York Methodist Hosp, Div Cardiol, Brooklyn, NY USA; [Dunbar, Christopher C.] CUNY Brooklyn Coll, New York, NY USA; [Lee, Leonard] New York Methodist Hosp, Div Cardiothorac Surg, Brooklyn, NY USA; [Klem, Igor] Duke Med Ctr, Div Cardiol, Durham, NC USA	University of Hull; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; City University of New York (CUNY) System; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; Duke University	Siegler, JC (corresponding author), Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	john.heitner@gmail.com		Siegler, Jason/0000-0003-1346-4982; REHMAN, SHAFIQ/0000-0002-4357-849X				*AM HEART ASS SCI, 2005, CIRCULATION, V111, P682; American College., 2006, ACSMS GUID EX TEST P; BAROLSKY SM, 1979, CIRCULATION, V5, P1021; Bokhari S, 2002, J AM COLL CARDIOL, V40, P1092, DOI 10.1016/S0735-1097(02)02111-3; CWAJG E, 2000, REV PORT CAR S1 0219, P39; de Simone G, 1998, HYPERTENSION, V31, P1077, DOI 10.1161/01.HYP.31.5.1077; Feng B, 2002, J NUCL MED, V43, P786; Ford PV, 2001, J NUCL MED, V42, P454; Germano G, 1998, J NUCL CARDIOL, V5, P477, DOI 10.1016/S1071-3581(98)90178-7; Gimelli A, 2008, INT J CARDIOVAS IMAG, V24, P793, DOI 10.1007/s10554-008-9317-1; Hachamovitch R, 1996, J AM COLL CARDIOL, V28, P34, DOI 10.1016/0735-1097(96)00095-2; Hansen CL, 2007, J NUCL CARDIOL, V14, P134, DOI 10.1016/j.nuclcard.2006.11.009; Hansen CL, 1996, J AM COLL CARDIOL, V28, P1214, DOI 10.1016/S0735-1097(96)00304-X; Iskandrian AE, 1997, J NUCL CARDIOL, V4, P329, DOI 10.1016/S1071-3581(97)90111-2; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; MAGDY MK, 2005, NUCL MED COMMUN, V26, P885; Maruyama K, 2003, ANN NUCL MED, V17, P31, DOI 10.1007/BF02988256; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; MIERES JH, 2003, J NUCL CARDIOL   JAN; Miller TD, 2001, AM J CARDIOL, V87, P868, DOI 10.1016/S0002-9149(00)01528-9; MORISE AP, 1995, AM HEART J, V130, P741, DOI 10.1016/0002-8703(95)90072-1; Nakajima K, 2000, EUR J NUCL MED, V27, P1372, DOI 10.1007/s002590000299; Nichols K, 1998, J NUCL CARDIOL, V5, P295, DOI 10.1016/S1071-3581(98)90131-3; Nichols K, 2000, J NUCL MED, V41, P1308; OKIN PM, 1995, CIRCULATION, V92, P1209, DOI 10.1161/01.CIR.92.5.1209; PANCHOLY SB, 1995, J NUCL CARDIOL, V2, P110, DOI 10.1016/S1071-3581(06)80020-6; PRATT JP, 1999, J NUCL MED S, V40; Santana-Boado C, 1998, J NUCL MED, V39, P751; SCHWARTZ RG, 1999, J NUCL CARDIOL, V6, pS17; Sharir T, 1999, CIRCULATION, V100, P1035, DOI 10.1161/01.CIR.100.10.1035; SKETCH MH, 1975, AM J CARDIOL, V36, P169, DOI 10.1016/0002-9149(75)90521-4; Toba M, 2000, ANN NUCL MED, V14, P421, DOI 10.1007/BF02988287; VAL P G, 1982, Circulation, V65, P1465	33	0	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23044	10.1371/journal.pone.0023044	http://dx.doi.org/10.1371/journal.pone.0023044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857990	Green Published, gold			2022-12-25	WOS:000294121300011
J	Steger, D; Berry, D; Haider, S; Horn, M; Wagner, M; Stocker, R; Loy, A				Steger, Doris; Berry, David; Haider, Susanne; Horn, Matthias; Wagner, Michael; Stocker, Roman; Loy, Alexander			Systematic Spatial Bias in DNA Microarray Hybridization Is Caused by Probe Spot Position-Dependent Variability in Lateral Diffusion	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; NORMALIZATION; DYNAMICS; KINETICS; SINGLE; MODEL	Background: The hybridization of nucleic acid targets with surface-immobilized probes is a widely used assay for the parallel detection of multiple targets in medical and biological research. Despite its widespread application, DNA microarray technology still suffers from several biases and lack of reproducibility, stemming in part from an incomplete understanding of the processes governing surface hybridization. In particular, non-random spatial variations within individual microarray hybridizations are often observed, but the mechanisms underpinning this positional bias remain incompletely explained. Methodology/Principal Findings: This study identifies and rationalizes a systematic spatial bias in the intensity of surface hybridization, characterized by markedly increased signal intensity of spots located at the boundaries of the spotted areas of the microarray slide. Combining observations from a simplified single-probe block array format with predictions from a mathematical model, the mechanism responsible for this bias is found to be a position-dependent variation in lateral diffusion of target molecules. Numerical simulations reveal a strong influence of microarray well geometry on the spatial bias. Conclusions: Reciprocal adjustment of the size of the microarray hybridization chamber to the area of surface-bound probes is a simple and effective measure to minimize or eliminate the diffusion-based bias, resulting in increased uniformity and accuracy of quantitative DNA microarray hybridization.	[Steger, Doris; Berry, David; Haider, Susanne; Horn, Matthias; Wagner, Michael; Loy, Alexander] Univ Vienna, Fac Life Sci, Vienna Ecol Ctr, Dept Microbial Ecol, Vienna, Austria; [Stocker, Roman] MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	University of Vienna; Massachusetts Institute of Technology (MIT)	Steger, D (corresponding author), Univ Vienna, Fac Life Sci, Vienna Ecol Ctr, Dept Microbial Ecol, Vienna, Austria.	loy@microbial-ecology.net	Stocker, Roman/T-9456-2017; Berry, David/C-8455-2011; Horn, Matthias/G-1136-2011; Stocker, Roman/N-8987-2019; Wagner, Michael/A-7801-2011; Loy, Alexander/A-8182-2008	Stocker, Roman/0000-0002-3199-0508; Berry, David/0000-0002-8997-608X; Horn, Matthias/0000-0002-8309-5855; Wagner, Michael/0000-0002-9778-7684; Loy, Alexander/0000-0001-8923-5882	Austrian Science Fund [P18836-B17, P20185-B17, P16566-B14]; Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); National Institutes of Health [1-R21-EB008844]; National Science Foundation [OCE-0744641-CAREER]; Austrian Science Fund (FWF) [P 20185] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008844] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was financially supported by the Austrian Science Fund (P18836-B17, P20185-B17 to AL and P16566-B14 to MH), the Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota to DB, MW, and AL), the National Institutes of Health (1-R21-EB008844 to RS), and the National Science Foundation (OCE-0744641-CAREER to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adey NB, 2002, ANAL CHEM, V74, P6413, DOI 10.1021/ac026082m; Balazsi G, 2003, NUCLEIC ACIDS RES, V31, P4425, DOI 10.1093/nar/gkg485; Bodrossy L, 2003, ENVIRON MICROBIOL, V5, P566, DOI 10.1046/j.1462-2920.2003.00450.x; Brody JP, 2002, P NATL ACAD SCI USA, V99, P12975, DOI 10.1073/pnas.162468199; Burden CJ, 2006, J PHYS-CONDENS MAT, V18, P5545, DOI 10.1088/0953-8984/18/23/024; Burden CJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016004; Carlon E, 2006, PHYSICA A, V362, P433, DOI 10.1016/j.physa.2005.09.067; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Dandy DS, 2007, P NATL ACAD SCI USA, V104, P8223, DOI 10.1073/pnas.0606054104; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Dufva Martin, 2009, V509, P47, DOI 10.1007/978-1-59745-372-1_4; Fish DJ, 2007, NUCLEIC ACIDS RES, V35, P7197, DOI 10.1093/nar/gkm865; Gadgil C, 2004, J BIOTECHNOL, V114, P31, DOI 10.1016/j.jbiotec.2004.05.008; Gong P, 2008, P NATL ACAD SCI USA, V105, P5301, DOI 10.1073/pnas.0709416105; Hagan MF, 2004, J CHEM PHYS, V120, P4958, DOI 10.1063/1.1645786; HAIDER S, 2009, THESIS U WIEN; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Hesselsoe M, 2009, ISME J, V3, P1349, DOI 10.1038/ismej.2009.78; Holloway AJ, 2002, NAT GENET, V32, P481, DOI 10.1038/ng1030; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kechris K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-551; Koren A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-164; Lazazzera BA, 2005, CURR OPIN MICROBIOL, V8, P222, DOI 10.1016/j.mib.2005.02.015; Levicky R, 2005, TRENDS BIOTECHNOL, V23, P143, DOI 10.1016/j.tibtech.2005.01.004; Livshits MA, 1996, BIOPHYS J, V71, P2795, DOI 10.1016/S0006-3495(96)79473-0; Loy A, 2006, CLIN CHIM ACTA, V363, P106, DOI 10.1016/j.cccn.2005.05.041; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Loy A, 2011, METHODS MOL BIOL, V688, P187, DOI 10.1007/978-1-60761-947-5_13; MASKOS U, 1993, NUCLEIC ACIDS RES, V21, P4663, DOI 10.1093/nar/21.20.4663; McQuain MK, 2004, ANAL BIOCHEM, V325, P215, DOI 10.1016/j.ab.2003.10.032; Ono N, 2008, BIOINFORMATICS, V24, P1278, DOI 10.1093/bioinformatics/btn109; Pappaert K, 2003, CHEM ENG SCI, V58, P4921, DOI 10.1016/j.ces.2002.12.007; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schonmann S, 2009, ENVIRON MICROBIOL, V11, P779, DOI 10.1111/j.1462-2920.2008.01800.x; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Singh R, 2009, ANN BIOMED ENG, V37, P255, DOI 10.1007/s10439-008-9584-y; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Toegl Andreas, 2003, J Biomol Tech, V14, P197; Wagner M, 2007, MICROB ECOL, V53, P498, DOI 10.1007/s00248-006-9197-7; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yeh IC, 2004, BIOPHYS J, V86, P681, DOI 10.1016/S0006-3495(04)74147-8; Yoo SM, 2009, J MICROBIOL BIOTECHN, V19, P635, DOI 10.4014/jmb.0803.226; Yuan DS, 2006, BIOINFORMATICS, V22, P3054, DOI 10.1093/bioinformatics/btl542	49	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23727	10.1371/journal.pone.0023727	http://dx.doi.org/10.1371/journal.pone.0023727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858215	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300088
J	Tran, TA; Nguyen, AD; Chang, JJ; Goldberg, MS; Lee, JK; Tansey, MG				Tran, Thi A.; Nguyen, Andrew D.; Chang, Jianjun; Goldberg, Matthew S.; Lee, Jae-Kyung; Tansey, Malu G.			Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; TNF-ALPHA; DOPAMINERGIC-NEURONS; DIRECT INHIBITION; INFLAMMATION; ACTIVATION; MUTATIONS; BRAIN; MICE; GENE	Inflammation and oxidative stress have been implicated in the pathophysiology of Parkinson's disease (PD) and inhibition of microglial activation attenuates degeneration of dopaminergic (DA) neurons in animal models of PD. Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, cause autosomal recessive parkinsonism. While most studies on Parkin have focused on its function in neurons, here we demonstrate that Parkin mRNA and protein is detectable in brain-resident microglia and peripheral macrophages. Using pharmacologic and genetic approaches, we found that Parkin levels are regulated by inflammatory signaling. Specifically, exposure to LPS or Tumor Necrosis Factor (TNF) induced a transient and dose-dependent decrease in Parkin mRNA and protein in microglia, macrophages and neuronal cells blockable by inhibitors of Nuclear Factor-Kappa B (NF-kappa B) signaling and not observed in MyD88-null cells. Moreover, using luciferase reporter assays, we identified an NF-kappa B response element in the mouse parkin promoter responsible for mediating the transcriptional repression, which was abrogated when the consensus sequence was mutated. Functionally, activated macrophages from Parkin-null mice displayed increased levels of TNF, IL-1 beta, and iNOS mRNA compared to wild type macrophages but no difference in levels of Nrf2, HO-1, or NQO1. One implication of our findings is that chronic inflammatory conditions may reduce Parkin levels and phenocopy parkin loss-of-function mutations, thereby increasing the vulnerability for degeneration of the nigrostriatal pathway and development of PD.	[Tran, Thi A.; Tansey, Malu G.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Nguyen, Andrew D.; Chang, Jianjun; Lee, Jae-Kyung; Tansey, Malu G.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tran, TA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	malu.tansey@emory.edu	Goldberg, Matthew/T-7827-2019	LEE, JAE-KYUNG/0000-0003-0104-8623; Goldberg, Matthew/0000-0002-5172-9841; Nguyen, Andrew/0000-0002-9492-9472	NIH-NINDS [5R01NS049433]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049433] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NIH-NINDS 5R01NS049433 and The Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOUMAN L, 2010, CELL DEATH DIFFER; Casarejos MJ, 2006, J NEUROCHEM, V97, P934, DOI 10.1111/j.1471-4159.2006.03777.x; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Ferger B, 2004, J NEUROCHEM, V89, P822, DOI 10.1111/j.1471-4159.2004.02399.x; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hirsch EC, 2005, PARKINSONISM RELAT D, V11, pS9, DOI 10.1016/j.parkreldis.2004.10.013; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jeong JY, 1997, IMMUNOLOGY, V92, P267, DOI 10.1046/j.1365-2567.1997.00335.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; LEE JK, 2009, J NEUROIMMUNE PHARM; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; McNaught KSP, 2006, NEUROBIOL AGING, V27, P530, DOI 10.1016/j.neurobiolaging.2005.08.012; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schmidt S., 2011, HUM MOL GENET; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wersinger Christophe, 2002, Current Drug Targets - Inflammation and Allergy, V1, P221, DOI 10.2174/1568010023344580; West AB, 2004, J BIOL CHEM, V279, P28896, DOI 10.1074/jbc.M400126200; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhao CH, 2007, NEUROBIOL DIS, V26, P36, DOI 10.1016/j.nbd.2006.11.012	47	70	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23660	10.1371/journal.pone.0023660	http://dx.doi.org/10.1371/journal.pone.0023660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858193	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300074
J	Lolignier, S; Amsalem, M; Maingret, F; Padilla, F; Gabriac, M; Chapuy, E; Eschalier, A; Delmas, P; Busserolles, J				Lolignier, Stephane; Amsalem, Muriel; Maingret, Francois; Padilla, Francoise; Gabriac, Melanie; Chapuy, Eric; Eschalier, Alain; Delmas, Patrick; Busserolles, Jerome			Nav1.9 Channel Contributes to Mechanical and Heat Pain Hypersensitivity Induced by Subacute and Chronic Inflammation	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNEL; PRIMARY SENSORY NEURONS; NA(V)1.9 KNOCKOUT MICE; PERSISTENT NA+ CURRENT; ROOT GANGLIA NEURONS; TETRODOTOXIN-RESISTANT; DRG NEURONS; EXPRESSION; RAT; MOUSE	Inflammation is known to be responsible for the sensitization of peripheral sensory neurons, leading to spontaneous pain and invalidating pain hypersensitivity. Given its role in regulating neuronal excitability, the voltage-gated Nav1.9 channel is a potential target for the treatment of pathological pain, but its implication in inflammatory pain is yet not fully described. In the present study, we examined the role of the Nav1.9 channel in acute, subacute and chronic inflammatory pain using Nav1.9-null mice and Nav1.9 knock-down rats. In mice we found that, although the Nav1.9 channel does not contribute to basal pain thresholds, it plays an important role in heat pain hypersensitivity induced by subacute paw inflammation (intraplantar carrageenan) and chronic ankle inflammation (complete Freund's adjuvant-induced monoarthritis). We showed for the first time that Nav1.9 also contributes to mechanical hypersensitivity in both models, as assessed using von Frey and dynamic weight bearing tests. Consistently, antisense-based Nav1.9 gene silencing in rats reduced carrageenan-induced heat and mechanical pain hypersensitivity. While no changes in Nav1.9 mRNA levels were detected in dorsal root ganglia (DRGs) during subacute and chronic inflammation, a significant increase in Nav1.9 immunoreactivity was observed in ipsilateral DRGs 24 hours following carrageenan injection. This was correlated with an increase in Nav1.9 immunolabeling in nerve fibers surrounding the inflamed area. No change in Nav1.9 current density could be detected in the soma of retrolabeled DRG neurons innervating inflamed tissues, suggesting that newly produced channels may be non-functional at this level and rather contribute to the observed increase in axonal transport. Our results provide evidence that Nav1.9 plays a crucial role in the generation of heat and mechanical pain hypersensitivity, both in subacute and chronic inflammatory pain models, and bring new elements for the understanding of its regulation in those models.	[Lolignier, Stephane; Chapuy, Eric; Eschalier, Alain; Busserolles, Jerome] Clermont Univ, Lab Pharmacol Fondamentale & Clin Douleur, Clermont Ferrand, France; [Lolignier, Stephane; Chapuy, Eric; Eschalier, Alain; Busserolles, Jerome] INSERM, U766, Clermont Ferrand, France; [Amsalem, Muriel; Maingret, Francois; Padilla, Francoise; Gabriac, Melanie; Delmas, Patrick] Univ Aix Marseille 2, CNRS, UMR 6231, Ctr Rech Neurobiol & Neurophysiol Marseille, Marseille, France; [Eschalier, Alain] CHU Clermont Ferrand, Serv Pharmacol, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CHU Clermont Ferrand	Lolignier, S (corresponding author), Clermont Univ, Lab Pharmacol Fondamentale & Clin Douleur, Clermont Ferrand, France.	jerome.busserolles@u-clermont1.fr	Busserolles, Jerome/K-4232-2014; Lolignier, Stéphane/K-1281-2015; ESCHALIER, Alain/L-9957-2015; Busserolles, Jerome/AAJ-1196-2020	Busserolles, Jerome/0000-0001-7542-9520; Lolignier, Stéphane/0000-0001-5407-4986; 	Agence Nationale de la Recherche; Institut UPSA de la Douleur (Union de Pharmacologie Scientifique Appliquee); Institut pour la Recherche sur la Moelle Epiniere; Fondation pour la Recherche Medicale; Fondation Schlumberger; Association pour la Recherche sur le Cancer; Institut National du Cancer; Institut National de la Santeet de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite d'Auvergne; Ministere de l'Education Nationale, de la Recherche et de la Technologie	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut UPSA de la Douleur (Union de Pharmacologie Scientifique Appliquee); Institut pour la Recherche sur la Moelle Epiniere; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Schlumberger(Schlumberger); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Institut National de la Santeet de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite d'Auvergne; Ministere de l'Education Nationale, de la Recherche et de la Technologie	This study was supported by grants from Agence Nationale de la Recherche, Institut UPSA de la Douleur (Union de Pharmacologie Scientifique Appliquee), Institut pour la Recherche sur la Moelle Epiniere, Fondation pour la Recherche Medicale, Fondation Schlumberger, Association pour la Recherche sur le Cancer, Institut National du Cancer and by Institut National de la Santeet de la Recherche Medicale, Centre National de la Recherche Scientifique and Universite d'Auvergne. S. Lolignier and M. Amsalem were supported by Ministere de l'Education Nationale, de la Recherche et de la Technologie fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Baker MD, 2003, J PHYSIOL-LONDON, V548, P373, DOI 10.1113/jphysiol.2003.039131; Baker MD, 2005, J PHYSIOL-LONDON, V567, P851, DOI 10.1113/jphysiol.2005.089771; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Blair NT, 2002, J NEUROSCI, V22, P10277; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; Coggeshall RE, 2004, NEUROSCI LETT, V355, P45, DOI 10.1016/j.neulet.2003.10.023; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; King DE, 2009, NEUROGASTROENT MOTIL, V21, P880, DOI 10.1111/j.1365-2982.2009.01279.x; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; Martinez V, 2008, EUR J PAIN, V12, P934, DOI 10.1016/j.ejpain.2007.12.011; McGaraughty S, 2003, BRIT J PHARMACOL, V140, P1381, DOI 10.1038/sj.bjp.0705574; Ostman JAR, 2008, J PHYSIOL-LONDON, V586, P1077, DOI 10.1113/jphysiol.2007.147942; Padilla F, 2007, MOL CELL NEUROSCI, V35, P138, DOI 10.1016/j.mcn.2007.02.008; Perlewitz A, 2010, NUCLEIC ACIDS RES, V38, P5746, DOI 10.1093/nar/gkq267; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2004, BRAIN RES, V1023, P264, DOI 10.1016/j.brainres.2004.07.042; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Wada A, 2004, FRONT BIOSCI-LANDMRK, V9, P1954, DOI 10.2741/1314; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; Yen YT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-1; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	42	73	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23083	10.1371/journal.pone.0023083	http://dx.doi.org/10.1371/journal.pone.0023083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857998	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500019
J	Ruiz-Ferrer, M; Torroglosa, A; Nunez-Torres, R; de Agustin, JC; Antinolo, G; Borrego, S				Ruiz-Ferrer, Macarena; Torroglosa, Ana; Nunez-Torres, Rocio; Carlos de Agustin, Juan; Antinolo, Guillermo; Borrego, Salud			Expression of PROKR1 and PROKR2 in Human Enteric Neural Precursor Cells and Identification of Sequence Variants Suggest a Role in HSCR	PLOS ONE			English	Article							NERVOUS-SYSTEM DEVELOPMENT; STEM-CELLS; HIRSCHSPRUNG-DISEASE; MUTATIONS; PROTEINS; DIFFERENTIATION; PROKINETICIN-2; PROLIFERATION; PATHOGENESIS; GENETICS	Background: The enteric nervous system (ENS) is entirely derived from neural crest and its normal development is regulated by specific molecular pathways. Failure in complete ENS formation results in aganglionic gut conditions such as Hirschsprung's disease (HSCR). Recently, PROKR1 expression has been demonstrated in mouse enteric neural crest derived cells and Prok-1 was shown to work coordinately with GDNF in the development of the ENS. Principal Findings: In the present report, ENS progenitors were isolated and characterized from the ganglionic gut from children diagnosed with and without HSCR, and the expression of prokineticin receptors was examined. Immunocytochemical analysis of neurosphere-forming cells demonstrated that both PROKR1 and PROKR2 were present in human enteric neural crest cells. In addition, we also performed a mutational analysis of PROKR1, PROKR2, PROK1 and PROK2 genes in a cohort of HSCR patients, evaluating them for the first time as susceptibility genes for the disease. Several missense variants were detected, most of them affecting highly conserved amino acid residues of the protein and located in functional domains of both receptors, which suggests a possible deleterious effect in their biological function. Conclusions: Our results suggest that not only PROKR1, but also PROKR2 might mediate a complementary signalling to the RET/GFR alpha 1/GDNF pathway supporting proliferation/survival and differentiation of precursor cells during ENS development. These findings, together with the detection of sequence variants in PROKR1, PROK1 and PROKR2 genes associated to HSCR and, in some cases in combination with RET or GDNF mutations, provide the first evidence to consider them as susceptibility genes for HSCR.	[Ruiz-Ferrer, Macarena; Torroglosa, Ana; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Inst Biomed Sevilla, Unidad Gest Clin Genet Reprod & Med Fetal, Seville, Spain; [Ruiz-Ferrer, Macarena; Torroglosa, Ana; Nunez-Torres, Rocio; Antinolo, Guillermo; Borrego, Salud] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Seville, Spain; [Carlos de Agustin, Juan] Hosp Univ Virgen del Rocio, Unidad Gest Clin Cirugia Infantil, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Virgen del Rocio University Hospital	Ruiz-Ferrer, M (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Inst Biomed Sevilla, Unidad Gest Clin Genet Reprod & Med Fetal, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	De Agustin, Juan/AAT-1824-2021; Borrego, Salud/M-6314-2015; Ruiz-Ferrer, Macarena/M-6168-2015; Torroglosa, Ana/AAU-9812-2020; IBIS, GENETICA/P-3384-2015; IBIS, MALFORMACIONES/H-7372-2016; IBIS, REPRODUCCION/P-3399-2015	De Agustin, Juan/0000-0002-2413-2871; Antinolo Gil, Guillermo/0000-0002-2113-074X; Torroglosa, Ana/0000-0003-1911-7906	Fondo de Investigacion Sanitaria, Spain [PI070080, PI1001290, PI071315]; Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia [CTS 2590]; Consejeria de Salud de la Junta de Andalucia [PI0249-2008]	Fondo de Investigacion Sanitaria, Spain(Instituto de Salud Carlos III); Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia); Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This work was supported by Fondo de Investigacion Sanitaria, Spain (PI070080, PI1001290 and PI071315 for the E-Rare project), Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia (CTS 2590) and Consejeria de Salud de la Junta de Andalucia (PI0249-2008). The CIBER de Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958; Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Kaser A, 2003, EMBO REP, V4, P469, DOI 10.1038/sj.embor.embor830; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Le Douarin N., 1999, NEURAL CREST, P445; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Negri L, 2007, LIFE SCI, V81, P1103, DOI 10.1016/j.lfs.2007.08.011; Ngan ESW, 2008, INT J BIOCHEM CELL B, V40, P1679, DOI 10.1016/j.biocel.2008.03.010; Ngan ESW, 2008, BBA-MOL CELL RES, V1783, P467, DOI 10.1016/j.bbamcr.2007.09.005; Ngan ESW, 2007, BBA-MOL CELL RES, V1773, P536, DOI 10.1016/j.bbamcr.2007.01.013; Ngan ESW, 2007, CLIN CANCER RES, V13, P868, DOI 10.1158/1078-0432.CCR-06-2176; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Ruiz-Ferrer M, 2008, J PEDIATR SURG, V43, P1308, DOI 10.1016/j.jpedsurg.2008.02.076; Ruiz-Ferrer M, 2006, GENET MED, V8, P704, DOI 10.1097/01.gim.0000245632.06064.f1; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Sanchez-Mejias A, 2009, J MED GENET, V46, P862, DOI 10.1136/jmg.2009.067819; Sanchez-Mejias A, 2010, J MOL MED, V88, P507, DOI 10.1007/s00109-010-0592-7; Sanchez-Mejias A, 2010, GENET MED, V12, P39, DOI 10.1097/GIM.0b013e3181c371b0; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Tam PKH, 2009, PEDIATR SURG INT, V25, P543, DOI 10.1007/s00383-009-2402-2; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	32	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23475	10.1371/journal.pone.0023475	http://dx.doi.org/10.1371/journal.pone.0023475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858136	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500046
J	Tan, HW; Liu, GH; Dong, X; Lin, RQ; Song, HQ; Huang, SY; Yuan, ZG; Zhao, GH; Zhu, XQ				Tan, Hong-Wei; Liu, Guo-Hua; Dong, Xia; Lin, Rui-Qing; Song, Hui-Qun; Huang, Si-Yang; Yuan, Zi-Guo; Zhao, Guang-Hui; Zhu, Xing-Quan			The Complete Mitochondrial Genome of the Asiatic Cavity-Nesting Honeybee Apis cerana (Hymenoptera: Apidae)	PLOS ONE			English	Article							DNA SEQUENCE; EVOLUTIONARY HISTORY; GENE REARRANGEMENTS; BEES HYMENOPTERA; TRANSFER-RNAS; MELLIFERA; ORGANIZATION; INSECTA; ARRANGEMENT; PHYLOGENY	In the present study, we determined the complete mitochondrial DNA (mtDNA) sequence of Apis cerana, the Asiatic cavity-nesting honeybee. We present here an analysis of features of its gene content and genome organization in comparison with Apis mellifera to assess the variation within the genus Apis and among main groups of Hymenoptera. The size of the entire mt genome of A. cerana is 15,895 bp, containing 2 ribosomal RNA genes, 13 protein-coding genes, 22 transfer RNA (tRNA) genes and one control region. These genes are transcribed from both strands and have a nucleotide composition high in A and T. The contents of A+T of the complete genomes are 83.96% for A. cerana. The AT bias had a significant effect on both the codon usage pattern and amino acid composition of proteins. There are a total of 3672 codons in all 13 protein-coding genes, excluding termination codons. The most frequently used amino acid is Leu (15.52%), followed by Ile (12.85%), Phe (10.10%), Ser (9.15%) and Met (8.96%). Intergenic regions in the mt genome of A. cerana are 705 bp in total. The order and orientation of the gene arrangement pattern is identical to that of A. mellifera, except for the position of the tRNA-Ser((AGN)) gene. Phylogenetic analyses using concatenated amino acid sequences of 13 protein-coding genes, with three different computational algorithms (NJ, MP and ML), all revealed two distinct groups with high statistical support, indicating that A. cerana and A. mellifera are two separate species, consistent with results of previous morphological and molecular studies. The complete mtDNA sequence of A. cerana provides additional genetic markers for studying population genetics, systematics and phylogeographics of honeybees.	[Tan, Hong-Wei; Liu, Guo-Hua; Lin, Rui-Qing; Song, Hui-Qun; Huang, Si-Yang; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Liu, Guo-Hua; Zhu, Xing-Quan] Hunan Agr Univ, Coll Vet Med, Changsha, Hunan, Peoples R China; [Tan, Hong-Wei; Dong, Xia] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Yunnan Prov, Peoples R China; [Lin, Rui-Qing; Yuan, Zi-Guo] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Zhao, Guang-Hui] NW A&F Univ, Coll Vet Med, Yangling, Shaanxi Prov, Peoples R China; [Tan, Hong-Wei] Anim Husb Technol Promot Stn Chongqing, Chongqing, Peoples R China; [Zhu, Xing-Quan] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Heilongjiang Pr, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Hunan Agricultural University; Yunnan Agricultural University; South China Agricultural University; Northwest A&F University - China; Heilongjiang Bayi Agricultural University	Tan, HW (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	237855236@qq.com; xingquanzhu1@hotmail.com			State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; Yunnan Provincial Program for Introducing High-Level Scientists [2009CI125]; National Natural Science Foundation of China [30960269]; Natural Science Foundation of Yunnan Province [2006C0035M]	State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; Yunnan Provincial Program for Introducing High-Level Scientists; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work was supported, in part, by the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, the Yunnan Provincial Program for Introducing High-Level Scientists (Grant No. 2009CI125), the National Natural Science Foundation of China (Grant No. 30960269), and the Natural Science Foundation of Yunnan Province (Grant No. 2006C0035M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; Behura SK, 2007, MOL BIOL EVOL, V24, P1492, DOI 10.1093/molbev/msm068; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; CAMERON SA, 1993, P NATL ACAD SCI USA, V90, P8687, DOI 10.1073/pnas.90.18.8687; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Castro LR, 2006, GENOME, V49, P752, DOI 10.1139/G06-030; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; Chapman NC, 2008, J ECON ENTOMOL, V101, P272, DOI 10.1603/0022-0493(2008)101[272:PGOCAF]2.0.CO;2; Cook CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-105; CORNUET JM, 1991, GENETICS, V128, P393; CROZIER RH, 1993, GENETICS, V133, P97; Cui P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-241; Dacke M, 2007, J EXP BIOL, V210, P845, DOI 10.1242/jeb.002089; De la Rua P, 2000, HEREDITY, V84, P124, DOI 10.1046/j.1365-2540.2000.00646.x; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; Dowton M, 2009, MOL PHYLOGENET EVOL, V52, P512, DOI 10.1016/j.ympev.2009.04.001; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Engel MS, 1997, ANN ENTOMOL SOC AM, V90, P43, DOI 10.1093/aesa/90.1.43; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; GARNERY L, 1995, MOL ECOL, V4, P465, DOI 10.1111/j.1365-294X.1995.tb00240.x; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; Hua JM, 2009, MOL BIOL REP, V36, P1757, DOI 10.1007/s11033-008-9379-0; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Lasalle John, 1993, P1; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Masta SE, 2000, MOL BIOL EVOL, V17, P1091, DOI 10.1093/oxfordjournals.molbev.a026390; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Nakao M, 2002, MITOCHONDRION, V1, P497, DOI 10.1016/S1567-7249(02)00040-5; Nakao M, 2007, PARASITOL RES, V101, P233, DOI 10.1007/s00436-006-0433-3; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Raffiudin R, 2007, MOL PHYLOGENET EVOL, V43, P543, DOI 10.1016/j.ympev.2006.10.013; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; Somanathan H, 2009, J EXP BIOL, V212, P2448, DOI 10.1242/jeb.031484; Songrarn O, 2006, BIOCHEM GENET, V44, P256, DOI 10.1007/s10528-006-9030-5; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wei SJ, 2010, MOL BIOL REP, V37, P1931, DOI 10.1007/s11033-009-9640-1; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Yatawara L, 2008, GENE, V424, P80, DOI 10.1016/j.gene.2008.07.026; Yatawara L, 2010, MOL BIOCHEM PARASIT, V173, P32, DOI 10.1016/j.molbiopara.2010.05.004; Yu ZN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-477; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	59	46	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23008	10.1371/journal.pone.0023008	http://dx.doi.org/10.1371/journal.pone.0023008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857981	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500013
J	Zhou, RM; Jing, YY; Guo, Y; Gao, C; Zhang, BY; Chen, C; Shi, Q; Tian, C; Wang, ZY; Gong, HS; Han, J; Xu, BL; Dong, XP				Zhou, Rui-Min; Jing, Yuan-Yuan; Guo, Yan; Gao, Chen; Zhang, Bao-Yun; Chen, Cao; Shi, Qi; Tian, Chan; Wang, Zhao-Yun; Gong, Han-Shi; Han, Jun; Xu, Bian-Li; Dong, Xiao-Ping			Molecular Interaction of TPPP with PrP Antagonized the CytoPrP-Induced Disruption of Microtubule Structures and Cytotoxicity	PLOS ONE			English	Article							CYTOSOLIC PRION PROTEIN; TUBULIN; P25; OLIGODENDROCYTES; NEUROTOXICITY; ASSEMBLIES; APOPTOSIS; TRANSPORT; SH-SY5Y; BLOCKS	Background: Tubulin polymerization promoting protein/p25 (TPPP/p25), known as a microtubule-associated protein (MAP), is a brain-specific unstructured protein with a physiological function of stabilizing cellular microtubular ultrastructures. Whether TPPP involves in the normal functions of PrP or the pathogenesis of prion disease remains unknown. Here, we proposed the data that TPPP formed molecular complex with PrP. We also investigated its influence on the aggregation of PrP and fibrillization of PrP106-126 in vitro, its antagonization against the disruption of microtubule structures and cytotoxicity of cytosolic PrP in cells, and its alternation in the brains of scrapie-infected experimental hamsters. Methodology/Principal Findings: Using pull-down and immunoprecipitation assays, distinct molecular interaction between TPPP and PrP were identified and the segment of TPPP spanning residues 100-219 and the segment of PrP spanning residues 106-126 were mapped as the regions responsible for protein interaction. Sedimentation experiments found that TPPP increased the aggregation of full-length recombinant PrP (PrP23-231) in vitro. Transmission electron microscopy and Thioflavin T (ThT) assays showed that TPPP enhanced fibril formation of synthetic peptide PrP106-126 in vitro. Expression of TPPP in the cultured cells did not obviously change the microtubule networks observed by a tubulin-specific immunofluorescent assay and cell growth features measured by CCK8 tests, but significantly antagonized the disruption of microtubule structures and rescued the cytotoxicity caused by the accumulation of cytosolic PrP (CytoPrP). Furthermore, Western blots identified that the levels of the endogenous TPPP in the brains of scrapie-infected experimental hamsters were significantly reduced. Conclusion/Significance: Those data highlight TPPP may work as a protective factor for cells against the damage effects of the accumulation of abnormal forms of PrPs, besides its function as an agent for dynamic stabilization of microtubular ultrastructures.	[Zhou, Rui-Min; Jing, Yuan-Yuan; Guo, Yan; Gao, Chen; Zhang, Bao-Yun; Chen, Cao; Shi, Qi; Tian, Chan; Wang, Zhao-Yun; Gong, Han-Shi; Han, Jun; Dong, Xiao-Ping] Chinese Ctr Dis Control Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Rui-Min; Xu, Bian-Li] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan Province, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhou, RM (corresponding author), Chinese Ctr Dis Control Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	China Mega-Project for Infectious Disease [2009ZX10004-101, 2008ZX]; National Basic Research Program of China (973 Program) [2008SKLID102, 2007CB310505]; Chinese National Natural Science Foundation [30771914, 30800975]; Institution Technique RD [2008EG150300]	China Mega-Project for Infectious Disease; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Institution Technique RD	This work was supported by China Mega-Project for Infectious Disease (2009ZX10004-101, 2008ZX), SKLID Development Grant (2008SKLID102) National Basic Research Program of China (973 Program) (2007CB310505), Chinese National Natural Science Foundation Grants 30771914 and 30800975 and Institution Technique R&D Grant (2008EG150300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Bergstrom AL, 2005, J BIOL CHEM, V280, P23114, DOI 10.1074/jbc.M500210200; BRANDT R, 1996, FRONT BIOSCI, V1, P118; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chen L, 2007, J BIOCHEM MOL BIOL, V40, P662; Colello RJ, 2002, ELECTROPHORESIS, V23, P144, DOI 10.1002/1522-2683(200201)23:1<144::AID-ELPS144>3.0.CO;2-P; Dong CF, 2008, MED MICROBIOL IMMUN, V197, P361, DOI 10.1007/s00430-007-0071-0; Dong CF, 2008, ARCH BIOCHEM BIOPHYS, V470, P83, DOI 10.1016/j.abb.2007.11.007; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Hachiya NS, 2004, BIOCHEM BIOPH RES CO, V313, P818, DOI 10.1016/j.bbrc.2003.11.167; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Keshet GI, 2000, J NEUROCHEM, V75, P1889, DOI 10.1046/j.1471-4159.2000.0751889.x; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Kovacs GG, 2007, ACTA NEUROPATHOL, V113, P153, DOI 10.1007/s00401-006-0167-4; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Li P, 2009, ACTA BIOCH BIOPH SIN, V41, P42, DOI 10.1093/abbs/gmn005; Li XL, 2011, J MOL NEUROSCI, V43, P316, DOI 10.1007/s12031-010-9443-9; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Liu YH, 2011, INT J BIOCHEM CELL B, V43, P768, DOI 10.1016/j.biocel.2011.01.022; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Martin CP, 2002, BBA-MOL BASIS DIS, V1586, P113; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Nandi PK, 1997, ARCH VIROL, V142, P2537, DOI 10.1007/s007050050261; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; Nieznanski K, 2005, BIOCHEM BIOPH RES CO, V334, P403, DOI 10.1016/j.bbrc.2005.06.092; Norstrom EM, 2007, J VIROL, V81, P2831, DOI 10.1128/JVI.02157-06; Olah J, 2006, FEBS LETT, V580, P5807, DOI 10.1016/j.febslet.2006.09.037; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Ovadi J, 2009, BIOESSAYS, V31, P676, DOI 10.1002/bies.200900008; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Seki N, 1999, J HUM GENET, V44, P121, DOI 10.1007/s100380050122; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; TAKAHASHI M, 1991, FEBS LETT, V289, P37, DOI 10.1016/0014-5793(91)80903-G; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wang GR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-86; Wang XH, 2005, J BIOL CHEM, V280, P317, DOI 10.1074/jbc.M410649200; Wang XF, 2008, MOL CELL BIOCHEM, V310, P49, DOI 10.1007/s11010-007-9664-6; Wang X, 2009, BMB REP, V42, P444, DOI 10.5483/BMBRep.2009.42.7.444; Yao HL, 2005, J VET MED B, V52, P437, DOI 10.1111/j.1439-0450.2005.00897.x	49	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23079	10.1371/journal.pone.0023079	http://dx.doi.org/10.1371/journal.pone.0023079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857997	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500018
J	Crivat, G; Tokumasu, F; Sa, JM; Hwang, J; Wellems, TE				Crivat, Georgeta; Tokumasu, Fuyuki; Sa, Juliana Martha; Hwang, Jeeseong; Wellems, Thomas E.			Tetracysteine-Based Fluorescent Tags to Study Protein Localization and Trafficking in Plasmodium falciparum-Infected Erythrocytes	PLOS ONE			English	Article							MEMBRANE PROTEIN-1; CYTOADHERENCE; GREEN; VIRULENCE; SURFACE; PFEMP1; KNOBS; CELLS; EXPRESSION; ADHERENCE	Plasmodium falciparum (Pf) malaria parasites remodel host erythrocytes by placing membranous structures in the host cell cytoplasm and inserting proteins into the surrounding erythrocyte membranes. Dynamic imaging techniques with high spatial and temporal resolutions are required to study the trafficking pathways of proteins and the time courses of their delivery to the host erythrocyte membrane. Methodology and Findings: Using a tetracysteine (TC) motif tag and TC-binding biarsenical fluorophores (BAFs) including fluorescein arsenical hairpin (FlAsH) and resorufin arsenical hairpin (ReAsH), we detected knob-associated histidine-rich protein (KAHRP) constructs in Pf-parasitized erythrocytes and compared their fluorescence signals to those of GFP (green fluorescent protein)-tagged KAHRP. Rigorous treatment with BAL (2, 3 dimercaptopropanol; British anti-Lewisite) was required to reduce high background due to nonspecific BAF interactions with endogenous cysteine-rich proteins. After this background reduction, similar patterns of fluorescence were obtained from the TC- and GFP-tagged proteins. The fluorescence from FlAsH and ReAsH-labeled protein bleached at faster rates than the fluorescence from GFP-labeled protein. Conclusion: While TC/BAF labeling to Pf-infected erythrocytes is presently limited by high background signals, it may offer a useful complement or alternative to GFP labeling methods. Our observations are in agreement with the currently-accepted model of KAHRP movement through the cytoplasm, including transient association of KAHRP with Maurer's clefts before its incorporation into knobs in the host erythrocyte membrane.	[Crivat, Georgeta; Tokumasu, Fuyuki; Sa, Juliana Martha; Wellems, Thomas E.] NIAID, Lab Malaria & Vector Res, Malaria Genet Sect, NIH, Bethesda, MD 20892 USA; [Crivat, Georgeta; Hwang, Jeeseong] Natl Inst Stand & Technol, Phys Measurement Lab, Biophys Grp, Opt Technol Div, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute of Standards & Technology (NIST) - USA	Crivat, G (corresponding author), NIAID, Lab Malaria & Vector Res, Malaria Genet Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twellems@niaid.nih.gov	Tokumasu, Fuyuki/GQP-4413-2022; Crivat, Georgeta/AAJ-5714-2020	Tokumasu, Fuyuki/0000-0003-2790-1071; 	National Institutes of Health, National Institute of Allergy and Infectious Diseases; National Institute of Standards and Technology (NIST); National Research Council at NIST; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH); National Institute for Biomedical Imaging and Bioengineering of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000099, ZIAAI000483] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Standards and Technology (NIST)(National Institute of Standards & Technology (NIST) - USA); National Research Council at NIST; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Biomedical Imaging and Bioengineering of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases, and by the Innovations in Measurement Science program of the National Institute of Standards and Technology (NIST). GC held a National Research Council Research Associateship Award at NIST and National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH); funding for the award was provided by NIST and the Intramural Program of the National Institute for Biomedical Imaging and Bioengineering of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; ADAMS SR, 2007, CHEM BIOL SAMLL MOL; AIKAWA M, 1983, J PARASITOL, V69, P435, DOI 10.2307/3281259; ALHANATY E, 1981, J CELL BIOL, V91, P884, DOI 10.1083/jcb.91.3.884; APOSHIAN HV, 1984, FUND APPL TOXICOL, V4, pS58, DOI 10.1016/0272-0590(84)90138-6; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Hearps AC, 2007, J FLUORESC, V17, P593, DOI 10.1007/s10895-007-0225-x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; JENSEN JB, 1978, AM J TROP MED HYG, V27, P1274, DOI 10.4269/ajtmh.1978.27.1274; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Langhorst MF, 2006, HISTOCHEM CELL BIOL, V125, P743, DOI 10.1007/s00418-005-0136-3; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Machleidt T, 2007, METH MOL B, V356, P209; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Nagao E, 2000, J STRUCT BIOL, V130, P34, DOI 10.1006/jsbi.2000.4236; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Thompson J, 2007, CELL MICROBIOL, V9, P1466, DOI 10.1111/j.1462-5822.2006.00885.x; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; TRUONG HTN, 1993, BIOCHIM BIOPHYS ACTA, V1150, P51, DOI 10.1016/0005-2736(93)90120-O; Van Engelenburg SB, 2010, CHEMBIOCHEM, V11, P489, DOI 10.1002/cbic.200900689; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	50	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22975	10.1371/journal.pone.0022975	http://dx.doi.org/10.1371/journal.pone.0022975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860664	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200030
J	De Vito, C; Riggi, N; Suva, ML; Janiszewska, M; Horlbeck, J; Baumer, K; Provero, P; Stamenkovic, I				De Vito, Claudio; Riggi, Nicolo; Suva, Mario-Luca; Janiszewska, Michalina; Horlbeck, Janine; Baumer, Karine; Provero, Paolo; Stamenkovic, Ivan			Let-7a Is a Direct EWS- FLI-1 Target Implicated in Ewing's Sarcoma Development	PLOS ONE			English	Article							SELF-RENEWAL; TUMOR-GROWTH; MICRORNA; METASTASIS; EXPRESSION; LIN28; HMGA2; IDENTIFICATION; TRANSFORMATION; GENES	Ewing's sarcoma family tumors (ESFT) are the second most common bone malignancy in children and young adults, characterized by unique chromosomal translocations that in 85% of cases lead to expression of the EWS-FLI-1 fusion protein. EWS-FLI-1 functions as an aberrant transcription factor that can both induce and suppress members of its target gene repertoire. We have recently demonstrated that EWS-FLI-1 can alter microRNA (miRNA) expression and that miRNA145 is a direct EWS-FLI-1 target whose suppression is implicated in ESFT development. Here, we use miRNA arrays to compare the global miRNA expression profile of human mesenchymal stem cells (MSC) and ESFT cell lines, and show that ESFT display a distinct miRNA signature that includes induction of the oncogenic miRNA 17-92 cluster and repression of the tumor suppressor let-7 family. We demonstrate that direct repression of let-7a by EWS-FLI-1 participates in the tumorigenic potential of ESFT cells in vivo. The mechanism whereby let-7a expression regulates ESFT growth is shown to be mediated by its target gene HMGA2, as let-7a overexpression and HMGA2 repression both block ESFT cell tumorigenicity. Consistent with these observations, systemic delivery of synthetic let-7a into ESFT-bearing mice restored its expression in tumor cells, decreased HMGA2 expression levels and resulted in ESFT growth inhibition in vivo. Our observations provide evidence that deregulation of let-7a target gene expression participates in ESFT development and identify let-7a as promising new therapeutic target for one of the most aggressive pediatric malignancies.	[De Vito, Claudio; Riggi, Nicolo; Suva, Mario-Luca; Janiszewska, Michalina; Horlbeck, Janine; Baumer, Karine; Stamenkovic, Ivan] Univ Lausanne, CHU Vaudois, Inst Pathol, Fac Biol & Med, Lausanne, Switzerland; [Provero, Paolo] Univ Turin, Dept Biochem Mol Biol & Biotechnol, Turin, Italy	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Turin	De Vito, C (corresponding author), Univ Lausanne, CHU Vaudois, Inst Pathol, Fac Biol & Med, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Provero, Paolo/AAC-1930-2019; Suva, Mario/AAY-7798-2020	Suva, Mario/0000-0001-9898-5351	Swiss Fonds National pour la Recherche Scientifique (FNRS) [310030_130350]; NCCR Molecular Oncology; Italian Association for Cancer Research [IG9408]	Swiss Fonds National pour la Recherche Scientifique (FNRS)(Swiss National Science Foundation (SNSF)); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Swiss Fonds National pour la Recherche Scientifique (FNRS) grant No. 310030_130350 and the NCCR Molecular Oncology. PP gratefully acknowledges support from the Italian Association for Cancer Research under grant IG9408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Dreux N, 2010, MOD PATHOL; Droge P, 2008, CELL STEM CELL, V2, P8, DOI 10.1016/j.stem.2007.12.003; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Henriksen J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-329; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23592	10.1371/journal.pone.0023592	http://dx.doi.org/10.1371/journal.pone.0023592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853155	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200099
J	Armistead, PM; Liang, SD; Li, H; Lu, SJ; Van Bergen, CAM; Alatrash, G; John, LS; Hunsucker, SA; Sarantopoulos, S; Falkenburg, JHF; Molldrem, JJ				Armistead, Paul M.; Liang, Shoudan; Li, Hua; Lu, Sijie; Van Bergen, Cornelis A. M.; Alatrash, Gheath; John, Lisa St.; Hunsucker, Sally A.; Sarantopoulos, Stefanie; Falkenburg, J. H. Frederik; Molldrem, Jeffrey J.			Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; REDUCED-INTENSITY; T-CELLS; PATIENTS OLDER; LEUKEMIA; HLA; GENE; HA-1	Background: Minor histocompatibility antigens (mHA) mediate much of the graft vs. leukemia (GvL) effect and graft vs. host disease (GvHD) in patients who undergo allogeneic stem cell transplantation (SCT) [1,2,3,4]. Therapeutic decision making and treatments [5] based upon mHAs will require the evaluation of multiple candidate mHAs and the selection of those with the potential to have the greatest impact on clinical outcomes. We hypothesized that common, immunodominant mHAs, which are presented by HLA-A, B, and C molecules, can mediate clinically significant GvL and/or GvHD, and that these mHAs can be identified through association of genomic data with clinical outcomes. Methodology/Principal Findings: Because most mHAs result from donor/recipient cSNP disparities, we genotyped 57 myeloid leukemia patients and their donors at 13,917 cSNPs [6]. We correlated the frequency of genetically predicted mHA disparities with clinical evidence of an immune response and then computationally screened all peptides mapping to the highly associated cSNPs for their ability to bind to HLA molecules. As proof-of-concept, we analyzed one predicted antigen, T4A, whose mHA mismatch trended towards improved overall and disease free survival in our cohort. T4A mHA mismatches occurred at the maximum theoretical frequency for any given SCT. T4A-specific CD8+ T lymphocytes (CTLs) were detected in 3 of 4 evaluable post-transplant patients predicted to have a T4A mismatch. Conclusions/Significance: Our method is the first to combine clinical outcomes data with genomics and bioinformatics methods to predict and confirm a mHA. Refinement of this method should enable the discovery of clinically relevant mHAs in the majority of transplant patients and possibly lead to novel immunotherapeutics [5].	[Armistead, Paul M.; Liang, Shoudan; Lu, Sijie; Alatrash, Gheath; John, Lisa St.; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Sect Transplantat Immunol, Houston, TX 77030 USA; [Liang, Shoudan; Li, Hua] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Van Bergen, Cornelis A. M.; Falkenburg, J. H. Frederik] Leiden Univ, Med Ctr, Lab Expt Hematol, Leiden, Netherlands; [Armistead, Paul M.; Hunsucker, Sally A.; Sarantopoulos, Stefanie] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of North Carolina; University of North Carolina Chapel Hill	Armistead, PM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Sect Transplantat Immunol, Houston, TX 77030 USA.	paul_armistead@med.unc.edu	Van Bergen, Cornelis/N-4773-2019; Van Bergen, Cornelis A.M./P-5782-2016	Van Bergen, Cornelis/0000-0001-6386-4517; Van Bergen, Cornelis A.M./0000-0001-6386-4517; Armistead, Paul/0000-0003-3983-5534; Alatrash, Gheath/0000-0002-7648-4377; Hunsucker, Sally/0000-0002-7034-7355; LI, HUA/0000-0003-2153-2500	National Institutes of Health [CA100632, CA049639]; Leukemia and Lymphoma Society [6031-07, 7262-08]; ASCO; NIH [CA123344A1]; DOD/CDMRP [CM064108]; National Institutes of Health through M.D. Anderson's Cancer Center [CA016672]; Barbara Rattay Advanced Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA016672, K25CA123344, P01CA049639, P50CA100632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ASCO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD/CDMRP(United States Department of Defense); National Institutes of Health through M.D. Anderson's Cancer Center; Barbara Rattay Advanced Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: CA100632 and CA049639 from the National Institutes of Health to JJM, and 6031-07 and 7262-08 from the Leukemia and Lymphoma Society to JJM. This work was also sponsored through an ASCO Young Investigator Award to PMA and CA123344A1 from the NIH and CM064108 from the DOD/CDMRP for S. Liang. This work was also supported in part by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant CA016672. PMA and GA received salary support through the Barbara Rattay Advanced Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Alyea EP, 2005, BLOOD, V105, P1810, DOI 10.1182/blood-2004-05-1947; Aoudjhane M, 2005, LEUKEMIA, V19, P2304, DOI 10.1038/sj.leu.2403967; Barrett AJ, 2006, LEUKEMIA, V20, P1661, DOI 10.1038/sj.leu.2404334; Bleakley M, 2010, BLOOD, V115, P4923, DOI 10.1182/blood-2009-12-260539; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; Falkenburg JHF, 2003, EXP HEMATOL, V31, P743, DOI 10.1016/S0301-472X(03)00190-5; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; GALE RP, 1994, ANN INTERN MED, V120, P646, DOI 10.7326/0003-4819-120-8-199404150-00004; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; HOROWITZ MM, 1990, BLOOD, V75, P555; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kamei M, 2009, BLOOD, V113, P5041, DOI 10.1182/blood-2008-07-171678; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Lazarus HM, 2006, LEUKEMIA, V20, P1673, DOI 10.1038/sj.leu.2404328; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin MT, 2001, BLOOD, V98, P3172, DOI 10.1182/blood.V98.10.3172; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; McCarroll SA, 2009, NAT GENET, V41, P1341, DOI 10.1038/ng.490; Mullally A, 2007, BLOOD, V109, P1355, DOI 10.1182/blood-2006-06-030858; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ratanatharathorn V, 1998, BLOOD, V92, P2303; Spierings E, 2009, J IMMUNOL, V182, P4809, DOI 10.4049/jimmunol.0803911; Tseng LH, 1999, BLOOD, V94, P2911, DOI 10.1182/blood.V94.8.2911.420k21_2911_2914; van Bergen CAM, 2007, BLOOD, V109, P4089, DOI 10.1182/blood-2006-08-043935; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; VANELS CACM, 1992, IMMUNOGENETICS, V35, P161, DOI 10.1007/BF00185109; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V323, P9, DOI 10.1016/j.bbrc.2004.08.048; Warren EH, 2010, BLOOD, V115, P3869, DOI 10.1182/blood-2009-10-248997	34	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23217	10.1371/journal.pone.0023217	http://dx.doi.org/10.1371/journal.pone.0023217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858034	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300027
J	Qi, JP; Ding, YS; Zhu, Y; Wu, YZ				Qi, Jinpeng; Ding, Yongsheng; Zhu, Ying; Wu, Yizhi			Kinetic Theory Approach to Modeling of Cellular Repair Mechanisms under Genome Stress	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; STOCHASTIC GAME-THEORY; IMMUNE COMPETITION; P53; DNA; SYSTEMS; PARADIGMS; BEHAVIOR; LOOKING	Under acute perturbations from outer environment, a normal cell can trigger cellular self-defense mechanism in response to genome stress. To investigate the kinetics of cellular self-repair process at single cell level further, a model of DNA damage generating and repair is proposed under acute Ion Radiation (IR) by using mathematical framework of kinetic theory of active particles (KTAP). Firstly, we focus on illustrating the profile of Cellular Repair System (CRS) instituted by two sub-populations, each of which is made up of the active particles with different discrete states. Then, we implement the mathematical framework of cellular self-repair mechanism, and illustrate the dynamic processes of Double Strand Breaks (DSBs) and Repair Protein (RP) generating, DSB-protein complexes (DSBCs) synthesizing, and toxins accumulating. Finally, we roughly analyze the capability of cellular self-repair mechanism, cellular activity of transferring DNA damage, and genome stability, especially the different fates of a certain cell before and after the time thresholds of IR perturbations that a cell can tolerate maximally under different IR perturbation circumstances.	[Qi, Jinpeng; Ding, Yongsheng; Wu, Yizhi] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China; [Zhu, Ying] CSIRO Plant Ind, Urrbrae, SA, Australia	Donghua University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Qi, JP (corresponding author), Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China.	qipengkai@dhu.edu.cn	Qi, Jinpeng/HDL-6725-2022; Zhu, Ying/F-6663-2011		National Nature Science Foundation of China [60975059]; Ministry of Education of China [20090075110002]; Specialized Research Fund for Natural Science Foundation of Shanghai [10ZR1401600]; Shanghai Committee of Science and Technology [10JC1400200]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Specialized Research Fund for Natural Science Foundation of Shanghai; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported in part by the National Nature Science Foundation of China (No. 60975059), Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China (No. 20090075110002), Specialized Research Fund for Natural Science Foundation of Shanghai (No. 10ZR1401600), and Project of the Shanghai Committee of Science and Technology (No. 10JC1400200). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zhu Ying is an employee of CSIRO Plant Industry and contributed to the writing of the manuscript.	Bellomo N, 2008, MODEL SIMUL SCI ENG, P1, DOI 10.1007/978-0-8176-4600-4; Bellomo N, 2010, MATH COMPUT MODEL, V51, P441, DOI 10.1016/j.mcm.2009.12.002; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Bellomo N, 2008, CURR TOP DEV BIOL, V81, P485, DOI 10.1016/S0070-2153(07)81017-9; Bellomo N, 2006, MATH MOD METH APPL S, V16, P1001, DOI 10.1142/S0218202506001443; Bellouquid A., 2006, MATH MODELING COMPLE; Bertotti ML, 2008, NONLINEAR ANAL-REAL, V9, P183, DOI 10.1016/j.nonrwa.2006.09.012; Bertotti ML, 2004, MATH MOD METH APPL S, V14, P1061, DOI 10.1142/S0218202504003544; Bonzani I, 2004, MATH COMPUT MODEL, V40, P1065, DOI 10.1016/j.mcm.2003.09.042; Brazzoli I, 2008, APPL MATH LETT, V21, P155, DOI 10.1016/j.aml.2007.02.018; Brazzoli I., 2006, COMPUT MATH METHOD M, V7, DOI [10.1080/10273660600968911, DOI 10.1080/10273660600968911]; Budman J, 2005, EMBO J, V24, P849, DOI 10.1038/sj.emboj.7600563; Cercignani C, 2007, MODEL SIMUL SCI ENG, P1, DOI 10.1007/978-0-8176-4554-0; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; De Angelis E, 2008, MATH COMPUT MODEL, V47, P196, DOI 10.1016/j.mcm.2007.02.016; Degond P, 2004, MODEL SIMUL SCI ENG, P3, DOI 10.1007/978-0-8176-8200-2_1; Deutsch A, 2005, CELLULAR AUTOMATON M; KURT W, 2005, BIOCH BIOPHYSICAL RE, V331, P816; Li L, 2001, INT J RADIAT ONCOL, V49, P1157, DOI 10.1016/S0360-3016(00)01524-8; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Pauklin S, 2005, BIOCHEM BIOPH RES CO, V334, P386, DOI 10.1016/j.bbrc.2005.06.097; PEREZ CA., 1998, PRINCIPLES PRACTICE, V3rd ed; Qi JP, 2007, BIOSYSTEMS, V90, P698, DOI 10.1016/j.biosystems.2007.02.007; Qi JP, 2007, AMINO ACIDS, V33, P75, DOI 10.1007/s00726-006-0454-3; Qi JP, 2008, APPL MATH COMPUT, V205, P73, DOI 10.1016/j.amc.2008.05.131; Qi JP, 2006, DYNAM CONT DIS SER B, V13, P11; Qi JP, 2009, PROG NAT SCI-MATER, V19, P1349, DOI 10.1016/j.pnsc.2009.03.008; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003	28	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22228	10.1371/journal.pone.0022228	http://dx.doi.org/10.1371/journal.pone.0022228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857915	Green Submitted, Green Published, gold			2022-12-25	WOS:000293774300003
J	de Koning, PJA; Kummer, JA; de Poot, SAH; Quadir, R; Broekhuizen, R; McGettrick, AF; Higgins, WJ; Devreese, B; Worrall, DM; Bovenschen, N				de Koning, Pieter J. A.; Kummer, J. Alain; de Poot, Stefanie A. H.; Quadir, Razi; Broekhuizen, Roel; McGettrick, Anne F.; Higgins, Wayne J.; Devreese, Bart; Worrall, D. Margaret; Bovenschen, Niels			Intracellular Serine Protease Inhibitor SERPINB4 Inhibits Granzyme M-Induced Cell Death	PLOS ONE			English	Article							MEDIATED APOPTOSIS; CARCINOMA ANTIGEN; MONOCLONAL-ANTIBODIES; ENDOGENOUS INHIBITOR; TUMOR-CELLS; B INHIBITOR; CATHEPSIN-G; EXPRESSION; LYMPHOCYTES; PROTEINS	Granzyme-mediated cell death is the major pathway for cytotoxic lymphocytes to kill virus-infected and tumor cells. In humans, five different granzymes (i.e. GrA, GrB, GrH, GrK, and GrM) are known that all induce cell death. Expression of intracellular serine protease inhibitors (serpins) is one of the mechanisms by which tumor cells evade cytotoxic lymphocyte-mediated killing. Intracellular expression of SERPINB9 by tumor cells renders them resistant to GrB-induced apoptosis. In contrast to GrB, however, no physiological intracellular inhibitors are known for the other four human granzymes. In the present study, we show that SERPINB4 formed a typical serpin-protease SDS-stable complex with both recombinant and native human GrM. Mutation of the P2-P1-P1' triplet in the SERPINB4 reactive center loop completely abolished complex formation with GrM and N-terminal sequencing revealed that GrM cleaves SERPINB4 after P1-Leu. SERPINB4 inhibited GrM activity with a stoichiometry of inhibition of 1.6 and an apparent second order rate constant of 1.3x10(4) M(-1) s(-1). SERPINB4 abolished cleavage of the macromolecular GrM substrates alpha-tubulin and nucleophosmin. Overexpression of SERPINB4 in tumor cells inhibited recombinant GrM-induced as well as NK cell-mediated cell death and this inhibition depended on the reactive center loop of the serpin. As SERPINB4 is highly expressed by squamous cell carcinomas, our results may represent a novel mechanism by which these tumor cells evade cytotoxic lymphocyte-induced GrM-mediated cell death.	[de Koning, Pieter J. A.] Univ Med Ctr Utrecht, Div Surg Specialties, Dept Pathol, Utrecht, Netherlands; [McGettrick, Anne F.; Higgins, Wayne J.; Worrall, D. Margaret] Univ Coll Dublin, Sch Biomol & Biochem Sci, Dublin 2, Ireland; [Devreese, Bart] Univ Ghent, Lab Prot Biochem & Biomol Engn, Dept Biochem & Microbiol, B-9000 Ghent, Belgium	Utrecht University; Utrecht University Medical Center; University College Dublin; Ghent University	de Koning, PJA (corresponding author), Univ Med Ctr Utrecht, Div Surg Specialties, Dept Pathol, Utrecht, Netherlands.	n.bovenschen@umcutrecht.nl	Devreese, Bart/B-2011-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581	Dutch Cancer Society (KWF) [UU-2004-3047, UU-2009-4302]; Netherlands Organization for Scientific Research (NWO) [916.66.044]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch Cancer Society (KWF) (grant UU-2004-3047 to JAK and grant UU-2009-4302 to NB and JAK) and the Netherlands Organization for Scientific Research (NWO) (grant 916.66.044 to NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bade B, 2005, INT IMMUNOL, V17, P1419, DOI 10.1093/intimm/dxh320; BARNES RC, 1995, FEBS LETT, V373, P61, DOI 10.1016/0014-5793(95)01015-7; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bladergroen BA, 2002, BLOOD, V99, P232, DOI 10.1182/blood.V99.1.232; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; Bovenschen N, 2008, J IMMUNOL, V180, P8184, DOI 10.4049/jimmunol.180.12.8184; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Cullen SP, 2009, J BIOL CHEM, V284, P5137, DOI 10.1074/jbc.M807913200; de Bruijn HWA, 1998, TUMOR BIOL, V19, P505, DOI 10.1159/000030044; de Koning PJA, 2010, MOL IMMUNOL, V47, P903, DOI 10.1016/j.molimm.2009.10.001; de Koning PJA, 2009, CRIT REV IMMUNOL, V29, P307, DOI 10.1615/CritRevImmunol.v29.i4.20; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; ESPANA F, 1991, BLOOD, V77, P1754; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hu DQ, 2010, J BIOL CHEM, V285, P18326, DOI 10.1074/jbc.M109.083170; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; KATO H, 1979, CANCER, V43, P585, DOI 10.1002/1097-0142(197902)43:2<585::AID-CNCR2820430227>3.0.CO;2-0; KATO H, 1987, JPN J CANCER RES, V78, P1246; KEIJER J, 1991, BLOOD, V78, P1254; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; KUMMER JA, 1993, J IMMUNOL METHODS, V163, P77, DOI 10.1016/0022-1759(93)90241-X; Lu HX, 2006, J IMMUNOL, V177, P1171, DOI 10.4049/jimmunol.177.2.1171; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; McGettrick AF, 2001, EUR J BIOCHEM, V268, P5868, DOI 10.1046/j.0014-2956.2001.02535.x; Murakami A, 2001, BRIT J CANCER, V84, P851, DOI 10.1054/bjoc.2000.1683; Patston PA, 2004, METHODS, V32, P93, DOI 10.1016/S1046-2023(03)00201-9; Pegram HJ, 2010, CANCER IMMUNOL IMMUN, V59, P1235, DOI 10.1007/s00262-010-0848-7; Sayers TJ, 2001, J IMMUNOL, V166, P765, DOI 10.4049/jimmunol.166.2.765; Schechter NM, 2004, METHODS, V32, P159, DOI 10.1016/S1046-2023(03)00207-X; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Smyth MJ, 1996, J IMMUNOL, V156, P4174; Smyth MJ, 2001, J LEUKOCYTE BIOL, V70, P18; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; ten Berge RL, 2002, BLOOD, V99, P4540, DOI 10.1182/blood.V99.12.4540; van Houdt IS, 2005, CLIN CANCER RES, V11, P6400, DOI 10.1158/1078-0432.CCR-05-0306; WACHTFOGEL YT, 1989, BLOOD, V73, P468; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769; Young JL, 2000, J EXP MED, V191, P1535, DOI 10.1084/jem.191.9.1535; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	49	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22645	10.1371/journal.pone.0022645	http://dx.doi.org/10.1371/journal.pone.0022645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857942	gold, Green Published, Green Submitted			2022-12-25	WOS:000293558900024
J	Seipke, RF; Barke, J; Brearley, C; Hill, L; Yu, DW; Goss, RJM; Hutchings, MI				Seipke, Ryan F.; Barke, Joerg; Brearley, Charles; Hill, Lionel; Yu, Douglas W.; Goss, Rebecca J. M.; Hutchings, Matthew I.			A Single Streptomyces Symbiont Makes Multiple Antifungals to Support the Fungus Farming Ant Acromyrmex octospinosus	PLOS ONE			English	Article							LEAF-CUTTING ANTS; GENE-CLUSTER; MICROBE SYMBIOSIS; GROWING ANTS; BACTERIA; BIOSYNTHESIS; CLONING; COEVOLUTION; ESCOVOPSIS; COMMUNITY	Attine ants are dependent on a cultivated fungus for food and use antibiotics produced by symbiotic Actinobacteria as weedkillers in their fungus gardens. Actinobacterial species belonging to the genera Pseudonocardia, Streptomyces and Amycolatopsis have been isolated from attine ant nests and shown to confer protection against a range of microfungal weeds. In previous work on the higher attine Acromyrmex octospinosus we isolated a Streptomyces strain that produces candicidin, consistent with another report that attine ants use Streptomyces-produced candicidin in their fungiculture. Here we report the genome analysis of this Streptomyces strain and identify multiple antibiotic biosynthetic pathways. We demonstrate, using gene disruptions and mass spectrometry, that this single strain has the capacity to make candicidin and multiple antimycin compounds. Although antimycins have been known for > 60 years we report the sequence of the biosynthetic gene cluster for the first time. Crucially, disrupting the candicidin and antimycin gene clusters in the same strain had no effect on bioactivity against a co-evolved nest pathogen called Escovopsis that has been identified in similar to 30% of attine ant nests. Since the Streptomyces strain has strong bioactivity against Escovopsis we conclude that it must make additional antifungal(s) to inhibit Escovopsis. However, candicidin and antimycins likely offer protection against other microfungal weeds that infect the attine fungal gardens. Thus, we propose that the selection of this biosynthetically prolific strain from the natural environment provides A. octospinosus with broad spectrum activity against Escovopsis and other microfungal weeds.	[Seipke, Ryan F.; Barke, Joerg; Brearley, Charles; Yu, Douglas W.; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Hill, Lionel] John Innes Ctr, Norwich, Norfolk, England; [Yu, Douglas W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources, Kunming, Peoples R China; [Goss, Rebecca J. M.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Yu, Douglas W.] Chinese Acad Sci, Kunming Inst Zool, Evolut Ecol Conservat & Environm Ctr, Kunming, Peoples R China	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia; Chinese Academy of Sciences; Kunming Institute of Zoology	Seipke, RF (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	r.seipke@uea.ac.uk; m.hutchings@uea.ac.uk	Yu, Douglas W./D-2536-2009; Hutchings, Matt/D-1923-2009	Yu, Douglas W./0000-0001-8551-5609; Hutchings, Matt/0000-0001-6628-5940; Brearley, Charles/0000-0001-6179-9109; Seipke, Ryan/0000-0002-6156-8498	Medical Research Council [G0801721]; BBSRC [BB/F010591/1] Funding Source: UKRI; MRC [G0801721] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F010591/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Medical Research Council Milstein Award (grant G0801721) to MIH, RJMG and DWY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Barke Joerg, 2011, Communicative & Integrative Biology, V4, P41, DOI 10.4161/cib.4.1.13552; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chen S, 2003, CHEM BIOL, V10, P1065, DOI 10.1016/j.chembiol.2003.10.007; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; DUNSHEE BR, 1949, J AM CHEM SOC, V71, P2436, DOI 10.1021/ja01175a057; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kost C, 2007, NATURWISSENSCHAFTEN, V94, P821, DOI 10.1007/s00114-007-0262-y; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Maconi P, 1976, ANN SCLAVO, V18, P61; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; PANDEY RC, 1981, J ANTIBIOT, V34, P1389, DOI 10.7164/antibiotics.34.1389; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Schoenian I, 2011, P NATL ACAD SCI USA, V108, P1955, DOI 10.1073/pnas.1008441108; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Seipke RF, 2011, J BACTERIOL, V193, P4270, DOI 10.1128/JB.05275-11; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u	27	119	125	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22028	10.1371/journal.pone.0022028	http://dx.doi.org/10.1371/journal.pone.0022028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857911	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900009
J	Biswas, A; Boutaghou, MN; Alvey, RM; Kronfel, CM; Cole, RB; Bryant, DA; Schluchter, WM				Biswas, Avijit; Boutaghou, M. Nazim; Alvey, Richard M.; Kronfel, Christina M.; Cole, Richard B.; Bryant, Donald A.; Schluchter, Wendy M.			Characterization of the Activities of the CpeY, CpeZ, and CpeS Bilin Lyases in Phycoerythrin Biosynthesis in Fremyella diplosiphon Strain UTEX 481	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCOCCUS SP PCC-7002; PHYCOBILIPROTEIN BETA-SUBUNITS; HOLO-ALPHA SUBUNIT; SP PCC 7002; CHROMOPHORE ATTACHMENT; LINKER POLYPEPTIDES; LINKAGE DIVERSITY; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; CPCS-I	When grown in green light, Fremyella diplosiphon strain UTEX 481 produces the red-colored protein phycoerythrin (PE) to maximize photosynthetic light harvesting. PE is composed of two subunits, CpeA and CpeB, which carry two and three phycoerythrobilin (PEB) chromophores, respectively, that are attached to specific Cys residues via thioether linkages. Specific bilin lyases are hypothesized to catalyze each PEB ligation. Using a heterologous, coexpression system in Escherichia coli, the PEB ligation activities of putative lyase subunits CpeY, CpeZ, and CpeS were tested on the CpeA and CpeB subunits from F. diplosiphon. Purified His(6)-tagged CpeA, obtained by coexpressing cpeA, cpeYZ, and the genes for PEB synthesis, had absorbance and fluorescence emission maxima at 566 and 574 nm, respectively. CpeY alone, but not CpeZ, could ligate PEB to CpeA, but the yield of CpeA-PEB was lower than achieved with CpeY and CpeZ together. Studies with site-specific variants of CpeA(C82S and C139S), together with mass spectrometric analysis of trypsin-digested CpeA-PEB, revealed that CpeY/CpeZ attached PEB at Cys(82) of CpeA. The CpeS bilin lyase ligated PEB at both Cys(82) and Cys(139) of CpeA but very inefficiently; the yield of PEB ligated at Cys(82) was much lower than observed with CpeY or CpeY/CpeZ. However, CpeS efficiently attached PEB to Cys(80) of CpeB but neither CpeY, CpeZ, nor CpeY/CpeZ could ligate PEB to CpeB.	[Biswas, Avijit; Kronfel, Christina M.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Boutaghou, M. Nazim; Cole, Richard B.] Univ New Orleans, Dept Chem, New Orleans, LA 70148 USA; [Alvey, Richard M.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	University of Louisiana System; University of New Orleans; University of Louisiana System; University of New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Schluchter, WM (corresponding author), 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	wschluch@uno.edu	Schluchter, Wendy/G-9662-2013		National Science Foundation [MCB-0843664, DBI-0619272, CHE-1058764, MCB-0519743, MCB-1021725]; Div Of Molecular and Cellular Bioscience [0843664] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0843664 (to W. M. S.), DBI-0619272 and CHE-1058764 (to R. B. C.), and MCB-0519743 and MCB-1021725 (to D. A. B.).	Alvey RM, 2011, BIOCHEMISTRY-US, V50, P4890, DOI 10.1021/bi200307s; Alvey RM, 2011, J BACTERIOL, V193, P1663, DOI 10.1128/JB.01392-10; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; [Anonymous], [No title captured]; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BISHOP JE, 1986, J BIOL CHEM, V261, P6790; BISHOP JE, 1987, J AM CHEM SOC, V109, P875, DOI 10.1021/ja00237a039; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Boutaghou M. N., 2011, P 59 ASMS C MASS SPE; Boutaghou M. N., 2010, P 58 ASMS C MASS SPE; Bryant D.A., 1988, LIGHT ENERGY TRANSDU, P62; Bryant D. A., 1991, CELL CULTURE SOMATIC, P257; BRYANT DA, 1990, ARCH MICROBIOL, V153, P550, DOI 10.1007/BF00245264; BRYANT DA, 1991, GENE, V107, P91, DOI 10.1016/0378-1119(91)90301-Q; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; DELORIMIER R, 1990, BIOCHIM BIOPHYS ACTA, V1019, P29, DOI 10.1016/0005-2728(90)90121-J; DELORIMIER R, 1984, P NATL ACAD SCI-BIOL, V81, P7946; DEMARSAC NT, 1988, METHOD ENZYMOL, V167, P318; Dines M, 2008, J BIOL CHEM, V283, P30330, DOI 10.1074/jbc.M804241200; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; FEDERSPIEL NA, 1990, J BACTERIOL, V172, P4072, DOI 10.1128/jb.172.7.4072-4081.1990; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; GINDT YM, 1992, J PHOTOCH PHOTOBIO B, V15, P75, DOI 10.1016/1011-1344(92)87007-V; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; Hirose Y, 2010, P NATL ACAD SCI USA, V107, P8854, DOI 10.1073/pnas.1000177107; Hu IC, 2006, BIOCHEMISTRY-US, V45, P7092, DOI 10.1021/bi052067a; Huang B, 2002, CANCER BIOTHER RADIO, V17, P35, DOI 10.1089/10849780252824055; Isailovic D, 2004, J CHROMATOGR A, V1051, P119, DOI 10.1016/j.chroma.2004.07.038; Isailovic D, 2006, ANAL BIOCHEM, V358, P38, DOI 10.1016/j.ab.2006.08.011; JUNG LJ, 1995, J BIOL CHEM, V270, P12877, DOI 10.1074/jbc.270.21.12877; Kahn K, 1997, J BACTERIOL, V179, P998, DOI 10.1128/jb.179.4.998-1006.1997; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; KLOTZ AV, 1986, J BIOL CHEM, V261, P6797; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; MAZEL D, 1986, NUCLEIC ACIDS RES, V14, P8279, DOI 10.1093/nar/14.21.8279; Miller CA, 2008, J BIOL CHEM, V283, P19293, DOI 10.1074/jbc.M802734200; NGUYEN DC, 1987, ANAL CHEM, V59, P2158, DOI 10.1021/ac00144a032; ONG LJ, 1991, J BIOL CHEM, V266, P9515; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; RAPS S, 1990, PLANT PHYSIOL, V92, P358, DOI 10.1104/pp.92.2.358; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Shen G., 2004, PS 2004 LIGHT HARV S, P14; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; SIDLER W, 1986, BIOL CHEM H-S, V367, P627, DOI 10.1515/bchm3.1986.367.2.627; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; Tooley AJ, 2001, P NATL ACAD SCI USA, V98, P10560, DOI 10.1073/pnas.181340998; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulijasz AT, 2009, J BIOL CHEM, V284, P29757, DOI 10.1074/jbc.M109.038513; Wiethaus J, 2010, J BIOL CHEM, V285, P37561, DOI 10.1074/jbc.M110.172619; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	79	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35509	35521		10.1074/jbc.M111.284281	http://dx.doi.org/10.1074/jbc.M111.284281			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865169	Green Published, hybrid			2022-12-25	WOS:000295927100023
J	Haldipur, P; Bharti, U; Alberti, C; Sarkar, C; Gulati, G; Iyengar, S; Gressens, P; Mani, S				Haldipur, Parthiv; Bharti, Upasna; Alberti, Corinne; Sarkar, Chitra; Gulati, Geetika; Iyengar, Soumya; Gressens, Pierre; Mani, Shyamala			Preterm Delivery Disrupts the Developmental Program of the Cerebellum	PLOS ONE			English	Article							1,4,5-TRISPHOSPHATE INSP3 RECEPTOR; CORTICAL LAYERS; PURKINJE-CELL; INFLAMMATION; INFANT; GROWTH	A rapid growth in human cerebellar development occurs in the third trimester, which is impeded by preterm delivery. The goal of this study was to characterize the impact of preterm delivery on the developmental program of the human cerebellum. Still born infants, which meant that all development up to that age had taken place in-utero, were age paired with preterm delivery infants, who had survived in an ex-utero environment, which meant that their development had also taken place outside the uterus. The two groups were assessed on quantitative measures that included molecular markers of granule neuron, purkinje neuron and bergmann glia differentiation, as well as the expression of the sonic hedgehog signaling pathway, that is important for cerebellar growth. We report that premature birth and development in an ex-utero environment leads to a significant decrease in the thickness and an increase in the packing density of the cells within the external granular layer and the inner granular layer well, as a reduction in the density of bergmann glial fibres. In addition, this also leads to a reduced expression of sonic hedgehog in the purkinje layer. We conclude that the developmental program of the cerebellum is specifically modified by events that follow preterm delivery.	[Haldipur, Parthiv; Bharti, Upasna; Iyengar, Soumya; Mani, Shyamala] Natl Brain Res Ctr, Manesar, Haryana, India; [Alberti, Corinne] CIE 5, INSERM, Paris, France; [Alberti, Corinne] Robert Debre Hosp, Assistance Publ Hop Paris, Unite Epidemiol Clin, Paris, France; [Alberti, Corinne; Gressens, Pierre] Univ Paris 07, Fac Med Denis Diderot, Paris, France; [Sarkar, Chitra; Gulati, Geetika] All India Inst Med Sci, New Delhi, India; [Gressens, Pierre] INSERM, U676, Paris, France; [Gressens, Pierre] PremUP, Paris, France	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; All India Institute of Medical Sciences (AIIMS) New Delhi; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Haldipur, P (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	shyamala@cns.iisc.ernet.in	gressens, pierre/M-7557-2017; Haldipur, Parthiv/ABH-8875-2020	gressens, pierre/0000-0002-0909-4221; HALDIPUR, PARTHIV/0000-0003-2865-8683	Indo-French Centre for the Promotion of Advanced Research [3803-3]; National Brain Research Centre, Manesar, India; Assistance Publique-Hospitaux de Paris (Contrat d'Interface)	Indo-French Centre for the Promotion of Advanced Research(French National Research Agency (ANR)); National Brain Research Centre, Manesar, India; Assistance Publique-Hospitaux de Paris (Contrat d'Interface)	This project was supported by Indo-French Centre for the Promotion of Advanced Research grant number 3803-3 to SM and PG, core support from the National Brain Research Centre, Manesar, India and a grant from Assistance Publique-Hospitaux de Paris (Contrat d'Interface to PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2001, INT J DEV NEUROSCI, V19, P53, DOI 10.1016/S0736-5748(00)00065-4; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P496, DOI 10.1016/j.clineuro.2008.01.003; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Baillieux H, 2009, BRAIN LANG, V108, P122, DOI 10.1016/j.bandl.2008.10.001; BAKALIAN A, 1995, J NEUROGENET, V9, P207, DOI 10.3109/01677069509084157; Beaino G, 2010, DEV MED CHILD NEUROL, V52, pE119, DOI 10.1111/j.1469-8749.2010.03612.x; Bellebaum C, 2011, CORTEX, V47, P128, DOI 10.1016/j.cortex.2009.07.016; Ben-Yehudah G, 2008, ANN NY ACAD SCI, V1145, P260, DOI 10.1196/annals.1416.015; Bueter W, 2009, PEDIATR RES, V66, P487, DOI 10.1203/PDR.0b013e3181baa083; Bugalho Paulo, 2006, Acta Med Port, V19, P257; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Cox C, 2001, LARYNGOSCOPE, V111, P696, DOI 10.1097/00005537-200104000-00024; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DEBLAS AL, 1985, BRAIN RES, V342, P234, DOI 10.1016/0006-8993(85)91121-7; Degos V, 2010, J NEURAL TRANSM, V117, P1009, DOI 10.1007/s00702-010-0411-x; Gordon N, 2007, EUR J PAEDIATR NEURO, V11, P232, DOI 10.1016/j.ejpn.2007.02.003; Haldipur P, 2011, STEM CELLS IN PRESS; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Limperopoulos C, 2005, PEDIATRICS, V116, P717, DOI 10.1542/peds.2005-0556; Limperopoulos C, 2005, PEDIATRICS, V115, P688, DOI 10.1542/peds.2004-1169; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; Marien P, 2009, CORTEX, V45, P527, DOI 10.1016/j.cortex.2007.12.010; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rollins NK, 1995, PEDIATR RADIOL, V25, pS20; Steer P, 2005, J PERINAT MED, V33, P273, DOI 10.1515/JPM.2005.053; Thoma P, 2008, CEREBELLUM, V7, P433, DOI 10.1007/s12311-008-0046-8; VINORES SA, 1994, HISTOCHEM J, V26, P678, DOI 10.1007/BF00158293; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0	39	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23449	10.1371/journal.pone.0023449	http://dx.doi.org/10.1371/journal.pone.0023449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858122	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300047
J	Nasidze, I; Li, J; Schroeder, R; Creasey, JL; Li, MK; Stoneking, M				Nasidze, Ivan; Li, Jing; Schroeder, Roland; Creasey, Jean L.; Li, Mingkun; Stoneking, Mark			High Diversity of the Saliva Microbiome in Batwa Pygmies	PLOS ONE			English	Article							WATER; NOV.	We describe the saliva microbiome diversity in Batwa Pygmies, a former hunter-gatherer group from Uganda, using next-generation sequencing of partial 16S rRNA sequences. Microbial community diversity in the Batwa is significantly higher than in agricultural groups from Sierra Leone and the Democratic Republic of Congo. We found 40 microbial genera in the Batwa, which have previously not been described in the human oral cavity. The distinctive composition of the salvia microbiome of the Batwa may have been influenced by their recent different lifestyle and diet.	[Nasidze, Ivan; Li, Jing; Schroeder, Roland; Li, Mingkun; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Creasey, Jean L.] DDS, Nevada City, CA USA	Max Planck Society	Nasidze, I (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	nasidze@eva.mpg.de	Li, Mingkun/G-7161-2012		Max Planck Society, Germany	Max Planck Society, Germany(Max Planck Society)	This research was funded by the Max Planck Society, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2006, INT J SYST EVOL MICR, V56, P1311, DOI 10.1099/ijs.0.64218-0; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Cao SJ, 2010, INT J SYST EVOL MICR, V60, P2023, DOI 10.1099/ijs.0.017681-0; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Conover WJ, 1998, PRACTICAL NONPARAMET; Gusinde M, 1955, ANTHR Q, V28, P3; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; SCHNEIDER S, 2000, ARELQUIN VERSION 2 0; *STATSOFT INC, 1984, STATISTICA PACK 6 1; Sundquist A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-108; WALKER PL, 1990, AM ANTHROPOL, V92, P383, DOI 10.1525/aa.1990.92.2.02a00080	16	70	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23352	10.1371/journal.pone.0023352	http://dx.doi.org/10.1371/journal.pone.0023352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858083	gold, Green Published, Green Submitted			2022-12-25	WOS:000294125500030
J	Eleore, L; Lopez-Ramos, JC; Guerra-Narbona, R; Delgado-Garcia, JM				Eleore, Lyndell; Carlos Lopez-Ramos, Juan; Guerra-Narbona, Rafael; Delgado-Garcia, Jose M.			Role of Reuniens Nucleus Projections to the Medial Prefrontal Cortex and to the Hippocampal Pyramidal CA1 Area in Associative Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PAIRED-PULSE FACILITATION; SYNAPTIC-TRANSMISSION; MIDLINE THALAMUS; CA3-CA1 SYNAPSE; IN-VIVO; RAT; PLASTICITY; STIMULATION; MEMORY	We studied the interactions between short- and long-term plastic changes taking place during the acquisition of a classical eyeblink conditioning and following high-frequency stimulation (HFS) of the reuniens nucleus in behaving mice. Synaptic changes in strength were studied at the reuniens-medial prefrontal cortex (mPFC) and the reuniens-CA1 synapses. Input/output curves and a paired-pulse study enabled determining the functional capabilities of the two synapses and the optimal intensities to be applied at the reuniens nucleus during classical eyeblink conditioning and for HFS applied to the reuniens nucleus. Animals were conditioned using a trace paradigm, with a tone as conditioned stimulus (CS) and an electric shock to the trigeminal nerve as unconditioned stimulus (US). A single pulse was presented to the reuniens nucleus to evoke field EPSPs (fEPSPs) in mPFC and CA1 areas during the CS-US interval. No significant changes in synaptic strength were observed at the reuniens-mPFC and reuniens-CA1 synapses during the acquisition of eyelid conditioned responses (CRs). Two successive HFS sessions carried out during the first two conditioning days decreased the percentage of CRs, without evoking any long-term potentiation (LTP) at the recording sites. HFS of the reuniens nucleus also prevented the proper acquisition of an object discrimination task. A subsequent study revealed that HFS of the reuniens nucleus evoked a significant decrease of paired-pulse facilitation. In conclusion, reuniens nucleus projections to prefrontal and hippocampal circuits seem to participate in the acquisition of associative learning through a mechanism that does not required the development of LTP.	[Eleore, Lyndell; Carlos Lopez-Ramos, Juan; Guerra-Narbona, Rafael; Delgado-Garcia, Jose M.] Univ Pablo de Olavide, Div Neurociencias, Seville, Spain	Universidad Pablo de Olavide	Eleore, L (corresponding author), Univ Pablo de Olavide, Div Neurociencias, Seville, Spain.	jmdelgar@upo.es	Delgado-Garcia, Jose M./V-1567-2019; Ramos, Juan Carlos López/K-9336-2014	Lopez Ramos, Juan Carlos/0000-0003-0943-8802	Spanish Ministry of Research and Innovation: Fundamental Biology [(BFU)-2008-0899]; Spanish "Junta de Andalucia" [Biology-122, Biology-2487]	Spanish Ministry of Research and Innovation: Fundamental Biology; Spanish "Junta de Andalucia"(Junta de Andalucia)	This work was supported by grants from the Spanish Ministry of Research and Innovation: Fundamental Biology (BFU)-2008-0899, and Spanish "Junta de Andalucia": Biology-122 and Biology-2487. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Burette F, 1997, J NEUROPHYSIOL, V78, P1155, DOI 10.1152/jn.1997.78.2.1155; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Davoodi FG, 2009, BEHAV BRAIN RES, V198, P130, DOI 10.1016/j.bbr.2008.10.037; de Sevilla DF, 2002, J PHYSIOL-LONDON, V545, P51, DOI 10.1113/jphysiol.2002.029165; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; DEJONGE M, 1985, BRAIN RES, V328, P181, DOI 10.1016/0006-8993(85)91341-1; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Dolleman-van der Weel MJ, 2009, BRAIN STRUCT FUNCT, V213, P329, DOI 10.1007/s00429-008-0200-6; DollemanVanderWeel MJ, 1997, J NEUROSCI, V17, P5640; Eichenbaum H, 1999, NAT NEUROSCI, V2, P775, DOI 10.1038/12137; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; HEMBROOK JR, 2011, HIPPOCAMPUS IN PRESS; Izaki Y, 2003, BRAIN RES, V992, P142, DOI 10.1016/S0006-8993(03)03538-8; Jay TM, 2004, NEUROTOX RES, V6, P233, DOI 10.1007/BF03033225; JAY TM, 1992, EUR J NEUROSCI, V4, P1285, DOI 10.1111/j.1460-9568.1992.tb00154.x; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Lagostena L, 2008, NEUROPHARMACOLOGY, V54, P676, DOI 10.1016/j.neuropharm.2007.11.016; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Leal-Campanario R, 2007, P NATL ACAD SCI USA, V104, P11459, DOI 10.1073/pnas.0704548104; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.007.2009; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; McKenna JT, 2004, J COMP NEUROL, V480, P115, DOI 10.1002/cne.20342; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Mulder AB, 1997, EUR J NEUROSCI, V9, P1603, DOI 10.1111/j.1460-9568.1997.tb01518.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Saviane C, 2002, J PHYSIOL-LONDON, V544, P469, DOI 10.1113/jphysiol.2002.026609; Schulz PE, 1997, J NEUROPHYSIOL, V78, P321, DOI 10.1152/jn.1997.78.1.321; Sokolov MV, 1998, NEUROSCIENCE, V85, P1, DOI 10.1016/S0306-4522(97)00592-7; THOMPSON RF, 1988, TRENDS NEUROSCI, V11, P152, DOI 10.1016/0166-2236(88)90141-5; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Urban Z, 2002, ACTA BIOL HUNG, V53, P205, DOI 10.1556/ABiol.53.2002.1-2.19; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	40	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23538	10.1371/journal.pone.0023538	http://dx.doi.org/10.1371/journal.pone.0023538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858159	gold, Green Submitted, Green Published			2022-12-25	WOS:000293953700031
J	Meiners, C; Sagaon-Teyssier, L; Hasenclever, L; Moatti, JP				Meiners, Constance; Sagaon-Teyssier, Luis; Hasenclever, Lia; Moatti, Jean-Paul			Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?	PLOS ONE			English	Article							UNIVERSAL ACCESS; AIDS TREATMENT; POLICY; SUSTAINABILITY; CHALLENGES; HEALTH; COSTS	Background: Brazil became the first developing country to guarantee free and universal access to HIV/AIDS treatment, with antiretroviral drugs (ARVs) being delivered to nearly 190,000 patients. The analysis of ARV price evolution and market dynamics in Brazil can help anticipate issues soon to afflict other developing countries, as the 2010 revision of the World Health Organization guidelines shifts demand towards more expensive treatments, and, at the same time, current evolution of international legislation and trade agreements on intellectual property rights may reduce availability of generic drugs for HIV care. Methods and Findings: Our analyses are based on effective prices paid for ARV procurement in Brazil between 1996 and 2009. Data panel structure was exploited to gather ex-ante and ex-post information and address various sources of statistical bias. In-difference estimation offered in-depth information on ARV market characteristics which significantly influence prices. Although overall ARV prices follow a declining trend, changing characteristics in the generic segment help explain recent increase in generic ARV prices. Our results show that generic suppliers are more likely to respond to factors influencing demand size and market competition, while originator suppliers tend to set prices strategically to offset compulsory licensing threats and generic competition. Significance: In order to guarantee the long term sustainability of access to antiretroviral treatment, our findings highlight the importance of preserving and stimulating generic market dynamics to sustain developing countries' bargaining power in price negotiations undertaken with originator companies.	[Meiners, Constance; Sagaon-Teyssier, Luis; Moatti, Jean-Paul] Aix Marseille Univ, IRD, INSERM, UMR 912, Marseille, France; [Meiners, Constance; Hasenclever, Lia] Univ Fed Rio de Janeiro, Inst Econ, Rio De Janeiro, Brazil; [Meiners, Constance] Minist Planning Budget & Adm, Brasilia, DF, Brazil; [Sagaon-Teyssier, Luis; Moatti, Jean-Paul] ORS PACA Reg Observ Dis Control SE France, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universidade Federal do Rio de Janeiro	Meiners, C (corresponding author), Aix Marseille Univ, IRD, INSERM, UMR 912, Marseille, France.	constance.meiners@inserm.fr	Hasenclever, Lia/GPF-5925-2022	Hasenclever, Lia/0000-0003-1384-6323; Sagaon-Teyssier, Luis/0000-0001-7318-6596	French AIDS Research Agency - ANRS, France; Sidaction, France; Unitaid	French AIDS Research Agency - ANRS, France; Sidaction, France; Unitaid	This study has been financed by the French AIDS Research Agency - ANRS (http://www.anrs.fr/) and Sidaction (http://www.sidaction.org/), both situated in France. Additional funding was received by Unitaid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors take entire responsibility for the views presented in this article.	*BRAZ MIN HLTH DEP, 2011, BRAS PROD VERS GEN M; *CNAIDS, 2010, TARG COMM MAD MEMB S; Crowley S, 2010, LANCET, V375, P874, DOI 10.1016/S0140-6736(09)62064-X; Davidson R, 1993, ESTIMATION INFERENCE; FIUZA EPS, 2010, 1511 IPEA; Galvao J, 2005, AM J PUBLIC HEALTH, V95, P1110, DOI 10.2105/AJPH.2004.044313; Grangeiro A, 2006, REV SAUDE PUBL, V40, P60, DOI 10.1590/S0034-89102006000800009; Greco DB, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000279705.24428.a3; HASENCLEVER L, 2006, PROPRIEDADE INTELECT; HASENCLEVER L, 2011, COLECOES AN IN PRESS; LISBOA M, 2001, 8 SEAEMF; Loyola MA, 2008, CIENC SAUDE COLETIVA, V13, P763, DOI 10.1590/S1413-81232008000700027; LUCCHINI S, 2003, EC AIDS ACCESS HIV A, P169; Meiners CMMA, 2008, CAD SAUDE PUBLICA, V24, P1467, DOI 10.1590/S0102-311X2008000700002; Moatti JP., 2003, EC AIDS ACCESS HIV A, P109; Morris K, 2010, LANCET INFECT DIS, V10, P11, DOI 10.1016/S1473-3099(09)70341-X; Mullard A, 2010, LANCET, V375, P1335, DOI 10.1016/S0140-6736(10)60560-0; Nakamura A, 1998, J ECONOMETRICS, V83, P213, DOI 10.1016/S0304-4076(97)00070-5; *NAT PROGR SEX TRA, 2008, REC TER ANT AD INF H; Nunn AS, 2007, PLOS MED, V4, P1804, DOI 10.1371/journal.pmed.0040305; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; Orsi F, 2010, LANCET, V375, P1693, DOI 10.1016/S0140-6736(10)60737-4; Orsi F, 2010, CURR OPIN HIV AIDS, V5, P237, DOI 10.1097/COH.0b013e32833860ba; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; Scheffer Mario C., 2005, SERIE LEGISLACAO, V1st; Vieira FS, 2009, REV SAUDE PUBL, V43, P674, DOI 10.1590/S0034-89102009005000041; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Waning B, 2009, B WORLD HEALTH ORGAN, V87, P520, DOI 10.2471/BLT.08.058925; Wirtz VJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S6; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	30	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23478	10.1371/journal.pone.0023478	http://dx.doi.org/10.1371/journal.pone.0023478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808CV	21858138	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953700026
J	Yarbrough, DK; Eckert, R; He, J; Hagerman, E; Qi, FX; Lux, R; Wu, B; Anderson, MH; Shi, WY				Yarbrough, Daniel K.; Eckert, Randal; He, Jian; Hagerman, Elizabeth; Qi, Fengxia; Lux, Renate; Wu, Ben; Anderson, Maxwell H.; Shi, Wenyuan			Rapid Probing of Biological Surfaces with a Sparse-Matrix Peptide Library	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; ANTIMICROBIAL PEPTIDES; CELL-SURFACE; PROTEIN MICROARRAYS; MYXOCOCCUS-XANTHUS; BIOACTIVE PEPTIDES; RATIONAL DESIGN; SOCIAL MOTILITY; PHAGE DISPLAY; CANCER-CELLS	Finding unique peptides to target specific biological surfaces is crucial to basic research and technology development, though methods based on biological arrays or large libraries limit the speed and ease with which these necessary compounds can be found. We reasoned that because biological surfaces, such as cell surfaces, mineralized tissues, and various extracellular matrices have unique molecular compositions, they present unique physicochemical signatures to the surrounding medium which could be probed by peptides with appropriately corresponding physicochemical properties. To test this hypothesis, a naive pilot library of 36 peptides, varying in their hydrophobicity and charge, was arranged in a two-dimensional matrix and screened against various biological surfaces. While the number of peptides in the matrix library was very small, we obtained "hits'' against all biological surfaces probed. Sequence refinement of the "hits'' led to peptides with markedly higher specificity and binding activity against screened biological surfaces. Genetic studies revealed that peptide binding to bacteria was mediated, at least in some cases, by specific cell-surface molecules, while examination of human tooth sections showed that this method can be used to derive peptides with highly specific binding to human tissue.	[Yarbrough, Daniel K.; Eckert, Randal; Anderson, Maxwell H.] C3 Jian Inc, Inglewood, CA 90301 USA; [He, Jian; Lux, Renate; Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Hagerman, Elizabeth; Wu, Ben] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA; [Qi, Fengxia] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma Health Sciences Center	Yarbrough, DK (corresponding author), C3 Jian Inc, Inglewood, CA 90301 USA.	wenyuan@ucla.edu	SHI, wen/GPW-9531-2022	Wu, Benjamin/0000-0001-5236-8534	UC Discovery Grant	UC Discovery Grant	This work was supported by a UC Discovery Grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; AOKI H, 1986, INFECT IMMUN, V53, P587, DOI 10.1128/IAI.53.3.587-594.1986; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; CALIS S, 1995, PHARM RES-DORDR, V12, P1072, DOI 10.1023/A:1016278902839; Chen L, 2005, J CLIN MICROBIOL, V43, P3574, DOI 10.1128/JCM.43.7.3574-3575.2005; CLACKSON T, 1994, TRENDS BIOTECHNOL, V12, P173, DOI 10.1016/0167-7799(94)90079-5; Dahlin S, 1998, EUR J ORAL SCI, V106, P239, DOI 10.1111/j.1600-0722.1998.tb02182.x; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Duburcq X, 2004, BIOCONJUGATE CHEM, V15, P307, DOI 10.1021/bc034226d; Duval E, 2009, PEPTIDES, V30, P1608, DOI 10.1016/j.peptides.2009.06.022; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P1480, DOI 10.1128/AAC.50.4.1480-1488.2006; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P3651, DOI 10.1128/AAC.00622-06; Falciani C, 2005, CHEM BIOL, V12, P417, DOI 10.1016/j.chembiol.2005.02.009; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fujisawa R, 1998, EUR J ORAL SCI, V106, P249, DOI 10.1111/j.1600-0722.1998.tb02183.x; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Groenink J, 1998, ANTON LEEUW INT J G, V73, P279, DOI 10.1023/A:1001543514171; Gu F, 2005, J MICROBIOL METH, V62, P145, DOI 10.1016/j.mimet.2005.02.013; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; He J, 2010, ANTIMICROB AGENTS CH, V54, P2143, DOI 10.1128/AAC.01391-09; Hu SJ, 2006, BIOCHEM BIOPH RES CO, V341, P964, DOI 10.1016/j.bbrc.2006.01.047; Katz BA, 1997, ANNU REV BIOPH BIOM, V26, P27, DOI 10.1146/annurev.biophys.26.1.27; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; Kazmierski WM, 2006, CHEM BIOL DRUG DES, V67, P13, DOI 10.1111/j.1747-0285.2005.00319.x; Klemm P, 2000, MICROBIOL-SGM, V146, P3025, DOI 10.1099/00221287-146-12-3025; Kreutzberger J, 2006, APPL MICROBIOL BIOT, V70, P383, DOI 10.1007/s00253-006-0312-y; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li L, 2010, CHEM BIOL DRUG DES, V75, P127, DOI 10.1111/j.1747-0285.2009.00904.x; Marasco D, 2008, CURR PROTEIN PEPT SC, V9, P447, DOI 10.2174/138920308785915209; Meloen R, 2004, MOL DIVERS, V8, P57, DOI 10.1023/B:MODI.0000025698.16766.11; Nikaido H, 1999, J BACTERIOL, V181, P4, DOI 10.1128/JB.181.1.4-8.1999; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; SCOGNAMIGLIO PL, 2011, CHEM BIOL DRUG DES; Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002; Thorgeirsson TE, 1996, BIOCHEMISTRY-US, V35, P1803, DOI 10.1021/bi952300c; Tomizaki KY, 2005, CHEMBIOCHEM, V6, P783, DOI 10.1002/cbic.200400232; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tozzi C, 2006, CURR PHARM DESIGN, V12, P191, DOI 10.2174/138161206775193082; VANDERNOOT TJ, 1991, J ELECTROANAL CHEM, V300, P191, DOI 10.1016/0022-0728(91)85394-5; WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Yang ZM, 1998, J BACTERIOL, V180, P218, DOI 10.1128/JB.180.2.218-224.1998; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Yarbrough DK, 2010, CALCIFIED TISSUE INT, V86, P58, DOI 10.1007/s00223-009-9312-0; Zhu L, 2006, MICROBIOL-SGM, V152, P2395, DOI 10.1099/mic.0.28883-0; Zhuang ZY, 2011, BIOPHYS J, V100, P1306, DOI 10.1016/j.bpj.2010.12.3735; Zita A, 1997, FEMS MICROBIOL LETT, V152, P299, DOI 10.1016/S0378-1097(97)00214-0	48	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23551	10.1371/journal.pone.0023551	http://dx.doi.org/10.1371/journal.pone.0023551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858167	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700033
J	Chong, R; Squires, R; Swiss, R; Agaisse, H				Chong, Ryan; Squires, Raynal; Swiss, Rachel; Agaisse, Herve			RNAi Screen Reveals Host Cell Kinases Specifically Involved in Listeria monocytogenes Spread from Cell to Cell	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ARP2/3 COMPLEX; VIRULENCE FACTOR; PHOSPHOLIPASE-C; PROTEIN; RICKETTSIA; GENE; IDENTIFICATION; PATHOGENS; SEQUENCE	Intracellular bacterial pathogens, such as Listeria monocytogenes and Rickettsia conorii display actin-based motility in the cytosol of infected cells and spread from cell to cell through the formation of membrane protrusions at the cell cortex. Whereas the mechanisms supporting cytosolic actin-based motility are fairly well understood, it is unclear whether specific host factors may be required for supporting the formation and resolution of membrane protrusions. To address this gap in knowledge, we have developed high-throughput fluorescence microscopy and computer-assisted image analysis procedures to quantify pathogen spread in human epithelial cells. We used the approach to screen a siRNA library covering the human kinome and identified 7 candidate kinases whose depletion led to severe spreading defects in cells infected with L. monocytogenes. We conducted systematic validation procedures with redundant silencing reagents and confirmed the involvement of the serine/threonine kinases, CSNK1A1 and CSNK2B. We conducted secondary assays showing that, in contrast with the situation observed in CSNK2B-depleted cells, L. monocytogenes formed wild-type cytosolic tails and displayed wild-type actin-based motility in the cytosol of CSNK1A1-depleted cells. Furthermore, we developed a protrusion formation assay and showed that the spreading defect observed in CSNK1A1-depleted cells correlated with the formation of protrusion that did not resolve into double-membrane vacuoles. Moreover, we developed sending and receiving cell-specific RNAi procedures and showed that CSNK1A was required in the sending cells, but was dispensable in the receiving cells, for protrusion resolution. Finally, we showed that the observed defects were specific to Listeria monocytogenes, as Rickettsia conorii displayed wild-type cell-to-cell spread in CSNK1A1- and CSNK2B-depleted cells. We conclude that, in addition to the specific host factors supporting cytosolic actin-based motility, such as CSNK2B, Listeria monocytogenes requires specific host factors, such as CSNK1A1 in order to form productive membrane protrusions and spread from cell to cell.	[Chong, Ryan; Squires, Raynal; Swiss, Rachel; Agaisse, Herve] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Chong, R (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA.	herve.agaisse@yale.edu			National Institutes of Health [T32 AI-07640, R01 AI-073904]; Mallinckrodt foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007640, R01AI073904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the Mallinckrodt foundation (H.A.), the National Institutes of Health training Grant T32 AI-07640 (R.C.) and Grant R01 AI-073904 (H.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman Nicole C, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a05s11; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; CAMILLI A, 1991, J EXP MED, V173, P751, DOI 10.1084/jem.173.3.751; CAMILLI A, 1989, P NATL ACAD SCI USA, V86, P5522, DOI 10.1073/pnas.86.14.5522; Chong R, 2009, CELL HOST MICROBE, V6, P268, DOI 10.1016/j.chom.2009.08.006; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; MENGAUD J, 1987, INFECT IMMUN, V55, P3225, DOI 10.1128/IAI.55.12.3225-3227.1987; MENGAUD J, 1991, MOL MICROBIOL, V5, P367, DOI 10.1111/j.1365-2958.1991.tb02118.x; Monack DM, 2001, CELL MICROBIOL, V3, P633, DOI 10.1046/j.1462-5822.2001.00143.x; Montes LR, 2004, BIOCHEMISTRY-US, V43, P3688, DOI 10.1021/bi0352522; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23399	10.1371/journal.pone.0023399	http://dx.doi.org/10.1371/journal.pone.0023399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853127	Green Submitted, gold, Green Published			2022-12-25	WOS:000295454200081
J	DeVries, AS; Lesher, L; Schlievert, PM; Rogers, T; Villaume, LG; Danila, R; Lynfield, R				DeVries, Aaron S.; Lesher, Lindsey; Schlievert, Patrick M.; Rogers, Tyson; Villaume, Lourdes G.; Danila, Richard; Lynfield, Ruth			Staphylococcal Toxic Shock Syndrome 2000-2006: Epidemiology, Clinical Features, and Molecular Characteristics	PLOS ONE			English	Article							UNITED-STATES; SYNDROME TSS; AUREUS; SURVEILLANCE; GENE; INFECTIONS; ANTIBODY; UPDATE; WOMEN	Introduction: Circulating strains of Staphylococcus aureus (SA) have changed in the last 30 years including the emergence of community-associated methicillin-resistant SA (MRSA). A report suggested staphylococcal toxic shock syndrome (TSS) was increasing over 2000-2003. The last population-based assessment of TSS was 1986. Methods: Population-based active surveillance for TSS meeting the CDC definition using ICD-9 codes was conducted in the Minneapolis-St. Paul area (population 2,642,056) from 2000-2006. Medical records of potential cases were reviewed for case criteria, antimicrobial susceptibility, risk factors, and outcome. Superantigen PCR testing and PFGE were performed on available isolates from probable and confirmed cases. Results: Of 7,491 hospitalizations that received one of the ICD-9 study codes, 61 TSS cases (33 menstrual, 28 non-menstrual) were identified. The average annual incidence per 100,000 of all, menstrual, and non-menstrual TSS was 0.52 (95% CI, 0.32-0.77), 0.69 (0.39-1.16), and 0.32 (0.12-0.67), respectively. Women 13-24 years had the highest incidence at 1.41 (0.63-2.61). No increase in incidence was observed from 2000-2006. MRSA was isolated in 1 menstrual and 3 non-menstrual cases (7% of TSS cases); 1 isolate was USA400. The superantigen gene tst-1 was identified in 20 (80%) of isolates and was more common in menstrual compared to non-menstrual isolates (89% vs. 50%, p = 0.07). Superantigen genes sea, seb and sec were found more frequently among non-menstrual compared to menstrual isolates [100% vs 25% (p = 0.4), 60% vs 0% (p < 0.01), and 25% vs 13% (p = 0.5), respectively]. Discussion: TSS incidence remained stable across our surveillance period of 2000-2006 and compared to past population-based estimates in the 1980s. MRSA accounted for a small percentage of TSS cases. tst-1 continues to be the superantigen associated with the majority of menstrual cases. The CDC case definition identifies the most severe cases and has been consistently used but likely results in a substantial underestimation of the total TSS disease burden.	[DeVries, Aaron S.; Lesher, Lindsey; Villaume, Lourdes G.; Danila, Richard; Lynfield, Ruth] Minnesota Dept Hlth, Emerging Infect Program, St Paul, MN 55101 USA; [Schlievert, Patrick M.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Rogers, Tyson; Villaume, Lourdes G.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	DeVries, AS (corresponding author), Minnesota Dept Hlth, Emerging Infect Program, St Paul, MN 55101 USA.	aaron.devries@state.mn.us		Schlievert, Patrick/0000-0001-8314-9369; DeVries, Aaron/0000-0001-9211-0722	National Institutes of Health from the Great Lakes Regional Center of Excellence in Biodefense Emerging Infectious Diseases [U54-AI57153, R01-AI06461]; Ruth L. Kirschstein National Research Service Awards [T32 AI 055433-2]; National Institutes of Health; National Institute of Allergy and Infectious Disease [L30 AI 071582-01]; Centers for Disease Control and Prevention [CDC 5 R01 CI000209]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055433, U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health from the Great Lakes Regional Center of Excellence in Biodefense Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (U54-AI57153 from the Great Lakes Regional Center of Excellence in Biodefense Emerging Infectious Diseases [of which PMS is a member] and R01-AI06461, Ruth L. Kirschstein National Research Service Awards T32 AI 055433-2, National Institutes of Health, Loan Repayment Program, the National Institute of Allergy and Infectious Disease, Extramural Clinical Research L30 AI 071582-01, and from the Centers for Disease Control and Prevention, Emerging Infections Program CDC 5 R01 CI000209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BONVENTRE PF, 1984, J INFECT DIS, V150, P662, DOI 10.1093/infdis/150.5.662; *CDCP, 2009, ABCS REP GROUP STREP; *CDCP, 2009, ABCS REP NEISS MEN; *CDCP, 2010, ACT BACT COR SURV; Centers for Disease Control and Prevention, 2011, TOX SHOCK SYNDR 2011; Centers for Disease Control Prevention, 1997, TOX SHOCK SYNDR 1997; Chini V, 2006, J CLIN MICROBIOL, V44, P1881, DOI 10.1128/JCM.44.5.1881-1883.2006; Como-Sabetti K, 2009, PUBLIC HEALTH REP, V124, P427, DOI 10.1177/003335490912400312; DAVIS JP, 1980, NEW ENGL J MED, V303, P1429, DOI 10.1056/NEJM198012183032501; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Durand G, 2006, J CLIN MICROBIOL, V44, P847, DOI 10.1128/JCM.44.3.847-853.2006; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Ferrero S, 2006, CONTRACEPTION, V73, P537, DOI 10.1016/j.contraception.2006.01.004; Ferry T, 2006, J CLIN MICROBIOL, V44, P2642, DOI 10.1128/JCM.00430-06; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; GAVENTA S, 1989, REV INFECT DIS, V11, pS28; Hajjeh RA, 2002, EMERG INFECT DIS, V8, P145, DOI 10.3201/eid0802.010165; Hajjeh RA, 1999, EMERG INFECT DIS, V5, P807, DOI 10.3201/eid0506.990611; Jamart S, 2005, EMERG INFECT DIS, V11, P636, DOI 10.3201/eid1104.040893; KAIN KC, 1993, CLIN INFECT DIS, V16, P100, DOI 10.1093/clinids/16.1.100; LANGE J, 2005, 43 IDSA C, V101; Lesher L, 2009, EMERG INFECT DIS, V15, P770, DOI 10.3201/eid1505.080826; Matsuda Y, 2003, EMERG INFECT DIS, V9, P387, DOI 10.3201/eid0903.020360; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nelson AL, 2006, J FAM PRACTICE, pS1; Okii K, 2006, J HOSP INFECT, V62, P37, DOI 10.1016/j.jhin.2005.05.013; OSTERHOLM MT, 1982, J INFECT DIS, V145, P458, DOI 10.1093/infdis/145.4.458; PETITTI DB, 1989, REV INFECT DIS, V11, pS22; REINGOLD AL, 1982, ANN INTERN MED, V96, P871, DOI 10.7326/0003-4819-96-6-871; ROSENE KA, 1982, ANN INTERN MED, V96, P865, DOI 10.7326/0003-4819-96-6-865; Schlievert Patrick M., 2007, V391, P113; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; SCHLIEVERT PM, 2004, REEMERGENCE STAPHYLO, P2875; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Stevens FA, 1927, J AMER MED ASSOC, V88, P1957, DOI 10.1001/jama.1927.02680510015006; STOLZ SJ, 1985, J INFECT DIS, V151, P883, DOI 10.1093/infdis/151.5.883; TODD J, 1978, LANCET, V2, P1116	42	79	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22997	10.1371/journal.pone.0022997	http://dx.doi.org/10.1371/journal.pone.0022997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860665	Green Published, gold			2022-12-25	WOS:000295454200032
J	Ellerkamp, V; Armeanu-Ebinger, S; Wenz, J; Warmann, SW; Schafer, J; Ruck, P; Fuchs, J				Ellerkamp, Verena; Armeanu-Ebinger, Sorin; Wenz, Julia; Warmann, Steven W.; Schaefer, Juergen; Ruck, Peter; Fuchs, Joerg			Successful Establishment of an Orthotopic Hepatoblastoma In Vivo Model in NOD/LtSz-scid IL2R gamma null Mice	PLOS ONE			English	Article							IMMUNODEFICIENT MICE; CELL-LINE; HEPATOCELLULAR-CARCINOMA; TUMOR-GROWTH; NUDE RATS; LIVER; TRANSPLANTATION; ADENOCARCINOMA; DOXORUBICIN; METASTASIS	Investigation of hepatoblastoma in experimental conditions contributes relevantly to a detailed understanding of tumor biology and the investigation of new treatment approaches. Most systematical analyses currently use subcutaneous xenografts. We established a reproducible intrahepatic model with the hepatoblastoma-cell lines HuH6 and HepT1. The cells were stably transfected with a plasmid vector encoding for Gaussia luciferase. HuH6 and HepT1 were injected intrasplenically in NOD/LtSz-scid IL2R gamma null mice. Mice were splenectomized in order to avoid intrasplenical tumor growth. Multifocal intrahepatic tumor growth was observed in 85% (11/13) of HuH6 tumors and 55% (5/9) of HepT1 tumors. Serum Alpha-fetoprotein and Gaussia luciferase increased 5 weeks after tumor-cell inoculation. Tumors were detected by MRI at this time point. Immunhistochemical analysis such as vascularity (CD31), proliferation index (Ki-67), cytokeratin 7 and distribution of beta - catenin in intrahepatic tumors were different to subcutaneous tumors. We established a reproducible xenograft model for intrahepatic hepatoblastoma growth with a high tumor incidence. Monitoring of tumor cell viability was optimized by measuring GLuc. This model enables further experimental investigations of HB in a more physiological milieu as emphasized by the beta-catenin distribution.	[Ellerkamp, Verena; Armeanu-Ebinger, Sorin; Wenz, Julia; Warmann, Steven W.; Fuchs, Joerg] Childrens Univ Hosp Tuebingen, Dept Pediat Surg, Tubingen, Germany; [Schaefer, Juergen] Childrens Univ Hosp Tuebingen, Dept Pediat Radiol, Tubingen, Germany; [Ruck, Peter] Inst Pathol Leonberg, Leonberg, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Ellerkamp, V (corresponding author), Childrens Univ Hosp Tuebingen, Dept Pediat Surg, Tubingen, Germany.	verenaellerkamp@googlemail.com	Ellerkamp, Verena/ABB-1100-2021	Ellerkamp, Verena/0000-0003-0221-5841	Lore Klaus Klosseck [10,000]	Lore Klaus Klosseck	Funding was provided by the Lore & Klaus Klosseck Start-Up Price (10,000(sic)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders are private funders who donated the money for the Start-up-price for young researchers of the university.	Alves F, 2001, PANCREAS, V23, P227, DOI 10.1097/00006676-200110000-00002; ARMENGOL C, 2009, INT J BIOCH CELL BIO; Belnoue E, 2004, J IMMUNOL, V173, P4882, DOI 10.4049/jimmunol.173.8.4882; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; DOI I, 1976, GANN, V67, P1; Freimuth J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-94; Fuchs J, 1996, J PEDIATR SURG, V31, P1241, DOI 10.1016/S0022-3468(96)90242-0; KERBEL RS, 1991, CANCER METAST REV, V10, P201, DOI 10.1007/BF00050792; Kim YR, 2005, CANCER RES, V65, P9253, DOI 10.1158/0008-5472.CAN-03-2619; LEDUC EH, 1959, CANCER RES, V19, P1091; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malogolowkin MH, 2008, J CLIN ONCOL, V26, P2379, DOI 10.1200/JCO.2006.09.7204; Martiniova L, 2009, J MAGN RESON IMAGING, V29, P685, DOI 10.1002/jmri.21654; McCrudden KW, 2003, J PEDIATR SURG, V38, P308, DOI 10.1053/jpsu.2003.50099; Melder RJ, 2002, NEOPLASIA, V4, P3, DOI 10.1038/sj.neo.7900209; MEN S, 1995, PEDIATR RADIOL, V25, P507, DOI 10.1007/BF02015780; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Perilongo G, 2004, EUR J CANCER, V40, P411, DOI 10.1016/j.ejca.2003.06.003; Perilongo G, 2009, NEW ENGL J MED, V361, P1662, DOI 10.1056/NEJMoa0810613; Pietsch T, 1996, LAB INVEST, V74, P809; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Schmitz V, 2004, J HEPATOL, V40, P787, DOI 10.1016/j.jhep.2004.01.010; Schnater JM, 2006, J HEPATOL, V45, P377, DOI 10.1016/j.jhep.2006.03.018; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; TANAKA M, 1983, BIOCHEM BIOPH RES CO, V110, P837, DOI 10.1016/0006-291X(83)91037-9; Till H, 2006, EUR J PEDIATR SURG, V16, P231, DOI 10.1055/s-2006-924373; Till H, 2005, SURG ENDOSC, V19, P1483, DOI 10.1007/s00464-005-0316-1; Varga N. L., 2010, STEM CELL STUD, V1, pe5, DOI DOI 10.4081/SCS.2010.E5; Warmann SW, 2007, CURR PHARM BIOTECHNO, V8, P93, DOI 10.2174/138920107780487456; Westwood JA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-42; Yamaoka H, 2006, ONCOL REP, V15, P551; Yamazaki M, 2004, HEPATOL RES, V30, P182, DOI 10.1016/j.hepres.2004.08.001; ZSIROS J, 2010, J CLIN ONCOL    0420	33	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23419	10.1371/journal.pone.0023419	http://dx.doi.org/10.1371/journal.pone.0023419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853130	gold, Green Published, Green Submitted			2022-12-25	WOS:000295454200083
J	Huang, T; Niu, S; Xu, ZP; Huang, Y; Kong, XY; Cai, YD; Chou, KC				Huang, Tao; Niu, Shen; Xu, Zhongping; Huang, Yun; Kong, Xiangyin; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Transcriptional Activity of Multiple Site p53 Mutants Based on Hybrid Properties	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; FEATURE-SELECTION; PROTEIN; CANCER; MUTATION; SUPPRESSOR; TUMOR; GENE; RESIDUES; FEATURES	As an important tumor suppressor protein, reactivate mutated p53 was found in many kinds of human cancers and that restoring active p53 would lead to tumor regression. In this work, we developed a new computational method to predict the transcriptional activity for one-, two-, three-and four-site p53 mutants, respectively. With the approach from the general form of pseudo amino acid composition, we used eight types of features to represent the mutation and then selected the optimal prediction features based on the maximum relevance, minimum redundancy, and incremental feature selection methods. The Mathew's correlation coefficients (MCC) obtained by using nearest neighbor algorithm and jackknife cross validation for one-, two-, three-and four-site p53 mutants were 0.678, 0.314, 0.705, and 0.907, respectively. It was revealed by the further optimal feature set analysis that the 2D (two-dimensional) structure features composed the largest part of the optimal feature set and maybe played the most important roles in all four types of p53 mutant active status prediction. It was also demonstrated by the optimal feature sets, especially those at the top level, that the 3D structure features, conservation, physicochemical and biochemical properties of amino acid near the mutation site, also played quite important roles for p53 mutant active status prediction. Our study has provided a new and promising approach for finding functionally important sites and the relevant features for in-depth study of p53 protein and its action mechanism.	[Huang, Tao; Niu, Shen] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Xu, Zhongping; Huang, Yun; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Xu, Zhongping; Huang, Yun; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University; Chinese Academy of Sciences; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31070752]; National Basic Research Program of China [2011CB510102, 2011CB510101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Natural Science Foundation of China (Grant No. 31070752) and National Basic Research Program of China (2011CB510102, 2011CB510101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Cai YD, 2012, AMINO ACIDS, V42, P1387, DOI 10.1007/s00726-011-0835-0; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Danziger SA, 2006, IEEE ACM T COMPUT BI, V3, P114, DOI 10.1109/TCBB.2006.22; Danziger SA, 2007, BIOINFORMATICS, V23, pI104, DOI 10.1093/bioinformatics/btm166; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Martin ACR, 2002, HUM MUTAT, V19, P149, DOI 10.1002/humu.10032; Meng L, 1999, MUTAT RES-DNA REPAIR, V435, P263, DOI 10.1016/S0921-8777(99)00053-1; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mukhopadhyay UK, 2009, CELL CYCLE, V8, P2481, DOI 10.4161/cc.8.16.9269; Niu S, 2010, J PROTEOME RES, V9, P6490, DOI 10.1021/pr1007152; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; QI JP, 2010, HEALTH, V2, P137; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Yang ZH, 2003, GENETICS, V165, P695; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	49	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22940	10.1371/journal.pone.0022940	http://dx.doi.org/10.1371/journal.pone.0022940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857971	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300014
J	Selvadurai, HJ; Mason, JO				Selvadurai, Hayden J.; Mason, John O.			Wnt/beta-catenin Signalling Is Active in a Highly Dynamic Pattern during Development of the Mouse Cerebellum	PLOS ONE			English	Article							RHOMBIC-LIP; GABAERGIC INTERNEURONS; SONIC HEDGEHOG; WHITE-MATTER; INT-1 PROTOONCOGENE; NEURAL PROGENITORS; MURINE CEREBELLUM; PURKINJE-CELLS; BETA-CATENIN; EXPRESSION	The adult cerebellum is composed of several distinct cell types with well defined developmental origins. However, the molecular mechanisms that govern the generation of these cell types are only partially resolved. Wnt/beta-catenin signalling has a wide variety of roles in generation of the central nervous system, though the specific activity of this pathway during cerebellum development is not well understood. Here, we present data that delineate the spatio-temporal specific pattern of Wnt/beta-catenin signaling during mouse cerebellum development between E12.5 and P21. Using the BAT-gal Wnt/beta-catenin reporter mouse, we found that Wnt/beta-catenin activity is present transiently at the embryonic rhombic lip but not at later stages during the expansion of cell populations that arise from there. At late embryonic and early postnatal stages, Wnt/beta-catenin activity shifts to the cerebellar ventricular zone and to cells arising from this germinal centre. Subsequently, the expression pattern becomes progressively restricted to Bergmann glial cells, which show expression of the reporter at P21. These results indicate a variety of potential functions for Wnt/beta-catenin activity during cerebellum development.	[Selvadurai, Hayden J.; Mason, John O.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Selvadurai, HJ (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	john.mason@ed.ac.uk	Mason, John O/A-1926-2010	Mason, John O/0000-0002-0489-2400	Wellcome Trust [083209/Z/07/A]; National Institute of Child Health and Human Development	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by award number 083209/Z/07/A from the Wellcome Trust, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Tom Pratt for useful comments on the manuscript. We are grateful to the staff of the University of Edinburgh Biological Research Resource facility for expert animal care. The mouse anti-beta-galactosidase antibody was developed by J. Sanes, and obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa (Department of Biological Sciences, Iowa City, IA).	Altman J, 1997, DEV CEREBELLAR SYSTE; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Fischer T, 2007, NEUROSCIENCE, V147, P693, DOI 10.1016/j.neuroscience.2007.04.060; Fotaki V, 2006, J NEUROSCI, V26, P9282, DOI 10.1523/JNEUROSCI.2673-06.2006; Fotaki V, 2011, J COMP NEUROL, V519, P1640, DOI 10.1002/cne.22592; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Grimaldi P, 2009, DEV BIOL, V328, P422, DOI 10.1016/j.ydbio.2009.02.008; Hachem S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-17; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hashimoto M, 2003, J NEUROSCI, V23, P11342; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; LANDRY CF, 1989, MOL BRAIN RES, V6, P251, DOI 10.1016/0169-328X(89)90071-5; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Milosevic A, 2004, MOL CELL NEUROSCI, V26, P342, DOI 10.1016/j.mcn.2004.02.008; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Zurawel RH, 1998, CANCER RES, V58, P896	45	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23012	10.1371/journal.pone.0023012	http://dx.doi.org/10.1371/journal.pone.0023012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857982	Green Submitted, Green Published, gold			2022-12-25	WOS:000293773300016
J	Johnson, S; Prendergast, G; Hymers, M; Green, G				Johnson, Sam; Prendergast, Garreth; Hymers, Mark; Green, Gary			Examining the Effects of One- and Three-Dimensional Spatial Filtering Analyses in Magnetoencephalography	PLOS ONE			English	Article							HUMAN BRAIN; MEG; BEAMFORMERS	Spatial filtering, or beamforming, is a commonly used data-driven analysis technique in the field of Magnetoencephalography (MEG). Although routinely referred to as a single technique, beamforming in fact encompasses several different methods, both with regard to defining the spatial filters used to reconstruct source-space time series and in terms of the analysis of these time series. This paper evaluates two alternative methods of spatial filter construction and application. It demonstrates how encoding different requirements into the design of these filters has an effect on the results obtained. The analyses presented demonstrate the potential value of implementations which examine the timeseries projections in multiple orientations at a single location by showing that beamforming can reconstruct predominantly radial sources in the case of a multiple-spheres forward model. The accuracy of source reconstruction appears to be more related to depth than source orientation. Furthermore, it is shown that using three 1-dimensional spatial filters can result in inaccurate source-space time series reconstruction. The paper concludes with brief recommendations regarding reporting beamforming methodologies in order to help remove ambiguity about the specifics of the techniques which have been used.	[Johnson, Sam; Prendergast, Garreth; Hymers, Mark; Green, Gary] Univ York, York NeuroImaging Ctr, York YO10 5DD, N Yorkshire, England; [Prendergast, Garreth; Green, Gary] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	Johnson, S (corresponding author), Univ York, York NeuroImaging Ctr, York YO10 5DD, N Yorkshire, England.	mark.hymers@ynic.york.ac.uk	Green, Gary GR/D-3543-2009	Green, Gary GR/0000-0003-1977-7509; Prendergast, Garreth/0000-0002-7255-6708	York NeuroImaging Centre, Department of Psychology, University of York	York NeuroImaging Centre, Department of Psychology, University of York	All authors are full-time employees of the University of York and/or Hull York Medical School. This study was internally funded by the York NeuroImaging Centre, Department of Psychology, University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardouille T, 2008, NEUROIMAGE, V42, P323, DOI 10.1016/j.neuroimage.2008.04.176; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hadjipapas A, 2009, NEUROIMAGE, V44, P1290, DOI 10.1016/j.neuroimage.2008.10.035; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hymers M, 2010, NEUROIMAGE, V49, P1385, DOI 10.1016/j.neuroimage.2009.09.055; JOHNSON S, 2005, THESIS U NEWCASTLE T; Prendergast G, 2011, NEUROIMAGE, V54, P906, DOI 10.1016/j.neuroimage.2010.08.005; Prendergast G, 2010, EUR J NEUROSCI, V32, P1599, DOI 10.1111/j.1460-9568.2010.07423.x; ROBINSON SE, 2004, NEUROL CLIN NEUROPHY, P109; ROBINSON SE, 1998, BIOMAG; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; VRBA J, 2000, BIOMAG 2000	21	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22251	10.1371/journal.pone.0022251	http://dx.doi.org/10.1371/journal.pone.0022251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857916	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900012
J	MacKellar, AL; Greenleaf, AL				MacKellar, April L.; Greenleaf, Arno L.			Cotranscriptional Association of mRNA Export Factor Yra1 with C-terminal Domain of RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; KINASE-I; NUCLEAR EXPORT; REPEAT DOMAIN; TRANSCRIPTION ELONGATION; PROCESSING FACTORS; LARGE SUBUNIT; CTD CODE; PHOSPHORYLATION	The unique C-terminal domain (CTD) of RNA polymerase II, composed of tandem heptad repeats of the consensus sequence YSPTSPS, is subject to differential phosphorylation throughout the transcription cycle. Several RNA processing factors have been shown to bind the phosphorylated CTD and use it to localize to nascent pre-mRNA during transcription. In Saccharomyces cerevisiae, the mRNA export protein Yra1 (ALY/RNA export factor in metazoa) cotranscriptionally associates with mRNA and delivers it to the nuclear pore complex for export to the cytoplasm. Here we report that Yra1 directly binds in vitro the hyperphosphorylated form of theCTDcharacteristic of elongating RNA polymerase II and contains a phospho-CTD-interacting domain within amino acids 18-184, which also include an "RNA recognition motif" (RRM) (residues 77-184). Using UV cross-linking, we showed that the RRM alone binds RNA, although a larger segment extending to the C terminus (amino acids 77-226) displayed stronger RNA binding activity. Although the RRM is implicated in both RNA and CTD binding, RRM point mutations separated these two functions. Both functions are important in vivo as RNA binding-defective or CTD binding-defective versions of Yra1 engendered growth and mRNA export defects. We also report the construction and characterization of a useful new temperature-sensitive YRA1 allele (R107A/F126A). Using ChIP, we demonstrated that removing the N-terminal 76 amino acids of Yra1 (all of the phospho-CTD-interacting domain up to the RRM) results in a 10-fold decrease in Yra1 recruitment to genes during elongation. These results indicate that the phospho-CTD is likely involved directly in the cotranscriptional recruitment of Yra1.	[Greenleaf, Arno L.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA	Duke University; Duke University	Greenleaf, AL (corresponding author), Duke Univ, Med Ctr, Dept Biochem, 0034 CARL Bldg, Durham, NC 27710 USA.	arno@duke.edu		MacKellar, April/0000-0001-9535-2719	National Institutes of Health [R01 GM040505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM040505.	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Golovanov AP, 2006, RNA, V12, P1933, DOI 10.1261/rna.212106; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Jona G, 2001, GENE, V267, P31, DOI 10.1016/S0378-1119(01)00389-4; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LEE JM, 1991, GENE EXPRESSION, V1, P149; Lee JM, 1997, J BIOL CHEM, V272, P10990; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lindstrom DL, 2001, GENETICS, V159, P487; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Moore David, 2002, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0201as59; Morris DP, 1997, METHODS, V12, P264, DOI 10.1006/meth.1997.0478; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani Hemali P, 2004, Methods Mol Biol, V257, P17, DOI 10.1385/1-59259-750-5:017; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Rollenhagen C, 2007, EUKARYOT CELL, V6, P505, DOI 10.1128/EC.00317-06; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rusche LN, 2001, GENE DEV, V15, P955; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Tokunaga K., 2008, CURR PROTOC CELL BIO; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001	50	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36385	36395		10.1074/jbc.M111.268144	http://dx.doi.org/10.1074/jbc.M111.268144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21856751	hybrid, Green Published			2022-12-25	WOS:000296538300024
J	Shigehara, K; Yokomuro, S; Ishibashi, O; Mizuguchi, Y; Arima, Y; Kawahigashi, Y; Kanda, T; Akagi, I; Tajiri, T; Yoshida, H; Takizawa, T; Uchida, E				Shigehara, Kengo; Yokomuro, Shigeki; Ishibashi, Osamu; Mizuguchi, Yoshiaki; Arima, Yasuo; Kawahigashi, Yutaka; Kanda, Tomohiro; Akagi, Ichiro; Tajiri, Takashi; Yoshida, Hiroshi; Takizawa, Toshihiro; Uchida, Eiji			Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BRUSH CYTOLOGY; ENDOSCOPIC ULTRASOUND; HUMAN CHOLANGIOCARCINOMA; CIRCULATING MICRORNAS; EXPRESSION PROFILES; E-CADHERIN; CELL; STRICTURES; EUS	Biliary tract cancer (BTC) is often difficult to diagnose definitively, even through histological examination. MicroRNAs (miRNAs) regulate a variety of physiological processes. In recent years, it has been suggested that profiles for circulating miRNAs, as well as those for tissue miRNAs, have the potential to be used as diagnostic biomarkers for cancer. The aim of this study was to confirm the existence of miRNAs in human bile and to assess their potential as clinical biomarkers for BTC. We sampled bile from patients who underwent biliary drainage for biliary diseases such as BTC and choledocholithiasis. PCR-based miRNA detection and miRNA cloning were performed to identify bile miRNAs. Using high-throughput real-time PCR-based miRNA microarrays, the expression profiles of 667 miRNAs were compared in patients with malignant disease (n = 9) and age-matched patients with the benign disease choledocholithiasis (n = 9). We subsequently characterized bile miRNAs in terms of stability and localization. Through cloning and using PCR methods, we confirmed that miRNAs exist in bile. Differential analysis of bile miRNAs demonstrated that 10 of the 667 miRNAs were significantly more highly expressed in the malignant group than in the benign group at P<0.0005. Setting the specificity threshold to 100% showed that some miRNAs (miR-9, miR-302c*, miR-199a-3p and miR-222*) had a sensitivity level of 88.9%, and receiver-operating characteristic analysis demonstrated that miR-9 and miR-145* could be useful diagnostic markers for BTC. Moreover, we verified the long-term stability of miRNAs in bile, a characteristic that makes them suitable for diagnostic use in clinical settings. We also confirmed that bile miRNAs are localized to the malignant/benign biliary epithelia. These findings suggest that bile miRNAs could be informative biomarkers for hepatobiliary disease and that some miRNAs, particularly miR-9, may be helpful in the diagnosis and clinical management of BTC.	[Shigehara, Kengo; Yokomuro, Shigeki; Mizuguchi, Yoshiaki; Arima, Yasuo; Kawahigashi, Yutaka; Kanda, Tomohiro; Akagi, Ichiro; Tajiri, Takashi; Yoshida, Hiroshi; Uchida, Eiji] Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, Tokyo 113, Japan; [Ishibashi, Osamu; Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Med & Anat, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Shigehara, K (corresponding author), Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, 1-1-5 Sendagi, Tokyo 113, Japan.	t-takizawa@nms.ac.jp; uchida@nms.ac.jp	Ishibashi, Osamu/J-8413-2019	Ishibashi, Osamu/0000-0003-4698-460X	Ministry of Education, Culture, Sports, Science and Technology, Japan [S0801034]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid and the "Research Core" Project for Private University: Matching Fund Subsidy (S0801034) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Aljiffry M, 2009, WORLD J GASTROENTERO, V15, P4240, DOI 10.3748/wjg.15.4240; Byrne MF, 2004, ENDOSCOPY, V36, P715, DOI 10.1055/s-2004-825657; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Eloubeidi MA, 2004, CLIN GASTROENTEROL H, V2, P209, DOI 10.1016/S1542-3565(04)00005-9; Endo K, 2002, HEPATOLOGY, V36, P439, DOI 10.1053/jhep.2002.34435; Esteller A, 2008, WORLD J GASTROENTERO, V14, P5641, DOI 10.3748/wjg.14.5641; FISCHER HP, 1987, AM J PATHOL, V127, P530; Fritscher-Ravens A, 2004, AM J GASTROENTEROL, V99, P45, DOI 10.1046/j.1572-0241.2003.04006.x; Fritscher-Ravens A, 2000, GASTROINTEST ENDOSC, V52, P534, DOI 10.1067/mge.2000.109589; Garrow D, 2007, CLIN GASTROENTEROL H, V5, P616, DOI 10.1016/j.cgh.2007.02.027; Glasbrenner B, 1999, ENDOSCOPY, V31, P712; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Jailwala J, 2000, GASTROINTEST ENDOSC, V51, P383, DOI 10.1016/S0016-5107(00)70435-4; Jarnagin WR, 2006, J CLIN ONCOL, V24, P1152, DOI 10.1200/JCO.2005.04.6631; Khan SA, 2002, GUT, V51, P1; KUBOTA Y, 1993, ABDOM IMAGING, V18, P145; Kuroki T, 2005, J HEPATO-BILIARY-PAN, V12, P463, DOI 10.1007/s00534-005-1004-1; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; LEE JG, 1995, AM J GASTROENTEROL, V90, P722; Lee JH, 2004, AM J GASTROENTEROL, V99, P1069, DOI 10.1111/j.1572-0241.2004.30223.x; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mansfield JC, 1997, GUT, V40, P671, DOI 10.1136/gut.40.5.671; Masyuk AI, 2010, AM J PHYSIOL-GASTR L, V299, pG990, DOI 10.1152/ajpgi.00093.2010; Melkonyan HS, 2008, ANN NY ACAD SCI, V1137, P73, DOI 10.1196/annals.1448.015; Menzel J, 2000, AM J GASTROENTEROL, V95, P605; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Okaro AC, 2001, J CLIN PATHOL, V54, P927, DOI 10.1136/jcp.54.12.927; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; PONCHON T, 1995, GASTROINTEST ENDOSC, V42, P565, DOI 10.1016/S0016-5107(95)70012-9; PUGLIESE V, 1995, GASTROINTEST ENDOSC, V42, P520, DOI 10.1016/S0016-5107(95)70004-8; RAJ V, 2000, AM J SURG PATHOL, V24, P870; Rosch T, 2004, GASTROINTEST ENDOSC, V60, P390, DOI 10.1016/S0016-5107(04)01732-8; Rosch T, 2002, GASTROINTEST ENDOSC, V55, P870, DOI 10.1067/mge.2002.124206; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Stewart CJR, 2001, J CLIN PATHOL, V54, P449, DOI 10.1136/jcp.54.6.449; Tajiri T, 2008, WORLD J GASTROENTERO, V14, P3000, DOI 10.3748/wjg.14.3000; Tamada K, 1998, GASTROINTEST ENDOSC, V47, P341, DOI 10.1016/S0016-5107(98)70216-0; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VANEYKEN P, 1988, HEPATOLOGY, V8, P1586, DOI 10.1002/hep.1840080619; Varghese JC, 1999, CLIN RADIOL, V54, P513, DOI 10.1016/S0009-9260(99)90848-6; Vazquez-Sequeiros E, 2002, GASTROINTEST ENDOSC, V56, P372, DOI 10.1067/mge.2002.126907; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	61	109	117	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23584	10.1371/journal.pone.0023584	http://dx.doi.org/10.1371/journal.pone.0023584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858175	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300064
J	Diring, J; Camuzeaux, B; Donzeau, M; Vigneron, M; Rosa-Calatrava, M; Kedinger, C; Chatton, B				Diring, Jessica; Camuzeaux, Barbara; Donzeau, Mariel; Vigneron, Marc; Rosa-Calatrava, Manuel; Kedinger, Claude; Chatton, Bruno			A Cytoplasmic Negative Regulator Isoform of ATF7 Impairs ATF7 and ATF2 Phosphorylation and Transcriptional Activity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ELEMENT-BINDING PROTEIN; AMP RESPONSE ELEMENT; C-JUN; MELANOMA-CELLS; IN-VIVO; FUNCTIONAL-ANALYSIS; FIREFLY LUCIFERASE; FACTOR-2 ATF2; DNA-BINDING	Alternative splicing and post-translational modifications are processes that give rise to the complexity of the proteome. The nuclear ATF7 and ATF2 (activating transcription factor) are structurally homologous leucine zipper transcription factors encoded by distinct genes. Stress and growth factors activate ATF2 and ATF7 mainly via sequential phosphorylation of two conserved threonine residues in their activation domain. Distinct protein kinases, among which mitogen-activated protein kinases (MAPK), phosphorylate ATF2 and ATF7 first on Thr71/Thr53 and next on Thr69/Thr51 residues respectively, resulting in transcriptional activation. Here, we identify and characterize a cytoplasmic alternatively spliced isoform of ATF7. This variant, named ATF7-4, inhibits both ATF2 and ATF7 transcriptional activities by impairing the first phosphorylation event on Thr71/Thr53 residues. ATF7-4 indeed sequesters the Thr53-phosphorylating kinase in the cytoplasm. Upon stimulus-induced phosphorylation, ATF7-4 is poly-ubiquitinated and degraded, enabling the release of the kinase and ATF7/ATF2 activation. Our data therefore conclusively establish that ATF7-4 is an important cytoplasmic negative regulator of ATF7 and ATF2 transcription factors.	[Diring, Jessica; Camuzeaux, Barbara; Donzeau, Mariel; Vigneron, Marc; Kedinger, Claude; Chatton, Bruno] Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, Illkirch Graffenstaden, France; [Rosa-Calatrava, Manuel] Univ Lyon 1, Lab Virol & Pathol Humaine VirPath, Hosp Civils Lyon, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Diring, J (corresponding author), Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Biotechnol & Signalisat Cellulaire UMR7242, BP10413, Illkirch Graffenstaden, France.	bchatton@unistra.fr	Rosa-calatrava, Manuel/M-7263-2014; CHATTON, Bruno/R-3813-2019	CHATTON, Bruno/0000-0003-4515-7119; Diring, Jessica/0000-0003-2348-3941; Rosa-calatrava, Manuel/0000-0002-7559-9527; Donzeau, Mariel/0000-0002-1145-9218	Universite de Strasbourg; Centre National de la Recherche Scientifique; Ministere de l'Enseignement Superieur et de la Recherche; Ligue contre le Cancer - Comites Haut-Rhin et Bas-Rhin; Fondation pour la Recherche Medicale, Alsace contre le Cancer; Ecos-Sud [A06B02]; Institut National du Cancer [PLBIO-127]	Universite de Strasbourg; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Ligue contre le Cancer - Comites Haut-Rhin et Bas-Rhin; Fondation pour la Recherche Medicale, Alsace contre le Cancer(Fondation pour la Recherche Medicale); Ecos-Sud; Institut National du Cancer(Institut National du Cancer (INCA) France)	This study was supported by Universite de Strasbourg, the Centre National de la Recherche Scientifique, the Ministere de l'Enseignement Superieur et de la Recherche, the Ligue contre le Cancer - Comites Haut-Rhin et Bas-Rhin, the Fondation pour la Recherche Medicale, Alsace contre le Cancer, the Ecos-Sud (action A06B02), and the Institut National du Cancer (PLBIO-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baan B, 2006, MOL ENDOCRINOL, V20, P1786, DOI 10.1210/me.2005-0289; Baan B, 2009, MOL CELL ENDOCRINOL, V311, P94, DOI 10.1016/j.mce.2009.07.023; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Bailey J, 2002, J CLIN ENDOCR METAB, V87, P1717, DOI 10.1210/jcem.87.4.8360; Bhoumik A, 2002, J CLIN INVEST, V110, P643, DOI 10.1172/JCI200216081; Bhoumik A, 2004, CANCER RES, V64, P8222, DOI 10.1158/0008-5472.CAN-04-0714; Bhoumik A, 2004, P NATL ACAD SCI USA, V101, P4222, DOI 10.1073/pnas.0400195101; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bhoumik A, 2007, PIGM CELL RES, V20, P498, DOI 10.1111/j.1600-0749.2007.00414.x; Birzele F, 2008, NUCLEIC ACIDS RES, V36, P550, DOI 10.1093/nar/gkm1054; Bocco JL, 1996, ONCOGENE, V12, P1971; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; Buschmann T, 2000, J BIOL CHEM, V275, P16590, DOI 10.1074/jbc.M910045199; Camuzeaux B, 2008, J MOL BIOL, V384, P980, DOI 10.1016/j.jmb.2008.10.008; Chao LC, 1999, MOL CELL BIOL, V19, P5588; CHATTON B, 1993, MOL CELL BIOL, V13, P561, DOI 10.1128/MCB.13.1.561; CHATTON B, 1994, ONCOGENE, V9, P375; De Graeve F, 1999, ONCOGENE, V18, P3491, DOI 10.1038/sj.onc.1202723; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dutertre S, 2002, J BIOL CHEM, V277, P6280, DOI 10.1074/jbc.M105735200; Duyndam MCA, 1999, ONCOGENE, V18, P2311, DOI 10.1038/sj.onc.1202584; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; Fuchs SY, 1999, MOL CELL BIOL, V19, P3289; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GAIRE M, 1990, NUCLEIC ACIDS RES, V18, P3467, DOI 10.1093/nar/18.12.3467; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; GEORGOPOULOS K, 1992, MOL CELL BIOL, V12, P747, DOI 10.1128/MCB.12.2.747; Goetz J, 1996, J BIOL CHEM, V271, P29589, DOI 10.1074/jbc.271.47.29589; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hai TW, 1989, MOLCELL BIOL, V9, P4390; Hamard PJ, 2007, NUCLEIC ACIDS RES, V35, P1134, DOI 10.1093/nar/gkl1168; Hamard PJ, 2005, ONCOGENE, V24, P3472, DOI 10.1038/sj.onc.1208565; Hirose N, 2009, BIOCHEM BIOPH RES CO, V385, P72, DOI 10.1016/j.bbrc.2009.05.001; Hong SH, 2004, J BIOL CHEM, V279, P16996, DOI 10.1074/jbc.M311752200; Huber AV, 2006, PLACENTA, V27, P127, DOI 10.1016/j.placenta.2005.02.012; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jin S, 2007, CANCER BIOL THER, V6, P261, DOI 10.4161/cbt.6.2.3621; KARA CJ, 1990, MOL CELL BIOL, V10, P1347, DOI 10.1128/MCB.10.4.1347; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Karlsson M, 2006, BIOCHEM SOC T, V34, P842, DOI 10.1042/BST0340842; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavigne AC, 1999, MOL CELL BIOL, V19, P5050; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lutz P, 1997, J VIROL, V71, P5102, DOI 10.1128/JVI.71.7.5102-5109.1997; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mesbah K, 2006, MOL CELL BIOL, V26, P7760, DOI 10.1128/MCB.00913-06; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; NOMURA N, 1993, J BIOL CHEM, V268, P4259; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Peterson ML, 2002, MOL CELL BIOL, V22, P5606, DOI 10.1128/MCB.22.15.5606-5615.2002; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rosa-Calatrava M, 2003, EMBO REP, V4, P969, DOI 10.1038/sj.embor.embor943; Rosa-Calatrava M, 2001, J VIROL, V75, P7131, DOI 10.1128/JVI.75.15.7131-7141.2001; Smerc A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019645; Steghens JP, 1998, BIOCHEM J, V336, P109, DOI 10.1042/bj3360109; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Winter N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018837; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426; Zimmerman T, 2006, J IMMUNOL METHODS, V314, P67, DOI 10.1016/j.jim.2006.05.012	80	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23351	10.1371/journal.pone.0023351	http://dx.doi.org/10.1371/journal.pone.0023351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858082	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500029
J	Espinal, J; Aldana, M; Guerrero, A; Wood, C; Darszon, A; Martinez-Mekler, G				Espinal, Jesus; Aldana, Maximino; Guerrero, Adan; Wood, Christopher; Darszon, Alberto; Martinez-Mekler, Gustavo			Discrete Dynamics Model for the Speract-Activated Ca2+ Signaling Network Relevant to Sperm Motility	PLOS ONE			English	Article							SEA-URCHIN SPERM; GENETIC REGULATORY NETWORKS; EGG PEPTIDE SPERACT; GUANYLATE-CYCLASE; CALCIUM-CHANNELS; K+ CHANNELS; CHEMOTAXIS; FLAGELLAR; SPERMATOZOA; CGMP	Understanding how spermatozoa approach the egg is a central biological issue. Recently a considerable amount of experimental evidence has accumulated on the relation between oscillations in intracellular calcium ion concentration ([Ca2+](i)) in the sea urchin sperm flagellum, triggered by peptides secreted from the egg, and sperm motility. Determination of the structure and dynamics of the signaling pathway leading to these oscillations is a fundamental problem. However, a biochemically based formulation for the comprehension of the molecular mechanisms operating in the axoneme as a response to external stimulus is still lacking. Based on experiments on the S. purpuratus sea urchin spermatozoa, we propose a signaling network model where nodes are discrete variables corresponding to the pathway elements and the signal transmission takes place at discrete time intervals according to logical rules. The validity of this model is corroborated by reproducing previous empirically determined signaling features. Prompted by the model predictions we performed experiments which identified novel characteristics of the signaling pathway. We uncovered the role of a high voltage-activated Ca2+ channel as a regulator of the delay in the onset of fluctuations after activation of the signaling cascade. This delay time has recently been shown to be an important regulatory factor for sea urchin sperm reorientation. Another finding is the participation of a voltage-dependent calcium-activated K+ channel in the determination of the period of the [Ca2+](i) fluctuations. Furthermore, by analyzing the spread of network perturbations we find that it operates in a dynamically critical regime. Our work demonstrates that a coarse-grained approach to the dynamics of the signaling pathway is capable of revealing regulatory sperm navigation elements and provides insight, in terms of criticality, on the concurrence of the high robustness and adaptability that the reproduction processes are predicted to have developed throughout evolution.	[Espinal, Jesus; Aldana, Maximino; Martinez-Mekler, Gustavo] Univ Nacl Autonoma Mexico, Inst Ciencias Fs, Cuernavaca 62191, Morelos, Mexico; [Espinal, Jesus; Aldana, Maximino; Martinez-Mekler, Gustavo] Ctr Ciencias Complejidad, Mexico City, DF, Mexico; [Guerrero, Adan; Wood, Christopher; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62191, Morelos, Mexico; [Martinez-Mekler, Gustavo] Ctr Int Ciencias, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Espinal, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fs, Cuernavaca 62191, Morelos, Mexico.	mekler@fis.unam.mx	Cardenas, Adan Oswaldo Guerrero/AAQ-9036-2021; Guerrero, Adán/I-4892-2013; Aldana, Maximino/D-9372-2017; Wood, Christopher D/H-5606-2012	Cardenas, Adan Oswaldo Guerrero/0000-0002-4389-5516; Guerrero, Adán/0000-0002-4389-5516; Aldana, Maximino/0000-0002-3419-6641; Wood, Christopher D/0000-0001-7175-7121; Martinez-Mekler, Gustavo/0000-0002-1192-9769; Darszon, Alberto/0000-0002-2502-0505	Consejo Nacional de Ciencia y Tecnologia (Mexico) [49113]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IN211907, IN109210-3, IN112407]	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	Grant 49113 from Consejo Nacional de Ciencia y Tecnologia (Mexico), and grants IN211907, IN109210-3, and IN112407 from Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, are acknowledged. J. Espinal and A. Guerrero thank the Consejo Nacional de Ciencia y Tecnologia (Mexico) for a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alon U, 2007, INTRO SYSTEMS BIOL D; BABCOCK DF, 1992, P NATL ACAD SCI USA, V89, P6001, DOI 10.1073/pnas.89.13.6001; Balleza E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002456; Beltran C, 1996, BIOCHEMISTRY-US, V35, P7591, DOI 10.1021/bi952806v; BENTLEY JK, 1986, J BIOL CHEM, V261, P4859; Bonigk W, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000516; Bohmer M, 2005, EMBO J, V24, P2741, DOI 10.1038/sj.emboj.7600744; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Carteret HA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218702; Chialvo DR, 2006, NAT PHYS, V2, P301, DOI 10.1038/nphys300; COOK SP, 1993, J BIOL CHEM, V268, P22408; COOK SP, 1993, J BIOL CHEM, V268, P22402; DANGOTT LJ, 1984, J BIOL CHEM, V259, P3712; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2008, INT J DEV BIOL, V52, P595, DOI 10.1387/ijdb.072550ad; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; DERRIDA B, 1986, EUROPHYS LETT, V1, P45, DOI 10.1209/0295-5075/1/2/001; Elgeti J, 2010, BIOPHYS J, V99, P1018, DOI 10.1016/j.bpj.2010.05.015; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Galindo BE, 2007, BIOCHEM BIOPH RES CO, V354, P668, DOI 10.1016/j.bbrc.2007.01.035; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; Galindo BE, 2005, BIOCHEM BIOPH RES CO, V334, P96, DOI 10.1016/j.bbrc.2005.06.074; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; GARBERS DL, 1976, J BIOL CHEM, V251, P4071; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Granados-Gonzalez G, 2005, FEBS LETT, V579, P6667, DOI 10.1016/j.febslet.2005.10.035; GRAY J, 1955, J EXP BIOL, V32, P802; Greenwood IA, 2007, TRENDS PHARMACOL SCI, V28, P1, DOI 10.1016/j.tips.2006.11.004; Guerrero A, 2010, BIOCHEM SOC T, V38, P1270, DOI 10.1042/BST0381270; Guerrero A, 2010, DEV BIOL, V344, P52, DOI 10.1016/j.ydbio.2010.04.013; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; LEE HC, 1986, J BIOL CHEM, V261, P6026; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Nishigaki T, 2004, DEV BIOL, V272, P376, DOI 10.1016/j.ydbio.2004.04.035; Nykter M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058702; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Riedel-Kruse IH, 2007, HFSP J, V1, P192, DOI 10.2976/1.2773861; Rodriguez E, 2003, J PHYSIOL-LONDON, V546, P89, DOI 10.1113/jphysiol.2002.030510; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Su YH, 2002, P NATL ACAD SCI USA, V99, P6743, DOI 10.1073/pnas.102186699; SUZUKI N, 1995, ZOOL SCI, V12, P13, DOI 10.2108/zsj.12.13; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Wood CD, 2003, J CELL BIOL, V161, P89, DOI 10.1083/jcb.200212053; Wood CD, 2007, DEV BIOL, V306, P525, DOI 10.1016/j.ydbio.2007.03.036	61	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22619	10.1371/journal.pone.0022619	http://dx.doi.org/10.1371/journal.pone.0022619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857937	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500009
J	Lundberg, J; Jonsson, S; Holmin, S				Lundberg, Johan; Jonsson, Stefan; Holmin, Staffan			Long Term Follow-Up of the Endovascular Trans-Vessel Wall Technique for Parenchymal Access in Rabbit with Full Clinical Integration	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; IMPLANTATION; STROKE; TYPE-1	Objective: Endovascular techniques are providing options to surgical/percutaneous cell transplantation methods. Some cells, e. g. insulin producing cells, are not suitable for intra-luminal transplantation and for such cells, other options must be found. We have constructed a "nanocatheter'' with a penetrating tip for vessel perforation, thereby creating a working channel for parenchymal access by endovascular technique. To finish the procedure safely, the distal tip is detached to provide a securing plug in the vessel wall defect. Materials and Methods: We have performed interventions with full clinical integration in the superior mesenteric artery (SMA), the subclavian artery and the external carotid artery in rabbits. No hemorrhagic-or thromboembolic events occurred during the procedure. Stenosis formation and distal embolisation were analyzed by angiography and macroscopic inspection during autopsy at five, 30 and 80 days. All animals and implanted devices were also evaluated by micro-dissections and histochemical analysis. Results: In this study we show safety data on the trans-vessel wall technique by behavioral, angiographical and histological analysis. No stenosis formation was observed at any of the follow-up time points. No animals or organs have shown any signs of distress due to the intervention. Histological examination showed no signs of hemorrhage, excellent biocompatibility with no inflammation and a very limited fibrous capsule formation around the device, comparable to titanium implants. Further, no histological changes were detected in the endothelia of the vessels subject to intervention. Conclusions: The trans-vessel wall technique can be applied for e. g. cell transplantations, local substance administration and tissue sampling with low risk for complications during the procedure and low risk for hemorrhage, stenosis development or adverse tissue reactions with an 80 days follow-up time. The benefit should be greatest in organs that are difficult or risky to reach with surgical techniques, such as the pancreas, the CNS and the heart.	[Lundberg, Johan; Holmin, Staffan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Jonsson, Stefan] Royal Inst Technol, Dept Mat Sci & Engn, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Lundberg, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	staffan.holmin@karolinska.se		Holmin, Staffan/0000-0002-1628-1615	Swedish Research Council [K2006-73X-20139-01-3]; Karolinska Institutet; Karolinska Institutet Innovations; Swedish Society of Medicine and Strokefonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska Institutet Innovations; Swedish Society of Medicine and Strokefonden	This study was supported by grants from the Swedish Research Council (K2006-73X-20139-01-3), Karolinska Institutet funds, Karolinska Institutet Innovations, the Swedish Society of Medicine and Strokefonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER PH, 1990, SCRIPTA METALL MATER, V24, P943, DOI 10.1016/0956-716X(90)90142-4; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gordon PH, 2004, ARCH NEUROL-CHICAGO, V61, P858, DOI 10.1001/archneur.61.6.858; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Hirshberg B, 2002, DIABETES, V51, P2135, DOI 10.2337/diabetes.51.7.2135; Humar A, 2000, ANN SURG, V231, P269, DOI 10.1097/00000658-200002000-00017; Kandaswamy R, 1999, TRANSPL P, V31, P602, DOI 10.1016/S0041-1345(98)01574-7; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; LUNDBERG J, 2011, CELL TRANSP IN PRESS; Lundberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010449; Lundberg J, 2009, NEURORADIOLOGY, V51, P661, DOI 10.1007/s00234-009-0551-6; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; SCHARP DW, 1991, TRANSPLANTATION, V51, P76, DOI 10.1097/00007890-199101000-00012; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23328	10.1371/journal.pone.0023328	http://dx.doi.org/10.1371/journal.pone.0023328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858072	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500027
J	Hampton, DD; Hale, LP				Hampton, Daniel D.; Hale, Laura P.			Mast Cells Are Critical for Protection against Peptic Ulcers Induced by the NSAID Piroxicam	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INDUCED GASTRIC-ULCERATION; FIBROBLAST-GROWTH-FACTOR; HISTAMINE-RELEASE; SKIN WOUNDS; BILE-DUCT; MUCOSAL; ROFECOXIB; ASPIRIN; STOMACH	Many commonly used non-steroidal anti-inflammatory drugs (NSAIDs) also cause gastrointestinal toxicity, including the development of life-threatening peptic ulcers. We report that mast cell-deficient mice have an extremely high incidence of severe peptic ulceration when exposed to the NSAID piroxicam. This enhanced ulcer susceptibility can be reversed by reconstitution with mast cells. Furthermore, wild type mice treated with diphenhydramine hydrochloride, a commonly used antihistamine that blocks histamine H1 receptors, develop a similarly high incidence of peptic ulcers following piroxicam exposure. The protective effect of mast cells is independent of TNF, blockade of H2 receptors, or acid secretion. These data indicate a critical role for mast cells and the histamine that they produce in prevention and/or repair of piroxicam-induced gastric mucosal injury. Additional studies will be required to determine whether this represents a NSAID class effect that can be exploited to develop novel therapeutic strategies to limit the incidence of NSAID-induced side effects in humans.	[Hampton, Daniel D.] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Hampton, DD (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.	laura.hale@duke.edu			National Institutes of Health [R21DK75522, CA115480]; NATIONAL CANCER INSTITUTE [R01CA115480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the National Institutes of Health (R21DK75522 and CA115480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABTAHI FS, 1975, BRIT J SURG, V62, P113, DOI 10.1002/bjs.1800620208; Azuma T, 1999, DIGEST DIS SCI, V44, P1177, DOI 10.1023/A:1026684425642; Barkun A, 2010, AM J MED, V358, P366; Barozzi N, 2007, PHARMACOEPIDEM DR S, V16, P1184, DOI 10.1002/pds.1451; Basso D, 1999, J CLIN PATHOL, V52, P210, DOI 10.1136/jcp.52.3.210; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cairns JA, 1996, J IMMUNOL, V156, P275; Chichlowski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012220; Darling RL, 2004, GASTROENTEROLOGY, V127, P94, DOI 10.1053/j.gastro.2004.04.003; dePaulis A, 1997, ARTHRITIS RHEUM-US, V40, P469, DOI 10.1002/art.1780400313; DJAHANGUIRI B, 1973, GASTROENTEROLOGY, V65, P630; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Egozi EI, 2003, WOUND REPAIR REGEN, V11, P46, DOI 10.1046/j.1524-475X.2003.11108.x; EHSANULLAH RSB, 1988, BRIT MED J, V297, P1017, DOI 10.1136/bmj.297.6655.1017; GOMES JC, 1988, AGENTS ACTIONS, V24, P266, DOI 10.1007/BF02028282; GOMPERTZ RHK, 1991, AGENTS ACTIONS, V33, P161, DOI 10.1007/BF01993155; Grosman N, 2007, INT IMMUNOPHARMACOL, V7, P532, DOI 10.1016/j.intimp.2006.12.010; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Hsiao FY, 2009, CLIN THER, V31, P2618, DOI 10.1016/j.clinthera.2009.11.022; Hull MA, 1997, GUT, V40, P204, DOI 10.1136/gut.40.2.204; HULL MA, 1995, GUT, V37, P610, DOI 10.1136/gut.37.5.610; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Kumar V, 2012, ROBBINS COTRAN PATHO; LACY ER, 1984, LAB INVEST, V51, P573; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malhotra Samir, 2004, MedGenMed, V6, P6; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Nakajima S, 1996, APMIS, V104, P19, DOI 10.1111/j.1699-0463.1996.tb00681.x; Ng FH, 2008, DIGESTION, V77, P173, DOI 10.1159/000141264; Oehmichen M, 2009, FORENSIC SCI INT, V191, P1, DOI 10.1016/j.forsciint.2009.05.020; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; Rudzki Zbigniew, 1995, Polish Journal of Pathology, V46, P225; Scheiman JM, 2010, CLIN THER, V32, P667, DOI 10.1016/j.clinthera.2010.04.009; SHIMADA M, 1980, NATURE, V283, P662, DOI 10.1038/283662a0; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Singh G, 1999, J RHEUMATOL, V26, P18; SOMASUNDARAM S, 1995, SCAND J GASTROENTERO, V30, P289, DOI 10.3109/00365529509093280; Sung JJY, 2009, ALIMENT PHARM THER, V29, P938, DOI 10.1111/j.1365-2036.2009.03960.x; Taha AS, 2009, LANCET, V374, P119, DOI 10.1016/S0140-6736(09)61246-0; TALLEY NJ, 1995, DIGEST DIS SCI, V40, P1345, DOI 10.1007/BF02065549; Tamblyn R, 1997, ANN INTERN MED, V127, P429, DOI 10.7326/0003-4819-127-6-199709150-00003; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; USPENSKY VM, 1980, ARK PATOL, V42, P14; Wallace JL, 1996, FASEB J, V10, P731, DOI 10.1096/fasebj.10.7.8635690; WALLACE JL, 1990, GASTROENTEROLOGY, V99, P295, DOI 10.1016/0016-5085(90)91009-U; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Yuan YH, 2006, NAT CLIN PRACT GASTR, V3, P80, DOI 10.1038/ncpgasthep0393; Zhu Amy, 2008, Curr Gastroenterol Rep, V10, P548, DOI 10.1007/s11894-008-0101-0	57	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23669	10.1371/journal.pone.0023669	http://dx.doi.org/10.1371/journal.pone.0023669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858200	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500061
J	Hu, G; He, B				Hu, Gang; He, Bin			Magnetoacoustic Imaging of Electrical Conductivity of Biological Tissues at a Spatial Resolution Better than 2 mm	PLOS ONE			English	Article							FINITE-ELEMENT-METHOD; INDUCTION MAT-MI; MAGNETIC INDUCTION; IMPEDANCE TOMOGRAPHY; BIOELECTRIC CURRENTS; RESISTIVITY; ALGORITHM; MHZ	Magnetoacoustic tomography with magnetic induction (MAT-MI) is an emerging approach for noninvasively imaging electrical impedance properties of biological tissues. The MAT-MI imaging system measures ultrasound waves generated by the Lorentz force, having been induced by magnetic stimulation, which is related to the electrical conductivity distribution in tissue samples. MAT-MI promises to provide fine spatial resolution for biological tissue imaging as compared to ultrasound resolution. In the present study, we first estimated the imaging spatial resolution by calculating the full width at half maximum (FWHM) of the system point spread function (PSF). The actual spatial resolution of our MAT-MI system was experimentally determined to be 1.51 mm by a parallel-line-source phantom with Rayleigh criterion. Reconstructed images made from tissue-mimicking gel phantoms, as well as animal tissue samples, were consistent with the morphological structures of the samples. The electrical conductivity value of the samples was determined directly by a calibrated four-electrode system. It has been demonstrated that MAT-MI is able to image the electrical impedance properties of biological tissues with better than 2 mm spatial resolution. These results suggest the potential of MAT-MI for application to early detection of small-size diseased tissues (e. g. small breast cancer).	[Hu, Gang; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hu, G (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	binhe@umn.edu			National Institutes of Health [R21EB006070]; National Science Foundation [BES-0602957]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health R21EB006070 and National Science Foundation BES-0602957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; FALLERT MA, 1993, CIRCULATION, V87, P199, DOI 10.1161/01.CIR.87.1.199; FRICKE HUGO, 1926, JOUR CANCER RES, V10, P340; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Gao N, 2005, PHYS MED BIOL, V50, P2675, DOI 10.1088/0031-9155/50/11/016; Hu G, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3543630; Hu G, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3486685; Jossinet J, 1998, PHYSIOL MEAS, V19, P61, DOI 10.1088/0967-3334/19/1/006; JOY M, 1989, MAGN RESON IMAGING, V7, P89, DOI 10.1016/0730-725X(89)90328-7; Kruger RA, 2000, PROC SPIE, V3916, P150, DOI 10.1117/12.386316; Kwon O, 2002, IEEE T BIO-MED ENG, V49, P160, DOI 10.1109/10.979355; Li X, 2006, J APPL PHYS, V99, DOI 10.1063/1.2186371; Li X, 2007, IEEE T BIO-MED ENG, V54, P323, DOI 10.1109/TBME.2006.883827; Li X, 2009, PHYS MED BIOL, V54, P2667, DOI 10.1088/0031-9155/54/9/005; Ma QY, 2008, IEEE T BIO-MED ENG, V55, P813, DOI 10.1109/TBME.2007.912674; Metherall P, 1996, NATURE, V380, P509, DOI 10.1038/380509a0; Morse P.M., 1953, METHODS THEORETICAL; Mueller JL, 1999, IEEE T BIO-MED ENG, V46, P1379, DOI 10.1109/10.797998; PAULSON K, 1993, IEEE T MED IMAGING, V12, P681, DOI 10.1109/42.251118; Peyton AJ, 1996, MEAS SCI TECHNOL, V7, P261, DOI 10.1088/0957-0233/7/3/006; ROTH BJ, 1994, IEEE T BIO-MED ENG, V41, P723, DOI 10.1109/10.310087; Scharfetter H, 2005, PHYSIOL MEAS, V26, pS307, DOI 10.1088/0967-3334/26/2/028; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; TOWE BC, 1988, IEEE T BIO-MED ENG, V35, P892, DOI 10.1109/10.7300; Tsai JZ, 2002, IEEE T BIO-MED ENG, V49, P472, DOI 10.1109/10.995686; WANG WP, 1994, IEEE T MAGN, V30, P5015; Wen H, 1998, IEEE T BIO-MED ENG, V45, P119, DOI 10.1109/10.650364; Xia R, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772763; Xu Y, 2005, PHYS MED BIOL, V50, P5175, DOI 10.1088/0031-9155/50/21/015; Xu Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033902; Yang S, 2007, MED PHYS, V34, P3294, DOI 10.1118/1.2757088	32	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23421	10.1371/journal.pone.0023421	http://dx.doi.org/10.1371/journal.pone.0023421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858111	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500039
J	McIntosh, KB; Bhattacharya, A; Willis, IM; Warner, JR				McIntosh, Kerri B.; Bhattacharya, Arpita; Willis, Ian M.; Warner, Jonathan R.			Eukaryotic Cells Producing Ribosomes Deficient in Rpl1 Are Hypersensitive to Defects in the Ubiquitin-Proteasome System	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; L1 STALK; YEAST; GENE; RNA; BIOSYNTHESIS; DEGRADATION; SUBUNIT	It has recently become clear that the misassembly of ribosomes in eukaryotic cells can have deleterious effects that go far beyond a simple shortage of ribosomes. In this work we find that cells deficient in ribosomal protein L1 (Rpl1; Rpl10a in mammals) produce ribosomes lacking Rpl1 that are exported to the cytoplasm and that can be incorporated into polyribosomes. The presence of such defective ribosomes leads to slow growth and appears to render the cells hypersensitive to lesions in the ubiquitin-proteasome system. Several genes that were reasonable candidates for degradation of 60S subunits lacking Rpl1 fail to do so, suggesting that key players in the surveillance of ribosomal subunits remain to be found. Interestingly, in spite of rendering the cells hypersensitive to the proteasome inhibitor MG132, shortage of Rpl1 partially suppresses the stress-invoked temporary repression of ribosome synthesis caused by MG132.	[McIntosh, Kerri B.; Bhattacharya, Arpita; Warner, Jonathan R.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McIntosh, KB (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.	jon.warner@einstein.yu.edu		Bhattacharya, Arpita/0000-0002-0252-1550; Willis, Ian/0000-0001-6599-2395	National Institutes of Health [GM25532, ARRAGM25532-S1, GM085177, CAI-3330]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085177, R01GM025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grants from the National Institutes of Health: GM25532 and ARRAGM25532-S1 to JRW, GM085177 to IMW, and CAI-3330 to the Albert Einstein Cancer Center. KBM was the recipient of a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bhattacharya A, 2010, MOL CELL BIOL, V30, P5562, DOI 10.1128/MCB.00618-10; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ellis SR, 2011, SEMIN HEMATOL, V48, P89, DOI 10.1053/j.seminhematol.2011.02.005; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Fewell SW, 1999, MOL CELL BIOL, V19, P826; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FIROOZAN M, 1991, YEAST, V7, P173, DOI 10.1002/yea.320070211; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; KRUSE C, 1985, P NATL ACAD SCI USA, V82, P7515, DOI 10.1073/pnas.82.22.7515; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493, DOI 10.1128/MCB.14.4.2493; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Park KC, 1997, ARCH BIOCHEM BIOPHYS, V347, P78, DOI 10.1006/abbi.1997.0311; PEARSON NJ, 1982, CELL, V29, P347, DOI 10.1016/0092-8674(82)90151-9; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; UDEM SA, 1973, J BIOL CHEM, V248, P1412; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao Y, 2003, MOL CELL BIOL, V23, P699, DOI 10.1128/MCB.23.2.699-707.2003	48	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23579	10.1371/journal.pone.0023579	http://dx.doi.org/10.1371/journal.pone.0023579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858174	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953500057
J	Shen, BY; Fang, Y; Wu, N; Gould, SJ				Shen, Beiyi; Fang, Yi; Wu, Ning; Gould, Stephen J.			Biogenesis of the Posterior Pole Is Mediated by the Exosome/Microvesicle Protein-sorting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LEADING-EDGE; SIGNALING PATHWAYS; PROTEOMIC ANALYSIS; DICTYOSTELIUM-DISCOIDEUM; EUKARYOTIC CHEMOTAXIS; CELL-MIGRATION; ERM PROTEINS; MYOSIN-II; EXOSOMES	Biogenesis of the posterior pole is critical to directed cell migration and other polarity-dependent processes. We show here that proteins are targeted to the posterior pole on the basis of higher order oligomerization and plasma membrane binding, the same elements that target proteins to exosomes/microvesicles (EMVs), HIV, and other retrovirus particles. We also demonstrate that the polarization of the EMV protein-sorting pathway can occur in morphologically non-polarized cells, defines the site of uropod formation, is induced by increased expression of EMV cargo proteins, and is evolutionarily conserved between humans and the protozoan Dictyostelium discoideum. Based on these results, we propose a mechanism of posterior pole biogenesis in which elevated levels of EMV cargoes (i) polarize the EMV protein-sorting pathway, (ii) generate a nascent posterior pole, and (iii) prime cells for signal-induced biogenesis of a uropod. This model also offers a mechanistic explanation for the polarized budding of EMVs and retroviruses, including HIV.	[Shen, Beiyi; Fang, Yi; Wu, Ning; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	sgould@jhmi.edu			National Institutes of Health [DK45787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45787.	Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; BOURGUIGNON LYW, 1983, BIOCHIM BIOPHYS ACTA, V728, P186, DOI 10.1016/0005-2736(83)90470-4; BOURGUIGNON LYW, 1981, J CELL BIOL, V91, P889, DOI 10.1083/jcb.91.3.889; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; ERRABOLU R, 1994, J CELL SCI, V107, P9; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fonseca AV, 2010, J BIOL CHEM, V285, P31661, DOI 10.1074/jbc.M110.145037; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Harada A, 2010, J BIOCHEM, V147, P619, DOI 10.1093/jb/mvq027; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; KELLER HU, 1984, BLOOD CELLS, V10, P505; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Meili R, 2003, CELL, V114, P153, DOI 10.1016/S0092-8674(03)00553-1; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Ratner S, 1997, J IMMUNOL, V159, P1063; Rericha EC, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122pe26; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Schreiner G F, 1976, Adv Immunol, V24, P37, DOI 10.1016/S0065-2776(08)60329-6; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Skoglund P, 2010, CURR OPIN CELL BIOL, V22, P589, DOI 10.1016/j.ceb.2010.07.012; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Haastert PJM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001708; Wu Y, 2004, BIOCHEM BIOPH RES CO, V316, P666, DOI 10.1016/j.bbrc.2004.02.107; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	75	60	65	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44162	44176		10.1074/jbc.M111.274803	http://dx.doi.org/10.1074/jbc.M111.274803			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21865156	Green Published, hybrid			2022-12-25	WOS:000298402300057
J	Chuang, PY; Dai, Y; Liu, RJ; He, HL; Kretzler, M; Jim, B; Cohen, CD; He, JC				Chuang, Peter Y.; Dai, Yan; Liu, Ruijie; He, Helen; Kretzler, Matthias; Jim, Belinda; Cohen, Clemens D.; He, John C.			Alteration of Forkhead Box O (Foxo4) Acetylation Mediates Apoptosis of Podocytes in Diabetes Mellitus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ACETYLATION; GENE-EXPRESSION; GLOMERULAR-DISEASE; OXIDATIVE STRESS; OXIDANT STRESS; SIRT1; NEPHROPATHY; ACTIVATION; GLYCATION; INJURY	The number of kidney podocytes is reduced in diabetic nephropathy. Advanced glycation end products (AGEs) accumulate in patients with diabetes and promote the apoptosis of podocyte by activating the forkhead box O4 (Foxo4) transcription factor to increase the expression of a pro-apoptosis gene, Bcl2l11. Using chromatin immunoprecipitation we demonstrate that AGE-modified bovine serum albumin (AGE-BSA) enhances Foxo4 binding to a forkhead binding element in the promoter of Bcl2lll. AGE-BSA also increases the acetylation of Foxo4. Lysine acetylation of Foxo4 is required for Foxo4 binding and transcription of Bcl2l11 in podocytes treated with AGE-BSA. The expression of a protein deacetylase that targets Foxo4 for deacetylation, sirtuin (Sirt1), is down regulated in cultured podocytes by AGE-BSA treatment and in glomeruli of diabetic patients. SIRT1 over expression in cultured murine podocytes prevents AGE-induced apoptosis. Glomeruli isolated from diabetic db/db mice have increased acetylation of Foxo4, suppressed expression of Sirt1, and increased expression of Bcl2l11 compared to non-diabetic littermates. Together, our data provide evidence that alteration of Foxo4 acetylation and down regulation of Sirt1 expression in diabetes promote podocyte apoptosis. Strategies to preserve Sirt1 expression or reduce Foxo4 acetylation could be used to prevent podocyte loss in diabetes.	[Chuang, Peter Y.; Dai, Yan; He, Helen; He, John C.] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Dai, Yan; He, John C.] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Nephrol, Shanghai 200030, Peoples R China; [Liu, Ruijie] James J Peters VA Med Ctr, Bronx, NY USA; [Kretzler, Matthias] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Jim, Belinda] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Div Nephrol, Bronx, NY 10467 USA; [Cohen, Clemens D.] Univ Zurich, Div Nephrol, Zurich, Switzerland; [Cohen, Clemens D.] Univ Zurich, Inst Physiol, Zurich, Switzerland	Icahn School of Medicine at Mount Sinai; Shanghai Jiao Tong University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Michigan System; University of Michigan; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Zurich; University of Zurich	Chuang, PY (corresponding author), Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA.	peter.chuang@mssm.edu	Wang, Ruzhu/A-6727-2012	Wang, Ruzhu/0000-0003-3586-5728	NIH [DK082760R01]; Else Kroner-Fresenius Foundation [P09/05//A62/04]; U.S. Department of Veterans Affairs [1I01BX000345]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK082760] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Else Kroner-Fresenius Foundation; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by an NIH career development award (DK082760R01) to P.Y.C., the Else Kroner-Fresenius Foundation (P09/05//A62/04) award to C. D. C., and a U.S. Department of Veterans Affairs Merit Review Award (1I01BX000345) to J.C.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; BAELDE JJ, 1994, NEPHROL DIAL TRANSPL, V9, P304; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Cohen CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002937; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Forbes JM, 2003, J AM SOC NEPHROL, V14, pS254, DOI 10.1097/01.ASN.0000077413.41276.17; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; KUME S, J CLIN INVEST, V120, P1043; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; LIU D, 2010, ANTIOXID REDOX SIGNA; Menini S, 2007, DIABETOLOGIA, V50, P2591, DOI 10.1007/s00125-007-0821-y; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Rasband W., 2006, IMAGEJ; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sharma S, 2006, PHARMACOLOGY, V76, P69, DOI 10.1159/000089720; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Yamagishi SI, 2007, CURR DRUG TARGETS, V8, P952; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yoo TH, 2007, KIDNEY INT, V71, P1019, DOI 10.1038/sj.ki.5002195; You H, 2005, CELL CYCLE, V4, P37, DOI 10.4161/cc.4.1.1401; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	50	90	97	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23566	10.1371/journal.pone.0023566	http://dx.doi.org/10.1371/journal.pone.0023566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858169	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300061
J	Eriksson, M; Andreasson, K; Weidmann, J; Lundberg, K; Tegerstedt, K; Dalianis, T; Ramqvist, T				Eriksson, Mathilda; Andreasson, Kalle; Weidmann, Joachim; Lundberg, Kajsa; Tegerstedt, Karin; Dalianis, Tina; Ramqvist, Torbjorn			Murine Polyomavirus Virus-Like Particles Carrying Full-Length Human PSA Protect BALB/c Mice from Outgrowth of a PSA Expressing Tumor	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS; T-CELLS; CANCER-PATIENTS; VACCINE; PEPTIDE; IMMUNOTHERAPY; RECOGNITION; INDUCTION	Virus-like particles (VLPs) consist of capsid proteins from viruses and have been shown to be usable as carriers of protein and peptide antigens for immune therapy. In this study, we have produced and assayed murine polyomavirus (MPyV) VLPs carrying the entire human Prostate Specific Antigen (PSA) (PSA-MPyVLPs) for their potential use for immune therapy in a mouse model system. BALB/c mice immunized with PSA-MPyVLPs were only marginally protected against outgrowth of a PSA-expressing tumor. To improve protection, PSA-MPyVLPs were co-injected with adjuvant CpG, either alone or loaded onto murine dendritic cells (DCs). Immunization with PSA-MPyVLPs loaded onto DCs in the presence of CpG was shown to efficiently protect mice from tumor outgrowth. In addition, cellular and humoral immune responses after immunization were examined. PSA-specific CD4(+) and CD8(+) cells were demonstrated, but no PSA-specific IgG antibodies. Vaccination with DCs loaded with PSA-MPyVLPs induced an eight-fold lower titre of anti-VLP antibodies than vaccination with PSA-MPyVLPs alone. In conclusion, immunization of BALB/c mice with PSA-MPyVLPs, loaded onto DCs and co-injected with CpG, induces an efficient PSA-specific tumor protective immune response, including both CD4(+) and CD8(+) cells with a low induction of anti-VLP antibodies.	[Eriksson, Mathilda; Andreasson, Kalle; Weidmann, Joachim; Lundberg, Kajsa; Tegerstedt, Karin; Dalianis, Tina; Ramqvist, Torbjorn] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Eriksson, M (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Mathilda.Eriksson@ki.se	duan, hf/F-9166-2011	Dalianis, Tina/0000-0001-7022-2424; Andreasson, Karl-Magnus/0000-0002-5981-1962	Swedish Cancer Society [100258]; Swedish Medical Research Council [K2011-56X-15282-07-06]; Stockholm Cancer Society [101081]; Konung Gustaf V:s Jubileumsfond [104062]; Karolinska Institutet; Stockholm City Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Cancer Society; Konung Gustaf V:s Jubileumsfond; Karolinska Institutet(Karolinska Institutet); Stockholm City Council	The Swedish Cancer Society (contract number 100258), the Swedish Medical Research Council (grant number K2011-56X-15282-07-06), the Stockholm Cancer Society (grant number 101081), Konung Gustaf V:s Jubileumsfond (grant number 104062), Karolinska Institutet and the Stockholm City Council are greatly acknowledged for their financial support. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 1998, UROLOGY, V51, P150, DOI 10.1016/S0090-4295(97)00480-9; *AMERICANCANCERSOC, 2007, GLOB CANC STAT; Andreasson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011580; Andreasson K, 2009, INT J CANCER, V124, P150, DOI 10.1002/ijc.23920; Chakraborty NG, 2003, CANCER IMMUNOL IMMUN, V52, P497, DOI 10.1007/s00262-003-0377-8; CHU TM, 1984, TRANSPLANT P, V16, P481; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Elkord E, 2005, INT IMMUNOL, V17, P1315, DOI 10.1093/intimm/dxh309; Feyerabend S, 2009, PROSTATE, V69, P917, DOI 10.1002/pros.20941; Forsberg O, 2009, PROSTATE, V69, P70, DOI 10.1002/pros.20858; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; ISAACS JT, 1994, VITAM HORM, V49, P433; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; LEPOR H, 1982, J UROLOGY, V128, P335, DOI 10.1016/S0022-5347(17)52915-8; LERNER SP, 1991, J UROLOGY, V146, P1040, DOI 10.1016/S0022-5347(17)37997-1; Lubaroff DM, 2006, VACCINE, V24, P6155, DOI 10.1016/j.vaccine.2006.04.022; MCCORMACK RT, 1995, UROLOGY, V45, P729, DOI 10.1016/S0090-4295(99)80076-4; Milowsky MI, 2004, J CLIN ONCOL, V22, P2522, DOI 10.1200/JCO.2004.09.154; MONTGOMERY BT, 1992, PROSTATE, V21, P63, DOI 10.1002/pros.2990210107; NILSSON SV, 1984, J VIROL, V51, P768, DOI 10.1128/JVI.51.3.768-775.1984; Pandha HS, 2004, BJU INT, V94, P412, DOI 10.1111/j.1464-410X.2004.04922.x; Pavlenko M, 2005, PROSTATE, V64, P50, DOI 10.1002/pros.20221; Pavlenko M, 2004, BRIT J CANCER, V91, P688, DOI 10.1038/sj.bjc.6602019; PEEHL DM, 2005, CANCER, P2021; Perambakam S, 2006, CANCER IMMUNOL IMMUN, V55, P1033, DOI 10.1007/s00262-005-0090-x; REDMOND MJ, 1993, VACCINE, V11, P273, DOI 10.1016/0264-410X(93)90029-W; SAJJA R, 2003, I J RAD ONCOLOGY, V57, P388; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Schafer K, 1999, INT J CANCER, V81, P881, DOI 10.1002/(SICI)1097-0215(19990611)81:6<881::AID-IJC8>3.3.CO;2-K; Simons JW, 2006, UROL ONCOL-SEMIN ORI, V24, P419, DOI 10.1016/j.urolonc.2005.08.021; SINHA AA, 1986, J UROLOGY, V136, P722, DOI 10.1016/S0022-5347(17)45036-1; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; Tegerstedt K, 2003, J GEN VIROL, V84, P3443, DOI 10.1099/vir.0.19443-0; Tegerstedt K, 2007, CANCER IMMUNOL IMMUN, V56, P1335, DOI 10.1007/s00262-007-0281-8; Turner MJ, 2001, J IMMUNOL METHODS, V256, P107, DOI 10.1016/S0022-1759(01)00436-7; Ziada A, 2004, PROSTATE, V60, P332, DOI 10.1002/pros.20065	39	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23828	10.1371/journal.pone.0023828	http://dx.doi.org/10.1371/journal.pone.0023828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858228	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300099
J	Naeem, H; Kuffner, R; Zimmer, R				Naeem, Haroon; Kueffner, Robert; Zimmer, Ralf			MIRTFnet: Analysis of miRNA Regulated Transcription Factors	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; GENE-EXPRESSION; TARGET RECOGNITION; PROTEIN-SYNTHESIS; MICRORNA; FAMILY; CANCER; IDENTIFICATION; SIGNATURES; APOPTOSIS	Background: Several expression datasets of miRNA transfection experiments are available to analyze the regulatory mechanisms downstream of miRNA effects. The miRNA induced regulatory effects can be propagated via transcription factors (TFs). We propose the method MIRTFnet to identify miRNA controlled TFs as active regulators if their downstream target genes are differentially expressed. Methodology/Principal Findings: MIRTFnet enables the determination of active transcription factors (TFs) and is sensitive enough to exploit the small expression changes induced by the activity of miRNAs. For this purpose, different statistical tests were evaluated and compared. Based on the identified TFs, databases, computational predictions and the literature we construct regulatory models downstream of miRNA actions. Transfecting miRNAs are connected to active regulators via a network of miRNA-TF, miRNA-kinase-TF as well as TF-TF relationships. Based on 43 transfection experiments involving 17 cancer relevant miRNAs we show that MIRTFnet detects active regulators reliably. Conclusions/Significance: The consensus of the individual regulatory models shows that the examined miRNAs induce activity changes in a common core of transcription factors involved in cancer related processes such as proliferation or apoptosis.	[Naeem, Haroon; Kueffner, Robert; Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany	University of Munich	Naeem, H (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	robert.kueffner@bio.ifi.lmu.de	Zimmer, Ralf/L-9295-2019	Naeem, Haroon/0000-0001-9019-8345	German Federal Ministry of Education and Research [FKZ 01GS0801]; Deutscher Akademischer Austausch Dienst [442, A/07/96865]; Higher Education Commission of Pakistan [442, A/07/96865]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work has been supported in part by the German Federal Ministry of Education and Research (FKZ 01GS0801). HN is supported by the Deutscher Akademischer Austausch Dienst in cooperation with Higher Education Commission of Pakistan (Referat 442, Code A/07/96865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Barh D, 2010, CURR ONCOL, V17, P70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; Benjamini Y, 2001, ANN STAT, V29, P1165; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Foissac S, 2009, INTEGROMICS WHITE PA, P1; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu George E., 2008, Genomics Proteomics & Bioinformatics, V6, P129, DOI 10.1016/S1672-0229(09)60001-2; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S5; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; PAPPAS PA, 2004, P SE SAS US GROUP C; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SIEGEL S., 1956, NONPARAMETRIC STAT B; Sohler F, 2005, BIOINFORMATICS, V21, P115, DOI 10.1093/bioinformatics/bti11120; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tschan MP, 2008, ONCOGENE, V27, P3489, DOI 10.1038/sj.onc.1211004; Tu K, 2009, NUCLEIC ACIDS RES, V37, P5969, DOI 10.1093/nar/gkp638; Volinia S, 2010, BIOINFORMATICS, V26, P91, DOI 10.1093/bioinformatics/btp598; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851	71	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22519	10.1371/journal.pone.0022519	http://dx.doi.org/10.1371/journal.pone.0022519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857930	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300005
J	Qi, J; Zhang, H; Guo, J; Yang, L; Wang, W; Chen, T; Li, H; Wu, SX; Li, YQ				Qi, Jian; Zhang, Hua; Guo, Jun; Yang, Le; Wang, Wen; Chen, Tao; Li, Hui; Wu, Sheng-Xi; Li, Yun-Qing			Synaptic Connections of the Neurokinin 1 Receptor-Like Immunoreactive Neurons in the Rat Medullary Dorsal Horn	PLOS ONE			English	Article							SUBSTANCE-P RECEPTOR; ROSTRAL VENTROMEDIAL MEDULLA; SEROTONIN-CONTAINING AXONS; SPINAL TRIGEMINAL NUCLEUS; I PROJECTION NEURONS; LAMINA-I; INHIBITORY NEUROTRANSMISSION; SUPERFICIAL LAMINAE; NOXIOUS-STIMULATION; GELATINOSA NEURONS	The synaptic connections between neurokinin 1 (NK1) receptor-like immunoreactive (LI) neurons and gamma-aminobutyric acid (GABA)-, glycine (Gly)-, serotonin (5-HT)-or dopamine-beta-hydroxylase (DBH, a specific marker for norepinephrinergic neuronal structures)-LI axon terminals in the rat medullary dorsal horn (MDH) were examined under electron microscope by using a pre-embedding immunohistochemical double-staining technique. NK1 receptor-LI neurons were observed principally in laminae I and III, only a few of them were found in lamina II of the MDH. GABA-, Gly-, 5-HT-, or DBH-LI axon terminals were densely encountered in laminae I and II, and sparsely in lamina III of the MDH. Some of these GABA-, Gly-, 5-HT-, or DBH-LI axon terminals were observed to make principally symmetric synapses with NK1 receptor-LI neuronal cell bodies and dendritic processes in laminae I, II and III of the MDH. The present results suggest that neurons expressing NK1 receptor within the MDH might be modulated by GABAergic and glycinergic inhibitory intrinsic neurons located in the MDH and 5-HT- or norepinephrine (NE)-containing descending fibers originated from structures in the brainstem.	[Qi, Jian; Zhang, Hua; Wang, Wen; Chen, Tao; Li, Hui; Wu, Sheng-Xi; Li, Yun-Qing] Fourth Mil Med Univ, Dept Anat, Xian 710032, Peoples R China; [Qi, Jian; Zhang, Hua; Wang, Wen; Chen, Tao; Li, Hui; Wu, Sheng-Xi; Li, Yun-Qing] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Guo, Jun] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Qi, J (corresponding author), Fourth Mil Med Univ, Dept Anat, Xian 710032, Peoples R China.	deptanat@fmmu.edu.cn			National Natural Science Foundation of China [30771133, 30971123, 31010103909]; National Program of Basic Research of China [G2006CB500808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Basic Research of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China ( Nos. 30771133, 30971123, 31010103909) and the National Program of Basic Research of China (G2006CB500808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghamdi KS, 2009, NEUROSCIENCE, V164, P1794, DOI 10.1016/j.neuroscience.2009.09.071; Antal M, 1996, NEUROSCIENCE, V73, P509, DOI 10.1016/0306-4522(96)00063-2; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; CARLTON SM, 1992, J COMP NEUROL, V322, P528, DOI 10.1002/cne.903220407; DING YQ, 1995, NEUROSCI RES, V23, P415, DOI 10.1016/0168-0102(95)00961-R; Guan ZL, 1998, NEUROSCI RES, V30, P213, DOI 10.1016/S0168-0102(97)00131-4; Hoyer D, 1996, BEHAV BRAIN RES, V73, P263; Ito A, 2000, J NEUROSCI, V20, P6302, DOI 10.1523/JNEUROSCI.20-16-06302.2000; Kato G, 2006, J NEUROSCI, V26, P1787, DOI 10.1523/JNEUROSCI.4856-05.2006; Kawasaki Y, 2003, ANESTHESIOLOGY, V98, P682, DOI 10.1097/00000542-200303000-00016; KWIAT GC, 1992, SOMATOSENS MOT RES, V9, P157, DOI 10.3109/08990229209144768; Labrakakis C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-24; Li H, 2000, BRAIN RES BULL, V53, P163, DOI 10.1016/S0361-9230(00)00320-8; Li H, 2002, BRAIN RES BULL, V58, P593, DOI 10.1016/S0361-9230(02)00826-2; Li JL, 1997, J COMP NEUROL, V384, P127, DOI 10.1002/(SICI)1096-9861(19970721)384:1<127::AID-CNE8>3.0.CO;2-3; Li JL, 2002, NEUROSCI LETT, V324, P9, DOI 10.1016/S0304-3940(02)00138-6; Li YQ, 2000, J COMP NEUROL, V424, P24, DOI 10.1002/1096-9861(20000814)424:1<24::AID-CNE2>3.0.CO;2-M; Li YQ, 1999, J COMP NEUROL, V411, P399; Li YQ, 1999, J BRAIN RES, V39, P277; Mackie M, 2003, NEUROSCIENCE, V119, P461, DOI 10.1016/S0306-4522(03)00174-X; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Martin WJ, 1999, PAIN, V80, P57, DOI 10.1016/S0304-3959(98)00194-8; MAXWELL DJ, 1983, BRAIN RES, V266, P253, DOI 10.1016/0006-8993(83)90656-X; Naim M, 1997, J NEUROSCI, V17, P5536; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; Polgar E, 2002, NEUROSCIENCE, V109, P799, DOI 10.1016/S0306-4522(01)00304-9; Puskar Z, 2001, NEUROSCIENCE, V102, P167, DOI 10.1016/S0306-4522(00)00445-0; Rahman W, 2007, NEUROSCI LETT, V419, P278, DOI 10.1016/j.neulet.2007.04.039; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; Taylor BK, 2009, CURR PAIN HEADACHE R, V13, P208, DOI 10.1007/s11916-009-0035-8; Todd AJ, 2002, EXP PHYSIOL, V87, P245, DOI 10.1113/eph8702351; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trafton JA, 1999, J NEUROSCI, V19, P9642; Wang D, 2000, NEUROSCI LETT, V288, P187, DOI 10.1016/S0304-3940(00)01226-X; WESTLUND KN, 1990, J COMP NEUROL, V299, P178, DOI 10.1002/cne.902990205; WILLIS WD, 1995, PAIN, P725; Worsley MA, 2005, EXP BRAIN RES, V160, P360, DOI 10.1007/s00221-004-2018-7; Xu Z, 2006, CURR OPIN NEUROBIOL, V16, P460, DOI 10.1016/j.conb.2006.06.002; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; 2010, PROG NEUROBIOL, V91, P38	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23275	10.1371/journal.pone.0023275	http://dx.doi.org/10.1371/journal.pone.0023275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858052	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300026
J	Qin, TC; Castoro, R; El Ahdab, S; Jelinek, J; Wang, XD; Si, JL; Shu, JM; He, R; Zhang, NX; Chung, WB; Kantarjian, HM; Issa, JPJ				Qin, Taichun; Castoro, Ryan; El Ahdab, Samih; Jelinek, Jaroslav; Wang, Xiaodan; Si, Jiali; Shu, Jingmin; He, Rong; Zhang, Nianxiang; Chung, Woonbok; Kantarjian, Hagop M.; Issa, Jean-Pierre J.			Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DEOXYCYTIDINE KINASE GENE; DNA METHYLATION; CYTOSINE-ARABINOSIDE; SCORING SYSTEM; MESSENGER-RNA; CANCER-CELLS; DCK GENE; 5-AZA-2'-DEOXYCYTIDINE; INACTIVATION	Purpose: The DNA methylation inhibitor 5-aza-2'-deoxycytidine (DAC) is approved for the treatment of myelodysplastic syndromes (MDS), but resistance to DAC develops during treatment and mechanisms of resistance remain unknown. Therefore, we investigated mechanisms of primary and secondary resistance to DAC in MDS. Patients and Methods: We performed Quantitative Real-Time PCR to examine expression of genes related to DAC metabolism prior to therapy in 32 responders and non-responders with MDS as well as 14 patients who achieved a complete remission and subsequently relapsed while on therapy (secondary resistance). We then performed quantitative methylation analyses by bisulfite pyrosequencing of 10 genes as well as Methylated CpG Island Amplification Microarray (MCAM) analysis of global methylation in secondary resistance. Results: Most genes showed no differences by response, but the CDA/DCK ratio was 3 fold higher in non-responders than responders (P,. 05), suggesting that this could be a mechanism of primary resistance. There were no significant differences at relapse in DAC metabolism genes, and no DCK mutations were detected. Global methylation measured by the LINE1 assay was lower at relapse than at diagnosis (P,. 05). On average, the methylation of 10 genes was lower at relapse (16.1%) compared to diagnosis (18.1%) (P<.05). MCAM analysis showed decreased methylation of an average of 4.5% (range 0.6%-9.7%) of the genes at relapse. By contrast, new cytogenetic changes were found in 20% of patients. Conclusion: Pharmacological mechanisms are involved in primary resistance to DAC, whereas hypomethylation does not prevent a relapse for patients with DAC treatment.	[Qin, Taichun; Castoro, Ryan; El Ahdab, Samih; Jelinek, Jaroslav; Si, Jiali; Shu, Jingmin; He, Rong; Zhang, Nianxiang; Chung, Woonbok; Kantarjian, Hagop M.; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Wang, Xiaodan] Harbin Inst Hematol & Oncol, Harbin, Peoples R China	University of Texas System; UTMD Anderson Cancer Center	Qin, TC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	jpissa@mdanderson.org	Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/O-6876-2019	Jelinek, Jaroslav/0000-0002-2533-0220; Castoro, Ryan/0000-0002-3242-3775; Castoro, Ryan/0000-0003-3619-484X; Issa, Jean-Pierre/0000-0003-2258-5030	National Institutes of Health [CA100632, CA121104, CA108631]; NATIONAL CANCER INSTITUTE [P50CA100632, P01CA108631, R01CA121104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA100632, CA121104 and CA108631. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Madhoun AS, 2004, BIOCHEM PHARMACOL, V68, P601, DOI 10.1016/j.bcp.2004.05.007; AUL C, 1992, BRIT J HAEMATOL, V82, P358, DOI 10.1111/j.1365-2141.1992.tb06430.x; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; CHABOT GG, 1983, BIOCHEM PHARMACOL, V32, P1327, DOI 10.1016/0006-2952(83)90293-9; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; FLASSHOVE M, 1994, LEUKEMIA, V8, P780; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Herman JG, 1996, CANCER RES, V56, P722; Hopfer O, 2007, EXP HEMATOL, V35, P712, DOI 10.1016/j.exphem.2007.01.054; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1351, DOI 10.1002/cncr.23697; KOBAYASHI T, 1994, LEUKEMIA LYMPHOMA, V15, P503, DOI 10.3109/10428199409049755; Konopleva M, 2007, CURR DRUG TARGETS, V8, P685, DOI 10.2174/138945007780830827; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Kroep JR, 2002, MOL CANCER THER, V1, P371; Liu ZJ, 2004, FEBS LETT, V567, P327, DOI 10.1016/j.febslet.2004.04.044; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; OWENS JK, 1992, CANCER RES, V52, P2389; Plimack ER, 2007, LEUKEMIA LYMPHOMA, V48, P1472, DOI 10.1080/10428190701471981; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Roman-Gomez J, 2003, J CLIN ONCOL, V21, P1472, DOI 10.1200/JCO.2003.08.166; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; STEGMANN APA, 1993, LEUKEMIA, V7, P1005; van den Heuvel-Eibrink MM, 2001, LEUKEMIA, V15, P855, DOI 10.1038/sj.leu.2402112; Veuger MJ, 2003, LEUKEMIA RES, V27, P445, DOI 10.1016/S0145-2126(02)00224-2; Wong KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019027	32	102	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23372	10.1371/journal.pone.0023372	http://dx.doi.org/10.1371/journal.pone.0023372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858090	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300040
J	Fang, Z; Zhou, LN; Bao, YY; Ding, W; Shi, HM; Luo, XP; Hu, RM				Fang, Zhou; Zhou, Linuo; Bao, Yuanyuan; Ding, Wei; Shi, Haiming; Luo, Xinping; Hu, Renming			Association of NT-proBNP and Multiple Biomarkers with Severity of Angiographic Coronary Artery Disease in Diabetic and Pre-Diabetic Chinese Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG-TERM MORTALITY; NATRIURETIC PEPTIDE; RISK PREDICTION; HEART-DISEASE; ISCHEMIA; ANGINA; WOMEN; MEN	Background: Little is known about the plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), and the relationship between the severity of coronary heart disease (CHD) with NT-proBNP and multiple biomarkers in diabetic and pre-diabetic patients, compared to individuals with normal glucose levels. Methods: Four hundred and fifteen consecutive Chinese patients of both sexes were assigned to three groups on the basis of the new hemoglobin (Hb) A1c (HbA1c) cut-off points for diagnosis of diabetes and pre-diabetes. The three groups were divided into tertiles according to NT-proBNP, hs-CRP, cystatin C, and troponin T levels. Gensini scores were compared among the three groups and biomarker tertiles. Receiver operating characteristic (ROC) curves were used to obtain the angiographic CHD cut-off points for each biomarker. Stepwise multivariate linear correlation analysis was applied to examine the association between the severity of CHD and biomarker levels. Results: Gensini scores increased with increasing biomarker tertile levels and HbA1c. Gensini scores were significantly different in the middle and upper NT-proBNP tertiles of the diabetic, pre-diabetic and control groups. NT-proBNP had the highest positive and negative predictive values and area under the curve for CHD. Only NT-proBNP was identified as an independent variable for Gensini score. Conclusions: Plasma NT-proBNP may be an important biomarker to evaluate the severity of CHD and screen for CHD in diabetic or pre-diabetic patients.	[Fang, Zhou] Inst Endocrinol & Diabeteol, Shanghai, Peoples R China; [Zhou, Linuo; Bao, Yuanyuan; Ding, Wei; Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Shi, Haiming; Luo, Xinping] Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai 200433, Peoples R China; [Fang, Zhou] State Key Lab Genet Engn, Shanghai, Peoples R China	Fudan University; Fudan University	Fang, Z (corresponding author), Inst Endocrinol & Diabeteol, Shanghai, Peoples R China.	nally_zhou@yahoo.com.cn		Fang, Zhou/0000-0002-5231-6539	Grant of Shanghai Science and Technology [10411961200]; China National Grant on Science and Technology [30570740, 30270627]	Grant of Shanghai Science and Technology; China National Grant on Science and Technology	This research was supported by the Grant of Shanghai Science and Technology (10411961200) and China National Grant on Science and Technology (30570740, 30270627). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Curhan G, 2005, CLIN CHEM, V51, P293, DOI 10.1373/clinchem.2004.044388; de Graaf FR, 2010, AM J CARDIOL, V106, P1747, DOI 10.1016/j.amjcard.2010.08.015; De Sutter J, 2005, EUR HEART J, V26, P2644, DOI 10.1093/eurheartj/ehi502; Dong X, 2008, METABOLISM, V57, P24, DOI 10.1016/j.metabol.2007.08.004; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Nakagawa K, 2004, CIRC J, V68, P923, DOI 10.1253/circj.68.923; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Peer A, 2009, HEART, V95, P297, DOI 10.1136/hrt.2008.145425; Sadanandan S, 2004, J AM COLL CARDIOL, V44, P564, DOI 10.1016/j.jacc.2004.03.072; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Sattar N, 2010, ATHEROSCLEROSIS, V209, P295, DOI 10.1016/j.atherosclerosis.2009.09.016; Shanghai investigation group of heart failure, 2002, J CHINESE CARDIOVASC, V30, P24; Singh HS, 2009, CLIN CARDIOL, V32, P447, DOI 10.1002/clc.20569; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Weber M, 2004, AM HEART J, V148, P612, DOI 10.1016/j.ahj.2004.04.021; Wilkins John T, 2010, Prev Cardiol, V13, P160, DOI 10.1111/j.1751-7141.2010.00081.x; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	25	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22563	10.1371/journal.pone.0022563	http://dx.doi.org/10.1371/journal.pone.0022563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857933	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500008
J	Zong, M; Wu, XG; Chan, CWL; Choi, MY; Chan, HC; Tanner, JA; Yu, S				Zong, Min; Wu, Xing-gang; Chan, Cecilia W. L.; Choi, Mei Y.; Chan, Hsiao Chang; Tanner, Julian A.; Yu, Sidney			The Adaptor Function of TRAPPC2 in Mammalian TRAPPs Explains TRAPPC2-Associated SEDT and TRAPPC9-Associated Congenital Intellectual Disability	PLOS ONE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA TARDA; RECESSIVE MENTAL-RETARDATION; VESICLE DOCKING; GOLGI TRANSPORT; IDENTIFICATION; GENE; COMPLEXES; AUTOPHAGY; BINDING; PROTEIN	Background: The TRAPP (Transport protein particle) complex is a conserved protein complex functioning at various steps in vesicle transport. Although yeast has three functionally and structurally distinct forms, TRAPPI, II and III, emerging evidence suggests that mammalian TRAPP complex may be different. Mutations in the TRAPP complex subunit 2 (TRAPPC2) cause X-linked spondyloepiphyseal dysplasia tarda, while mutations in the TRAPP complex subunit 9 (TRAPPC9) cause postnatal mental retardation with microcephaly. The structural interplay between these subunits found in mammalian equivalent of TRAPPI and those specific to TRAPPII and TRAPPIII remains largely unknown and we undertook the present study to examine the interaction between these subunits. Here, we reveal that the mammalian equivalent of the TRAPPII complex is structurally distinct from the yeast counterpart thus leading to insight into mechanism of disease. Principal Findings: We analyzed how TRAPPII- or TRAPPIII-specific subunits interact with the six-subunit core complex of TRAPP by co-immunoprecipitation in mammalian cells. TRAPPC2 binds to TRAPPII-specific subunit TRAPPC9, which in turn binds to TRAPPC10. Unexpectedly, TRAPPC2 can also bind to the putative TRAPPIII-specific subunit, TRAPPC8. Endogenous TRAPPC9-positive TRAPPII complex does not contain TRAPPC8, suggesting that TRAPPC2 binds to either TRAPPC9 or TRAPPC8 during the formation of the mammalian equivalents of TRAPPII or TRAPPIII, respectively. Therefore, TRAPPC2 serves as an adaptor for the formation of these complexes. A disease-causing mutation of TRAPPC2, D47Y, failed to interact with either TRAPPC9 or TRAPPC8, suggesting that aspartate 47 in TRAPPC2 is at or near the site of interaction with TRAPPC9 or TRAPPC8, mediating the formation of TRAPPII and/or TRAPPIII. Furthermore, disease-causing deletional mutants of TRAPPC9 all failed to interact with TRAPPC2 and TRAPPC10. Conclusions: TRAPPC2 serves as an adaptor for the formation of TRAPPII or TRAPPIII in mammalian cells. The mammalian equivalent of TRAPPII is likely different from the yeast TRAPPII structurally.	[Zong, Min; Wu, Xing-gang; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Chan, Cecilia W. L.; Choi, Mei Y.; Tanner, Julian A.] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Zong, M (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	Sidney.yu@cuhk.edu.hk	Zong, Min/B-6706-2016; Tanner, Julian A./C-4412-2009; Chan, Hsiao Chang/E-1507-2016; Bin Sidney Yu, Siu/R-4936-2018	Zong, Min/0000-0001-9381-5791; Tanner, Julian A./0000-0002-5459-1526; Bin Sidney Yu, Siu/0000-0001-9643-2729	Hong Kong UGC GRF [479410]; Chinese University of Hong Kong; AoE	Hong Kong UGC GRF; Chinese University of Hong Kong(Chinese University of Hong Kong); AoE	This work was supported by Hong Kong UGC GRF grant 479410 (SY), by one-line budget of the Chinese University of Hong Kong (SY) and by AoE grant "Developmental Genomics and Skeletal Research'' (JAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Bar-Yosef U, 2004, AM J MED GENET A, V125A, P45, DOI 10.1002/ajmg.a.20435; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; CHOI C, ORG ASSEMBLY TRAPPII; Choi MY, 2009, BIOCHEM J, V423, P233, DOI 10.1042/BJ20090541; Christie PT, 2001, J CLIN ENDOCR METAB, V86, P3233, DOI 10.1210/jc.86.7.3233; Fiedler Jorg, 2004, Hum Mutat, V24, P103, DOI 10.1002/humu.9254; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; HU WH, 2005, TEST, V280, P29233; JEYABALAN J, PLOS ONE, V5; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Loh E, 2005, J CELL SCI, V118, P1209, DOI 10.1242/jcs.01723; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Matsui Y, 2001, AM J MED GENET, V99, P328, DOI 10.1002/ajmg.1179; Meiling-Wesse K, 2005, J BIOL CHEM, V280, P33669, DOI 10.1074/jbc.M501701200; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Montpetit B, 2009, TRAFFIC, V10, P713, DOI 10.1111/j.1600-0854.2009.00895.x; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nazarko TY, 2005, AUTOPHAGY, V1, P37, DOI 10.4161/auto.1.1.1512; Philippe O, 2009, AM J HUM GENET, V85, P903, DOI 10.1016/j.ajhg.2009.11.007; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sacher M, 2008, TRAFFIC, V9, P2032, DOI 10.1111/j.1600-0854.2008.00833.x; SAVARIRAYAN R, EUR J HUM GENET, V11, P639; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Siu KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018458; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Xiao CY, 2003, MUTAT RES-FUND MOL M, V525, P61, DOI 10.1016/S0027-5107(02)00315-9; YAMASAKI A, 2009, MOL BIOL CELL; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044; ZAHOOR MA, J GEN VIROL, V91, P1939	39	44	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23350	10.1371/journal.pone.0023350	http://dx.doi.org/10.1371/journal.pone.0023350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858081	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700017
J	DeRose-Wilson, L; Gaut, BS				DeRose-Wilson, Leah; Gaut, Brandon S.			Mapping Salinity Tolerance during Arabidopsis thaliana Germination and Seedling Growth	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BETAINE ALDEHYDE DEHYDROGENASE; NATURAL GENETIC-VARIATION; ACID SIGNAL-TRANSDUCTION; RECOMBINANT INBRED LINES; GENOME-WIDE ASSOCIATION; PLANT SALT TOLERANCE; ABSCISIC-ACID; OSMOTIC-STRESS; FREEZING TOLERANCE	To characterize and dissect genetic variation for salinity tolerance, we assessed variation in salinity tolerance during germination and seedling growth for a worldwide sample of Arabidopsis thaliana accessions. By combining QTL mapping, association mapping and expression data, we identified genomic regions involved in salinity response. Among the worldwide sample, we found germination ability within a moderately saline environment (150 mM NaCl) varied considerable, from >90% among the most tolerant lines to complete inability to germinate among the most susceptible. Our results also demonstrated wide variation in salinity tolerance within A. thaliana RIL populations and identified multiple genomic regions that contribute to this variation. These regions contain known candidate genes, but at least four of the regions contain loci not yet associated with salinity tolerance response phenotypes. Our observations suggest A. thaliana natural variation may be an underutilized resource for investigating salinity stress response.	[DeRose-Wilson, Leah; Gaut, Brandon S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	DeRose-Wilson, L (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	bgaut@uci.edu			NIH; NSF [DEB-0723860]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported in part by an NIH Bioinformatics Training Grant and by NSF grant DEB-0723860 to B.S. Gaut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel G, 1963, CROP SCI, V3, P159; Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87; Alonso-Blanco C, 2005, PLANT PHYSIOL, V139, P1304, DOI 10.1104/pp.105.068510; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Becker RA, 1988, NEW S LANGUAGE, P451; BEGUM F, 1992, PLANT CELL PHYSIOL, V33, P1009; Ben Hassine A, 2008, J EXP BOT, V59, P1315, DOI 10.1093/jxb/ern040; BIANCHI G, 1991, PLANT J, V1, P355, DOI 10.1046/j.1365-313X.1991.t01-11-00999.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; CHURCHILL GA, 1994, GENETICS, V138, P963; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Culley TM, 2006, NEW PHYTOL, V169, P589, DOI 10.1111/j.1469-8137.2005.01588.x; Doerge RW, 1996, GENETICS, V142, P285; Easlon HM, 2009, AM J BOT, V96, P605, DOI 10.3732/ajb.0800189; EHRET DL, 1999, ENV STRESS CROP PLAN, P69; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Foolad MR, 1999, PLANT BREEDING, V118, P49, DOI 10.1046/j.1439-0523.1999.118001049.x; Fujii H, 2009, MOL PLANT, V2, P183, DOI 10.1093/mp/ssn087; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gong ZZ, 2001, PLANT PHYSIOL, V126, P363, DOI 10.1104/pp.126.1.363; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hausmann NJ, 2005, EVOLUTION, V59, P81; Heschel MS, 2004, INT J PLANT SCI, V165, P817, DOI 10.1086/421477; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; HORVATH DP, 1993, PLANT PHYSIOL, V103, P1047, DOI 10.1104/pp.103.4.1047; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; ISHITANI M, 1995, PLANT MOL BIOL, V27, P307, DOI 10.1007/BF00020185; Johnson D. A., 1993, Stable isotopes and plant carbon-water relations., P269; JOHNSON DW, 1992, THEOR APPL GENET, V83, P833, DOI 10.1007/BF00226705; Juenger TE, 2006, MOL ECOL, V15, P1351, DOI 10.1111/j.1365-294X.2006.02774.x; Juenger TE, 2005, GENETICA, V123, P87, DOI 10.1007/s10709-003-2717-1; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar D., 1983, Sabrao Journal, V15, P71; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Lowry DB, 2009, NEW PHYTOL, V183, P776, DOI 10.1111/j.1469-8137.2009.02901.x; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; MCCUE KF, 1992, PLANT MOL BIOL, V18, P1, DOI 10.1007/BF00018451; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Nelson DE, 1998, GENET ENG P, V20, P153; NI BR, 1993, PLANT PHYSIOL, V101, P607, DOI 10.1104/pp.101.2.607; NIENHUIS J, 1994, AM J BOT, V81, P943, DOI 10.2307/2445286; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; NORDIN K, 1993, PLANT MOL BIOL, V21, P641, DOI 10.1007/BF00014547; Peters JL, 2001, PLANT PHYSIOL, V127, P1579, DOI 10.1104/pp.010504; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quesada V, 2000, GENETICS, V154, P421; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Sherrard ME, 2009, EVOLUTION, V63, P702, DOI 10.1111/j.1558-5646.2008.00580.x; Shinozaki K, 2002, PLANT CELL PHYSIOL, V43, pS19; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Taji T, 1999, PLANT CELL PHYSIOL, V40, P119, DOI 10.1093/oxfordjournals.pcp.a029469; Teixeira J, 2007, ENVIRON EXP BOT, V60, P121, DOI 10.1016/j.envexpbot.2006.09.003; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Thorlby G, 1999, PLANT J, V17, P445, DOI 10.1046/j.1365-313X.1999.00395.x; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; VOLKER U, 1992, J GEN MICROBIOL, V138, P2125, DOI 10.1099/00221287-138-10-2125; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; YOSHIBA Y, 1995, PLANT J, V7, P751, DOI 10.1046/j.1365-313X.1995.07050751.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhen Y, 2008, MOL BIOL EVOL, V25, P2547, DOI 10.1093/molbev/msn196; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	108	53	55	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22832	10.1371/journal.pone.0022832	http://dx.doi.org/10.1371/journal.pone.0022832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857956	Green Published, gold			2022-12-25	WOS:000293953500007
J	Huang, YC; Lien, RI; Su, LH; Chou, YH; Lin, TY				Huang, Yhu-Chering; Lien, Rey-In; Su, Lin-Hui; Chou, Yi-Hong; Lin, Tzou-Yien			Successful Control of Methicillin-Resistant Staphylococcus aureus in Endemic Neonatal Intensive Care Units-A 7-Year Campaign	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; NASAL CARRIAGE; SURVEILLANCE CULTURES; INTRANASAL MUPIROCIN; TAIWANESE CHILDREN; HOSPITAL ADMISSION; CLINICAL-FEATURES; NORTHERN TAIWAN; DOUBLE-BLIND; COLONIZATION	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is among the most important nosocomial pathogens in the intensive care unit (ICU) worldwide, including Taiwan. Since 1997, our neonatal ICUs (NICUs) had become endemic for MRSA. Methodology/Principal Findings: To control MRSA spread in our NICUs, we implemented a series of infection control measures stepwise, including reinforcement of hand hygiene since January 2000, augmentation of aseptic care over the insertion site of central venous catheter since July 2001, introduction of alcohol-based handrubs since April 2003, surveillance culture for MRSA and cohort care for the colonized patients between March 2003 and February 2004, and surveillance culture with subsequent decolonization of MRSA between August 2005 and July 2006. After implementation of these measures, MRSA healthcare-associated infection (HAI) density reduced by 92%, from 5.47 episodes per 1000 patient-days in 1999 to 0.45 episodes per 1000 patient-days in 2006; MRSA bloodstream infection reduced from 40 cases in 1999 to only one case in 2006. Compared to those obtained during the period of surveillance culture without decolonization, both rates of MRSA colonization (8.6% vs. 41%, p<0.001) and infection (1.1% vs. 12%, p<0.001) decreased significantly during the period of surveillance and decolonization. Molecular analysis of the clinical isolates during the study period showed that the endemic clone, which dominated between 1998 and 2005, almost disappeared in 2006, while the community clones increased significantly in 2006-2007. Conclusion/Significance: Through infection control measures, MRSA HAIs can be successfully controlled, even in areas with high levels of endemic MRSA infections such as our NICUs.	[Huang, Yhu-Chering; Lin, Tzou-Yien] Chang Gung Mem Hosp Linkou, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Lien, Rey-In; Chou, Yi-Hong] Chang Gung Mem Hosp Linkou, Div Neonatol, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Su, Lin-Hui; Lin, Tzou-Yien] Chang Gung Mem Hosp Linkou, Comm Infect Control, Tao Yuan, Taiwan; [Su, Lin-Hui] Chang Gung Mem Hosp Linkou, Dept Lab Med, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Lien, Rey-In; Su, Lin-Hui; Lin, Tzou-Yien] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, YC (corresponding author), Chang Gung Mem Hosp Linkou, Div Pediat Infect Dis, Tao Yuan, Taiwan.	ychuang@cgmh.org.tw			National Science Council (NSC) [94-2314-B-182A-090, 96-2314-B-182A-022]; Chang Gung Memorial Hospital [CMRPG 33128]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from the National Science Council (NSC 94-2314-B-182A-090, 96-2314-B-182A-022) and Chang Gung Memorial Hospital (CMRPG 33128). The funders had no role in study design, data collection and analysis, decision to publish.	Aly H, 2005, PEDIATRICS, V115, P1513, DOI 10.1542/peds.2004-1785; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; CHANG SC, 1988, J FORMOS MED ASSOC, V87, P157; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen CJ, 2009, DIAGN MICR INFEC DIS, V65, P199, DOI 10.1016/j.diagmicrobio.2009.05.020; Chen ML, 1999, J FORMOS MED ASSOC, V98, P426; Chuang YY, 2004, ACTA PAEDIATR, V93, P786, DOI [10.1111/j.1651-2227.2004.tb03019.x, 10.1080/08035250410028084]; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Garrouste-Orgeas M, 2001, INFECT CONT HOSP EP, V22, P687, DOI 10.1086/501846; Gregory ML, 2009, PEDIATRICS, V123, pE790, DOI 10.1542/peds.2008-1526; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hsueh PR, 2002, EMERG INFECT DIS, V8, P132; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2005, INFECT CONT HOSP EP, V26, P157, DOI 10.1086/502520; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang Yhu-Chering, 2005, Acta Paediatrica Taiwanica, V46, P156; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Laupland KB, 2003, CLIN INFECT DIS, V37, P933, DOI 10.1086/377735; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; *NAT COMM CLIN LAB, 2000, PERF STAND ANT DISK; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Raineri E, 2007, J HOSP INFECT, V67, P308, DOI 10.1016/j.jhin.2007.08.013; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Roghmann MC, 2001, J HOSP INFECT, V47, P98, DOI 10.1053/jhin.2000.0903; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Santos RP, 2008, CLIN INFECT DIS, V47, P110, DOI 10.1086/588789; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	44	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23001	10.1371/journal.pone.0023001	http://dx.doi.org/10.1371/journal.pone.0023001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857979	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500012
J	Maurage, P; Callot, C; Chang, B; Philippot, P; Rombaux, P; de Timary, P				Maurage, Pierre; Callot, Christophe; Chang, Betty; Philippot, Pierre; Rombaux, Philippe; de Timary, Philippe			Olfactory Impairment Is Correlated with Confabulation in Alcoholism: Towards a Multimodal Testing of Orbitofrontal Cortex	PLOS ONE			English	Article							STOP SIGNAL TASK; ODOR IDENTIFICATION; SEX-DIFFERENCES; OLDER-ADULTS; SCHIZOPHRENIA; DEFICITS; MEMORY; DISCRIMINATION; PERFORMANCE; PERCEPTION	Background: Olfactory abilities are now a flourishing field in psychiatry research. As the orbitofrontal cortex appears to be simultaneously implicated in odour processing and executive impairments, it has been proposed that olfaction could constitute a cognitive marker of psychiatric states. While this assumption appears promising, very few studies have been conducted on this topic among psychopathological populations. The present study thus aimed at exploring the links between olfaction and executive functions. These links were evaluated using two tasks of comparable difficulty, one known to rely on orbitofrontal cortex processing (i.e., a confabulation task), and one not associated with this area (i.e., Stop-Signal task). Methodology/Principal Findings: Twenty recently detoxified alcoholic individuals and twenty paired controls took part in an experiment evaluating olfactory abilities and executive functioning (i.e., Stop-Signal task and confabulation task). Comorbidities and potential biasing variables were also controlled for. Alcoholic individuals exhibited impaired performance for high-level olfactory processing and significant confabulation problems as compared to controls (but no deficit in Stop-Signal task), even when the influence of comorbidities was taken into account. Most importantly, olfactory abilities and confabulation rates were significantly correlated in both groups. Conclusions/Significance: Alcoholism jointly leads to olfactory and memory source impairments, and these two categories of deficits are associated. These results strongly support the proposition that olfactory and confabulation measures both index orbitofrontal functioning, and suggest that olfaction could become a reliable cognitive marker in psychiatric disorders. Moreover, it underlines the need to take into account these olfactory and source memory impairments in a clinical context.	[Maurage, Pierre; Callot, Christophe] Catholic Univ Louvain, Inst Psychol, Neurosci Syst & Cognit NEUROCS Res Unit, B-3000 Louvain, Belgium; [Maurage, Pierre; Callot, Christophe; Chang, Betty; Philippot, Pierre; de Timary, Philippe] Catholic Univ Louvain, Inst Psychol, Hlth & Psychol Dev CSDP Res Unit, B-3000 Louvain, Belgium; [Rombaux, Philippe] Catholic Univ Louvain, St Luc Hosp, Dept Otorhinolaryngol, Brussels, Belgium; [Rombaux, Philippe; de Timary, Philippe] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [de Timary, Philippe] Catholic Univ Louvain, St Luc Hosp, Dept Psychiat, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Maurage, P (corresponding author), Catholic Univ Louvain, Inst Psychol, Neurosci Syst & Cognit NEUROCS Res Unit, B-3000 Louvain, Belgium.	pierre.maurage@uclouvain.be		Maurage, Pierre/0000-0003-0197-0810	National Fund for Scientific Research (FNRS, Belgium)	National Fund for Scientific Research (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS)	Pierre Maurage and Philippe de Timary are supported by grants from the National Fund for Scientific Research (FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasova B, 2008, NEUROSCI BIOBEHAV R, V32, P1315, DOI 10.1016/j.neubiorev.2008.05.003; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Beck AT., 1996, BECK DEPRESSION INVE; Brewer WJ, 1996, BIOL PSYCHIAT, V40, P1021, DOI 10.1016/0006-3223(95)00594-3; CAREY GB, 1989, OCCUP MED, V4, P311; Chevrier A, 2010, NEUROIMAGE, V53, P664, DOI 10.1016/j.neuroimage.2010.06.056; Clepce M, 2010, NEUROSCI LETT, V471, P139, DOI 10.1016/j.neulet.2010.01.027; Corcoran C, 2005, SCHIZOPHR RES, V80, P283, DOI 10.1016/j.schres.2005.07.028; DITRAGLIA GM, 1991, ALCOHOL, V8, P109, DOI 10.1016/0741-8329(91)91318-V; Dulay MF, 2008, J CLIN EXP NEUROPSYC, V30, P327, DOI 10.1080/13803390701415892; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; Fukatsu R, 1998, NEUROLOGY, V50, P539, DOI 10.1212/WNL.50.2.539; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Hedner M, 2010, J CLIN EXP NEUROPSYC, V30, P1; Heilmann S, 2002, ARCH OTOLARYNGOL, V128, P414, DOI 10.1001/archotol.128.4.414; Hendrick OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013155; Hummel T, 2008, CHEM BIODIVERS, V5, P853, DOI 10.1002/cbdv.200890100; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; JONES BP, 1978, NEUROPSYCHOLOGIA, V16, P323, DOI 10.1016/0028-3932(78)90026-X; KESSLAK JP, 1991, PERCEPT MOTOR SKILL, V73, P551, DOI 10.2466/PMS.73.5.551-554; Kim YY, 2009, PSYCHIAT RES, V165, P47, DOI 10.1016/j.psychres.2008.03.025; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; LEEVY CM, 1970, MED CLIN N AM, V54, P1567, DOI 10.1016/S0025-7125(16)32572-X; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Logan Gordon D., 1994, P189; Lombion S, 2010, PSYCHIAT RES, V177, P135, DOI 10.1016/j.psychres.2009.01.018; Luzzi S, 2007, NEUROPSYCHOLOGIA, V45, P1823, DOI 10.1016/j.neuropsychologia.2006.12.008; MAIR RG, 1986, NEUROPSYCHOLOGIA, V24, P831, DOI 10.1016/0028-3932(86)90082-5; Mann K, 1999, ALCOHOL ALCOHOLISM, V34, P567, DOI 10.1093/alcalc/34.4.567; Martzke JS, 1997, BIOL PSYCHIAT, V42, P721, DOI 10.1016/S0006-3223(96)00442-8; Metcalf K, 2007, COGN NEUROPSYCHOL, V24, P23, DOI 10.1080/02643290600694901; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Ohtake H, 2005, J NEUROL NEUROSUR PS, V76, P1309, DOI 10.1136/jnnp.2004.061846; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Potter H, 1979, Curr Alcohol, V7, P261; Price J.L., 1987, P179; Ptak R, 1999, NEUROCASE, V5, P243, DOI 10.1093/neucas/5.3.243; Purdon SE, 1998, J PSYCHIATR NEUROSCI, V23, P163; Roessner V, 2005, EUR ARCH PSY CLIN N, V255, P6, DOI 10.1007/s00406-004-0525-y; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2010, J COGNITIVE NEUROSCI, V22, P1069, DOI 10.1162/jocn.2009.21231; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rupp CI, 2004, ALCOHOL ALCOHOLISM, V39, P514, DOI 10.1093/alcalc/agh100; Rupp CI, 2003, ALCOHOL CLIN EXP RES, V27, P432, DOI 10.1097/01.ALC.0000057945.57330.2C; Rupp CI, 2006, ALCOHOL CLIN EXP RES, V30, P1355, DOI 10.1111/j.1530-0277.2006.00162.x; Rupp CI, 2010, CURR OPIN PSYCHIATR, V23, P97, DOI 10.1097/YCO.0b013e328336643f; Saoud M, 1998, PSYCHIAT RES, V81, P251, DOI 10.1016/S0165-1781(98)00104-8; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Schillerstrom JE, 2003, PSYCHOSOMATICS, V44, P290, DOI 10.1176/appi.psy.44.4.290; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2000, NEUROLOGY, V55, P74, DOI 10.1212/WNL.55.1.74; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 2001, BRAIN RES REV, V36, P150, DOI 10.1016/S0165-0173(01)00090-X; Scinska A, 2008, PSYCHIAT CLIN NEUROS, V62, P450, DOI 10.1111/j.1440-1819.2008.01824.x; Seidman LJ, 1997, BIOL PSYCHIAT, V42, P104, DOI 10.1016/S0006-3223(96)00300-9; SHEAR PK, 1992, ALCOHOL, V9, P247, DOI 10.1016/0741-8329(92)90061-E; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Spielberger C, 1983, MANUAL STATE TRAIT A; Strauss GP, 2010, SCHIZOPHRENIA BULL, V36, P860, DOI 10.1093/schbul/sbn178; Turetsky BI, 2003, BIOL PSYCHIAT, V53, P403, DOI 10.1016/S0006-3223(02)01865-6; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; Westervelt HJ, 2005, ARCH CLIN NEUROPSYCH, V20, P761, DOI 10.1016/j.acn.2005.04.010; Wiggins LD, 2009, J AUTISM DEV DISORD, V39, P1087, DOI 10.1007/s10803-009-0711-x; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zhang S, 2011, HUM BRAIN M IN PRESS	72	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23190	10.1371/journal.pone.0023190	http://dx.doi.org/10.1371/journal.pone.0023190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	808CT	21858026	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500023
J	Watanabe, Y; Castoro, RJ; Kim, HS; North, B; Oikawa, R; Hiraishi, T; Ahmed, SS; Chung, W; Cho, MY; Toyota, M; Itoh, F; Estecio, MRH; Shen, LL; Jelinek, J; Issa, JPJ				Watanabe, Yoshiyuki; Castoro, Ryan J.; Kim, Hyun Soo; North, Brittany; Oikawa, Ritsuko; Hiraishi, Tetsuya; Ahmed, Saira S.; Chung, Woonbok; Cho, Mee-Yon; Toyota, Minoru; Itoh, Fumio; Estecio, Marcos R. H.; Shen, Lanlan; Jelinek, Jaroslav; Issa, Jean-Pierre J.			Frequent Alteration of MLL3 Frameshift Mutations in Microsatellite Deficient Colorectal Cancer	PLOS ONE			English	Article							DNA METHYLATION; COLON-CANCER; GASTRIC-CANCER; REGION; GENE; PSEUDOGENES; INSTABILITY; LEUKEMIA; MAPS; P53	Background: MLL3 is a histone 3-lysine 4 methyltransferase with tumor-suppressor properties that belongs to a family of chromatin regulator genes potentially altered in neoplasia. Mutations in MLL3 were found in a whole genome analysis of colorectal cancer but have not been confirmed by a separate study. Methods and Results: We analyzed mutations of coding region and promoter methylation in MLL3 using 126 cases of colorectal cancer. We found two isoforms of MLL3 and DNA sequencing revealed frameshift and other mutations affecting both isoforms of MLL3 in colorectal cancer cells and 19 of 134 (14%) primary colorectal samples analyzed. Moreover, frameshift mutations were more common in cases with microsatellite instability (31%) both in CRC cell lines and primary tumors. The largest isoform of MLL3 is transcribed from a CpG island-associated promoter that has highly homology with a pseudo-gene on chromosome 22 (psiTPTE22). Using an assay which measured both loci simultaneously we found prominent age related methylation in normal colon (from 21% in individuals less than 25 years old to 56% in individuals older than 70, R = 0.88, p<0.001) and frequent hypermethylation (83%) in both CRC cell lines and primary tumors. We next studied the two loci separately and found that age and cancer related methylation was solely a property of the pseudogene CpG island and that the MLL3 loci was unmethylated. Conclusions: We found that frameshift mutations of MLL3 in both CRC cells and primary tumor that were more common in cases with microsatellite instability. Moreover, we have shown CpG island-associated promoter of MLL3 gene has no DNA methylation in CRC cells but also primary tumor and normal colon, and this region has a highly homologous of pseudo gene (psiTPTE22) that was age relate DNA methylation.	[Watanabe, Yoshiyuki; Castoro, Ryan J.; Kim, Hyun Soo; North, Brittany; Ahmed, Saira S.; Chung, Woonbok; Estecio, Marcos R. H.; Shen, Lanlan; Jelinek, Jaroslav; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Watanabe, Yoshiyuki; Oikawa, Ritsuko; Hiraishi, Tetsuya; Itoh, Fumio] St Marianna Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kanagawa, Japan; [Cho, Mee-Yon] Yonsei Univ, Dept Pathol, Wonju Coll Med, Wonju, South Korea; [Toyota, Minoru] Sapporo Med Univ, Dept Biochem, Sapporo, Hokkaido, Japan	University of Texas System; UTMD Anderson Cancer Center; Saint Marianna University; Yonsei University; Sapporo Medical University	Watanabe, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	ponponta@marianna-u.ac.jp	Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/O-6876-2019	Jelinek, Jaroslav/0000-0002-2533-0220; Castoro, Ryan/0000-0003-3619-484X; Issa, Jean-Pierre/0000-0003-2258-5030; Castoro, Ryan/0000-0002-3242-3775; Estecio, Marcos/0000-0002-6874-7413	National Institutes of Health [CA098006, CA105346, CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA098006, R01CA105346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants #CA098006 and CA105346. J-PJI is an American Cancer Society Clinical Research Professor supported by a generous gift from the F. M. Kirby Foundation. DNA sequencing in the Core Sequencing facility at the M. D. Anderson Cancer Center is supported by Core Grant #CA16672 from the National Institutes of Health. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2007, APMIS, V115, P859, DOI 10.1111/j.1600-0463.2007.apm_696.x; Ahuja N, 1998, CANCER RES, V58, P5489; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Chen HM, 1999, HUM GENET, V105, P399, DOI 10.1007/s004390051122; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Liang QY, 2010, INT J CANCER, V127, P1833, DOI 10.1002/ijc.25213; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Melcher R, 2002, CYTOGENET GENOME RES, V98, P22, DOI 10.1159/000068544; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Shen L, 2003, GASTROENTEROLOGY, V124, P626, DOI 10.1053/gast.2003.50102; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wang G, 2004, GENOME RES, V14, P2357, DOI 10.1101/gr.2813404; Watanabe Y, 2007, CLIN CANCER RES, V13, P4786, DOI 10.1158/1078-0432.CCR-07-0305; Watanabe Y, 2009, GASTROENTEROLOGY, V136, P2149, DOI 10.1053/j.gastro.2009.02.085	19	53	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23320	10.1371/journal.pone.0023320	http://dx.doi.org/10.1371/journal.pone.0023320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853109	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953400037
J	Brauner, R; Neve, M; Allali, S; Trivin, C; Lottmann, H; Bashamboo, A; McElreavey, K				Brauner, Raja; Neve, Mathieu; Allali, Slimane; Trivin, Christine; Lottmann, Henri; Bashamboo, Anu; McElreavey, Ken			Clinical, Biological and Genetic Analysis of Anorchia in 26 Boys	PLOS ONE			English	Article							TESTICULAR REGRESSION SYNDROME; BILATERAL CONGENITAL ANORCHIA; MULLERIAN-INHIBITING SUBSTANCE; 46,XY; CRYPTORCHIDISM; EXPRESSION; MANAGEMENT; ENDOCRINE; SIBLINGS; SPECTRUM	Background: Anorchia is defined as the absence of testes in a 46, XY individual with a male phenotype. The cause is unknown. Methods: We evaluated the clinical and biological presentation, and family histories of 26 boys with anorchia, and sequenced their SRY, NR5A1, INSL3, MAMLD1 genes and the T222P variant for LGR8. Results: No patient had any associated congenital anomaly. At birth, testes were palpable bilaterally or unilaterally in 13 cases and not in 7; one patient presented with bilateral testicular torsion immediately after birth. The basal plasma concentrations of anti-Mullerian hormone (AMH, n = 15), inhibin B (n = 7) and testosterone (n = 19) were very low or undetectable in all the patients evaluated, as were the increases in testosterone after human chorionic gonadotropin (hCG, n = 12). The basal plasma concentrations of follicle stimulating hormone (FSH) were increased in 20/25, as was that of luteinising hormone in 10/22 cases. Family members of 7/26 cases had histories of primary ovarian failure in the mother (n = 2), or sister 46, XX, together with fetal malformations of the only boy with microphallus and secondary foot edema (n = 1), secondary infertility in the father (n = 2), or cryptorchidism in first cousins (n = 2). The sequences of all the genes studied were normal. Conclusion: Undetectable plasma concentrations of AMH and inhibin B and an elevated plasma FSH, together with 46, XY complement are sufficient for diagnosis of anorchia. The hCG test is unnecessary. NR5A1 and other genes implicated in gonadal development and testicle descent were not mutated, which suggests that other genes involved in these developments contribute to the phenotypes.	[Brauner, Raja; Neve, Mathieu; Allali, Slimane] Univ Paris 05, Le Kremlin Bicetre, France; [Brauner, Raja; Neve, Mathieu; Allali, Slimane] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Trivin, Christine] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France; [Lottmann, Henri] Hop Necker Enfants Malad, AP HP, Serv Chirurg Viscerale Pediat, Paris, France; [Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Human Dev Genet Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brauner, R (corresponding author), Univ Paris 05, Le Kremlin Bicetre, France.	raja.brauner@wanadoo.fr	Allali, Slimane/AGW-0037-2022	Allali, Slimane/0000-0001-7068-4530				ABEYARATNE MR, 1969, LANCET, V2, P822; AYNSLEYGREEN A, 1976, CLIN ENDOCRINOL, V5, P381, DOI 10.1111/j.1365-2265.1976.tb01966.x; BOBROW M, 1970, LANCET, V1, P366; DEGROUCHY J, 1985, ANN GENET-PARIS, V28, P154; DeRosa M, 1996, ANDROLOGIA, V28, P281; Dumic M, 2008, J CLIN ENDOCR METAB, V93, P182, DOI 10.1210/jc.2007-2155; EDMAN CD, 1977, OBSTET GYNECOL, V49, P208; Ferlin A, 2008, JAMA-J AM MED ASSOC, V300, P2271, DOI 10.1001/jama.2008.668; GRANAT M, 1983, FERTIL STERIL, V40, P215; JOSSO N, 1980, J PEDIATR-US, V97, P200, DOI 10.1016/S0022-3476(80)80474-4; KENNERKNECHT I, 1993, AM J MED GENET, V47, P1166, DOI 10.1002/ajmg.1320470807; Kubini K, 2000, J CLIN ENDOCR METAB, V85, P134, DOI 10.1210/jc.85.1.134; Lee MM, 1997, NEW ENGL J MED, V336, P1480, DOI 10.1056/NEJM199705223362102; LOBACCARO JM, 1993, CLIN ENDOCRINOL, V38, P197, DOI 10.1111/j.1365-2265.1993.tb00993.x; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; MARCANTONIO SM, 1994, AM J MED GENET, V49, P1, DOI 10.1002/ajmg.1320490102; Misra M, 2002, J CLIN ENDOCR METAB, V87, P3598, DOI 10.1210/jc.87.8.3598; NAFFAH J, 1989, B ACAD NAT MED PARIS, V173, P709; Parigi GB, 1999, EUR J PEDIATR SURG, V9, P312, DOI 10.1055/s-2008-1072271; Philibert P, 2007, HUM REPROD, V22, P3255, DOI 10.1093/humrep/dem278; PIERSON M, 1983, ARCH FR PEDIATR, V40, P767; RAI M, 1994, CLIN PEDIATR, V33, P367, DOI 10.1177/000992289403300610; SARTO GE, 1973, J MED GENET, V10, P288, DOI 10.1136/jmg.10.3.288; SMITH NM, 1991, HISTOPATHOLOGY, V19, P269, DOI 10.1111/j.1365-2559.1991.tb00033.x; Vinci G, 2004, J CLIN ENDOCR METAB, V89, P6282, DOI 10.1210/jc.2004-0891; Yerkes EB, 2005, J UROLOGY, V174, P1579, DOI 10.1097/01.ju.0000179542.05953.11; Zenaty D, 2006, J PEDIATR-US, V149, P687, DOI 10.1016/j.jpeds.2006.07.044; Zenteno JC, 2001, AM J MED GENET, V99, P244, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1170>3.0.CO;2-A	28	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23292	10.1371/journal.pone.0023292	http://dx.doi.org/10.1371/journal.pone.0023292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853106	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200066
J	Fujimura, Y; Kurihara, K; Ida, M; Kosaka, R; Miura, D; Wariishi, H; Maeda-Yamamoto, M; Nesumi, A; Saito, T; Kanda, T; Yamada, K; Tachibana, H				Fujimura, Yoshinori; Kurihara, Kana; Ida, Megumi; Kosaka, Reia; Miura, Daisuke; Wariishi, Hiroyuki; Maeda-Yamamoto, Mari; Nesumi, Atsushi; Saito, Takeshi; Kanda, Tomomasa; Yamada, Koji; Tachibana, Hirofumi			Metabolomics-Driven Nutraceutical Evaluation of Diverse Green Tea Cultivars	PLOS ONE			English	Article							CAMELLIA-SINENSIS L.; PU-ERH TEA; ENDOTHELIAL DYSFUNCTION; QUALITY ASSESSMENT; BLACK TEA; EXTRACT; PATHWAY; SYSTEMS; MODELS; MS	Background: Green tea has various health promotion effects. Although there are numerous tea cultivars, little is known about the differences in their nutraceutical properties. Metabolic profiling techniques can provide information on the relationship between the metabolome and factors such as phenotype or quality. Here, we performed metabolomic analyses to explore the relationship between the metabolome and health-promoting attributes (bioactivity) of diverse Japanese green tea cultivars. Methodology/Principal Findings: We investigated the ability of leaf extracts from 43 Japanese green tea cultivars to inhibit thrombin-induced phosphorylation of myosin regulatory light chain (MRLC) in human umbilical vein endothelial cells (HUVECs). This thrombin-induced phosphorylation is a potential hallmark of vascular endothelial dysfunction. Among the tested cultivars, Cha Chuukanbohon Nou-6 (Nou-6) and Sunrouge (SR) strongly inhibited MRLC phosphorylation. To evaluate the bioactivity of green tea cultivars using a metabolomics approach, the metabolite profiles of all tea extracts were determined by high-performance liquid chromatography-mass spectrometry (LC-MS). Multivariate statistical analyses, principal component analysis (PCA) and orthogonal partial least-squares-discriminant analysis (OPLS-DA), revealed differences among green tea cultivars with respect to their ability to inhibit MRLC phosphorylation. In the SR cultivar, polyphenols were associated with its unique metabolic profile and its bioactivity. In addition, using partial least-squares (PLS) regression analysis, we succeeded in constructing a reliable bioactivity-prediction model to predict the inhibitory effect of tea cultivars based on their metabolome. This model was based on certain identified metabolites that were associated with bioactivity. When added to an extract from the non-bioactive cultivar Yabukita, several metabolites enriched in SR were able to transform the extract into a bioactive extract. Conclusions/Significance: Our findings suggest that metabolic profiling is a useful approach for nutraceutical evaluation of the health promotion effects of diverse tea cultivars. This may propose a novel strategy for functional food design.	[Fujimura, Yoshinori; Miura, Daisuke; Wariishi, Hiroyuki; Tachibana, Hirofumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 812, Japan; [Kurihara, Kana; Ida, Megumi; Kosaka, Reia; Wariishi, Hiroyuki; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 812, Japan; [Wariishi, Hiroyuki; Tachibana, Hirofumi] Kyushu Univ, Bioarchitecture Ctr, Higashi Ku, Fukuoka 812, Japan; [Maeda-Yamamoto, Mari; Nesumi, Atsushi] Natl Agr & Food Res Org, Natl Inst Vegetable & Tea Sci, Shizuoka, Japan; [Saito, Takeshi; Kanda, Tomomasa] Asahi Brewery Co Ltd, Moriya, Ibaraki, Japan	Kyushu University; Kyushu University; Kyushu University; National Agriculture & Food Research Organization - Japan; Asahi Group Holdings Ltd.	Fujimura, Y (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 812, Japan.	tatibana@agr.kyushu-u.ac.jp	fujimura, yoshinori/E-4684-2012; Fujimura, Yoshinori/AAG-4403-2019; Miura, Daisuke/H-1517-2019	Maeda-Yamamoto, Mari/0000-0002-4494-7509; Fujimura, Yoshinori/0000-0003-0798-0649	Ministry of Agriculture, Forestry and Fisheries, Japan [23005, 22228002]	Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by research and development projects for application in promoting new policy of agriculture forestry and fisheries, Ministry of Agriculture, Forestry and Fisheries, Japan (Grant No. 23005) to HT and Grants-in-Aid for Scientific Research (S) (Grant 22228002) to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewicz MR, 2006, METABOLOMICS, V2, P41, DOI 10.1007/s11306-006-0018-2; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; CHISAKA T, 1988, CHEM PHARM BULL, V36, P227; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Cuadros-Inostroza A, 2010, ANAL CHEM, V82, P3573, DOI 10.1021/ac902678t; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fujiwara M, 2006, ANAL SCI, V22, P1307, DOI 10.2116/analsci.22.1307; Heuberger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012915; Hodgson JM, 1999, J HYPERTENS, V17, P457, DOI 10.1097/00004872-199917040-00002; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Honma D, 2010, J SCI FOOD AGR, V90, P168, DOI 10.1002/jsfa.3807; Ku KM, 2010, J AGR FOOD CHEM, V58, P418, DOI 10.1021/jf902929h; Ku KM, 2010, J AGR FOOD CHEM, V58, P345, DOI 10.1021/jf902818c; Kurihara K, 2010, FOOD SCI TECHNOL RES, V16, P263, DOI 10.3136/fstr.16.263; Kurita I, 2010, J AGR FOOD CHEM, V58, P1903, DOI 10.1021/jf904335g; Le Gall G, 2004, J AGR FOOD CHEM, V52, P692, DOI 10.1021/jf034828r; Lee JE, 2010, J AGR FOOD CHEM, V58, P10582, DOI 10.1021/jf102415m; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; Luthria DL, 2008, J AGR FOOD CHEM, V56, P9819, DOI 10.1021/jf801606x; Maeda-Yamamoto M, 2007, CYTOTECHNOLOGY, V55, P135, DOI 10.1007/s10616-007-9112-1; Okazaki K, 2008, PLANT CELL PHYSIOL, V49, P170, DOI 10.1093/pcp/pcm173; Pongsuwan W, 2008, J AGR FOOD CHEM, V56, P10705, DOI 10.1021/jf8018003; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; SANO M, 1995, BIOL PHARM BULL, V18, P1006, DOI 10.1248/bpb.18.1006; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wang QM, 2010, CIRC J, V74, P294, DOI 10.1253/circj.CJ-09-0543; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Xie GX, 2009, J AGR FOOD CHEM, V57, P3046, DOI 10.1021/jf804000y; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	33	74	78	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23426	10.1371/journal.pone.0023426	http://dx.doi.org/10.1371/journal.pone.0023426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853132	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200085
J	Looi, CY; Imanishi, M; Takaki, S; Sato, M; Chiba, N; Sasahara, Y; Futaki, S; Tsuchiya, S; Kumaki, S				Looi, Chung Yeng; Imanishi, Miki; Takaki, Satoshi; Sato, Miki; Chiba, Natsuko; Sasahara, Yoji; Futaki, Shiroh; Tsuchiya, Shigeru; Kumaki, Satoru			Octa-Arginine Mediated Delivery of Wild-Type Lnk Protein Inhibits TPO-Induced M-MOK Megakaryoblastic Leukemic Cell Growth by Promoting Apoptosis	PLOS ONE			English	Article							MEMBRANE-PERMEABLE PEPTIDES; SCID GENE-THERAPY; ADAPTER PROTEIN; MYELOPROLIFERATIVE NEOPLASMS; INSERTIONAL MUTAGENESIS; SIGNALING PATHWAYS; POLYCYTHEMIA-VERA; RICH PEPTIDES; JAK2; TRANSDUCTION	Background: Lnk plays a non-redundant role by negatively regulating cytokine signaling of TPO, SCF or EPO. Retroviral expression of Lnk has been shown to suppress hematopoietic leukemic cell proliferation indicating its therapeutic value in cancer therapy. However, retroviral gene delivery carries risks of insertional mutagenesis. To circumvent this undesired consequence, we fused a cell permeable peptide octa-arginine to Lnk and evaluated the efficacy of inhibition of leukemic cell proliferation in vitro. Methodology/Principal Findings: In this study, proliferation assays, flow cytometry, Western Blot analyses were performed on wild-type (WT), mutant Lnk R8 or BSA treated M-MOK cells. We found that delivered WT, but not mutant Lnk R8 blocked TPO-induced M-MOK megakaryoblastic leukemic cell proliferation. In contrast, WT Lnk R8 showed no growth inhibitive effect on non-hematopoietic HELA or COS-7 cell. Moreover, we demonstrated that TPO-induced M-MOK cell growth inhibition by WT Lnk R8 was dose-dependent. Penetrated WT Lnk R8 induced cell cycle arrest and apoptosis. Immunoprecipitation and Western blots data indicated WT Lnk R8 interacted with endogeneous Jak2 and downregulated Jak-Stat and MAPK phosphorylation level in M-MOK cells after TPO stimulation. Treatment with specific inhibitors (TG101348 and PD98059) indicated Jak-Stat and MAPK pathways were crucial for TPO-induced proliferation of M-MOK cells. Further analyses using TF-1 and HEL leukemic cell-lines showed that WT Lnk R8 inhibited Jak2-dependent cell proliferation. Using cord blood-derived CD34+ stem cells, we found that delivered WT Lnk R8 blocked TPO-induced megakaryopoiesis in vitro. Conclusions/Significance: Intracellular delivery of WT Lnk R8 fusion protein efficiently inhibited TPO-induced M-MOK leukemic cell growth by promoting apoptosis. WT Lnk R8 protein delivery may provide a safer and more practical approach to inhibit leukemic cell growth worthy of further development.	[Looi, Chung Yeng; Sato, Miki; Sasahara, Yoji; Tsuchiya, Shigeru; Kumaki, Satoru] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Imanishi, Miki; Futaki, Shiroh] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Takaki, Satoshi] Int Med Ctr Japan, Res Inst, Tokyo, Japan; [Chiba, Natsuko] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Sendai, Miyagi 980, Japan	Tohoku University; Kyoto University; National Center for Global Health & Medicine - Japan; Tohoku University	Looi, CY (corresponding author), Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan.	kumakis@gmail.com	Looi, Chung Yeng/A-2623-2013	Looi, Chung Yeng/0000-0002-4830-3495; Futaki, Shiroh/0000-0002-0124-4002; Imanishi, Miki/0000-0002-4172-0966	Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was financially supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, and a grant from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran-Marszak F, 2010, BLOOD, V116, P5961, DOI 10.1182/blood-2009-12-256768; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Chikh GG, 2001, J IMMUNOL, V167, P6462, DOI 10.4049/jimmunol.167.11.6462; Drexler HG, 1997, LEUKEMIA, V11, P541, DOI 10.1038/sj.leu.2400621; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Ford KG, 2001, GENE THER, V8, P1, DOI 10.1038/sj.gt.3301383; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Gery S, 2007, BLOOD, V110, P3360, DOI 10.1182/blood-2007-05-089326; Gery S, 2009, J LEUKOCYTE BIOL, V85, P957, DOI 10.1189/jlb.0908575; Gery S, 2009, EXP HEMATOL, V37, P585, DOI 10.1016/j.exphem.2009.01.009; Gueller S, 2008, BIOCHEM J, V415, P241, DOI 10.1042/BJ20080102; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; ITANO M, 1995, EXP HEMATOL, V23, P1301; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Joliot A, 2005, M S-MED SCI, V21, P309, DOI 10.1051/medsci/2005213309; KAUSHANSKY K, 1995, BLOOD, V86, P419, DOI 10.1182/blood.V86.2.419.bloodjournal862419; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Noguchi H, 2006, ACTA MED OKAYAMA, V60, P1; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Pardanani A, 2010, LEUKEMIA, V24, P1713, DOI 10.1038/leu.2010.163; Pike-Overzet K, 2007, MOL THER, V15, P1910, DOI 10.1038/sj.mt.6300297; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Quentmeier H, 2008, LEUKEMIA, V22, P2169, DOI 10.1038/leu.2008.226; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Simon C, 2008, BLOOD, V112, P1039, DOI 10.1182/blood-2008-05-154849; Takaki S, 2003, J IMMUNOL, V170, P703, DOI 10.4049/jimmunol.170.2.703; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Takenobu T, 2002, MOL CANCER THER, V1, P1043; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong W, 2004, J EXP MED, V200, P569, DOI 10.1084/jem.20040762; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Uchiyama T, 2006, BIOCHEM BIOPH RES CO, V341, P391, DOI 10.1016/j.bbrc.2005.12.199; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wendling F, 1998, EUR CYTOKINE NETW, V9, P221; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Y, 2008, BLOOD, V112, P2474, DOI 10.1182/blood-2007-12-130211	48	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23640	10.1371/journal.pone.0023640	http://dx.doi.org/10.1371/journal.pone.0023640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853157	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200101
J	Al Alam, D; Green, M; Irani, RT; Parsa, S; Danopoulos, S; Sala, FG; Branch, J; El Agha, E; Tiozzo, C; Voswinckel, R; Jesudason, EC; Warburton, D; Bellusci, S				Al Alam, Denise; Green, Melissa; Irani, Reza Tabatabai; Parsa, Sara; Danopoulos, Soula; Sala, Frederic G.; Branch, Jonathan; El Agha, Elie; Tiozzo, Caterina; Voswinckel, Robert; Jesudason, Edwin C.; Warburton, David; Bellusci, Saverio			Contrasting Expression of Canonical Wnt Signaling Reporters TOPGAL, BATGAL and Axin2(LacZ) during Murine Lung Development and Repair	PLOS ONE			English	Article							BETA-CATENIN; INJURY; MORPHOGENESIS; ACTIVATION; PROMOTES; TUMORS; CELLS	Canonical Wnt signaling plays multiple roles in lung organogenesis and repair by regulating early progenitor cell fates: investigation has been enhanced by canonical Wnt reporter mice, TOPGAL, BATGAL and Axin2(LacZ). Although widely used, it remains unclear whether these reporters convey the same information about canonical Wnt signaling. We therefore compared beta-galactosidase expression patterns in canonical Wnt signaling of these reporter mice in whole embryo versus isolated prenatal lungs. To determine if expression varied further during repair, we analyzed comparative pulmonary expression of beta-galactosidase after naphthalene injury. Our data show important differences between reporter mice. While TOPGAL and BATGAL lines demonstrate Wnt signaling well in early lung epithelium, BATGAL expression is markedly reduced in late embryonic and adult lungs. By contrast, Axin2(LacZ) expression is sustained in embryonic lung mesenchyme as well as epithelium. Three days into repair after naphthalene, BATGAL expression is induced in bronchial epithelium as well as TOPGAL expression (already strongly expressed without injury). Axin2(LacZ) expression is increased in bronchial epithelium of injured lungs. Interestingly, both TOPGAL and Axin2(LacZ) are up regulated in parabronchial smooth muscle cells during repair. Therefore the optimal choice of Wnt reporter line depends on whether up- or down-regulation of canonical Wnt signal reporting in either lung epithelium or mesenchyme is being compared.	[Al Alam, Denise; Green, Melissa; Irani, Reza Tabatabai; Parsa, Sara; Danopoulos, Soula; Sala, Frederic G.; Branch, Jonathan; Tiozzo, Caterina; Jesudason, Edwin C.; Warburton, David; Bellusci, Saverio] Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA; [El Agha, Elie; Bellusci, Saverio] Univ Giessen, Lung Ctr, Dept Internal Med 2, Giessen, Germany; [Voswinckel, Robert] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Jesudason, Edwin C.] Univ Liverpool, Dept Child Hlth, Alder Hey Childrens Hosp, Liverpool L69 3BX, Merseyside, England	Children's Hospital Los Angeles; Justus Liebig University Giessen; Max Planck Society; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Al Alam, D (corresponding author), Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA.	sbellusci@chla.usc.edu	Warburton, David/AAD-5709-2020; Alam, Denise Al/AAG-9406-2019; tiozzo, caterina/AAD-1170-2022	El Agha, Elie/0000-0001-7504-3417; Tiozzo, Caterina/0000-0001-8317-7183	American Lung association; NIH [HL074832, HL086322]; Excellence Cluster in Cardio-Pulmonary Systems (ECCPS); DFG [62280319]; Medical Research Council [G0802057] Funding Source: researchfish; MRC [G0802057] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086322, R01HL074832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096195] Funding Source: NIH RePORTER	American Lung association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Cluster in Cardio-Pulmonary Systems (ECCPS)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Denise Al Alam was supported by American Lung association postdoctoral National Award. SB was supported by the NIH (HL074832 and HL086322), the Excellence Cluster in Cardio-Pulmonary Systems (ECCPS) and the DFG (62280319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; De Langhe Stijn P, 2008, Organogenesis, V4, P100; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; KNEIDINGER N, 2010, AM J RESP CRIT CARE; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MAHVI D, 1977, AM J PATHOL, V86, P559; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Stripp BR, 1995, AM J PHYSIOL-LUNG C, V269, pL791, DOI 10.1152/ajplung.1995.269.6.L791; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Winkle LS, 2002, AM J PHYSIOL-LUNG C, V282, pL1122, DOI 10.1152/ajplung.00309.2001; vanWinkle LS, 1995, AM J PHYSIOL-LUNG C, V269, pL800, DOI 10.1152/ajplung.1995.269.6.L800; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	25	68	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23139	10.1371/journal.pone.0023139	http://dx.doi.org/10.1371/journal.pone.0023139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858009	gold, Green Submitted, Green Published			2022-12-25	WOS:000293774300023
J	Klein, T; Henn, C; Negri, M; Frotscher, M				Klein, Tobias; Henn, Claudia; Negri, Matthias; Frotscher, Martin			Structural Basis for Species Specific Inhibition of 17 beta-Hydroxysteroid Dehydrogenase Type 1 (17 beta-HSD1): Computational Study and Biological Validation	PLOS ONE			English	Article							SELECTIVE NONSTEROIDAL INHIBITORS; ESTROGEN-DEPENDENT DISEASES; MOLECULAR-DYNAMICS; AROMATASE INHIBITORS; PROTEIN STRUCTURES; ALPHA-HELICES; 3D QSAR; DESIGN; POTENT; DEHYDROGENASE	17 beta-Hydroxysteroid dehydrogenase type 1 (17 beta-HSD1) catalyzes the reduction of estrone to estradiol, which is the most potent estrogen in humans. Inhibition of 17 beta-HSD1 and thereby reducing the intracellular estradiol concentration is thus a promising approach for the treatment of estrogen dependent diseases. In the past, several steroidal and non-steroidal inhibitors of 17 beta-HSD1 have been described but so far there is no cocrystal structure of the latter in complex with 17 beta-HSD1. However, a distinct knowledge of active site topologies and protein-ligand interactions is a prerequisite for structure-based drug design and optimization. An elegant strategy to enhance this knowledge is to compare inhibition values obtained for one compound toward ortholog proteins from various species, which are highly conserved in sequence and differ only in few residues. In this study the inhibitory potencies of selected members of different non-steroidal inhibitor classes toward marmoset 17 beta-HSD1 were determined and the data were compared with the values obtained for the human enzyme. A species specific inhibition profile was observed in the class of the (hydroxyphenyl)naphthols. Using a combination of computational methods, including homology modelling, molecular docking, MD simulation, and binding energy calculation, a reasonable model of the three-dimensional structure of marmoset 17 beta-HSD1 was developed and inhibition data were rationalized on the structural basis. In marmoset 17 beta-HSD1, residues 190 to 196 form a small alpha-helix, which induces conformational changes compared to the human enzyme. The docking poses suggest these conformational changes as determinants for species specificity and energy decomposition analysis highlighted the outstanding role of Asn152 as interaction partner for inhibitor binding. In summary, this strategy of comparing the biological activities of inhibitors toward highly conserved ortholog proteins might be an alternative to laborious x-ray or site-directed mutagenesis experiments in certain cases. Additionally, it facilitates inhibitor design and optimization by offering new information on protein-ligand interactions.	[Klein, Tobias; Henn, Claudia; Negri, Matthias; Frotscher, Martin] Univ Saarland, D-6600 Saarbrucken, Germany; [Klein, Tobias; Henn, Claudia; Negri, Matthias] Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat, Saarbrucken, Germany	Saarland University; Helmholtz Association	Klein, T (corresponding author), Univ Saarland, D-6600 Saarbrucken, Germany.	m.frotscher@mx.uni-saarland.de			Saarland University	Saarland University	The study was founded by financial resources of Saarland University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; Baston E, 2000, EUR J MED CHEM, V35, P931, DOI 10.1016/S0223-5234(00)01167-3; Baston E, 1999, BIOORG MED CHEM LETT, V9, P1601, DOI 10.1016/S0960-894X(99)00234-6; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bey E, 2008, J MED CHEM, V51, P6725, DOI 10.1021/jm8006917; Bey E, 2008, BIOORGAN MED CHEM, V16, P6423, DOI 10.1016/j.bmc.2008.04.073; Bey E, 2009, J MED CHEM, V52, P6724, DOI 10.1021/jm901195w; Brozic P, 2008, CURR MED CHEM, V15, P137; Case D, 2006, AMBER 9; Cavalli A, 2005, J MED CHEM, V48, P7282, DOI 10.1021/jm058042r; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Day JM, 2010, MINERVA ENDOCRINOL, V35, P87; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; DIZEREGA GS, 1980, FERTIL STERIL, V33, P649; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Frotscher MT, 2008, J MED CHEM, V51, P2158, DOI 10.1021/jm701447v; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Gobbi S, 2006, J MED CHEM, V49, P4777, DOI 10.1021/jm060186y; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karkola S, 2008, CHEMMEDCHEM, V3, P461, DOI 10.1002/cmdc.200700271; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruchten P, 2009, CR CHIM, V12, P1110, DOI 10.1016/j.crci.2009.05.005; Kruchten P, 2009, MOL CELL ENDOCRINOL, V301, P154, DOI 10.1016/j.mce.2008.09.035; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonetti F, 2004, J MED CHEM, V47, P6792, DOI 10.1021/jm049535j; Lilienkampf A, 2009, J MED CHEM, V52, P6660, DOI 10.1021/jm900928k; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; Marchais-Oberwinkler S, 2011, J MED CHEM, V54, P534, DOI 10.1021/jm1009082; Marchais-Oberwinkler S, 2009, MOL CELL ENDOCRINOL, V301, P205, DOI 10.1016/j.mce.2008.09.024; MARCHAISOBERWIN.S, 2010, J STEROID BIOCHEM, V125, P66; MAZUMDAR M, MOL BASIS SEX STEROI; Messinger J, 2006, MOL CELL ENDOCRINOL, V248, P192, DOI 10.1016/j.mce.2005.11.044; Messinger J, 2009, MOL CELL ENDOCRINOL, V301, P216, DOI 10.1016/j.mce.2008.10.022; Moller G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010969; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NEGRI M, 2011, J COMPUT AIDED UNPUB; Negri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012026; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oster A, 2011, CHEMMEDCHEM, V6, P476, DOI 10.1002/cmdc.201000457; Oster A, 2010, J MED CHEM, V53, P8176, DOI 10.1021/jm101073q; Oster A, 2010, BIOORGAN MED CHEM, V18, P3494, DOI 10.1016/j.bmc.2010.03.065; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; Picard F, 2002, BIOORGAN MED CHEM, V10, P437, DOI 10.1016/S0968-0896(01)00293-0; Poirier D, 2009, ANTI-CANCER AGENT ME, V9, P642, DOI 10.2174/187152009788680000; Poutanen M, 1995, J STEROID BIOCHEM, V55, P525, DOI 10.1016/0960-0760(95)00201-4; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saloniemi T, 2010, AM J PATHOL, V176, P1443, DOI 10.2353/ajpath.2010.090325; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Travis RC, 2003, BREAST CANCER RES, V5, P239, DOI 10.1186/bcr628; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Wetzel M, 2011, BIOORGAN MED CHEM, V19, P807, DOI 10.1016/j.bmc.2010.12.013	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22990	10.1371/journal.pone.0022990	http://dx.doi.org/10.1371/journal.pone.0022990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857977	Green Published, gold, Green Submitted			2022-12-25	WOS:000293774300014
J	Carroll, DS; Emerson, GL; Li, Y; Sammons, S; Olson, V; Frace, M; Nakazawa, Y; Czerny, CP; Tryland, M; Kolodziejek, J; Nowotny, N; Olsen-Rasmussen, M; Khristova, M; Govil, D; Karem, K; Damon, IK; Meyer, H				Carroll, Darin S.; Emerson, Ginny L.; Li, Yu; Sammons, Scott; Olson, Victoria; Frace, Michael; Nakazawa, Yoshinori; Czerny, Claus Peter; Tryland, Morten; Kolodziejek, Jolanta; Nowotny, Norbert; Olsen-Rasmussen, Melissa; Khristova, Marina; Govil, Dhwani; Karem, Kevin; Damon, Inger K.; Meyer, Hermann			Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification	PLOS ONE			English	Article							CELL-SURFACE; ORTHOPOXVIRUSES; GENOME; CAT; SEQUENCES; DIVERSITY; WILDLIFE	Cowpox virus (CPXV) is described as the source of the first vaccine used to prevent the onset and spread of an infectious disease. It is one of the earliest described members of the genus Orthopoxvirus, which includes the viruses that cause smallpox and monkeypox in humans. Both the historic and current literature describe "cowpox" as a disease with a single etiologic agent. Genotypic data presented herein indicate that CPXV is not a single species, but a composite of several (up to 5) species that can infect cows, humans, and other animals. The practice of naming agents after the host in which the resultant disease manifests obfuscates the true taxonomic relationships of "cowpox" isolates. These data support the elevation of as many as four new species within the traditional "cowpox" group and suggest that both wild and modern vaccine strains of Vaccinia virus are most closely related to CPXV of continental Europe rather than the United Kingdom, the homeland of the vaccine.	[Carroll, Darin S.; Emerson, Ginny L.; Li, Yu; Olson, Victoria; Nakazawa, Yoshinori; Karem, Kevin; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA; [Sammons, Scott; Frace, Michael; Olsen-Rasmussen, Melissa; Khristova, Marina; Govil, Dhwani] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Atlanta, GA USA; [Nakazawa, Yoshinori] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Czerny, Claus Peter] Univ Gottingen, Dept Anim Sci, Div Microbiol & Anim Hyg, Gottingen, Germany; [Tryland, Morten] Norwegian Sch Vet Sci, Sect Arctic Vet Med, Dept Food Safety & Infect Biol, Tromso, Norway; [Tryland, Morten] Genok, Ctr Biosafety, Tromso, Norway; [Kolodziejek, Jolanta; Nowotny, Norbert] Univ Vet Med Vienna, Dept Pathobiol, Zoonoses & Emerging Infect Grp, Vienna, Austria; [Nowotny, Norbert] Sultan Qaboos Univ, Fac Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman; [Meyer, Hermann] Bundeswehr Inst Microbiol, Munich, Germany	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; University of Gottingen; Norwegian University of Life Sciences; University of Veterinary Medicine Vienna; Sultan Qaboos University; Bundeswehr Institute of Microbiology (IMB)	Carroll, DS (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA.	DCarroll@cdc.gov	Nowotny, Norbert/A-5474-2019	Nowotny, Norbert/0000-0002-3548-571X; Tryland, Morten/0000-0001-5394-5196				Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Baxby D., 1981, TRENDS IMMUNOL, V3, P26; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; CROUCH AC, 1995, EPIDEMIOL INFECT, V115, P185, DOI 10.1017/S0950268800058258; CZERNY CP, 1991, J VET MED B, V38, P421, DOI 10.1111/j.1439-0450.1991.tb00891.x; da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217; EISHUBINGER AM, 1990, LANCET, V336, P880, DOI 10.1016/0140-6736(90)92387-W; Emerson GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007666; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Jenner E, 1798, INQUIRY CAUSES EFFEC; Jenner E, 1799, FURTHER OBSERVATIONS; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kaysser P, 2010, VET MICROBIOL, V141, P282, DOI 10.1016/j.vetmic.2009.09.029; NAIDOO J, 1992, ARCH VIROL, V125, P261, DOI 10.1007/BF01309643; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; PILASKI J, 1986, ARCH VIROL, V88, P135, DOI 10.1007/BF01310898; Sandvik T, 1998, J CLIN MICROBIOL, V36, P2542, DOI 10.1128/JCM.36.9.2542-2547.1998; Shchelkunov SN, 1998, VIROLOGY, V243, P432, DOI 10.1006/viro.1998.9039; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THOMSETT LR, 1978, VET REC, V103, P567, DOI 10.1136/vr.103.25.567-b; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Yeruham I, 1996, Rev Elev Med Vet Pays Trop, V49, P299	25	70	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23086	10.1371/journal.pone.0023086	http://dx.doi.org/10.1371/journal.pone.0023086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858000	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300018
J	Matera, JT; Monroe, J; Smelser, W; Gabay-Laughnan, S; Newton, KJ				Matera, John T.; Monroe, Jessica; Smelser, Woodson; Gabay-Laughnan, Susan; Newton, Kathleen J.			Unique Changes in Mitochondrial Genomes Associated with Reversions of S-Type Cytoplasmic Male Sterility in Maizemar	PLOS ONE			English	Article							CMS-S; OF-FERTILITY; REVERTANTS; RESTORER; RECOMBINATION; TEOSINTE; GENE	Cytoplasmic male sterility (CMS) in plants is usually associated with the expression of specific chimeric regions within rearranged mitochondrial genomes. Maize CMS-S plants express high amounts of a 1.6-kb mitochondrial RNA during microspore maturation, which is associated with the observed pollen abortion. This transcript carries two chimeric open reading frames, orf355 and orf77, both unique to CMS-S. CMS-S mitochondria also contain free linear DNA plasmids bearing terminal inverted repeats (TIRs). These TIRs recombine with TIR-homologous sequences that precede orf355/orf77 within the main mitochondrial genome to produce linear ends. Transcription of the 1.6-kb RNA is initiated from a promoter within the TIRs only when they are at linear ends. Reversions of CMS-S to fertility occur in certain nuclear backgrounds and are usually associated with loss of the S plasmids and/or the sterility-associated region. We describe an unusual set of independently recovered revertants from a single maternal lineage that retain both the S plasmids and an intact orf355/orf77 region but which do not produce the 1.6-kb RNA. A 7.3-kb inversion resulting from illegitmate recombination between 14-bp microrepeats has separated the genomic TIR sequences from the CMS-associated region. Although RNAs containing orf355/orf77 can still be detected in the revertants, they are not highly expressed during pollen development and they are no longer initiated from the TIR promoter at a protein-stabilized linear end. They appear instead to be co-transcribed with cytochrome oxidase subunit 2. The 7.3-kb inversion was not detected in CMS-S or in other fertile revertants. Therefore, this inversion appears to be a de novo mutation that has continued to sort out within a single maternal lineage, giving rise to fertile progeny in successive generations.	[Matera, John T.; Monroe, Jessica; Smelser, Woodson; Newton, Kathleen J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Gabay-Laughnan, Susan] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	University of Missouri System; University of Missouri Columbia; University of Illinois System; University of Illinois Urbana-Champaign	Matera, JT (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	newtonk@missouri.edu			United States National Science Foundation; Department of Energy; University of Missouri; MU-Monsanto Undergraduate Research Fund; Colleges of Arts and Sciences and of Agriculture, Food and Natural Resources	United States National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); University of Missouri; MU-Monsanto Undergraduate Research Fund; Colleges of Arts and Sciences and of Agriculture, Food and Natural Resources	This research was funded by grants from the United States National Science Foundation (to KJN) and the Department of Energy (to SGL). Undergraduate fellowships for JTM, JM and WS were provided by the University of Missouri Life Sciences Undergraduate Research Opportunity Program, the MU-Monsanto Undergraduate Research Fund, as well as by the Colleges of Arts and Sciences and of Agriculture, Food and Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Allen JO, 2005, GENETICS, V169, P863, DOI 10.1534/genetics.104.027300; ALLEN JO, 1992, THESIS U WISCONSIN M; BECKETT JB, 1971, CROP SCI, V11, P724; BUCHERT JG, 1961, P NATL ACAD SCI USA, V47, P1436, DOI 10.1073/pnas.47.9.1436; ESCOTE LJ, 1985, PLASMID, V14, P264, DOI 10.1016/0147-619X(85)90011-3; ESCOTECARLSON LJ, 1988, THEOR APPL GENET, V75, P659, DOI 10.1007/BF00289135; FAURON C, 1995, TRENDS GENET, V11, P228, DOI 10.1016/S0168-9525(00)89056-3; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; Gabay-Laughnan S, 2005, MAYDICA, V50, P349; Gabay-Laughnan S, 2000, MAYDICA, V45, P117; Gabay-Laughnan S, 2004, GENETICS, V166, P959, DOI 10.1534/genetics.166.2.959; Gabay-Laughnan S, 1995, ADV CELLULAR MOL BIO, V2, P395; Gabay-Laughnan Susan, 1994, P418; Gabay-Laughnan S, 2009, GENETICS, V182, P91, DOI 10.1534/genetics.108.099895; ISHIGE T, 1985, JPN J BREED, V35, P285; KEMBLE R J, 1983, Journal of Molecular and Applied Genetics, V2, P161; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; LAUER M, 1990, New Biologist, V2, P179; LAUGHNAN JR, 1981, CHARACTERISTICS CMS, P93; LEVINGS CS, 1980, SCIENCE, V209, P1021, DOI 10.1126/science.209.4460.1021; Lupold DS, 1999, J BIOL CHEM, V274, P3897, DOI 10.1074/jbc.274.6.3897; Lupold DS, 1999, P NATL ACAD SCI USA, V96, P11670, DOI 10.1073/pnas.96.20.11670; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Newton Kathleen J., 1994, P549; NEWTON KJ, 1990, PLANT CELL, V2, P107, DOI 10.1105/tpc.2.2.107; Newton KJ, 2004, ADV PHOTO RESPIRAT, V17, P121; NEWTON KJ, 1986, P NATL ACAD SCI USA, V83, P7363, DOI 10.1073/pnas.83.19.7363; Newton KJ, 1996, DEV GENET, V19, P277, DOI 10.1002/(SICI)1520-6408(1996)19:3<277::AID-DVG11>3.0.CO;2-X; NEWTON KJ, 2009, MITOCHONDRIA CHLOROP, P481; PRING DR, 1977, P NATL ACAD SCI USA, V74, P2904, DOI 10.1073/pnas.74.7.2904; SCHARDL CL, 1985, CELL, V43, P361, DOI 10.1016/0092-8674(85)90041-8; SCHARDL CL, 1984, NATURE, V310, P292, DOI 10.1038/310292a0; Singer T, 2003, METH MOL B, V236, P241; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; SMALL ID, 1988, THEOR APPL GENET, V76, P609, DOI 10.1007/BF00260916; STERN DB, 1986, METHOD ENZYMOL, V118, P488; Wen LY, 1999, CURR GENET, V35, P521, DOI 10.1007/s002940050448; Zabala G, 1997, GENETICS, V147, P847	39	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23405	10.1371/journal.pone.0023405	http://dx.doi.org/10.1371/journal.pone.0023405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858103	gold, Green Published, Green Submitted			2022-12-25	WOS:000293773300027
J	Rederstorff, M; Castets, P; Arbogast, S; Laine, J; Vassilopoulos, S; Beuvin, M; Dubourg, O; Vignaud, A; Ferry, A; Krol, A; Allamand, V; Guicheney, P; Ferreiro, A; Lescure, A				Rederstorff, Mathieu; Castets, Perrine; Arbogast, Sandrine; Laine, Jeanne; Vassilopoulos, Stephane; Beuvin, Maud; Dubourg, Odile; Vignaud, Alban; Ferry, Arnaud; Krol, Alain; Allamand, Valerie; Guicheney, Pascale; Ferreiro, Ana; Lescure, Alain			Increased Muscle Stress-Sensitivity Induced by Selenoprotein N Inactivation in Mouse: A Mammalian Model for SEPN1-Related Myopathy	PLOS ONE			English	Article							FORCED SWIMMING TEST; OXIDATIVE STRESS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; MUTATIONS; PHENOTYPE; ARCHITECTURE; DISEASE; SEPN1; MICE	Selenium is an essential trace element and selenoprotein N (SelN) was the first selenium-containing protein shown to be directly involved in human inherited diseases. Mutations in the SEPN1 gene, encoding SelN, cause a group of muscular disorders characterized by predominant affection of axial muscles. SelN has been shown to participate in calcium and redox homeostasis, but its pathophysiological role in skeletal muscle remains largely unknown. To address SelN function in vivo, we generated a Sepn1-null mouse model by gene targeting. The Sepn1(-/-) mice had normal growth and lifespan, and were macroscopically indistinguishable from wild-type littermates. Only minor defects were observed in muscle morphology and contractile properties in SelN-deficient mice in basal conditions. However, when subjected to challenging physical exercise and stress conditions (forced swimming test), Sepn1(-/-) mice developed an obvious phenotype, characterized by limited motility and body rigidity during the swimming session, as well as a progressive curvature of the spine and predominant alteration of paravertebral muscles. This induced phenotype recapitulates the distribution of muscle involvement in patients with SEPN1-Related Myopathy, hence positioning this new animal model as a valuable tool to dissect the role of SelN in muscle function and to characterize the pathophysiological process.	[Rederstorff, Mathieu; Krol, Alain; Lescure, Alain] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, Strasbourg, France; [Castets, Perrine; Arbogast, Sandrine; Laine, Jeanne; Vassilopoulos, Stephane; Beuvin, Maud; Dubourg, Odile; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie; Guicheney, Pascale; Ferreiro, Ana] Univ Paris 06, IFR14, Paris, France; [Castets, Perrine; Laine, Jeanne; Beuvin, Maud; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie] CNRS, UMR7215, Paris, France; [Castets, Perrine; Laine, Jeanne; Beuvin, Maud; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie] INSERM, U974, Paris, France; [Castets, Perrine; Arbogast, Sandrine; Laine, Jeanne; Vassilopoulos, Stephane; Beuvin, Maud; Dubourg, Odile; Vignaud, Alban; Ferry, Arnaud; Allamand, Valerie; Ferreiro, Ana] Inst Myol, Paris, France; [Arbogast, Sandrine; Vassilopoulos, Stephane; Dubourg, Odile; Ferreiro, Ana] INSERM, UMR, U787, Paris, France; [Laine, Jeanne] Univ Paris 06, Dept Physiol, Paris, France; [Ferry, Arnaud] Univ Paris 05, Paris, France; [Guicheney, Pascale] INSERM, U956, Paris, France; [Ferreiro, Ana] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rederstorff, M (corresponding author), Nancy Univ, CNRS, UMR 7214, AREMS, Vandoeuvre Les Nancy, France.	a.lescure@ibmc-cnrs.unistra.fr	Guicheney, Pascale/D-1034-2017; Arbogast, Sandrine/F-1965-2016; Ferreiro, Ana/F-5371-2011; vassilopoulos, stephane/AAF-3865-2021; REDERSTORFF, Mathieu/A-8270-2008; vassilopoulos, stéphane/F-6041-2014; ferry, arnaud/D-2816-2019; Allamand, Valerie/M-4333-2017; Allamand, Valérie/AAH-6272-2021	Guicheney, Pascale/0000-0002-7663-2050; Arbogast, Sandrine/0000-0001-5228-2255; Ferreiro, Ana/0000-0003-2806-5386; vassilopoulos, stephane/0000-0003-0172-330X; REDERSTORFF, Mathieu/0000-0002-4931-0777; ferry, arnaud/0000-0002-6050-4556; Allamand, Valérie/0000-0001-8997-9742	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); Contrat d'Interface INSERM-APHP; Ministere de la recherche et de l'enseignement; University Strasbourg; UPMC	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Contrat d'Interface INSERM-APHP; Ministere de la recherche et de l'enseignement; University Strasbourg; UPMC	This work was supported by funds from the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Association Francaise contre les Myopathies (AFM). A. Ferreiro is the recipient of a Contrat d'Interface INSERM-APHP. M. R. received PhD fellowships from the Ministere de la recherche et de l'enseignement and University Strasbourg. P. C. received PhD fellowships from the Ministere de la recherche et de l'enseignement, UPMC Univ Paris 06 and AFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Arbogast S, 2010, ANTIOXID REDOX SIGN, V12, P893, DOI 10.1089/ars.2009.2890; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Barker T, 2007, J PHYSIOL-LONDON, V583, P421, DOI 10.1113/jphysiol.2007.139378; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; BRADFORD DS, 1974, J BONE JOINT SURG AM, VA 56, P740, DOI 10.2106/00004623-197456040-00009; Cagliani R, 2011, J NEUROL SCI, V300, P107, DOI 10.1016/j.jns.2010.09.011; CASTETS P, 2010, HUM MOL GENET; Castets P, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-46; Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832; Clarke NF, 2006, ANN NEUROL, V59, P546, DOI 10.1002/ana.20761; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Deniziak M, 2007, EXP CELL RES, V313, P156, DOI 10.1016/j.yexcr.2006.10.005; Ferreiro A, 2004, ANN NEUROL, V55, P676, DOI 10.1002/ana.20077; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Jurynec MJ, 2008, P NATL ACAD SCI USA, V105, P12485, DOI 10.1073/pnas.0806015105; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Lescure A, 2009, BBA-GEN SUBJECTS, V1790, P1569, DOI 10.1016/j.bbagen.2009.03.002; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; MACLENNAN DH, 2010, BIOCH BIOPHYS ACTA; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Rederstorff M, 2006, CELL MOL LIFE SCI, V63, P52, DOI 10.1007/s00018-005-5313-y; RUDERT CP, 1978, VET REC, V102, P374, DOI 10.1136/vr.102.17.374; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Schara U, 2008, EUR J PAEDIATR NEURO, V12, P224, DOI 10.1016/j.ejpn.2007.08.011; Scoto M, 2011, NEUROLOGY, V76, P2073, DOI 10.1212/WNL.0b013e31821f467c; Serrano AL, 2001, P NATL ACAD SCI USA, V98, P13108, DOI 10.1073/pnas.231148598; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Taille C, 2001, AM J RESP CRIT CARE, V163, P753, DOI 10.1164/ajrccm.163.3.2004202; Thisse C, 2003, GENE EXPR PATTERNS, V3, P525, DOI 10.1016/S1567-133X(03)00054-1; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Vignaud A, 2005, TOXICON, V45, P789, DOI 10.1016/j.toxicon.2005.02.001; Wang WX, 2008, PROG NEURO-PSYCHOPH, V32, P1179, DOI 10.1016/j.pnpbp.2007.12.021; Xia X, 2007, J ETHNOPHARMACOL, V110, P356, DOI 10.1016/j.jep.2006.09.042	47	54	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23094	10.1371/journal.pone.0023094	http://dx.doi.org/10.1371/journal.pone.0023094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858002	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300020
J	Caldwell, ME; DeNicola, GM; Martins, CP; Jacobetz, MA; Maitra, A; Hruban, RH; Tuveson, DA				Caldwell, M. E.; DeNicola, G. M.; Martins, C. P.; Jacobetz, M. A.; Maitra, A.; Hruban, R. H.; Tuveson, D. A.			Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer	ONCOGENE			English	Article						senescence; Kras; PanIN; ADM; PDA; SA beta gal	ONCOGENE-INDUCED SENESCENCE; BARRIER; CELLS; MODEL; KRAS; PROGRESSION; MUTATIONS	During tumor initiation, oncogene-induced senescence (OIS) is proposed to limit the progression of preneoplasms to invasive carcinoma unless circumvented by the acquisition of certain tumor suppressor mutations. Using a variety of biomarkers, OIS has been previously reported in a wide range of human and murine precursor lesions, including the pancreas, lung, colon and skin. Here, we have characterized a panel of potential OIS biomarkers in human and murine pancreatic intraepithelial neoplasia (PanIN), and found that only senescence-associated beta-galactosidase (SA beta gal) activity is specifically enriched in these precursors, compared with pancreatic ductal adenocarcinoma (PDA). Indeed, many of the other proposed OIS biomarkers are detected in actively proliferating PanIN epithelium and in cells within the microenvironment. Surprisingly, acinar to ductal metaplasia (ADM), a distinct preneoplasm that is potentially a precursor for PanIN, also exhibits SA beta gal activity and contains a higher content of p21 and p53 than PanIN. Therefore, SA beta gal activity is the only biomarker that accurately identifies a small and heterogeneous population of non-proliferating premalignant cells in the pancreas, and the concomitant expression of p53 and p21 in ADM supports the possibility that PanIN and ADM each exhibit discrete senescence blocks. Oncogene (2012) 31, 1599-1608; doi:10.1038/onc.2011.350; published online 22 August 2011	[Caldwell, M. E.; DeNicola, G. M.; Martins, C. P.; Jacobetz, M. A.; Tuveson, D. A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 ORE, England; [Maitra, A.; Hruban, R. H.] Johns Hopkins Univ, Sch Med, Dept Pathol & Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA	Cancer Research UK; CRUK Cambridge Institute; Johns Hopkins University	Tuveson, DA (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 ORE, England.	david.tuveson@cancer.org.uk		DeNicola, Gina/0000-0001-6611-6696	The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; NIH [CA101973, CA111294, CA084291, CA105490]; University of Cambridge; Cancer Research UK; NATIONAL CANCER INSTITUTE [U01CA105490, R01CA101973, U01CA084291, U01CA111294] Funding Source: NIH RePORTER	The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P Krimpenfort, A Berns, R Taneja, F Alt, A Harris, M Malumbres C, Trejo, M McMahon, M Ferreira and F Watt for tissues and reagents. We thank Frances Connor and other members of the Tuveson lab for assistance and advice, the CRI animal care staff; S Vowler for statistical advice; Cancer Research UK Histopathology and In situ Hybridization Core, and the Microscopy and Imaging Core. This research was supported by the University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, the NIHR Cambridge Biomedical Research Centre and the NIH (grants CA101973, CA111294, CA084291 and CA105490) to DAT.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chien Y, 2008, CELL, V132, P339, DOI 10.1016/j.cell.2008.01.022; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Ivanova A, 2005, J MED GENET, V42, P565, DOI 10.1136/jmg.2004.029835; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lee KE, 2010, CANCER CELL, V18, P448, DOI 10.1016/j.ccr.2010.10.020; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Moskaluk CA, 1997, CANCER RES, V57, P2140; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	43	60	60	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1599	1608		10.1038/onc.2011.350	http://dx.doi.org/10.1038/onc.2011.350			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21860420	Green Accepted			2022-12-25	WOS:000302132000012
J	Gaude, H; Aznar, N; Delay, A; Bres, A; Buchet-Poyau, K; Caillat, C; Vigouroux, A; Rogon, C; Woods, A; Vanacker, JM; Hohfeld, J; Perret, C; Meyer, P; Billaud, M; Forcet, C				Gaude, H.; Aznar, N.; Delay, A.; Bres, A.; Buchet-Poyau, K.; Caillat, C.; Vigouroux, A.; Rogon, C.; Woods, A.; Vanacker, J-M; Hoehfeld, J.; Perret, C.; Meyer, P.; Billaud, M.; Forcet, C.			Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1	ONCOGENE			English	Article						LKB1; Hsp90; CHIP; tumor suppressor; chaperones	ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; E3 UBIQUITIN LIGASE; HEAT-SHOCK PROTEINS; QUALITY-CONTROL; SPLICE VARIANT; CELL STRUCTURE; HSP90; CHIP; INHIBITION	LKB1 is a tumor suppressor that is constitutionally mutated in a cancer-prone condition, called Peutz-Jeghers syndrome, as well as somatically inactivated in a sizeable fraction of lung and cervical neoplasms. The LKB1 gene encodes a serine/threonine kinase that associates with the pseudokinase STRAD (STE-20-related pseudokinase) and the scaffolding protein MO25, the formation of this heterotrimeric complex promotes allosteric activation of LKB1. We have previously reported that the molecular chaperone heat shock protein 90 (Hsp90) binds to and stabilizes LKB1. Combining pharmacological studies and RNA interference approaches, we now provide evidence that the co-chaperone Cdc37 participates to the regulation of LKB1 stability. It is known that the Hsp90-Cdc37 complex recognizes a surface within the N-terminal catalytic lobe of client protein kinases. In agreement with this finding, we found that the chaperones Hsp90 and Cdc37 interact with an LKB1 isoform that differs in the C-terminal region, but not with a novel LKB1 variant that lacks a portion of the kinase N-terminal lobe domain. Reconstitution of the two complexes LKB1-STRAD and LKB1-Hsp90-Cdc37 with recombinant proteins revealed that the former is catalytically active whereas the latter is inactive. Furthermore, consistent with a documented repressor function of Hsp90, LKB1 kinase activity was transiently stimulated upon dissociation of Hsp90. Finally, disruption of the LKB1-Hsp90 complex favors the recruitment of both Hsp/Hsc70 and the U-box dependent E3 ubiquitin ligase CHIP (carboxyl terminus of Hsc70-interacting protein) that triggers LKB1 degradation. Taken together, our results establish that the Hsp90-Cdc37 complex controls both the stability and activity of the LKB1 kinase. This study further shows that two chaperone complexes with antagonizing activities, Hsp90-Cdc37 and Hsp/Hsc70-CHIP, finely control the cellular level of LKB1 protein. Oncogene (2012) 31, 1582-1591; doi:10.1038/onc.2011.342; published online 22 August 2011	[Billaud, M.] UFJ, Inst Albert Bonniot, CRI, INSERM,U823, F-38706 La Tronche, France; [Gaude, H.; Aznar, N.; Delay, A.; Bres, A.; Buchet-Poyau, K.] CRCL, CNRS, INSERM, U1052,UMR 5286, Lyon, France; [Caillat, C.; Vigouroux, A.; Meyer, P.] Ctr Rech, CNRS Gif Sur Yvette, Lab Enzymol & Biochim Struct, UPR 3082, Gif Sur Yvette, France; [Rogon, C.; Hoehfeld, J.] Univ Bonn, Inst Cell Biol & Bonner Forum Biomed, Bonn, Germany; [Woods, A.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cellular Stress Grp, London, England; [Vanacker, J-M; Forcet, C.] Ecole Normale Super Lyon, Inst Genom Fonctionnelle Lyon, CNRS UCBL ENS UMR 5242, F-69364 Lyon, France; [Perret, C.] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); University of Bonn; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Billaud, M (corresponding author), UFJ, Inst Albert Bonniot, CRI, INSERM,U823, F-38706 La Tronche, France.	Marc.Billaud@ujf-grenoble.fr; christelle.forcet@ens-lyon.fr	Meyer, Philippe/AAC-6038-2019; Billaud, Marc N/M-6954-2013; Perret-Mayeux, Christine/L-3297-2017	Meyer, Philippe/0000-0002-6220-0679; christophe, caillat/0000-0003-2959-1871; Aznar, Nicolas/0000-0003-3338-9932; perret, christine/0000-0003-4710-7051	Ligue Nationale Contre le Cancer; Association de Recherche sur le Cancer; Comite de l'Isere; Fondation pour la Recherche Medicale; CNRS	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association de Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Comite de l'Isere; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank Len Neckers and Dirk Bohmann for the kind gifts of the CHIP and HA-ubiquitin vectors, respectively. This work was supported by the Ligue Nationale Contre le Cancer, and Association de Recherche sur le Cancer. During this work HG, NA and CC have been the recipients of fellowship from the Ligue Nationale Contre le Cancer, Ligue Nationale Contre le Cancer, Comite de l'Isere, Association de Recherche sur le Cancer and Fondation pour la Recherche Medicale and CNRS, respectively.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beers M, 2006, DEVELOPMENT, V133, P3745, DOI 10.1242/dev.02544; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Boudeau J, 2003, BIOCHEM J, V370, P849, DOI 10.1042/BJ20021813; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu WP, 2007, MOL CELL BIOL, V27, P220, DOI 10.1128/MCB.00899-06; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532	46	34	36	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	12					1582	1591		10.1038/onc.2011.342	http://dx.doi.org/10.1038/onc.2011.342			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21860411				2022-12-25	WOS:000302132000010
J	Kumar, SM; Zhang, G; Bastian, BC; Arcasoy, MO; Karande, P; Pushparajan, A; Acs, G; Xu, X				Kumar, S. M.; Zhang, G.; Bastian, B. C.; Arcasoy, M. O.; Karande, P.; Pushparajan, A.; Acs, G.; Xu, X.			Erythropoietin receptor contributes to melanoma cell survival in vivo	ONCOGENE			English	Article						erythropoietin; erythropoietin receptor; melanoma; hypoxia	RECOMBINANT ERYTHROPOIETIN; BREAST-CANCER; CARCINOMA CELLS; TUMOR-GROWTH; NECK-CANCER; EXPRESSION; HYPOXIA; HEAD; PROMOTES; MODELS	Erythropoietin (Epo) is widely used clinically to treat anemia associated with various clinical conditions including cancer. Data from several clinical trials suggest significant adverse effect of Epo treatment on cancer patient survival. However, controversy exists whether Epo receptor (EpoR) is functional in cancer cells. In this study, we demonstrated that EpoR mRNA expression was detectable in 90.1% of 65 melanoma cell lines, and increased copy number of the Epo and EpoR loci occurred in 30 and 24.6% of 130 primary melanomas, respectively. EpoR knockdown in melanoma cells resulted in diminished ERK phosphorylation in response to Epo stimulation, decreased cell proliferation and increased response to the inhibitory effect of hypoxia and cisplatin in vitro. EpoR knockdown significantly decreased melanoma xenograft size and tumor invasion in vivo. On the contrary, constitutive activation of EpoR activated cell proliferation pathways in melanoma cells and resulted in increased cell proliferation and resistance to hypoxia and cisplatin treatment in vitro. EpoR activation resulted in significantly larger xenografts with increased tumor invasion of surrounding tissue in vivo. Daily administration of recombinant Epo fails to stimulate melanoma growth in vivo, but the treatment increased vascular size in the xenografts. Increased local recurrence after excision of the primary tumors was observed after Epo treatment. Epo induced angiogenesis in Matrigel plug assays, and neutralization of Epo secreted by melanoma cells results in decreased angiogenesis. These data support that EpoR is functional in melanoma and EpoR activation may promote melanoma progression, and suggest that Epo may stimulate angiogenesis and increase survival of melanoma cells under hypoxic condition in vivo. Oncogene (2012) 31, 1649-1660; doi:10.1038/onc.2011.366; published online 22 August 2011	[Kumar, S. M.; Pushparajan, A.; Xu, X.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Zhang, G.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Bastian, B. C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Bastian, B. C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Arcasoy, M. O.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Karande, P.] Rensselaer Polytechnol Inst, Dept Chem Engn, Troy, NY USA; [Karande, P.] Rensselaer Polytechnol Inst, Dept Biol Engn, Troy, NY USA; [Acs, G.] Moffitt Canc, Dept Anat Pathol, Tampa, FL USA; [Acs, G.] Moffitt Canc, Dept Womens Oncol, Tampa, FL USA	University of Pennsylvania; The Wistar Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Duke University; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Xu, X (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 3400 Spruce St,6 Founders Bldg, Philadelphia, PA 19104 USA.	xug@mail.med.upenn.edu	Zhang, Gao/D-3471-2017	Bastian, Boris/0000-0003-1836-6062	Melanoma Research Foundation;  [CA-093372];  [CA-116103];  [AR-054593];  [CA-100844]; NATIONAL CANCER INSTITUTE [R21CA116103, R01CA100844, P50CA093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054593] Funding Source: NIH RePORTER	Melanoma Research Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to M Herlyn from the Wistar Institute for providing melanoma cell lines. Financial support was provided by CA-093372, CA-116103, AR-054593 and Melanoma Research Foundation (to X Xu) and CA-100844 (to MO Arcasoy).	Acs G, 2004, CANCER LETT, V214, P243, DOI 10.1016/j.canlet.2004.04.027; Acs G, 2004, CANCER-AM CANCER SOC, V100, P2376, DOI 10.1002/cncr.20244; Acs G, 2001, CANCER RES, V61, P3561; Arcasoy MO, 2005, CLIN CANCER RES, V11, P20; Arcasoy MO, 2003, BIOCHEM BIOPH RES CO, V307, P999, DOI 10.1016/S0006-291X(03)01303-2; Arcasoy MO, 2002, LAB INVEST, V82, P911, DOI 10.1097/01.LAB.0000020415.72863.40; Arcasoy MO, 2008, CLIN CANCER RES, V14, P4685, DOI 10.1158/1078-0432.CCR-08-0264; Beldo-Iniesta C, 2007, CANCER BIOL THER, V6, P1600, DOI 10.4161/cbt.6.10.4726; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Blau CA, 2007, STEM CELLS, V25, P2094, DOI 10.1634/stemcells.2007-0229; Bohlius J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007303.pub2; Carlin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010857; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Daniel RJ, 2002, J INVEST DERMATOL, V119, P1304, DOI 10.1046/j.1523-1747.2002.19533.x; Fu P, 2009, BIOCHEM BIOPH RES CO, V379, P696, DOI 10.1016/j.bbrc.2008.12.146; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Jelkmann W, 2008, CRIT REV ONCOL HEMAT, V67, P39, DOI 10.1016/j.critrevonc.2008.03.006; Jeong JY, 2009, MOL CANCER RES, V7, P1150, DOI 10.1158/1541-7786.MCR-08-0243; Knabe W, 2005, ANAT EMBRYOL, V210, P209, DOI 10.1007/s00429-005-0019-3; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Kumar SM, 2005, AM J PATHOL, V166, P823, DOI 10.1016/S0002-9440(10)62303-6; Kumar SM, 2007, CANCER RES, V67, P3177, DOI 10.1158/0008-5472.CAN-06-3312; Lai SY, 2005, ONCOGENE, V24, P4442, DOI 10.1038/sj.onc.1208635; LaMontagne KR, 2006, MOL CANCER THER, V5, P347, DOI 10.1158/1535-7163.MCT-05-0203; Ley CD, 2004, MICROVASC RES, V68, P161, DOI 10.1016/j.mvr.2004.06.002; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Mirmohammadsadegh A, 2010, J INVEST DERMATOL, V130, P201, DOI 10.1038/jid.2009.162; Mohyeldin A, 2005, NEOPLASIA, V7, P537, DOI 10.1593/neo.04685; Noguchi Constance Tom, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000860; Okazaki T, 2008, NEOPLASIA, V10, P932, DOI 10.1593/neo.08140; Paragh G, 2009, AM J PATHOL, V174, P1504, DOI 10.2353/ajpath.2009.080592; PHARR PN, 1993, P NATL ACAD SCI USA, V90, P938, DOI 10.1073/pnas.90.3.938; Reynolds CP, 2005, METH MOLEC MED, V111, P335; Seaman ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020807; Sinclair AM, 2007, CANCER-AM CANCER SOC, V110, P477, DOI 10.1002/cncr.22832; Sytkowski AJ, 2007, SCI STKE, V2007, ppe38, DOI DOI 10.1126/STKE.3952007PE38; Tovari J, 2005, CANCER RES, V65, P7186, DOI 10.1158/0008-5472.CAN-04-2498; Tovari J, 2008, CURR MOL MED, V8, P481, DOI 10.2174/156652408785747979; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Um M, 2007, CELL SIGNAL, V19, P634, DOI 10.1016/j.cellsig.2006.08.014; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; Yates CM, 2006, J ENDOCRINOL INVEST, V29, P320, DOI 10.1007/BF03344103; Yu TW, 2008, FRONT BIOSCI-LANDMRK, V13, P2714, DOI 10.2741/2878	48	39	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	13					1649	1660		10.1038/onc.2011.366	http://dx.doi.org/10.1038/onc.2011.366			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21860424	Green Published, Green Accepted			2022-12-25	WOS:000302231400004
J	Joshi, A; Nyakeriga, AM; Ravi, R; Garg, H				Joshi, Anjali; Nyakeriga, Alice M.; Ravi, Revathi; Garg, Himanshu			HIV ENV Glycoprotein-mediated Bystander Apoptosis Depends on Expression of the CCR5 Co-receptor at the Cell Surface and ENV Fusogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4 T-CELLS; HUMAN LYMPHOID-TISSUE; AIDS-LIKE DISEASE; SCID-HU MICE; TYPE-1 INFECTION; CHEMOKINE RECEPTORS; CLINICAL-COURSE; IN-VITRO; PROMOTER POLYMORPHISM	HIV-1 infections lead to a progressive depletion of CD4 cells culminating in AIDS. The coreceptor usage by HIV varies from CCR5(R5) tropic early in infection to CXCR4(X4) tropic in later infections. Although the coreceptor switch from R5 to X4 tropic HIV is well associated with progression to AIDS, the role of CCR5 in disease progression especially in patients infected exclusively with R5 isolates throughout the disease remains enigmatic. To better understand the role of CCR5 and R5 tropic HIV envelope in AIDS pathogenesis, we asked whether the levels of CCR5 and/or HIV Env-mediated fusion determine apoptosis of bystander cells. We generated CD4(+) T cell lines expressing varying levels of CCR5 on the cell surface to show that CCR5 expression levels correlate with bystander apoptosis induction. The mechanism of apoptosis involved caspase-3 activation and mitochondrial depolarization and was dependent on gp41 fusion activity as confirmed by fusion-restricted gp41 point mutants and use of the fusion inhibitor T20. Interestingly, lower levels of CCR5 were able to support virus replication in the absence of bystander apoptosis. Our findings suggest that R5 HIV-1-mediated bystander apoptosis is dependent on both CCR5 expression levels as well as fusogenic activity of the Env glycoprotein.	[Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis, El Paso, TX 79905 USA; [Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, El Paso, TX 79905 USA; [Ravi, Revathi] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Garg, H (corresponding author), 5001 El Paso Dr,MSB-1 Annex, El Paso, TX 79905 USA.	himanshu.garg@ttuhsc.edu			Texas Tech University Health Sciences Center	Texas Tech University Health Sciences Center	This work was supported in part by a Seed Grant from Texas Tech University Health Sciences Center (to H.G.).	Ahr Barbara, 2004, Retrovirology, V1, P12, DOI 10.1186/1742-4690-1-12; Albright AV, 1999, J VIROL, V73, P205, DOI 10.1128/JVI.73.1.205-213.1999; Bazan HA, 1998, J VIROL, V72, P4485, DOI 10.1128/JVI.72.5.4485-4491.1998; Blanco J, 1999, AIDS, V13, P909, DOI 10.1097/00002030-199905280-00006; Blanco J, 2003, VIROLOGY, V305, P318, DOI 10.1006/viro.2002.1764; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Camerini D, 2000, J VIROL, V74, P3196, DOI 10.1128/JVI.74.7.3196-3204.2000; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Edo-Matas D, 2011, VIROLOGY, V412, P269, DOI 10.1016/j.virol.2011.01.010; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Etemad-Moghadam B, 2001, J VIROL, V75, P5646, DOI 10.1128/JVI.75.12.5646-5655.2001; FREED EO, 1992, P NATL ACAD SCI USA, V89, P70, DOI 10.1073/pnas.89.1.70; Gallo SA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-90; Garg H, 2008, CELL MOL LIFE SCI, V65, P3134, DOI 10.1007/s00018-008-8147-6; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Garg H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-34; Garg H, 2009, AIDS RES HUM RETROV, V25, P811, DOI 10.1089/aid.2009.0010; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; GOUGEON ML, 1993, SCIENCE, V260, P1269, DOI 10.1126/science.8098552; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Jian H, 2003, J BIOL CHEM, V278, P44326, DOI 10.1074/jbc.C300378200; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; Karlsson I, 2005, J VIROL, V79, P11151, DOI 10.1128/JVI.79.17.11151-11160.2005; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kitchen SG, 1999, AIDS RES HUM RETROV, V15, P143, DOI 10.1089/088922299311565; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Kwa D, 2003, AIDS, V17, P759, DOI 10.1097/00002030-200303280-00017; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Olivieri K, 2007, VIROLOGY, V358, P23, DOI 10.1016/j.virol.2006.08.027; Ostrowski MA, 1998, J IMMUNOL, V161, P3195; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Penn ML, 1999, P NATL ACAD SCI USA, V96, P663, DOI 10.1073/pnas.96.2.663; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Priceputu E, 2005, J VIROL, V79, P6377, DOI 10.1128/JVI.79.10.6377-6391.2005; PURVIS SF, 1995, AIDS RES HUM RETROV, V11, P443, DOI 10.1089/aid.1995.11.443; Reiche EMV, 2007, CURR MED CHEM, V14, P1325; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Scheller C, 2001, VIROLOGY, V282, P48, DOI 10.1006/viro.2000.0811; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Scoggins RM, 2000, J VIROL, V74, P3205, DOI 10.1128/JVI.74.7.3205-3216.2000; Shieh B, 2000, INT IMMUNOL, V12, P1311, DOI 10.1093/intimm/12.9.1311; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Spijkerman I, 1998, J INFECT DIS, V178, P397, DOI 10.1086/515627; van Rij RP, 2003, VIROLOGY, V314, P451, DOI 10.1016/S0042-6822(03)00454-9; van't Wout AB, 1998, J VIROL, V72, P5099; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Zauli G, 1999, BLOOD, V93, P1000, DOI 10.1182/blood.V93.3.1000.403a12_1000_1010	69	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36404	36413		10.1074/jbc.M111.281659	http://dx.doi.org/10.1074/jbc.M111.281659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21859712	Green Published, hybrid			2022-12-25	WOS:000296538300026
J	Bae, B; Cobb, RE; DeSieno, MA; Zhao, HM; Nair, SK				Bae, Brian; Cobb, Ryan E.; DeSieno, Matthew A.; Zhao, Huimin; Nair, Satish K.			New N-Acetyltransferase Fold in the Structure and Mechanism of the Phosphonate Biosynthetic Enzyme FrbF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; VIVO ANTIMALARIAL ACTIVITY; MACROMOLECULAR STRUCTURES; NONMEVALONATE PATHWAY; MAXIMUM-LIKELIHOOD; ESTER PRODRUGS; FOSMIDOMYCIN; FR900098; REFINEMENT; MALARIA	The enzyme FrbF from Streptomyces rubellomurinus has attracted significant attention due to its role in the biosynthesis of the antimalarial phosphonate FR-900098. The enzyme catalyzes acetyl transfer onto the hydroxamate of the FR-900098 precursors cytidine 5'-monophosphate-3-aminopropylphosphonate and cytidine 5'-monophosphate-N-hydroxy-3-aminopropylphosphonate. Despite the established function as a bona fide N-acetyltransferase, FrbF shows no sequence similarity to any member of the GCN5-like N-acetyltransferase (GNAT) superfamily. Here, we present the 2.0 angstrom resolution crystal structure of FrbF in complex with acetyl-CoA, which demonstrates a unique architecture that is distinct from those of canonical GNAT-like acetyltransferases. We also utilized the co-crystal structure to guide structure-function studies that identified the roles of putative active site residues in the acetyltransferase mechanism. The combined biochemical and structural analyses of FrbF provide insights into this previously uncharacterized family of N-acetyltransferases and also provide a molecular framework toward the production of novel N-acyl derivatives of FR-900098.	[Bae, Brian; Zhao, Huimin; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cobb, Ryan E.; DeSieno, Matthew A.; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Cobb, Ryan E.; DeSieno, Matthew A.; Zhao, Huimin; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhao, HM (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@illinois.edu; snair@illinois.edu	Nair, Satish/AAY-2510-2021		National Institutes of Health [P01 GM077596]; NIGMS, National Institutes of Health [5 T32 GM070421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421, P01GM077596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant P01 GM077596 (to H. Z. and S. K. N.) and National Institutes of Health Ruth L. Kirschstein National Research Award 5 T32 GM070421 from NIGMS (to R. E. C. and M. A. D.).	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264; Hastings I, 2011, TRENDS PARASITOL, V27, P67, DOI 10.1016/j.pt.2010.09.005; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Johannes TW, 2010, CHEM BIOL, V17, P57, DOI 10.1016/j.chembiol.2009.12.009; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kurz T, 2006, BIOORGAN MED CHEM, V14, P5121, DOI 10.1016/j.bmc.2006.04.018; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKUHARA M, 1980, J ANTIBIOT, V33, P13, DOI 10.7164/antibiotics.33.13; Ortmann R, 2005, ARCH PHARM, V338, P305, DOI 10.1002/ardp.200500976; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Proteau PJ, 2004, BIOORG CHEM, V32, P483, DOI 10.1016/j.bioorg.2004.08.004; Reichenberg A, 2001, BIOORG MED CHEM LETT, V11, P833, DOI 10.1016/S0960-894X(01)00075-0; Schluter K, 2006, EUR J MED CHEM, V41, P1385, DOI 10.1016/j.ejmech.2006.06.015; Sim E, 2008, CURR DRUG METAB, V9, P510, DOI 10.2174/138920008784892100; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wiesner J, 2003, PARASITOL RES, V90, pS71, DOI 10.1007/s00436-002-0770-9; Wiesner J, 2002, ANTIMICROB AGENTS CH, V46, P2889, DOI 10.1128/AAC.46.9.2889-2894.2002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36132	36141		10.1074/jbc.M111.263533	http://dx.doi.org/10.1074/jbc.M111.263533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865168	Green Published, hybrid			2022-12-25	WOS:000295927100085
J	Jiang, R; Zhang, B; Kurokawa, K; So, YI; Kim, EH; Hwang, HO; Lee, JH; Shiratsuchi, A; Zhang, JH; Nakanishi, Y; Lee, HS; Lee, BL				Jiang, Rui; Zhang, Bing; Kurokawa, Kenji; So, Young-In; Kim, Eun-Hye; Hwang, Hyun Ok; Lee, Joon-Hee; Shiratsuchi, Akiko; Zhang, Jinghai; Nakanishi, Yoshinobu; Lee, Hee-Seung; Lee, Bok Luel			93-kDa Twin-domain Serine Protease Inhibitor (Serpin) Has a Regulatory Function on the Beetle Toll Proteolytic Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL-INFECTIONS; CRYSTAL-STRUCTURE; DROSOPHILA; ACTIVATION; INSECT; PEPTIDOGLYCAN; MELANIZATION; RECOGNITION; PATHWAY; MECHANISM	Serpins are protease inhibitors that play essential roles in the down-regulation of extracellular proteolytic cascades. The core serpin domain is highly conserved, and typical serpins are encoded with a molecular size of 35-50 kDa. Here, we describe a novel 93-kDa protein that contains two complete, tandemly arrayed serpin domains. This twin serpin, SPN93, was isolated from the larval hemolymph of the large beetle Tenebrio molitor. The N-terminal serpin domain of SPN93 forms a covalent complex with the Spatzle-processing enzyme, a terminal serine protease of the Toll signaling cascade, whereas the C-terminal serpin domain of SPN93 forms complexes with a modular serine protease and the Spatzle-processing enzyme-activating enzyme, which are two different enzymes of the cascade. Consequently, SPN93 inhibited beta-1,3-glucan-mediated Toll proteolytic cascade activation in an in vitro system. Site-specific proteolysis of SPN93 at the N-terminal serpin domain was observed after activation of the Toll proteolytic cascade in vivo, and down-regulation of SPN93 by RNAi sensitized beta-1,3-glucan-mediated larval death. Therefore, SPN93 is the first serpin that contains twin tandemly arrayed and functionally active serpin domains that have a regulatory role in the larval Toll proteolytic signaling cascade.	[Lee, Hee-Seung] Korea Adv Inst Sci & Technol, Dept Chem, Mol Level Interface Res Ctr, Taejon 305701, South Korea; [Jiang, Rui; Zhang, Bing; Kurokawa, Kenji; So, Young-In; Kim, Eun-Hye; Hwang, Hyun Ok; Lee, Joon-Hee; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab Insect Symbiosis, Pusan 609735, South Korea; [Jiang, Rui; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China; [Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	Korea Advanced Institute of Science & Technology (KAIST); Pusan National University; Shenyang Pharmaceutical University; Kanazawa University	Lee, HS (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Mol Level Interface Res Ctr, Taejon 305701, South Korea.	hee-seung_lee@kaist.ac.kr; brlee@pusan.ac.kr	Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015; Lee, Hee-Seung/C-1627-2011; Jiang, Rui/F-9248-2011	Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409; Jiang, Rui/0000-0002-5580-9822; Lee, Yongseok/0000-0002-8687-589X	Rural Development Administration, Republic of Korea [PJ008186022011]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Grant PJ008186022011 from the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea.	BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fullaondo A, 2011, MOL CELL BIOL, V31, P2960, DOI 10.1128/MCB.01397-10; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Park SH, 2011, J BIOL CHEM, V286, P1567, DOI 10.1074/jbc.M110.144006; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roberts RM, 1995, CRIT REV EUKAR GENE, V5, P385, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.80; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yu Y, 2010, J BIOL CHEM, V285, P32937, DOI 10.1074/jbc.M110.144014	27	22	24	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35087	35095		10.1074/jbc.M111.277343	http://dx.doi.org/10.1074/jbc.M111.277343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862574	hybrid, Green Published			2022-12-25	WOS:000295406300062
J	Chono, H; Saito, N; Tsuda, H; Shibata, H; Ageyama, N; Terao, K; Yasutomi, Y; Mineno, J; Kato, I				Chono, Hideto; Saito, Naoki; Tsuda, Hiroshi; Shibata, Hiroaki; Ageyama, Naohide; Terao, Keiji; Yasutomi, Yasuhiro; Mineno, Junichi; Kato, Ikunoshin			In Vivo Safety and Persistence of Endoribonuclease Gene-Transduced CD4+T Cells in Cynomolgus Macaques for HIV-1 Gene Therapy Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; PROTEIN-SYNTHESIS; INFECTION; MEMORY; DEPLETION; REPLICATION; RESTORATION; EXPANSION; DELIVERY	Background: MazF is an endoribonuclease encoded by Escherichia coli that specifically cleaves the ACA sequence of mRNA. In our previous report, conditional expression of MazF in the HIV-1 LTR rendered CD4+ T lymphocytes resistant to HIV-1 replication. In this study, we examined the in vivo safety and persistence of MazF-transduced cynomolgus macaque CD4+ T cells infused into autologous monkeys. Methodology/Principal Findings: The in vivo persistence of the gene-modified CD4+ T cells in the peripheral blood was monitored for more than half a year using quantitative real-time PCR and flow cytometry, followed by experimental autopsy in order to examine the safety and distribution pattern of the infused cells in several organs. Although the levels of the MazF-transduced CD4+ T cells gradually decreased in the peripheral blood, they were clearly detected throughout the experimental period. Moreover, the infused cells were detected in the distal lymphoid tissues, such as several lymph nodes and the spleen. Histopathological analyses of tissues revealed that there were no lesions related to the infused gene modified cells. Antibodies against MazF were not detected. These data suggest the safety and the low immunogenicity of MazF-transduced CD4+ T cells. Finally, gene modified cells harvested from the monkey more than half a year post-infusion suppressed the replication of SHIV 89.6P. Conclusions/Significance: The long-term persistence, safety and continuous HIV replication resistance of the mazF gene-modified CD4+ T cells in the non-human primate model suggests that autologous transplantation of mazF gene-modified cells is an attractive strategy for HIV gene therapy.	[Chono, Hideto; Saito, Naoki; Tsuda, Hiroshi; Mineno, Junichi; Kato, Ikunoshin] Takara Bio Inc, Ctr Cell & Gene Therapy, Shiga, Japan; [Shibata, Hiroaki; Ageyama, Naohide; Terao, Keiji; Yasutomi, Yasuhiro] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan	Takara Bio Inc.; National Institute of Health Sciences - Japan	Chono, H (corresponding author), Takara Bio Inc, Ctr Cell & Gene Therapy, Shiga, Japan.	chonoh@takara-bio.co.jp	Ageyama, Naohide/ABG-5014-2020	Ageyama, Naohide/0000-0002-5722-2638				Ageyama N, 2003, J CLIN APHERESIS, V18, P26, DOI 10.1002/jca.10043; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baik S, 2009, J BACTERIOL, V191, P6157, DOI 10.1128/JB.00699-09; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chono H, 2011, HUM GENE THER, V22, P35, DOI 10.1089/hum.2010.001; DROPULIC B, 1994, HUM GENE THER, V5, P927, DOI 10.1089/hum.1994.5.8-927; Dropulic B, 2006, HUM GENE THER, V17, P577, DOI 10.1089/hum.2006.17.577; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kuramoto K, 2004, BLOOD, V104, P1273, DOI 10.1182/blood-2003-08-2935; Laurent J, 2010, J IMMUNOTHER, V33, P723, DOI 10.1097/CJI.0b013e3181ea7e6e; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Masuda S, 2009, EXP HEMATOL, V37, P1250, DOI 10.1016/j.exphem.2009.07.008; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Miyake A, 2006, J GEN VIROL, V87, P1311, DOI 10.1099/vir.0.81307-0; Onlamoon N, 2007, J MED PRIMATOL, V36, P206, DOI 10.1111/j.1600-0684.2007.00238.x; Onlamoon N, 2006, J MED PRIMATOL, V35, P178, DOI 10.1111/j.1600-0684.2006.00182.x; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; *PRIM SOC JAP, 1986, PRIMATE RES, V2, P111; Ranga U, 1998, P NATL ACAD SCI USA, V95, P1201, DOI 10.1073/pnas.95.3.1201; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; SARVER N, 1993, AIDS RES HUM RETROV, V9, P483, DOI 10.1089/aid.1993.9.483; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; van Lunzen J, 2007, MOL THER, V15, P1024, DOI 10.1038/mt.sj.6300124; Verzeletti S, 1998, HUM GENE THER, V9, P2243, DOI 10.1089/hum.1998.9.15-2243; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	39	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23585	10.1371/journal.pone.0023585	http://dx.doi.org/10.1371/journal.pone.0023585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858176	Green Submitted, gold, Green Published			2022-12-25	WOS:000294121300065
J	Yallowitz, AR; Hrycaj, SM; Short, KM; Smyth, IM; Wellik, DM				Yallowitz, Alisha R.; Hrycaj, Steven M.; Short, Kieran M.; Smyth, Ian M.; Wellik, Deneen M.			Hox10 Genes Function in Kidney Development in the Differentiation and Integration of the Cortical Stroma	PLOS ONE			English	Article							MICE LACKING GDNF; NEPHRON PROGENITOR POPULATION; ENTERIC NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; METANEPHRIC MESENCHYME; MAMMALIAN KIDNEY; EPITHELIAL TRANSFORMATION; INTERMEDIATE MESODERM; EXPRESSION PATTERN; RENAL DEVELOPMENT	Organogenesis requires the differentiation and integration of distinct populations of cells to form a functional organ. In the kidney, reciprocal interactions between the ureter and the nephrogenic mesenchyme are required for organ formation. Additionally, the differentiation and integration of stromal cells are also necessary for the proper development of this organ. Much remains to be understood regarding the origin of cortical stromal cells and the pathways involved in their formation and function. By generating triple mutants in the Hox10 paralogous group genes, we demonstrate that Hox10 genes play a critical role in the developing kidney. Careful examination of control kidneys show that Foxd1-expressing stromal precursor cells are first observed in a cap-like pattern anterior to the metanephric mesenchyme and these cells subsequently integrate posteriorly into the kidney periphery as development proceeds. While the initial cap-like pattern of Foxd1-expressing cortical stromal cells is unaffected in Hox10 mutants, these cells fail to become properly integrated into the kidney, and do not differentiate to form the kidney capsule. Consistent with loss of cortical stromal cell function, Hox10 mutant kidneys display reduced and aberrant ureter branching, decreased nephrogenesis. These data therefore provide critical novel insights into the cellular and genetic mechanisms governing cortical cell development during kidney organogenesis. These results, combined with previous evidence demonstrating that Hox11 genes are necessary for patterning the metanephric mesenchyme, support a model whereby distinct populations in the nephrogenic cord are regulated by unique Hox codes, and that differential Hox function along the AP axis of the nephrogenic cord is critical for the differentiation and integration of these cell types during kidney organogenesis.	[Yallowitz, Alisha R.; Hrycaj, Steven M.; Wellik, Deneen M.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Short, Kieran M.; Smyth, Ian M.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Smyth, Ian M.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia	University of Michigan System; University of Michigan; Monash University; Monash University	Yallowitz, AR (corresponding author), SUNY Stony Brook, Med Ctr, Dept Pathol, Stony Brook, NY 11794 USA.	dwellik@umich.edu	Short, Kieran/A-2604-2012; Short, Kieran/O-4476-2019	Short, Kieran/0000-0001-9137-008X; Short, Kieran/0000-0001-9137-008X; Smyth, Ian/0000-0002-1727-7829	National Institutes of Health [DK071929]; University of Michigan [T32-HD007505, T32-DK065517]; National Institutes of Health through University of Michigan's Cancer Center [5 P30 CA46592]; National Health and Medical Research Council (NHMRC); Monash University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071929, T32DK065517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); National Institutes of Health through University of Michigan's Cancer Center; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grant DK071929 (DW), by the University of Michigan's Training Program in Organogenesis T32-HD007505 (AY), by University of Michigan's Pediatric Nephrology fellowship T32-DK065517 (AY AND SH), and in part by the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (5 P30 CA46592). This work was also supported in part by fellowship support from the National Health and Medical Research Council (NH&MRC) and Monash University and Project Grant funding from the NH&MRC (IS and KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2002, KIDNEY INT, V61, P387, DOI 10.1046/j.1523-1755.2002.00164.x; Alcorn D, 1999, PEDIATR NEPHROL, V13, P347, DOI 10.1007/s004670050624; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Cho EA, 1998, DEVELOPMENT, V125, P803; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Cullen-McEwen LA, 2005, NEPHRON EXP NEPHROL, V99, pE1, DOI 10.1159/000081792; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Di Giacomo G, 2006, GENE EXPR PATTERNS; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Dudley AT, 1997, DEV DYNAM, V208, P349; EKBLOM P, 1991, KIDNEY INT, V39, P394, DOI 10.1038/ki.1991.51; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Guillaume R, 2009, DEV BIOL, V329, P169, DOI 10.1016/j.ydbio.2009.02.034; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hedlund E, 2004, J NEUROSCI RES, V75, P307, DOI 10.1002/jnr.10844; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; Hostikka SL, 1998, MECH DEVELOP, V70, P133, DOI 10.1016/S0925-4773(97)00182-2; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Levinson R, 2003, SEMIN CELL DEV BIOL, V14, P225, DOI 10.1016/S1084-9521(03)00025-9; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mugford JW, 2008, DEV BIOL, V319, P396, DOI 10.1016/j.ydbio.2008.03.044; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Nelson LT, 2008, DEV DYNAM, V237, P3410, DOI 10.1002/dvdy.21756; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Patterson LT, 2004, DEV DYNAM, V229, P771, DOI 10.1002/dvdy.10474; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Schnabel CA, 2003, GENESIS, V37, P123, DOI 10.1002/gene.10235; Schnabel CA, 2003, DEV BIOL, V254, P262, DOI 10.1016/S0012-1606(02)00038-6; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Short KM, 2010, KIDNEY INT IN PRESS; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Torres M, 1995, DEVELOPMENT, V121, P4057; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; Vega QC, 1996, P NATL ACAD SCI USA, V93, P10657, DOI 10.1073/pnas.93.20.10657; Wellik DM, 2002, GENE DEV, V16, P1423, DOI 10.1101/gad.993302; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yallowitz AR, 2009, DEV BIOL, V335, P156, DOI 10.1016/j.ydbio.2009.08.020; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9	72	41	42	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23410	10.1371/journal.pone.0023410	http://dx.doi.org/10.1371/journal.pone.0023410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858105	Green Submitted, gold, Green Published			2022-12-25	WOS:000294125500032
J	Khalife, M; Young, R; Passet, B; Halliez, S; Vilotte, M; Jaffrezic, F; Marthey, S; Beringue, V; Vaiman, D; Le Provost, F; Laude, H; Vilotte, JL				Khalife, Manal; Young, Rachel; Passet, Bruno; Halliez, Sophie; Vilotte, Marthe; Jaffrezic, Florence; Marthey, Sylvain; Beringue, Vincent; Vaiman, Daniel; Le Provost, Fabienne; Laude, Hubert; Vilotte, Jean-Luc			Transcriptomic Analysis Brings New Insight into the Biological Role of the Prion Protein during Mouse Embryogenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION PROFILE; DEVELOPMENTAL EXPRESSION; PRP; MICE; PROLIFERATION; LACKING; DIFFERENTIATION; IDENTIFICATION; SUPPRESSES	The biological function of the Prion protein remains largely unknown but recent data revealed its implication in early zebrafish and mammalian embryogenesis. To gain further insight into its biological function, comparative transcriptomic analysis between FVB/N and FVB/N Prnp knockout mice was performed at early embryonic stages. RNAseq analysis revealed the differential expression of 73 and 263 genes at E6.5 and E7.5, respectively. The related metabolic pathways identified in this analysis partially overlap with those described in PrP1 and PrP2 knockdown zebrafish embryos and prion-infected mammalian brains and emphasize a potentially important role for the PrP family genes in early developmental processes.	[Khalife, Manal; Young, Rachel; Passet, Bruno; Vilotte, Marthe; Jaffrezic, Florence; Marthey, Sylvain; Le Provost, Fabienne; Vilotte, Jean-Luc] INRA, UMR1313, Jouy En Josas, France; [Halliez, Sophie; Beringue, Vincent; Laude, Hubert] INRA, UR892, Jouy En Josas, France; [Vaiman, Daniel] Inst Cochin Genet Mol, INSERM, U567, F-75014 Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Khalife, M (corresponding author), INRA, UMR1313, Jouy En Josas, France.	jean-luc.vilotte@jouy.inra.fr	Vaiman, Daniel/O-6030-2015; Vilotte, Jean-Luc/AAF-4688-2019; Halliez, Sophie/ABA-1356-2020	Vaiman, Daniel/0000-0002-1915-0717; Halliez, Sophie/0000-0002-6173-9752	INRA; INRA AIP BioRessource PRIFASTEM;  [ANR-09-BLAN-0015-01]	INRA; INRA AIP BioRessource PRIFASTEM; 	R.Y. is a post-doctoral scientist supported by the ANR-09-BLAN-0015-01. S. H. is a post-doctoral scientist supported by an INRA-Transfert fellowship and by the ANR-09-BLAN-0015-01. This work was supported by the ANR-09-BLAN-0015-01 and by the INRA AIP BioRessource PRIFASTEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; Bedi A, 2010, J SHOULDER ELB SURG, V19, P384, DOI 10.1016/j.jse.2009.07.010; Benvegnu S, 2011, PHYSIOL GENOMICS, V43, P711, DOI 10.1152/physiolgenomics.00205.2010; Bianco C, 2010, AM J PATHOL, V177, P532, DOI 10.2353/ajpath.2010.100102; Biswas S, 2010, J CELL BIOL, V191, P1029, DOI 10.1083/jcb.201007008; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CERVENAKOVA L, 2011, TRANSFUSION; Chadi S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-448; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Crecelius AC, 2008, NEUROREPORT, V19, P1027, DOI 10.1097/WNR.0b013e3283046157; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gao F, 2004, MOL CELL BIOL, V24, P9899, DOI 10.1128/MCB.24.22.9899-9910.2004; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Hajj GNM, 2009, J COMP NEUROL, V517, P371, DOI 10.1002/cne.22157; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hidaka K, 2010, CIRC RES, V106, P111, DOI 10.1161/CIRCRESAHA.109.209478; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Hwang HS, 2010, ACTA OBSTET GYN SCAN, V89, P1155, DOI 10.3109/00016349.2010.498497; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kovacs GG, 2009, INT J MOL SCI, V10, P976, DOI 10.3390/ijms10030976; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Lee YJ, 2010, J NEUROCHEM, V114, P362, DOI 10.1111/j.1471-4159.2010.06601.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Malaga-Trillo E, 2011, BBA-MOL BASIS DIS, V1812, P402, DOI 10.1016/j.bbadis.2010.09.013; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON J, 1992, DEVELOPMENT, V115, P117; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; Miele G, 2003, GENE EXPRESSION, V11, P1, DOI 10.3727/000000003783992324; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Natale DRC, 2009, DEV BIOL, V335, P120, DOI 10.1016/j.ydbio.2009.08.022; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Ostlund P, 2001, J BIOL CHEM, V276, P36110, DOI 10.1074/jbc.M105710200; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pelton TA, 2002, J CELL SCI, V115, P329; Peralta OA, 2011, DIFFERENTIATION, V81, P68, DOI 10.1016/j.diff.2010.09.181; Prcina M, 2011, MED HYPOTHESES, V76, P567, DOI 10.1016/j.mehy.2011.01.002; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Satoh J, 2000, AM J PATHOL, V157, P59, DOI 10.1016/S0002-9440(10)64517-8; Schneider B, 2011, FRONT BIOSCI-LANDMRK, V16, P169, DOI 10.2741/3682; Screen M, 2008, DEVELOPMENT, V135, P3311, DOI 10.1242/dev.025627; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Strom A, 2011, EUR J CELL BIOL, V90, P414, DOI 10.1016/j.ejcb.2010.11.015; Tremblay P, 2007, BRAIN RES, V1139, P60, DOI 10.1016/j.brainres.2006.12.055; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhang HJ, 2008, PLACENTA, V29, P549, DOI 10.1016/j.placenta.2008.03.003; Zhang YH, 1997, J CLIN INVEST, V99, P894, DOI 10.1172/JCI119254; Zhong W, 2006, MOL REPROD DEV, V73, P540, DOI 10.1002/mrd.20417; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	74	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23253	10.1371/journal.pone.0023253	http://dx.doi.org/10.1371/journal.pone.0023253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858045	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700010
J	Bhattacharyya, S; Tian, JM; Bouhassira, EE; Locker, J				Bhattacharyya, Sanchari; Tian, Jianmin; Bouhassira, Eric E.; Locker, Joseph			Systematic Targeted Integration to Study Albumin Gene Control Elements	PLOS ONE			English	Article							HEPATOMA-CELL LINES; CHROMOSOMAL INTEGRATION; TRANSCRIPTION FACTOR; ENHANCER ELEMENTS; EXPRESSION; CHROMATIN; PROMOTER; INTERFERENCE; ORGANIZATION; EFFICIENT	To study transcriptional regulation by distant enhancers, we devised a system of easilymodified reporter plasmids for integration into single-copy targeting cassettes in clones of HuH7, a human hepatocellular carcinoma. The plasmid constructs tested transcriptional function of a 35-kb region that contained the rat albumin gene and its upstream flanking region. Expression of integrants was analyzed in two orientations, and compared to transient expression of non-integrated plasmids. Enhancers were studied in their natural positions relative to the promoter and localized by deletion. All constructs were also analyzed by transient transfection assays. In addition to the known albumin gene enhancer (E1 at -10 kb), we demonstrated two new enhancers, E2 at -13, and E4 at +1.2 kb. All three enhancers functioned in both transient assays and integrated constructs. However, chromosomal integration demonstrated several differences from transient expression. For example, analysis of E2 showed that enhancer function within the chromosome required a larger gene region than in transient assays. Another conserved region, E3 at -0.7 kb, functioned as an enhancer in transient assays but inhibited the function of E1 and E2 when chromosomally integrated. The enhancers did not show additive or synergistic behavior, an effect consistent with competition for the promoter or inhibitory interactions among enhancers. Growth arrest by serum starvation strongly stimulated the function of some integrated enhancers, consistent with the expected disruption of enhancer-promoter looping during the cell cycle.	[Bhattacharyya, Sanchari; Tian, Jianmin; Locker, Joseph] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Tian, Jianmin; Locker, Joseph] Albert Einstein Coll Med, Marion Bessin Liver Ctr, Bronx, NY 10467 USA; [Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bhattacharyya, S (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	joseph.locker@einstein.yu.edu	Bouhassira, Eric/AAZ-4184-2021		National Institutes of Health [CA68440, CA76394, CA104292, HL088467]; NATIONAL CANCER INSTITUTE [R01CA104292, R01CA068440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants, CA68440, CA76394, and CA104292 to JL and HL088467 to EEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; BUTTGEREIT D, 1993, J CELL SCI, V105, P721; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; FUKUSHIGE S, 1992, P NATL ACAD SCI USA, V89, P7905, DOI 10.1073/pnas.89.17.7905; FULTON R, 1994, NUCLEIC ACIDS RES, V22, P4216, DOI 10.1093/nar/22.20.4216; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Grosveld F, 1987, Prog Clin Biol Res, V251, P133; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HERBST RS, 1989, P NATL ACAD SCI USA, V86, P1553, DOI 10.1073/pnas.86.5.1553; Holohan EE, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-53; JIN JR, 1995, DNA CELL BIOL, V14, P267, DOI 10.1089/dna.1995.14.267; Jin L, 2009, DEV BIOL, V336, P294, DOI 10.1016/j.ydbio.2009.09.026; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kohler S, 2010, J BIOL CHEM, V285, P464, DOI 10.1074/jbc.M109.063149; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3237, DOI 10.1073/pnas.0605730104; LOCKER J, 1989, AM J PATHOL, V135, P977; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; MILLAND J, 1990, AM J PHYSIOL, V259, pG340, DOI 10.1152/ajpgi.1990.259.3.G340; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Narlikar Leelavati, 2009, Briefings in Functional Genomics & Proteomics, V8, P215, DOI 10.1093/bfgp/elp014; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Visel A, 2009, GENOMICS, V93, P509, DOI 10.1016/j.ygeno.2009.02.002; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vorachek WR, 2000, J BIOL CHEM, V275, P29031, DOI 10.1074/jbc.M003039200; WEBER F, 1984, CELL, V36, P983, DOI 10.1016/0092-8674(84)90048-5; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; ZARET KS, 1990, P NATL ACAD SCI USA, V87, P5469, DOI 10.1073/pnas.87.14.5469; ZARET KS, 1988, P NATL ACAD SCI USA, V85, P9076, DOI 10.1073/pnas.85.23.9076; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	48	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23234	10.1371/journal.pone.0023234	http://dx.doi.org/10.1371/journal.pone.0023234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858039	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953500027
J	Lin, JH; Chiu, SC; Cheng, JC; Chang, HW; Hsiao, KL; Lin, YC; Wu, HS; Salemi, M; Liu, HF				Lin, Jih-Hui; Chiu, Shu-Chun; Cheng, Ju-Chien; Chang, Hui-Wen; Hsiao, Kuang-Liang; Lin, Yung-Cheng; Wu, Ho-Sheng; Salemi, Marco; Liu, Hsin-Fu			Phylodynamics and Molecular Evolution of Influenza A Virus Nucleoprotein Genes in Taiwan between 1979 and 2009	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; ORIGIN; H3N2; INFERENCE; DYNAMICS; BINDING; RECOGNITION; SEQUENCES; HISTORY; SKYLINE	Background: Many studies concentrate on variation in the hemagglutinin glycoprotein (HA) because of its significance in host immune response, the evolution of this virus is even more complex when other genome segments are considered. Recently, it was found that cytotoxic T lymphocytes (CTL) play an important role in immunity against influenza and most CTL epitopes of human influenza viruses were remarkably conserved. The NP gene has evolved independently in human and avian hosts after 1918 flu pandemic and it has been assigned a putative role as a determinant of host range. Methods and Findings: Phylodynamic patterns of the genes encoding nucleoprotein (NP) of influenza A viruses isolated from 1979-2009 were analyzed by applying the Bayesian Markov Chain Monte Carlo framework to better understand the evolutionary mechanisms of these Taiwanese isolates. Phylogenetic analysis of the NP gene showed that all available H3 worldwide isolates collected so far were genetically similar and divided into two major clades after the year 2004. We compared the deduced amino acid sequences of the NP sequences from human, avian and swine hosts to investigate the emergence of potential adaptive mutations. Overall, selective pressure on the NP gene of human influenza A viruses appeared to be dominated by purifying selection with a mean d(N)/d(S) ratio of 0.105. Site-selection analysis of 488 codons, however, also revealed 3 positively selected sites in addition to 139 negatively selected ones. Conclusions: The demographic history inferred by Bayesian skyline plot showed that the effective number of infections underwent a period of smooth and steady growth from 1998 to 2001, followed by a more recent rise in the rate of spread. Further understanding the correlates of interspecies transmission of influenza A virus genes from other host reservoirs to the human population may help to elucidate the mechanisms of variability among influenza A virus.	[Lin, Jih-Hui; Chiu, Shu-Chun; Chang, Hui-Wen; Wu, Ho-Sheng] Ctr Dis Control, Ctr Res & Diagnost, Taipei, Taiwan; [Lin, Jih-Hui; Hsiao, Kuang-Liang; Lin, Yung-Cheng; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Chiu, Shu-Chun] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Cheng, Ju-Chien] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, New Taipei City, Taiwan; [Liu, Hsin-Fu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Centers For Disease Control - Taiwan; National Taiwan Ocean University; National Yang Ming Chiao Tung University; China Medical University Taiwan; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Lin, JH (corresponding author), Ctr Dis Control, Ctr Res & Diagnost, Taipei, Taiwan.	salemi@pathology.ufl.edu; hsinfu@ms1.mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269; Hsiao, Kuang-Liang/0000-0003-4397-7762	Centers for Disease Control, Taiwan [DOH96-DC2402]; National Science Council [NSC 98-2314-B-195-010-MY3]; Mackay Memorial Hospital [MMH 9843]	Centers for Disease Control, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This study was supported by the Centers for Disease Control, Taiwan (grant DOH96-DC2402), and was funded in part by the National Science Council (grant NSC 98-2314-B-195-010-MY3) and Mackay Memorial Hospital (grant MMH 9843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the funding agency.	Andersen MH, 1999, TISSUE ANTIGENS, V54, P185, DOI 10.1034/j.1399-0039.1999.540210.x; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; Fu TM, 1997, J VIROL, V71, P2715, DOI 10.1128/JVI.71.4.2715-2721.1997; GAMMELIN M, 1990, MOL BIOL EVOL, V7, P194; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; GORMAN OT, 1990, J VIROL, V64, P4893, DOI 10.1128/JVI.64.10.4893-4902.1990; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HINSHAW VS, 1982, BASIC APPLIED INFLUE, P79; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; KIDA H, 1988, VIROLOGY, V162, P160, DOI 10.1016/0042-6822(88)90405-9; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kingman JFC, 1982, COALESCENT STOCH P A, V13, P235; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lamb R.A., 1989, INFLUENZA VIRUSES, P1; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P362; Lin JH, 2011, CLIN MICROBIOL INFEC, V17, P214, DOI 10.1111/j.1469-0691.2010.03228.x; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2000, GENETICS, V155, P1429; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Rimmelzwaan GF, 2004, VIRUS RES, V103, P97, DOI 10.1016/j.virusres.2004.02.020; Rodrigo AG, 1999, EVOLUTION OF HIV, P233; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shih ACC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-63; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Suzuki Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/molbev/msl050; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Varich NL, 2011, VIRAL IMMUNOL, V24, P101, DOI 10.1089/vim.2010.0088; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	49	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23454	10.1371/journal.pone.0023454	http://dx.doi.org/10.1371/journal.pone.0023454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858124	Green Published, gold			2022-12-25	WOS:000293953500041
J	Malik, A; Korol, A; Hubner, S; Hernandez, AG; Thimmapuram, J; Ali, S; Glaser, F; Paz, A; Avivi, A; Band, M				Malik, Assaf; Korol, Abraham; Huebner, Sariel; Hernandez, Alvaro G.; Thimmapuram, Jyothi; Ali, Shahjahan; Glaser, Fabian; Paz, Arnon; Avivi, Aaron; Band, Mark			Transcriptome Sequencing of the Blind Subterranean Mole Rat, Spalax galili: Utility and Potential for the Discovery of Novel Evolutionary Patterns	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; HEART-RATE; EHRENBERGI; HYPOXIA; TOLERANCE; EXPRESSION; SYSTEM; GROWTH; GENES; IDENTIFICATION	The blind subterranean mole rat (Spalax ehrenbergi superspecies) is a model animal for survival under extreme environments due to its ability to live in underground habitats under severe hypoxic stress and darkness. Here we report the transcriptome sequencing of Spalax galili, a chromosomal type of S. ehrenbergi. cDNA pools from muscle and brain tissues isolated from animals exposed to hypoxic and normoxic conditions were sequenced using Sanger, GS FLX, and GS FLX Titanium technologies. Assembly of the sequences yielded over 51,000 isotigs with homology to similar to 12,000 mouse, rat or human genes. Based on these results, it was possible to detect large numbers of splice variants, SNPs, and novel transcribed regions. In addition, multiple differential expression patterns were detected between tissues and treatments. The results presented here will serve as a valuable resource for future studies aimed at identifying genes and gene regions evolved during the adaptive radiation associated with underground life of the blind mole rat.	[Malik, Assaf; Korol, Abraham; Huebner, Sariel; Avivi, Aaron] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Hernandez, Alvaro G.; Thimmapuram, Jyothi; Ali, Shahjahan; Band, Mark] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL 61801 USA; [Glaser, Fabian] Technion Israel Inst Technol, Bioinformat Knowledge Unit, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Haifa, Israel; [Paz, Arnon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	University of Haifa; University of Illinois System; University of Illinois Urbana-Champaign; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine	Malik, A (corresponding author), Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel.	aaron@research.haifa.ac.il; markband@illinois.edu			United States-Israel Binational Scientific Foundation (BSF) [2005346]	United States-Israel Binational Scientific Foundation (BSF)(US-Israel Binational Science Foundation)	This study was supported by grant no. 2005346 from The United States-Israel Binational Scientific Foundation (BSF), www.bsf.org.il, to Aaron Avivi, Mark Band and Alvaro Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARIELI R, 1981, PHYSIOL ZOOL, V54, P14, DOI 10.1086/physzool.54.1.30155800; ARIELI R, 1991, COMP BIOCHEM PHYS A, V100, P543, DOI 10.1016/0300-9629(91)90367-L; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Avivi A, 2007, ONCOGENE, V26, P2507, DOI 10.1038/sj.onc.1210045; Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje; Avivi A, 2002, P NATL ACAD SCI USA, V99, P11718, DOI 10.1073/pnas.182423299; Avivi A, 2001, P NATL ACAD SCI USA, V98, P13751, DOI 10.1073/pnas.181484498; Avivi A, 1999, FEBS LETT, V452, P133, DOI 10.1016/S0014-5793(99)00584-0; Avivi A, 2010, P NATL ACAD SCI US; Avivi A, 2006, PHYSIOL GENOMICS, V27, P54, DOI 10.1152/physiolgenomics.00001.2006; Band M, 2010, J MOL EVOL, V70, P1, DOI 10.1007/s00239-009-9306-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENSHLOMO R, 1995, BEHAV GENET, V25, P239, DOI 10.1007/BF02197182; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; Catania KC, 2002, P NATL ACAD SCI USA, V99, P5692, DOI 10.1073/pnas.072097999; Chuang CK, 2010, NAT STRUCT MOL BIOL, V17, P990, DOI 10.1038/nsmb.1870; COOPER HM, 1993, NATURE, V361, P156, DOI 10.1038/361156a0; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Frahm HD, 1997, J BRAIN RES, V38, P209; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gerlach F, 2006, ISR J ECOL EVOL, V52, P389, DOI 10.1560/IJEE_52_3-4_389; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GURNETT AM, 1984, J PROTEIN CHEM, V3, P445, DOI 10.1007/BF01025063; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hough RB, 2002, P NATL ACAD SCI USA, V99, P8145, DOI 10.1073/pnas.122231099; Jubb AM, 2004, J CLIN PATHOL, V57, P504, DOI 10.1136/jcp.2003.012963; Jubb AM, 2003, J PATHOL, V200, P577, DOI 10.1002/path.1371; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KLEINSCHMIDT T, 1984, H-S Z PHYSIOL CHEM, V365, P531, DOI 10.1515/bchm2.1984.365.1.531; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Mark B, 2010, CELL CYCLE, V9, P3347, DOI 10.4161/cc.9.16.12712; Marks Jeremy D., 2009, P3, DOI 10.1007/978-1-60327-579-8_1; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Nasser NJ, 2005, P NATL ACAD SCI USA, V102, P15161, DOI 10.1073/pnas.0507279102; NECKER R, 1992, NEUROREPORT, V3, P505, DOI 10.1097/00001756-199206000-00012; Nevo, 1999, MOSAIC EVOLUTION SUB; NEVO E, 1989, HEREDITY, V62, P85, DOI 10.1038/hdy.1989.11; NEVO E., 2001, ADAPTIVE RAD BLIND S; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shams I, 2005, COMP BIOCHEM PHYS A, V142, P376, DOI 10.1016/j.cbpa.2005.09.003; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; Shams Imad, 2005, FASEB J, V19, P307; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STORIER D, 1981, J COMP PHYSIOL, V142, P533, DOI 10.1007/BF00688986; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wetterbom A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r78; Widmer HR, 1997, P NATL ACAD SCI USA, V94, P2062, DOI 10.1073/pnas.94.5.2062	63	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e21227	10.1371/journal.pone.0021227	http://dx.doi.org/10.1371/journal.pone.0021227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857902	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500001
J	Zare, H; Kaveh, M; Khodursky, A				Zare, Hossein; Kaveh, Mostafa; Khodursky, Arkady			Inferring a Transcriptional Regulatory Network from Gene Expression Data Using Nonlinear Manifold Embedding	PLOS ONE			English	Article							RECONSTRUCTION; MICROARRAY	Transcriptional networks consist of multiple regulatory layers corresponding to the activity of global regulators, specialized repressors and activators as well as proteins and enzymes shaping the DNA template. Such intrinsic complexity makes uncovering connections difficult and it calls for corresponding methodologies, which are adapted to the available data. Here we present a new computational method that predicts interactions between transcription factors and target genes using compendia of microarray gene expression data and documented interactions between genes and transcription factors. The proposed method, called Kernel Embedding of Regulatory Networks (KEREN), is based on the concept of generegulon association, and captures hidden geometric patterns of the network via manifold embedding. We applied KEREN to reconstruct transcription regulatory interactions on a genome-wide scale in the model bacteria Escherichia coli (E. coli). Application of the method not only yielded accurate predictions of verifiable interactions, which outperformed on certain metrics comparable methodologies, but also demonstrated the utility of a geometric approach in the analysis of highdimensional biological data. We also described possible applications of kernel embedding techniques to other function and network discovery algorithms.	[Zare, Hossein] NIH, Bethesda, MD 20892 USA; [Kaveh, Mostafa] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA; [Khodursky, Arkady] Univ Minnesota, Dept Biochem Biophys & Mol Biol, St Paul, MN 55108 USA	National Institutes of Health (NIH) - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zare, H (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	khodu001@umn.edu	zare, hossein/ABB-5871-2021					Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Belkin M., 2002, ADV NEURAL INFORM PR, V14; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Butte AJ, 2002, PAC S BIOC, P418; Chen G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r4; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Ernst J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000044; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Ham J, 2004, P 21 INT C MACH LEAR, P69; Kim S, 2004, BIOSYSTEMS, V75, P57, DOI 10.1016/j.biosystems.2004.03.004; Lemmens K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r37; Lerman G, 2007, P NATL ACAD SCI USA, V104, P11334, DOI 10.1073/pnas.0702965104; Li H, 2008, BIOINFORMATICS, V24, P1874, DOI 10.1093/bioinformatics/btn332; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; Scholkopf B, KERNEL METHODS COMPU; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Thomas MC, 2006, ELEMENTS INFORM THEO; Zare H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-39	26	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e21969	10.1371/journal.pone.0021969	http://dx.doi.org/10.1371/journal.pone.0021969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857910	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500002
J	Zhang, Y; van Deursen, J; Galardy, PJ				Zhang, Ying; van Deursen, Jan; Galardy, Paul J.			Overexpression of Ubiquitin Specific Protease 44 (USP44) Induces Chromosomal Instability and Is Frequently Observed in Human T-Cell Leukemia	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE-ASSEMBLY CHECKPOINT; AGING-ASSOCIATED PHENOTYPES; MITOTIC CHECKPOINT; SECURIN DEGRADATION; TUMOR-SUPPRESSOR; ANEUPLOIDY; BUBR1; TUMORIGENESIS; DRIVES	Cdc20-anaphase promoting complex/cyclosome (Cdc20-APC/C) E3 ubiquitin ligase activity is essential for orderly mitotic progression. The deubiqituinase USP44 was identified as a key regulator of APC/C and has been proposed to suppress Cdc20-APC/C activity by maintaining its association with the inhibitory protein Mad2 until all chromosomes are properly attached to the mitotic spindle. However, this notion has been challenged by data in which a lysine-less mutant of Cdc20 leads to premature anaphase, suggesting that it's ubiquitination is not required for APC/C activation. To further evaluate its role in checkpoint function and chromosome instability, we studied the consequences of over-expression of mouse Usp44 in non-transformed murine embryonic fibroblasts. Here we show that cells with high Usp44 are prone to chromosome segregation errors and aneuploidization. We find that high Usp44 promotes association of Mad2 with Cdc20 and reinforces the mitotic checkpoint. Surprisingly, the APC/C-Cdc20 substrate cyclin B1 is stabilized in G2 when Usp44 is over-expressed, but is degraded with normal kinetics once cells enter mitosis. Furthermore, we show that USP44 expression is elevated in subset of T-cell leukemias. These data are consistent with an important role for USP44 in regulating Cdc20-APC/C activity and suggest that high levels of this enzyme may contribute to the pathogenesis of T-ALL.	[Zhang, Ying; van Deursen, Jan; Galardy, Paul J.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Zhang, Ying; van Deursen, Jan; Galardy, Paul J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Zhang, Y (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	Galardy.paul@mayo.edu	Galardy, Paul/AAE-9297-2019		Howard Hughes Medical Institute; Mayo Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mayo Foundation	P.J.G. received funds for this work from the Howard Hughes Medical Institute Physician-Scientist Early Career Award (www.hhmi.org) and the Mayo Foundation (www.MayoClinic.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan KL, 2009, CELL CYCLE, V8, P3065, DOI 10.4161/cc.8.19.9513; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Izawa D, 2011, NAT CELL BIOL, V13, P633, DOI 10.1038/ncb0511-633a; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Sofueva S, 2011, NUCLEIC ACIDS RES, V39, P6568, DOI 10.1093/nar/gkr340; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suresh B, 2010, CELL BIOL INT, V34, P799, DOI 10.1042/CBI20090144; Taylor SS, 2001, J CELL SCI, V114, P4385; TODARO GJ, 1966, P NATL ACAD SCI USA, V55, P302, DOI 10.1073/pnas.55.2.302; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	40	43	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23389	10.1371/journal.pone.0023389	http://dx.doi.org/10.1371/journal.pone.0023389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853124	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953400043
J	Taaseh, N; Yaron, A; Nelken, I				Taaseh, Nevo; Yaron, Amit; Nelken, Israel			Stimulus-Specific Adaptation and Deviance Detection in the Rat Auditory Cortex	PLOS ONE			English	Article							MISMATCH NEGATIVITY; CORTICAL-NEURONS; ANESTHETIZED RAT; POTENTIALS; REPRESENTATION; SYSTEM; PITCH	Stimulus-specific adaptation (SSA) is the specific decrease in the response to a frequent ('standard') stimulus, which does not generalize, or generalizes only partially, to another, rare stimulus ('deviant'). Stimulus-specific adaptation could result simply from the depression of the responses to the standard. Alternatively, there may be an increase in the responses to the deviant stimulus due to the violation of expectations set by the standard, indicating the presence of true deviance detection. We studied SSA in the auditory cortex of halothane-anesthetized rats, recording local field potentials and multi-unit activity. We tested the responses to pure tones of one frequency when embedded in sequences that differed from each other in the frequency and probability of the tones composing them. The responses to tones of the same frequency were larger when deviant than when standard, even with inter-stimulus time intervals of almost 2 seconds. Thus, SSA is present and strong in rat auditory cortex. SSA was present even when the frequency difference between deviants and standards was as small as 10%, substantially smaller than the typical width of cortical tuning curves, revealing hyper-resolution in frequency. Strong responses were evoked also by a rare tone presented by itself, and by rare tones presented as part of a sequence of many widely spaced frequencies. On the other hand, when presented within a sequence of narrowly spaced frequencies, the responses to a tone, even when rare, were smaller. A model of SSA that included only adaptation of the responses in narrow frequency channels predicted responses to the deviants that were substantially smaller than the observed ones. Thus, the response to a deviant is at least partially due to the change it represents relative to the regularity set by the standard tone, indicating the presence of true deviance detection in rat auditory cortex.	[Taaseh, Nevo; Yaron, Amit; Nelken, Israel] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Taaseh, N (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel.	Israel@cc.huji.ac.il	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X	EU (NOVELTUNE consortium); Israel Science Foundation [219/05, 72/09]; Gatsby Charitable Foundation	EU (NOVELTUNE consortium)(European Commission); Israel Science Foundation(Israel Science Foundation); Gatsby Charitable Foundation	Funding: This study was supported by an EU FP6 grant (NOVELTUNE consortium, http://cordis.europa.eu/fp6), by grants from the Israel Science Foundation (219/05 and 72/09) to I.N. (http://www.isf.org.il/), and by a grant from the Gatsby Charitable Foundation to the Interdisciplinary Center for Neural Computation at the Hebrew University (http://www.gatsby.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Haidarliu S, 1996, PHYSIOL BEHAV, V60, P111, DOI 10.1016/0031-9384(95)02257-0; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jacobsen T, 2003, NEUROSCI LETT, V344, P79, DOI 10.1016/S0304-3940(03)00408-7; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; PICTON TW, 1978, ELECTROEN CLIN NEURO, V45, P198, DOI 10.1016/0013-4694(78)90004-4; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; SAMS M, 1983, BIOL PSYCHOL, V17, P41, DOI 10.1016/0301-0511(83)90065-0; SAMS M, 1985, ELECTROEN CLIN NEURO, V61, P254, DOI 10.1016/0013-4694(85)91092-2; Storace DA, 2011, J COMP NEUROL, V519, P177, DOI 10.1002/cne.22501; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Winkler I, 2006, EUR J NEUROSCI, V24, P625, DOI 10.1111/j.1460-9568.2006.04925.x; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003	27	158	160	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23369	10.1371/journal.pone.0023369	http://dx.doi.org/10.1371/journal.pone.0023369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853120	gold, Green Published			2022-12-25	WOS:000295454200077
J	Atkinson, GC; Tenson, T; Hauryliuk, V				Atkinson, Gemma C.; Tenson, Tanel; Hauryliuk, Vasili			The RelA/SpoT Homolog (RSH) Superfamily: Distribution and Functional Evolution of ppGpp Synthetases and Hydrolases across the Tree of Life	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI; STRINGENT RESPONSE; GUANOSINE TETRAPHOSPHATE; PROTEIN-SYNTHESIS; (P)PPGPP SYNTHETASE; MYCOBACTERIUM-TUBERCULOSIS; COMPARATIVE GENOMICS; GUANINE-NUCLEOTIDES	RelA/SpoT Homologue (RSH) proteins, named for their sequence similarity to the RelA and SpoT enzymes of Escherichia coli, comprise a superfamily of enzymes that synthesize and/or hydrolyze the alarmone ppGpp, activator of the "stringent" response and regulator of cellular metabolism. The classical "long" RSHs Rel, RelA and SpoT with the ppGpp hydrolase, synthetase, TGS and ACT domain architecture have been found across diverse bacteria and plant chloroplasts, while dedicated single domain ppGpp-synthesizing and -hydrolyzing RSHs have also been discovered in disparate bacteria and animals respectively. However, there is considerable confusion in terms of nomenclature and no comprehensive phylogenetic and sequence analyses have previously been carried out to classify RSHs on a genomic scale. We have performed high-throughput sensitive sequence searching of over 1000 genomes from across the tree of life, in combination with phylogenetic analyses to consolidate previous ad hoc identification of diverse RSHs in different organisms and provide a much-needed unifying terminology for the field. We classify RSHs into 30 subgroups comprising three groups: long RSHs, small alarmone synthetases (SASs), and small alarmone hydrolases (SAHs). Members of nineteen previously unidentified RSH subgroups can now be studied experimentally, including previously unknown RSHs in archaea, expanding the "stringent response" to this domain of life. We have analyzed possible combinations of RSH proteins and their domains in bacterial genomes and compared RSH content with available RSH knock-out data for various organisms to determine the rules of combining RSHs. Through comparative sequence analysis of long and small RSHs, we find exposed sites limited in conservation to the long RSHs that we propose are involved in transmitting regulatory signals. Such signals may be transmitted via NTD to CTD intra-molecular interactions, or inter-molecular interactions either among individual RSH molecules or among long RSHs and other binding partners such as the ribosome.	[Atkinson, Gemma C.; Tenson, Tanel; Hauryliuk, Vasili] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu	Atkinson, GC (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	gemma.atkinson@ut.ee	Hauryliuk, Vasili/J-3930-2019; Tenson, Tanel/I-6431-2015; Atkinson, Gemma/L-9655-2019	Hauryliuk, Vasili/0000-0003-2389-5057; Tenson, Tanel/0000-0002-0260-3601; Atkinson, Gemma/0000-0002-4861-4584	Estonian Science Foundation [MJD99, 7616]; Center of Excellence in Chemical Biology [RLOTITIPP]	Estonian Science Foundation; Center of Excellence in Chemical Biology	This work was supported financially by Estonian Science Foundation grants (codes MJD99 to GCA, and 7616 to VH) and European Regional Development Fund through the Center of Excellence in Chemical Biology (code RLOTITIPP to VH and TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Atkinson GC, 2011, MOL BIOL EVOL, V28, P1281, DOI 10.1093/molbev/msq316; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Battesti A, 2009, J BACTERIOL, V191, P616, DOI 10.1128/JB.01195-08; Boutte CC, 2011, MOL MICROBIOL, V80, P695, DOI 10.1111/j.1365-2958.2011.07602.x; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; CHEUNG MY, 2010, J BIOL CHEM; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Das B, 2009, MOL MICROBIOL, V72, P380, DOI 10.1111/j.1365-2958.2009.06653.x; Devos DP, 2010, SCIENCE, V330, P1187, DOI 10.1126/science.1196720; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ENGLISH BP, 2011, P NATL ACAD SCI US; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLARDH K, 1994, J BACTERIOL, V176, P5949; GALLANT J, 1977, CELL, V11, P181, DOI 10.1016/0092-8674(77)90329-4; Ghosh S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-18; Godfrey HP, 2002, TRENDS MICROBIOL, V10, P349, DOI 10.1016/S0966-842X(02)02403-4; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gribaldo S, 2009, RES MICROBIOL, V160, P513, DOI 10.1016/j.resmic.2009.07.006; Gropp M, 2001, J BACTERIOL, V183, P570, DOI 10.1128/JB.183.2.570-579.2001; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Gupta RS, 1998, J MOL EVOL, V46, P716, DOI 10.1007/PL00006352; HAMEL E, 1974, ARCH BIOCHEM BIOPHYS, V162, P293, DOI 10.1016/0003-9861(74)90128-3; HAMEL E, 1973, P NATL ACAD SCI USA, V70, P3250, DOI 10.1073/pnas.70.11.3250; HARA A, 1983, J BIOL CHEM, V258, P1678; HASELTIN.WA, 1972, NATURE, V238, P381, DOI 10.1038/238381a0; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; HEINEMEYER EA, 1978, P NATL ACAD SCI USA, V75, P4180, DOI 10.1073/pnas.75.9.4180; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; Jin W, 2004, MICROBIOL-SGM, V150, P1485, DOI 10.1099/mic.0.26811-0; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; LAZZARINI RA, 1971, J BIOL CHEM, V246, P4381; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maciag M, 2010, PLASMID, V63, P61, DOI 10.1016/j.plasmid.2009.11.002; Martinez-Costa OH, 1998, J BACTERIOL, V180, P4123; MartinezCosta OH, 1996, J BIOL CHEM, V271, P10627, DOI 10.1074/jbc.271.18.10627; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mitkevich VA, 2010, J MOL BIOL, V402, P838, DOI 10.1016/j.jmb.2010.08.016; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ohno S., 1970, EVOLUTION GENE DUPLI; OKI T, 1975, BIOCHIM BIOPHYS ACTA, V410, P262, DOI 10.1016/0005-2744(75)90228-4; Ooga T, 2009, J BIOL CHEM, V284, P15549, DOI 10.1074/jbc.M900582200; PEDERSEN FS, 1977, EUR J BIOCHEM, V76, P91, DOI 10.1111/j.1432-1033.1977.tb11573.x; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Polkinghorne A, 2011, MICROB PATHOGENESIS, V50, P200, DOI 10.1016/j.micpath.2010.12.005; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rovery C, 2005, RES MICROBIOL, V156, P211, DOI 10.1016/j.resmic.2004.09.002; Sajish M, 2007, J BIOL CHEM, V282, P34977, DOI 10.1074/jbc.M704828200; Sajish M, 2009, J BIOL CHEM, V284, P9115, DOI 10.1074/jbc.M807187200; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; SILVERMAN RH, 1979, MICROBIOL REV, V43, P27, DOI 10.1128/MMBR.43.1.27-41.1979; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; SPRINZL M, 1976, EUR J BIOCHEM, V71, P171, DOI 10.1111/j.1432-1033.1976.tb11103.x; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun D, 2010, NAT STRUCT MOL BIOL, V17, P1188, DOI 10.1038/nsmb.1906; Sun JH, 2001, J BACTERIOL, V183, P3488, DOI 10.1128/JB.183.11.3488-3498.2001; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; TOZAWA Y, 2011, PLANT BIOL IN PRESS; Tozawa Y, 2007, J BIOL CHEM, V282, P35536, DOI 10.1074/jbc.M703820200; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Vrentas CE, 2008, J MOL BIOL, V377, P551, DOI 10.1016/j.jmb.2008.01.042; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yang XM, 2001, BIOCHEM CELL BIOL, V79, P729, DOI 10.1139/bcb-79-6-729	101	272	279	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23479	10.1371/journal.pone.0023479	http://dx.doi.org/10.1371/journal.pone.0023479			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858139	Green Published, gold, Green Submitted			2022-12-25	WOS:000293774300036
J	Cardenas, C; Quesada, AR; Medina, MA				Cardenas, Casimiro; Quesada, Ana R.; Medina, Miguel A.			Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; MATRIX METALLOPROTEINASES; INHIBIT ANGIOGENESIS; KEY STEPS; CANCER; RISK; CONSUMPTION; GROWTH; METAANALYSIS	Background: Epidemiological studies have shown that unfiltered coffee consumption is associated with a low incidence of cancer. This study aims to identify the effects of kahweol, an antioxidant diterpene contained in unfiltered coffee, on angiogenesis and key inflammatory molecules. Methodology/Principal Findings: The experimental procedures included in vivo angiogenesis assays (both the chicken and quail choriallantoic membrane assay and the angiogenesis assay with fluorescent zebrafish), the ex vivo mouse aortic ring assay and the in vitro analysis of the effects of treatment of human endothelial cells with kahweol in cell growth, cell viability, cell migration and zymographic assays, as well as the tube formation assay on Matrigel. Additionally, two inflammation markers were determined, namely, the expression levels of cyclooxygenase 2 and the levels of secreted monocyte chemoattractant protein-1. We show for the first time that kahweol is an anti-angiogenic compound with inhibitory effects in two in vivo and one ex vivo angiogenesis models, with effects on specific steps of the angiogenic process: endothelial cell proliferation, migration, invasion and tube formation on Matrigel. We also demonstrate the inhibitory effect of kahweol on the endothelial cell potential to remodel extracellular matrix by targeting two key molecules involved in the process, MMP-2 and uPA. Finally, the anti-inflammatory potential of this compound is demonstrated by its inhibition of both COX-2 expression and MCP-1 secretion in endothelial cells. Conclusion/Significance: Taken together, our data indicate that, indeed, kahweol behaves as an anti-inflammatory and anti-angiogenic compound with potential use in antitumoral therapies. These data may contribute to the explanation of the reported antitumoral effects of kahweol, including the recent epidemiological meta-analysis showing that drinking coffee could decrease the risk of certain cancers.	[Cardenas, Casimiro; Quesada, Ana R.; Medina, Miguel A.] Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Quesada, Ana R.; Medina, Miguel A.] CIBER Enfermedades Raras CIBERER, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Cardenas, C (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain.	medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Cardenas, Casimiro/L-1051-2014	Medina, Miguel Ángel/0000-0001-7275-6462; Cardenas, Casimiro/0000-0001-6259-8296; Rodriguez Quesada, Ana Maria/0000-0002-6419-8867	Spanish Ministry of Science and Innovation [PS09/02216, TRACE PT2008-0145]; group BIO-267 (Andalusian Government); Instituto de Salud Carlos III (Spain);  [PIE P08-CTS-3759];  [CVI-6585]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); group BIO-267 (Andalusian Government); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); ; 	Our experimental work is supported by grants PS09/02216 and TRACE PT2008-0145 (Spanish Ministry of Science and Innovation, www.micinn.es, www.juntadeandalucia.es), and PIE P08-CTS-3759, CVI-6585, and funds from group BIO-267 (Andalusian Government). The "CIBER de Enfermedades Raras" (www.ciberer.es) is an initiative from the Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Medina MA, 2007, J CELL MOL MED, V11, P374, DOI 10.1111/j.1582-4934.2007.00056.x; Bellisle F, 1998, BRIT J NUTR, V80, pS173, DOI 10.1079/BJN19980109; Bengis RO, 1932, J BIOL CHEM, V97, P99; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Cardenas C, 2006, CELL MOL LIFE SCI, V63, P3083, DOI 10.1007/s00018-006-6399-6; Cardenas C, 2004, BIOCHEM BIOPH RES CO, V320, P402, DOI 10.1016/j.bbrc.2004.05.183; Castro ME, 2004, INT J CANCER, V110, P31, DOI 10.1002/ijc.20068; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Friberg E, 2009, INT J CANCER, V125, P2413, DOI 10.1002/ijc.24543; Futagami S, 2008, PROSTAG LEUKOTR ESS, V78, P137, DOI 10.1016/j.plefa.2007.10.030; Giovannucci E, 1998, AM J EPIDEMIOL, V147, P1043, DOI 10.1093/oxfordjournals.aje.a009398; Gonzalez-Iriarte Mauricio, 2003, Angiogenesis, V6, P251, DOI 10.1023/B:AGEN.0000021388.59617.6b; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Igura K, 2001, CANCER LETT, V171, P11, DOI 10.1016/S0304-3835(01)00443-8; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim HG, 2009, TOXICOL LETT, V187, P28, DOI 10.1016/j.toxlet.2009.01.022; Kim JY, 2004, FEBS LETT, V569, P321, DOI 10.1016/j.febslet.2004.05.070; Kim MS, 2000, INT J CANCER, V87, P269, DOI 10.1002/1097-0215(20000715)87:2&lt;269::AID-IJC19&gt;3.0.CO;2-W; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044; Lee KJ, 2007, TOXICOL LETT, V173, P80, DOI 10.1016/j.toxlet.2007.06.008; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Martinez-Poveda B, 2005, INT J CANCER, V117, P775, DOI 10.1002/ijc.21246; Martinez-Poveda B, 2005, EUR J PHARMACOL, V516, P97, DOI 10.1016/j.ejphar.2005.03.047; Martinez-Poveda B, 2007, MOL CANCER THER, V6, P2675, DOI 10.1158/1535-7163.MCT-07-0136; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; NICOSIA RF, 1990, LAB INVEST, V63, P115; Nkondjock A, 2009, CANCER LETT, V277, P121, DOI 10.1016/j.canlet.2008.08.022; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; Quesada AR, 2010, CURR PHARM DESIGN, V16, P3932; Rabbani SA, 1998, IN VIVO, V12, P135; Rakic JM, 2003, CELL MOL LIFE SCI, V60, P463, DOI 10.1007/s000180300039; Rodriguez-Nieto S, 2001, ANTICANCER RES, V21, P3457; Rodriguez-Nieto S, 2001, FASEB J, V15, P261, DOI 10.1096/fj.01-0427fje; Rodriguez-Nieto S, 2002, BIOCHEM BIOPH RES CO, V293, P497, DOI 10.1016/S0006-291X(02)00232-2; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Shimamura M, 2001, BIOCHEM BIOPH RES CO, V289, P220, DOI 10.1006/bbrc.2001.5934; Spiller M A, 1984, Prog Clin Biol Res, V158, P91; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Totzke G, 2003, ONCOGENE, V22, P8021, DOI 10.1038/sj.onc.1206837	47	98	101	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23407	10.1371/journal.pone.0023407	http://dx.doi.org/10.1371/journal.pone.0023407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858104	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300033
J	Aranha, MM; Santos, DM; Sola, S; Steer, CJ; Rodrigues, CMP				Aranha, Marcia M.; Santos, Daniela M.; Sola, Susana; Steer, Clifford J.; Rodrigues, Cecilia M. P.			miR-34a Regulates Mouse Neural Stem Cell Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOTHELIAL-CELLS; P53; RESVERATROL; MICRORNAS; APOPTOSIS; TRANSCRIPTION; CONTRIBUTES; ACTIVATION; TARGET	Background: MicroRNAs (miRNAs or miRs) participate in the regulation of several biological processes, including cell differentiation. Recently, miR-34a has been implicated in the differentiation of monocyte-derived dendritic cells, human erythroleukemia cells, and mouse embryonic stem cells. In addition, members of the miR-34 family have been identified as direct p53 targets. However, the function of miR-34a in the control of the differentiation program of specific neural cell types remains largely unknown. Here, we investigated the role of miR-34a in regulating mouse neural stem (NS) cell differentiation. Methodology/Principal Findings: miR-34a overexpression increased postmitotic neurons and neurite elongation of mouse NS cells, whereas anti-miR-34a had the opposite effect. SIRT1 was identified as a target of miR-34a, which may mediate the effect of miR-34a on neurite elongation. In addition, acetylation of p53 (Lys 379) and p53-DNA binding activity were increased and cell death unchanged after miR-34a overexpression, thus reinforcing the role of p53 during neural differentiation. Interestingly, in conditions where SIRT1 was activated by pharmacologic treatment with resveratrol, miR-34a promoted astrocytic differentiation, through a SIRT1-independent mechanism. Conclusions: Our results provide new insight into the molecular mechanisms by which miR-34a modulates neural differentiation, suggesting that miR-34a is required for proper neuronal differentiation, in part, by targeting SIRT1 and modulating p53 activity.	[Aranha, Marcia M.; Santos, Daniela M.; Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Universidade de Lisboa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Aranha, MM (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal.	cmprodrigues@ff.ul.pt	Solá, Susana/M-5251-2013; iMed.ULisboa, CellFun/A-4244-2014; Solá, Susana/AAI-4580-2021; Santos, Daniela/W-3903-2019; Rodrigues, Cecilia MP/M-3572-2013; Aranha, Marcia/AAO-7240-2021	Solá, Susana/0000-0003-2036-797X; Solá, Susana/0000-0003-2036-797X; Rodrigues, Cecilia MP/0000-0002-4829-754X; Moutinho Dos Santos, Daniela/0000-0002-3740-1305; Aranha, Marcia/0000-0001-9842-4335	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal [PTDC/BIA-BCM/67922/2006, PTDC/SAU-GMG/099162/2008]; FCT, Portugal [SFRH/BD/28429/2006, SFRH/BD/42008/2007]	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grant PTDC/BIA-BCM/67922/2006 and PTDC/SAU-GMG/099162/2008 from Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal. MM Aranha and DM Santos are recipients of PhD fellowships from FCT, Portugal (SFRH/BD/28429/2006 and SFRH/BD/42008/2007, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2000, MOL CARCINOGEN, V28, P129, DOI 10.1002/1098-2744(200007)28:3&lt;129::AID-MC1&gt;3.0.CO;2-0; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Brynczka C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-139; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Ichimura A, 2010, MOL PHARMACOL, V77, P1016, DOI 10.1124/mol.109.063321; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mantel C, 2008, CURR OPIN HEMATOL, V15, P326, DOI 10.1097/MOH.0b013e3283043819; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Ou XA, 2011, BLOOD, V117, P440, DOI 10.1182/blood-2010-03-273011; Pezzuto JM, 2006, OXIDAT STRESS DIS, V20, P233; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schutte B, 1998, J NEUROSCI METH, V86, P63, DOI 10.1016/S0165-0270(98)00147-2; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; WANG Y, 1995, MOL CELL BIOL, V15, P2157; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Zhang J, 2006, CELL DEATH DIFFER, V13, P2118, DOI 10.1038/sj.cdd.4401972	63	145	155	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21396	10.1371/journal.pone.0021396	http://dx.doi.org/10.1371/journal.pone.0021396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857907	gold, Green Submitted, Green Published			2022-12-25	WOS:000293558900008
J	Karadedou, CT; Gomes, AR; Chen, J; Petkovic, M; Ho, KK; Zwolinska, AK; Feltes, A; Wong, SY; Chan, KYK; Cheung, YN; Tsang, JWH; Brosens, JJ; Khoo, US; Lam, EWF				Karadedou, C. T.; Gomes, A. R.; Chen, J.; Petkovic, M.; Ho, K-K; Zwolinska, A. K.; Feltes, A.; Wong, S. Y.; Chan, K. Y. K.; Cheung, Y-N; Tsang, J. W. H.; Brosens, J. J.; Khoo, U-S; Lam, E. W-F			FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer	ONCOGENE			English	Article						VEGF; FOXO3a; FOXM1; breast cancer; transcription	TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR FOXO3A; LEUKEMIC-CELLS; GROWTH-INHIBITION; GEFITINIB IRESSA; GENE-EXPRESSION; DUAL INHIBITOR; SOLID TUMORS; LUNG-CANCER; LAPATINIB	Vascular endothelial growth factor (VEGF) has a central role in breast cancer development and progression, but the mechanisms that control its expression are poorly understood. Breast cancer tissue microarrays revealed an inverse correlation between the Forkhead transcription factor Forkhead box class O (FOXO)3a and VEGF expression. Using the lapatinib-sensitive breast cancer cell lines BT474 and SKBR3 as model systems, we tested the possibility that VEGF expression is negatively regulated by FOXO3a. Lapatinib treatment of BT474 or SKBR3 cells resulted in nuclear translocation and activation of FOXO3a, followed by a reduction in VEGF expression. Transient transfection and inducible expression experiments showed that FOXO3a represses the proximal VEGF promoter, whereas another Forkhead member, FOXM1, induces VEGF expression. Chromatin immunoprecipitation and oligonucleotide pull-down assays showed that both FOXO3a and FOXM1 bind a consensus Forkhead response element (FHRE) in the VEGF promoter. Upon lapatinib stimulation, activated FOXO3a displaces FOXM1 bound to the FHRE before recruiting histone deacetylase 2 (HDAC2) to the promoter, leading to decreased histones H3 and H4 acetylation, and concomitant transcriptional inhibition of VEGF. These results show that FOXO3a-dependent repression of target genes in breast cancer cells, such as VEGF, involves competitive displacement of DNA-bound FOXM1 and active recruitment of transcriptional repressor complexes. Oncogene (2012) 31, 1845-1858; doi: 10.1038/onc.2011.368; published online 22 August 2011	[Karadedou, C. T.; Gomes, A. R.; Chen, J.; Petkovic, M.; Ho, K-K; Zwolinska, A. K.; Feltes, A.; Brosens, J. J.; Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Canc Res UK Labs, London W12 0NN, England; [Chen, J.; Wong, S. Y.; Chan, K. Y. K.; Cheung, Y-N; Khoo, U-S] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tsang, J. W. H.] Univ Hong Kong, Dept Clin Oncol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	Cancer Research UK; Imperial College London; University of Hong Kong; University of Hong Kong	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Canc Res UK Labs, MRC Hammersmith Hosp Campus,Cyclotron Bldg,Du Can, London W12 0NN, England.	eric.lam@imperial.ac.uk	Khoo, Ui Soon/C-4293-2009; Khoo, Ui Soon/C-1345-2014; Chan, Kelvin/HGA-3097-2022; Khoo, Ui Soon/K-2041-2019; Lam, Eric W-F/AAW-8566-2020	Khoo, Ui Soon/0000-0003-2200-7505; Khoo, Ui Soon/0000-0003-2200-7505; Lam, Eric W-F/0000-0003-1274-3576; Brosens, Jan/0000-0003-0116-9329	Cancer Research UK; Breast Cancer Campaign; Portuguese Science and Technology Foundation (FCT); Cancer Research UK [12011] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology); Cancer Research UK(Cancer Research UK)	This study was supported by the Cancer Research UK (M Petkovic, KK Ho and EW-F Lam), Breast Cancer Campaign (EW-F Lam), the Portuguese Science and Technology Foundation (FCT; AR Gomes).	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Ciardiello Fortunato, 2005, Future Oncol, V1, P221, DOI 10.1517/14796694.1.2.221; DAVIE JR, 1978, P NATL ACAD SCI USA, V75, P3574, DOI 10.1073/pnas.75.8.3574; Davis R, 2009, ONCOL REP, V22, P1473, DOI 10.3892/or_00000589; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Diaz R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-188; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Essafi Abdelkader, 2009, V462, P201, DOI 10.1007/978-1-60327-115-8_13; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Ferrer FA, 1998, UROLOGY, V51, P161, DOI 10.1016/S0090-4295(97)00491-3; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gomes AR, 2008, CELL CYCLE, V7, P3133, DOI 10.4161/cc.7.20.6920; Hegde PS, 2007, MOL CANCER THER, V6, P1629, DOI 10.1158/1535-7163.MCT-05-0399; Heist RS, 2008, J CLIN ONCOL, V26, P856, DOI 10.1200/JCO.2007.13.5947; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Ikezoe T, 2006, MOL CANCER THER, V5, P2522, DOI 10.1158/1535-7163.MCT-06-0071; Ikezoe T, 2006, CANCER SCI, V97, P945, DOI 10.1111/j.1349-7006.2006.00263.x; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Kitadai Y, 2010, J ONCOL, V2010, DOI 10.1155/2010/468725; Kondo N, 2010, ONCOL REP, V23, P957, DOI 10.3892/or_00000720; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P112, DOI 10.1161/ATVBAHA.107.153304; Lentzsch S, 2004, LEUKEMIA, V18, P1883, DOI 10.1038/sj.leu.2403486; Littler DR, 2010, NUCLEIC ACIDS RES, V38, P4527, DOI 10.1093/nar/gkq194; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Maiese K, 2008, TRENDS MOL MED, V14, P219, DOI 10.1016/j.molmed.2008.03.002; Makrilia N, 2009, EUR J INTERN MED, V20, P663, DOI 10.1016/j.ejim.2009.07.009; Margolin Kim, 2002, Curr Oncol Rep, V4, P20, DOI 10.1007/s11912-002-0044-9; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Montemurro F, 2007, EXPERT OPIN BIOL TH, V7, P257, DOI 10.1517/14712598.7.2.257; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nelson MH, 2006, ANN PHARMACOTHER, V40, P261, DOI 10.1345/aph.1G387; Nordigarden A, 2009, BLOOD, V113, P2302, DOI 10.1182/blood-2008-07-167023; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Park SH, 2009, BIOCHEM BIOPH RES CO, V390, P861, DOI 10.1016/j.bbrc.2009.10.063; Pytel D, 2009, ANTI-CANCER AGENT ME, V9, P66, DOI 10.2174/187152009787047752; Reedquist KA, 2006, BIOCHEM SOC T, V34, P727, DOI 10.1042/BST0340727; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Schneider BP, 2007, NAT CLIN PRACT ONCOL, V4, P181, DOI 10.1038/ncponc0740; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Wakeling AE, 2002, CURR OPIN PHARMACOL, V2, P382, DOI 10.1016/S1471-4892(02)00183-2; Yamaguchi T, 2007, CANCER SCI, V98, P405, DOI 10.1111/j.1349-7006.2007.00402.x; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	59	118	131	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	14					1845	1858		10.1038/onc.2011.368	http://dx.doi.org/10.1038/onc.2011.368			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21860419	Green Submitted, Green Accepted			2022-12-25	WOS:000302785200010
J	Roepke, TK; Kanda, VA; Purtell, K; King, EC; Lerner, DJ; Abbott, GW				Roepke, Torsten K.; Kanda, Vikram A.; Purtell, Kerry; King, Elizabeth C.; Lerner, Daniel J.; Abbott, Geoffrey W.			KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium	FASEB JOURNAL			English	Article						MiRP1; cerebrospinal fluid; polarized trafficking; central nervous system; ventricles	DISRUPTION; EXPRESSION; BRAIN; MINK; AQUAPORIN-1; CONTRIBUTE; SUBUNIT; MIRP1	Cerebrospinal fluid (CSF) is crucial for normal function and mechanical protection of the CNS. The choroid plexus epithelium (CPe) is primarily responsible for secreting CSF and regulating its composition by mechanisms currently not fully understood. Previously, the heteromeric KCNQ1-KCNE2 K+ channel was functionally linked to epithelial processes including gastric acid secretion and thyroid hormone biosynthesis. Here, using Kcne2(-/-) tissue as a negative control, we found cerebral expression of KCNE2 to be markedly enriched in the CPe apical membrane, where we also discovered expression of KCNQ1. Targeted Kcne2 gene deletion in C57B6 mice increased CPe outward K+ current 2-fold. The Kcne2 deletion-enhanced portion of the current was inhibited by XE991 (10 mu M) and margatoxin (10 mu M) but not by dendrotoxin (100 nM), indicating that it arose from augmentation of KCNQ subfamily and KCNA3 but not KCNA1 K+ channel activity. Kcne2 deletion in C57B6 mice also altered the polarity of CPe KCNQ1 and KCNA3 trafficking, hyperpolarized the CPe membrane by 9 +/- 2 mV, and increased CSF [Cl-] by 14% compared with wild-type mice. These findings constitute the first report of CPe dysfunction caused by cation channel gene disruption and suggest that KCNE2 influences blood-CSF anion flux by regulating KCNQ1 and KCNA3 in the CPe.-Roepke, T. K., Kanda, V. A., Purtell, K., King, E. C., Lerner, D. J., Abbott, G. W. KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium. FASEB J. 25, 4264-4273 (2011). www.fasebj.org	[Roepke, Torsten K.; Kanda, Vikram A.; Purtell, Kerry; King, Elizabeth C.; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Roepke, Torsten K.; King, Elizabeth C.; Lerner, Daniel J.; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; Cornell University	Abbott, GW (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, Box 70,1300 York Ave, New York, NY 10021 USA.	gwa2001@med.cornell.edu		Abbott, Geoffrey/0000-0003-4552-496X	U.S. National Heart, Lung, and Blood Institute, National Institutes of Health (NIH) [R01-HL079275]; American Heart Association [0855756D]; Irma T. Hirschl Career Scientist Award; NIH [T32-GM073546]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Irma T. Hirschl Career Scientist Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for expert assistance from K. La Perle, L. Cohen-Gould (Director of the Electron Microscopy and Histology Core Facility at Weill Cornell Medical College), M. S. Jiao, and the Molecular Cytology Core Facility of Memorial Sloan-Kettering Cancer Center. The authors thank Antonio Felipe (Universitat de Barcelona, Barcelona, Spain), Neil Harrison (Columbia University, New York, NY, USA), and Charles Inturrisi (Weill Cornell Medical College, New York, NY, USA) for advice, reagents, and other resources. This work was supported by the U.S. National Heart, Lung, and Blood Institute, National Institutes of Health (NIH; R01-HL079275), the American Heart Association (grant-in-aid 0855756D), and an Irma T. Hirschl Career Scientist Award (to G. W. A.). K.P. was supported by an NIH predoctoral training grant (T32-GM073546).	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; AMES A, 1965, J PHYSIOL-LONDON, V181, P506, DOI 10.1113/jphysiol.1965.sp007779; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Heron SE, 2010, EPILEPSIA, V51, P293, DOI 10.1111/j.1528-1167.2009.02317.x; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; LINDVALLAXELSSON M, 1989, EXP BRAIN RES, V77, P605; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Millar Ian D, 2007, Cerebrospinal Fluid Res, V4, P8, DOI 10.1186/1743-8454-4-8; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Speake T, 2003, BBA-BIOMEMBRANES, V1609, P80, DOI 10.1016/S0005-2736(02)00658-2; Speake T, 2004, AM J PHYSIOL-CELL PH, V286, pC611, DOI 10.1152/ajpcell.00292.2003; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; VermaKurvari S, 1997, MOL BRAIN RES, V46, P54, DOI 10.1016/S0169-328X(96)00271-9; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511	30	34	34	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4264	4273		10.1096/fj.11-187609	http://dx.doi.org/10.1096/fj.11-187609			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21859894	Green Published, Green Submitted			2022-12-25	WOS:000298138100019
J	Tang, HF; Yan, CG; Cao, J; Sarma, JV; Haura, EB; Wu, M; Gao, HW				Tang, Huifang; Yan, Chunguang; Cao, Jay; Sarma, J. Vidya; Haura, Eric B.; Wu, Min; Gao, Hongwei			An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation	FASEB JOURNAL			English	Article						signal transducer and activator of transcription; ALI	ACUTE LUNG INJURY; NECROSIS-FACTOR-ALPHA; FC-GAMMA RECEPTORS; MONOCYTIC CELLS; IN-VIVO; ACTIVATION; EXPRESSION; OVEREXPRESSION; HOMEOSTASIS; EPITHELIUM	Growing evidence suggests that transcription factor signal transducer and activator of transcription (Stat) 3 may play an important regulatory role during inflammation. However, the function of Stat3 in acute lung injury (ALI) is largely unknown. In the current study, by using an adenoviral vector expressing a dominant-negative Stat3 isoform (Ad-Stat3-EVA), we determined the role of Stat3 in IgG immune complex (IC)-induced inflammatory responses and injury in the lung from C57BL/6J mice. We show that IgG IC-induced DNA binding activity of Stat3 in the lung was significantly inhibited by Stat3-EVA. We demonstrate that both lung vascular permeability (albumin leak) and lung myeloperoxidase accumulation in the Ad-Stat-EVA treated mice were substantially reduced when compared with values in mice receiving control virus (Ad-GFP) during the injury. Furthermore, intratracheal administration of Ad-Stat3-EVA caused significant decreases in the contents of neutrophils, inflammatory cytokines (TNF-alpha and IL-6), chemokines [ keratinocyte cell-derived chemokine, macrophage inflammatory protein (MIP)-1 alpha, and MIP-1 beta], and complement component C5a in bronchoalveolar lavage fluids. Using Stat3-specific small interfering RNA, we show that knocking down Stat3 expression in alveolar macrophages (MH-S cells) significantly reduced the production of proinflammatory mediators on IgG IC stimulation. These data suggest that Stat3 plays an essential role in the pathogenesis of IgG IC-induced ALI by mediating the acute inflammatory responses in the lung and alveolar macrophages.-Tang, H., Yan, C., Cao, J., Sarma, J. V., Haura, E. B., Wu, M., Gao, H. An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation. FASEB J. 25, 4292-4300 (2011). www.fasebj.org	[Tang, Huifang; Yan, Chunguang; Gao, Hongwei] Harvard Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp,Ctr Expt Therapeut & Reperf, Boston, MA 02115 USA; [Tang, Huifang] Zhejiang Univ, Sch Med, State Food & Drug Adm China, Zhejiang Resp Drugs Res Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Jay] ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND USA; [Sarma, J. Vidya] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Haura, Eric B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Yan, Chunguang; Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Zhejiang University; United States Department of Agriculture (USDA); University of Michigan System; University of Michigan; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of North Dakota Grand Forks	Gao, HW (corresponding author), Harvard Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp,Ctr Expt Therapeut & Reperf, Boston, MA 02115 USA.	hgao@zeus.bwh.harvard.edu	Tang, Huifang/ADI-7037-2022		U.S. National Institutes of Health [5R01-HL-092905-04, 3R01-HL-092905-02S1]; U.S. Department of Agriculture, Agricultural Research Service (ARS) [CRIS 5450-51000-046-00D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture, Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Peter A. Ward (University of Michigan, Ann Arbor, MI, USA) and Dr. Richard C. Schwartz (Michigan State University, Lansing, MI, USA) for constant encouragement and advice. The authors also thank Dr. Wei Zhang for preparing the adenovirus. This research was supported by U.S. National Institutes of Health grants 5R01-HL-092905-04 and 3R01-HL-092905-02S1 (to H.G.) and the U.S. Department of Agriculture, Agricultural Research Service (ARS) program, CRIS 5450-51000-046-00D (to J.C.). The authors declare no competing financial interests.	BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Cappelletti M, 1996, CELL DEATH DIFFER, V3, P29; Chouchakova N, 2001, J IMMUNOL, V166, P5193, DOI 10.4049/jimmunol.166.8.5193; Crockett Elahe T, 2004, BMC Clin Pathol, V4, P2, DOI 10.1186/1472-6890-4-2; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Fernandez N, 2002, EUR J IMMUNOL, V32, P383, DOI 10.1002/1521-4141(200202)32:2<383::AID-IMMU383>3.0.CO;2-9; Fernandez N, 2002, J IMMUNOL, V169, P3321, DOI 10.4049/jimmunol.169.6.3321; Fu XY, 2006, CELL RES, V16, P214, DOI 10.1038/sj.cr.7310029; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao HW, 2004, J IMMUNOL, V172, P7703, DOI 10.4049/jimmunol.172.12.7703; Guo RF, 2002, AM J PATHOL, V161, P275, DOI 10.1016/S0002-9440(10)64179-X; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Ikegami M, 2008, J APPL PHYSIOL, V104, P1753, DOI 10.1152/japplphysiol.00875.2007; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; LARSEN GL, 1981, AM REV RESPIR DIS, V123, P434; Lentsch AB, 1999, AM J RESP CELL MOL, V20, P692, DOI 10.1165/ajrcmb.20.4.3414; Lian XM, 2005, J IMMUNOL, V174, P7250, DOI 10.4049/jimmunol.174.11.7250; Matsuzaki Y, 2006, J IMMUNOL, V177, P527, DOI 10.4049/jimmunol.177.1.527; Meng ZH, 2001, AM J PHYSIOL-CELL PH, V280, pC343, DOI 10.1152/ajpcell.2001.280.2.C343; MULLIGAN MS, 1993, AM J PATHOL, V142, P1739; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Severgnini M, 2005, AM J RESP CRIT CARE, V171, P858, DOI 10.1164/rccm.200407-981OC; SHANLEY TP, 1995, J IMMUNOL, V154, P4793; Shanley TP, 1997, J IMMUNOL, V158, P3439; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Trcka J, 2002, IMMUNITY, V16, P861, DOI 10.1016/S1074-7613(02)00327-8; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje	36	14	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4292	4300		10.1096/fj.11-187955	http://dx.doi.org/10.1096/fj.11-187955			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21859893	Green Published, Green Submitted			2022-12-25	WOS:000298138100021
J	Espinosa, A; Hennig, J; Ambrosi, A; Anandapadmanaban, M; Abelius, MS; Sheng, Y; Nyberg, F; Arrowsmith, CH; Sunnerhagen, M; Wahren-Herlenius, M				Espinosa, Alexander; Hennig, Janosch; Ambrosi, Aurelie; Anandapadmanaban, Madhanagopal; Abelius, Martina Sandberg; Sheng, Yi; Nyberg, Filippa; Arrowsmith, Cheryl H.; Sunnerhagen, Maria; Wahren-Herlenius, Marie			Anti-Ro52 Autoantibodies from Patients with Sjogren's Syndrome Inhibit the Ro52 E3 Ligase Activity by Blocking the E3/E2 Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; UBIQUITIN-CONJUGATING ENZYMES; CONGENITAL HEART-BLOCK; AUTOANTIGEN RO52; CYTOKINE EXPRESSION; FINGER PROTEIN; RING DOMAIN; RO/SS-A; COMPLEX; UBIQUITYLATION	Ro52 (TRIM21) is an E3 ligase of the tripartite motif family that negatively regulates proinflammatory cytokine production by ubiquitinating transcription factors of the interferon regulatory factor family. Autoantibodies to Ro52 are present in patients with lupus and Sjogren's syndrome, but it is not known if these autoantibodies affect the function of Ro52. To address this question, the requirements for Ro52 E3 ligase activity were first analyzed in detail. Scanning a panel of E2 ubiquitin-conjugating enzymes, we found that UBE2D1-4 and UBE2E1-2 supported the E3 ligase activity of Ro52 and that the E3 ligase activity of Ro52 was dependent on its RING domain. We also found that the N-terminal extensions in the class III E2 enzymes affected their interaction with Ro52. Although the N-terminal extension in UBE2E3 made this E2 enzyme unable to function together with Ro52, the N-terminal extensions in UBE2E1 and UBE2E2 allowed for a functional interaction with Ro52. Anti-Ro52-positive patient sera and affinity-purified anti-RING domain autoantibodies inhibited the E3 activity of Ro52 in ubiquitination assays. Using NMR, limited proteolysis, ELISA, and Ro52 mutants, we mapped the interactions between Ro52, UBE2E1, and anti-Ro52 autoantibodies. We found that anti-Ro52 autoantibodies inhibited the E3 ligase activity of Ro52 by sterically blocking the E2/E3 interaction between Ro52 and UBE2E1. Our data suggest that anti-Ro52 autoantibodies binding the RING domain of Ro52 may be actively involved in the pathogenesis of rheumatic autoimmune disease by inhibiting Ro52-mediated ubiquitination.	[Sunnerhagen, Maria] Linkoping Univ, Div Mol Biotechnol, IFM, SE-58183 Linkoping, Sweden; [Espinosa, Alexander; Ambrosi, Aurelie; Wahren-Herlenius, Marie] Karolinska Inst, Rheumatol Unit, Ctr Mol Med, Dept Med, SE-17176 Stockholm, Sweden; [Sheng, Yi; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Nyberg, Filippa] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, SE-18288 Stockholm, Sweden; [Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	Linkoping University; Karolinska Institutet; University of Toronto; Danderyds Hospital; Karolinska Institutet; York University - Canada	Sunnerhagen, M (corresponding author), Linkoping Univ, Div Mol Biotechnol, IFM, SE-58183 Linkoping, Sweden.	marsu@ifm.liu.se; marie.wahren@ki.se	Anandapadamanaban, Madhanagopal/F-3702-2014; Wahren-Herlenius, Marie/AAN-6942-2021	Wahren-Herlenius, Marie/0000-0002-0915-7245; Hennig, Janosch/0000-0001-5214-7002; Arrowsmith, Cheryl/0000-0002-4971-3250; Anandapadamanaban, Madhanagopal/0000-0002-4237-0048	Swedish Research Council; Swedish Foundation for Strategic Research; VINNOVA; CeNano; Swedish Cancer Society; Karolinska Institutet; Linkoping University; King Gustaf V's 80-Year Foundation; Heart-Lung Foundation; Stockholm County Council; Gustafsson Foundation; Soderberg Foundation; National Cancer Institute of Canada; Swedish Rheumatism Association; Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); VINNOVA(Vinnova); CeNano; Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Linkoping University; King Gustaf V's 80-Year Foundation; Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Gustafsson Foundation; Soderberg Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Swedish Rheumatism Association; Wallenberg Foundation(European Commission)	This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, VINNOVA, CeNano, Swedish Cancer Society, Karolinska Institutet, Linkoping University, King Gustaf V's 80-Year Foundation, the Heart-Lung Foundation, the Stockholm County Council, The Gustafsson Foundation, The Soderberg Foundation, the National Cancer Institute of Canada, the Swedish Rheumatism Association, and The Wallenberg Foundation.	Arnett F C, 1990, Orthop Nurs, V9, P58, DOI 10.1097/00006416-199003000-00011; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Ciechanover A, 2000, J CELL BIOCHEM, P40; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Espinosa A, 2008, EXP CELL RES, V314, P3605, DOI 10.1016/j.yexcr.2008.09.011; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hennig J, 2005, J BIOL CHEM, V280, P33250, DOI 10.1074/jbc.M503066200; Hennig J, 2008, BIOINFORMATICS, V24, P1310, DOI 10.1093/bioinformatics/btn116; Hennig J, 2008, J MOL BIOL, V377, P431, DOI 10.1016/j.jmb.2008.01.005; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; JULKUNEN H, 1995, BRIT J RHEUMATOL, V34, P901; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Ottosson L, 2005, SCAND J IMMUNOL, V61, P109, DOI 10.1111/j.0300-9475.2005.01542.x; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Salomonsson S, 2002, ARTHRITIS RHEUM-US, V46, P1233, DOI 10.1002/art.10232; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Shloush J, 2011, J BIOL CHEM, V286, P4796, DOI 10.1074/jbc.M110.157669; Strandberg L, 2008, J CLIN IMMUNOL, V28, P220, DOI 10.1007/s10875-007-9157-0; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P415, DOI 10.1016/j.bbrc.2005.11.029; Wahren M, 1998, J AUTOIMMUN, V11, P29, DOI 10.1006/jaut.1997.0173; Wahren-Herlenius M, 1999, IMMUNOL TODAY, V20, P234, DOI 10.1016/S0167-5699(99)01458-9; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	46	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36478	36491		10.1074/jbc.M111.241786	http://dx.doi.org/10.1074/jbc.M111.241786			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21862588	Green Published, hybrid			2022-12-25	WOS:000296538300033
J	Cohen, CJ; Rebollo, R; Babovic, S; Dai, EL; Robinson, WP; Mager, DL				Cohen, Carla J.; Rebollo, Rita; Babovic, Sonja; Dai, Elizabeth L.; Robinson, Wendy P.; Mager, Dixie L.			Placenta-specific Expression of the Interleukin-2 (IL-2) Receptor beta Subunit from an Endogenous Retroviral Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIN-B RECEPTOR; NATURAL-KILLER-CELLS; LONG TERMINAL REPEAT; ALTERNATIVE PROMOTERS; MAMMALIAN GENOMES; IN-VITRO; METHYLATION; GENES; CHAIN; IDENTIFICATION	The long terminal repeat (LTR) sequences of endogenous retroviruses and retroelements contain promoter elements and are known to form chimeric transcripts with nearby cellular genes. Here we show that an LTR of the THE1D retroelement family has been domesticated as an alternative promoter of human IL2RB, the gene encoding the beta subunit of the IL-2 receptor. The LTR promoter confers expression specifically in the placental trophoblast as opposed to its native transcription in the hematopoietic system. Rather than sequence-specific determinants, DNA methylation was found to regulate transcription initiation and splicing efficiency in a tissue-specific manner. Furthermore, we detected the cytoplasmic signaling domain of the IL-2R beta protein in the placenta, suggesting that IL-2R beta undergoes preferential proteolytic cleavage in this tissue. These findings implicate novel functions for this cytokine receptor subunit in the villous trophoblast and reveal an intriguing example of ancient LTR exaptation to drive tissue-specific gene expression.	[Cohen, Carla J.; Rebollo, Rita; Babovic, Sonja; Dai, Elizabeth L.; Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Robinson, Wendy P.] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	British Columbia Cancer Agency; University of British Columbia; Child & Family Research Institute	Mager, DL (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	dmager@bccrc.ca	Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; Rebollo, Rita/0000-0002-8138-5082; Cohen, Carla/0000-0002-8398-0010	Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute for Health Research (to D. L. M.) with core support provided by the BC Cancer Agency.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Amash A, 2007, EUR CYTOKINE NETW, V18, P188, DOI 10.1684/ecn.2007.0102; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Belshaw R, 2007, J VIROL, V81, P9437, DOI 10.1128/JVI.02216-06; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; BOEHM KD, 1989, P NATL ACAD SCI USA, V86, P656, DOI 10.1073/pnas.86.2.656; Bulmer JN, 2010, INT J DEV BIOL, V54, P281, DOI 10.1387/ijdb.082763jb; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Fernandez-Botran R, 1999, CRIT REV CL LAB SCI, V36, P165, DOI 10.1080/10408369991239196; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Hamai Y, 1999, AM J REPROD IMMUNOL, V41, P153; Henderson KG, 1996, HUM GENET, V97, P650; HONDA M, 1990, J IMMUNOL, V145, P4131; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kilic M, 1999, AM J REPROD IMMUNOL, V41, P61; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Landry JR, 2003, J VIROL, V77, P7459, DOI 10.1128/JVI.77.13.7459-7466.2003; Landry JR, 2002, MOL BIOL EVOL, V19, P1934, DOI 10.1093/oxfordjournals.molbev.a004017; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; MAJORS J, 1990, CURR TOP MICROBIOL, V157, P49; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; de Oca PM, 2010, J BIOL CHEM, V285, P22050, DOI 10.1074/jbc.M109.093088; Murakami S, 2004, FRONT BIOSCI-LANDMRK, V9, P3085, DOI 10.2741/1461; MURANYI W, 1991, J VIROL, V65, P727, DOI 10.1128/JVI.65.2.727-735.1991; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Rein DT, 2003, CYTOKINE, V23, P119, DOI 10.1016/S1043-4666(03)00220-5; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Sugimoto J, 2009, REPROD SCI, V16, P1023, DOI 10.1177/1933719109336620; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Varela M, 2009, ANN NY ACAD SCI, V1178, P157, DOI 10.1111/j.1749-6632.2009.05002.x; Verma S, 2000, BIOL REPROD, V62, P959, DOI 10.1095/biolreprod62.4.959; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zygmunt M, 1998, AM J REPROD IMMUNOL, V40, P326	57	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35543	35552		10.1074/jbc.M111.227637	http://dx.doi.org/10.1074/jbc.M111.227637			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865161	Green Published, hybrid			2022-12-25	WOS:000295927100026
J	Torrelles, JB; Sieling, PA; Arcos, J; Knaup, R; Bartling, C; Rajaram, MVS; Stenger, S; Modlin, RL; Schlesinger, LS				Torrelles, Jordi B.; Sieling, Peter A.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Stenger, Steffen; Modlin, Robert L.; Schlesinger, Larry S.			Structural Differences in Lipomannans from Pathogenic and Nonpathogenic Mycobacteria That Impact CD1b-restricted T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROCOCCUS-LYSODEIKTICUS; ANTIGEN PRESENTATION; LIPOGLYCAN ANTIGENS; HUMAN MACROPHAGES; HOST-DEFENSE; BOVIS BCG; LIPOARABINOMANNAN; TUBERCULOSIS; RECOGNITION; CD1B	Mannosylated molecules on the Mycobacterium tuberculosis surface are important determinants in the immunopathogenesis of tuberculosis. To date, much attention has been paid to mannose-capped lipoarabinomannan, which mediates phagocytosis and intracellular trafficking of M. tuberculosis by engaging the macrophage mannose receptor and subsequently binds to intracellular CD1b molecules for presentation to T cells. Another important mannosylated lipoglycan on the M. tuberculosis surface is lipomannan (LM). Comparative structural detail of the LMs from virulent and avirulent strains is limited as is knowledge regarding their differential capacity to be recognized by the adaptive immune response. Here, we purified LM from the avirulent M. smegmatis and the virulent M. tuberculosis H37Rv, performed a comparative structural biochemical analysis, and addressed their ability to stimulate CD1b-restricted T cell clones. We found that M. tuberculosis H37Rv produces a large neutral LM (TB-LM); in contrast, M. smegmatis produces a smaller linear acidic LM (SmegLM) with a high succinate content. Correspondingly, TB-LM was not as efficiently presented to CD1b-restricted T cells as SmegLM. Thus, here we correlate the structure-function relationships for LMs with CD1b-restricted T cell responses and provide evidence that the structural features of TB-LM contribute to its diminished T cell responsiveness.	[Torrelles, Jordi B.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Arcos, Jesus; Knaup, Rose; Bartling, Craig; Rajaram, Murugesan V. S.; Schlesinger, Larry S.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Sieling, Peter A.; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Stenger, Steffen] Univ Hosp Ulm, Inst Med Microbiol & Hyg, D-89081 Ulm, Germany	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ulm University	Schlesinger, LS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, 460 W 12th Ave,Rm 1004, Columbus, OH 43210 USA.	larry.schlesinger@osumc.edu	Modlin, Robert L/M-7941-2014; Torrelles, Jordi/E-4204-2011; Rajaram, Murugesan/E-5203-2013	Modlin, Robert L/0000-0003-4720-031X; Rajaram, Murugesan/0000-0002-1515-1122	National Institutes of Health [AI052458, AI33004, AR040312, AI073856]; Parker B. Francis Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI033004, R21AI052458, R01AI033004, K99AI073856, R01AI052458, R00AI073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI052458 and AI33004 (to L. S. S.), AR040312 (to R. L. M. and P. A. S.), and AI073856. This work was also supported by a Parker B. Francis Fellowship (to J. B. T.).	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; DELL A, 1994, METHOD ENZYMOL, V230, P108; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Guerardel Y, 2003, J BIOL CHEM, V278, P36637, DOI 10.1074/jbc.M305427200; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; KASINRERK W, 1993, J IMMUNOL, V150, P579; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; LIM SH, 1981, BIOCHIM BIOPHYS ACTA, V638, P275, DOI 10.1016/0005-2728(81)90237-1; MEHRA V, 1992, J EXP MED, V175, P275, DOI 10.1084/jem.175.1.275; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; OWEN P, 1975, BIOCHEM BIOPH RES CO, V63, P875, DOI 10.1016/0006-291X(75)90649-X; PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550; PLESS DD, 1975, J BIOL CHEM, V250, P1319; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Schlesinger LS, 2008, HDB TUBERCULOSIS IMM, P1; Sieling PA, 2005, J IMMUNOL, V174, P2637, DOI 10.4049/jimmunol.174.5.2637; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; Vercellone A, 1998, FRONT BIOSCI-LANDMRK, V3, pE149; Zajonc DM, 2007, CURR OPIN STRUC BIOL, V17, P521, DOI 10.1016/j.sbi.2007.09.010	39	27	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35438	35446		10.1074/jbc.M111.232587	http://dx.doi.org/10.1074/jbc.M111.232587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859718	Green Published, hybrid			2022-12-25	WOS:000295927100015
J	Chen, GB; Tan, CS; Teh, BK; Lu, JH				Chen, Guobao; Tan, Carol Shurong; Teh, Boon King; Lu, Jinhua			Molecular Mechanisms for Synchronized Transcription of Three Complement C1q Subunit Genes in Dendritic Cells and Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPOTENT HEMATOPOIETIC PROGENITORS; APOPTOTIC CELLS; CYTOKINE PRODUCTION; INTERFERON-GAMMA; 1ST COMPONENT; IN-VIVO; DEFICIENCY; ACTIVATION; EXPRESSION	Hereditary homozygous C1q deficiency is rare, but it almost certainly causes systemic lupus erythematosus. On the other hand, C1q levels can decline in systemic lupus erythematosus patients without apparent C1q gene defects and the versatility in C1q production is a likely cause. As an 18-subunit protein, C1q is assembled in a 1:1:1 ratio from three different subunits. The three human C1q genes are closely bundled on chromosome 1 (C1qA-C1qC-C1qB) and their basal and IFN gamma-stimulated expression, largely restricted to macrophages and dendritic cells, is apparently synchronized. We cloned the three gene promoters and observed that although the C1qB promoter exhibited basal and IFN gamma-stimulated activities consistent with the endogenous C1qB gene, the activities of the cloned C1qA and C1qC promoters were suppressed by IFN gamma. To certain extents, these were corrected when the C1qB promoter was cloned at the 3' end across the luciferase reporter gene. A 53-bp element is essential to the activities of the C1qB promoter and the transcription factors PU.1 and IRF8 bound to this region. By chromatin immunoprecipitation, the C1qB promoter was co-precipitated with PU.1 and IRF8. shRNA knockdown of PU.1 and IRF8 diminished C1qB promoter response to IFN gamma. STAT1 instead regulated C1qB promoter through IRF8 induction. Collectively, our results reveal a novel transcriptional mechanism by which the expression of the three C1q genes is synchronized.	[Lu, Jinhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; Natl Univ Singapore, Immunol Programme, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Lu, JH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Blk MD4,5 Sci Dr 2, Singapore 117597, Singapore.	miclujh@nus.edu.sg	Chen, Guobao/D-1198-2017	Chen, Guobao/0000-0001-5853-5962; Lu, Jinhua/0000-0002-3699-9894	National Medical Research Council (Singapore) [NMRC/0950/2005, NMRC/1144/200]	National Medical Research Council (Singapore)(National Medical Research Council, Singapore)	This work was supported by National Medical Research Council (Singapore) Grants NMRC/0950/2005 and NMRC/1144/200.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Agostinis C, 2010, J IMMUNOL, V185, P4420, DOI 10.4049/jimmunol.0903215; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Baruah P, 2009, BLOOD, V113, P3485, DOI 10.1182/blood-2008-06-164392; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Cao WP, 2003, CARDIOVASC RES, V60, P175, DOI 10.1016/S0008-6363(03)00345-6; Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; COLTEN HR, 1986, CIBA F SYMP, V118, P141, DOI 10.1002/9780470720998.ch10; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; Edelbauer M, 2011, PEDIATR NEPHROL, V26, P401, DOI 10.1007/s00467-010-1720-x; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gordon MM, 2000, LUPUS, V9, P68, DOI 10.1177/096120330000900113; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; GREISMAN SG, 1987, J IMMUNOL, V138, P739; Hu YL, 2010, J BIOL CHEM, V285, P28777, DOI 10.1074/jbc.M110.131318; Kaneko T, 2006, EXP DERMATOL, V15, P308, DOI 10.1111/j.0906-6705.2006.00408.x; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Korb LC, 1997, J IMMUNOL, V158, P4525; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; LOOS M, 1980, J IMMUNOL, V124, P59; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; Lu J, 2008, CELL MOL IMMUNOL, V5, P9, DOI 10.1038/cmi.2008.2; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; MIRKOVITCH J, 1992, MOL CELL BIOL, V12, P1; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; MULLER W, 1978, J IMMUNOL, V121, P1578; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Petry F, 2005, IMMUNOGENETICS, V57, P566, DOI 10.1007/s00251-005-0023-z; Pickering M C, 2000, Adv Immunol, V76, P227; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; SCHWAEBLE W, 1995, J IMMUNOL, V155, P4971; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Teh BK, 2011, MOL IMMUNOL, V48, P1128, DOI 10.1016/j.molimm.2011.02.006; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wu FQ, 2011, RHEUMATOL INT, V31, P501, DOI 10.1007/s00296-009-1257-0; Yamada M, 2004, EUR J IMMUNOL, V34, P221, DOI 10.1002/eji.200324026; Yuzaki M, 2011, CURR OPIN NEUROBIOL, V21, P215, DOI 10.1016/j.conb.2011.01.010	49	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34941	34950		10.1074/jbc.M111.286427	http://dx.doi.org/10.1074/jbc.M111.286427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862594	hybrid, Green Published			2022-12-25	WOS:000295406300048
J	Baldi, A; Piccolo, MT; Boccellino, MR; Donizetti, A; Cardillo, I; La Porta, R; Quagliuolo, L; Spugnini, EP; Cordero, F; Citro, G; Menegozzo, M; Calogero, RA; Crispi, S				Baldi, Alfonso; Piccolo, Maria Teresa; Boccellino, Maria Rosaria; Donizetti, Aldo; Cardillo, Irene; La Porta, Raffaele; Quagliuolo, Lucio; Spugnini, Enrico P.; Cordero, Francesca; Citro, Gennaro; Menegozzo, Massimo; Calogero, Raffaele A.; Crispi, Stefania			Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; CYCLOOXYGENASE-2 COX-2; INHIBITOR; CANCER; EXPRESSION; SURVIVIN; GENE; IDENTIFICATION; CELECOXIB; GROWTH	Background: Malignant mesothelioma (MM) is a rare, highly aggressive tumor, associated to asbestos exposure. To date no chemotherapy regimen for MM has proven to be definitively curative, and new therapies for MM treatment need to be developed. We have previously shown in vivo that piroxicam/cisplatin combined treatment in MM, specifically acts on cell cycle regulation triggering apoptosis, with survival increase. Methodology/Principal Findings: We analyzed, at molecular level, the apoptotic increase caused by piroxicam/cisplatin treatment in MM cell lines. By means of genome wide analyses, we analyzed transcriptional gene deregulation both after the single piroxicam or cisplatin and the combined treatment. Here we show that apoptotic increase following combined treatment is mediated by p21, since apoptotic increase in piroxicam/cisplatin combined treatment is abolished upon p21 silencing. Conclusions/Significance: Piroxicam/cisplatin combined treatment determines an apoptosis increase in MM cells, which is dependent on the p21 expression. The results provided suggest that piroxicam/cisplatin combination might be tested in clinical settings in tumor specimens that express p21.	[Baldi, Alfonso; Boccellino, Maria Rosaria; La Porta, Raffaele; Quagliuolo, Lucio] Univ Naples 2, Sect Pathol, Dept Biochem, Naples, Italy; [Piccolo, Maria Teresa; Donizetti, Aldo; Crispi, Stefania] CNR, Inst Genet & Biophys, Gene Express & Human Mol Genet Lab, I-80125 Naples, Italy; [Cardillo, Irene; Spugnini, Enrico P.; Citro, Gennaro] Regina Elena Inst Canc Res, SAFU Dept, Rome, Italy; [Menegozzo, Massimo] Univ Naples 2, Dept Expt Med, Natl Mesothelioma Registry ReNaM, Campania Reg Operating Ctr COR, Naples, Italy; [Cordero, Francesca; Calogero, Raffaele A.] Univ Turin, Dept Clin & Biol Sci, Bioinformat & Genom Unit, Turin, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Universita della Campania Vanvitelli; University of Turin	Baldi, A (corresponding author), Univ Naples 2, Sect Pathol, Dept Biochem, Naples, Italy.	stefania.crispi@igb.cnr.it	Calogero, Raffaele/K-9428-2019; Cordero, Francesca/AAB-3655-2019; Baldi, Alfonso/ABG-2397-2021	Calogero, Raffaele/0000-0002-2848-628X; Cordero, Francesca/0000-0002-3143-3330; DONIZETTI, Aldo/0000-0002-4344-0140; QUAGLIUOLO, Lucio/0000-0003-0651-3264; La Porta, Raffaele/0000-0002-0569-369X; Baldi, Alfonso/0000-0002-8693-3842; Crispi, Stefania/0000-0002-7566-1554; BOCCELLINO, MARIAROSARIA/0000-0001-6989-010X	Campania Region [2072]; Italian Ministry of Health; "AiCC'' Grant; FUTURA-onlus Grant; Second University of Naples	Campania Region(Regione Campania); Italian Ministry of Health(Ministry of Health, Italy); "AiCC'' Grant; FUTURA-onlus Grant; Second University of Naples	This work was supported by Campania Region (Del. 12-14-06 n.2072) to Registro Regionale Mesoteliomi - COR Campania del RENAM to S. C. and M. M; by "Grant 2008'' of the Italian Ministry of Health and by a "AiCC'' Grant to E. P. S and G. C., and by a FUTURA-onlus Grant and a Second University of Naples Grant to A. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altorki NK, 2003, J CLIN ONCOL, V21, P2645, DOI 10.1200/JCO.2003.07.127; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baldi A, 2004, THORAX, V59, P428, DOI 10.1136/thx.2003.008912; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Caraglia M, 2007, INT J CANCER, V121, P2317, DOI 10.1002/ijc.22964; Catalano A, 2004, INT J CANCER, V109, P322, DOI 10.1002/ijc.11710; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Crispi S, 2010, CURR CANCER DRUG TAR, V10, P19, DOI 10.2174/156800910790980232; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Favaretto AG, 2003, CANCER, V97, P2791, DOI 10.1002/cncr.11405; Fischgrabe J, 2008, CURR CLIN PHARMACOL, V3, P85, DOI 10.2174/157488408784293732; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Gordon GJ, 2008, CANCER CHEMOTH PHARM, V61, P549, DOI 10.1007/s00280-007-0500-1; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Ishitsuka K, 2008, BRIT J HAEMATOL, V141, P598, DOI 10.1111/j.1365-2141.2008.07044.x; Kim KW, 2007, INT J RADIAT ONCOL, V67, P1519, DOI 10.1016/j.ijrobp.2006.12.018; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Leaper D J, 1980, Adv Prostaglandin Thromboxane Res, V6, P591; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Marrogi A, 2000, CANCER RES, V60, P3696; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pistolesi M, 2004, CHEST, V126, P1318, DOI 10.1378/chest.126.4.1318; Pruthi RS, 2004, BJU INT, V93, P275, DOI 10.1111/j.1464-410X.2004.04601.x; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Roe OD, 2010, LUNG CANCER, V67, P57, DOI 10.1016/j.lungcan.2009.03.016; Romagnoli S, 2009, AM J PATHOL, V174, P762, DOI 10.2353/ajpath.2009.080721; Sambrook J, 2001, MOL CLONING LAB MANU; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Spugnini EP, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-58; Spugnini EP, 2006, CLIN CANCER RES, V12, P6133, DOI 10.1158/1078-0432.CCR-06-1056; STOPPOLONI D, MOL CANC, V9, P27; Treasure T, 2004, BRIT MED J, V329, P424, DOI 10.1136/bmj.38176.444745.63; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Verdina A, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-27; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; VONHEYDEBRECK A, 2004, BIOCONDUCTOR PROJECT; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wu Z., 2004, STOCHASTIC MODELS IN, P98; Zaffaroni N, 2007, CELL ONCOL, V29, P453	51	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23569	10.1371/journal.pone.0023569	http://dx.doi.org/10.1371/journal.pone.0023569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858171	Green Submitted, gold, Green Published			2022-12-25	WOS:000294121300062
J	Dahlbom, SJ; Lagman, D; Lundstedt-Enkel, K; Sundstrom, LF; Winberg, S				Dahlbom, S. Josefin; Lagman, David; Lundstedt-Enkel, Katrin; Sundstrom, L. Fredrik; Winberg, Svante			Boldness Predicts Social Status in Zebrafish (Danio rerio)	PLOS ONE			English	Article							DOMINANT-SUBORDINATE RELATIONSHIPS; BRAIN SEROTONERGIC ACTIVITY; INDIVIDUAL-DIFFERENCES; STRESS RESPONSIVENESS; BEHAVIORAL SYNDROMES; AGONISTIC BEHAVIOR; SALVELINUS-ALPINUS; RAINBOW-TROUT; COPING STYLES; AGGRESSION	This study explored if boldness could be used to predict social status. First, boldness was assessed by monitoring individual zebrafish behaviour in (1) an unfamiliar barren environment with no shelter (open field), (2) the same environment when a roof was introduced as a shelter, and (3) when the roof was removed and an unfamiliar object (Lego (R) brick) was introduced. Next, after a resting period of minimum one week, social status of the fish was determined in a dyadic contest and dominant/subordinate individuals were determined as the winner/loser of two consecutive contests. Multivariate data analyses showed that males were bolder than females and that the behaviours expressed by the fish during the boldness tests could be used to predict which fish would later become dominant and subordinate in the ensuing dyadic contest. We conclude that bold behaviour is positively correlated to dominance in zebrafish and that boldness is not solely a consequence of social dominance.	[Dahlbom, S. Josefin; Lagman, David; Winberg, Svante] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lundstedt-Enkel, Katrin] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden; [Sundstrom, L. Fredrik] Uppsala Univ, Dept Anim Ecol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Dahlbom, SJ (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	josefin.dahlbom@neuro.uu.se	Lundstedt-Enkel, Katrin/A-8913-2012; Winberg, Svante/ABB-6458-2021; Sundstrom, Fred/E-6736-2011	Winberg, Svante/0000-0003-4252-3144; Sundstrom, Fred/0000-0002-3157-7289	Facias Foundation	Facias Foundation	The work was financially supported by the Facias Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basquill SP, 1998, CAN J ZOOL, V76, P770, DOI 10.1139/cjz-76-4-770; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bernier NJ, 2008, J ENDOCRINOL, V196, P637, DOI 10.1677/JOE-07-0568; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Filby AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-498; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Hoglund E, 2001, PHYSIOL BEHAV, V74, P381, DOI 10.1016/S0031-9384(01)00571-6; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P694, DOI 10.1016/S0003-3472(76)80083-8; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; JOHNSSON JI, 2005, BEHAV PHYSL FISH, P151; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Larson ET, 2001, BEHAV BRAIN RES, V121, P95, DOI 10.1016/S0166-4328(00)00393-4; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Overli O, 1998, CAN J ZOOL, V76, P1366, DOI 10.1139/cjz-76-7-1366; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Schjolden J, 2005, PHYSIOL BIOCHEM ZOOL, V78, P715, DOI 10.1086/432153; Schjolden J, 2005, HORM BEHAV, V48, P537, DOI 10.1016/j.yhbeh.2005.04.008; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Wright D, 2006, BEHAV GENET, V36, P271, DOI 10.1007/s10519-005-9029-4	41	140	140	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23565	10.1371/journal.pone.0023565	http://dx.doi.org/10.1371/journal.pone.0023565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858168	Green Published, gold			2022-12-25	WOS:000294121300060
J	Dong, J; Sutor, S; Jiang, GJ; Cao, YJ; Asmann, YW; Wigle, DA				Dong, Jie; Sutor, Shari; Jiang, Guoqian; Cao, Yajun; Asmann, Yan W.; Wigle, Dennis A.			c-Myc Regulates Self-Renewal in Bronchoalveolar Stem Cells	PLOS ONE			English	Article							EPITHELIAL PROGENITOR CELLS; TRANSGENIC MICE; LUNG-CANCER; BRANCHING MORPHOGENESIS; GENE-EXPRESSION; TENASCIN-C; MOUSE LUNG; MICRORNAS; DIFFERENTIATION; IDENTIFICATION	Background: Bronchoalveolar stem cells (BASCs) located in the bronchoalveolar duct junction are thought to regenerate both bronchiolar and alveolar epithelium during homeostatic turnover and in response to injury. The mechanisms directing self-renewal in BASCs are poorly understood. Methods: BASCs (Sca-1(+), CD34(+), CD31(-) and, CD45(-)) were isolated from adult mouse lung using FACS, and their capacity for self-renewal and differentiation were demonstrated by immunostaining. A transcription factor network of 53 genes required for pluripotency in embryonic stem cells was assessed in BASCs, Kras-initiated lung tumor tissue, and lung organogenesis by real-time PCR. c-Myc was knocked down in BASCs by infection with c-Myc shRNA lentivirus. Comprehensive miRNA and mRNA profiling for BASCs was performed, and significant miRNAs and mRNAs potentially regulated by c-Myc were identified. We explored a c-Myc regulatory network in BASCs using a number of statistical and computational approaches through two different strategies; 1) c-Myc/Max binding sites within individual gene promoters, and 2) miRNA-regulated target genes. Results: c-Myc expression was upregulated in BASCs and downregulated over the time course of lung organogenesis in vivo. The depletion of c-Myc in BASCs resulted in decreased proliferation and cell death. Multiple mRNAs and miRNAs were dynamically regulated in c-Myc depleted BASCs. Among a total of 250 dynamically regulated genes in c-Myc depleted BASCs, 57 genes were identified as potential targets of miRNAs through miRBase and TargetScan-based computational mapping. A further 88 genes were identified as potential downstream targets through their c-Myc binding motif. Conclusion: c-Myc plays a critical role in maintaining the self-renewal capacity of lung bronchoalveolar stem cells through a combination of miRNA and transcription factor regulatory networks.	[Dong, Jie; Sutor, Shari; Cao, Yajun; Wigle, Dennis A.] Mayo Clin, Dept Surg, Div Gen Thorac Surg, Rochester, MN 55905 USA; [Jiang, Guoqian; Asmann, Yan W.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Dong, J (corresponding author), Mayo Clin, Dept Surg, Div Gen Thorac Surg, Rochester, MN 55905 USA.	wigle.dennis@mayo.edu			NIH through the Mayo Clinic Cancer Center; International Society for Heart and Lung Transplantation (ISHLT)	NIH through the Mayo Clinic Cancer Center; International Society for Heart and Lung Transplantation (ISHLT)	Dr. Wigle is supported by an NIH K12 Career Development Award through the Mayo Clinic Cancer Center, and a Career Development Award from the International Society for Heart and Lung Transplantation (ISHLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Couillard M, 2009, DEV DYNAM, V238, P405, DOI 10.1002/dvdy.21841; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; DONG J, PLOS ONE, V5; Dong J, 2009, CANCER BIOL THER, V8, P312, DOI 10.4161/cbt.8.4.7522; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; GUERVILLY JH, HUM MOL GENET; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kaarteenaho-Wiik R, 2001, AM J RESP CELL MOL, V25, P341, DOI 10.1165/ajrcmb.25.3.4460; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morettin A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-319; MOROY T, 1991, ONCOGENE, V6, P1941; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reymann S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-46; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; YOUNG SL, 1994, DEV BIOL, V161, P615, DOI 10.1006/dbio.1994.1057; Zhang XJ, 2000, PROSTATE, V43, P278; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	51	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23707	10.1371/journal.pone.0023707	http://dx.doi.org/10.1371/journal.pone.0023707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858211	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300085
J	Bansal, R; Hulbert, S; Schemerhorn, B; Reese, JC; Whitworth, RJ; Stuart, JJ; Chen, MS				Bansal, Raman; Hulbert, Scot; Schemerhorn, Brandi; Reese, John C.; Whitworth, R. Jeff; Stuart, Jeffrey J.; Chen, Ming-Shun			Hessian Fly-Associated Bacteria: Transmission, Essentiality, and Composition	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; ACYRTHOSIPHON-PISUM; SYMBIOTIC BACTERIA; NITROGEN-FIXATION; APHIDS; HOST; REPRODUCTION; PROTEINS; INSECTS; DIPTERA	Plant-feeding insects have been recently found to use microbes to manipulate host plant physiology and morphology. Gall midges are one of the largest groups of insects that manipulate host plants extensively. Hessian fly (HF, Mayetiola destructor) is an important pest of wheat and a model system for studying gall midges. To examine the role of bacteria in parasitism, a systematic analysis of bacteria associated with HF was performed for the first time. Diverse bacteria were found in different developmental HF stages. Fluorescent in situ hybridization detected a bacteriocyte-like structure in developing eggs. Bacterial DNA was also detected in eggs by PCR using primers targeted to different bacterial groups. These results indicated that HF hosted different types of bacteria that were maternally transmitted to the next generation. Eliminating bacteria from the insect with antibiotics resulted in highmortality of HF larvae, indicating that symbiotic bacteria are essential for the insect to survive on wheat seedlings. A preliminary survey identified various types of bacteria associated with different HF stages, including the genera Enterobacter, Pantoea, Stenotrophomonas, Pseudomonas, Bacillus, Ochrobactrum, Acinetobacter, Alcaligenes, Nitrosomonas, Arcanobacterium, Microbacterium, Paenibacillus, and Klebsiella. Similar bacteria were also found specifically in HF-infested susceptible wheat, suggesting that HF larvae had either transmitted bacteria into plant tissue or brought secondary infection of bacteria to the wheat host. The bacteria associated with wheat seedlings may play an essential role in the wheat-HF interaction.	[Bansal, Raman; Reese, John C.; Whitworth, R. Jeff; Chen, Ming-Shun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Hulbert, Scot] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Schemerhorn, Brandi] Purdue Univ, USDA ARS, W Lafayette, IN 47907 USA; [Schemerhorn, Brandi; Stuart, Jeffrey J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Chen, Ming-Shun] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA	Kansas State University; Washington State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kansas State University; United States Department of Agriculture (USDA)	Bansal, R (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	ming-shun.chen@ars.usda.gov		Bansal, Raman/0000-0001-7133-0785	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan TN, BIOL GALL INSECTS; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; BOOSALIS MG, 1954, PHYTOPATHOLOGY, V44, P224; Brune A., 2003, ENCY INSECTS, P1102; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; BYERS RA, 1972, J ECON ENTOMOL, V65, P955, DOI 10.1093/jee/65.4.955; Chen MS, 2008, J INSECT PHYSIOL, V54, P1, DOI 10.1016/j.jinsphys.2007.07.007; Chen MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-296; Chen MS, 2009, J ECON ENTOMOL, V102, P1663, DOI 10.1603/029.102.0434; Chen MS, 2004, INSECT MOL BIOL, V13, P101, DOI 10.1111/j.1365-2583.2004.00465.x; Costa HS, 1996, ANN ENTOMOL SOC AM, V89, P694, DOI 10.1093/aesa/89.5.694; DENLINGER DL, 1975, ANN NY ACAD SCI, V266, P162, DOI 10.1111/j.1749-6632.1975.tb35097.x; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; FEBVAY G, 1995, ARCH INSECT BIOCHEM, V29, P45, DOI 10.1002/arch.940290106; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; GAGNE RJ, 1989, ANN ENTOMOL SOC AM, V82, P73, DOI 10.1093/aesa/82.1.73; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Giovanini MP, 2006, MOL PLANT MICROBE IN, V19, P1023, DOI 10.1094/MPMI-19-1023; HARRIS MO, 1989, ENTOMOL EXP APPL, V53, P17, DOI 10.1007/BF00369228; Harris MO, 2006, ANN ENTOMOL SOC AM, V99, P305, DOI 10.1603/0013-8746(2006)099[0305:VHFDCL]2.0.CO;2; Hatchett J. H., 1987, Agronomy, P625; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; HOWARD DJ, 1985, EVOLUTION, V39, P405, DOI 10.1111/j.1558-5646.1985.tb05677.x; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; Kneip C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-55; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Liu X, 2007, J CHEM ECOL, V33, P2171, DOI 10.1007/s10886-007-9382-2; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; Mittapalli O, 2006, J INSECT PHYSIOL, V52, P1143, DOI 10.1016/j.jinsphys.2006.08.007; Moran NA, 2001, P NATL ACAD SCI USA, V292, P1096; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; NOGGE G, 1976, EXPERIENTIA, V32, P995, DOI 10.1007/BF01933932; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Pauly PJ, 2002, ENV HIST, V7, P385; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; SASAKI T, 1991, J INSECT PHYSIOL, V37, P749, DOI 10.1016/0022-1910(91)90109-D; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schaefer C. W., 2000, HETEROPTERA EC IMPOR; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Stuart Jeffrey J., 2008, V1, P93, DOI 10.1007/978-3-540-73833-6_7; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Vorburger C, 2009, BIOL LETT; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; WILKINSON TL, 1995, J INSECT PHYSIOL, V41, P635, DOI 10.1016/0022-1910(95)00036-T; Wilkinson TL, 1996, ENTOMOL EXP APPL, V80, P279, DOI 10.1007/BF00194774; Wilkinson TL, 1998, COMP BIOCHEM PHYS A, V119, P871, DOI 10.1016/S1095-6433(98)00013-0; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Zhu L, 2008, MOL PLANT MICROBE IN, V21, P70, DOI 10.1094/MPMI-21-1-0070	59	42	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23170	10.1371/journal.pone.0023170	http://dx.doi.org/10.1371/journal.pone.0023170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858016	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500015
J	Kroner, A; Hamelin, G; Andrivon, D; Val, F				Kroener, Alexander; Hamelin, Gaelle; Andrivon, Didier; Val, Florence			Quantitative Resistance of Potato to Pectobacterium atrosepticum and Phytophthora infestans: Integrating PAMP-Triggered Response and Pathogen Growth	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; HYPERSENSITIVE RESPONSE; TUBER TISSUE; LATE BLIGHT; SUSCEPTIBILITY; ACTIVATION; EXPRESSION; INDUCTION; CULTIVARS; INFECTION	While the mechanisms underlying quantitative resistance of plants to pathogens are still not fully elucidated, the Pathogen-Associated Molecular Patterns (PAMPs)-triggered response model suggests that such resistance depends on a dynamic interplay between the plant and the pathogen. In this model, the pathogens themselves or elicitors they produce would induce general defense pathways, which in turn limit pathogen growth and host colonisation. It therefore suggests that quantitative resistance is directly linked to a common set of general host defense mechanisms, but experimental evidence is still inconclusive. We tested the PAMP-triggered model using two pathogens (Pectobacterium atrosepticum and Phytophthora infestans) differing by their infectious processes and five potato cultivars spanning a range of resistance levels to each pathogen. Phenylalanine ammonia-lyase (PAL) activity, used as a defense marker, and accumulation of phenolics were measured in tuber slices challenged with lipopolysaccharides from P. atrosepticum or a concentrated culture filtrate from P. infestans. PAL activity increased following treatment with the filtrate but not with lipopolysaccharides, and varied among cultivars. It was positively related to tuber resistance to P. atrosepticum, but negatively related to tuber resistance to P. infestans. It was also positively related to the accumulation of total phenolics. Chlorogenic acid, the main phenolic accumulated, inhibited growth of both pathogens in vitro, showing that PAL induction caused active defense against each of them. Tuber slices in which PAL activity had been induced before inoculation showed increased resistance to P. atrosepticum, but not to P. infestans. Our results show that inducing a general defense mechanism does not necessarily result in quantitative resistance. As such, they invalidate the hypothesis that the PAMP-triggered model alone can explain quantitative resistance. We thus designed a more complex model integrating physiological host response and a key pathogen life history trait, pathogen growth, to explain the differences between the two pathosystems.	[Kroener, Alexander; Hamelin, Gaelle; Andrivon, Didier; Val, Florence] Univ Rennes 1, INRA French Natl Inst Agr Res, UMR 1099 BiO3P, Rennes, France	INRAE; Universite de Rennes	Kroner, A (corresponding author), Univ Rennes 1, INRA French Natl Inst Agr Res, UMR 1099 BiO3P, Agrocampus Ouest, Rennes, France.	Florence.Val@agrocampus-ouest.fr	, AGROCAMPUS OUEST/O-6651-2016	, AGROCAMPUS OUEST/0000-0002-1800-4558	Agrocampus Ouest; Regional Council of Bretagne	Agrocampus Ouest; Regional Council of Bretagne(Region Bretagne)	Alexander Kroner is supported by a Ph.D. scholarship from Agrocampus Ouest and the Regional Council of Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andreu A, 2001, POTATO RES, V44, P1, DOI 10.1007/BF02360281; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Bariya HS, 2011, INDIAN J EXP BIOL, V49, P151; BHATIA SK, 1985, AM POTATO J, V62, P471, DOI 10.1007/BF02854520; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Desender S, 2006, PLANT BIOLOGY, V8, P636, DOI 10.1055/s-2006-924102; Desender S, 2007, CELL MICROBIOL, V9, P21, DOI 10.1111/j.1462-5822.2006.00831.x; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Folin O, 1927, J BIOL CHEM, V73, P627; FRIEND J, 1973, PHYSIOL PLANT PATHOL, V3, P495, DOI 10.1016/0048-4059(73)90060-X; GUPTA RP, 1976, INDIAN J EXP BIOL, V14, P365; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; KEENAN P, 1985, PHYSIOL PLANT PATHOL, V26, P343, DOI 10.1016/0048-4059(85)90009-8; KUMAR A, 1991, POTATO RES, V34, P9, DOI 10.1007/BF02358090; Kumar G, 2010, AGE INDUCED LOSS WOU, P1; Montarry J, 2007, FUNCT ECOL, V21, P603, DOI 10.1111/j.1365-2435.2007.01252.x; Navarre DA, 2011, FOOD CHEM IN PRESS; Niemira BA, 1999, PLANT DIS, V83, P469, DOI 10.1094/PDIS.1999.83.5.469; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; Pasco C., 2006, POTATO RES, V49, P91, DOI [DOI 10.1007/S11540-006-9006-1, 10.1007/s11540-006-9006-1]; R Development Core Team, 2009, R FDN STAT COMP; RUMEAU D, 1990, PLANT PHYSIOL, V93, P1134, DOI 10.1104/pp.93.3.1134; STOLLE K, 1984, POTATO RES, V27, P173, DOI 10.1007/BF02357462; Swiezynski KM, 2001, POTATO RES, V44, P97, DOI 10.1007/BF02360291; Trognitz F, 2002, MOL PLANT MICROBE IN, V15, P587, DOI 10.1094/MPMI.2002.15.6.587; Vanderplank JE., 1968, DIS RESISTANCE PLANT; VAYDA ME, 1992, AM POTATO J, V69, P239, DOI 10.1007/BF02853878; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; Wang X, 2008, PLANT PATHOL, V57, P1026, DOI 10.1111/j.1365-3059.2008.01866.x; Yang YL, 2011, AGR SCI CHINA, V10, P238, DOI 10.1016/S1671-2927(09)60310-2; YAO KN, 1995, PLANT CELL, V7, P1787, DOI 10.1105/tpc.7.11.1787; Yoshioka H, 1996, PLANT CELL PHYSIOL, V37, P81, DOI 10.1093/oxfordjournals.pcp.a028917; ZUCKER M, 1968, PLANT PHYSIOL, V43, P365, DOI 10.1104/pp.43.3.365	36	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23331	10.1371/journal.pone.0023331	http://dx.doi.org/10.1371/journal.pone.0023331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853112	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953400038
J	Dececchi, TA; Larsson, HCE				Dececchi, T. Alexander; Larsson, Hans C. E.			Assessing Arboreal Adaptations of Bird Antecedents: Testing the Ecological Setting of the Origin of the Avian Flight Stroke	PLOS ONE			English	Article							EARLY EVOLUTION; TREE-KANGAROO; SUBSTRATE USE; THEROPOD; DINOSAUR; MORPHOLOGY; FORELIMB; ANATOMY; CHINA; ARCHAEOPTERYX	The origin of avian flight is a classic macroevolutionary transition with research spanning over a century. Two competing models explaining this locomotory transition have been discussed for decades: ground up versus trees down. Although it is impossible to directly test either of these theories, it is possible to test one of the requirements for the trees-down model, that of an arboreal paravian. We test for arboreality in non-avian theropods and early birds with comparisons to extant avian, mammalian, and reptilian scansors and climbers using a comprehensive set of morphological characters. Non-avian theropods, including the small, feathered deinonychosaurs, and Archaeopteryx, consistently and significantly cluster with fully terrestrial extant mammals and ground-based birds, such as ratites. Basal birds, more advanced than Archaeopteryx, cluster with extant perching ground-foraging birds. Evolutionary trends immediately prior to the origin of birds indicate skeletal adaptations opposite that expected for arboreal climbers. Results reject an arboreal capacity for the avian stem lineage, thus lending no support for the trees-down model. Support for a fully terrestrial ecology and origin of the avian flight stroke has broad implications for the origin of powered flight for this clade. A terrestrial origin for the avian flight stroke challenges the need for an intermediate gliding phase, presents the best resolved series of the evolution of vertebrate powered flight, and may differ fundamentally from the origin of bat and pterosaur flight, whose antecedents have been postulated to have been arboreal and gliding.	[Dececchi, T. Alexander; Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	McGill University	Dececchi, TA (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	hans.ce.larsson@mcgill.ca	Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770; Dececchi, Thomas Alexander/0000-0001-7972-3866	Fonds Quebecois de la Recherche sur la Nature et les Technologies; Natural Sciences and Engineering Research Council [261796]; Canada Research Chair	Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This research was supported by a Fonds Quebecois de la Recherche sur la Nature et les Technologies doctoral fellowship to TAD, and a Natural Sciences and Engineering Research Council Discovery Grant (261796) and Canada Research Chair to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; ALEXANDER DE, 2010, P NATL ACAD SCI USA, P1; Alexander R, 2003, CLIMBING AND WALKING ROBOTS: AND THEIR SUPPORTING TECHNOLOGIES, P777; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bassarova M, 2009, J MAMM EVOL, V16, P1, DOI 10.1007/s10914-008-9093-7; Bennett MB, 2008, COMP BIOCHEM PHYS A, V150, P159, DOI 10.1016/j.cbpa.2006.06.011; Bennett S. Christopher, 1997, Historical Biology, V12, P265; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BINJEFFERY A, 2009, J VERTEBR PALEONTOL, V29, pA64; Bishop Nicolas, 1997, Proceedings of the Linnean Society of New South Wales, V117, P17; Blob RW, 2001, J EXP BIOL, V204, P1099; Brougham J, 2010, P NATL ACAD SCI USA, V107, pE155, DOI 10.1073/pnas.1004977107; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Callison G., 1984, Journal of Vertebrate Paleontology, V3, P200; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Cartmill M., 1985, P73; Cartmill M, 2002, ZOOL J LINN SOC-LOND, V136, P401, DOI 10.1046/j.1096-3642.2002.00038.x; CHATTERJEE S, 2004, STUDIES TRANSITION D, P251; Chatterjee S., 1997, THE RISE OF BIRDS; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chen XM, 2005, J MORPHOL, V266, P167, DOI 10.1002/jmor.10370; Chiappe Luis M., 2006, Journal of the Paleontological Society of Korea, V22, P133; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Clark James M., 1999, American Museum Novitates, V3265, P1; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; de Muizon Christian, 2003, P43; Dial KP, 2008, TRENDS ECOL EVOL, V23, P394, DOI 10.1016/j.tree.2008.03.005; Dial KP, 2008, NATURE, V451, P985, DOI 10.1038/nature06517; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; FARROW JO, 2002, PALEONTOLOGICAL SOC, V8, P251; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; FEENEY S, 1999, THESIS UMASS AMHERST; Fischer MS, 2010, ZOOLOGY, V113, P67, DOI 10.1016/j.zool.2009.07.001; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gebo Daniel L., 1993, Journal of Vertebrate Paleontology, V13, P125; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; GRAND TI, 1990, ANAT EMBRYOL, V182, P85; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEILMANN G, 1926, ORIGIN BIRDS; Heinrich RE, 2006, J VERTEBR PALEONTOL, V26, P422, DOI 10.1671/0272-4634(2006)26[422:PAOVMC]2.0.CO;2; HENDENSTROM A, 2009, BIOINSPIR BIOMIM, V4, P1; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Huxley TH, 1868, GEOLOGY MAGAZINE, V5, P357, DOI [10.1017/S0016756800207784, DOI 10.1017/S0016756800207784]; Hwang S.H., 2002, NEW SPECIMENS MICROR, P1; Iwaniuk AN, 1998, AUST J ZOOL, V46, P235, DOI 10.1071/ZO98004; Iwaniuk AN, 1999, CAN J ZOOL, V77, P1064, DOI 10.1139/cjz-77-7-1064; JENKINS FA, 1984, J MORPHOL, V182, P197, DOI 10.1002/jmor.1051820207; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Johansson LC, 2010, J R SOC INTERFACE, V7, P61, DOI 10.1098/rsif.2008.0541; Kear Benjamin P., 2008, P25, DOI 10.1007/978-1-4020-6997-0_2; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Lemelin P, 1999, J ZOOL, V247, P165, DOI 10.1017/S0952836999002046; Lemelin P, 2003, J ZOOL, V260, P423, DOI 10.1017/S0952836903003856; Li PP, 2007, P NATL ACAD SCI USA, V104, P5507, DOI 10.1073/pnas.0609552104; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; Mayr G, 2007, AUK, V124, P1450, DOI 10.1642/0004-8038(2007)124[1450:TFOART]2.0.CO;2; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; MEIRI S, 2010, J ZOOL, P1; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; Milner ARC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004591; Newell GR, 1999, BIOL CONSERV, V87, P1, DOI 10.1016/S0006-3207(98)00052-4; NORBERG RA, 1986, ORNIS SCAND, V17, P191, DOI 10.2307/3676828; NORBERG UM, 1979, PHILOS T ROY SOC B, V287, P131, DOI 10.1098/rstb.1979.0054; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; OSTROM JH, 1973, NATURE, V242, P136, DOI 10.1038/242136a0; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; PADIAN K, 2001, P INT S HON JH OSTR, P255; PERLE S, 1979, T SESTNAYA SOVETSKO, P45; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Pike AVL, 2004, J ZOOL, V262, P73, DOI 10.1017/S0952836903004382; Polly P. David, 2007, P245; Porfiri Juan D., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P545; PRIDEAUX GJ, 2008, J VERTEBR PALEONTOL, V225, P1, DOI DOI 10.1671/0272-4634(2008)28[463:ANPTDM]2.0.C0;2; PROCTERGRAY E, 1986, J MAMMAL, V67, P343, DOI 10.2307/1380888; Prum RO, 2002, AUK, V119, P1, DOI 10.1642/0004-8038(2002)119[0001:WOSCAT]2.0.CO;2; Reilly SM, 2000, J MORPHOL, V243, P173, DOI 10.1002/(SICI)1097-4687(200002)243:2<173::AID-JMOR6>3.3.CO;2-5; RENESTO S, 1994, J VERTEBR PALEONTOL, V14, P38, DOI 10.1080/02724634.1994.10011537; RICHARDSON FRANK, 1942, UNIV CALIFORNIA PUBL ZOOL, V46, P317; ROSE KD, 1987, SCIENCE, V236, P314, DOI 10.1126/science.3426662; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; Russell AP, 2001, COMP BIOCHEM PHYS A, V131, P89, DOI 10.1016/S1095-6433(01)00469-X; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Sasaki M, 2005, ANN ANAT, V187, P153, DOI 10.1016/j.aanat.2004.10.001; Schaller NU, 2009, J ANAT, V214, P830, DOI 10.1111/j.1469-7580.2009.01083.x; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; SERENO PC, 1992, SCIENCE, V255, P845, DOI 10.1126/science.255.5046.845; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; SERENO PC, 1991, SOC VERTEBRATE PALEO, V2, P1, DOI DOI 10.2307/3889336; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simpson G. G., 1944, P1; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; TAYLOR ME, 1976, J MORPHOL, V148, P227, DOI 10.1002/jmor.1051480208; Team RDC, 2010, R LANG ENV STAT COMP; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Van Valkenburgh B, 2002, PALEOBIOLOGY, V28, P527, DOI 10.1666/0094-8373(2002)028<0527:DAMPC>2.0.CO;2; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Warburton NM, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P137; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zanno LE, 2006, J VERTEBR PALEONTOL, V26, P636, DOI 10.1671/0272-4634(2006)26[636:TPGAFO]2.0.CO;2; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2006, ZOOL SCR, V35, P363, DOI 10.1111/j.1463-6409.2006.00234.x	128	36	40	1	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22292	10.1371/journal.pone.0022292	http://dx.doi.org/10.1371/journal.pone.0022292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857918	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300004
J	Wu, SG; Chang, YL; Lin, JW; Wu, CT; Chen, HY; Tsai, MF; Lee, YC; Yu, CJ; Shih, JY				Wu, Shang-Gin; Chang, Yih-Leong; Lin, Jou-Wei; Wu, Chen-Tu; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; Yu, Chong-Jen; Shih, Jin-Yuan			Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction	PLOS ONE			English	Article							CELL LUNG-CANCER; EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR MUTATIONS; TYROSINE KINASE; IMMUNOHISTOCHEMICAL DETECTION; GEFITINIB; ADENOCARCINOMA; TUMORS; CHEMOTHERAPY; INHIBITOR	Epidermal growth factor receptor (EGFR) is a novel target for therapy in subsets of non-small cell lung cancer, especially adenocarcinoma. Tumors with EGFR mutations showed good response to EGFR tyrosine kinase inhibitors (TKIs). We aimed to identify the discriminating capacity of immunohistochemical (IHC) scoring to detect L858R and E746-A750 deletion mutation in lung adenocarcinoma patients and predict EGFR TKIs response. Patients with surgically resected lung adenocarcinoma were enrolled. EGFR mutation status was genotyped by PCR and direct sequencing. Mutation-specific antibodies for L858R and E746-A750 deletion were used for IHC staining. Receiver operating characteristic (ROC) curves were used to determine the capacity of IHC, including intensity and/or quickscore (Q score), in differentiating L858R and E746-A750 deletion. We enrolled 143 patients during September 2000 to May 2009. Logistic-regression-model-based scoring containing both L858R Q score and total EGFR expression Q score was able to obtain a maximal area under the curve (AUC: 0.891) to differentiate the patients with L858R. Predictive model based on IHC Q score of E746-A750 deletion and IHC intensity of total EGFR expression reached an AUC of 0.969. The predictive model of L858R had a significantly higher AUC than L858R intensity only (p = 0.036). Of the six patients harboring complex EGFR mutations with classical mutation patterns, five had positive IHC staining. For EGFR TKI treated cancer recurrence patients, those with positive mutation-specific antibody IHC staining had better EGFR TKI response (p = 0.008) and longer progression-free survival (p = 0.012) than those without. In conclusion, total EGFR expression should be included in the IHC interpretation of L858R. After adjusting for total EGFR expression, the scoring method decreased the false positive rate and increased diagnostic power. According to the scoring method, the IHC method is useful to predict the clinical outcome and refine personalized therapy.	[Wu, Shang-Gin; Lin, Jou-Wei] Natl Taiwan Univ Hosp, Coll Med, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Lee, Yung-Chie] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Meng-Feng] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan; [Yu, Chong-Jen; Shih, Jin-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Da Yeh University; National Taiwan University; National Taiwan University Hospital	Wu, SG (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan.	jyshih@ntu.edu.tw	Wu, Shang-Gin/X-6183-2018; Chen, Hsuan-Yu/AAE-8428-2019	Yu, Chong-Jen/0000-0001-5664-9392; WU, CHEN-TU/0000-0001-8458-4119; CHANG, YIH-LEONG/0000-0001-5309-0554	National Science Council, Taiwan [98-2314-B-002-117-MY3, 98-2628-B-002-087-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from the National Science Council, Taiwan (98-2314-B-002-117-MY3 and 98-2628-B-002-087-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES DM, 1993, HUM PATHOL, V24, P469, DOI 10.1016/0046-8177(93)90158-D; BRAMBILLA E, 2004, PATHOLOGY GENETICS T, P9; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; DAVIES RL, 1980, P NATL ACAD SCI-BIOL, V77, P4188, DOI 10.1073/pnas.77.7.4188; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gow CH, 2009, ANN ONCOL, V20, P696, DOI 10.1093/annonc/mdn679; Ilie MI, 2010, VIRCHOWS ARCH, V457, P483, DOI 10.1007/s00428-010-0963-z; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; KOZU Y, LUNG CANC IN PRESS; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shih JY, 2006, INT J CANCER, V118, P963, DOI 10.1002/ijc.21458; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Wu JY, 2010, LUNG CANCER, V67, P348, DOI 10.1016/j.lungcan.2009.04.018; Wu SG, 2008, ONCOLOGIST, V13, P1276, DOI 10.1634/theoncologist.2008-0093; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739	24	41	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23303	10.1371/journal.pone.0023303	http://dx.doi.org/10.1371/journal.pone.0023303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858063	gold, Green Published, Green Submitted			2022-12-25	WOS:000293774300030
J	Liu, Q; Jiang, HY; Liu, ZJ; Wang, Y; Zhao, MN; Hao, CY; Feng, SA; Guo, HY; Xu, B; Yang, QF; Gong, YQ; Shao, CS				Liu, Qiao; Jiang, Haiyan; Liu, Zhaojian; Wang, Yu; Zhao, Minnan; Hao, Chunyan; Feng, Shuai; Guo, Haiyang; Xu, Bing; Yang, Qifeng; Gong, Yaoqin; Shao, Changshun			Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51	PLOS ONE			English	Article							HUMAN HEPATOMA-CELLS; LUNG-CANCER; CYCLE ARREST; TUMOR-CELLS; CARCINOMA-CELLS; APOPTOSIS; EXPRESSION; PATHWAY; DNA; OVEREXPRESSION	Background: Esophageal squamous cell carcinomas (ESCC) have poor prognosis. While combined modality of chemotherapy and radiotherapy increases survival, most patients die within five years. Development of agents that confer cancer cell-specific chemo- and radiosensitivity may improve the therapy of ESCC. We here reported the discovery of berberine as a potent radiosensitizing agent on ESCC cells. Principal Findings: Berberine at low concentrations (< 15 mu M) substantially radiosensitized ESCC cells. X-ray induced DNA double-strand breaks (DSBs) persist longer in ESCC cells pretreated with berberine. Berberine pretreatment led to a significant downregulation of RAD51, a key player in homologous recombination repair, in ESCC cells, but not in nonmalignant human cells. Downregulation of RAD51 by RNA interference similarly radiosensitized the cancer cells, and, conversely, introduction of exogenous RAD51 was able to significantly counteract the radiosensitizing effect of berberine, thus establishing RAD51 as a key determinant in radiation sensitivity. We also observed that RAD51 was commonly overexpressed in human ESCC tissues, suggesting that it is necessary to downregulate RAD51 to achieve high radio- or chemotherapeutic efficacy of ESCC in clinic, because overexpression of RAD51 is known to confer radio- and chemoresistance. Conclusions/Significance: Berberine can effectively downregulate RAD51 in conferring radiosensitivity on esophageal cancer cells. Its clinical application as an adjuvant in chemotherapy and radiotherapy of esophageal cancers should be explored.	[Liu, Qiao; Jiang, Haiyan; Liu, Zhaojian; Wang, Yu; Zhao, Minnan; Feng, Shuai; Guo, Haiyang; Xu, Bing; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Liu, Qiao; Jiang, Haiyan; Liu, Zhaojian; Wang, Yu; Zhao, Minnan; Feng, Shuai; Guo, Haiyang; Xu, Bing; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China; [Hao, Chunyan] Shandong Univ, Dept Pathol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Liu, Q (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China.	yxg8@sdu.edu.cn; changshun.shao@gmail.com	yang, qiang/GYJ-0971-2022; Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342; Yang, Qifeng/0000-0003-0576-8513; guo, haiyang/0000-0001-5503-6922	National Natural Science Foundation of China; Ministry of Science and Technology of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The study was funded by National Natural Science Foundation of China; Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Chen FQ, 1997, MUTAT RES-DNA REPAIR, V384, P205, DOI 10.1016/S0921-8777(97)00020-7; Chen RS, 2009, EXP CELL RES, V315, P2658, DOI 10.1016/j.yexcr.2009.06.002; Chen TC, 2009, INT J ONCOL, V34, P1681, DOI 10.3892/ijo_00000299; Chendil D, 2004, ONCOGENE, V23, P1599, DOI 10.1038/sj.onc.1207284; Choudhury A, 2009, MOL CANCER THER, V8, P203, DOI 10.1158/1535-7163.MCT-08-0959; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; EARLAM R, 1980, BRIT J SURG, V67, P457, DOI 10.1002/bjs.1800670702; EARLAM R, 1980, BRIT J SURG, V67, P381, DOI 10.1002/bjs.1800670602; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; Hur JM, 2009, J CELL BIOCHEM, V107, P955, DOI 10.1002/jcb.22198; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Javvadi P, 2008, MOL PHARMACOL, V73, P1491, DOI 10.1124/mol.107.043554; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Ko JC, 2008, CARCINOGENESIS, V29, P1448, DOI 10.1093/carcin/bgn130; Ko JC, 2010, BIOCHEM PHARMACOL, V79, P655, DOI 10.1016/j.bcp.2009.09.024; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kvols LK, 2005, J NUCL MED, V46, p187S; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin CC, 2006, ANTICANCER RES, V26, P1097; Lin CC, 2007, ANTICANCER RES, V27, P3371; Lin JP, 2006, WORLD J GASTROENTERO, V12, P21, DOI 10.3748/wjg.v12.i1.21; Lin SK, 2004, MOL PHARMACOL, V66, P612; Liu ZJ, 2009, MUTAT RES-FUND MOL M, V662, P75, DOI 10.1016/j.mrfmmm.2008.12.009; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Mitra A, 2009, HISTOPATHOLOGY, V55, P696, DOI 10.1111/j.1365-2559.2009.03448.x; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Pandey MK, 2008, CANCER RES, V68, P5370, DOI 10.1158/0008-5472.CAN-08-0511; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Raderschall E, 2002, CANCER RES, V62, P219; Russell JS, 2003, CANCER RES, V63, P7377; Sanders MM, 1998, BIOCHEM PHARMACOL, V56, P1157, DOI 10.1016/S0006-2952(98)00243-3; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tsai MS, 2010, J PHARMACOL EXP THER, V335, P830, DOI 10.1124/jpet.110.173146; Yamamoto A, 1996, MOL GEN GENET, V251, P1; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Zhang XL, 2010, CANCER RES, V70, P9895, DOI 10.1158/0008-5472.CAN-10-1546; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404	47	58	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23427	10.1371/journal.pone.0023427	http://dx.doi.org/10.1371/journal.pone.0023427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858113	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300028
J	Song, XR; Shen, JL; Wen, HQ; Zhong, ZR; Luo, QL; Chu, DY; Qi, Y; Xu, YH; Wei, W				Song, Xiaorong; Shen, Jilong; Wen, Huiqin; Zhong, Zhengrong; Luo, Qinli; Chu, Deyong; Qi, Yao; Xu, Yuanhong; Wei, Wei			Impact of Schistosoma japonicum Infection on Collagen-Induced Arthritis in DBA/1 Mice: A Murine Model of Human Rheumatoid Arthritis	PLOS ONE			English	Article							REGULATORY T-CELLS; TRICHURIS-SUIS THERAPY; HELMINTH INFECTION; AUTOIMMUNE-DISEASE; MANSONI INFECTION; TH2 POLARIZATION; DENDRITIC CELLS; INFLAMMATION; INTERPLAY; RESPONSES	Background: The hygiene hypothesis suggests that helminth infections prevent a range of autoimmune diseases. Methodology/Principal Findings: To investigate the effects of S. japonicum infection on collagen-induced arthritis (CIA), male DBA/1 mice were challenged with unisexual or bisexual S. japonicum cercariae two weeks prior to bovine type II collagen (CII) immunization or at the onset of CIA. S. japonicum infection prior to CII immunization significantly reduced the severity of CIA. ELISA (enzyme linked immunosorbent assay) showed that the levels of anti-CII IgG and IgG2a were reduced in prior schistosome-infected mice, while anti-CII IgG1 was elevated. Splenocyte proliferation against both polyclonal and antigen-specific stimuli was reduced by prior schistosome infection as measured by tritiated thymidine incorporation ((3)H-TdR). Cytokine profiles and CD4(+) T cells subpopulation analysis by ELISA and flow cytometry (FCM) demonstrated that prior schistosome infection resulted in a significant down-regulation of pro-inflammatory cytokines (IFN-gamma, TNF-alpha, IL-1 beta and IL-6) and Th1 cells, together with up-regulation of the anti-inflammatory cytokine IL-10 and Th2 cells. Interestingly, the expansion of Treg cells and the reduction of Th17 cells were only observed in bisexually infected mice. In addition, prior schistosome infection notably reduced the expression of pro-inflammatory cytokines and receptor activator of NF-kappa B ligand (RANKL) in the inflamed joint. However, the disease was exacerbated at one week after infection when established CIA mice were challenged with bisexual cercariae. Conclusion/Significance: Our data provide direct evidence that the Th2 response evoked by prior S. japonicum infection can suppress the Th1 response and pro-inflammatory mediator and that bisexual infection with egg-laying up-regulates the Treg response and down-regulates the Th17 response, resulting in an amelioration of autoimmune arthritis. The beneficial effects might depend on the establishment of a Th2-dominant response rather than the presence of the eggs. Our results suggest that anti-inflammatory molecules from the parasite could treat autoimmune diseases.	[Song, Xiaorong; Shen, Jilong; Wei, Wei] Anhui Med Univ, Inst Clin Pharmacol, Hefei, Anhui, Peoples R China; [Song, Xiaorong; Shen, Jilong; Wen, Huiqin; Zhong, Zhengrong; Luo, Qinli; Chu, Deyong; Qi, Yao; Xu, Yuanhong] Anhui Med Univ, Key Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Song, Xiaorong; Shen, Jilong; Wen, Huiqin; Zhong, Zhengrong; Luo, Qinli; Chu, Deyong; Qi, Yao; Xu, Yuanhong] Anhui Med Univ, Key Lab Zoonoses, Hefei, Anhui, Peoples R China; [Song, Xiaorong] Anhui Prov Hosp, Inst Anhui Cardiovasc Res, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Song, XR (corresponding author), Anhui Med Univ, Inst Clin Pharmacol, Hefei, Anhui, Peoples R China.	shenjilong53@126.com			National Nature Science Foundation of China [81071376, 30872209]; Research Fund for the Doctoral Program of Higher Education of China [200803660003]; Provincial Natural Science Foundation of Anhui [090413089]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Provincial Natural Science Foundation of Anhui	This work was funded by: the National Nature Science Foundation of China (No. 81071376, No. 30872209) http://www.nsfc.gov.cn/Portal0/default124.htm; the Research Fund for the Doctoral Program of Higher Education of China (No. 200803660003) http://www.cutech.edu.cn/cn/index.htm; and the Provincial Natural Science Foundation of Anhui (No. 090413089) http://www.ahinfo.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisakwattana P, 2009, ADV EXP MED BIOL, V666, P95; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Rocha FAC, 2008, INFECT IMMUN, V76, P2736, DOI 10.1128/IAI.01085-07; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Fraga LAD, 2010, J INFECT DIS, V201, P464, DOI 10.1086/649841; DeMarco R, 2009, DRUG DISCOV TODAY, V14, P472, DOI 10.1016/j.drudis.2009.01.011; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Esensten JH, 2009, NAT REV RHEUMATOL, V5, P560, DOI 10.1038/nrrheum.2009.183; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; GERMANN T, 1995, P NATL ACAD SCI USA, V92, P4823, DOI 10.1073/pnas.92.11.4823; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Layland LE, 2010, J IMMUNOL, V184, P713, DOI 10.4049/jimmunol.0901435; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Liu P, 2010, PARASITE IMMUNOL, V32, P57, DOI 10.1111/j.1365-3024.2009.01161.x; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Reddy A, 2009, PARASITOL RES, V104, P217, DOI 10.1007/s00436-008-1297-5; Rutitzky LI, 2009, EUR J IMMUNOL, V39, P2470, DOI 10.1002/eji.200939325; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2010, MICROBES INFECT, V12, P881, DOI 10.1016/j.micinf.2010.06.001; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Williams Richard O, 2007, Methods Mol Biol, V361, P265; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x; Zaccone P, 2008, TRENDS PARASITOL, V24, P35, DOI 10.1016/j.pt.2007.10.006; Zaccone P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795210; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	41	37	66	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23453	10.1371/journal.pone.0023453	http://dx.doi.org/10.1371/journal.pone.0023453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858123	Green Submitted, Green Published, gold			2022-12-25	WOS:000293773300031
J	McMillan, DJ; Kaul, SY; Bramhachari, PV; Smeesters, PR; Vu, T; Karmarkar, MG; Shaila, MS; Sriprakash, KS				McMillan, David J.; Kaul, Santosh Y.; Bramhachari, P. V.; Smeesters, Pierre R.; Vu, Therese; Karmarkar, M. G.; Shaila, Melkote S.; Sriprakash, Kadaba S.			Recombination Drives Genetic Diversification of Streptococcus dysgalactiae Subspecies equisimilis in a Region of Streptococcal Endemicity	PLOS ONE			English	Article							BETA-HEMOLYTIC STREPTOCOCCI; GROUP-A; HORIZONTAL TRANSFER; EMM TYPES; GROUP-C; PYOGENES; INFECTIONS; DIVERSITY; DISEASE; PROTEIN	Infection of the skin or throat by Streptococcus dysgalactiae subspecies equisimilis (SDSE) may result in a number of human diseases. To understand mechanisms that give rise to new genetic variants in this species, we used multi-locus sequence typing (MLST) to characterise relationships in the SDSE population from India, a country where streptococcal disease is endemic. The study revealed Indian SDSE isolates have sequence types (STs) predominantly different to those reported from other regions of the world. Emm-ST combinations in India are also largely unique. Split decomposition analysis, the presence of emm-types in unrelated clonal complexes, and analysis of phylogenetic trees based on concatenated sequences all reveal an extensive history of recombination within the population. The ratio of recombination to mutation (r/m) events (11:1) and per site r/m ratio (41:1) in this population is twice as high as reported for SDSE from non-endemic regions. Recombination involving the emm-gene is also more frequent than recombination involving housekeeping genes, consistent with diversification of M proteins offering selective advantages to the pathogen. Our data demonstrate that genetic recombination in endemic regions is more frequent than non-endemic regions, and gives rise to novel local SDSE variants, some of which may have increased fitness or pathogenic potential.	[McMillan, David J.; Sriprakash, Kadaba S.] Queensland Inst Med Res, Bacterial Pathogenesis Lab, Brisbane, Qld 4006, Australia; [McMillan, David J.; Vu, Therese] Griffith Med Res Coll, Brisbane, Qld, Australia; [Kaul, Santosh Y.; Karmarkar, M. G.] King Edward Mem Hosp, Dept Microbiol, Bombay, Maharashtra, India; [Bramhachari, P. V.; Shaila, Melkote S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Smeesters, Pierre R.] Univ Libre Bruxelles, Fac Sci, Inst Biol & Med Mol, Lab Genet & Physiol Bacterienne, Brussels, Belgium	QIMR Berghofer Medical Research Institute; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Indian Institute of Science (IISC) - Bangalore; Universite Libre de Bruxelles	McMillan, DJ (corresponding author), Queensland Inst Med Res, Bacterial Pathogenesis Lab, Brisbane, Qld 4006, Australia.	david.mcmillan@qimr.edu.au	McMillan, David/P-5582-2016; Smeesters, Pierre/I-7723-2012; Chari, Pallaval Veera Bramha/AAL-3587-2020	McMillan, David/0000-0002-9339-0639; Smeesters, Pierre/0000-0002-2642-9919; Chari, Pallaval Veera Bramha/0000-0003-0084-4652; Sriprakash, Kadaba/0000-0001-7844-323X; Vu, Therese/0000-0003-2831-2957; Vu, Therese/0000-0002-5924-9359	Australian Government National Health and Medical Research Council; National and International Alliance Program of Queensland, Australia; India-Australia Strategic Research Fund; Department of Biotechnology, India	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National and International Alliance Program of Queensland, Australia; India-Australia Strategic Research Fund; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by an Australian Government National Health and Medical Research Council, National and International Alliance Program of Queensland, Australia, and India-Australia Strategic Research Fund and Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, J CLIN MICROBIOL, V47, P2046, DOI 10.1128/JCM.00246-09; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bramhachari PV, 2010, J MED MICROBIOL, V59, P220, DOI 10.1099/jmm.0.015644-0; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Broyles LN, 2009, CLIN INFECT DIS, V48, P706, DOI 10.1086/597035; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chhatwal G. S., 2006, Gram-positive pathogens, P213; Cohen-Poradosu R, 2004, EMERG INFECT DIS, V10, P1455, DOI 10.3201/eid1008.030840; Davies MR, 2007, CLIN INFECT DIS, V44, P1442, DOI 10.1086/516780; Davies MR, 2009, J BACTERIOL, V191, P2257, DOI 10.1128/JB.01624-08; Dey N, 2005, CLIN INFECT DIS, V40, P46, DOI 10.1086/426443; Efstratiou A, 1997, J APPL MICROBIOL, V83, pS72, DOI 10.1046/j.1365-2672.83.s1.8.x; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hartas J, 1998, J CLIN MICROBIOL, V36, P1428, DOI 10.1128/JCM.36.5.1428-1429.1998; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikebe T, 2004, EPIDEMIOL INFECT, V132, P145, DOI 10.1017/S0950268803001262; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopardo HA, 2005, J CLIN MICROBIOL, V43, P802, DOI 10.1128/JCM.43.2.802-807.2005; McDonald M, 2007, EMERG INFECT DIS, V13, P1694, DOI 10.3201/eid1311.061258; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; McMillan DJ, 2010, EUR J CLIN MICROBIOL, V29, P585, DOI 10.1007/s10096-010-0899-x; McMillan DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011741; Menon T, 2008, J MED MICROBIOL, V57, P540, DOI 10.1099/jmm.0.47726-0; Padmavati S, 2001, HEART, V86, P127, DOI 10.1136/heart.86.2.127; Panchaud A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-198; Pinho MD, 2006, J CLIN MICROBIOL, V44, P841, DOI 10.1128/JCM.44.3.841-846.2006; Shet Anita, 2004, Indian Journal of Pediatrics, V71, P41, DOI 10.1007/BF02725655; SIMPSON WJ, 1992, INFECT IMMUN, V60, P1890, DOI 10.1128/IAI.60.5.1890-1893.1992; SKOGBERG K, 1988, SCAND J INFECT DIS, V20, P119, DOI 10.3109/00365548809032427; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Sriprakash KS, 1996, MICROB PATHOGENESIS, V20, P275, DOI 10.1006/mpat.1996.0026; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Towers RJ, 2004, J CLIN MICROBIOL, V42, P5357, DOI 10.1128/JCM.42.11.5357-5361.2004	42	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21346	10.1371/journal.pone.0021346	http://dx.doi.org/10.1371/journal.pone.0021346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857905	Green Published, Green Accepted, gold			2022-12-25	WOS:000293558900006
J	Sarkany, Z; Ikonen, TP; Ferreira-da-Silva, F; Saraiva, MJ; Svergun, D; Damas, AM				Sarkany, Zsuzsa; Ikonen, Teemu P.; Ferreira-da-Silva, Frederico; Saraiva, Maria Joao; Svergun, Dmitri; Damas, Ana Margarida			Solution Structure of the Soluble Receptor for Advanced Glycation End Products (sRAGE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE SCATTERING DATA; CELL-SURFACE RECEPTOR; X-RAY-SCATTERING; RAGE; PROTEINS; BLOCKADE; RECOGNITION; ENDPRODUCTS; ACTIVATION; EXPRESSION	The receptor for advanced glycation end products (RAGE) is a multiligand cell surface receptor involved in various human diseases, as it binds to numerous molecules and proteins that modulate the activity of other proteins. Elucidating the three-dimensional structure of this receptor is therefore most important for understanding its function during activation and cellular signaling. The major alternative splice product of RAGE comprises its extracellular region that occurs as a soluble protein (sRAGE). Although the structures of sRAGE domains were available, their assembly into the functional full-length protein remained unknown. We observed that the protein has concentration-dependent oligomerization behavior, and this is also mediated by the presence of Ca2+ ions. Moreover, using synchrotron small angle x-ray scattering, the solution structure of human sRAGE was determined in the monomeric and dimeric forms. The model for the monomer displays a J-like shape, whereas the dimer is formed through the association of the two N-terminal domains and has an elongated structure. These results provide insights into the assembly of the RAGE homodimer, which is essential for signal transduction, and the sRAGE:RAGE heterodimer that leads to blockage of the receptor signaling, paving the way for the design of therapeutic strategies for a large number of different pathologies.	[Svergun, Dmitri] EMBL Hamburg, DESY, Hamburg Outstn, D-22603 Hamburg, Germany; [Sarkany, Zsuzsa; Ferreira-da-Silva, Frederico; Saraiva, Maria Joao; Damas, Ana Margarida] Univ Porto, Inst Mol & Cell Biol, P-4150180 Oporto, Portugal; [Saraiva, Maria Joao; Damas, Ana Margarida] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Universidade do Porto; Universidade do Porto	Svergun, D (corresponding author), EMBL Hamburg, DESY, Hamburg Outstn, Bldg 25A,Notkestr 85, D-22603 Hamburg, Germany.	svergun@embl-hamburg.de; amdamas@ibmc.up.pt	Silva, Frederico F/K-3820-2013; Sarkany, Zsuzsa/K-1298-2013; Saraiva, Maria João/K-3907-2013	Silva, Frederico F/0000-0002-8890-4228; Sarkany, Zsuzsa/0000-0001-9185-8210; Saraiva, Maria João/0000-0002-3360-6899; Svergun, Dmitri/0000-0003-0830-5696	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-NEU/69123/2006, SFRH/BPD/63465/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Grants PTDC/SAU-NEU/69123/2006 and SFRH/BPD/63465/2009 (to Z.S.) from Fundacao para a Ciencia e Tecnologia, Portugal.	[Anonymous], 2004, ZETASIZER NANOSERIES; Berne B. J, 2000, DYNAMIC LIGHT SCATTE, P10; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Cohn E. J., 1943, PROTEINS AMINOACIDS, P153; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Monteiro FA, 2006, FEBS LETT, V580, P3451, DOI 10.1016/j.febslet.2006.05.020; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Sevillano N, 2009, J BIOCHEM, V145, P21, DOI 10.1093/jb/mvn137; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Zhou L., 2010, MRK70401 MALV INSTR; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	35	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37525	37534		10.1074/jbc.M111.223438	http://dx.doi.org/10.1074/jbc.M111.223438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21865159	Green Published, hybrid			2022-12-25	WOS:000296542400051
J	Zheng, Y; Anderson, S; Zhang, YF; Garavito, RM				Zheng, Yi; Anderson, Spencer; Zhang, Yanfeng; Garavito, R. Michael			The Structure of Sucrose Synthase-1 from Arabidopsis thaliana and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO PHOSPHORYLATION; SOLANUM-TUBEROSUM L.; ESCHERICHIA-COLI; CELL-WALL; MEMBRANE ASSOCIATION; CRYSTAL-STRUCTURE; METABOLISM; LOCALIZATION; ENZYMES; GLYCOSYLTRANSFERASES	Sucrose transport is the central system for the allocation of carbon resources in vascular plants. During growth and development, plants control carbon distribution by coordinating sites of sucrose synthesis and cleavage in different plant organs and different cellular locations. Sucrose synthase, which reversibly catalyzes sucrose synthesis and cleavage, provides a direct and reversible means to regulate sucrose flux. Depending on the metabolic environment, sucrose synthase alters its cellular location to participate in cellulose, callose, and starch biosynthesis through its interactions with membranes, organelles, and cytoskeletal actin. The x-ray crystal structure of sucrose synthase isoform 1 from Arabidopsis thaliana (AtSus1) has been determined as a complex with UDP-glucose and as a complex with UDP and fructose, at 2.8- and 2.85-angstrom resolutions, respectively. The AtSus1 structure provides insights into sucrose catalysis and cleavage, as well as the regulation of sucrose synthase and its interactions with cellular targets.	[Zheng, Yi; Zhang, Yanfeng; Garavito, R. Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Anderson, Spencer] Northwestern Univ, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Michigan State University; Northwestern University	Garavito, RM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	garavito@msu.edu	zheng, yi/G-1917-2016	zheng, yi/0000-0002-4871-0779	National Institutes of Health [GM65501]; Michigan State University [REF03-016]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65501 and Michigan State University Grant REF03-016 (to R. M. G.).; We thank Dexin Sui for assistance and suggestions on DNA cloning and Drs. C. Benning and Y. Shachar-Hill for helpful comments on the manuscript. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract number DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the research program of the Michigan Technology Tri-Corridor under Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht G, 2003, PLANTA, V217, P252, DOI 10.1007/s00425-003-0995-6; Baier MC, 2007, PLANT PHYSIOL, V145, P1600, DOI 10.1104/pp.107.106955; Baier MC, 2010, PLANT PHYSIOL, V152, P1000, DOI 10.1104/pp.109.149898; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Barrero-Sicilia C, 2011, PLANTA, V234, P391, DOI 10.1007/s00425-011-1408-x; Batut J, 2011, CURR OPIN MICROBIOL, V14, P181, DOI 10.1016/j.mib.2010.12.010; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Bologa KL, 2003, PLANT PHYSIOL, V132, P2058, DOI 10.1104/pp.103.022236; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Coleman HD, 2010, TRANSGENIC RES, V19, P269, DOI 10.1007/s11248-009-9309-5; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; Duncan KA, 2007, PLANT CELL PHYSIOL, V48, P1612, DOI 10.1093/pcp/pcm133; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Etxeberria E, 2003, J EXP BOT, V54, P1407, DOI 10.1093/jxb/erg148; FRENCH AD, 1990, BIOPOLYMERS, V29, P1599, DOI 10.1002/bip.360291210; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Hardin SC, 2004, PLANT PHYSIOL BIOCH, V42, P197, DOI 10.1016/j.plaphy.2003.12.004; Hardin SC, 2004, PLANT PHYSIOL, V134, P1427, DOI 10.1104/pp.103.036780; Hardin SC, 2003, PLANT J, V35, P588, DOI 10.1046/j.1365-313X.2003.01831.x; Hardin SC, 2006, PLANT PHYSIOL, V141, P1106, DOI 10.1104/pp.106.078006; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huber C, 1996, PLANT PHYSIOL, V112, P793, DOI 10.1104/pp.112.2.793; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Komina O, 2002, PLANT PHYSIOL, V129, P1664, DOI 10.1104/pp.002360; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Nakai T, 1998, PLANT CELL PHYSIOL, V39, P1337, DOI 10.1093/oxfordjournals.pcp.a029339; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Persia D, 2008, PLANT PHYSIOL, V147, P1603, DOI 10.1104/pp.108.115956; Rohrig H, 2004, BIOCHEM BIOPH RES CO, V325, P864, DOI 10.1016/j.bbrc.2004.10.100; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Romer U, 2004, J BIOTECHNOL, V107, P135, DOI 10.1016/j.jbiotec.2003.10.017; Salerno GL, 2003, TRENDS PLANT SCI, V8, P63, DOI 10.1016/S1360-1385(02)00029-8; Sauerzapfe B, 2008, ENZYME MICROB TECH, V43, P289, DOI 10.1016/j.enzmictec.2008.04.001; Schubert M, 2011, PLANTA, V233, P139, DOI 10.1007/s00425-010-1285-8; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Subbaiah CC, 2006, J BIOL CHEM, V281, P15625, DOI 10.1074/jbc.M600355200; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Wachter R, 2003, PLANT PHYSIOL, V133, P1024, DOI 10.1104/pp.103.028142; Winter H, 1998, FEBS LETT, V430, P205, DOI 10.1016/S0014-5793(98)00659-0; Winter H, 2000, CRIT REV BIOCHEM MOL, V35, P253, DOI 10.1080/10409230008984165; Yang JC, 2004, PLANT PHYSIOL, V135, P1621, DOI 10.1104/pp.104.041038; Yep A, 2004, BIOCHEM BIOPH RES CO, V316, P960, DOI 10.1016/j.bbrc.2004.02.136; Yu SK, 2008, IUBMB LIFE, V60, P798, DOI 10.1002/iub.125	58	65	87	7	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36108	36118		10.1074/jbc.M111.275974	http://dx.doi.org/10.1074/jbc.M111.275974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865170	Green Published, hybrid			2022-12-25	WOS:000295927100083
J	Deikus, G; Bechhofer, DH				Deikus, Gintaras; Bechhofer, David H.			5 ' End-independent RNase J1 Endonuclease Cleavage of Bacillus subtilis Model RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRP LEADER RNA; MESSENGER-RNA; ESCHERICHIA-COLI; TRANSCRIPTION ATTENUATION; RIBOSOMAL-RNA; DECAY; TURNOVER; DEGRADATION; MATURATION; INITIATION	Bacillus subtilis trp leader RNA is a small (140-nucleotide) RNA that results from attenuation of trp operon transcription upon binding of the regulatory TRAP complex. Previously, endonucleolytic cleavage by ribonuclease RNase J1 in a 3'-proximal, single-stranded region was shown to be critical for initiation of trp leader RNA decay. RNase J1 is a dual-specificity enzyme, with both 5' exonucleolytic and endonucleolytic activities. Here, we provide in vivo and in vitro evidence that RNase J1 accesses its internal target site on trp leader RNA in a 5' end-independent manner. This has important implications for the role of RNase J1 in RNA decay. We also tested the involvement in trp leader RNA decay of the more recently discovered endonuclease RNase Y. Half-lives of several trp leader RNA constructs, which were designed to probe pathways of endonucleolytic versus exonucleolytic decay, were measured in an RNase Y-deficient mutant. Remarkably, the half-lives of these constructs were indistinguishable from their half-lives in an RNase J1-deficient mutant. These results suggest that lowering RNase Y concentration may affect RNA decay indirectly via an effect on RNase J1, which is thought to exist with RNase Y in a degradosome complex. To generalize our findings with trp leader RNA to other RNAs, we show that the mechanism of trp leader RNA decay is not dependent on TRAP binding.	[Deikus, Gintaras; Bechhofer, David H.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Bechhofer, DH (corresponding author), Box 1603,1 Gustave L Levy Pl, New York, NY 10029 USA.	david.bechhofer@mssm.edu			National Institutes of Health [GM48804]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM48804 (to D. H. B.) from the National Institutes of Health.	[Anonymous], 2011, OCTOBER; Babitzke P, 1997, MOL MICROBIOL, V26, P1, DOI 10.1046/j.1365-2958.1997.5541915.x; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Bechhofer DH, 2009, PROG MOL BIOL TRANSL, V85, P231, DOI 10.1016/S0079-6603(08)00806-4; Bechhofer DH, 1998, J BACTERIOL, V180, P3470, DOI 10.1128/JB.180.13.3470-3473.1998; Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; Condon C, 2008, METHOD ENZYMOL, V447, P277, DOI 10.1016/S0076-6879(08)02215-5; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deikus G, 2004, P NATL ACAD SCI USA, V101, P2747, DOI 10.1073/pnas.0307343101; Deikus G, 2008, J BIOL CHEM, V283, P17158, DOI 10.1074/jbc.M801461200; Deikus G, 2007, J BIOL CHEM, V282, P20238, DOI 10.1074/jbc.M702747200; Deikus G, 2009, J BIOL CHEM, V284, P26394, DOI 10.1074/jbc.M109.015875; Du H, 2000, J BACTERIOL, V182, P1819, DOI 10.1128/JB.182.7.1819-1827.2000; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Garrey SM, 2011, MOL MICROBIOL, V80, P1613, DOI 10.1111/j.1365-2958.2011.07670.x; Garrey SM, 2009, J BIOL CHEM, V284, P31843, DOI 10.1074/jbc.M109.063263; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Kime L, 2010, MOL MICROBIOL, V76, P590, DOI 10.1111/j.1365-2958.2009.06935.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Richards J., 2011, MOL CELL IN PRESS; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Wang W, 1996, J BACTERIOL, V178, P2375, DOI 10.1128/jb.178.8.2375-2382.1996; Yakhnin AV, 2000, J BIOL CHEM, V275, P4519, DOI 10.1074/jbc.275.6.4519	35	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34932	34940		10.1074/jbc.M111.287409	http://dx.doi.org/10.1074/jbc.M111.287409			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21862575	hybrid, Green Published			2022-12-25	WOS:000295406300047
J	Feng, SR; Cen, JN; Huang, YH; Shen, HJ; Yao, L; Wang, YY; Chen, ZX				Feng, Saran; Cen, Jiannong; Huang, Yihong; Shen, Hongjie; Yao, Li; Wang, Yuanyuan; Chen, Zixing			Matrix Metalloproteinase-2 and-9 Secreted by Leukemic Cells Increase the Permeability of Blood-Brain Barrier by Disrupting Tight Junction Proteins	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; FOCAL CEREBRAL-ISCHEMIA; INVASIVE CAPACITY; ENDOTHELIAL-CELLS; MEDIATED DISRUPTION; MONOCYTIC LEUKEMIA; CANCER METASTASIS; TISSUE INHIBITORS; OCCLUDIN	Central nervous system (CNS) involvement remains an important cause of morbidity and mortality in acute leukemia, the mechanisms of leukemic cell infiltration into the CNS have not yet been elucidated. The blood-brain barrier (BBB) makes CNS become a refugee to leukemic cells and serves as a resource of cells that seed extraneural sites. How can the leukemic cells disrupt this barrier and invasive the CNS, even if many of the currently available chemotherapies can not cross the BBB? Tight junction in endothelial cells occupies a central role in the function of the BBB. Except the well known role of degrading extracellular matrix in metastasis of cancer cells, here we show matrix metalloproteinase (MMP)-2 and -9, secreted by leukemic cells, mediate the BBB opening by disrupting tight junction proteins in the CNS leukemia. We demonstrated that leukemic cells impaired tight junction proteins ZO-1, claudin-5 and occludin resulting in increased permeability of the BBB. However, these alterations reduced when MMP-2 and -9 activities were inhibited by RNA interference strategy or by MMP inhibitor GM6001 in an in vitro BBB model. We also found that the disruption of the BBB in company with the downregulation of ZO-1, claudin-5 and occludin and the up-regulation of MMP-2 and -9 in mouse brain tissues with leukemic cell infiltration by confocal imaging and the assay of in situ gelatin zymography. Besides, GM6001 protected all mice against CNS leukemia. Our findings suggest that the degradation of tight junction proteins ZO-1, claudin-5 and occludin by MMP-2 and -9 secreted by leukemic cells constitutes an important mechanism in the BBB breakdown which contributes to the invasion of leukemic cells to the CNS in acute leukemia.	[Feng, Saran; Cen, Jiannong; Shen, Hongjie; Yao, Li; Wang, Yuanyuan; Chen, Zixing] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,Leukemia Res Unit, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Peoples R China; [Huang, Yihong] Xuzhou Med Coll, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China; [Feng, Saran] Xuzhou Cent Hosp, Dept Hematol, Xuzhou, Peoples R China	Soochow University - China; Xuzhou Medical University	Feng, SR (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,Leukemia Res Unit, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Peoples R China.	szchenzx@263.net	Lv, Yuanjie/AER-0767-2022		The National Natural Scientific Foundation of China [30670905]	The National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by a grant (30670905) from The National Natural Scientific Foundation of China, http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Chen KM, 2006, INT J EXP PATHOL, V87, P113, DOI 10.1111/j.0959-9673.2006.00459.x; Chen SD, 2005, INT J ELEC POWER, V27, P53, DOI 10.1016/j.ijepes.2004.08.008; Cunnea P, 2010, ACTA NEUROPATHOL, V119, P601, DOI 10.1007/s00401-009-0618-9; Demers M, 2005, CRIT REV IMMUNOL, V25, P493, DOI 10.1615/CritRevImmunol.v25.i6.30; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Janowska-Wieczorek A, 1999, BRIT J HAEMATOL, V105, P402, DOI 10.1046/j.1365-2141.1999.01352.x; Johnston DL, 2005, J CLIN ONCOL, V23, P9172, DOI 10.1200/JCO.2005.02.7482; Klein G, 2004, CRIT REV ONCOL HEMAT, V50, P87, DOI 10.1016/j.critevonc.2003.09.001; Laningham FH, 2007, NEURORADIOLOGY, V49, P873, DOI 10.1007/s00234-007-0300-7; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Li ZJ, 2006, EUR J HAEMATOL, V77, P128, DOI 10.1111/j.1600-0609.2006.00686.x; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Lin LI, 2002, BRIT J HAEMATOL, V117, P835, DOI 10.1046/j.1365-2141.2002.03510.x; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; Martin TA, 2002, J CELL PHYSIOL, V192, P268, DOI 10.1002/jcp.10133; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Paupert J, 2008, CELL CYCLE, V7, P1047, DOI 10.4161/cc.7.8.5645; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; Reikvam H, 2010, EUR J HAEMATOL, V84, P239, DOI 10.1111/j.1600-0609.2009.01382.x; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Sancho JM, 2006, CANCER-AM CANCER SOC, V106, P2540, DOI 10.1002/cncr.21948; Seelbach M, 2010, ENVIRON HEALTH PERSP, V118, P479, DOI 10.1289/ehp.0901334; Sulminoe A, 2007, LEUKEMIA RES, V31, P1437, DOI 10.1016/j.leukres.2007.01.015; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Wang CL, 2010, LEUKEMIA RES, V34, P1083, DOI 10.1016/j.leukres.2010.01.016; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	44	151	167	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e20599	10.1371/journal.pone.0020599	http://dx.doi.org/10.1371/journal.pone.0020599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857898	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300002
J	Li, B; Zhong, L; Yang, XL; Andersson, T; Huang, M; Tang, SJ				Li, Bei; Zhong, Ling; Yang, Xiangling; Andersson, Tommy; Huang, Min; Tang, Shao-Jun			WNT5A Signaling Contributes to A beta-Induced Neuroinflammation and Neurotoxicity	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; NF-KAPPA-B; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; PRESENILIN-1 TRANSGENES; BEHAVIORAL IMPAIRMENTS; FRIZZLED HOMOLOGS; HYDROGEN-PEROXIDE; GLIAL-CELLS; MOUSE MODEL	Neurodegenration is a pathological hallmark of Alzheimer's disease (AD), but the underlying molecular mechanism remains elusive. Here, we present evidence that reveals a crucial role of Wnt5a signaling in this process. We showed that Wnt5a and its receptor Frizzled-5 (Fz5) were up-regulated in the AD mouse brain, and that beta-amyloid peptide (A beta), a major constituent of amyloid plaques, stimulated Wnt5a and Fz5 expression in primary cortical cultures; these observations indicate that Wnt5a signaling could be aberrantly activated during AD pathogenesis. In support of such a possibility, we observed that inhibition of Wnt5a signaling attenuated while activation of Wnt5a signaling enhanced A beta-evoked neurotoxicity, suggesting a role of Wnt5a signaling in AD-related neurodegeneration. Furthermore, we also demonstrated that A beta-induced neurotoxicity depends on inflammatory processes, and that activation of Wnt5a signaling elicited the expression of proinflammatory cytokines IL-1 beta and TNF-alpha whereas inhibition of Wnt5a signaling attenuated the A beta-induced expression of the cytokines in cortical cultures. Our findings collectively suggest that aberrantly up-regulated Wnt5a signaling is a crucial pathological step that contributes to AD-related neurodegeneration by regulating neuroinflammation.	[Li, Bei; Tang, Shao-Jun] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Li, Bei; Zhong, Ling; Yang, Xiangling; Huang, Min] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Andersson, Tommy] Lund Univ, Dept Lab Med, Clin Res Ctr, Skane Univ Hosp, Malmo, Sweden	University of Texas System; University of Texas Medical Branch Galveston; Sun Yat Sen University; Lund University; Skane University Hospital	Li, B (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	shtang@utmb.edu			University of Texas Medical Branch; National Natural Science Foundation of China [30873457]; Scientific Technology Project of Guangdong Province of China [2008A060202010, 2010B050700019]; China Scholarship Council	University of Texas Medical Branch; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Project of Guangdong Province of China; China Scholarship Council(China Scholarship Council)	This work was supported by the start-up funds from the University of Texas Medical Branch to S-JT and by grant No. 30873457 from the National Natural Science Foundation of China and No. 2008A060202010 and 2010B050700019 from the Scientific Technology Project of Guangdong Province of China to LZ. BL is a Ph.D. student fellow supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Camilli TC, 2010, BIOCHEM PHARMACOL, V80, P702, DOI 10.1016/j.bcp.2010.03.002; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Carter MD, 2010, CLIN PHARMACOL THER, V88, P475, DOI 10.1038/clpt.2010.165; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chong YH, 1997, LIFE SCI, V61, P2323, DOI 10.1016/S0024-3205(97)00936-3; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; CRAWLEY JN, 2007, SHORT PROTOCOLS NEUR, P2; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Giovannini MG, 2002, NEUROBIOL DIS, V11, P257, DOI 10.1006/nbdi.2002.0538; GITTER BD, 1995, P NATL ACAD SCI USA, V92, P10738, DOI 10.1073/pnas.92.23.10738; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Gorlovoy P, 2009, FASEB J, V23, P2502, DOI 10.1096/fj.08-123877; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Kang DE, 1999, J NEUROSCI, V19, P4229; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Ma FY, 2011, ARQ NEURO-PSIQUIAT, V69, P105, DOI 10.1590/S0004-282X2011000100020; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Meda L, 1999, J NEUROIMMUNOL, V93, P45, DOI 10.1016/S0165-5728(98)00188-X; Parachikova A, 2010, J ALZHEIMERS DIS, V21, P527, DOI 10.3233/JAD-2010-100204; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tang SJ, 2007, SYNAPSE, V61, P866, DOI 10.1002/syn.20434; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	67	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22920	10.1371/journal.pone.0022920	http://dx.doi.org/10.1371/journal.pone.0022920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857966	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300008
J	Mans, BJ; de Klerk, D; Pienaar, R; Latif, AA				Mans, Ben J.; de Klerk, Daniel; Pienaar, Ronel; Latif, Abdalla A.			Nuttalliella namaqua: A Living Fossil and Closest Relative the Ancestral Tick Lineage: Implications for the Evolution of Blood-Feeding in Ticks	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; KAROO BASIN; SOFT TICKS; HARD TICKS; ACARI; SYSTEMATICS; MORPHOLOGY; ALIGNMENT; IXODIDAE; GENUS	Ticks are monophyletic and composed of the hard ( Ixodidae) and soft ( Argasidae) tick families, as well as the Nuttalliellidae, a family with a single species, Nuttalliella namaqua. Significant biological differences in lifestyle strategies for hard and soft ticks suggest that various blood-feeding adaptations occurred after their divergence. The phylogenetic relationships between the tick families have not yet been resolved due to the lack of molecular data for N. namaqua. This tick possesses a pseudo-scutum and apical gnathostoma as observed for ixodids, has a leathery cuticle similar to argasids and has been considered the evolutionary missing link between the two families. Little knowledge exists with regard to its feeding biology or host preferences. Data on its biology and systematic relationship to the other tick families could therefore be crucial in understanding the evolution of blood-feeding behaviour in ticks. Live specimens were collected and blood meal analysis showed the presence of DNA for girdled lizards from the Cordylid family. Feeding of ticks on lizards showed that engorgement occurred rapidly, similar to argasids, but that blood meal concentration occurs via malpighian excretion of water. Phylogenetic analysis of the 18S nuclear and 16S mitochondrial genes indicate that N. namaqua grouped basal to the main tick families. The data supports the monophyly of all tick families and suggests the evolution of argasid-like blood-feeding behaviour in the ancestral tick lineage. Based on the data and considerations from literature we propose an origin for ticks in the Karoo basin of Gondwanaland during the late Permian. The nuttalliellid family almost became extinct during the End Permian event, leaving N. namaqua as the closest living relative to the ancestral tick lineage and the evolutionary missing link between the tick families.	[Mans, Ben J.; de Klerk, Daniel; Pienaar, Ronel; Latif, Abdalla A.] Agr Res Council, Onderstepoort Vet Inst, Onderstepoort, South Africa; [Mans, Ben J.; Latif, Abdalla A.] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Mans, BJ (corresponding author), Agr Res Council, Onderstepoort Vet Inst, Onderstepoort, South Africa.	mansb@arc.agric.za	Mans, Ben J./M-2427-2017; Pienaar, Ronel/T-6705-2018	Mans, Ben J./0000-0002-0177-0029; Pienaar, Ronel/0000-0002-9096-0237; Latif, Abdalla/0000-0003-3138-3975	Joy Liebenberg Trust [21/19/JT02]; South African National Research Foundation	Joy Liebenberg Trust; South African National Research Foundation(National Research Foundation - South Africa)	This project was funded by the Joy Liebenberg Trust (21/19/JT02) allocated to BM and a South African National Research Foundation grant allocated to AL (NRF-Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks JPH., 1988, MEMOIRS BOT SURVEY S, P1, DOI DOI 10.2307/212246; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aragao H.de B., 1936, Memorias do Instituto Oswaldo Cruz, V31, P759; BALASHOV YS, 1989, PARAZITOLOGIYA+, V23, P368; Balashov YS., 1972, MISCELLANEOUS PUBLIC, V8, P268; Balashov Yu. S., 1994, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V73, P42; Barker SC, 2004, PARASITOLOGY, V129, pS15, DOI 10.1017/S0031182004005207; BEDFORD G. A. H., 1931, PARASITOLOGY, V23, P230, DOI 10.1017/S0031182000013573; Black WC, 1997, MOL PHYLOGENET EVOL, V7, P129, DOI 10.1006/mpev.1996.0382; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Bordy EM, 2011, LETHAIA, V44, P33, DOI 10.1111/j.1502-3931.2010.00223.x; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; Claver JA, 2009, J EXOT PET MED, V18, P87, DOI 10.1053/j.jepm.2009.04.006; Coons L.B., 1986, P248; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Desmet P.G., 1999, KAROO ECOLOGICAL PAT, P3; Dobson SJ, 1999, MOL PHYLOGENET EVOL, V11, P288, DOI 10.1006/mpev.1998.0565; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Durand JF, 2005, J AFR EARTH SCI, V43, P53, DOI 10.1016/j.jafrearsci.2005.07.014; ELSHOURA SM, 1984, J PARASITOL, V70, P114; ELSHOURA SM, 1990, ACAROLOGIA, V31, P349; FILLIPOVA NA, 1977, IXODID TICKS IXODINA; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; HOOGSTRAAL H, 1985, ADV PARASIT, V24, P135, DOI 10.1016/S0065-308X(08)60563-1; HOOGSTRAAL H, 1982, B SOC ENTOMOL SUISSE, V55, P5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; JUPP PG, 1987, MED VET ENTOMOL, V1, P361, DOI 10.1111/j.1365-2915.1987.tb00367.x; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kaufman W.R., 1983, Current Topics in Vector Research, V1, P215; KEIRANS JE, 1976, ANN ENTOMOL SOC AM, V69, P926, DOI 10.1093/aesa/69.5.926; KENNER T, 1989, BASIC RES CARDIOL, V84, P111, DOI 10.1007/BF01907921; Klompen H, 2007, MOL PHYLOGENET EVOL, V43, P936, DOI 10.1016/j.ympev.2006.10.024; Klompen Hans, 2010, Acarologia (Paris), V50, P269, DOI 10.1051/acarologia/20101970; Klompen JSH, 1996, ANNU REV ENTOMOL, V41, P141, DOI 10.1146/annurev.en.41.010196.001041; Klompen JSH, 1997, SYST PARASITOL, V38, P1, DOI 10.1023/A:1005815925466; Klompen JSH, 2000, CLADISTICS, V16, P79, DOI 10.1111/j.1096-0031.2000.tb00349.x; LAVOIPIERRE M. M. J., 1955, ANN TROP MED AND PARASITOL, V49, P96; LEES AD, 1946, PARASITOLOGY, V37, P172, DOI 10.1017/S0031182000013330; Lehtinen Pekka T., 1999, Acta Amazonica, V29, P325; LEHTINEN PT, 1991, MODERN ACAROLOGY, VOLS 1 AND 2, pB101; Lindquist E. E., 1984, ACAROLOGY 6, V1, P28; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Mans BJ, 2002, MOL BIOL EVOL, V19, P1695, DOI 10.1093/oxfordjournals.molbev.a003992; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Moyes CD, 2002, BBA-MOL CELL RES, V1591, P11, DOI 10.1016/S0167-4889(02)00224-0; Nuttall George H. F., 1911, Parasitology Cambridge, V4; OLIVER JH, 1989, ANNU REV ECOL SYST, V20, P397, DOI 10.1146/annurev.es.20.110189.002145; Ponsen S., 2008, International Journal of Zoological Research, V4, P119; Reisz RR, 2000, S AFR J SCI, V96, P443; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Rutherford M. C., 1997, P91; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; SCHULZE P[AUL], 1935, ZEITSCHR MORPH U OKOL TIERE, V30, P1; SELLERS JC, 1980, J HERPETOL, V14, P185, DOI 10.2307/1563853; Sonenshine D.E, 1991, BIOL TICKS, P447; Stanley EL, 2011, MOL PHYLOGENET EVOL, V58, P53, DOI 10.1016/j.ympev.2010.08.024; Stutzer C, 2009, EXP PARASITOL, V122, P318, DOI 10.1016/j.exppara.2009.04.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TATCHELL RJ, 1967, NATURE, V213, P940, DOI 10.1038/213940a0; THEILER G, 1962, ARTHROPOD PARASITES, P1; van der Hammen L., 1983, Zoologische Mededelingen (Leiden), V57, P209; Van der Hammen L, 1983, ZOOL VERHAND, V207, P3; VISSER JNJ, 1995, PALAEOGEOGR PALAEOCL, V118, P213, DOI 10.1016/0031-0182(95)00008-3; Wardell-Johnson G, 2000, POPULATION DEV ENV N, P17; Whiting AS, 2003, MOL PHYLOGENET EVOL, V29, P582, DOI 10.1016/S1055-7903(03)00142-8	74	58	60	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23675	10.1371/journal.pone.0023675	http://dx.doi.org/10.1371/journal.pone.0023675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858204	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300080
J	Minozzi, M; Lattanzi, G; Benz, R; Costi, MP; Venturelli, A; Carloni, P				Minozzi, Manuela; Lattanzi, Gianluca; Benz, Roland; Costi, Maria P.; Venturelli, Alberto; Carloni, Paolo			Permeation through the Cell Membrane of a Boron-Based beta-Lactamase Inhibitor	PLOS ONE			English	Article							LIPID-BILAYER; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; PERMEABILITY; TRANSPORT; CHANNELS; PORIN; ACID; PENICILLINS; SIMULATION	Bacteria express beta-lactamases to counteract the beneficial action of antibiotics. Benzo[b]-thiophene-2-boronic acid (BZB) derivatives are beta-lactamase inhibitors and, as such, promising compounds to be associated with beta-lactam antibacterial therapies. The uncharged form of BZB, in particular, is suggested to diffuse through the outer membrane of Gram negative bacteria. In this study, through the combination of electrophysiological experiments across reconstituted PC/n-decane bilayers and metadynamics-based free energy calculations, we investigate the permeation mechanism of boronic compounds. Our experimental data establish that BZB passes through the membrane, while computer simulations provide hints for the existence of an aqueous, water-filled monomolecular channel. These findings provide new perspectives for the design of boronic acid derivatives with high membrane permeability.	[Minozzi, Manuela] Univ Roma Tre, Modeling & Simulat Lab, Dept Studies Struct, Rome, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Dept Basic Med Sci, TIRES Ctr, Bari, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Ist Nazl Fis Nucl, Bari, Italy; [Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, Bremen, Germany; [Costi, Maria P.; Venturelli, Alberto] Univ Modena & Reggio Emilia, Dept Pharmaceut Sci, Modena, Italy; [Carloni, Paolo] Forschungszentrum Julich, German Res Sch Simulat Sci, D-52425 Julich, Germany; [Carloni, Paolo] Rhein Westfal TH Aachen, Julich, Germany	Roma Tre University; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Jacobs University; Universita di Modena e Reggio Emilia; Helmholtz Association; Research Center Julich; RWTH Aachen University	Minozzi, M (corresponding author), Univ Roma Tre, Modeling & Simulat Lab, Dept Studies Struct, Rome, Italy.	gl.lattanzi@gmail.com	Lattanzi, Gianluca/AAA-3173-2019; Lattanzi, Gianluca/E-1753-2011; Venturelli, Alberto/AAG-2701-2019; Costi, Maria Paola/F-4747-2015; Minozzi, Manuela/AAS-6547-2020; Carloni, Paolo/H-8736-2013	Lattanzi, Gianluca/0000-0002-0808-6457; Lattanzi, Gianluca/0000-0002-0808-6457; Costi, Maria Paola/0000-0002-0443-5402; Carloni, Paolo/0000-0002-9010-0149; Benz, Roland/0000-0002-9510-9265	Instituto Nazionale per la Fisica della Materia - National Institute for the Physics of Matter, Italy center DEMOCRITOS; Italian Ministry for University and Research [2007B57EAB_003]; Fonds der Chemischen Industrie; NIH [GM63815]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063815] Funding Source: NIH RePORTER	Instituto Nazionale per la Fisica della Materia - National Institute for the Physics of Matter, Italy center DEMOCRITOS; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Instituto Nazionale per la Fisica della Materia - National Institute for the Physics of Matter, Italy center DEMOCRITOS. We also acknowledge financial support from the Italian Ministry for University and Research under the scheme PRIN2007 no. 2007B57EAB_003 (GL), the Fonds der Chemischen Industrie (RB) and NIH Grant GM63815 (to Brian Shoichet, subcontract to University of Modena and Reggio Emilia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 1997, TRENDS ECOL EVOL, V12, P482, DOI 10.1016/S0169-5347(97)01223-8; Bemporad D, 2004, BIOPHYS J, V87, P1, DOI 10.1529/biophysj.103.030601; Bemporad D, 2005, BBA-BIOMEMBRANES, V1718, P1, DOI 10.1016/j.bbamem.2005.07.009; BENNETT PM, 1993, ANTIMICROB AGENTS CH, V37, P153, DOI 10.1128/AAC.37.2.153; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1976, BIOCHIM BIOPHYS ACTA, V455, P701, DOI 10.1016/0005-2736(76)90042-0; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026; Buzzoni V, 2004, BIOORG MED CHEM LETT, V14, P3979, DOI 10.1016/j.bmcl.2004.05.054; Ceccarelli M, 2009, FRONT BIOSCI-LANDMRK, V14, P3222, DOI 10.2741/3446; COLLU F, 2009, DRUG DESIGN INSIGH C, V32; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cseh R, 1998, BIOPHYS J, V74, P1399, DOI 10.1016/S0006-3495(98)77852-X; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Fenollar-Ferrer C, 2003, PROTEINS, V51, P442, DOI 10.1002/prot.10358; Fiorin G, 2006, BIOPHYS J, V91, P2768, DOI 10.1529/biophysj.106.086611; Guidoni L, 2000, FEBS LETT, V477, P37, DOI 10.1016/S0014-5793(00)01712-9; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; LINDQUIST RN, 1974, ARCH BIOCHEM BIOPHYS, V160, P135, DOI 10.1016/S0003-9861(74)80018-4; LOBKOVSKY E, 1994, BIOCHEMISTRY-US, V33, P6762, DOI 10.1021/bi00188a004; MARRINK SJ, 1994, J PHYS CHEM-US, V98, P4155, DOI 10.1021/j100066a040; Marrink SJ, 1996, J PHYS CHEM-US, V100, P16729, DOI 10.1021/jp952956f; Micheletti C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.170601; Morandi F, 2003, J AM CHEM SOC, V125, P685, DOI 10.1021/ja0288338; Neves P, 2005, BIOPHYS CHEM, V113, P123, DOI 10.1016/j.bpc.2004.08.004; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1985, PHARMACOL THERAPEUT, V27, P197, DOI 10.1016/0163-7258(85)90069-5; Powers RA, 1999, PROTEIN SCI, V8, P2330; Powers RA, 2002, J MED CHEM, V45, P3222, DOI 10.1021/jm020002p; Tafi A, 2005, EUR J MED CHEM, V40, P1134, DOI 10.1016/j.ejmech.2005.06.011; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Venturelli A, 2007, J MED CHEM, V50, P5644, DOI 10.1021/jm070643q; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Weston GS, 1998, J MED CHEM, V41, P4577, DOI 10.1021/jm980343w; YAMAGUCHI A, 1985, FEBS LETT, V181, P143, DOI 10.1016/0014-5793(85)81130-3; Yang WQ, 2003, MED RES REV, V23, P346, DOI 10.1002/med.10043	41	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23187	10.1371/journal.pone.0023187	http://dx.doi.org/10.1371/journal.pone.0023187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858024	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300018
J	Zhang, ZY; Li, H; Chen, LY; Lu, XY; Zhang, J; Xu, P; Lin, K; Wu, G				Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Zhang, Jian; Xu, Ping; Lin, Kui; Wu, Geng			Molecular Basis for the Recognition of Adenomatous Polyposis Coli by the Discs Large 1 Protein	PLOS ONE			English	Article							2ND PDZ DOMAIN; HUMAN HOMOLOG; CRYSTAL-STRUCTURE; LIGAND-BINDING; BETA-CATENIN; APC; COMPLEX; PSD-95; ACTIVATION; MUTATIONS	The human Discs Large 1 (DLG1) protein uses two of its three PDZ domains to interact with the C-terminal peptide of the Adenomatous Polyposis Coli (APC) tumor suppressor protein. The DLG1/APC complex inhibits the cell cycle progression from the G0/G1 to the S phase, regulates epithelial cell migration and morphogenesis, and is required for polarization of the microtubule cytoskeleton. However, the molecular details of how DLG1 recognizes APC is not clear. In this study, we performed biochemical and biophysical assays to investigate the interactions between PDZ domains of DLG1 and the C-terminal peptide of APC. In addition, we determined the crystal structures of the PDZ1 and PDZ2 domains of DLG1 each in complex with the C-terminal 11-residue peptide of APC. Our biochemical, biophysical, and structural results revealed structural elements and residues on PDZ1 and PDZ2 domains of DLG1 and on APC crucial for their mutual interaction. In particular, our results show that the beta 2/beta 3 loops of PDZ1 and PDZ2 play important roles in contributing to the binding affinities between PDZ domains and APC, through interacting with the residues upstream of the canonical PDZ-binding S/T-X-V motif. The results provide new insights into the binding mode of a defined C-terminal segment of APC by the PDZ domains of DLG1.	[Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Xu, Ping; Lin, Kui; Wu, Geng] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Xu, Ping; Lin, Kui; Wu, Geng] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zhang, Zhenyi; Li, Hua; Chen, Leyi; Lu, Xingyu; Lin, Kui; Wu, Geng] Shanghai Jiao Tong Univ, Key Lab MOE Dev Genet & Neuropsychiat Dis, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	klin@sjtu.edu.cn; geng.wu@sjtu.edu.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X	National Natural Science Foundation of China [30900225, 30821005, 90919021]; Shanghai Municipal Education Commission [09ZZ23]; Shanghai Education Commission [08SG11]; Shanghai Pujiang Program [09PJ1405500]; Chinese Ministry of Education [109060]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD [2009ZX09301-007]; State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China); State Key Laboratory of Drug Research (China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Commission; Shanghai Pujiang Program(Shanghai Pujiang Program); Chinese Ministry of Education(Ministry of Education, China); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD; State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China)(Chinese Academy of Sciences); State Key Laboratory of Drug Research (China)	This work was supported by grants from the National Natural Science Foundation of China (grant numbers 30900225, 30821005, and 90919021), the Innovation Program of Shanghai Municipal Education Commission (grant number 09ZZ23), the "Dawn" Program of Shanghai Education Commission (grant number 08SG11), Shanghai Pujiang Program (grant number 09PJ1405500), the Key Project of Chinese Ministry of Education (grant number 109060), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the National Comprehensive Technology Platforms for Innovative Drug R&D (2009ZX09301-007), the State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China) and the State Key Laboratory of Drug Research (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; JOSLYN G, 1993, P NATL ACAD SCI USA, V90, P11109, DOI 10.1073/pnas.90.23.11109; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Marfatia SM, 1996, J CELL BIOL, V135, P753, DOI 10.1083/jcb.135.3.753; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Mimori-Kiyosue Y, 2007, GENES CELLS, V12, P219, DOI 10.1111/j.1365-2443.2007.01045.x; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Pedemonte S, 1998, GENE CHROMOSOME CANC, V22, P257, DOI 10.1002/(SICI)1098-2264(199808)22:4<257::AID-GCC1>3.0.CO;2-U; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Wang L, 2005, J BIOL CHEM, V280, P26992, DOI 10.1074/jbc.M503555200; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23507	10.1371/journal.pone.0023507	http://dx.doi.org/10.1371/journal.pone.0023507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858148	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300053
J	Dou, ZH; Xu, JH; Jiao, JH; Ma, Y; Durako, S; Yu, L; Zhao, Y; Zhang, FJ				Dou, Zhihui; Xu, Jiahong; Jiao, Jin Hua; Ma, Ye; Durako, Stephen; Yu, Lan; Zhao, Yan; Zhang, Fujie			Gender Difference in 2-Year Mortality and Immunological Response to ART in an HIV-Infected Chinese Population, 2006-2008	PLOS ONE			English	Article							UNITED-STATES; RNA LEVELS; PROGRESSION; WOMEN; AIDS	Background: Since it was initiated in 2002, the China Free Antiretroviral Treatment (ART) Program has been progressing from an emergency response to a standardized treatment and care system. As of December 31, 2009, a total of 81,880 patients in 31 provinces, autonomous regions, and special municipalities received free ART. Gender differences, however, in mortality and immunological response to ART in this cohort have never been described. Objective: To understand whether women and men who enrolled in the China National Free ART Program responded equally well to the treatment. Methods: A retrospective analysis of the national free ART databases from June 2006-December 2008 was performed. HIV-infected subjects who were 18 years or older, ART naive at baseline, and on a 3TC regimen enrolled in the program from June 1 to December 31, 2006, were included in this study, then followed up to 2 years. Results: Among 3457 enrolled subjects who met the inclusion criteria, 59.2% were male and 40.8% female. The majority of the subjects were 19-44 years old (77%) and married (72%). Over the full 24 months of follow-up, the mortality rate was 19.0% in males and 11.4% in females (p = 0.0014). Males on therapy for 3-24 months were more likely to die than females (HR = 1.46, 95% CI: 1.04-2.06, p = 0.0307) after adjusting for baseline characteristics. Compared to men, women had higher CD4+ counts over time after initiating ART (p < 0.0001). Conclusions: Our study showed that women had an overall lower mortality and higher CD4+ counts than men in response to ART treatment, which may be attributed to adherence, biological factors, social, cultural and economic reasons. Further study is needed to explore these factors that might contribute to the gender differences in mortality and immunological response to ART.	[Dou, Zhihui; Ma, Ye; Yu, Lan; Zhao, Yan; Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Xu, Jiahong; Jiao, Jin Hua; Durako, Stephen] Westat Corp, Rockville, MD USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Westat	Dou, ZH (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	treatment@chinaaids.cn			Chinese National Antiretroviral Treatment Program; U.S. National Institutes of Health [1R03TW008203-01]; FOGARTY INTERNATIONAL CENTER [R03TW008203] Funding Source: NIH RePORTER	Chinese National Antiretroviral Treatment Program; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Chinese National Antiretroviral Treatment Program, and by U.S. National Institutes of Health Research Grants (1R03TW008203-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhail A, 2010, UGANDA INT J WOMENS, V2, P45; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Heath KV, 2002, INT J EPIDEMIOL, V31, P1016, DOI 10.1093/ije/31.5.1016; Jain MK, 2003, CLIN INFECT DIS, V36, P1030, DOI 10.1086/368186; Joint United Nations Program on HIV/AIDS (UNAIDS), 2007, UNAIDS0727EJC1322E W; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Ma Y., 2009, P IEEE WORLD NONGR C, P1, DOI DOI 10.1109/NAPS.2009.5484048; Moore J, 1999, AIDS, V13, P2459, DOI 10.1097/00002030-199912030-00018; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Rotger Margalida, 2006, Curr HIV/AIDS Rep, V3, P118, DOI 10.1007/BF02696655; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; van Sighem AI, 2003, AIDS, V17, P2227, DOI 10.1097/00002030-200310170-00011; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	20	21	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22707	10.1371/journal.pone.0022707	http://dx.doi.org/10.1371/journal.pone.0022707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857947	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500011
J	Harris, JR; Marston, BJ; Sangrujee, N; DuPlessis, D; Park, B				Harris, Julie R.; Marston, Barbara J.; Sangrujee, Nalinee; DuPlessis, Desiree; Park, Benjamin			Cost-Effectiveness Analysis of Diagnostic Options for Pneumocystis Pneumonia (PCP)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN-IMMUNODEFICIENCY-VIRUS; BRONCHOALVEOLAR LAVAGE SPECIMENS; REAL-TIME PCR; HIV-INFECTED PATIENTS; MEDIATED ISOTHERMAL AMPLIFICATION; TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; ORAL-WASH SAMPLES; CARINII-PNEUMONIA; RESPIRATORY SPECIMENS	Background: Diagnosis of Pneumocystis jirovecii pneumonia (PCP) is challenging, particularly in developing countries. Highly sensitive diagnostic methods are costly, while less expensive methods often lack sensitivity or specificity. Cost-effectiveness comparisons of the various diagnostic options have not been presented. Methods and Findings: We compared cost-effectiveness, as measured by cost per life-years gained and proportion of patients successfully diagnosed and treated, of 33 PCP diagnostic options, involving combinations of specimen collection methods [oral washes, induced and expectorated sputum, and bronchoalveolar lavage (BAL)] and laboratory diagnostic procedures [various staining procedures or polymerase chain reactions (PCR)], or clinical diagnosis with chest x-ray alone. Our analyses were conducted from the perspective of the government payer among ambulatory, HIV-infected patients with symptoms of pneumonia presenting to HIV clinics and hospitals in South Africa. Costing data were obtained from the National Institutes of Communicable Diseases in South Africa. At 50% disease prevalence, diagnostic procedures involving expectorated sputum with any PCR method, or induced sputum with nested or real-time PCR, were all highly cost-effective, successfully treating 77-90% of patients at $26-51 per life-year gained. Procedures using BAL specimens were significantly more expensive without added benefit, successfully treating 68-90% of patients at costs of $189-232 per life-year gained. A relatively cost-effective diagnostic procedure that did not require PCR was Toluidine Blue O staining of induced sputum ($25 per life-year gained, successfully treating 68% of patients). Diagnosis using chest x-rays alone resulted in successful treatment of 77% of patients, though cost-effectiveness was reduced ($109 per life-year gained) compared with several molecular diagnostic options. Conclusions: For diagnosis of PCP, use of PCR technologies, when combined with less-invasive patient specimens such as expectorated or induced sputum, represent more cost-effective options than any diagnostic procedure using BAL, or chest x-ray alone.	[Harris, Julie R.; Park, Benjamin] Ctr Dis Control & Prevent, Mycot Dis Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA; [Marston, Barbara J.; Sangrujee, Nalinee] Ctr Dis Control & Prevent, Global AIDS Program, Ctr Global Hlth, Atlanta, GA USA; [DuPlessis, Desiree] Natl Inst Communicable Dis, Parasitol Reference Unit, Natl Hlth Lab Serv, Johannesburg, South Africa	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Harris, JR (corresponding author), Ctr Dis Control & Prevent, Mycot Dis Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA.	ggt5@cdc.gov						Aderaye G, 2008, INFECTION, V36, P237, DOI 10.1007/s15010-007-7191-8; Aderaye G, 2003, AIDS, V17, P435, DOI 10.1097/00002030-200302140-00018; Aderaye G, 2007, SCAND J INFECT DIS, V39, P1045, DOI 10.1080/00365540701474508; Adrian PV, 1997, ANTIMICROB AGENTS CH, V41, P2406, DOI 10.1128/AAC.41.11.2406; Alvarez F, 1997, CRIT CARE MED, V25, P948, DOI 10.1097/00003246-199706000-00009; Alvarez-Martinez MJ, 2006, DIAGN MICR INFEC DIS, V56, P153, DOI 10.1016/j.diagmicrobio.2006.03.010; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Archontoulis NK, 2009, EXP CLIN TRANSPLANT, V7, P129; Atzori C, 1998, Int J Infect Dis, V3, P76; Atzori C, 1998, EUR J CLIN MICROBIOL, V17, P241, DOI 10.1007/s100960050056; Bakeera-Kitaka S, 2004, ANN TROP PAEDIATR, V24, P227, DOI 10.1179/027249304225019046; Bandt D, 2007, TRANSPL INFECT DIS, V9, P196, DOI 10.1111/j.1399-3062.2007.00246.x; BASELSKI VS, 1990, J CLIN MICROBIOL, V28, P393, DOI 10.1128/JCM.28.2.393-394.1990; BHOOPAT L, 1994, ASIAN PAC J ALLERGY, V12, P95; Bijl AMH, 1998, CLIN EXP ALLERGY, V28, P510, DOI 10.1046/j.1365-2222.1998.00258.x; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brancart F, 2005, J MICROBIOL METH, V61, P381, DOI 10.1016/j.mimet.2005.01.001; Caliendo AM, 1998, J CLIN MICROBIOL, V36, P979, DOI 10.1128/JCM.36.4.979-982.1998; Capra C, 2000, INTENS CARE MED, V26, P212, DOI 10.1007/s001340050048; CARMICHAEL A, 1991, CYTOPATHOLOGY, V2, P61, DOI 10.1111/j.1365-2303.1991.tb00388.x; CARTWRIGHT CP, 1994, J CLIN MICROBIOL, V32, P1634, DOI 10.1128/JCM.32.7.1634-1638.1994; Chakaya J M, 2003, East Afr Med J, V80, P30; Chawla K, 2011, INDIAN J PATHOL MICR, V54, P326, DOI 10.4103/0377-4929.81624; Chiller T M, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P165, DOI 10.1177/1545109709333112; CHOUAID C, 1995, AM J CLIN PATHOL, V104, P72, DOI 10.1093/ajcp/104.1.72; CHUMPITAZI BF, 2011, MED MYCOL; Contini C, 1998, J MED MICROBIOL, V47, P329, DOI 10.1099/00222615-47-4-329; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; Crans CA, 1999, CRIT REV DIAGN IMAG, V40, P251; CREGAN P, 1990, J CLIN MICROBIOL, V28, P2432, DOI 10.1128/JCM.28.11.2432-2436.1990; Fillaux J, 2008, J MICROBIOL METH, V75, P258, DOI 10.1016/j.mimet.2008.06.009; Fischer S, 2001, J INFECT DIS, V184, P1485, DOI 10.1086/324520; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Flori P, 2004, J MED MICROBIOL, V53, P603, DOI 10.1099/jmm.0.45528-0; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Gerhart JL, 2010, J AM ACAD DERMATOL, V62, P957, DOI 10.1016/j.jaad.2009.07.042; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; GOSEY LL, 1985, J CLIN MICROBIOL, V22, P803, DOI 10.1128/JCM.22.5.803-807.1985; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Gupta R, 2009, DIAGN MICR INFEC DIS, V64, P381, DOI 10.1016/j.diagmicrobio.2009.04.008; Gwanzura L, 2003, INT J ANTIMICROB AG, V21, P557, DOI 10.1016/S0924-8579(03)00052-9; Hargreaves NJ, 2001, T ROY SOC TROP MED H, V95, P402, DOI 10.1016/S0035-9203(01)90197-X; Helweg-Larsen J, 1998, J CLIN MICROBIOL, V36, P2068, DOI 10.1128/JCM.36.7.2068-2072.1998; Helweg-Larsen J, 1997, J EUKARYOT MICROBIOL, V44, p59S; Hua Liwei, 2002, Zhonghua Nei Ke Za Zhi, V41, P610; Huang SN, 1999, DIAGN MICR INFEC DIS, V35, P27, DOI 10.1016/S0732-8893(99)00050-4; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Iliades P, 2005, MICROB DRUG RESIST, V11, P1, DOI 10.1089/mdr.2005.11.1; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kelley CF, 2009, CHEST, V136, P190, DOI 10.1378/chest.08-2859; KIRSCH CM, 1990, AM J MED SCI, V299, P386, DOI 10.1097/00000441-199006000-00006; KOVACS JA, 1988, NEW ENGL J MED, V318, P589, DOI 10.1056/NEJM198803103181001; Krajicek BJ, 2009, CLIN CHEST MED, V30, P265, DOI 10.1016/j.ccm.2009.02.005; Kubo T, 2010, J CLIN MICROBIOL, V48, P728, DOI 10.1128/JCM.01481-09; Larsen HH, 2004, J INFECT DIS, V189, P1679, DOI 10.1086/383322; Larsen HH, 2002, J CLIN MICROBIOL, V40, P490, DOI 10.1128/JCM.40.2.490-494.2002; Lautenschlager I, 1996, J CLIN MICROBIOL, V34, P728, DOI 10.1128/JCM.34.3.728-730.1996; Le Minor O, 2008, JAIDS-J ACQ IMM DEF, V48, P620, DOI 10.1097/QAI.0b013e31817efb3c; LEIGH TR, 1989, LANCET, V2, P205; LEIGH TR, 1993, J CLIN PATHOL, V46, P140, DOI 10.1136/jcp.46.2.140; LEIGH TR, 1992, TRANSPLANTATION, V54, P468, DOI 10.1097/00007890-199209000-00016; LIPSCHIK GY, 1992, LANCET, V340, P203, DOI 10.1016/0140-6736(92)90469-J; Lishimpi K, 2002, AIDS, V16, P932, DOI 10.1097/00002030-200204120-00017; LU JJ, 1995, J CLIN MICROBIOL, V33, P2785, DOI 10.1128/JCM.33.10.2785-2788.1995; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; Lumbiganon Pagakrong, 2000, Journal of the Medical Association of Thailand, V83, P652; Madhi SA, 2002, CLIN INFECT DIS, V35, P1120, DOI 10.1086/343049; MALIN AS, 1995, LANCET, V346, P1258, DOI 10.1016/S0140-6736(95)91862-0; Mandomando I, 2009, ANTIMICROB AGENTS CH, V53, P2450, DOI 10.1128/AAC.01282-08; Marais E, 2009, SAMJ S AFR MED J, V99, P170; Mathis A, 1997, J CLIN MICROBIOL, V35, P1691, DOI 10.1128/JCM.35.7.1691-1695.1997; Matos O, 2001, EUR J CLIN MICROBIOL, V20, P573, DOI 10.1007/s100960100563; McWilliams T, 2002, THORAX, V57, P1010, DOI 10.1136/thorax.57.12.1010; Metersky ML, 1998, CHEST, V113, P1555, DOI 10.1378/chest.113.6.1555; MOONENS F, 1995, SCAND J INFECT DIS, V27, P358, DOI 10.3109/00365549509032731; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Nahimana A, 2004, ANTIMICROB AGENTS CH, V48, P4301, DOI 10.1128/AAC.48.11.4301-4305.2004; Neff RT, 2009, TRANSPLANTATION, V88, P135, DOI 10.1097/TP.0b013e3181aad256; Nicolay N., 2008, SUMMARY PROVINCIAL H; Nyamande K, 2005, CHEST, V128, P167, DOI 10.1378/chest.128.1.167; OGNIBENE FP, 1984, AM REV RESPIR DIS, V129, P929; Onyango AO, 2009, TRAVEL MED INFECT DI, V7, P359, DOI 10.1016/j.tmaid.2009.07.005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pinlaor S, 2004, PARASITOL RES, V94, P213, DOI 10.1007/s00436-004-1200-y; PITCHENIK AE, 1986, AM REV RESPIR DIS, V133, P226; Procop GW, 2004, J CLIN MICROBIOL, V42, P3333, DOI 10.1128/JCM.42.7.3333-3335.2004; RAAB SS, 1994, MODERN PATHOL, V7, P599; Rabodonirina M, 1997, J CLIN MICROBIOL, V35, P2748, DOI 10.1128/JCM.35.11.2748-2751.1997; Ribes JA, 1997, J CLIN MICROBIOL, V35, P830, DOI 10.1128/JCM.35.4.830-835.1997; Rohner P, 2009, INFECTION, V37, P261, DOI 10.1007/s15010-008-8027-x; ROUX P, 1994, J CLIN MICROBIOL, V32, P2324, DOI 10.1128/JCM.32.9.2324-2326.1994; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; Saksirisampant Wilai, 2002, Journal of the Medical Association of Thailand, V85, pS407; Savoia D, 1997, DIAGN MICR INFEC DIS, V29, P61, DOI 10.1016/S0732-8893(97)00126-0; Schneider M, 2004, NATURAL HIST MORTALI; Serraino D, 2003, AIDS, V17, P2109, DOI 10.1097/00002030-200309260-00012; Sing A, 2000, J CLIN MICROBIOL, V38, P1461, DOI 10.1128/JCM.38.4.1461-1467.2000; STRATTON N, 1991, J CLIN MICROBIOL, V29, P645, DOI 10.1128/JCM.29.3.645-647.1991; Tamburrini E, 1997, J EUKARYOT MICROBIOL, V44, p48S, DOI 10.1111/j.1550-7408.1997.tb05769.x; TAMBURRINI E, 1993, J MED MICROBIOL, V38, P449, DOI 10.1099/00222615-38-6-449; Torres J, 2000, CLIN INFECT DIS, V30, P141, DOI 10.1086/313584; *UNAIDS, 2011, AIDSINFO COUNTR FACT; VANDENBERG O, PEDIAT INFECT DIS J, V29, P504; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004; Zingale A, 2003, J CLIN MICROBIOL, V41, P2709, DOI 10.1128/JCM.41.6.2709-2712.2003	111	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23158	10.1371/journal.pone.0023158	http://dx.doi.org/10.1371/journal.pone.0023158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858013	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700005
J	Shen, T; Chen, XM; Zhang, WD; Xi, YL; Cao, GH; Zhi, YH; Wang, SW; Xu, CH; Wei, L; Lu, FM; Zhuang, H				Shen, Tao; Chen, Xiangmei; Zhang, Weidong; Xi, Yuanlin; Cao, Guanghua; Zhi, Yuhong; Wang, Shuiwang; Xu, Chunhui; Wei, Lai; Lu, Fengmin; Zhuang, Hui			A Higher Correlation of HCV Core Antigen with CD4+T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; COMMERCIAL PLASMA DONORS; RISK-FACTORS; ANTIRETROVIRAL THERAPY; LIVER-DISEASE; BLOOD-DONORS; ENZYME-IMMUNOASSAY; INFECTED PATIENTS; PREVALENCE; HIV	Development of HCV infection is typically followed by chronic hepatitis C (CHC) in most patients, while spontaneous HCV viral clearance (SVC) occurs in only a minority of subjects. Compared with the widespread application of HCV RNA testing by quantitative RT-PCR technique, HCV core antigen detection may be an alternative indicator in the diagnosis of hepatitis C virus infections and in monitoring the status of infectious individuals. However, the correlation and differences between these two indicators in HCV infection need more investigation, especially in patients coinfected by HIV-1. In this study, a total of 354 anti-HCV and/or anti-HIV serum positive residents from a village of central China were enrolled. Besides HCV-related hepatopathic variables including clinical status, ALT, AST, anti-HCV Abs, as well as the altered CD4+/CD8+ T cell counts, HCV core antigen and HCV viral load were also measured. The concentration of serum HCV core antigen was highly correlated with level of HCV RNA in CHC patients with or without HIV-1 coinfection. Of note, HCV core antigen concentration was negatively correlated with CD4+ T cell count, while no correlation was found between HCV RNA level and CD4+ T cell count. Our findings suggested that quantitative detection of plasma HCV core antigen may be an alternative indicator of HCV RNA qPCR assay when evaluating the association between HCV replication and host immune status in HCV/HIV-1 coinfected patients.	[Shen, Tao; Chen, Xiangmei; Xu, Chunhui; Lu, Fengmin; Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Shen, Tao; Chen, Xiangmei; Xu, Chunhui; Lu, Fengmin; Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Ctr Infect Dis, Beijing 100871, Peoples R China; [Zhang, Weidong; Xi, Yuanlin] Zhengzhou Univ, Dept Epidemiol, Coll Publ Hlth, Zhengzhou, Henan, Peoples R China; [Cao, Guanghua] Shangcai Cty Peoples Hosp, Shangcai, Henan, Peoples R China; [Zhi, Yuhong; Wang, Shuiwang] Shangcai Ctr Dis Control & Prevent, Shangcai, Henan, Peoples R China; [Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China	Peking University; Peking University; Zhengzhou University; Shanghai Center for Disease Control & Prevention; Peking University	Shen, T (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China.	lu.fengmin@hsc.pku.edu.cn; zhuangbmu@126.com		Zhang, Weidong/0000-0002-0314-7820; Chen, Xiangmei/0000-0003-0302-6866; Shen, Tao/0000-0002-1365-9862	National Science and Technology Major Project for Infectious Diseases [2008ZX10002-012, 2008ZX10002-013, 2009ZX10004-903]	National Science and Technology Major Project for Infectious Diseases	This work was supported by grants from the National Science and Technology Major Project for Infectious Diseases (2008ZX10002-012, 2008ZX10002-013, and 2009ZX10004-903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Aoyagi K, 1999, J CLIN MICROBIOL, V37, P1802, DOI 10.1128/JCM.37.6.1802-1808.1999; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Bouvier-Alias M, 2002, HEPATOLOGY, V36, P211, DOI 10.1053/jhep.2002.34130; Busch MP, 2006, TRANSFUSION, V46, P469, DOI 10.1111/j.1537-2995.2006.00745.x; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Dienstag JL, 1997, HEPATOLOGY, V26, pS66, DOI 10.1002/hep.510260712; Gerlich WHVA, 2010, HIGHLY SENSITIVE ASS; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kovari H, 2010, CLIN INFECT DIS, V50, P502, DOI 10.1086/649922; Lee PL, 2004, T ROY SOC TROP MED H, V98, P367, DOI 10.1016/j.trstmh.2003.10.013; Maida I, 2006, JAIDS-J ACQ IMM DEF, V42, P177, DOI 10.1097/01.qai.0000221683.44940.62; Merchante N, 2010, ANTIVIR THER, V15, P753, DOI 10.3851/IMP1612; Messick K, 2001, HAEMOPHILIA, V7, P568, DOI 10.1046/j.1365-2516.2001.00559.x; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Muller R, 1996, J HEPATOL, V24, P52; Nakamuta M, 2001, HEPATOL RES, V19, P254, DOI 10.1016/S1386-6346(00)00115-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; ROCKSTROH JK, 1995, INFECTION, V23, P29, DOI 10.1007/BF01710054; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Sterling RK, 2008, DIGEST DIS SCI, V53, P1375, DOI 10.1007/s10620-007-9999-6; Takahashi M, 2005, J CLIN MICROBIOL, V43, P186, DOI 10.1128/JCM.43.1.186-191.2005; Tanaka Y, 2003, HEPATOL RES, V26, P261, DOI 10.1016/S1386-6346(03)00113-X; Thomas DL, 2002, HEPATOLOGY, V36, pS201, DOI 10.1053/jhep.2002.36380; THOMAS DL, 1995, J INFECT DIS, V171, P768, DOI 10.1093/infdis/171.4.768; Uto H, 2009, HEPATOLOGY, V50, P393, DOI 10.1002/hep.23002; Valdez H, 2000, AIDS, V14, P2239, DOI 10.1097/00002030-200010200-00004; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	35	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23550	10.1371/journal.pone.0023550	http://dx.doi.org/10.1371/journal.pone.0023550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858166	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500055
J	Cervelli, T; Backovic, A; Galli, A				Cervelli, Tiziana; Backovic, Ana; Galli, Alvaro			Formation of AAV Single Stranded DNA Genome from a Circular Plasmid in Saccharomyces cerevisiae	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS; IN-VITRO REPLICATION; CIS-ACTING ELEMENT; TERMINAL REPEATS; YEAST-CELLS; NONDIVIDING CELLS; BINDING-PROTEIN; MODEL HOST; GENE	Adeno-associated virus (AAV)-based vectors are promising tools for targeted transfer in gene therapy studies. Many efforts have been accomplished to improve production and purification methods. We thought to develop a simple eukaryotic system allowing AAV replication which could provide an excellent opportunity for studying AAV biology and, more importantly, for AAV vector production. It has been shown that yeast Saccharomyces cerevisiae is able to replicate and form the capsid of many viruses. We investigated the ability of the yeast Saccharomyces cerevisiae to carry out the replication of a recombinant AAV (rAAV). When a plasmid containing a rAAV genome in which the cap gene was replaced with the S. cerevisiae URA3 gene, was co-transformed in yeast with a plasmid expressing Rep68, a significant number of URA3(+) clones were scored (more than 30-fold over controls). Molecular analysis of low molecular weight DNA by Southern blotting revealed that single stranded DNA is formed and that the plasmid is entirely replicated. The ssDNA contains the ITRs, URA3 gene and also vector sequences suggesting the presence of two distinct molecules. Its formation was dependent on Rep68 expression and ITR. These data indicate that DNA is not obtained by the canonical AAV replication pathway.	[Cervelli, Tiziana; Galli, Alvaro] CNR, Ist Fisiol Clin, Lab Terapia Gen & Mol, I-56100 Pisa, Italy; [Backovic, Ana] Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Scuola Normale Superiore di Pisa	Cervelli, T (corresponding author), CNR, Ist Fisiol Clin, Lab Terapia Gen & Mol, I-56100 Pisa, Italy.	alvaro.galli@ifc.cnr.it	Galli, Alvaro/K-3146-2018; Galli, Alvaro/AAL-7247-2020	Galli, Alvaro/0000-0002-9091-5639; 	Telethon-Italy [GGP09166]	Telethon-Italy(Fondazione Telethon)	The work was supported by the Grant n. GGP09166 assigned from Telethon-Italy to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER IE, 1994, J VIROL, V68, P8282, DOI 10.1128/JVI.68.12.8282-8287.1994; Alexander IE, 1996, HUM GENE THER, V7, P841, DOI 10.1089/hum.1996.7.7-841; Alves-Rodrigues I, 2006, VIRUS RES, V120, P49, DOI 10.1016/j.virusres.2005.11.018; Angeletti PC, 2005, METH MOLEC MED, V119, P247; Angeletti PC, 2002, J VIROL, V76, P3350, DOI 10.1128/JVI.76.7.3350-3358.2002; BLAKESLEY RW, 1977, J BIOL CHEM, V252, P7300; Cathomen T, 2000, J VIROL, V74, P2372, DOI 10.1128/JVI.74.5.2372-2382.2000; Cervelli T, 2008, J CELL SCI, V121, P349, DOI 10.1242/jcs.003632; CHEJANOVSKY N, 1989, VIROLOGY, V173, P120, DOI 10.1016/0042-6822(89)90227-4; Conrad CK, 1996, GENE THER, V3, P658; Delan-Forino C, 2011, J VIROL, V85, P3229, DOI 10.1128/JVI.01320-10; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; Galli A, 2003, GENETICS, V164, P65; Galli A, 1998, GENETICS, V149, P1235; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; GOTTLIEB J, 1988, MOL CELL BIOL, V8, P2513, DOI 10.1128/MCB.8.6.2513; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; HONG G, 1992, P NATL ACAD SCI USA, V89, P4673, DOI 10.1073/pnas.89.10.4673; Hughes Timothy R, 2002, Funct Integr Genomics, V2, P199, DOI 10.1007/s10142-002-0059-1; IM DS, 1992, J VIROL, V66, P1119, DOI 10.1128/JVI.66.2.1119-1128.1992; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; KYOSTIO SRM, 1995, J VIROL, V69, P6787; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Manivasakam P, 1998, MOL CELL BIOL, V18, P1736, DOI 10.1128/MCB.18.3.1736; Musatov S, 2002, J VIROL, V76, P12792, DOI 10.1128/JVI.76.24.12792-12802.2002; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; NI TH, 1994, J VIROL, V68, P1128, DOI 10.1128/JVI.68.2.1128-1138.1994; NISHIGAKI K, 1985, NUCLEIC ACIDS RES, V13, P5747, DOI 10.1093/nar/13.16.5747; Nony P, 2001, J VIROL, V75, P9991, DOI 10.1128/JVI.75.20.9991-9994.2001; Raghavan V, 2004, J VIROL, V78, P2405, DOI 10.1128/JVI.78.5.2405-2413.2004; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/pnas.79.6.2077; SAMULSKI RJ, 1983, CELL, V33, P135, DOI 10.1016/0092-8674(83)90342-2; SCHIESTL RH, 1991, P NATL ACAD SCI USA, V88, P7585, DOI 10.1073/pnas.88.17.7585; SCHIESTL RH, 1993, MOL CELL BIOL, V13, P2697, DOI 10.1128/MCB.13.5.2697; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; Smith RH, 1998, J VIROL, V72, P4874, DOI 10.1128/JVI.72.6.4874-4881.1998; Stanley M, 2007, BRIT J CANCER, V96, P1320, DOI 10.1038/sj.bjc.6603695; Surosky RT, 1997, J VIROL, V71, P7951, DOI 10.1128/JVI.71.10.7951-7959.1997; Tullis GE, 2000, J VIROL, V74, P11511, DOI 10.1128/JVI.74.24.11511-11521.2000; Urabe M, 2006, J VIROL, V80, P1874, DOI 10.1128/JVI.80.4.1874-1885.2006; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; WANG XS, 1995, J MOL BIOL, V250, P573, DOI 10.1006/jmbi.1995.0398; Wang XS, 1996, J VIROL, V70, P1668, DOI 10.1128/JVI.70.3.1668-1677.1996; Ward P, 2003, J VIROL, V77, P11480, DOI 10.1128/JVI.77.21.11480-11490.2003; WARD P, 1991, J MOL BIOL, V218, P791, DOI 10.1016/0022-2836(91)90267-A; WARD P, 1994, J VIROL, V68, P6029, DOI 10.1128/JVI.68.9.6029-6037.1994; Xiao X, 1997, J VIROL, V71, P941, DOI 10.1128/JVI.71.2.941-948.1997; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; YALKINOGLU AO, 1991, J VIROL, V65, P3175, DOI 10.1128/JVI.65.6.3175-3184.1991; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001; Zhou CH, 1999, BBA-GENE STRUCT EXPR, V1444, P371, DOI 10.1016/S0167-4781(99)00014-7	58	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23474	10.1371/journal.pone.0023474	http://dx.doi.org/10.1371/journal.pone.0023474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853137	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200088
J	Choudhury, SR; Bisht, NC; Thompson, R; Todorov, O; Pandey, S				Choudhury, Swarup Roy; Bisht, Naveen C.; Thompson, Rheannon; Todorov, Oleg; Pandey, Sona			Conventional and Novel G gamma Protein Families Constitute the Heterotrimeric G-Protein Signaling Network in Soybean	PLOS ONE			English	Article							GTP-BINDING PROTEINS; ARABIDOPSIS-THALIANA; G-BETA; EXTRA-LARGE; NATURAL VARIATION; COUPLED RECEPTOR; CONTROL REGION; BLUE-LIGHT; SUBUNIT; ACID	Heterotrimeric G-proteins comprised of G alpha, G beta and G gamma proteins are important signal transducers in all eukaryotes. The G gamma protein of the G-protein heterotrimer is crucial for its proper targeting at the plasma membrane and correct functioning. G gamma proteins are significantly smaller and more diverse than the G alpha and G beta proteins. In model plants Arabidopsis and rice that have a single G alpha and G beta protein, the presence of two canonical G gamma proteins provide some diversity to the possible heterotrimeric combinations. Our recent analysis of the latest version of the soybean genome has identified ten G gamma proteins which belong to three distinct families based on their C-termini. We amplified the full length cDNAs, analyzed their detailed expression profile by quantitative PCR, assessed their localization and performed yeast-based interaction analysis to evaluate interaction specificity with different G beta proteins. Our results show that ten G gamma genes are retained in the soybean genome and have interesting expression profiles across different developmental stages. Six of the newly identified proteins belong to two plant-specific G gamma protein families. Yeast-based interaction analyses predict some degree of interaction specificity between different G beta and G gamma proteins. This research thus identifies a highly diverse G-protein network from a plant species. Homologs of these novel proteins have been previously identified as QTLs for grain size and yield in rice.	[Choudhury, Swarup Roy; Bisht, Naveen C.; Thompson, Rheannon; Todorov, Oleg; Pandey, Sona] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Choudhury, SR (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.		Pandey, Sona/M-2847-2013	Pandey, Sona/0000-0002-5570-3120	National Institute for Plant Genome Research, India; National Science Foundation [0851838]; United States Department of Agriculture/Agriculture and Food Research Initiative [2010-65116-20454]	National Institute for Plant Genome Research, India; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture/Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	NB was supported by a visiting scholar fellowship from National Institute for Plant Genome Research, India and RT was supported by an National Science Foundation-Research Experiences for Undergraduates grant, (0851838). This work was supported by a United States Department of Agriculture/Agriculture and Food Research Initiative grant to SP, (2010-65116-20454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Bisht NC, 2011, NEW PHYTOL, V190, P35, DOI 10.1111/j.1469-8137.2010.03581.x; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen Jin-Gui, 2008, Front Biosci, V13, P3321; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Crowell DN, 2009, TRENDS PLANT SCI, V14, P163, DOI 10.1016/j.tplants.2008.12.001; De Los Santos-Briones C, 2009, PHYSIOL PLANTARUM, V135, P237, DOI 10.1111/j.1399-3054.2008.01184.x; den Hartog M, 2001, PLANT J, V25, P55, DOI 10.1046/j.1365-313x.2001.00931.x; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; Dingus J, 2005, BIOCHEMISTRY-US, V44, P11882, DOI 10.1021/bi0504254; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; FUKADA Y, 1995, METHOD ENZYMOL, V250, P91; Gautam N, 2003, STRUCTURE, V11, P359, DOI 10.1016/S0969-2126(03)00054-6; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kato C, 2004, PLANT J, V38, P320, DOI 10.1111/j.1365-313X.2004.02046.x; Kelly MN, 2003, PLANTA, V216, P674, DOI 10.1007/s00425-002-0900-8; Kino T, 2005, EUR J CLIN INVEST, V35, P508, DOI 10.1111/j.1365-2362.2005.01539.x; Lee YRJ, 1999, PLANT MOL BIOL, V40, P55, DOI 10.1023/A:1026483823176; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; McIntire WE, 2009, NEUROSIGNALS, V17, P82, DOI 10.1159/000186692; Misra S, 2007, PLANT J, V51, P656, DOI 10.1111/j.1365-313X.2007.03169.x; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pandey S, 2008, PLANT J, V55, P311, DOI 10.1111/j.1365-313X.2008.03506.x; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Pingret JL, 1998, PLANT CELL, V10, P659; Prinz WA, 2009, CRIT REV BIOCHEM MOL, V44, P278, DOI 10.1080/10409230903183472; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Subramanian S, 2004, PLANT MOL BIOL, V54, P623, DOI 10.1023/B:PLAN.0000040814.28507.35; Sun J, 2007, PLANT PHYSIOL, V144, P695, DOI 10.1104/pp.106.093294; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WILCOX MD, 1995, J BIOL CHEM, V270, P4189, DOI 10.1074/jbc.270.9.4189; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583	59	47	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23361	10.1371/journal.pone.0023361	http://dx.doi.org/10.1371/journal.pone.0023361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853116	Green Published, gold, Green Submitted			2022-12-25	WOS:000295454200073
J	Kreutzman, A; Rohon, P; Faber, E; Indrak, K; Juvonen, V; Kairisto, V; Voglova, J; Sinisalo, M; Flochova, E; Vakkila, J; Arstila, P; Porkka, K; Mustjoki, S				Kreutzman, Anna; Rohon, Peter; Faber, Edgar; Indrak, Karel; Juvonen, Vesa; Kairisto, Veli; Voglova, Jaroslava; Sinisalo, Marjatta; Flochova, Emilia; Vakkila, Jukka; Arstila, Petteri; Porkka, Kimmo; Mustjoki, Satu			Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-alpha Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; T-CELLS; BCR-ABL; IMMUNE-SURVEILLANCE; DASATINIB THERAPY; CHRONIC-PHASE; NK CELLS	Before the era of tyrosine kinase inhibitors (TKIs), interferon-alpha (IFN-alpha) was the treatment of choice in chronic myeloid leukemia (CML). Curiously, some IFN-alpha treated patients were able to discontinue therapy without disease progression. The aim of this project was to study the immunomodulatory effects of IFN-alpha in CML patients in prolonged remission and isolate biological markers predicting response. Due to rarity of patients on IFN-alpha monotherapy, a relatively small cohort of patients still on treatment (IFN-ON, n = 10, median therapy duration 11.8 years) or had discontinued IFN-alpha therapy but remained in remission for >2 years (IFN-OFF, n = 9) were studied. The lymphocyte immunophenotype was analyzed with a comprehensive flow cytometry panel and plasma cytokine levels were measured with multiplex bead-based assay. In addition, the clonality status of different lymphocyte subpopulations was analyzed by TCR gamma/delta rearrangement assay. Median NK-cell absolute number and proportion from lymphocytes in blood was higher in IFN-OFF patients as compared to IFN-ON patients or controls (0.42, 0.19, 0.21x10(9)/L; 26%, 12%, 11%, respectively, p<0.001). The proportion of CD8+ T-cells was significantly increased in both patient groups and a larger proportion of T-cells expressed CD45RO. Most (95%) patients had significant numbers of oligoclonal lymphocytes characterized by T-cell receptor gamma/delta rearrangements. Strikingly, in the majority of patients (79%) a distinct clonal V gamma 9 gene rearrangement was observed residing in gamma delta(+) T-cell population. Similar unique clonality pattern was not observed in TKI treated CML patients. Plasma eotaxin and MCP-1 cytokines were significantly increased in IFN-OFF patients. Despite the limited number of patients, our data indicates that IFN-alpha treated CML patients in remission have increased numbers of NK-cells and clonal gamma delta(+) T-cells and a unique plasma cytokine profile. These factors may relate to anti-leukemic effects of IFN-alpha in this specific group of patients and account for prolonged therapy responses even after drug discontinuation.	[Kreutzman, Anna; Rohon, Peter; Vakkila, Jukka; Porkka, Kimmo; Mustjoki, Satu] HUCH, Biomedicum Helsinki, Hematol Res Unit, Helsinki, Finland; [Rohon, Peter; Faber, Edgar; Indrak, Karel] Univ Hosp Olomouc, Dept Hematooncol, Olomouc, Czech Republic; [Juvonen, Vesa; Kairisto, Veli] Turku Univ Cent Hosp, Dept Clin Chem, Turku, Finland; [Juvonen, Vesa; Kairisto, Veli] Turku Univ Cent Hosp, TYKSLAB, Turku, Finland; [Voglova, Jaroslava] Univ Hosp Hradec Kralove, Dept Internal Med 2, Hradec Kralove, Czech Republic; [Sinisalo, Marjatta] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Flochova, Emilia] Univ Hosp Martin, Dept Hematol & Transfusiol, Martin, Slovakia; [Arstila, Petteri] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Porkka, Kimmo; Mustjoki, Satu] HUCH, Dept Med, Div Hematol, Helsinki, Finland; [Mustjoki, Satu] HUCH, Dept Clin Chem, Hematol Lab, Helsinki, Finland	University of Helsinki; University Hospital Olomouc; University of Turku; University of Turku; University Hospital Hradec Kralove; Tampere University; Tampere University Hospital; University of Helsinki	Kreutzman, A (corresponding author), HUCH, Biomedicum Helsinki, Hematol Res Unit, Helsinki, Finland.	satu.mustjoki@helsinki.fi	Kreutzman, Anna/V-5769-2019; Mustjoki, Satu/AAD-9974-2020; Voglová, Jaroslava/D-4227-2019; ROHOŇ, Peter/ABE-5177-2021; Porkka, Kimmo/O-2323-2016	Kreutzman, Anna/0000-0002-5587-8844; Mustjoki, Satu/0000-0002-0816-8241; Porkka, Kimmo/0000-0003-4112-5902	Finnish special government; Finnish Cancer Societies; Emil Aaltonen Foundation; Academy of Finland; Finnish Medical Foundation; Blood Disease Foundation; Finnish Association of Haematology; KA Johansson Foundation; MSMT CR [6198959205, 6198959223, LF_2010_004]; Cancer Foundation Finland sr [110101, 100118] Funding Source: researchfish	Finnish special government; Finnish Cancer Societies; Emil Aaltonen Foundation; Academy of Finland(Academy of Finland); Finnish Medical Foundation; Blood Disease Foundation; Finnish Association of Haematology; KA Johansson Foundation; MSMT CR(Ministry of Education, Youth & Sports - Czech Republic); Cancer Foundation Finland sr	This work was supported by the Finnish special governmental subsidy for health sciences, research and training, by the Finnish Cancer Societies, Emil Aaltonen Foundation, Academy of Finland, Finnish Medical Foundation, Blood Disease Foundation, Finnish Association of Haematology, KA Johansson Foundation, MSMT CR 6198959205 and 6198959223 and LF_2010_004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DF, 1987, CANCER RES, V47, P6629; Barrett AJ, 2009, LEUKEMIA, V23, P53, DOI 10.1038/leu.2008.273; Bhatia R, 1996, BLOOD, V87, P3883, DOI 10.1182/blood.V87.9.3883.bloodjournal8793883; Bocchia M, 2005, LANCET, V365, P657; Bonifazi F, 2001, BLOOD, V98, P3074, DOI 10.1182/blood.V98.10.3074; BREIT TM, 1994, J IMMUNOL, V152, P2860; Burchert A, 2003, BLOOD, V101, P259, DOI 10.1182/blood-2002-02-0659; Burchert A, 2010, J CLIN ONCOL, V28, P1429, DOI 10.1200/JCO.2009.25.5075; Cortes J, 1998, LEUKEMIA, V12, P455, DOI 10.1038/sj.leu.2400965; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Deng M, 2001, BLOOD, V97, P3491, DOI 10.1182/blood.V97.11.3491; DOWDING C, 1991, BLOOD, V78, P499; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferrarini M, 2002, TRENDS IMMUNOL, V23, P14, DOI 10.1016/S1471-4906(01)02110-X; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hochhaus A, 1997, LEUKEMIA, V11, P933, DOI 10.1038/sj.leu.2400723; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Kanodia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011770; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kreutzman A, 2010, BLOOD, V116, P772, DOI 10.1182/blood-2009-12-256800; LEE MS, 1992, BLOOD, V79, P1920; Mahon FX, 2002, J CLIN ONCOL, V20, P214, DOI 10.1200/JCO.20.1.214; Molldrem JJ, 1999, CANCER RES, V59, P2675; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Monti P, 2003, CANCER RES, V63, P7451; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Nicolini FE, 2011, LEUKEMIA RES, V35, P80, DOI 10.1016/j.leukres.2010.04.010; Oka T, 1998, LEUKEMIA, V12, P155, DOI 10.1038/sj.leu.2400919; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Palandri F, 2010, HAEMATOL-HEMATOL J, V95, P1415, DOI 10.3324/haematol.2009.021246; Pane F, 1999, BLOOD, V94, P2200, DOI 10.1182/blood.V94.7.2200.419a33_2200_2207; Pongers-Willemse MJ, 1999, LEUKEMIA, V13, P110, DOI 10.1038/sj.leu.2401245; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Rey J, 2009, TRENDS MOL MED, V15, P275, DOI 10.1016/j.molmed.2009.04.005; Rezvani K, 2003, BLOOD, V102, P2892, DOI 10.1182/blood-2003-01-0150; Rohon P, 2010, EUR J HAEMATOL, V85, P387, DOI 10.1111/j.1600-0609.2010.01501.x; Rojas JM, 2007, LEUKEMIA, V21, P2287, DOI 10.1038/sj.leu.2404858; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Saudemont A, 2005, BLOOD, V105, P2428, DOI 10.1182/blood-2004-09-3458; Savani BN, 2007, LEUKEMIA, V21, P2145, DOI 10.1038/sj.leu.2404892; Siegers GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016700; Simonsson B, 2011, CURR DRUG TARGETS, V12, P420, DOI 10.2174/138945011794815301; TALPAZ M, 1991, ANN INTERN MED, V114, P532, DOI 10.7326/0003-4819-114-7-532; Usuki Kensuke, 2009, Leuk Res, V33, pe164, DOI 10.1016/j.leukres.2009.03.024; Yong ASM, 2009, BLOOD, V113, P875, DOI 10.1182/blood-2008-05-158253	47	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23022	10.1371/journal.pone.0023022	http://dx.doi.org/10.1371/journal.pone.0023022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857985	Green Published, gold, Green Submitted			2022-12-25	WOS:000293774300016
J	Santo, EE; Ebus, ME; Koster, J; Schulte, JH; Lakeman, A; van Sluis, P; Vermeulen, J; Gisselsson, D; Ora, I; Lindner, S; Buckley, PG; Stallings, RL; Vandesompele, J; Eggert, A; Caron, HN; Versteeg, R; Molenaar, JJ				Santo, E. E.; Ebus, M. E.; Koster, J.; Schulte, J. H.; Lakeman, A.; van Sluis, P.; Vermeulen, J.; Gisselsson, D.; Ora, I.; Lindner, S.; Buckley, P. G.; Stallings, R. L.; Vandesompele, J.; Eggert, A.; Caron, H. N.; Versteeg, R.; Molenaar, J. J.			Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma	ONCOGENE			English	Article						FOXR1; FOXO; forkhead-box; neuroblastoma; MLL; 11q23	FORKHEAD TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR GENE; ALVEOLAR RHABDOMYOSARCOMA; EXPRESSION PATTERNS; CELL-SURVIVAL; IN-SILICO; IDENTIFICATION; CANCER; COMMON; MLL	Neuroblastoma tumors frequently show loss of heterozygosity of chromosome 11q with a shortest region of overlap in the 11q23 region. These deletions are thought to cause inactivation of tumor suppressor genes leading to haploinsufficiency. Alternatively, micro-deletions could lead to gene fusion products that are tumor driving. To identify such events we analyzed a series of neuroblastomas by comparative genomic hybridization and single-nucleotide polymorphism arrays and integrated these data with Affymetrix mRNA profiling data with the bioinformatic tool R2 (http://r2.amc.nl). We identified three neuroblastoma samples with small interstitial deletions at 11q23, upstream of the forkhead-box R1 transcription factor (FOXR1). Genes at the proximal side of the deletion were fused to FOXR1, resulting in fusion transcripts of MLL-FOXR1 and PAFAH1B2-FOXR1. FOXR1 expression has only been detected in early embryogenesis. Affymetrix microarray analysis showed high FOXR1 mRNA expression exclusively in the neuroblastomas with micro-deletions and rare cases of other tumor types, including osteosarcoma cell line HOS. RNAi silencing of FOXR1 strongly inhibited proliferation of HOS cells and triggered apoptosis. Expression profiling of these cells and reporter assays suggested that FOXR1 is a negative regulator of fork-head box factor-mediated transcription. The neural crest stem cell line JoMa1 proliferates in culture conditional to activity of a MYC-ER transgene. Over-expression of the wild-type FOXR1 could functionally replace MYC and drive proliferation of JoMa1. We conclude that FOXR1 is recurrently activated in neuroblastoma by intrachromosomal deletion/fusion events, resulting in overexpression of fusion transcripts. Forkhead-box transcription factors have not been previously implicated in neuroblastoma pathogenesis. Furthermore, this is the first identification of intrachromosomal fusion genes in neuroblastoma. Oncogene (2012) 31, 1571-1581; doi:10.1038/onc.2011.344; published online 22 August 2011	[Santo, E. E.; Ebus, M. E.; Koster, J.; Lakeman, A.; van Sluis, P.; Versteeg, R.; Molenaar, J. J.] Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, NL-1105 AZ Amsterdam, Netherlands; [Schulte, J. H.; Lindner, S.; Eggert, A.] Univ Childrens Hosp Essen, Dept Pediat Oncol, Essen, Germany; [Vermeulen, J.; Vandesompele, J.] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Gisselsson, D.; Ora, I.] Lund Univ, Dept Clin Genet, Lund, Sweden; [Buckley, P. G.; Stallings, R. L.] Royal Coll Surgeons Ireland, Natl Childrens Res Ctr, Dept Canc Genet, Dublin, Ireland; [Caron, H. N.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, Emma Kinderziekenhuis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Duisburg Essen; Ghent University; Ghent University Hospital; Lund University; National Children's Research Centre (NCRC); Royal College of Surgeons - Ireland; Trinity College Dublin; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Molenaar, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, M1-132,Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	j.j.molenaar@amc.uva.nl	Eggert, Angelika/AAE-6907-2022; Koster, Jan/C-5934-2008; Schulte, Johannes H./V-2474-2018; Schulte, Johannes H/G-3981-2010; Øra, Ingrid/J-2596-2013; Vandesompele, Jo/W-3411-2018; Stallings, Raymond/A-7213-2008; Versteeg, Rogier/AAQ-1765-2020	Eggert, Angelika/0000-0003-3476-8184; Koster, Jan/0000-0002-0890-7585; Øra, Ingrid/0000-0002-3931-4125; Vandesompele, Jo/0000-0001-6274-0184; Schulte, Johannes Hubertus/0000-0003-0671-1201; Versteeg, Rogier/0000-0001-7172-0388	Stichting Koningin Wilhelmina Fonds (KWF); Stichting Kindergeneeskundig Kankeronderzoek (SKK); Stichting Kinderen Kankervrij (KiKa)	Stichting Koningin Wilhelmina Fonds (KWF); Stichting Kindergeneeskundig Kankeronderzoek (SKK); Stichting Kinderen Kankervrij (KiKa)	This work was supported by the Stichting Koningin Wilhelmina Fonds (KWF), Stichting Kindergeneeskundig Kankeronderzoek (SKK) and the Stichting Kinderen Kankervrij (KiKa).	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; DAVIS RJ, 1994, CANCER RES, V54, P2869; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gomez-Ferreria MA, 2003, J MOL BIOL, V329, P631, DOI 10.1016/S0022-2836(03)00524-2; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; HAMPTON GM, 1994, CANCER RES, V54, P4586; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoeller S, 2010, HISTOPATHOLOGY, V57, P73, DOI 10.1111/j.1365-2559.2010.03600.x; Katoh M, 2004, INT J MOL MED, V14, P463; Katoh M, 2004, INT J ONCOL, V25, P219; Katoh M, 2004, INT J ONCOL, V24, P1339; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lee ASG, 2000, BRIT J CANCER, V83, P750, DOI 10.1054/bjoc.2000.1366; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Martinez MJ, 2007, BIOINFORMATICS, V23, P21, DOI 10.1093/bioinformatics/btl531; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nowacki S, 2008, ONCOGENE, V27, P3329, DOI 10.1038/sj.onc.1210996; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pulido HA, 2000, CANCER RES, V60, P6677; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Schuff M, 2006, INT J DEV BIOL, V50, P429, DOI 10.1387/ijdb.052126ms; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	41	43	44	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	12					1571	1581		10.1038/onc.2011.344	http://dx.doi.org/10.1038/onc.2011.344			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21860421				2022-12-25	WOS:000302132000009
J	Adwan, TS; Ohm, AM; Jones, DNM; Humphries, MJ; Reyland, ME				Adwan, Tariq S.; Ohm, Angela M.; Jones, David N. M.; Humphries, Michael J.; Reyland, Mary E.			Regulated Binding of Importin-alpha to Protein Kinase C delta in Response to Apoptotic Signals Facilitates Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLAND ACINAR-CELLS; SALIVARY EPITHELIAL-CELLS; ABL TYROSINE KINASE; PKC-DELTA; LOCALIZATION SIGNALS; DNA-DAMAGE; PHOSPHORYLATION; ACTIVATION; HSP90; TRANSLOCATION	PKC delta translocates into the nucleus in response to apoptotic agents and functions as a potent cell death signal. Cytoplasmic retention of PKC delta and its transport into the nucleus are essential for cell homeostasis, but how these processes are regulated is poorly understood. We show that PKC delta resides in the cytoplasm in a conformation that precludes binding of importin-alpha. A structural model of PKC delta in the inactive state suggests that the nuclear localization sequence (NLS) is prevented from binding to importin-alpha through intramolecular contacts between the C2 and catalytic domains. We have previously shown that PKC delta is phosphorylated on specific tyrosine residues in response to apoptotic agents. Here, we show that phosphorylation of PKC delta at Tyr-64 and Tyr-155 results in a conformational change that allows exposure of the NLS and binding of importin-alpha. In addition, Hsp90 binds to PKC delta with similar kinetics as importin-alpha and is required for the interaction of importin-alpha with the NLS. Finally, we elucidate a role for a conserved PPxxP motif, which overlaps the NLS, in nuclear exclusion of PKC delta. Mutagenesis of the conserved prolines to alanines enhanced importin-alpha binding to PKC delta and induced its nuclear import in resting cells. Thus, the PPxxP motif is important for maintaining a conformation that facilitates cytosplasmic retention of PKC delta. Taken together, this study establishes a novel mechanism that retains PKC delta in the cytoplasm of resting cells and regulates its nuclear import in response to apoptotic stimuli.	[Adwan, Tariq S.; Humphries, Michael J.; Reyland, Mary E.] Univ Colorado, Program Cell Biol Stem Cells & Dev, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Ohm, Angela M.; Reyland, Mary E.] Univ Colorado, Dept Craniofacial Biol, Sch Dent Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Program Cell Biol Stem Cells & Dev, Mail Stop 8120,POB 6511,Anschutz Med Campus, Aurora, CO 80045 USA.	Mary.Reyland@UCDenver.edu	Jones, David N/C-5764-2013		NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA046934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acs P, 2000, CARCINOGENESIS, V21, P887, DOI 10.1093/carcin/21.5.887; An WG, 2000, CELL GROWTH DIFFER, V11, P355; Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Damelin M, 2002, METHOD ENZYMOL, V351, P587; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Feldherr C, 2002, J CELL SCI, V115, P2997; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Jackson D, 2005, ONCOGENE, V24, P3067, DOI 10.1038/sj.onc.1208465; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kakuk A, 2008, EXP CELL RES, V314, P2376, DOI 10.1016/j.yexcr.2008.05.006; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leitges M, 2001, J CLIN INVEST, V108, P1505; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; Li WQ, 1996, J BIOL CHEM, V271, P26404, DOI 10.1074/jbc.271.42.26404; Liu J, 2010, J TISSUE ENG REGEN M, V4, P329, DOI 10.1002/term.242; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Matassa A, 2003, CELL DEATH DIFFER, V10, P269, DOI 10.1038/sj.cdd.4401149; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Solodukhin AS, 2007, CELL SIGNAL, V19, P2035, DOI 10.1016/j.cellsig.2007.05.010; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Tapia JA, 2003, J BIOL CHEM, V278, P35220, DOI 10.1074/jbc.M303119200; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yoshida K, 2005, CELL CYCLE, V4, P777, DOI 10.4161/cc.4.6.1746; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698	56	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35716	35724		10.1074/jbc.M111.255950	http://dx.doi.org/10.1074/jbc.M111.255950			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865164	Green Published, hybrid			2022-12-25	WOS:000295927100044
J	Bueter, CL; Lee, CK; Rathinam, VAK; Healy, GJ; Taron, CH; Specht, CA; Levitz, SM				Bueter, Chelsea L.; Lee, Chrono K.; Rathinam, Vijay A. K.; Healy, Gloria J.; Taron, Christopher H.; Specht, Charles A.; Levitz, Stuart M.			Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN CANDIDA-ALBICANS; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; NLRP3 INFLAMMASOME; DENDRITIC CELLS; BRUGIA-MALAYI; CUTTING EDGE; HOST-DEFENSE; INNATE; MACROPHAGES	Chitin is an abundant polysaccharide found in fungal cell walls, crustacean shells, and insect exoskeletons. The immunological properties of both chitin and its deacetylated derivative chitosan are of relevance because of frequent natural exposure and their use in medical applications. Depending on the preparation studied and the end point measured, these compounds have been reported to induce allergic responses, inflammatory responses, or no response at all. We prepared highly purified chitosan and chitin and examined the capacity of these glycans to stimulate murine macrophages to release the inflammasome-associated cytokine IL-1 beta. We found that although chitosan was a potent NLRP3 inflammasome activator, acetylation of the chitosan to chitin resulted in a near total loss of activity. The size of the chitosan particles played an important role, with small particles eliciting the greatest activity. An inverse relationship between size and stimulatory activity was demonstrated using chitosan passed through size exclusion filters as well as with chitosan-coated beads of defined size. Partial digestion of chitosan with pepsin resulted in a larger fraction of small phagocytosable particles and more potent inflammasome activity. Inhibition of phagocytosis with cytochalasin D abolished the IL-1 beta stimulatory activity of chitosan, offering an explanation for why the largest particles were nearly devoid of activity. Thus, the deacetylated polysaccharide chitosan potently activates the NLRP3 inflammasome in a phagocytosis-dependent manner. In contrast, chitin is relatively inert.	[Levitz, Stuart M.] Univ Massachusetts, Med Ctr, Dept Med, Sch Med, Worcester, MA 01605 USA; [Rathinam, Vijay A. K.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Healy, Gloria J.; Taron, Christopher H.] New England Biolabs Inc, Ipswich, MA 01938 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; New England Biolabs	Levitz, SM (corresponding author), Univ Massachusetts, Med Ctr, Dept Med, Sch Med, 346 Plantat St,LRB317, Worcester, MA 01605 USA.	stuart.levitz@umassmed.edu	Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Taron, Christopher/0000-0001-8149-4556	National Institutes of Health [RO1 AI025780, R21 AI093302-01, RO1 AI066087]; University of Massachusetts Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066087, T32AI095213, R01AI025780, R21AI093302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI025780, R21 AI093302-01, and RO1 AI066087. This work was also supported by the University of Massachusetts Medical School.	Aranaz I., 2009, CURR CHEM BIOL, V3, P203, DOI [10.2174/187231309788166415, DOI 10.2174/187231309788166415]; ARAUJO ACG, 1993, J HISTOCHEM CYTOCHEM, V41, P571, DOI 10.1177/41.4.8450196; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; ESCOTT GM, 1995, INFECT IMMUN, V63, P4770, DOI 10.1128/IAI.63.12.4770-4773.1995; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; FUHRMAN JA, 1985, MOL BIOCHEM PARASIT, V17, P93, DOI 10.1016/0166-6851(85)90130-6; GAL AE, 1968, ANAL BIOCHEM, V24, P452, DOI 10.1016/0003-2697(68)90152-8; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gorzelanny C, 2010, BIOMATERIALS, V31, P8556, DOI 10.1016/j.biomaterials.2010.07.100; GOW NAR, 1980, CURR MICROBIOL, V4, P357, DOI 10.1007/BF02605377; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; HUNSLEY D, 1968, NATURE, V218, P462, DOI 10.1038/218462a0; Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001; JOHNSON CR, 1983, J IMMUNOL METHODS, V65, P319, DOI 10.1016/0022-1759(83)90127-8; Kang ML, 2006, EUR J PHARM BIOPHARM, V63, P215, DOI 10.1016/j.ejpb.2006.01.010; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Lenardon MD, 2007, MOL MICROBIOL, V66, P1164, DOI 10.1111/j.1365-2958.2007.05990.x; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McNeela EA, 2004, VACCINE, V22, P909, DOI 10.1016/j.vaccine.2003.09.012; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Morganti P, 2008, CLIN DERMATOL, V26, P334, DOI 10.1016/j.clindermatol.2008.01.003; Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020; Netea MG, 2004, MICROBES INFECT, V6, P985, DOI 10.1016/j.micinf.2004.05.013; NEVILLE AC, 1976, J CELL SCI, V21, P73; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; Read RC, 2005, VACCINE, V23, P4367, DOI 10.1016/j.vaccine.2005.04.021; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Roncal T, 2007, CARBOHYD RES, V342, P2750, DOI 10.1016/j.carres.2007.08.023; SHAHABUDDIN M, 1994, EXP PARASITOL, V79, P85, DOI 10.1006/expr.1994.1066; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shibata Y, 1997, INFECT IMMUN, V65, P1734, DOI 10.1128/IAI.65.5.1734-1741.1997; SOMLYO B, 1992, INT J IMMUNOPHARMACO, V14, P131, DOI 10.1016/0192-0561(92)90023-E; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; van der Lubben IM, 2003, VACCINE, V21, P1400, DOI 10.1016/S0264-410X(02)00686-2; van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1; Wagner CJ, 2010, EUR J IMMUNOL, V40, P2882, DOI 10.1002/eji.201040422	59	127	133	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35447	35455		10.1074/jbc.M111.274936	http://dx.doi.org/10.1074/jbc.M111.274936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862582	Green Published, hybrid			2022-12-25	WOS:000295927100016
J	House, PK; Vyas, A; Sapolsky, R				House, Patrick K.; Vyas, Ajai; Sapolsky, Robert			Predator Cat Odors Activate Sexual Arousal Pathways in Brains of Toxoplasma gondii Infected Rats	PLOS ONE			English	Article							HOST BEHAVIOR; SCHIZOPHRENIA; MANIPULATION; SPECIFICITY; ANTIBODIES; PARASITES; AMYGDALA; AGENTS	Cat odors induce rapid, innate and stereotyped defensive behaviors in rats at first exposure, a presumed response to the evolutionary pressures of predation. Bizarrely, rats infected with the brain parasite Toxoplasma gondii approach the cat odors they typically avoid. Since the protozoan Toxoplasma requires the cat to sexually reproduce, this change in host behavior is thought to be a remarkable example of a parasite manipulating a mammalian host for its own benefit. Toxoplasma does not influence host response to non-feline predator odor nor does it alter behavior on olfactory, social, fear or anxiety tests, arguing for specific manipulation in the processing of cat odor. We report that Toxoplasma infection alters neural activity in limbic brain areas necessary for innate defensive behavior in response to cat odor. Moreover, Toxoplasma increases activity in nearby limbic regions of sexual attraction when the rat is exposed to cat urine, compelling evidence that Toxoplasma overwhelms the innate fear response by causing, in its stead, a type of sexual attraction to the normally aversive cat odor.	[House, Patrick K.] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Vyas, Ajai] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Sapolsky, Robert] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sapolsky, Robert] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Sapolsky, Robert] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University; Stanford University; Stanford University	House, PK (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA 94305 USA.	pathouse@stanford.edu	Vyas, Ajai/A-2223-2011	Vyas, Ajai/0000-0002-2592-6796	National Institutes of Health [5R01 MH079296]; Stanley Medical Research Institute [06R-1463]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (5R01 MH079296) and The Stanley Medical Research Institute (06R-1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Cetinkaya Z, 2007, SCHIZOPHRENIA BULL, V33, P789, DOI 10.1093/schbul/sbm021; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Goodson JL, 2009, FRONT NEUROENDOCRIN, V30, P429, DOI 10.1016/j.yfrne.2009.05.007; Kuris AM, 2007, INT J PARASITOL, V37, P539, DOI 10.1016/j.ijpara.2006.12.003; Lafferty KD, 2006, P ROY SOC B-BIOL SCI, V273, P2749, DOI 10.1098/rspb.2006.3641; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; Leweke FM, 2004, EUR ARCH PSY CLIN N, V254, P4, DOI 10.1007/s00406-004-0481-6; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Maras PM, 2006, EUR J NEUROSCI, V24, P3541, DOI 10.1111/j.1460-9568.2006.05216.x; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413	21	94	97	1	263	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23277	10.1371/journal.pone.0023277	http://dx.doi.org/10.1371/journal.pone.0023277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858053	Green Published, gold			2022-12-25	WOS:000294121300027
J	Kim, DM; Yun, NR; Neupane, GP; Shin, SH; Ryu, SY; Yoon, HJ; Wie, SH; Kim, WJ; Lee, CY; Choi, JS; Yang, TY				Kim, Dong-Min; Yun, Na Ra; Neupane, Ganesh Prasad; Shin, Sung Heui; Ryu, So Yeon; Yoon, Hee Jung; Wie, Seong Heon; Kim, Woo Jin; Lee, Chang Youl; Choi, Jong Soo; Yang, Tae Young			Differences in Clinical Features According to Boryoung and Karp Genotypes of Orientia tsutsugamushi	PLOS ONE			English	Article							SCRUB TYPHUS; GEOGRAPHIC-DISTRIBUTION; VIRULENCE; SEROTYPES; THAILAND; HUMANS	Background: Scrub typhus is an infectious disease caused by Orientia tsutsugamushi. The differences in virulence of O. tsutsugamushi prototypes in humans are still unknown. We investigated whether there are any differences in the clinical features of the Boryoung and Karp genotypes. Methodology/Principal Findings: Patients infected with O. tsutsugamushi, as Boryoung and Karp clusters, who had visited 6 different hospitals in southwestern Korea were prospectively compared for clinical features, complications, laboratory parameters, and treatment responses. Infected patients in the Boryoung cluster had significantly more generalized weakness, eschars, skin rashes, conjunctival injection, high albumin levels, and greater ESR and fibrinogen levels compared to the Karp cluster. The treatment response to current antibiotics was significantly slower in the Karp cluster as compared to the Boryoung cluster. Conclusion: The frequency of occurrence of eschars and rashes may depend on the genotype of O. tsutsugamushi.	[Kim, Dong-Min; Yun, Na Ra; Neupane, Ganesh Prasad] Chosun Univ, Sch Med, Dept Internal Med, Div Infect Dis, Kwangju, South Korea; [Shin, Sung Heui] Chosun Univ, Sch Med, Dept Microbiol, Kwangju, South Korea; [Ryu, So Yeon] Chosun Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea; [Yoon, Hee Jung] Eulji Univ, Coll Med, Dept Internal Med, Taejon, South Korea; [Wie, Seong Heon] Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Sch Med, Suwon, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Chunchon, South Korea; [Lee, Chang Youl] Hallym Univ, Med Ctr, Chuncheon Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med,Dept Internal Me, Chunchon, South Korea; [Choi, Jong Soo] Univ Ulsan, Coll Med, Dept Internal Med, Gangneung Asan Hosp, Kangnung, South Korea; [Choi, Jong Soo] Haenam Gen Hosp, Dept Internal Med, Haenam, South Korea; [Kim, Dong-Min; Shin, Sung Heui] MRC, Res Ctr Resistant Cells, Kwangju, South Korea	Chosun University; Chosun University; Chosun University; Eulji University; Catholic University of Korea; Kangwon National University; Hallym University; University of Ulsan	Kim, DM (corresponding author), Chosun Univ, Sch Med, Dept Internal Med, Div Infect Dis, Kwangju, South Korea.	drongkim@chosun.ac.kr; wiesh@chollian.net		Kim, Dong-Min/0000-0001-6373-0922				Agrawal S, 1999, Indian J Gastroenterol, V18, P5; BERMAN SJ, 1973, ANN INTERN MED, V79, P26, DOI 10.7326/0003-4819-79-1-26; BLAKE FG, 1945, AM J PUBLIC HEALTH, V35, P1121; Chang Woo-Hyun, 1995, Journal of Korean Medical Science, V10, P227; Chu H, 2010, J MICROBIOL, V48, P124, DOI 10.1007/s12275-009-0267-7; Enatsu T, 1999, FEMS MICROBIOL LETT, V180, P163, DOI 10.1111/j.1574-6968.1999.tb08791.x; Fournier PE, 2008, CLIN MICROBIOL INFEC, V14, P168, DOI 10.1111/j.1469-0691.2007.01889.x; GROVES MG, 1978, INFECT IMMUN, V19, P583, DOI 10.1128/IAI.19.2.583-588.1978; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kim DM, 2007, AM J TROP MED HYG, V76, P806; Kim DM, 2006, CLIN INFECT DIS, V43, P1296, DOI 10.1086/508464; Manosroi J, 2006, DIAGN MICR INFEC DIS, V55, P185, DOI 10.1016/j.diagmicrobio.2006.01.014; Nagano I, 1996, MICROBIOL IMMUNOL, V40, P743, DOI 10.1111/j.1348-0421.1996.tb01135.x; Parola P, 2008, EMERG INFECT DIS, V14, P1483, DOI 10.3201/eid1409.071259; Premaratna R, 2006, Clin Infect Dis, V42, pe6, DOI 10.1086/498747; Ree HI, 2001, AM J TROP MED HYG, V65, P528, DOI 10.4269/ajtmh.2001.65.528; Saini Ritu, 2004, J Am Acad Dermatol, V51, pS137, DOI 10.1016/j.jaad.2004.03.036; SAYEN JJ, 1946, MEDICINE, V25, P155, DOI 10.1097/00005792-194605000-00003; Shishime E, 1987, Kansenshogaku Zasshi, V61, P297; Silpapojakul K, 2004, T ROY SOC TROP MED H, V98, P354, DOI 10.1016/j.trstmh.2003.10.011; SILPAPOJAKUL K, 1991, PEDIATR INFECT DIS J, V10, P200, DOI 10.1097/00006454-199103000-00006; SIPE JD, 1995, SEMIN ARTHRITIS RHEU, V25, P75, DOI 10.1016/S0049-0172(95)80020-4; TAMURA A, 1995, INT J SYST BACTERIOL, V45, P589, DOI 10.1099/00207713-45-3-589; Tamura A, 2001, MICROBIOL IMMUNOL, V45, P439, DOI 10.1111/j.1348-0421.2001.tb02643.x; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Yu MJ, 2000, CRIT CARE MED, V28, P1777, DOI 10.1097/00003246-200006000-00013	26	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e22731	10.1371/journal.pone.0022731	http://dx.doi.org/10.1371/journal.pone.0022731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21857951	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953700001
J	Atsumi, Y; Fujimori, H; Fukuda, H; Inase, A; Shinohe, K; Yoshioka, Y; Shikanai, M; Ichijima, Y; Unno, J; Mizutani, S; Tsuchiya, N; Hippo, Y; Nakagama, H; Masutani, M; Teraoka, H; Yoshioka, K				Atsumi, Yuko; Fujimori, Hiroaki; Fukuda, Hirokazu; Inase, Aki; Shinohe, Keitaro; Yoshioka, Yoshiko; Shikanai, Mima; Ichijima, Yosuke; Unno, Junya; Mizutani, Shuki; Tsuchiya, Naoto; Hippo, Yoshitaka; Nakagama, Hitoshi; Masutani, Mitsuko; Teraoka, Hirobumi; Yoshioka, Ken-ichi			Onset of Quiescence Following p53 Mediated Down-Regulation of H2AX in Normal Cells	PLOS ONE			English	Article							DNA-DAMAGE; GENOMIC INSTABILITY; ARF/P53 PATHWAY; HISTONE H2AX; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; CANCER; MICE; ACTIVATION; LESIONS	Normal cells, both in vivo and in vitro, become quiescent after serial cell proliferation. During this process, cells can develop immortality with genomic instability, although the mechanisms by which this is regulated are unclear. Here, we show that a growth-arrested cellular status is produced by the down-regulation of histone H2AX in normal cells. Normal mouse embryonic fibroblast cells preserve an H2AX diminished quiescent status through p53 regulation and stable-diploidy maintenance. However, such quiescence is abrogated under continuous growth stimulation, inducing DNA replication stress. Because DNA replication stress-associated lesions are cryptogenic and capable of mediating chromosome-bridge formation and cytokinesis failure, this results in tetraploidization. Arf/p53 module-mutation is induced during tetraploidization with the resulting H2AX recovery and immortality acquisition. Thus, although cellular homeostasis is preserved under quiescence with stable diploidy, tetraploidization induced under growth stimulation disrupts the homeostasis and triggers immortality acquisition.	[Atsumi, Yuko; Fujimori, Hiroaki; Masutani, Mitsuko; Yoshioka, Ken-ichi] Natl Canc Ctr, Res Inst, Div Genome Stabil Res, Tokyo 104, Japan; [Fukuda, Hirokazu; Inase, Aki; Tsuchiya, Naoto; Hippo, Yoshitaka; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Fujimori, Hiroaki; Shinohe, Keitaro; Yoshioka, Yoshiko; Shikanai, Mima; Ichijima, Yosuke; Teraoka, Hirobumi; Yoshioka, Ken-ichi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo, Japan; [Unno, Junya; Mizutani, Shuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Atsumi, Y (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Stabil Res, Tokyo 104, Japan.	kyoshiok@ncc.go.jp			MEXT KAKENHI [20770136, 20659047]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT KAKENHI (20770136 and 20659047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; DANES BS, 1978, CANCER-AM CANCER SOC, V41, P2330, DOI 10.1002/1097-0142(197806)41:6<2330::AID-CNCR2820410635>3.0.CO;2-X; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Geigl JB, 2004, CANCER RES, V64, P8550, DOI 10.1158/0008-5472.CAN-04-2151; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lengauer C, 1997, NATURE, V386, P632; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tatemichi M, 2004, INT J CANCER, V111, P819, DOI 10.1002/ijc.20350; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	38	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23432	10.1371/journal.pone.0023432	http://dx.doi.org/10.1371/journal.pone.0023432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858116	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953500040
J	Bates, AJ; Sadler, JP; Fairbrass, AJ; Falk, SJ; Hale, JD; Matthews, TJ				Bates, Adam J.; Sadler, Jon P.; Fairbrass, Alison J.; Falk, Steven J.; Hale, James D.; Matthews, Tom J.			Changing Bee and Hoverfly Pollinator Assemblages along an Urban-Rural Gradient	PLOS ONE			English	Article							LAND-USE; FORAGING RANGES; HYMENOPTERA; LANDSCAPE; CONSERVATION; ENVIRONMENT; COMMUNITIES; BUMBLEBEE; DECLINES; DIPTERA	Background: The potential for reduced pollination ecosystem service due to global declines of bees and other pollinators is cause for considerable concern. Habitat degradation, destruction and fragmentation due to agricultural intensification have historically been the main causes of this pollinator decline. However, despite increasing and accelerating levels of global urbanization, very little research has investigated the effects of urbanization on pollinator assemblages. We assessed changes in the diversity, abundance and species composition of bee and hoverfly pollinator assemblages in urban, suburban, and rural sites across a UK city. Methodology/Principal Findings: Bees and hoverflies were trapped and netted at 24 sites of similar habitat character (churchyards and cemeteries) that varied in position along a gradient of urbanization. Local habitat quality (altitude, shelter from wind, diversity and abundance of flowers), and the broader-scale degree of urbanization (e. g. percentage of built landscape and gardens within 100 m, 250 m, 500 m, 1 km, and 2.5 km of the site) were assessed for each study site. The diversity and abundance of pollinators were both significantly negatively associated with higher levels of urbanization. Assemblage composition changed along the urbanization gradient with some species positively associated with urban and suburban land-use, but more species negatively so. Pollinator assemblages were positively affected by good site habitat quality, in particular the availability of flowering plants. Conclusions/Significance: Our results show that urban areas can support diverse pollinator assemblages, but that this capacity is strongly affected by local habitat quality. Nonetheless, in both urban and suburban areas of the city the assemblages had fewer individuals and lower diversity than similar rural habitats. The unique development histories of different urban areas, and the difficulty of assessing mobile pollinator assemblages in just part of their range, mean that complementary studies in different cities and urban habitats are required to discover if these findings are more widely applicable.	[Bates, Adam J.; Sadler, Jon P.; Fairbrass, Alison J.; Hale, James D.; Matthews, Tom J.] Univ Birmingham, Birmingham, W Midlands, England; [Falk, Steven J.] Warwickshire Museum, Warwick, England	University of Birmingham	Bates, AJ (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	a.j.bates@bham.ac.uk	Fairbrass, Alison/K-6563-2016; Bates, Adam/G-1795-2011	Fairbrass, Alison/0000-0002-4907-9683; Hale, James/0000-0001-9662-1853; Bates, Adam/0000-0001-7854-5260; Sadler, Jonathan/0000-0003-0443-4458; Matthews, Thomas/0000-0002-7624-244X	National Lottery (UK);  [EP/E021603]; EPSRC [EP/F007426/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F007426/1] Funding Source: researchfish	National Lottery (UK); ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research is part of the OPAL (Open Air Laboratories) project (http://www.opalexplorenature.org/) which is funded by The National Lottery (UK) through the Big Lottery Fund (http://www.biglotteryfund.org.uk/). The GIS work forms part of the Urban Futures (SUE II) program (EP/E021603) (http://www.epsrc.ac.uk/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Almohamad R, 2009, BIOTECHNOL AGRON SOC, V13, P467; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brodgar, 2010, SOFTWARE PACKAGE DAT; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Colwell RK, 2009, ESTIMATES STAT ESTIM; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; DISNEY R H L, 1982, Field Studies, V5, P607; Drescher AW, 2004, ACTA HORTIC, P227, DOI 10.17660/ActaHortic.2004.643.29; Falk SJ, 2009, WARWICKSHIRES WILDFL; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Ghazoul J, 2010, FRONT ECOL ENVIRON, V8, P9, DOI 10.1890/10.WB.001; GILBERT F, 1990, J ANIM ECOL, V59, P21, DOI 10.2307/5156; Gill S.E., 2007, BUILT ENV, V33, P115, DOI [10.2148/benv.33.1.115, 10.2148/benv.33.1.115., DOI 10.2148/BENV.33.1.115]; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Heard MS, 2007, BIOL LETTERS, V3, P638, DOI 10.1098/rsbl.2007.0425; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kearns CA, 2009, J INSECT CONSERV, V13, P655, DOI 10.1007/s10841-009-9215-4; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Laubertie EA, 2006, ANN APPL BIOL, V148, P173, DOI 10.1111/j.1744-7348.2006.00046.x; Leong JM, 1999, ECOL ENTOMOL, V24, P329, DOI 10.1046/j.1365-2311.1999.00196.x; Leps J, 2003, MULTIVARIATE ANAL EC; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marlin JC, 2001, CONSERV ECOL, V5, part. no.; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Maxwell D, 1998, FOOD POLICY, V23, P411, DOI 10.1016/S0306-9192(98)00047-5; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING GE; Mortberg U, 2000, LANDSCAPE URBAN PLAN, V50, P215, DOI 10.1016/S0169-2046(00)00090-6; Niemela J, 2000, J INSECT CONSERV, V4, P3, DOI 10.1023/A:1009655127440; Niemela J, 2009, LANDSCAPE URBAN PLAN, V92, P65, DOI 10.1016/j.landurbplan.2009.05.016; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Ordnance Survey, 2006, MASTERMAP US GUID VE; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Owen J., 2010, WILDLIFE GARDEN 30 Y; Owen SM, 2006, LANDSCAPE URBAN PLAN, V78, P311, DOI 10.1016/j.landurbplan.2005.11.002; Parris KM, 2006, J ANIM ECOL, V75, P757, DOI 10.1111/j.1365-2656.2006.01096.x; Potts SG, 1997, ECOL ENTOMOL, V22, P319, DOI 10.1046/j.1365-2311.1997.00071.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Development Core Team, 2006, R LANG ENV STAT COMP; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; Samways MJ, 2010, INSECT CONSERVATION; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Small EC, 2002, J INSECT CONSERV, V6, P233, DOI 10.1023/A:1024491111572; Stubbs A. E., 2002, British hoverflies: an illustrated identification guide; TERBRAAK CJF, 1998, CANOCO REFERENCE MAN; Thompson K, 2008, J ECOL, V96, P853, DOI 10.1111/j.1365-2745.2008.01383.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Wheater C. Philip, 2000, USING STAT UNDERSTAN; Williams NSG, 2005, J ECOL, V93, P1203, DOI 10.1111/j.1365-2745.2005.01039.x; Wilson JS, 2008, J KANSAS ENTOMOL SOC, V81, P288, DOI 10.2317/JKES-802.06.1; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	85	212	216	5	361	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23459	10.1371/journal.pone.0023459	http://dx.doi.org/10.1371/journal.pone.0023459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858128	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500043
J	Sirbu, BM; Lachmayer, SJ; Wulfing, V; Marten, LM; Clarkson, KE; Lee, LW; Gheorghiu, L; Zou, L; Powell, SN; Dahm-Daphi, J; Willers, H				Sirbu, Bianca M.; Lachmayer, Sarah J.; Wuelfing, Verena; Marten, Lara M.; Clarkson, Katie E.; Lee, Linda W.; Gheorghiu, Liliana; Zou, Lee; Powell, Simon N.; Dahm-Daphi, Jochen; Willers, Henning			ATR-p53 Restricts Homologous Recombination in Response to Replicative Stress but Does Not Limit DNA Interstrand Crosslink Repair in Lung Cancer Cells	PLOS ONE			English	Article							WILD-TYPE P53; STRAND BREAK REPAIR; TRANSACTIVATION DOMAIN; HOLLIDAY JUNCTIONS; BLM HELICASE; MUTANT P53; PROTEIN-A; CHECKPOINT; PHOSPHORYLATION; DAMAGE	Homologous recombination (HR) is required for the restart of collapsed DNA replication forks and error-free repair of DNA double-strand breaks (DSB). However, unscheduled or hyperactive HR may lead to genomic instability and promote cancer development. The cellular factors that restrict HR processes in mammalian cells are only beginning to be elucidated. The tumor suppressor p53 has been implicated in the suppression of HR though it has remained unclear why p53, as the guardian of the genome, would impair an error-free repair process. Here, we show for the first time that p53 downregulates foci formation of the RAD51 recombinase in response to replicative stress in H1299 lung cancer cells in a manner that is independent of its role as a transcription factor. We find that this downregulation of HR is not only completely dependent on the binding site of p53 with replication protein A but also the ATR/ATM serine 15 phosphorylation site. Genetic analysis suggests that ATR but not ATM kinase modulates p53's function in HR. The suppression of HR by p53 can be bypassed under experimental conditions that cause DSB either directly or indirectly, in line with p53's role as a guardian of the genome. As a result, transactivation-inactive p53 does not compromise the resistance of H1299 cells to the interstrand crosslinking agent mitomycin C. Altogether, our data support a model in which p53 plays an anti-recombinogenic role in the ATR-dependent mammalian replication checkpoint but does not impair a cell's ability to use HR for the removal of DSB induced by cytotoxic agents.	[Sirbu, Bianca M.; Lachmayer, Sarah J.; Wuelfing, Verena; Marten, Lara M.; Clarkson, Katie E.; Lee, Linda W.; Gheorghiu, Liliana; Willers, Henning] Massachusetts Gen Hosp, Ctr Canc, Lab Cellular & Mol Radiat Oncol, Charlestown, MA 02129 USA; [Lachmayer, Sarah J.; Wuelfing, Verena; Marten, Lara M.; Dahm-Daphi, Jochen] Univ Hamburg, Dept Radiat Oncol, Hamburg, Germany; [Zou, Lee] Massachusetts Gen Hosp, Ctr Canc, Ctr Canc Res, Charlestown, MA USA; [Powell, Simon N.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Zou, Lee; Dahm-Daphi, Jochen] Univ Marburg, Inst Radiobiol & Mol Radiat Oncol, Marburg, Germany; [Willers, Henning] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of Hamburg; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Philipps University Marburg; Harvard University; Harvard Medical School	Sirbu, BM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Lab Cellular & Mol Radiat Oncol, Charlestown, MA 02129 USA.	hwillers@partners.org			NCI [R01 CA58985, R01 GM076388]; NCI Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer [P50 CA090578]; Department of Defense [W81XWH-06-1-0309]; Massachusetts General Hospital [C06 CA059267]; Proton Therapy Research and Treatment Center; Deutsche Krebshilfe (German Cancer Aid) [10-1843-Da]; NATIONAL CANCER INSTITUTE [R01CA058985, P50CA090578, C06CA059267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Massachusetts General Hospital(General Electric); Proton Therapy Research and Treatment Center; Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI grants R01 CA58985 (SNP) and R01 GM076388 (LZ), the NCI Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer P50 CA090578 (HW, LZ), Department of Defense W81XWH-06-1-0309 (HW), Federal Share of program income earned by Massachusetts General Hospital on C06 CA059267, Proton Therapy Research and Treatment Center (HW), and Deutsche Krebshilfe (German Cancer Aid) 10-1843-Da (JDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Al Rashid ST, 2005, CANCER RES, V65, P10810, DOI 10.1158/0008-5472.CAN-05-0729; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boehden GS, 2003, ONCOGENE, V22, P4111, DOI 10.1038/sj.onc.1206632; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Bunz F, 2002, CANCER RES, V62, P1129; Dahm-Daphi J, 2000, STRAHLENTHER ONKOL, V176, P278, DOI 10.1007/s000660050010; Dahm-Daphi J, 2005, ONCOGENE, V24, P1663, DOI 10.1038/sj.onc.1208396; Dudenhoffer C, 1999, ONCOGENE, V18, P5773, DOI 10.1038/sj.onc.1202964; Dudenhoffer C, 1998, MOL CELL BIOL, V18, P5332, DOI 10.1128/MCB.18.9.5332; FAN SJ, 1995, CANCER RES, V55, P1649; Fan SJ, 1997, ONCOGENE, V14, P2127, DOI 10.1038/sj.onc.1201052; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Hawkins DS, 1996, CANCER RES, V56, P892; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Huang P, 1998, ONCOGENE, V17, P261, DOI 10.1038/sj.onc.1201946; Janz C, 2002, ONCOGENE, V21, P2130, DOI 10.1038/sj.onc.1205292; Janz C, 2002, ONCOGENE, V21, P5929, DOI 10.1038/sj.onc.1205757; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Linke SP, 2003, CANCER RES, V63, P2596; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Lowry DF, 2008, PROTEINS, V71, P587, DOI 10.1002/prot.21721; Luo CM, 1996, J BIOL CHEM, V271, P4497; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; MOSNER J, 1994, ONCOGENE, V9, P3321; OConnor PM, 1997, CANCER RES, V57, P4285; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Reliene R, 2007, ADV GENET, V58, P67, DOI 10.1016/S0065-2660(06)58003-4; Restle A, 2008, NUCLEIC ACIDS RES, V36, P5362, DOI 10.1093/nar/gkn503; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Saintigny Y, 1999, ONCOGENE, V18, P3553, DOI 10.1038/sj.onc.1202941; Saintigny Y, 2002, ONCOGENE, V21, P488, DOI 10.1038/sj.onc.1205040; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; SHAULSKY G, 1990, ONCOGENE, V5, P1707; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Subramanian D, 2005, BIOCHEMISTRY-US, V44, P2536, DOI 10.1021/bi048700u; Susse S, 2000, ONCOGENE, V19, P4500, DOI 10.1038/sj.onc.1203809; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Warnock LJ, 2008, ONCOGENE, V27, P1639, DOI 10.1038/sj.onc.1210787; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Willers H, 2000, INT J RADIAT BIOL, V76, P1055; Willers H, 2000, ONCOGENE, V19, P632, DOI 10.1038/sj.onc.1203142; Willers H, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/821529; Yang Q, 2002, J BIOL CHEM, V277, P31980, DOI 10.1074/jbc.M204111200; Yun S, 2004, NUCLEIC ACIDS RES, V32, P6479, DOI 10.1093/nar/gkh986; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhou JM, 2003, NUCLEIC ACIDS RES, V31, P3881, DOI 10.1093/nar/gkg468; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	68	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23053	10.1371/journal.pone.0023053	http://dx.doi.org/10.1371/journal.pone.0023053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857991	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500016
J	Tsuji, T; Matsuzaki, J; Ritter, E; Miliotto, A; Ritter, G; Odunsi, K; Old, LJ; Gnjatic, S				Tsuji, Takemasa; Matsuzaki, Junko; Ritter, Erika; Miliotto, Anthony; Ritter, Gerd; Odunsi, Kunle; Old, Lloyd J.; Gnjatic, Sacha			Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4(+) but Not CD8(+) T Cell Responses against p53 in Cancer Patients and Healthy Donors	PLOS ONE			English	Article							LONG PEPTIDE VACCINE; HUMAN COLON-CANCER; NY-ESO-1 PROTEIN; DENDRITIC CELLS; TUMOR-ANTIGEN; BREAST-CANCER; HUMAN CTL; IN-VITRO; IDENTIFICATION; LYMPHOCYTES	Analyses of NY-ESO-1-specific spontaneous immune responses in cancer patients revealed that antibody and both CD4(+) and CD8(+) T cell responses were induced together in cancer patients. To explore whether such integrated immune responses are also spontaneously induced for other tumor antigens, we have evaluated antibody and T cell responses against self/tumor antigen p53 in ovarian cancer patients and healthy individuals. We found that 21% (64/298) of ovarian cancer patients but no healthy donors showed specific IgG responses against wild-type p53 protein. While none of 12 patients with high titer p53 antibody showed spontaneous p53-specific CD8(+) T cell responses following a single in vitro sensitization, significant p53-specific IFN-gamma producing CD4(+) T cells were detected in 6 patients. Surprisingly, similar levels of p53-specific CD4(+) T cells but not CD8(+) T cells were also detected in 5/10 seronegative cancer patients and 9/12 healthy donors. Importantly, p53-specific CD4(+) T cells in healthy donors originated from a CD45RA(-) antigen-experienced T cell population and recognized naturally processed wild-type p53 protein. These results raise the possibility that p53-specific CD4(+) T cells reflect abnormalities in p53 occurring in normal individuals and that they may play a role in processes of immunosurveillance or immunoregulation of p53-related neoplastic events.	[Tsuji, Takemasa; Ritter, Erika; Ritter, Gerd; Old, Lloyd J.; Gnjatic, Sacha] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res Ltd, New York Branch, New York, NY 10021 USA; [Matsuzaki, Junko; Miliotto, Anthony; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA	Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute	Tsuji, T (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res Ltd, New York Branch, 1275 York Ave, New York, NY 10021 USA.	gnjatics@mskcc.org		Ritter, Erika/0000-0002-5161-7874; Matsuzaki, Junko/0000-0002-2555-1234; Tsuji, Takemasa/0000-0001-7563-2211; Gnjatic, Sacha/0000-0001-5643-9520	Cancer Research Institute Ovarian Cancer Working Group; Cancer Research Institute; Ludwig Institute for Cancer Research Ltd.	Cancer Research Institute Ovarian Cancer Working Group; Cancer Research Institute; Ludwig Institute for Cancer Research Ltd.	This work was supported in part by Cancer Research Institute Ovarian Cancer Working Group Grant and the Cancer Vaccine Collaborative funded by Cancer Research Institute and Ludwig Institute for Cancer Research Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AE, 2009, HEAD NECK-J SCI SPEC, V31, P773, DOI 10.1002/hed.21031; Amyes E, 2005, J IMMUNOL, V175, P5765, DOI 10.4049/jimmunol.175.9.5765; Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Barfoed AM, 2000, SCAND J IMMUNOL, V51, P128; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Decraene D, 2001, J PHOTOCH PHOTOBIO B, V63, P78, DOI 10.1016/S1011-1344(01)00204-4; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Enelow RI, 1996, J CLIN INVEST, V98, P914, DOI 10.1172/JCI118874; Eura M, 2000, CLIN CANCER RES, V6, P979; Ferries E, 2001, HUM IMMUNOL, V62, P791, DOI 10.1016/S0198-8859(01)00266-X; GNJATIC S, 1995, EUR J IMMUNOL, V25, P1638, DOI 10.1002/eji.1830250625; Gnjatic S, 2003, P NATL ACAD SCI USA, V100, P8862, DOI 10.1073/pnas.1133324100; Gnjatic S, 1998, J IMMUNOL, V160, P328; Gnjatic S, 2010, INT J CANCER, V127, P381, DOI 10.1002/ijc.25058; Gnjatic Sacha, 2009, V520, P11, DOI 10.1007/978-1-60327-811-9_2; Hasegawa K, 2006, CLIN CANCER RES, V12, P1921, DOI 10.1158/1078-0432.CCR-05-1900; Hernandez J, 2001, J IMMUNOL, V166, P3908, DOI 10.4049/jimmunol.166.6.3908; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kuball J, 2002, GENE THER, V9, P833, DOI 10.1038/sj.gt.3301709; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lauwen MM, 2008, CANCER RES, V68, P893, DOI 10.1158/0008-5472.CAN-07-3166; Leffers N, 2008, GYNECOL ONCOL, V110, P365, DOI 10.1016/j.ygyno.2008.04.043; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Li YL, 2005, INT J CANCER, V114, P157, DOI 10.1002/ijc.20715; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Nijman HW, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-34; Nishikawa H, 2005, BLOOD, V106, P1008, DOI 10.1182/blood-2005-02-0607; Nishikawa H, 2006, J IMMUNOL, V176, P6340, DOI 10.4049/jimmunol.176.10.6340; NOGUCHI Y, 1994, P NATL ACAD SCI USA, V91, P3171, DOI 10.1073/pnas.91.8.3171; NOGUCHI Y, 1995, P NATL ACAD SCI USA, V92, P2219, DOI 10.1073/pnas.92.6.2219; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Offringa R, 2000, ANN NY ACAD SCI, V910, P223; Ohkuri T, 2007, CANCER SCI, V98, P1092, DOI 10.1111/j.1349-7006.2007.00501.x; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Piura B, 2009, J ONCOL, V2009, DOI 10.1155/2009/581939; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Ropke M, 1996, P NATL ACAD SCI USA, V93, P14704, DOI 10.1073/pnas.93.25.14704; Scanlan M J, 2001, Cancer Immun, V1, P4; Scanlan MJ, 2002, CANCER RES, V62, P4041; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Sorensen RB, 2009, CLIN CANCER RES, V15, P1543, DOI 10.1158/1078-0432.CCR-08-1412; Soussi T, 2006, CLIN CANCER RES, V12, P62, DOI 10.1158/1078-0432.CCR-05-0413; Soussi T, 2000, CANCER RES, V60, P1777; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Svane IM, 2007, CANCER IMMUNOL IMMUN, V56, P1485, DOI 10.1007/s00262-007-0293-4; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Theoret MR, 2008, HUM GENE THER, V19, P1219, DOI [10.1089/hum.2008.083, 10.1089/hgt.2008.083]; Tominaga O, 2001, BRIT J CANCER, V84, P57, DOI 10.1054/bjoc.2000.1542; Tsuji T, 2009, J IMMUNOL, V183, P4800, DOI 10.4049/jimmunol.0900903; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; van der Burg SH, 2001, EUR J IMMUNOL, V31, P146, DOI 10.1002/1521-4141(200101)31:1<146::AID-IMMU146>3.0.CO;2-T; Wurtzen PA, 2002, INT J CANCER, V99, P568, DOI 10.1002/ijc.10375; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	60	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23651	10.1371/journal.pone.0023651	http://dx.doi.org/10.1371/journal.pone.0023651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858191	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953500060
J	Campanharo, ASLO; Sirer, MI; Malmgren, RD; Ramos, FM; Amaral, LAN				Campanharo, Andriana S. L. O.; Sirer, M. Irmak; Malmgren, R. Dean; Ramos, Fernando M.; Amaral, Luis A. Nunes			Duality between Time Series and Networks	PLOS ONE			English	Article							COMPLEX NETWORKS	Studying the interaction between a system's components and the temporal evolution of the system are two common ways to uncover and characterize its internal workings. Recently, several maps from a time series to a network have been proposed with the intent of using network metrics to characterize time series. Although these maps demonstrate that different time series result in networks with distinct topological properties, it remains unclear how these topological properties relate to the original time series. Here, we propose a map from a time series to a network with an approximate inverse operation, making it possible to use network statistics to characterize time series and time series statistics to characterize networks. As a proof of concept, we generate an ensemble of time series ranging from periodic to random and confirm that application of the proposed map retains much of the information encoded in the original time series (or networks) after application of the map (or its inverse). Our results suggest that network analysis can be used to distinguish different dynamic regimes in time series and, perhaps more importantly, time series analysis can provide a powerful set of tools that augment the traditional network analysis toolkit to quantify networks in new and useful ways.	[Campanharo, Andriana S. L. O.] Inst Nacl Pesquisas Espaciais, Lab Comp & Appl Math, Sao Paulo, Brazil; [Campanharo, Andriana S. L. O.; Sirer, M. Irmak; Malmgren, R. Dean; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Campanharo, Andriana S. L. O.] Pontificia Univ Catolica Minas Gerais, Dept Comp Engn, Belo Horizonte, MG, Brazil; [Malmgren, R. Dean] Datascope Analyt, Chicago, IL USA; [Ramos, Fernando M.] Inst Nacl Pesquisas Espaciais, Ctr Earth Syst Sci, Sao Paulo, Brazil; [Amaral, Luis A. Nunes] Northwestern Univ, NW Inst Complex Syst, Evanston, IL USA; [Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA	Instituto Nacional de Pesquisas Espaciais (INPE); Northwestern University; Pontificia Universidade Catolica de Minas Gerais; Instituto Nacional de Pesquisas Espaciais (INPE); Northwestern University; Howard Hughes Medical Institute; Northwestern University	Campanharo, ASLO (corresponding author), Inst Nacl Pesquisas Espaciais, Lab Comp & Appl Math, Sao Paulo, Brazil.	amaral@northwestern.edu	Amaral, Luis N./C-5485-2009; Sirer, Mehmet Irmak/E-1072-2013; Campanharo, Andriana S L O/J-4600-2013; Amaral, LAN/A-4980-2008	Sirer, Mehmet Irmak/0000-0002-0300-5582; Campanharo, Andriana S L O/0000-0002-0501-5303; Amaral, LAN/0000-0002-3762-789X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); National Science Foundation (NSF) [SBE 0624318]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil - doctoral fellowship), and National Science Foundation (NSF) award SBE 0624318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aguchi Y., 2009, ICANN 09; [Anonymous], 2011, PHYS RES RES COMPL P, V23; Ao Sio-Long, 2010, APPL TIME SERIES ANA; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Donner RV, 2010, INT J BIFUR IN PRESS; Eckmann J. P., 1987, EUROPHYSICS LETT, V4; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Gao ZK, 2009, CHAOS, V19, DOI 10.1063/1.3227736; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Kantz H., 2003, NONLINEAR TIME SERIE; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Korner T.W., 1988, FOURIER ANAL; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lai C, 2010, EXPERT SYSTEMS APPL, V37; Li P, 2007, PHYSICA A, V378, P519, DOI 10.1016/j.physa.2006.10.089; Lind D., 1995, INTRO SYMBOLIC DYNAM, DOI 10.1017/CBO9780511626302; Lorenz E.N, 1963, J ATMOSPHERIC SCI, V20; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Marwan N., 2009, PHYS LETT A, V46; NetGeo, NETGEO INTERNET GEOG; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicolis G., 2005, INT J BIFURCATION CH, V15; Percival D., 2000, CA ST PR MA; Ramos FM, 2008, PHIL T R SOC A, V366; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Shirazi AH, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07046; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Verplancke T, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-4; Wasserman S., 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu X., 2008, P NATL ACAD SCI US, V105; Yang Y, 2008, PHYSICA A, V387, P1381, DOI 10.1016/j.physa.2007.10.055; Zaldivar J. M., 2009, JRC SCI TECHNICAL RE; Zhang JJ, 2006, Progress on Post-Genome Technologies, P73; Zhang JY, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.093201	39	133	135	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23378	10.1371/journal.pone.0023378	http://dx.doi.org/10.1371/journal.pone.0023378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21858093	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953400041
J	Bever, GS; Brusatte, SL; Balanoff, AM; Norell, MA				Bever, Gabe S.; Brusatte, Stephen L.; Balanoff, Amy M.; Norell, Mark A.			Variation, Variability, and the Origin of the Avian Endocranium: Insights from the Anatomy of Alioramus altai (Theropoda: Tyrannosauroidea)	PLOS ONE			English	Article							TARBOSAURUS-BATAAR THEROPODA; EVOLUTION; DINOSAUR; BRAIN; PHYLOGENY; COMPLEX	The internal braincase anatomy of the holotype of Alioramus altai, a relatively small-bodied tyrannosauroid from the Late Cretaceous of Mongolia, was studied using high-resolution computed tomography. A number of derived characters strengthen the diagnosis of this taxon as both a tyrannosauroid and a unique, new species (e.g., endocranial position of the gasserian ganglion, internal ramification of the facial nerve). Also present are features intermediate between the basal theropod and avialan conditions that optimize as the ancestral condition for Coelurosauria-a diverse group of derived theropods that includes modern birds. The expression of several primitive theropod features as derived character states within Tyrannosauroidea establishes previously unrecognized evolutionary complexity and morphological plasticity at the base of Coelurosauria. It also demonstrates the critical role heterochrony may have played in driving patterns of endocranial variability within the group and potentially reveals stages in the evolution of neuroanatomical development that could not be inferred based solely on developmental observations of the major archosaurian crown clades. We discuss the integration of paleontology with variability studies, especially as applied to the nature of morphological transformations along the phylogenetically long branches that tend to separate the crown clades of major vertebrate groups.	[Bever, Gabe S.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Bever, Gabe S.; Brusatte, Stephen L.; Balanoff, Amy M.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brusatte, Stephen L.; Balanoff, Amy M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA	Yale University; American Museum of Natural History (AMNH); Columbia University	Bever, GS (corresponding author), New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	gbever@nyit.edu	Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319	American Museum of Natural History; National Science Foundation [DEB 1110357, DEB 0909970, DEB-9300700, ATOL 0228693]; Yale University	American Museum of Natural History; National Science Foundation(National Science Foundation (NSF)); Yale University	Funding: This work was funded by the American Museum of Natural History, Yale University, and the National Science Foundation (Graduate Research Fellowship to SLB, Doctoral Dissertation Improvement Grants DEB 1110357 and DEB 0909970 to SLB and MAN and AMB and MAN, respectively, and DEB-9300700 and ATOL 0228693 to MAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2008, J VERTEBR PALEONTOL, V28, P123, DOI 10.1671/0272-4634(2008)28[123:HOTECO]2.0.CO;2; Bever GS, 2011, EVOL DEV, V13, P269, DOI 10.1111/j.1525-142X.2011.00478.x; Bever GS, 2009, B AM MUS NAT HIST, P3; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Bever GS, 2009, J MORPHOL, V270, P97, DOI 10.1002/jmor.10677; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Clabaut C, 2009, EVOL DEV, V11, P636, DOI 10.1111/j.1525-142X.2009.00371.x; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Currie P.J., 1997, ENCY DINOSAURS, P81; DONOGHUE MJ, 1989, ANNU REV ECOL SYST, V20, P431, DOI 10.1146/annurev.es.20.110189.002243; Emerson S.B., 1993, SKULL, V3, P384; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Evans H. E., 1993, HDB AVIAN ANATOMY NO, P585; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Kallersjo M, 1999, CLADISTICS, V15, P91; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Klembara J, 2008, ACTA ZOOLOGICA, V89, P275; Kurzanov S. M., 1976, SOVMESTNAA SOVETSKO, V3, P93; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Lewontin R., 2000, TRIPLE HELIX GENE OR, DOI 10.5061/dryad.f7m0cfxx6; Marugan-Lobon J, 2009, ANAT REC, V292, P364, DOI 10.1002/ar.20865; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Salazar-Ciudad I, 2006, J EXP ZOOL PART B, V306B, P107, DOI 10.1002/jez.b.21078; SAMPSON SD, 2007, SOC VERTEBRATE PALEO, V8, P225; Sanderson Michael J., 1996, P67, DOI 10.1016/B978-012618030-5/50005-8; Saveliev SV, 2007, PALEONTOL J+, V41, P281, DOI 10.1134/S0031030107030070; Sedlmayr, 2002, THESIS OHIO U; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wagner G. P., 2001, CHARACTER CONCEPT EV, P1; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Wagner GP, 2003, J EXP ZOOL PART B, V300B, P1, DOI 10.1002/jez.b.00041; Witmer Lawrence M., 2010, Kirtlandia, V57, P61; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Young RL, 2011, DEV DYNAM, V240, P1042, DOI 10.1002/dvdy.22595; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	53	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23393	10.1371/journal.pone.0023393	http://dx.doi.org/10.1371/journal.pone.0023393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853125	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200079
J	Liang, GY; Schernhammer, E; Qi, L; Gao, X; De Vivo, I; Han, JL				Liang, Geyu; Schernhammer, Eva; Qi, Lu; Gao, Xiang; De Vivo, Immaculata; Han, Jiali			Associations between Rotating Night Shifts, Sleep Duration, and Telomere Length in Women	PLOS ONE			English	Article							LIFE-STYLE FACTORS; BREAST-CANCER; OXIDATIVE DAMAGE; RISK; WORK; MELATONIN; COHORT	Background: Telomere length has been proposed as a marker of aging. However, our knowledge of lifestyle risk factors determining telomere length is limited. Methods: We evaluated the associations between years of rotating night shifts, self-reported sleep duration, and telomere length in 4,117 female participants from the Nurses' Health Study. Telomere length in peripheral blood leukocytes was determined by Real-Time PCR assay. Information on rotating night shifts and sleep duration was collected via questionnaires prior to blood collection. We used multivariable linear regression to investigate the associations between rotating night shifts, sleep duration, and telomere length. Results: Compared with women in the category (9 hours), those in the lowest category of sleep duration (<6 hours) had a 0.12 unit decrease in z score after adjustment for age, BMI and cigarette smoking (equivalent to 9-year telomere attrition, P for trend = 0.05). Significant positive association between sleep duration and telomere length was seen among women under age of 50 (P for trend = 0.004), but not among those over 50 (P for trend = 0.33) (P for interaction = 0.005). In addition, we observed that women with a longer history of rotating night shifts tended to have shorter telomere length, but this relation was not statistically significant (P for trend = 0.36). Conclusion: We found that sleep duration was positively associated with telomere length among women under 50 years old. Further research is needed to confirm the observed associations.	[Liang, Geyu] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Liang, Geyu] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Peoples R China; [Schernhammer, Eva; Qi, Lu; Gao, Xiang; De Vivo, Immaculata; Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Schernhammer, Eva; De Vivo, Immaculata; Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schernhammer, Eva] VIEnna CEADDP, LBI ACR, Vienna, Austria; [Schernhammer, Eva] VIEnna CEADDP, ACR ITR, Vienna, Austria; [Qi, Lu; Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Southeast University - China; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liang, GY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA.	jiali.han@channing.harvard.edu	Schernhammer, Eva S/L-7898-2018	Schernhammer, Eva S/0000-0002-4337-9415; , Xiang/0000-0003-2617-6509; De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health [CA133914, CA87969, CA49449]; NATIONAL CANCER INSTITUTE [U01CA049449, P01CA087969, R03CA133914, R01CA049449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants CA133914, CA87969, and CA49449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Barcelo A, 2010, RESP MED, V104, P1225, DOI 10.1016/j.rmed.2010.03.025; Blask DE, 2005, ENDOCRINE, V27, P179, DOI 10.1385/ENDO:27:2:179; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Chen HL, 2006, AM J EPIDEMIOL, V163, P726, DOI 10.1093/aje/kwj096; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Hernandez C, 2007, EUR RESPIR J, V30, P496, DOI 10.1183/09031936.00051906; Hou LF, 2009, CANCER EPIDEM BIOMAR, V18, P3103, DOI 10.1158/1055-9965.EPI-09-0347; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Ozen OA, 2008, SYST BIOL REPROD MED, V54, P169, DOI 10.1080/19396360802422402; Page JH, 2008, CLIN CHEM, V54, P1682, DOI 10.1373/clinchem.2008.105825; Parks CG, 2011, OCCUP ENV MED; Pinheiro SP, 2006, CANCER RES, V66, P5521, DOI 10.1158/0008-5472.CAN-05-4652; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Pronk A, 2010, AM J EPIDEMIOL, V171, P953, DOI 10.1093/aje/kwq029; Reiter RJ, 2004, J PINEAL RES, V37, P213, DOI 10.1111/j.1600-079X.2004.00165.x; Rocca WA, 2010, NEURODEGENER DIS, V7, P163, DOI 10.1159/000289229; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Schernhammer ES, 2011, J NATL CANCER I, V103, P602, DOI 10.1093/jnci/djr044; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P649, DOI 10.1093/gerona/glq017; Thompson CL, 2011, CANCER-AM CANCER SOC, V117, P841, DOI 10.1002/cncr.25507; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Viswanathan AN, 2007, CANCER RES, V67, P10618, DOI 10.1158/0008-5472.CAN-07-2485; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; Wu AH, 2008, CARCINOGENESIS, V29, P1244, DOI 10.1093/carcin/bgn100; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	40	60	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23462	10.1371/journal.pone.0023462	http://dx.doi.org/10.1371/journal.pone.0023462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853136	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200087
J	Chang, CQ; Hu, MJ; Zhu, ZH; Lo, LJ; Chen, J; Peng, JR				Chang, Changqing; Hu, Minjie; Zhu, Zhihui; Lo, Li Jan; Chen, Jun; Peng, Jinrong			liver-enriched gene 1a and 1b Encode Novel Secretory Proteins Essential for Normal Liver Development in Zebrafish	PLOS ONE			English	Article							DIGESTIVE ORGANS; EXPRESSION; CELLS; MORPHOGENESIS; REGENERATION; DELTA-113P53; ENDODERM; PANCREAS; GROWTH	liver-enriched gene 1 (leg1) is a liver-enriched gene in zebrafish and encodes a novel protein. Our preliminary data suggested that Leg1 is probably involved in early liver development. However, no detailed characterization of Leg1 has been reported thus far. We undertook both bioinformatic and experimental approaches to study leg1 gene structure and its role in early liver development. We found that Leg1 identifies a new conserved protein superfamily featured by the presence of domain of unknown function 781 (DUF781). There are two copies of leg1 in zebrafish, namely leg1a and leg1b. Both leg1a and leg1b are expressed in the larvae and adult liver with leg1a being the predominant form. Knockdown of Leg1a or Leg1b by their respective morpholinos specifically targeting their 59-UTR each resulted in a small liver phenotype, demonstrating that both Leg1a and Leg1b are important for early liver development. Meanwhile, we found that injection of leg1-ATG(MO), a morpholino which can simultaneously block the translation of Leg1a and Leg1b, caused not only a small liver phenotype but hypoplastic exocrine pancreas and intestinal tube as well. Further examination of leg1-ATG(MO) morphants with early endoderm markers and early hepatic markers revealed that although depletion of total Leg1 does not alter the hepatic and pancreatic fate of the endoderm cells, it leads to cell cycle arrest that results in growth retardation of liver, exocrine pancreas and intestine. Finally, we proved that Leg1 is a secretory protein. This intrigued us to propose that Leg1 might act as a novel secreted regulator that is essential for liver and other digestive organ development in zebrafish.	[Chang, Changqing; Hu, Minjie; Zhu, Zhihui; Lo, Li Jan; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chang, CQ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	pengjr@zju.edu.cn	Hu, Minjie/AAP-4915-2020	Peng, Jinrong/0000-0002-0793-4848	National Natural Science Foundation of China [30825025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Natural Science Foundation of China (30825025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Chen Y, 2003, MECH DEVELOP, V120, P277, DOI 10.1016/S0925-4773(02)00460-4; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Jochheim A, 2003, DIFFERENTIATION, V71, P62, DOI 10.1046/j.1432-0436.2003.700606.x; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; Kawamoto S, 1996, GENE, V174, P151, DOI 10.1016/0378-1119(96)00512-4; Matthews RP, 2004, DEV BIOL, V274, P245, DOI 10.1016/j.ydbio.2004.06.016; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Petkov PM, 2004, HEPATOLOGY, V39, P617, DOI 10.1002/hep.20088; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Stuckenholz C, 2009, GASTROENTEROLOGY, V137, P1321, DOI 10.1053/j.gastro.2009.06.050; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wallace KN, 2001, GENESIS, V30, P141, DOI 10.1002/gene.1050; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zorn AM, 2001, MECH DEVELOP, V103, P153, DOI 10.1016/S0925-4773(01)00341-0	28	32	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22910	10.1371/journal.pone.0022910	http://dx.doi.org/10.1371/journal.pone.0022910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857963	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300010
J	Hartemink, N; Vanwambeke, SO; Heesterbeek, H; Rogers, D; Morley, D; Pesson, B; Davies, C; Mahamdallie, S; Ready, P				Hartemink, Nienke; Vanwambeke, Sophie O.; Heesterbeek, Hans; Rogers, David; Morley, David; Pesson, Bernard; Davies, Clive; Mahamdallie, Shazia; Ready, Paul			Integrated Mapping of Establishment Risk for Emerging Vector-Borne Infections: A Case Study of Canine Leishmaniasis in Southwest France	PLOS ONE			English	Article							PHLEBOTOMUS-PERNICIOSUS DIPTERA; BASIC REPRODUCTION NUMBER; ARIASI TONNOIR; SAND FLIES; TRANSMISSION; EPIDEMIOLOGY; INFANTUM; DISEASES; ECOLOGY; DOGS	Background: Zoonotic visceral leishmaniasis is endemic in the Mediterranean Basin, where the dog is the main reservoir host. The disease's causative agent, Leishmania infantum, is transmitted by blood-feeding female sandflies. This paper reports an integrative study of canine leishmaniasis in a region of France spanning the southwest Massif Central and the northeast Pyrenees, where the vectors are the sandflies Phlebotomus ariasi and P. perniciosus. Methods: Sandflies were sampled in 2005 using sticky traps placed uniformly over an area of approximately 100 by 150 km. High-and low-resolution satellite data for the area were combined to construct a model of the sandfly data, which was then used to predict sandfly abundance throughout the area on a pixel by pixel basis (resolution of c. 1 km). Using literature-and expert-derived estimates of other variables and parameters, a spatially explicit R-0 map for leishmaniasis was constructed within a Geographical Information System. R-0 is a measure of the risk of establishment of a disease in an area, and it also correlates with the amount of control needed to stop transmission. Conclusions: To our knowledge, this is the first analysis that combines a vector abundance prediction model, based on remotely-sensed variables measured at different levels of spatial resolution, with a fully mechanistic process-based temperature-dependent R-0 model. The resulting maps should be considered as proofs-of-principle rather than as ready-to-use risk maps, since validation is currently not possible. The described approach, based on integrating several modeling methods, provides a useful new set of tools for the study of the risk of outbreaks of vector-borne diseases.	[Hartemink, Nienke; Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Hartemink, Nienke; Vanwambeke, Sophie O.] Catholic Univ Louvain, Georges Lemaitre Earth & Climate Res, Earth & Life Inst, B-1348 Louvain, Belgium; [Rogers, David; Morley, David] Dept Zool, Spatial Ecol & Epidemiol Res Grp, Oxford OX1 3PS, England; [Pesson, Bernard] Univ Strasbourg, Dept Parasitol, Strasbourg, France; [Davies, Clive] London Sch Hyg & Trop Med, London WC1, England; [Mahamdallie, Shazia; Ready, Paul] Nat Hist Museum, Dept Entomol, London SW7 5BD, England	Utrecht University; Universite Catholique Louvain; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; London School of Hygiene & Tropical Medicine; Natural History Museum London	Hartemink, N (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	n.a.hartemink@uu.nl	hartemink, nienke/B-4304-2012	Heesterbeek, Hans/0000-0001-8537-6418; Vanwambeke, Sophie/0000-0001-6620-6173; hartemink, nienke/0000-0001-9820-7699	EU [1.1.6.3]; Global Change and Ecosystems (European Commission) [GOCECT-2003-010284 EDEN]	EU(European Commission); Global Change and Ecosystems (European Commission)(European CommissionEuropean Commission Joint Research Centre)	This publication was funded under the EU 6th Framework Program for Research, Technological Development and Demonstration, Priority 1.1.6.3. Global Change and Ecosystems (European Commission, DG Research, GOCECT-2003-010284 EDEN) and is officially catalogued by the EDEN Steering Committee as EDEN218. The content of this paper does not represent the official position of the European Commission and is entirely under the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1957, ANNU REV ENTOMOL, V2, P203, DOI 10.1146/annurev.en.02.010157.001223; Adler S, 1935, PROC R SOC SER B-BIO, V116, P516, DOI 10.1098/rspb.1935.0007; Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Anderson R M, 1990, Lancet, V335, P641; Aransay AM, 2004, PARASITOL RES, V94, P416, DOI 10.1007/s00436-004-1231-4; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Bongiorno G, 2003, ACTA TROP, V88, P109, DOI 10.1016/S0001-706X(03)00190-6; CHAMAILLE L, PARASITES VECTORS, V3, P31; DECOLMENARES M, 1995, J MED ENTOMOL, V32, P229, DOI 10.1093/jmedent/32.3.229; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN, P3; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; DYE C, 1992, PARASITOLOGY, V105, P35, DOI 10.1017/S0031182000073662; DYE C, 1987, MED VET ENTOMOL, V1, P417, DOI 10.1111/j.1365-2915.1987.tb00372.x; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Guarga JL, 2000, RES VET SCI, V69, P249, DOI 10.1053/rvsc.2000.0419; GUILVARD E, 1980, ANN PARASITOLOGIE, V6, P659; GUY MW, 1984, ANN PARASIT HUM COMP, V59, P449, DOI 10.1051/parasite/1984595449; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Killick-Kendrick R., 2002, Parassitologia (Rome), V44, P67; Killick-Kendrick R., 1999, Canine leishmaniasis: an update. Proceedings of the International Canine Leishmaniasis Forum, Barcelona, Spain, 1999., P26; Marsella R, 1998, INT J DERMATOL, V37, P801, DOI 10.1046/j.1365-4362.1998.00449.x; Martin S., 2007, POPULATION RESETTLEM, P1; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Moreno I, 2007, MICROBES INFECT, V9, P1574, DOI 10.1016/j.micinf.2007.09.009; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Pasquau F, 2005, EUR J CLIN MICROBIOL, V24, P411, DOI 10.1007/s10096-005-1342-6; Quinnell RJ, 1997, PARASITOLOGY, V115, P143, DOI 10.1017/S0031182097001200; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Ready PD, 2008, TRENDS PARASITOL, V24, P151, DOI 10.1016/j.pt.2008.03.001; READY PD, 2010, EURO SURVEILLANCE, V15; Riera C, 1999, VET PARASITOL, V84, P33, DOI 10.1016/S0304-4017(99)00084-9; Rioux J.A., 1969, EPIDEMIOLOGIE LEISHM; RIOUX JA, 1979, ANN PARASIT HUM COMP, V54, P401, DOI 10.1051/parasite/1979544401; Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; Rossi E, 2008, ACTA TROP, V105, P158, DOI 10.1016/j.actatropica.2007.10.005; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Schroder W, 2008, PARASITOL RES, V103, pS55, DOI 10.1007/s00436-008-1051-z; Sobrino R, 2008, VET PARASITOL, V155, P198, DOI 10.1016/j.vetpar.2008.05.003; Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P1; Trotz-Williams L, 2003, IN PRACTICE, V25, P190, DOI 10.1136/inpract.25.4.190	49	61	63	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e20817	10.1371/journal.pone.0020817	http://dx.doi.org/10.1371/journal.pone.0020817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857899	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000293774300001
J	Sacilotto, N; Espert, A; Castillo, J; Franco, L; Lopez-Rodas, G				Sacilotto, Natalia; Espert, Antonio; Castillo, Josefa; Franco, Luis; Lopez-Rodas, Gerardo			Epigenetic Transcriptional Regulation of the Growth Arrest-Specific gene 1 (Gas1) in Hepatic Cell Proliferation at Mononucleosomal Resolution	PLOS ONE			English	Article							ARREST-SPECIFIC GENE; C-MYC PROMOTER; GROWTH ARREST; LIVER-REGENERATION; CHROMATIN MODIFICATIONS; NUCLEOSOME ORGANIZATION; HISTONE MODIFICATIONS; MAMMALIAN CHROMATIN; HUMAN GENOME; MECHANISMS	Background: Gas1 (growth arrest-specific 1) gene is known to inhibit cell proliferation in a variety of models, but its possible implication in regulating quiescence in adult tissues has not been examined to date. The knowledge of how Gas1 is regulated in quiescence may contribute to understand the deregulation occurring in neoplastic diseases. Methodology/Principal Findings: Gas1 expression has been studied in quiescent murine liver and during the naturally synchronized cell proliferation after partial hepatectomy. Chromatin immunoprecipitation at nucleosomal resolution (Nuc-ChIP) has been used to carry out the study preserving the in vivo conditions. Transcription has been assessed at real time by quantifying the presence of RNA polymerase II in coding regions (RNApol-ChIP). It has been found that Gas1 is expressed not only in quiescent liver but also at the cell cycle G(1)/S transition. The latter expression peak had not been previously reported. Two nucleosomes, flanking a nucleosome-free region, are positioned close to the transcription start site. Both nucleosomes slide in going from the active to the inactive state and vice versa. Nuc-ChIP analysis of the acquisition of histone epigenetic marks show distinctive features in both active states: H3K9ac and H3K4me2 are characteristic of transcription in G(0) and H4R3me2 in G(1)/S transition. Sequential-ChIP analysis revealed that the "repressing" mark H3K9me2 colocalize with several "activating" marks at nucleosome N-1 when Gas1 is actively transcribed suggesting a greater plasticity of epigenetic marks than proposed until now. The recruitment of chromatin-remodeling or modifying complexes also displayed distinct characteristics in quiescence and the G(1)/S transition. Conclusions/Significance: The finding that Gas1 is transcribed at the G(1)/S transition suggests that the gene may exert a novel function during cell proliferation. Transcription of this gene is modulated by specific "activating" and "repressing" epigenetic marks, and by chromatin remodeling and histone modifying complexes recruitment, at specific nucleosomes in Gas1 promoter.	[Sacilotto, Natalia; Espert, Antonio; Castillo, Josefa; Franco, Luis; Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem & Mol Biol, Chromatin Lab, Valencia, Spain	University of Valencia	Sacilotto, N (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Chromatin Lab, Valencia, Spain.	gerardo.lopez@uv.es	; LOPEZ-RODAS, GERARDO/I-1349-2015	Espert, Antonio/0000-0002-7434-9622; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X; Castillo Aliaga, Josefa/0000-0002-4092-0085; Franco, Luis/0000-0001-9610-6448	Ministerio de Ciencia y Tecnologia [BFU2007-63120, CSD2006-49]; Conselleria d'Educacio [ACOM2010/133]; Conselleria d'Educacio, Generalitat Valenciana	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria d'Educacio; Conselleria d'Educacio, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	Grant support is provided by Ministerio de Ciencia y Tecnologia [BFU2007-63120, and Consolider-Ingenio CSD2006-49] and by Conselleria d'Educacio [ACOM2010/133] to G. Lopez-Rodas. N. Sacilotto was recipient of a fellow grant of Formacion de Personal Investigador Predoctoral from Conselleria d'Educacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez JA, 2007, CANCER GENE THER, V14, P836, DOI 10.1038/sj.cgt.7701076; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; DELSAL G, 1994, P NATL ACAD SCI USA, V91, P1848, DOI 10.1073/pnas.91.5.1848; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; DEMARTIN R, 1993, J BIOL CHEM, V268, P22788; Dominguez-Monzon G, 2009, INT J DEV NEUROSCI, V27, P305, DOI 10.1016/j.ijdevneu.2009.03.009; Evdokiou A, 1998, EXP CELL RES, V240, P359, DOI 10.1006/excr.1998.4011; Evdokiou A, 1998, INT J CANCER, V75, P568, DOI 10.1002/(SICI)1097-0215(19980209)75:4<568::AID-IJC13>3.0.CO;2-5; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Grossi M, 1998, ONCOGENE, V17, P1629, DOI 10.1038/sj.onc.1202090; Higgins GM, 1931, ARCH PATHOL, V12, P186; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; KURINNA S, 2010, INT J BIOCH CEL 0320; Lee KKH, 2001, DEV BIOL, V234, P188, DOI 10.1006/dbio.2001.0249; Lee TC, 1997, P NATL ACAD SCI USA, V94, P12886, DOI 10.1073/pnas.94.24.12886; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mellstrom B, 2002, MOL CELL NEUROSCI, V19, P417, DOI 10.1006/mcne.2001.1092; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; NIMURA K, 2010, J MOL MED       0817; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Rizzi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003617; Rodriguez JL, 2007, INT J BIOCHEM CELL B, V39, P842, DOI 10.1016/j.biocel.2007.01.009; Rodriguez JL, 2006, BIOCHEM J, V398, P431, DOI 10.1042/BJ20060380; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sandoval J, 2010, CELL MOL LIFE SCI, V67, P1687, DOI 10.1007/s00018-010-0272-3; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Zamorano A, 2004, NEUROBIOL DIS, V15, P483, DOI 10.1016/j.nbd.2003.11.022; Zamorano A, 2003, J NEUROSCI RES, V71, P256, DOI 10.1002/jnr.10461; Zhao L, 2009, J BIOL CHEM, V284, P26273, DOI 10.1074/jbc.M109.028068	58	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23318	10.1371/journal.pone.0023318	http://dx.doi.org/10.1371/journal.pone.0023318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858068	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300031
J	Ding, CB; Zhang, JP; Zhao, Y; Peng, ZG; Song, DQ; Jiang, JD				Ding, Cun-Bao; Zhang, Jing-Pu; Zhao, Ye; Peng, Zong-Gen; Song, Dan-Qing; Jiang, Jian-Dong			Zebrafish as a Potential Model Organism for Drug Test Against Hepatitis C Virus	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ANIMAL-MODEL; EXPRESSION; INFECTION; THERAPY; HEPATOCYTES; REPLICATION; STEATOSIS; DISEASE; EMBRYOS	Screening and evaluating anti-hepatitis C virus (HCV) drugs in vivo is difficult worldwide, mainly because of the lack of suitable small animal models. We investigate whether zebrafish could be a model organism for HCV replication. To achieve NS5B-dependent replication an HCV sub-replicon was designed and created with two vectors, one with HCV ns5b and fluorescent rfp genes, and the other containing HCV's 5'UTR, core, 3'UTR and fluorescent gfp genes. The vectors containing sub-replicons were co-injected into zebrafish zygotes. The sub-replicon amplified in liver showing a significant expression of HCV core RNA and protein. The sub-replicon amplification caused no abnormality in development and growth of zebrafish larvae, but induced gene expression change similar to that in human hepatocytes. As the amplified core fluorescence in live zebrafish was detectable microscopically, it rendered us an advantage to select those with replicating sub-replicon for drug experiments. Ribavirin and oxymatrine, two known anti-HCV drugs, inhibited sub-replicon amplification in this model showing reduced levels of HCV core RNA and protein. Technically, this method had a good reproducibility and is easy to operate. Thus, zebrafish might be a model organism to host HCV, and this zebrafish/HCV (sub-replicon) system could be an animal model for anti-HCV drug screening and evaluation.	[Ding, Cun-Bao; Zhang, Jing-Pu; Zhao, Ye; Peng, Zong-Gen; Song, Dan-Qing; Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Ding, Cun-Bao; Zhang, Jing-Pu; Zhao, Ye; Peng, Zong-Gen; Song, Dan-Qing; Jiang, Jian-Dong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ding, Cun-Bao] Hebei Polytech Univ, Coll Chem Engn & Biotechnol, Tangshan, Hebei, Peoples R China; [Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Ding, CB (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zjp5577@126.com; jiang.jdong@163.com	Peng, Zong-Gen/GVU-2327-2022	Peng, Zong-Gen/0000-0001-7662-6892; Zhao, Ye/0000-0002-2852-7432	Ministry of Science and Technology [2009ZX09301-003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the National S&T Major Special Project, 11th 5-Year Plan "New Drug R&D Program", the Ministry of Science and Technology, (2009ZX09301-003, J.D. Jiang and J.P. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2008, J HEPATOL, V49, P134, DOI 10.1016/j.jhep.2008.03.012; Blais DR, 2010, J PROTEOME RES, V9, P912, DOI 10.1021/pr900788a; Boonstra A, 2009, HEPATOLOGY, V50, P1646, DOI 10.1002/hep.23138; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Chak Eric, 2010, Curr Hepat Rep, V9, P147, DOI 10.1007/s11901-010-0047-1; Chang ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-109; Chen Yan-xi, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P335; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gallego J, 2002, BIOCHEM SOC T, V30, P140, DOI 10.1042/BST0300140; Gates AT, 2004, VIRUS RES, V100, P213, DOI 10.1016/j.virusres.2003.12.029; Guevin C, 2009, ANTIVIR RES, V84, P14, DOI 10.1016/j.antiviral.2009.07.009; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Koike K, 2010, HEPATOL RES, V40, P69, DOI 10.1111/j.1872-034X.2009.00593.x; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Li J, 1998, Zhongguo Zhong Xi Yi Jie He Za Zhi, V18, P227; Ling JY, 2007, J CHROMATOGR A, V1145, P123, DOI 10.1016/j.chroma.2007.01.080; Liu JP, 2003, AM J GASTROENTEROL, V98, P538, DOI 10.1111/j.1572-0241.2003.07298.x; Lu LG, 2003, WORLD J GASTROENTERO, V9, P2480; Mancuso ME, 2009, J THROMB HAEMOST, V7, P1997, DOI 10.1111/j.1538-7836.2009.03624.x; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Park IW, 2009, BIOCHEM BIOPH RES CO, V387, P489, DOI 10.1016/j.bbrc.2009.07.076; Piai G, 2006, DIGEST DIS SCI, V51, P1619, DOI 10.1007/s10620-006-9110-8; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Qureshi SA, 2007, MED RES REV, V27, P353, DOI 10.1002/med.20063; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Suzuki T, 2007, ADV DRUG DELIVER REV, V59, P1200, DOI 10.1016/j.addr.2007.04.014; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Tumurbaatar B, 2007, J VIROL METHODS, V146, P5, DOI 10.1016/j.jviromet.2007.05.025; Walker Michelle P., 2003, Antiviral Chemistry & Chemotherapy, V14, P1; Webster DP, 2009, LANCET INFECT DIS, V9, P108, DOI 10.1016/S1473-3099(09)70020-9; [姚玉娜 Yao Yuna], 2004, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V16, P110	38	30	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22921	10.1371/journal.pone.0022921	http://dx.doi.org/10.1371/journal.pone.0022921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857967	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300012
J	Anensen, N; Hjelle, SM; Van Belle, W; Haaland, I; Silden, E; Bourdon, JC; Hovland, R; Tasken, K; Knappskog, S; Lonning, PE; Bruserud, O; Gjertsen, BT				Anensen, N.; Hjelle, S. M.; Van Belle, W.; Haaland, I.; Silden, E.; Bourdon, J-C; Hovland, R.; Tasken, K.; Knappskog, S.; Lonning, P. E.; Bruserud, O.; Gjertsen, B. T.			Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia	ONCOGENE			English	Article						p53 protein isoform; p53 beta; p53 gamma; acute myeloid leukemia/NPM1/FLT3-ITD	ACUTE MYELOGENOUS LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; BREAST-CANCER PATIENTS; WILD-TYPE P53; AML 10 TRIAL; FUNCTIONAL-CHARACTERIZATION; FAVORABLE PROGNOSIS; NUCLEOPHOSMIN NPM1; NORMAL KARYOTYPE; KINASE-ACTIVITY	The wild-type tumor-suppressor gene TP53 encodes several isoforms of the p53 protein. However, while the role of p53 in controlling normal cell cycle progression and tumor suppression is well established, the clinical significance of p53 isoform expression is unknown. A novel bioinformatic analysis of p53 isoform expression in 68 patients with acute myeloid leukemia revealed distinct p53 protein biosignatures correlating with clinical outcome. Furthermore, we show that mutated FLT3, a prognostic marker for short survival in AML, is associated with expression of full-length p53. In contrast, mutated NPM1, a prognostic marker for long-term survival, correlated with p53 isoforms beta and gamma expression. In conclusion, p53 biosignatures contain useful information for cancer evaluation and prognostication. Oncogene (2012) 31, 1533-1545; doi:10.1038/onc.2011.348; published online 22 August 2011	[Gjertsen, B. T.] Univ Bergen, Haukeland Univ Hosp, Hematol Sect, Dept Internal Med,Inst Med, N-5021 Bergen, Norway; [Van Belle, W.] Norut IT, Tromso, Norway; [Bourdon, J-C] Univ Dundee, Sch Med, Dept Surg & Mol Oncol, Inserm European Associated Lab Inserm, Dundee, Scotland; [Hovland, R.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Tasken, K.] Univ Oslo, Biotechnol Ctr, Oslo, Norway; [Tasken, K.] Univ Oslo, Ctr Mol Med Norway, Nord EMBL Partnership, Oslo, Norway; [Knappskog, S.; Lonning, P. E.] Univ Bergen, Sect Oncol, Inst Med, N-5021 Bergen, Norway; [Knappskog, S.; Lonning, P. E.] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Anensen, N.; Hjelle, S. M.; Haaland, I.; Silden, E.; Bruserud, O.; Gjertsen, B. T.] Univ Bergen, Inst Med, Hematol Sect, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Dundee; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Gjertsen, BT (corresponding author), Univ Bergen, Haukeland Univ Hosp, Hematol Sect, Dept Internal Med,Inst Med, N-5021 Bergen, Norway.	bjorn.gjertsen@med.uib.no	Hjelle, Sigrun M./AAZ-5585-2020; JC, Bourdon/A-4439-2008; Gjertsen, Bjorn T/O-1542-2015; Gjertsen, Bjørn T/AAP-3281-2020	JC, Bourdon/0000-0003-4623-9386; Gjertsen, Bjorn T/0000-0001-9358-9704; Gjertsen, Bjørn T/0000-0001-9358-9704; Lonning, Per Eystein/0000-0002-8890-6303; Tasken, Kjetil/0000-0003-2841-4697; Knappskog, Stian/0000-0002-4153-1655; Haaland, Ingvild/0000-0002-9974-2308	Research Council of Norway; Western Norway Regional Health Authority; Norwegian Cancer Society	Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society)	This study was supported by grants from the Research Council of Norway's National Program for Research in Functional Genomics, the Western Norway Regional Health Authority and the Norwegian Cancer Society.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Anensen N, 2006, CLIN CANCER RES, V12, P3985, DOI 10.1158/1078-0432.CCR-05-1970; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Bruserud O, 2003, HAEMATOLOGICA, V88, P416; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Chrisanthar R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003062; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; FENAUX P, 1992, BRIT J HAEMATOL, V80, P178, DOI 10.1111/j.1365-2141.1992.tb08897.x; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gale RE, 2005, BLOOD, V106, P3768, DOI 10.1182/blood-2005-04-1746; Gale RE, 2005, BLOOD, V106, P3658, DOI 10.1182/blood-2005-03-1323; GJERTSEN BT, 1994, J CELL SCI, V107, P3363; Gjertsen BT, 2002, J HEMATOTH STEM CELL, V11, P469, DOI 10.1089/15258160260090933; Graupner V, 2009, CELL CYCLE, V8, P1238, DOI 10.4161/cc.8.8.8251; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Haferlach C, 2008, LEUKEMIA, V22, P1539, DOI 10.1038/leu.2008.143; Hainaut Pierre, 1995, Current Opinion in Oncology, V7, P76; Hall PA, 2006, J PATHOL, V208, P1, DOI 10.1002/path.1913; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2007, BLOOD, V109, P2589, DOI 10.1182/blood-2006-02-004234; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Komeno Y, 2005, LEUKEMIA, V19, P930, DOI 10.1038/sj.leu.2403736; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lonning PE, 2003, LANCET ONCOL, V4, P177; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; Lowenberg Bob, 2008, Hematology Am Soc Hematol Educ Program, P1, DOI 10.1182/asheducation-2008.1.1; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Pardee TS, 2011, EXP HEMATOL, V39, P473, DOI 10.1016/j.exphem.2011.01.009; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Preudhomme C, 1997, BRIT J HAEMATOL, V98, P502, DOI 10.1046/j.1365-2141.1997.2403057.x; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; SCHOTTELIUS A, 1994, LEUKEMIA, V8, P1673; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Srinivasa SP, 2002, LEUKEMIA, V16, P244, DOI 10.1038/sj.leu.2402367; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Van Belle Werner, 2006, BMC Bioinformatics, V7, P198, DOI 10.1186/1471-2105-7-198; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wahlin A, 1997, EUR J HAEMATOL, V58, P233; Wheatley K, 1999, BRIT J HAEMATOL, V107, P69, DOI 10.1046/j.1365-2141.1999.01684.x; Yeh PY, 2004, ONCOGENE, V23, P3580, DOI 10.1038/sj.onc.1207426	51	46	47	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1533	1545		10.1038/onc.2011.348	http://dx.doi.org/10.1038/onc.2011.348			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21860418				2022-12-25	WOS:000302132000006
J	Kjaersgaard, T; Jensen, MK; Christiansen, MW; Gregersen, P; Kragelund, BB; Skriver, K				Kjaersgaard, Trine; Jensen, Michael K.; Christiansen, Michael W.; Gregersen, Per; Kragelund, Birthe B.; Skriver, Karen			Senescence-associated Barley NAC (NAM, ATAF1,2, CUC) Transcription Factor Interacts with Radical-induced Cell Death 1 through a Disordered Regulatory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; LEAF SENESCENCE; BINDING-SPECIFICITY; STRUCTURAL DISORDER; ACTIVATION DOMAINS; PROTEIN INTERACTS; FACTOR FAMILY; IDENTIFICATION; CONSERVATION; RCD1	Senescence in plants involves massive nutrient relocation and age-related cell death. Characterization of the molecular components, such as transcription factors (TFs), involved in these processes is required to understand senescence. We found that HvNAC005 and HvNAC013 of the plant-specific NAC (NAM, ATAF1,2, CUC) TF family are up-regulated during senescence in barley (Hordeum vulgare). Both HvNAC005 and HvNAC013 bound the conserved NAC DNA target sequence. Computational and biophysical analyses showed that both proteins are intrinsically disordered in their large C-terminal domains, which are transcription regulatory domains (TRDs) in many NAC TFs. Using motif searches and interaction studies in yeast we identified an evolutionarily conserved sequence, the LP motif, in the TRD of HvNAC013. This motif was sufficient for transcriptional activity. In contrast, HvNAC005 did not function as a transcriptional activator suggesting that an involvement of HvNAC013 and HvNAC005 in senescence will be different. HvNAC013 interacted with barley radical-induced cell death 1 (RCD1) via the very C-terminal part of its TRD, outside of the region containing the LP motif. No significant secondary structure was induced in the HvNAC013 TRD upon interaction with RCD1. RCD1 also interacted with regions dominated by intrinsic disorder in TFs of the MYB and basic helix-loop-helix families. We propose that RCD1 is a regulatory protein capable of interacting with many different TFs by exploiting their intrinsic disorder. In addition, we present the first structural characterization of NAC C-terminal domains and relate intrinsic disorder and sequence motifs to activity and protein-protein interactions.	[Kjaersgaard, Trine; Jensen, Michael K.; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Christiansen, Michael W.; Gregersen, Per] Univ Aarhus, Res Ctr Flakkebjerg, Dept Genet & Biotechnol, DK-4200 Slagelse, Denmark	University of Copenhagen; Aarhus University	Skriver, K (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloesvej 5, DK-2200 Copenhagen, Denmark.	KSkriver@bio.ku.dk	Gregersen, Per/P-8896-2019; Skriver, Karen/K-9860-2014; Kragelund, Birthe/M-3927-2014; Gregersen, Per L/R-1950-2018	Gregersen, Per/0000-0001-8243-0976; Skriver, Karen/0000-0003-2225-4012; Kragelund, Birthe/0000-0002-7454-1761; Gregersen, Per L/0000-0001-8243-0976; Jensen, Michael Krogh/0000-0001-7574-4707	Danish Agency for Science [274-07-0173]; Villum Kann Rasmussen Foundation	Danish Agency for Science; Villum Kann Rasmussen Foundation(Villum Fonden)	This work was supported by Danish Agency for Science Grant 274-07-0173 (to K. S. and P. G.) and the Villum Kann Rasmussen Foundation (to M. K. J.).	Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Choi Y, 2000, J BIOL CHEM, V275, P15912, DOI 10.1074/jbc.275.21.15912; Christiansen Michael W, 2011, BMC Res Notes, V4, P302, DOI 10.1186/1756-0500-4-302; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Gregersen PL, 2008, PLANT BIOLOGY, V10, P37, DOI 10.1111/j.1438-8677.2008.00114.x; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Jaspers P, 2009, PLANT J, V60, P268, DOI 10.1111/j.1365-313X.2009.03951.x; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18816, DOI 10.1073/pnas.0604711103; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Ko JH, 2007, PLANT J, V50, P1035, DOI 10.1111/j.1365-313X.2007.03109.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Lin B, 2001, J GEN VIROL, V82, P1245, DOI 10.1099/0022-1317-82-5-1245; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Nestoras K, 2010, GENE DEV, V24, P1145, DOI 10.1101/gad.561910; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Olsen AN, 2005, PLANT SCI, V169, P785, DOI 10.1016/j.plantsci.2005.05.035; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Sigalov AB, 2007, BIOCHIMIE, V89, P419, DOI 10.1016/j.biochi.2006.11.003; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Smyczynski C, 2006, J BIOL CHEM, V281, P25475, DOI 10.1074/jbc.M601815200; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Teotia S, 2011, J EXP BOT, V62, P1271, DOI 10.1093/jxb/erq363; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Yoon HK, 2008, MOL CELLS, V25, P438; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007	53	65	77	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35418	35429		10.1074/jbc.M111.247221	http://dx.doi.org/10.1074/jbc.M111.247221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21856750	Green Published, hybrid			2022-12-25	WOS:000295927100013
J	Crist, RC; Roth, JJ; Waldman, SA; Buchberg, AM				Crist, Richard C.; Roth, Jacquelyn J.; Waldman, Scott A.; Buchberg, Arthur M.			A Conserved Tissue-Specific Homeodomain-Less Isoform of MEIS1 Is Downregulated in Colorectal Cancer	PLOS ONE			English	Article							PROTEIN EXPRESSION; HOMEOBOX GENES; MESSENGER-RNA; RISK; GENETICS	Colorectal cancer is one of the most common cancers in developed nations and is the result of both environmental and genetic factors. Many of the genetic lesions observed in colorectal cancer alter expression of homeobox genes, which encode homeodomain transcription factors. The MEIS1 homeobox gene is known to be involved in several hematological malignancies and solid tumors and recent evidence suggests that expression of the MEIS1 transcript is altered in colorectal cancer. Despite this potential connection, little is known about the role of the gene in the intestines. We probed murine gastrointestinal tissue samples with an N-terminal Meis1 antibody, revealing expression of two previously described isoforms, as well as two novel Meis1 products. A 32 kD Meis1 product was expressed in the nuclei of non-epithelial cells in the stomach and colon, while a 27 kD product was expressed in the cytoplasm of epithelial cells in the proximal colon. Our data suggest that the 27 kD and 32 kD Meis1 proteins are both forms of the Meis1d protein, a homeodomain-less isoform whose transcript was previously identified in cDNA screens. Both the MEIS1D transcript and protein were expressed in human colon mucosa. Expression of the MEIS1D protein was downregulated in 83% (10/12) of primary colorectal cancer samples compared to matched normal mucosa, indicating that MEIS1D is a biomarker of colorectal tumorigenesis. The decreased expression of MEIS1D in colon tumors also suggests that this conserved homeodomain-less isoform may act as a tumor suppressor in human colorectal cancer.	[Crist, Richard C.; Roth, Jacquelyn J.; Buchberg, Arthur M.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Waldman, Scott A.] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Crist, RC (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	Arthur.Buchberg@jefferson.edu		Buchberg, Arthur/0000-0002-0543-5631; Waldman, Scott/0000-0001-6619-175X	National Institutes of Health [T32-CA09678, T32-CA09683]; National Cancer Institute; NATIONAL CANCER INSTITUTE [T32CA009678, T32CA009683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [T32-CA09678 to RCC, T32-CA09683 to JJR] and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; CANTILE M, 2009, INT J CANC; Cantile M, 2009, INT J CANCER, V125, P1532, DOI 10.1002/ijc.24438; Chariot A, 1999, BIOCHEM PHARMACOL, V58, P1851, DOI 10.1016/S0006-2952(99)00234-8; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Diergaarde B, 2007, CLIN GASTROENTEROL H, V5, P736, DOI 10.1016/j.cgh.2007.02.019; EE HC, 1995, AM J PATHOL, V147, P586; Fearnhead NS, 2002, BRIT MED BULL, V64, P27, DOI 10.1093/bmb/64.1.27; Geerts D, 2005, CANCER LETT, V228, P43, DOI 10.1016/j.canlet.2005.01.047; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Jung C, 2005, BRIT J CANCER, V92, P2233, DOI 10.1038/sj.bjc.6602631; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Lamba JK, 2004, J PHARMACOL EXP THER, V311, P811, DOI 10.1124/jpet.104.069310; Magnani E, 2008, PLANT CELL, V20, P875, DOI 10.1105/tpc.108.058495; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; Spieker N, 2001, GENOMICS, V71, P214, DOI 10.1006/geno.2000.6408; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Tucker SC, 1999, J BIOL CHEM, V274, P32325, DOI 10.1074/jbc.274.45.32325; van Engeland M, 2003, CANCER RES, V63, P3133; Vider BZ, 1997, BIOCHEM BIOPH RES CO, V232, P742, DOI 10.1006/bbrc.1997.6364; Vider BZ, 2000, BIOCHEM BIOPH RES CO, V272, P513, DOI 10.1006/bbrc.2000.2804; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Watson AJM, 2004, GUT, V53, P1701, DOI 10.1136/gut.2004.052704; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199	41	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23665	10.1371/journal.pone.0023665	http://dx.doi.org/10.1371/journal.pone.0023665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858198	gold, Green Published			2022-12-25	WOS:000294121300076
J	Inagaki, A; Sleddens-Linkels, E; van Cappellen, WA; Hibbert, RG; Sixma, TK; Hoeijmakers, JHJ; Grootegoed, JA; Baarends, WM				Inagaki, Akiko; Sleddens-Linkels, Esther; van Cappellen, Wiggert A.; Hibbert, Richard G.; Sixma, Titia K.; Hoeijmakers, Jan H. J.; Grootegoed, J. Anton; Baarends, Willy M.			Human RAD18 Interacts with Ubiquitylated Chromatin Components and Facilitates RAD9 Recruitment to DNA Double Strand Breaks	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DEFECTIVE POSTREPLICATION REPAIR; UBIQUITIN-CONJUGATING ACTIVITY; HISTONE H2AX PHOSPHORYLATION; 9-1-1 CHECKPOINT CLAMP; ZINC-FINGER DOMAIN; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; PCNA MONOUBIQUITINATION; GENOMIC INSTABILITY	RAD18 is an ubiquitin ligase involved in replicative damage bypass and DNA double-strand break (DSB) repair processes. We found that RPA is required for the dynamic pattern of RAD18 localization during the cell cycle, and for accumulation of RAD18 at sites of c-irradiation-induced DNA damage. In addition, RAD18 colocalizes with chromatin-associated conjugated ubiquitin and ubiquitylated H2A throughout the cell cycle and following irradiation. This localization pattern depends on the presence of an intact, ubiquitin-binding Zinc finger domain. Using a biochemical approach, we show that RAD18 directly binds to ubiquitylated H2A and several other unknown ubiquitylated chromatin components. This interaction also depends on the RAD18 Zinc finger, and increases upon the induction of DSBs by gamma-irradiation. Intriguingly, RAD18 does not always colocalize with regions that show enhanced H2A ubiquitylation. In human female primary fibroblasts, where one of the two X chromosomes is inactivated to equalize X-chromosomal gene expression between male (XY) and female (XX) cells, this inactive X is enriched for ubiquitylated H2A, but only rarely accumulates RAD18. This indicates that the binding of RAD18 to ubiquitylated H2A is context-dependent. Regarding the functional relevance of RAD18 localization at DSBs, we found that RAD18 is required for recruitment of RAD9, one of the components of the 9-1-1 checkpoint complex, to these sites. Recruitment of RAD9 requires the functions of the RING and Zinc finger domains of RAD18. Together, our data indicate that association of RAD18 with DSBs through ubiquitylated H2A and other ubiquitylated chromatin components allows recruitment of RAD9, which may function directly in DSB repair, independent of downstream activation of the checkpoint kinases CHK1 and CHK2.	[Inagaki, Akiko; Sleddens-Linkels, Esther; van Cappellen, Wiggert A.; Grootegoed, J. Anton; Baarends, Willy M.] Erasmus MC, Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands; [Hoeijmakers, Jan H. J.] Erasmus MC, Univ Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Hibbert, Richard G.; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands; [Hibbert, Richard G.; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; Netherlands Cancer Institute	Inagaki, A (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Chromosome Biol, 1275 York Ave, New York, NY 10021 USA.	w.baarends@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021	Sixma, Titia K/0000-0001-6180-0632	Netherlands Organization for Scientific Research (NWO) through ALW [VIDI 864.05.003]	Netherlands Organization for Scientific Research (NWO) through ALW(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO) through ALW (VIDI 864.05.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baarends WM, 2003, MOL CELL BIOL, V23, P1151, DOI 10.1128/MCB.23.4.1151-1162.2003; Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Davies AA, 2010, CELL, V141, P1080, DOI 10.1016/j.cell.2010.04.039; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Greer DA, 2003, CANCER RES, V63, P4829; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Inagaki A, 2009, DNA REPAIR, V8, P190, DOI 10.1016/j.dnarep.2008.10.008; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Medhurst AL, 2008, J CELL SCI, V121, P3933, DOI 10.1242/jcs.033688; Melo JA, 2001, GENE DEV, V15, P2809; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sorkin A, 2007, MOL CELL, V26, P771, DOI 10.1016/j.molcel.2007.06.003; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Warmerdam DO, 2009, CELL CYCLE, V8, P1765, DOI 10.4161/cc.8.11.8721; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xin H, 2000, NUCLEIC ACIDS RES, V28, P2847, DOI 10.1093/nar/28.14.2847; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	78	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23155	10.1371/journal.pone.0023155	http://dx.doi.org/10.1371/journal.pone.0023155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858012	gold, Green Published			2022-12-25	WOS:000294121300014
J	Jonczyk, M; Sobkowiak, A; Siedlecki, P; Biecek, P; Trzcinska-Danielewicz, J; Tiuryn, J; Fronk, J; Sowinski, P				Jonczyk, Maciej; Sobkowiak, Alicja; Siedlecki, Pawel; Biecek, Przemyslaw; Trzcinska-Danielewicz, Joanna; Tiuryn, Jerzy; Fronk, Jan; Sowinski, Pawel			Rhythmic Diel Pattern of Gene Expression in Juvenile Maize Leaf	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ARABIDOPSIS; PROTEINS; CLOCK; PHOTOSYNTHESIS; QUINTET; PLANTS; CCA1	Background: Numerous biochemical and physiological parameters of living organisms follow a circadian rhythm. Although such rhythmic behavior is particularly pronounced in plants, which are strictly dependent on the daily photoperiod, data on the molecular aspects of the diurnal cycle in plants is scarce and mostly concerns the model species Arabidopsis thaliana. Here we studied the leaf transcriptome in seedlings of maize, an important C4 crop only distantly related to A. thaliana, throughout a cycle of 10 h darkness and 14 h light to look for rhythmic patterns of gene expression. Results: Using DNA microarrays comprising ca. 43,000 maize-specific probes we found that ca. 12% of all genes showed clear-cut diel rhythms of expression. Cluster analysis identified 35 groups containing from four to ca. 1,000 genes, each comprising genes of similar expression patterns. Perhaps unexpectedly, the most pronounced and most common (concerning the highest number of genes) expression maxima were observed towards and during the dark phase. Using Gene Ontology classification several meaningful functional associations were found among genes showing similar diel expression patterns, including massive induction of expression of genes related to gene expression, translation, protein modification and folding at dusk and night. Additionally, we found a clear-cut tendency among genes belonging to individual clusters to share defined transcription factor-binding sequences. Conclusions: Co-expressed genes belonging to individual clusters are likely to be regulated by common mechanisms. The nocturnal phase of the diurnal cycle involves gross induction of fundamental biochemical processes and should be studied more thoroughly than was appreciated in most earlier physiological studies. Although some general mechanisms responsible for the diel regulation of gene expression might be shared among plants, details of the diurnal regulation of gene expression seem to differ between taxa.	[Jonczyk, Maciej; Sowinski, Pawel] Univ Warsaw, Fac Biol, Inst Plant Expt Biol & Biotechnol, Dept Plant Mol Ecophysiol, Warsaw, Poland; [Sobkowiak, Alicja; Sowinski, Pawel] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Plant Biochem & Physiol Dept, Radzikow, Poland; [Siedlecki, Pawel] Univ Warsaw, Fac Biol, Inst Plant Expt Biol & Biotechnol, Dept Plant Mol Biol, Warsaw, Poland; [Biecek, Przemyslaw] Univ Warsaw, Fac Math Informat & Mech, Inst Appl Math & Mech, Warsaw, Poland; [Trzcinska-Danielewicz, Joanna; Fronk, Jan] Univ Warsaw, Fac Biol, Inst Biochem, Dept Mol Biol, Warsaw, Poland; [Tiuryn, Jerzy] Univ Warsaw, Fac Math Informat & Mech, Inst Informat, Warsaw, Poland	University of Warsaw; Institute of Plant Breeding & Acclimatization; University of Warsaw; University of Warsaw; University of Warsaw; University of Warsaw	Jonczyk, M (corresponding author), Univ Warsaw, Fac Biol, Inst Plant Expt Biol & Biotechnol, Dept Plant Mol Ecophysiol, Warsaw, Poland.	pawes@biol.uw.edu.pl	Siedlecki, Pawel/Q-3265-2017	Siedlecki, Pawel/0000-0002-7482-1341; Sobkowiak, Alicja/0000-0003-4879-1254; Tiuryn, Jerzy/0000-0002-0285-5606; Trzcinska-Danielewicz, Joanna/0000-0001-5504-1553; Biecek, Przemyslaw/0000-0001-8423-1823; Jonczyk, Maciej/0000-0002-8865-6586; Sowinski, Pawel/0000-0001-5222-8128; Fronk, Jan/0000-0002-6564-4339	Ministry of Science and Higher Education [N303 032/1109, N310 133638]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grants N303 032/1109 and N310 133638 from the Ministry of Science and Higher Education (www.nauka.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carpita NC, 2008, TRENDS PLANT SCI, V13, P415, DOI 10.1016/j.tplants.2008.06.002; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Fujimori T, 2005, BIOSCI BIOTECH BIOCH, V69, P426, DOI 10.1271/bbb.69.426; FURBANK RT, 1988, NEW PHYTOL, V109, P265, DOI 10.1111/j.1469-8137.1988.tb04195.x; Gardiner JM, 2005, MAYDICA, V50, P425; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayes KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012887; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; KALTTORRES W, 1987, PLANT PHYSIOL, V83, P283, DOI 10.1104/pp.83.2.283; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Kondo T, 1999, TRENDS PLANT SCI, V4, P171, DOI 10.1016/S1360-1385(99)01410-7; Ledford H, 2010, NATURE, V464, P154, DOI 10.1038/464154a; Martinez-Garcia JF, 1998, PLANT J, V13, P489, DOI 10.1046/j.1365-313X.1998.00050.x; Marzabal P, 2008, PLANT MOL BIOL, V67, P441, DOI 10.1007/s11103-008-9325-5; Millar AJ, 2000, CURR BIOL, V10, pR529, DOI 10.1016/S0960-9822(00)00586-8; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; PRIOUL JL, 1996, PHOTOASSIMILATE DIST, P549; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Sowinski P, 2007, ENVIRON EXP BOT, V61, P74, DOI 10.1016/j.envexpbot.2007.03.002; STAMP P, 1984, ADV AGRONOMY CROP SC, V7; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thain SC, 2002, PLANT PHYSIOL, V130, P102, DOI 10.1104/pp.005405; Trzcinska-Danielewicz J, 2009, PLANT SCI, V177, P648, DOI 10.1016/j.plantsci.2009.09.001; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Woodger FJ, 2003, J PLANT GROWTH REGUL, V22, P176, DOI 10.1007/s00344-003-0025-8; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75	43	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23628	10.1371/journal.pone.0023628	http://dx.doi.org/10.1371/journal.pone.0023628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858187	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300072
J	Ko, JH; Reilhac, A; Ray, N; Rusjan, P; Bloomfield, P; Pellecchia, G; Houle, S; Strafella, AP				Ko, Ji Hyun; Reilhac, Anthonin; Ray, Nicola; Rusjan, Pablo; Bloomfield, Peter; Pellecchia, Giovanna; Houle, Sylvain; Strafella, Antonio P.			Analysis of Variance in Neuroreceptor Ligand Imaging Studies	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; STRIATAL DOPAMINE RELEASE; PARTIAL VOLUME CORRECTION; PARKINSONS-DISEASE; PET-SORTEO; BINDING; QUANTIFICATION; CORTEX; REGISTRATION	Radioligand positron emission tomography (PET) with dual scan paradigms can provide valuable insight into changes in synaptic neurotransmitter concentration due to experimental manipulation. The residual t-test has been utilized to improve the sensitivity of the t-test in PET studies. However, no further development of statistical tests using residuals has been proposed so far to be applied in cases when there are more than two conditions. Here, we propose the residual f-test, a one-way analysis of variance (ANOVA), and examine its feasibility using simulated [C-11] raclopride PET data. We also re-visit data from our previously published [C-11] raclopride PET study, in which 10 individuals underwent three PET scans under different conditions. We found that the residual f-test is superior in terms of sensitivity than the conventional f-test while still controlling for type 1 error. The test will therefore allow us to reliably test hypotheses in the smaller sample sizes often used in explorative PET studies.	[Ko, Ji Hyun; Ray, Nicola; Rusjan, Pablo; Bloomfield, Peter; Pellecchia, Giovanna; Houle, Sylvain; Strafella, Antonio P.] Univ Toronto, Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada; [Ko, Ji Hyun; Ray, Nicola; Pellecchia, Giovanna; Strafella, Antonio P.] Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Ko, Ji Hyun; Ray, Nicola; Pellecchia, Giovanna; Strafella, Antonio P.] Univ Toronto, Res Inst, Toronto, ON, Canada; [Reilhac, Anthonin] Australian Nucl Sci & Technol Org, Dept Life Sci, Lucas Heights, NSW, Australia	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Australian Nuclear Science & Technology Organisation	Ko, JH (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada.	jihyun.ko@camhpet.ca	Ko, Ji Hyun/E-5150-2011	Ko, Ji Hyun/0000-0002-9700-7692; Houle, Sylvain/0000-0002-4231-6316; Reilhac, Anthonin/0000-0002-9997-9540; Rusjan, Pablo/0000-0003-0075-2918; Ray, Nicola/0000-0001-9645-0812	Canadian Institutes of Health Research [MOP 64423]; Edmond J. Safra Philanthropic Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Edmond J. Safra Philanthropic Foundation	This work was supported in part by a grant from the Canadian Institutes of Health Research [grant number MOP 64423 to APS] and the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Aston JAD, 2000, NEUROIMAGE, V12, P245, DOI 10.1006/nimg.2000.0620; COLLINS DL, 1995, COMP IMAG VIS, V3, P139; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; FARDE L, 1989, J CEREBR BLOOD F MET, V9, P696, DOI 10.1038/jcbfm.1989.98; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Harri M, 2007, J MED PHYS, V32, P108, DOI 10.4103/0971-6203.35723; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Ko JH, 2009, NEUROIMAGE, V46, P516, DOI 10.1016/j.neuroimage.2009.02.031; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Monchi O, 2006, NEUROIMAGE, V33, P907, DOI 10.1016/j.neuroimage.2006.06.058; Montgomery AJ, 2006, J NUCL MED, V47, P1936; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; Perruchot F, 2004, IEEE NUCL SCI CONF R, P3186; Reilhac A, 2005, IEEE T NUCL SCI, V52, P1321, DOI 10.1109/TNS.2005.858242; Reilhac A, 2004, IEEE T NUCL SCI, V51, P46, DOI 10.1109/TNS.2003.823011; Reilhac A, 2008, NEUROIMAGE, V39, P359, DOI 10.1016/j.neuroimage.2007.07.038; Reilhac A, 2006, IEEE T MED IMAGING, V25, P1431, DOI 10.1109/TMI.2006.879922; Rousset OG, 2000, SYNAPSE, V37, P81, DOI 10.1002/1098-2396(200008)37:2<81::AID-SYN1>3.3.CO;2-R; Rousset OG, 1998, J NUCL MED, V39, P904; Rousset OG, 2008, J NUCL MED, V49, P1097, DOI 10.2967/jnumed.107.048330; Seber G., 1989, NONLINEAR REGRESSION; Steeves TDL, 2010, ANN NEUROL, V67, P170, DOI 10.1002/ana.21809; Strafella AP, 2006, NEUROIMAGE, V31, P1666, DOI 10.1016/j.neuroimage.2006.02.005; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Strafella AP, 2005, EUR J NEUROSCI, V22, P2946, DOI 10.1111/j.1460-9568.2005.04476.x; Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268; Talairach J., 1988, COPLANAR STEREOTAXIC; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23298	10.1371/journal.pone.0023298	http://dx.doi.org/10.1371/journal.pone.0023298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858062	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300031
J	Seoane, M; Mosquera-Miguel, A; Gonzalez, T; Fraga, M; Salas, A; Costoya, JA				Seoane, Marcos; Mosquera-Miguel, Ana; Gonzalez, Teresa; Fraga, Maximo; Salas, Antonio; Costoya, Jose A.			The Mitochondrial Genome Is a "Genetic Sanctuary" during the Oncogenic Process	PLOS ONE			English	Article							N-ACETYLCYSTEINE; DNA-DAMAGE; MTDNA; CELLS; INSTABILITY; DYSFUNCTION; POPULATION; SUPEROXIDE; MUTATIONS; EVOLUTION	Since Otto Warburg linked mitochondrial physiology and oncogenesis in the 1930s, a number of studies have focused on the analysis of the genetic basis for the presence of aerobic glycolysis in cancer cells. However, little or no evidence exists today to indicate that mtDNA mutations are directly responsible for the initiation of tumor onset. Based on a model of gliomagenesis in the mouse, we aimed to explore whether or not mtDNA mutations are associated with the initiation of tumor formation, maintenance and aggressiveness. We reproduced the different molecular events that lead from tumor initiation to progression in the mouse glioma. In human gliomas, most of the genetic alterations that have been previously identified result in the aberrant activation of different signaling pathways and deregulation of the cell cycle. Our data indicates that mitochondrial dysfunction is associated with reactive oxygen species (ROS) generation, leading to increased nuclear DNA (nDNA) mutagenesis, but maintaining the integrity of the mitochondrial genome. In addition, mutational stability has been observed in entire mtDNA of human gliomas; this is in full agreement with the results obtained in the cancer mouse model. We use this model as a paradigm of oncogenic transformation due to the fact that mutations commonly found in gliomas appear to be the most common molecular alterations leading to tumor development in most types of human cancer. Our results indicate that the mtDNA genome is kept by the cell as a "genetic sanctuary" during tumor development in the mouse and humans. This is compatible with the hypothesis that the mtDNA molecule plays an essential role in the control of the cellular adaptive survival response to tumor-induced oxidative stress. The integrity of mtDNA seems to be a necessary element for responding to the increased ROS production associated with the oncogenic process.	[Seoane, Marcos; Costoya, Jose A.] Univ Santiago de Compostela, Dept Fisiol, Fac Med, Mol Oncol Lab, Galicia, Spain; [Mosquera-Miguel, Ana; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Inst Med Legal, Fac Med, Galicia, Spain; [Gonzalez, Teresa] Fdn Galega Med Xenom, Serv Galego Saude, Santiago De Compostela, Galicia, Spain; [Fraga, Maximo; Salas, Antonio] Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Seoane, M (corresponding author), Univ Santiago de Compostela, Dept Fisiol, Fac Med, Mol Oncol Lab, Galicia, Spain.	josea.costoya@usc.es	Salas, Antonio/U-2029-2019; Fraga, Máximo/AAC-9417-2020; Costoya, Jose A./B-2718-2009; Miguel, Ana Mosquera/ABG-9735-2020; Souto, Marcos Seoane/I-3380-2018; Salas, Antonio/E-3977-2012	Salas, Antonio/0000-0002-2336-702X; Costoya, Jose A./0000-0003-3691-6419; Miguel, Ana Mosquera/0000-0003-3939-8338; Salas, Antonio/0000-0002-2336-702X; Fraga Rodriguez, Maximo/0000-0001-6185-9562	Spanish Ministry of Education and Science [SAF2008-00543, SAF2009-08629, SAF2008-02971]; Xunta de Galicia [INCITE08PXIB208091PR]; Fundacion de Investigacion Medica Mutua Madrilena [2008/CL444]	Spanish Ministry of Education and Science(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena	This study was supported by the Spanish Ministry of Education and Science SAF2008-00543 (JAC), SAF2009-08629 (JAC), SAF2008-02971 (AS), Xunta de Galicia INCITE08PXIB208091PR (JAC) and Fundacion de Investigacion Medica Mutua Madrilena 2008/CL444 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bandelt HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-113; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Dai JG, 2005, J EXP BIOL, V208, P4445, DOI 10.1242/jeb.01920; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishikawa K, 2008, MITOCHONDRION, V8, P339, DOI 10.1016/j.mito.2008.07.006; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Marino S, 2000, GENE DEV, V14, P994; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Sathyan KM, 2007, MODERN PATHOL, V20, P1141, DOI 10.1038/modpathol.3800948; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; SINGH G, 1992, PHARMACOL THERAPEUT, V54, P217, DOI 10.1016/0163-7258(92)90033-V; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Toschi A, 2010, CANCER LETT, V299, P72, DOI 10.1016/j.canlet.2010.08.006; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; Warburg O, 1926, STOFFWECHSEL TUMORE; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	41	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23327	10.1371/journal.pone.0023327	http://dx.doi.org/10.1371/journal.pone.0023327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858071	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300035
J	Valva, P; Casciato, P; Carrasco, JMD; Gadano, A; Galdame, O; Galoppo, MC; Mullen, E; De Matteo, E; Preciado, MV				Valva, Pamela; Casciato, Paola; Diaz Carrasco, Juan M.; Gadano, Adrian; Galdame, Omar; Cristina Galoppo, Maria; Mullen, Eduardo; De Matteo, Elena; Victoria Preciado, Maria			The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic Infection	PLOS ONE			English	Article							LIVER FIBROSIS; HYALURONIC-ACID; TRANSFORMING GROWTH-FACTOR-BETA-1; NONINVASIVE ASSESSMENT; DIAGNOSTIC EVALUATION; STELLATE CELLS; CHILDREN; BIOPSY; MARKERS; APOPTOSIS	Background/Aims: Liver biopsy represents the gold standard for damage evaluation, but noninvasive serum markers that mirror liver fibrosis progression are actual goals both in adults and especially in children. The aim was to determine specific serum markers that correlate with liver fibrosis progression during chronic HCV infection. Methods: Liver biopsies and concomitant serum samples from 22 pediatric and 22 adult HCV patients were analyzed. Histological parameters were evaluated. On serum TGF-beta 1, tissue inhibitor of matrix metalloprotein inhibitor-1 (TIMP-1), hyaluronic acid (HA) and aminoterminal peptide of procollagen type III (PIIINP) were tested. Results: Significant fibrosis (F >= 2) and advanced fibrosis (F >= 3) represented 64% and 20%, respectively in children; while 54% F >= 2 and 23% F >= 3 in adults. Hyaluronic acid (p = 0.011) and PIIINP (p = 0.016) were related to worse fibrosis stages only in adults, along with TIMP-1 (p = 0.039) just in children; but TGF-beta 1 was associated with mild fibrosis (p = 0.022) in adults. The AUROC of TIMP-1 in children to discriminate advanced fibrosis was 0.800 (95% IC 0.598-0.932). In adults, the best AUROCs were that of HA, PIIINP and TGF-beta 1 [ 0.929 (IC95% 0.736-0.994), 0.894 (IC95% 0.689-0.984) and 0.835 (IC95% 0.617-0.957)], respectively. In children, according to the cut off (165.7 ng/mL) value for TIMP-1, biopsies could have been avoided in 72% (18/25). Considering the cut off for HA (109.7 ng/mL), PIIINP (9.1 mg/L), and TGF-beta 1 (10,848.3 pg/mL), biopsies could have been avoided in 87% (19/22) of adult patients by using HA and 73% (16/22) using PIIINP or TGF-beta 1. Conclusions: In adults given the diagnostic accuracy of HA, PIIINP, TGF-beta 1, their combination may provide a potential useful tool to assess liver fibrosis. This first pediatric study suggests that TIMP-1 is clinically useful for predicting liver fibrosis in HCV patients.	[Valva, Pamela; Diaz Carrasco, Juan M.; De Matteo, Elena; Victoria Preciado, Maria] Ricardo Gutierrez Childrens Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, DF, Argentina; [Casciato, Paola; Gadano, Adrian; Galdame, Omar] Hosp Italiano Buenos Aires, Liver Unit, Buenos Aires, DF, Argentina; [Cristina Galoppo, Maria] Univ Buenos Aires, Liver Unit, Ricardo Gutierrez Childrens Hosp, Buenos Aires, DF, Argentina; [Mullen, Eduardo] Hosp Italiano Buenos Aires, Div Pathol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	Valva, P (corresponding author), Ricardo Gutierrez Childrens Hosp, Mol Biol Lab, Div Pathol, Buenos Aires, DF, Argentina.	valvapamela@yahoo.com	Carrasco, Juan Diaz/AAO-2693-2020	Preciado, Maria Victoria/0000-0003-4082-0698	International Society for Infectious Diseases; National Research Council (CONICET)	International Society for Infectious Diseases; National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by grants from the International Society for Infectious Diseases (2009). No additional external funding received for this study. PV and JMDC are supported by a fellowship from National Research Council (CONICET), MVP is a member of the CONICET Research Career Program, and EDM is a member of the Research Career of Buenos Aires City Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; *AS ARG EST ENF HI, 2007, CONS ARG HEP C; Badizadegan K, 1998, HEPATOLOGY, V28, P1416, DOI 10.1002/hep.510280534; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Dienstag JL, 2002, HEPATOLOGY, V36, pS152, DOI 10.1053/jhep.2002.36381; El-Shabrawi MH, 2010, EUR J GASTROEN HEPAT, V22, P946, DOI 10.1097/MEG.0b013e328336ec84; Elmetwally IM, 2009, SAUDI MED J, V30, P638; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Fontana RJ, 2009, CLIN GASTROENTEROL H, V7, P219, DOI 10.1016/j.cgh.2008.10.034; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Gismondi MI, 2004, J CLIN MICROBIOL, V42, P1199, DOI 10.1128/JCM.42.3.1199-1202.2004; Goto Takashi, 2004, Pathophysiology, V11, P153, DOI 10.1016/j.pathophys.2004.07.003; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Hartley JL, 2006, J PEDIATR GASTR NUTR, V43, P217, DOI 10.1097/01.mpg.0000228121.44606.9f; Hermeziu B, 2010, GASTROEN CLIN BIOL, V34, P16, DOI 10.1016/j.gcb.2009.06.007; Jara P, 2003, CLIN INFECT DIS, V36, P275, DOI 10.1086/345908; Kage M, 1997, HEPATOLOGY, V26, P771, DOI 10.1002/hep.510260333; Lebensztejn DM, 2006, WORLD J GASTROENTERO, V12, P3338, DOI 10.3748/wjg.v12.i21.3338; Lebensztejn DM, 2004, HEPATOLOGY, V39, P868, DOI 10.1002/hep.20147; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Macias J, 2011, HIV MED, V12, P14, DOI 10.1111/j.1468-1293.2010.00836.x; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; Moreno S, 2009, J VIRAL HEPATITIS, V16, P249, DOI 10.1111/j.1365-2893.2009.01088.x; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Murray KF, 2005, J PEDIATR GASTR NUTR, V41, P634, DOI 10.1097/01.mpg.0000179758.82919.1f; Nelson DR, 1997, J VIRAL HEPATITIS, V4, P29, DOI 10.1046/j.1365-2893.1997.00124.x; Nobili V, 2010, TRANSL RES, V156, P229, DOI 10.1016/j.trsl.2010.05.008; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Patel K, 2003, J GASTROEN HEPATOL, V18, P253, DOI 10.1046/j.1440-1746.2003.02930.x; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Plebani M, 2007, CLIN CHIM ACTA, V381, P39, DOI 10.1016/j.cca.2007.02.019; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Rallon NI, 2011, EUR J CLIN INVEST, V41, P70, DOI 10.1111/j.1365-2362.2010.02381.x; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Resino S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-244; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476, DOI 10.3748/wjg.v11.i4.476; Saltik-Temizel Inci Nur, 2004, Indian J Gastroenterol, V23, P129; Sanai FM, 2008, LIVER INT, V28, P1011, DOI 10.1111/j.1478-3231.2008.01733.x; Sanvisens A, 2009, J VIRAL HEPATITIS, V16, P513, DOI 10.1111/j.1365-2893.2009.01103.x; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; Soliman Gamal M. M., 2010, Journal of the Egyptian Society of Parasitology, V40, P759; Taniguchi H, 2004, J MED VIROL, V72, P52, DOI 10.1002/jmv.10545; Thampanitchawong P, 1999, WORLD J GASTROENTERO, V5, P301; THEISE N, 2007, MACSWEENS PATHOLOGY, P418	59	38	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23218	10.1371/journal.pone.0023218	http://dx.doi.org/10.1371/journal.pone.0023218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858035	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300020
J	Bonomelli, C; Doores, KJ; Dunlop, DC; Thaney, V; Dwek, RA; Burton, DR; Crispin, M; Scanlan, CN				Bonomelli, Camille; Doores, Katie J.; Dunlop, D. Cameron; Thaney, Victoria; Dwek, Raymond A.; Burton, Dennis R.; Crispin, Max; Scanlan, Christopher N.			The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SITE-SPECIFIC ANALYSIS; ANTIBODY 2G12; VACCINE DESIGN; LINKED OLIGOSACCHARIDES; ENVELOPE GLYCOPROTEINS; GP120; RECOGNITION; ANTIGENS; CELLS	The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design. The extent of cross-clade conservation of HIV oligomannose glycans is therefore a critical consideration for the development of HIV prophylaxes. We measured the oligomannose content of virion-associated gp120 from primary virus from PBMCs for a range of viral isolates and showed cross-clade elevation (62-79%) of these glycans relative to recombinant, monomeric gp120 (similar to 30%). We also confirmed that pseudoviral production systems can give rise to notably elevated gp120 oligomannose levels (similar to 98%), compared to gp120 derived from a single-plasmid viral system using the HIV(LAI) backbone (56%). This study highlights differences in glycosylation between virion-associated and recombinant gp120.	[Bonomelli, Camille; Dwek, Raymond A.; Crispin, Max; Scanlan, Christopher N.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Doores, Katie J.; Dunlop, D. Cameron; Thaney, Victoria; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Doores, Katie J.; Dunlop, D. Cameron; Thaney, Victoria; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Doores, Katie J.; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA USA	University of Oxford; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Bonomelli, C (corresponding author), Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England.	chris.scanlan@bioch.ox.ac.uk	Crispin, Max/AAG-4098-2020	Crispin, Max/0000-0002-1072-2694; Doores, Katie/0000-0002-5507-1725	International AIDS Vaccine Initiative [UOXFORCOA1101]; Glycobiology Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative; Glycobiology Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a project grant from the International AIDS Vaccine Initiative (#UOXFORCOA1101). CB was supported by a Glycobiology Institute graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal-Gamse C, 2011, J VIROL, V85, P470, DOI 10.1128/JVI.01349-10; Alexandre KB, 2010, VIROLOGY, V402, P187, DOI 10.1016/j.virol.2010.03.021; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Crispin M, 2009, J BIOL CHEM, V284, P21684, DOI 10.1074/jbc.M109.006254; CROOKS ET, 2011, J VIROL; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Dunlop DC, 2008, AIDS, V22, P2214, DOI 10.1097/QAD.0b013e328314b5df; Dunlop DC, 2010, GLYCOBIOLOGY, V20, P812, DOI 10.1093/glycob/cwq020; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Kabanova A, 2010, GLYCOCONJUGATE J, V27, P501, DOI 10.1007/s10719-010-9295-0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Lee HK, 2004, ANGEW CHEM INT EDIT, V43, P1000, DOI 10.1002/anie.200353105; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Luallen RJ, 2008, J VIROL, V82, P6447, DOI 10.1128/JVI.00412-08; Luallen RJ, 2010, GLYCOBIOLOGY, V20, P280, DOI 10.1093/glycob/cwp184; Luallen RJ, 2009, J VIROL, V83, P4861, DOI 10.1128/JVI.02537-08; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Provine NM, 2009, J VIROL, V83, P9002, DOI 10.1128/JVI.00423-09; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, J MOL BIOL, V372, P16, DOI 10.1016/j.jmb.2007.06.027; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shapiro J, 1997, J HISTOCHEM CYTOCHEM, V45, P3, DOI 10.1177/002215549704500102; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	46	171	173	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23521	10.1371/journal.pone.0023521	http://dx.doi.org/10.1371/journal.pone.0023521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858152	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000294125500036
J	Gasse, P; Riteau, N; Vacher, R; Michel, ML; Fautrel, A; di Padova, F; Fick, L; Charron, S; Lagente, V; Eberl, G; Le Bert, M; Quesniaux, VFJ; Huaux, F; Leite-de-Moraes, M; Ryffel, B; Couillin, I				Gasse, Pamela; Riteau, Nicolas; Vacher, Rachel; Michel, Marie-Laure; Fautrel, Alain; di Padova, Franco; Fick, Lizette; Charron, Sabine; Lagente, Vincent; Eberl, Gerard; Le Bert, Marc; Quesniaux, Valerie F. J.; Huaux, Francois; Leite-de-Moraes, Maria; Ryffel, Bernhard; Couillin, Isabelle			IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis	PLOS ONE			English	Article							DELTA-T-CELLS; COLLAGEN-INDUCED ARTHRITIS; ROR-GAMMA-T; NEUTROPHIL RECRUITMENT; AIRWAY NEUTROPHILIA; RECEPTOR ANTAGONIST; HELPER-CELLS; LUNG INJURY; TH17 CELLS; TGF-BETA	Background: Idiopathic pulmonary fibrosis is a devastating as yet untreatable disease. We demonstrated recently the predominant role of the NLRP3 inflammasome activation and IL-1 beta expression in the establishment of pulmonary inflammation and fibrosis in mice. Methods: The contribution of IL-23 or IL-17 in pulmonary inflammation and fibrosis was assessed using the bleomycin model in deficient mice. Results: We show that bleomycin or IL-1 beta-induced lung injury leads to increased expression of early IL-23p19, and IL-17A or IL-17F expression. Early IL-23p19 and IL-17A, but not IL-17F, and IL-17RA signaling are required for inflammatory response to BLM as shown with gene deficient mice or mice treated with neutralizing antibodies. Using FACS analysis, we show a very early IL-17A and IL-17F expression by ROR gamma t(+) gamma delta cells and to a lesser extent by CD4 alpha beta(+) T cells, but not by iNKT cells, 24 hrs after BLM administration. Moreover, IL-23p19 and IL-17A expressions or IL-17RA signaling are necessary to pulmonary TGF-beta 1 production, collagen deposition and evolution to fibrosis. Conclusions: Our findings demonstrate the existence of an early IL-1 beta-IL-23-IL-17A axis leading to pulmonary inflammation and fibrosis and identify innate IL-23 and IL-17A as interesting drug targets for IL-1 beta driven lung pathology.	[Gasse, Pamela; Riteau, Nicolas; Vacher, Rachel; Charron, Sabine; Le Bert, Marc; Quesniaux, Valerie F. J.; Ryffel, Bernhard; Couillin, Isabelle] Univ Orleans, Orleans, France; [Gasse, Pamela; Riteau, Nicolas; Vacher, Rachel; Charron, Sabine; Le Bert, Marc; Quesniaux, Valerie F. J.; Ryffel, Bernhard; Couillin, Isabelle] CNRS, UMR6218, F-45071 Orleans, France; [Michel, Marie-Laure; Leite-de-Moraes, Maria] Univ Paris 05, Paris, France; [Michel, Marie-Laure; Leite-de-Moraes, Maria] CNRS, UMR8147, Paris, France; [Fautrel, Alain] Univ Rennes 1, INSERM, U991, IFR140,Histopathol Platform H2P2, Rennes, France; [di Padova, Franco] Novartis Pharmaceut, Basel, Switzerland; [Fick, Lizette; Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Eberl, Gerard] Inst Pasteur, CNRS, URA 1961, Lab Lymphoid Tissue Dev, Paris, France; [Huaux, Francois] Catholic Univ Louvain, Brussels, Belgium; [Couillin, Isabelle] Key Obs SAS, Orleans, France	Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Novartis; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Catholique Louvain	Gasse, P (corresponding author), Univ Orleans, Orleans, France.	couillin@cnrs-orleans.fr	Riteau, Nicolas/ABC-1764-2020; Le Bert, Marc/AAR-4577-2021; Fautrel, Alain/AAL-7391-2020; Eberl, Gerard/A-1160-2013; de Moraes, Maria Leite/AAV-9159-2020	Riteau, Nicolas/0000-0003-1306-6466; Le Bert, Marc/0000-0002-5945-3800; de Moraes, Maria Leite/0000-0002-2891-2269; Eberl, Gerard/0000-0002-1119-5638; FAUTREL, Alain/0000-0002-3449-0779; Michel, Marie-Laure/0000-0003-2657-4662; Lagente, Vincent/0000-0003-4920-009X				Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Crossgrove K, 2008, MOL BIOCHEM PARASIT, V157, P92, DOI 10.1016/j.molbiopara.2007.08.010; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huaux F, 2002, J IMMUNOL, V169, P2653, DOI 10.4049/jimmunol.169.5.2653; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Joosten LAB, 2008, ARTHRITIS RHEUM-US, V58, P98, DOI 10.1002/art.23152; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Komura K, 2008, J RHEUMATOL, V35, P120; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pons J, 2005, EUR RESPIR J, V25, P441, DOI 10.1183/09031936.05.00069304; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Shainheit MG, 2008, J IMMUNOL, V181, P8559, DOI 10.4049/jimmunol.181.12.8559; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sparwasser T, 2004, GENESIS, V38, P39, DOI 10.1002/gene.10249; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Suga M, 2000, AM J RESP CRIT CARE, V162, P1949, DOI 10.1164/ajrccm.162.5.9906096; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	47	144	159	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23185	10.1371/journal.pone.0023185	http://dx.doi.org/10.1371/journal.pone.0023185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858022	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500019
J	Stehle, J; Voirin, N; Barrat, A; Cattuto, C; Isella, L; Pinton, JF; Quaggiotto, M; Van den Broeck, W; Regis, C; Lina, B; Vanhems, P				Stehle, Juliette; Voirin, Nicolas; Barrat, Alain; Cattuto, Ciro; Isella, Lorenzo; Pinton, Jean-Francois; Quaggiotto, Marco; Van den Broeck, Wouter; Regis, Corinne; Lina, Bruno; Vanhems, Philippe			High-Resolution Measurements of Face-to-Face Contact Patterns in a Primary School	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; TRANSMISSION PARAMETERS; SPREAD; INFLUENZA; NETWORKS; CHILDREN	Background: Little quantitative information is available on the mixing patterns of children in school environments. Describing and understanding contacts between children at school would help quantify the transmission opportunities of respiratory infections and identify situations within schools where the risk of transmission is higher. We report on measurements carried out in a French school (6-12 years children), where we collected data on the time-resolved face-to-face proximity of children and teachers using a proximity-sensing infrastructure based on radio frequency identification devices. Methods and Findings: Data on face-to-face interactions were collected on Thursday, October 1(st) and Friday, October 2(nd) 2009. We recorded 77,602 contact events between 242 individuals (232 children and 10 teachers). In this setting, each child has on average 323 contacts per day with 47 other children, leading to an average daily interaction time of 176 minutes. Most contacts are brief, but long contacts are also observed. Contacts occur mostly within each class, and each child spends on average three times more time in contact with classmates than with children of other classes. We describe the temporal evolution of the contact network and the trajectories followed by the children in the school, which constrain the contact patterns. We determine an exposure matrix aimed at informing mathematical models. This matrix exhibits a class and age structure which is very different from the homogeneous mixing hypothesis. Conclusions: We report on important properties of the contact patterns between school children that are relevant for modeling the propagation of diseases and for evaluating control measures. We discuss public health implications related to the management of schools in case of epidemics and pandemics. Our results can help define a prioritization of control measures based on preventive measures, case isolation, classes and school closures, that could reduce the disruption to education during epidemics.	[Stehle, Juliette; Barrat, Alain] CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France; [Voirin, Nicolas; Vanhems, Philippe] Hop Edouard Herriot, Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France; [Voirin, Nicolas; Regis, Corinne; Vanhems, Philippe] Univ Lyon 1, CNRS, Equipe Epidemiol & Sante Publ, Lab Biometrie & Biol Evolut,UMR 5558, F-69365 Lyon, France; [Barrat, Alain; Cattuto, Ciro; Isella, Lorenzo; Quaggiotto, Marco; Van den Broeck, Wouter] Inst Sci interchange ISI Fdn, Data Sci Lab, Turin, Italy; [Pinton, Jean-Francois] CNRS, UMR 5672, Ecole Normale Super, Phys Lab, Lyon, France; [Lina, Bruno] Hosp Civils Lyon, Natl Influenza Ctr, Virol Lab, Lyon, France; [Lina, Bruno] Univ Lyon, Fac Med, RTH Laennec, CNRS,VIRPATH,FRE 3011,UCBL, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Stehle, J (corresponding author), CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France.	alain.barrat@cpt.univ-mrs.fr	LINA, bruno/M-4572-2014; lina, bruno/N-3663-2019	lina, bruno/0000-0002-8959-2123; Quaggiotto, Marco/0000-0003-4195-2369; Voirin, Nicolas/0000-0003-3317-056X; Isella, Lorenzo/0000-0001-9525-4123	Programme de Recherche, A(H1N1); Institut de Microbiologie et Maladies Infectieuses; EC [233847]	Programme de Recherche, A(H1N1); Institut de Microbiologie et Maladies Infectieuses; EC(European CommissionEuropean Commission Joint Research Centre)	This project was partially supported by a grant from the "Programme de Recherche, A(H1N1)" co-ordinated by the "Institut de Microbiologie et Maladies Infectieuses". L.I. acknowledges the support of the EC FET-Open project DYNANETS (contract number 233847). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani H, 2009, LECT NOTES COMPUT SC, V5823, P698, DOI 10.1007/978-3-642-04930-9_44; [Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Conlan AJK, 2011, P ROY SOC B-BIOL SCI, V278, P1467, DOI 10.1098/rspb.2010.1807; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Hui P., 2005, P 2005 ACM SIGCOMM W; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Jackson C, 2011, EMERG INFECT DIS, V17, P245, DOI 10.3201/eid1702.100458; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; O'Neill E, 2006, LECT NOTES COMPUT SC, V4206, P315; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Zagheni E, 2008, AM J EPIDEMIOLOGY, V168	24	395	407	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23176	10.1371/journal.pone.0023176	http://dx.doi.org/10.1371/journal.pone.0023176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858018	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500017
J	Abdelkarim, M; Vintonenko, N; Starzec, A; Robles, A; Aubert, J; Martin, ML; Mourah, S; Podgorniak, MP; Rodrigues-Ferreira, S; Nahmias, C; Couraud, PO; Doliger, C; Sainte-Catherine, O; Peyri, N; Chen, L; Mariau, J; Etienne, M; Perret, GY; Crepin, M; Poyet, JL; Khatib, AM; Di Benedetto, M				Abdelkarim, Mohamed; Vintonenko, Nadejda; Starzec, Anna; Robles, Aniela; Aubert, Julie; Martin, Marie-Laure; Mourah, Samia; Podgorniak, Marie-Pierre; Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier; Doliger, Christelle; Sainte-Catherine, Odile; Peyri, Nicole; Chen, Lei; Mariau, Jeremie; Etienne, Monique; Perret, Gerard-Yves; Crepin, Michel; Poyet, Jean-Luc; Khatib, Abdel-Majid; Di Benedetto, Melanie			Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TGF-BETA; GROWTH; EXPRESSION; ANGIOGENESIS; CARCINOMA; PROTEINS	Introduction: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM) environment to this phenomenon, we isolated ECM surrogate invading cell populations from MDA-MB-231 breast cancer cells and studied their genotype and malignant phenotype. Methods: We isolated invasive subpopulations (INV) from non invasive populations (REF) using a 2D-Matrigel assay, a surrogate of basal membrane passage. INV and REF populations were investigated by microarray assay and for their capacities to adhere, invade and transmigrate in vitro, and to form metastases in nude mice. Results: REF and INV subpopulations were stable in culture and present different transcriptome profiles. INV cells were characterized by reduced expression of cell adhesion and cell-cell junction genes (44% of down regulated genes) and by a gain in expression of anti-apoptotic and pro-angiogenic gene sets. In line with this observation, in vitro INV cells showed reduced adhesion and increased motility through endothelial monolayers and fibronectin. When injected into the circulation, INV cells induced metastases formation, and reduced injected mice survival by up to 80% as compared to REF cells. In nude mice, INV xenografts grew rapidly inducing vessel formation and displaying resistance to apoptosis. Conclusion: Our findings reveal that the in vitro ECM microenvironment per se was sufficient to select for tumor cells with a stable metastatic phenotype in vivo characterized by loss of adhesion molecules expression and induction of proangiogenic and survival factors.	[Abdelkarim, Mohamed; Vintonenko, Nadejda; Robles, Aniela; Sainte-Catherine, Odile; Peyri, Nicole; Di Benedetto, Melanie] Univ Paris 13, CNRS FRE CSPBAT, UFR SMBH, Lab Chim Struct Biomol, Bobigny, France; [Abdelkarim, Mohamed; Vintonenko, Nadejda; Chen, Lei; Mariau, Jeremie; Crepin, Michel] INSERM 553 Endothelium & Angiogenese, Hemostase Lab, Paris, France; [Starzec, Anna; Perret, Gerard-Yves] Univ Paris 13, EA4222, Li2P, Bobigny, France; [Robles, Aniela; Mourah, Samia; Podgorniak, Marie-Pierre; Peyri, Nicole; Poyet, Jean-Luc; Khatib, Abdel-Majid; Di Benedetto, Melanie] Univ Paris 07, UMRS 940, Equipe Avenir, IGM, Paris, France; [Aubert, Julie; Martin, Marie-Laure] AgroParisTech, UMR 518, Paris, France; [Martin, Marie-Laure] URGV UMR INRA 1165 CNRS 8114 UEVE, Evry, France; [Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier] CNRS, UMR 8104, Paris, France; [Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier] Univ Paris 05, Paris, France; [Doliger, Christelle] Hop St Louis, Inst Hematol, Serv Commun Imagerie, Paris, France; [Etienne, Monique] Univ Paris 13, Histol Lab, Bobigny, France; [Khatib, Abdel-Majid] Univ Bordeaux 1, INSERM, U1029, Bordeaux, France	Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Abdelkarim, M (corresponding author), Univ Paris 13, CNRS FRE CSPBAT, UFR SMBH, Lab Chim Struct Biomol, Bobigny, France.	dibenedetto22@yahoo.fr	Di Benedetto, Melanie MD/C-1512-2018; AUBERT, Julie/D-9120-2011; abdelkarim, mohamed/AAK-5563-2020; AUBERT, Julie/AAJ-8960-2021; PERRET, gerard/A-7379-2008; KHATIB, Abdel-Majid/A-9948-2015; Poyet, Jean-Luc/G-7114-2017	Di Benedetto, Melanie MD/0000-0003-1119-3752; abdelkarim, mohamed/0000-0002-0984-6083; AUBERT, Julie/0000-0001-5203-5748; PERRET, gerard/0000-0003-0645-3337; KHATIB, Abdel-Majid/0000-0001-6957-0384; Poyet, Jean-Luc/0000-0002-3747-255X	"La Ligue nationale contre le cancer Comite Ile-de France'' the INCA [PL06_130]; Association pour la Recherche contre le Cancer (ARC); Association Martine Midy	"La Ligue nationale contre le cancer Comite Ile-de France'' the INCA; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Association Martine Midy	The authors thank "La Ligue nationale contre le cancer Comite Ile-de France'' the INCA PL06_130, the Association pour la Recherche contre le Cancer (ARC) and the Association Martine Midy for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004685; Aesoy R, 2008, MOL CANCER RES, V6, P1630, DOI 10.1158/1541-7786.MCR-07-2172; ALBINI A, 1987, CANCER RES, V47, P3239; AOKAGE K, 2010, INT J CANC IN PRESS; Bachelder RE, 2001, CANCER RES, V61, P5736; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; CUNHA GR, 1992, J ANDROL, V13, P465; De Angelis PM, 2004, INT J ONCOL, V24, P1279; Delmar P, 2005, BIOINFORMATICS, V21, P502, DOI 10.1093/bioinformatics/bti023; Di Benedetto M, 2006, GENE, V380, P127, DOI 10.1016/j.gene.2006.05.021; Di Benedetto M, 2003, BRIT J CANCER, V88, P1987, DOI 10.1038/sj.bjc.6600985; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Hamma-Kourbali Y, 2003, BIOCHEM BIOPH RES CO, V310, P816, DOI 10.1016/j.bbrc.2003.09.083; Haslam SZ, 2001, BREAST CANCER RES, V3, P365, DOI 10.1186/bcr324; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kleinman H K, 2001, Surg Oncol Clin N Am, V10, P329; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Kranz A, 1999, INT J CANCER, V84, P293, DOI 10.1002/(SICI)1097-0215(19990621)84:3<293::AID-IJC16>3.0.CO;2-T; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; PERRET GY, 2008, FUNDAMENTAL CLIN PHA, V5, P465; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Rajaraman R, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-25; Shekhar MPV, 2003, BREAST CANCER RES, V5, P130, DOI 10.1186/bcr580; Shekhar MPV, 2001, CANCER RES, V61, P1320; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney KJ, 1997, ONCOGENE, V14, P1329, DOI 10.1038/sj.onc.1200951; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Wang T, 2010, INT J CANCER, V126, P362, DOI 10.1002/ijc.24753; WEIGAND M, 2005, ANGIOGENESIS, V3, P197; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; WEISS L, 1986, J PATHOL, V150, P195, DOI 10.1002/path.1711500308; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yang L, 2010, CANCER METAST REV, V29, P263, DOI 10.1007/s10555-010-9226-3; Yang SH, 2007, BBA-MOL CELL RES, V1773, P903, DOI 10.1016/j.bbamcr.2007.03.021	46	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23334	10.1371/journal.pone.0023334	http://dx.doi.org/10.1371/journal.pone.0023334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858074	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953700016
J	Hashimoto, A; Hashimoto, S; Ando, R; Noda, K; Ogawa, E; Kotani, H; Hirose, M; Menju, T; Morishige, M; Manabe, T; Toda, Y; Ishida, S; Sabe, H				Hashimoto, Ari; Hashimoto, Shigeru; Ando, Ryo; Noda, Kosuke; Ogawa, Eiji; Kotani, Hirokazu; Hirose, Mayumi; Menju, Toshi; Morishige, Masaki; Manabe, Toshiaki; Toda, Yoshinobu; Ishida, Susumu; Sabe, Hisataka			GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; IN-VIVO; CHOROIDAL NEOVASCULARIZATION; SIGNALING PROMOTES; DRUG-RESISTANCE; VE-CADHERIN; ARF6; GROWTH; CELLS; PERMEABILITY	Angiogenesis and cancer invasiveness greatly contribute to cancer malignancy. Arf6 and its effector, AMAP1, are frequently overexpressed in breast cancer, and constitute a central pathway to induce the invasion and metastasis. In this pathway, Arf6 is activated by EGFR via GEP100. Arf6 is highly expressed also in human umbilical vein endothelial cells (HUVECs) and is implicated in angiogenesis. Here, we found that HUVECs also highly express AMAP1, and that vascular endothelial growth factor receptor-2 (VEGFR2) recruits GEP100 to activate Arf6. AMAP1 functions by binding to cortactin in cancer invasion and metastasis. We demonstrate that the same GEP100-Arf6-AMAP1-cortactin pathway is essential for angiogenesis activities, including cell migration and tubular formation, as well as for the enhancement of cell permeability and VE-cadherin endocytosis of VEGF-stimulated HUVECs. Components of this pathway are highly expressed in pathologic angiogenesis, and blocking of this pathway effectively inhibits VEGF-or tumor-induced angiogenesis and choroidal neovascularization. The GEP100-Arf6-AMAP1-cortactin pathway, activated by receptor tyrosine kinases, appears to be common in angiogenesis and cancer invasion and metastasis, and provides their new therapeutic targets.	[Hashimoto, Ari; Hashimoto, Shigeru; Sabe, Hisataka] Hokkaido Univ, Dept Mol Biol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hashimoto, Ari; Hashimoto, Shigeru; Ogawa, Eiji; Menju, Toshi; Morishige, Masaki; Sabe, Hisataka] Osaka Biosci Inst, Dept Mol Biol, Suita, Osaka 565, Japan; [Ando, Ryo; Noda, Kosuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Ogawa, Eiji; Manabe, Toshiaki] Kyoto Univ, Fac Med, Lab Diagnost Pathol, Kyoto, Japan; [Ogawa, Eiji; Kotani, Hirokazu; Menju, Toshi] Kyoto Univ, Fac Med, Dept Thorac Surg, Kyoto, Japan; [Kotani, Hirokazu; Toda, Yoshinobu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto, Japan; [Hirose, Mayumi] Osaka Univ, Inst Prot Res, Lab Supramol Crystallog, Osaka, Japan; [Morishige, Masaki] Oita Univ, Sch Med, Dept Neurosurg, Oita 87011, Japan	Hokkaido University; Hokkaido University; Kyoto University; Kyoto University; Kyoto University; Osaka University; Oita University	Hashimoto, A (corresponding author), Hokkaido Univ, Dept Mol Biol, Grad Sch Med, Sapporo, Hokkaido, Japan.	sabeh@med.hokudai.ac.jp	Sabe, Hisataka/A-4066-2012; Hashimoto, Shigeru/D-7138-2012; まゆみ, 廣瀬/AAK-5735-2020; ISHIDA, SUSUMU/D-7067-2012; Hashimoto, Ari/D-7125-2012; Sabe, Hisataka/GPF-4385-2022	Menju, Toshi/0000-0002-7341-6002	Ministry of Education, Science, Sports and Culture of Japan (MESSC); Takeda Science Foundation; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [23590323] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan (MESSC)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (MESSC), the Takeda Science Foundation, and the Mitsubishi Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hashimoto S, 2004, J BIOL CHEM, V279, P37677, DOI 10.1074/jbc.M404196200; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; KAWAI Y, AM J PHYSL CELL PHYS, V295, pC1123; Kerbel RS, 2001, CANCER METAST REV, V20, P1, DOI 10.1023/A:1013129128673; LIOTTA LA, 2003, CANC MED, P151; MADRI JA, 1986, J HISTOCHEM CYTOCHEM, V34, P85, DOI 10.1177/34.1.2416801; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Noda K, 2008, FASEB J, V22, P2928, DOI 10.1096/fj.07-105346; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987	49	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23359	10.1371/journal.pone.0023359	http://dx.doi.org/10.1371/journal.pone.0023359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858086	Green Published, gold			2022-12-25	WOS:000293953700018
J	Shahin, K; Doran, PM				Shahin, Kifah; Doran, Pauline M.			Strategies for Enhancing the Accumulation and Retention of Extracellular Matrix in Tissue-Engineered Cartilage Cultured in Bioreactors	PLOS ONE			English	Article							POLYGLYCOLIC ACID SCAFFOLDS; ARTICULAR CHONDROCYTES; MECHANICAL-PROPERTIES; GEL-ELECTROPHORESIS; IN-VITRO; PROTEOGLYCANS; DIFFERENTIATION; EXPRESSION; PERFUSION; FETAL	Production of tissue-engineered cartilage involves the synthesis and accumulation of key constituents such as glycosaminoglycan (GAG) and collagen type II to form insoluble extracellular matrix (ECM). During cartilage culture, macromolecular components are released from nascent tissues into the medium, representing a significant waste of biosynthetic resources. This work was aimed at developing strategies for improving ECM retention in cartilage constructs and thus the quality of engineered tissues produced in bioreactors. Human chondrocytes seeded into polyglycolic acid (PGA) scaffolds were cultured in perfusion bioreactors for up to 5 weeks. Analysis of the size and integrity of proteoglycans in the constructs and medium showed that full-sized aggrecan was being stripped from the tissues without proteolytic degradation. Application of low (0.075 mL min(-1)) and gradually increasing (0.075-0.2 mL min(-1)) medium flow rates in the bioreactor resulted in the generation of larger constructs, a 4.0-4.4-fold increase in the percentage of GAG retained in the ECM, and a 4.8-5.2-fold increase in GAG concentration in the tissues compared with operation at 0.2 mL min(-1). GAG retention was also improved by pre-culturing seeded scaffolds in flasks for 5 days prior to bioreactor culture. In contrast, GAG retention in PGA scaffolds infused with alginate hydrogel did not vary significantly with medium flow rate or pre-culture treatment. This work demonstrates that substantial improvements in cartilage quality can be achieved using scaffold and bioreactor culture strategies that specifically target and improve ECM retention.	[Shahin, Kifah] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Doran, Pauline M.] Monash Univ, Sch Biol Sci, Dept Chem Engn, Melbourne, Vic 3004, Australia	University of New South Wales Sydney; Monash University	Shahin, K (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	pauline.doran@monash.edu			Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	This work was funded by the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]; Choi BY, 2002, INT J PHARMACEUT, V239, P81, DOI 10.1016/S0378-5173(02)00054-6; Cioffi M, 2006, BIOTECHNOL BIOENG, V93, P500, DOI 10.1002/bit.20740; Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492; Davisson T, 2002, TISSUE ENG, V8, P807, DOI 10.1089/10763270260424169; Devarapalli M, 2009, BIOTECHNOL BIOENG, V103, P1003, DOI 10.1002/bit.22333; Dodge G R, 2001, Methods Mol Biol, V171, P149; Duda GN, 2000, J BIOMED MATER RES, V53, P673, DOI 10.1002/1097-4636(2000)53:6<673::AID-JBM9>3.0.CO;2-V; DUNKELMAN NS, 1995, BIOTECHNOL BIOENG, V46, P299, DOI 10.1002/bit.260460402; Eichhorn SJ, 2010, J R SOC INTERFACE, V7, P641, DOI 10.1098/rsif.2009.0374; Feng C, 2010, J BIOMED MATER RES A, V94A, P317, DOI 10.1002/jbm.a.32729; Fertala A, 1996, J BIOL CHEM, V271, P14864, DOI 10.1074/jbc.271.25.14864; FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710; Freyria AM, 2005, TISSUE ENG, V11, P674, DOI 10.1089/ten.2005.11.674; Freyria AM, 2004, BIOMATERIALS, V25, P687, DOI 10.1016/S0142-9612(03)00568-4; Garvican ER, 2010, VET J, V185, P36, DOI 10.1016/j.tvjl.2010.04.011; Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469; Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q; Hardmeier R, 2010, J TISSUE ENG REGEN M, V4, P1, DOI 10.1002/term.211; HAUSELMANN HJ, 1992, MATRIX, V12, P116; Heath CA, 1996, BIOTECHNOL BIOENG, V50, P430, DOI 10.1002/(SICI)1097-0290(19960520)50:4<430::AID-BIT10>3.0.CO;2-N; HEINEGARD D, 1985, ANAL BIOCHEM, V151, P41, DOI 10.1016/0003-2697(85)90050-8; Kinner B, 2001, J ORTHOP RES, V19, P233, DOI 10.1016/S0736-0266(00)00081-4; LAVIETES BB, 1971, EXP CELL RES, V68, P43, DOI 10.1016/0014-4827(71)90584-2; Mahmoudifar N, 2005, BIOTECHNOL BIOENG, V91, P338, DOI 10.1002/bit.20490; MAHMOUDIFAR N, 2007, MAT SCI RES HORIZONS, P171; Mahmoudifar N, 2006, TISSUE ENG, V12, P1675, DOI 10.1089/ten.2006.12.1675; Mahmoudifar N, 2010, BIOTECHNOL BIOENG, V107, P393, DOI 10.1002/bit.22798; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; MCDEVITT CA, 1971, ANAL BIOCHEM, V44, P612, DOI 10.1016/0003-2697(71)90250-8; McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V; Mow Van C., 1997, P113; Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997; Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v; Pierre J, 2008, BIOMECH MODEL MECHAN, V7, P497, DOI 10.1007/s10237-007-0107-9; Sandy J D, 2001, Methods Mol Biol, V171, P335; Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1; Shahin K, 2011, BIOTECHNOL PROGR, V27, P191, DOI 10.1002/btpr.509; Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345; VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323; Yanagishita M, 2001, Methods Mol Biol, V171, P3	44	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23119	10.1371/journal.pone.0023119	http://dx.doi.org/10.1371/journal.pone.0023119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858004	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953700004
J	Wei, HY; Masterson, SP; Petry, HM; Bickford, ME				Wei, Haiyang; Masterson, Sean P.; Petry, Heywood M.; Bickford, Martha E.			Diffuse and Specific Tectopulvinar Terminals in the Tree Shrew: Synapses, Synapsins, and Synaptic Potentials	PLOS ONE			English	Article							DORSAL LATERAL GENICULATE; VESICULAR GLUTAMATE TRANSPORTERS; PROTEIN-KINASE-II; PULVINAR NUCLEUS; THALAMOCORTICAL NEURONS; PERIGENICULATE NUCLEUS; SUPERIOR COLLICULUS; ORGANIZATION; PROJECTIONS; CORTEX	The pulvinar nucleus of the tree shrew receives both topographic (specific) and nontopographic (diffuse) projections from superior colliculus (SC), which form distinct synaptic arrangements. We characterized the physiological properties of these synapses and describe two distinct types of excitatory postsynaptic potentials (EPSPs) that correlate with structural properties of the specific and diffuse terminals. Synapses formed by specific terminals were found to be significantly longer than those formed by diffuse terminals. Stimulation of these two terminal types elicited two types of EPSPs that differed in their latency and threshold amplitudes. In addition, in response to repetitive stimulation (0.5-20 Hz) one type of EPSP displayed frequency-dependent depression whereas the amplitudes of the second type of EPSP were not changed by repetitive stimulation of up to 20Hz. To relate these features to vesicle release, we compared the synapsin content of terminals in the pulvinar nucleus and the dorsal lateral geniculate (dLGN) by combining immunohistochemical staining for synapsin I or II with staining for the type 1 or type 2 vesicular glutamate transporters (markers for corticothalamic and tectothalamic/retinogeniculate terminals, respectively). We found that retinogeniculate terminals do not contain either synapsin I or synapsin II, corticothalamic terminals in the dLGN and pulvinar contain synapsin I, but not synapsin II, whereas tectopulvinar terminals contain both synapsin I and synapsin II. Finally, both types of EPSPs showed a graded increase in amplitude with increasing stimulation intensity, suggesting convergence; this was confirmed using a combination of anterograde tract tracing and immunocytochemisty. We suggest that the convergent synaptic arrangements, as well as the unique synapsin content of tectopulvinar terminals, allow them to relay a dynamic range of visual signals from the SC.	[Wei, Haiyang; Masterson, Sean P.; Bickford, Martha E.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Petry, Heywood M.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Wei, HY (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	martha.bickford@louisville.edu		Wei, Haiyang/0000-0002-0145-9353	National Institutes of Health [EY01655, NS35377]; NATIONAL EYE INSTITUTE [R01EY001655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035377, R01NS035377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Grant sponsor: National Institutes of Health, Grant Number EY01655 and Grant Number NS35377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANO JE, 1978, J NEUROPHYSIOL, V41, P1140, DOI 10.1152/jn.1978.41.5.1140; Baldauf ZB, 2005, J COMP NEUROL, V485, P87, DOI 10.1002/cne.20480; BENFENATI F, 1991, P NATL ACAD SCI USA, V88, P575, DOI 10.1073/pnas.88.2.575; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; Bickford ME, 2010, J COMP NEUROL, V518, P622, DOI 10.1002/cne.22223; Bickford ME, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-17-j0004.1999; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; BRUNSOBECHTOLD JK, 1985, DEV BRAIN RES, V23, P310, DOI 10.1016/0165-3806(85)90057-4; CASSEDAY JH, 1979, J COMP NEUROL, V185, P253, DOI 10.1002/cne.901850204; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chomsung RD, 2008, J COMP NEUROL, V510, P24, DOI 10.1002/cne.21763; Chomsung RD, 2010, CEREB CORTEX, V20, P997, DOI 10.1093/cercor/bhp162; Day-Brown JD, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00143; De Graan P N, 1990, Adv Exp Med Biol, V268, P347; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Erisir A, 1997, P NATL ACAD SCI USA, V94, P1517, DOI 10.1073/pnas.94.4.1517; FITZPATRICK D, 1988, J COMP NEUROL, V272, P43, DOI 10.1002/cne.902720105; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Gitler D, 2008, J NEUROSCI, V28, P10835, DOI 10.1523/JNEUROSCI.0924-08.2008; GRAHAM J, 1980, J COMP NEUROL, V191, P133, DOI 10.1002/cne.901910108; Granseth B, 2002, J PHYSIOL-LONDON, V544, P477, DOI 10.1113/jphysiol.2002.024703; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P1, DOI 10.1007/BF00321474; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kelly LR, 2003, J COMP NEUROL, V464, P472, DOI 10.1002/cne.10800; Kielland A, 2002, J PHYSIOL-LONDON, V542, P99, DOI 10.1113/jphysiol.2002.019240; Kielland A, 2006, J NEUROSCI, V26, P5786, DOI 10.1523/JNEUROSCI.4631-05.2006; Li JL, 2003, J NEUROPHYSIOL, V90, P3429, DOI 10.1152/jn.00456.2003; Li JL, 2003, J COMP NEUROL, V460, P394, DOI 10.1002/cne.10646; LINDSTROM S, 1990, EXP BRAIN RES, V79, P313, DOI 10.1007/BF00608240; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LUPPINO G, 1988, J COMP NEUROL, V273, P67, DOI 10.1002/cne.902730107; Lyon DC, 2003, J COMP NEUROL, V467, P593, DOI 10.1002/cne.10939; Masterson SP, 2010, J NEUROPHYSIOL, V104, P1758, DOI 10.1152/jn.00010.2010; Masterson SP, 2009, J COMP NEUROL, V515, P647, DOI 10.1002/cne.22077; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MONTERO VM, 1989, EXP BRAIN RES, V75, P65; MOONEY RD, 1984, J NEUROPHYSIOL, V51, P407, DOI 10.1152/jn.1984.51.3.407; OGREN MP, 1979, J COMP NEUROL, V188, P147, DOI 10.1002/cne.901880112; OGREN MP, 1979, J COMP NEUROL, V188, P179, DOI 10.1002/cne.901880113; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; ROBSON JA, 1977, J COMP NEUROL, V173, P389, DOI 10.1002/cne.901730211; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Samigullin D, 2004, J PHYSIOL-LONDON, V561, P149, DOI 10.1113/jphysiol.2004.073494; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Smith PH, 2007, J NEUROPHYSIOL, V98, P681, DOI 10.1152/jn.00235.2007; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Van Horn SC, 2000, J COMP NEUROL, V416, P509; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; WILSON JR, 1993, ACTA ANAT, V147, P1	61	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23781	10.1371/journal.pone.0023781	http://dx.doi.org/10.1371/journal.pone.0023781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858222	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700042
J	Yang, JS; Nam, HJ; Seo, M; Han, SK; Choi, Y; Nam, HG; Lee, SJ; Kim, S				Yang, Jae-Seong; Nam, Hyun-Jun; Seo, Mihwa; Han, Seong Kyu; Choi, Yonghwan; Nam, Hong Gil; Lee, Seung-Jae; Kim, Sanguk			OASIS: Online Application for the Survival Analysis of Lifespan Assays Performed in Aging Research	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; LONGEVITY; DAF-16; INGESTION; ONSET; LONG; MICE	Background: Aging is a fundamental biological process. Characterization of genetic and environmental factors that influence lifespan is a crucial step toward understanding the mechanisms of aging at the organism level. To capture the different effects of genetic and environmental factors on lifespan, appropriate statistical analyses are needed. Methodology/Principal Findings: We developed an online application for survival analysis (OASIS) that helps conduct various novel statistical tasks involved in analyzing survival data in a user-friendly manner. OASIS provides standard survival analysis results including Kaplan-Meier estimates and mean/median survival time by taking censored survival data. OASIS also provides various statistical tests including comparison of mean survival time, overall survival curve, and survival rate at specific time point. To visualize survival data, OASIS generates survival and log cumulative hazard plots that enable researchers to easily interpret their experimental results. Furthermore, we provide statistical methods that can analyze variances among survival datasets. In addition, users can analyze proportional effects of risk factors on survival. Conclusions/Significance: OASIS provides a platform that is essential to facilitate efficient statistical analyses of survival data in the field of aging research. Web application and a detailed description of algorithms are accessible from http://sbi.postech.ac.kr/oasis.	[Yang, Jae-Seong; Nam, Hyun-Jun; Seo, Mihwa; Choi, Yonghwan; Nam, Hong Gil; Lee, Seung-Jae; Kim, Sanguk] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Han, Seong Kyu; Nam, Hong Gil; Lee, Seung-Jae; Kim, Sanguk] Pohang Univ Sci & Technol, Dept Mol Life Sci, Pohang, South Korea; [Lee, Seung-Jae; Kim, Sanguk] Pohang Univ Sci & Technol, World Class Univ Informat Technol Convergence Eng, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Yang, JS (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	seungjaelee@postech.ac.kr; sukim@postech.ac.kr	Yang, Jae-Seong/AAH-6965-2019; Lee, Seung Jae V/E-2468-2019	Yang, Jae-Seong/0000-0001-9910-3170; Lee, Seung-Jae/0000-0002-6103-156X; Kim, Sanguk/0000-0002-3449-3814	National Core Research Center for Systems Bio-Dynamics [20090091509]; World Class University [R31-2010-000-10100-0]; POSTECH BRI	National Core Research Center for Systems Bio-Dynamics; World Class University; POSTECH BRI	This work was supported by the National Core Research Center for Systems Bio-Dynamics (20090091509); World Class University program (R31-2010-000-10100-0), and POSTECH BRI Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 2005, BIOL LETT-UK, V1, P276, DOI 10.1098/rsbl.2005.0318; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; COX DR, 1972, J R STAT SOC B, V34, P187; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fleming TR, 1991, COUNTING PROCESSES S; Gallagher IM, 2000, NEUROSCI LETT, V289, P221, DOI 10.1016/S0304-3940(00)01279-9; Guarente L, 2007, MOL BIOL AGING; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kraus D, 2009, J STAT PLAN INFER, V139, P3559, DOI 10.1016/j.jspi.2009.04.009; Lambert HE, 2004, INT J GYNECOL CANCER, V14, P772, DOI 10.1111/j.1048-891X.2004.014507.x; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Li WQ, 2000, DEV BIOL, V218, P172, DOI 10.1006/dbio.1999.9593; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LUDER HU, 1993, MECH AGEING DEV, V67, P247, DOI 10.1016/0047-6374(93)90003-A; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; MILLER RG, 1983, BIOMETRICS, V39, P1077, DOI 10.2307/2531341; Minder CE, 1996, STAT MED, V15, P1033, DOI 10.1002/(SICI)1097-0258(19960530)15:10<1033::AID-SIM215>3.0.CO;2-Y; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PETO R, 1973, BIOMETRICS, V29, P579, DOI 10.2307/2529177; Promislow DEL, 1996, GENETICS, V143, P839; *R DEV COR TEAM, 2008, R DEV COR TEAM CONTR; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Sheridan RL, 2000, ARCH PEDIAT ADOL MED, V154, P245, DOI 10.1001/archpedi.154.3.245; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; WU D, 2009, EXP GERONTOL	42	198	198	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23525	10.1371/journal.pone.0023525	http://dx.doi.org/10.1371/journal.pone.0023525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858155	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953700030
J	Yan, CG; He, Y				Yan, Chaogan; He, Yong			Driving and Driven Architectures of Directed Small-World Human Brain Functional Networks	PLOS ONE			English	Article							DEFAULT-MODE; GRANGER CAUSALITY; BASAL GANGLIA; MODULAR ORGANIZATION; CORTICAL THICKNESS; LOW-FREQUENCY; CONNECTIVITY; CORTEX; FMRI; MRI	Recently, increasing attention has been focused on the investigation of the human brain connectome that describes the patterns of structural and functional connectivity networks of the human brain. Many studies of the human connectome have demonstrated that the brain network follows a small-world topology with an intrinsically cohesive modular structure and includes several network hubs in the medial parietal regions. However, most of these studies have only focused on undirected connections between regions in which the directions of information flow are not taken into account. How the brain regions causally influence each other and how the directed network of human brain is topologically organized remain largely unknown. Here, we applied linear multivariate Granger causality analysis (GCA) and graph theoretical approaches to a resting-state functional MRI dataset with a large cohort of young healthy participants (n = 86) to explore connectivity patterns of the population-based whole-brain functional directed network. This directed brain network exhibited prominent small-world properties, which obviously improved previous results of functional MRI studies showing weak small-world properties in the directed brain networks in terms of a kernel-based GCA and individual analysis. This brain network also showed significant modular structures associated with 5 well known subsystems: fronto-parietal, visual, paralimbic/limbic, subcortical and primary systems. Importantly, we identified several driving hubs predominantly located in the components of the attentional network (e. g., the inferior frontal gyrus, supplementary motor area, insula and fusiform gyrus) and several driven hubs predominantly located in the components of the default mode network (e. g., the precuneus, posterior cingulate gyrus, medial prefrontal cortex and inferior parietal lobule). Further split-half analyses indicated that our results were highly reproducible between two independent subgroups. The current study demonstrated the directions of spontaneous information flow and causal influences in the directed brain networks, thus providing new insights into our understanding of human brain functional connectome.	[Yan, Chaogan; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Yan, CG (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	Yan, Chao-Gan/D-1713-2015; He, Yong/Q-5756-2018; He, Yong/C-2161-2009	Yan, Chao-Gan/0000-0003-3413-5977; 	National Natural Science Foundation of China [81030028, 30870667]; Beijing Municipal Natural Science Foundation [7102090]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry); Beijing Normal University [08046]; Ministry of Education, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Beijing Normal University; Ministry of Education, China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81030028 and 30870667), Beijing Municipal Natural Science Foundation (Grant No. 7102090), the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry, YH), Fund for Outstanding Doctoral Dissertation of Beijing Normal University (08046, CY) and Fund for Outstanding Young Scholar (for doctoral candidates, Ministry of Education, China, CY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BARBAS H, 1995, NEUROSCI BIOBEHAV R, V19, P499, DOI 10.1016/0149-7634(94)00053-4; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Booth JR, 2007, BRAIN RES, V1133, P136, DOI 10.1016/j.brainres.2006.11.074; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; da Silva FL, 2004, MAGN RESON IMAGING, V22, P1533, DOI 10.1016/j.mri.2004.10.010; David O, NEUROIMAGE IN PRESS; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston K, NEUROIMAGE IN PRESS; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gomez-Herrero G, 2008, NEUROIMAGE, V43, P497, DOI 10.1016/j.neuroimage.2008.07.032; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Marinazzo D, 2011, NEUROIMAGE, V58, P330, DOI 10.1016/j.neuroimage.2010.01.099; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MICHEL CM, 1992, ELECTROEN CLIN NEURO, V82, P38, DOI 10.1016/0013-4694(92)90180-P; Nakano K, 2000, J NEUROL, V247, P1; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Roebroeck A, NEUROIMAGE IN PRESS; Rosa MJ, 2010, NEUROIMAGE, V49, P1496, DOI 10.1016/j.neuroimage.2009.09.011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	93	45	48	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23460	10.1371/journal.pone.0023460	http://dx.doi.org/10.1371/journal.pone.0023460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858129	Green Published, gold			2022-12-25	WOS:000293953500044
J	Yurkov, AM; Kemler, M; Begerow, D				Yurkov, Andrey M.; Kemler, Martin; Begerow, Dominik			Species Accumulation Curves and Incidence-Based Species Richness Estimators to Appraise the Diversity of Cultivable Yeasts from Beech Forest Soils	PLOS ONE			English	Article							BASIDIOMYCETOUS YEAST; POLYPHASIC TAXONOMY; COMMUNITY STRUCTURE; POPULATION-SIZE; GEN. NOV.; FUNGI; IDENTIFICATION; BIODIVERSITY; RHODOTORULA; SYSTEMATICS	Background: Yeast-like fungi inhabit soils throughout all climatic zones in a great abundance. While recent estimations predicted a plethora of prokaryotic taxa in one gram of soil, similar data are lacking for fungi, especially yeasts. Methodology/Principal Findings: We assessed the diversity of soil yeasts in different forests of central Germany using cultivation-based techniques with subsequent identification based on rDNA sequence data. Based on experiments using various pre-cultivation sample treatment and different cultivation media we obtained the highest number of yeasts by analysing mixed soil samples with a single nutrient-rich medium. Additionally, several species richness estimators were applied to incidence-based data of 165 samples. All of them predicted a similar range of yeast diversity, namely 14 to 16 species. Randomized species richness curves reached saturation in all applied estimators, thus indicating that the majority of species is detected after approximately 30 to 50 samples analysed. Conclusions/Significance: In this study we demonstrate that robust species identification as well as mathematical approaches are essential to reliably estimate the sampling effort needed to describe soil yeast communities. This approach has great potential for optimisation of cultivation techniques and allows high throughput analysis in the future.	[Yurkov, Andrey M.; Kemler, Martin; Begerow, Dominik] Ruhr Univ Bochum, Dept Evolut & Biodivers Plants, Fac Biol & Biotechnol, Bochum, Germany; [Kemler, Martin] Univ Pretoria, Ctr Excellence Tree Hlth Biotechnol, FABI, ZA-0002 Pretoria, South Africa	Ruhr University Bochum; National Research Foundation - South Africa; University of Pretoria	Yurkov, AM (corresponding author), Ruhr Univ Bochum, Dept Evolut & Biodivers Plants, Fac Biol & Biotechnol, Bochum, Germany.	andrey.yurkov@rub.de	Kemler, Martin/GSD-6740-2022; Yurkov, Andrey M./E-7854-2011	Kemler, Martin/0000-0002-0738-4233; Yurkov, Andrey M./0000-0002-1072-5166; Begerow, Dominik/0000-0002-8286-1597	German Research Foundation (DFG) [BE 2201/9-1]; German Academic Exchange Service (DAAD) [A/07/94549]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was funded by the German Research Foundation (DFG) Priority Program 1374 "Biodiversity Exploratories" (BE 2201/9-1) and by the German Academic Exchange Service (DAAD) Program "Sustainable forestry and forest products" (A/07/94549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AD-HOC-AG BODEN, 2005, BOD KART KA5; Bab'eva IP, 1995, PHYSL GEN BIOL REV 3, V9, P1; Babjeva IP, 1987, SOIL YEASTS, P87; Barnett JA, 2004, YEAST, V21, P1141, DOI 10.1002/yea.1154; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Boundy-Mills K, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P67, DOI 10.1007/3-540-30985-3_5; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; BROWN M. E., 1962, Plant and Soil, V17, P309, DOI 10.1007/BF01377670; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Chernov IY, 2005, ZH OBSHCH BIOL, V66, P123; Collado J, 2007, FEMS MICROBIOL ECOL, V60, P521, DOI 10.1111/j.1574-6941.2007.00294.x; Colwell R. K., 2006, BIOTA BIODIVERSITY D; Cornelissen S, 2003, CAN J MICROBIOL, V49, P425, DOI 10.1139/W03-057; DANIELSON RM, 1973, MYCOPATH MYCOL APPL, V51, P191, DOI 10.1007/BF02141110; DiMENNA MARGARET E., 1965, NEW ZEAL J BOT, V3, P194; FAO, 2006, GUID SOIL DESCR; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x; Fonseca A, 2000, CAN J MICROBIOL, V46, P7, DOI 10.1139/cjm-46-1-7; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Fredlund E, 2002, FEMS YEAST RES, V2, P395, DOI 10.1111/j.1567-1364.2002.tb00109.x; Gadanho M, 2002, FEMS YEAST RES, V2, P47, DOI 10.1111/j.1567-1364.2002.tb00068.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Golubev VI, 2000, MICROBIOLOGY+, V69, P490, DOI 10.1007/BF02756776; Golubev WI, 2006, ANTON LEEUW INT J G, V89, P45, DOI 10.1007/s10482-005-9008-z; Golubev WI, 2009, J GEN APPL MICROBIOL, V55, P441; Golubtsova YV, 2007, EURASIAN SOIL SCI+, V40, P875, DOI 10.1134/S1064229307080108; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P1, DOI 10.1007/3-540-30985-3_1; LARUE TA, 1967, CAN J MICROBIOL, V13, P789, DOI 10.1139/m67-104; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; Maksimova IA, 2004, MICROBIOLOGY+, V73, P474, DOI 10.1023/B:MICI.0000036994.21650.3a; Marinoni G, 2004, FEMS YEAST RES, V4, P587, DOI 10.1016/j.femsyr.2003.12.005; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Okoli I, 2007, FEMS YEAST RES, V7, P339, DOI 10.1111/j.1567-1364.2006.00164.x; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sampaio Jose Paulo, 2003, Mycological Progress, V2, P53, DOI 10.1007/s11557-006-0044-5; Sampaio JP, 2004, INT J SYST EVOL MICR, V54, P1401, DOI 10.1099/ijs.0.03037-0; Sampaio JP, 2001, INT J SYST EVOL MICR, V51, P687, DOI 10.1099/00207713-51-2-687; Schonrogge K, 2002, BIOL J LINN SOC, V75, P291, DOI 10.1111/j.1095-8312.2002.tb02070.x; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Slavikova E, 2000, J BASIC MICROB, V40, P207, DOI 10.1002/1521-4028(200007)40:3<207::AID-JOBM207>3.0.CO;2-H; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Starkey RL, 1927, SOIL SCI, V23, P33, DOI 10.1097/00010694-192701000-00004; Takashima M, 2003, INT J SYST EVOL MICR, V53, P1187, DOI 10.1099/ijs.0.02498-0; Takashima M, 2001, INT J SYST EVOL MICR, V51, P2199, DOI 10.1099/00207713-51-6-2199; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Unterseher M, 2008, FEMS MICROBIOL LETT, V282, P205, DOI 10.1111/j.1574-6968.2008.01128.x; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Unterseher M, 2009, MYCOL RES, V113, P645, DOI 10.1016/j.mycres.2009.02.002; VANDERWALT JP, 1992, ANTON LEEUW INT J G, V62, P247, DOI 10.1007/BF00572591; Vishniac HS, 2006, MICROB ECOL, V52, P90, DOI 10.1007/s00248-006-9066-4; Vishniac HS, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P419, DOI 10.1007/3-540-30985-3_16; Wuczkowski M, 2004, MICROBIOL RES, V159, P263, DOI 10.1016/j.micres.2004.05.001; Yurkov A., 2009, PERSOONIA, V23, P188; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004; Yurkov AM, 2009, PERSOONIA, V23, P182	70	46	48	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23671	10.1371/journal.pone.0023671	http://dx.doi.org/10.1371/journal.pone.0023671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858201	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500062
J	Perez, D; Martin, S; Fernandez-Lorente, G; Filice, M; Guisan, JM; Ventosa, A; Garcia, MT; Mellado, E				Perez, Dolores; Martin, Sara; Fernandez-Lorente, Gloria; Filice, Marco; Manuel Guisan, Jose; Ventosa, Antonio; Teresa Garcia, Maria; Mellado, Encarnacion			A Novel Halophilic Lipase, LipBL, Showing High Efficiency in the Production of Eicosapentaenoic Acid (EPA)	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INTERFACIAL ADSORPTION; SELECTIVE ADSORPTION; FISH-OIL; PURIFICATION; IMMOBILIZATION; EXTREMOPHILES; HYDROLYSIS; ENRICHMENT; INDUSTRIAL	Background: Among extremophiles, halophiles are defined as microorganisms adapted to live and thrive in diverse extreme saline environments. These extremophilic microorganisms constitute the source of a number of hydrolases with great biotechnological applications. The interest to use extremozymes from halophiles in industrial applications is their resistance to organic solvents and extreme temperatures. Marinobacter lipolyticus SM19 is a moderately halophilic bacterium, isolated previously from a saline habitat in South Spain, showing lipolytic activity. Methods and Findings: A lipolytic enzyme from the halophilic bacterium Marinobacter lipolyticus SM19 was isolated. This enzyme, designated LipBL, was expressed in Escherichia coli. LipBL is a protein of 404 amino acids with a molecular mass of 45.3 kDa and high identity to class C beta-lactamases. LipBL was purified and biochemically characterized. The temperature for its maximal activity was 80 degrees C and the pH optimum determined at 25 degrees C was 7.0, showing optimal activity without sodium chloride, while maintaining 20% activity in a wide range of NaCl concentrations. This enzyme exhibited high activity against short-medium length acyl chain substrates, although it also hydrolyzes olive oil and fish oil. The fish oil hydrolysis using LipBL results in an enrichment of free eicosapentaenoic acid (EPA), but not docosahexaenoic acid (DHA), relative to its levels present in fish oil. For improving the stability and to be used in industrial processes LipBL was immobilized in different supports. The immobilized derivatives CNBr-activated Sepharose were highly selective towards the release of EPA versus DHA. The enzyme is also active towards different chiral and prochiral esters. Exposure of LipBL to buffer-solvent mixtures showed that the enzyme had remarkable activity and stability in all organic solvents tested. Conclusions: In this study we isolated, purified, biochemically characterized and immobilized a lipolytic enzyme from a halophilic bacterium M. lipolyticus, which constitutes an enzyme with excellent properties to be used in the food industry, in the enrichment in omega-3 PUFAs.	[Perez, Dolores; Martin, Sara; Ventosa, Antonio; Teresa Garcia, Maria; Mellado, Encarnacion] Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain; [Fernandez-Lorente, Gloria] CSIC, Inst Fermentac Ind, E-28006 Madrid, Spain; [Filice, Marco; Manuel Guisan, Jose] CSIC, Dept Biocatalysis, Inst Catalysis & Petrochem, Madrid, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fermentaciones Industriales (IFI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Perez, D (corresponding author), Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain.	emellado@us.es	Ventosa, Antonio/K-8239-2017; Filice, Marco/O-2892-2019; MELLADO, ENCARNACIÓN/K-8665-2014; Fernandez-Lorente, Gloria/M-8455-2013; Guisan, Jose M/K-4110-2016; Filice, Marco/L-4848-2014; GARCÍA GUTIÉRREZ, MARIA TERESA/K-6515-2014	Ventosa, Antonio/0000-0002-7573-0556; Filice, Marco/0000-0001-8142-4566; MELLADO, ENCARNACIÓN/0000-0002-7135-1428; Guisan, Jose M/0000-0003-1627-6522; Filice, Marco/0000-0001-8142-4566; GARCÍA GUTIÉRREZ, MARIA TERESA/0000-0002-0916-6256; Lorente, Fernandez/0000-0002-0756-439X	Spanish Ministerio de Ciencia e Innovacion [BIO2006-06927, CTM2006-03310]; Junta de Andalucia [P06-CVI-01829, P08-RNM-3515]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia)	This study was supported by grants from Spanish Ministerio de Ciencia e Innovacion (BIO2006-06927 and CTM2006-03310) and Junta de Andalucia (P06-CVI-01829 and P08-RNM-3515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bastida A, 1998, BIOTECHNOL BIOENG, V58, P486, DOI 10.1002/(SICI)1097-0290(19980605)58:5<486::AID-BIT4>3.0.CO;2-9; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Chakraborty K, 2008, J AGR FOOD CHEM, V56, P1428, DOI 10.1021/jf073176u; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Diaz P, 1999, BIOTECHNIQUES, V27, P696, DOI 10.2144/99274bm14; Fernandez-Lorente G, 2005, BIOTECHNOL BIOENG, V92, P773, DOI 10.1002/bit.20656; Fernandez-Lorente G, 2008, BIOMACROMOLECULES, V9, P2553, DOI 10.1021/bm800609g; HOHN B, 1980, GENE, V11, P291, DOI 10.1016/0378-1119(80)90069-4; HOSHINO T, 1990, AGR BIOL CHEM TOKYO, V54, P1459, DOI 10.1080/00021369.1990.10870149; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; LAANE C, 1987, BIOTECHNOL BIOENG, V30, P81, DOI 10.1002/bit.260300112; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linder M, 2005, MAR BIOTECHNOL, V7, P70, DOI 10.1007/s10126-004-0149-2; Makrides M, 2010, NESTLE NUTR WORKS SE, V65, P123, DOI 10.1159/000281154; Martin S, 2003, INT J SYST EVOL MICR, V53, P1383, DOI 10.1099/ijs.0.02528-0; Martin S, 2006, THESIS U SEVILLE; Mellado E, 2005, MICROORGANISMS IND E, P25; Oh K, 2005, CANCER EPIDEM BIOMAR, V14, P835, DOI 10.1158/1055-9965.EPI-04-0545; Okada T, 2008, J FOOD SCI, V73, pC146, DOI 10.1111/j.1750-3841.2008.00661.x; Oren A, 2010, ENVIRON TECHNOL, V31, P825, DOI 10.1080/09593330903370026; Palomo JM, 2004, BIOTECHNOL PROGR, V20, P630, DOI 10.1021/bp0342957; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Sabuquillo P, 1998, BBA-PROTEIN STRUCT M, V1388, P337, DOI 10.1016/S0167-4838(98)00183-6; Salameh M, 2007, ADV APPL MICROBIOL, V61, P253, DOI 10.1016/S0065-2164(06)61007-1; Sambrook J, 2001, MOL CLONING LAB MANU; Schmitt-Rozieres M, 2000, J AM OIL CHEM SOC, V77, P329, DOI 10.1007/s11746-000-0053-1; Segura RL, 2004, BIOTECHNOL PROGR, V20, P825, DOI 10.1021/bp034363p; Shahidi F, 1998, TRENDS FOOD SCI TECH, V9, P230, DOI 10.1016/S0924-2244(98)00044-2; Shimada Y, 2001, J BIOSCI BIOENG, V91, P529, DOI 10.1263/jbb.91.529; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; TANAKA Y, 1992, J AM OIL CHEM SOC, V69, P1210, DOI 10.1007/BF02637682; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; VENTOSA A, 1982, J GEN MICROBIOL, V128, P1959; Wanasundara UN, 1998, J AM OIL CHEM SOC, V75, P945, DOI 10.1007/s11746-998-0271-9; Wijendran V, 2004, ANNU REV NUTR, V24, P597, DOI 10.1146/annurev.nutr.24.012003.132106; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Xu XB, 2000, EUR J LIPID SCI TECH, V102, P287; [郑毅 Zheng Yi], 2005, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V11, P571	44	54	62	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23325	10.1371/journal.pone.0023325	http://dx.doi.org/10.1371/journal.pone.0023325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853111	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200070
J	Reddington, K; O'Grady, J; Dorai-Raj, S; Niemann, S; van Soolingen, D; Barry, T				Reddington, Kate; O'Grady, Justin; Dorai-Raj, Siobhan; Niemann, Stefan; van Soolingen, Dick; Barry, Thomas			A Novel Multiplex Real-Time PCR for the Identification of Mycobacteria Associated with Zoonotic Tuberculosis	PLOS ONE			English	Article							BOVIS SUBSP CAPRAE; RAPID IDENTIFICATION; NONTUBERCULOUS MYCOBACTERIA; DISCRIMINATORY POWER; COMPARATIVE GENOMICS; COMPLEX STRAINS; HUMANS; ASSAY; HIV; DIFFERENTIATION	Background: Tuberculosis (TB) is the leading cause of death worldwide from a single infectious agent. An ability to detect the Mycobacterium tuberculosis complex (MTC) in clinical material while simultaneously differentiating its members is considered important. This allows for the gathering of epidemiological information pertaining to the prevalence, transmission and geographical distribution of the MTC, including those MTC members associated with zoonotic TB infection in humans. Also differentiating between members of the MTC provides the clinician with inherent MTC specific drug susceptibility profiles to guide appropriate chemotherapy. Methodology/Principal Findings: The aim of this study was to develop a multiplex real-time PCR assay using novel molecular targets to identify and differentiate between the phylogenetically closely related M. bovis, M. bovis BCG and M. caprae. The lpqT gene was explored for the collective identification of M. bovis, M. bovis BCG and M. caprae, the lepA gene was targeted for the specific identification of M. caprae and a Region of Difference 1 (RD1) assay was incorporated in the test to differentiate M. bovis BCG. The multiplex real-time PCR assay was evaluated on 133 bacterial strains and was determined to be 100% specific for the members of the MTC targeted. Conclusions/Significance: The multiplex real-time PCR assay developed in this study is the first assay described for the identification and simultaneous differentiation of M. bovis, M. bovis BCG and M. caprae in one internally controlled reaction. Future validation of this multiplex assay should demonstrate its potential in the rapid and accurate diagnosis of TB caused by these three mycobacteria. Furthermore, the developed assay may be used in conjunction with a recently described multiplex real-time PCR assay for identification of the MTC and simultaneous differentiation of M. tuberculosis, M. canettii resulting in an ability to differentiate five of the eight members of the MTC.	[Reddington, Kate; O'Grady, Justin; Dorai-Raj, Siobhan; Barry, Thomas] Natl Univ Ireland, Sch Nat Sci, Galway, Ireland; [Reddington, Kate; O'Grady, Justin; Dorai-Raj, Siobhan; Barry, Thomas] Natl Univ Ireland, NCBES, Mol Diagnost Res Grp, Galway, Ireland; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Natl TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [Niemann, Stefan] Res Ctr Borstel, Borstel, Germany	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Netherlands National Institute for Public Health & the Environment; Forschungszentrum Borstel	Reddington, K (corresponding author), Natl Univ Ireland, Sch Nat Sci, Galway, Ireland.	thomas.barry@nuigalway.ie	Niemann, Stefan/C-9327-2011; Reddington, Kate/J-7868-2015; O'Grady, Justin/I-2982-2012	Reddington, Kate/0000-0002-9559-5638; O'Grady, Justin/0000-0001-5412-7152; Barry, Thomas/0000-0002-1869-0172; Niemann, Stefan/0000-0002-6604-0684	College of Sciences, National University of Ireland Galway	College of Sciences, National University of Ireland Galway	College of Sciences, National University of Ireland Galway funded KR Postgraduate Scholarship (http://www.nuigalway.ie/science/scholarshipsandprizes.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2010, EUR RESPIR J, V35, P692, DOI 10.1183/09031936.00137309; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BLAKEMORE R, 2010, J CLIN MICROBIOL; Brosch R, 2000, INT J MED MICROBIOL, V290, P143; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Cicero R, 2009, EUR J CLIN MICROBIOL, V28, P455, DOI 10.1007/s10096-008-0649-5; Cleary TJ, 2003, J CLIN MICROBIOL, V41, P4783, DOI 10.1128/JCM.41.10.4783-4786.2003; Cole ST, 2002, MICROBIOL-SGM, V148, P2919, DOI 10.1099/00221287-148-10-2919; Coll P, 2003, INT J TUBERC LUNG D, V7, P886; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Cvetnic Z, 2007, INT J TUBERC LUNG D, V11, P652; Das S, 2007, MICROBIOL IMMUNOL, V51, P231, DOI 10.1111/j.1348-0421.2007.tb03905.x; De Baere T, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-4; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Djelouadji Z, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000253; Dorak MT, REAL TIME PCR; Ereqat S, 2010, J CLIN MICROBIOL, V48, P4269, DOI 10.1128/JCM.00943-10; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Hofmann-Thiel S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-95; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; Kiers A, 2008, INT J TUBERC LUNG D, V12, P1469; Kjeldsen MK, 2009, SCAND J INFECT DIS, V41, P635, DOI 10.1080/00365540903127425; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kubica T, 2003, J CLIN MICROBIOL, V41, P3070, DOI 10.1128/JCM.41.7.3070-3077.2003; Majoor CJ, 2011, EMERG INFECT DIS, V17, P457, DOI 10.3201/eid1703.101111; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; Niemann S, 2002, INT J SYST EVOL MICR, V52, P433, DOI 10.1099/00207713-52-2-433; O' Grady J, 2008, FOOD MICROBIOL, V25, P75, DOI 10.1016/j.fm.2007.07.007; OJO O, 2008, MYCOBACTERIUM BOVIS, P1931; Panteix G, 2010, J MED MICROBIOL, V59, P984, DOI 10.1099/jmm.0.019372-0; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Pinsky BA, 2008, J CLIN MICROBIOL, V46, P2241, DOI 10.1128/JCM.00347-08; Prodinger WM, 2005, J CLIN MICROBIOL, V43, P4984, DOI 10.1128/JCM.43.10.4984-4992.2005; Prodinger WM, 2002, J CLIN MICROBIOL, V40, P2270, DOI 10.1128/JCM.40.6.2270-2272.2002; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Reddington K, 2011, J CLIN MICROBIOL, V49, P651, DOI 10.1128/JCM.01426-10; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Rezwan M, 2007, MICROBIOL-SGM, V153, P652, DOI 10.1099/mic.0.2006/000216-0; Richardson ET, 2009, J CLIN MICROBIOL, V47, P1497, DOI 10.1128/JCM.01868-08; Richter E, 2004, J CLIN MICROBIOL, V42, P4303, DOI 10.1128/JCM.42.9.4303-4306.2004; ROBERTSON JM, 1998, INTRO PCR PRIMER DES, P121; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SOMOSKOVI A, 2006, J CLIN MICROBIOL; Somoskovi A, 2009, J CLIN MICROBIOL, V47, P255, DOI 10.1128/JCM.01268-08; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; van Soolingen D, 1998, J CLIN MICROBIOL, V36, P1840, DOI 10.1128/JCM.36.7.1840-1845.1998; VANEECHOUTTE M, 1993, J CLIN MICROBIOL, V31, P2061, DOI 10.1128/JCM.31.8.2061-2065.1993; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1992, J CLIN MICROBIOL, V30, P1772, DOI 10.1128/JCM.30.7.1772-1777.1992; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Wauters G, 2005, J CLIN MICROBIOL, V43, P2624, DOI 10.1128/JCM.43.6.2624-2628.2005; *WHO, 2006, JOINT WHO DFID AHP M, P62; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; 2008, LIGHTCYCLER 480 INST, P248	63	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23481	10.1371/journal.pone.0023481	http://dx.doi.org/10.1371/journal.pone.0023481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858140	Green Published, gold, Green Accepted			2022-12-25	WOS:000293774300037
J	Levi, JE; Nascimento, MC; Sumita, LM; de Souza, VAUF; Freire, WS; Mayaud, P; Pannuti, CS				Levi, Jose Eduardo; Nascimento, Maria Claudia; Sumita, Laura Masami; Ueda Fick de Souza, Vanda Akico; Freire, Wilton S.; Mayaud, Philippe; Pannuti, Claudio S.			Non-Detection of Human Herpesvirus 8 (HHV-8) DNA in HHV-8-Seropositive Blood Donors from Three Brazilian Regions	PLOS ONE			English	Article							HUMAN-HERPESVIRUS TYPE-8; LATENT CLASS ANALYSIS; KAPOSIS-SARCOMA; MONONUCLEAR-CELLS; RISK-FACTORS; VIRAL LOAD; TRANSMISSION; TRANSFUSION; PREVALENCE; INFECTION	Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the etiologic agent of all forms of Kaposi's sarcoma, primary effusion lymphoma and the plasmablastic cell variant of multicentric Castleman disease. In endemic areas of sub-Saharan Africa, blood transfusions have been associated with a substantial risk of HHV-8 transmission. By contrast, several studies among healthy blood donors from North America have failed to detect HHV-8 DNA in samples of seropositive individuals. In this study, using a real-time PCR assay, we investigated the presence of HHV-8 DNA in whole-blood samples of 803 HHV-8 blood donors from three Brazilian states (Sao Paulo, Amazon, Bahia) who tested positive for HHV-8 antibodies, in a previous multicenter study. HHV-8 DNA was not detected in any sample. Our findings do not support the introduction of routine HHV-8 screening among healthy blood donors in Brazil. (WC = 140).	[Levi, Jose Eduardo; Nascimento, Maria Claudia; Sumita, Laura Masami; Ueda Fick de Souza, Vanda Akico; Freire, Wilton S.; Pannuti, Claudio S.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil; [Ueda Fick de Souza, Vanda Akico; Pannuti, Claudio S.] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias LIM HC, Sao Paulo, Brazil; [Nascimento, Maria Claudia; Mayaud, Philippe] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine	Levi, JE (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.	cpannuti@usp.br	Pannuti, Claudio/B-7649-2012	MAYAUD, Philippe/0000-0001-5730-947X	Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq); agency of the Brazilian Ministry of Science and Technology [304879/2003-7, 305258/2006-0, 473867/2006-0]; UK's Department for International Development (DFID); HIV in Developing Countries of the LSHTM	Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); agency of the Brazilian Ministry of Science and Technology; UK's Department for International Development (DFID); HIV in Developing Countries of the LSHTM	The study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Technologico (CNPq), an agency of the Brazilian Ministry of Science and Technology (Grants 304879/2003-7, 305258/2006-0 and 473867/2006-0). Additional financial support was provided by the UK's Department for International Development (DFID)-funded Research Programme Consortium on Research and Capacity Building on Sexual and Reproductive Health and HIV in Developing Countries of the LSHTM. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript. The views expressed herein do not necessarily represent the views and policies of CNPq and DFID.	Belec L, 1998, TRANSFUSION, V38, P771, DOI 10.1046/j.1537-2995.1998.38898375517.x; Bigoni B, 1996, J INFECT DIS, V173, P542, DOI 10.1093/infdis/173.3.542; Blackbourn DJ, 1997, LANCET, V349, P609, DOI 10.1016/S0140-6736(96)10004-0; Brown EE, 2005, INT J EPIDEMIOL, V34, P1110, DOI 10.1093/ije/dyi131; Brown EE, 2006, CANCER, V107, P2282, DOI 10.1002/cncr.22236; Cannon MJ, 2009, J INFECT DIS, V199, P1592, DOI 10.1086/598859; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.6600745; Enbom M, 2002, J MED VIROL, V68, P264, DOI 10.1002/jmv.10183; Engels EA, 1999, J NATL CANCER I, V91, P1773, DOI 10.1093/jnci/91.20.1773; Engels EA, 2000, INT J CANCER, V88, P1003, DOI 10.1002/1097-0215(20001215)88:6&lt;1003::AID-IJC26&gt;3.0.CO;2-9; Ferreira S, 2003, TRANSFUSION, V43, P1764, DOI 10.1111/j.0041-1132.2003.00602.x; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Hudnall SD, 2008, TRANSFUSION, V48, P1180, DOI 10.1111/j.1537-2995.2008.01685.x; Hudnall SD, 2003, TRANSFUSION, V43, P85, DOI 10.1046/j.1537-2995.2003.00272.x; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lam LL, 2002, J CLIN MICROBIOL, V40, P325, DOI 10.1128/JCM.40.02.325-329.2002; Martro E, 2004, J VIROL, V78, P11707, DOI 10.1128/JVI.78.21.11707-11714.2004; Mbulaiteye SM, 2003, J NATL CANCER I, V95, P1330, DOI 10.1093/jnci/djg039; Nascimento MC, 2008, J MED VIROL, V80, P1202, DOI 10.1002/jmv.21188; Nascimento MC, 2007, J CLIN MICROBIOL, V45, P715, DOI 10.1128/JCM.01264-06; Pellett PE, 2003, TRANSFUSION, V43, P1260, DOI 10.1046/j.1537-2995.2003.00490.x; Polstra AM, 2003, J CLIN MICROBIOL, V41, P5488, DOI 10.1128/JCM.41.12.5488-5491.2003; Qu L, 2011, VOX SANG, V100, P267, DOI 10.1111/j.1423-0410.2010.01404.x; Qu LR, 2010, TRANSFUSION, V50, P1050, DOI 10.1111/j.1537-2995.2009.02559.x; Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x; Uldrick TS, 2011, CANCER LETT, V305, P150, DOI 10.1016/j.canlet.2011.02.006; Vitale F, 2000, EPIDEMIOL INFECT, V125, P671, DOI 10.1017/S0950268800004726	27	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23546	10.1371/journal.pone.0023546	http://dx.doi.org/10.1371/journal.pone.0023546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858163	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000293773300032
J	Yearsley, JM; Sigwart, JD				Yearsley, Jon M.; Sigwart, Julia D.			Larval Transport Modeling of Deep-Sea Invertebrates Can Aid the Search for Undiscovered Populations	PLOS ONE			English	Article							CALANUS-FINMARCHICUS; NORTH-ATLANTIC; HYDROTHERMAL VENTS; PROFILING FLOATS; TEMPERATURE; DISPERSAL; OCEAN; ECOLOGY; LIFE; CONSERVATION	Background: Many deep-sea benthic animals occur in patchy distributions separated by thousands of kilometres, yet because deep-sea habitats are remote, little is known about their larval dispersal. Our novel method simulates dispersal by combining data from the Argo array of autonomous oceanographic probes, deep-sea ecological surveys, and comparative invertebrate physiology. The predicted particle tracks allow quantitative, testable predictions about the dispersal of benthic invertebrate larvae in the south-west Pacific. Principal Findings: In a test case presented here, using non-feeding, non-swimming (lecithotrophic trochophore) larvae of polyplacophoran molluscs (chitons), we show that the likely dispersal pathways in a single generation are significantly shorter than the distances between the three known population centres in our study region. The large-scale density of chiton populations throughout our study region is potentially much greater than present survey data suggest, with intermediate 'stepping stone' populations yet to be discovered. Conclusions/Significance: We present a new method that is broadly applicable to studies of the dispersal of deep-sea organisms. This test case demonstrates the power and potential applications of our new method, in generating quantitative, testable hypotheses at multiple levels to solve the mismatch between observed and expected distributions: probabilistic predictions of locations of intermediate populations, potential alternative dispersal mechanisms, and expected population genetic structure. The global Argo data have never previously been used to address benthic biology, and our method can be applied to any non-swimming larvae of the deep-sea, giving information upon dispersal corridors and population densities in habitats that remain intrinsically difficult to assess.	[Yearsley, Jon M.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Sigwart, Julia D.] Queens Univ Belfast, Sch Biol Sci, Marine Lab, Portaferry, North Ireland	University College Dublin; Queens University Belfast	Yearsley, JM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	jon.yearsley@ucd.ie	Sigwart, Julia D/J-2928-2014; Yearsley, Jon/H-5301-2011	Sigwart, Julia D/0000-0002-3005-6246; Yearsley, Jon/0000-0003-1838-0454	Science Foundation Ireland; IRCSET; Institut de la Recherche pour le Developement	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); IRCSET(Irish Research Council for Science, Engineering and Technology); Institut de la Recherche pour le Developement	This study was supported by the Science Foundation Ireland (CoBiD-UREKA Site award; http://www.sfi.ie) and IRCSET Mathematical Biology Summer Studentships http://www.ircset.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Frederique Viard, Sophie Plouvier and Stephane Hourdez for stimulating discussion and comments that improved this study. We also thank the anonymous reviewers for the helpful comments. The float data for this study were collected and made freely available by the International Argo Project and the national initiatives that contribute to it (http://www.argo.net). Argo is a pilot programme of the Global Ocean Observing System. Biological records are from specimens in the Museum National d'Histoire Naturelle, Paris (MNHN), collected onboard the RV M/V DA-BFAR in the Philippines (expedition led by the Philippe Bouchet and the National Fisheries Research and Development Institute Ludivina Labe), and the RV ALIS in Vanuatu and Solomon Islands (funding by the Institut de la Recherche pour le Developement to Bertrand Richer de Forges, Sarah Samadi, and Philippe Bouchet). All records used here represent preserved specimens in the MNHN collections. Preliminary work that led to this project was assisted by Katie Murphy and Iarliath Kirrane, who were supported by Science Foundation Ireland (CoBiD-UREKA Site award) and IRCSET.	Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; ARELLANO SM, 2008, THESIS U OREGON CHAR, P218; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; BIRKELAND C, 1971, BIOL BULL-US, V141, P99, DOI 10.2307/1539994; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Campbell RW, 2008, DEEP-SEA RES PT I, V55, P630, DOI 10.1016/j.dsr.2008.02.009; CHRISTIANSEN MARIT ELLEN, 1954, NYTT MAG ZOOL [OSLO], V2, P52; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Forget G, 2008, OCEAN MODEL, V20, P1, DOI 10.1016/j.ocemod.2007.06.001; GAGE JD, 1996, DEEP SEA BIOL NATURA; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Grave BH, 1922, BIOL BULL-US, V42, P234, DOI 10.2307/1536471; HAIN S, 1992, POLAR BIOL, V12, P303; Heath MR, 2004, ICES J MAR SCI, V61, P698, DOI 10.1016/j.icesjms.2004.03.013; HOEGHGULDBERG O, 1995, AM ZOOL, V35, P415; HOLLISTER CD, 1984, NATURE, V309, P220, DOI 10.1038/309220a0; JAECKLE WB, 1989, MAR BIOL, V103, P87, DOI 10.1007/BF00391067; KILLINGLEY J, 2005, DEEP-SEA RES PT 1, V32, P809; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; LEBEDEV KV, 2007, 4 INT PAC RES CTR, P16; *MATHW INC, 2009, MATL; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Metaxas A, 2004, LIMNOL OCEANOGR, V49, P1949, DOI 10.4319/lo.2004.49.6.1949; MILEIKOVSKY SA, 1973, MAR BIOL, V23, P11, DOI 10.1007/BF00394107; Molcard A, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001240; Mullineaux LS, 2005, MAR ECOL PROG SER, V293, P1, DOI 10.3354/meps293001; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Pailleret M, 2007, MAR ECOL-EVOL PERSP, V28, P233, DOI 10.1111/j.1439-0485.2006.00149.x; PEARSE JS, 1979, REPRODUCTION MARINE, V5, P27; R Development Core Team, 2005, R LANG ENV STAT COMP; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; Roemmich D, 2009, OCEANOGRAPHY, V22, P34, DOI 10.5670/oceanog.2009.36; Scheltema RS, 2009, DEEP-SEA RES PT II, V56, P1835, DOI 10.1016/j.dsr2.2009.05.024; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Sigwart J.D., 2008, THESIS QUEENS U BELF; SIGWART JD, 2011, DEEP SEA CHITONS SUN; Sigwart JD, 2009, J NAT HIST, V43, P447, DOI 10.1080/00222930802604157; Sirenko B., 2004, BOLL MALACOL, V5, P111; Sirenko Boris, 2001, Memoires du Museum National d'Histoire Naturelle, V185, P39; Speirs DC, 2005, FISH OCEANOGR, V14, P333, DOI 10.1111/j.1365-2419.2005.00339.x; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Todt Christiane, 2008, P71; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; WATTS SA, 1982, BIOL BULL-US, V163, P348, DOI 10.2307/1541272; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Young CM, 1997, MAR ECOL PROG SER, V154, P197, DOI 10.3354/meps154197; Young Craig M., 1994, P1	49	29	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23063	10.1371/journal.pone.0023063	http://dx.doi.org/10.1371/journal.pone.0023063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857992	gold, Green Submitted, Green Published			2022-12-25	WOS:000293773300017
J	Wang, ML; Wang, SS; Song, ZF; Ji, XM; Zhang, ZD; Zhou, JW; Ni, CH				Wang, Meilin; Wang, Shasha; Song, Zhifang; Ji, Xiaoming; Zhang, Zhengdong; Zhou, Jianwei; Ni, Chunhui			Associations of IL-4, IL-4R, and IL-13 Gene Polymorphisms in Coal Workers' Pneumoconiosis in China: A Case-Control Study	PLOS ONE			English	Article							RECEPTOR-ALPHA-CHAIN; ILE50VAL VARIANT; IGE SYNTHESIS; ASTHMA; INTERLEUKIN-4; ATOPY; SILICOSIS; RISK; TRANSCRIPTION; ARTHRITIS	Background: The IL-4, IL-4 receptor (IL4R), and IL-13 genes are crucial immune factors and may influence the course of various diseases. In the present study, we investigated the association between the potential functional polymorphisms in IL-4, IL-4R, and IL-13 and coal workers' pneumoconiosis (CWP) risk in a Chinese population. Methods: Six polymorphisms (C-590T in IL-4, Ile50Val, Ser478Pro, and Gln551Arg in IL-4R, C-1055T and Arg130Gln in IL-13) were genotyped and analyzed in a case-control study of 556 CWP and 541 control subjects. Results: Our results revealed that the IL-4 CT/CC genotypes were associated with a significantly decreased risk of CWP (odds ratio (OR) = 0.74, 95% confidence interval (CI) = 0.58-0.95), compared with the TT genotype, particularly among subgroups of age <65 years (OR = 0.68, 95%CI = 0.46-0.99) and dust exposure years >= 26 years (OR = 0.69, 95%CI = 0.50-0.94). Moreover, the polymorphism was significantly associated with risk of CWP patients with stage I. In addition, a combined effect was observed in a dose-dependent manner with increasing numbers of risk variant alleles (P-trend = 0.023), and individuals with 11-12 risk alleles had a 47% higher risk of CWP than those with 0-8 risk alleles (OR = 1.47, 95%CI = 1.05-2.05). Conclusions: Our results suggest that the IL-4 C-590T polymorphism is involved in the etiology of CWP and susceptibility to this disease. Larger studies are warranted to validate our findings.	[Wang, Meilin; Wang, Shasha; Zhang, Zhengdong; Zhou, Jianwei; Ni, Chunhui] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Peoples R China; [Song, Zhifang; Ji, Xiaoming] Xuzhou Min Business Grp Co Ltd, Gen Hosp, Xuzhou, Peoples R China	Nanjing Medical University	Wang, ML (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Peoples R China.	chni@njmu.edu.cn	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [30872093, 81072282]; Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions	This study was partly supported by the National Natural Science Foundation of China (30872093, 81072282) and the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates I, 2008, AM J IND MED, V51, P741, DOI 10.1002/ajim.20632; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chang KC, 2001, INT J TUBERC LUNG D, V5, P177; Choi BS, 2010, J KOREAN MED SCI, V25, pS13, DOI 10.3346/jkms.2010.25.S.S13; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Cisneros-Lira J, 2003, AM J PHYSIOL-LUNG C, V285, pL949, DOI 10.1152/ajplung.00074.2003; Elias JA, 2003, AM J RESP CELL MOL, V28, P401, DOI 10.1165/rcmb.F264; Franjkovic I, 2005, IMMUNOGENETICS, V56, P808, DOI 10.1007/s00251-004-0763-1; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hessel PA, 2003, SCAND J WORK ENV HEA, V29, P329, DOI 10.5271/sjweh.739; Huang X, 2008, J TOXICOL ENV HEAL B, V11, P45, DOI 10.1080/10937400701600552; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kruse S, 1999, IMMUNOLOGY, V96, P365; Liu B, 2007, CHINESE J IND MED, V20, P3; Miossec P, 1997, ARTHRITIS RHEUM-US, V40, P2105, DOI 10.1002/art.1780401203; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Mitsuyasu H, 1999, J IMMUNOL, V162, P1227; Modesto C, 2001, CLIN EXP RHEUMATOL, V19, P211; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nawrot TS, 2008, AM J RESP CRIT CARE, V177, P696, DOI 10.1164/rccm.200801-116UP; NG TP, 1991, THORAX, V46, P229, DOI 10.1136/thx.46.4.229; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Song ZM, 1996, J IMMUNOL, V156, P424; Vercelli D, 2002, CURR OPIN ALLERGY CL, V2, P389, DOI 10.1097/00130832-200210000-00004; Wang ML, 2010, J HUM GENET, V55, P13, DOI 10.1038/jhg.2009.112; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yucesoy B, 2001, TOXICOL APPL PHARM, V172, P75, DOI 10.1006/taap.2001.9124; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	36	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22624	10.1371/journal.pone.0022624	http://dx.doi.org/10.1371/journal.pone.0022624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857939	Green Submitted, gold, Green Published			2022-12-25	WOS:000293558900023
J	Gabibov, AG; Belogurov, AA; Lomakin, YA; Zakharova, MY; Avakyan, ME; Dubrovskaya, VV; Smirnov, IV; Ivanov, AS; Molnar, AA; Gurtsevitch, VE; Diduk, SV; Smirnova, KV; Avalle, B; Sharanova, SN; Tramontano, A; Friboulet, A; Boyko, AN; Ponomarenko, NA; Tikunova, NV				Gabibov, Alexander G.; Belogurov, Alexey A., Jr.; Lomakin, Yakov A.; Zakharova, Maria Yu; Avakyan, Marat E.; Dubrovskaya, Viktorya V.; Smirnov, Ivan V.; Ivanov, Alexis S.; Molnar, Andrey A.; Gurtsevitch, Vladimir E.; Diduk, Sergey V.; Smirnova, Ksenia V.; Avalle, Berangere; Sharanova, Svetlana N.; Tramontano, Alfonso; Friboulet, Alain; Boyko, Alexey N.; Ponomarenko, Natalia A.; Tikunova, Nina V.			Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen	FASEB JOURNAL			English	Article						Epstein-Barr virus; latent membrane protein 1; phage-display library	EPSTEIN-BARR-VIRUS; DISABILITY STATUS SCALE; CEREBROSPINAL-FLUID; B-CELLS; LATENT MEMBRANE-PROTEIN-1; CATALYTIC ANTIBODIES; IMMUNE-RESPONSE; MS; INFECTION; AUTOANTIBODIES	Multiple sclerosis (MS) is a widespread neurodegenerative autoimmune disease with unknown etiology. It is increasingly evident that, together with pathogenic T cells, autoreactive B cells are among the major players in MS development. The analysis of myelin neuroantigen-specific antibody repertoires and their possible cross-reactivity against environmental antigens, including viral proteins, could shed light on the mechanism of MS induction and progression. A phage display library of single-chain variable fragments (scFvs) was constructed from blood lymphocytes of patienst with MS as a potential source of representative MS autoantibodies. Structural alignment of 13 clones selected toward myelin basic protein (MBP), one of the major myelin antigens, showed high homology within variable regions with cerebrospinal fluid MS-associated antibodies as well as with antibodies toward Epstein-Barr latent membrane protein 1 (LMP1). Three scFv clones showed pronounced specificity to MBP fragments 65-92 and 130-156, similar to the serum MS antibodies. One of these clones, designated E2, in both scFv and full-size human antibody constructs, was shown to react with both MBP and LMP1 proteins in vitro, suggesting natural cross-reactivity. Thus, antibodies induced against LMP1 during Epstein-Barr virus infection might act as inflammatory trigger by reacting with MBP, suggesting molecular mimicry in the mechanism of MS pathogenesis.-Gabibov, A. G., Belogurov, A. A., Jr. Lomakin, Y. A., Zakharova, M. Y., Avakyan, M. E., Dubrovskaya, V. V., Smirnov, I. V., Ivanov, A. S., Molnar, A. A., Gurtsevitch, V. E., Diduk, S. V., Smirnova, K. V., Avalle, B., Sharanova, S. N., Tramontano, A., Friboulet, A., Boyko, A. N., Ponomarenko, N. A., Tikunova, N. V. Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J. 25, 4211-4221 (2011). www.fasebj.org	[Gabibov, Alexander G.; Belogurov, Alexey A., Jr.; Lomakin, Yakov A.; Zakharova, Maria Yu; Avakyan, Marat E.; Smirnov, Ivan V.; Ponomarenko, Natalia A.] Russian Acad Sci, MM Shemyakin & YA Ovchinnikov Inst Bioorgan Chem, Moscow 117901, Russia; [Gabibov, Alexander G.; Belogurov, Alexey A., Jr.] Russian Acad Sci, Inst Gene Biol, Moscow 117901, Russia; [Dubrovskaya, Viktorya V.; Tikunova, Nina V.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Ivanov, Alexis S.; Molnar, Andrey A.] Russian Acad Med Sci, Inst Biomed Chem, Moscow, Russia; [Gurtsevitch, Vladimir E.; Diduk, Sergey V.; Smirnova, Ksenia V.] Russian Acad Med Sci, NN Blokhin Inst Carcinogenesis, Moscow, Russia; [Avalle, Berangere; Friboulet, Alain] Univ Technol Compiegne, CNRS, UMR 6022, F-60206 Compiegne, France; [Sharanova, Svetlana N.; Boyko, Alexey N.] Russian State Med Univ, Dept Neurol & Neurosurg, City Hosp 11, Moscow Multiple Sclerosis Ctr, Moscow 117437, Russia; [Tramontano, Alfonso] Univ Calif Davis, Sch Med, Davis, CA 95616 USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Pirogov Russian National Research Medical University; University of California System; University of California Davis	Gabibov, AG (corresponding author), RAS, Inst Bioorgan Chem, Miklukho Maklaya 16-10, Moscow 117901, Russia.	gabibov@mx.ibch.ru	Boyko, Alexey N/Z-2106-2018; Diduk, Sergey/AAV-2269-2021; Tikunova, Nina/J-5701-2014; Lomakin, Yakov/F-9700-2017; Belogurov, Alexey/L-5859-2017; Ivanov, Alexis S/B-7090-2012; Smirnov, Ivan/N-5635-2017; Lomakin, Yakov/ABF-7470-2020; Smirnov, Ivan V/B-2491-2014	Lomakin, Yakov/0000-0002-3514-5395; Belogurov, Alexey/0000-0002-2033-9621; Ivanov, Alexis S/0000-0002-7022-6748; Smirnov, Ivan/0000-0002-0384-6568; Lomakin, Yakov/0000-0002-3514-5395; Smirnov, Ivan V/0000-0002-0384-6568; Diduk, S.V./0000-0002-8415-9275; Smirnova, K.V./0000-0001-6209-977X; Ponomarenko, Natalia/0000-0003-3129-3515; Gurtsevitch, V.E./0000-0003-1840-4364; Boyko, Alexei/0000-0003-3306-9541	NATO [982833]; Russian Education Agency [N P1371]; PICS CNRS France-Russia [N 4238]; Russian Foundation for Basic Research [10.04.00673a, 07.04.92168]; Federal Special-Purpose Program, Research and Development in Priority Directions of Growth of Scientific-Technological Complex of Russia; ICGEB Scientific Schools [64658.2010]; Russian Academy of Sciences	NATO(NATO (North Atlantic Treaty Organisation)); Russian Education Agency; PICS CNRS France-Russia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Special-Purpose Program, Research and Development in Priority Directions of Growth of Scientific-Technological Complex of Russia; ICGEB Scientific Schools; Russian Academy of Sciences(Russian Academy of Sciences)	Anti-LMP1 monoclonal antibody (clone S12) and pSG5/LMP1 plasmid were a generous gift from Dr. Friedrich A. Grasser (Institute of Medical Microbiology, Virology, and Hygiene, Hamburg, Germany). Anti-MBP murine polyclonal serum antibodies were kindly provided by Dr. Dobroslav Melamed (Assaf Harofeh Medical Center, Zerifin, Israel). This research was performed in frames of the Skolkovo program and supported by NATO SfP#982833; Russian Education Agency contract N P1371; PICS CNRS N 4238 France-Russia; Russian Foundation for Basic Research grants 10.04.00673a and 07.04.92168; the Federal Special-Purpose Program, Research and Development in Priority Directions of Growth of Scientific-Technological Complex of Russia for 2007-2012; ICGEB Scientific Schools grant 64658.2010, Chemical Basis of Biocatalysis; and the Fundamental Science for Medicine and Molecular and Cellular Biology programs of the Russian Academy of Sciences.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov A, 2009, BIOESSAYS, V31, P1161, DOI 10.1002/bies.200900020; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Chamczuk AJ, 2002, J IMMUNOL METHODS, V262, P21, DOI 10.1016/S0022-1759(01)00522-1; Diduk SV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1134, DOI 10.1134/S0006297908100106; Fang CY, 2007, INTERVIROLOGY, V50, P254, DOI 10.1159/000101996; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; FRASER KB, 1979, LANCET, V2, P715; Haahr S, 2004, ACTA NEUROL SCAND, V109, P270, DOI 10.1046/j.1600-0404.2003.00221.x; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hikada Masaki, 2010, Nat Immunol, V11, P1065, DOI 10.1038/ni1210-1065; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Jafari N, 2010, J CLIN VIROL, V49, P26, DOI 10.1016/j.jcv.2010.06.007; Jaquiery E, 2010, EUR J IMMUNOL, V40, P878, DOI 10.1002/eji.200939761; KABAT EA, 1948, AM J MED, V4, P653, DOI 10.1016/S0002-9343(48)90389-1; Korn T, 2010, RESULTS PROBL CELL D, V51, P43, DOI 10.1007/400_2008_17; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lamboy JA, 2008, CHEMBIOCHEM, V9, P2846, DOI 10.1002/cbic.200800366; Lambracht-Washington D, 2007, J NEUROIMMUNOL, V186, P164, DOI 10.1016/j.jneuroim.2007.03.002; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Libbey JE, 2010, RESULTS PROBL CELL D, V51, P21, DOI 10.1007/400_2008_12; Lindsey JW, 2010, EUR J NEUROL, V17, P1263, DOI 10.1111/j.1468-1331.2010.03005.x; Lunemann JD, 2007, J VIROL, V81, P6777, DOI 10.1128/JVI.00153-07; Lunemann JD, 2009, TRENDS IMMUNOL, V30, P243, DOI 10.1016/j.it.2009.03.007; Lycke J, 1996, J NEUROL, V243, P214, DOI 10.1007/BF00868517; Maghzi Amir-Hadi, 2011, Pathophysiology, V18, P13, DOI 10.1016/j.pathophys.2010.04.003; Meij P, 1999, J INFECT DIS, V179, P1108, DOI 10.1086/314704; Meij P, 2002, INT J CANCER, V99, P93, DOI 10.1002/ijc.10309; Meij P, 2002, J MED VIROL, V68, P370, DOI 10.1002/jmv.10213; Nociti V, 2010, J NEUROIMMUNOL, V225, P149, DOI 10.1016/j.jneuroim.2010.04.007; Pender MP, 2007, CURR ALLERGY ASTHM R, V7, P285, DOI 10.1007/s11882-007-0043-x; Pender MP, 2009, AUTOIMMUN REV, V8, P563, DOI 10.1016/j.autrev.2009.01.017; PESCE AJ, 1986, J IMMUNOL METHODS, V87, P21, DOI 10.1016/0022-1759(86)90339-X; Ponomarenko NA, 2006, IMMUNOL LETT, V103, P45, DOI 10.1016/j.imlet.2005.10.006; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Ponomarenko NA, 2002, J IMMUNOL METHODS, V269, P197, DOI 10.1016/S0022-1759(02)00324-1; Reindl M, 2010, RESULTS PROBL CELL D, V51, P99, DOI 10.1007/400_2008_16; Reindl M, 2006, J NEUROIMMUNOL, V180, P50, DOI 10.1016/j.jneuroim.2006.06.028; Sawcer S, 2010, ANN NEUROL, V67, P3, DOI 10.1002/ana.21911; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Souza TA, 2005, P NATL ACAD SCI USA, V102, P18093, DOI 10.1073/pnas.0509311102; Stepanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020991; SUMAYA CV, 1980, ARCH NEUROL-CHICAGO, V37, P94, DOI 10.1001/archneur.1980.00500510052009; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; von Budingen HC, 2008, EUR J IMMUNOL, V38, P2014, DOI 10.1002/eji.200737784; Vorob'ev I I, 2001, Bioorg Khim, V27, P257; XIAO BG, 1991, J NEUROIMMUNOL, V31, P91, DOI 10.1016/0165-5728(91)90014-X; Yu XL, 2011, J NEUROIMMUNOL, V233, P192, DOI 10.1016/j.jneuroim.2010.11.007; Yu XL, 2006, J NEUROIMMUNOL, V172, P121, DOI 10.1016/j.jneuroim.2005.11.010; Zhang YP, 2005, J CLIN IMMUNOL, V25, P254, DOI 10.1007/s10875-005-4083-5	51	47	54	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4211	4221		10.1096/fj.11-190769	http://dx.doi.org/10.1096/fj.11-190769			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21859892				2022-12-25	WOS:000298138100014
J	Montana, CL; Lawrence, KA; Williams, NL; Tran, NM; Peng, GH; Chen, SM; Corbo, JC				Montana, Cynthia L.; Lawrence, Karen A.; Williams, Natecia L.; Tran, Nicholas M.; Peng, Guang-Hua; Chen, Shiming; Corbo, Joseph C.			Transcriptional Regulation of Neural Retina Leucine Zipper (Nrl), a Photoreceptor Cell Fate Determinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; IN-VIVO; DIFFERENTIATION FACTOR; ROD PHOTORECEPTORS; GENE-EXPRESSION; HOMEOBOX GENE; MOUSE RETINA; PINEAL-GLAND; CRX; OTX2	The transcription factor neural retina leucine zipper (Nrl) is a critical determinant of rod photoreceptor cell fate and a key regulator of rod differentiation. Nrl(-/-) rod precursors fail to turn on rod genes and instead differentiate as cones. Furthermore, NRL mutations in humans cause retinitis pigmentosa. Despite the developmental and clinical significance of this gene, little is known about the transcriptional regulation of Nrl itself. In this study, we sought to define the cis- and trans-acting factors responsible for initiation and maintenance of Nrl transcription in the mouse retina. Utilizing a quantitative mouse retinal explant electroporation assay, we discovered a phylogenetically conserved, 30-base pair region immediately upstream of the transcription start site that is required for Nrl promoter activity. This region contains binding sites for the retinal transcription factors CRX, OTX2, and ROR beta, and point mutations in these sites completely abolish promoter activity in living retinas. Gelshift experiments show that CRX, OTX2, and ROR beta can bind to the critical region in vitro, whereas ChIP experiments demonstrate binding of CRX and OTX2 to the critical region in vivo. Thus, our results indicate that CRX, OTX2, and ROR beta directly regulate Nrl transcription by binding to critical sites within the Nrl promoter. We propose a model in which Nrl expression is primarily initiated by OTX2 and ROR beta and later maintained at high levels by CRX and ROR beta	[Montana, Cynthia L.; Lawrence, Karen A.; Williams, Natecia L.; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Tran, Nicholas M.; Peng, Guang-Hua; Chen, Shiming] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Shiming] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Corbo, Joseph C.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbo, JC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	jcorbo@pathology.wustl.edu	Huang, Yifei/ABE-7566-2020; Lawrence, Karen/AFQ-3557-2022	Corbo, Joseph/0000-0002-9323-7140; Lawrence, Karen/0000-0002-7235-5594; Tran, Nicholas/0000-0002-4213-3499	National Institutes of Health, NEI [EY018826, 5-T32-EY13360-08]; Hope Center for Neurologic Diseases; Children's Discovery Institute; NATIONAL EYE INSTITUTE [R01EY012543, R01EY018826, T32EY013360] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hope Center for Neurologic Diseases; Children's Discovery Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI Grant EY018826 (to J. C. C.) and Institutional Vision Science Training Grant 5-T32-EY13360-08 (to C. L. M. and N. M. T.). This work was also supported by The Hope Center for Neurologic Diseases (to J. C. C.) and The Children's Discovery Institute (to J. C. C.).	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen CMA, 2000, MECH DEVELOP, V90, P293; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kautzmann MAI, 2011, J BIOL CHEM, V286, P28247, DOI 10.1074/jbc.M111.257246; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; Khanna H, 2006, J BIOL CHEM, V281, P27327, DOI 10.1074/jbc.M605500200; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Lee J, 2010, GENE THER, V17, P1390, DOI 10.1038/gt.2010.77; Liu H, 2008, J NEUROSCI, V28, P749, DOI 10.1523/JNEUROSCI.4832-07.2008; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	41	35	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36921	36931		10.1074/jbc.M111.279026	http://dx.doi.org/10.1074/jbc.M111.279026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21865162	hybrid, Green Published			2022-12-25	WOS:000296538300071
J	Scott, AJ; O'Dea, KP; O'Callaghan, D; Williams, L; Dokpesi, JO; Tatton, L; Handy, JM; Hogg, PJ; Takata, M				Scott, Alasdair J.; O'Dea, Kieran P.; O'Callaghan, David; Williams, Lynn; Dokpesi, Justina O.; Tatton, Louise; Handy, Jonathan M.; Hogg, Philip J.; Takata, Masao			Reactive Oxygen Species and p38 Mitogen-activated Protein Kinase Mediate Tumor Necrosis Factor alpha-Converting Enzyme (TACE/ADAM-17) Activation in Primary Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC DISULFIDE BONDS; THIOL ISOMERASE ACTIVITY; NF-KAPPA-B; L-SELECTIN; TNF-ALPHA; NITRIC-OXIDE; INTRACELLULAR MATURATION; CELLS; RECEPTOR; ADAM17	Tumor necrosis factor alpha-converting enzyme (TACE) is responsible for the shedding of cell surface TNF. Studies suggest that reactive oxygen species (ROS) mediate up-regulation of TACE activity by direct oxidization or modification of the protein. However, these investigations have been largely based upon nonphysiological stimulation of promonocytic cell lines which may respond and process TACE differently from primary cells. Furthermore, investigators have relied upon TACE substrate shedding as a surrogate for activity quantification. We addressed these concerns, employing a direct, cell-based fluorometric assay to investigate the regulation of TACE catalytic activity on freshly isolated primary human monocytes during LPS stimulation. We hypothesized that ROS mediate up-regulation of TACE activity indirectly, by activation of intracellular signaling pathways. LPS up-regulated TACE activity rapidly (within 30 min) without changing cell surface TACE expression. Scavenging of ROS or inhibiting their production by flavoprotein oxidoreductases significantly attenuated LPS-induced TACE activity up-regulation. Exogenous ROS (H2O2) also up-regulated TACE activity with similar kinetics and magnitude as LPS. H2O2- and LPS-induced TACE activity up-regulation were effectively abolished by a variety of selective p38 MAPK inhibitors. Activation of p38 was redox-sensitive as H2O2 caused p38 phosphorylation, and ROS scavenging significantly reduced LPS-induced phospho-p38 expression. Inhibition of the p38 substrate, MAPK-activated protein kinase 2, completely attenuated TACE activity up-regulation, whereas inhibition of ERK had little effect. Lastly, inhibition of cell surface oxidoreductases prevented TACE activity up-regulation distal to p38 activation. In conclusion, our data indicate that in primary human monocytes, ROS mediate LPS-induced up-regulation of TACE activity indirectly through activation of the p38 signaling pathway.	[Scott, Alasdair J.; O'Dea, Kieran P.; O'Callaghan, David; Dokpesi, Justina O.; Tatton, Louise; Handy, Jonathan M.; Takata, Masao] Chelsea & Westminster Hosp, Sect Anaesthet Pain Med & Intens Care, Fac Med, London SW10 9NH, England; [Williams, Lynn] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London SW7 2AZ, England; [Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia	Imperial College London; Imperial College London; University of Oxford; University of New South Wales Sydney	Takata, M (corresponding author), Chelsea & Westminster Hosp, Sect Anaesthet Pain Med & Intens Care, Fac Med, 369 Fulham Rd, London SW10 9NH, England.	m.takata@imperial.ac.uk	Scott, Alasdair/AAE-8715-2020	Scott, Alasdair/0000-0003-4621-9756; Hogg, Philip/0000-0001-6486-2863	Westminster Medical School Research Trust; Medical Research Council [G0700128] Funding Source: researchfish; MRC [G0700128] Funding Source: UKRI	Westminster Medical School Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Westminster Medical School Research Trust.	AFFRES H, 1991, KIDNEY INT, V39, P822, DOI 10.1038/ki.1991.103; Alvarez-Iglesias M, 2005, LAB INVEST, V85, P1440, DOI 10.1038/labinvest.3700340; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blouin E, 1999, EUR J IMMUNOL, V29, P3419, DOI 10.1002/(SICI)1521-4141(199911)29:11<3419::AID-IMMU3419>3.3.CO;2-T; Brennan FM, 2008, EUR J IMMUNOL, V38, P1106, DOI 10.1002/eji.200737821; Brill A, 2009, CARDIOVASC RES, V84, P137, DOI 10.1093/cvr/cvp176; Bzowska M, 2009, ACTA BIOCHIM POL, V56, P325; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; Condon TP, 2001, ANTISENSE NUCLEIC A, V11, P107, DOI 10.1089/108729001750171353; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Foxwell B, 1998, P NATL ACAD SCI USA, V95, P8211, DOI 10.1073/pnas.95.14.8211; Ganesan Srinivasan, 2002, Curr Opin Investig Drugs, V3, P1301; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Griffith CE, 1998, J BIOL CHEM, V273, P10771, DOI 10.1074/jbc.273.17.10771; Hino T, 1999, AM J RESP CELL MOL, V20, P122, DOI 10.1165/ajrcmb.20.1.3217; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Ottosen ER, 2003, J MED CHEM, V46, P5651, DOI 10.1021/jm030851s; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pedron T, 2003, J BIOL CHEM, V278, P20555, DOI 10.1074/jbc.M203551200; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PHILIPPE C, 1992, CLIN EXP IMMUNOL, V87, P499; Pietri M, 2005, FASEB J, V19, P1078, DOI 10.1096/fj.04-3631com; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Riche FC, 2000, CRIT CARE MED, V28, P433, DOI 10.1097/00003246-200002000-00024; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Shurety W, 2001, LAB INVEST, V81, P107, DOI 10.1038/labinvest.3780216; SPERTINI O, 1991, J IMMUNOL, V147, P2565; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Walsh GM, 2004, BIOCHEMISTRY-US, V43, P473, DOI 10.1021/bi0354536; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200; Zhang ZL, 2001, FASEB J, V15, P303	64	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35466	35476		10.1074/jbc.M111.277434	http://dx.doi.org/10.1074/jbc.M111.277434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865167	Green Published, hybrid			2022-12-25	WOS:000295927100018
J	Zhao, DQ; Ai, HB				Zhao, Dong-Qin; Ai, Hong-Bin			Oxytocin and Vasopressin Involved in Restraint Water-Immersion Stress Mediated by Oxytocin Receptor and Vasopressin 1b Receptor in Rat Brain	PLOS ONE			English	Article							DORSAL MOTOR NUCLEUS; MESSENGER RIBONUCLEIC-ACIDS; C-FOS IMMUNOREACTIVITY; PARAVENTRICULAR NUCLEUS; GASTRIC-MOTILITY; VAGAL COMPLEX; NEURONS; EXPRESSION; HYPOTHALAMUS; VAGUS	Aims: Vasopressin (AVP) and oxytocin (OT) are considered to be related to gastric functions and the regulation of stress response. The present study was to study the role of vasopressinergic and oxytocinergic neurons during the restraint water-immersion stress. Methods: Ten male Wistar rats were divided into two groups, control and RWIS for 1h. The brain sections were treated with a dual immunohistochemistry of Fos and oxytocin (OT) or vasopressin (AVP) or OT receptor or AVP 1b receptor (V1bR). Results: (1) Fos-immunoreactive (Fos-IR) neurons dramatically increased in the hypothalamic paraventricular nucleus (PVN), the supraoptic nucleus (SON), the neucleus of solitary tract (NTS) and motor nucleus of the vagus (DMV) in the RWIS rats; (2) OT-immunoreactive (OT-IR) neurons were mainly observed in the medial magnocellular part of the PVN and the dorsal portion of the SON, while AVP-immunoreactive (AVP-IR) neurons mainly distributed in the magnocellular part of the PVN and the ventral portion of the SON. In the RWIS rats, Fos-IR neurons were indentified in 31% of OT-IR neurons and 40% of AVP-IR neurons in the PVN, while in the SON it represented 28%, 53% respectively; (3) V1bR-IR and OTR-IR neurons occupied all portions of the NTS and DMV. In the RWIS rats, more than 10% of OTR-IR and V1bR-IR neurons were activated in the DMV, while lower ratio in the NTS. Conclusion: RWIS activates both oxytocinergic and vasopressinergic neurons in the PVN and SON, which may project to the NTS or DMV mediating the activity of the neurons by OTR and V1bR.	[Zhao, Dong-Qin; Ai, Hong-Bin] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Shandong Prov, Jinan, Shandong, Peoples R China	Shandong Normal University	Zhao, DQ (corresponding author), Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Shandong Prov, Jinan, Shandong, Peoples R China.	aihongbin@sdnu.edu.cn			National Science Foundation of China [30770277, 30970354, 31071920]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (No. 30770277, 30970354, 31071920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscipt.	AI H-B, 1990, Acta Physiologica Sinica, V42, P496; Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119; Benarroch EE, 2005, CLIN AUTON RES, V15, P254, DOI 10.1007/s10286-005-0290-7; BONAZ B, 1994, BRAIN RES, V652, P56, DOI 10.1016/0006-8993(94)90316-6; Briski K, 2001, BRAIN RES BULL, V55, P401, DOI 10.1016/S0361-9230(01)00532-9; CECCATELLI S, 1989, NEUROENDOCRINOLOGY, V49, P309, DOI 10.1159/000125133; Cruz MT, 2007, AM J PHYSIOL-REG I, V292, pR291, DOI 10.1152/ajpregu.00863.2005; du Plessis I, 2006, BRAIN RES, V1120, P124, DOI 10.1016/j.brainres.2006.08.062; GARRICK T, 1986, AM J PHYSIOL, V250, pG191, DOI 10.1152/ajpgi.1986.250.2.G191; GEORGE JM, 1975, BRAIN RES, V93, P363, DOI 10.1016/0006-8993(75)90360-1; GIOVANNELLI L, 1992, BRAIN RES, V588, P41, DOI 10.1016/0006-8993(92)91342-C; GIOVANNELLI L, 1990, BRAIN RES, V531, P299, DOI 10.1016/0006-8993(90)90789-E; Harrison TA, 2001, BRAIN RES, V904, P54, DOI 10.1016/S0006-8993(01)02449-0; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Higa KT, 2002, AM J PHYSIOL-REG I, V282, pR537, DOI 10.1152/ajpregu.00806.2000; KREMARIK P, 1995, BRAIN RES BULL, V36, P195, DOI 10.1016/0361-9230(94)00196-8; Krowicki ZK, 2002, AM J PHYSIOL-GASTR L, V283, pG465, DOI 10.1152/ajpgi.00264.2001; MCCANN MJ, 1990, J PHYSIOL-LONDON, V428, P95, DOI 10.1113/jphysiol.1990.sp018202; Michelini LC, 2001, ANN NY ACAD SCI, V940, P206; MIYATA S, 1995, BRAIN RES BULL, V37, P391, DOI 10.1016/0361-9230(95)00017-8; Nishitani S, 2004, CELL MOL NEUROBIOL, V24, P283, DOI 10.1023/B:CEMN.0000018622.44317.14; OKUMURA T, 1990, J AUTONOM NERV SYST, V29, P157, DOI 10.1016/0165-1838(90)90181-H; OSTROWSKI NL, 1992, ENDOCRINOLOGY, V131, P533, DOI 10.1210/en.131.1.533; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Palkovits M, 2000, EUR J PHARMACOL, V405, P161, DOI 10.1016/S0014-2999(00)00549-5; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pirnik Z, 2005, BRAIN RES BULL, V65, P423, DOI 10.1016/j.brainresbull.2005.02.023; Pirnik Z, 2004, NEUROCHEM INT, V45, P597, DOI 10.1016/j.neuint.2004.04.003; Rinaman L, 1998, J COMP NEUROL, V399, P101, DOI 10.1002/(SICI)1096-9861(19980914)399:1<101::AID-CNE8>3.0.CO;2-5; ROGERS RC, 1987, PEPTIDES, V8, P505, DOI 10.1016/0196-9781(87)90017-9; Rogers RC, 1999, J PHYSIOL-LONDON, V514, P369, DOI 10.1111/j.1469-7793.1999.369ae.x; Rogers RC, 1996, NEUROSCI BIOBEHAV R, V20, P57, DOI 10.1016/0149-7634(95)00040-L; SOFRONIEW MV, 1980, J COMP NEUROL, V193, P659, DOI 10.1002/cne.901930305; SOFRONIEW MV, 1981, NEUROSCIENCE, V6, P619, DOI 10.1016/0306-4522(81)90147-0; Sun HZ, 2010, CHINESE MED J-PEKING, V123, P1052, DOI 10.3760/cma.j.issn.0366-6999.2010.08.014; SWAAB DF, 1975, J ENDOCRINOL, V67, P461, DOI 10.1677/joe.0.0670461; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; Volpi S, 2004, STRESS, V7, P75, DOI 10.1080/10253890410001733535; Wang LX, 2009, BRAIN RES, V1247, P79, DOI 10.1016/j.brainres.2008.09.094; Wang YH, 2007, SCAND J CLIN LAB INV, V67, P489, DOI 10.1080/00365510601161505; Xiong JJ, 1996, BRAIN RES, V719, P143, DOI 10.1016/0006-8993(95)01466-7; Young WS, 2006, NEUROSCIENCE, V143, P1031, DOI 10.1016/j.neuroscience.2006.08.040; Zhang JF, 1997, BRAIN RES, V761, P203, DOI 10.1016/S0006-8993(97)00257-6; Zhang YY, 2009, J PHYSIOL SCI, V59, P367, DOI 10.1007/s12576-009-0044-8; Zhang YY, 2009, CHINESE J PHYSIOL, V52, P143, DOI 10.4077/CJP.2009.AMH045; Zhao DQ, 2011, J PHYSIOL SCI, V61, P37, DOI 10.1007/s12576-010-0119-6; Zhou SY, 2008, AM J PHYSIOL-GASTR L, V294, pG1201, DOI 10.1152/ajpgi.00309.2006; ZIMMERMANN M, 1986, ACTA PHYSIOL SCAND, V128, P221	53	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23362	10.1371/journal.pone.0023362	http://dx.doi.org/10.1371/journal.pone.0023362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858088	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300039
J	Tjomsland, V; Ellegard, R; Che, K; Hinkula, J; Lifson, JD; Larsson, M				Tjomsland, Veronica; Ellegard, Rada; Che, Karlhans; Hinkula, Jorma; Lifson, Jeffrey D.; Larsson, Marie			Complement Opsonization of HIV-1 Enhances the Uptake by Dendritic Cells and Involves the Endocytic Lectin and Integrin Receptor Families	PLOS ONE			English	Article							CD4 T-CELLS; DC-SIGN; APOPTOTIC CELLS; INFECTION; ADHESION; VIRUS; ANTIBODY; MEDIATE; CR3; VISUALIZATION	Interaction with the complement system is an underappreciated aspect of HIV-1 infection; even in primary infection, complement fragments are found on virions with potential to affect the interplay between the virus and dendritic cells (DC). Since opsonization may affect the efficiency of uptake and the type of receptors utilized, we compared the interactions of DC with free HIV-1 (F-HIV) and complement opsonized HIV-1 (C-HIV). We demonstrate that C-HIV significantly enhanced the uptake by immature DC (IDC) and mature DC (MDC) and that the internalization rate was dependent on both opsonization of the virus and DC maturation state. Increased DC uptake of C-HIV was not due to opsonization related increased binding of virus to the surface of DC but rather increased internalization of C-HIV despite utilizing a similar repertoire of receptors as F-HIV. Both F-HIV and C-HIV interacted with C-type lectins, integrins, and CD4 and blocking these receptor families prevented HIV-1 from binding to DC at 4 degrees C. Blocking integrins significantly reduced the binding and uptake of F-HIV and C-HIV implicating the involvement of several integrins such as beta 1-integrin, CR3, LFA-1, and alpha 4 beta 7. Distinctive for C-HIV was usage of beta 1-integrin and for F-HIV, usage of beta 7-integrin, whereas both F-HIV and C-HIV utilized both integrin chains of CR3. We have in this study identified the receptor types used by both F-HIV and C-HIV to bind to DC. Noteworthy, C-HIV was internalized more efficiently by DC than F-HIV, probably via receptor mediated endocytosis, which may entail different intracellular processing of the virus leading to both elevated infection and altered activation of HIV specific immune responses.	[Tjomsland, Veronica; Ellegard, Rada; Che, Karlhans; Hinkula, Jorma; Larsson, Marie] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	Linkoping University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Tjomsland, V (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	marie.larsson@liu.se	Hinkula, Jorma/P-6849-2018	Larsson, Marie/0000-0002-4524-0177; Hinkula, Jorma/0000-0003-1908-5609	Swedish Research Council [ML: AI52731]; Swedish, Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova; Linkoping University Hospital; C ALF; Swedish Society of Medicine; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052731, R01AI052731] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish, Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); Linkoping University Hospital; C ALF; Swedish Society of Medicine; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by grants through: ML: AI52731, The Swedish Research Council, The Swedish, Physicians against AIDS Research Foundation, The Swedish International Development Cooperation Agency; SIDA SARC, VINNMER for Vinnova, Linkoping University Hospital Research Fund, C ALF, and The Swedish Society of Medicine; also in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E (JDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bajtay Z, 2004, J IMMUNOL, V173, P4775, DOI 10.4049/jimmunol.173.8.4775; Ballana E, 2009, BLOOD, V113, P1278, DOI 10.1182/blood-2008-06-161869; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Bouhlal H, 2002, J IMMUNOL, V169, P3301, DOI 10.4049/jimmunol.169.6.3301; Bouhlal H, 2007, J IMMUNOL, V178, P1086, DOI 10.4049/jimmunol.178.2.1086; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CARPENTIER JL, 1991, CELL REGUL, V2, P41, DOI 10.1091/mbc.2.1.41; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Cummings KL, 2007, VIRAL IMMUNOL, V20, P505, DOI 10.1089/vim.2007.0061; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Gilbert C, 2007, J VIROL, V81, P7672, DOI 10.1128/JVI.02810-06; Guay LA, 2002, AIDS, V16, P1391, DOI 10.1097/00002030-200207050-00011; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Larsson M, 2005, SPRINGER SEMIN IMMUN, V26, P309, DOI 10.1007/s00281-004-0178-y; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Pruenster M, 2005, EUR J IMMUNOL, V35, P2691, DOI 10.1002/eji.200425940; Rahimi A, 1999, AM J REPROD IMMUNOL, V41, P330; Sattentau Q, 2008, NAT IMMUNOL, V9, P225, DOI 10.1038/ni0308-225; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Stoiber H, 2005, MOL IMMUNOL, V42, P153, DOI 10.1016/j.molimm.2004.06.024; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; THIEBLEMONT N, 1993, IMMUNOPHARMACOLOGY, V25, P87, DOI 10.1016/0162-3109(93)90012-F; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Wilflingseder D, 2007, J IMMUNOL, V178, P7840, DOI 10.4049/jimmunol.178.12.7840; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	40	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23542	10.1371/journal.pone.0023542	http://dx.doi.org/10.1371/journal.pone.0023542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853149	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953400051
J	Hesse, K; Vaupel, K; Kurt, S; Buettner, R; Kirfel, J; Moser, M				Hesse, Katrin; Vaupel, Kristina; Kurt, Simone; Buettner, Reinhard; Kirfel, Jutta; Moser, Markus			AP-2 delta Is a Crucial Transcriptional Regulator of the Posterior Midbrain	PLOS ONE			English	Article							DNA-BINDING; FACTOR AP-2; MOUSE EMBRYOGENESIS; FACTOR AP-2-GAMMA; EPITHELIAL-CELLS; FACTOR AP-2-BETA; GENE-EXPRESSION; MUTANT MICE; AP-2-EPSILON; POU4F3	Ap-2 transcription factors comprise a family of 5 closely related sequence-specific DNA binding proteins that play pivotal and non-redundant roles in embryonic organogenesis. To investigate the function of Ap-2 delta, w delta e analyzed its expression during embryogenesis and generated Ap-2 delta-deficient mice. In line with the specific expression pattern of Ap-2 delta in the mesencephalic tectum and the dorsal midbrain, Ap-2 delta-deficient mice failed to maintain the colliculus inferior, a derivative of the dorsal midbrain, as a consequence of increased apoptotic cell death. To identify specific Ap-2 delta target genes in cells of the developing dorsal midbrain, we performed whole genome analysis of cDNA expression levels. This approach identified a set of 12 putative target genes being expressed in the developing midbrain, including the transcription factors Pitx2, Mef2c, Bhlhb4 and Pou4f3. Using chromatin immunoprecipitation (CHIP) we showed that some of these genes are direct targets of Ap-2 delta. Consistently, we demonstrate that Ap-2 delta d occupies and activates the Pou4f3 and Bhlhb4 promoters. In addition, known Pou4f3 target genes were downregulated in the posterior midbrain of Ap-2 delta-deficient mice. Despite the absence of a central part of the auditory pathway, the presence of neuronal responses to sounds in the neocortex of Ap-2 delta-deficient mice indicates that auditory information from the brainstem still reaches the neocortex. In summary, our data define Ap-2 delta as an important transcription factor, specifying gene expression patterns required for the development of the posterior midbrain.	[Hesse, Katrin; Kirfel, Jutta] Univ Bonn, Inst Pathol, D-5300 Bonn, Germany; [Vaupel, Kristina; Moser, Markus] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kurt, Simone] Univ Ulm, Inst Neurobiol, Ulm, Germany; [Buettner, Reinhard] Univ Cologne, Inst Pathol, Cologne, Germany	University of Bonn; Max Planck Society; Ulm University; University of Cologne	Hesse, K (corresponding author), Univ Bonn, Inst Pathol, D-5300 Bonn, Germany.	moser@biochem.mpg.de	Kurt, Simone/I-2927-2012	Kurt, Simone/0000-0002-1820-2597	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	M.M. and R.B. were funded by grants from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish or preparartion of the manuscript.	ABELES M, 1975, HDB SENSORY PHYSL; Auman HJ, 2002, DEVELOPMENT, V129, P2733; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; CASSEDAY JH, 1989, J COMP NEUROL, V287, P247, DOI 10.1002/cne.902870208; Chazaud C, 1996, MECH DEVELOP, V54, P83, DOI 10.1016/0925-4773(95)00463-7; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; Clough RL, 2004, BIOCHEM BIOPH RES CO, V324, P372, DOI 10.1016/j.bbrc.2004.09.074; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Feng W, 2009, MOL CELL NEUROSCI, V42, P161, DOI 10.1016/j.mcn.2009.06.010; Feng WG, 2003, MOL CELL NEUROSCI, V24, P460, DOI 10.1016/S1044-7431(03)00209-4; Gurung B, 2004, J COMP NEUROL, V479, P309, DOI 10.1002/cne.20328; Hertzano R, 2007, EUR J NEUROSCI, V25, P999, DOI 10.1111/j.1460-9568.2007.05332.x; Jafari MR, 2007, CEREB CORTEX, V17, P71, DOI 10.1093/cercor/bhj125; KOBLER JB, 1987, SCIENCE, V236, P824, DOI 10.1126/science.2437655; LIM S, CARCINOGENESIS, V31, P512; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; Moser M, 1997, GENE DEV, V11, P1938, DOI 10.1101/gad.11.15.1938; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; Moser M, 2003, LAB INVEST, V83, P571, DOI 10.1097/01.LAB.0000064703.92382.50; MOSER M, 1995, DEVELOPMENT, V121, P2779; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Pfeffer PL, 2000, DEVELOPMENT, V127, P1017; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Schwarz M, 1997, P NATL ACAD SCI USA, V94, P14518, DOI 10.1073/pnas.94.26.14518; Shi DQ, 1998, J BIOL CHEM, V273, P27331, DOI 10.1074/jbc.273.42.27331; Sun LY, 2007, FRONT BIOSCI-LANDMRK, V12, P1699, DOI 10.2741/2182; Tan CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008535; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wang HV, 2004, DEV DYNAM, V231, P128, DOI 10.1002/dvdy.20119; Wenke AK, 2006, BIOCHEM BIOPH RES CO, V345, P495, DOI 10.1016/j.bbrc.2006.04.123; Werling U, 2002, MOL CELL BIOL, V22, P3149, DOI 10.1128/MCB.22.9.3149-3156.2002; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WURST W, 1994, DEVELOPMENT, V120, P2065; Xiang MQ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-2; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhao F, 2003, GENE EXPR PATTERNS, V3, P213, DOI 10.1016/S1567-133X(02)00067-4	44	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23483	10.1371/journal.pone.0023483	http://dx.doi.org/10.1371/journal.pone.0023483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858141	Green Published, gold, Green Submitted			2022-12-25	WOS:000293774300038
J	Peng, A; Wu, TF; Zeng, CH; Rakheja, D; Zhu, JK; Ye, T; Hutcheson, J; Vaziri, ND; Liu, ZH; Mohan, C; Zhou, XJ				Peng, Ai; Wu, Tianfu; Zeng, Caihong; Rakheja, Dinesh; Zhu, Jiankun; Ye, Ting; Hutcheson, Jack; Vaziri, Nosratola D.; Liu, Zhihong; Mohan, Chandra; Zhou, Xin J.			Adverse Effects of Simulated Hyper- and Hypo-Phosphatemia on Endothelial Cell Function and Viability	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PHASE PROTEIN MICROARRAYS; CARDIOVASCULAR-DISEASE; POTENTIAL CONSEQUENCES; INTRACELLULAR CALCIUM; FLOW-CYTOMETRY; APOPTOSIS; DYSFUNCTION; PATHWAYS; KINASE	Background: Dysregulaiton of phosphate homeostasis as occurs in chronic kidney disease is associated with cardiovascular complications. It has been suggested that both hyperphosphatemia and hypophosphatemia can cause cardiovascular disease. The molecular mechanisms by which high or low serum phosphate levels adversely affect cardiovascular function are poorly understood. The purpose of this study was to explore the mechanisms of endothelial dysfunction in the presence of non-physiologic phosphate levels. Methodology/Principal Findings: We studied the effects of simulated hyper- and hypophosphatemia in human umbilical vein endothelial cells in vitro. We found both simulated hyperphosphatemia and hypophosphatemia decrease eNOS expression and NO production. This was associated with reduced intracellular calcium, increased protein kinase C beta 2 (PKC beta 2), reduced cell viability, and increased apoptosis. While simulated hyperphosphatemia was associated with decreased Akt/p-Akt, Bcl-xl/Bax ratios, NFkB-p65 and p-Erk abundance, simulated hypophosphatemia was associated with increased Akt/p-Akt and Bcl-xl/Bax ratios and p-Mek, p38, and p-p38 abundance. Conclusions/Significance: This is the first demonstration of endothelial dysfunction with hypophosphatemia. Our data suggests that both hyperphosphatemia and hypophosphatemia decrease eNOS activity via reduced intracellular calcium and increased PKCb2. Hyperphosphatemia also appears to reduce eNOS transcription via reduced signaling through PI3K/Akt/NF-kB and MAPK/NF-kB pathways. On the other hand, hypophosphatemia appears to activate these pathways. Our data provides the basis for further studies to elucidate the relationship between altered phosphate homeostasis and cardiovascular disease. As a corollary, our data suggests that the level of phosphate in the culture media, if not in the physiologic range, may inadvertently affect experimental results.	[Peng, Ai] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nephrol, Shanghai 200092, Peoples R China; [Peng, Ai; Rakheja, Dinesh; Ye, Ting; Zhou, Xin J.] UT SW Med Ctr, Dept Pathol, Dallas, TX USA; [Wu, Tianfu; Zhu, Jiankun; Hutcheson, Jack; Mohan, Chandra] UT SW Med Ctr, Dept Internal Med, Div Rheumatol, Dallas, TX USA; [Zeng, Caihong; Liu, Zhihong] Nanjing Univ, Jinling Hosp, Sch Med, Res Inst Nephrol, Nanjing 210008, Peoples R China; [Vaziri, Nosratola D.] Univ Calif Irvine, Div Nephrol & Hypertens, Irvine, CA USA	Tongji University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Nanjing University; University of California System; University of California Irvine	Peng, A (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Nephrol, Shanghai 200092, Peoples R China.	zhihong-liu@hotmail.com; Chandra.mohan@utsouthwestern.edu; joseph.zhou@ymail.com	Wu, Tianfu/G-6672-2019; Mohan, Chandra/GPX-8233-2022	Wu, Tianfu/0000-0003-4406-1449; Hutcheson, Jack/0000-0002-6317-2788; Wu, Tianfu/0000-0001-8235-5929	National Institutes of Health [AR055600]; National Natural Science Foundation of China [30472163, 30871202]; High Technology Research and Development Program of China [2009AA02Z416]; Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from the National Institutes of Health (AR055600), the National Natural Science Foundation of China (30472163 and 30871202), and the High Technology Research and Development Program of China (2009AA02Z416), and by funds from the Drs. George and Anne Race Distinguished Professorship in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2002, CAN J APPL PHYSIOL, V27, P83, DOI 10.1139/h02-006; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chae HD, 2008, ONCOGENE, V27, P4115, DOI 10.1038/onc.2008.46; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Chicoine LM, 2004, J NEUROSCI RES, V75, P408, DOI 10.1002/jnr.10871; Deo R, 2008, AM HEART J, V155, P62, DOI 10.1016/j.ahj.2007.08.012; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ditzel J, 2010, VASC HEALTH RISK MAN, V6, P829, DOI 10.2147/VHRM.S13368; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Duncan JS, 2010, BBA-PROTEINS PROTEOM, V1804, P505, DOI 10.1016/j.bbapap.2009.11.001; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Farrow EG, 2010, NAT REV NEPHROL, V6, P207, DOI 10.1038/nrneph.2010.17; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Heames RM, 2006, ANAESTHESIA, V61, P1211, DOI 10.1111/j.1365-2044.2006.04839.x; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Hirata Y, 2010, INT HEART J, V51, P1, DOI 10.1536/ihj.51.1; Jeon YJ, 2000, J PHARMACOL EXP THER, V294, P548; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Malinowsky K, 2010, J CELL PHYSIOL, V225, P364, DOI 10.1002/jcp.22307; Matsubara M, 2003, J BIOCHEM, V133, P773, DOI 10.1093/jb/mvg099; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Musicki B, 2009, J SEX MED, V6, P247, DOI 10.1111/j.1743-6109.2008.01122.x; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; Osuka A, 2009, INTERNAL MED, V48, P1391, DOI 10.2169/internalmedicine.48.2236; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; SZCZEPANSKAKONKEL M, 1986, J BIOL CHEM, V261, P6375; Takeda E, 2006, ADV ENZYME REGUL, V46, P154, DOI 10.1016/j.advenzreg.2006.01.003; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Vangamudi B, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-32; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Vaziri ND, 2010, NAT REV NEPHROL, V6, P287, DOI 10.1038/nrneph.2010.36; Wang XD, 2001, GENE DEV, V15, P2922; Westerblad H, 1996, PFLUG ARCH EUR J PHY, V431, P964, DOI 10.1007/s004240050092; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Xian M, 2000, BIOCHEM BIOPH RES CO, V268, P310, DOI 10.1006/bbrc.2000.2117; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	42	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23268	10.1371/journal.pone.0023268	http://dx.doi.org/10.1371/journal.pone.0023268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858050	gold, Green Published			2022-12-25	WOS:000293774300029
J	Trosch, R; Jarvis, P				Troesch, Raphael; Jarvis, Paul			The Stromal Processing Peptidase of Chloroplasts is Essential in Arabidopsis, with Knockout Mutations Causing Embryo Arrest after the 16-Cell Stage	PLOS ONE			English	Article							PLASTID PROTEIN IMPORT; TRANSIT PEPTIDES; IN-VIVO; INSERTIONAL MUTAGENESIS; PLANT DEVELOPMENT; THALIANA; ENZYME; GENE; EMBRYOGENESIS; MITOCHONDRIA	Stromal processing peptidase (SPP) is a metalloendopeptidase located in the stroma of chloroplasts, and it is responsible for the cleavage of transit peptides from preproteins upon their import into the organelle. Two independent mutant Arabidopsis lines with T-DNA insertions in the SPP gene were analysed (spp-1 and spp-2). For both lines, no homozygous mutant plants could be detected, and the segregating progeny of spp heterozygotes contained heterozygous and wild-type plants in a ratio of 2:1. The siliques of heterozygous spp-1 and spp-2 plants contained many aborted seeds, at a frequency of similar to 25%, suggesting embryo lethality. By contrast, transmission of the spp mutations through the male and female gametes was found to be normal, and so gametophytic effects could be ruled out. To further elucidate the timing of the developmental arrest, mutant and wild-type seeds were cleared and analysed by Nomarski microscopy. A significant proportion (similar to 25%) of the seeds in mutant siliques exhibited delayed embryogenesis compared to those in wild type. Moreover, the mutant embryos never progressed normally beyond the 16-cell stage, with cell divisions not completing properly thereafter. Heterozygous spp mutant plants were phenotypically indistinguishable from the wild type, indicating that the spp knockout mutations are completely recessive and suggesting that one copy of the SPP gene is able to produce sufficient SPP protein for normal development under standard growth conditions.	[Troesch, Raphael; Jarvis, Paul] Univ Leicester, Dept Biol, Leicester, Leics, England	University of Leicester	Trosch, R (corresponding author), Univ Leicester, Dept Biol, Leicester, Leics, England.	rpj3@le.ac.uk		Jarvis, Paul/0000-0003-2127-5671; Trosch, Raphael/0000-0002-0632-3324	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council [BB/D016541/1, BB/F020325/1, BB/H008039/1]; BBSRC [BB/H008039/1, BB/D016541/1, BB/F020325/1] Funding Source: UKRI	Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Gatsby Charitable Foundation Sainsbury PhD Studentship (http://www.gatsby.org.uk/) (to RT), and by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) grants BB/D016541/1, BB/F020325/1, and BB/H008039/1 (to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, PLANT J, V46, P641, DOI 10.1111/j.1365-313X.2006.02727.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Aronsson H, 2010, PLANT J, V63, P297, DOI 10.1111/j.1365-313X.2010.04242.x; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; BLAIR GE, 1973, BIOCHIM BIOPHYS ACTA, V319, P223, DOI 10.1016/0005-2787(73)90013-0; Blobel G., 1971, BIOMEMBRANE, P193; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; BRYANT N, 2011, PLANT PHYSL IN PRESS; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Goubet F, 2003, PLANT PHYSIOL, V131, P547, DOI 10.1104/pp.014555; Howden R, 1998, GENETICS, V149, P621; Hsu SC, 2010, CURR GENOMICS, V11, P338, DOI 10.2174/138920210791616716; Hust B, 2006, PLANT BIOLOGY, V8, P18, DOI 10.1055/s-2005-873044; Inaba T, 2005, PLANT CELL, V17, P1482, DOI 10.1105/tpc.105.030700; Inaba T, 2008, BIOCHEM J, V413, P15, DOI 10.1042/BJ20080490; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kasmati AR, 2011, PLANT J, V66, P877, DOI 10.1111/j.1365-313X.2011.04551.x; KASMATI AR, 2011, PLANT J IN PRESS; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; Krimm I, 1999, EUR J BIOCHEM, V265, P171, DOI 10.1046/j.1432-1327.1999.00701.x; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Ling QH, 2011, PHOTOSYNTH RES, V107, P209, DOI 10.1007/s11120-010-9606-0; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; McElver J, 2001, GENETICS, V159, P1751; Moberg P, 2003, PLANT J, V36, P616, DOI 10.1046/j.1365-313X.2003.01904.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Richter S, 2005, PHYSIOL PLANTARUM, V123, P362, DOI 10.1111/j.1399-3054.2005.00476.x; Richter S, 2003, J BIOL CHEM, V278, P39497, DOI 10.1074/jbc.M305729200; Richter S, 2002, J BIOL CHEM, V277, P43888, DOI 10.1074/jbc.M206020200; Richter S, 1998, P NATL ACAD SCI USA, V95, P7463, DOI 10.1073/pnas.95.13.7463; Rudhe C, 2004, J MOL BIOL, V343, P639, DOI 10.1016/j.jmb.2004.08.053; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; VANDERVERE PS, 1995, P NATL ACAD SCI USA, V92, P7177, DOI 10.1073/pnas.92.16.7177; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; Wan JX, 1998, PLANT J, V15, P459, DOI 10.1046/j.1365-313X.1998.00224.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yue RQ, 2010, PLANT CELL PHYSIOL, V51, P475, DOI 10.1093/pcp/pcq012; Zhong R, 2003, PLANT J, V34, P802, DOI 10.1046/j.1365-313X.2003.01772.x	53	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23039	10.1371/journal.pone.0023039	http://dx.doi.org/10.1371/journal.pone.0023039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857988	Green Published, gold			2022-12-25	WOS:000294125500014
J	Segawa, S; Fujiya, M; Konishi, H; Ueno, N; Kobayashi, N; Shigyo, T; Kohgo, Y				Segawa, Shuichi; Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Kobayashi, Naoyuki; Shigyo, Tatsuro; Kohgo, Yutaka			Probiotic-Derived Polyphosphate Enhances the Epithelial Barrier Function and Maintains Intestinal Homeostasis through Integrin-p38 MAPK Pathway	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; SHOCK-PROTEIN 27; NF-KAPPA-B; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; EXTRACELLULAR SEGMENT; BACTERIAL LIGANDS; CRYSTAL-STRUCTURE; SOLUBLE FACTORS; TIGHT JUNCTION	Probiotics exhibit beneficial effects on human health, particularly in the maintenance of intestinal homeostasis in a complex manner notwithstanding the diversity of an intestinal flora between individuals. Thus, it is highly probable that some common molecules secreted by probiotic and/or commensal bacteria contribute to the maintenance of intestinal homeostasis and protect the intestinal epithelium from injurious stimuli. To address this question, we aimed to isolate the cytoprotective compound from a lactobacillus strain, Lactobacillus brevis SBC8803 which possess the ability to induce cytoprotective heat shock proteins in mouse small intestine. L. brevis was incubated in MRS broth and the supernatant was passed through with a 0.2-mu m filter. Caco2/bbe cells were treated with the culture supernatant, and HSP27 expression was evaluated by Western blotting. HSP27-inducible components were separated by ammonium sulfate precipitation, DEAE anion exchange chromatography, gel filtration, and HPLC. Finally, we identified that the HSP27-inducible fraction was polyphosphate (poly P), a simple repeated structure of phosphates, which is a common product of lactobacilli and other bacteria associated with intestinal microflora without any definitive physiological functions. Then, poly P was synthesized by poly P-synthesizing enzyme polyphosphate kinase. The synthesized poly P significantly induced HSP27 from Caco2/BBE cells. In addition, Poly P suppressed the oxidant-induced intestinal permeability in the mouse small intestine and pharmacological inhibitors of p38 MAPK and integrins counteract its protective effect. Daily intrarectal administration of poly P (10 mu g) improved the inflammation grade and survival rate in 4% sodium dextran sulfate-administered mice. This study, for the first time, demonstrated that poly P is the molecule responsible for maintaining intestinal barrier actions which are mediated through the intestinal integrin beta 1-p38 MAPK.	[Segawa, Shuichi; Kobayashi, Naoyuki; Shigyo, Tatsuro] Sapporo Breweries Ltd, Frontier Labs Value Creat, Yaizu, Japan; [Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan	Sapporo Holdings Limited; Asahikawa Medical College	Segawa, S (corresponding author), Sapporo Breweries Ltd, Frontier Labs Value Creat, Yaizu, Japan.	fjym@asahikawa-med.ac.jp	Kohgo, Yutaka/AAN-4863-2020		Ministry of Education, Culture, Sports, Science and Technology in Japan [20590734]; Sapporo Bio Cluster "Bio-S''; Sapporo Breweries Ltd	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Bio Cluster "Bio-S''; Sapporo Breweries Ltd	This study was supported by a Grant-in Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology in Japan to M.F. (#20590734), Sapporo Bio Cluster "Bio-S'', the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sapporo Breweries Ltd also funded this study and their role was to provide the lactic acid bacteira strain. Through the employment of Shuichi Segawa, Naoyuki Kobayashi and Tatsuro Shigyo they were also involved in conceiving, designing and performing the experiments and also with analyzing the data.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Coulson BS, 1997, P NATL ACAD SCI USA, V94, P5389, DOI 10.1073/pnas.94.10.5389; De Keersmaecker SCJ, 2006, FEMS MICROBIOL LETT, V259, P89, DOI 10.1111/j.1574-6968.2006.00250.x; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Garcia MC, 2009, J BIOL CHEM, V284, P20936, DOI 10.1074/jbc.M109.020271; Guay J, 1997, J CELL SCI, V110, P357; Heuvelin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005184; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kumar CC, 1997, J PHARMACOL EXP THER, V283, P843; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; Nishimura T, 2008, WORLD J GASTROENTERO, V14, P5851, DOI 10.3748/wjg.14.5851; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; RAO NN, 1985, J BACTERIOL, V162, P242, DOI 10.1128/JB.162.1.242-247.1985; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Tafazoli F, 2000, INFECT IMMUN, V68, P5335, DOI 10.1128/IAI.68.9.5335-5343.2000; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; TINSLEY CR, 1995, INFECT IMMUN, V63, P1624, DOI 10.1128/IAI.63.5.1624-1630.1995; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; UENO N, 2011, INFLAMM BOWEL D 0106; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	42	128	138	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23278	10.1371/journal.pone.0023278	http://dx.doi.org/10.1371/journal.pone.0023278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858054	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700014
J	Furuta, Y; Yahara, K; Hatakeyama, M; Kobayashi, I				Furuta, Yoshikazu; Yahara, Koji; Hatakeyama, Masanori; Kobayashi, Ichizo			Evolution of cagA Oncogene of Helicobacter pylori through Recombination	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HOMOLOGOUS RECOMBINATION; INSERTION SPECIFICITY; DIVERSITY; GENES; ORGANIZATION; KINASES; LOCALIZATION; DEPENDENCE; ACCURACY	Helicobacter pylori is a gastric pathogen that infects half the human population and causes gastritis, ulcers, and cancer. The cagA gene product is a major virulence factor associated with gastric cancer. It is injected into epithelial cells, undergoes phosphorylation by host cell kinases, and perturbs host signaling pathways. CagA is known for its geographical, structural, and functional diversity in the C-terminal half, where an EPIYA host-interacting motif is repeated. The Western version of CagA carries the EPIYA segment types A, B, and C, while the East Asian CagA carries types A, B, and D and shows higher virulence. Many structural variants such as duplications and deletions are reported. In this study, we gained insight into the relationships of CagA variants through various modes of recombination, by analyzing all known cagA variants at the DNA sequence level with the single nucleotide resolution. Processes that occurred were: (i) homologous recombination between DNA sequences for CagA multimerization (CM) sequence; (ii) recombination between DNA sequences for the EPIYA motif; and (iii) recombination between short similar DNA sequences. The left half of the EPIYA-D segment characteristic of East Asian CagA was derived from Western type EPIYA, with Amerind type EPIYA as the intermediate, through rearrangements of specific sequences within the gene. Adaptive amino acid changes were detected in the variable region as well as in the conserved region at sites to which no specific function has yet been assigned. Each showed a unique evolutionary distribution. These results clarify recombination-mediated routes of cagA evolution and provide a solid basis for a deeper understanding of its function in pathogenesis.	[Furuta, Yoshikazu; Kobayashi, Ichizo] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo, Japan; [Furuta, Yoshikazu; Kobayashi, Ichizo] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Yahara, Koji] Kurume Univ, Grad Sch Med, Fukuoka, Japan; [Yahara, Koji] Fujitsu Kyushu Syst Ltd, Fukuoka, Japan; [Hatakeyama, Masanori] Univ Tokyo, Dept Microbiol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Kobayashi, Ichizo] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Minato Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; Kurume University; Fujitsu Ltd; University of Tokyo; University of Tokyo	Furuta, Y (corresponding author), Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo, Japan.	ikobaya@ims.u-tokyo.ac.jp	Kobayashi, Ichizo/GVT-8377-2022; Furuta, Yoshikazu/AAB-2219-2020	Furuta, Yoshikazu/0000-0003-4710-1389; Kobayashi, Ichizo/0000-0002-3854-1879	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT); Japan Society for the Promotion of Science (JSPS) [21370001]; Urakami Foundation; Grants-in-Aid for Scientific Research [22114002, 22114001, 22240085] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Urakami Foundation(Urakami Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants to I.K. from the global COE (Center of Excellence) project of "Genome Information Big Bang" from Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT), the 'Grants-in-Aid for Scientific Research' from the Japan Society for the Promotion of Science (JSPS) (21370001), and from Urakami Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; Bui XT, 2009, J CLIN MICROBIOL, V47, P4021, DOI 10.1128/JCM.00504-09; Craig NL, 2002, MOBILE DNA 2; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrlich S. D., 1989, MOBILE DNA-UK, P799; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fischer Wolfgang, 2008, P115; Fujitani Y, 1999, GENETICS, V153, P1973; FUJITANI Y, 1995, GENETICS, V140, P797; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai M, 2011, BMC MICROBI IN PRESS; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Kersulyte D, 1998, GENE, V223, P175, DOI 10.1016/S0378-1119(98)00164-4; Kersulyte D, 2004, J BACTERIOL, V186, P7521, DOI 10.1128/JB.186.22.7521-7528.2004; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Losich R., 2008, MOL BIOL GENE; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Satomi S, 2006, J GASTROENTEROL, V41, P668, DOI 10.1007/s00535-006-1838-6; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; SHEN P, 1986, GENETICS, V112, P441; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Morquecho A, 2010, INFECT GENET EVOL, V10, P764, DOI 10.1016/j.meegid.2010.04.005; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zeaiter Z, 2008, CELL MICROBIOL, V10, P781, DOI 10.1111/j.1462-5822.2007.01084.x	60	32	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23499	10.1371/journal.pone.0023499	http://dx.doi.org/10.1371/journal.pone.0023499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853141	Green Submitted, Green Published, gold			2022-12-25	WOS:000293953400049
J	Gazeau, F; Gattuso, JP; Greaves, M; Elderfield, H; Peene, J; Heip, CHR; Middelburg, JJ				Gazeau, Frederic; Gattuso, Jean-Pierre; Greaves, Mervyn; Elderfield, Henry; Peene, Jan; Heip, Carlo H. R.; Middelburg, Jack J.			Effect of Carbonate Chemistry Alteration on the Early Embryonic Development of the Pacific Oyster (Crassostrea gigas)	PLOS ONE			English	Article							OCEAN ACIDIFICATION; MYTILUS-EDULIS; DIOXIDE CONCENTRATIONS; SACCOSTREA-GLOMERATA; LARVAL DEVELOPMENT; FUTURE; CALCIFICATION; SHELLFISH; SURVIVAL; SEAWATER	Ocean acidification, due to anthropogenic CO2 absorption by the ocean, may have profound impacts on marine biota. Calcareous organisms are expected to be particularly sensitive due to the decreasing availability of carbonate ions driven by decreasing pH levels. Recently, some studies focused on the early life stages of mollusks that are supposedly more sensitive to environmental disturbances than adult stages. Although these studies have shown decreased growth rates and increased proportions of abnormal development under low pH conditions, they did not allow attribution to pH induced changes in physiology or changes due to a decrease in aragonite saturation state. This study aims to assess the impact of several carbonate-system perturbations on the growth of Pacific oyster (Crassostrea gigas) larvae during the first 3 days of development (until shelled D-veliger larvae). Seawater with five different chemistries was obtained by separately manipulating pH, total alkalinity and aragonite saturation state (calcium addition). Results showed that the developmental success and growth rates were not directly affected by changes in pH or aragonite saturation state but were highly correlated with the availability of carbonate ions. In contrast to previous studies, both developmental success into viable D-shaped larvae and growth rates were not significantly altered as long as carbonate ion concentrations were above aragonite saturation levels, but they strongly decreased below saturation levels. These results suggest that the mechanisms used by these organisms to regulate calcification rates are not efficient enough to compensate for the low availability of carbonate ions under corrosive conditions.	[Gazeau, Frederic; Gattuso, Jean-Pierre] CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Gazeau, Frederic; Gattuso, Jean-Pierre] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France; [Greaves, Mervyn; Elderfield, Henry] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Peene, Jan; Heip, Carlo H. R.; Middelburg, Jack J.] Netherlands Inst Ecol, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Heip, Carlo H. R.] Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, Den Burg, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Cambridge; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Gazeau, F (corresponding author), CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France.	f.gazeau@obs-vlfr.fr	Gattuso, Jean-Pierre/E-6631-2010; Gattuso, Jean-Pierre/AAG-8643-2019; Gazeau, Frédéric/G-3050-2011; Middelburg, Jack/B-4951-2011	Gattuso, Jean-Pierre/0000-0002-4533-4114; Gattuso, Jean-Pierre/0000-0002-4533-4114; Gazeau, Frédéric/0000-0001-8807-4597; Middelburg, Jack/0000-0003-3601-9072; Greaves, Mervyn/0000-0001-8014-8627	Netherlands Organization of Scientific Research; European Community [211384]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This research has received support from the Netherlands Organization of Scientific Research and is a contribution to the "European Project on Ocean Acidification" (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne B.L., 1976, MARINE MUSSELS THEIR; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Caldeira K, 2007, GEOPHYS RES LETT, V34, P3; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; His E, 1997, WATER RES, V31, P351, DOI 10.1016/S0043-1354(96)00244-8; IP YK, 1991, J EXP ZOOL, V258, P273, DOI 10.1002/jez.1402580219; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lavigne H., 2011, SEACARB SEAWATER CAR; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; Medakovic D, 2000, HELGOLAND MAR RES, V54, P1, DOI 10.1007/s101520050030; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tambutte E, 1996, J EXP BIOL, V199, P1029; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004	28	70	71	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23010	10.1371/journal.pone.0023010	http://dx.doi.org/10.1371/journal.pone.0023010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860666	Green Published, gold			2022-12-25	WOS:000295454200034
J	Reyda, FB; Marques, FPL				Reyda, Florian B.; Marques, Fernando P. L.			Diversification and Species Boundaries of Rhinebothrium (Cestoda; Rhinebothriidea) in South American Freshwater Stingrays (Batoidea; Potamotrygonidae)	PLOS ONE			English	Article							OCELLATE RIVER STINGRAY; EVOLUTIONARY RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; PHYLOGENETIC ANALYSIS; AMENDED DESCRIPTIONS; MODEL SELECTION; TETRAPHYLLIDEA; EUCESTODA; CHONDRICHTHYES; DELIMITATION	Background: Neotropical freshwater stingrays (Batoidea: Potamotrygonidae) host a diverse parasite fauna, including cestodes. Both cestodes and their stingray hosts are marine-derived, but the taxonomy of this host/parasite system is poorly understood. Methodology: Morphological and molecular (Cytochrome oxidase I) data were used to investigate diversity in freshwater lineages of the cestode genus Rhinebothrium Linton, 1890. Results were based on a phylogenetic hypothesis for 74 COI sequences and morphological analysis of over 400 specimens. Cestodes studied were obtained from 888 individual potamotrygonids, representing 14 recognized and 18 potentially undescribed species from most river systems of South America. Results: Morphological species boundaries were based mainly on microthrix characters observed with scanning electron microscopy, and were supported by COI data. Four species were recognized, including two redescribed (Rhinebothrium copianullum and R. paratrygoni), and two newly described (R. brooksi n. sp. and R. fulbrighti n. sp.). Rhinebothrium paranaensis Menoret & Ivanov, 2009 is considered a junior synonym of R. paratrygoni because the morphological features of the two species overlap substantially. The diagnosis of Rhinebothrium Linton, 1890 is emended to accommodate the presence of marginal longitudinal septa observed in R. copianullum and R. brooksi n. sp. Patterns of host specificity and distribution ranged from use of few host species in few river basins, to use of as many as eight host species in multiple river basins. Significance: The level of intra-specific morphological variation observed in features such as total length and number of proglottids is unparalleled among other elasmobranch cestodes. This is attributed to the large representation of host and biogeographical samples. It is unclear whether the intra-specific morphological variation observed is unique to this freshwater system. Nonetheless, caution is urged when using morphological discontinuities to delimit elasmobranch cestode species because the amount of variation encountered is highly dependent on sample size and/or biogeographical representation.	[Reyda, Florian B.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Marques, Fernando P. L.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Lab Helmintol Evolut, Sao Paulo, Brazil; [Reyda, Florian B.] SUNY Coll Oneonta, Dept Biol, Oneonta, NY 13820 USA; [Reyda, Florian B.] SUNY Coll Oneonta, Biol Field Stn, Oneonta, NY 13820 USA	University of Connecticut; Universidade de Sao Paulo; State University of New York (SUNY) System; State University of New York (SUNY) System	Reyda, FB (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	reydafb@oneonta.edu	Marques, Fernando/J-3629-2012	Marques, Fernando/0000-0002-4281-8711	National Science Foundation (NSF) [9532943, 0118882, 0818696, 0818823, 0418932]; University of Connecticut; Harvard Museum of Comparative Zoology, United States of America; Fulbright Award; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo State Government, Brazil [2003/01816-2, 2005/01299-3, 2008/09436-8]; Direct For Biological Sciences [0818823] Funding Source: National Science Foundation; Division Of Environmental Biology [0818696] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Connecticut; Harvard Museum of Comparative Zoology, United States of America; Fulbright Award; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo State Government, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was partially supported with funds from the National Science Foundation (NSF) Partnerships for Enhancing Expertise in Taxonomy grants and an NSF Planetary Biodiversity Inventories collaborative grant (DEB Nos. 9532943, 0118882, 0818696, and 0818823, respectively). This work was supported with funds from the Judith Shaw Parasitology Fund (University of Connecticut), an Ernst Mayr Travel Grant in Animal Systematics (Harvard Museum of Comparative Zoology, United States of America), an NSF Doctoral Dissertation Improvement Grant (DEB No. 0418932) to J. Caira and FR, a Fulbright Award to FR, and funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo State Government, Brazil (No. 2003/01816-2, 2005/01299-3, and 2008/09436-8) to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Blackburn TM, 1998, AM NAT, V151, P68, DOI 10.1086/286103; Boeger WA, 2003, ZOOL SCR, V32, P3, DOI 10.1046/j.1463-6409.2003.00109.x; Bristow G.A., 1981, ADV CLADISTICS, V1, P147; Brooks D.R., 1976, Journal Parasit, V62, P943, DOI 10.2307/3279188; BROOKS DR, 1992, J PARASITOL, V78, P393, DOI 10.2307/3283633; BROOKS DR, 1988, J PARASITOL, V74, P459, DOI 10.2307/3282056; BROOKS DR, 1992, J PARASITOL, V78, P588, DOI 10.2307/3283533; BROOKS DR, 1991, P BIOL SOC WASH, V104, P651; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bueno VM, 2010, THESIS U SAO PAULO S; CAIRA J N, 1990, NOAA Technical Report NMFS, P71; Caira J. N., 2001, INTERRELATIONSHIPS P, P135; CAIRA JN, 1995, J HELMINTHOL SOC W, V62, P22; Caira JN, 2001, INT J PARASITOL, V31, P960, DOI 10.1016/S0020-7519(01)00206-5; Caira JN, 2011, PLANETARY BIODIVERSI; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Campbell RA, 1999, J PARASITOL, V85, P313, DOI 10.2307/3285640; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Charvet-Almeida P, 2001, AM EL SOC 17 ANN M P; Chervy L, 2009, FOLIA PARASIT, V56, P199, DOI 10.14411/fp.2009.025; Clayton DH, 2004, SYST BIOL, V53, P165, DOI 10.1080/10635150490265102; Clopton RE, 2004, COMP PARASITOL, V71, P130, DOI 10.1654/4151; Silva João Paulo C.B. da, 2011, Pap. Avulsos Zool. (São Paulo), V51, P139, DOI 10.1590/S0031-10492011000800001; da Silva JPCB, 2011, NEOTROP ICHTHYOL, V9, P209, DOI 10.1590/S1679-62252011000100021; de Carvalho M, 2001, AM EL SOC 17 ANN M P; De Carvalho MR, 2011, ZOOTAXA, P1; Carvalho Marcelo R. de, 2011, Pap. Avulsos Zool. (São Paulo), V51, P101, DOI 10.1590/S0031-10492011000700001; de Carvalho Marcelo R., 2011, Zootaxa, V2776, P13; de Carvalho MR, 2003, CHECKLIST FRESHWATER, P22; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K., 2005, BIOESSAYS, V26, P67; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Deynat P, 2006, CR BIOL, V329, P483, DOI 10.1016/j.crvi.2006.02.003; Domingues MV, 2010, J HELMINTHOL, DOI 101017/S0022149X10000684; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Euzet L., 1994, P149; Euzet L, 1980, MEMOIRE SOC ZOOLO 40, V3, P239; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fehlauer-Ale KH, 2009, THESIS U SAO PAULO B; FROST DR, 1994, CLADISTICS, V10, P259, DOI 10.1111/j.1096-0031.1994.tb00178.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Grabert H, 1983, NAT MUS, V113, P61; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hausdorf B, 2010, SYST BIOL, V59, P491, DOI 10.1093/sysbio/syq039; Healy CJ, 2006, J PARASITOL, V92, P364, DOI 10.1645/GE-560R.1; Healy CJ, 2006, THESIS U CONNECTICUT; Healy CJ, 2009, INT J PARASITOL, V39, P497, DOI 10.1016/j.ijpara.2008.09.002; Hoberg EP, 1997, J PARASITOL, V83, P1128, DOI 10.2307/3284374; Hoberg EP, 1999, SYST PARASITOL, V42, P1, DOI 10.1023/A:1006099009495; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Ivanov VA, 2005, J PARASITOL, V91, P390, DOI 10.1645/GE-354R1; Ivanov VA, 2004, SYST PARASITOL, V58, P159, DOI 10.1023/B:SYPA.0000032933.71645.1e; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Lopez-Neyra C. R., 1958, Novedades Cientificas Museo de Historia Natural La Salle Ser Zool, VNo. 23, P1; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Luchetti NM, 2008, SYST PARASITOL, V70, P131, DOI 10.1007/s11230-008-9135-9; Lundberg John G., 1998, P13; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Marlier G., 1967, Amazoniana, V1, P91; Marques F. P. L., 2000, THESIS U TORONTO TOR; Marques FPL, 2003, J PARASITOL, V89, P994, DOI 10.1645/GE-3059; Marques FPL, 2003, ZOOL SCR, V32, P367, DOI 10.1046/j.1463-6409.2003.00111.x; Marques FPL, 2001, J PARASITOL, V87, P666, DOI 10.1645/0022-3395(2001)087[0666:ANGETI]2.0.CO;2; Marques FPL, 2011, COLLECTION DATABASE; Mayden R. L., 1997, V54, P381; MAYES MA, 1978, J PARASITOL, V64, P838, DOI 10.2307/3279513; McCormack JE, 2009, SYST BIOL, V58, P501, DOI 10.1093/sysbio/syp045; Menoret A, 2009, J PARASITOL, V95, P994, DOI 10.1645/GE-1850.1; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x; Pleijel F, 2008, MOL PHYLOGENET EVOL, V48, P369, DOI 10.1016/j.ympev.2008.03.024; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Rego A.A., 1979, Revista Brasileira de Biologia, V39, P879; REGO A A, 1976, Revista Brasileira de Biologia, V36, P941; Reyda FB, 2007, THESIS U CONNECTICUT; Reyda FB, 2008, J PARASITOL, V94, P684, DOI 10.1645/GE-1230.1; Ripplinger J, 2008, SYST BIOL, V57, P76, DOI 10.1080/10635150801898920; ROBERTS T R, 1972, Bulletin of the Museum of Comparative Zoology, V143, P117; Rosa RS, 2008, NEOTROP ICHTHYOL, V6, P1, DOI 10.1590/S1679-62252008000100001; ROSA RS, 1985, THESIS COLL WILLIAM; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; RUHNKE TR, 1994, SYST PARASITOL, V28, P65, DOI 10.1007/BF00006910; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Shibuya Akemi, 2009, Pan-American Journal of Aquatic Sciences, V4, P466; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Sites JW, 1997, CONSERV BIOL, V11, P1289, DOI 10.1046/j.1523-1739.1997.96254.x; Swofford DL, 2001, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermeij GJ, 2002, J PALEONTOL, V76, P265, DOI 10.1666/0022-3360(2002)076<0265:NMFTMO>2.0.CO;2; Waeschenbach A, 2007, MOL PHYLOGENET EVOL, V45, P311, DOI 10.1016/j.ympev.2007.03.019; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wiens JJ, 1999, ANNU REV ECOL SYST, V30, P327, DOI 10.1146/annurev.ecolsys.30.1.327; Wilkinson MJ, 2010, AMAZONIA LANDSCAPE S, P62; Williams H. H., 1969, Nytt Magasin for Zoologi, V17, P1; WILLIAMS HH, 1964, PARASITOLOGY, V54, P737, DOI 10.1017/S0031182000082743; WOODLAND W. N. F., 1934, PROC ZOOL SOC LONDON, V1934, P33; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI; Zwickl DJ, 2005, GARLI GENETIC ALGORI	116	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22604	10.1371/journal.pone.0022604	http://dx.doi.org/10.1371/journal.pone.0022604			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857936	Green Published, Green Submitted, gold			2022-12-25	WOS:000293558900020
J	Asim, M; Bin Hafeez, B; Siddiqui, IA; Gerlach, C; Patz, M; Mukhtar, H; Baniahmad, A				Asim, Mohammad; Bin Hafeez, Bilal; Siddiqui, Imtiaz Ahmad; Gerlach, Claudia; Patz, Michaela; Mukhtar, Hasan; Baniahmad, Aria			Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; C4-2; SMRT; PHOSPHORYLATION; PROMOTES; PATHWAY; AR	The activated androgen receptor (AR) promotes prostate cancer (PCa) growth. AR antagonists repress the AR by recruitment of corepressors. Not much is known about the inactivation of AR by corepressors in the presence of agonists (androgens). Here we show that the corepressor LCoR acts as an androgen-dependent corepressor that represses human PCa growth in vivo. In line with this, progressive decrease of ligand-dependent corepressor expression was observed in the PCa TRAMP mouse model with increasing age. LCoR interacts with AR and is recruited to chromatin in an androgen-induced manner. Unexpectedly, the LXXLL motif of LCoR is dispensable for interaction with the AR. Rather, the data indicate that LCoR interacts with the AR DNA binding domain on DNA. Interestingly, the interaction of LCoR with AR is inhibited by signaling pathways that are associated with androgen-independent PCa. Here we also show that the Src kinase inactivates the corepressive function of LCoR. Interfering with endogenous Src function by a dominant negative Src mutant, the growth inhibitory activity of LCoR is enhanced in vivo in a xenograft mouse model system. Thus, our studies indicate a role of LCoR as an AR corepressor and a tumor suppressor. Further, the decreased expression or in activation of LCoR is as an important step toward PCa carcinogenesis in vivo.	[Asim, Mohammad; Bin Hafeez, Bilal; Siddiqui, Imtiaz Ahmad; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA; [Gerlach, Claudia; Patz, Michaela; Baniahmad, Aria] Jena Univ Hosp, Inst Human Genet, Jena, Germany	University of Wisconsin System; University of Wisconsin Madison; Friedrich Schiller University of Jena	Mukhtar, H (corresponding author), Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.	hmukhtar@wisc.edu; aban@mti.uni-jena.de			German Research Foundation [DFG BA 1457/2]; United States Public Health Service [RO1CA78809, RO1CA101039, RO1CA120451]; O'Brian Center [P50DK065303-01]; NATIONAL CANCER INSTITUTE [R01CA101039, R01CA120451, R01CA078809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065303] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); O'Brian Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by German Research Foundation Grant DFG BA 1457/2 (to A. B.), by United States Public Health Service Grants RO1CA78809, RO1CA101039, and RO1CA120451 (to H. M.), and by O'Brian Center Grant P50DK065303-01 (to H. M.).	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Bakin RE, 2003, CANCER RES, V63, P1975; Barnes CJ, 2003, NAT STRUCT BIOL, V10, P622, DOI 10.1038/nsb957; Berrevoets CA, 2004, BIOCHEM J, V379, P731, DOI 10.1042/BJ20031456; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Eisold M, 2009, J MOL ENDOCRINOL, V42, P429, DOI 10.1677/JME-08-0084; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Liao GQ, 2003, J BIOL CHEM, V278, P5052, DOI 10.1074/jbc.M206374200; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; Moehren U, 2007, MOL ENDOCRINOL, V21, P1039, DOI 10.1210/me.2006-0468; Murillo H, 2001, CANCER RES, V61, P7408; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Taplin ME, 1999, CANCER RES, V59, P2511; Wang L, 2005, PROSTATE, V63, P117, DOI 10.1002/pros.20170	24	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37108	37117		10.1074/jbc.M111.292771	http://dx.doi.org/10.1074/jbc.M111.292771			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21856747	Green Published, hybrid			2022-12-25	WOS:000296542400011
J	Seifert, W; Kuhnisch, J; Maritzen, T; Horn, D; Haucke, V; Hennies, HC				Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Horn, Denise; Haucke, Volker; Hennies, Hans Christian			Cohen Syndrome-associated Protein, COH1, Is a Novel, Giant Golgi Matrix Protein Required for Golgi Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; ORGANELLE STRUCTURE; MENTAL-RETARDATION; RIBBON FORMATION; GRIP DOMAIN; GENE; LOCALIZATION; EXPRESSION; MUTATIONS; TRANSPORT	Loss-of-function mutations in the gene COH1, also known as VPS13B, lead to autosomal recessive Cohen syndrome. However, the cellular distribution and function of the encoded protein COH1 ( 3997 amino acids), which lacks functional homologies to other mammalian proteins, have remained enigmatic. We show here that COH1 is a peripheral Golgi membrane protein that strongly co-localizes with the cis-Golgi matrix protein GM130. Consistent with its subcellular localization, COH1 depletion using RNAi causes fragmentation of the Golgi ribbon into ministacks. Disruption of Golgi organization observed in fibroblasts from Cohen syndrome patients suggests that Golgi dysfunction contributes to Cohen syndrome pathology. In conclusion, our findings establish COH1 as a Golgi-associated matrix protein required for Golgi integrity.	[Seifert, Wenke] Charite, CCM, Inst Vegetat Anat, D-10115 Berlin, Germany; [Seifert, Wenke; Hennies, Hans Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Haucke, Volker] Charite, D-14195 Berlin, Germany; [Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Haucke, Volker] Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, D-14195 Berlin, Germany; [Kuehnisch, Jirko; Horn, Denise] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Kuehnisch, Jirko] Max Planck Inst Mol Genet, Res Grp Dev & Dis, D-14195 Berlin, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Univ Cologne, D-50674 Cologne, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Cologne; University of Cologne	Seifert, W (corresponding author), Charite, CCM, Inst Vegetat Anat, Philippstr 12, D-10115 Berlin, Germany.	wenke.seifert@charite.de	Kühnisch, Jirko/L-7761-2013; Seifert, Wenke/B-8772-2011; Kühnisch, Jirko/M-3744-2019; Hennies, Hans C/G-9424-2014	Kühnisch, Jirko/0000-0003-4744-5421; Hennies, Hans C/0000-0001-7210-2389; Haucke, Volker/0000-0003-3119-6993; Seifert, Wenke/0000-0003-1432-9862; Maritzen, Tanja/0000-0003-4993-0340	Deutsche Forschungsgemeinschaft; Charite Universitatsmedizin Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Charite Universitatsmedizin Berlin	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to T. M., V. H., D. H., and H. C. H.) and a studentship from the Charite Universitatsmedizin Berlin (to W. S.).	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Brown DL, 2001, TRAFFIC, V2, P336, DOI 10.1034/j.1600-0854.2001.002005336.x; COHEN MM, 1973, J PEDIATR-US, V83, P280; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; de Figueiredo P, 1999, MOL BIOL CELL, V10, P1763, DOI 10.1091/mbc.10.6.1763; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; El Chehadeh S, 2010, J MED GENET, V47, P549, DOI 10.1136/jmg.2009.075028; El Chehadeh-Djebbar S., 2011, J MED GENET IN PRESS; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Hennies HC, 2004, AM J HUM GENET, V75, P138, DOI 10.1086/422219; Horn D, 2000, AM J MED GENET, V92, P285, DOI 10.1002/(SICI)1096-8628(20000605)92:4<285::AID-AJMG13>3.3.CO;2-4; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kivitie-Kallio S, 1998, NEUROPEDIATRICS, V29, P298, DOI 10.1055/s-2007-973581; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kolehmainen J, 1997, EUR J HUM GENET, V5, P206, DOI 10.1159/000484765; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Mochida GH, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014779; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Parri V, 2010, EUR J HUM GENET, V18, P1133, DOI 10.1038/ejhg.2010.59; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Redding K, 1996, MOL CELL BIOL, V16, P6208; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; Seifert W, 2009, HUM MUTAT, V30, pE404, DOI 10.1002/humu.20886; Short B, 2003, CURR BIOL, V13, pR311, DOI 10.1016/S0960-9822(03)00234-3; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012	36	76	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37665	37675		10.1074/jbc.M111.267971	http://dx.doi.org/10.1074/jbc.M111.267971			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21865173	hybrid, Green Published			2022-12-25	WOS:000296542400063
J	Rahaman, SO; Zhou, G; Silverstein, RL				Rahaman, S. Ohidar; Zhou, Gang; Silverstein, Roy L.			Vav Protein Guanine Nucleotide Exchange Factor Regulates CD36 Protein-mediated Macrophage Foam Cell Formation via Calcium and Dynamin-dependent Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; LOW-DENSITY-LIPOPROTEIN; T-CELLS; ACTIN CYTOSKELETON; MEMBRANE FISSION; OXIDATIVE BURST; REQUIRE VAV; ACTIVATION; FAMILY; MICE	Background: The scavenger receptor CD36 is known to activate Vav proteins, which function as GEFs for Rho GTPases and scaffolds for assembly of various signaling proteins. Results: CD36-dependent activation of Vav proteins in macrophages by oxidized phospholipids was shown to trigger lipid uptake and foam cell formation by activating dynamin 2 and generating calcium signals. Conclusion: Vav family GEFs regulate CD36-mediated oxLDL uptake and foam cell formation via calcium and dynamin 2-dependent processes. Significance: Results from these studies will have therapeutic interest because small chemical inhibitors of dynamin GTPase activity or calcium antagonists may be useful as potential anti-atherosclerotic reagents.	[Rahaman, S. Ohidar; Zhou, Gang; Silverstein, Roy L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Silverstein, Roy L.] Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Rahaman, SO (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA.	rahamao@ccf.org; silverr2@ccf.org			National Institutes of Health [HL087018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL087018.	Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Etzion Y, 2009, CIRC RES, V105, P148, DOI 10.1161/CIRCRESAHA.109.195818; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Henry P. D., 1990, AM J CARDIOL, V66, p3I; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Kasri NN, 2006, J BIOL CHEM, V281, P8332, DOI 10.1074/jbc.M510971200; Koncz G, 2008, CELL DEATH DIFFER, V15, P494, DOI 10.1038/sj.cdd.4402282; LEW PD, 1980, J BIOL CHEM, V255, P5841; MacDonald PE, 2005, J CELL SCI, V118, P5911, DOI 10.1242/jcs.02685; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Moller A, 2001, J BIOL CHEM, V276, P20022, DOI 10.1074/jbc.M011139200; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Phillipson M, 2009, J IMMUNOL, V182, P6870, DOI 10.4049/jimmunol.0803414; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rahaman SO, 2011, J BIOL CHEM, V286, P7010, DOI 10.1074/jbc.M110.192450; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Spurrell DR, 2009, J IMMUNOL, V183, P310, DOI 10.4049/jimmunol.0802096; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; van Tits LJH, 2000, FREE RADICAL BIO MED, V29, P747, DOI 10.1016/S0891-5849(00)00372-5; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wells CM, 2005, EXP CELL RES, V310, P303, DOI 10.1016/j.yexcr.2005.07.015; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Zhao ZZ, 2005, ARTERIOSCL THROM VAS, V25, P168, DOI 10.1161/01.ATV.0000149145.00865.d9; Zhou Z, 2007, J BIOL CHEM, V282, P23737, DOI 10.1074/jbc.M702975200	38	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36011	36019		10.1074/jbc.M111.265082	http://dx.doi.org/10.1074/jbc.M111.265082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21865158	Green Published, hybrid			2022-12-25	WOS:000295927100074
J	Devera, TS; Joshi, SK; Aye, LM; Lang, GA; Ballard, JD; Lang, ML				Devera, T. Scott; Joshi, Sunil K.; Aye, Lindsay M.; Lang, Gillian A.; Ballard, Jimmy D.; Lang, Mark L.			Regulation of Anthrax Toxin-Specific Antibody Titers by Natural Killer T Cell-Derived IL-4 and IFN gamma	PLOS ONE			English	Article							PROTECTIVE-ANTIGEN; BACILLUS-ANTHRACIS; LETHAL TOXIN; ALPHA-GALACTOSYLCERAMIDE; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; NKT CELLS; VACCINE ADJUVANT; NOD MICE; MECHANISMS	Activation of Natural Killer-like T cells (NKT) with the CD1d ligand alpha-GC leads to enhanced production of anthrax toxin protective Ag (PA)-neutralizing Abs, yet the underlying mechanism for this adjuvant effect is not known. In the current study we examined the role of Th1 and Th2 type responses in NKT-mediated enhancement of antibody responses to PA. First, the contribution of IL-4 and IFN gamma to the production of PA-specific toxin-neutralizing Abs was examined. By immunizing C57Bl/6 controls IL-4(-/-) mice and IFN gamma(-/-) mice and performing passive serum transfer experiments, it was observed that sera containing PA-specific IgG1, IgG2b and IgG2c neutralized toxin in vitro and conferred protection in vivo. Sera containing IgG2b and IgG2c neutralized toxin in vitro but were not sufficient for protection in vivo. Sera containing IgG1 and IgG2b neutralized toxin in vitro and conferred protection in vivo. IgG1 therefore emerged as a good correlate of protection. Next, C57Bl/6 mice were immunized with PA alone or PA plus a Th2-skewing alpha-GC derivative known as OCH. Neutralizing PA-specific IgG1 responses were modestly enhanced by OCH in C57Bl/6 mice. Conversely, IgG2b and IgG2c were considerably enhanced in PA/OCH-immunized IL-4(-/-) mice but did not confer protection. Finally, bone marrow chimeras were generated such that NKT cells were unable to express IL-4 or IFN gamma. NKT-derived IL-4 was required for OCH-enhanced primary IgG1 responses but not recall responses. NKT-derived IL-4 and IFN gamma also influenced primary and recall IgG2b and IgG2c titers. These data suggest targeted skewing of the Th2 response by alpha-GC derivatives can be exploited to optimize anthrax vaccination.	[Devera, T. Scott; Joshi, Sunil K.; Aye, Lindsay M.; Lang, Gillian A.; Ballard, Jimmy D.; Lang, Mark L.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Devera, TS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	mark-lang@ouhsc.edu			Defense Threat Reduction Agency (DTRA) [HDTRA1-08-C-0013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Defense Threat Reduction Agency (DTRA) contract HDTRA1-08-C-0013 to MLL. Approval for public release of the information herein was required and obtained from DTRA prior to submission of the manuscript. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Abboud N, 2008, CLIN VACCINE IMMUNOL, V15, P1115, DOI 10.1128/CVI.00015-08; Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Belperron AA, 2005, J IMMUNOL, V174, P5681, DOI 10.4049/jimmunol.174.9.5681; Boyaka PN, 2003, J IMMUNOL, V170, P5636, DOI 10.4049/jimmunol.170.11.5636; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Devera TS, 2008, EUR J IMMUNOL, V38, P1001, DOI 10.1002/eji.200738000; Devera TS, 2010, INFECT IMMUN, V78, P1610, DOI 10.1128/IAI.00002-10; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Joshi SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000588; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lang GA, 2004, IMMUNOLOGY, V112, P386, DOI 10.1111/j.1365-2567.2004.01896.x; Lang GA, 2008, BLOOD, V111, P2158, DOI 10.1182/blood-2007-10-117309; Lang GA, 2006, IMMUNOLOGY, V119, P116, DOI 10.1111/j.1365-2567.2006.02413.x; LEPPLA SH, 1984, ADV CYCLIC NUCL PROT, V17, P189; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mizuno M, 2004, J AUTOIMMUN, V23, P293, DOI 10.1016/j.jaut.2004.09.008; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Mohamed N, 2004, INFECT IMMUN, V72, P3276, DOI 10.1128/IAI.72.6.3276-3283.2004; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nguyen ML, 2009, INFECT IMMUN, V77, P4714, DOI 10.1128/IAI.00749-09; Nguyen ML, 2009, INFECT IMMUN, V77, P162, DOI 10.1128/IAI.00788-08; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park YS, 2008, INFECT IMMUN, V76, P1952, DOI 10.1128/IAI.01722-07; Peachman KK, 2006, INFECT IMMUN, V74, P794, DOI 10.1128/IAI.74.1.794-797.2006; Pittman PR, 2005, CLIN DIAGN LAB IMMUN, V12, P713, DOI 10.1128/CDLI.12.6.713-721.2005; Quinn CP, 2004, J INFECT DIS, V190, P1228, DOI 10.1086/423937; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Salles II, 2006, CELL MICROBIOL, V8, P1272, DOI 10.1111/j.1462-5822.2006.00708.x; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; Williamson ED, 1999, J APPL MICROBIOL, V87, P315, DOI 10.1046/j.1365-2672.1999.00901.x	40	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23817	10.1371/journal.pone.0023817	http://dx.doi.org/10.1371/journal.pone.0023817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858226	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300097
J	Gardner, AF; Guan, C; Jack, WE				Gardner, Andrew F.; Guan, Chudi; Jack, William E.			Biochemical Characterization of a Structure-Specific Resolving Enzyme from Sulfolobus islandicus Rod-Shaped Virus 2	PLOS ONE			English	Article							HOLLIDAY JUNCTION RESOLVASE; BACTERIOPHAGE-T7 ENDONUCLEASE-I; BRANCHED DNA-STRUCTURE; PYROCOCCUS-FURIOSUS; T7 ENDONUCLEASE; VACCINIA VIRUS; CLEAVAGE; RESOLUTION; GENOME; HJC	Sulfolobus islandicus rod shaped virus 2 (SIRV2) infects the archaeon Sulfolobus islandicus at extreme temperature (70 degrees C-80 degrees C) and acidity (pH 3). SIRV2 encodes a Holliday junction resolving enzyme (SIRV2 Hjr) that has been proposed as a key enzyme in SIRV2 genome replication. The molecular mechanism for SIRV2 Hjr four-way junction cleavage bias, minimal requirements for four-way junction cleavage, and substrate specificity were determined. SIRV2 Hjr cleaves four-way DNA junctions with a preference for cleavage of exchange strand pairs, in contrast to host-derived resolving enzymes, suggesting fundamental differences in substrate recognition and cleavage among closely related Sulfolobus resolving enzymes. Unlike other viral resolving enzymes, such as T4 endonuclease VII or T7 endonuclease I, that cleave branched DNA replication intermediates, SIRV2 Hjr cleavage is specific to four-way DNA junctions and inactive on other branched DNA molecules. In addition, a specific interaction was detected between SIRV2 Hjr and the SIRV2 virion body coat protein (SIRV2gp26). Based on this observation, a model is proposed linking SIRV2 Hjr genome resolution to viral particle assembly.	[Gardner, Andrew F.; Guan, Chudi; Jack, William E.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Gardner, AF (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	gardner@neb.com			New England Biolabs, Inc	New England Biolabs, Inc	This work was supported by New England Biolabs, Inc (www.neb.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annamalai P, 2008, J VIROL, V82, P1484, DOI 10.1128/JVI.01540-07; BALTIMORE D, 1969, BIOCH VIRUSES, P101; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Birkenbihl RP, 2001, J MOL BIOL, V309, P1067, DOI 10.1006/jmbi.2001.4761; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Blum H, 2001, VIROLOGY, V281, P6, DOI 10.1006/viro.2000.0776; Bond CS, 2001, P NATL ACAD SCI USA, V98, P5509, DOI 10.1073/pnas.091613398; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Culyba MJ, 2007, J BIOL CHEM, V282, P34644, DOI 10.1074/jbc.M705322200; Culyba MJ, 2006, VIROLOGY, V352, P466, DOI 10.1016/j.virol.2006.05.007; Culyba MJ, 2009, J BIOL CHEM, V284, P1190, DOI 10.1074/jbc.M807864200; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; DICKIE P, 1987, J BIOL CHEM, V262, P14826; Dorazi R, 2006, J MOL BIOL, V364, P243, DOI 10.1016/j.jmb.2006.09.011; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Grubisha O, 2003, J VIROL, V77, P10929, DOI 10.1128/JVI.77.20.10929-10942.2003; Guan C, 2005, NUCLEIC ACIDS RES, V33, P6225, DOI 10.1093/nar/gki921; Hadden JM, 2007, NATURE, V449, P621, DOI 10.1038/nature06158; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; KEMPER B, 1976, J VIROL, V18, P1000, DOI 10.1128/JVI.18.3.1000-1015.1976; KEMPER B, 1997, BIOCH GENETICS CELL, P179; Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001; KOERNER JF, 1979, MICROBIOL REV, V43, P199, DOI 10.1128/MMBR.43.2.199-223.1979; Komori K, 1999, P NATL ACAD SCI USA, V96, P8873, DOI 10.1073/pnas.96.16.8873; Komori K, 2000, NUCLEIC ACIDS RES, V28, P4544, DOI 10.1093/nar/28.22.4544; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Kvaratskhelia M, 2000, J BIOL CHEM, V275, P25540, DOI 10.1074/jbc.M003420200; Kvaratskhelia M, 2000, J MOL BIOL, V297, P923, DOI 10.1006/jmbi.2000.3624; Kvaratskhelia M, 2001, FEBS LETT, V491, P243, DOI 10.1016/S0014-5793(01)02200-1; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057x; Mansky LM, 1998, J VIROL, V72, P3196, DOI 10.1128/JVI.72.4.3196-3204.1998; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; McBride MS, 1997, J VIROL, V71, P4544, DOI 10.1128/JVI.71.6.4544-4554.1997; Middleton CL, 2004, NUCLEIC ACIDS RES, V32, P5442, DOI 10.1093/nar/gkh869; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; MULLER B, 1990, NUCLEIC ACIDS RES, V18, P5633, DOI 10.1093/nar/18.19.5633; MURCHIE AIH, 1991, EMBO J, V10, P713, DOI 10.1002/j.1460-2075.1991.tb08001.x; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Neef K, 2002, EXTREMOPHILES, V6, P359, DOI 10.1007/s00792-002-0265-8; Parker JL, 2005, J MOL BIOL, V350, P1, DOI 10.1016/j.jmb.2005.04.056; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; PICKSLEY SM, 1990, J MOL BIOL, V212, P723, DOI 10.1016/0022-2836(90)90233-C; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; White MF, 1997, J MOL BIOL, V269, P647, DOI 10.1006/jmbi.1997.1097; Zeffman A, 2000, J MOL BIOL, V297, P877, DOI 10.1006/jmbi.2000.3611	49	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23668	10.1371/journal.pone.0023668	http://dx.doi.org/10.1371/journal.pone.0023668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858199	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300078
J	Janzen, DH; Hallwachs, W; Burns, JM; Hajibabaei, M; Bertrand, C; Hebert, PDN				Janzen, Daniel H.; Hallwachs, Winnie; Burns, John M.; Hajibabaei, Mehrdad; Bertrand, Claudia; Hebert, Paul D. N.			Reading the Complex Skipper Butterfly Fauna of One Tropical Place	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; DNA BARCODES; SWEEP SAMPLES; FOLIAGE INSECTS; HESPERIIDAE; GENUS; BIODIVERSITY; INTEGRATION; INVENTORY; GENITALIA	Background: An intense, 30-year, ongoing biodiversity inventory of Lepidoptera, together with their food plants and parasitoids, is centered on the rearing of wild-caught caterpillars in the 120,000 terrestrial hectares of dry, rain, and cloud forest of Area de Conservacion Guanacaste (ACG) in northwestern Costa Rica. Since 2003, DNA barcoding of all species has aided their identification and discovery. We summarize the process and results for a large set of the species of two speciose subfamilies of ACG skipper butterflies (Hesperiidae) and emphasize the effectiveness of barcoding these species (which are often difficult and time-consuming to identify). Methodology/Principal Findings: Adults are DNA barcoded by the Biodiversity Institute of Ontario, Guelph, Canada; and they are identified by correlating the resulting COI barcode information with more traditional information such as food plant, facies, genitalia, microlocation within ACG, caterpillar traits, etc. This process has found about 303 morphologically defined species of eudamine and pyrgine Hesperiidae breeding in ACG (about 25% of the ACG butterfly fauna) and another 44 units indicated by distinct barcodes (n = 9,094), which may be additional species and therefore may represent as much as a 13% increase. All but the members of one complex can be identified by their DNA barcodes. Conclusions/Significance: Addition of DNA barcoding to the methodology greatly improved the inventory, both through faster (hence cheaper) accurate identification of the species that are distinguishable without barcoding, as well as those that require it, and through the revelation of species "hidden" within what have long been viewed as single species. Barcoding increased the recognition of species-level specialization. It would be no more appropriate to ignore barcode data in a species inventory than it would be to ignore adult genitalia variation or caterpillar ecology.	[Janzen, Daniel H.; Hallwachs, Winnie] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Burns, John M.] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Hajibabaei, Mehrdad; Bertrand, Claudia; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Pennsylvania; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Guelph	Janzen, DH (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	djanzen@sas.upenn.edu	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	National Museum of Natural History Small Grants Program; U.S. National Science Foundation [BSR 9024770, DEB 9306296, 9400829, 9705072, 0072730, 0515699]; Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania; Gordon and Betty Moore Foundation; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program	National Museum of Natural History Small Grants Program; U.S. National Science Foundation(National Science Foundation (NSF)); Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs)	This research was supported by the National Museum of Natural History Small Grants Program (J.M.B.); U.S. National Science Foundation grants BSR 9024770 and DEB 9306296, 9400829, 9705072, 0072730, and 0515699, and grants from the Wege Foundation, International Conservation Fund of Canada, Jessie B. Cox Charitable Trust, Blue Moon Fund, Guanacaste Dry Forest Conservation Fund, Area de Conservacion Guanacaste, and University of Pennsylvania (D.H.J.); and the Gordon and Betty Moore Foundation, the Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chairs program (P.D.N.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Burns John M., 2005, Journal of the Lepidopterists' Society, V59, P19; Burns John M., 1996, Journal of the Lepidopterists' Society, V50, P173; Burns John M., 2001, Journal of the Lepidopterists' Society, V55, P15; Burns John M., 1999, Journal of the Lepidopterists' Society, V53, P77; Burns JM, 2010, J LEPID SOC, V64, P69; Burns JM, 2010, P ENTOMOL SOC WASH, V112, P32, DOI 10.4289/0013-8797-112.1.32; Burns JM, 2009, J LEPID SOC, V63, P141; CHACON IA, 2007, MARIPOSAS COSTA RICA; DEVRIES PJ, 1997, BUTTERFLIES COSTA RI, V2; DEVRIES PJ, 1987, BUTTERFLIES COSTA RI, V1, P327; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Greeney H, 2003, J RES LEPIDOPTERA, V37, P27; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; JANZEN D H, 1976, Biotropica, V8, P193, DOI 10.2307/2989685; Janzen D. H., 2000, Biodiversity, V1, P7; JANZEN D H, 1976, Revista de Biologia Tropical, V24, P149; Janzen Daniel H., 1997, P251; Janzen Daniel H., 1993, P448; Janzen Daniel H., 2002, P559; Janzen DH, 2010, P NATL ACAD SCI USA, V107, P11659, DOI 10.1073/pnas.0912122107; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; JANZEN DH, 1973, ECOLOGY, V54, P687, DOI 10.2307/1935359; JANZEN DH, 1987, INSECT SCI APPL, V8, P489, DOI 10.1017/S1742758400022530; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; JANZEN DH, 1973, ECOLOGY, V54, P659, DOI 10.2307/1935358; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; JANZEN DH, 1987, OIKOS, V48, P3, DOI 10.2307/3565679; JANZEN DH, 1975, T ROY ENT SOC LONDON, V127, P33; JANZEN DH, 1988, REHABILITATING DAMAG, P143; JANZEN DH, 1996, ASC NEWSLETTER, V24, P45; JANZEN DH, 1996, ASS SYSTEMATICS COLL, V24, P49; JANZEN DH, COSTA RICAN NATURAL, P816; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Miller J. S., 1997, Tropical Lepidoptera, V8, P81; Miller JC, 2006, 100 CATERPILLARS; MILLER JC, 2007, 100 BUTTERFLIES MOTH; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pelham Jonathan P., 2008, Journal of Research on the Lepidoptera, V40; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stoeckle MY, 2008, SCI AM, V299, P82; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Warren AD, 2009, SYST ENTOMOL, V34, P467, DOI 10.1111/j.1365-3113.2008.00463.x	51	39	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e19874	10.1371/journal.pone.0019874	http://dx.doi.org/10.1371/journal.pone.0019874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857895	Green Submitted, Green Published, gold			2022-12-25	WOS:000294125500002
J	Nelson, A; Chomitz, KM				Nelson, Andrew; Chomitz, Kenneth M.			Effectiveness of Strict vs. Multiple Use Protected Areas in Reducing Tropical Forest Fires: A Global Analysis Using Matching Methods	PLOS ONE			English	Article							LAND-USE; PARKS; DEFORESTATION; LOCATION; IMPACT; BIODIVERSITY; EMISSIONS; RESERVES; WORLDS; ROADS	Protected areas (PAs) cover a quarter of the tropical forest estate. Yet there is debate over the effectiveness of PAs in reducing deforestation, especially when local people have rights to use the forest. A key analytic problem is the likely placement of PAs on marginal lands with low pressure for deforestation, biasing comparisons between protected and unprotected areas. Using matching techniques to control for this bias, this paper analyzes the global tropical forest biome using forest fires as a high resolution proxy for deforestation; disaggregates impacts by remoteness, a proxy for deforestation pressure; and compares strictly protected vs. multiple use PAs vs indigenous areas. Fire activity was overlaid on a 1 km map of tropical forest extent in 2000; land use change was inferred for any point experiencing one or more fires. Sampled points in pre-2000 PAs were matched with randomly selected never-protected points in the same country. Matching criteria included distance to road network, distance to major cities, elevation and slope, and rainfall. In Latin America and Asia, strict PAs substantially reduced fire incidence, but multi-use PAs were even more effective. In Latin America, where there is data on indigenous areas, these areas reduce forest fire incidence by 16 percentage points, over two and a half times as much as naive (unmatched) comparison with unprotected areas would suggest. In Africa, more recently established strict PAs appear to be effective, but multi-use tropical forest protected areas yield few sample points, and their impacts are not robustly estimated. These results suggest that forest protection can contribute both to biodiversity conservation and CO2 mitigation goals, with particular relevance to the REDD agenda. Encouragingly, indigenous areas and multi-use protected areas can help to accomplish these goals, suggesting some compatibility between global environmental goals and support for local livelihoods.	[Nelson, Andrew] Int Rice Res Inst, Manila, Philippines; [Chomitz, Kenneth M.] World Bank, Independent Evaluat Grp, Washington, DC 20433 USA	CGIAR; International Rice Research Institute (IRRI); The World Bank	Nelson, A (corresponding author), Int Rice Res Inst, Manila, Philippines.	kchomitz@worldbank.org	Nelson, Andy/G-3649-2012	Nelson, Andy/0000-0002-7249-3778	Evaluation Department of the Norwegian Agency for Development Cooperation (Norad)	Evaluation Department of the Norwegian Agency for Development Cooperation (Norad)	This work was undertaken at the World Bank Group's Independent Evaluation Group and was supported in part by the Evaluation Department of the Norwegian Agency for Development Cooperation (Norad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; [Anonymous], 2009, SCIENCE, V323, P19; Applegate G, 2001, UNDERLYING CAUSES IM; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bonham CA, 2008, BIODIVERS CONSERV, V17, P1581, DOI 10.1007/s10531-008-9368-6; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Chomitz KM, 2002, CLIM POLICY, V2, P35, DOI 10.1016/S1469-3062(02)00011-6; Chomitz KM, 2007, AT LOGGERHEADS: AGRICULTURAL EXPANSION, POVERTY REDUCTION, AND ENVIRONMENT IN THE TROPICAL FORESTS, P1, DOI 10.1596/978-0-8213-6735-3; Chomitz KM, 1996, WORLD BANK ECON REV, V10, P487, DOI 10.1093/wber/10.3.487; Chomitz KM, 2003, AM J AGR ECON, V85, P1016, DOI 10.1111/1467-8276.00504; Chowdhury J. A., 2006, BETTER FOREST MANAGE; CIESIN, 2004, GLOB RUR URB MAPP PR; Coad L, 2008, STATE WORLDS PROTECT; Cropper M, 2001, LAND ECON, V77, P172, DOI 10.2307/3147088; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dudley N, GUIDELINES APPL PROT; FAO, 2008, UN COLL PROGR RED EM; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Ferraro Paul J., 2006, PLOS BIOL       0411; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gaveau DLA, 2009, BIOL CONSERV, V142, P597, DOI 10.1016/j.biocon.2008.11.024; Gaveau DL, 2009, ENVIRON RES LETT, V4, P1; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Gorenflo LJ, 2011, ECOL STUD-ANAL SYNTH, V214, P197, DOI 10.1007/978-3-642-16707-2_11; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hansen MC, 2003, EARTH INTERACT, V7; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; HIJMANS R, 2008, GLOBAL ADM AREAS VER; Ho DE, 2007, POLIT ANAL, pmp1013; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Joppa LN, 2010, P ROYAL SOC B; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; LEADERWILLIAMS N, 1990, SCI PROGRESS-UK, V74, P189; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Morgan SL, 2006, SOCIOL METHOD RES, V35, P3, DOI 10.1177/0049124106289164; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nelson A., 2006, CODATA SCI J, V5, P223, DOI [DOI 10.2481/dsj.5.223, DOI 10.2481/DSJ.5.223]; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Sanchez-Azofeifa GA, 2003, BIOL CONSERV, V109, P123, DOI 10.1016/S0006-3207(02)00145-3; SCHENKER N, 1985, J AM STAT ASSOC, V80, P360, DOI 10.2307/2287897; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Sekhon JS, 2007, J STAT SOFTWARE; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Southworth J, 2006, APPL GEOGR, V26, P87, DOI 10.1016/j.apgeog.2005.11.001; Southworth J, 2004, APPL GEOGR, V24, P303, DOI 10.1016/j.apgeog.2004.07.003; Stott P, 2000, PROG PHYS GEOG, V24, P355, DOI 10.1177/030913330002400303; Tang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019116; UNEP/IUCN, 2009, PROT AR EXTR 2009 WO; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308	65	260	265	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22722	10.1371/journal.pone.0022722	http://dx.doi.org/10.1371/journal.pone.0022722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810KZ	21857950	Green Published, gold			2022-12-25	WOS:000294125500012
J	Wang, S; Yang, S; An, BY; Wang, SC; Yin, YJ; Lu, Y; Xu, Y; Hao, DY				Wang, Shan; Yang, Shuo; An, Baiyi; Wang, Shichen; Yin, Yuejia; Lu, Yang; Xu, Ying; Hao, Dongyun			Molecular Dynamics Analysis Reveals Structural Insights into Mechanism of Nicotine N-Demethylation Catalyzed by Tobacco Cytochrome P450 Mono-Oxygenase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ACTIVE-SITE; HETEROLOGOUS EXPRESSION; ACCESS CHANNELS; RESOLUTION; SIMULATION; BINDING; MODEL; 3A4; CRYSTALLOGRAPHY	CYP82E4, a cytochrome P450 monooxygenase, has nicotine N-demethylase (NND) activity, which mediates the bioconversion of nicotine into nornicotine in senescing tobacco leaves. Nornicotine is a precursor of the carcinogen, tobacco-specific nitrosamine. CYP82E3 is an ortholog of CYP82E4 with 95% sequence identity, but it lacks NND activity. A recent site-directed mutagenesis study revealed that a single amino acid substitution, i.e., cysteine to tryptophan at the 330 position in the middle of protein, restores the NND activity of CYP82E3 entirely. However, the same amino acid change caused the loss of the NND activity of CYP82E4. To determine the mechanism of the functional turnover of the two molecules, four 3D structures, i.e., the two molecules and their corresponding cys-trp mutants were modeled. The resulting structures exhibited that the mutation site is far from the active site, which suggests that no direct interaction occurs between the two sites. Simulation studies in different biological scenarios revealed that the mutation introduces a conformation drift with the largest change at the F-G loop. The dynamics trajectories analysis using principal component analysis and covariance analysis suggests that the single amino acid change causes the opening and closing of the transfer channels of the substrates, products, and water by altering the motion of the F-G and B-C loops. The motion of helix I is also correlated with the motion of both the F-G loop and the B-C loop and; the single amino acid mutation resulted in the curvature of helix I. These results suggest that the single amino acid mutation outside the active site region may have indirectly mediated the flexibility of the F-G and B-C loops through helix I, causing a functional turnover of the P450 monooxygenase.	[Wang, Shan; Yang, Shuo; An, Baiyi; Lu, Yang; Hao, Dongyun] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Peoples R China; [Wang, Shichen; Yin, Yuejia; Hao, Dongyun] Jilin Acad Agr Sci, Biotechnol Res Ctr, Changchun, Peoples R China; [Xu, Ying] Univ Georgia, Computat Syst Biol Lab, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Jilin University; Jilin Academy of Agricultural Sciences; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University	Wang, S (corresponding author), Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Peoples R China.	dyhao@cjaas.com			National High-Technology R&D Program of China [2007AA10Z110, 2007AA021307]; Jilin University [200903094]; Structure Prediction of Helical Transmembrane Proteins (NIH) [1R01GM075331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	National High-Technology R&D Program of China; Jilin University(Jilin University); Structure Prediction of Helical Transmembrane Proteins (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was financially supported by the National High-Technology R&D Program of China (Grant No. 2007AA10Z110) (Grant No. 2007AA021307), Scientific Forefront and Interdisciplinary Innovation Project, Jilin University (Grant No. 200903094), and Structure Prediction of Helical Transmembrane Proteins (NIH 1R01GM075331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Baudry B, 2005, IEEE SOFTWARE, V22, P76, DOI 10.1109/MS.2005.30; Billeter S.R., 1996, GROMOS96 MANUAL USER; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; de Graaf C, 2007, CURR DRUG METAB, V8, P59, DOI 10.2174/138920007779315062; Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612; Domanski TL, 2001, ARCH BIOCHEM BIOPHYS, V394, P21, DOI 10.1006/abbi.2001.2504; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gavilano LB, 2007, J BIOL CHEM, V282, P249, DOI 10.1074/jbc.M609512200; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HECHT SS, 1989, CANCER SURV, V8, P273; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Kemp CA, 2005, ARCH BIOCHEM BIOPHYS, V433, P361, DOI 10.1016/j.abb.2004.08.026; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lauria A, 2009, COMPUT BIOL CHEM, V33, P386, DOI 10.1016/j.compbiolchem.2009.07.010; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; LUNDEMANN SK, 2000, J MOL BIOL, V303, P797; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott EE, 2004, ARCH BIOCHEM BIOPHYS, V423, P266, DOI 10.1016/j.abb.2003.12.035; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Tang L, 2000, SCIENCE, V287, P640, DOI 10.1126/science.287.5453.640; TELEMAN O, 1987, MOL PHYS, V60, P193, DOI 10.1080/00268978700100141; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wade RC, 2004, J INORG BIOCHEM, V98, P1175, DOI 10.1016/j.jinorgbio.2004.02.007; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; XU J, 2005, BIOINFORMATICS, V26, P889; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; [No title captured], DOI DOI 10.1038/NBT0795-658	46	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23342	10.1371/journal.pone.0023342	http://dx.doi.org/10.1371/journal.pone.0023342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858078	Green Published, gold, Green Submitted			2022-12-25	WOS:000294125500028
J	Larriba, MJ; Ordonez-Moran, P; Chicote, I; Martin-Fernandez, G; Puig, I; Munoz, A; Palmer, HG				Jesus Larriba, Maria; Ordonez-Moran, Paloma; Chicote, Irene; Martin-Fernandez, Genesis; Puig, Isabel; Munoz, Alberto; Palmer, Hector G.			Vitamin D Receptor Deficiency Enhances Wnt/beta-Catenin Signaling and Tumor Burden in Colon Cancer	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; E-CADHERIN; WNT; EXPRESSION; GROWTH; DIFFERENTIATION; PHENOTYPE; APC; PHOSPHORYLATION	Aberrant activation of the Wnt/beta-catenin pathway is critical for the initiation and progression of most colon cancers. This activation provokes the accumulation of nuclear beta-catenin and the induction of its target genes. Apc(min/+) mice are the most commonly used model for colon cancer. They harbor a mutated Apc allele and develop intestinal adenomas and carcinomas during the first months of life. This phenotype is caused by the mutation of the second Apc allele and the consequent accumulation of nuclear beta-catenin in the affected cells. Here we describe that vitamin D receptor (VDR) is a crucial modulator of nuclear beta-catenin levels in colon cancer in vivo. By appropriate breeding of Apc(min/+) mice and Vdr(+/-) mice we have generated animals expressing a mutated Apc allele and two, one, or none Vdr wild type alleles. Lack of Vdr increased the number of colonic Aberrant Crypt Foci (ACF) but not that of adenomas or carcinomas in either small intestine or colon. Importantly, colon ACF and tumors of Apc(min/+) Vdr(-/-) mice had increased nuclear beta-catenin and the tumors reached a larger size than those of Apc(min/+) Vdr(+/+). Both ACF and carcinomas in Apc(min/+) Vdr(-/-) mice showed higher expression of beta-catenin/TCF target genes. In line with this, VDR knock-down in cultured human colon cancer cells enhanced beta-catenin nuclear content and target gene expression. Consistently, VDR depletion abrogated the capacity of 1,25(OH)(2)D-3 to promote the relocation of beta-catenin from the nucleus to the plasma membrane and to inhibit beta-catenin/TCF target genes. In conclusion, VDR controls the level of nuclear beta-catenin in colon cancer cells and can therefore attenuate the impact of oncogenic mutations that activate the Wnt/beta-catenin pathway.	[Jesus Larriba, Maria; Ordonez-Moran, Paloma; Martin-Fernandez, Genesis; Munoz, Alberto] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Chicote, Irene; Puig, Isabel; Palmer, Hector G.] Vall dHebron Inst Oncol, Stem Cells & Canc Lab, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Vall d'Hebron Institut d'Oncologia (VHIO)	Larriba, MJ (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain.	hgpalmer@vhio.net	LARRIBA, MARIA JESUS/O-4652-2014; Palmer, Héctor G./AAG-8332-2019; Munoz, Alberto/O-6393-2014; Seoane, Joan/AAG-9173-2019; Ordonez-Moran, Paloma/B-6371-2016	LARRIBA, MARIA JESUS/0000-0001-9035-7414; Munoz, Alberto/0000-0003-3890-4251; Seoane, Joan/0000-0002-6541-5974; Puig Borreil, Isabel/0000-0001-5614-4298; Palmer, Hector/0000-0002-9823-5638; Martin Fernandez, Genesis/0000-0002-1052-9763; Ordonez-Moran, Paloma/0000-0001-7688-1252	Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (ISCIII) [PI081356]; Vall d'Hebron Institute of Oncology; Olga Torres Foundation; Fundacion de la Asociacion Espanola de Lucha Contra el Cancer (AECC); Ministerio de Ciencia e Innovacion [SAF2010-18302]; Red Tematica de Investigacion Cooperativa en Cancer (ISCIII) [RD06/0020/0009]	Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III); Vall d'Hebron Institute of Oncology; Olga Torres Foundation; Fundacion de la Asociacion Espanola de Lucha Contra el Cancer (AECC); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer (ISCIII)(Instituto de Salud Carlos III)	This work was supported by Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III (ISCIII, PI081356), Vall d'Hebron Institute of Oncology, Olga Torres Foundation, Fundacion de la Asociacion Espanola de Lucha Contra el Cancer (AECC), Ministerio de Ciencia e Innovacion (SAF2010-18302) and Red Tematica de Investigacion Cooperativa en Cancer (ISCIII, RD06/0020/0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Campbell MJ, 2006, EXPERT OPIN THER TAR, V10, P735, DOI 10.1517/14728222.10.5.735; Cross HS, 1996, ANTICANCER RES, V16, P2333; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Eelen G, 2007, CURR MED CHEM, V14, P1893; Egan JB, 2010, MOL CARCINOGEN, V49, P337, DOI 10.1002/mc.20603; Evans SRT, 1998, CLIN CANCER RES, V4, P1591; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Garcia SB, 2000, INT J EXP PATHOL, V81, P89, DOI 10.1046/j.1365-2613.2000.00142.x; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Huerta S, 2002, CANCER RES, V62, P741; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Larriba MJ, 2010, J STEROID BIOCHEM, V121, P106, DOI 10.1016/j.jsbmb.2010.01.014; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Larriba MJ, 2007, ENDOCR-RELAT CANCER, V14, P141, DOI 10.1677/ERC-06-0028; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Ordonez-Moran P, 2008, J CELL BIOL, V183, P697, DOI 10.1083/jcb.200803020; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Xu HB, 2010, CARCINOGENESIS, V31, P1434, DOI 10.1093/carcin/bgq098; Xu HB, 2009, MOL CARCINOGEN, V48, P758, DOI 10.1002/mc.20520; ZHENG W, 2011, INT J CANC IN PRESS	45	104	112	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23524	10.1371/journal.pone.0023524	http://dx.doi.org/10.1371/journal.pone.0023524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858154	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953700029
J	Alves, JMP; Voegtly, L; Matveyev, AV; Lara, AM; da Silva, FM; Serrano, MG; Buck, GA; Teixeira, MMG; Camargo, EP				Alves, Joao M. P.; Voegtly, Logan; Matveyev, Andrey V.; Lara, Ana M.; da Silva, Flavia Maia; Serrano, Myrna G.; Buck, Gregory A.; Teixeira, Marta M. G.; Camargo, Erney P.			Identification and Phylogenetic Analysis of Heme Synthesis Genes in Trypanosomatids and Their Bacterial Endosymbionts	PLOS ONE			English	Article							BLASTOCRITHIDIA-CULICIS; EVOLUTION; GENOME; BIOSYNTHESIS; ONCOPELTI; INSIGHTS; PROTOZOA; GROWTH	It has been known for decades that some insect-infecting trypanosomatids can survive in culture without heme supplementation while others cannot, and that this capability is associated with the presence of a betaproteobacterial endosymbiont in the flagellate's cytoplasm. However, the specific mechanisms involved in this process remained obscure. In this work, we sequence and phylogenetically analyze the heme pathway genes from the symbionts and from their hosts, as well as from a number of heme synthesis-deficient Kinetoplastida. Our results show that the enzymes responsible for synthesis of heme are encoded on the symbiont genomes and produced in close cooperation with the flagellate host. Our evidence suggests that this synergistic relationship is the end result of a history of extensive gene loss and multiple lateral gene transfer events in different branches of the phylogeny of the Trypanosomatidae.	[Alves, Joao M. P.; Voegtly, Logan; Matveyev, Andrey V.; Lara, Ana M.; Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Alves, Joao M. P.; Voegtly, Logan; Matveyev, Andrey V.; Lara, Ana M.; Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [da Silva, Flavia Maia; Teixeira, Marta M. G.; Camargo, Erney P.] Univ Sao Paulo, Dept Parasitol, ICB, Sao Paulo, Brazil	Virginia Commonwealth University; Virginia Commonwealth University; Universidade de Sao Paulo	Alves, JMP (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	jmalves@vcu.edu	Teixeira, Marta M G/B-1115-2009; Camargo, Erney/A-6765-2009; Alves, Joao M.P./G-8927-2011	Camargo, Erney/0000-0003-0011-5871; Alves, Joao M.P./0000-0001-5914-2087	National Science Foundation [0830056]; National Council for Scientific and Technological Development (CNPq); Flavia Maia da Silva receives a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-CNPq)	National Science Foundation(National Science Foundation (NSF)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Flavia Maia da Silva receives a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-CNPq)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been funded by grants from the National Science Foundation's Assembling the Tree of Life program (Gregory A. Buck, award #0830056), and National Council for Scientific and Technological Development (CNPq) (Marta M. G. Teixeira and Erney P. Camargo). Flavia Maia da Silva receives a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-CNPq) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilov OE, 2007, EXP DERMATOL, V16, P651, DOI 10.1111/j.1600-0625.2007.00578.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], NUCLEIC ACIDS RES S1; BEALE SI, 1975, P NATL ACAD SCI USA, V72, P2719, DOI 10.1073/pnas.72.7.2719; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CHANG KP, 1975, J PROTOZOOL, V22, P271, DOI 10.1111/j.1550-7408.1975.tb05866.x; CHANG KP, 1974, SCIENCE, V183, P531, DOI 10.1126/science.183.4124.531; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; CHANG KP, 1975, S SOC EXP BIOL, V29, P409; de Souza W, 1999, FEMS MICROBIOL LETT, V173, P1, DOI 10.1111/j.1574-6968.1999.tb13477.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kato K, 2010, P NATL ACAD SCI USA, V107, P16649, DOI 10.1073/pnas.1000771107; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LWOFF M, 1940, THESIS I PASTEUR PAR; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maslov DA, 2001, MEM I OSWALDO CRUZ, V96, P397, DOI 10.1590/S0074-02762001000300021; MOTTA MCM, 1991, CAN J ZOOL, V69, P571, DOI 10.1139/z91-086; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUNDIM MH, 1974, J PROTOZOOL, V21, P518, DOI 10.1111/j.1550-7408.1974.tb03691.x; NEWTON BA, 1956, NATURE, V177, P279, DOI 10.1038/177279b0; NEWTON BA, 1957, EXP CELL RES, V13, P563, DOI 10.1016/0014-4827(57)90086-1; NEWTON BA, 1957, J GEN MICROBIOL, V17, P708, DOI 10.1099/00221287-17-3-708; Novy FG, 1904, J INFECT DIS, V1, P1; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ozaki LS, 1984, GENES ANTIGENS PARAS, P165; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Roitman I., 1985, Parasitology Today, V1, P143, DOI 10.1016/0169-4758(85)90060-2; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; SHEMIN D, 1945, J BIOL CHEM, V159, P567; SILVA PMFE, 1991, J PROTOZOOL, V38, P489, DOI 10.1111/j.1550-7408.1991.tb04822.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; TEIXEIRA MMG, 2011, PHYLOGENETIC VALIDAT, DOI DOI 10.1016/J.PROTIS.2011.01.001; Tobey EN, 1906, J MED RES, V15, P117; UMAKI ACS, 2009, P 13 INT C PROT BUZ; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	42	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23518	10.1371/journal.pone.0023518	http://dx.doi.org/10.1371/journal.pone.0023518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853145	Green Published, gold			2022-12-25	WOS:000295454200093
J	Corfield, JR; Gsell, AC; Brunton, D; Heesy, CP; Hall, MI; Acosta, ML; Iwaniuk, AN				Corfield, Jeremy R.; Gsell, Anna C.; Brunton, Dianne; Heesy, Christopher P.; Hall, Margaret I.; Acosta, Monica L.; Iwaniuk, Andrew N.			Anatomical Specializations for Nocturnality in a Critically Endangered Parrot, the Kakapo (Strigops habroptilus)	PLOS ONE			English	Article							BINOCULAR VISUAL-FIELD; EYE SIZE; ORBIT ORIENTATION; STEATORNIS-CARIPENSIS; MOLECULAR PHYLOGENY; ACTIVITY PATTERN; BRAIN SIZE; AVIAN EYE; BIRDS; EVOLUTION	The shift from a diurnal to nocturnal lifestyle in vertebrates is generally associated with either enhanced visual sensitivity or a decreased reliance on vision. Within birds, most studies have focused on differences in the visual system across all birds with respect to nocturnality-diurnality. The critically endangered Kakapo (Strigops habroptilus), a parrot endemic to New Zealand, is an example of a species that has evolved a nocturnal lifestyle in an otherwise diurnal lineage, but nothing is known about its' visual system. Here, we provide a detailed morphological analysis of the orbits, brain, eye, and retina of the Kakapo and comparisons with other birds. Morphometric analyses revealed that the Kakapo's orbits are significantly more convergent than other parrots, suggesting an increased binocular overlap in the visual field. The Kakapo exhibits an eye shape that is consistent with other nocturnal birds, including owls and nightjars, but is also within the range of the diurnal parrots. With respect to the brain, the Kakapo has a significantly smaller optic nerve and tectofugal visual pathway. Specifically, the optic tectum, nucleus rotundus and entopallium were significantly reduced in relative size compared to other parrots. There was no apparent reduction to the thalamofugal visual pathway. Finally, the retinal morphology of the Kakapo is similar to that of both diurnal and nocturnal birds, suggesting a retina that is specialised for a crepuscular niche. Overall, this suggests that the Kakapo has enhanced light sensitivity, poor visual acuity and a larger binocular field than other parrots. We conclude that the Kakapo possesses a visual system unlike that of either strictly nocturnal or diurnal birds and therefore does not adhere to the traditional view of the evolution of nocturnality in birds.	[Corfield, Jeremy R.; Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Gsell, Anna C.; Brunton, Dianne] Massey Univ, Inst Nat Sci, Auckland, New Zealand; [Heesy, Christopher P.] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Hall, Margaret I.] Midwestern Univ, Dept Physiol, Glendale, AZ USA; [Acosta, Monica L.] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand	University of Lethbridge; Massey University; Midwestern University; Midwestern University; University of Auckland	Corfield, JR (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	jr.corfield@gmail.com	Heesy, Christopher P./AAP-8737-2021; Acosta, Monica/H-2700-2019; Iwaniuk, Andrew/H-7255-2019	Heesy, Christopher P./0000-0003-1258-2506; Acosta, Monica/0000-0002-5018-339X; Iwaniuk, Andrew/0000-0001-9273-3655	Midwestern University; Smithsonian Office of Grants and Fellowships; Natural Sciences and Engineering Research Council (NSERC); Institute for Natural Sciences, Massey University, Auckland, New Zealand	Midwestern University; Smithsonian Office of Grants and Fellowships; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Institute for Natural Sciences, Massey University, Auckland, New Zealand	Funding for this study was provided by intramural funds from Midwestern University to CPH and MIH, and the Smithsonian Office of Grants and Fellowships and the Natural Sciences and Engineering Research Council (NSERC) to ANI and the Institute for Natural Sciences, Massey University, Auckland, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Barton RA, 2004, P NATL ACAD SCI USA, V101, P10113, DOI 10.1073/pnas.0401955101; BEYER W. H., 1979, CRC STANDARD MATH TA; BOWMAKER JK, 1978, VISION RES, V18, P1125, DOI 10.1016/0042-6989(78)90095-0; Braun MJ, 2009, MOL PHYLOGENET EVOL, V53, P948, DOI 10.1016/j.ympev.2009.08.025; Brauth SE, BUDGERIGAR BRAIN ATL; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; Burton RF, 2008, VISION RES, V48, P2345, DOI 10.1016/j.visres.2008.08.001; Butler D, 1989, QUEST KAKAPO; CAMPBELL FW, 1965, NATURE, V208, P191, DOI 10.1038/208191a0; Catania KC, 2000, BRAIN BEHAV EVOLUT, V55, P311, DOI 10.1159/000006666; CORFIELD JR, 2009, THESIS U AUCKLAND AU; Crish SD, 2006, ANAT REC PART A, V288A, P205, DOI 10.1002/ar.a.20288; Dowling J. E., 1987, RETINA APPROACHABLE; Eason Daryl K., 2006, Notornis, V53, P27; Eberhard JR, 1998, AUK, V115, P455, DOI 10.2307/4089204; EBINGER P, 1995, BRAIN BEHAV EVOLUT, V45, P286, DOI 10.1159/000113557; EBINGER P, 1992, CELL TISSUE RES, V268, P81, DOI 10.1007/BF00338056; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fernandez P, 1997, REV CHIL HIST NAT, V70, P269; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Hagelin JC, 2004, IBIS, V146, P161, DOI 10.1111/j.1474-919X.2004.00212.x; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Hall MI, 2008, J ANAT, V212, P781, DOI 10.1111/j.1469-7580.2008.00897.x; Hall MI, 2009, ANAT REC, V292, P1827, DOI 10.1002/ar.21007; Harmening WM, 2007, VISION RES, V47, P1020, DOI 10.1016/j.visres.2007.01.005; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Heesy CP, 2008, BRAIN BEHAV EVOLUT, V71, P54, DOI 10.1159/000108621; Heesy CP, 2010, BRAIN BEHAV EVOLUT, V75, P195, DOI 10.1159/000314278; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; Heesy CP, 2004, ANAT REC PART A, V281A, P1104, DOI 10.1002/ar.a.20116; Husband S., 2001, AVIAN VISUAL COGNITI; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Iwaniuk AN, 2010, BRAIN BEHAV EVOLUT, V75, P122, DOI 10.1159/000311729; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; Juniper T, 1998, PARROTS GUIDE PARROT; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Konig C, 2008, OWLS WORLD; Krutzfeldt NOE, 2005, J COMP NEUROL, V490, P40, DOI 10.1002/cne.20627; Krutzfeldt NOE, 2004, J COMP NEUROL, V468, P452, DOI 10.1002/cne.10972; Land MF., 2001, ANIMAL EYES; Lockwood CA, 2002, J ANAT, V201, P447, DOI 10.1046/j.1469-7580.2002.00122.x; Lythgoe J.N., 1979, ECOLOGY VISION; Maddison, 2019, MESQUITE MODULAR SYS; Martin G, 2004, NATURWISSENSCHAFTEN, V91, P26, DOI 10.1007/s00114-003-0495-3; MARTIN GR, 1986, IBIS, V128, P266, DOI 10.1111/j.1474-919X.1986.tb02674.x; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; Martin Graham R., 1993, P5; MATOCHIK JA, 1991, BRAIN BEHAV EVOLUT, V37, P215, DOI 10.1159/000114360; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Midford P. E., 2008, PDAP PDTREE PACKAGE; Mpodozis J, 1996, J COMP NEUROL, V374, P204, DOI 10.1002/(SICI)1096-9861(19961014)374:2<204::AID-CNE4>3.0.CO;2-6; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Nieder A, 2000, J NEUROPHYSIOL, V83, P2967, DOI 10.1152/jn.2000.83.5.2967; Pettigrew J.D., 1986, P208; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; Pirenne MH, 1943, NATURE, V152, P698, DOI 10.1038/152698a0; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Powlesland Ralph G., 2006, Notornis, V53, P3; PUELLES L, CHICK BRAIN STEREOTA; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P125, DOI 10.1159/000114353; Ritland S. M., 1982, ALLOMETRY VERTEBRATE; Rojas LM, 2004, BRAIN BEHAV EVOLUT, V64, P19, DOI 10.1159/000077540; Russello MA, 2004, MOL PHYLOGENET EVOL, V30, P421, DOI 10.1016/S1055-7903(03)00192-1; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Thomas RJ, 2002, P ROY SOC B-BIOL SCI, V269, P831, DOI 10.1098/rspb.2001.1941; TURBOTT EG, 1967, BULLERS BIRDS NZ; WAGNER H, 1993, NATURE, V364, P796, DOI 10.1038/364796a0; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant E. J., 2008, SENSES COMPREHENSIVE, V2, P53; WATHEY JC, 1989, BRAIN BEHAV EVOLUT, V33, P279, DOI 10.1159/000115936; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; [No title captured]	84	32	32	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22945	10.1371/journal.pone.0022945	http://dx.doi.org/10.1371/journal.pone.0022945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860663	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200028
J	Eikenaar, C; Whitham, M; Komdeur, J; van der Velde, M; Moore, IT				Eikenaar, Cas; Whitham, Megan; Komdeur, Jan; van der Velde, Marco; Moore, Ignacio T.			Testosterone, Plumage Colouration and Extra-Pair Paternity in Male North-American Barn Swallows	PLOS ONE			English	Article							TAIL STREAMER LENGTH; REPRODUCTIVE SUCCESS; MICROSATELLITE LOCI; CIRCULATING LEVELS; STEROID-HORMONES; SEXUAL SELECTION; MATING SYSTEMS; BEHAVIOR; POLYGYNY; BLACK	In most monogamous bird species, circulating testosterone concentration in males is elevated around the social female's fertile period. Variation in elevated testosterone concentrations among males may have a considerable impact on fitness. For example, testosterone implants enhance behaviours important for social and extra-pair mate choice. However, little is known about the relationship between natural male testosterone concentration and sexual selection. To investigate this relationship we measured testosterone concentration and sexual signals (ventral plumage colour and tail length), and determined within and extra-pair fertilization success in male North American barn swallows (Hirundo rustica erythrogaster). Dark rusty coloured males had higher testosterone concentrations than drab males. Extra-pair paternity was common (42% and 31% of young in 2009 and 2010, respectively), but neither within-nor extra-pair fertilization success was related to male testosterone concentration. Dark rusty males were less often cuckolded, but did not have higher extra-pair or total fertilization success than drab males. Tail length did not affect within-or extra-pair fertilization success. Our findings suggest that, in North American barn swallows, male testosterone concentration does not play a significant direct role in female mate choice and sexual selection. Possibly plumage colour co-varies with a male behavioural trait, such as aggressiveness, that reduces the chance of cuckoldry. This could also explain why dark males have higher testosterone concentrations than drab males.	[Eikenaar, Cas; Whitham, Megan; Moore, Ignacio T.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA; [van der Velde, Marco] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Haren, Netherlands	Virginia Polytechnic Institute & State University; University of Groningen	Eikenaar, C (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA.	eikenaar@vt.edu	Komdeur, Jan/X-1261-2019	Komdeur, Jan/0000-0002-9241-0124; Moore, Ignacio/0000-0001-8875-8913; Whitham, Megan/0000-0002-6685-8881	National Science Foundation [IOS 0545735]; Netherlands Organisation for Scientific Research [VICI 86503003]; Stichting Nicolaas Mulerius Fonds and Dobberke Stichting [DOBB2008-03]	National Science Foundation(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Stichting Nicolaas Mulerius Fonds and Dobberke Stichting	This research was supported by grants from the National Science Foundation (http://www.nsf.gov/) awarded to Ignacio Moore (IOS 0545735), from the Netherlands Organisation for Scientific Research (http://www.nwo.nl/) awarded to Jan Komdeur (VICI 86503003), and from Stichting Nicolaas Mulerius Fonds and Dobberke Stichting (DOBB2008-03) both allocated to Cas Eikenaar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo RV, 1996, P ROY SOC B-BIOL SCI, V263, P1697, DOI 10.1098/rspb.1996.0248; BALTHAZART J, 1976, J ZOOL, V180, P155, DOI 10.1111/j.1469-7998.1976.tb04670.x; BELETSKY LD, 1989, AUK, V106, P107, DOI 10.2307/4087763; Bensch S, 1997, MOL ECOL, V6, P91, DOI 10.1046/j.1365-294X.1997.00150.x; Birkhead TR, 1992, SPERM COMPETITION BI; BORGIA G, 1991, CONDOR, V93, P935, DOI 10.2307/3247728; De Ridder E, 2000, BEHAV ECOL SOCIOBIOL, V49, P24, DOI 10.1007/s002650000266; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Eikenaar C, 2011, BEHAV ECOL, V22, P601, DOI 10.1093/beheco/arr030; Enstrom DA, 1997, ANIM BEHAV, V54, P1135, DOI 10.1006/anbe.1997.0555; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foerster K, 2004, BEHAV ECOL SOCIOBIOL, V56, P482, DOI 10.1007/s00265-004-0809-2; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fusani L, 1997, ANIM BEHAV, V54, P1013, DOI 10.1006/anbe.1997.0518; Goymann W, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P465, DOI 10.1007/978-3-642-02624-9_16; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HANOTTE O, 1994, MOL ECOL, V3, P529, DOI 10.1111/j.1365-294X.1994.tb00133.x; HEGNER RE, 1986, HORM BEHAV, V20, P294, DOI 10.1016/0018-506X(86)90039-5; Hoskyn JL, 1988, THESIS YALE U NEW HA; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kleven O, 2006, BEHAV ECOL SOCIOBIOL, V59, P412, DOI 10.1007/s00265-005-0065-0; McGraw KJ, 2004, BEHAV ECOL, V15, P889, DOI 10.1093/beheco/arh109; MOLLER AP, 1987, ANIM BEHAV, V35, P247, DOI 10.1016/S0003-3472(87)80230-0; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Montgomerie Robert, 2006, P90; Moore IT, 2002, GEN COMP ENDOCR, V129, P13, DOI 10.1016/S0016-6480(02)00563-4; MOORE MC, 1984, BEHAVIOUR, V88, P215, DOI 10.1163/156853984X00326; Neuman CR, 2007, J AVIAN BIOL, V38, P28, DOI 10.1111/j.2007.0908-8857.03713.x; PRIMMER CR, 1995, MOL ECOL, V4, P493, DOI 10.1111/j.1365-294X.1995.tb00243.x; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Rasbash J., 2004, USERS GUIDE MLWIN VE; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; SAINO N, 1995, ANIM BEHAV, V49, P465, DOI 10.1006/anbe.1995.0060; SAINO N, 1994, ANIM BEHAV, V48, P1325, DOI 10.1006/anbe.1994.1369; Savari L, 2009, ACTA ORNITHOL, V44, P59, DOI DOI 10.3161/000164509X464894; SHIELDS WM, 1987, ECOLOGY, V68, P1373, DOI 10.2307/1939221; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH HG, 1991, BEHAV ECOL SOCIOBIOL, V28, P195; van de Crommenacker J, 2004, P ROY SOC B-BIOL SCI, V271, P1023, DOI 10.1098/rspb.2004.2697; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WINGFIELD JC, 1984, AUK, V101, P665, DOI 10.2307/4086893; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1991, J ZOOL, V225, P43, DOI 10.1111/j.1469-7998.1991.tb03800.x	48	27	29	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23288	10.1371/journal.pone.0023288	http://dx.doi.org/10.1371/journal.pone.0023288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853105	gold, Green Published, Green Submitted			2022-12-25	WOS:000295454200065
J	Jacobs, U; De Castro, MS; Fuchs, FD; Ferreira, MBC				Jacobs, Ursula; De Castro, Mauro S.; Fuchs, Flavio D.; Ferreira, Maria Beatriz C.			The Influence of Cognition, Anxiety and Psychiatric Disorders over Treatment Adherence in Uncontrolled Hypertensive Patients	PLOS ONE			English	Article							STROKE RISK PROFILE; BLOOD-PRESSURE; MEDICATION ADHERENCE; VERSION; MEMORY; CARE	Background: Poor adherence is estimated to cause 125 thousand deaths per year and is linked to 10% of all hospital stays in the U. S. Up to one third of elderly hypertensive patients don't have adherence, which is responsible for high proportion of hospitalizations. Hypertension is also related to poor performance in tests that assess cognitive functions. On the other hand, poor cognitive performance is associated with low adherence to treatment. Objective: To assess the association between cognitive function, anxiety and psychiatric disorders with adherence to drug treatment in patients with hypertension. Methodology and Principal Findings: This a cohort studies with 56 adult patients with uncontrolled hypertension who participated of all meetings of a pharmaceutical intervention in a randomized clinical trial of pharmaceutical care. Cognitive function was measured by the Mini Mental State Examination (Mini-mental). The memory was measured by digit and word spans, tower and church shadow test, short story test and metamemory. Anxiety and psychiatric disorders were evaluated by the State Trace Anxiety Inventory and the Self-Report Questionnaire, respectively. The participants were classified as adherent or non-adherent to the drug treatment, according to the identification of plasma levels of hydrochlorothiazide. All non-adherent patients (n = 12) and 35 out 44 (79.5%) patients with adherence to treatment had at least one memory test with an altered score (P = 0.180). Participants with an unsatisfactory score in the Mini-mental had six-fold higher risk of non-adherence to treatment when compared to those with a normal score (RR = 5.8; CI 95%: 1.6-20.8; P = 0.007). The scores of anxiety and psychiatric disorders were not associated with adherence to the pharmacological treatment. Conclusion: Cognitive deficit impairs adherence to drug therapy and should be screened as part of a program of pharmaceutical care to improve adherence to treatment.	[Jacobs, Ursula] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Sch Med, Porto Alegre, RS, Brazil; [De Castro, Mauro S.] Univ Fed Rio Grande do Sul, Sch Pharm, Dept Drug Prod & Qual Control, Porto Alegre, RS, Brazil; [De Castro, Mauro S.] Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil; [Ferreira, Maria Beatriz C.] Univ Fed Rio Grande do Sul, Dept Pharmacol, Hlth Basic Sci Inst, Porto Alegre, RS, Brazil; [Ferreira, Maria Beatriz C.] Hosp Clin Porto Alegre, Postgrad Program Med Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Jacobs, U (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Sch Med, Porto Alegre, RS, Brazil.	decastro.mauro@gmail.com	Fuchs, Flávio D/L-5078-2016; Iats, Inct/K-2300-2013; Ferreira, Maria Beatriz C/G-6561-2012	Ferreira, Maria Beatriz/0000-0002-6814-6773; fuchs, flavio/0000-0002-1191-0523	FIPE-Hospital de Clinicas de Porto Alegre; CNPq/Brazil	FIPE-Hospital de Clinicas de Porto Alegre; CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported in part by grants from FIPE-Hospital de Clinicas de Porto Alegre and CNPq/Brazil and had the cooperation of the Institute of Science and Technology for Pharmaceutical Innovation and the Institute of Science and Technology for Health Technology Assessment (IATS)I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 5 DIR BRAS HIP ART; BIAGGIO AMB, 1977, ARQ BRAS PSICOL APL, V29, P31; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; CASTRO MS, 2006, HYPERTENSION, V19, P528; CEITLIN LHF, 1992, JORNAL BRASILEIRO PS, V41, P317; Contardo C, 2009, ARCH CLIN NEUROPSYCH, V24, P547, DOI 10.1093/arclin/acp046; CURTIN M, 1990, CHRONIC ILLNESS IMPA, P2; ELIAS MF, 1993, AM J EPIDEMIOL, V138, P353, DOI 10.1093/oxfordjournals.aje.a116868; Elias MF, 2004, STROKE, V35, P404, DOI 10.1161/01.STR.0000103141.82869.77; FARMER ME, 1990, J CLIN EPIDEMIOL, V43, P475, DOI 10.1016/0895-4356(90)90136-D; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Maia ALG, 2006, ARQ NEURO-PSIQUIAT, V64, P485, DOI 10.1590/S0004-282X2006000300025; Hayes TL, 2009, J AGING HEALTH, V21, P567, DOI 10.1177/0898264309332836; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Izquierdo I., 2002, MEMORIA; Kuhl EA, 2009, AM J CARDIOL, V103, P1629, DOI 10.1016/j.amjcard.2009.02.014; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; Loayza MP, 2001, ARQ NEURO-PSIQUIAT, V59, P180, DOI 10.1590/S0004-282X2001000200005; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; Miura M, 2007, YAKUGAKU ZASSHI, V127, P1731, DOI 10.1248/yakushi.127.1731; Peterson AM, 2003, AM J HEALTH-SYST PH, V60, P657, DOI 10.1093/ajhp/60.7.657; ROSAT RM, 1990, BRAZ J MED BIOL RES, V23, P805; SANZ A, 1995, COMUNICACION INTERPE; Seshadri S, 2004, NEUROLOGY, V63, P1591, DOI 10.1212/01.WNL.0000142968.22691.70; WECHSLER D, 1981, ADULT INTELIGENCE SC; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization, WORLD HLTH REP 2002	27	15	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22925	10.1371/journal.pone.0022925	http://dx.doi.org/10.1371/journal.pone.0022925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	806AW	21857969	gold, Green Published, Green Submitted			2022-12-25	WOS:000293774300012
J	Zhang, HN; Yin, W; Zhao, J; Jin, L; Yang, YH; Wu, SW; Tabashnik, BE; Wu, YD				Zhang, Haonan; Yin, Wei; Zhao, Jing; Jin, Lin; Yang, Yihua; Wu, Shuwen; Tabashnik, Bruce E.; Wu, Yidong			Early Warning of Cotton Bollworm Resistance Associated with Intensive Planting of Bt Cotton in China	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; THURINGIENSIS TOXIN CRY1AC; BACILLUS-THURINGIENSIS; INSECTICIDAL PROTEIN; TOLERANCE RESPONSE; MULTIPLE CROPS; NORTHERN CHINA; NOCTUIDAE; POPULATIONS; FREQUENCY	Transgenic crops producing Bacillus thuringiensis (Bt) toxins kill some key insect pests, but evolution of resistance by pests can reduce their efficacy. The predominant strategy for delaying pest resistance to Bt crops requires refuges of non-Bt host plants to promote survival of susceptible pests. To delay pest resistance to transgenic cotton producing Bt toxin Cry1Ac, farmers in the United States and Australia planted refuges of non-Bt cotton, while farmers in China have relied on "natural" refuges of non-Bt host plants other than cotton. Here we report data from a 2010 survey showing field-evolved resistance to Cry1Ac of the major target pest, cotton bollworm (Helicoverpa armigera), in northern China. Laboratory bioassay results show that susceptibility to Cry1Ac was significantly lower in 13 field populations from northern China, where Bt cotton has been planted intensively, than in two populations from sites in northwestern China where exposure to Bt cotton has been limited. Susceptibility to Bt toxin Cry2Ab did not differ between northern and northwestern China, demonstrating that resistance to Cry1Ac did not cause cross-resistance to Cry2Ab, and implying that resistance to Cry1Ac in northern China is a specific adaptation caused by exposure to this toxin in Bt cotton. Despite the resistance detected in laboratory bioassays, control failures of Bt cotton have not been reported in China. This early warning may spur proactive countermeasures, including a switch to transgenic cotton producing two or more toxins distinct from Cry1A toxins.	[Zhang, Haonan; Yin, Wei; Zhao, Jing; Jin, Lin; Yang, Yihua; Wu, Shuwen; Wu, Yidong] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China; [Zhang, Haonan; Yin, Wei; Zhao, Jing; Jin, Lin; Yang, Yihua; Wu, Shuwen; Wu, Yidong] Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Nanjing Agricultural University; Nanjing Agricultural University; University of Arizona	Zhang, HN (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China.	wyd@njau.edu.cn	Jin, Lin/N-1361-2018; Wu, Yidong/E-9720-2012; ZHANG, HAONAN/N-6395-2018; Zhang, Haonan/J-2245-2019	Jin, Lin/0000-0002-5114-7139; Wu, Yidong/0000-0003-3456-3373; ZHANG, HAONAN/0000-0003-1196-2750; Zhang, Haonan/0000-0003-1196-2750	Ministry of Science and Technology of China [2007CB109204, 2008ZX08011-02, 2008ZX08012-04]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); U.S. Department of Agriculture-Agriculture and Food Research Initiative [2008-35302-0390]; Cotton Foundation; Cotton Inc.; National Cotton Council, Monsanto; Dow AgroSciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); U.S. Department of Agriculture-Agriculture and Food Research Initiative; Cotton Foundation; Cotton Inc.(Cotton R&D Corp); National Cotton Council, Monsanto; Dow AgroSciences	This work was supported by grants 2007CB109204, 2008ZX08011-02, and 2008ZX08012-04 from the Ministry of Science and Technology of China, a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and 2008-35302-0390 from the U.S. Department of Agriculture-Agriculture and Food Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; B. E. Tabashnik has received support for research that is not related to this publication from the following sources: Cotton Foundation, Cotton Inc., National Cotton Council, Monsanto, and Dow AgroSciences. He is also a coauthor of a patent application on engineering modified Bt toxins to counter pest resistance, which is related to research described by Soberon et al. (2007, Science 318: 1640-1642). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Caprio MA., 2007, FIELD MANUAL TECHNIQ, P769; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Du WenXiao, 2010, Xinjiang Agricultural Sciences, V47, P902; Gao YL, 2009, ENVIRON ENTOMOL, V38, P1336, DOI 10.1603/022.038.0445; Gao YL, 2009, J ECON ENTOMOL, V102, P1217, DOI 10.1603/029.102.0347; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; LeOra Software, 2002, POL PLUS US GUID PRO; Li GP, 2004, ENTOMOL EXP APPL, V112, P135, DOI 10.1111/j.0013-8703.2004.00191.x; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; Li GP, 2010, ENVIRON ENTOMOL, V39, P1698, DOI 10.1603/EN10077; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mahon RJ, 2007, J ECON ENTOMOL, V100, P1844, DOI 10.1603/0022-0493(2007)100[1844:FOACRT]2.0.CO;2; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; National Research Council, 2010, IMP GEN ENG CROPS FA; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1987, J ECON ENTOMOL, V80, P1091, DOI 10.1093/jee/80.6.1091; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; Wu KM, 1999, J ECON ENTOMOL, V92, P273, DOI 10.1093/jee/92.2.273; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu KM, 2007, J INVERTEBR PATHOL, V95, P220, DOI 10.1016/j.jip.2007.03.012; Wu KM, 2006, J ECON ENTOMOL, V99, P893, DOI 10.1603/0022-0493-99.3.893; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YH, 2009, B ENTOMOL RES, V99, P175, DOI 10.1017/S0007485308006226; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07	38	195	216	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22874	10.1371/journal.pone.0022874	http://dx.doi.org/10.1371/journal.pone.0022874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857961	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300008
J	Aheng, C; Ly, N; Kelly, M; Ibrahim, S; Ricquier, D; Alves-Guerra, MC; Miroux, B				Aheng, Caroline; Ly, Nathalie; Kelly, Mairead; Ibrahim, Saleh; Ricquier, Daniel; Alves-Guerra, Marie-Clotilde; Miroux, Bruno			Deletion of UCP2 in iNOS Deficient Mice Reduces the Severity of the Disease during Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; UNCOUPLING PROTEIN UCP2; NITRIC-OXIDE; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS; GENE; MACROPHAGES; IMMUNITY; GLUCOSE; CELLS	Uncoupling protein 2 is a member of the mitochondrial anion carrier family that is widely expressed in neurons and the immune cells of humans. Deletion of Ucp2 gene in mice pre-activates the immune system leading to higher resistance toward infection and to an increased susceptibility to develop chronic inflammatory diseases as previously exemplified with the Experimental Autoimmune Encephalomyelitis (EAE), a mouse model for multiple sclerosis. Given that oxidative stress is enhanced in Ucp2-/- mice and that nitric oxide (NO) also plays a critical function in redox balance and in chronic inflammation, we generated mice deficient for both Ucp2 and iNos genes and submitted them to EAE. Mice lacking iNos gene exhibited the highest clinical score (3.4+/-0.5 p<0.05). Surprisingly, mice deficient for both genes developed milder disease with reduced immune cell infiltration, cytokines and ROS production as compared to iNos-/- mice.	[Aheng, Caroline; Ly, Nathalie; Ricquier, Daniel; Alves-Guerra, Marie-Clotilde] Fac Paris Descartes, CNRS, Inst Cochin, INSERM,U1016,UMR8104, Paris, France; [Kelly, Mairead] Univ Paris 05, INSERMU845, Paris, France; [Kelly, Mairead] Hop Necker Enfants Malad, Lab Biochim A, Paris, France; [Ibrahim, Saleh] Med Univ Lubeck, Dept Dermatol, Genet Grp, D-23538 Lubeck, Germany; [Ibrahim, Saleh] Univ Rostock, Dept Immunol, Rostock, Germany; [Miroux, Bruno] Univ Paris Diderot, CNRS, Inst Biol Phys Chim, Lab Biol Phys Chim Prot Membranaires,UMR 7099, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lubeck; University of Rostock; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Aheng, C (corresponding author), Fac Paris Descartes, CNRS, Inst Cochin, INSERM,U1016,UMR8104, Paris, France.	clotilde.alves-guerra@inserm.fr; Bruno.Miroux@ibpc.fr	Miroux, Bruno/E-9267-2017; Ibrahim, Saleh/AAO-9541-2020; Alves-Guerra, Marie-Clotilde/P-4356-2017	Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; Ibrahim, Saleh/0000-0001-7827-2290; Miroux, Bruno/0000-0002-3066-4700	Centre National de la Recherche Scientifique (CNRS); Federal Ministry of Education and Research (FKZ) [01ZZ0108]; l'Agence Nationale de la Recherche (ANR); Ministere de la Recherche et de l'enseignement superieur; Fondation pour la Recherche Medicale [FDT20090916769]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Federal Ministry of Education and Research (FKZ)(Federal Ministry of Education & Research (BMBF)); l'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de la Recherche et de l'enseignement superieur; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), by grants from The Federal Ministry of Education and Research (FKZ 01ZZ0108 to S. M. I.) and from l'Agence Nationale de la Recherche (ANR JCJC Ucp2 to BM). Caroline Aheng received a PhD fellowship from the Ministere de la Recherche et de l'enseignement superieur and from the Fondation pour la Recherche Medicale (FDT20090916769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; Dumollard R, 2009, SEMIN CELL DEV BIOL, V20, P346, DOI 10.1016/j.semcdb.2008.12.013; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Jekabsone A, 2007, J NEUROCHEM, V103, P346, DOI 10.1111/j.1471-4159.2007.04756.x; Kean RB, 2000, J IMMUNOL, V165, P6511, DOI 10.4049/jimmunol.165.11.6511; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; LIN RF, 1993, J EXP MED, V178, P643, DOI 10.1084/jem.178.2.643; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mozo J, 2006, BIOCHEM J, V393, P431, DOI 10.1042/BJ20050494; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nicotera P, 1997, TRENDS PHARMACOL SCI, V18, P189, DOI 10.1016/S0165-6147(97)90619-2; Nubel T, 2008, BBA-BIOENERGETICS, V1777, P48, DOI 10.1016/j.bbabio.2007.11.002; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Sahrbacher UC, 1998, EUR J IMMUNOL, V28, P1332, DOI 10.1002/(SICI)1521-4141(199804)28:04<1332::AID-IMMU1332>3.3.CO;2-7; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Vogler S, 2005, J MOL MED, V83, P806, DOI 10.1007/s00109-005-0661-5; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29	33	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22841	10.1371/journal.pone.0022841	http://dx.doi.org/10.1371/journal.pone.0022841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857957	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300009
J	Prot, JM; Briffaut, AS; Letourneur, F; Chafey, P; Merlier, F; Grandvalet, Y; Legallais, C; Leclerc, E				Prot, Jean Matthieu; Briffaut, Anne-Sophie; Letourneur, Franck; Chafey, Philippe; Merlier, Franck; Grandvalet, Yves; Legallais, Cecile; Leclerc, Eric			Integrated Proteomic and Transcriptomic Investigation of the Acetaminophen Toxicity in Liver Microfluidic Biochip	PLOS ONE			English	Article							INDUCED HEPATIC-NECROSIS; COVALENT BINDING; CELL-DEATH; DRUG; PARACETAMOL; HOMEOSTASIS; ACTIVATION; CLEARANCE	Microfluidic bioartificial organs allow the reproduction of in vivo-like properties such as cell culture in a 3D dynamical micro environment. In this work, we established a method and a protocol for performing a toxicogenomic analysis of HepG2/C3A cultivated in a microfluidic biochip. Transcriptomic and proteomic analyses have shown the induction of the NRF2 pathway and the related drug metabolism pathways when the HepG2/C3A cells were cultivated in the biochip. The induction of those pathways in the biochip enhanced the metabolism of the N-acetyl-p-aminophenol drug (acetaminophen-APAP) when compared to Petri cultures. Thus, we observed 50% growth inhibition of cell proliferation at 1 mM in the biochip, which appeared similar to human plasmatic toxic concentrations reported at 2 mM. The metabolic signature of APAP toxicity in the biochip showed similar biomarkers as those reported in vivo, such as the calcium homeostasis, lipid metabolism and reorganization of the cytoskeleton, at the transcriptome and proteome levels (which was not the case in Petri dishes). These results demonstrate a specific molecular signature for acetaminophen at transcriptomic and proteomic levels closed to situations found in vivo. Interestingly, a common component of the signature of the APAP molecule was identified in Petri and biochip cultures via the perturbations of the DNA replication and cell cycle. These findings provide an important insight into the use of microfluidic biochips as new tools in biomarker research in pharmaceutical drug studies and predictive toxicity investigations.	[Prot, Jean Matthieu; Legallais, Cecile; Leclerc, Eric] Univ Technol Compiegne, CNRS, UMR 6600, Lab Biomecan & Bioingn, F-60206 Compiegne, France; [Briffaut, Anne-Sophie; Grandvalet, Yves] Univ Technol Compiegne, CNRS, UMR 6599, F-60206 Compiegne, France; [Merlier, Franck] Univ Technol Compiegne, CNRS, UMR 6022, Lab Genie Enzymat & Cellulaire, F-60206 Compiegne, France; [Letourneur, Franck; Chafey, Philippe] Inst Cochin, INSERM, U1016, Paris, France	Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Technologie de Compiegne; Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prot, JM (corresponding author), Univ Technol Compiegne, CNRS, UMR 6600, Lab Biomecan & Bioingn, F-60206 Compiegne, France.	eric.leclerc@utc.fr		Grandvalet, Yves/0000-0002-5645-5149; merlier, franck/0000-0002-8895-8357; Legallais, Cecile/0000-0002-8061-906X	foundation of the University of Technology in Compiegne "La Fondation UTC pour l'innovation"; ANR	foundation of the University of Technology in Compiegne "La Fondation UTC pour l'innovation"; ANR(French National Research Agency (ANR))	Part of the project was supported by the foundation of the University of Technology in Compiegne "La Fondation UTC pour l'innovation" and by the ANR PCV, mu HepaReTox. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DN, 1998, J ANAL TOXICOL, V22, P587, DOI 10.1093/jat/22.7.587; Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513; Baudoin R, 2011, BIOCHEM ENG J, V53, P172, DOI 10.1016/j.bej.2010.10.007; Boulares HA, 1999, TOXICOL SCI, V48, P264, DOI 10.1093/toxsci/48.2.264; BRUSCHI SA, 1990, TOXICOL IN VITRO, V4, P743, DOI 10.1016/0887-2333(90)90043-S; Bruschi SA, 2005, METHOD PHARMACOL TOX, P197; Chao P, 2009, BIOCHEM PHARMACOL, V78, P625, DOI 10.1016/j.bcp.2009.05.013; Coen M, 2004, J PHARMACEUT BIOMED, V35, P93, DOI 10.1016/j.jpba.2003.12.019; Domansky K, 2005, P ANN INT IEEE EMBS, P7490, DOI 10.1109/IEMBS.2005.1616244; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Ferrer-Dufol A, 2009, TOXICOL LETT, V186, P2, DOI 10.1016/j.toxlet.2008.10.025; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jemnitz K, 2008, TOXICOL IN VITRO, V22, P961, DOI 10.1016/j.tiv.2008.02.001; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Li YJ, 2008, CLIN IMMUNOL, V128, P366, DOI 10.1016/j.clim.2008.05.005; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; MORRIS ME, 1984, J PHARM SCI, V73, P1038, DOI 10.1002/jps.2600730806; NAVARRO C, 1994, FASEB J, V8, pA1468; Novik E, 2010, BIOCHEM PHARMACOL, V79, P1036, DOI 10.1016/j.bcp.2009.11.010; Oberemm A, 2009, TOXICOL APPL PHARM, V241, P230, DOI 10.1016/j.taap.2009.08.020; Pierce RH, 2002, BIOCHEM PHARMACOL, V64, P413, DOI 10.1016/S0006-2952(02)01180-2; POTTER WZ, 1974, PHARMACOLOGY, V12, P129, DOI 10.1159/000136531; Prot JM, 2011, BIOTECHNOL BIOENG, V108, P1704, DOI 10.1002/bit.23104; RAY SD, 1993, FASEB J, V7, P453, DOI 10.1096/fasebj.7.5.8462787; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Sigdel TK, 2008, PEDIATR TRANSPLANT, V12, P737, DOI 10.1111/j.1399-3046.2008.01018.x; Sung JH, 2010, BIOPROC BIOSYST ENG, V33, P5, DOI 10.1007/s00449-009-0369-y; SYLVIA C, 2003, J CELL BIOCHEM, V88, P695; TIRMENSTEIN MA, 1989, J BIOL CHEM, V264, P9814; VEENSTRA TD, 2006, DRUG DISCOV TODAY TE, V3, P433, DOI DOI 10.1016/J.DDTEC.2006.10.001; Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P590, DOI 10.1021/bp034238d; WALKER RM, 1983, EXP MOL PATHOL, V39, P163, DOI 10.1016/0014-4800(83)90049-7; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501	34	38	40	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e21268	10.1371/journal.pone.0021268	http://dx.doi.org/10.1371/journal.pone.0021268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857903	gold, Green Submitted, Green Published			2022-12-25	WOS:000293773300002
J	Martin, AR; Thomas, SC				Martin, Adam R.; Thomas, Sean C.			A Reassessment of Carbon Content in Tropical Trees	PLOS ONE			English	Article							CARBOHYDRATE STORAGE; WOOD DENSITY; FOREST; BIOMASS; EMISSIONS; PATTERNS; BALANCE; TRAITS; HEIGHT; STOCKS	Accurate knowledge of carbon (C) content in live wood is essential for quantifying tropical forest C stocks, yet generic assumptions (such as biomass consisting of 50% carbon on a weight/weight basis) remain widely used despite being supported by little chemical analysis. Empirical data from stem cores of 59 Panamanian rainforest tree species demonstrate that wood C content is highly variable among co-occurring species, with an average (47.4+/-2.51% S. D.) significantly lower than widely assumed values. Prior published values have neglected to account for volatile C content of tropical woods. By comparing freeze- and oven-dried wood samples, we show that volatile C is non-negligible, and excluding the volatile fraction underestimates wood C content by 2.48+/-1.28% (S. D.) on average. Wood C content varied substantially among species (from 41.9-51.6%), but was neither strongly phylogenetically conserved, nor correlated to ecological (i.e. wood density, maximum tree height) or demographic traits (i.e. relative growth rate, mortality rate). Overall, assuming generic C fractions in tropical wood overestimates forest C stocks by similar to 3.3-5.3%, a non-trivial margin of error leading to overestimates of 4.1-6.8 Mg C ha(-1) in a 50-ha forest dynamics plot on Barro Colorado Island, Panama. In addition to addressing other sources of error in tropical forest C accounting, such as uncertainties in allometric models and belowground biomass, compilation and use of species-specific C fractions for tropical tree species would substantially improve both local and global estimates of terrestrial C stocks and fluxes.	[Martin, Adam R.; Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada	University of Toronto	Martin, AR (corresponding author), Univ Toronto, Fac Forestry, Earth Sci Bldg, Toronto, ON, Canada.	adam.martin@utoronto.ca	THOMAS, Sean C./B-6089-2008	THOMAS, Sean C./0000-0002-0686-2483; Martin, Adam Robert/0000-0002-7207-4004	Hong Kong and Shanghai Banking Corporation Limited; Natural Sciences and Engineering Research Council of Canada; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; University of Toronto Centre for Global Change Science	Hong Kong and Shanghai Banking Corporation Limited; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of Toronto Centre for Global Change Science	Funding was provided by the Hong Kong and Shanghai Banking Corporation Limited Climate Partnership; Natural Sciences and Engineering Research Council of Canada; The Center for Tropical Forest Science; The Smithsonian Tropical Research Institute; and The University of Toronto Centre for Global Change Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Bates D. M., 2010, LME4 MIXED EFFECTS M; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bremer B, 2003, BOT J LINN SOC, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2001, J TROP ECOL, V17, P79, DOI 10.1017/S0266467401001055; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Coomes OT, 2008, ECOL ECON, V65, P207, DOI 10.1016/j.ecolecon.2007.12.028; Croat T.B., 1978, FLORA BARRO COLORADO; Elias M, 2003, CAN J FOREST RES, V33, P1039, DOI 10.1139/X03-018; Feldpausch TR, 2004, ECOL APPL, V14, pS164; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hubbell S.P., 2005, BARRO COLORADO FORES; Hughes RF, 2000, ECOL APPL, V10, P515, DOI 10.1890/1051-0761(2000)010[0515:ESIODA]2.0.CO;2; *IPCC, 2006, IPCC GOOD PRACT GUID, pCH4; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; King DA, 2006, J TROP ECOL, V22, P11, DOI 10.1017/S0266467405002774; Kirby KR, 2007, FOREST ECOL MANAG, V246, P208, DOI 10.1016/j.foreco.2007.03.072; Kraenzel M, 2003, FOREST ECOL MANAG, V173, P213, DOI 10.1016/S0378-1127(02)00002-6; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lamlom SH, 2006, TREE PHYSIOL, V26, P459, DOI 10.1093/treephys/26.4.459; Lamlom SH, 2003, BIOMASS BIOENERG, V25, P381, DOI 10.1016/S0961-9534(03)00033-3; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P492; Newell EA, 2002, OECOLOGIA, V131, P333, DOI 10.1007/s00442-002-0888-6; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P1853, DOI 10.1016/j.foreco.2008.07.022; Pastore TCM, 2004, BIORESOURCE TECHNOL, V93, P37, DOI 10.1016/j.biortech.2003.10.035; PETTERSEN RC, 1984, ADV CHEM SER, P57; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Poorter L, 2007, ECOLOGY, V88, P1000, DOI 10.1890/06-0984; Pyle EH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000592; Rana R, 2010, WOOD SCI TECHNOL, V44, P225, DOI 10.1007/s00226-009-0281-2; Thomas SC, 2007, J ENVIRON MANAGE, V85, P659, DOI 10.1016/j.jenvman.2006.04.022; Thomas SC, 1999, ECOLOGY, V80, P1607; UNFCCC, 2007, 2 WORKSH RED EM DEF; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; ZANNE AE, 2009, DRYAD GLOBAL WOOD DE	53	170	182	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23533	10.1371/journal.pone.0023533	http://dx.doi.org/10.1371/journal.pone.0023533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858157	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300057
J	Sisti, HM; Geurts, M; Clerckx, R; Gooijers, J; Coxon, JP; Heitger, MH; Caeyenberghs, K; Beets, IAM; Serbruyns, L; Swinnen, SP				Sisti, Helene M.; Geurts, Monique; Clerckx, Rene; Gooijers, Jolien; Coxon, James P.; Heitger, Marcus H.; Caeyenberghs, Karen; Beets, Iseult A. M.; Serbruyns, Leen; Swinnen, Stephan P.			Testing Multiple Coordination Constraints with a Novel Bimanual Visuomotor Task	PLOS ONE			English	Article							INTERLIMB COORDINATION; PHASE-TRANSITIONS; PARKINSONS-DISEASE; AUGMENTED FEEDBACK; COUPLING STRENGTH; MOVEMENT; INTERFERENCE; PERFORMANCE; GENERATION; HANDEDNESS	The acquisition of a new bimanual skill depends on several motor coordination constraints. To date, coordination constraints have often been tested relatively independently of one another, particularly with respect to isofrequency and multifrequency rhythms. Here, we used a new paradigm to test the interaction of multiple coordination constraints. Coordination constraints that were tested included temporal complexity, directionality, muscle grouping, and hand dominance. Twenty-two healthy young adults performed a bimanual dial rotation task that required left and right hand coordination to track a moving target on a computer monitor. Two groups were compared, either with or without four days of practice with augmented visual feedback. Four directional patterns were tested such that both hands moved either rightward (clockwise), leftward (counterclockwise), inward or outward relative to each other. Seven frequency ratios (3:1, 2:1, 3:2, 1:1, 2:3. 1:2, 1:3) between the left and right hand were introduced. As expected, isofrequency patterns (1:1) were performed more successfully than multifrequency patterns (non 1:1). In addition, performance was more accurate when participants were required to move faster with the dominant right hand (1:3, 1:2 and 2:3) than with the non-dominant left hand (3:1, 2:1, 3:2). Interestingly, performance deteriorated as the relative angular velocity between the two hands increased, regardless of whether the required frequency ratio was an integer or non-integer. This contrasted with previous finger tapping research where the integer ratios generally led to less error than the non-integer ratios. We suggest that this is due to the different movement topologies that are required of each paradigm. Overall, we found that this visuomotor task was useful for testing the interaction of multiple coordination constraints as well as the release from these constraints with practice in the presence of augmented visual feedback.	[Sisti, Helene M.; Geurts, Monique; Clerckx, Rene; Gooijers, Jolien; Coxon, James P.; Heitger, Marcus H.; Caeyenberghs, Karen; Beets, Iseult A. M.; Serbruyns, Leen; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Dept Biomed Kinesiol, Motor Control Lab,Res Ctr Movement Control & Neur, Louvain, Belgium	KU Leuven	Sisti, HM (corresponding author), Katholieke Univ Leuven, Grp Biomed Sci, Dept Biomed Kinesiol, Motor Control Lab,Res Ctr Movement Control & Neur, Louvain, Belgium.	Helene.Sisti@faber.kuleuven.be	Gooijers, Jolien/AAH-9202-2020; Coxon, James/S-1286-2019	Coxon, James/0000-0003-2351-8489; Caeyenberghs, Karen/0000-0001-7009-6843; Gooijers, Jolien/0000-0002-7569-7223	Research Program of the Research Foundation - Flanders (FWO) [G.0593.08, G.0483.010]; Research Fund K.U. Leuven [OT/07/073]; Belgian federal government [P6/29]; Research Foundation - Flanders (FWO)	Research Program of the Research Foundation - Flanders (FWO)(FWO); Research Fund K.U. Leuven(KU Leuven); Belgian federal government; Research Foundation - Flanders (FWO)(FWO)	Support for this study was provided through grants from the Research Program of the Research Foundation - Flanders (FWO) (G.0593.08; G.0483.010), the Research Fund K.U. Leuven (OT/07/073) and Grant P6/29 from the Interuniversity Attraction Poles program of the Belgian federal government. KC and MH are postdoctoral fellows of the Research Foundation - Flanders (FWO). JG is funded by a PhD fellowship of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2009, CORTEX, V45, P377, DOI 10.1016/j.cortex.2007.11.012; BEEK PJ, 1995, BIOL CYBERN, V73, P499, DOI 10.1007/BF00199542; Bingham GP, 1999, PERCEPT PSYCHOPHYS, V61, P246, DOI 10.3758/BF03206886; BYBLOW WD, 1995, J MOTOR BEHAV, V27, P123, DOI 10.1080/00222895.1995.9941705; Carson RG, 2000, EXP BRAIN RES, V131, P196, DOI 10.1007/s002219900272; de Poel HJ, 2007, ACTA PSYCHOL, V124, P209, DOI 10.1016/j.actpsy.2006.03.003; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; DEUTSCH D, 1983, PERCEPT PSYCHOPHYS, V34, P331, DOI 10.3758/BF03203045; Dounskaia N, 2010, J NEUROPHYSIOL, V103, P2027, DOI 10.1152/jn.00778.2009; ESSENS PJ, 1985, PERCEPT PSYCHOPHYS, V37, P1, DOI 10.3758/BF03207132; Fontaine RJ, 1997, CAN J EXP PSYCHOL, V51, P1, DOI 10.1037/1196-1961.51.1.1; Franz EA, 2002, J MOTOR BEHAV, V34, P402, DOI 10.1080/00222890209601956; Franz EA, 2001, J MOTOR BEHAV, V33, P103, DOI 10.1080/00222890109601906; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hurley SR, 2006, HUM MOVEMENT SCI, V25, P339, DOI 10.1016/j.humov.2006.03.006; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; KLAPP ST, 1985, J EXP PSYCHOL HUMAN, V11, P814, DOI 10.1037/0096-1523.11.6.814; Kovacs AJ, 2010, J EXP PSYCHOL HUMAN, V36, P936, DOI 10.1037/a0019259; Kovacs AJ, 2010, EXP BRAIN RES, V202, P519, DOI 10.1007/s00221-009-2154-1; Kurtz S, 2003, NEUROSCI LETT, V338, P205, DOI 10.1016/S0304-3940(02)01394-0; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Levin O, 2004, BEHAV BRAIN RES, V152, P437, DOI 10.1016/j.bbr.2003.10.029; Li Y, 2009, ACTA PSYCHOL, V130, P183, DOI 10.1016/j.actpsy.2008.12.003; MAGILL RA, MOTOR LEARNING CONTR; Maslovat D, 2004, MOTOR CONTROL, V8, P213, DOI 10.1123/mcj.8.2.213; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Meesen RLJ, 2008, BEHAV BRAIN RES, V187, P361, DOI 10.1016/j.bbr.2007.09.030; Neilson PD, 2002, HUM MOVEMENT SCI, V21, P723, DOI 10.1016/S0167-9457(02)00181-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira FTP, 2008, CURR DIR PSYCHOL SCI, V17, P130, DOI 10.1111/j.1467-8721.2008.00562.x; Peper CE, 2008, NEUROSCI LETT, V437, P10, DOI 10.1016/j.neulet.2008.03.066; PEPER CE, 1995, BIOL CYBERN, V73, P301, DOI 10.1007/BF00199466; Peters M., 1994, INTERLIMB COORDINATI, P595, DOI [10.1016/B978-0-12-679270-6.50032-2, DOI 10.1016/B978-0-12-679270-6.50032-2]; PREILOWSKI BF, 1972, NEUROPSYCHOLOGIA, V10, P267, DOI 10.1016/0028-3932(72)90018-8; Proteau L., 1992, VISION MOTOR CONTROL; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Ronsse R, 2011, CEREB CORTEX, V21, P1283, DOI 10.1093/cercor/bhq209; ROSENBAUM DA, 1995, PSYCHOL REV, V102, P28, DOI 10.1037/0033-295X.102.1.28; Rosenbaum DA, 2001, MOTOR CONTROL, V5, P99, DOI 10.1123/mcj.5.2.99; SALMONI AW, 1983, HUM MOVEMENT SCI, V2, P77, DOI 10.1016/0167-9457(83)90008-8; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Serrien DJ, 2008, NEUROPSYCHOLOGIA, V46, P419, DOI 10.1016/j.neuropsychologia.2007.08.011; Serrien DJ, 2009, EXP BRAIN RES, V199, P195, DOI 10.1007/s00221-009-1998-8; Serrien DJ, 2009, EXP BRAIN RES, V197, P269, DOI 10.1007/s00221-009-1910-6; Serrien DJ, 1998, PSYCHOL RES-PSYCH FO, V61, P191, DOI 10.1007/s004260050024; Spencer RMC, 2005, J NEUROPHYSIOL, V94, P2901, DOI 10.1152/jn.00363.2005; Summers J, 2002, BRAIN COGNITION, V48, P166, DOI 10.1006/brcg.2001.1311; Summers J J, 1998, Motor Control, V2, P106; SUMMERS JJ, 1993, J EXP PSYCHOL HUMAN, V19, P416, DOI 10.1037/0096-1523.19.2.416; Swinnen SP, 1998, BEHAV BRAIN RES, V90, P79, DOI 10.1016/S0166-4328(97)00083-1; Swinnen SP, 1997, MOVEMENT DISORD, V12, P958, DOI 10.1002/mds.870120619; Swinnen SP, 1996, NEUROPSYCHOLOGIA, V34, P1203, DOI 10.1016/0028-3932(96)00047-4; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Swinnen SP, 2002, ACTA PSYCHOL, V110, P129, DOI 10.1016/S0001-6918(02)00030-6; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Temprado JJ, 2007, HUM MOVEMENT SCI, V26, P235, DOI 10.1016/j.humov.2007.01.012; Temprado JJ, 2003, HUM MOVEMENT SCI, V22, P339, DOI 10.1016/S0167-9457(03)00049-6; TREFFNER PJ, 1993, J EXP PSYCHOL HUMAN, V19, P1221, DOI 10.1037/0096-1523.19.6.1221; van der Wel RPRD, 2010, EXP BRAIN RES, V205, P351, DOI 10.1007/s00221-010-2368-2; Verschueren SMP, 1997, EXP BRAIN RES, V113, P497, DOI 10.1007/PL00005602; von Holst E, 1973, BEHAV PHYSL ANIMALS; Walter CB, 2002, J MOTOR BEHAV, V34, P183, DOI 10.1080/00222890209601940; Walter CB, 1997, PSYCHOL RES-PSYCH FO, V60, P202, DOI 10.1007/BF00419405; WALTER CB, 1990, BRAIN COGNITION, V14, P185, DOI 10.1016/0278-2626(90)90028-M; Wenderoth N, 2009, J NEUROPHYSIOL, V102, P302, DOI 10.1152/jn.91090.2008; Wiesendanger M, 2004, PROG BRAIN RES, V143, P491, DOI 10.1016/S0079-6123(03)43046-X; Wilson AD, 2005, EXP BRAIN RES, V165, P351, DOI 10.1007/s00221-005-2301-2; Wilson AD, 2010, EXP BRAIN RES, V205, P513, DOI 10.1007/s00221-010-2388-y; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	73	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23619	10.1371/journal.pone.0023619	http://dx.doi.org/10.1371/journal.pone.0023619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21858185	Green Published, gold			2022-12-25	WOS:000294121300070
J	Norden-Krichmar, TM; Allen, AE; Gaasterland, T; Hildebrand, M				Norden-Krichmar, Trina M.; Allen, Andrew E.; Gaasterland, Terry; Hildebrand, Mark			Characterization of the Small RNA Transcriptome of the Diatom, Thalassiosira pseudonana	PLOS ONE			English	Article							SEQUENCING TECHNOLOGIES; ENDOGENOUS SIRNAS; REGULATORY ROLES; GENE-EXPRESSION; MICRORNAS; GENOME; BIOGENESIS; EVOLUTION; REVEALS; DIVERSE	This study presents the first characterization of endogenous small RNAs in a diatom, Thalassiosira pseudonana. Small RNAs act as transcriptional and translational regulators, controlling specific target genes involved in various cellular functions. Diatoms are unicellular photosynthetic organisms that play major roles in environmental processes, such as food webs and global carbon fixation. Small RNA cDNA libraries were constructed for exponentially growing T. pseudonana, and then subjected to highly parallel pyrosequencing (454) and sequencing-by-ligation (Applied Biosystems SOLiD). From the computational analysis of approximately 300,000 sequences in the 454 library and over 17 million sequences in the SOLiD libraries, there exists evidence of a core set of small RNA genes including: novel microRNAs, repeat-associated short interfering RNAs, and endogenous short interfering RNAs. The diatom genome contains elements similar to plant small RNA systems, such as the RNAi machinery, a high percentage of short interfering RNAs originating from protein-coding and repetitive regions of the genome, and putative binding sites of the small RNAs occurring primarily in the coding section of the predicted targets. The characterization of the small RNA transcriptome of T. pseudonana establishes the possibility of a wide range of gene regulatory mechanisms in diatoms.	[Norden-Krichmar, Trina M.; Gaasterland, Terry; Hildebrand, Mark] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Norden-Krichmar, Trina M.; Allen, Andrew E.] J Craig Venter Inst, San Diego, CA USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; J. Craig Venter Institute	Norden-Krichmar, TM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	aallen@jcvi.org	Allen, Andrew E/C-4896-2012	Allen, Andrew E/0000-0001-5911-6081	National Science Foundation [NSF-OCE-0722374, NSF-OCE-0727997, NSF-MCB-1024913]; Air Force Office of Scientific Research [FA9550-08-1-0178]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the National Science Foundation [NSF-OCE-0722374, NSF-OCE-0727997, and NSF-MCB-1024913 to A.E.A.; NSF Graduate Research Fellowship to T.M.N.-K.]; and the Air Force Office of Scientific Research [FA9550-08-1-0178 to M.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; DARLEY WM, 1969, EXP CELL RES, V58, P334, DOI 10.1016/0014-4827(69)90514-X; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hildebrand M, 2000, J PHYCOL, V36, P702, DOI 10.1046/j.1529-8817.2000.99153.x; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HSU D, 1994, J BACTERIOL, V176, P4761, DOI 10.1128/JB.176.15.4761-4765.1994; Hu Z, 2007, GEN ONT GO TERMS CLA; Hudson D, 1995, FASTA SOFTWARE; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Maheswari U, 2009, NUCLEIC ACIDS RES, V37, pD1001, DOI 10.1093/nar/gkn905; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maumus F, 2009, BMC EVOLUTI IN PRESS; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Norden-Krichmar TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-445; Ondov BD, 2008, BIOINFORMATICS, V24, P2776, DOI 10.1093/bioinformatics/btn512; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	75	25	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22870	10.1371/journal.pone.0022870	http://dx.doi.org/10.1371/journal.pone.0022870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857960	gold, Green Submitted, Green Published			2022-12-25	WOS:000293953500008
J	Xayarath, B; Volz, KW; Smart, JI; Freitag, NE				Xayarath, Bobbi; Volz, Karl W.; Smart, Jennifer I.; Freitag, Nancy E.			Probing the Role of Protein Surface Charge in the Activation of PrfA, the Central Regulator of Listeria monocytogenes Pathogenesis	PLOS ONE			English	Article							VIRULENCE REGULATOR; TRANSCRIPTIONAL ACTIVATOR; INTRACELLULAR GROWTH; BINDING-AFFINITY; RECEPTOR PROTEIN; HOST-CELLS; IN-VITRO; MUTATION; ACTA; EXPRESSION	Listeria monocytogenes is a food-borne intracellular bacterial pathogen capable of causing serious human disease. L. monocytogenes survival within mammalian cells depends upon the synthesis of a number of secreted virulence factors whose expression is regulated by the transcriptional activator PrfA. PrfA becomes activated following bacterial entry into host cells where it induces the expression of gene products required for bacterial spread to adjacent cells. Activation of PrfA appears to occur via the binding of a small molecule cofactor whose identity remains unknown. Electrostatic modeling of the predicted PrfA cofactor binding pocket revealed a highly positively charged region with two lysine residues, K64 and K122, located at the edge of the pocket and another (K130) located deep within the interior. Mutational analysis of these residues indicated that K64 and K122 contribute to intracellular activation of PrfA, whereas a K130 substitution abolished protein activity. The requirement of K64 and K122 for intracellular PrfA activation could be bypassed via the introduction of the prfA G145S mutation that constitutively activates PrfA in the absence of cofactor binding. Our data indicate that the positive charge of the PrfA binding pocket contributes to intracellular activation of PrfA, presumably by facilitating binding of an anionic cofactor.	[Xayarath, Bobbi; Volz, Karl W.; Smart, Jennifer I.; Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xayarath, B (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA.	nfreitag@uic.edu			Public Health Service, National Institute of Allergy and Infectious Diseases (NIAID) [AI41816]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041816, R01AI041816, R56AI041816] Funding Source: NIH RePORTER	Public Health Service, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI41816 (NEF) from the National Institute of Allergy and Infectious Diseases (NIAID). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Alonzo 3rd F, 2009, INFECT IMMUN; Alonzo F, 2009, INFECT IMMUN, V77, P2612, DOI 10.1128/IAI.00280-09; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bitar AP, 2008, J BACTERIOL, V190, P107, DOI 10.1128/JB.00852-07; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Bruno JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015138; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; CAMILLI A, 1989, P NATL ACAD SCI USA, V86, P5522, DOI 10.1073/pnas.86.14.5522; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Czuprynski Charles J., 2005, Animal Health Research Reviews, V6, P211, DOI 10.1079/AHR2005111; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freitag NE, 2006, FUTURE MICROBIOL, V1, P89, DOI 10.2217/17460913.1.1.89; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; FREITAG NE, 1994, MOL MICROBIOL, V12, P845, DOI 10.1111/j.1365-2958.1994.tb01070.x; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; HARMAN JG, 1986, J BIOL CHEM, V261, P6332; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Joseph B, 2007, MICROBES INFECT, V9, P1188, DOI 10.1016/j.micinf.2007.05.006; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; LAMPIDIS R, 1994, MOL MICROBIOL, V13, P141, DOI 10.1111/j.1365-2958.1994.tb00409.x; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; MARQUIS H, 1995, INFECT IMMUN, V63, P4531, DOI 10.1128/IAI.63.11.4531-4534.1995; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Miner MD, 2008, MICROB PATHOGENESIS, V45, P273, DOI 10.1016/j.micpath.2008.06.006; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Mueller KJ, 2005, INFECT IMMUN, V73, P1917, DOI 10.1128/IAI.73.4.1917-1926.2005; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Shetron-Rama LM, 2003, MOL MICROBIOL, V48, P1537, DOI 10.1046/j.1365-2958.2003.03534.x; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Swaminathan B, 2006, FOODBORNE PATHOG DIS, V3, P316, DOI 10.1089/fpd.2006.3.316; TAN GS, 1991, BIOCHEMISTRY-US, V30, P5076, DOI 10.1021/bi00234a034; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vega Y, 2004, MOL MICROBIOL, V52, P1553, DOI 10.1111/j.1365-2958.2004.04052.x; Vega Y, 1998, J BACTERIOL, V180, P6655, DOI 10.1128/JB.180.24.6655-6660.1998; Velge P, 2007, MICROBIOL-SGM, V153, P995, DOI 10.1099/mic.0.2006/002238-0; Vugia D., 2004, Morbidity and Mortality Weekly Report, V53, P340; Wong KKY, 2004, J BACTERIOL, V186, P6265, DOI 10.1128/JB.186.18.6265-6276.2004; Wong KKY, 2004, CELL MICROBIOL, V6, P155, DOI 10.1046/j.1462-5822.2003.00348.x; YOUNGMAN P, 1987, PLASMIDS PRACTICAL A, P79	57	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23502	10.1371/journal.pone.0023502	http://dx.doi.org/10.1371/journal.pone.0023502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858145	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500050
J	Maina, J; McClanahan, TR; Venus, V; Ateweberhan, M; Madin, J				Maina, Joseph; McClanahan, Tim R.; Venus, Valentijn; Ateweberhan, Mebrahtu; Madin, Joshua			Global Gradients of Coral Exposure to Environmental Stresses and Implications for Local Management	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; MODELING SUSCEPTIBILITY; CHAGOS ARCHIPELAGO; REEF DEVELOPMENT; SOLAR-RADIATION; WATER-QUALITY; OCEAN; RESILIENCE; MORTALITY	Background: The decline of coral reefs globally underscores the need for a spatial assessment of their exposure to multiple environmental stressors to estimate vulnerability and evaluate potential counter-measures. Methodology/Principal Findings: This study combined global spatial gradients of coral exposure to radiation stress factors (temperature, UV light and doldrums), stress-reinforcing factors (sedimentation and eutrophication), and stress-reducing factors (temperature variability and tidal amplitude) to produce a global map of coral exposure and identify areas where exposure depends on factors that can be locally managed. A systems analytical approach was used to define interactions between radiation stress variables, stress reinforcing variables and stress reducing variables. Fuzzy logic and spatial ordinations were employed to quantify coral exposure to these stressors. Globally, corals are exposed to radiation and reinforcing stress, albeit with high spatial variability within regions. Based on ordination of exposure grades, regions group into two clusters. The first cluster was composed of severely exposed regions with high radiation and low reducing stress scores (South East Asia, Micronesia, Eastern Pacific and the central Indian Ocean) or alternatively high reinforcing stress scores (the Middle East and the Western Australia). The second cluster was composed of moderately to highly exposed regions with moderate to high scores in both radiation and reducing factors (Caribbean, Great Barrier Reef (GBR), Central Pacific, Polynesia and the western Indian Ocean) where the GBR was strongly associated with reinforcing stress. Conclusions/Significance: Despite radiation stress being the most dominant stressor, the exposure of coral reefs could be reduced by locally managing chronic human impacts that act to reinforce radiation stress. Future research and management efforts should focus on incorporating the factors that mitigate the effect of coral stressors until long-term carbon reductions are achieved through global negotiations.	[Maina, Joseph; Madin, Joshua] Macquarie Univ, Dept Biol Sci, Computat Ecol Grp, Sydney, NSW 2109, Australia; [Maina, Joseph; McClanahan, Tim R.; Ateweberhan, Mebrahtu] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [Venus, Valentijn] Univ Twente, Fac Geoinformat Sci & Earth Observat, NL-7500 AE Enschede, Netherlands; [Ateweberhan, Mebrahtu] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Macquarie University; Wildlife Conservation Society; University of Twente; University of Warwick	Maina, J (corresponding author), Macquarie Univ, Dept Biol Sci, Computat Ecol Grp, Sydney, NSW 2109, Australia.	joseph.mbui@mq.edu.au	McClanahan, Tim/K-4998-2019; Venus, Valentijn/N-7766-2015	Venus, Valentijn/0000-0002-8313-9627; Maina, Joseph/0000-0003-1268-6137; Madin, Joshua/0000-0002-5005-6227; McClanahan, Timothy/0000-0001-5821-3584	Macquarie University; Australian Research Council; Wildlife Conservation Society; John D and Catherine T MacArthur Foundation	Macquarie University; Australian Research Council(Australian Research Council); Wildlife Conservation Society; John D and Catherine T MacArthur Foundation	This work was supported by Macquarie University's Higher Degree Research program, the Australian Research Council, and the Wildlife Conservation Society marine programs through financial support from the John D and Catherine T MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; ALBIETZ JM, 2006, WATERSHED PROT UNPUB; An P., 1991, CANADIAN J EXPLORATI, V27, P1; [Anonymous], 1987, HUMAN EXPOSURE ULTRA; Anthony KRN, 2007, MAR BIOL, V151, P1623, DOI 10.1007/s00227-006-0573-0; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Boss E, 2003, LIMNOL OCEANOGR, V48, P346, DOI 10.4319/lo.2003.48.1_part_2.0346; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; BURROUGH P. A., 2005, PRINCIPLES GEOGRAPHI; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carreiro-Silva M, 2009, MAR ECOL PROG SER, V392, P1, DOI 10.3354/meps08251; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Crabbe MJC, 2008, COMPUT BIOL CHEM, V32, P311, DOI 10.1016/j.compbiolchem.2008.04.001; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dunne RP, 2008, ECOL MODEL, V218, P188, DOI 10.1016/j.ecolmodel.2008.04.004; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Dunne RP, 1996, MAR ECOL PROG SER, V144, P109, DOI 10.3354/meps144109; Dunne RP, 2001, CORAL REEFS, V20, P201; Eastman J.R., 2003, IDRISI KILIMANJARO G; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fleitmann D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028525; Furnas M., 2003, CATCHMENTS CORALS TE; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Gibson J, 1998, OCEAN COAST MANAGE, V39, P229, DOI 10.1016/S0964-5691(98)00007-6; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Herman JR, 1999, J GEOPHYS RES-ATMOS, V104, P12059, DOI 10.1029/1999JD900062; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013913; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; ISUKAPALLI SS, 2001, COMPUTATIONAL METHOD; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Le Provost C, 1998, J GEOPHYS RES-OCEANS, V103, P5513, DOI 10.1029/97JC01733; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li AN, 2006, ECOL MODEL, V192, P175, DOI 10.1016/j.ecolmodel.2005.07.005; Liu X, 2003, ATMOS CHEM PHYS, V3, P1113, DOI 10.5194/acp-3-1113-2003; LOYA Y, 1976, B MAR SCI, V26, P450; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2009, MAR ECOL PROG SER, V380, P117, DOI 10.3354/meps07879; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; McClanahan TR, 2003, MAR ECOL PROG SER, V261, P135, DOI 10.3354/meps261135; McClanahan TR, 2002, ENVIRON CONSERV, V29, P460, DOI 10.1017/S0376892902000334; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V209, P103, DOI 10.1016/S0022-0981(96)02663-9; McKergow LA, 2005, MAR POLLUT BULL, V51, P200, DOI 10.1016/j.marpolbul.2004.11.029; Meesters EH, 1998, CONSERV BIOL, V12, P957, DOI 10.1046/j.1523-1739.1998.96421.x; MORA M, 2008, P ROYAL SOC B, V275, P767; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Morel A, 2006, REMOTE SENS ENVIRON, V102, P237, DOI 10.1016/j.rse.2006.01.022; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Palumbi SR, 2005, NATURE, V434, P713, DOI 10.1038/434713a; Parinet B, 2004, ECOL MODEL, V178, P295, DOI 10.1016/j.ecolmodel.2004.03.007; Qian SS, 2003, ECOL MODEL, V166, P87, DOI 10.1016/S0304-3800(03)00097-8; RAKOTOARISON HF, 2003, MEMOIRE FIN ETUDES U; Schroeder T, 2007, INT J REMOTE SENS, V28, P1469, DOI 10.1080/01431160600962574; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 1999, AMBIO, V28, P472; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Silvert W, 1997, ECOL MODEL, V96, P1, DOI 10.1016/S0304-3800(96)00051-8; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Vasilkov A, 2001, J GEOPHYS RES-OCEANS, V106, P27205, DOI 10.1029/2000JC000373; Vasilkov AP, 2005, APPL OPTICS, V44, P2863, DOI 10.1364/AO.44.002863; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wang HQ, 2010, INT J REMOTE SENS, V31, P439, DOI 10.1080/01431160902893485; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90046-8; Zhang HM, 2009, B AM METEOROL SOC, V90, P31, DOI 10.1175/2008BAMS2577.1; Zhang HM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027086; Zhao DZ, 2010, INT J REMOTE SENS, V31, P39, DOI 10.1080/01431160902882512	97	99	100	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23064	10.1371/journal.pone.0023064	http://dx.doi.org/10.1371/journal.pone.0023064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860667	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200039
J	Jiang, N; Wang, MH; Jia, TY; Wang, L; Leach, L; Hackett, C; Marshall, D; Luo, ZW				Jiang, Ning; Wang, Minghui; Jia, Tianye; Wang, Lin; Leach, Lindsey; Hackett, Christine; Marshall, David; Luo, Zewei			A Robust Statistical Method for Association-Based eQTL Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; COMPLEX TRAITS; COMMON DISEASE; HAPLOTYPE MAP; MODEL; STRATIFICATION; VARIANTS	Background: It has been well established that theoretical kernel for recently surging genome-wide association study (GWAS) is statistical inference of linkage disequilibrium (LD) between a tested genetic marker and a putative locus affecting a disease trait. However, LD analysis is vulnerable to several confounding factors of which population stratification is the most prominent. Whilst many methods have been proposed to correct for the influence either through predicting the structure parameters or correcting inflation in the test statistic due to the stratification, these may not be feasible or may impose further statistical problems in practical implementation. Methodology: We propose here a novel statistical method to control spurious LD in GWAS from population structure by incorporating a control marker into testing for significance of genetic association of a polymorphic marker with phenotypic variation of a complex trait. The method avoids the need of structure prediction which may be infeasible or inadequate in practice and accounts properly for a varying effect of population stratification on different regions of the genome under study. Utility and statistical properties of the new method were tested through an intensive computer simulation study and an association-based genome-wide mapping of expression quantitative trait loci in genetically divergent human populations. Results/Conclusions: The analyses show that the new method confers an improved statistical power for detecting genuine genetic association in subpopulations and an effective control of spurious associations stemmed from population structure when compared with other two popularly implemented methods in the literature of GWAS.	[Jiang, Ning; Wang, Minghui; Jia, Tianye; Leach, Lindsey; Luo, Zewei] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wang, Lin; Luo, Zewei] Fudan Univ, Lab Populat & Quantitat Genet, Inst Biostat, Shanghai 200433, Peoples R China; [Jiang, Ning; Hackett, Christine] Invergowrie, BioSS, Dundee, Scotland; [Marshall, David] Invergowrie, Scottish Crop Res Inst, Dundee, Scotland	University of Birmingham; Fudan University; James Hutton Institute; University of Dundee; James Hutton Institute	Jiang, N (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	z.luo@bham.ac.uk	Jia, Tianye/AAC-3925-2019; Wang, Minghui/P-8300-2017; Marshall, David F/F-2471-2011; Hackett, Christine/F-1196-2011	Jia, Tianye/0000-0001-5399-2953; Wang, Minghui/0000-0001-9171-4962; Marshall, David F/0000-0001-9309-2570; Compton, Lindsey/0000-0002-8441-2381	Biotechnology and Biological Sciences Research Council [RRAD11534]; Leverhulme Trust [RCEJ14713]; University of Birmingham and Biomathematics and Statistics Scotland (BioSS)	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); University of Birmingham and Biomathematics and Statistics Scotland (BioSS)	The research was funded by the Biotechnology and Biological Sciences Research Council (RRAD11534) and the Leverhulme Trust (RCEJ14713). NJ was also supported by a joint studentship between the University of Birmingham and Biomathematics and Statistics Scotland (BioSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P3071, DOI 10.1073/pnas.85.9.3071; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Ching OY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003362; Cochran W.G., 1967, STAT METHODS; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Johnson N.L., 1970, DISTRIBUTIONS STAT C; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Luo ZW, 1998, HEREDITY, V80, P198, DOI 10.1046/j.1365-2540.1998.00275.x; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peng Jie, 2007, BMC Proc, V1 Suppl 1, pS157; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wang MH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-328; Wang YT, 2005, HUM HERED, V59, P165, DOI 10.1159/000085940; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	56	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23192	10.1371/journal.pone.0023192	http://dx.doi.org/10.1371/journal.pone.0023192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858027	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300025
J	Kang, HT; Lee, KB; Kim, SY; Choi, HR; Park, SC				Kang, Hyun Tae; Lee, Ki Baek; Kim, Sung Young; Choi, Hae Ri; Park, Sang Chul			Autophagy Impairment Induces Premature Senescence in Primary Human Fibroblasts	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CELL BIOLOGY; INHIBITION; RESISTANCE; GENES; PATHOGENESIS; SUPPRESSION; DISRUPTION	Background: Recent studies have demonstrated that activation of autophagy increases the lifespan of organisms from yeast to flies. In contrast to the lifespan extension effect in lower organisms, it has been reported that overexpression of unc-51-like kinase 3 (ULK3), the mammalian homolog of autophagy-specific gene 1 (ATG1), induces premature senescence in human fibroblasts. Therefore, we assessed whether the activation of autophagy would genuinely induce premature senescence in human cells. Methodology/Principal Findings: Depletion of ATG7, ATG12, or lysosomal-associated membrane protein 2 (Lamp2) by transfecting siRNA or infecting cells with a virus containing gene-specific shRNA resulted in a senescence-like state in two strains of primary human fibroblasts. Prematurely senescent cells induced by autophagy impairment exhibited the senescent phenotypes, similar to the replicatively senescent cells, such as increased senescence associated beta-galactosidase (SA-beta-gal) activity, reactive oxygen species (ROS) generation, and accumulation of lipofuscin. In addition, expression levels of ribosomal protein S6 kinase1 (S6K1), p-S6K1, p-S6, and eukaryotic translation initiation factor 4E (eIF4E) binding protein 1 (4E-BP1) in the mammalian target of rapamycin (mTOR) pathway and beclin-1, ATG7, ATG12-ATG5 conjugate, and the sequestosome 1 (SQSTM1/p62) monomer in the autophagy pathway were decreased in both the replicatively and the autophagy impairment-induced prematurely senescent cells. Furthermore, it was found that ROS scavenging by N-acetylcysteine (NAC) and inhibition of p53 activation by pifithrin-alpha or knockdown of p53 using siRNA, respectively, delayed autophagy impairment-induced premature senescence and restored the expression levels of components in the mTOR and autophagy pathways. Conclusion: Taken together, we concluded that autophagy impairment induces premature senescence through a ROS- and p53-dependent manner in primary human fibroblasts.	[Kang, Hyun Tae; Park, Sang Chul] Seoul Natl Univ, Coll Med, Inst Aging, Seoul, South Korea; [Lee, Ki Baek; Kim, Sung Young; Choi, Hae Ri; Park, Sang Chul] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Park, Sang Chul] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Gachon University	Kang, HT (corresponding author), Seoul Natl Univ, Coll Med, Inst Aging, Seoul, South Korea.	scpark@snu.ac.kr	Kim, Sung Young/GMW-7968-2022	Kim, Sung Young/0000-0003-4702-8265; Lee, Ki Baek/0000-0002-0208-272X	Korean government (MEST) [2010-0029150]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation (NRF) grant funded by the Korean government (MEST) (No. 2010-0029150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; CUERVO AM, 2003, SCI AGING KNOWLEDGE, pPE25; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; DOLBEARE FA, 1977, CLIN CHEM, V23, P1485; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hashimoto Y, 2009, GENES CELLS, V14, P717, DOI 10.1111/j.1365-2443.2009.01306.x; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ren CL, 2009, EXP GERONTOL, V44, P228, DOI 10.1016/j.exger.2008.10.002; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Straniero S, 2009, REJUV RES, V12, P77, DOI 10.1089/rej.2008.0806; Stroikin Y, 2007, BIOGERONTOLOGY, V8, P43, DOI 10.1007/s10522-006-9029-7; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Terman A, 1999, EXP GERONTOL, V34, P943, DOI 10.1016/S0531-5565(99)00070-4; Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015; VANNOORDEN CJF, 1987, HISTOCHEM J, V19, P483, DOI 10.1007/BF01675418; Wang A.L., 2009, PLOS ONE, V4; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang H, 2000, EXP CELL RES, V259, P284, DOI 10.1006/excr.2000.4965; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838	57	166	172	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23367	10.1371/journal.pone.0023367	http://dx.doi.org/10.1371/journal.pone.0023367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858089	Green Published, Green Submitted, gold			2022-12-25	WOS:000293773300025
J	Gehring, M; Missirian, V; Henikoff, S				Gehring, Mary; Missirian, Victor; Henikoff, Steven			Genomic Analysis of Parent-of-Origin Allelic Expression in Arabidopsis thaliana Seeds	PLOS ONE			English	Article							POLYCOMB GROUP GENE; DNA HYPOMETHYLATION; IMPRINTED GENES; ENDOSPERM; MEDEA; PROTEIN; AUXIN; MAIZE; EMBRYOGENESIS; DEMETHYLATION	Differential expression of maternally and paternally inherited alleles of a gene is referred to as gene imprinting, a form of epigenetic gene regulation common to flowering plants and mammals. In plants, imprinting primarily occurs in the endosperm, a seed tissue that supports the embryo during its growth and development. Previously, we demonstrated that widespread DNA demethylation at remnants of transposable elements accompanies endosperm development and that a subset of these methylation changes are associated with gene imprinting. Here we assay imprinted gene expression genome-wide by performing high-throughput sequencing of RNA derived from seeds of reciprocal intraspecific crosses. We identify more than 200 loci that exhibit parent-of-origin effects on gene expression in the endosperm, including a large number of transcription factors, hormone biosynthesis and response genes, and genes that encode regulators of epigenetic information, such as methylcytosine binding proteins, histone methyltransferases, and chromatin remodelers. The majority of these genes are partially, rather than completely, imprinted, suggesting that gene dosage regulation is an important aspect of imprinted gene expression.	[Gehring, Mary; Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Gehring, Mary; Missirian, Victor; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gehring, Mary] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gehring, Mary] MIT, Dept Biol, Cambridge, MA USA; [Missirian, Victor] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Davis	Gehring, M (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	mgehring@wi.mit.edu		Henikoff, Steven/0000-0002-7621-8685	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funded by Howard Hughes Medical Institute (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Baroux C, 2007, PLANT CELL, V19, P1782, DOI 10.1105/tpc.106.046235; Becerra C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-38; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Bomblies K, 2007, CURR OPIN GENET DEV, V17, P500, DOI 10.1016/j.gde.2007.09.006; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Bureau M, 2010, PLANT MOL BIOL, V74, P479, DOI 10.1007/s11103-010-9688-2; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jahnke S, 2009, CURR BIOL, V19, P1677, DOI 10.1016/j.cub.2009.08.053; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; KERMICLE JL, 1970, GENETICS, V66, P69; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; Stupar RM, 2007, PLANT PHYSIOL, V145, P411, DOI 10.1104/pp.107.101428; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tiwari S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-72; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Yang S, 2008, DEVELOPMENT, V135, P3501, DOI 10.1242/dev.026708; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	59	138	145	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23687	10.1371/journal.pone.0023687	http://dx.doi.org/10.1371/journal.pone.0023687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858209	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300084
J	Jang, Y; Hahm, EH; Lee, HJ; Park, S; Won, YJ; Choe, JC				Jang, Yikweon; Hahm, Eun Hye; Lee, Hyun-Jung; Park, Soyeon; Won, Yong-Jin; Choe, Jae C.			Geographic Variation in Advertisement Calls in a Tree Frog Species: Gene Flow and Selection Hypotheses	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; GRYLLUS-FULTONI ORTHOPTERA; FEMALE MATE CHOICE; ALLOPATRIC POPULATIONS; DETERMINISTIC CHAOS; SEXUAL SELECTION; CANYON TREEFROG; XENOPUS-LAEVIS; SPECIATION; DIVERGENCE	Background: In a species with a large distribution relative to its dispersal capacity, geographic variation in traits may be explained by gene flow, selection, or the combined effects of both. Studies of genetic diversity using neutral molecular markers show that patterns of isolation by distance (IBD) or barrier effect may be evident for geographic variation at the molecular level in amphibian species. However, selective factors such as habitat, predator, or interspecific interactions may be critical for geographic variation in sexual traits. We studied geographic variation in advertisement calls in the tree frog Hyla japonica to understand patterns of variation in these traits across Korea and provide clues about the underlying forces for variation. Methodology: We recorded calls of H. japonica in three breeding seasons from 17 localities including localities in remote Jeju Island. Call characters analyzed were note repetition rate (NRR), note duration (ND), and dominant frequency (DF), along with snout-to-vent length. Results: The findings of a barrier effect on DF and a longitudinal variation in NRR seemed to suggest that an open sea between the mainland and Jeju Island and mountain ranges dominated by the north-south Taebaek Mountains were related to geographic variation in call characters. Furthermore, there was a pattern of IBD in mitochondrial DNA sequences. However, no comparable pattern of IBD was found between geographic distance and call characters. We also failed to detect any effects of habitat or interspecific interaction on call characters. Conclusions: Geographic variations in call characters as well as mitochondrial DNA sequences were largely stratified by geographic factors such as distance and barriers in Korean populations of H. japoinca. Although we did not detect effects of habitat or interspecific interaction, some other selective factors such as sexual selection might still be operating on call characters in conjunction with restricted gene flow.	[Jang, Yikweon; Hahm, Eun Hye; Lee, Hyun-Jung; Park, Soyeon; Won, Yong-Jin; Choe, Jae C.] Ewha Womans Univ, Div EcoSci, Seoul, South Korea	Ewha Womans University	Jang, Y (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	jangy@ewha.ac.kr; won@ewha.ac.kr; jaechoe@ewha.ac.kr			National Academy of Agricultural Science [PJ006788]; National Research Foundation of Korea [371-2009-1-C00001]	National Academy of Agricultural Science; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported financially by a research grant of the National Academy of Agricultural Science (PJ006788) to YJ and by a National Research Foundation of Korea grant (371-2009-1-C00001) to Y-JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Barber PH, 1999, MOL ECOL, V8, P563, DOI 10.1046/j.1365-294x.1999.00594.x; Barber PH, 1999, MOL ECOL, V8, P547, DOI 10.1046/j.1365-294x.1999.00593.x; Benko TP, 2006, J BIOL SYST, V14, P555, DOI 10.1142/S0218339006002008; Benko TP, 2007, J BIOSCIENCES, V32, P797, DOI 10.1007/s12038-007-0081-5; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Bradbury Jack W., 1998, pi; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Carr JA, 2003, ENVIRON TOXICOL CHEM, V22, P396, DOI [10.1897/1551-5028(2003)022&lt;0396:ROLXLT&gt;2.0.CO;2, 10.1002/etc.5620220222]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cuenca A, 2003, MOL ECOL, V12, P2087, DOI 10.1046/j.1365-294X.2003.01890.x; Davidson C, 2002, CONSERV BIOL, V16, P1588, DOI 10.1046/j.1523-1739.2002.01030.x; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Doutrelant C, 1999, BEHAVIOUR, V136, P481, DOI 10.1163/156853999501432; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; FOUQUETTE MJ, 1975, SYST ZOOL, V24, P16, DOI 10.2307/2412694; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gabor CR, 2001, P ROY SOC B-BIOL SCI, V268, P1063, DOI 10.1098/rspb.2001.1626; GERHARDT HC, 1994, ANIM BEHAV, V47, P959, DOI 10.1006/anbe.1994.1127; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Guarnizo CE, 2009, MOL PHYLOGENET EVOL, V50, P84, DOI 10.1016/j.ympev.2008.10.005; Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hitchings SP, 1997, HEREDITY, V79, P117, DOI 10.1038/hdy.1997.134; Hobel G, 2003, EVOLUTION, V57, P894; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Jang Y, 2006, J EVOLUTION BIOL, V19, P459, DOI 10.1111/j.1420-9101.2005.01014.x; Jang Y, 2007, J INSECT BEHAV, V20, P33, DOI 10.1007/s10905-006-9061-0; Jang Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P150, DOI 10.1007/s00265-005-0151-3; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura MA, 1985, NEUTRAL THEORY MOL E; Knoll S, 1998, HEREDITY, V81, P412, DOI 10.1046/j.1365-2540.1998.00411.x; Kodba S, 2005, EUR J PHYS, V26, P205, DOI 10.1088/0143-0807/26/1/021; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KURAMOTO M, 1984, COPEIA, P609; KURAMOTO M, 1980, COPEIA, P100; Lee Jung Eun, 1999, Korean Journal of Biological Sciences, V3, P295; Lefebvre T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-38; LOFTUSHILLS JJ, 1992, EVOLUTION, V46, P896, DOI 10.1111/j.1558-5646.1992.tb00607.x; Marquez R, 1997, ANIM BEHAV, V54, P1333, DOI 10.1006/anbe.1997.0529; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Monsen KJ, 2004, CONSERV GENET, V5, P827, DOI 10.1007/s10592-004-1981-z; Ohta T, 1972, J Mol Evol, V1, P150, DOI 10.1007/BF01659161; Palo JU, 2004, MOL ECOL, V13, P2631, DOI 10.1111/j.1365-294X.2004.02269.x; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Prohl H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-146; Prohl H, 2006, EVOLUTION, V60, P1669; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Ryan MJ, 1996, EVOLUTION, V50, P2435, DOI 10.1111/j.1558-5646.1996.tb03630.x; RYAN MJ, 2002, ACOUSTIC COMMUNICATI, P225; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Siva-Jothy MT, 1999, BEHAVIOUR, V136, P1365, DOI 10.1163/156853999500776; Slabbekoom H, 2004, J ACOUST SOC AM, V116, P3727, DOI 10.1121/1.1811121; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1978, J THEOR BIOL, V70, P213, DOI 10.1016/0022-5193(78)90348-X; Sokal R. R., 2012, BIOMETRY; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; Svensson EI, 2004, HEREDITY, V93, P423, DOI 10.1038/sj.hdy.6800519; Tavera-Mendoza L, 2002, ENVIRON TOXICOL CHEM, V21, P527, DOI 10.1897/1551-5028(2002)021&lt;0527:ROTATX&gt;2.0.CO;2; Thompson DB, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P33; van Dongen WFD, 2006, J AVIAN BIOL, V37, P349, DOI 10.1111/j.2006.0908-8857.03578.x; WALDMANN B, 1993, INBREEDING OUTBREEDI; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2; WRIGHT S., 1938, Science (Washington), V87, P430; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; Wycherley J, 2002, J ZOOL, V258, P479, DOI 10.1017/S0952836902001632; YANG S-Y, 1988, Korean Journal of Zoology, V31, P11; Yang SY, 1997, KOREAN J GENETIC, V19, P71; YANG SY, 2000, MONOGRAPH KOREAN AMP; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21	86	36	36	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23297	10.1371/journal.pone.0023297	http://dx.doi.org/10.1371/journal.pone.0023297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858061	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300030
J	Piro, RM; Molineris, I; Ala, U; Di Cunto, F				Piro, Rosario M.; Molineris, Ivan; Ala, Ugo; Di Cunto, Ferdinando			Evaluation of Candidate Genes from Orphan FEB and GEFS plus Loci by Analysis of Human Brain Gene Expression Atlases	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; FEBRILE SEIZURES PLUS; CHILDHOOD ABSENCE EPILEPSY; GENERALIZED EPILEPSY; SODIUM-CHANNEL; SUSCEPTIBILITY LOCUS; BIPOLAR DISORDER; MENKES-DISEASE; LOBE EPILEPSY; NAPG GENE	Febrile seizures, or febrile convulsions (FEB), represent the most common form of childhood seizures and are believed to be influenced by variations in several susceptibility genes. Most of the associated loci, however, remain 'orphan', i.e. the susceptibility genes they contain still remain to be identified. Further orphan loci have been mapped for a related disorder, genetic (generalized) epilepsy with febrile seizures plus (GEFS+). We show that both spatially mapped and 'traditional' gene expression data from the human brain can be successfully employed to predict the most promising candidate genes for FEB and GEFS+, apply our prediction method to the remaining orphan loci and discuss the validity of the predictions. For several of the orphan FEB/GEFS+ loci we propose excellent, and not always obvious, candidates for mutation screening in order to aid in gaining a better understanding of the genetic origin of the susceptibility to seizures.	Univ Turin, Ctr Mol Biotechnol, Turin, Italy; Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	University of Turin; University of Turin	Piro, RM (corresponding author), German Canc Res Ctr, Dept Theoret Bioinformat, Heidelberg, Germany.	r.piro@dkfz.de	Di Cunto, Ferdinando/K-5575-2016; Piro, Rosario M./AAT-6937-2020; Ala, Ugo/K-2029-2016	Piro, Rosario M./0000-0002-3066-7397; Ala, Ugo/0000-0001-5408-6397; di cunto, ferdinando/0000-0001-9367-6357; Molineris, Ivan/0000-0003-2102-0804	Regione Piemonte; Italian Ministry of Education, University and Research; Fondazione San Paolo; Progetto Neuroscienze	Regione Piemonte(Regione Piemonte); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione San Paolo(Compagnia di San Paolo); Progetto Neuroscienze	Funding was provided by Regione Piemonte (to F.D.C.); the FIRB-Italbionet program of the Italian Ministry of Education, University and Research (to F.D.C.); the Fondazione San Paolo (to F.D.C.); and Progetto Neuroscienze (to F.D.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; Audenaert D, 2005, J MED GENET, V42, P947, DOI 10.1136/jmg.2005.031393; Bahi-Buisson N, 2006, EPILEPSIA, V47, P380, DOI 10.1111/j.1528-1167.2006.00432.x; BARAM TZ, 1991, DEV BRAIN RES, V61, P97, DOI 10.1016/0165-3806(91)90118-3; Baram TZ, 1998, TRENDS NEUROSCI, V21, P471, DOI 10.1016/S0166-2236(98)01275-2; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Bousquet-Moore D, 2010, NEUROBIOL DIS, V37, P130, DOI 10.1016/j.nbd.2009.09.016; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Brunson KL, 2001, BRAIN DEV-JPN, V23, P533, DOI 10.1016/S0387-7604(01)00312-6; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Dai XH, 2008, HUM GENET, V124, P423, DOI 10.1007/s00439-008-0566-9; Deprez L, 2006, HUM GENET, V118, P618, DOI 10.1007/s00439-005-0077-x; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; EIPPER BA, 1993, ANN NY ACAD SCI, V680, P147, DOI 10.1111/j.1749-6632.1993.tb19681.x; Empson RM, 2001, NEUROSCIENCE, V102, P297, DOI 10.1016/S0306-4522(00)00494-2; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Hedera P, 2006, EPILEPSIA, V47, P1622, DOI 10.1111/j.1528-1167.2006.00637.x; Howlett E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000277; *HUM BRAIN, HUM BRAIN ATL; Ito M, 2006, EPILEPSY RES, V70, pS199, DOI 10.1016/j.eplepsyres.2005.11.028; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V219, P795, DOI 10.1006/bbrc.1996.0313; Kaler SG, 2010, J INHERIT METAB DIS, V33, P583, DOI 10.1007/s10545-010-9118-2; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klaassen A, 2006, P NATL ACAD SCI USA, V103, P19152, DOI 10.1073/pnas.0608215103; Koyama R, 2010, J PHARMACOL SCI, V113, P14, DOI 10.1254/jphs.09R19FM; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Lewis D V, 1999, Curr Opin Neurol, V12, P197, DOI 10.1097/00019052-199904000-00011; Li XW, 2009, NEUROSCI LETT, V457, P159, DOI 10.1016/j.neulet.2009.03.070; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Nabbout R, 2007, NEUROLOGY, V68, P1374, DOI 10.1212/01.wnl.0000260062.02829.e3; Nabbout R, 2002, BRAIN, V125, P2668, DOI 10.1093/brain/awf281; Nakayama J, 2000, HUM MOL GENET, V9, P87, DOI 10.1093/hmg/9.1.87; Nakayama J, 2004, NEUROLOGY, V63, P1803, DOI 10.1212/01.WNL.0000144499.34164.E0; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Nakayama J, 2006, EPILEPSY RES, V70, pS190, DOI 10.1016/j.eplepyres.2005.11.023; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; PESTANA K, 2009, EPILEPTIC DISORD, V11, P138; Piro RM, 2010, BIOINFORMATICS, V26, pI618, DOI 10.1093/bioinformatics/btq396; Poduri A, 2009, NEUROLOGY, V73, P1264, DOI 10.1212/WNL.0b013e3181bd10d3; Prashanth LK, 2010, J NEUROL SCI, V291, P44, DOI 10.1016/j.jns.2010.01.007; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Reid AY, 2009, CAN J NEUROL SCI, V36, P679, DOI 10.1017/S0317167100008246; Russ J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-305; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Scheffer IE, 2008, EPILEPSY COMPREHENSI, V2nd, P2553; Schlachter K, 2009, NEUROLOGY, V72, P974, DOI 10.1212/01.wnl.0000344401.02915.00; Shinnar, 2002, FEBRILE SEIZURES, P63; Shinoda S, 2004, J CLIN INVEST, V113, P1059, DOI 10.1172/JCI200419971; Sijben AEJ, 2009, EPILEPSIA, V50, P953, DOI 10.1111/j.1528-1167.2009.02023.x; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Singleton WCJ, 2010, J BIOL CHEM, V285, P27111, DOI 10.1074/jbc.M110.154468; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Skradski SL, 1998, GENOMICS, V49, P188, DOI 10.1006/geno.1998.5229; SMITH BN, 1994, J NEUROPHYSIOL, V72, P2328, DOI 10.1152/jn.1994.72.5.2328; Stocker M, 1998, BIOCHEM BIOPH RES CO, V248, P927, DOI 10.1006/bbrc.1998.9072; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Taylor GA, 2008, GENES BRAIN BEHAV, V7, P786, DOI 10.1111/j.1601-183X.2008.00420.x; Tran V, 1999, EPILEPSIA, V40, P1190, DOI 10.1111/j.1528-1157.1999.tb00847.x; Valdivia CR, 2009, AM J PHYSIOL-HEART C, V297, pH1446, DOI 10.1152/ajpheart.00513.2009; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; Weller AE, 2006, PSYCHIAT GENET, V16, P3, DOI 10.1097/01.ypg.0000180678.88169.b0; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; Xu L, 2008, J CLIN INVEST, V118, P272, DOI 10.1172/JCI33009; Yosifova A, 2009, J AFFECT DISORDERS, V117, P87, DOI 10.1016/j.jad.2008.12.021; Yuhas Y, 2004, J NEUROIMMUNOL, V153, P36, DOI 10.1016/j.jneuroim.2004.04.009; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001	86	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23149	10.1371/journal.pone.0023149	http://dx.doi.org/10.1371/journal.pone.0023149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858011	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300013
J	Shono, T; Kurokawa, D; Miyake, T; Okabe, M				Shono, Takanori; Kurokawa, Daisuke; Miyake, Tsutomu; Okabe, Masataka			Acquisition of glial cells missing 2 Enhancers Contributes to a Diversity of Ionocytes in Zebrafish	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CHLORIDE CELLS; HUMAN HOMOLOG; H+-ATPASE; DROSOPHILA; DIFFERENTIATION; FISH; GCM2; SPECIFICATION; EXPRESSION	Glial cells missing 2 (gcm2) encoding a GCM-motif transcription factor is expressed in the parathyroid in amniotes. In contrast, gcm2 is expressed in pharyngeal pouches (a homologous site of the parathyroid), gills, and H+-ATPase-rich cells (HRCs), a subset of ionocytes on the skin surface of the teleost fish zebrafish. Ionocytes are specialized cells that are involved in osmotic homeostasis in aquatic vertebrates. Here, we showed that gcm2 is essential for the development of HRCs and Na+-Cl- co-transporter-rich cells (NCCCs), another subset of ionocytes in zebrafish. We also identified gcm2 enhancer regions that control gcm2 expression in ionocytes of zebrafish. Comparisons of the gcm2 locus with its neighboring regions revealed no conserved elements between zebrafish and tetrapods. Furthermore, We observed gcm2 expression patterns in embryos of the teleost fishes Medaka (Oryzias latipes) and fugu (Fugu niphobles), the extant primitive ray-finned fishes Polypterus (Polypterus senegalus) and sturgeon (a hybrid of Huso huso x Acipenser ruhenus), and the amphibian Xenopus (Xenopus laevis). Although gcm2-expressing cells were observed on the skin surface of Medaka and fugu, they were not found in Polypterus, sturgeon, or Xenopus. Our results suggest that an acquisition of enhancers for the expression of gcm2 contributes to a diversity of ionocytes in zebrafish during evolution.	[Shono, Takanori; Miyake, Tsutomu; Okabe, Masataka] Jikei Univ, Dept Anat, Sch Med, Tokyo 105, Japan; [Kurokawa, Daisuke] Univ Tokyo, Misaki Marine Biol Stn, Kanagawa, Japan	Jikei University; University of Tokyo	Shono, T (corresponding author), Jikei Univ, Dept Anat, Sch Med, Tokyo 105, Japan.	maokabe@jikei.ac.jp		Miyake, Tsutomu/0000-0001-9066-3219	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Altshuller Y, 1996, FEBS LETT, V393, P201, DOI 10.1016/0014-5793(96)00890-3; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; BALLARD WW, 1964, J MORPHOL, V114, P465, DOI 10.1002/jmor.1051140307; Basyuk E, 1999, DEV DYNAM, V214, P303, DOI 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.3.CO;2-2; Bernardoni R, 1997, DEV BIOL, V191, P118; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chang WJ, 2009, AM J PHYSIOL-REG I, V296, pR1192, DOI 10.1152/ajpregu.90973.2008; Dubaissi E, 2011, DIS MODEL MECH, V4, P179, DOI 10.1242/dmm.006494; Esaki M, 2009, DEV BIOL, V329, P116, DOI 10.1016/j.ydbio.2009.02.026; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hanaoka R, 2004, MECH DEVELOP, V121, P1235, DOI 10.1016/j.mod.2004.05.011; Hashemolhosseini S, 2002, MECH DEVELOP, V118, P175, DOI 10.1016/S0925-4773(02)00239-3; Hirose S, 2003, COMP BIOCHEM PHYS B, V136, P593, DOI 10.1016/S1096-4959(03)00287-2; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hogan BM, 2004, DEV BIOL, V276, P508, DOI 10.1016/j.ydbio.2004.09.018; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Hwang PP, 2009, J EXP BIOL, V212, P1745, DOI 10.1242/jeb.026054; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Janicke M, 2007, DEV BIOL, V307, P258, DOI 10.1016/j.ydbio.2007.04.044; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 1999, CYTOGENET CELL GENET, V84, P43, DOI 10.1159/000015210; Kaneko T, 2002, FISHERIES SCI, V68, P1, DOI 10.1046/j.1444-2906.2002.00382.x; Kanemura Y, 1999, FEBS LETT, V442, P151, DOI 10.1016/S0014-5793(98)01650-0; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Nait-Oumesmar B, 2000, J HISTOCHEM CYTOCHEM, V48, P915, DOI 10.1177/002215540004800704; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ohno S., 1970, EVOLUTION GENE DUPLI; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; PHILPOTT CW, 1980, AM J PHYSIOL, V238, pR171, DOI 10.1152/ajpregu.1980.238.3.R171; Quigley IK, 2011, DEVELOPMENT, V138, P705, DOI 10.1242/dev.055699; Vincent S, 1996, DEVELOPMENT, V122, P131; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010; Wang YF, 2009, AM J PHYSIOL-REG I, V296, pR1650, DOI 10.1152/ajpregu.00119.2009; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	50	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23746	10.1371/journal.pone.0023746	http://dx.doi.org/10.1371/journal.pone.0023746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858216	gold, Green Submitted, Green Published			2022-12-25	WOS:000294121300090
J	Prevorovsky, M; Atkinson, SR; Ptackova, M; McLean, JR; Gould, K; Folk, P; Puta, F; Bahler, J				Prevorovsky, Martin; Atkinson, Sophie R.; Ptackova, Martina; McLean, Janel R.; Gould, Kathleen; Folk, Petr; Puta, Frantisek; Baehler, Juerg			N-Termini of Fungal CSL Transcription Factors Are Disordered, Enriched in Regulatory Motifs and Inhibit DNA Binding in Fission Yeast	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; UNSTRUCTURED PROTEINS; CRYSTAL-STRUCTURE; NOTCH; SUPPRESSOR; PREDICTION; HAIRLESS; COMPLEX; GENOME; CELL	Background: CSL (CBF1/RBP-J kappa/Suppressor of Hairless/LAG-1) transcription factors are the effector components of the Notch receptor signalling pathway, which is critical for metazoan development. The metazoan CSL proteins (class M) can also function in a Notch-independent manner. Recently, two novel classes of CSL proteins, designated F1 and F2, have been identified in fungi. The role of the fungal CSL proteins is unclear, because the Notch pathway is not present in fungi. In fission yeast, the Cbf11 and Cbf12 CSL paralogs play antagonistic roles in cell adhesion and the coordination of cell and nuclear division. Unusually long N-terminal extensions are typical for fungal and invertebrate CSL family members. In this study, we investigate the functional significance of these extended N-termini of CSL proteins. Methodology/Principal Findings: We identify 15 novel CSL family members from 7 fungal species and conduct bioinformatic analyses of a combined dataset containing 34 fungal and 11 metazoan CSL protein sequences. We show that the long, non-conserved N-terminal tails of fungal CSL proteins are likely disordered and enriched in phosphorylation sites and PEST motifs. In a case study of Cbf12 (class F2), we provide experimental evidence that the protein is proteolytically processed and that the N-terminus inhibits the Cbf12-dependent DNA binding activity in an electrophoretic mobility shift assay. Conclusions/Significance: This study provides insight into the characteristics of the long N-terminal tails of fungal CSL proteins that may be crucial for controlling DNA-binding and CSL function. We propose that the regulation of DNA binding by Cbf12 via its N-terminal region represents an important means by which fission yeast strikes a balance between the class F1 and class F2 paralog activities. This mode of regulation might be shared with other CSL-positive fungi, some of which are relevant to human disease and biotechnology.	[Prevorovsky, Martin; Atkinson, Sophie R.; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London, England; [Prevorovsky, Martin; Atkinson, Sophie R.; Baehler, Juerg] UCL, UCL Canc Inst, London, England; [Prevorovsky, Martin; Ptackova, Martina; Folk, Petr; Puta, Frantisek] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic; [McLean, Janel R.; Gould, Kathleen] Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37212 USA; [McLean, Janel R.; Gould, Kathleen] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA	University of London; University College London; University of London; University College London; Charles University Prague; Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Prevorovsky, M (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	m.prevorovsky@ucl.ac.uk	Folk, Petr/V-7545-2017; Převorovský, Martin/R-5191-2016; Bahler, Jurg/B-4572-2009; Půta, František/K-6731-2017	Folk, Petr/0000-0003-3813-7777; Převorovský, Martin/0000-0003-0277-8361; Bahler, Jurg/0000-0003-4036-1532; Půta, František/0000-0002-8313-878X; Gould, Kathleen/0000-0002-3810-4070	Cancer Research UK; Czech Ministry of Education, Youth and Sports [MSM0021620858, LC07032]; Charles University Grant Agency [92009]; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Charles University Grant Agency; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by Cancer Research UK, and Grants No. MSM0021620858 and LC07032 of the Czech Ministry of Education, Youth and Sports, and No. 92009 of the Charles University Grant Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Edwards YJK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r50; Erchiga VC, 2002, CURR OPIN INFECT DIS, V15, P133, DOI 10.1097/00001432-200204000-00006; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Gsponer J, 2009, PROGR BIOPHYSICS MOL; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hayward SD, 2004, SEMIN CANCER BIOL, V14, P387, DOI 10.1016/j.semcancer.2004.04.018; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XH, 2006, BIOINFORMATICS, V22, P2980, DOI 10.1093/bioinformatics/btl495; Liu F, 2004, J BIOL CHEM, V279, P34537, DOI 10.1074/jbc.M402475200; Liu ZQ, 1996, FEBS LETT, V385, P109, DOI 10.1016/0014-5793(96)00360-2; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mendes-Giannini MJS, 2005, FEMS IMMUNOL MED MIC, V45, P383, DOI 10.1016/j.femsim.2005.05.014; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Prabhu RM, 2004, CLIN MICROBIOL INFEC, V10, P31, DOI 10.1111/j.1470-9465.2004.00843.x; Prevorovsky M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-233; Prevorovsky M, 2009, EXP CELL RES, V315, P1533, DOI 10.1016/j.yexcr.2008.12.001; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Raijmakers R, 2010, ANAL CHEM, V82, P824, DOI 10.1021/ac901764g; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts-Galbraith RH, 2009, J CELL BIOL, V184, P113, DOI 10.1083/jcb.200806044; Sandoval A, 2006, EUR J NEUROSCI, V23, P2311, DOI 10.1111/j.1460-9568.2006.04749.x; Singh GP, 2006, PROTEINS, V62, P309, DOI 10.1002/prot.20746; Snellinx Z, 2002, ENVIRON SCI POLLUT R, V9, P48, DOI 10.1007/BF02987316; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warringer J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-61; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	67	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23650	10.1371/journal.pone.0023650	http://dx.doi.org/10.1371/journal.pone.0023650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858190	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500059
J	Rahman, TJ; Walker, EA; Mayosi, BM; Hall, DH; Avery, PJ; Connell, JMC; Watkins, H; Stewart, PM; Keavney, B				Rahman, Thahira J.; Walker, Elizabeth A.; Mayosi, Bongani M.; Hall, Darroch H.; Avery, Peter J.; Connell, John M. C.; Watkins, Hugh; Stewart, Paul M.; Keavney, Bernard			Genotype at the P554L Variant of the Hexose-6 Phosphate Dehydrogenase Gene Is Associated with Carotid Intima-Medial Thickness	PLOS ONE			English	Article							HEXOSE-6-PHOSPHATE DEHYDROGENASE; BLOOD-PRESSURE; ATHEROSCLEROSIS; POLYMORPHISMS; DISEASE; TYPE-1; FAMILY; MAPS	Objective: The combined thickness of the intima and media of the carotid artery (carotid intima-medial thickness, CIMT) is associated with cardiovascular disease and stroke. Previous studies indicate that carotid intima-medial thickness is a significantly heritable phenotype, but the responsible genes are largely unknown. Hexose-6 phosphate dehydrogenase (H6PDH) is a microsomal enzyme whose activity regulates corticosteroid metabolism in the liver and adipose tissue; variability in measures of corticosteroid metabolism within the normal range have been associated with risk factors for cardiovascular disease. We performed a genetic association study in 854 members of 224 families to assess the relationship between polymorphisms in the gene coding for hexose-6 phosphate dehydrogenase (H6PD) and carotid intima-medial thickness. Methods: Families were ascertained via a hypertensive proband. CIMT was measured using B-mode ultrasound. Single nucleotide polymorphisms (SNPs) tagging common variation in the H6PD gene were genotyped. Association was assessed following adjustment for significant covariates including "classical" cardiovascular risk factors. Functional studies to determine the effect of particular SNPs on H6PDH were performed. Results: There was evidence of association between the single nucleotide polymorphism rs17368528 in exon five of the H6PD gene, which encodes an amino-acid change from proline to leucine in the H6PDH protein, and mean carotid intimamedial thickness (p = 0.00065). Genotype was associated with a 5% (or 0.04 mm) higher mean carotid intima-medial thickness measurement per allele, and determined 2% of the population variability in the phenotype. Conclusions: Our results suggest a novel role for the H6PD gene in atherosclerosis susceptibility.	[Rahman, Thahira J.; Hall, Darroch H.; Keavney, Bernard] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Walker, Elizabeth A.; Stewart, Paul M.] Univ Birmingham, Dept Med, Birmingham, W Midlands, England; [Mayosi, Bongani M.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Avery, Peter J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Connell, John M. C.] Univ Dundee, Dept Med, Dundee, Scotland; [Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England	Newcastle University - UK; University of Birmingham; University of Cape Town; Newcastle University - UK; University of Dundee; University of Oxford	Rahman, TJ (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	b.d.keavney@ncl.ac.uk		s, hema/0000-0002-3440-9475; Keavney, Bernard/0000-0001-9573-0812; Mayosi, Bongani/0000-0001-6641-8950; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Watkins, Hugh/0000-0002-5287-9016	British Heart Foundation; MRC [G0400874] Funding Source: UKRI; British Heart Foundation [RG/08/012/25941] Funding Source: researchfish; Medical Research Council [G0400874] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; ADAMS MR, 1995, CIRCULATION, V92, P2127, DOI 10.1161/01.CIR.92.8.2127; Baker M, 2005, DIABETES, V54, P2492, DOI 10.2337/diabetes.54.8.2492; Banhegyi G, 2009, J MOL ENDOCRINOL, V42, P283, DOI 10.1677/JME-08-0156; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; Hewitt KN, 2005, ENDOCRINOLOGY, V146, P2539, DOI 10.1210/en.2005-0117; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Lanktree MB, 2009, STROKE, V40, P3173, DOI 10.1161/STROKEAHA.109.556563; Lavery GG, 2008, J CLIN ENDOCR METAB, V93, P3827, DOI 10.1210/jc.2008-0743; Mayosi BM, 2005, STROKE, V36, P2215, DOI 10.1161/01.STR.0000182254.47941.96; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Palomino-Doza J, 2008, HYPERTENSION, V52, P980, DOI 10.1161/HYPERTENSIONAHA.108.113282; Paternoster L, 2010, CIRC-CARDIOVASC GENE, V3, P15, DOI 10.1161/CIRCGENETICS.108.834366; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; SZARAZ P, 2002, INT J BIOCHEM CELL B, V42, P157; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Zhang YL, 2009, ARCH BIOCHEM BIOPHYS, V483, P45, DOI 10.1016/j.abb.2008.12.004	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23248	10.1371/journal.pone.0023248	http://dx.doi.org/10.1371/journal.pone.0023248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858044	Green Published, gold			2022-12-25	WOS:000293953500028
J	Watanabe, S				Watanabe, Shigeru			Empathy and Reversed Empathy of Stress in Mice	PLOS ONE			English	Article							CORTICOSTERONE; PAIN; MEMORY	Empathy is an emotional response to display of distress in others and reversed-empathy is an emotional response to non-distressed others in distressed subjects. Stress has memory enhancing effect on aversive experience. Here, I examine empathy and reversed empathy using the memory enhancing effects of stress in mice. Restrain stress enhanced aversive memory of a floor with electric shock, but restrain stress, with cage mates also restrained, reduced the enhancing effect. On the other hand, restrain stress with free-moving cage mates increased the memory enhancing effect, suggesting the stronger stress. This is the reversed-empathy. Level of corticosterone is the highest after the restrain with free-moving mates and lowest after the restrain with restrained mates.	Keio Univ, Dept Psychol, Tokyo, Japan	Keio University	Watanabe, S (corresponding author), Keio Univ, Dept Psychol, Tokyo, Japan.	swat@flet.keio.ac.jp			Japanese Government (JSPS)	Japanese Government (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Global COE Program (D-1) of Japanese Government (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Cabib S, 1996, BRAIN RES, V729, P110, DOI 10.1016/0006-8993(96)00418-0; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Darwin G., 1871, P423; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Hashimoto T, 2005, NEUROREPORT, V16, P1129, DOI 10.1097/00001756-200507130-00019; Kavaliers M, 2003, HORM BEHAV, V43, P99, DOI 10.1016/S0018-506X(02)00021-1; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Miracle AD, 2006, NEUROBIOL LEARN MEM, V85, P213, DOI 10.1016/j.nlm.2005.10.005; NABORS CJ, 1974, STEROIDS, V23, P363, DOI 10.1016/0039-128X(74)90088-9; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; Watanabe S, 2011, BEHAV PHARMACOL, V22, P203, DOI 10.1097/FBP.0b013e328345c815	15	24	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23357	10.1371/journal.pone.0023357	http://dx.doi.org/10.1371/journal.pone.0023357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853115	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200072
J	Combosch, DJ; Vollmer, SV				Combosch, David J.; Vollmer, Steven V.			Population Genetics of an Ecosystem-Defining Reef Coral Pocillopora damicornis in the Tropical Eastern Pacific	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SPATIAL AUTOCORRELATION ANALYSIS; LARVAL DISPERSAL; GENOTYPIC DIVERSITY; BROODING CORAL; EL-NINO; PLANT-POPULATIONS; PERIPHERAL-POPULATIONS; BALANOPHYLLIA-ELEGANS; CONSERVATION GENETICS	Background: Coral reefs in the Tropical Eastern Pacific (TEP) are amongst the most peripheral and geographically isolated in the world. This isolation has shaped the biology of TEP organisms and lead to the formation of numerous endemic species. For example, the coral Pocillopora damicornis is a minor reef-builder elsewhere in the Indo-West Pacific, but is the dominant reef-building coral in the TEP, where it forms large, mono-specific stands, covering many hectares of reef. Moreover, TEP P. damicornis reproduces by broadcast spawning, while it broods mostly parthenogenetic larvae throughout the rest of the Indo-West Pacific. Population genetic surveys for P. damicornis from across its Indo-Pacific range indicate that gene flow (i.e. larval dispersal) is generally limited over hundreds of kilometers or less. Little is known about the population genetic structure and the dispersal potential of P. damicornis in the TEP. Methodology: Using multilocus microsatellite data, we analyzed the population structure of TEP P. damicornis among and within nine reefs and test for significant genetic structure across three geographically and ecologically distinct regions in Panama. Principal Findings/Conclusions: We detected significant levels of population genetic structure (global R-ST = 0.162), indicating restricted gene flow (i.e. larvae dispersal), both among the three regions (R-RT = 0.081) as well as within regions (R-SR = 0.089). Limited gene flow across a distinct environmental cline, like the regional upwelling gradient in Panama, indicates a significant potential for differential adaptation and population differentiation. Individual reefs were characterized by unexpectedly high genet diversity (avg. 94%), relatively high inbreeding coefficients (global F-IS = 0.183), and localized spatial genetic structure among individuals (i.e. unique genets) over 10 m intervals. These findings suggest that gene flow is limited in TEP P. damicornis populations, particularly among regions, but even over meter scales within populations.	[Combosch, David J.; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University	Combosch, DJ (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	combosch.d@neu.edu		Combosch, David/0000-0001-7004-7435	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Funding was provided to DJC by the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 1999, MAR BIOL, V134, P753, DOI 10.1007/s002270050592; [Anonymous], P 3 INT COR REEF S M; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Ayre DJ, 1997, MAR ECOL PROG SER, V159, P175, DOI 10.3354/meps159175; Ayre DJ, 2000, EVOLUTION, V54, P1590; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Beatty GE, 2008, DIVERS DISTRIB, V14, P546, DOI 10.1111/j.1472-4642.2008.00469.x; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; BEST BA, 1987, AM ZOOL, V127, pA103; Blanquer A, 2009, MAR ECOL PROG SER, V380, P95, DOI 10.3354/meps07931; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Calderon I, 2007, MOL ECOL, V16, P1799, DOI 10.1111/j.1365-294X.2007.03276.x; Carlon DB, 1999, TRENDS ECOL EVOL, V14, P491, DOI 10.1016/S0169-5347(99)01709-7; CARLON DB, 1993, J EXP MAR BIOL ECOL, V173, P247, DOI 10.1016/0022-0981(93)90056-T; CARPIZOITUARTE E, 2010, CIENC MAR, V37, P97; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Colborn J, 2001, EVOLUTION, V55, P807, DOI 10.1554/0014-3820(2001)055[0807:TEEOBA]2.0.CO;2; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Darwin C, 1859, ORIGINS SPECIES MEAN; David GK, 2010, MAR BIOL, V157, P1955, DOI 10.1007/s00227-010-1464-y; Duda TF, 2009, CORAL REEFS, V28, P651, DOI 10.1007/s00338-009-0485-9; Eakin CM, 1996, CORAL REEFS, V15, P120; ECKERT CG, 1993, AM J BOT, V80, P1175, DOI 10.2307/2445546; Ekman S., 1935, TIERGEOGRAPHIE MEERE; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI [10.1111/j.1558-5646.1997.tb02384.x, 10.2307/2410956]; GERRODETTE T, 1981, ECOLOGY, V62, P611, DOI 10.2307/1937728; Gilmour JP, 2002, MAR ECOL PROG SER, V235, P81, DOI 10.3354/meps235081; GLYNN P, 1985, MARINE ECOLOGY PROGR, V26, P4; GLYNN P, 1977, P 3 INT COR REEF S, P251; GLYNN P, 2001, CORAL BLEACHING MARI, P36; GLYNN P, 1997, FIELD GUIDE PACIFIC, P145; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; Glynn P.W., 1988, P 6 INT COR REEF S, V1, P51; Glynn P. W., 1983, CORALS CORAL REEFS G; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Glynn PW, 1996, CORAL REEFS, V15, P71; GLYNN PW, 1992, AM ZOOL, V32, P707; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; GLYNN PW, 1973, SCIENCE, V180, P504, DOI 10.1126/science.180.4085.504; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; GLYNN PW, 1977, J MAR RES, V35, P567; Glynn PW, 1997, REV BIOL TROP, V45, P1033; GLYNN PW, 1973, LIMNOL OCEANOGR, V18, P367, DOI 10.4319/lo.1973.18.3.0367; GLYNN PW, 1972, INT J EARTH SCI, V61, P483; GUO SW, 1992, AM J HUM GENET, V51, P1111; GUZMAN HM, 1993, REV BIOL TROP, V41, P535; GUZMAN HM, 1990, MAR ECOL PROG SER, V60, P299, DOI 10.3354/meps060299; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; HELLBERG ME, 1995, MAR BIOL, V123, P573, DOI 10.1007/BF00349236; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; HEYWOOD JS, 1991, ANNU REV ECOL SYST, V22, P335, DOI 10.1146/annurev.es.22.110191.002003; HIGHSMITH RC, 1980, J EXP MAR BIOL ECOL, V46, P177, DOI 10.1016/0022-0981(80)90030-1; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kinzie Robert A. Iii, 1993, Galaxea, V11, P93; Krupp D.A., 1983, Coral Reefs, V2, P159, DOI 10.1007/BF00336722; LaJeunesse TC, 2007, CORAL REEFS, V26, P265, DOI 10.1007/s00338-006-0189-3; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lessios HA, 2006, P ROY SOC B-BIOL SCI, V273, P2201, DOI 10.1098/rspb.2006.3543; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1999, EVOLUTION, V53, P806, DOI 10.1111/j.1558-5646.1999.tb05374.x; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Magalon H, 2004, MOL ECOL NOTES, V4, P206, DOI 10.1111/j.1471-8286.2004.00618.x; MAYR E, 1954, EVOLUTION PROCESS, P1; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; McFadden CS, 1996, MAR BIOL, V126, P215, DOI 10.1007/BF00347446; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Miller KJ, 1998, MAR ECOL PROG SER, V163, P225, DOI 10.3354/meps163225; NEIGEL J, 1983, EVOLUTION, P437; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Nishikawa A, 2008, PAC SCI, V62, P413, DOI 10.2984/1534-6188(2008)62[413:DAPOGF]2.0.CO;2; Noreen AME, 2009, P ROY SOC B-BIOL SCI, V276, P3927, DOI 10.1098/rspb.2009.1050; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; ORLOCI L, 1978, MULTIVARIANTE ANAL V, P135; Palumbi Stephen R., 1995, P369; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pemberton AJ, 2007, MAR BIOL, V153, P71, DOI 10.1007/s00227-007-0785-y; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RICHMOND RH, 1987, B MAR SCI, V41, P594; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Richmond RH, 1985, P 5 INT COR REEF S, V6, P101; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ruzzante DE, 1996, CAN J FISH AQUAT SCI, V53, P2695, DOI 10.1139/cjfas-53-12-2695; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SOKAL RR, 1983, GENETICS, V105, P219; Soule M., 1973, Annual Rev Ecol Syst, V4, P165, DOI 10.1146/annurev.es.04.110173.001121; Souter Petra, 2009, BMC Ecology, V9, P19, DOI 10.1186/1472-6785-9-19; STARGER C, 2010, CORAL REEFS, P1; STARGER CJ, 2007, MOL ECOLOGY NOTES; Stoddart J.A., 1988, P111; STODDART JA, 1984, CORAL REEFS, V3, P149, DOI 10.1007/BF00301959; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; STODDART JA, 1988, AUST J MAR FRESH RES, V39, P109; TEMPLETON AR, 1980, GENETICS, V94, P1011; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Woesik R., 2009, P R SOC B, V277, P715, DOI DOI 10.1098/RSPB.2009.1524; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; WILLIS BL, 1990, OPHELIA, V32, P145, DOI 10.1080/00785236.1990.10422029; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y; Yund PO, 2000, MAR BIOL, V137, P583, DOI 10.1007/s002270000378; Zhao R, 2009, AM J BOT, V96, P1138, DOI 10.3732/ajb.0800173	148	52	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e21200	10.1371/journal.pone.0021200	http://dx.doi.org/10.1371/journal.pone.0021200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857900	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300002
J	Honda, Y; Fujita, Y; Maruyama, H; Araki, Y; Ichihara, K; Sato, A; Kojima, T; Tanaka, M; Nozawa, Y; Ito, M; Honda, S				Honda, Yoko; Fujita, Yasunori; Maruyama, Hiroe; Araki, Yoko; Ichihara, Kenji; Sato, Akira; Kojima, Toshio; Tanaka, Masashi; Nozawa, Yoshinori; Ito, Masafumi; Honda, Shuji			Lifespan-Extending Effects of Royal Jelly and Its Related Substances on the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; IN-VITRO; SIGNALING PATHWAY; APIS-MELLIFERA; 10-HYDROXY-2-DECENOIC ACID; STRESS RESISTANCE; MAMMALIAN PROTEIN; NEURITE OUTGROWTH; REDOX REGULATION; GENE-EXPRESSION	Background: One of the most important challenges in the study of aging is to discover compounds with longevity-promoting activities and to unravel their underlying mechanisms. Royal jelly (RJ) has been reported to possess diverse beneficial properties. Furthermore, protease-treated RJ (pRJ) has additional pharmacological activities. Exactly how RJ and pRJ exert these effects and which of their components are responsible for these effects are largely unknown. The evolutionarily conserved mechanisms that control longevity have been indicated. The purpose of the present study was to determine whether RJ and its related substances exert a lifespan-extending function in the nematode Caenorhabditis elegans and to gain insights into the active agents in RJ and their mechanism of action. Principal Findings: We found that both RJ and pRJ extended the lifespan of C. elegans. The lifespan-extending activity of pRJ was enhanced by Octadecyl-silica column chromatography (pRJ-Fraction 5). pRJ-Fr.5 increased the animals' lifespan in part by acting through the FOXO transcription factor DAF-16, the activation of which is known to promote longevity in C. elegans by reducing insulin/IGF-1 signaling (IIS). pRJ-Fr.5 reduced the expression of ins-9, one of the insulin-like peptide genes. Moreover, pRJ-Fr.5 and reduced IIS shared some common features in terms of their effects on gene expression, such as the up-regulation of dod-3 and the down-regulation of dod-19, dao-4 and fkb-4. 10-Hydroxy-2-decenoic acid (10-HDA), which was present at high concentrations in pRJ-Fr.5, increased lifespan independently of DAF-16 activity. Conclusions/Significance: These results demonstrate that RJ and its related substances extend lifespan in C. elegans, suggesting that RJ may contain longevity-promoting factors. Further analysis and characterization of the lifespan-extending agents in RJ and pRJ may broaden our understanding of the gene network involved in longevity regulation in diverse species and may lead to the development of nutraceutical interventions in the aging process.	[Honda, Yoko; Tanaka, Masashi; Honda, Shuji] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo, Japan; [Fujita, Yasunori; Nozawa, Yoshinori; Ito, Masafumi] Gifu Int Inst Biotechnol, Dept Longev & Aging Res, Gifu, Japan; [Maruyama, Hiroe; Araki, Yoko; Ichihara, Kenji] API Co Ltd, Nagaragawa Res Ctr, Gifu, Japan; [Sato, Akira; Kojima, Toshio] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Tsurumi Ku, Kanagawa, Japan; [Kojima, Toshio] Hamamatsu Univ Sch Med, Higashi Ku, Shizuoka, Japan; [Nozawa, Yoshinori] Tokai Gakuin Univ, Dept Food & Hlth, Gifu, Japan	Tokyo Metropolitan Institute of Gerontology; RIKEN	Honda, Y (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Sakaecho, Tokyo, Japan.	hondas@center.tmig.or.jp	HONDA, Yoko/F-4558-2018	HONDA, Yoko/0000-0002-9978-8672	Tokyo Metropolitan Institute of Gerontology; API Company Limited; Gifu Prefecture, Japan	Tokyo Metropolitan Institute of Gerontology; API Company Limited; Gifu Prefecture, Japan	This work was essentially supported by Tokyo Metropolitan Institute of Gerontology financially, and was partially funded by API Company Limited and partially by a Grant for Biological Research from Gifu Prefecture, Japan. API Co. Ltd. played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Bincoletto C, 2005, INT IMMUNOPHARMACOL, V5, P679, DOI 10.1016/j.intimp.2004.11.015; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BLUM MS, 1959, SCIENCE, V130, P452, DOI 10.1126/science.130.3373.452; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRENNER S, 1974, GENETICS, V77, P71; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; BUTENANDT A, 1957, HOPPESEYLERS Z PHYSL, V203, P284; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Driver C, 2003, BIOGERONTOLOGY, V4, P91, DOI 10.1023/A:1023347803932; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Erem C, 2006, ENDOCRINE, V30, P175, DOI 10.1385/ENDO:30:2:175; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJII A, 1990, JPN J PHARMACOL, V53, P331, DOI 10.1254/jjp.53.331; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GARDNER TS, 1948, J GERONTOL, V3, P1; Gasic S, 2007, IMMUNOPHARM IMMUNOT, V29, P521, DOI 10.1080/08923970701690977; Guo H, 2008, J NUTR SCI VITAMINOL, V54, P191, DOI 10.3177/jnsv.54.191; HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Hattori N, 2007, BIOMED RES-TOKYO, V28, P261, DOI 10.2220/biomedres.28.261; Hattori N, 2007, BIOMED RES-TOKYO, V28, P139, DOI 10.2220/biomedres.28.139; Hattori N, 2010, EVID-BASED COMPL ALT, V7, P63, DOI 10.1093/ecam/nem146; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HENSCHLER D, 1956, H-S Z PHYSIOL CHEM, V305, P34, DOI 10.1515/bchm2.1956.305.1.34; Hidaka S, 2006, EVID-BASED COMPL ALT, V3, P339, DOI 10.1093/ecam/nel019; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Honda Y, 2010, GERIATR GERONTOL INT, V10, pS59, DOI 10.1111/j.1447-0594.2010.00591.x; Inoue S, 2003, EXP GERONTOL, V38, P965, DOI 10.1016/S0531-5565(03)00165-7; Izuta H, 2009, EVID-BASED COMPL ALT, V6, P489, DOI 10.1093/ecam/nem152; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394, DOI 10.3177/jnsv.47.394; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KATAOKA M, 2001, J NAT MED, V55, P174; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kawano T, 2006, BIOSCI BIOTECH BIOCH, V70, P3084, DOI 10.1271/bbb.60472; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KINOSHITA G, 1975, CAN J ZOOL, V53, P311, DOI 10.1139/z75-040; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kohno K, 2004, BIOSCI BIOTECH BIOCH, V68, P138, DOI 10.1271/bbb.68.138; Koya-Miyata S, 2004, BIOSCI BIOTECH BIOCH, V68, P767, DOI 10.1271/bbb.68.767; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Malone EA, 1996, GENETICS, V143, P1193; Matsui T, 2002, J NUTR BIOCHEM, V13, P80, DOI 10.1016/S0955-2863(01)00198-X; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nagai T, 2006, J MED FOOD, V9, P363, DOI 10.1089/jmf.2006.9.363; Narita Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2508, DOI 10.1271/bbb.60240; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PHILPOTT DE, 1974, AEROSPACE MED, V45, P283; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4; Sabatini DM, 1997, MOL NEUROBIOL, V15, P223, DOI 10.1007/BF02740635; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Sultana A, 2008, INT J MOL MED, V21, P677; Suzuki KM, 2003, J JPN SOC FOOD SCI, V50, P286, DOI 10.3136/nskkk.50.286; Takenaka T., 1982, Honeybee Science, V3, P69; Taniguchi Y, 2003, INT IMMUNOPHARMACOL, V3, P1313, DOI 10.1016/S1567-5769(03)00132-2; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; TOWNSEND GF, 1960, CANCER RES, V20, P503; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; VITTEK J, 1995, EXPERIENTIA, V51, P927, DOI 10.1007/BF01921742; Wei W, 2009, ELECTROPHORESIS, V30, P1949, DOI 10.1002/elps.200800721; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; WINSTON ML, 1991, BIOL HONEY BEE, P56; Winter AD, 2007, J BIOL CHEM, V282, P12813, DOI 10.1074/jbc.M700274200; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Yang XY, 2010, J ETHNOPHARMACOL, V128, P314, DOI 10.1016/j.jep.2010.01.055; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210; Zou SG, 2007, MECH AGEING DEV, V128, P222, DOI 10.1016/j.mad.2006.11.026	96	58	64	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23527	10.1371/journal.pone.0023527	http://dx.doi.org/10.1371/journal.pone.0023527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858156	gold, Green Published, Green Submitted			2022-12-25	WOS:000293774300039
J	Sanz, C; Velayos, A; Alvarez, MI; Benito, EP; Eslava, AP				Sanz, Catalina; Velayos, Antonio; Isabel Alvarez, Maria; Benito, Ernesto P.; Eslava, Arturo P.			Functional Analysis of the Phycomyces carRA Gene Encoding the Enzymes Phytoene Synthase and Lycopene Cyclase	PLOS ONE			English	Article							BETA-CAROTENE BIOSYNTHESIS; BLUE-LIGHT PHOTORECEPTOR; MUCOR-CIRCINELLOIDES; DEHYDROGENASE GENE; SUBSTRATE TRANSFER; NEUROSPORA-CRASSA; WHITE COLLAR-1; BLAKESLEEANUS; EXPRESSION; COMPLEMENTATION	Phycomyces carRA gene encodes a protein with two domains. Domain R is characterized by red carR mutants that accumulate lycopene. Domain A is characterized by white carA mutants that do not accumulate significant amounts of carotenoids. The carRA-encoded protein was identified as the lycopene cyclase and phytoene synthase enzyme by sequence homology with other proteins. However, no direct data showing the function of this protein have been reported so far. Different Mucor circinelloides mutants altered at the phytoene synthase, the lycopene cyclase or both activities were transformed with the Phycomyces carRA gene. Fully transcribed carRA mRNA molecules were detected by Northern assays in the transformants and the correct processing of the carRA messenger was verified by RT-PCR. These results showed that Phycomyces carRA gene was correctly expressed in Mucor. Carotenoids analysis in these transformants showed the presence of beta-carotene, absent in the untransformed strains, providing functional evidence that the Phycomyces carRA gene complements the M. circinelloides mutations. Co-transformation of the carRA cDNA in E. coli with different combinations of the carotenoid structural genes from Erwinia uredovora was also performed. Newly formed carotenoids were accumulated showing that the Phycomyces CarRA protein does contain lycopene cyclase and phytoene synthase activities. The heterologous expression of the carRA gene and the functional complementation of the mentioned activities are not very efficient in E. coli. However, the simultaneous presence of both carRA and carB gene products from Phycomyces increases the efficiency of these enzymes, presumably due to an interaction mechanism.	[Sanz, Catalina; Velayos, Antonio; Isabel Alvarez, Maria; Eslava, Arturo P.] Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Benito, Ernesto P.] Univ Salamanca, Ctr Hispano Luso Invest Agr, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca	Sanz, C (corresponding author), Univ Salamanca, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	catsof@usal.es	Sanz, Catalina/H-6759-2015; Benito, Ernesto/M-4371-2019; Velayos-Baeza, Antonio/K-6310-2019; Benito, Ernesto/B-5437-2017	Sanz, Catalina/0000-0003-2974-0873; Benito, Ernesto/0000-0002-9873-0970; Velayos-Baeza, Antonio/0000-0002-7717-4477; Benito, Ernesto/0000-0002-9873-0970	Junta de Castilla y Leon, Spain [WAS GR64]	Junta de Castilla y Leon, Spain(Junta de Castilla y Leon)	This work was supported by Grant WAS GR64 (Junta de Castilla y Leon, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Almeida ERA, 2008, CURR GENET, V53, P129, DOI 10.1007/s00294-007-0170-x; ALVAREZ MI, 1983, GENETICS, V105, P873; ARAGON CMG, 1976, EUR J BIOCHEM, V63, P71, DOI 10.1111/j.1432-1033.1976.tb10208.x; ARNAU J, 1993, CURR GENET, V23, P542, DOI 10.1007/BF00312649; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; BEJARANO ER, 1988, ARCH MICROBIOL, V150, P209, DOI 10.1007/BF00407781; Blasco JL, 2001, J PLANT RES, V114, P25, DOI 10.1007/PL00013965; CANDAU R, 1991, P NATL ACAD SCI USA, V88, P4936, DOI 10.1073/pnas.88.11.4936; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cerda-Olmedo E, 2001, FEMS MICROBIOL REV, V25, P503; Cerda-Olmedo E, 1987, PHYCOMYCES, P199; CERDAOLMEDO E, 1975, GENET RES, V25, P285, DOI 10.1017/S0016672300015718; CHOI HT, 1988, GENE, V71, P85, DOI 10.1016/0378-1119(88)90080-7; DELAGUARDIA MD, 1971, P NATL ACAD SCI USA, V68, P2012; ESLAVA AP, 1974, PLANT SCI LETT, V2, P9, DOI 10.1016/0304-4211(74)90032-7; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Fraser PD, 1996, BBA-GEN SUBJECTS, V1289, P203, DOI 10.1016/0304-4165(95)00169-7; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; GAUGER WL, 1980, EXP MYCOL, V4, P49; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; ITURRIAGA EA, 1992, CURR GENET, V21, P215, DOI 10.1007/BF00336844; Iturriaga EA., 2000, BIOTECHNOL BIOPROC E, V5, P263; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; MURILLO FJ, 1981, EUR J BIOCHEM, V119, P511, DOI 10.1111/j.1432-1033.1981.tb05637.x; Namitha KK, 2010, CRIT REV FOOD SCI, V50, P728, DOI 10.1080/10408398.2010.499811; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; OOTAKI T, 1973, MOL GEN GENET, V121, P57, DOI 10.1007/BF00353693; OREJAS M, 1987, MOL GEN GENET, V210, P69, DOI 10.1007/BF00337760; Rodriguez-Saiz M, 2004, APPL ENVIRON MICROB, V70, P5589, DOI 10.1128/AEM.70.9.5589-5594.2004; Ruiz-Hidalgo MJ, 1999, CURR MICROBIOL, V39, P259, DOI 10.1007/s002849900456; RuizHidalgo MJ, 1997, MOL GEN GENET, V253, P734, DOI 10.1007/s004380050378; RUIZHIDALGO MJ, 1995, BOT ACTA, V108, P396, DOI 10.1111/j.1438-8677.1995.tb00511.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sandmann G, 2002, PHYSIOL PLANTARUM, V116, P431, DOI 10.1034/j.1399-3054.2002.1160401.x; Sandmann G, 2002, CHEMBIOCHEM, V3, P629, DOI 10.1002/1439-7633(20020703)3:7<629::AID-CBIC629>3.0.CO;2-5; Sandmann G, 2006, BBA-MOL CELL BIOL L, V1761, P1085, DOI 10.1016/j.bbalip.2006.06.002; Sanz C, 2002, EUR J BIOCHEM, V269, P902, DOI 10.1046/j.0014-2956.2001.02724.x; Sanz C, 2010, FUNGAL GENET BIOL, V47, P773, DOI 10.1016/j.fgb.2010.05.009; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; SCHMIDHAUSER TJ, 1994, J BIOL CHEM, V269, P12060; SUTTER RP, 1975, P NATL ACAD SCI USA, V72, P127, DOI 10.1073/pnas.72.1.127; TORRESMARTINEZ S, 1980, GENET RES, V36, P299, DOI 10.1017/S0016672300019911; VANHEESWIJCK R, 1984, CARLSBERG RES COMMUN, V49, P578; Velayos A, 1997, FUNGAL GENET BIOL, V22, P19, DOI 10.1006/fgbi.1997.0998; Velayos A, 2000, PLANTA, V210, P938, DOI 10.1007/s004250050701; Velayos A, 2000, EUR J BIOCHEM, V267, P5509, DOI 10.1046/j.1432-1327.2000.01612.x; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	53	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23102	10.1371/journal.pone.0023102	http://dx.doi.org/10.1371/journal.pone.0023102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21858003	Green Submitted, gold, Green Published			2022-12-25	WOS:000293774300021
J	Sunday, JM; Crim, RN; Harley, CDG; Hart, MW				Sunday, Jennifer M.; Crim, Ryan N.; Harley, Christopher D. G.; Hart, Michael W.			Quantifying Rates of Evolutionary Adaptation in Response to Ocean Acidification	PLOS ONE			English	Article							LARVAL; SIZE; LIFE; CO2; GROWTH; SURVIVAL; IMPACTS; MUSSELS; CARBON	The global acidification of the earth's oceans is predicted to impact biodiversity via physiological effects impacting growth, survival, reproduction, and immunology, leading to changes in species abundances and global distributions. However, the degree to which these changes will play out critically depends on the evolutionary rate at which populations will respond to natural selection imposed by ocean acidification, which remains largely unquantified. Here we measure the potential for an evolutionary response to ocean acidification in larval development rate in two coastal invertebrates using a full-factorial breeding design. We show that the sea urchin species Strongylocentrotus franciscanus has vastly greater levels of phenotypic and genetic variation for larval size in future CO2 conditions compared to the mussel species Mytilus trossulus. Using these measures we demonstrate that S. franciscanus may have faster evolutionary responses within 50 years of the onset of predicted year-2100 CO2 conditions despite having lower population turnover rates. Our comparisons suggest that information on genetic variation, phenotypic variation, and key demographic parameters, may lend valuable insight into relative evolutionary potentials across a large number of species.	[Sunday, Jennifer M.; Hart, Michael W.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Crim, Ryan N.; Harley, Christopher D. G.] Simon Fraser Univ, Dept Zool, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Sunday, JM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	sunday@sfu.ca	Sunday, Jennifer/ABE-7396-2020; Harley, Christopher D. G./K-5593-2012	Harley, Christopher D. G./0000-0003-4099-943X	Natural Sciences and Engineering Research Council of Canada [357084-07, 328205-10]; Canada Foundation for Innovation [CFI 12723]; Bamfield Marines Sciences Center; Pacific Northwest Shell Club	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Bamfield Marines Sciences Center; Pacific Northwest Shell Club	This work was financially supported by grants from the Natural Sciences and Engineering Research Council of Canada (357084-07 and 328205-10), the Canada Foundation for Innovation (CFI 12723), the Bamfield Marines Sciences Center (http://www.bms.bc.ca/), and the Pacific Northwest Shell Club (http://www.bily.com/pnwsc/web-content/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bergfeld Cord, 1999, Senckenbergiana Maritima, V29, P23; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; BOWDER LW, 1991, DEV BIOL; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; CLARKE A, 1991, AM ZOOL, V31, P81; Collins S, 2006, ECOL LETT, V9, P129, DOI 10.1111/j.1461-0248.2005.00854.x; COMSTOCK RE, 1948, BIOMETRICS, V4, P254, DOI 10.2307/3001412; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Falconer D. S., 1989, Introduction to quantitative genetics.; Featherstone M., 2008, FAO Fisheries Technical Paper, P383; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Findlay HS, 2010, ECOLOGY, V91, P2931, DOI 10.1890/09-1987.1; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gilmour A., 2006, ASREML USER GUIDE RE; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; HALE R, 2011, OIKOS IN PRESS; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hare JA, 1997, ECOLOGY, V78, P2415; HETTINGER A, 2010, EOS T AGU, V91; Borthagaray AI, 2007, ACTA OECOL, V31, P243, DOI 10.1016/j.actao.2006.10.008; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Lynch Michael, 1998; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; MCEDWARD LR, 1986, J EXP MAR BIOL ECOL, V96, P251, DOI 10.1016/0022-0981(86)90206-6; Meekan MG, 1996, MAR ECOL PROG SER, V137, P25, DOI 10.3354/meps137025; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Nakicenovic N., 2000, SPECIAL REPORT EMISS; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Orr JC, 2009, 2 S OC HIGH CO2 WORL; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; PISTEVOS JCA, 2011, OIKOS IN PRESS; PORTNER HO, 2010, STUDIES METABOLIC CH; Potvin C, 1996, OECOLOGIA, V108, P683, DOI 10.1007/BF00329043; Przeslawski R, 2009, J SHELLFISH RES, V28, P505, DOI 10.2983/035.028.0312; R Development Core Team, 2009, R FDN STAT COMP; Rasband W.S., 1997, IMAGE J; Roff D.A., 1997, EVOLUTIONARY QUANTIT; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Shima JS, 2002, MAR ECOL PROG SER, V235, P303, DOI 10.3354/meps235303; SLOAN NA, 1987, FISH RES, V5, P55, DOI 10.1016/0165-7836(87)90015-4; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Strathmann MF, 1987, REPROD DEV MARINE IN; SUCHANEK TH, 1981, OECOLOGIA, V50, P143, DOI 10.1007/BF00348028; Ward JK, 1999, TREE PHYSIOL, V19, P211; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	58	203	208	2	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22881	10.1371/journal.pone.0022881	http://dx.doi.org/10.1371/journal.pone.0022881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857962	gold, Green Published, Green Submitted			2022-12-25	WOS:000293774300009
J	Kohman, RA; Rodriguez-Zas, SL; Southey, BR; Kelley, KW; Dantzer, R; Rhodes, JS				Kohman, Rachel A.; Rodriguez-Zas, Sandra L.; Southey, Bruce R.; Kelley, Keith W.; Dantzer, Robert; Rhodes, Justin S.			Voluntary Wheel Running Reverses Age-Induced Changes in Hippocampal Gene Expression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SPATIAL MEMORY; CALORIC RESTRICTION; PHYSICAL-ACTIVITY; EXERCISE; NEUROGENESIS; MICE; PROFILE; COMPLEMENT; PLASTICITY	Normal aging alters expression of numerous genes within the brain. Some of these transcription changes likely contribute to age-associated cognitive decline, reduced neural plasticity, and the higher incidence of neuropathology. Identifying factors that modulate brain aging is crucial for improving quality of life. One promising intervention to counteract negative effects of aging is aerobic exercise. Aged subjects that exercise show enhanced cognitive performance and increased hippocampal neurogenesis and synaptic plasticity. Currently, the mechanisms behind the anti-aging effects of exercise are not understood. The present study conducted a microarray on whole hippocampal samples from adult (3.5-month-old) and aged (18-month-old) male BALB/c mice that were individually housed with or without running wheels for 8 weeks. Results showed that aging altered genes related to chromatin remodeling, cell growth, immune activity, and synapse organization compared to adult mice. Exercise was found to modulate many of the genes altered by aging, but in the opposite direction. For example, wheel running increased expression of genes related to cell growth and attenuated expression of genes involved in immune function and chromatin remodeling. Collectively, findings show that even late-onset exercise may attenuate age-related changes in gene expression and identifies possible pathways through which exercise may exert its beneficial effects.	[Kohman, Rachel A.; Rhodes, Justin S.] Univ Illinois, Beckman Inst, Dept Psychol, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.; Southey, Bruce R.; Kelley, Keith W.; Dantzer, Robert] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Kelley, Keith W.; Dantzer, Robert] Univ Illinois, Integrated Immunol & Behav Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kohman, RA (corresponding author), Univ Illinois, Beckman Inst, Dept Psychol, Urbana, IL 61801 USA.	rakohman@illinois.edu		Southey, Bruce/0000-0002-8959-7709; Kohman, Rachel/0000-0002-9737-3668; Kelley, Keith W./0000-0002-6837-8793; Dantzer, Robert/0000-0001-9399-6107	National Institutes of Health [MH083807, DA027487]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548, P30DA018310, R01DA027487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health, MH083807 and DA027487, to JSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2008, EXP NEUROL, V211, P141, DOI 10.1016/j.expneurol.2008.01.016; Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; BRANDEIS R, 1990, PHARMACOL BIOCHEM BE, V36, P89, DOI 10.1016/0091-3057(90)90131-Z; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Christie BR, 2008, NEUROMOL MED, V10, P47, DOI 10.1007/s12017-008-8033-2; Chung YH, 2004, BRAIN RES, V1021, P132, DOI 10.1016/j.brainres.2004.06.043; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; DCOSTA AP, 1993, ANN NY ACAD SCI, V692, P253; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; FESER J, 2011, FEBS LETT; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; Haga S, 1996, NEUROSCI LETT, V216, P191, DOI 10.1016/S0304-3940(96)13040-8; HANES J, 1994, J MOL BIOL, V244, P665, DOI 10.1006/jmbi.1994.1763; Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Kelley KW, 2007, BRAIN BEHAV IMMUN, V21, P384, DOI 10.1016/j.bbi.2006.11.010; Kelley KW, 2004, BRAIN BEHAV IMMUN, V18, P95, DOI 10.1016/j.bbi.2003.10.003; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; Koteja P, 1999, ANIM BEHAV, V58, P1307, DOI 10.1006/anbe.1999.1270; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Liang KY, 2010, ANN NEUROL, V68, P311, DOI 10.1002/ana.22096; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Llorens-Martin M, 2008, NEUROMOL MED, V10, P99, DOI 10.1007/s12017-008-8026-1; Malykhin NV, 2008, NEUROREPORT, V19, P543, DOI 10.1097/WNR.0b013e3282f8b18c; Martin DM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001010; Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x; Min W, 2010, CARCINOGENESIS, V31, P2058, DOI 10.1093/carcin/bgq205; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Moyer JR, 2006, BEHAV NEUROSCI, V120, P612, DOI 10.1037/0735-7044.120.3.612; Murray CA, 1998, J BIOL CHEM, V273, P12161, DOI 10.1074/jbc.273.20.12161; Nakajima S, 2010, BEHAV BRAIN RES, V211, P178, DOI 10.1016/j.bbr.2010.03.028; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Rhodes JS, 2000, J THERM BIOL, V25, P391, DOI 10.1016/S0306-4565(99)00112-6; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Stranahan AM, 2008, NEUROMOL MED, V10, P118, DOI 10.1007/s12017-008-8027-0; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X; Terry AV, 2011, PHYSIOL BEHAV, V102, P149, DOI 10.1016/j.physbeh.2010.11.005; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Woods JA, 2009, IMMUNOL ALLERGY CLIN, V29, P381, DOI 10.1016/j.iac.2009.02.011; Xu Q, 2010, NEUROLOGY, V75, P341, DOI 10.1212/WNL.0b013e3181ea1597; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265	71	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22654	10.1371/journal.pone.0022654	http://dx.doi.org/10.1371/journal.pone.0022654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857943	Green Published, gold			2022-12-25	WOS:000293773300007
J	Richards, JS; Fan, HY; Liu, Z; Tsoi, M; Lague, MN; Boyer, A; Boerboom, D				Richards, J. S.; Fan, H-Y; Liu, Z.; Tsoi, M.; Lague, M-N; Boyer, A.; Boerboom, D.			Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis	ONCOGENE			English	Article						CTNNB1; KRAS; PTEN; granulosa cell tumor; ovary; testis	BETA-CATENIN EXPRESSION; GROWTH-FACTOR NETWORK; TRANSCRIPTION FACTOR; CUMULUS CELLS; FOLLICLE DEVELOPMENT; TARGETED DISRUPTION; SIGNALING PATHWAY; FACTOR FOXL2; GERM-CELLS; PROLIFERATION	WNT, RAS or phosphoinositide 3-kinase signaling pathways control specific stages of ovarian follicular development. To analyze the functional interactions of these pathways in granulosa cells during follicular development in vivo, we generated specific mutant mouse models. Stable activation of the WNT signaling effector beta-catenin (CTNNB1) in granulosa cells results in the formation of premalignant lesions that develop into granulosa cell tumors (GCTs) spontaneously later in life or following targeted deletion of the tumor suppressor gene Pten. Conversely, expression of oncogenic KRAS(G12D) dramatically arrests proliferation, differentiation and apoptosis in granulosa cells, and consequently, small abnormal follicle-like structures devoid of oocytes accumulate in the ovary. Because of the potent anti-proliferative effects of KRAS(G12D) in granulosa cells, we sought to determine whether KRAS(G12D) would block precancerous lesion and tumor formation in follicles of the CTNNB1-mutant mice. Unexpectedly, transgenic Ctnnb1;Kras-mutant mice exhibited increased GC proliferation, decreased apoptosis and impaired differentiation and developed early-onset GCTs leading to premature death in a manner similar to the Ctnnb1; Pten-mutant mice. Microarray and reverse transcription-PCR analyses revealed that gene regulatory processes induced by CTNNB1 were mostly enhanced by either KRAS activation or Pten loss in remarkably similar patterns and degree. The concomitant activation of CTNNB1 and KRAS in Sertoli cells also caused testicular granulosa cell tumors that showed gene expression patterns that partially overlapped those observed in GCTs of the ovary. Although the mutations analyzed herein have not yet been linked to adult GCTs in humans, they may be related to juvenile GCTs or to tumors in other tissues where CTNNB1 is mutated. Importantly, the results provide strong evidence that CTNNB1 is the driver in these contexts and that KRAS(G12D) and Pten loss promote the program set in motion by the CTNNB1. Oncogene (2012) 31, 1504-1520; doi:10.1038/onc.2011.341; published online 22 August 2011	[Richards, J. S.; Fan, H-Y; Liu, Z.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tsoi, M.; Lague, M-N; Boyer, A.; Boerboom, D.] Univ Montreal, Ctr Rech Reprod Anim, Dept Biomed Vet, St Hyacinthe, PQ, Canada	Baylor College of Medicine; Universite de Montreal	Richards, JS (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	joanner@bcm.edu			Eunice Kennedy Shriver NICHD/NIH [U54-(HD07945)]; Canadian Institutes of Health Research; National Sciences and Engineering Research Council; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD29034];  [NIH-HD-16229]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD016229, U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016272, R56HD016229, R37HD016229, F32HD007945] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Microarray Core Facility at Baylor College of Medicine (Lisa K White, director) for performing the microarray analyses. Supported, in part, by NIH-HD-16229 and the Eunice Kennedy Shriver NICHD/NIH cooperative agreement (U54-(HD07945)) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (JSR), an operating grant from the Canadian Institutes of Health Research (DB) and a Discovery Grant from the National Sciences and Engineering Research Council (DB). We also acknowledge that hormone assays were done by The University of Virginia Research in Reproduction Ligand Assay and Analysis Core supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) grant U54-HD29034.	Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Boyer A, 2009, CARCINOGENESIS, V30, P869, DOI 10.1093/carcin/bgp051; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Broad KD, 2009, DEV NEUROBIOL, V69, P314, DOI 10.1002/dneu.20702; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; DILWORTH JP, 1991, UROLOGY, V37, P399, DOI 10.1016/0090-4295(91)80100-L; Drews-Elger K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005245; Edson MA, 2010, MOL ENDOCRINOL, V24, P1251, DOI 10.1210/me.2009-0461; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Eo J, 2008, J ENDOCRINOL, V198, P281, DOI 10.1677/JOE-08-0142; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2010, MOL ENDOCRINOL, V24, P286, DOI 10.1210/me.2009-0251; Fan HY, 2009, CANCER RES, V69, P6463, DOI 10.1158/0008-5472.CAN-08-3363; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fellenberg J, 2010, INT J CANCER, V127, P1804, DOI 10.1002/ijc.25205; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Heinrich MC, 2010, NATURE, V467, P796, DOI 10.1038/467796a; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Hsieh M, 2005, TRENDS ENDOCRIN MET, V16, P320, DOI 10.1016/j.tem.2005.07.005; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Jubb I, 1993, PATHOLOGY DOMESTIC A; KALFA N, 2008, SEX DEV, V2, P142; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kobel M, 2009, CANCER RES, V69, P9160, DOI 10.1158/0008-5472.CAN-09-2669; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Li G, 2002, DEVELOPMENT, V129, P4159; Liu ZL, 2010, MOL ENDOCRINOL, V24, P1794, DOI 10.1210/me.2010-0086; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Park, 2004, SCIENCE, V290, P395; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; RAO MC, 1978, CELL, V14, P71, DOI 10.1016/0092-8674(78)90302-1; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Steinmetz R, 2004, MOL ENDOCRINOL, V18, P2570, DOI 10.1210/me.2004-0082; Takahashi M, 2002, CANCER RES, V62, P5651; Tania M, 2010, BIOCHEM BIOPH RES CO, V401, P493, DOI 10.1016/j.bbrc.2010.09.114; Tanwar PS, 2010, P NATL ACAD SCI USA, V107, P16142, DOI 10.1073/pnas.1011606107; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; Trazzi S, 2010, J BIOL CHEM, V285, P10098, DOI 10.1074/jbc.M109.043711; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Tyagi G, 2009, BIOL REPROD, V81, P258, DOI 10.1095/biolreprod.108.075200; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu M, 2009, ENDOCRINOLOGY, V150, P2064, DOI 10.1210/en.2008-1265	74	36	36	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1504	1520		10.1038/onc.2011.341	http://dx.doi.org/10.1038/onc.2011.341			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21860425	Green Accepted			2022-12-25	WOS:000302132000004
J	Cisneros, KO; Smit, AJ; Laudien, J; Schoeman, DS				Cisneros, Kelly Ortega; Smit, Albertus J.; Laudien, Juergen; Schoeman, David S.			Complex, Dynamic Combination of Physical, Chemical and Nutritional Variables Controls Spatio-Temporal Variation of Sandy Beach Community Structure	PLOS ONE			English	Article							MACROFAUNA COMMUNITIES; FOOD AVAILABILITY; SPECIES RICHNESS; ECOSYSTEMS; ABUNDANCE; PATTERNS; MICROPHYTOBENTHOS; PHYTOPLANKTON; ESTIMATORS; BONFERRONI	Sandy beach ecological theory states that physical features of the beach control macrobenthic community structure on all but the most dissipative beaches. However, few studies have simultaneously evaluated the relative importance of physical, chemical and biological factors as potential explanatory variables for meso-scale spatio-temporal patterns of intertidal community structure in these systems. Here, we investigate macroinfaunal community structure of a micro-tidal sandy beach that is located on an oligotrophic subtropical coast and is influenced by seasonal estuarine input. We repeatedly sampled biological and environmental variables at a series of beach transects arranged at increasing distances from the estuary mouth. Sampling took place over a period of five months, corresponding with the transition between the dry and wet season. This allowed assessment of biological-physical relationships across chemical and nutritional gradients associated with a range of estuarine inputs. Physical, chemical, and biological response variables, as well as measures of community structure, showed significant spatio-temporal patterns. In general, bivariate relationships between biological and environmental variables were rare and weak. However, multivariate correlation approaches identified a variety of environmental variables (i.e., sampling session, the C:N ratio of particulate organic matter, dissolved inorganic nutrient concentrations, various size fractions of photopigment concentrations, salinity and, to a lesser extent, beach width and sediment kurtosis) that either alone or combined provided significant explanatory power for spatio-temporal patterns of macroinfaunal community structure. Overall, these results showed that the macrobenthic community on Mtunzini Beach was not structured primarily by physical factors, but instead by a complex and dynamic blend of nutritional, chemical and physical drivers. This emphasises the need to recognise ocean-exposed sandy beaches as functional ecosystems in their own right.	[Cisneros, Kelly Ortega] Leibnitz Ctr Marine Trop Ecol, Bremen, Germany; [Cisneros, Kelly Ortega; Smit, Albertus J.; Schoeman, David S.] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa; [Laudien, Juergen] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Schoeman, David S.] Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland	University of Kwazulu Natal; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ulster University	Cisneros, KO (corresponding author), Leibnitz Ctr Marine Trop Ecol, Bremen, Germany.	kortegac@gmail.com	Ortega, Kelly/I-4520-2019; Smit, Albertus/K-3826-2012	Ortega-Cisneros, Kelly/0000-0003-2511-5448; Laudien, Jurgen/0000-0003-2663-4821; Schoeman, David/0000-0003-1258-0885	NRF-IRDP [ICD2006072700035]; DAAD (Deutscher Akademischer Austausch Dienst); Royal Society	NRF-IRDP; DAAD (Deutscher Akademischer Austausch Dienst)(Deutscher Akademischer Austausch Dienst (DAAD)); Royal Society(Royal Society of London)	This study was financed within the framework of the NRF-IRDP project (KZN Coastal Trophic Flows, ICD2006072700035). Additional financial support was provided by a DAAD (Deutscher Akademischer Austausch Dienst) scholarship to KOC, a Royal Society grant to DSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; AMBROSE WG, 1984, J EXP MAR BIOL ECOL, V81, P115, DOI 10.1016/0022-0981(84)90002-9; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2010, R LANG ENV STAT COMP; Basaguren A, 1996, INT REV GES HYDROBIO, V81, P79, DOI 10.1002/iroh.19960810109; Begon M., 2009, ECOLOGY INDIVIDUALS; Bergamino L, 2009, ECOL INDIC, V9, P584, DOI 10.1016/j.ecolind.2008.07.008; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Blott S., 2000, GRADISTAT VERSION 4; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Bosley KL, 1999, CAN J FISH AQUAT SCI, V56, P2181, DOI 10.1139/cjfas-56-11-2181; Brazeiro A, 1996, ESTUAR COAST SHELF S, V42, P523, DOI 10.1006/ecss.1996.0033; Celentano E, 2010, MAR ECOL PROG SER, V398, P193, DOI 10.3354/meps08342; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 1994, CHANGE MARINE COMMUN; Cooper J.A.G., 1999, ESTUARIES S AFRICA, P5, DOI DOI 10.1017/CBO9780511525490.002; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Day J.H., 1981, ESTUARINE ECOLOGY PA, P1; Dean R.G., 1973, P C ENG DYN SURF ZON, P208; Defeo O, 1997, ESTUAR COAST SHELF S, V45, P453, DOI 10.1006/ecss.1996.0200; Defeo O, 2005, MAR ECOL PROG SER, V295, P1, DOI 10.3354/meps295001; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Defeo Omar, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P257; Duarte C, 2009, REV BIOL MAR OCEANOG, V44, P691; Dugan JE, 2004, OECOLOGIA, V139, P630, DOI 10.1007/s00442-004-1547-x; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Froneman PW, 2006, ESTUAR COAST SHELF S, V70, P693, DOI 10.1016/j.ecss.2006.07.008; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gourlay M.R, 1968, M935M936 DELFT HYDR; GRAF G, 1989, NATURE, V341, P437, DOI 10.1038/341437a0; Grant J., 1987, Biological Oceanography, V4, P243; Gray J S, 1981, ECOLOGY MARINE SEDIM; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hewitt JE, 1997, LIMNOL OCEANOGR, V42, P282, DOI 10.4319/lo.1997.42.2.0282; HILL B. J., 1966, ZOOL AFRICANA, V2, P1; HODGSON AN, 1987, S AFR J ZOOL, V22, P153; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Lercari D, 2003, ESTUAR COAST SHELF S, V58, P17, DOI 10.1016/S0272-7714(03)00043-X; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; MCLACHLAN A, 1990, J COASTAL RES, V6, P57; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A, 2006, ECOLOGY SANDY SHORES; MCLACHLAN A, 1983, SANDY BEACHES ECOSYS, P321; McLachlan A, 2007, OCEANOLOGIA, V49, P91; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mosterd S.A., 1983, S AFR J MARINE SCI, V1, P189, DOI [10.2989/025776183784447584, DOI 10.2989/025776183784447584]; Norkko A, 2001, MAR ECOL PROG SER, V212, P131, DOI 10.3354/meps212131; Oksanen J., 2013, R PACKAGE VERSION 2, P292; PEARCE AF, 1978, S AFR J SCI, V74, P328; Pearson T.H., 1987, P373; Peres-Neto PR, 1999, MAR ECOL PROG SER, V176, P303, DOI 10.3354/meps176303; Perissinotto R, 2003, ACTA OECOL, V24, pS307, DOI 10.1016/S1146-609X(03)00028-6; Perissinotto R, 2002, ESTUAR COAST SHELF S, V55, P47, DOI 10.1006/ecss.2001.0885; Ponsard S, 1999, CR ACAD SCI III-VIE, V322, P35, DOI 10.1016/S0764-4469(99)80015-8; Quinn GP, 2003, EXPT DESIGN DATA ANA; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Rodil IF, 2007, HYDROBIOLOGIA, V579, P301, DOI 10.1007/s10750-006-0443-2; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Schlacher TA, 2008, INT REV HYDROBIOL, V93, P641, DOI 10.1002/iroh.200711050; Schlacher TA, 2009, ECOSYSTEMS, V12, P311, DOI 10.1007/s10021-008-9224-2; Schoeman DS, 2008, MAR ECOL-EVOL PERSP, V29, P134, DOI 10.1111/j.1439-0485.2008.00223.x; Schoeman DS, 2003, ESTUAR COAST SHELF S, V58, P5, DOI 10.1016/S0272-7714(03)00038-6; Schoeman DS, 2002, J EXP MAR BIOL ECOL, V276, P67, DOI 10.1016/S0022-0981(02)00239-3; Sheppard N, 2009, J EXP MAR BIOL ECOL, V380, P113, DOI 10.1016/j.jembe.2009.09.009; Short AD, 1996, REV CHIL HIST NAT, V69, P589; Skinner T, 2006, ESTUAR COAST SHELF S, V70, P161, DOI 10.1016/j.ecss.2006.04.007; Stein R., 1991, ACCUMULATION ORGANIC; THOMPSON JK, 1988, J EXP MAR BIOL ECOL, V116, P43, DOI 10.1016/0022-0981(88)90245-6; Vorwerk PD, 2003, ENVIRON BIOL FISH, V66, P237, DOI 10.1023/A:1023922521835; Whitfield A. K., 1992, Southern African Journal of Aquatic Sciences, V18, P89; Wooldridge Tris, 1999, P141, DOI 10.1017/CBO9780511525490.007; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	82	41	44	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23724	10.1371/journal.pone.0023724	http://dx.doi.org/10.1371/journal.pone.0023724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858213	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300086
J	Haagsma, AC; Podasca, I; Koul, A; Andries, K; Guillemont, J; Lill, H; Bald, D				Haagsma, Anna C.; Podasca, Ioana; Koul, Anil; Andries, Koen; Guillemont, Jerome; Lill, Holger; Bald, Dirk			Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase	PLOS ONE			English	Article							DRUG CANDIDATE; TUBERCULOSIS; R207910; PYRAZINAMIDE; HYDROLYSIS; MECHANISMS; GENERATION; RESISTANCE; ROTATION	Infections with Mycobacterium tuberculosis are substantially increasing on a worldwide scale and new antibiotics are urgently needed to combat concomitantly emerging drug-resistant mycobacterial strains. The diarylquinoline TMC207 is a highly promising drug candidate for treatment of tuberculosis. This compound kills M. tuberculosis by binding to a new target, mycobacterial ATP synthase. In this study we used biochemical assays and binding studies to characterize the interaction between TMC207 and ATP synthase. We show that TMC207 acts independent of the proton motive force and does not compete with protons for a common binding site. The drug is active on mycobacterial ATP synthesis at neutral and acidic pH with no significant change in affinity between pH 5.25 and pH 7.5, indicating that the protonated form of TMC207 is the active drug entity. The interaction of TMC207 with ATP synthase can be explained by a one-site binding mechanism, the drug molecule thus binds to a defined binding site on ATP synthase. TMC207 affinity for its target decreases with increasing ionic strength, suggesting that electrostatic forces play a significant role in drug binding. Our results are consistent with previous docking studies and provide experimental support for a predicted function of TMC207 in mimicking key residues in the proton transfer chain and blocking rotary movement of subunit c during catalysis. Furthermore, the high affinity of TMC207 at low proton motive force and low pH values may in part explain the exceptional ability of this compound to efficiently kill mycobacteria in different microenvironments.	[Haagsma, Anna C.; Podasca, Ioana; Lill, Holger; Bald, Dirk] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Biol, Amsterdam, Netherlands; [Haagsma, Anna C.; Podasca, Ioana; Lill, Holger; Bald, Dirk] AIMMS, Amsterdam, Netherlands; [Koul, Anil; Andries, Koen] Johnson & Johnson Pharmaceut Res & Dev, Tibotec NV, Dept Antimicrobial Res, Beerse, Belgium; [Guillemont, Jerome] Johnson & Johnson, Janssen Res & Dev, Dept Med Chem, Val De Reuil, France	Vrije Universiteit Amsterdam; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Haagsma, AC (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Biol, Amsterdam, Netherlands.	dirk.bald@falw.vu.nl		Haagsma, Anna C./0000-0001-7656-3932; Lill, H./0000-0001-9336-5428	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-ECHO) [700.55.017]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-ECHO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-ECHO grant 700.55.017, http://www.nwo.nl). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AK, KA and JG are employees of Tibotec NV and contributed to the analysis of the experiment and provided expertise.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Bald D, 1998, J BIOL CHEM, V273, P865, DOI 10.1074/jbc.273.2.865; Bald D, 1999, EUR J BIOCHEM, V262, P563, DOI 10.1046/j.1432-1327.1999.00410.x; Bald D, 2010, FEMS MICROBIOL LETT, V308, P1, DOI 10.1111/j.1574-6968.2010.01959.x; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; de Jonge MR, 2007, PROTEINS, V67, P971, DOI 10.1002/prot.21376; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gaurrand S, 2006, CHEM BIOL DRUG DES, V68, P77, DOI 10.1111/j.1747-0285.2006.00410.x; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; Haagsma AC, 2009, ANTIMICROB AGENTS CH, V53, P1290, DOI 10.1128/AAC.01393-08; Huang Q, 2007, CHEMOTHERAPY, V53, P338, DOI 10.1159/000107723; Huitric E, 2010, ANTIMICROB AGENTS CH, V54, P1022, DOI 10.1128/AAC.01611-09; Huitric E, 2007, ANTIMICROB AGENTS CH, V51, P4202, DOI 10.1128/AAC.00181-07; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lounis N, 2006, ANTIMICROB AGENTS CH, V50, P3543, DOI 10.1128/AAC.00766-06; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Mandavilli A, 2007, NAT MED, V13, P271, DOI 10.1038/nm0307-271a; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Petrella S, 2006, ANTIMICROB AGENTS CH, V50, P2853, DOI 10.1128/AAC.00244-06; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; SYROESHKIN AV, 1995, FEBS LETT, V366, P29, DOI 10.1016/0014-5793(95)00487-T; Tran SL, 2005, J BACTERIOL, V187, P5023, DOI 10.1128/JB.187.14.5023-5028.2005; Upadhayaya RS, 2009, BIOORGAN MED CHEM, V17, P2830, DOI 10.1016/j.bmc.2009.02.026; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6	40	96	99	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23575	10.1371/journal.pone.0023575	http://dx.doi.org/10.1371/journal.pone.0023575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858172	Green Published, gold			2022-12-25	WOS:000294121300063
J	Karmarkar, SW; Bottum, KM; Krager, SL; Tischkau, SA				Karmarkar, Sumedha W.; Bottum, Kathleen M.; Krager, Stacey L.; Tischkau, Shelley A.			ERK/MAPK Is Essential for Endogenous Neuroprotection in SCN2.2 Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SUPRACHIASMATIC NUCLEUS ABLATION; PYRUVATE-DEHYDROGENASE ACTIVITY; SIGNAL-REGULATED KINASE; D-ASPARTATE RECEPTORS; CYTOCHROME-C RELEASE; N-TERMINAL KINASES; PHASE-SHIFTS; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH	Background: Glutamate (Glu) is essential to central nervous system function; however excessive Glu release leads to neurodegenerative disease. Strategies to protect neurons are underdeveloped, in part due to a limited understanding of natural neuroprotective mechanisms, such as those present in the suprachiasmatic nucleus (SCN). This study tests the hypothesis that activation of ERK/MAPK provides essential protection to the SCN after exposure to excessive Glu using the SCN2.2 cells as a model. Methodology: Immortalized SCN2.2 cells (derived from SCN) and GT1-7 cells (neurons from the neighboring hypothalamus) were treated with 10 mM Glu in the presence or absence of the ERK/MAPK inhibitor PD98059. Cell death was assessed by Live/Dead assay, MTS assay and TUNEL. Caspase 3 activity was also measured. Activation of MAPK family members was determined by immunoblot. Bcl2, neuritin and Bid mRNA (by quantitative-PCR) and protein levels (by immunoblot) were also measured. Principal Findings: As expected Glu treatment increased caspase 3 activity and cell death in the GT1-7 cells, but Glu alone did not induce cell death or affect caspase 3 activity in the SCN2.2 cells. However, pretreatment with PD98059 increased caspase 3 activity and resulted in cell death after Glu treatment in SCN2.2 cells. This effect was dependent on NMDA receptor activation. Glu treatment in the SCN2.2 cells resulted in sustained activation of the anti-apoptotic pERK/MAPK, without affecting the pro-apoptotic p-p38/MAPK. In contrast, Glu exposure in GT1-7 cells caused an increase in p-p38/MAPK and a decrease in pERK/MAPK. Bcl2-protein increased in SCN2.2 cells following Glu treatment, but not in GT1-7 cells; bid mRNA and cleaved-Bid protein increased in GT1-7, but not SCN2.2 cells. Conclusions: Facilitation of ERK activation and inhibition of caspase activation promotes resistance to Glu excitotoxicity in SCN2.2 cells. Significance: Further research will explore ERK/MAPK as a key molecule in the prevention of neurodegenerative processes.	[Karmarkar, Sumedha W.; Tischkau, Shelley A.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Bottum, Kathleen M.; Krager, Stacey L.] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Karmarkar, SW (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	stischkau@siumed.edu			Southern Illinois University (SIU) School of Medicine [561306]; Central Research Committee, SIU School of Medicine	Southern Illinois University (SIU) School of Medicine; Central Research Committee, SIU School of Medicine	Funding for this work was provided by an Excellence in Academic Medicine Grant (#561306) from Southern Illinois University (SIU) School of Medicine to ST and a Central Research Committee grant from SIU School of Medicine to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Anderson CNG, 1999, J NEUROSCI, V19, P664; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Bendova Z, 2009, NEUROSCIENCE, V159, P599, DOI 10.1016/j.neuroscience.2009.01.016; Bottum K, 2010, EXP BIOL MED, V235, P237, DOI 10.1258/ebm.2009.009244; BUIJS RM, 1994, J COMP NEUROL, V340, P381, DOI 10.1002/cne.903400308; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clark JP, 2010, J NEUROPHYSIOL, V103, P3448, DOI 10.1152/jn.01069.2009; COLWELL CS, 1992, CHRONOBIOL INT, V9, P163, DOI 10.3109/07420529209064528; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Eminel S, 2008, J NEUROCHEM, V104, P957, DOI 10.1111/j.1471-4159.2007.05101.x; Eminel S, 2004, J BIOL CHEM, V279, P55385, DOI 10.1074/jbc.M405858200; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Jiang XJ, 2009, ANESTHESIOLOGY, V111, P1197, DOI 10.1097/ALN.0b013e3181bf1d93; KAFKA MS, 1985, BRAIN RES, V327, P344, DOI 10.1016/0006-8993(85)91533-1; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li WM, 2007, MOL PHARMACOL, V71, P1258, DOI 10.1124/mol.106.029108; LIOU SY, 1986, BRAIN RES BULL, V16, P527, DOI 10.1016/0361-9230(86)90182-6; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Marais R, 1996, CANCER SURV, V27, P101; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; Mintz EM, 1999, J NEUROSCI, V19, P5124; MOSKO S, 1978, P NATL ACAD SCI USA, V75, P6243, DOI 10.1073/pnas.75.12.6243; MOSKO SS, 1979, NEUROENDOCRINOLOGY, V29, P350, DOI 10.1159/000122944; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; O'Sullivan AW, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-89; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Park MA, 2008, MOL CANCER THER, V7, P2633, DOI 10.1158/1535-7163.MCT-08-0400; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Phong MS, 2010, MOL CELL BIOL, V30, P3816, DOI 10.1128/MCB.00949-09; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; PROSSER RA, 1989, P NATL ACAD SCI USA, V86, P6812, DOI 10.1073/pnas.86.17.6812; REPPERT SM, 1981, J NEUROSCI, V1, P1414; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Saitoh Y, 1987, Acta Neurochir Suppl (Wien), V41, P41; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SAWAKI Y, 1984, Neuroscience Research, V1, P67, DOI 10.1016/0168-0102(84)90031-2; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Sinor JD, 2000, J NEUROSCI, V20, P8831; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Tischkau S A, 1999, J Neurosci, V19, pRC15; Tischkau SA, 2003, J NEUROSCI, V23, P7543; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Tovar-y-Romo LB, 2010, J NEUROCHEM, V115, P1090, DOI 10.1111/j.1471-4159.2010.06766.x; Verheij M, 1998, RADIOTHER ONCOL, V47, P225, DOI 10.1016/S0167-8140(98)00007-3; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Waetzig V, 2003, MOL CELL NEUROSCI, V24, P238, DOI 10.1016/S1044-7431(03)00126-X; Waetzig V, 2004, NEUROSCI LETT, V361, P64, DOI 10.1016/j.neulet.2004.02.041; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; WANG S, 2011, J MOL NEUROSCI; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Yazlovitskaya EM, 1999, MOL CARCINOGEN, V25, P14, DOI 10.1002/(SICI)1098-2744(199905)25:1<14::AID-MC2>3.0.CO;2-V; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069; Yustein JT, 2000, ONCOGENE, V19, P710, DOI 10.1038/sj.onc.1203342; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	81	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23493	10.1371/journal.pone.0023493	http://dx.doi.org/10.1371/journal.pone.0023493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858143	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300052
J	Mowles, SL; Rundle, SD; Cotton, PA				Mowles, Sophie L.; Rundle, Simon D.; Cotton, Peter A.			Susceptibility to Predation Affects Trait-Mediated Indirect Interactions by Reversing Interspecific Competition	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; TROPHIC CASCADES; PREY INTERACTIONS; FOOD-WEB; LITTORINA-LITTOREA; AVOIDANCE-BEHAVIOR; LYMNAEA-STAGNALIS; CRAB PREDATOR; TRADE-OFFS; SNAIL	Numerous studies indicate that the behavioral responses of prey to the presence of predators can have an important role in structuring assemblages through trait-mediated indirect interactions. Few studies, however, have addressed how relative susceptibility to predation influences such interactions. Here we examine the effect of chemical cues from the common shore crab Carcinus maenas on the foraging behavior of two common intertidal gastropod molluscs. Of the two model consumers studied, Littorina littorea is morphologically more vulnerable to crab predation than Gibbula umbilicalis, and it exhibited greater competitive ability in the absence of predation threat. However, Littorina demonstrated a greater antipredator response when experimentally exposed to predation cues, resulting in a lower level of foraging. This reversed the competitive interaction, allowing Gibbula substantially increased access to shared resources. Our results demonstrate that the susceptibility of consumers to predation can influence species interactions, and suggest that inter-specific differences in trait-mediated indirect interactions are another mechanism through which non-consumptive predator effects may influence trophic interactions.	[Mowles, Sophie L.; Rundle, Simon D.; Cotton, Peter A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Mowles, Sophie L.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of Plymouth; University of Nottingham	Mowles, SL (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	sophie.mowles@gmail.com		Cotton, Peter/0000-0002-4830-0868				Abrams P., 1987, P38; Abrams Peter A., 1996, P371; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Bertness MD., 1999, ECOLOGY ATLANTIC SHO; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Cotton PA, 2004, ECOLOGY, V85, P1581, DOI 10.1890/03-3104; Dalesman S, 2006, ANIM BEHAV, V71, P789, DOI 10.1016/j.anbehav.2005.05.028; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; Dalesman S, 2009, ANIM BEHAV, V78, P987, DOI 10.1016/j.anbehav.2009.07.018; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; DUDLEY R, 1980, NAUTILUS, V94, P108; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Grabowski JH, 2005, ECOLOGY, V86, P1312, DOI 10.1890/04-1216; Jacobsen HP, 1999, MAR BIOL, V134, P551, DOI 10.1007/s002270050570; Little C., 1996, BIOL ROCKY SHORES; LUBCHENCO L, 1978, AM NAT, V112, P23; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peacor SD, 2002, ECOL LETT, V5, P77, DOI 10.1046/j.1461-0248.2002.00287.x; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peacor SD, 2000, ECOLOGY, V81, P1998, DOI 10.2307/177288; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Rundle SD, 2001, P ROY SOC B-BIOL SCI, V268, P1463, DOI 10.1098/rspb.2001.1682; RUNDLE SD, 2004, P ROY SOC LOND B BIO, V271, P67, DOI DOI 10.1098/RSBL.2003.0106); Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2002, ECOL LETT, V5, P241, DOI 10.1046/j.1461-0248.2002.00304.x; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; Trussell GC, 2008, ECOLOGY, V89, P2798, DOI 10.1890/08-0250.1; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Vermeij G.J., 1993, NATURAL HIST SHELLS; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	47	29	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23068	10.1371/journal.pone.0023068	http://dx.doi.org/10.1371/journal.pone.0023068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857993	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300012
J	Salton, M; Elkon, R; Borodina, T; Davydov, A; Yaspo, ML; Halperin, E; Shiloh, Y				Salton, Maayan; Elkon, Ran; Borodina, Tatiana; Davydov, Aleksey; Yaspo, Marie-Laure; Halperin, Eran; Shiloh, Yosef			Matrin 3 Binds and Stabilizes mRNA	PLOS ONE			English	Article							NUCLEAR SCAFFOLD PROTEIN; SMALL NUCLEOLAR RNAS; HELICASE-A; P-TEFB; TRANSCRIPTIONAL COACTIVATOR; POLYMERASE-II; DNA-DAMAGE; 7SK SNRNP; HNRNP-K; LOCALIZATION	Matrin 3 (MATR3) is a highly conserved, inner nuclear matrix protein with two zinc finger domains and two RNA recognition motifs (RRM), whose function is largely unknown. Recently we found MATR3 to be phosphorylated by the protein kinase ATM, which activates the cellular response to double strand breaks in the DNA. Here, we show that MATR3 interacts in an RNA-dependent manner with several proteins with established roles in RNA processing, and maintains its interaction with RNA via its RRM2 domain. Deep sequencing of the bound RNA (RIP-seq) identified several small noncoding RNA species. Using microarray analysis to explore MATR39s role in transcription, we identified 77 transcripts whose amounts depended on the presence of MATR3. We validated this finding with nine transcripts which were also bound to the MATR3 complex. Finally, we demonstrated the importance of MATR3 for maintaining the stability of several of these mRNA species and conclude that it has a role in mRNA stabilization. The data suggest that the cellular level of MATR3, known to be highly regulated, modulates the stability of a group of gene transcripts.	[Salton, Maayan; Shiloh, Yosef] Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Canc Res, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Elkon, Ran] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Borodina, Tatiana; Davydov, Aleksey; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Berlin, Germany; [Halperin, Eran] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Netherlands Cancer Institute; Max Planck Society; Tel Aviv University	Salton, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Canc Res, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	maayan.salton@gmail.com		Borodina, Tatiana/0000-0002-6978-016X; Salton, Maayan/0000-0001-8812-5577	A-T Medical Research Foundation; Israel Cancer Research Fund; Israeli Science Foundation [04514831]	A-T Medical Research Foundation; Israel Cancer Research Fund; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the A-T Medical Research Foundation and The Israel Cancer Research Fund. M. Salton is a Joseph Sassoon Fellow. Y. Shiloh is a Research Professor of the Israel Cancer Research Fund. E. Halperin is supported by the Israeli Science Foundation, grant no. 04514831. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Bernert G, 2002, PROTEOMICS, V2, P1752, DOI 10.1002/1615-9861(200212)2:12<1752::AID-PROT1752>3.0.CO;2-Y; Bimpaki EI, 2010, CLIN ENDOCRINOL, V72, P744, DOI 10.1111/j.1365-2265.2009.03725.x; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Butcher SE, 2005, BIOCHEM SOC T, V33, P447, DOI 10.1042/BST0330447; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Fuchs D, 2006, MOL NUTR FOOD RES, V50, P58, DOI 10.1002/mnfr.200500133; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hibino Y, 2000, BIOCHEM BIOPH RES CO, V279, P282, DOI 10.1006/bbrc.2000.3938; Hibino Y, 2006, BBA-GENE STRUCT EXPR, V1759, P195, DOI 10.1016/j.bbaexp.2006.04.010; Hisada-Ishii S, 2007, BIOCHEM BIOPH RES CO, V354, P72, DOI 10.1016/j.bbrc.2006.12.191; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Martin AN, 2007, CELL RES, V17, P219, DOI 10.1038/sj.cr.7310120; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; RIMOLDI OJ, 1993, MOL CELL BIOL, V13, P4382, DOI 10.1128/MCB.13.7.4382; RUFF EA, 1993, P NATL ACAD SCI USA, V90, P635, DOI 10.1073/pnas.90.2.635; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V361, P281, DOI 10.1016/j.bbrc.2007.06.156; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	39	103	106	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23882	10.1371/journal.pone.0023882	http://dx.doi.org/10.1371/journal.pone.0023882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858232	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300103
J	Lim, KH; Kim, KH; Choi, SI; Park, ES; Park, SH; Ryu, K; Park, YK; Kwon, SY; Yang, SI; Lee, HC; Sung, IK; Seong, BL				Lim, Keo-Heun; Kim, Kyun-Hwan; Choi, Seong Il; Park, Eun-Sook; Park, Seung Hwa; Ryu, Kisun; Park, Yong Kwang; Kwon, So Young; Yang, Sung-Il; Lee, Han Chu; Sung, In-Kyung; Seong, Baik L.			RPS3a Over-Expressed in HBV-Associated Hepatocellular Carcinoma Enhances the HBx-Induced NF-kappa B Signaling via Its Novel Chaperoning Function	PLOS ONE			English	Article							VIRUS-X-PROTEIN; HEPATITIS-B; GENE-EXPRESSION; RIBOSOMAL-PROTEINS; CELL-GROWTH; CANCER; TRANSLATION; SOLUBILITY; ACTIVATION; INDUCTION	Hepatitis B virus (HBV) infection is one of the major causes of hepatocellular carcinoma (HCC) development. Hepatitis B virus X protein (HBx) is known to play a key role in the development of hepatocellular carcinoma (HCC). Several cellular proteins have been reported to be over-expressed in HBV-associated HCC tissues, but their role in the HBV-mediated oncogenesis remains largely unknown. Here, we explored the effect of the over-expressed cellular protein, a ribosomal protein S3a (RPS3a), on the HBx-induced NF-kappa B signaling as a critical step for HCC development. The enhancement of HBx-induced NF-kappa B signaling by RPS3a was investigated by its ability to translocate NF-kappa B (p65) into the nucleus and the knock-down analysis of RPS3a. Notably, further study revealed that the enhancement of NF-kappa B by RPS3a is mediated by its novel chaperoning activity toward physiological HBx. The over-expression of RPS3a significantly increased the solubility of highly aggregation-prone HBx. This chaperoning function of RPS3a for HBx is closely correlated with the enhanced NF-kappa B activity by RPS3a. In addition, the mutational study of RPS3a showed that its N-terminal domain (1-50 amino acids) is important for the chaperoning function and interaction with HBx. The results suggest that RPS3a, via extra-ribosomal chaperoning function for HBx, contributes to virally induced oncogenesis by enhancing HBx-induced NF-kB signaling pathway.	[Lim, Keo-Heun; Ryu, Kisun; Seong, Baik L.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Kim, Kyun-Hwan; Park, Eun-Sook; Park, Yong Kwang; Yang, Sung-Il] Konkuk Univ, Sch Med, IBST, Dept Pharmacol, Seoul, South Korea; [Kwon, So Young; Sung, In-Kyung] Konkuk Univ, Sch Med, IBST, Dept Internal Med, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Sch Med, IBST, Dept Anat, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Sch Med, IBST, Ctr Canc Res & Diagnost Med, Seoul, South Korea; [Kim, Kyun-Hwan; Yang, Sung-Il] Konkuk Univ, Res Inst Med Sci, Seoul, South Korea; [Lee, Han Chu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Choi, Seong Il; Seong, Baik L.] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Yonsei University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; University of Ulsan; Asan Medical Center; Yonsei University	Lim, KH (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea.	khkim10@kku.ac.kr; blseong@yonsei.ac.kr		Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X	Ministry of Knowledge Economy/Korea Evaluation Institute of Industrial Technology (MKE/KEIT) [10031969]; Ministry of Education, Science and Technology (MEST), Republic of Korea [2010-0001932]; Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea [A084826, A085105]	Ministry of Knowledge Economy/Korea Evaluation Institute of Industrial Technology (MKE/KEIT)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea	This work was supported by the R&D Program of Ministry of Knowledge Economy/Korea Evaluation Institute of Industrial Technology (MKE/KEIT) [10031969] and Ministry of Education, Science and Technology (MEST) [2010-0001932], Republic of Korea. This study was also supported in part by a grant from the Korea Healthcare Technology R&D Project [A084826 to K.H.K., A085105 to B.L.S.], Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Choi SI, 2009, RNA BIOL, V6, P21, DOI 10.4161/rna.6.1.7441; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Henkler F, 2001, J GEN VIROL, V82, P871, DOI 10.1099/0022-1317-82-4-871; Iizuka N, 2002, CANCER RES, V62, P3939; JAMEEL S, 1990, J VIROL, V64, P3963, DOI 10.1128/JVI.64.8.3963-3966.1990; Kabir MA, 2008, FEMS YEAST RES, V8, P1236, DOI 10.1111/j.1567-1364.2008.00425.x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kashuba E, 2005, EXP CELL RES, V303, P47, DOI 10.1016/j.yexcr.2004.08.025; KHO CJ, 1992, P NATL ACAD SCI USA, V89, P2200, DOI 10.1073/pnas.89.6.2200; Kho CJ, 1996, CELL GROWTH DIFFER, V7, P1157; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Kim HK, 2010, BIOCHEM BIOPH RES CO, V391, P1177, DOI 10.1016/j.bbrc.2009.11.176; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Kim KH, 2003, EMBO J, V22, P2104, DOI 10.1093/emboj/cdg210; Kim MY, 2001, ONCOGENE, V20, P4568, DOI 10.1038/sj.onc.1204626; Kovacs D, 2009, FEBS LETT, V583, P88, DOI 10.1016/j.febslet.2008.11.049; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Liu D, 2009, BIOTECHNOL APPL BIOC, V54, P141, DOI 10.1042/BA20090116; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; LUTSCH G, 1990, EUR J CELL BIOL, V51, P140; Marczinovits I, 1997, J BIOTECHNOL, V56, P81, DOI 10.1016/S0168-1656(97)00080-1; Musholt TJ, 1997, J SURG RES, V69, P94, DOI 10.1006/jsre.1997.5038; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Naora H, 1996, BIOCHEM BIOPH RES CO, V224, P258, DOI 10.1006/bbrc.1996.1017; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; Shuda M, 2000, ANTICANCER RES, V20, P2489; Slizhikova D. K., 2005, Bioorganicheskaya Khimiya, V31, P195; Song CZ, 2003, WORLD J GASTROENTERO, V9, P1521, DOI 10.3748/wjg.v9.i7.1521; Song DM, 2002, BIOCHEMISTRY-US, V41, P929, DOI 10.1021/bi015669c; STARKEY CR, 1995, INT J CANCER, V62, P325, DOI 10.1002/ijc.2910620316; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tarantul VZ, 2000, AIDS RES HUM RETROV, V16, P173, DOI 10.1089/088922200309511; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Urban S, 1997, HEPATOLOGY, V26, P1045, DOI 10.1002/hep.510260437; Wang T, 2004, WORLD J GASTROENTERO, V10, P356; WANG WL, 1991, HEPATOLOGY, V14, P29, DOI 10.1002/hep.1840140106; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yun C, 2002, CANCER LETT, V184, P97, DOI 10.1016/S0304-3835(02)00187-8	47	36	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22258	10.1371/journal.pone.0022258	http://dx.doi.org/10.1371/journal.pone.0022258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857917	Green Submitted, Green Published, gold			2022-12-25	WOS:000294125500006
J	Kanatsu-Shinohara, M; Takashima, S; Ishii, K; Shinohara, T				Kanatsu-Shinohara, Mito; Takashima, Seiji; Ishii, Kei; Shinohara, Takashi			Dynamic Changes in EPCAM Expression during Spermatogonial Stem Cell Differentiation in the Mouse Testis	PLOS ONE			English	Article							LONG-TERM CULTURE; FUNCTIONAL-CHARACTERISTICS; ADHESION MOLECULE; SELF-RENEWAL; SPERMATOGENESIS; TRANSPLANTATION; MAINTENANCE; GONOCYTES; SHARE	Background: Spermatogonial stem cells (SSCs) have the unique ability to undergo self-renewal division. However, these cells are morphologically indistinguishable from committed spermatogonia, which have limited mitotic activity. To establish a system for SSC purification, we analyzed the expression of SSC markers CD9 and epithelial cell adhesion molecule (EPCAM), both of which are also expressed on embryonic stem (ES) cells. We examined the correlation between their expression patterns and SSC activities. Methodology and Principal Findings: By magnetic cell sorting, we found that EPCAM-selected mouse germ cells have limited clonogenic potential in vitro. Moreover, these cells showed stronger expression of progenitor markers than CD9-selected cells, which are significantly more enriched in SSCs. Fluorescence-activated cell sorting of CD9-selected cells indicated a significantly higher frequency of SSCs among the CD9(+)EPCAM(low/-) population than among the CD9(+)EPCAM(+) population. Overexpression of the active form of EPCAM in germline stem (GS) cell cultures did not significantly influence SSC activity, whereas EPCAM suppression by short hairpin RNA compromised GS cell proliferation and increased the concentration of SSCs, as revealed by germ cell transplantation. Conclusions/Significance: These results show that SSCs are the most concentrated in CD9(+)EPCAM(low/-) population and also suggest that EPCAM plays an important role in progenitor cell amplification in the mouse spermatogenic system. The establishment of a method to distinguish progenitor spermatogonia from SSCs will be useful for developing an improved purification strategy for SSCs from testis cells.	[Kanatsu-Shinohara, Mito; Takashima, Seiji; Ishii, Kei; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto, Japan; [Shinohara, Takashi] Japan Sci & Technol Agcy, CREST, Kyoto, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kanatsu-Shinohara, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto, Japan.	takashi@mfour.med.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019	Takashima, Seiji/0000-0002-9176-3139; Ishii, Kei/0000-0002-5303-842X	Genome Network; Japan Science and Technology Agency (CREST); Program for Promotion of Basic and Applied Researches for Innovation in Bio-orientated Industry; Ministry of Health, Labour, and Welfare; Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Genome Network; Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Researches for Innovation in Bio-orientated Industry; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this research was supported by the Genome Network Project, Japan Science and Technology Agency (CREST), Program for Promotion of Basic and Applied Researches for Innovation in Bio-orientated Industry, the Ministry of Health, Labour, and Welfare, The Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers," and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; De Rooij DG, 2000, J ANDROL, V21, P776; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2007, BIOL REPROD, V76, P55, DOI 10.1095/biolreprod.106.055863; Kanatsu-Shinohara M, 2010, METHOD ENZYMOL, V477, P17, DOI 10.1016/S0076-6879(10)77002-6; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lolicato F, 2008, DEV BIOL, V313, P725, DOI 10.1016/j.ydbio.2007.11.011; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Moore TJ, 2002, ENDOCRINOLOGY, V143, P3171, DOI 10.1210/en.143.8.3171; Morimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007909; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	37	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23663	10.1371/journal.pone.0023663	http://dx.doi.org/10.1371/journal.pone.0023663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858196	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953700038
J	Lahiri, S; Shen, KL; Klein, M; Tang, AJ; Kane, E; Gershow, M; Garrity, P; Samuel, ADT				Lahiri, Subhaneil; Shen, Konlin; Klein, Mason; Tang, Anji; Kane, Elizabeth; Gershow, Marc; Garrity, Paul; Samuel, Aravinthan D. T.			Two Alternating Motor Programs Drive Navigation in Drosophila Larva	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEURONS; THERMOTAXIS; CHEMOTAXIS; LOCOMOTION; AVOIDANCE; SEROTONIN; BEHAVIOR; CIRCUIT; LIGHT	When placed on a temperature gradient, a Drosophila larva navigates away from excessive cold or heat by regulating the size, frequency, and direction of reorientation maneuvers between successive periods of forward movement. Forward movement is driven by peristalsis waves that travel from tail to head. During each reorientation maneuver, the larva pauses and sweeps its head from side to side until it picks a new direction for forward movement. Here, we characterized the motor programs that underlie the initiation, execution, and completion of reorientation maneuvers by measuring body segment dynamics of freely moving larvae with fluorescent muscle fibers as they were exposed to temporal changes in temperature. We find that reorientation maneuvers are characterized by highly stereotyped spatiotemporal patterns of segment dynamics. Reorientation maneuvers are initiated with head sweeping movement driven by asymmetric contraction of a portion of anterior body segments. The larva attains a new direction for forward movement after head sweeping movement by using peristalsis waves that gradually push posterior body segments out of alignment with the tail (i.e., the previous direction of forward movement) into alignment with the head. Thus, reorientation maneuvers during thermotaxis are carried out by two alternating motor programs: (1) peristalsis for driving forward movement and (2) asymmetric contraction of anterior body segments for driving head sweeping movement.	[Lahiri, Subhaneil; Shen, Konlin; Klein, Mason; Tang, Anji; Kane, Elizabeth; Gershow, Marc; Samuel, Aravinthan D. T.] Harvard Univ, Dept Phys, Ctr Brain Sci, Cambridge, MA 02138 USA; [Garrity, Paul] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Harvard University; Brandeis University	Lahiri, S (corresponding author), Harvard Univ, Dept Phys, Ctr Brain Sci, Cambridge, MA 02138 USA.	samuel@physics.harvard.edu	Lahiri, Subhaneil/AGI-0957-2022	Lahiri, Subhaneil/0000-0003-2028-6635; Garrity, Paul/0000-0002-8274-6564; Gershow, Marc/0000-0001-7528-6101	National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105383] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Samuel was the recipient of a National Institutes of Health (NIH) Pioneer Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERRIGAN D, 1993, J EXP BIOL, V179, P245; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Dixit R, 2008, DEV NEUROBIOL, V68, P309, DOI 10.1002/dneu.20589; FRAENKEL GS, 1940, ORIENTATION ANIMALS, V6; Holmes SJ, 1905, J COMP NEUROL PSYCHO, V15, P98, DOI 10.1002/cne.920150203; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Neckameyer WS, 2010, DEV NEUROSCI-BASEL, V32, P217, DOI 10.1159/000304888; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576	24	69	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23180	10.1371/journal.pone.0023180	http://dx.doi.org/10.1371/journal.pone.0023180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858019	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953700006
J	Doyle, GA; Wang, MJ; Chou, AD; Oleynick, JU; Arnold, SE; Buono, RJ; Ferraro, TN; Berrettini, WH				Doyle, Glenn A.; Wang, Min-Jung; Chou, Andrew D.; Oleynick, John U.; Arnold, Steven E.; Buono, Russell J.; Ferraro, Thomas N.; Berrettini, Wade H.			In Vitro and Ex Vivo Analysis of CHRNA3 and CHRNA5 Haplotype Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; RECEPTOR SUBUNIT GENE; NICOTINE DEPENDENCE; ALLELIC EXPRESSION; LUNG-CANCER; CANDIDATE GENES; RISK; SMOKING; ASSOCIATION; POLYMORPHISMS	Genome-wide association studies implicate variations in CHRNA5 and CHRNA3 as being associated with nicotine addiction (NA). Multiple common haplotypes ("risk", "mixed" and "protective") exist in Europeans; however, high linkage disequilibrium between variations in CHRNA5 and CHRNA3 makes assigning causative allele(s) for NA difficult through genotyping experiments alone. We investigated whether CHRNA5 or CHRNA3 promoter haplotypes, associated previously with NA, might influence allelic expression levels. For in vitro analyses, promoter haplotypes were sub-cloned into a luciferase reporter vector. When assessed in BE(2)-C cells, luciferase expression was equivalent among CHRNA3 haplotypes, but the combination of deletion at rs3841324 and variation at rs503464 decreased CHRNA5 promoter-derived luciferase activity, possibly due to loss of an SP-1 and other site(s). Variation within the CHRNA5 5'UTR at rs55853698 and rs55781567 also altered luciferase expression in BE(2)-C cells. Allelic expression imbalance (AEI) from the "risk" or "protective" haplotypes was assessed in post-mortem brain tissue from individuals heterozygous at coding polymorphisms in CHRNA3 (rs1051730) or CHRNA5 (rs16969968). In most cases, equivalent allelic expression was observed; however, one individual showed CHRNA5 AEI that favored the "protective" allele and that was concordant with heterozygosity at polymorphisms similar to 13.5 kb upstream of the CHRNA5 transcription start site. Putative enhancer activity from these distal promoter elements was assessed using heterologous promoter constructs. We observed no differences in promoter activity from the two distal promoter haplotypes examined, but found that the distal promoter region strongly repressed transcription. We conclude that CHRNA5 promoter variants may affect relative risk for NA in some heterozygous individuals.	[Doyle, Glenn A.; Wang, Min-Jung; Chou, Andrew D.; Arnold, Steven E.; Ferraro, Thomas N.; Berrettini, Wade H.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Oleynick, John U.] Johnson & Johnson, Malvern, PA USA; [Buono, Russell J.] Dept Vet Affairs Med Ctr, Res Serv, Coatesville, PA USA	University of Pennsylvania; Pennsylvania Medicine; Johnson & Johnson; Johnson & Johnson USA	Doyle, GA (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	gadoyle@mail.med.upenn.edu	Arnold, Steven E/J-7546-2012	Ferraro, Thomas/0000-0003-2250-8772	National Institutes of Health [R01 DA025201, AG10124, MH64045]; Tzedakah Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tzedakah Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by funding from the National Institutes of Health [grant number R01 DA025201 to WHB] and from the Tzedakah Foundation. Brain tissue from the University of Pennsylvania Brain Bank was acquired through funding from the National Institutes of Health [grant numbers AG10124, MH64045]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Buckland PR, 2005, HUM MUTAT, V26, P214, DOI 10.1002/humu.20207; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Falvella FS, 2010, J NATL CANCER I, V102, P1366, DOI 10.1093/jnci/djq264; Flora A, 2000, EUR J PHARMACOL, V393, P85, DOI 10.1016/S0014-2999(00)00040-6; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mineur YS, 2008, BIOCHEM PHARMACOL, V75, P323, DOI 10.1016/j.bcp.2007.06.010; Nicita-Mauro V, 2010, CURR PHARM DESIGN, V16, P775, DOI 10.2174/138161210790883552; Paliwal A, 2010, CANCER RES, V70, P2779, DOI 10.1158/0008-5472.CAN-09-4550; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Quinn EM, 2010, BIPOLAR DISORD, V12, P440, DOI 10.1111/j.1399-5618.2010.00817.x; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sasaki H, 2010, J SURG RES, V162, P75, DOI 10.1016/j.jss.2009.01.008; Smith RM, 2011, EUR J HUM GENET, V19, P76, DOI 10.1038/ejhg.2010.120; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200	34	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23373	10.1371/journal.pone.0023373	http://dx.doi.org/10.1371/journal.pone.0023373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858091	Green Published, gold, Green Submitted			2022-12-25	WOS:000293953500034
J	Pham, CD; Sims, HI; Archer, TK; Schnitzler, GR				Pham, Chuong D.; Sims, Hillel I.; Archer, Trevor K.; Schnitzler, Gavin R.			Multiple Distinct Stimuli Increase Measured Nucleosome Occupancy around Human Promoters	PLOS ONE			English	Article							TUMOR VIRUS PROMOTER; CHROMATIN REMODELING COMPLEXES; MEDIATES CRITICAL INTERACTIONS; SWI/SNF-RELATED COMPLEXES; LONG TERMINAL REPEAT; CELL-CYCLE CONTROL; C-MYC GENE; GLUCOCORTICOID-RECEPTOR; IN-VIVO; NUCLEAR RECEPTORS	Nucleosomes can block access to transcription factors. Thus the precise localization of nucleosomes relative to transcription start sites and other factor binding sites is expected to be a critical component of transcriptional regulation. Recently developed microarray approaches have allowed the rapid mapping of nucleosome positions over hundreds of kilobases (kb) of human genomic DNA, although these approaches have not yet been widely used to measure chromatin changes associated with changes in transcription. Here, we use custom tiling microarrays to reveal changes in nucleosome positions and abundance that occur when hormone-bound glucocorticoid receptor (GR) binds to sites near target gene promoters in human osteosarcoma cells. The most striking change is an increase in measured nucleosome occupancy at sites spanning similar to 1 kb upstream and downstream of transcription start sites, which occurs one hour after addition of hormone, but is lost at 4 hours. Unexpectedly, this increase was seen both on GR-regulated and GR-non-regulated genes. In addition, the human SWI/SNF chromatin remodeling factor (a GR co-activator) was found to be important for increased occupancy upon hormone treatment and also for low nucleosome occupancy without hormone. Most surprisingly, similar increases in nucleosome occupancy were also seen on both regulated and non-regulated promoters during differentiation of human myeloid leukemia cells and upon activation of human CD4+ T-cells. These results indicate that dramatic changes in chromatin structure over similar to 2 kb of human promoters may occur genomewide and in response to a variety of stimuli, and suggest novel models for transcriptional regulation.	[Pham, Chuong D.] AstraZeneca R&D Boston, Waltham, MA 02451 USA; [Sims, Hillel I.] Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Archer, Trevor K.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Schnitzler, Gavin R.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA	AstraZeneca; Brandeis University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tufts Medical Center	Pham, CD (corresponding author), AstraZeneca R&D Boston, Waltham, MA 02451 USA.	gschnitzler@tuftsmedicalcenter.org	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	American Cancer Society [RSG-04-188-01-GMC]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES071006] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant to GRS from the American Cancer Society (#RSG-04-188-01-GMC, www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P865, DOI 10.1093/nar/20.4.865; Burkhart BA, 2009, MOL CELL ENDOCRINOL, V298, P66, DOI 10.1016/j.mce.2008.10.011; Chen JG, 2006, MOL ENDOCRINOL, V20, P1, DOI 10.1210/me.2005-0192; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Flavin M, 2004, MOL CELL BIOL, V24, P7891, DOI 10.1128/MCB.24.18.7891-7901.2004; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Fryer CJ, 2000, J BIOL CHEM, V275, P17771, DOI 10.1074/jbc.M908729199; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; GROSSO LE, 1985, CANCER RES, V45, P5035; Hebbar PB, 2003, CHROMOSOMA, V111, P495, DOI 10.1007/s00412-003-0232-x; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hebbar PB, 2007, J BIOL CHEM, V282, P8284, DOI 10.1074/jbc.M610554200; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE HL, 1994, MOL CELL BIOL, V14, P32, DOI 10.1128/MCB.14.1.32; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu H, 2006, MOL CELL BIOL, V26, P2550, DOI 10.1128/MCB.26.7.2550-2559.2006; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Morand EF, 2007, CURR OPIN RHEUMATOL, V19, P302, DOI 10.1097/BOR.0b013e32805e87d0; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; MYMRYK JS, 1995, MOL ENDOCRINOL, V9, P1825, DOI 10.1210/me.9.12.1825; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Pham CD, 2010, NUCLEIC ACIDS RES, V38, P400, DOI 10.1093/nar/gkp1030; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Pullner A, 1996, J BIOL CHEM, V271, P31452, DOI 10.1074/jbc.271.49.31452; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Schnitzler GR, 2008, CELL BIOCHEM BIOPHYS, V51, P67, DOI 10.1007/s12013-008-9015-6; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Sims HI, 2008, NUCLEIC ACIDS RES, V36, P6118, DOI 10.1093/nar/gkn623; Sims HI, 2007, BIOCHEMISTRY-US, V46, P11377, DOI 10.1021/bi7008823; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Sugatani J, 2005, MOL PHARMACOL, V67, P845, DOI 10.1124/mol.104.007161; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Ulyanova NP, 2005, MOL CELL BIOL, V25, P11156, DOI 10.1128/MCB.25.24.11156-11170.2005; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	78	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23490	10.1371/journal.pone.0023490	http://dx.doi.org/10.1371/journal.pone.0023490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853138	Green Submitted, gold, Green Published			2022-12-25	WOS:000293953400047
J	Hoffman, JI; Nichols, HJ				Hoffman, Joseph I.; Nichols, Hazel J.			A Novel Approach for Mining Polymorphic Microsatellite Markers In Silico	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; NULL ALLELES; GENOTYPING ERRORS; SIMPLE SEQUENCES; CANINE SIZE; LOCI; HETEROZYGOSITY; DNA; IDENTIFICATION; TRANSCRIPTOME	An important emerging application of high-throughput 454 sequencing is the isolation of molecular markers such as microsatellites from genomic DNA. However, few studies have developed microsatellites from cDNA despite the added potential for targeting candidate genes. Moreover, to develop microsatellites usually requires the evaluation of numerous primer pairs for polymorphism in the focal species. This can be time-consuming and wasteful, particularly for taxa with low genetic diversity where the majority of primers often yield monomorphic polymerase chain reaction (PCR) products. Transcriptome assemblies provide a convenient solution, functional annotation of transcripts allowing markers to be targeted towards candidate genes, while high sequence coverage in principle permits the assessment of variability in silico. Consequently, we evaluated fifty primer pairs designed to amplify microsatellites, primarily residing within transcripts related to immunity and growth, identified from an Antarctic fur seal (Arctocephalus gazella) transcriptome assembly. In silico visualization was used to classify each microsatellite as being either polymorphic or monomorphic and to quantify the number of distinct length variants, each taken to represent a different allele. The majority of loci (n = 36, 76.0%) yielded interpretable PCR products, 23 of which were polymorphic in a sample of 24 fur seal individuals. Loci that appeared variable in silico were significantly more likely to yield polymorphic PCR products, even after controlling for microsatellite length measured in silico. We also found a significant positive relationship between inferred and observed allele number. This study not only demonstrates the feasibility of generating modest panels of microsatellites targeted towards specific classes of gene, but also suggests that in silico microsatellite variability may provide a useful proxy for PCR product polymorphism.	[Hoffman, Joseph I.] Univ Bielefeld, Dept Anim Behav, Bielefeld, North Rhine Wes, Germany; [Nichols, Hazel J.] Univ Cambridge, Dept Zool, Cambridge, Cambs, England	University of Bielefeld; University of Cambridge	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, North Rhine Wes, Germany.	joseph.hoffman@uni-bielefeld.de	Nichols, Hazel/D-4737-2013; Hoffman, Joseph i/K-7725-2012	Hoffman, Joseph i/0000-0001-5895-8949	Biology Faculty, University of Bielefeld; Natural Environment Research Council	Biology Faculty, University of Bielefeld; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a FIF grant (Biology Faculty, University of Bielefeld) awarded to JIH. HJN is currently supported by the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Crawley M. J, 2002, STAT COMPUTING INTRO; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Gemmell NJ, 1997, MAR MAMMAL SCI, V13, P512, DOI 10.1111/j.1748-7692.1997.tb00661.x; Grover A, 2007, MOL GENET GENOMICS, V277, P469, DOI 10.1007/s00438-006-0204-y; Habel JC, 2009, CONSERV GENET, V10, P1659, DOI 10.1007/s10592-008-9744-5; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hoffjan S, 2006, INT J IMMUNOGENET, V33, P401, DOI 10.1111/j.1744-313X.2006.00631.x; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoffman JI, 2008, MOL ECOL RESOUR, V8, P459, DOI 10.1111/j.1471-8286.2007.01993.x; Hoffman JI, 2011, MOL ECOL RESOUR, V11, P703, DOI 10.1111/j.1755-0998.2011.02999.x; Hoffman JI, 2010, J HERED, V101, P539, DOI 10.1093/jhered/esq046; Hoffman JI, 2010, J HERED, V101, P527, DOI 10.1093/jhered/esq045; Hoffman JI, 2009, CONSERV GENET, V10, P989, DOI 10.1007/s10592-008-9669-z; Huang SW, 2003, GENETICA, V119, P201, DOI 10.1023/A:1026061216816; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Leclerc MC, 2004, P NATL ACAD SCI USA, V101, P14455, DOI 10.1073/pnas.0405186101; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merkel A, 2008, BRIEF BIOINFORM, V9, P355, DOI 10.1093/bib/bbn028; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; MITTON JB, 1984, ANNU REV ECOL SYST, V15, P479; Obexer-Ruff G, 2003, GENET SEL EVOL, V35, pS113, DOI 10.1051/gse:2003020; PAETKAU D, 1995, MOL ECOL, V4, P519, DOI 10.1111/j.1365-294X.1995.tb00248.x; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Perry JC, 2011, J HERED, V102, P125, DOI 10.1093/jhered/esq099; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rozen S, 2000, BIOINFORMATICS METHO; Saarinen EV, 2010, J HERED, V101, P784, DOI 10.1093/jhered/esq080; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Santucci F, 2007, HEREDITY, V99, P340, DOI 10.1038/sj.hdy.6801006; Scaglione D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-454; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schultz Jennifer K., 2010, Diversity, V2, P863; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Team RDC, 2005, R LANG ENV STAT COMP; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wagner JL, 2003, J HERED, V94, P23, DOI 10.1093/jhered/esg002; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	64	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23283	10.1371/journal.pone.0023283	http://dx.doi.org/10.1371/journal.pone.0023283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853104	Green Published, Green Submitted, gold			2022-12-25	WOS:000295454200064
J	Safronetz, D; Haddock, E; Feldmann, F; Ebihara, H; Feldmann, H				Safronetz, David; Haddock, Elaine; Feldmann, Friederike; Ebihara, Hideki; Feldmann, Heinz			In Vitro and In Vivo Activity of Ribavirin against Andes Virus Infection	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; TO-PERSON TRANSMISSION; SIN-NOMBRE-VIRUS; HANTAAN VIRUS; INTRAVENOUS RIBAVIRIN; CARDIOPULMONARY SYNDROME; ANTIVIRAL ACTIVITY; DOUBLE-BLIND; EXPERIENCE; HAMSTERS	In Pathogenic hantaviruses are a closely related group of rodent- borne viruses which are responsible for two distinct diseases in humans, hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome (HPS, otherwise known as hantavirus cardiopulmonary syndrome, HCPS). The antiviral effect of ribavirin against Old World hantaviruses, most notably Hantaan virus, is well documented; however, only a few studies have addressed its inhibitory effect on New World hantaviruses. In the present study, we demonstrate that ribavirin is highly active against Andes virus (ANDV), an important etiological agent of HPS, both in vitro and in vivo using a lethal hamster model of HPS. Treatment of ANDV infected Vero E6 cells with ribavirin resulted in dose-dependent reductions in viral RNA and protein as well as virus yields with a half maximal inhibitory concentration between 5 and 12.5 mu g.ml(-1). In hamsters, treatment with as little as 5 mg kg 21 day 21 was 100% effective at preventing lethal HPS disease when therapy was administered by intraperitoneal injection from day1 through day 10 post-infection. Significant reductions were observed in ANDV RNA and antigen positive cells in lung and liver tissues. Ribavirin remained completely protective when administered by intraperitoneal injections up to three days post-infection. In addition, we show that daily oral ribavirin therapy initiated 1 day post-infection and continuing for ten days is also protective against lethal ANDV disease, even at doses of 5 mg kg(-1) day(-1). Our results suggest ribavirin treatment is beneficial for postexposure prophylaxis against HPS-causing hantaviruses and should be considered in scenarios where exposure to the virus is probable. The similarities between the results obtained in this study and those from previous clinical evaluations of ribavirin against HPS, further validate the hamster model of lethal HPS and demonstrate its usefulness in screening antiviral agents against this disease.	[Safronetz, David; Haddock, Elaine; Ebihara, Hideki; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Feldmann, Friederike] NIAID, Off Operat & Management, Div Intramural Res, NIH, Hamilton, MT USA; [Feldmann, Heinz] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Manitoba	Safronetz, D (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA.	feldmannh@niaid.nih.gov		Ebihara, Hideki/0000-0002-2576-9735	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Intramural Research Program of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges AA, 2008, MICROBES INFECT, V10, P1150, DOI 10.1016/j.micinf.2008.06.006; Bossi Philippe, 2004, Euro Surveill, V9, pE11, DOI 10.2807/esm.09.12.00504-en; Chapman LE, 1999, ANTIVIR THER, V4, P211; Chung DH, 2007, J VIROL, V81, P11722, DOI 10.1128/JVI.00874-07; Dietl CA, 2008, J THORAC CARDIOV SUR, V135, P579, DOI 10.1016/j.jtcvs.2007.11.020; Enria DA, 2001, CURR TOP MICROBIOL, V256, P117; FELDMANN H, 1993, VIRUS RES, V30, P351, DOI 10.1016/0168-1702(93)90101-R; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; HUGGINS JW, 1991, J INFECT DIS, V164, P1119, DOI 10.1093/infdis/164.6.1119; HUGGINS JW, 1986, J INFECT DIS, V153, P489, DOI 10.1093/infdis/153.3.489; Jonsson CB, 2008, ANTIVIR RES, V78, P162, DOI 10.1016/j.antiviral.2007.10.012; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIRSI JJ, 1983, ANTIMICROB AGENTS CH, V24, P353, DOI 10.1128/AAC.24.3.353; Martinez VP, 2005, EMERG INFECT DIS, V11, P1848, DOI 10.3201/eid1112.050501; Medina RA, 2007, J GEN VIROL, V88, P493, DOI 10.1099/vir.0.82459-0; Meissner JD, 2002, VIRUS RES, V89, P131, DOI 10.1016/S0168-1702(02)00129-6; Mertz GJ, 2004, CLIN INFECT DIS, V39, P1307, DOI 10.1086/425007; Murphy ME, 2001, J VET MED SCI, V63, P637, DOI 10.1292/jvms.63.637; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Olschlager S, 2011, ANTIVIR RES, V91, P89, DOI 10.1016/j.antiviral.2011.05.006; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Rusnak JM, 2009, ANTIVIR RES, V81, P68, DOI 10.1016/j.antiviral.2008.09.007; Rusnak JM, 2004, J OCCUP ENVIRON MED, V46, P801, DOI 10.1097/01.jom.0000135539.99691.4e; Safronetz D, 2009, J VIROL, V83, P7285, DOI 10.1128/JVI.00373-09; Schmaljohn C, 2009, VACCINE, V27, pD61, DOI 10.1016/j.vaccine.2009.07.096; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317; Sun YJ, 2007, ANTIMICROB AGENTS CH, V51, P84, DOI 10.1128/AAC.00790-06; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	31	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23560	10.1371/journal.pone.0023560	http://dx.doi.org/10.1371/journal.pone.0023560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853152	Green Submitted, Green Published, gold			2022-12-25	WOS:000295454200097
J	Jensen, H; Andresen, L; Nielsen, J; Christensen, JP; Skov, S				Jensen, Helle; Andresen, Lars; Nielsen, Jens; Christensen, Jan Pravsgaard; Skov, Soren			Vesicular Stomatitis Virus Infection Promotes Immune Evasion by Preventing NKG2D-Ligand Surface Expression	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NKG2D LIGANDS; HUMAN CYTOMEGALOVIRUS; MATRIX PROTEIN; INTRACELLULAR SEQUESTRATION; CLINICAL-SIGNIFICANCE; MIC LIGANDS; T-CELLS; NK; TRANSLATION	Vesicular stomatitis virus (VSV) has recently gained attention for its oncolytic ability in cancer treatment. Initially, we hypothesized that VSV infection could increase immune recognition of cancer cells through induction of the immune stimulatory NKG2D-ligands. Here we show that VSV infection leads to a robust induction of MICA mRNA expression, however the subsequent surface expression is potently hindered. Thus, VSV lines up with human cytomegalovirus (HCMV) and adenovirus, which actively subvert the immune system by negatively affecting NKG2D-ligand surface expression. VSV infection caused an active suppression of NKG2D-ligand surface expression, affecting both endogenous and histone deacetylase (HDAC)-inhibitor induced MICA, MICB and ULBP-2 expression. The classical immune escape mechanism of VSV (i.e., the M protein blockade of nucleocytoplasmic mRNA transport) was not involved, as the VSV mutant strain, VSV DM51, which possess a defective M protein, prevented MICA surface expression similarly to wild-type VSV. The VSV mediated down modulation of NKG2D-ligand expression did not involve apoptosis. Constitutive expression of MICA bypassed the escape mechanism, suggesting that VSV affect NKG2D-ligand expression at an early post-transcriptional level. Our results show that VSV possess an escape mechanism, which could affect the immune recognition of VSV infected cancer cells. This may also have implications for immune recognition of cancer cells after combined treatment with VSV and chemotherapeutic drugs.	[Jensen, Helle; Andresen, Lars; Skov, Soren] Univ Copenhagen, LIFE, Sect Biomed, Immunol Lab, Copenhagen, Denmark; [Nielsen, Jens] Tech Univ Denmark, Natl Vet Inst, Lindholm, Denmark; [Christensen, Jan Pravsgaard] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	Jensen, H (corresponding author), Univ Copenhagen, LIFE, Sect Biomed, Immunol Lab, Copenhagen, Denmark.	sosk@life.ku.dk	Andresen, Lars/O-2271-2019; Christensen, Jan Pravsgaard/I-4782-2017; Andresen, Lars/K-1287-2012	Andresen, Lars/0000-0002-6362-7973; Christensen, Jan Pravsgaard/0000-0002-4299-9479; Skov, Soren/0000-0003-0732-0026	The Novo Nordisk Foundation; Grosserer M. Brogaard og Hustrus Mindefond, Odense; Fru Astrid Thaysens Legat for laegevidenskabelig Grundforskning	The Novo Nordisk Foundation(Novo Nordisk Foundation); Grosserer M. Brogaard og Hustrus Mindefond, Odense; Fru Astrid Thaysens Legat for laegevidenskabelig Grundforskning	This work was supported by The Novo Nordisk Foundation (www.novonordiskfonden.dk); "Grosserer M. Brogaard og Hustrus Mindefond, Odense" and "Fru Astrid Thaysens Legat for laegevidenskabelig Grundforskning." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomonte J, 2009, CANCER GENE THER, V16, P266, DOI 10.1038/cgt.2008.74; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Armeanu S, 2005, CANCER RES, V65, P6321, DOI 10.1158/0008-5472.CAN-04-4252; Ashiru O, 2009, J VIROL, V83, P12345, DOI 10.1128/JVI.01175-09; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; CLINTON GM, 1978, CELL, V15, P1455, DOI 10.1016/0092-8674(78)90069-7; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Ireland DDC, 2006, VIRAL IMMUNOL, V19, P536, DOI 10.1089/vim.2006.19.536; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; Jensen H, 2009, J LEUKOCYTE BIOL, V86, P923, DOI 10.1189/jlb.0209056; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; von K.C., 2000, MOL CELL, V6, P1243; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Whitlow ZW, 2006, J VIROL, V80, P11733, DOI 10.1128/JVI.00971-06; Wu J, 2003, J IMMUNOL, V170, P4196, DOI 10.4049/jimmunol.170.8.4196; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206	49	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23023	10.1371/journal.pone.0023023	http://dx.doi.org/10.1371/journal.pone.0023023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857986	Green Published, gold, Green Submitted			2022-12-25	WOS:000293774300017
J	Perna, D; Faga, G; Verrecchia, A; Gorski, MM; Barozzi, I; Narang, V; Khng, J; Lim, KC; Sung, WK; Sanges, R; Stupka, E; Oskarsson, T; Trumpp, A; Wei, CL; Muller, H; Amati, B				Perna, D.; Faga, G.; Verrecchia, A.; Gorski, M. M.; Barozzi, I.; Narang, V.; Khng, J.; Lim, K. C.; Sung, W-K; Sanges, R.; Stupka, E.; Oskarsson, T.; Trumpp, A.; Wei, C-L; Mueller, H.; Amati, B.			Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts	ONCOGENE			English	Article						Myc; chromatin; transcription; serum	EMBRYONIC STEM-CELLS; C-MYC; TRANSCRIPTION FACTOR; IN-VIVO; CHROMATIN-STRUCTURE; CYCLE PROGRESSION; PROTEIN-SYNTHESIS; DNA-REPLICATION; NUCLEAR IMPORT; RNA EXOSOME	The transition from quiescence to proliferation is a key regulatory step that can be induced by serum stimulation in cultured fibroblasts. The transcription factor Myc is directly induced by serum mitogens and drives a secondary gene expression program that remains largely unknown. Using mRNA profiling, we identify close to 300 Myc-dependent serum response (MDSR) genes, which are induced by serum in a Myc-dependent manner in mouse fibroblasts. Mapping of genomic Myc-binding sites by ChIP-seq technology revealed that most MDSR genes were directly targeted by Myc, but represented a minor fraction (5.5%) of all Myc-bound promoters (which were 22.4% of all promoters). Other target loci were either induced by serum in a Myc-independent manner, were not significantly regulated or were negatively regulated. MDSR gene products were involved in a variety of processes, including nucleotide biosynthesis, ribosome biogenesis, DNA replication and RNA control. Of the 29 MDSR genes targeted by RNA interference, three showed a requirement for cell-cycle entry upon serum stimulation and 11 for long-term proliferation and/or survival. Hence, proper coordination of key regulatory and biosynthetic pathways following mitogenic stimulation relies upon the concerted regulation of multiple Myc-dependent genes. Oncogene (2012) 31, 1695-1709; doi:10.1038/onc.2011.359; published online 22 August 2011	[Perna, D.; Faga, G.; Verrecchia, A.; Gorski, M. M.; Barozzi, I.; Mueller, H.; Amati, B.] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Narang, V.; Sung, W-K; Wei, C-L] Genome Inst Singapore, Computat & Math Biol Grp, Singapore, Singapore; [Khng, J.; Lim, K. C.] Genome Inst Singapore, Genome Technol & Biol Grp, Singapore, Singapore; [Sanges, R.; Stupka, E.] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Oskarsson, T.; Trumpp, A.] Ecole Polytech Fed Lausanne, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland; [Mueller, H.; Amati, B.] Ist Italiano Tecnol, Ctr Genom Sci IIT SEMM, Milan, Italy	IRCCS European Institute of Oncology (IEO); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Istituto Italiano di Tecnologia - IIT	Amati, B (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	Sanges, Remo/M-9814-2019; Barozzi, Iros/GLQ-8907-2022; Amati, Bruno/AAM-3418-2020; Verrecchia, Alessandro/AAQ-6454-2020; Stupka, Elia/J-6279-2012; Trumpp, Andreas/Z-2141-2019; Oskarsson, Thordur/HBP-9601-2022; Faga, Giovanni/AAB-5540-2021	Sanges, Remo/0000-0002-5047-9713; Barozzi, Iros/0000-0003-0690-3473; Verrecchia, Alessandro/0000-0002-8596-6650; Stupka, Elia/0000-0003-3154-4011; Trumpp, Andreas/0000-0002-6212-3466; Muller, Heiko/0000-0001-9873-3146; Sung, Wing-Kin/0000-0001-7806-7086; Gorski, Marcin M./0000-0002-8276-3866; Oskarsson, Thordur/0000-0002-0983-6969; Narang, Vipin/0000-0001-8669-9964; Amati, Bruno/0000-0002-2958-1799	Agency for Science, Technology and Research (A*STAR) of Singapore; NIH ENCODE; Swiss National Science Foundation; EU; Association for International Cancer Research (AICR); Italian health ministry; Italian Association for Cancer Research (AIRC)	Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); NIH ENCODE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Association for International Cancer Research (AICR); Italian health ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We thank Gioacchino Natoli for critical discussion; Lucilla Luzi for help with data analysis; Ivan Muradore and Simona Ronzoni for help with imaging; Simone Minardi and Davide Cittaro for help with microarrays; Loris Bernard, Valentina Dall' Olio and Laura Tizzoni for help with real-time PCR; and Atif Shahab and CheeSeng Chan for technical guidance on processing and mapping sequencing data. We also acknowledge the Genome Technology and Biology Group at the Genome Institute of Singapore, in particular the GIS sequencing team, for technical support. Part of this work was supported by grants from the Agency for Science, Technology and Research (A*STAR) of Singapore and NIH ENCODE to C-LW, and from the Swiss National Science Foundation to AT. Work in the Amati lab was supported by grants from the EU-FP7 Program EuroSyStem, the Association for International Cancer Research (AICR), the Italian health ministry and the Italian Association for Cancer Research (AIRC).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Amundson SA, 1998, ONCOGENE, V17, P2149, DOI 10.1038/sj.onc.1202136; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Blow JJ, 2005, EMBO REP, V6, P1028, DOI 10.1038/sj.embor.7400557; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Corbett AH, 1996, J BIOL CHEM, V271, P18477, DOI 10.1074/jbc.271.31.18477; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FISHER F, 1993, EMBO J, V12, P5075, DOI 10.1002/j.1460-2075.1993.tb06201.x; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hirano Y, 2009, GENES CELLS, V14, P155, DOI 10.1111/j.1365-2443.2008.01262.x; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Izumi H, 2001, J CELL SCI, V114, P1533; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Masai H, 2005, IUBMB LIFE, V57, P323, DOI 10.1080/15216540500092419; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Quimby BB, 2000, MOL BIOL CELL, V11, P2617, DOI 10.1091/mbc.11.8.2617; Quimby BB, 2000, J BIOL CHEM, V275, P28575, DOI 10.1074/jbc.M005055200; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shen V, 2006, CELL, V127, P1093, DOI 10.1016/j.cell.2006.11.035; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; SOLOMON DLC, 1993, NUCLEIC ACIDS RES, V21, P5372, DOI 10.1093/nar/21.23.5372; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tao H, 1999, DNA CELL BIOL, V18, P75, DOI 10.1089/104454999315646; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	82	67	70	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	13					1695	1709		10.1038/onc.2011.359	http://dx.doi.org/10.1038/onc.2011.359			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21860422	hybrid, Green Published			2022-12-25	WOS:000302231400008
J	Gleason, CE; Ordureau, A; Gourlay, R; Arthur, JSC; Cohen, P				Gleason, Catherine E.; Ordureau, Alban; Gourlay, Robert; Arthur, J. Simon C.; Cohen, Philip			Polyubiquitin Binding to Optineurin Is Required for Optimal Activation of TANK-binding Kinase 1 and Production of Interferon beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; UBIQUITIN CHAINS; VIRAL-INFECTION; INNATE IMMUNITY; IFN RESPONSES; CUTTING EDGE; IKK-EPSILON; NEMO; DOMAIN	TANK-binding kinase (TBK1) is essential for transcription of the interferon (IFN) beta gene in response to lipopolysaccharide (LPS) and double-stranded RNA, but the molecular mechanisms that underlie the activation of TBK1 are incompletely understood. Previously, we identified the NF-kappa B essential modulator (NEMO)-related polyubiquitin-binding protein, optineurin (OPTN), as a novel binding partner of TBK1. To determine whether the ubiquitin-binding function of OPTN is involved in regulating TBK1 and IFN beta production, we generated a mouse in which wild-type optineurin was replaced by the polyubiquitin binding-defective mutant, OPTND477N/D477N. In this study, we found that LPS or poly(I:C)-induced TBK1 activity was significantly reduced in bone marrow-derived macrophage (BMDM) from OPTND477N/D477N mice. Consistent with this, the phosphorylation of IFN regulatory factor 3 (IRF3) and the production of IFN beta mRNA and secretion were reduced. Stimulation of BMDMs with LPS triggered the phosphorylation of OPTN, which was reversed by phosphatase treatment and prevented by pharmacological inhibition of both the canonical I kappa B kinases (IKK alpha/beta) and the IKK-related kinases (TBK1/IKK epsilon). In contrast, LPS-stimulated phosphorylation of OPTN(D477N) was markedly reduced in BMDMs from OPTND477N/D477N mice, and inhibition of the canonical IKKs alone prevented phosphorylation, providing further evidence that ubiquitin binding to OPTN contributes to LPS-induced TBK1 activation. TBK1 and IKK beta phosphorylated OPTN preferentially at Ser-177 and Ser-513, respectively, in vitro. In conclusion, our results suggest that OPTN binds to polyubiquity-lated species formed in response to LPS and poly(I:C), enhancing the activation of TBK1 that is required for optimal phosphorylation of IRF3 and production of IFN beta.	[Gleason, Catherine E.; Ordureau, Alban; Gourlay, Robert; Arthur, J. Simon C.; Cohen, Philip] Univ Dundee, Prot Phosphorylat Unit, MRC, Sir James Black Ctr,Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Cohen, P (corresponding author), Univ Dundee, Prot Phosphorylat Unit, MRC, Sir James Black Ctr,Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	Arthur, J. Simon/B-8058-2010; Ordureau, Alban/C-7558-2012	Arthur, J. Simon/0000-0002-8135-1958; Ordureau, Alban/0000-0002-4924-8520	United Kingdom Medical Research Council; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck-Serono; Pfizer; Medical Research Council [MC_U127084348, MC_U127081014] Funding Source: researchfish; MRC [MC_U127084348, MC_U127081014] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck-Serono(Merck & Company); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck-Serono, and Pfizer.	Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Campbell David G, 2002, J Biomol Tech, V13, P119; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Miyahira AK, 2009, J IMMUNOL, V182, P2248, DOI 10.4049/jimmunol.0802466; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Morton S, 2006, BIOCHEM J, V399, P265, DOI 10.1042/BJ20060681; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pietras EM, 2006, J ENDOTOXIN RES, V12, P246, DOI 10.1179/096805106X118799; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	49	134	137	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35663	35674		10.1074/jbc.M111.267567	http://dx.doi.org/10.1074/jbc.M111.267567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862579	hybrid, Green Published			2022-12-25	WOS:000295927100038
J	Jian, JL; Yang, Q; Huang, X				Jian, Jinlong; Yang, Qing; Huang, Xi			Src Regulates Tyr(20) Phosphorylation of Transferrin Receptor-1 and Potentiates Breast Cancer Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INDUCED APOPTOSIS; IRON-DEFICIENCY; TARGETING SRC; GAMBOGIC ACID; YOUNG-WOMEN; P38 MAPK; PROLIFERATION; PROTEIN; INTERNALIZATION	Transferrin receptor 1 (TfR1) is a ubiquitous type II membrane receptor with 61 amino acids in the N-terminal cytoplasmic region. TfR1 is highly expressed in cancer cells, particularly under iron deficient conditions. Overexpression of TfR1 is thought to meet the increased requirement of iron uptake necessary for cell growth. In the present study, we used transferrin (Tf), a known ligand of TfR1, and gambogic acid (GA), an apoptosis-inducing agent and newly identified TfR1 ligand to investigate the signaling role of TfR1 in breast cancer cells. We found that GA but not Tf induced apoptosis in a TfR1-dependent manner in breast cancer MDA-MB-231 cells. Estrogen receptor-positive MCF-7 cells lack caspase-3 and were not responsive to GA treatment. GA activated the three major signaling pathways of the MAPK family, as well as caspase-3,-8, and Poly(ADP-ribose)-polymerase apoptotic pathway. Interestingly, only Src inhibitor PP2 greatly sensitized the cells to GA-mediated apoptosis. Further investigations by confocal fluorescence microscopy and immunoprecipitation revealed that Src and TfR1 are constitutively bound. Using TfR1-deficient CHO TRVB cells, point mutation studies showed that Tyr(20) within the (YTRF23)-Y-20 motif of the cytoplasmic region of TfR1 is the phosphorylation site by Src. TfR1 Tyr(20) phosphomutants were more sensitive to GA-mediated apoptosis. Our results indicate that, albeit its iron uptake function, TfR1 is a signaling molecule and tyrosine phosphorylation at position 20 by Src enhances anti-apoptosis and potentiates breast cancer cell survival.	[Huang, Xi] NYU, Dept Med, Inst Canc, Sch Med, New York, NY 10016 USA; [Huang, Xi] NYU, Dept Environm Med, Inst Canc, Sch Med, New York, NY 10016 USA	New York University; New York University	Huang, X (corresponding author), NYU, Dept Med, Inst Canc, Sch Med, HJD Rm 1600,550 1st Ave, New York, NY 10016 USA.	xi.huang@nyumc.org			National Institutes of Health [ES00260, CA34588, CA16087]; NCI, National Institutes of Health [R21 CA132684]; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA132684, R01CA034588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants ES00260, CA34588, and CA16087 and by NCI, National Institutes of Health Grant R21 CA132684 (to X. H.).	Aebi S, 2005, BREAST, V14, P594, DOI 10.1016/j.breast.2005.08.011; Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Asano J, 1996, PHYTOCHEMISTRY, V41, P815, DOI 10.1016/0031-9422(95)00682-6; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Blanc C, 2000, CANCER RES, V60, P4386; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Carlson H, 2005, BLOOD, V105, P2564, DOI 10.1182/blood-2004-03-1204; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Cuadrado A, 2003, J BIOL CHEM, V278, P241, DOI 10.1074/jbc.M201010200; Dai JS, 2008, BREAST, V17, P172, DOI 10.1016/j.breast.2007.08.009; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Eckard J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-28; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Gabriel CA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2647; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li QL, 2010, BIOL PHARM BULL, V33, P415, DOI 10.1248/bpb.33.415; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; Pandey MK, 2007, BLOOD, V110, P3517, DOI 10.1182/blood-2007-03-079616; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Rucci N, 2006, J PHARMACOL EXP THER, V318, P161, DOI 10.1124/jpet.106.102004; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; TONIK SE, 1986, BREAST CANCER RES TR, V7, P71, DOI 10.1007/BF01806791; WALKER RA, 1986, J PATHOL, V148, P217, DOI 10.1002/path.1711480305; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	42	47	49	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35708	35715		10.1074/jbc.M111.271585	http://dx.doi.org/10.1074/jbc.M111.271585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859709	Green Published, hybrid			2022-12-25	WOS:000295927100043
J	Sinnberg, T; Menzel, M; Ewerth, D; Sauer, B; Schwarz, M; Schaller, M; Garbe, C; Schittek, B				Sinnberg, Tobias; Menzel, Moritz; Ewerth, Daniel; Sauer, Birgit; Schwarz, Michael; Schaller, Martin; Garbe, Claus; Schittek, Birgit			beta-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; IN-VITRO; MALIGNANT-MELANOMA; EXPRESSION; COMPLEX; GROWTH; WNT; INHIBITION; ADHESION; PROLIFERATION	Beta-catenin plays an important role in embryogenesis and carcinogenesis by controlling either cadherin-mediated cell adhesion or transcriptional activation of target gene expression. In many types of cancers nuclear translocation of beta-catenin has been observed. Our data indicate that during melanoma progression an increased dependency on the transcriptional function of beta-catenin takes place. Blockade of beta-catenin in metastatic melanoma cell lines efficiently induces apoptosis, inhibits proliferation, migration and invasion in monolayer and 3-dimensional skin reconstructs and decreases chemoresistance. In addition, subcutaneous melanoma growth in SCID mice was almost completely inhibited by an inducible beta-catenin knockdown. In contrast, the survival of benign melanocytes and primary melanoma cell lines was less affected by beta-catenin depletion. However, enhanced expression of beta-catenin in primary melanoma cell lines increased invasive capacity in vitro and tumor growth in the SCID mouse model. These data suggest that beta-catenin is an essential survival factor for metastatic melanoma cells, whereas it is dispensable for the survival of benign melanocytes and primary, non-invasive melanoma cells. Furthermore, beta-catenin increases tumorigenicity of primary melanoma cell lines. The differential requirements for beta-catenin signaling in aggressive melanoma versus benign melanocytic cells make betacatenin a possible new target in melanoma therapy.	[Sinnberg, Tobias; Menzel, Moritz; Ewerth, Daniel; Sauer, Birgit; Garbe, Claus; Schittek, Birgit] Univ Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany; [Schwarz, Michael] Univ Tubingen, Inst Pharmacol & Toxicol, Dept Toxicol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sinnberg, T (corresponding author), Univ Tubingen, Dept Dermatol, Div Dermatooncol, Tubingen, Germany.	birgit.schittek@med.uni-tuebingen.de	Sinnberg, Tobias/AFN-8316-2022; Garbe, Claus/ABH-2128-2021	Sinnberg, Tobias/0000-0003-3922-3327; Garbe, Claus/0000-0001-8530-780X; Schittek, Birgit/0000-0003-0081-2001	Deutsche Forschungsgemeinschaft [SFB 773]; Melanoma Research Network of the Deutsche Krebshilfe e. V. (German Cancer Aid)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Melanoma Research Network of the Deutsche Krebshilfe e. V. (German Cancer Aid)(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft SFB 773 and the Melanoma Research Network of the Deutsche Krebshilfe e. V. (German Cancer Aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Curley DP, 2008, PIGM CELL MELANOMA R, V21, P5, DOI 10.1111/j.1755-148X.2007.00434.x; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; HERLYN D, 1990, CANCER RES, V50, P2296; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; *HSU M YEDHM, 1999, HUM CELL CULT, V1, P259; Hsu MY, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P188; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jansen SR, 2010, AM J PHYSIOL-LUNG C, V299, pL204, DOI 10.1152/ajplung.00020.2010; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lapham A, 2009, GENE, V432, P112, DOI 10.1016/j.gene.2008.12.002; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li G, 2004, EXP CELL RES, V297, P142, DOI 10.1016/j.yexcr.2004.03.012; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Meier F, 2003, EXP DERMATOL, V12, P296, DOI 10.1034/j.1600-0625.2003.120310.x; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Minke KS, 2009, EUR J HAEMATOL, V82, P165, DOI 10.1111/j.1600-0609.2008.01188.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schittek B, 2007, INT J CANCER, V120, P2110, DOI 10.1002/ijc.22512; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Takahashi Y, 2008, INT J CANCER, V123, P2315, DOI 10.1002/ijc.23812; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Zhang T, 2001, CANCER RES, V61, P8664	57	95	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23429	10.1371/journal.pone.0023429	http://dx.doi.org/10.1371/journal.pone.0023429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858114	Green Submitted, Green Published, gold			2022-12-25	WOS:000294121300046
J	Song, W; He, DN; Brill, I; Malhotra, R; Mulenga, J; Allen, S; Hunter, E; Tang, JM; Kaslow, RA				Song, Wei; He, Dongning; Brill, Ilene; Malhotra, Rakhi; Mulenga, Joseph; Allen, Susan; Hunter, Eric; Tang, Jianming; Kaslow, Richard A.			Disparate Associations of HLA Class I Markers with HIV-1 Acquisition and Control of Viremia in an African Population	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIGEN CLASS-I; T-CELL RESPONSES; DISCORDANT COUPLES; SEX WORKERS; VIRAL LOAD; B ALLELES; HETEROSEXUAL TRANSMISSION; DISEASE PROGRESSION; ZAMBIAN COUPLES	Background: Acquisition of human immunodeficiency virus type 1 (HIV-1) infection is mediated by a combination of characteristics of the infectious and the susceptible member of a transmission pair, including human behavioral and genetic factors, as well as viral fitness and tropism. Here we report on the impact of established and potential new HLA class I determinants of heterosexual HIV-1 acquisition in the HIV-1-exposed seronegative (HESN) partners of serodiscordant Zambian couples. Methodology/Principal Findings: We assessed the relationships of behavioral and clinically documented risk factors, index partner viral load, and host genetic markers to HIV-1 transmission among 568 cohabiting couples followed for at least nine months. We genotyped subjects for three classical HLA class I genes known to influence immune control of HIV-1 infection. From 1995 to December 2006, 240 HESNs seroconverted and 328 remained seronegative. In Cox proportional hazards models, HLA-A*68:02 and the B*42-C*17 haplotype in HESN partners were significantly and independently associated with faster HIV-1 acquisition (relative hazards = 1.57 and 1.55; p = 0.007 and 0.013, respectively) after controlling for other previously established contributing factors in the index partner (viral load and specific class I alleles), in the HESN partner (age, gender), or in the couple (behavioral and clinical risk score). Few if any previously implicated class I markers were associated here with the rate of acquiring infection. Conclusions/Significance: A few HLA class I markers showed modest effects on acquisition of HIV-1 subtype C infection in HESN partners of discordant Zambian couples. However, the striking disparity between those few markers and the more numerous, different markers found to determine HIV-1 disease course makes it highly unlikely that, whatever the influence of class I variation on the rate of infection, the mechanism mediating that phenomenon is identical to that involved in disease control.	[Song, Wei; He, Dongning; Brill, Ilene; Malhotra, Rakhi; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Tang, Jianming; Kaslow, Richard A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Mulenga, Joseph; Allen, Susan] Rwanda Zambia HIV 1 Res Grp, Lusaka, Zambia; [Allen, Susan] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Hunter, Eric] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Emory University	Song, W (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	rkaslow@uab.edu	Tang, Jianming "James"/O-4980-2019	Tang, Jianming "James"/0000-0003-0137-7486	National Institute of Allergy and Infectious Diseases (NIAID) [AI040951, AI071906, AI064060, AI076123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071906, R01AI040951, K02AI076123, R01AI064060] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) through grants AI040951 (to S.A.), AI071906 (to R.A.K.), and AI064060 (to E.H.). J.T. is the recipient of an Independent Scientist Award (AI076123) from NIAID. The funding agency had no role in study design, data collection, data analysis, decision to publish, or preparation of this manuscript.	Addo MM, 2011, J INFECT DIS, V203, P258, DOI 10.1093/infdis/jiq028; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Brumme Z, 2009, CLIN INFECT DIS, V49, P956, DOI 10.1086/605503; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2010, AIDS, V24, P1835, DOI 10.1097/QAD.0b013e32833c3219; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Hladik F, 2003, J IMMUNOL, V171, P2671, DOI 10.4049/jimmunol.171.5.2671; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kaul R, 2004, AIDS, V18, P2087, DOI 10.1097/00002030-200410210-00015; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Lazaryan A, 2010, J VIROL, V84, P2610, DOI 10.1128/JVI.01962-09; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Liu CL, 2003, J INFECT DIS, V187, P1404, DOI 10.1086/374394; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Mackelprang RD, 2010, J INFECT DIS, V202, P1273, DOI 10.1086/656318; Teixeira SLM, 2009, INFECT GENET EVOL, V9, P638, DOI 10.1016/j.meegid.2009.03.007; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McKenna SL, 1997, AIDS, V11, pS103; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Merino A, 2011, J INFECT DIS, V203, P487, DOI 10.1093/infdis/jiq075; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang Jianming, 2003, AIDS, V17 Suppl 4, pS51, DOI 10.1097/00002030-200317004-00006; Tang JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009629; Tang JM, 2004, J INFECT DIS, V189, P1696, DOI 10.1086/383280; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Tomiyama H, 2000, EUR J IMMUNOL, V30, P2521, DOI 10.1002/1521-4141(200009)30:9<2521::AID-IMMU2521>3.0.CO;2-Q; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Turnquist HR, 2002, IMMUNOGENETICS, V53, P830, DOI 10.1007/s00251-001-0404-x; WALKER B, 2002, HARNESSING IMMUNE SY; Winchester R, 2004, JAIDS-J ACQ IMM DEF, V36, P659, DOI 10.1097/00126334-200406010-00002; Xu MY, 2004, BIOMED ENVIRON SCI, V17, P203; Yunis Edmond J, 2007, J Stem Cells, V2, P237	60	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23469	10.1371/journal.pone.0023469	http://dx.doi.org/10.1371/journal.pone.0023469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858133	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300050
J	Wang, JL; Lin, YW; Chen, HM; Kong, X; Xiong, H; Shen, N; Hong, J; Fang, JY				Wang, Ji-Lin; Lin, Yan-Wei; Chen, Hui-Min; Kong, Xuan; Xiong, Hua; Shen, Nan; Hong, Jie; Fang, Jing-Yuan			Calcium Prevents Tumorigenesis in a Mouse Model of Colorectal Cancer	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; GENE-EXPRESSION PROFILES; NORMAL COLON MUCOSA; MATRIX METALLOPROTEINASES; TRANSCRIPTION FACTOR; DIETARY CALCIUM; TRANSGENIC MICE; POOLED ANALYSIS; CLINICAL-TRIAL; RISK	Background and Aim: Calcium has been proposed as a mediator of the chemoprevention of colorectal cancer (CRC), but the comprehensive mechanism underlying this preventive effect is not yet clear. Hence, we conducted this study to evaluate the possible roles and mechanisms of calcium-mediated prevention of CRC induced by 1,2-dimethylhydrazine (DMH) in mice. Methods: For gene expression analysis, 6 non-tumor colorectal tissues of mice from the DMH + Calcium group and 3 samples each from the DMH and control groups were hybridized on a 4644 K Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction (PCR). Functional analysis of the microarray data was performed using KEGG and Gene Ontology (GO) analyses. Hub genes were identified using Pathway Studio software. Results: The tumor incidence rates in the DMH and DMH + Calcium groups were 90% and 40%, respectively. Microarray gene expression analysis showed that S100a9, Defa20, Mmp10, Mmp7, Ptgs2, and Ang2 were among the most downregulated genes, whereas Per3, Tef, Rnf152, and Prdx6 were significantly upregulated in the DMH + Calcium group compared with the DMH group. Functional analysis showed that the Wnt, cell cycle, and arachidonic acid pathways were significantly downregulated in the DMH + Calcium group, and that the GO terms related to cell differentiation, cell cycle, proliferation, cell death, adhesion, and cell migration were significantly affected. Forkhead box M1 (FoxM1) and nuclear factor kappa-B (NF-kappa B) were considered as potent hub genes. Conclusion: In the DMH-induced CRC mouse model, comprehensive mechanisms were involved with complex gene expression alterations encompassing many altered pathways and GO terms. However, how calcium regulates these events remains to be studied.	[Wang, Ji-Lin; Lin, Yan-Wei; Chen, Hui-Min; Kong, Xuan; Xiong, Hua; Hong, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol, Shanghai Inst Digest Dis,Renji Hosp, Shanghai 200030, Peoples R China; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Rheumatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, JL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol, Shanghai Inst Digest Dis,Renji Hosp, Shanghai 200030, Peoples R China.	jingyuanfang2007@126.com	Shen, Nan/AGK-6807-2022		Ministry of Public Health, China [200802094]; National Science Found of China [30830055]; National Natural Science Foundation of China [30900757]	Ministry of Public Health, China; National Science Found of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Ministry of Public Health, China (No. 200802094), a grant from the National Science Found of China (30830055) to Jing-Yuan Fang; and a grant from the National Natural Science Foundation of China (No: 30900757) to Hua Xiong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benito A, 2006, J BIOL CHEM, V281, P38351, DOI 10.1074/jbc.M607004200; Bonnet Agnes, 2009, BMC Proc, V3 Suppl 4, pS11, DOI 10.1186/1753-6561-3-S4-S11; Bousserouel S, 2010, INT J ONCOL, V36, P1485, DOI 10.3892/ijo_00000635; Carroll C, 2010, CLIN THER, V32, P789, DOI 10.1016/j.clinthera.2010.04.024; Chakrabarty S, 2003, CANCER RES, V63, P67; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chen-Goodspeed M, 2007, J BIOL RHYTHM, V22, P291, DOI 10.1177/0748730407303387; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Cooper K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI [10.3310/hta.14320, 10.3310/hta14320]; Corpet DE, 2005, EUR J CANCER, V41, P1911, DOI 10.1016/j.ejca.2005.06.006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vogel S, 2008, J NUTR, V138, P2372, DOI 10.3945/jn.108.091157; Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311; Fedirko V, 2009, CANCER EPIDEM BIOMAR, V18, P2933, DOI 10.1158/1055-9965.EPI-09-0239; Fedirko V, 2009, CANCER PREV RES, V2, P213, DOI 10.1158/1940-6207.CAPR-08-0157; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gutierrez O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017169; Holterman DA, 2006, UROL ONCOL-SEMIN ORI, V24, P97, DOI 10.1016/j.urolonc.2005.07.010; Hubner RA, 2009, BRIT J CANCER, V100, P233, DOI 10.1038/sj.bjc.6604823; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koushik A, 2007, JNCI-J NATL CANCER I, V99, P1471, DOI 10.1093/jnci/djm155; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Liu H, 2008, CANCER SCI, V99, P2185, DOI 10.1111/j.1349-7006.2008.00922.x; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Lu R, 2008, EPIGENETICS-US, V3, P330, DOI 10.4161/epi.3.6.7125; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Molck AM, 2002, CANCER LETT, V186, P19, DOI 10.1016/S0304-3835(02)00285-9; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Muller CA, 2002, AM J PATHOL, V160, P1311, DOI 10.1016/S0002-9440(10)62558-8; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Notterman DA, 2001, CANCER RES, V61, P3124; Oshima T, 2011, ONCOL REP, V25, P1439, DOI 10.3892/or.2011.1207; Patrignani P, 2005, BRAIN RES REV, V48, P352, DOI 10.1016/j.brainresrev.2004.12.024; Peleg S, 2010, AM J PHYSIOL-GASTR L, V299, pG593, DOI 10.1152/ajpgi.00193.2010; PENCE BC, 1988, CARCINOGENESIS, V9, P187, DOI 10.1093/carcin/9.1.187; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; SANO H, 1995, CANCER RES, V55, P3785; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; SITRIN MD, 1991, CANCER RES, V51, P5608; Turner SL, 2009, BRIT J BIOMED SCI, V66, P117, DOI 10.1080/09674845.2009.11730257; Uddin S, 2011, AM J PATHOL, V178, P537, DOI 10.1016/j.ajpath.2010.10.020; VANDERMEER R, 1985, BIOCHEM J, V229, P265, DOI 10.1042/bj2290265; Vinas-Salas J, 1998, EUR J CANCER, V34, P1941, DOI 10.1016/S0959-8049(98)00197-X; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yang K, 2008, CANCER RES, V68, P7803, DOI 10.1158/0008-5472.CAN-08-1209; Yoo DR, 2009, CANCER LETT, V282, P48, DOI 10.1016/j.canlet.2009.02.051; Zhang SL, 2010, PROTEIN CELL, V1, P656, DOI 10.1007/s13238-010-0083-1	61	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22566	10.1371/journal.pone.0022566	http://dx.doi.org/10.1371/journal.pone.0022566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857934	Green Published, gold, Green Submitted			2022-12-25	WOS:000294121300006
J	Oshima, K; Ishii, Y; Kakizawa, S; Sugawara, K; Neriya, Y; Himeno, M; Minato, N; Miura, C; Shiraishi, T; Yamaji, Y; Namba, S				Oshima, Kenro; Ishii, Yoshiko; Kakizawa, Shigeyuki; Sugawara, Kyoko; Neriya, Yutaro; Himeno, Misako; Minato, Nami; Miura, Chihiro; Shiraishi, Takuya; Yamaji, Yasuyuki; Namba, Shigetou			Dramatic Transcriptional Changes in an Intracellular Parasite Enable Host Switching between Plant and Insect	PLOS ONE			English	Article							ONION YELLOWS PHYTOPLASMA; GENE-EXPRESSION; MECHANOSENSITIVE CHANNELS; PROTEIN; GENOME; VIRULENCE; ENVIRONMENTS; DIVERSITY; SURVIVAL; PLASMID	Phytoplasmas are bacterial plant pathogens that have devastating effects on the yields of crops and plants worldwide. They are intracellular parasites of both plants and insects, and are spread among plants by insects. How phytoplasmas can adapt to two diverse environments is of considerable interest; however, the mechanisms enabling the "host switching" between plant and insect hosts are poorly understood. Here, we report that phytoplasmas dramatically alter their gene expression in response to "host switching" between plant and insect. We performed a detailed characterization of the dramatic change that occurs in the gene expression profile of Candidatus Phytoplasma asteris OY-M strain (approximately 33% of the genes change) upon host switching between plant and insect. The phytoplasma may use transporters, secreted proteins, and metabolic enzymes in a host-specific manner. As phytoplasmas reside within the host cell, the proteins secreted from phytoplasmas are thought to play crucial roles in the interplay between phytoplasmas and host cells. Our microarray analysis revealed that the expression of the gene encoding the secreted protein PAM486 was highly upregulated in the plant host, which is also observed by immunohistochemical analysis, suggesting that this protein functions mainly when the phytoplasma grows in the plant host. Additionally, phytoplasma growth in planta was partially suppressed by an inhibitor of the MscL osmotic channel that is highly expressed in the plant host, suggesting that the osmotic channel might play an important role in survival in the plant host. These results also suggest that the elucidation of "host switching" mechanism may contribute to the development of novel pest controls.	[Oshima, Kenro; Ishii, Yoshiko; Kakizawa, Shigeyuki; Sugawara, Kyoko; Neriya, Yutaro; Himeno, Misako; Minato, Nami; Miura, Chihiro; Shiraishi, Takuya; Yamaji, Yasuyuki; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan	University of Tokyo	Oshima, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Yamazaki, Kyoko/O-4931-2014; kakizawa, shigeyuki/L-8901-2018	kakizawa, shigeyuki/0000-0003-3885-4434; Neriya, Yutaro/0000-0002-1385-0050; Oshima, Kenro/0000-0001-7327-4481	Japan Society for the Promotion of Science [21248004]; Funding Program for Next Generation World-Leading Researchers [GS005]; Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Grants-in-Aid for Scientific Research [21248004, 11J02951] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (category "A" of Scientific Research Grant 21248004), by the Funding Program for Next Generation World-Leading Researchers (project: GS005), and by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Arashida R, 2008, DNA CELL BIOL, V27, P209, DOI 10.1089/dna.2007.0654; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Christensen NM, 2004, MOL PLANT MICROBE IN, V17, P1175, DOI 10.1094/MPMI.2004.17.11.1175; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Firrao G, 2007, FRONT BIOSCI-LANDMRK, V12, P1353, DOI 10.2741/2153; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hogenhout SA, 2008, CURR OPIN PLANT BIOL, V11, P449, DOI 10.1016/j.pbi.2008.05.007; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Ishii Y, 2009, MICROBIOL-SGM, V155, P2058, DOI 10.1099/mic.0.027409-0; Kakizawa S, 2006, TRENDS MICROBIOL, V14, P254, DOI 10.1016/j.tim.2006.04.008; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim S, 2004, J VET MED SCI, V66, P1059, DOI 10.1292/jvms.66.1059; KUBE M, 2008, BMC GENOMICS, V8, P850; Nicolaisen M, 2008, J PHYTOPATHOL, V156, P403, DOI 10.1111/j.1439-0434.2007.01372.x; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Oshima K, 2001, VIROLOGY, V285, P270, DOI 10.1006/viro.2001.0938; Oshima K, 2001, PHYTOPATHOLOGY, V91, P1024, DOI 10.1094/PHYTO.2001.91.11.1024; Oshima K, 2007, MOL PLANT PATHOL, V8, P481, DOI [10.1111/j.1364-3703.2007.00408.x, 10.1111/J.1364-3703.2007.00408.X]; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sokolov BP, 2003, J NEUROSCI RES, V72, P756, DOI 10.1002/jnr.10631; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Wei W, 2004, PHYTOPATHOLOGY, V94, P244, DOI 10.1094/PHYTO.2004.94.3.244; Wirth DF, 2002, NATURE, V419, P495, DOI 10.1038/419495a	38	53	54	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23242	10.1371/journal.pone.0023242	http://dx.doi.org/10.1371/journal.pone.0023242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858041	gold, Green Published, Green Submitted			2022-12-25	WOS:000294125500022
J	Truppa, V; Mortari, EP; Garofoli, D; Privitera, S; Visalberghi, E				Truppa, Valentina; Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara; Visalberghi, Elisabetta			Same/Different Concept Learning by Capuchin Monkeys in Matching-to-Sample Tasks	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; BABOONS PAPIO-PAPIO; DISCRIMINATION; PIGEONS	The ability to understand similarities and analogies is a fundamental aspect of human advanced cognition. Although subject of considerable research in comparative cognition, the extent to which nonhuman species are capable of analogical reasoning is still debated. This study examined the conditions under which tufted capuchin monkeys (Cebus apella) acquire a same/different concept in a matching-to-sample task on the basis of relational similarity among multi-item stimuli. We evaluated (i) the ability of five capuchin monkeys to learn the same/different concept on the basis of the number of items composing the stimuli and (ii) the ability to match novel stimuli after training with both several small stimulus sets and a large stimulus set. We found the first evidence of same/different relational matching-to-sample abilities in a New World monkey and demonstrated that the ability to match novel stimuli is within the capacity of this species. Therefore, analogical reasoning can emerge in monkeys under specific training conditions.	[Truppa, Valentina; Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara; Visalberghi, Elisabetta] CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy; [Truppa, Valentina; Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara; Visalberghi, Elisabetta] CNR, Inst Cognit Sci & Technol, Ctr Primate, Rome, Italy; [Truppa, Valentina] Univ Padua, Dept Gen Psychol, Padua, Italy; [Mortari, Eva Piano; Garofoli, Duilio; Privitera, Sara] Univ Roma La Sapienza, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Padua; Sapienza University Rome	Truppa, V (corresponding author), CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy.	valentina.truppa@istc.cnr.it	Piano Mortari, Eva/Q-9402-2016; Truppa, Valentina/AAK-4510-2021	Piano Mortari, Eva/0000-0002-0054-4732; Truppa, Valentina/0000-0001-7623-7547; Visalberghi, Elisabetta/0000-0001-7407-5468	EC [29088, 231722]	EC(European CommissionEuropean Commission Joint Research Centre)	This research was supported by the EC-ANALOGY grant (#29088) and by the EC-IM-CLeVeR grant (#231722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodily KD, 2008, J EXP PSYCHOL ANIM B, V34, P178, DOI 10.1037/0097-7403.34.1.178; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; Cook RG, 2007, PSYCHON B REV, V14, P1107, DOI 10.3758/BF03193099; COSTELLO F, 2009, NEW FRONTIERS ANALOG, P97; DAMATO MR, 1989, J EXP ANAL BEHAV, V52, P225, DOI 10.1901/jeab.1989.52-225; Elmore LC, 2009, LEARN BEHAV, V37, P204, DOI 10.3758/LB.37.2.204; Fagot J, 2001, J EXP PSYCHOL ANIM B, V27, P316, DOI 10.1037/0097-7403.27.4.316; Fagot J, 2010, J EXP PSYCHOL-ANIM B, V36, P184, DOI 10.1037/a0017169; Flemming TM, 2008, J COMP PSYCHOL, V122, P176, DOI 10.1037/0735-7036.122.2.176; Flemming TM, 2007, J EXP PSYCHOL ANIM B, V33, P55, DOI 10.1037/0097-7403.33.1.55; Flemming TM, 2011, BEHAV PROCESS, V86, P316, DOI 10.1016/j.beproc.2011.01.001; French R.M., 1995, SUBTLETY SAMENESS TH; Gentner D, 1998, COGNITION, V65, P263, DOI 10.1016/S0010-0277(98)00002-X; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; Kennedy EH, 2008, J COMP PSYCHOL, V122, P167, DOI 10.1037/0735-7036.122.2.167; Maddox WT, 2004, PSYCHON B REV, V11, P945, DOI 10.3758/BF03196726; Ortony A., 1989, SIMILARITY ANALOGICA; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Premack D., 1983, MIND APE; Spinozzi G, 2004, J COMP PSYCHOL, V118, P403, DOI 10.1037/0735-7036.118.4.403; Thompson RK., 1995, COMP APPROACHES COGN, V175, P224; Thompson RKR, 2000, COGNITIVE SCI, V24, P363; Thompson RKR, 1997, J EXP PSYCHOL ANIM B, V23, P31, DOI 10.1037/0097-7403.23.1.31; Tomasello M, 1997, PRIMATE COGNITION; Truppa V, 2010, ANIM COGN, V13, P835, DOI 10.1007/s10071-010-0332-y; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; Vonk J, 2003, ANIM COGN, V6, P77, DOI 10.1007/s10071-003-0159-x; Wasserman EA, 2010, J EXP PSYCHOL-ANIM B, V36, P3, DOI 10.1037/a0016327; WRIGHT AA, 1988, ANIM LEARN BEHAV, V16, P436, DOI 10.3758/BF03209384; Young ME, 1997, J EXP PSYCHOL ANIM B, V23, P491, DOI 10.1037/0097-7403.23.4.491; Young ME, 1999, J EXP PSYCHOL ANIM B, V25, P475, DOI 10.1037/0097-7403.25.4.475; Zentall TR, 2008, COMP COGN BEHAV REV, V3, P13, DOI 10.3819/ccbr.2008.30002	35	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23809	10.1371/journal.pone.0023809	http://dx.doi.org/10.1371/journal.pone.0023809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858225	Green Submitted, Green Published, gold			2022-12-25	WOS:000294125500043
J	Tsumori, Y; Ndounga, M; Sunahara, T; Hayashida, N; Inoue, M; Nakazawa, S; Casimiro, P; Isozumi, R; Uemura, H; Tanabe, K; Kaneko, O; Culleton, R				Tsumori, Yoko; Ndounga, Mathieu; Sunahara, Toshihiko; Hayashida, Nozomi; Inoue, Megumi; Nakazawa, Shusuke; Casimiro, Prisca; Isozumi, Rie; Uemura, Haruki; Tanabe, Kazuyuki; Kaneko, Osamu; Culleton, Richard			Plasmodium falciparum: Differential Selection of Drug Resistance Alleles in Contiguous Urban and Peri-Urban Areas of Brazzaville, Republic of Congo	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; CENTRAL-AFRICA; MALARIA TRANSMISSION; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; GENETIC DIVERSITY; VARIABLE LEVELS; BLOOD-SAMPLES; IMMUNE HOSTS; BURKINA-FASO	The African continent is currently experiencing rapid population growth, with rising urbanization increasing the percentage of the population living in large towns and cities. We studied the impact of the degree of urbanization on the population genetics of Plasmodium falciparum in urban and peri-urban areas in and around the city of Brazzaville, Republic of Congo. This field setting, which incorporates local health centers situated in areas of varying urbanization, is of interest as it allows the characterization of malaria parasites from areas where the human, parasite, and mosquito populations are shared, but where differences in the degree of urbanization (leading to dramatic differences in transmission intensity) cause the pattern of malaria transmission to differ greatly. We have investigated how these differences in transmission intensity affect parasite genetic diversity, including the amount of genetic polymorphism in each area, the degree of linkage disequilibrium within the populations, and the prevalence and frequency of drug resistance markers. To determine parasite population structure, heterozygosity and linkage disequilibrium, we typed eight microsatellite markers and performed haplotype analysis of the msp1 gene by PCR. Mutations known to be associated with resistance to the antimalarial drugs chloroquine and pyrimethamine were determined by sequencing the relevant portions of the crt and dhfr genes, respectively. We found that parasite genetic diversity was comparable between the two sites, with high levels of polymorphism being maintained in both areas despite dramatic differences in transmission intensity. Crucially, we found that the frequencies of genetic markers of drug resistance against pyrimethamine and chloroquine differed significantly between the sites, indicative of differing selection pressures in the two areas.	[Tsumori, Yoko; Hayashida, Nozomi; Inoue, Megumi; Nakazawa, Shusuke; Isozumi, Rie; Uemura, Haruki; Kaneko, Osamu; Culleton, Richard] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan; [Tsumori, Yoko; Hayashida, Nozomi; Inoue, Megumi; Nakazawa, Shusuke; Isozumi, Rie; Uemura, Haruki; Kaneko, Osamu; Culleton, Richard] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan; [Ndounga, Mathieu; Casimiro, Prisca] Ctr Etud Resources Veget, Brazzaville, Rep Congo; [Sunahara, Toshihiko] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Int Hlth, Nagasaki 852, Japan; [Tanabe, Kazuyuki; Culleton, Richard] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan; [Culleton, Richard] Nagasaki Univ, Inst Trop Med NEKKEN, Malaria Unit, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Osaka University; Nagasaki University	Tsumori, Y (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan.	richard@nagasaki-u.ac.jp	Culleton, Richard/H-8327-2014	Culleton, Richard/0000-0001-8808-5771	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science [17-05495]; Grants-in-Aid for Scientific Research [22406010] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)'s Special Coordination Funds for Promoting Science and Technology Tenure-Track Research Grant (to R.C.), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science No. 17-05495 (to R.C. and K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Artzy-Randrup Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013588; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Bendixen M, 2001, T ROY SOC TROP MED H, V95, P143, DOI 10.1016/S0035-9203(01)90140-3; COENE J, 1993, MED VET ENTOMOL, V7, P127, DOI 10.1111/j.1365-2915.1993.tb00665.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; Cravo P, 2001, ANTIMICROB AGENTS CH, V45, P2897, DOI 10.1128/AAC.45.10.2897-2901.2001; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; FORSYTH KP, 1989, AM J TROP MED HYG, V41, P259, DOI 10.4269/ajtmh.1989.41.259; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Hastings IM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-130; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; HAY SI, 2005, TEST, V3, P81; HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x; Isozumi R, 2010, J CLIN MICROBIOL, V48, P70, DOI 10.1128/JCM.01449-09; Klein EY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-67; Konate L, 1999, T ROY SOC TROP MED H, V93, pS21, DOI 10.1016/S0035-9203(99)90323-1; Mackinnon MJ, 1998, T ROY SOC TROP MED H, V92, P188, DOI 10.1016/S0035-9203(98)90745-3; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; *NAT U, 2002, POP DIV DOEASA; Ndounga M, 2008, Bull Soc Pathol Exot, V101, P329, DOI 10.3185/pathexo3111; Nei M., 1987, MOL EVOLUTIONARY GEN; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; Omumbo JA, 2005, ACTA TROP, V93, P11, DOI 10.1016/j.actatropica.2004.08.010; Paganotti GM, 2004, AM J TROP MED HYG, V71, P173, DOI 10.4269/ajtmh.2004.71.173; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Plowe CV, 1998, DRUG RESIST UPDATE, V1, P389, DOI 10.1016/S1368-7646(98)80014-9; Sakihama N, 2006, AM J TROP MED HYG, V74, P31, DOI 10.4269/ajtmh.2006.74.31; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Talisuna AO, 2007, AM J TROP MED HYG, V77, P170; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P34; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P19, DOI 10.1016/0035-9203(87)90473-1; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P26, DOI 10.1016/0035-9203(87)90474-3; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P1, DOI 10.1016/0035-9203(87)90471-8; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	56	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23430	10.1371/journal.pone.0023430	http://dx.doi.org/10.1371/journal.pone.0023430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858115	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953700022
J	Wang, P; Xiao, X; Chou, KC				Wang, Pu; Xiao, Xuan; Chou, Kuo-Chen			NR-2L: A Two-Level Predictor for Identifying Nuclear Receptor Subfamilies Based on Sequence-Derived Features	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; SUBCELLULAR LOCATION; ALGORITHM	Nuclear receptors (NRs) are one of the most abundant classes of transcriptional regulators in animals. They regulate diverse functions, such as homeostasis, reproduction, development and metabolism. Therefore, NRs are a very important target for drug development. Nuclear receptors form a superfamily of phylogenetically related proteins and have been subdivided into different subfamilies due to their domain diversity. In this study, a two-level predictor, called NR-2L, was developed that can be used to identify a query protein as a nuclear receptor or not based on its sequence information alone; if it is, the prediction will be automatically continued to further identify it among the following seven subfamilies: (1) thyroid hormone like (NR1), (2) HNF4-like (NR2), (3) estrogen like, (4) nerve growth factor IB-like (NR4), (5) fushi tarazu-F1 like (NR5), (6) germ cell nuclear factor like (NR6), and (7) knirps like (NR0). The identification was made by the Fuzzy K nearest neighbor (FK-NN) classifier based on the pseudo amino acid composition formed by incorporating various physicochemical and statistical features derived from the protein sequences, such as amino acid composition, dipeptide composition, complexity factor, and low-frequency Fourier spectrum components. As a demonstration, it was shown through some benchmark datasets derived from the NucleaRDB and UniProt with low redundancy that the overall success rates achieved by the jackknife test were about 93% and 89% in the first and second level, respectively. The high success rates indicate that the novel two-level predictor can be a useful vehicle for identifying NRs and their subfamilies. As a user-friendly web server, NR-2L is freely accessible at either http://icpr.jci.edu.cn/bioinfo/NR2Lor http://www.jci-bioinfo.cn/NR2L. Each job submitted to NR-2L can contain up to 500 query protein sequences and be finished in less than 2 minutes. The less the number of query proteins is, the shorter the time will usually be. All the program codes for NR-2L are available for non-commercial purpose upon request.	[Wang, Pu; Xiao, Xuan] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Jingdezhen Ceramic Institute	Wang, P (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xiaoxuan0326@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2009GZS0064, 2010GZS0122]; Department of Education of JiangXi Province [GJJ09271]; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; Department of Education of JiangXi Province; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of JiangXi (2009GZS0064 and 2010GZS0122), the Department of Education of JiangXi Province (No. GJJ09271), and the plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018; Gusev VD, 1999, BIOINFORMATICS, V15, P994; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu T, 2010, PROTEIN PEPTIDE LETT, V17, P1263, DOI 10.2174/092986610792231528; Liu TA, 2010, J THEOR BIOL, V267, P272, DOI 10.1016/j.jtbi.2010.09.007; Liu WM, 1999, PROTEIN ENG, V12, P1041, DOI 10.1093/protein/12.12.1041; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Wang T, 2010, J THEOR BIOL, V262, P208, DOI 10.1016/j.jtbi.2009.09.027; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365	32	98	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23505	10.1371/journal.pone.0023505	http://dx.doi.org/10.1371/journal.pone.0023505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21858146	Green Published, Green Submitted, gold			2022-12-25	WOS:000293953700027
J	Marsh, L				Marsh, Lorraine			Prediction of Ligand Binding Using an Approach Designed to Accommodate Diversity in Protein-Ligand Interactions	PLOS ONE			English	Article							MOLECULAR DOCKING; SCORING FUNCTION; AFFINITY PREDICTION; NEURAL-NETWORK; COMPLEXES; ACCURACY; OPTIMIZATION; VALIDATION; INHIBITORS; DISCOVERY	Computational determination of protein-ligand interaction potential is important for many biological applications including virtual screening for therapeutic drugs. The novel internal consensus scoring strategy is an empirical approach with an extended set of 9 binding terms combined with a neural network capable of analysis of diverse complexes. Like conventional consensus methods, internal consensus is capable of maintaining multiple distinct representations of protein-ligand interactions. In a typical use the method was trained using ligand classification data (binding/no binding) for a single receptor. The internal consensus analyses successfully distinguished protein-ligand complexes from decoys (r(2), 0.895 for a series of typical proteins). Results are superior to other tested empirical methods. In virtual screening experiments, internal consensus analyses provide consistent enrichment as determined by ROC-AUC and pROC metrics.	Long Isl Univ, Dept Biol, Brooklyn, NY 11201 USA	Long Island University-Brooklyn Campus	Marsh, L (corresponding author), Long Isl Univ, Dept Biol, Brooklyn, NY 11201 USA.	lmarsh@liu.edu						Baum EB, 1989, NEURAL COMPUT, V1, P151, DOI 10.1162/neco.1989.1.1.151; Brylinski M, 2010, J CHEM INF MODEL, V50, P1839, DOI 10.1021/ci100235n; Chae MH, 2010, PROTEINS, V78, P1026, DOI 10.1002/prot.22626; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; Cheng TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-193; Cross S, 2010, J CHEM INF MODEL, V50, P1442, DOI 10.1021/ci100221g; Durrant JD, 2010, J CHEM INF MODEL, V50, P1865, DOI 10.1021/ci100244v; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fukunishi H, 2008, J CHEM INF MODEL, V48, P988, DOI 10.1021/ci700204v; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Goodarzi M, 2010, EUR J MED CHEM, V45, P3911, DOI 10.1016/j.ejmech.2010.05.045; Guimaraes CRW, 2009, J AM CHEM SOC, V131, P18139, DOI 10.1021/ja9064359; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2008, J COMPUT AID MOL DES, V22, P193, DOI 10.1007/s10822-008-9189-4; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; KIM JH, 2011, J MOL MODEL; Ko GM, 2010, J CHEM INF MODEL, V50, P1759, DOI 10.1021/ci100200u; Lee K, 2010, EUR J MED CHEM, V45, P5420, DOI 10.1016/j.ejmech.2010.09.002; Li HL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-58; Li X, 2010, J COMPUT CHEM, V31, P2109, DOI 10.1002/jcc.21498; Li Y, 2010, J CHEM INF MODEL, V50, P1682, DOI 10.1021/ci100036a; Liang SD, 2009, PROTEINS, V75, P397, DOI 10.1002/prot.22252; Lu SH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-8; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Simon Z, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-32; Thompson DC, 2008, J CHEM INF MODEL, V48, P1081, DOI 10.1021/ci700470c; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai KC, 2008, BIOORG MED CHEM LETT, V18, P3509, DOI 10.1016/j.bmcl.2008.05.026; VON KM, 2009, J CHEM INF MODEL, V49, P209; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wei DG, 2010, J CHEM INF MODEL, V50, P1855, DOI 10.1021/ci900463u; Zhao W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-225	37	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23215	10.1371/journal.pone.0023215	http://dx.doi.org/10.1371/journal.pone.0023215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21860668	gold, Green Published			2022-12-25	WOS:000295454200054
J	Pastor, T; Pagani, F				Pastor, Tibor; Pagani, Franco			Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-Derived Intronic Splicing Enhancer Regulates ATM Aberrant Splicing	PLOS ONE			English	Article							BINDING; INSERTION; PROTEINS; HUR	We have previously identified an Alu-derived Intronic Splicing enhancer (ISE) in the Ataxia Teleangectasia Mutated gene (ATM) that facilitates intron pre-mRNA processing and leads to the inclusion of a cryptic exon in the final mRNA transcript. By using an RNA pull-down assay, we show here that hnRNPA1/A2, HuR and DAZAP1 splicing factors and DHX36 RNA helicase bind to the ISE. By functional studies (overexpression and siRNA experiments), we demonstrate that hnRNPA1 and DAZAP1 are indeed involved in ISE-dependent ATM cryptic exon activation, with hnRNPA1 acting negatively and DAZAP1 positively on splicing selection. On the contrary, HuR and DHX36 have no effect on ATM splicing pattern. These data suggest that splicing factors with both negative and positive effect can assemble on the intronic Alu repeats and regulate pre-mRNA splicing.	[Pastor, Tibor; Pagani, Franco] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Pastor, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	pagani@icgeb.org		Pagani, Franco/0000-0002-2678-3459	Associazione Italiana Ricerca sul Cancro [10387]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors thank the Associazione Italiana Ricerca sul Cancro, grant no. 10387. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; Dhir A, 2010, FEBS J, V277, P841, DOI 10.1111/j.1742-4658.2009.07520.x; Dhir A, 2010, EMBO J, V29, P749, DOI 10.1038/emboj.2009.397; Ganguly A, 2003, HUM GENET, V113, P348, DOI 10.1007/s00439-003-0986-5; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Khanna A, 2010, RNA BIOL, V7, P480, DOI 10.4161/rna.7.4.12746; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lewandowska MA, 2005, NUCLEIC ACIDS RES, V33, P4007, DOI 10.1093/nar/gki710; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; PAGANI F, 2003, J BIOL CHEM; Papadopoulou C, 2010, BBA-PROTEINS PROTEOM, V1804, P692, DOI 10.1016/j.bbapap.2009.11.007; Pastor T, 2009, NUCLEIC ACIDS RES, V37, P7258, DOI 10.1093/nar/gkp778; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Skoko N, 2008, FEBS LETT, V582, P2231, DOI 10.1016/j.febslet.2008.05.018; Tighe PJ, 2002, GENES IMMUN, V3, pS66, DOI 10.1038/sj.gene.6363864; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Yang HT, 2009, BIOCHEM BIOPH RES CO, V380, P705, DOI 10.1016/j.bbrc.2009.01.166	23	26	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23349	10.1371/journal.pone.0023349	http://dx.doi.org/10.1371/journal.pone.0023349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21858080	Green Published, gold, Green Submitted			2022-12-25	WOS:000293773300024
J	Vargas, N; Alvarez-Cubela, S; Giraldo, JA; Nieto, M; Fort, NM; Cechin, S; Garcia, E; Espino-Grosso, P; Fraker, CA; Ricordi, C; Inverardi, L; Pastori, RL; Dominguez-Bendala, J				Vargas, Nancy; Alvarez-Cubela, Silvia; Giraldo, Jaime A.; Nieto, Margarita; Fort, Nicholas M.; Cechin, Sirlene; Garcia, Enrique; Espino-Grosso, Pedro; Fraker, Christopher A.; Ricordi, Camillo; Inverardi, Luca; Pastori, Ricardo L.; Dominguez-Bendala, Juan			TAT-Mediated Transduction of MafA Protein In Utero Results in Enhanced Pancreatic Insulin Expression and Changes in Islet Morphology	PLOS ONE			English	Article							BETA-CELLS; TRANSCRIPTION FACTOR; THERAPEUTIC TARGET; GENE-TRANSCRIPTION; KEY REGULATOR; DNA-BINDING; DIFFERENTIATION; MATURATION; DELIVERY; DOMAIN	Alongside Pdx1 and Beta2/NeuroD, the transcription factor MafA has been shown to be instrumental in the maintenance of the beta cell phenotype. Indeed, a combination of MafA, Pdx1 and Ngn3 (an upstream regulator of Beta2/NeuroD) was recently reported to lead to the effective reprogramming of acinar cells into insulin-producing beta cells. These experiments set the stage for the development of new strategies to address the impairment of glycemic control in diabetic patients. However, the clinical applicability of reprogramming in this context is deemed to be poor due to the need to use viral vehicles for the delivery of the above factors. Here we describe a recombinant transducible version of the MafA protein (TAT-MafA) that penetrates across cell membranes with an efficiency of 100% and binds to the insulin promoter in vitro. When injected in utero into living mouse embryos, TAT-MafA significantly up-regulates target genes and induces enhanced insulin production as well as cytoarchitectural changes consistent with faster islet maturation. As the latest addition to our armamentarium of transducible proteins (which already includes Pdx1 and Ngn3), the purification and characterization of a functional TAT-MafA protein opens the door to prospective therapeutic uses that circumvent the use of viral delivery. To our knowledge, this is also the first report on the use of protein transduction in utero.	[Vargas, Nancy; Alvarez-Cubela, Silvia; Giraldo, Jaime A.; Nieto, Margarita; Fort, Nicholas M.; Cechin, Sirlene; Garcia, Enrique; Espino-Grosso, Pedro; Fraker, Christopher A.; Ricordi, Camillo; Inverardi, Luca; Pastori, Ricardo L.; Dominguez-Bendala, Juan] Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33152 USA; [Ricordi, Camillo; Dominguez-Bendala, Juan] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL USA; [Inverardi, Luca; Pastori, Ricardo L.] Univ Miami, Dept Med, Div Endocrinol Diabet & Metab, Leonard M Miller Sch Med, Miami, FL USA; [Giraldo, Jaime A.; Fraker, Christopher A.] Univ Miami, Dept Biomed Engn, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami	Vargas, N (corresponding author), Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33152 USA.	rpastori@med.miami.edu; j.dominguezbendala@miami.edu	Dominguez-Bendala, Juan/AAE-8296-2019; RICORDI, CAMILLO/AAA-4740-2019; Fraker, Christopher/R-6404-2018	Ricordi, Camillo/0000-0001-8092-7153; Fraker, Christopher/0000-0002-2010-0573; Garcia, Enrique/0000-0002-4779-5766	Diabetes Research Institute Foundation (DRIF)	Diabetes Research Institute Foundation (DRIF)	This work was funded by the Diabetes Research Institute Foundation (DRIF). The DRIF funds work conducted at the Diabetes Research Institute with the goal of achieving a cure for type 1 diabetes in the fastest, safest and most efficient way possible. Funding is internal and as such is not associated with grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Carvalho CPF, 2010, DIABETOLOGIA, V53, P1428, DOI 10.1007/s00125-010-1726-8; Chiou SH, 2011, J CELL MOL MED; Collares-Buzato CB, 2004, J MOL HISTOL, V35, P811, DOI 10.1007/s10735-004-1746-0; Carvalho CPDF, 2006, ANN ANAT, V188, P221, DOI 10.1016/j.annat.2005.10.009; Deutsch G, 2001, DEVELOPMENT, V128, P871; Do Kwon Y, 2005, MOL THER, V12, P28, DOI 10.1016/y.ymthe.2005.03.01; Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720; Dominguez-Bendala J, 2006, CELL TRANSPLANT, V15, pS85; Embury J, 2001, DIABETES, V50, P1706, DOI 10.2337/diabetes.50.8.1706; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; GALLIGAN BR, 1989, TRANSFUSION, V29, P179, DOI 10.1046/j.1537-2995.1989.29289146839.x; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 2007, DIABETES RES CLIN PR, V77, pS127, DOI 10.1016/j.diabres.2007.01.046; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Klein D, 2005, CELL TRANSPLANT, V14, P241, DOI 10.3727/000000005783983016; Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116; Lajic Svetlana, 2008, V13, P82, DOI 10.1159/000134827; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Mendoza V, 2005, TRANSPL P, V37, P237, DOI 10.1016/j.transproceed.2004.12.270; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Ogino H, 1998, SCIENCE, V280, P115, DOI 10.1126/science.280.5360.115; Pastori RL, 2004, TRANSPLANTATION, V77, P1627, DOI 10.1097/01.TP.0000119589.12467.20; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Rehman KK, 2003, J BIOL CHEM, V278, P9862, DOI 10.1074/jbc.M207700200; Ribeiro MM, 2003, BIOCHEM BIOPH RES CO, V305, P876, DOI 10.1016/S0006-291X(03)00856-8; Sambrook J, 2001, MOL CLONING LAB MANU; SHIEH SY, 1991, J BIOL CHEM, V266, P16708; Strasburger JF, 2010, NAT REV CARDIOL, V7, P277, DOI 10.1038/nrcardio.2010.32; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Yinon YM, 2010, ULTRASOUND OBSTET GY; Zaro JL, 2003, BIOCHEM BIOPH RES CO, V307, P241, DOI 10.1016/S0006-291X(03)01167-7; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22364	10.1371/journal.pone.0022364	http://dx.doi.org/10.1371/journal.pone.0022364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21857924	Green Published, gold, Green Submitted			2022-12-25	WOS:000293561200014
J	Oneyama, C; Morii, E; Okuzaki, D; Takahashi, Y; Ikeda, J; Wakabayashi, N; Akamatsu, H; Tsujimoto, M; Nishida, T; Aozasa, K; Okada, M				Oneyama, C.; Morii, E.; Okuzaki, D.; Takahashi, Y.; Ikeda, J.; Wakabayashi, N.; Akamatsu, H.; Tsujimoto, M.; Nishida, T.; Aozasa, K.; Okada, M.			MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression	ONCOGENE			English	Article						c-Src; miRNA; ILK; tumor progression	CANCER-CELLS; C-SRC; THERAPEUTIC TARGET; DOWN-REGULATION; FAMILY KINASES; PROTEIN-KINASE; BREAST-CANCER; ILK; GROWTH; EXPRESSION	The tyrosine kinase c-Src is upregulated in various human cancers; however, the molecular mechanisms underlying c-Src-mediated tumor progression remain unclear. Here we show that downregulation of microRNA (miR)-542-3p is tightly associated with tumor progression via c-Src-related oncogenic pathways. In c-Src-transformed fibroblasts and human cancer cells that overexpress c-Src, miR-542-3p is substantially downregulated, and the ectopic expression of miR-542-3p suppresses tumor growth. We identified the integrin-linked kinase (ILK) as a conserved target of miR-542-3p. ILK upregulation promotes cell adhesion and invasion by activating the integrin-focal adhesion kinase (FAK)/c-Src pathway, and can also contribute to tumor growth via the AKT and glycogen synthase kinase 3 beta pathways. MiR-542-3p expression is downregulated by the activation of c-Src-related signaling molecules, including epidermal growth factor receptor, K-Ras and Ras/Raf/mitogen-activated protein kinase/extracellular signal-regulated kinase. In human colon cancer tissues, downregulation of miR-542-3p is significantly correlated with the upregulation of c-Src and ILK. Our results suggest that the novel c-Src-miR-542-3p-ILK-FAK circuit plays a crucial role in controlling tumor progression. Oncogene (2012) 31, 1623-1635; doi:10.1038/onc.2011.367; published online 22 August 2011	[Oneyama, C.; Takahashi, Y.; Wakabayashi, N.; Okada, M.] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 5650871, Japan; [Morii, E.; Ikeda, J.; Aozasa, K.] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Okuzaki, D.] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 5650871, Japan; [Akamatsu, H.; Tsujimoto, M.; Nishida, T.] Osaka Police Hosp, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka Police Hospital	Oneyama, C (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	coneyama@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Osaka University; Grants-in-Aid for Scientific Research [22689009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs A Imamoto, T Akagi and M Yutsudo for their generous gifts of reagents. This work was supported by a Grant-in-aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan and The Exciting Leading-Edge Research Project at Osaka University.	Abboud ER, 2007, INT J ONCOL, V30, P113; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kim M, 2008, MOL CANCER RES, V6, P222, DOI 10.1158/1541-7786.MCR-07-0142; Kim YB, 2008, J BIOL CHEM, V283, P10089, DOI 10.1074/jbc.M708300200; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; OKADA M, 1991, J BIOL CHEM, V266, P24249; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Toloubeydokhti T, 2008, REPROD SCI, V15, P993, DOI 10.1177/1933719108324132; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; Yang L, 2010, ONCOGENE, V29, P516, DOI 10.1038/onc.2009.370; Yau CYF, 2005, CANCER RES, V65, P1497, DOI 10.1158/0008-5472.CAN-04-2940; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yoganathan TN, 2000, BIOCHEM PHARMACOL, V60, P1115, DOI 10.1016/S0006-2952(00)00444-5; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025	43	59	61	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	13					1623	1635		10.1038/onc.2011.367	http://dx.doi.org/10.1038/onc.2011.367			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21860426				2022-12-25	WOS:000302231400002
J	Streicher, KL; Zhu, W; Lehmann, KP; Georgantas, RW; Morehouse, CA; Brohawn, P; Carrasco, RA; Xiao, Z; Tice, DA; Higgs, BW; Richman, L; Jallal, B; Ranade, K; Yao, Y				Streicher, K. L.; Zhu, W.; Lehmann, K. P.; Georgantas, R. W.; Morehouse, C. A.; Brohawn, P.; Carrasco, R. A.; Xiao, Z.; Tice, D. A.; Higgs, B. W.; Richman, L.; Jallal, B.; Ranade, K.; Yao, Y.			A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth	ONCOGENE			English	Article						miRNA cluster; melanoma; melanocyte transformation	MICRORNA CLUSTER; SOFT AGAR; EXPRESSION; CANCER; EVOLUTION; CELLS; GENE; OVEREXPRESSION; PROGRESSION; PROFILES	Malignant melanoma is the most aggressive form of skin cancer and its incidence has doubled in the last two decades. It represents only 4% of skin cancer cases per year, but causes as many as 74% of skin cancer deaths. Early detection of malignant melanoma is associated with survival rates of up to 90%, but later detection (stage III to stage IV) is associated with survival rates of only 10%. Dysregulation of microRNA (miRNA) expression has been linked to tumor development and progression by functioning either as a tumor suppressor, an oncogene or a metastasis regulator in multiple cancer types. To understand the role of miRNA in the pathogenesis of malignant melanoma and identify biomarkers of metastasis, miRNA expression profiles in skin punches from 33 metastatic melanoma patients and 14 normal healthy donors were compared. We identified a cluster of 14 miRNAs on the X chromosome, termed the miR-506-514 cluster, which was consistently overexpressed in nearly all melanomas tested (30-60 fold, P < 0.001), regardless of mutations in N-ras or B-raf. Inhibition of the expression of this cluster as a whole, or one of its sub-clusters (Sub-cluster A) consisting of six mature miRNAs, led to significant inhibition of cell growth, induction of apoptosis, decreased invasiveness and decreased colony formation in soft agar across multiple melanoma cell lines. Sub-cluster A of the miR-506-514 cluster was critical for maintaining the cancer phenotype, but the overexpression of the full cluster was necessary for melanocyte transformation. Our results provide new insights into the functional role of this miRNA cluster in melanoma, and suggest new approaches to treat or diagnose this disease. Oncogene (2012) 31, 1558-1570; doi:10.1038/onc.2011.345; published online 22 August 2011	[Streicher, K. L.; Zhu, W.; Lehmann, K. P.; Georgantas, R. W.; Morehouse, C. A.; Brohawn, P.; Higgs, B. W.; Richman, L.; Jallal, B.; Ranade, K.; Yao, Y.] MedImmune LLC, Dept Translat Sci, Gaithersburg, MD USA; [Carrasco, R. A.; Xiao, Z.; Tice, D. A.] MedImmune LLC, Dept Oncol, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Streicher, KL (corresponding author), Medimmune Inc, 1 MedImmune Way, Gaithersburg, MD 20878 USA.	StreicherK@MedImmune.com; YaoY@MedImmune.com	Xie, Huangming/B-2260-2012	Higgs, Brandon/0000-0002-2951-0245				Ambros Victor, 2004, Methods Mol Biol, V265, P131; Bandarchi B, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/583748; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chin M, 2009, ONCOGENE, V28, P2100, DOI 10.1038/onc.2009.74; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Hartman ZC, 2011, CANCER RES, V71, P4380, DOI 10.1158/0008-5472.CAN-11-0308; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262; Li JJ, 2010, MOL BIOL EVOL, V27, P671, DOI 10.1093/molbev/msp284; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mirnezami AHF, 2009, EJSO-EUR J SURG ONC, V35, P339, DOI 10.1016/j.ejso.2008.06.006; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; MONTESANO R, 1977, J NATL CANCER I, V59, P1651, DOI 10.1093/jnci/59.6.1651; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Osawa M, 2008, J INVEST DERMATOL, V128, P2571, DOI 10.1038/jid.2008.289; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; RHIM JS, 1983, CANCER DETECT PREV, V6, P381; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; SCHOLZ CC, 1990, EUR J CANCER, V26, P901, DOI 10.1016/0277-5379(90)90196-Z; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Syed M, 2008, CLIN EXP METASTAS, V25, P787, DOI 10.1007/s10585-008-9192-0; TRAINER DL, 1988, INT J CANCER, V41, P287, DOI 10.1002/ijc.2910410221; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; ZIRVI KA, 1983, INT J CANCER, V32, P45, DOI 10.1002/ijc.2910320108	39	115	127	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	12					1558	1570		10.1038/onc.2011.345	http://dx.doi.org/10.1038/onc.2011.345			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	916VT	21860416				2022-12-25	WOS:000302132000008
J	Klemm, EJ; Spooner, E; Ploegh, HL				Klemm, Elizabeth J.; Spooner, Eric; Ploegh, Hidde L.			Dual Role of Ancient Ubiquitous Protein 1 (AUP1) in Lipid Droplet Accumulation and Endoplasmic Reticulum (ER) Protein Quality Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUE DOMAIN; MISFOLDED GLYCOPROTEINS; DEGRADATION; DISLOCATION; MEMBRANE; COMPLEX; GP78; UBIQUITINATION; BINDING; REVEALS	Quality control of endoplasmic reticulum proteins involves the identification and engagement of misfolded proteins, dislocation of the misfolded protein across the endoplasmic reticulum (ER) membrane, and ubiquitin-mediated targeting to the proteasome for degradation. Ancient ubiquitous protein 1 (AUP1) physically associates with the mammalian HRD1-SEL1L complex, and AUP1 depletion impairs degradation of misfolded ER proteins. One of the functions of AUP1 in ER quality control is to recruit the soluble E2 ubiquitin-conjugating enzyme UBE2G2. We further show that the CUE domain of AUP1 regulates polyubiquitylation and facilitates the interaction of AUP1 with the HRD1 complex and with dislocation substrates. AUP1 localizes both to the ER and to lipid droplets. The AUP1 expression level affects the abundance of cellular lipid droplets and as such represents the first protein with lipid droplet regulatory activity to be linked to ER quality control. These findings indicate a possible connection between ER protein quality control and lipid droplets.	[Klemm, Elizabeth J.; Spooner, Eric; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu						Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kato A, 2002, J BIOL CHEM, V277, P28934, DOI 10.1074/jbc.M204340200; Kato A, 2009, PLATELETS, V20, P105, DOI 10.1080/09537100802641507; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	61	76	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37602	37614		10.1074/jbc.M111.284794	http://dx.doi.org/10.1074/jbc.M111.284794			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21857022	hybrid, Green Published			2022-12-25	WOS:000296542400058
J	Majumder, R; Liang, XE; Quinn-Allen, MA; Kane, WH; Lentz, BR				Majumder, Rinku; Liang, Xiaoe; Quinn-Allen, Mary Ann; Kane, William H.; Lentz, Barry R.			Modulation of Prothrombinase Assembly and Activity by Phosphatidylethanolamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE FACTOR-V; PHOSPHATIDYLSERINE BINDING-SITE; COAGULATION FACTOR-V; PHOSPHOLIPID-MEMBRANES; FACTOR-VIII; C2 DOMAIN; FACTOR XA; COMPLEX; ACTIVATION; CURVATURE	Constituents of platelet membranes regulate the activity of the prothrombinase complex. We demonstrate that membranes containing phosphatidylcholine and phosphatidylethanolamine (PE) bind factor Va with high affinity (K-d = similar to 10 nM) in the absence of phosphatidylserine (PS). These membranes support formation of a 60-70% functional prothrombinase complex at saturating factor Va concentrations. Although reduced interfacial packing does contribute to factor Va binding in the absence of PS, it does not correlate with the enhanced activity of the Xa-Va complex assembled on PE-containing membranes. Instead, specific protein-PE interactions appear to contribute to the effects of PE. In support of this, soluble C6PE binds to recombinant factor Va(2) (K-d = similar to 6.5 mu M) and to factor Xa (K-d = similar to 91 mu M). C6PE and C6PS binding sites of factor Xa are specific, distinct, and linked, because binding of one lipid enhances the binding and activity effects of the other. C6PE triggers assembly (K-d(app) = similar to 40 nM) of a partially active prothrombinase complex between factor Xa and factor Va(2), compared with K-d(app) for C6PS similar to 2 nM. These findings provide new insights into the possible synergistic roles of platelet PE and PS in regulating thrombin formation, particularly when exposed membrane PS may be limiting.	[Majumder, Rinku; Lentz, Barry R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Liang, Xiaoe; Quinn-Allen, Mary Ann; Kane, William H.] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27702 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University	Majumder, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	rinku-majumder@med.unc.edu; william.kane@duke.edu; uncbrl@med.unc.edu	Majumder, Rinku/J-7512-2019	majumder, Rinku/0000-0002-1727-7220	National Institutes of Health [GM32707, HL 072827, HL43106]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043106, R01HL072827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32707 and HL 072827 (to B. R. L.) and HL43106 (to W. H. K.).	Banerjee M, 2002, BIOCHEMISTRY-US, V41, P7751, DOI 10.1021/bi020017p; Banerjee M, 2002, BIOCHEMISTRY-US, V41, P950, DOI 10.1021/bi0116902; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; BILLY D, 1995, J BIOL CHEM, V270, P26883, DOI 10.1074/jbc.270.45.26883; Boskovic DS, 2004, J BIOL CHEM, V279, P20786, DOI 10.1074/jbc.M400469200; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; CUTSFORTH GA, 1989, BIOCHEMISTRY-US, V28, P7453, DOI 10.1021/bi00444a045; Cutsforth GA, 1996, BIOPHYS J, V70, P2938, DOI 10.1016/S0006-3495(96)79864-8; GILBERT GE, 1990, J BIOL CHEM, V265, P815; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Haque ME, 2005, BIOPHYS J, V89, P3183, DOI 10.1529/biophysj.105.063032; Haque ME, 2004, BIOCHEMISTRY-US, V43, P3507, DOI 10.1021/bi035794j; HO C, 1995, BIOCHEMISTRY-US, V34, P6188, DOI 10.1021/bi00018a023; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; JONES ME, 1985, THROMB RES, V39, P711, DOI 10.1016/0049-3848(85)90255-5; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; KANE WH, 1988, BLOOD, V71, P539; Klein S, 2001, ARTERIOSCL THROM VAS, V21, P1695; Koppaka V, 1996, BIOCHEMISTRY-US, V35, P7482, DOI 10.1021/bi952063d; Koppaka V, 1996, BIOPHYS J, V70, P2930, DOI 10.1016/S0006-3495(96)79863-6; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KUNG C, 1994, J BIOL CHEM, V269, P25838; Majumder R, 2005, BIOCHEMISTRY-US, V44, P16998, DOI 10.1021/bi051469f; Majumder R, 2005, BIOCHEMISTRY-US, V44, P711, DOI 10.1021/bi047962t; Majumder R, 2004, BIOPHYS J, V86, p92A; Majumder R, 2002, J BIOL CHEM, V277, P29765, DOI 10.1074/jbc.M200893200; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; MANN KG, 1990, BLOOD, V76, P1; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Peng WM, 2004, BIOCHEMISTRY-US, V43, P4385, DOI 10.1021/bi035763o; RAND RP, 1990, BIOCHEMISTRY-US, V29, P76, DOI 10.1021/bi00453a010; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Smeets EF, 1996, THROMB RES, V81, P419, DOI 10.1016/0049-3848(96)00014-X; Smirnov MD, 1999, BIOCHEMISTRY-US, V38, P3591, DOI 10.1021/bi982538b; Smirnov MD, 1999, BLOOD, V94, P3839, DOI 10.1182/blood.V94.11.3839.423k07_3839_3846; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Srivastava A, 2002, J BIOL CHEM, V277, P1855, DOI 10.1074/jbc.M105697200; Weinreb GE, 2003, J BIOL CHEM, V278, P5679, DOI 10.1074/jbc.M208423200; Wu H, 1996, BIOCHEMISTRY-US, V35, P12602, DOI 10.1021/bi960168q; Zhai X, 2002, BIOCHEMISTRY-US, V41, P5675, DOI 10.1021/bi011844d; Zieseniss S, 2001, J BIOL CHEM, V276, P19828, DOI 10.1074/jbc.M007506200; Zwaal R F, 1983, Subcell Biochem, V9, P299	44	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35535	35542		10.1074/jbc.M111.260141	http://dx.doi.org/10.1074/jbc.M111.260141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21859710	Green Published, hybrid			2022-12-25	WOS:000295927100025
J	Wakabayashi, Y; Tamiya, T; Takada, I; Fukaya, T; Sugiyama, Y; Inoue, N; Kimura, A; Morita, R; Kashiwagi, I; Takimoto, T; Nomura, M; Yoshimura, A				Wakabayashi, Yu; Tamiya, Taiga; Takada, Ichiro; Fukaya, Tomohiro; Sugiyama, Yuki; Inoue, Naoko; Kimura, Akihiro; Morita, Rimpei; Kashiwagi, Ikko; Takimoto, Tomohito; Nomura, Masatoshi; Yoshimura, Akihiko			Histone 3 Lysine 9 (H3K9) Methyltransferase Recruitment to the Interleukin-2 (IL-2) Promoter Is a Mechanism of Suppression of IL-2 Transcription by the Transforming Growth Factor-beta-Smad Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DISRUPTION; DIRECT BINDING; T-CELLS; FOXP3; DIFFERENTIATION; PLASTICITY; GENE; INFLAMMATION; ACTIVATION; INDUCTION	Suppression of IL-2 beta production from T cells is an important process for the immune regulation by TGF-beta. However, the mechanism by which this suppression occurs remains to be established. Here, we demonstrate that Smad2 and Smad3, two major TGF-beta-downstream transcription factors, are redundantly essential for TGF-beta-mediated suppression of IL-2 production in CD4(+) T cells using Smad2- and Smad3-deficient T cells. Both Smad2 and Smad3 were recruited into the proximal region of the IL-2 promoter in response to TGF-beta. We then investigated the histone methylation status of the IL-2 promoter. Although both histone H3 lysine 9 (H3K9) and H3K27 trimethylation have been implicated in gene silencing, only H3K9 trimethylation was increased in the proximal region of the IL-2 promoter in a Smad2/3-dependent manner, whereas H3K27 trimethylation was not. The H3K9 methyltransferases Setdb1 and Suv39h1 bound to Smad3 and suppressed IL-2 promoter activity in collaboration with Smad3. Overexpression of Suv39h1 in 68-41 T cells strongly inhibited IL-2 production in response to T cell receptor stimulation irrespective of the presence or absence of TGF-beta, whereas Setdb1 overexpression only slightly suppressed IL-2 production. Silencing of Suv39h1 by shRNA reverted the suppressive effect of TGF-beta on IL-2 production. Furthermore, TGF-beta induced Suv39h1 recruitment to the proximal region of the IL-2 promoter in wild type primary T cells; however, this was not observed in Smad2(-/-) Smad3(+/-) T cells. Thus, we propose that Smads recruit H3K9 methyltransferases Suv39h1 to the IL-2 promoter, thereby inducing suppressive histone methylation and inhibiting T cell receptor-mediated IL-2 transcription.	[Wakabayashi, Yu; Tamiya, Taiga; Takada, Ichiro; Fukaya, Tomohiro; Sugiyama, Yuki; Inoue, Naoko; Kimura, Akihiro; Morita, Rimpei; Kashiwagi, Ikko; Takimoto, Tomohito; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Nomura, Masatoshi] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Wakabayashi, Yu; Tamiya, Taiga; Takada, Ichiro; Fukaya, Tomohiro; Sugiyama, Yuki; Inoue, Naoko; Kimura, Akihiro; Morita, Rimpei; Kashiwagi, Ikko; Takimoto, Tomohito; Yoshimura, Akihiko] CREST, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Keio University; Kyushu University; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	KASHIWAGI, IKKOH/0000-0001-5386-5719; Kimura, Akihiro/0000-0001-5614-8547; Tamiya, Taiga/0000-0002-8021-4628	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, grants-in-aid for Basic Research on Priority Areas (Dynamics of Extracellular Environments, Immunological Self), the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO), the Mitsubishi Pharma Research Foundation, the Kanae Foundation for the Promotion of Medical Science, the Mochida Memorial Foundation, and the Takeda Science Foundation.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BRABLETZ T, 1993, MOL CELL BIOL, V13, P1155, DOI 10.1128/MCB.13.2.1155; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Rudner LA, 2003, J IMMUNOL, V170, P4785, DOI 10.4049/jimmunol.170.9.4785; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Ward SB, 1998, NUCLEIC ACIDS RES, V26, P2923, DOI 10.1093/nar/26.12.2923; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	39	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35456	35465		10.1074/jbc.M111.236794	http://dx.doi.org/10.1074/jbc.M111.236794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21862595	Green Published, hybrid			2022-12-25	WOS:000295927100017
J	Anwar, A; Hosoya, T; Leong, KM; Onogi, H; Okuno, Y; Hiramatsu, T; Koyama, H; Suzuki, M; Hagiwara, M; Garcia-Blanco, MA				Anwar, Azlinda; Hosoya, Takamitsu; Leong, Kok Mun; Onogi, Hiroshi; Okuno, Yukiko; Hiramatsu, Toshiyuki; Koyama, Hiroko; Suzuki, Masaaki; Hagiwara, Masatoshi; Garcia-Blanco, Mariano A.			The Kinase Inhibitor SFV785 Dislocates Dengue Virus Envelope Protein from the Replication Complex and Blocks Virus Assembly	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; NERVE GROWTH-FACTOR; VIRAL REPLICATION; CORE PROTEIN; NONSTRUCTURAL PROTEIN; RNA REPLICATION; GENE-EXPRESSION; LIPID DROPLET; CELL-LINES; INFECTION	Dengue virus (DENV) is the etiologic agent for dengue fever, for which there is no approved vaccine or specific anti-viral drug. As a remedy for this, we explored the use of compounds that interfere with the action of required host factors and describe here the characterization of a kinase inhibitor (SFV785), which has selective effects on NTRK1 and MAPKAPK5 kinase activity, and anti-viral activity on Hepatitis C, DENV and yellow fever viruses. SFV785 inhibited DENV propagation without inhibiting DENV RNA synthesis or translation. The compound did not cause any changes in the cellular distribution of non-structural 3, a protein critical for DENV RNA synthesis, but altered the distribution of the structural envelope protein from a reticulate network to enlarged discrete vesicles, which altered the co-localization with the DENV replication complex. Ultrastructural electron microscopy analyses of DENV-infected SFV785-treated cells showed the presence of viral particles that were distinctly different from viable enveloped virions within enlarged ER cisternae. These viral particles were devoid of the dense nucleocapsid. The secretion of the viral particles was not inhibited by SFV785, however a reduction in the amount of secreted infectious virions, DENV RNA and capsid were observed. Collectively, these observations suggest that SFV785 inhibited the recruitment and assembly of the nucleocapsid in specific ER compartments during the DENV assembly process and hence the production of infectious DENV. SFV785 and derivative compounds could be useful biochemical probes to explore the DENV lifecycle and could also represent a new class of anti-virals.	[Anwar, Azlinda; Leong, Kok Mun; Garcia-Blanco, Mariano A.] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Hosoya, Takamitsu; Hiramatsu, Toshiyuki] Tokyo Med & Dent Univ, Biol Chem Lab, Grad Sch Biomed Sci, Tokyo, Japan; [Hosoya, Takamitsu; Onogi, Hiroshi; Okuno, Yukiko; Hiramatsu, Toshiyuki; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Onogi, Hiroshi; Okuno, Yukiko; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Gene Express Lab, Grad Sch Biomed Sci, Tokyo, Japan; [Onogi, Hiroshi] KinoPharma Inc, Tokyo, Japan; [Koyama, Hiroko] Gifu Univ, Grad Sch Med, Div Regenerat & Adv Med Sci, Gifu, Japan; [Suzuki, Masaaki] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan; [Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto, Japan; [Garcia-Blanco, Mariano A.] Duke Univ, Sch Med, Ctr RNA Biol, Dept Mol Genet & Microbiol, Durham, NC USA; [Garcia-Blanco, Mariano A.] Duke Univ, Sch Med, Ctr RNA Biol, Dept Med, Durham, NC USA	National University of Singapore; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Gifu University; RIKEN; Kyoto University; Duke University; Duke University	Anwar, A (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.	gmsaa@nus.edu.sg; hagiwara.masatoshi.8c@kyoto-u.ac.jp; mariano.garciablanco@duke-nus.edu.sg	Hosoya, Takamitsu/N-7762-2015	Hosoya, Takamitsu/0000-0002-7270-351X	Agency for Science, Technology and Research of Singapore; Singapore Ministry of Health [R-913-200-002-304]; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21249013]; The Uehara Memorial Foundation; The Naito Foundation; Takeda Science Foundation	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health(Ministry of Health-Singapore); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); The Naito Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Agency for Science, Technology and Research of Singapore and the Singapore Ministry of Health Awards R-913-200-002-304 (to M. G. B), and by Grants-in-aid (MH) from Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science, and Technology of Japan (21249013), The Uehara Memorial Foundation, The Naito Foundation Natural Science Scholarship, and Takeda Science Foundation (to M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 2006, ANAL BIOCHEM, V352, P120, DOI 10.1016/j.ab.2006.01.046; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Bhattacharya D, 2009, J VIROL, V83, P9195, DOI 10.1128/JVI.00271-09; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Choi Yook-Wah, 2004, Biochemical and Biophysical Research Communications, V318, P514, DOI 10.1016/j.bbrc.2004.04.052; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gould E., 1985, VIROLOGY PRACTICAL A, P43; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Houlden H, 2001, ANN NEUROL, V49, P521; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jordan R, 1998, J VIROL, V72, P5373, DOI 10.1128/JVI.72.7.5373-5382.1998; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Kriesel JD, 2002, DNA CELL BIOL, V21, P475, DOI 10.1089/10445490260099773; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Murakami K, 2008, J GEN VIROL, V89, P1587, DOI 10.1099/vir.0.83618-0; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; *PED DENG VACC INT, GLOB BURD DENG; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Tanabe Y, 2004, J INFECT DIS, V189, P1129, DOI 10.1086/382595; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Yoon SW, 2006, MOL CELLS, V21, P112	53	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23246	10.1371/journal.pone.0023246	http://dx.doi.org/10.1371/journal.pone.0023246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858043	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300023
J	Dey, B; Jain, R; Gupta, UD; Katoch, VM; Ramanathan, VD; Tyagi, AK				Dey, Bappaditya; Jain, Ruchi; Gupta, Umesh D.; Katoch, V. M.; Ramanathan, V. D.; Tyagi, Anil K.			A Booster Vaccine Expressing a Latency-Associated Antigen Augments BCG Induced Immunity and Confers Enhanced Protection against Tuberculosis	PLOS ONE			English	Article							CD4 T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; DNA VACCINES; GUINEA-PIGS; EFFICACY; IMMUNOGENICITY; COMPONENTS; INFECTION; EFFICIENT; RESPONSES	Background: In spite of a consistent protection against tuberculosis (TB) in children, Mycobacterium bovis Bacille Calmette-Guerin (BCG) fails to provide adequate protection against the disease in adults as well as against reactivation of latent infections or exogenous reinfections. It has been speculated that failure to generate adequate memory T cell response, elicitation of inadequate immune response against latency-associated antigens and inability to impart long-term immunity against M. tuberculosis infections are some of the key factors responsible for the limited efficiency of BCG in controlling TB. Methods/Principal Findings: In this study, we evaluated the ability of a DNA vaccine expressing alpha-crystallin-a key latency antigen of M. tuberculosis to boost the BCG induced immunity. 'BCG prime - DNA boost' regimen (B/D) confers robust protection in guinea pigs along with a reduced pathology in comparison to BCG vaccination (1.37 log(10) and 1.96 log10 fewer bacilli in lungs and spleen, respectively; p<0.01). In addition, B/D regimen also confers enhanced protection in mice. Further, we show that B/D immunization in mice results in a heightened frequency of PPD and antigen specific multifunctional CD4 T cells (3(+)) simultaneously producing interferon (IFN)gamma, tumor necrosis factor (TNF)alpha and interleukin (IL)2. Conclusions/Significance: These results clearly indicate the superiority of alpha-crystallin based B/D regimen over BCG. Our study, also demonstrates that protection against TB is predictable by an increased frequency of 3(+) Th1 cells with superior effector functions. We anticipate that this study would significantly contribute towards the development of superior booster vaccines for BCG vaccinated individuals. In addition, this regimen can also be expected to reduce the risk of developing active TB due to reactivation of latent infection.	[Dey, Bappaditya; Jain, Ruchi; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Umesh D.; Katoch, V. M.] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Ramanathan, V. D.] TB Res Ctr, Dept Clin Pathol, Chennai, Tamil Nadu, India	University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Dey, B (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in	Dey, Bappaditya/H-1831-2018	Dey, Bappaditya/0000-0003-2728-4683	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brooks JV, 2001, INFECT IMMUN, V69, P2714, DOI 10.1128/IAI.69.4.2714-2717.2001; Chambers MA, 2002, INFECT IMMUN, V70, P2159, DOI 10.1128/IAI.70.4.2159-2165.2002; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018773; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Goncalves Eduardo D C, 2007, Genet Vaccines Ther, V5, P7, DOI 10.1186/1479-0556-5-7; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Khera A, 2005, VACCINE, V23, P5655, DOI 10.1016/j.vaccine.2005.03.056; Lozes E, 1997, VACCINE, V15, P830, DOI 10.1016/S0264-410X(96)00274-5; Ly LH, 2008, EXPERT REV VACCINES, V7, P635, DOI 10.1586/14760584.7.5.635; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; PGAMAR S, EPIDEMIOLOGY TUBERCU; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SHI C, VACCINE, V28, P5237; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Sugawara I, 2003, TUBERCULOSIS, V83, P331, DOI 10.1016/S1472-9792(03)00054-4; Tanghe A, 1999, J IMMUNOL, V162, P1113; Tascon RE, 1996, NAT MED, V2, P888, DOI 10.1038/nm0896-888; Taylor JL, 2003, INFECT IMMUN, V71, P2192, DOI 10.1128/IAI.71.4.2192-2198.2003	35	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23360	10.1371/journal.pone.0023360	http://dx.doi.org/10.1371/journal.pone.0023360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858087	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000294121300038
J	Reinecke, JB; DeVos, SL; McGrath, JP; Shepard, AM; Goncharoff, DK; Tait, DN; Fleming, SR; Vincent, MP; Steinhilb, ML				Reinecke, James B.; DeVos, Sarah L.; McGrath, James P.; Shepard, Amanda M.; Goncharoff, Dustin K.; Tait, Don N.; Fleming, Samantha R.; Vincent, Michael P.; Steinhilb, Michelle L.			Implicating Calpain in Tau-Mediated Toxicity In Vivo	PLOS ONE			English	Article							CONFOCAL IMMUNOFLUORESCENCE; INDUCED NEURODEGENERATION; CLEAVAGE; DROSOPHILA; AGGREGATION; ACTIVATION; TAUOPATHY; PHOSPHORYLATION; NEUROTOXICITY; PROTEOLYSIS	Alzheimer's disease and other related neurodegenerative disorders known as tauopathies are characterized by the accumulation of abnormally phosphorylated and aggregated forms of the microtubule-associated protein tau. Several laboratories have identified a 17 kD proteolytic fragment of tau in degenerating neurons and in numerous cell culture models that is generated by calpain cleavage and speculated to contribute to tau toxicity. In the current study, we employed a Drosophila tauopathy model to investigate the importance of calpain-mediated tau proteolysis in contributing to tau neurotoxicity in an animal model of human neurodegenerative disease. We found that mutations that disrupted endogenous calpainA or calpainB activity in transgenic flies suppressed tau toxicity. Expression of a calpain-resistant form of tau in Drosophila revealed that mutating the putative calpain cleavage sites that produce the 17 kD fragment was sufficient to abrogate tau toxicity in vivo. Furthermore, we found significant toxicity in the fly retina associated with expression of only the 17 kD tau fragment. Collectively, our data implicate calpain-mediated proteolysis of tau as an important pathway mediating tau neurotoxicity in vivo.	[Reinecke, James B.; DeVos, Sarah L.; McGrath, James P.; Shepard, Amanda M.; Goncharoff, Dustin K.; Tait, Don N.; Fleming, Samantha R.; Vincent, Michael P.; Steinhilb, Michelle L.] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA	Central Michigan University	Reinecke, JB (corresponding author), Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA.	stein3ml@cmich.edu	Vincent, Michael/H-4939-2015	Vincent, Michael/0000-0001-9669-4921	National Institutes of Health [1 R15 AG032105-01]; Central Michigan University through the Office of Research; NATIONAL INSTITUTE ON AGING [R15AG032105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Michigan University through the Office of Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health Academic Research Enhancement Award (1 R15 AG032105-01) to MLS (www.nih.gov), and a Research Excellence Fund award - internal grant from Central Michigan University through the Office of Research and Sponsored Programs to MLS (http://www.orsp.cmich.edu/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec E, 2000, NEUROSCIENCE, V100, P663, DOI 10.1016/S0306-4522(00)00281-5; Adamec E, 2002, J NEUROL SCI, V200, P85, DOI 10.1016/S0022-510X(02)00150-8; Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; Amadoro G, 2007, NEUROPHARMACOLOGY, V52, P1366, DOI 10.1016/j.neuropharm.2007.01.020; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Canu N, 1998, J NEUROSCI, V18, P7061; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Delobel P, 2005, FEBS LETT, V579, P1, DOI 10.1016/j.febslet.2004.11.018; Delobel P, 2003, ANN NY ACAD SCI, V1010, P623, DOI 10.1196/annals.1299.115; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Feuillette S, 2010, BRAIN RES, V1345, P182, DOI 10.1016/j.brainres.2010.05.007; Feuillette S, 2010, J NEUROCHEM, V113, P895, DOI 10.1111/j.1471-4159.2010.06663.x; Friedrich P, 2004, BIOESSAYS, V26, P1088, DOI 10.1002/bies.20106; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hung KS, 2005, J NEUROPATH EXP NEUR, V64, P15, DOI 10.1093/jnen/64.1.15; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima-Ando K, 2010, HUM MOL GENET, V19, P1930, DOI 10.1093/hmg/ddq068; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Kraft R, 1998, J NEUROSCI, V18, P8886; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li PA, 1998, NEUROSCI LETT, V247, P17, DOI 10.1016/S0304-3940(98)00266-3; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Loewen CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013084; Mittoo S, 2003, ANAL BIOCHEM, V319, P234, DOI 10.1016/S0003-2697(03)00324-5; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Nicholson AM, 2011, J BIOL CHEM, V286, P976, DOI 10.1074/jbc.M110.154138; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; PETERSON C, 1986, P NATL ACAD SCI USA, V83, P2758, DOI 10.1073/pnas.83.8.2758; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Shulman JM, 2003, GENETICS, V165, P1233; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sinjoanu RC, 2008, NEUROCHEM INT, V53, P79, DOI 10.1016/j.neuint.2008.06.003; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Steinhilb ML, 2007, J NEUROSCI RES, V85, P1271, DOI 10.1002/jnr.21232; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Xie HQ, 1998, J NEUROSCI RES, V53, P153, DOI 10.1002/(SICI)1097-4547(19980715)53:2<153::AID-JNR4>3.3.CO;2-5; Xie HQ, 1997, J NEUROCHEM, V69, P1020; YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x	63	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23865	10.1371/journal.pone.0023865	http://dx.doi.org/10.1371/journal.pone.0023865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21858230	Green Published, Green Submitted, gold			2022-12-25	WOS:000294121300101
J	Shindo, Y; Fujii, T; Komatsu, H; Citterio, D; Hotta, K; Suzuki, K; Oka, K				Shindo, Yutaka; Fujii, Tomohiko; Komatsu, Hirokazu; Citterio, Daniel; Hotta, Kohji; Suzuki, Koji; Oka, Kotaro			Newly Developed Mg2+-Selective Fluorescent Probe Enables Visualization of Mg2+ Dynamics in Mitochondria	PLOS ONE			English	Article							PC12 CELLS; EMBRYONIC-DEVELOPMENT; MAGNESIUM-DEFICIENCY; CELLULAR MAGNESIUM; CALCIUM; MECHANISM; DISEASE; NEURONS; NEURODEGENERATION; TRANSPORTERS	Mg2+ plays important roles in numerous cellular functions. Mitochondria take part in intracellular Mg2+ regulation and the Mg2+ concentration in mitochondria affects the synthesis of ATP. However, there are few methods to observe Mg2+ in mitochondria in intact cells. Here, we have developed a novel Mg2+-selective fluorescent probe, KMG-301, that is functional in mitochondria. This probe changes its fluorescence properties solely depending on the Mg2+ concentration in mitochondria under physiologically normal conditions. Simultaneous measurements using this probe together with a probe for cytosolic Mg2+, KMG-104, enabled us to compare the dynamics of Mg2+ in the cytosol and in mitochondria. With this method, carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP)-induced Mg2+ mobilization from mitochondria to the cytosol was visualized. Although a FCCP-induced decrease in the Mg2+ concentration in mitochondria and an increase in the cytosol were observed both in differentiated PC12 cells and in hippocampal neurons, the time-courses of concentration changes varied with cell type. Moreover, the relationship between mitochondrial Mg2+ and Parkinson's disease was analyzed in a cellular model of Parkinson's disease by using the 1-methyl-4-phenylpyridinium ion (MPP+). A gradual decrease in the Mg2+ concentration in mitochondria was observed in response to MPP+ in differentiated PC12 cells. These results indicate that KMG-301 is useful for investigating Mg2+ dynamics in mitochondria. All animal procedures to obtain neurons from Wistar rats were approved by the ethical committee of Keio University (permit number is 09106-(1)).	[Shindo, Yutaka; Fujii, Tomohiko; Hotta, Kohji; Oka, Kotaro] Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Grad Sch Sci & Technol, Kanagawa, Japan; [Komatsu, Hirokazu; Citterio, Daniel; Suzuki, Koji] Keio Univ, Ctr Sci & Technol Designing Funct, Sch Integrated Design Engn, Grad Sch Sci & Technol, Kanagawa, Japan	Keio University; Keio University	Shindo, Y (corresponding author), Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Grad Sch Sci & Technol, Kanagawa, Japan.	oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014; Citterio, Daniel/B-7975-2008	Hotta, Kohji/0000-0003-4614-7473; Citterio, Daniel/0000-0001-7420-045X	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [S0801008]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2008-2012, (S0801008) (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasi E, 2005, J ALZHEIMERS DIS, V7, P273; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; BOGUCKA K, 1976, BIOCHEM BIOPH RES CO, V71, P161, DOI 10.1016/0006-291X(76)90263-1; Boska MD, 2002, NEUROLOGY, V58, P1227, DOI 10.1212/WNL.58.8.1227; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Chaudhary DP, 2010, BIOL TRACE ELEM RES, V134, P119, DOI 10.1007/s12011-009-8465-z; Cole DEC, 2000, J AM SOC NEPHROL, V11, P1937, DOI 10.1681/ASN.V11101937; Di Francesco A, 1998, ARCH BIOCHEM BIOPHYS, V360, P149, DOI 10.1006/abbi.1998.0937; Drummond RM, 1999, J PHYSIOL-LONDON, V516, P139, DOI 10.1111/j.1469-7793.1999.139aa.x; Gabriel TE, 2007, ARCH BIOCHEM BIOPHYS, V458, P3, DOI 10.1016/j.abb.2006.07.007; Gunzel D, 2001, BIOPHYS J, V80, P1298, DOI 10.1016/S0006-3495(01)76104-8; Hashimoto T, 2008, BRAIN RES, V1197, P143, DOI 10.1016/j.brainres.2007.12.033; Jaiswal MK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-64; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Ko YH, 1999, J BIOL CHEM, V274, P28853, DOI 10.1074/jbc.274.41.28853; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Komatsu H, 2005, J AM CHEM SOC, V127, P10798, DOI 10.1021/ja0528228; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Kubota T, 2005, BBA-MOL CELL RES, V1744, P19, DOI 10.1016/j.bbamcr.2004.10.013; Kubota T, 2003, BIOCHEM BIOPH RES CO, V303, P332, DOI 10.1016/S0006-291X(03)00346-2; Liou AKF, 2005, FASEB J, V19, P1350, DOI 10.1096/fj.04-3258fje; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Oyanagi K, 2006, NEUROPATHOLOGY, V26, P115, DOI 10.1111/j.1440-1789.2006.00672.x; Panov A, 1996, BIOCHEMISTRY-US, V35, P12849, DOI 10.1021/bi960139f; Piskacek M, 2009, J CELL MOL MED, V13, P693, DOI 10.1111/j.1582-4934.2008.00328.x; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shindo Y, 2010, J NEUROSCI RES, V88, P3125, DOI 10.1002/jnr.22467; Shoda T, 2003, ANALYST, V128, P719, DOI 10.1039/b212835g; SONTIA B, 2006, ARCH BIOCH BIOPHYS; Stout AK, 1999, NEUROSCIENCE, V89, P91, DOI 10.1016/S0306-4522(98)00441-2; Suzuki Y, 2002, ANAL CHEM, V74, P1423, DOI 10.1021/ac010914j; Trapani V, 2010, ANALYST, V135, P1855, DOI 10.1039/c0an00087f; Trollinger DR, 2000, BIOPHYS J, V79, P39, DOI 10.1016/S0006-3495(00)76272-2; vandePut FHMM, 1996, J BIOL CHEM, V271, P4999; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Xu Z, 2005, NEUROTOXICOLOGY, V26, P729, DOI 10.1016/j.neuro.2004.12.008; YASUI M, 1992, NEUROTOXICOLOGY, V13, P593; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zsurka G, 2001, GENOMICS, V72, P158, DOI 10.1006/geno.2000.6407	50	47	50	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23684	10.1371/journal.pone.0023684	http://dx.doi.org/10.1371/journal.pone.0023684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21858208	Green Published, Green Submitted, gold			2022-12-25	WOS:000294125500041
J	Kasukawa, T; Masumoto, K; Nikaido, I; Nagano, M; Uno, KD; Tsujino, K; Hanashima, C; Shigeyoshi, Y; Ueda, HR				Kasukawa, Takeya; Masumoto, Koh-hei; Nikaido, Itoshi; Nagano, Mamoru; Uno, Kenichiro D.; Tsujino, Kaori; Hanashima, Carina; Shigeyoshi, Yasufumi; Ueda, Hiroki R.			Quantitative Expression Profile of Distinct Functional Regions in the Adult Mouse Brain	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; TRANSCRIPTIONAL NETWORK; CIRCADIAN CLOCK; MICROARRAY DATA; HOMEOBOX GENES; RAT-BRAIN; GENOME; ATLAS	The adult mammalian brain is composed of distinct regions with specialized roles including regulation of circadian clocks, feeding, sleep/awake, and seasonal rhythms. To find quantitative differences of expression among such various brain regions, we conducted the BrainStars (B*) project, in which we profiled the genome-wide expression of similar to 50 small brain regions, including sensory centers, and centers for motion, time, memory, fear, and feeding. To avoid confounds from temporal differences in gene expression, we sampled each region every 4 hours for 24 hours, and pooled the samples for DNA-microarray assays. Therefore, we focused on spatial differences in gene expression. We used informatics to identify candidate genes with expression changes showing high or low expression in specific regions. We also identified candidate genes with stable expression across brain regions that can be used as new internal control genes, and ligand-receptor interactions of neurohormones and neurotransmitters. Through these analyses, we found 8,159 multi-state genes, 2,212 regional marker gene candidates for 44 small brain regions, 915 internal control gene candidates, and 23,864 inferred ligand-receptor interactions. We also found that these sets include well-known genes as well as novel candidate genes that might be related to specific functions in brain regions. We used our findings to develop an integrated database (http://brainstars.org/) for exploring genome-wide expression in the adult mouse brain, and have made this database openly accessible. These new resources will help accelerate the functional analysis of the mammalian brain and the elucidation of its regulatory network systems.	[Kasukawa, Takeya; Nikaido, Itoshi; Uno, Kenichiro D.; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Kobe, Hyogo, Japan; [Masumoto, Koh-hei; Nikaido, Itoshi; Tsujino, Kaori; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Kobe, Hyogo, Japan; [Masumoto, Koh-hei; Nagano, Mamoru; Shigeyoshi, Yasufumi] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan; [Tsujino, Kaori; Ueda, Hiroki R.] Osaka Univ, Grad Sch Sci, Osaka, Japan; [Hanashima, Carina] RIKEN Ctr Dev Biol, Lab Neocort Dev, Kobe, Hyogo, Japan; [Ueda, Hiroki R.] Kyoto Univ, Grad Sch Sci, Dept Math, Kyoto, Japan; [Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Kobe, Hyogo, Japan	RIKEN; RIKEN; Kindai University (Kinki University); Osaka University; RIKEN; Kyoto University; RIKEN	Kasukawa, T (corresponding author), RIKEN Ctr Dev Biol, Funct Genom Unit, Kobe, Hyogo, Japan.	shigey@med.kindai.ac.jp; uedah-tky@umin.ac.jp	Kasukawa, Takeya/N-5070-2015; Nikaido, Itoshi/K-2058-2014; Ueda, Hiroki R/C-5037-2014	Kasukawa, Takeya/0000-0001-5085-0802; Nikaido, Itoshi/0000-0002-7261-2570; Ueda, Hiroki R/0000-0001-8342-9176	RIKEN Center for Developmental Biology; Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Center for Developmental Biology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was done as a part of the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (H. R. U.). This research was supported by an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology (H. R. U.), and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; Ahmad Sultan, 2004, Curr Opin Investig Drugs, V5, P67; Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bear MF, 2006, NEUROSCIENCE EXPLORI; Bishop C.M., 2006, PATTERN RECOGNITION; Bitton DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-118; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BREDER CD, 1992, J NEUROSCI, V12, P3920; Brodmann, 1909, VERGLEICHENDE LOKALI; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin MH, 2007, PHYSIOL GENOMICS, V30, P313, DOI 10.1152/physiolgenomics.00287.2006; Dunlap JC, CHRONOBIOLOGY BIOL T; Ertel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-3; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Gormley M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-486; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HalbachOvBu, 2006, NEUROTRANSMITTERS NE; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Horuk R, 1996, J LEUKOCYTE BIOL, V59, P29, DOI 10.1002/jlb.59.1.29; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Ignatov A, 2004, NEUROPHARMACOLOGY, V46, P1114, DOI 10.1016/j.neuropharm.2004.02.004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Isogawa K, 2005, NEUROPSYCHOBIOLOGY, V51, P34, DOI 10.1159/000082853; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; JAMES R, 1991, J BIOL CHEM, V266, P3246; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lau C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-153; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee CK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r23; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Miano JM, 1996, P NATL ACAD SCI USA, V93, P900, DOI 10.1073/pnas.93.2.900; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nadler JJ, 2006, GENETICS, V174, P1229, DOI 10.1534/genetics.106.061481; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; PERRY EK, 1993, HIPPOCAMPUS, V3, P307, DOI 10.1002/hipo.450030306; Reghunandanan Vallath, 2006, J Circadian Rhythms, V4, P2; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Venkataraman S, 2008, NUCLEIC ACIDS RES, V36, pD860, DOI 10.1093/nar/gkm938; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; Wolpert L, 2007, PRINCIPLES DEV; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	69	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23228	10.1371/journal.pone.0023228	http://dx.doi.org/10.1371/journal.pone.0023228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21858037	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953500026
J	Leushacke, M; Sporle, R; Bernemann, C; Brouwer-Lehmitz, A; Fritzmann, J; Theis, M; Buchholz, F; Herrmann, BG; Morkel, M				Leushacke, Marc; Spoerle, Ralf; Bernemann, Christof; Brouwer-Lehmitz, Antje; Fritzmann, Johannes; Theis, Mirko; Buchholz, Frank; Herrmann, Bernhard G.; Morkel, Markus			An RNA Interference Phenotypic Screen Identifies a Role for FGF Signals in Colon Cancer Progression	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; BETA-CATENIN; STEM-CELLS; METASTASIS; EXPRESSION; MICE; ADHESION	In tumor cells, stepwise oncogenic deregulation of signaling cascades induces alterations of cellular morphology and promotes the acquisition of malignant traits. Here, we identified a set of 21 genes, including FGF9, as determinants of tumor cell morphology by an RNA interference phenotypic screen in SW480 colon cancer cells. Using a panel of small molecular inhibitors, we subsequently established phenotypic effects, downstream signaling cascades, and associated gene expression signatures of FGF receptor signals. We found that inhibition of FGF signals induces epithelial cell adhesion and loss of motility in colon cancer cells. These effects are mediated via the mitogen-activated protein kinase (MAPK) and Rho GTPase cascades. In agreement with these findings, inhibition of the MEK1/2 or JNK cascades, but not of the PI3K-AKT signaling axis also induced epithelial cell morphology. Finally, we found that expression of FGF9 was strong in a subset of advanced colon cancers, and overexpression negatively correlated with patients' survival. Our functional and expression analyses suggest that FGF receptor signals can contribute to colon cancer progression.	[Leushacke, Marc; Spoerle, Ralf; Bernemann, Christof; Brouwer-Lehmitz, Antje; Herrmann, Bernhard G.; Morkel, Markus] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Leushacke, Marc] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Fritzmann, Johannes] Max Delbruck Ctr Mol Med, Berlin, Germany; [Fritzmann, Johannes] Univ Heidelberg Hosp, Dept Surg, Heidelberg, Germany; [Theis, Mirko; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Theis, Mirko; Buchholz, Frank] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany; [Herrmann, Bernhard G.] Charite Campus Benjamin Franklin, Inst Med Genet, Berlin, Germany; [Theis, Mirko; Buchholz, Frank] Tech Univ Dresden, Fac Med, D-8027 Dresden, Germany	Max Planck Society; Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden	Leushacke, M (corresponding author), Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany.	morkel@molgen.mpg.de	Buchholz, Frank/B-4700-2017	Buchholz, Frank/0000-0002-4577-3344; Morkel, Markus/0000-0002-2553-9999	German Bundesministerium fur Bildung und Forschung [NGFN2 01GR0405, PKT-01GS08111-5, PKM-01GS08105-8]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Parts of the work were funded by the German Bundesministerium fur Bildung und Forschung (grant NGFN2 01GR0405 to BGH, and grants PKT-01GS08111-5 and PKM-01GS08105-8 to BGH and MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bisson N, 2007, MOL BIOL CELL, V18, P1030, DOI 10.1091/mbc.E06-04-0294; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Camarero N, 2006, MOL CANCER RES, V4, P645, DOI 10.1158/1541-7786.MCR-05-0267; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christensen KL, 2008, ADV CANCER RES, V101, P93, DOI 10.1016/S0065-230X(08)00405-3; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fu YL, 2010, EUR J CELL BIOL, V89, P428, DOI 10.1016/j.ejcb.2010.01.002; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Gulino A, 2009, EMBO MOL MED, V1, P300, DOI 10.1002/emmm.200900042; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; Sonvilla G, 2010, BRIT J CANCER, V102, P1145, DOI 10.1038/sj.bjc.6605596; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Winder T, 2010, GASTROENTEROLOGY, V138, P2163, DOI 10.1053/j.gastro.2010.02.005; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392	56	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23381	10.1371/journal.pone.0023381	http://dx.doi.org/10.1371/journal.pone.0023381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853123	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000293953400042
J	Schussler, A; Kruger, M; Walker, C				Schuessler, Arthur; Krueger, Manuela; Walker, Christopher			Revealing Natural Relationships among Arbuscular Mycorrhizal Fungi: Culture Line BEG47 Represents Diversispora epigaea, Not Glomus versiforme	PLOS ONE			English	Article							SP-NOV; GLOMALES; PCR; GLOMEROMYCOTA; PHYLOGENY; PATTERNS; SPORE	Background: Understanding the mechanisms underlying biological phenomena, such as evolutionarily conservative trait inheritance, is predicated on knowledge of the natural relationships among organisms. However, despite their enormous ecological significance, many of the ubiquitous soil inhabiting and plant symbiotic arbuscular mycorrhizal fungi (AMF, phylum Glomeromycota) are incorrectly classified. Methodology/Principal Findings: Here, we focused on a frequently used model AMF registered as culture BEG47. This fungus is a descendent of the ex-type culture-lineage of Glomus epigaeum, which in 1983 was synonymised with Glomus versiforme. It has since then been used as 'G. versiforme BEG47'. We show by morphological comparisons, based on type material, collected 1860-61, of G. versiforme and on type material and living ex-type cultures of G. epigaeum, that these two AMF species cannot be conspecific, and by molecular phylogenetics that BEG47 is a member of the genus Diversispora. Conclusions: This study highlights that experimental works published during the last >25 years on an AMF named 'G. versiforme' or 'BEG47' refer to D. epigaea, a species that is actually evolutionarily separated by hundreds of millions of years from all members of the genera in the Glomerales and thus from most other commonly used AMF 'laboratory strains'. Detailed redescriptions substantiate the renaming of G. epigaeum (BEG47) as D. epigaea, positioning it systematically in the order Diversisporales, thus enabling an evolutionary understanding of genetical, physiological, and ecological traits, relative to those of other AMF. Diversispora epigaea is widely cultured as a laboratory strain of AMF, whereas G. versiforme appears not to have been cultured nor found in the field since its original description.	[Schuessler, Arthur; Krueger, Manuela] Univ Munich, Dept Biol, Bioctr, Martinsried, Germany; [Walker, Christopher] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Walker, Christopher] Univ Western Australia, Sch Earth & Environm, Nedlands, WA 6009, Australia	University of Munich; University of Western Australia	Schussler, A (corresponding author), Univ Munich, Dept Biol, Bioctr, Martinsried, Germany.	arthur.schuessler@lmu.de	Schüßler, Arthur/F-1681-2011; Krüger, Manuela/H-1603-2014	Krüger, Manuela/0000-0001-9223-3570; Walker, Christopher/0000-0003-0008-0664	DFG (German Research foundation) [Schu1203/8]	DFG (German Research foundation)(German Research Foundation (DFG))	Part of the work was funded by the DFG (German Research foundation) under grant number Schu1203/8 (was running until end 2007). There is no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERCH SM, 1983, CAN J BOT, V61, P2608, DOI 10.1139/b83-287; BONFANTEFASOLO P, 1984, PROTOPLASMA, V120, P51, DOI 10.1007/BF01287617; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; DANIELS BA, 1979, CAN J BOT, V57, P539, DOI 10.1139/b79-070; DANIELS BA, 1980, PHYTOPATHOLOGY, V70, P584, DOI 10.1094/Phyto-70-584; de la Providencia IE, 2005, NEW PHYTOL, V165, P261, DOI 10.1111/j.1469-8137.2004.01236.x; Gamper H, 2007, MYCORRHIZA, V17, P145, DOI 10.1007/s00572-006-0092-3; Gamper HA, 2009, NEW PHYTOL, V182, P495, DOI 10.1111/j.1469-8137.2008.02750.x; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; GERDEMANN JW, 1955, MYCOLOGIA, V47, P916, DOI 10.2307/3755515; Gomez SK, 2009, PEST MANAG SCI, V65, P504, DOI 10.1002/ps.1715; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; HAWKSWORTH DL, 1983, AINSWORTH BISBYS DIC; Karsten PA., 1884, HEDWIGIA, V23, P39; Kornerup A., 1978, METHUEN HDB COLOUR; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lanfranco L, 1999, FEMS MICROBIOL LETT, V170, P59, DOI 10.1111/j.1574-6968.1999.tb13355.x; Liu JY, 2007, PLANT J, V50, P529, DOI 10.1111/j.1365-313X.2007.03069.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Morton JB, 2001, MYCOLOGIA, V93, P181, DOI 10.2307/3761615; Naumann M, 2010, ISME J, V4, P862, DOI 10.1038/ismej.2010.21; Palenzuela J, 2010, MYCOLOGIA, V102, P624, DOI 10.3852/09-145; Pfeiffer CM, 1996, MYCOTAXON, V59, P373; Redecker D, 2000, MOL PHYLOGENET EVOL, V14, P276, DOI 10.1006/mpev.1999.0713; Redecker D, 2007, MYCOL PROG, V6, P35, DOI 10.1007/s11557-007-0524-2; Renker C, 2003, MYCORRHIZA, V13, P191, DOI 10.1007/s00572-002-0214-5; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2001, MYCOL RES, V105, P5, DOI 10.1017/S0953756200003725; Schussler A., 2010, GLOMEROMYCOTA SPECIE; Schwarzott D, 2001, MOL PHYLOGENET EVOL, V21, P190, DOI 10.1006/mpev.2001.1007; Sokolski S, 2010, BOTANY, V88, P829, DOI 10.1139/B10-050; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Thaxter R, 1922, P AM ACAD ARTS SCI, V57, P289; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Voets L, 2006, NEW PHYTOL, V172, P185, DOI 10.1111/j.1469-8137.2006.01873.x; WALKER C, 1983, MYCOTAXON, V18, P443; Walker C, 1998, ANN BOT-LONDON, V82, P601, DOI 10.1006/anbo.1998.0714; WALKER C, 1982, CAN J BOT, V60, P2518, DOI 10.1139/b82-305; Walker C., 2004, MYCOL RES, V108, P981, DOI [10.1017/S0953756204231173, DOI 10.1017/S0953756204231173]; Walker C, 2007, MYCOL RES, V111, P253, DOI DOI 10.1017/S0953756204231173; Walker C, 2007, MYCOL RES, V111, P137, DOI 10.1016/j.mycres.2006.11.008; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955; [No title captured]	45	37	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23333	10.1371/journal.pone.0023333	http://dx.doi.org/10.1371/journal.pone.0023333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853113	gold, Green Published, Green Submitted			2022-12-25	WOS:000293953400039
J	Ballandras, A; Moreau, K; Robert, X; Confort, MP; Merceron, R; Haser, R; Ronfort, C; Gouet, P				Ballandras, Allison; Moreau, Karen; Robert, Xavier; Confort, Marie-Pierre; Merceron, Romain; Haser, Richard; Ronfort, Corinne; Gouet, Patrice			A Crystal Structure of the Catalytic Core Domain of an Avian Sarcoma and Leukemia Virus Integrase Suggests an Alternate Dimeric Assembly	PLOS ONE			English	Article							RETROVIRAL DNA INTEGRATION; CARBOXYL-TERMINAL DOMAINS; HIV-1 INTEGRASE; ACTIVE-SITE; REVERSE TRANSCRIPTION; TYPE-1 INTEGRASE; PROTEIN; INHIBITORS; MUTATIONS; BINDING	Integrase (IN) is an important therapeutic target in the search for anti-Human Immunodeficiency Virus (HIV) inhibitors. This enzyme is composed of three domains and is hard to crystallize in its full form. First structural results on IN were obtained on the catalytic core domain (CCD) of the avian Rous and Sarcoma Virus strain Schmidt-Ruppin A (RSV-A) and on the CCD of HIV-1 IN. A ribonuclease-H like motif was revealed as well as a dimeric interface stabilized by two pairs of alpha-helices (alpha 1/alpha 5, alpha 5/alpha 1). These structural features have been validated in other structures of IN CCDs. We have determined the crystal structure of the Rous-associated virus type-1 (RAV-1) IN CCD to 1.8 angstrom resolution. RAV-1 IN shows a standard activity for integration and its CCD differs in sequence from that of RSV-A by a single accessible residue in position 182 (substitution A182T). Surprisingly, the CCD of RAV-1 IN associates itself with an unexpected dimeric interface characterized by three pairs of alpha-helices (alpha 3/alpha 5, alpha 1/alpha 1, alpha 5/alpha 3). A182 is not involved in this novel interface, which results from a rigid body rearrangement of the protein at its alpha 1, alpha 3, alpha 5 surface. A new basic groove that is suitable for single-stranded nucleic acid binding is observed at the surface of the dimer. We have subsequently determined the structure of the mutant A182T of RAV-1 IN CCD and obtained a RSV-A IN CCD-like structure with two pairs of buried alpha-helices at the interface. Our results suggest that the CCD of avian INs can dimerize in more than one state. Such flexibility can further explain the multifunctionality of retroviral INs, which beside integration of dsDNA are implicated in different steps of the retroviral cycle in presence of viral ssRNA.	[Ballandras, Allison; Robert, Xavier; Merceron, Romain; Haser, Richard; Gouet, Patrice] Univ Lyon, Inst Biol & Chim Prot, BMSSI Ctr Natl Rech Sci, UMR 5086, Lyon, France; [Moreau, Karen; Confort, Marie-Pierre; Ronfort, Corinne] Univ Lyon, Lab Retrovirus & Pathol Comparee, Inst Natl Rech Agron, Ecole Natl Vet Lyon,UMR 754, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; VetAgro Sup	Ballandras, A (corresponding author), Univ Lyon, Inst Biol & Chim Prot, BMSSI Ctr Natl Rech Sci, UMR 5086, Lyon, France.	ronfort@univ-lyon1.fr; p.gouet@ibcp.fr	Moreau, Karen L/L-9903-2014; ROBERT, Xavier/C-3879-2015	Moreau, Karen L/0000-0001-6297-3543; ROBERT, Xavier/0000-0002-6174-8595; Ballandras-Colas, Allison/0000-0003-4735-4984; gouet, patrice/0000-0001-9485-6157	Cluster 10 Infectiology of the Rhone-Alpes Region	Cluster 10 Infectiology of the Rhone-Alpes Region(Region Auvergne-Rhone-Alpes)	AB is supported by a Ph. D. grant from the Cluster 10 Infectiology of the Rhone-Alpes Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrake MD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-73; ANDRAKE MD, 1995, J BIOL CHEM, V270, P29299, DOI 10.1074/jbc.270.49.29299; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Coleman J, 1999, J BIOL CHEM, V274, P32842, DOI 10.1074/jbc.274.46.32842; *DELANO WL, 2008, PYMOL MOL GRAPH SYST; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kukolj G, 1997, J VIROL, V71, P843, DOI 10.1128/JVI.71.1.843-847.1997; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Lubkowski J, 1998, P NATL ACAD SCI USA, V95, P4831, DOI 10.1073/pnas.95.9.4831; Lubkowski J, 1998, J BIOL CHEM, V273, P32685, DOI 10.1074/jbc.273.49.32685; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Moreau K, 2004, VIROLOGY, V318, P566, DOI 10.1016/j.virol.2003.09.037; Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x; Moreau K, 2002, ARCH VIROL, V147, P1761, DOI 10.1007/s00705-002-0831-5; Moreau K, 2009, VIROLOGY, V392, P94, DOI 10.1016/j.virol.2009.06.031; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishitsuji H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007825; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Pommier Y, 1999, ADV VIRUS RES, V52, P427, DOI 10.1016/S0065-3527(08)60310-3; Reingewertz TH, 2010, PROTEIN PEPTIDE LETT, V17, P988; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Smith JA, 2006, ACS CHEM BIOL, V1, P217, DOI 10.1021/cb600131q; Smith JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-11; SOLTIS DA, 1988, P NATL ACAD SCI USA, V85, P3372, DOI 10.1073/pnas.85.10.3372; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Werner S, 1999, J BIOL CHEM, V274, P26329, DOI 10.1074/jbc.274.37.26329; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yao X, 2010, PROTEIN CELL, V1, P363, DOI 10.1007/s13238-010-0047-5; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	63	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e23032	10.1371/journal.pone.0023032	http://dx.doi.org/10.1371/journal.pone.0023032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857987	Green Published, Green Submitted, gold			2022-12-25	WOS:000293774300018
J	Gagliardo, A; Ioale, P; Filannino, C; Wikelski, M				Gagliardo, Anna; Ioale, Paolo; Filannino, Caterina; Wikelski, Martin			Homing Pigeons Only Navigate in Air with Intact Environmental Odours: A Test of the Olfactory Activation Hypothesis with GPS Data Loggers	PLOS ONE			English	Article							ORIENTATION; INFORMATION; HOME; ABILITIES; BEHAVIOR; MAP	A large body of evidence has shown that anosmic pigeons are impaired in their navigation. However, the role of odours in navigation is still subject to debate. While according to the olfactory navigation hypothesis homing pigeons possess a navigational map based on the distribution of environmental odours, the olfactory activation hypothesis proposes that odour perception is only needed to activate a navigational mechanism based on cues of another nature. Here we tested experimentally whether the perception of artificial odours is sufficient to allow pigeons to navigate, as expected from the olfactory activation hypothesis. We transported three groups of pigeons in air-tight containers to release sites 53 and 61 km from home in three different olfactory conditions. The Control group received natural environmental air; both the Pure Air and the Artificial Odour groups received pure air filtered through an active charcoal filter. Only the Artificial Odour group received additional puffs of artificial odours until release. We then released pigeons while recording their tracks with 1 Hz GPS data loggers. We also followed non-homing pigeons using an aerial data readout to a Cessna plane, allowing, for the first time, the tracking of non-homing homing pigeons. Within the first hour after release, the pigeons in both the Artificial Odour and the Pure Air group (receiving no environmental odours) showed impaired navigational performances at each release site. Our data provide evidence against an activation role of odours in navigation, and document that pigeons only navigate well when they perceive environmental odours.	[Gagliardo, Anna; Ioale, Paolo; Filannino, Caterina] Univ Pisa, Dept Biol, Pisa, Italy; [Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany	University of Pisa; Max Planck Society	Gagliardo, A (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	agagliardo@biologia.unipi.it			National Science Foundation, Innovation and Organizational Sciences [0744704]; Progetti di Ricerca di Interesse Nazionale [20083ML4XC]; Division Of Integrative Organismal Systems [0744704] Funding Source: National Science Foundation	National Science Foundation, Innovation and Organizational Sciences(National Science Foundation (NSF)); Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation, Innovation and Organizational Sciences, [0744704], http://nsf.gov/, and Progetti di Ricerca di Interesse Nazionale, [20083ML4XC], http://prin.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDACCINI NE, 1975, J COMP PHYSIOL, V99, P177, DOI 10.1007/BF00613834; Baldaccini NE, 1978, ANIMAL MIGRATION NAV, P65; Batschelet E, 1981, CIRCULAR STAT BIOL; BENVENUTI S, 1977, J COMP PHYSIOL, V120, P173, DOI 10.1007/BF00619313; BENVENUTI S, 1973, Monitore Zoologico Italiano, V7, P117; Gagliardo A, 2006, J EXP BIOL, V209, P2888, DOI 10.1242/jeb.02313; Gagliardo A, 2001, P ROY SOC B-BIOL SCI, V268, P197; Gagliardo A, 2008, J EXP BIOL, V211, P2046, DOI 10.1242/jeb.017608; Gagliardo A, 2011, J EXP BIOL, V214, P593, DOI 10.1242/jeb.049510; Gagliardo A, 2009, BEHAV ECOL SOCIOBIOL, V64, P289, DOI 10.1007/s00265-009-0847-x; Gagliardo A, 2009, J EXP BIOL, V212, P3119, DOI 10.1242/jeb.031864; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; IOALE P, 1990, BEHAV ECOL SOCIOBIOL, V26, P301; IOALE P, 1978, J COMP PHYSIOL, V128, P285, DOI 10.1007/BF00657603; Jorge PE, 2010, P R SOC B, V277, P45, DOI 10.1098/rspb.2009.1521; Jorge PE, 2009, CURR BIOL, V19, P650, DOI 10.1016/j.cub.2009.02.066; Odetti F, 2003, ANIM BEHAV, V66, P1093, DOI 10.1006/anbe.2003.2293; PAPI F, 1972, Monitore Zoologico Italiano, V6, P85; PAPI F, 1974, J COMP PHYSIOL, V94, P187, DOI 10.1007/BF00611866; PAPI F, 1971, Monitore Zoologico Italiano, V5, P265; Schmidt-Koenig K, 1978, ANIMAL MIGRATION NAV, P119; WALDVOGEL JA, 1978, J COMP PHYSIOL, V128, P297, DOI 10.1007/BF00657604; WALLRAFF HG, 1966, Z VERGL PHYSIOL, V52, P215, DOI 10.1007/BF02427711; WALLRAFF HG, 1988, COMP BIOCHEM PHYS A, V89, P621, DOI 10.1016/0300-9629(88)90844-4; WALLRAFF HG, 1970, Z VERGL PHYSIOL, V68, P182, DOI 10.1007/BF00297694; WALLRAFF HG, 1992, EXPERIENTIA, V48, P1153, DOI 10.1007/BF01948013; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wikelski M, 2010, MOVEBANK ARCH ANAL S; Wiltschko R, 1996, J EXP BIOL, V199, P113	29	43	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22385	10.1371/journal.pone.0022385	http://dx.doi.org/10.1371/journal.pone.0022385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857925	gold, Green Published, Green Submitted			2022-12-25	WOS:000293558900017
J	Wang, SY; Sudduth, EB; Wallenstein, MD; Wright, JP; Bernhardt, ES				Wang, Si-Yi; Sudduth, Elizabeth B.; Wallenstein, Matthew D.; Wright, Justin P.; Bernhardt, Emily S.			Watershed Urbanization Alters the Composition and Function of Stream Bacterial Communities	PLOS ONE			English	Article							GLOBAL NITROGEN-CYCLE; DENITRIFYING COMMUNITIES; MICROBIAL COMMUNITIES; CURRENT KNOWLEDGE; DENITRIFICATION; ECOLOGY; URBAN; SOIL; ENRICHMENT; DIVERSITY	Watershed urbanization leads to dramatic changes in draining streams, with urban streams receiving a high frequency of scouring flows, together with the nutrient, contaminant, and thermal pollution associated with urbanization. These changes are known to cause significant losses of sensitive insect and fish species from urban streams, yet little is known about how these changes affect the composition and function of stream microbial communities. Over the course of two years, we repeatedly sampled sediments from eight central North Carolina streams affected to varying degrees by watershed urbanization. For each stream and sampling date, we characterized both overall and denitrifying bacterial communities and measured denitrification potentials. Denitrification is an ecologically important process, mediated by denitrifying bacteria that use nitrate and organic carbon as substrates. Differences in overall and denitrifying bacterial community composition were strongly associated with the gradient in urbanization. Denitrification potentials, which varied widely, were not significantly associated with substrate supply. By incorporating information on the community composition of denitrifying bacteria together with substrate supply in a linear mixed-effects model, we explained 45% of the variation in denitrification potential (p-value<0.001). Our results suggest that (1) the composition of stream bacterial communities change in response to watershed urbanization and (2) such changes may have important consequences for critical ecosystem functions such as denitrification.	[Wang, Si-Yi; Sudduth, Elizabeth B.; Wright, Justin P.; Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Wallenstein, Matthew D.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Duke University; Colorado State University	Wang, SY (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	sw56@duke.edu	Bernhardt, Emily/B-4541-2010; Wallenstein, Matthew D/S-3512-2016; Wright, Justin/AAG-6461-2019; Wallenstein, Matthew/C-6441-2008; Bernhardt, Emily S/D-9940-2011	Wallenstein, Matthew D/0000-0002-6219-1442; Wright, Justin/0000-0002-9102-5347; Wallenstein, Matthew/0000-0002-6219-1442; Bernhardt, Emily S/0000-0003-3031-621X; Sudduth, Elizabeth/0000-0001-8274-8159; Sun, Dianjianyi/0000-0003-3651-6693; Lv, Jun/0000-0001-7916-3870; Liu, Miao/0000-0002-7975-6702	National Science Foundation [DEB 0546251]; NC Water Resources Institute; Sigma Xi; Wellesley College; Division Of Environmental Biology [1011376] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NC Water Resources Institute; Sigma Xi; Wellesley College; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from the National Science Foundation (DEB 0546251) (www.nsf.gov) and NC Water Resources Institute (water.usgs.gov/wrri/) to ESB and from Sigma Xi (www.sigmaxi.org) and Wellesley College (web.wellesley.edu) to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beaulieu JJ, 2011, P NATL ACAD SCI USA, V108, P214, DOI 10.1073/pnas.1011464108; Bernhardt ES, 2008, ANN NY ACAD SCI, V1134, P61, DOI 10.1196/annals.1439.014; Bernot MJ, 2003, APPL ENVIRON MICROB, V69, P5950, DOI 10.1128/AEM.69.10.5950-5956.2003; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Crawley MJ., 2007, R BOOK; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goslee SC, 2007, J STAT SOFTWARE, V22; Gotelli NJ, 2013, ECOSIMR 1 00; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017434; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lear G, 2009, ECOL INDIC, V9, P848, DOI 10.1016/j.ecolind.2008.10.001; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LORING DH, 1991, ICES J MAR SCI, V48, P101, DOI 10.1093/icesjms/48.1.101; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meyer JL, 2005, J N AM BENTHOL SOC, V24, P602, DOI 10.1899/04-021.1; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Perryman SE, 2008, AQUAT ECOL, V42, P95, DOI 10.1007/s10452-007-9085-3; Pinheiro J., 2011, NLME LINEAR NONLINEA; Roltsch WJ, 1999, INT J BIOMETEOROL, V42, P169, DOI 10.1007/s004840050101; Rosenberg D.M.., 1993, FRESHWATER BIOMONITO; Roy AH, 2009, J N AM BENTHOL SOC, V28, P908, DOI 10.1899/08-185.1; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Throback IN, 2007, FEMS MICROBIOL LETT, V270, P189, DOI 10.1111/j.1574-6968.2007.00632.x; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Urban D, 2002, ECOSCIENCE, V9, P200, DOI 10.1080/11956860.2002.11682706; USEPA-UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, 1996, AC DIG SED SLUDG SOI; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waldrop MP, 2006, MICROB ECOL, V52, P716, DOI 10.1007/s00248-006-9103-3; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI [10.1899/04-020.1, 10.1899/04-028.1]; Wang SG, 2010, PEDOBIOLOGIA, V54, P9, DOI 10.1016/j.pedobi.2010.08.002; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; Zak DR, 2006, TRENDS ECOL EVOL, V21, P288, DOI 10.1016/j.tree.2006.04.003; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	55	71	73	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22972	10.1371/journal.pone.0022972	http://dx.doi.org/10.1371/journal.pone.0022972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857975	gold, Green Submitted, Green Published			2022-12-25	WOS:000293953500011
